Number	NN	ROOT	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
and	CC	cc	O
their	PRP$	nmod:poss	O
sensitivity	NN	conj	O
to	TO	case	O
hormone	NN	compound	O
action	NN	nmod	O
.	.	punct	O

The	DT	det	O
study	NN	nsubj	O
demonstrated	VBD	ROOT	O
a	DT	det	O
decreased	VBN	amod	O
level	NN	dobj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
from	IN	case	O
hypercholesterolemic	JJ	amod	O
subjects	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
an	DT	det	O
elevated	JJ	amod	O
level	NN	conj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
myocardial	JJ	amod	O
infarction	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
lymphocytes	NNS	nmod	B-cell_type
with	IN	case	O
a	DT	det	O
high	JJ	amod	O
GR	NN	compound	B-protein
number	NN	nmod	O
,	,	punct	O
dexamethasone	NN	nsubj	O
inhibited	VBD	ROOT	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
-thymidine	NN	dobj	O
and	CC	cc	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
-acetate	JJ	amod	O
incorporation	NN	conj	O
into	IN	case	O
DNA	NN	nmod	O
and	CC	cc	O
cholesterol	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
manner	NN	nmod	O
as	IN	case	O
in	IN	case	O
the	DT	det	O
control	NN	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
a	DT	det	O
decreased	VBN	amod	O
GR	NN	compound	B-protein
number	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
less	RBR	advmod	O
efficient	JJ	amod	O
dexamethasone	NN	compound	O
inhibition	NN	nmod	O
of	IN	case	O
the	DT	det	O
incorporation	NN	nmod	O
of	IN	case	O
labeled	VBN	amod	O
compounds	NNS	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
sensitivity	NN	nsubj	O
of	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
to	TO	case	O
glucocorticoids	NNS	nmod	O
changed	VBD	ccomp	O
only	RB	advmod	O
with	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
of	IN	case	O
GR	NN	compound	B-protein
level	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
1	CD	nummod	B-protein
,	,	punct	I-protein
25-Dihydroxyvitamin	CD	nummod	I-protein
D3	NN	compound	I-protein
receptors	NNS	ROOT	I-protein
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
and	CC	cc	O
T-	NN	compound	B-cell_type
and	CC	cc	I-cell_type
B-lymphocyte	NN	conj	I-cell_type
count	NN	conj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
glomerulonephritis	NN	nmod	O
]	-RRB-	punct	O

Content	NN	nsubj	O
of	IN	case	O
receptors	NNS	nmod	O
to	TO	case	O
hormonal	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
vitamin	NN	compound	O
D3	NN	nmod	O
,	,	punct	O
1.25	CD	compound	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	appos	O
,	,	punct	O
constituted	VBD	ROOT	O
27.3	CD	nummod	O
fmole/mg	NN	dobj	O
of	IN	case	O
protein	NN	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
of	IN	case	O
peripheric	JJ	amod	O
blood	NN	nmod	O
of	IN	case	O
children	NNS	nmod	O
with	IN	case	O
glomerulonephritis	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
patients	NNS	compound	O
concentration	NN	nmod	O
of	IN	case	O
total	JJ	amod	O
and	CC	cc	O
ionized	JJ	conj	O
form	NN	nmod	O
of	IN	case	O
Ca2+	NN	nmod	O
was	VBD	auxpass	O
decreased	VBN	ROOT	O
down	RB	case	O
to	TO	case	O
2.04	CD	nummod	O
mmole/L	NN	nmod	O
and	CC	cc	O
1.09	CD	nummod	O
mmole/L	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
while	IN	mark	O
an	DT	det	O
increase	NN	nsubjpass	O
in	IN	case	O
parathormone	NN	nmod	O
(	-LRB-	punct	O
PTH	NN	appos	O
)	-RRB-	punct	O
by	IN	case	O
36	CD	nummod	O
%	NN	nmod	O
and	CC	cc	O
a	DT	det	O
distinct	JJ	amod	O
decrease	NN	conj	O
in	IN	case	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
D	NN	compound	O
concentration	NN	nmod	O
(	-LRB-	punct	O
lower	JJR	dep	O
than	IN	case	O
1.25	CD	nummod	O
ng/ml	NN	nmod	O
)	-RRB-	punct	O
was	VBD	auxpass	O
found	VBN	advcl	O
in	IN	case	O
blood	NN	nmod	O
;	:	punct	O
content	NN	nsubjpass	O
of	IN	case	O
cAMP	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
decreased	VBN	parataxis	O
in	IN	case	O
lymphocytes	NNS	nmod	O
by	IN	case	O
33	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

At	IN	prep	O
the	DT	det	O
same	JJ	amod	O
time	NN	pobj	O
,	,	punct	O
total	JJ	amod	O
content	NN	nsubjpass	O
of	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
was	VBD	auxpass	O
decreased	VBN	ROOT	O
1.5-fold	RB	dobj	O
in	IN	case	O
peripheric	JJ	amod	O
blood	NN	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
I-hydroxyvitamin	NN	compound	O
D3	NN	nmod	O
(	-LRB-	punct	O
1-1.5	CD	compound	O
mg	NN	appos	O
daily	RB	advmod	O
,	,	punct	O
within	IN	case	O
4	CD	nummod	O
weeks	NNS	nmod	O
)	-RRB-	punct	O
led	VBD	ROOT	O
to	TO	case	O
normalization	NN	nmod	O
of	IN	case	O
total	JJ	nmod	O
and	CC	cc	O
ionized	JJ	conj	O
form	NN	dep	O
of	IN	case	O
Ca2+	NN	nmod	O
and	CC	cc	O
of	IN	case	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
D	NN	conj	O
,	,	punct	O
but	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	conj	O
the	DT	det	O
PTH	NN	compound	O
content	NN	dobj	O
in	IN	case	O
blood	NN	nmod	O
.	.	punct	O

Concentration	NN	nsubj	O
of	IN	case	O
the	DT	det	O
receptors	NNS	nmod	B-protein
to	IN	case	O
1.25	CD	compound	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	nmod	O
was	VBD	auxpass	O
elevated	JJ	ROOT	O
up	IN	advmod	O
to	TO	case	O
39.7	CD	nummod	O
fmole/mg	NN	nmod	O
after	IN	case	O
I	PRP	compound	O
week	NN	nmod	O
of	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
decreased	VBN	parataxis	O
to	TO	case	O
the	DT	det	O
initial	JJ	amod	O
level	NN	nmod	O
24.8	CD	nummod	O
fmole/mg	NN	dep	O
within	IN	case	O
4	CD	nummod	O
weeks	NNS	nmod	O
;	:	punct	O
simultaneous	JJ	amod	O
alteration	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
cAMP	NN	compound	O
content	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	parataxis	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
1-	CD	compound	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
D3	NN	nmod	O
normalized	VBD	ROOT	O
also	RB	advmod	O
the	DT	det	O
T	NN	compound	B-cell_type
lymphocytes	NNS	compound	I-cell_type
content	NN	dobj	O
in	IN	case	O
peripheric	JJ	amod	O
blood	NN	nmod	O
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
obtained	VBN	acl	O
suggest	VBP	ROOT	O
that	IN	mark	O
under	IN	case	O
conditions	NNS	nmod	O
of	IN	case	O
glomerulonephritis	NN	nmod	O
only	RB	advmod	O
high	JJ	amod	O
content	NN	nsubj	O
of	IN	case	O
receptors	NNS	nmod	B-protein
to	TO	case	O
1.25	CD	compound	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
enabled	VBN	ccomp	O
to	TO	mark	O
perform	VB	xcomp	O
the	DT	det	O
cell	NN	compound	O
response	NN	dobj	O
to	TO	case	O
the	DT	det	O
hormone	NN	compound	O
effect	NN	nmod	O
.	.	punct	O

Tumor	NN	compound	O
and	CC	cc	O
serum	NN	conj	O
beta-2-microglobulin	JJ	compound	O
expression	NN	ROOT	O
in	IN	case	O
women	NNS	nmod	O
with	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
whether	IN	mark	O
the	DT	det	O
tumor	NN	compound	B-cell_type
expression	NN	nsubj	O
of	IN	case	O
beta-2-microglobulin	NN	nmod	B-protein
(	-LRB-	punct	O
beta	NN	appos	B-protein
2-M	NN	nummod	I-protein
)	-RRB-	punct	O
could	MD	aux	O
serve	VB	ccomp	O
as	IN	case	O
a	DT	det	O
marker	NN	nmod	O
of	IN	case	O
tumor	NN	compound	O
biologic	JJ	amod	O
behavior	NN	nmod	O
,	,	punct	O
the	DT	det	O
authors	NNS	nsubj	O
studied	VBD	ROOT	O
specimens	NNS	dobj	O
of	IN	case	O
breast	NN	compound	B-cell_type
carcinomas	NNS	nmod	I-cell_type
from	IN	case	O
60	CD	nummod	O
consecutive	JJ	amod	O
female	JJ	amod	O
patients	NNS	nmod	O
.	.	punct	O

Presence	NN	nsubjpass	O
of	IN	case	O
beta	NN	nmod	B-protein
2-M	NN	nummod	I-protein
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
correlations	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
tumor	NN	compound	B-protein
beta	NN	compound	I-protein
2-M	NN	compound	I-protein
expression	NN	nmod	O
and	CC	cc	O
several	JJ	amod	O
histologic	JJ	amod	O
attributes	NNS	conj	O
such	JJ	case	O
as	IN	mwe	O
type	NN	nmod	O
,	,	punct	O
histologic	JJ	amod	O
and	CC	cc	O
nuclear	JJ	conj	O
grades	NNS	conj	O
,	,	punct	O
mitotic	JJ	amod	O
index	NN	conj	O
,	,	punct	O
necrosis	NN	conj	O
,	,	punct	O
vascular	JJ	amod	O
invasion	NN	conj	O
,	,	punct	O
and	CC	cc	O
lymphocytic	JJ	amod	O
infiltration	NN	conj	O
.	.	punct	O

Likewise	RB	advmod	O
,	,	punct	O
beta	NN	nsubjpass	B-protein
2-M	NN	nummod	I-protein
was	VBD	auxpass	O
not	RB	neg	O
associated	VBN	ROOT	O
with	IN	case	O
markers	NNS	nmod	O
of	IN	case	O
disease	NN	compound	O
extension	NN	nmod	O
such	JJ	case	O
as	IN	mwe	O
TNM	NN	nmod	O
,	,	punct	O
(	-LRB-	punct	O
UICC	NN	appos	O
,	,	punct	O
classification	NN	appos	O
of	IN	case	O
malignant	JJ	amod	B-cell_type
tumors	NNS	nmod	I-cell_type
)	-RRB-	punct	O
staging	NN	dep	O
and	CC	cc	O
axillary	JJ	amod	O
lymph	NN	compound	O
node	NN	compound	O
involvement	NN	conj	O
or	CC	cc	O
with	IN	case	O
estrogen	NN	conj	O
,	,	punct	O
progesterone	NN	conj	O
,	,	punct	O
and	CC	cc	O
glucocorticoid	NN	compound	O
receptor	NN	compound	O
levels	NNS	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significantly	RB	advmod	O
positive	JJ	amod	O
association	NN	nsubj	O
between	IN	case	O
tumor	NN	compound	B-protein
beta	NN	compound	I-protein
2-M	NN	compound	I-protein
expression	NN	nmod	O
and	CC	cc	O
the	DT	det	O
degree	NN	conj	O
of	IN	case	O
lymphocytic	JJ	amod	O
infiltration	NN	nmod	O
in	IN	case	O
the	DT	det	O
tumor	NN	compound	O
tissue	NN	nmod	O
.	.	punct	O

Beta	NN	compound	B-protein
2-M	NN	nummod	I-protein
serum	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
an	DT	det	O
enzyme-linked	JJ	amod	O
immunosorbent	JJ	amod	O
assay	NN	nmod	O
in	IN	case	O
samples	NNS	nmod	O
from	IN	case	O
22	CD	nmod	O
of	IN	case	O
the	DT	det	O
above	JJ	amod	O
women	NNS	nmod	O
.	.	punct	O

Although	IN	mark	O
some	DT	nsubjpass	O
of	IN	prep	O
the	DT	det	O
highest	JJS	amod	O
values	NNS	pobj	O
had	VBD	aux	O
been	VBN	auxpass	O
obtained	VBN	advcl	O
in	IN	case	O
women	NNS	nmod	O
with	IN	case	O
larger	JJR	amod	O
(	-LRB-	punct	O
T4	NN	appos	O
)	-RRB-	punct	O
primary	JJ	amod	O
tumors	NNS	nmod	O
,	,	punct	O
the	DT	det	O
authors	NNS	nsubj	O
failed	VBD	ROOT	O
to	TO	mark	O
detect	VB	xcomp	O
any	DT	det	O
statistical	JJ	amod	O
relationship	NN	dobj	O
between	IN	case	O
beta	NN	compound	B-protein
2-M	NN	compound	I-protein
expression	NN	nmod	O
in	IN	case	O
the	DT	det	O
tumor	NN	nmod	O
with	IN	case	O
serum	NN	compound	O
levels	NNS	nmod	O
or	CC	cc	O
between	IN	case	O
serum	NN	compound	B-protein
beta	NN	conj	I-protein
2-M	NN	dep	I-protein
and	CC	cc	O
the	DT	det	O
above	JJ	amod	O
histologic	JJ	amod	O
,	,	punct	O
laboratory	NN	conj	O
,	,	punct	O
and	CC	cc	O
clinical	JJ	conj	O
factors	NNS	conj	O
.	.	punct	O

[	-LRB-	punct	O
Preliminary	JJ	amod	O
observation	NN	ROOT	O
of	IN	case	O
level	NN	compound	O
free-form	NN	amod	B-protein
E	NN	compound	I-protein
receptor	NN	compound	I-protein
levels	NNS	nmod	O
in	IN	case	O
serum	NN	nmod	O
of	IN	case	O
normal	JJ	amod	O
childbearing-aged	JJ	amod	O
and	CC	cc	O
pregnant	JJ	conj	O
women	NNS	nmod	O
]	-RRB-	punct	O

In	IN	case	O
137	CD	nummod	O
cases	NNS	nmod	O
of	IN	case	O
childbearing-aged	JJ	amod	O
and	CC	cc	O
pregnant	JJ	conj	O
women	NNS	nmod	O
,	,	punct	O
free	JJ	amod	B-protein
form	NN	compound	I-protein
E	NN	compound	I-protein
receptor	NN	compound	I-protein
levels	NNS	nsubjpass	O
(	-LRB-	punct	O
sE	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
serum	NN	nmod	O
were	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
ELISA	NN	nmod	O
.	.	punct	O

The	DT	det	O
level	NN	nsubjpass	O
of	IN	case	O
sE	NN	nmod	B-protein
was	VBD	auxpass	O
significantly	RB	advmod	O
decreased	VBN	ROOT	O
during	IN	case	O
the	DT	det	O
first	JJ	amod	O
trimester	NN	nmod	O
,	,	punct	O
slightly	RB	advmod	O
higher	JJR	advcl	O
in	IN	case	O
the	DT	det	O
second	JJ	amod	O
trimester	NN	nmod	O
,	,	punct	O
and	CC	cc	O
recovered	VBN	conj	O
to	TO	case	O
normal	JJ	nmod	O
in	IN	case	O
the	DT	det	O
third	JJ	amod	O
trimester	NN	nmod	O
.	.	punct	O

The	DT	det	O
level	NN	nsubj	O
remained	VBD	ROOT	O
lower	JJR	xcomp	O
in	IN	case	O
29	CD	nummod	O
PIH	NN	compound	O
women	NNS	nmod	O
but	CC	cc	O
appeared	VBD	conj	O
higher	JJR	dobj	O
in	IN	case	O
overdue	JJ	amod	O
pregnancies	NNS	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
the	DT	det	O
normal	JJ	amod	O
3rd	JJ	amod	O
trimester	NN	compound	O
range	NN	nmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
there	EX	expl	O
is	VBZ	ccomp	O
a	DT	det	O
relationship	NN	nsubj	O
between	IN	case	O
a	DT	det	O
change	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
function	NN	nmod	O
and	CC	cc	O
pregnancy	NN	conj	O
.	.	punct	O

Kappa	NN	compound	B-protein
B-specific	JJ	amod	I-protein
DNA	NN	compound	I-protein
binding	NN	compound	I-protein
proteins	NNS	ROOT	I-protein
:	:	punct	O
role	NN	dep	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-DNA
interleukin-2	NN	compound	I-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
.	.	punct	O

Transcriptional	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
interleukin-2	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
IL-2	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
like	IN	case	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
IL-2R	NN	compound	I-DNA
alpha	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
the	DT	det	O
type	NN	compound	O
1	CD	nummod	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	conj	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
modulated	VBN	xcomp	O
by	IN	case	O
a	DT	det	O
kappa	NN	compound	B-protein
B-like	JJ	amod	I-protein
enhancer	NN	compound	I-protein
element	NN	nmod	I-protein
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
a	DT	det	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
core	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
identified	VBN	acl	O
in	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
(	-LRB-	punct	O
-206	CD	nummod	O
to	TO	dep	O
-195	CD	appos	O
)	-RRB-	punct	O
partially	RB	advmod	O
inhibits	VBZ	ROOT	O
both	CC	cc:preconj	O
mitogen-	NN	dobj	O
and	CC	cc	O
HTLV-I	NN	conj	O
Tax-mediated	JJ	amod	O
activation	NN	dep	O
of	IN	case	O
this	DT	det	O
transcription	NN	compound	B-protein
unit	NN	nmod	I-protein
and	CC	cc	O
blocks	VBZ	conj	O
the	DT	det	O
specific	JJ	amod	O
binding	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
inducible	JJ	amod	B-protein
cellular	JJ	amod	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

These	DT	det	O
kappa	NN	compound	B-protein
B-specific	JJ	amod	I-protein
proteins	NNS	nsubj	I-protein
(	-LRB-	punct	O
80	CD	compound	O
to	TO	dep	O
90	CD	dep	O
and	CC	cc	O
50	CD	compound	O
to	TO	dep	O
55	CD	nummod	O
kilodaltons	NNS	conj	O
)	-RRB-	punct	O
similarly	RB	advmod	O
interact	VBP	ROOT	O
with	IN	case	O
the	DT	det	O
functional	JJ	amod	O
kappa	NN	compound	B-protein
B	NN	compound	I-protein
enhancer	NN	nmod	I-protein
present	JJ	amod	O
in	IN	case	O
the	DT	det	O
IL-2R	NN	compound	B-DNA
alpha	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
these	DT	det	O
kappa	NN	compound	B-protein
B-specific	JJ	amod	I-protein
proteins	NNS	nsubj	I-protein
have	VBP	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
coordinate	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
this	DT	det	O
growth	NN	compound	O
factor-growth	JJ	compound	O
factor	NN	compound	O
receptor	NN	compound	O
gene	NN	compound	O
system	NN	nmod	O
that	WDT	nsubj	O
controls	VBZ	acl:relcl	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
proliferation	NN	dobj	O
.	.	punct	O

Novel	JJ	amod	O
region	NN	nsubj	O
within	IN	case	O
the	DT	det	O
V	NN	compound	B-DNA
kappa	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
is	VBZ	cop	O
responsible	JJ	ROOT	O
for	IN	case	O
tissue	NN	nmod	O
and	CC	cc	O
stage-specific	JJ	conj	O
expression	NN	dep	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
human	JJ	amod	B-cell_type
lymphoid	JJ	amod	I-cell_type
neoplasms	NNS	nmod	I-cell_type
.	.	punct	O

Immunoglobulin	NN	compound	B-protein
gene-specific	JJ	amod	I-protein
transacting	VBG	compound	I-protein
factors	NNS	nsubjpass	I-protein
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
lymphoid	JJ	amod	O
tissue-specific	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
factors	NNS	nmod	O
in	IN	case	O
B-cell	NN	compound	B-cell_type
differentiation	NN	nmod	O
and	CC	cc	O
stage-specific	JJ	amod	O
expression	NN	conj	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
is	VBZ	auxpass	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
not	RB	neg	O
fully	RB	advmod	O
understood	VBN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
a	DT	det	O
model	NN	dobj	O
of	IN	case	O
human	JJ	amod	O
lymphoid	JJ	amod	O
neoplasia	NN	nmod	O
to	TO	mark	O
address	VB	xcomp	O
this	DT	det	O
question	NN	dobj	O
.	.	punct	O

Different	JJ	amod	O
fragments	NNS	nsubjpass	O
of	IN	case	O
unrearranged	JJ	amod	B-DNA
human	JJ	amod	I-DNA
variable	JJ	amod	I-DNA
region	NN	nmod	I-DNA
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
kappa	NN	compound	I-DNA
gene	NN	nmod	I-DNA
(	-LRB-	punct	O
V	NN	compound	B-DNA
kappa	NN	appos	I-DNA
)	-RRB-	punct	O
were	VBD	auxpass	O
used	VBN	ROOT	O
for	IN	case	O
cell-free	JJ	amod	O
in	FW	amod	O
vitro	FW	dep	O
transcription	NN	nmod	O
and	CC	cc	O
DNA	NN	compound	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	conj	O
.	.	punct	O

Previously	RB	advmod	O
described	VBN	advcl	O
enhancement	NN	nsubjpass	O
of	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
transcription	NN	nmod	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
only	RB	advmod	O
seen	VBN	acl:relcl	O
with	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
derived	VBN	acl	O
from	IN	case	O
B-cell	NN	compound	B-cell_type
neoplasms	NNS	nmod	I-cell_type
corresponding	VBG	acl	O
to	TO	case	O
the	DT	det	O
late	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
B-cell	NN	compound	B-cell_type
differentiation	NN	nmod	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
dependent	JJ	xcomp	O
on	IN	case	O
the	DT	det	O
actions	NNS	nmod	O
of	IN	case	O
these	DT	det	O
factor	NN	compound	O
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
on	IN	case	O
the	DT	det	O
DNA	NN	compound	O
region	NN	nmod	O
within	IN	case	O
the	DT	det	O
V	NN	compound	B-DNA
kappa	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

This	DT	det	O
region	NN	nsubj	O
is	VBZ	cop	O
located	JJ	ROOT	O
within	IN	case	O
the	DT	det	O
920	CD	nummod	O
bp	NN	compound	O
fragment	NN	nmod	O
located	JJ	amod	O
210	CD	nummod	O
bp	NN	nmod:npmod	O
upstream	JJ	advmod	O
from	IN	case	O
the	DT	det	O
coding	VBG	amod	O
region	NN	nmod	O
and	CC	cc	O
this	DT	det	O
fragment	NN	nsubj	O
represents	VBZ	conj	O
a	DT	det	O
possible	JJ	amod	O
novel	JJ	amod	O
DNA	NN	compound	O
region	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
plays	VBZ	acl:relcl	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
stage-	NN	amod	O
and	CC	cc	O
tissue-specific	JJ	conj	O
expression	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

[	-LRB-	punct	O
Determination	NN	ROOT	O
of	IN	case	O
the	DT	det	O
sensitivity	NN	nmod	O
to	TO	case	O
glucocorticoids	NNS	nmod	B-protein
in	FW	compound	O
vitro	FW	advmod	O
]	-RRB-	punct	O

A	DT	det	O
modified	JJ	amod	O
method	NN	nsubjpass	O
for	IN	case	O
the	DT	det	O
determination	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
suggested	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
principal	JJ	amod	O
distinction	NN	nsubj	O
of	IN	case	O
the	DT	det	O
method	NN	nmod	O
is	VBZ	cop	O
standardization	NN	ROOT	O
by	IN	case	O
the	DT	det	O
lymphocyte	NN	compound	B-cell_type
count	NN	nmod	O
in	IN	case	O
a	DT	det	O
sample	NN	nmod	O
(	-LRB-	punct	O
1	CD	nummod	O
mln	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
labeled	VBN	amod	O
hormone	NN	compound	B-protein
concentration	NN	conj	O
.	.	punct	O

The	DT	det	O
modification	NN	nsubj	O
saves	VBZ	ROOT	O
time	NN	dobj	O
and	CC	cc	O
money	NN	conj	O
,	,	punct	O
limits	VBZ	conj	O
the	DT	det	O
range	NN	dobj	O
of	IN	prep	O
the	DT	det	O
data	NNS	compound	O
variations	NNS	pobj	O
,	,	punct	O
and	CC	cc	O
makes	VBZ	conj	O
use	NN	dobj	O
of	IN	prep	O
a	DT	det	O
lesser	JJR	amod	O
volume	NN	pobj	O
of	IN	prep	O
blood	NN	pobj	O
.	.	punct	O

Examinations	NNS	nsubj	O
of	IN	case	O
70	CD	nummod	O
children	NNS	nmod	O
aged	JJ	amod	O
4	CD	compound	O
to	TO	dep	O
15	CD	nummod	O
suffering	NN	nmod	O
from	IN	case	O
the	DT	det	O
nephrotic	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
glomerulonephritis	NN	nmod	O
have	VBP	aux	O
made	VBN	ROOT	O
it	PRP	nsubj	O
possible	JJ	ccomp	O
to	TO	aux	O
distinguish	VB	xcomp	O
two	CD	nummod	O
groups	NNS	dobj	O
of	IN	case	O
patients	NNS	nmod	O
:	:	punct	O
with	IN	case	O
relatively	RB	advmod	O
high	JJ	amod	O
values	NNS	nsubj	O
of	IN	case	O
specific	JJ	amod	O
binding	NN	compound	O
X	NN	nmod	O
=	JJ	parataxis	O
6820.1	CD	dobj	O
+/-	CC	cc	O
530.0	CD	conj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
30	CD	dobj	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0.95	CD	dobj	O
,	,	punct	O
t	NN	dep	O
=	JJ	amod	O
2.04	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
this	DT	nsubj	O
corresponding	VBG	acl	O
to	TO	case	O
a	DT	det	O
clinical	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
hormone	NN	compound	B-protein
-sensitive	JJ	amod	O
glomerulonephritis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
with	IN	case	O
relatively	RB	advmod	O
low	JJ	amod	O
values	NNS	nmod	O
of	IN	case	O
specific	JJ	amod	O
binding	NN	compound	O
X	NN	nmod	O
=	JJ	amod	O
1815.2	CD	dobj	O
+/-	CC	cc	O
302.8	CD	conj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
40	CD	dobj	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0.95	CD	dobj	O
,	,	punct	O
t	NN	dep	O
=	JJ	amod	O
1.96	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
that	WDT	nsubj	O
corresponds	VBZ	ccomp	O
to	TO	case	O
hormone	NN	compound	B-protein
-resistant	JJ	amod	O
glomerulonephritis	NN	nmod	O
.	.	punct	O

Dynamic	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
not	RB	neg	O
shown	VBN	ROOT	O
any	DT	det	O
statistically	RB	advmod	O
significant	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
the	DT	det	O
specific	JJ	amod	O
binding	NN	compound	O
values	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
permit	VBP	ROOT	O
regarding	VBG	case	O
the	DT	det	O
specific	JJ	amod	O
binding	NN	compound	O
value	NN	nmod	O
as	IN	case	O
a	DT	det	O
prognostic	JJ	amod	O
criterion	NN	nmod	O
in	IN	case	O
the	DT	det	O
assessment	NN	nmod	O
of	IN	case	O
corticosteroid	NN	compound	B-protein
therapy	NN	nmod	O
;	:	punct	O
this	DT	nsubj	O
allows	VBZ	parataxis	O
a	DT	det	O
wide	JJ	amod	O
employment	NN	dobj	O
of	IN	case	O
the	DT	det	O
described	VBN	amod	O
method	NN	nmod	O
in	IN	case	O
practical	JJ	amod	O
nephrology	NN	nmod	O
.	.	punct	O

Octamer-binding	JJ	amod	B-protein
proteins	NNS	nsubj	I-protein
from	IN	case	O
B	NN	nmod	B-cell_line
or	CC	cc	I-cell_line
HeLa	NN	conj	I-cell_line
cells	NNS	dep	I-cell_line
stimulate	VBP	ROOT	O
transcription	NN	dobj	O
of	IN	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
heavy-chain	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

The	DT	det	O
B-cell	NN	compound	B-cell_type
-type	JJ	amod	O
specificity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-protein
(	-LRB-	punct	O
Ig	NN	appos	B-protein
)	-RRB-	punct	O
heavy-chain	JJ	amod	O
and	CC	cc	O
light-chain	JJ	conj	O
promoters	NNS	nmod	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
an	DT	det	O
octanucleotide	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
OCTA	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
element	NN	nmod	I-DNA
,	,	punct	O
ATGCAAAT	NN	appos	O
,	,	punct	O
that	WDT	nsubj	O
is	VBZ	cop	O
also	RB	advmod	O
a	DT	det	O
functional	JJ	amod	O
component	NN	acl:relcl	O
of	IN	case	O
other	JJ	amod	O
RNA	NN	compound	B-DNA
polymerase	NN	compound	I-DNA
II	CD	nummod	I-DNA
promoters	NNS	nmod	I-DNA
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
snRNA	NN	nmod	O
and	CC	cc	O
histone	NN	compound	O
H2B	NN	compound	O
promoters	NNS	conj	O
.	.	punct	O

Two	CD	nummod	O
nuclear	JJ	amod	B-protein
proteins	NNS	nsubjpass	I-protein
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
specifically	RB	advmod	O
and	CC	advmod	O
with	IN	case	O
high	JJ	amod	O
affinity	NN	conj	O
to	TO	case	O
the	DT	det	O
OCTA	NN	compound	B-DNA
element	NN	nmod	I-DNA
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
.	.	punct	O

NF-A1	NN	nsubj	B-protein
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
types	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
presence	NN	nsubjpass	O
of	IN	case	O
NF-A2	NN	nmod	B-protein
is	VBZ	auxpass	O
essentially	RB	advmod	O
confined	VBN	parataxis	O
to	TO	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
leading	VBG	xcomp	O
to	TO	case	O
the	DT	det	O
hypothesis	NN	nmod	O
that	IN	mark	O
NF-A2	NN	nsubj	B-protein
activates	VBZ	ccomp	O
cell-type-specific	JJ	amod	O
transcription	NN	dobj	O
of	IN	case	O
the	DT	det	O
Ig	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
and	CC	cc	O
NF-A1	NN	conj	B-protein
mediates	VBZ	conj	O
the	DT	det	O
other	JJ	amod	O
responses	NNS	dobj	O
of	IN	case	O
the	DT	det	O
OCTA	NN	compound	B-DNA
element	NN	nmod	I-DNA
.	.	punct	O

Extracts	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
B-cell	NN	compound	B-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
BJA-B	NN	appos	B-cell_line
,	,	punct	O
contain	VBP	ROOT	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
NF-A2	NN	nmod	B-protein
and	CC	cc	O
specifically	RB	advmod	O
transcribe	VBP	amod	O
Ig	NN	compound	B-DNA
promoters	NNS	dobj	I-DNA
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
extracts	NNS	nsubj	O
from	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
transcribed	VBD	ROOT	O
the	DT	det	O
Ig	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
poorly	RB	advmod	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
addition	NN	nsubj	O
of	IN	case	O
either	CC	cc:preconj	O
affinity-enriched	JJ	amod	O
NF-A2	NN	nmod	O
or	CC	cc	O
NF-A1	NN	conj	O
to	TO	case	O
either	CC	cc:preconj	O
a	DT	det	O
HeLa	NN	compound	O
extract	NN	nmod	O
or	CC	cc	O
a	DT	det	O
partially	RB	advmod	O
purified	VBN	amod	O
reaction	NN	compound	O
system	NN	conj	O
specifically	RB	advmod	O
stimulates	VBZ	ROOT	O
the	DT	det	O
Ig	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
.	.	punct	O

This	DT	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
constitutive	JJ	amod	O
OCTA-binding	JJ	amod	B-protein
factor	NN	compound	I-protein
NF-A1	NN	nsubj	I-protein
can	MD	aux	O
activate	VB	ccomp	O
transcription	NN	dobj	O
of	IN	case	O
the	DT	det	O
Ig	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
and	CC	cc	O
that	IN	mark	O
B-cell	NN	compound	B-cell_type
-specific	JJ	amod	O
transcription	NN	nsubj	O
of	IN	case	O
this	DT	det	O
promoter	NN	nmod	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
is	VBZ	cop	O
partially	RB	advmod	O
due	JJ	case	O
to	TO	mwe	O
a	DT	det	O
quantitative	JJ	amod	O
difference	NN	conj	O
in	IN	case	O
the	DT	det	O
amount	NN	nmod	O
of	IN	case	O
OCTA-binding	JJ	amod	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

Because	IN	mark	O
NF-A1	NN	nsubj	B-protein
can	MD	aux	O
stimulate	VB	advcl	O
Ig	NN	compound	B-protein
transcription	NN	dobj	O
,	,	punct	O
the	DT	det	O
inability	NN	nsubj	O
of	IN	case	O
this	DT	det	O
factor	NN	nmod	O
to	TO	mark	O
activate	VB	acl	O
in	FW	compound	O
vivo	FW	advmod	O
the	DT	det	O
Ig	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
to	TO	case	O
the	DT	det	O
same	JJ	amod	O
degree	NN	nmod	O
as	IN	case	O
the	DT	det	O
snRNA	NN	compound	B-DNA
promoters	NNS	nmod	I-DNA
probably	RB	advmod	O
reflects	VBZ	ROOT	O
a	DT	det	O
difference	NN	dobj	O
in	IN	case	O
the	DT	det	O
context	NN	nmod	O
of	IN	case	O
the	DT	det	O
OCTA	NN	compound	B-DNA
element	NN	nmod	I-DNA
in	IN	case	O
these	DT	det	O
two	CD	nummod	O
types	NNS	nmod	O
of	IN	case	O
promoters	NNS	nmod	B-DNA
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
a	DT	det	O
putative	JJ	amod	O
regulator	NN	nmod	O
of	IN	case	O
early	JJ	amod	B-DNA
T	NN	compound	I-DNA
cell	NN	compound	I-DNA
activation	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Molecules	NNS	nsubjpass	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
antigen	NN	compound	O
receptor-dependent	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
early	JJ	amod	B-DNA
T	NN	compound	I-DNA
cell	NN	compound	I-DNA
activation	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
were	VBD	auxpass	O
investigated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
functional	JJ	amod	O
sequences	NNS	nmod	O
of	IN	case	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
activation-specific	JJ	amod	I-protein
enhancer	NN	nmod	I-protein
of	IN	case	O
interleukin-2	NN	nmod	B-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
these	DT	det	O
sequences	NNS	nmod	O
forms	VBZ	ROOT	O
a	DT	det	O
protein	NN	compound	O
complex	NN	dobj	O
,	,	punct	O
NFAT-1	NN	appos	B-protein
,	,	punct	O
specifically	RB	advmod	O
with	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
of	IN	case	O
activated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	det	O
complex	NN	nsubj	O
appeared	VBD	ROOT	O
10	CD	compound	O
to	TO	dep	O
25	CD	nummod	O
minutes	NNS	nmod	O
before	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Studies	NNS	nsubj	O
with	IN	case	O
inhibitors	NNS	nmod	O
of	IN	case	O
protein	NN	compound	O
synthesis	NN	nmod	O
indicated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
time	NN	nsubj	O
of	IN	case	O
synthesis	NN	nmod	O
of	IN	case	O
the	DT	det	O
activator	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
corresponds	VBZ	ccomp	O
to	TO	case	O
the	DT	det	O
time	NN	nmod	O
of	IN	case	O
appearance	NN	nmod	O
of	IN	case	O
NFAT-1	NN	nmod	B-protein
.	.	punct	O

NFAT-1	NN	nsubj	B-protein
,	,	punct	O
or	CC	cc	O
a	DT	det	O
very	RB	advmod	O
similar	JJ	amod	O
protein	NN	conj	O
,	,	punct	O
bound	VBD	ROOT	O
functional	JJ	amod	O
sequences	NNS	dobj	O
of	IN	case	O
the	DT	det	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
;	:	punct	O
the	DT	det	O
LTR	NN	nsubjpass	B-DNA
of	IN	case	O
this	DT	det	O
virus	NN	nmod	O
is	VBZ	auxpass	O
known	VBN	parataxis	O
to	TO	mark	O
be	VB	auxpass	O
stimulated	VBN	xcomp	O
during	IN	case	O
early	JJ	amod	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	nmod	O
.	.	punct	O

The	DT	det	O
binding	VBG	amod	B-DNA
site	NN	nsubj	I-DNA
for	IN	case	O
this	DT	det	O
complex	NN	nmod	O
activated	VBD	ROOT	O
a	DT	det	O
linked	VBN	amod	O
promoter	NN	dobj	O
after	IN	case	O
transfection	NN	nmod	O
into	IN	case	O
antigen	NN	compound	B-cell_type
receptor-activated	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
not	RB	cc	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	conj	O
.	.	punct	O

These	DT	det	O
characteristics	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
NFAT-1	NN	nsubj	B-protein
transmits	VBZ	ccomp	O
signals	NNS	dobj	O
initiated	VBN	acl	O
at	IN	case	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
antigen	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Characterization	NN	ROOT	O
of	IN	case	O
thyroid	NN	compound	B-protein
hormone	NN	compound	I-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_line
IM-9	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

Although	IN	mark	O
putatively	RB	advmod	O
identified	VBN	advcl	O
more	JJR	amod	O
than	IN	quantmod	O
10	CD	nummod	O
years	NNS	npadvmod	O
ago	RB	advmod	O
,	,	punct	O
thyroid	NN	compound	B-protein
hormone	NN	compound	I-protein
receptors	NNS	nsubj	I-protein
in	IN	case	O
human	JJ	amod	O
tissues	NNS	nmod	O
remain	VBP	auxpass	O
poorly	RB	advmod	O
characterized	VBN	ROOT	O
.	.	punct	O

As	IN	case	O
a	DT	det	O
first	JJ	amod	O
step	NN	nmod	O
towards	IN	mark	O
understanding	VBG	acl	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
thyroid	NN	compound	O
hormone	NN	compound	O
action	NN	nmod	O
in	IN	case	O
man	NN	nmod	O
we	PRP	nsubj	O
have	VBP	aux	O
characterized	VBN	ROOT	O
T3	NN	compound	B-protein
binding	NN	compound	I-protein
sites	NNS	dobj	I-protein
in	IN	case	O
nuclei	NNS	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
lymphoblastoid	JJ	amod	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
IM-9	NN	compound	B-cell_line
cells	NNS	appos	I-cell_line
.	.	punct	O

In	IN	case	O
whole	JJ	amod	O
cell	NN	compound	O
experiments	NNS	nmod	O
at	IN	case	O
37	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
,	,	punct	O
nuclear	JJ	amod	O
binding	NN	appos	O
of	IN	case	O
[	-LRB-	punct	B-protein
125I	NN	nmod	I-protein
]	-RRB-	punct	I-protein
T3	NN	nsubj	I-protein
was	VBD	cop	O
saturable	JJ	ROOT	O
(	-LRB-	punct	O
Kd	NN	intj	O
34	CD	nummod	O
+/-	CC	cc	O
6	CD	conj	O
pmol/l	NN	dep	O
)	-RRB-	punct	O
and	CC	cc	O
of	IN	case	O
finite	JJ	amod	O
capacity	NN	conj	O
(	-LRB-	punct	O
approximately	RB	advmod	O
equal	JJ	dep	O
to	TO	case	O
350	CD	nummod	O
sites/cell	NNS	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
binding	VBG	amod	B-protein
sites	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
extracted	VBN	ROOT	O
from	IN	case	O
a	DT	det	O
nuclear	JJ	amod	O
pellet	NN	nmod	O
by	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
0.4	CD	nummod	O
mol/l	NN	compound	O
KCl	NN	nmod	O
and	CC	cc	O
sonication	NN	conj	O
.	.	punct	O

Separation	NN	nsubjpass	O
of	IN	case	O
bound	VBN	acl	O
from	IN	case	O
free	JJ	amod	O
[	-LRB-	punct	B-protein
125I	NN	dep	I-protein
]	-RRB-	punct	I-protein
T3	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
extracts	NNS	nmod	O
was	VBD	auxpass	O
achieved	VBN	ROOT	O
using	VBG	xcomp	O
the	DT	det	O
calcium	NN	compound	O
phosphate	NN	compound	O
matrix	NN	dobj	O
,	,	punct	O
hydroxyapatite	NN	appos	O
at	IN	case	O
a	DT	det	O
concentration	NN	nmod	O
of	IN	case	O
0.3	CD	nummod	O
ml	NN	nmod	O
of	IN	case	O
a	DT	det	O
150	CD	nummod	O
g/l	NN	compound	O
slurry	VB	nmod	O
.	.	punct	O

Rectilinear	JJ	compound	O
Scatchard	NN	compound	O
plots	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
only	RB	advmod	O
when	WRB	advmod	O
the	DT	det	O
hydroxyapatite	NN	nsubjpass	O
was	VBD	auxpass	O
washed	VBN	advcl	O
with	IN	prep	O
a	DT	det	O
buffer	NN	pobj	O
containing	VBG	acl	O
0.5	CD	nummod	O
%	NN	compound	O
Triton	NN	compound	O
X-100	NN	dobj	O
.	.	punct	O

Under	IN	case	O
these	DT	det	O
conditions	NNS	nmod	O
T3	NN	compound	B-protein
binding	NN	compound	I-protein
sites	NNS	nsubj	I-protein
in	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
were	VBD	cop	O
present	JJ	ROOT	O
at	IN	case	O
a	DT	det	O
concentration	NN	nmod	O
of	IN	case	O
22.4	CD	nummod	O
+/-	CC	cc	O
8.6	CD	conj	O
fmol/mg	NN	compound	O
protein	NN	nmod	O
and	CC	cc	O
showed	VBD	conj	O
an	DT	det	O
affinity	NN	dobj	O
of	IN	case	O
(	-LRB-	punct	O
Kd	NN	nmod	O
,	,	punct	O
room	NN	compound	O
temperature	NN	appos	O
)	-RRB-	punct	O
140	CD	nummod	O
+/-	CC	cc	O
10	CD	conj	O
pmol/l	NN	nmod	O
.	.	punct	O

The	DT	det	O
same	JJ	amod	O
assay	NN	compound	O
system	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
hierarchy	NN	dobj	O
of	IN	prep	O
affinities	NNS	pobj	O
for	IN	case	O
a	DT	det	O
range	NN	nmod	O
of	IN	case	O
natural	JJ	amod	O
and	CC	cc	O
synthetic	JJ	conj	O
analogues	NNS	nmod	O
.	.	punct	O

Calling	VBG	advcl	O
T3	NN	dobj	O
100	CD	nummod	O
,	,	punct	O
the	DT	det	O
order	NN	nsubj	O
of	IN	case	O
potencies	NNS	nmod	O
observed	VBN	acl	O
was	VBD	ROOT	O
:	:	punct	O
Triac	NNP	attr	O
,	,	punct	O
500	CD	conj	O
;	:	punct	O
3	CD	dep	O
,	,	punct	O
5-diiodo-3'-isopropylthyronine	NN	conj	O
,	,	punct	O
89	CD	conj	O
;	:	punct	O
T4	NN	conj	O
,	,	punct	O
32	CD	conj	O
;	:	punct	O
3	CD	conj	O
,	,	punct	O
5-dimethyl-3'isopropylthyronine	NN	conj	O
2	CD	nummod	O
;	:	punct	O
3	CD	conj	O
,	,	punct	O
5-T2	CD	conj	O
,	,	punct	O
0.7	CD	conj	O
,	,	punct	O
rT3	NN	conj	O
,	,	punct	O
0.4	CD	conj	O
;	:	punct	O
3'5'-T2	CD	dep	O
,	,	punct	O
less	JJR	advmod	O
than	IN	case	O
0.01	CD	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
T3	NN	compound	B-protein
binding	NN	compound	I-protein
sites	NNS	nsubj	I-protein
present	JJ	amod	O
in	IN	case	O
human	JJ	amod	B-cell_line
IM-9	NN	compound	I-cell_line
lymphocyte	NN	compound	I-cell_line
nuclei	NNS	nmod	O
and	CC	cc	O
extracts	NNS	conj	O
thereof	RB	advmod	O
are	VBP	cop	O
thyroid	NN	compound	B-protein
hormone	NN	compound	I-protein
receptors	NNS	ccomp	I-protein
.	.	punct	O

These	DT	det	O
cells	NNS	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
useful	JJ	amod	O
tool	NN	ROOT	O
to	TO	mark	O
increase	VB	acl	O
our	PRP$	nmod:poss	O
understanding	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-protein
T3	NN	compound	I-protein
receptors	NNS	nmod	I-protein

Definition	NN	ROOT	O
of	IN	case	O
T-cell	NN	compound	B-protein
specific	JJ	amod	I-protein
DNA-binding	JJ	amod	I-protein
factors	NNS	nmod	I-protein
that	WDT	nsubj	O
interact	VBP	acl:relcl	O
with	IN	case	O
a	DT	det	O
3'-silencer	NN	nmod	B-DNA
in	IN	case	O
the	DT	det	O
CD4+	JJ	amod	B-DNA
T-cell	NN	compound	I-DNA
gene	NN	compound	I-DNA
Rpt-1	NN	nmod	I-DNA
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
region	NN	nmod	O
3	CD	nummod	O
'	''	punct	O
to	TO	case	O
the	DT	det	O
CD4+	JJ	amod	B-DNA
T-cell	NN	compound	I-DNA
gene	NN	compound	I-DNA
Rpt-1	NN	nmod	I-DNA
(	-LRB-	punct	O
encoding	VBG	acl	O
regulatory	JJ	amod	O
protein	NN	compound	O
T-lymphocyte	NN	dobj	B-protein
1	CD	nummod	I-protein
)	-RRB-	punct	O
led	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
definition	NN	nmod	O
of	IN	case	O
a	DT	det	O
silencer	NN	compound	B-DNA
element	NN	nmod	I-DNA
that	WDT	nsubj	O
inhibits	VBZ	acl:relcl	O
heterologous	JJ	amod	B-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
in	IN	case	O
certain	JJ	amod	O
CD4+	JJ	amod	B-cell_type
T-cell	NN	compound	I-cell_type
lines	NNS	nmod	I-cell_type
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
B-cell	NN	conj	B-cell_type
or	CC	cc	O
non-lymphoid	JJ	conj	B-cell_type
cell	NN	compound	I-cell_type
lines	NNS	dep	I-cell_type
.	.	punct	O

Functional	JJ	amod	O
silencer	NN	compound	B-DNA
activity	NN	nsubjpass	O
in	FW	compound	O
vivo	FW	advmod	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
a	DT	det	O
specific	JJ	amod	O
silencer-DNA-protein	JJ	amod	B-protein
complex	NN	nmod	I-protein
in	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
with	IN	case	O
T-cell	NN	compound	B-cell_type
extracts	NNS	nmod	O
.	.	punct	O

Formation	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
complex	NN	nmod	O
was	VBD	auxpass	O
selectively	RB	advmod	O
inhibited	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
region	NN	nmod	O
in	IN	case	O
HIV-1	NN	nmod	B-DNA
containing	VBG	acl	O
a	DT	det	O
silencer	NN	compound	B-DNA
element	NN	dobj	I-DNA
.	.	punct	O

We	PRP	nsubj	O
discuss	VBP	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
DNA-binding	JJ	amod	B-protein
factors	NNS	nsubj	I-protein
may	MD	aux	O
coregulate	VB	ccomp	O
HIV-1	NN	compound	O
and	CC	cc	O
Rpt-1	NN	conj	O
gene	NN	compound	O
expression	NN	dobj	O
through	IN	case	O
a	DT	det	O
common	JJ	amod	O
transcriptional	JJ	amod	B-DNA
silencer	NN	compound	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

Congenital	JJ	amod	O
immunodeficiencies	NNS	nsubj	O
associated	VBN	acl	O
with	IN	case	O
absence	NN	nmod	O
of	IN	case	O
HLA	NN	compound	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
antigens	NNS	nmod	I-protein
on	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
result	VBP	ROOT	O
from	IN	case	O
distinct	JJ	amod	O
mutations	NNS	nmod	O
in	IN	case	O
trans-acting	JJ	amod	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Coordinate	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
HLA	NN	compound	B-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
during	IN	case	O
development	NN	nmod	O
and	CC	cc	O
coinduction	NN	conj	O
of	IN	case	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
genes	NNS	nmod	I-DNA
by	IN	case	O
soluble	JJ	amod	B-protein
factors	NNS	nmod	I-protein
suggests	VBZ	ROOT	O
that	IN	mark	O
common	JJ	amod	O
trans-acting	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
control	VBP	amod	O
expression	NN	ccomp	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
.	.	punct	O

In	IN	case	O
B-lymphoblastoid	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
lines	NNS	nmod	I-cell_type
derived	VBN	acl	O
from	IN	case	O
two	CD	nummod	O
independent	JJ	amod	O
class	NN	nmod:npmod	O
II-deficient	JJ	amod	O
bare	JJ	amod	O
lymphocyte	NN	compound	O
syndrome	NN	compound	O
patients	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
a	DT	det	O
drastic	JJ	amod	O
decrease	NN	dobj	O
in	IN	case	O
transcription	NN	compound	O
rates	NNS	nmod	O
of	IN	case	O
the	DT	det	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

When	WRB	advmod	O
these	DT	det	O
cell	NN	compound	O
lines	NNS	nsubjpass	O
are	VBP	auxpass	O
fused	VBN	advcl	O
,	,	punct	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
genes	NNS	nsubjpass	I-DNA
are	VBP	auxpass	O
reexpressed	VBN	ROOT	O
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
immunodeficiencies	NNS	nsubj	O
in	IN	case	O
bare	JJ	amod	O
lymphocyte	NN	compound	O
syndrome	NN	compound	O
patients	NNS	nmod	O
are	VBP	cop	O
the	DT	det	O
result	NN	ccomp	O
of	IN	case	O
two	CD	nummod	O
distinct	JJ	amod	O
mutations	NNS	nmod	O
.	.	punct	O

Further	JJ	amod	O
studies	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
genes	NNS	nsubj	O
governing	VBG	acl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
class	NN	compound	B-protein
II	CD	nummod	I-protein
antigens	NNS	nmod	I-protein
fall	VBP	ccomp	O
into	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
three	CD	nummod	O
complementation	NN	compound	O
groups	NNS	nmod	O
;	:	punct	O
two	CD	nsubj	O
of	IN	case	O
these	DT	nmod	O
were	VBD	cop	O
previously	RB	advmod	O
unidentified	JJ	parataxis	O
in	IN	case	O
mutant	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
generated	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
the	DT	det	O
identification	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
discrete	JJ	amod	O
complexes	NNS	nmod	O
,	,	punct	O
NFX1.1	NN	appos	B-protein
and	CC	cc	O
NFX1.2	NN	conj	B-protein
,	,	punct	O
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
DRA	NN	compound	B-DNA
X	NN	compound	I-DNA
consensus	NN	compound	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

Though	IN	mark	O
the	DT	det	O
mutation	NN	nsubj	O
in	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
one	CD	nummod	O
mutant	JJ	amod	B-cell_line
line	NN	nmod	I-cell_line
generated	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
(	-LRB-	punct	O
RJ2.2.5	NN	appos	B-cell_line
)	-RRB-	punct	O
affects	VBZ	advcl	O
products	NNS	dobj	O
functioning	VBG	acl	O
via	IN	case	O
interaction	NN	nmod	O
with	IN	case	O
the	DT	det	O
X	NN	compound	B-DNA
box	NN	nmod	I-DNA
,	,	punct	O
clear	JJ	amod	O
alterations	NNS	nsubjpass	O
in	IN	case	O
either	CC	cc:preconj	O
NFX1.1	NN	nmod	B-protein
or	CC	cc	O
NFX1.2	NN	conj	B-protein
are	VBP	auxpass	O
not	RB	neg	O
found	VBN	ROOT	O
in	IN	case	O
any	DT	nmod	O
of	IN	case	O
the	DT	det	O
mutant	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
responsiveness	NN	nsubj	O
to	TO	case	O
glucocorticoid	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
content	NN	nmod	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
leukocytes	NNS	nmod	I-cell_type
in	IN	case	O
normal	JJ	amod	O
humans	NNS	nmod	O
.	.	punct	O

Dexamethasone	NN	compound	O
loading	NN	compound	O
tests	NNS	nsubjpass	O
(	-LRB-	punct	O
0.1	CD	compound	O
mg	NN	compound	O
dexamethasone/kg	NN	dep	O
,	,	punct	O
iv	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
in	IN	case	O
18	CD	nummod	O
normal	JJ	amod	O
males	NNS	nmod	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
individual	JJ	amod	O
responsiveness	NN	dobj	O
to	TO	case	O
glucocorticoid	NN	nmod	O
.	.	punct	O

There	EX	expl	O
were	VBD	ROOT	O
inter-individual	JJ	amod	O
differences	NNS	nsubj	O
in	IN	case	O
increase	NN	nmod	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
polymorphonuclear	JJ	amod	I-cell_type
leukocyte	NN	compound	I-cell_type
count	NN	nmod	O
,	,	punct	O
decrease	NN	xcomp	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
lymphocyte	NN	compound	I-cell_type
count	NN	nmod	O
,	,	punct	O
and	CC	cc	O
increase	NN	conj	O
in	IN	case	O
plasma	NN	compound	O
free	JJ	amod	O
fatty	JJ	amod	O
acids	NNS	compound	O
levels	NNS	nmod	O
after	IN	case	O
dexamethasone	NN	compound	O
injection	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
the	DT	det	O
maximum	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
polymorphonuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
and	CC	cc	O
the	DT	det	O
maximum	JJ	amod	O
decrease	NN	conj	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	parataxis	O
0.7514	CD	dobj	O
,	,	punct	O
p	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0.0003	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Simultaneous	JJ	amod	O
measurements	NNS	nsubj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
content	NN	nmod	O
by	IN	case	O
whole-cell	JJ	amod	O
assay	NN	nmod	O
revealed	VBD	ROOT	O
that	IN	mark	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
content	NN	nsubj	O
in	IN	case	O
polymorphonuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
linearly	RB	advmod	O
correlated	VBD	ccomp	O
with	IN	case	O
that	DT	nmod	O
in	IN	case	O
the	DT	det	O
corresponding	JJ	amod	O
lymphocytes	NNS	nmod	B-cell_type
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	dep	O
0.9482	CD	dobj	O
,	,	punct	O
p	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0.0001	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

There	EX	expl	O
were	VBD	ROOT	O
also	RB	advmod	O
significant	JJ	amod	O
correlations	NNS	attr	O
between	IN	case	O
the	DT	det	O
maximum	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
polymorphonuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
and	CC	cc	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
content	NN	conj	O
in	IN	case	O
polymorphonuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	parataxis	O
0.7239	CD	dobj	O
,	,	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0.0007	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
between	IN	case	O
the	DT	det	O
maximum	JJ	amod	O
decrease	NN	conj	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
and	CC	cc	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
content	NN	conj	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	parataxis	O
0.7703	CD	dobj	O
,	,	punct	O
p	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0.0002	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
individual	JJ	amod	O
differences	NNS	nsubjpass	O
are	VBP	auxpass	O
preserved	VBN	ccomp	O
both	CC	cc:preconj	O
in	IN	case	O
glucocorticoid	NN	compound	O
responsiveness	NN	nmod	O
and	CC	cc	O
in	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
content	NN	conj	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
leukocytes	NNS	nmod	I-cell_type
in	IN	case	O
normal	JJ	amod	O
humans	NNS	nmod	O
.	.	punct	O

Estradiol	NN	compound	O
receptors	NNS	ROOT	O
in	IN	case	O
the	DT	det	O
cytosol	NN	nmod	O
of	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
hepatitis	NN	compound	O
B	NN	compound	O
virus	NN	compound	O
carriers	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
interferon-alpha	NN	nmod	B-protein
.	.	punct	O

Estradiol	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
in	IN	case	O
the	DT	det	O
cytosol	NN	nmod	O
of	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
the	DT	det	O
effects	NNS	conj	O
of	IN	case	O
interferon-alpha	NN	nmod	B-protein
(	-LRB-	punct	O
IFN-alpha	NN	appos	B-protein
)	-RRB-	punct	O
on	IN	case	O
estradiol	NN	compound	B-protein
receptors	NNS	nmod	I-protein
were	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
asymptomatic	JJ	amod	O
hepatitis	NN	compound	O
B	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
HBV	NN	appos	O
)	-RRB-	punct	O
carriers	NNS	nmod	O
,	,	punct	O
patients	NNS	dep	O
with	IN	case	O
chronic	JJ	amod	O
hepatitis	NN	compound	O
B	NN	nmod	O
and	CC	cc	O
normal	JJ	amod	O
controls	NNS	conj	O
.	.	punct	O

The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
estradiol	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
cytosol	NN	nmod	O
of	IN	case	O
mononuclear	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	cop	O
significantly	RB	advmod	O
lower	JJR	ROOT	O
in	IN	case	O
asymptomatic	JJ	amod	O
HBV	NN	compound	O
carriers	NNS	nmod	O
and	CC	cc	O
patients	NNS	conj	O
with	IN	case	O
chronic	JJ	amod	O
hepatitis	NN	compound	O
B	NN	nmod	O
,	,	punct	O
compared	VBN	case	O
to	TO	case	O
normal	JJ	amod	O
controls	NNS	advcl	O
.	.	punct	O

This	DT	det	O
low	JJ	amod	O
level	NN	nsubjpass	O
of	IN	case	O
cytosol	NN	compound	O
estradiol	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
hepatitis	NN	compound	O
B	NN	nmod	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
administration	NN	nmod	O
of	IN	case	O
IFN-alpha	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
when	WRB	advmod	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nsubjpass	I-cell_type
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
hepatitis	NN	compound	O
B	NN	nmod	O
were	VBD	auxpass	O
incubated	VBN	advcl	O
with	IN	case	O
IFN-alpha	NN	nmod	B-protein
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
the	DT	det	O
level	NN	nsubj	O
of	IN	case	O
cytosol	NN	compound	O
estradiol	NN	compound	B-protein
receptors	NNS	nmod	I-protein
also	RB	advmod	O
increased	VBD	ROOT	O
by	IN	mark	O
increasing	VBG	advcl	O
the	DT	det	O
concentration	NN	dobj	O
of	IN	case	O
IFN-alpha	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
reported	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
response	NN	nsubj	O
of	IN	case	O
mononuclear	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
estrogen	NN	nmod	O
is	VBZ	cop	O
impaired	JJ	ccomp	O
in	IN	case	O
HBV	NN	compound	O
carriers	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
our	PRP$	nmod:poss	O
present	JJ	amod	O
results	NNS	nsubj	O
suggested	VBD	conj	O
that	IN	mark	O
this	DT	nsubj	O
may	MD	aux	O
be	VB	cop	O
due	JJ	case	O
to	TO	case	O
the	DT	det	O
low	JJ	amod	O
level	NN	ccomp	O
of	IN	case	O
estradiol	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
cytosol	NN	nmod	O
of	IN	case	O
mononuclear	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Association	NN	ROOT	O
of	IN	case	O
increased	VBN	amod	O
lytic	JJ	amod	O
effector	NN	compound	O
cell	NN	compound	O
function	NN	nmod	O
with	IN	case	O
high	JJ	amod	O
estrogen	NN	compound	B-protein
receptor	NN	compound	I-protein
levels	NNS	nmod	O
in	IN	case	O
tumor-bearing	JJ	amod	O
patients	NNS	nmod	O
with	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O

Tumor-bearing	JJ	amod	O
patients	NNS	nsubjpass	O
with	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
were	VBD	auxpass	O
assayed	VBN	ROOT	O
for	IN	case	O
their	PRP$	nmod:poss	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
NK	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
cell	NN	compound	I-cell_type
activity	NN	nmod	O
and	CC	cc	O
for	IN	case	O
the	DT	det	O
function	NN	conj	O
of	IN	case	O
activated	VBN	amod	O
cytotoxic	JJ	amod	B-cell_type
T-cells	NNS	nmod	I-cell_type
,	,	punct	O
as	IN	mark	O
assessed	VBN	advcl	O
by	IN	case	O
lectin-dependent	JJ	amod	O
cellular	JJ	amod	O
cytotoxicity	NN	nmod	O
(	-LRB-	punct	O
LDCC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Tumor-bearing	JJ	amod	O
patients	NNS	nsubj	O
with	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
had	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
NK	NN	compound	B-cell_type
activity	NN	nmod	O
and	CC	cc	O
in	IN	case	O
LDCC	NN	conj	O
,	,	punct	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
healthy	JJ	amod	O
control	NN	compound	O
individuals	NNS	nmod	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
enhanced	VBN	amod	O
NK	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activity	NN	nsubjpass	O
and	CC	cc	O
LDCC	NN	conj	O
were	VBD	auxpass	O
closely	RB	advmod	O
associated	VBN	advcl	O
with	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
(	-LRB-	punct	O
greater	JJR	dep	O
than	IN	case	O
31	CD	nummod	O
fmol/mg	NN	nmod	O
)	-RRB-	punct	O
of	IN	case	O
estrogen	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
ER	NN	appos	B-protein
)	-RRB-	punct	O
content	NN	nmod	O
in	IN	case	O
the	DT	det	O
primary	JJ	amod	O
tumor	NN	nmod	O
,	,	punct	O
no	DT	neg	O
other	JJ	amod	O
clinical	JJ	amod	O
or	CC	cc	O
histologic	JJ	conj	O
correlation	NN	nsubjpass	O
between	IN	case	O
the	DT	det	O
increase	NN	nmod	O
in	IN	case	O
either	DT	det	O
parameter	NN	nmod	O
of	IN	case	O
cytotoxic	JJ	amod	B-cell_type
effector	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
function	NN	nmod	O
could	MD	aux	O
be	VB	auxpass	O
found	VBN	ROOT	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
ER	NN	compound	B-protein
levels	NNS	nsubjpass	O
greater	JJR	amod	O
than	IN	case	O
31	CD	nummod	O
fmol/mg	NN	nmod	O
might	MD	aux	O
be	VB	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
increased	VBN	amod	O
cytotoxic	JJ	amod	B-cell_type
effector	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
function	NN	nmod	O
in	IN	case	O
tumor-bearing	JJ	amod	O
patients	NNS	nmod	O
with	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O

Properties	NNS	ROOT	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
Epstein-Barr	JJ	amod	B-cell_line
virus-transformed	JJ	amod	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
familial	JJ	amod	O
cortisol	NN	compound	O
resistance	NN	nmod	O
.	.	punct	O

In	IN	case	O
a	DT	det	O
previous	JJ	amod	O
report	NN	nmod	O
of	IN	case	O
two	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
familial	JJ	amod	O
glucocorticoid	NN	compound	O
resistance	NN	nmod	O
due	JJ	case	O
to	TO	case	O
reduced	VBN	amod	O
numbers	NNS	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
decreased	VBN	amod	O
numbers	NNS	dobj	O
of	IN	case	O
GR	NN	nmod	B-protein
in	IN	case	O
peripheral	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
cultured	VBN	amod	B-cell_line
fibroblasts	NNS	conj	I-cell_line
but	CC	cc	O
normal	JJ	amod	O
affinity	NN	conj	O
of	IN	case	O
GR	NN	nmod	B-protein
in	IN	case	O
both	DT	det	O
patients	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
peripheral	JJ	amod	B-cell_type
lymphocytes	NNS	nsubjpass	I-cell_type
from	IN	case	O
these	DT	det	O
patients	NNS	nmod	O
,	,	punct	O
one	CD	nummod	O
patient	NN	nmod:poss	O
's	POS	case	O
son	NN	appos	O
and	CC	cc	O
daughter	NN	conj	O
,	,	punct	O
and	CC	cc	O
normal	JJ	amod	O
subjects	NNS	conj	O
were	VBD	auxpass	O
transformed	VBN	ROOT	O
with	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	nmod	O
.	.	punct	O

Reduced	VBN	amod	O
numbers	NNS	nsubjpass	O
and	CC	cc	O
normal	JJ	amod	O
affinity	NN	conj	O
of	IN	case	O
GR	NN	nmod	B-protein
were	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
Epstein-Barr	JJ	amod	B-cell_line
virus-transformed	JJ	amod	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
from	IN	case	O
both	DT	det	O
patients	NNS	nmod	O
while	IN	mark	O
the	DT	det	O
son	NN	nsubj	O
and	CC	cc	O
daughter	NN	conj	O
had	VBD	advcl	O
normal	JJ	amod	O
numbers	NNS	dobj	O
and	CC	cc	O
affinity	NN	conj	O
of	IN	case	O
GR	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
thermal	JJ	amod	O
stability	NN	nsubjpass	O
of	IN	case	O
GR	NN	nmod	B-protein
and	CC	cc	O
thermal	JJ	amod	O
activation	NN	conj	O
of	IN	case	O
cytosolic	JJ	amod	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
both	DT	det	O
patients	NNS	nmod	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
normal	JJ	xcomp	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
percentages	NNS	nsubj	O
of	IN	case	O
nuclear	JJ	amod	O
bound	VBN	amod	O
GR	NN	nmod	B-protein
were	VBD	cop	O
similar	JJ	advcl	O
in	IN	case	O
both	CC	cc:preconj	O
patients	NNS	nmod	O
and	CC	cc	O
normal	JJ	amod	O
controls	NNS	conj	O
,	,	punct	O
the	DT	det	O
absolute	JJ	amod	O
amounts	NNS	nsubj	O
of	IN	case	O
nuclear	JJ	amod	O
bound	VBN	amod	O
GR	NN	nmod	B-protein
of	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
were	VBD	cop	O
about	RB	advmod	O
one-half	JJ	ROOT	O
that	DT	dobj	O
of	IN	case	O
normal	JJ	amod	O
controls	NNS	nmod	O
.	.	punct	O

These	DT	det	O
abnormal	JJ	amod	O
properties	NNS	nsubjpass	O
of	IN	case	O
GR	NN	nmod	B-protein
(	-LRB-	punct	O
reduced	VBN	amod	O
numbers	NNS	dep	O
of	IN	case	O
GR	NN	nmod	B-protein
)	-RRB-	punct	O
were	VBD	auxpass	O
preserved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
transformed	VBN	amod	B-cell_line
cells	NNS	nmod	I-cell_line
from	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
.	.	punct	O

Octamer	NN	compound	O
transcription	NN	compound	O
factors	NNS	nsubj	O
1	CD	dep	O
and	CC	cc	O
2	CD	conj	O
each	DT	nsubj	O
bind	VBP	ROOT	O
to	TO	case	O
two	CD	nummod	O
different	JJ	amod	O
functional	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
heavy-chain	JJ	amod	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Immunoglobulin	NN	compound	B-DNA
heavy-chain	JJ	amod	I-DNA
genes	NNS	nsubj	I-DNA
contain	VBP	ROOT	O
two	CD	nummod	O
conserved	VBN	amod	B-DNA
sequence	NN	compound	I-DNA
elements	NNS	dobj	I-DNA
5	CD	nummod	O
'	''	punct	O
to	TO	case	O
the	DT	det	O
site	NN	nmod	O
of	IN	case	O
transcription	NN	compound	O
initiation	NN	nmod	O
:	:	punct	O
the	DT	det	O
octamer	NN	compound	O
ATGCAAAT	NN	dobj	O
and	CC	cc	O
the	DT	det	O
heptamer	NN	compound	O
CTCATGA	NN	conj	O
.	.	punct	O

Both	DT	nsubjpass	O
of	IN	case	O
these	DT	det	O
elements	NNS	nmod	O
are	VBP	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
normal	JJ	amod	B-DNA
cell-specific	JJ	amod	I-DNA
promoter	NN	compound	I-DNA
function	NN	nmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
the	DT	det	O
ubiquitous	JJ	amod	B-protein
and	CC	cc	I-protein
lymphoid-cell-specific	JJ	conj	I-protein
octamer	NN	compound	I-protein
transcription	NN	compound	I-protein
factors	NNS	nsubj	I-protein
(	-LRB-	punct	O
OTF-1	NN	dep	B-protein
and	CC	cc	O
OTF-2	NN	conj	B-protein
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
interact	VBP	ccomp	O
specifically	RB	advmod	O
with	IN	case	O
each	DT	nmod	O
of	IN	case	O
the	DT	det	O
two	CD	nummod	O
conserved	VBN	amod	B-DNA
sequence	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
,	,	punct	O
forming	VBG	advcl	O
either	CC	cc:preconj	O
homo-	JJ	amod	B-protein
or	CC	cc	I-protein
heterodimeric	JJ	conj	I-protein
complexes	NNS	dobj	I-protein
.	.	punct	O

This	DT	nsubj	O
was	VBD	aux	O
surprising	JJ	ROOT	O
,	,	punct	O
since	IN	mark	O
the	DT	det	O
heptamer	NN	compound	O
and	CC	cc	O
octamer	NN	compound	O
sequence	NN	compound	O
motifs	NNS	nsubj	O
bear	VBP	advcl	O
no	DT	neg	O
obvious	JJ	amod	O
similarity	NN	dobj	O
to	TO	case	O
each	DT	det	O
other	JJ	nmod	O
.	.	punct	O

Binding	NN	nsubj	O
of	IN	case	O
either	CC	det	O
factor	NN	nmod	O
to	TO	case	O
the	DT	det	O
octamer	NN	compound	B-DNA
element	NN	nmod	I-DNA
occurred	VBD	ROOT	O
independently	RB	advmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
OTF	NN	compound	B-protein
interaction	NN	nsubj	O
with	IN	case	O
the	DT	det	O
heptamer	NN	compound	B-DNA
sequence	NN	nmod	I-DNA
appeared	VBD	ROOT	O
to	TO	mark	O
require	VB	xcomp	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
an	DT	det	O
intact	JJ	amod	O
octamer	NN	compound	O
motif	NN	nmod	O
and	CC	cc	O
occurred	VBD	conj	O
with	IN	case	O
a	DT	det	O
spacing	NN	nmod	O
of	IN	case	O
either	CC	cc:preconj	O
2	CD	nummod	B-DNA
or	CC	cc	I-DNA
14	CD	conj	I-DNA
base	NN	compound	I-DNA
pairs	NNS	nmod	I-DNA
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
elements	NNS	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
coordinate	JJ	amod	O
binding	NN	dobj	O
resulting	VBG	acl	O
from	IN	case	O
protein-protein	JJ	amod	O
interactions	NNS	nmod	O
.	.	punct	O

The	DT	det	O
degeneracy	NN	nsubj	O
in	IN	case	O
sequences	NNS	nmod	O
recognized	VBN	acl	O
by	IN	case	O
the	DT	det	O
OTFs	NNS	nmod	B-protein
may	MD	aux	O
be	VB	cop	O
important	JJ	ROOT	O
in	IN	mark	O
widening	VBG	advcl	O
the	DT	det	O
range	NN	dobj	O
over	IN	case	O
which	WDT	nmod	O
gene	NN	compound	O
expression	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
modulated	VBN	acl:relcl	O
and	CC	cc	O
in	IN	mark	O
establishing	VBG	conj	O
cell	NN	compound	O
type	NN	compound	O
specificity	NN	dobj	O
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	O
lymphoid	JJ	amod	B-protein
specific	JJ	amod	I-protein
octamer	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
OTF-2B	NN	appos	B-protein
)	-RRB-	punct	O
by	IN	case	O
proteolytic	JJ	amod	O
clipping	JJ	amod	O
bandshift	NN	compound	O
assay	NN	nmod	O
(	-LRB-	punct	O
PCBA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
octamer	NN	compound	O
sequence	NN	compound	O
ATGCAAAT	NN	nsubjpass	O
is	VBZ	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
promoters	NNS	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
Ig	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
heavy	JJ	amod	I-DNA
and	CC	cc	I-DNA
light	JJ	conj	I-DNA
chain	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
in	IN	case	O
the	DT	det	O
heavy	JJ	amod	B-DNA
chain	NN	compound	I-DNA
enhancer	NN	conj	I-DNA
and	CC	cc	O
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
determinant	NN	conj	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
type	NN	compound	O
specific	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
Ig	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

An	DT	det	O
apparent	JJ	amod	O
paradox	NN	nsubj	O
is	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
same	JJ	amod	O
sequence	NN	nsubj	O
serves	VBZ	ccomp	O
as	IN	case	O
an	DT	det	O
upstream	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
or	CC	cc	I-DNA
enhancer	NN	compound	I-DNA
element	NN	conj	I-DNA
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
housekeeping	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
histone	NN	compound	B-DNA
H2B	NN	nmod	I-DNA
and	CC	cc	I-DNA
U	NN	compound	I-DNA
snRNA	NN	compound	I-DNA
genes	NNS	conj	I-DNA
.	.	punct	O

The	DT	det	O
differential	JJ	amod	O
usage	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
regulatory	JJ	amod	O
sequence	NN	compound	O
motif	NN	nmod	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
by	IN	case	O
different	JJ	amod	O
species	NNS	nmod	O
of	IN	case	O
octamer	NN	compound	B-protein
binding	NN	compound	I-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

One	CD	nummod	O
species	NNS	nsubj	O
of	IN	case	O
100	CD	nummod	O
kd	NN	nmod	O
,	,	punct	O
designated	VBN	acl	O
OTF-1	NN	xcomp	B-protein
,	,	punct	O
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
all	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
and	CC	cc	O
may	MD	aux	O
exert	VB	conj	O
its	PRP$	nmod:poss	O
activating	VBG	amod	O
function	NN	dobj	O
only	RB	advmod	O
when	WRB	advmod	O
it	PRP	nsubj	O
can	MD	aux	O
interact	VB	advcl	O
with	IN	case	O
additional	JJ	amod	O
adjacent	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
lymphoid	JJ	amod	B-protein
cell	NN	compound	I-protein
specific	JJ	amod	I-protein
octamer	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	nsubj	I-protein
of	IN	case	O
60	CD	nummod	O
kd	NN	nmod	O
(	-LRB-	punct	O
OTF-2A	NN	appos	B-protein
)	-RRB-	punct	O
specifically	RB	advmod	O
stimulates	VBZ	ROOT	O
Ig	NN	compound	B-DNA
promoters	NNS	dobj	I-DNA
which	WDT	nsubj	O
consist	VBP	acl:relcl	O
essentially	RB	advmod	O
of	IN	case	O
a	DT	det	O
TATA-box	NN	nmod	B-DNA
and	CC	cc	O
an	DT	det	O
octamer	NN	compound	B-DNA
sequence	NN	conj	I-DNA
upstream	JJ	amod	O
of	IN	case	O
it	PRP	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
present	VBP	ROOT	O
evidence	NN	dobj	O
for	IN	case	O
yet	RB	advmod	O
another	DT	det	O
B	NN	compound	B-protein
cell	NN	compound	I-protein
specific	JJ	amod	I-protein
octamer	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	dep	I-protein
of	IN	case	O
75	CD	nummod	O
kd	NN	nmod	O
(	-LRB-	punct	O
OTF-2B	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

From	IN	case	O
several	JJ	amod	O
findings	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
OTF-2B	NN	nmod	B-protein
(	-LRB-	punct	O
but	CC	cc	O
not	RB	neg	O
OTF-2A	NN	conj	B-protein
)	-RRB-	punct	O
from	IN	case	O
a	DT	det	O
lymphocyte	NN	compound	B-cell_line
line	NN	nmod	I-cell_line
that	WDT	nsubj	O
can	MD	aux	O
not	RB	neg	O
respond	VB	acl:relcl	O
to	TO	case	O
the	DT	det	O
IgH	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
a	DT	det	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
novel	JJ	amod	B-protein
octamer	NN	compound	I-protein
factor	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
long	JJ	amod	O
range	NN	compound	O
activation	NN	nmod	O
by	IN	case	O
the	DT	det	O
IgH	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
the	DT	det	O
proteolytic	JJ	amod	O
clipping	JJ	amod	O
bandshift	NN	compound	O
assay	NN	compound	O
(	-LRB-	punct	O
PCBA	NN	appos	O
)	-RRB-	punct	O
technique	NN	dobj	O
to	TO	mark	O
distinguish	VB	advcl	O
the	DT	det	O
three	CD	nummod	O
different	JJ	amod	O
forms	NNS	dobj	O
found	VBN	acl	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	det	O
analysis	NN	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
75	CD	nummod	O
kd-species	NNS	compound	O
OTF-2B	NN	nsubj	B-protein
is	VBZ	cop	O
closely	RB	advmod	O
related	JJ	ccomp	O
to	TO	case	O
the	DT	det	O
60	CD	nummod	B-protein
kd	NN	compound	I-protein
species	NNS	compound	I-protein
OTF-2A	NN	nmod	I-protein
.	.	punct	O

Inhibition	NN	ROOT	O
of	IN	case	O
interleukin	NN	compound	B-protein
2	CD	nummod	I-protein
-induced	JJ	amod	O
proliferation	NN	nmod	O
of	IN	case	O
cloned	VBN	amod	B-cell_line
murine	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
by	IN	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

Possible	JJ	amod	O
involvement	NN	ROOT	O
of	IN	case	O
an	DT	det	O
inhibitory	JJ	amod	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
ability	NN	nsubjpass	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
to	TO	mark	O
inhibit	VB	acl	O
interleukin	NN	compound	B-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
IL	NN	compound	B-protein
2	CD	nummod	I-protein
)	-RRB-	punct	O
-induced	JJ	amod	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
proliferation	NN	dobj	O
in	IN	case	O
two	CD	nummod	O
cytotoxic	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
CTL	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
clones	NNS	nmod	I-cell_line
has	VBZ	aux	O
been	VBN	auxpass	O
studied	VBN	ROOT	O
.	.	punct	O

A	DT	det	O
complete	JJ	amod	O
inhibition	NN	nsubjpass	O
of	IN	case	O
DNA	NN	compound	O
synthesis	NN	nmod	O
by	IN	case	O
dexamethasone	NN	nmod	O
(	-LRB-	punct	O
Dx	NN	appos	O
)	-RRB-	punct	O
could	MD	aux	O
be	VB	auxpass	O
observed	VBN	ROOT	O
when	WRB	advmod	O
IL	NN	nmod:npmod	B-cell_line
2-depleted	JJ	amod	I-cell_line
cultures	NNS	nsubjpass	I-cell_line
of	IN	case	O
CTL	NN	nmod	B-cell_line
were	VBD	auxpass	O
either	CC	dep	O
incubated	VBN	advcl	O
for	IN	case	O
6	CD	nummod	O
h	NN	nmod	O
with	IN	case	O
the	DT	det	O
hormone	NN	nmod	B-protein
prior	JJ	case	O
to	TO	mwe	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
IL	NN	nmod	B-protein
2	CD	nummod	I-protein
or	CC	cc	O
treated	VBN	conj	O
simultaneously	RB	advmod	O
with	IN	case	O
Dx	NN	nmod	O
and	CC	cc	O
a	DT	det	O
low	JJ	amod	O
concentration	NN	conj	O
of	IN	case	O
IL	NN	nmod	B-protein
2	CD	nummod	I-protein
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
reduction	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
number	NN	nmod	O
and	CC	cc	O
affinity	NN	conj	O
of	IN	case	O
IL	NN	compound	B-protein
2	CD	nummod	I-protein
receptors	NNS	nmod	I-protein
was	VBD	auxpass	O
seen	VBN	ROOT	O
after	IN	case	O
6	CD	nummod	O
h	NN	compound	O
incubation	NN	nmod	O
with	IN	case	O
Dx	NN	nmod	O
.	.	punct	O

The	DT	det	O
order	NN	nsubj	O
of	IN	case	O
potency	NN	nmod	O
observed	VBN	acl	O
with	IN	case	O
the	DT	det	O
different	JJ	amod	O
steroids	NNS	nmod	O
indicated	VBD	ROOT	O
that	IN	mark	O
this	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nsubjpass	O
was	VBD	auxpass	O
mediated	VBN	ccomp	O
through	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
a	DT	det	O
specific	JJ	amod	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
action	NN	nsubj	O
of	IN	case	O
these	DT	det	O
hormones	NNS	nmod	B-protein
possibly	RB	advmod	O
involves	VBZ	ROOT	O
the	DT	det	O
synthesis	NN	dobj	O
of	IN	case	O
an	DT	det	O
inhibitory	JJ	amod	B-protein
protein	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
,	,	punct	O
since	IN	mark	O
the	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
cycloheximide	NN	nmod	O
during	IN	case	O
the	DT	det	O
incubation	NN	nmod	O
with	IN	case	O
Dx	NN	nmod	O
prevented	VBD	advcl	O
the	DT	det	O
inhibition	NN	dobj	O
of	IN	case	O
DNA	NN	compound	O
synthesis	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
supernatant	JJ	nsubj	O
from	IN	case	O
Dx-treated	JJ	amod	O
CTL	NN	nmod	B-cell_line
contained	VBD	ROOT	O
a	DT	det	O
nondialyzable	JJ	amod	O
factor	NN	dobj	O
which	WDT	nsubj	O
inhibited	VBD	acl:relcl	O
DNA	NN	compound	O
synthesis	NN	dobj	O
and	CC	cc	O
cell	NN	compound	O
growth	NN	conj	O
of	IN	case	O
CTL	NN	compound	B-cell_line
clones	NNS	nmod	I-cell_line
induced	VBN	acl	O
by	IN	case	O
IL	NN	nmod	B-protein
2	CD	nummod	I-protein
.	.	punct	O

Blocking	NN	nsubjpass	O
of	IN	case	O
IL	NN	compound	B-protein
2	CD	nummod	I-protein
synthesis	NN	nmod	O
and	CC	cc	O
IL	NN	compound	B-protein
2	CD	nummod	I-protein
receptor	NN	compound	I-protein
formation	NN	conj	O
have	VBP	aux	O
been	VBN	auxpass	O
proposed	VBN	ROOT	O
as	IN	case	O
one	CD	nmod	O
of	IN	case	O
the	DT	det	O
major	JJ	amod	O
mechanisms	NNS	nmod	O
of	IN	case	O
glucocorticoid-induced	JJ	amod	O
immunosuppression	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
these	DT	det	O
hormones	NNS	nsubj	B-protein
may	MD	aux	O
also	RB	advmod	O
affect	VB	ccomp	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
proliferation	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
IL	NN	compound	B-protein
2	CD	nummod	I-protein
activity	NN	dobj	O
.	.	punct	O

Identification	NN	ROOT	O
and	CC	cc	O
purification	NN	conj	O
of	IN	case	O
a	DT	det	O
human	JJ	amod	B-protein
immunoglobulin-enhancer-binding	JJ	amod	I-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
that	WDT	nsubj	O
activates	VBZ	acl:relcl	O
transcription	NN	dobj	O
from	IN	case	O
a	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
1	CD	nummod	I-DNA
promoter	NN	nmod	I-DNA
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

The	DT	det	O
enhancer-binding	JJ	amod	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	I-protein
B	NN	nsubjpass	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
found	VBN	acl:relcl	O
only	RB	advmod	O
in	IN	case	O
cells	NNS	nmod	O
that	WDT	nsubj	O
transcribe	VBP	acl:relcl	O
immunoglobulin	NN	compound	B-DNA
light	JJ	amod	I-DNA
chain	NN	compound	I-DNA
genes	NNS	dobj	I-DNA
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
purified	VBN	ROOT	O
from	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
of	IN	case	O
Namalwa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
(	-LRB-	punct	O
human	JJ	amod	B-cell_line
Burkitt	NN	compound	I-cell_line
lymphoma	NN	compound	I-cell_line
cells	NNS	appos	I-cell_line
)	-RRB-	punct	O
by	IN	case	O
sequence-specific	JJ	amod	O
DNA	NN	compound	O
affinity	NN	compound	O
chromatography	NN	nmod	O
.	.	punct	O

The	DT	det	O
purified	VBN	amod	O
NF-kappa	NN	compound	B-protein
B	NN	nsubjpass	I-protein
has	VBZ	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
51-kDa	JJ	amod	B-protein
polypeptide	NN	nmod	I-protein
by	IN	case	O
UV-crosslinking	JJ	amod	O
analysis	NN	nmod	O
.	.	punct	O

``	``	punct	O
Footprint	NNP	nsubj	O
''	''	punct	O
and	CC	cc	O
methylation-interference	JJ	amod	O
analyses	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
purified	VBN	amod	O
NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
has	VBZ	ccomp	O
a	DT	det	O
binding	NN	compound	O
activity	NN	dobj	O
specific	JJ	amod	O
for	IN	case	O
the	DT	det	O
kappa	NN	compound	B-DNA
light	JJ	amod	I-DNA
chain	NN	compound	I-DNA
enhancer	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
purified	VBN	amod	O
factor	NN	ROOT	O
activated	VBN	acl	O
in	FW	amod	O
vitro	FW	dep	O
transcription	NN	dobj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
I	CD	nummod	I-DNA
promoter	NN	nmod	I-DNA
by	IN	mark	O
binding	VBG	acl	O
to	TO	case	O
an	DT	det	O
upstream	JJ	amod	B-DNA
NF-kappa	NN	compound	I-DNA
B-binding	JJ	amod	I-DNA
site	NN	nmod	I-DNA

Lymphocyte	NN	compound	B-cell_type
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
binding	NN	ROOT	O
in	IN	case	O
depression	NN	nmod	O
:	:	punct	O
normal	JJ	amod	O
values	NNS	dep	O
following	VBG	case	O
recovery	NN	nmod	O
.	.	punct	O

The	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
sites	NNS	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
and	CC	cc	O
plasma	NN	compound	O
cortisol	NN	compound	O
concentrations	NNS	conj	O
were	VBD	auxpass	O
measured	VBN	ROOT	O
in	IN	case	O
20	CD	nummod	O
patients	NNS	nmod	O
who	WP	nsubj	O
had	VBD	aux	O
recovered	VBN	acl:relcl	O
from	IN	case	O
major	JJ	amod	O
depressive	JJ	amod	O
disorder	NN	nmod	O
and	CC	cc	O
20	CD	nummod	O
healthy	JJ	amod	O
control	NN	compound	O
subjects	NNS	conj	O
.	.	punct	O

The	DT	det	O
number	NN	nsubj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
sites	NNS	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
from	IN	case	O
the	DT	det	O
recovered	VBN	amod	O
depressed	JJ	amod	O
group	NN	nmod	O
was	VBD	cop	O
not	RB	neg	O
significantly	RB	advmod	O
different	JJ	ROOT	O
from	IN	case	O
that	DT	nmod	O
of	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
mean	NN	amod	O
plasma	NN	compound	O
cortisol	NN	compound	O
concentration	NN	nsubj	O
in	IN	case	O
recovered	VBN	amod	O
depressives	NNS	nmod	O
was	VBD	cop	O
higher	JJR	advcl	O
than	IN	case	O
in	IN	case	O
control	JJ	amod	O
subjects	NNS	nmod	O
,	,	punct	O
the	DT	det	O
difference	NN	nsubj	O
only	RB	advmod	O
just	RB	advmod	O
reached	VBN	ROOT	O
significance	NN	dobj	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
reduction	NN	nsubj	O
in	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
numbers	NNS	nmod	O
which	WDT	nsubj	O
occurs	VBZ	acl:relcl	O
during	IN	case	O
acute	JJ	amod	O
depressive	JJ	amod	O
illness	NN	nmod	O
does	VBZ	aux	O
not	RB	neg	O
persist	VB	ccomp	O
on	IN	prep	O
recovery	NN	pobj	O
and	CC	cc	O
is	VBZ	cop	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
state-dependent	JJ	conj	O
.	.	punct	O

Identification	NN	ROOT	O
and	CC	cc	O
purification	NN	conj	O
of	IN	case	O
a	DT	det	O
human	JJ	amod	B-protein
lymphoid-specific	JJ	amod	I-protein
octamer-binding	JJ	amod	I-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
OTF-2	NN	appos	B-protein
)	-RRB-	punct	O
that	WDT	nsubj	O
activates	VBZ	acl:relcl	O
transcription	NN	dobj	O
of	IN	case	O
an	DT	det	O
immunoglobulin	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

The	DT	det	O
octamer	NN	compound	O
sequence	NN	compound	O
5'-ATGCAAAT	NN	nsubj	O
,	,	punct	O
in	IN	case	O
either	DT	det	O
orientation	NN	nmod	O
,	,	punct	O
serves	VBZ	ROOT	O
as	IN	case	O
an	DT	det	O
upstream	JJ	amod	B-DNA
element	NN	nmod	I-DNA
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
promoters	NNS	nmod	B-DNA
and	CC	cc	O
also	RB	advmod	O
occurs	VBZ	conj	O
as	IN	case	O
a	DT	det	O
modular	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
of	IN	case	O
particular	JJ	amod	O
interest	NN	ROOT	O
in	IN	case	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
since	IN	mark	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
found	VBN	advcl	O
in	IN	case	O
the	DT	det	O
upstream	JJ	amod	B-DNA
regions	NNS	nmod	I-DNA
of	IN	case	O
all	DT	det	O
heavy	JJ	amod	B-DNA
and	CC	cc	I-DNA
light	JJ	conj	I-DNA
chain	NN	compound	I-DNA
promoters	NNS	nmod	I-DNA
and	CC	cc	O
in	IN	case	O
the	DT	det	O
heavy	JJ	amod	B-DNA
chain	NN	compound	I-DNA
enhancer	NN	conj	I-DNA
,	,	punct	O
both	DT	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
are	VBP	auxpass	O
known	VBN	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
necessary	JJ	xcomp	O
for	IN	case	O
cell-specific	JJ	amod	O
expression	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
the	DT	det	O
chromatographic	JJ	amod	O
separation	NN	dobj	O
of	IN	case	O
ubiquitous	JJ	amod	B-protein
and	CC	cc	I-protein
B	NN	nmod:npmod	I-protein
cell-specific	JJ	conj	I-protein
octamer-binding	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
B	NN	compound	B-protein
cell	NN	compound	I-protein
factor	NN	nsubjpass	I-protein
was	VBD	auxpass	O
purified	VBN	ROOT	O
to	TO	case	O
homogeneity	NN	nmod	O
using	VBG	acl	O
affinity	NN	compound	O
chromatography	NN	dobj	O
and	CC	cc	O
consists	VBZ	conj	O
of	IN	case	O
three	CD	nummod	O
peptides	NNS	nmod	O
of	IN	case	O
62	CD	nummod	O
,	,	punct	O
61	CD	nmod	O
,	,	punct	O
and	CC	cc	O
58.5	CD	nummod	O
+/-	CC	cc	O
1.5	CD	conj	O
kd	NN	conj	O
.	.	punct	O

Each	DT	nsubjpass	O
of	IN	case	O
the	DT	det	O
polypeptides	NNS	nmod	O
was	VBD	auxpass	O
renatured	VBN	ROOT	O
after	IN	case	O
SDS-PAGE	NN	nmod	O
and	CC	cc	O
shown	VBN	conj	O
to	TO	mark	O
bind	VB	xcomp	O
to	TO	case	O
the	DT	det	O
octamer	NN	compound	O
sequence	NN	nmod	O
.	.	punct	O

The	DT	det	O
specific	JJ	amod	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
pure	JJ	amod	O
B	NN	compound	B-protein
cell-specific	JJ	amod	I-protein
factor	NN	nmod	I-protein
was	VBD	cop	O
indistinguishable	JJ	ROOT	O
from	IN	case	O
that	DT	nmod	O
of	IN	case	O
the	DT	det	O
affinity-purified	JJ	amod	B-protein
ubiquitous	JJ	amod	I-protein
factor	NN	nmod	I-protein
.	.	punct	O

This	DT	det	O
B	NN	compound	B-protein
cell-specific	JJ	amod	I-protein
octamer-binding	JJ	amod	I-protein
factor	NN	nsubj	I-protein
,	,	punct	O
in	IN	case	O
pure	JJ	amod	O
form	NN	nmod	O
,	,	punct	O
activated	VBD	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
a	DT	det	O
kappa	NN	compound	B-DNA
light	JJ	amod	I-DNA
chain	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
thus	RB	advmod	O
demonstrating	VBG	xcomp	O
that	IN	mark	O
it	PRP	nsubj	O
is	VBZ	cop	O
indeed	RB	advmod	O
a	DT	det	O
B	NN	nmod:npmod	B-protein
cell-specific	JJ	amod	I-protein
transcription	NN	compound	I-protein
factor	NN	ccomp	I-protein
for	IN	case	O
this	DT	det	O
gene	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	case	O
the	DT	det	O
ubiquitous	JJ	amod	B-protein
and	CC	cc	I-protein
B	NN	nmod:npmod	I-protein
cell-specific	JJ	conj	I-protein
octamer-binding	JJ	amod	I-protein
factors	NNS	nmod	I-protein
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
several	JJ	amod	O
additional	JJ	amod	O
proteins	NNS	dobj	O
,	,	punct	O
one	CD	nsubj	O
of	IN	case	O
which	WDT	nmod	O
is	VBZ	cop	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
-specific	JJ	acl:relcl	O
,	,	punct	O
that	WDT	nsubj	O
interact	VBP	acl:relcl	O
with	IN	case	O
the	DT	det	O
kappa	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Decreased	VBN	amod	O
deoxyribonucleic	JJ	amod	O
acid	NN	compound	O
binding	NN	ROOT	O
of	IN	case	O
glucocorticoid-receptor	JJ	amod	B-protein
complex	NN	nmod	I-protein
in	IN	case	O
cultured	VBN	amod	O
skin	NN	compound	B-cell_line
fibroblasts	NNS	nmod	I-cell_line
from	IN	case	O
a	DT	det	O
patient	NN	nmod	O
with	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	O
resistance	NN	compound	O
syndrome	NN	nmod	O
.	.	punct	O

A	DT	det	O
patient	NN	nsubjpass	O
with	IN	case	O
the	DT	det	O
syndrome	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	O
resistance	NN	nmod	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
.	.	punct	O

A	DT	det	O
27-yr-old	JJ	nummod	O
woman	NN	nsubjpass	O
initially	RB	advmod	O
was	VBD	auxpass	O
diagnosed	VBN	ROOT	O
as	IN	prep	O
having	VBG	pcomp	O
Cushing	NN	nmod:poss	O
's	POS	case	O
disease	NN	dobj	O
,	,	punct	O
based	VBN	case	O
on	IN	case	O
the	DT	det	O
findings	NNS	advcl	O
of	IN	case	O
high	JJ	amod	O
plasma	NN	compound	O
ACTH	NN	nmod	O
and	CC	cc	O
serum	NN	compound	O
cortisol	NN	compound	O
levels	NNS	conj	O
,	,	punct	O
increased	VBN	amod	O
urinary	JJ	amod	O
cortisol	NN	compound	O
secretion	NN	conj	O
,	,	punct	O
resistance	NN	appos	O
to	TO	case	O
adrenal	JJ	amod	O
suppression	NN	nmod	O
with	IN	case	O
dexamethasone	NN	nmod	O
,	,	punct	O
and	CC	cc	O
bilateral	JJ	amod	O
adrenal	JJ	amod	O
hyperplasia	NN	conj	O
by	IN	case	O
computed	JJ	amod	O
tomography	NN	nmod	O
and	CC	cc	O
scintigraphy	NN	conj	O
of	IN	prep	O
the	DT	det	O
adrenal	JJ	amod	O
glands	NNS	pobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
she	PRP	nsubj	O
had	VBD	ROOT	O
no	DT	det	O
signs	NNS	dobj	O
or	CC	cc	O
symptoms	NNS	conj	O
of	IN	prep	O
Cushing	NN	nmod:poss	O
's	POS	case	O
syndrome	NN	pobj	O
.	.	punct	O

During	IN	case	O
a	DT	det	O
5-yr	JJ	amod	O
follow-up	NN	nmod	O
,	,	punct	O
no	DT	neg	O
clinical	JJ	amod	O
abnormalities	NNS	nsubj	O
developed	VBN	ROOT	O
,	,	punct	O
although	IN	mark	O
hypercortisolism	NN	nsubj	O
persisted	VBD	advcl	O
.	.	punct	O

End-organ	JJ	amod	O
resistance	NN	nsubjpass	O
to	TO	case	O
cortisol	NN	nmod	O
was	VBD	auxpass	O
suspected	VBN	ROOT	O
.	.	punct	O

To	TO	mark	O
explain	VB	ROOT	O
the	DT	det	O
end-organ	JJ	amod	O
resistance	NN	dobj	O
to	TO	case	O
cortisol	NN	nmod	O
,	,	punct	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
and	CC	cc	O
cultured	VBN	amod	B-cell_line
skin	NN	compound	I-cell_line
fibroblasts	NNS	conj	I-cell_line
from	IN	case	O
a	DT	det	O
forearm	JJ	amod	O
skin	NN	compound	O
biopsy	NN	nmod	O
were	VBD	auxpass	O
characterized	VBN	parataxis	O
and	CC	cc	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
results	NNS	conj	O
of	IN	case	O
similar	JJ	amod	O
studies	NNS	nmod	O
in	IN	case	O
normal	JJ	amod	O
subjects	NNS	nmod	O
.	.	punct	O

The	DT	det	O
patient	NN	nmod:poss	O
's	POS	case	O
GR	NN	nsubj	B-protein
in	IN	case	O
whole	JJ	amod	O
cell	NN	compound	O
assays	NNS	nmod	O
had	VBD	ROOT	O
an	DT	det	O
increased	VBN	amod	O
dissociation	NN	compound	O
constant	NN	dobj	O
(	-LRB-	punct	O
Kd	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
cytosol	NN	nmod	O
of	IN	case	O
cultured	VBN	amod	B-cell_line
skin	NN	compound	I-cell_line
fibroblasts	NNS	nmod	I-cell_line
from	IN	case	O
the	DT	det	O
patient	NN	nmod	O
,	,	punct	O
there	EX	expl	O
was	VBD	auxpass	O
also	RB	advmod	O
decreased	VBN	ROOT	O
binding	NN	compound	O
capacity	NN	dobj	O
.	.	punct	O

The	DT	det	O
thermal	JJ	amod	O
stability	NN	nsubj	O
and	CC	cc	O
the	DT	det	O
sedimentation	NN	compound	O
coefficient	NN	conj	O
in	IN	case	O
a	DT	det	O
sucrose	NN	compound	O
density	NN	compound	O
gradient	NN	nmod	O
of	IN	case	O
the	DT	det	O
receptors	NNS	nmod	O
in	IN	case	O
the	DT	det	O
cytosol	NN	nmod	O
of	IN	case	O
cultured	VBN	amod	B-cell_line
skin	NN	compound	I-cell_line
fibroblasts	NNS	nmod	I-cell_line
from	IN	case	O
the	DT	det	O
patient	NN	nmod	O
and	CC	cc	O
normal	JJ	amod	O
subjects	NNS	conj	O
were	VBD	cop	O
similar	JJ	ROOT	O
.	.	punct	O

GR	NN	compound	B-cell_line
complex	NN	compound	I-cell_line
activation	NN	nsubjpass	I-cell_line
,	,	punct	O
analyzed	VBN	acl	O
by	IN	case	O
DEAE-cellulose	JJ	amod	B-cell_line
chromatography	NN	nmod	I-cell_line
,	,	punct	O
was	VBD	auxpass	O
decreased	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
patient	NN	nmod	O
.	.	punct	O

DNA	NN	compound	B-DNA
binding	NN	nsubj	O
of	IN	case	O
the	DT	det	O
GR	NN	compound	B-protein
complex	NN	nmod	I-protein
after	IN	case	O
temperature-induced	JJ	amod	O
activation	NN	nmod	O
was	VBD	cop	O
lower	JJR	ROOT	O
in	IN	case	O
the	DT	det	O
patient	NN	nmod	O
than	IN	case	O
in	IN	case	O
normal	JJ	amod	O
subjects	NNS	nmod	O
.	.	punct	O

Nuclear	JJ	amod	O
translocation	NN	nsubjpass	O
of	IN	case	O
GR	NN	compound	B-protein
complexes	NNS	nmod	I-protein
from	IN	case	O
the	DT	det	O
patient	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
slightly	RB	advmod	O
decreased	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
patient	NN	nmod:poss	O
's	POS	case	O
glucocorticoid	NN	compound	O
resistance	NN	nsubj	O
was	VBD	cop	O
due	JJ	case	O
to	TO	case	O
a	DT	det	O
decrease	NN	ccomp	O
in	IN	case	O
the	DT	det	O
affinity	NN	nmod	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
for	IN	case	O
glucocorticoids	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
decrease	NN	conj	O
in	IN	case	O
the	DT	det	O
binding	NN	nmod	O
of	IN	case	O
the	DT	det	O
GR	NN	compound	B-protein
complex	NN	nmod	I-protein
to	TO	case	O
DNA	NN	nmod	B-DNA
.	.	punct	O

Granulocyte-macrophage	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	ROOT	I-protein
.	.	punct	O

Sensitive	JJ	amod	O
and	CC	cc	O
receptor-mediated	JJ	conj	O
regulation	NN	ROOT	O
by	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nsubj	O
(	-LRB-	punct	O
1	CD	dep	O
,	,	punct	O
25	CD	appos	O
[	-LRB-	punct	O
OH	NN	dep	O
]	-RRB-	punct	O
2D3	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
most	RBS	advmod	O
hormonally	RB	advmod	O
active	JJ	amod	O
metabolite	NN	appos	O
of	IN	case	O
vitamin	NN	compound	O
D3	NN	nmod	O
,	,	punct	O
modulates	VBZ	ccomp	O
sensitively	RB	advmod	O
and	CC	cc	O
specifically	RB	advmod	O
both	CC	cc:preconj	O
the	DT	dep	O
protein	NN	compound	O
and	CC	cc	O
messenger	NN	conj	B-RNA
RNA	NN	compound	I-RNA
accumulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
multilineage	NN	compound	B-protein
growth	NN	compound	I-protein
factor	NN	compound	I-protein
granulocyte-macrophage	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
GM-CSF	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
regulation	NN	nsubjpass	O
of	IN	case	O
GM-CSF	NN	compound	B-protein
expression	NN	nmod	O
is	VBZ	auxpass	O
seen	VBN	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
normal	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
mitogen-activated	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
T	NN	compound	B-cell_line
lymphocytes	NNS	conj	I-cell_line
from	IN	case	I-cell_line
a	DT	det	I-cell_line
line	NN	nmod	I-cell_line
(	-LRB-	punct	I-cell_line
S-LB1	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
transformed	VBN	acl	I-cell_line
with	IN	case	I-cell_line
human	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lymphotropic	JJ	amod	I-cell_line
virus	NN	nmod	I-cell_line
1	CD	nummod	I-cell_line
(	-LRB-	punct	O
HTLV-1	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
cells	NNS	nsubj	O
from	IN	case	O
a	DT	det	O
HTLV-1	NN	compound	B-cell_line
transformed	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
lymphocyte	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
(	-LRB-	punct	O
Ab-VDR	NN	appos	B-cell_line
)	-RRB-	punct	O
established	VBN	acl	O
from	IN	case	O
a	DT	det	O
patient	NN	nmod	O
with	IN	case	O
vitamin	NN	compound	O
D-resistant	JJ	amod	O
rickets	NN	compound	O
type	NN	nmod	O
II	CD	nummod	O
with	IN	case	O
undetectable	JJ	amod	O
1	CD	dep	B-protein
,	,	punct	I-protein
25	CD	nummod	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	compound	I-protein
cellular	JJ	amod	I-protein
receptors	NNS	nmod	I-protein
are	VBP	cop	O
resistant	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
action	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
GM-CSF	NN	compound	B-protein
expression	NN	nmod	O
by	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
can	MD	aux	O
occur	VB	ROOT	O
independently	RB	advmod	O
of	IN	case	O
interleukin	NN	compound	B-protein
2	CD	nummod	I-protein
regulation	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
probably	RB	advmod	O
mediated	VBN	conj	O
through	IN	case	O
cellular	JJ	nmod	B-protein
1	CD	dep	I-protein
,	,	punct	I-protein
25	CD	nummod	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	compound	I-protein
receptors	NNS	dep	I-protein
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
important	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
physiology	NN	nmod	O
of	IN	case	O
hematopoiesis	NN	nmod	O
.	.	punct	O

Altered	JJ	amod	O
interaction	NN	ROOT	O
between	IN	case	O
triiodothyronine	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
nuclear	JJ	amod	B-protein
receptors	NNS	conj	I-protein
in	IN	case	O
absence	NN	nmod	O
of	IN	case	O
cortisol	NN	nmod	O
:	:	punct	O
a	DT	det	O
proposed	VBN	amod	O
mechanism	NN	dep	O
for	IN	case	O
increased	VBN	amod	O
thyrotropin	NN	compound	O
secretion	NN	nmod	O
in	IN	case	O
corticosteroid	NN	compound	O
deficiency	NN	compound	O
states	NNS	nmod	O
.	.	punct	O

Thyroid	NN	compound	O
hormones	NNS	nsubj	O
occasionally	RB	advmod	O
appear	VBP	ROOT	O
less	RBR	advmod	O
effective	JJ	xcomp	O
when	WRB	advmod	O
administered	VBN	advcl	O
alone	RB	advmod	O
to	TO	case	O
patients	NNS	nmod	O
with	IN	case	O
panhypopituitarism	NN	nmod	O
,	,	punct	O
and	CC	cc	O
manifestations	NNS	nsubjpass	O
suggestive	JJ	amod	O
of	IN	case	O
hypothyroidism	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	conj	O
in	IN	case	O
patients	NNS	nmod	O
suffering	VBG	acl	O
from	IN	case	O
untreated	JJ	amod	O
Addison	NNP	poss	O
's	POS	case	O
disease	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
latter	JJ	amod	O
condition	NN	nmod	O
,	,	punct	O
thyrotropin	NN	compound	O
secretion	NN	nsubjpass	O
is	VBZ	auxpass	O
increased	VBN	ROOT	O
:	:	punct	O
this	DT	nsubj	O
occurs	VBZ	dep	O
already	RB	advmod	O
after	IN	case	O
as	RB	advmod	O
little	JJ	amod	O
as	IN	quantmod	O
2	CD	nummod	O
days	NNS	nmod	O
of	IN	case	O
temporary	JJ	amod	O
withdrawal	NN	nmod	O
of	IN	case	O
therapy	NN	nmod	O
with	IN	case	O
substitution	NN	compound	O
doses	NNS	nmod	O
of	IN	case	O
corticosteroids	NNS	nmod	O
while	IN	mark	O
circulating	VBG	amod	O
levels	NNS	nsubj	O
of	IN	case	O
thyroid	NN	compound	O
hormones	NNS	nmod	O
remain	VBP	advcl	O
within	IN	case	O
normal	JJ	amod	O
limits	NNS	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
a	DT	det	O
possible	JJ	amod	O
role	NN	nsubjpass	O
of	IN	case	O
cortisol	NN	nmod	O
in	IN	case	O
interaction	NN	nmod	O
between	IN	case	O
triiodothyronine	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
nuclear	JJ	amod	B-protein
receptors	NNS	conj	I-protein
was	VBD	auxpass	O
examined	VBN	ROOT	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
circulating	VBG	amod	O
lymphocytes	NNS	nmod	O
obtained	VBN	acl	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
primary	JJ	amod	O
or	CC	cc	O
secondary	JJ	conj	O
adrenocortical	JJ	amod	O
failure	NN	nmod	O
.	.	punct	O

The	DT	det	O
affinity	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
receptors	NNS	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
decreased	VBN	xcomp	O
,	,	punct	O
by	IN	prep	O
more	JJR	amod	O
than	IN	quantmod	O
50	CD	nummod	O
%	NN	pobj	O
on	IN	prep	O
average	JJ	pobj	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
cortisol	NN	compound	O
treatments	NNS	nmod	O
.	.	punct	O

This	DT	det	O
change	NN	nsubjpass	O
was	VBD	auxpass	O
promptly	RB	advmod	O
corrected	VBN	ROOT	O
upon	IN	case	O
resumption	NN	nmod	O
of	IN	case	O
therapy	NN	nmod	O
.	.	punct	O

The	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
binding	VBG	amod	O
sites	NNS	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
significantly	RB	advmod	O
modified	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
influence	NN	nsubj	O
of	IN	case	O
cortisol	NN	nmod	O
on	IN	case	O
thyroid	NN	compound	B-protein
hormone	NN	compound	I-protein
receptors	NNS	nmod	I-protein
discussed	VBN	csubj	O
here	RB	advmod	O
might	MD	aux	O
account	VB	ROOT	O
for	IN	case	O
the	DT	det	O
clinical	JJ	amod	O
observations	NNS	nmod	O
mentioned	VBN	acl	O
above	RB	advmod	O
.	.	punct	O

Inhibition	NN	ROOT	O
by	IN	case	O
cortisol	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
natural	JJ	amod	I-cell_type
killer	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
NK	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
cell	NN	compound	I-cell_type
activity	NN	nmod	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
cortisol	NN	nmod	O
on	IN	case	O
the	DT	det	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
(	-LRB-	punct	O
NK	NN	appos	O
)	-RRB-	punct	O
activity	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
(	-LRB-	punct	I-cell_type
PBM	NN	dep	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	auxpass	O
studied	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
using	VBG	xcomp	O
a	DT	det	O
direct	JJ	amod	O
4-h	JJ	amod	O
51Cr-release	NN	amod	O
assay	NN	dobj	O
and	CC	cc	O
K	NN	compound	B-cell_line
562	CD	nummod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	conj	I-cell_line
as	IN	case	O
a	DT	det	O
target	NN	nmod	O
.	.	punct	O

Preincubation	NN	nsubj	O
for	IN	case	O
20	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
PBM	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
drawn	VBN	ROOT	O
from	IN	case	O
healthy	JJ	amod	O
donors	NNS	nmod	O
with	IN	case	O
1	CD	nummod	O
X	NN	nmod	O
10	CD	nummod	O
(	-LRB-	punct	O
-8	CD	appos	O
)	-RRB-	punct	O
to	TO	case	O
1	CD	nummod	O
X	NN	compound	O
10	CD	nummod	O
(	-LRB-	punct	O
-5	CD	appos	O
)	-RRB-	punct	O
M	NN	compound	O
cortisol	NN	nmod	O
resulted	VBD	conj	O
in	IN	case	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	nmod	O
of	IN	case	O
NK	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activity	NN	nmod	O
.	.	punct	O

The	DT	det	O
magnitude	NN	nsubj	O
of	IN	case	O
the	DT	det	O
suppression	NN	nmod	O
was	VBD	cop	O
directly	RB	advmod	O
related	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
steroid	NN	compound	O
concentration	NN	nmod	O
and	CC	cc	O
inversely	RB	advmod	O
related	JJ	conj	O
to	TO	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
effector	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Cortisol	NN	nsubj	O
was	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
minimize	VB	xcomp	O
the	DT	det	O
enhancement	NN	dobj	O
of	IN	case	O
NK	NN	compound	O
cytotoxicity	NN	nmod	O
obtainable	NN	amod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
immune	JJ	amod	O
interferon	NN	nmod	O
(	-LRB-	punct	O
IFN-gamma	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
significantly	RB	advmod	O
higher	JJR	amod	O
suppression	NN	nsubjpass	O
was	VBD	auxpass	O
achieved	VBN	ROOT	O
after	IN	case	O
sequential	JJ	amod	O
exposure	NN	nmod	O
of	IN	case	O
PBM	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
cortisol	NN	nmod	O
and	CC	cc	O
equimolar	JJ	amod	O
levels	NNS	conj	O
of	IN	case	O
prostaglandin	NN	compound	O
E2	NN	nmod	O
(	-LRB-	punct	O
PgE2	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
concomitant	JJ	amod	O
incubation	NN	nsubj	O
with	IN	case	O
theophylline	NN	nmod	O
and	CC	cc	O
isobutyl-methylxanthine	NN	conj	O
failed	VBD	ROOT	O
to	TO	mark	O
enhance	VB	xcomp	O
the	DT	det	O
cortisol-induced	JJ	amod	O
suppression	NN	dobj	O
,	,	punct	O
whereas	IN	mark	O
PgE2-dependent	JJ	amod	O
inhibition	NN	nsubj	O
significantly	RB	advmod	O
increased	VBD	advcl	O
after	IN	case	O
exposure	NN	nmod	O
of	IN	case	O
PBM	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
methyl-xanthines	NNS	nmod	O
.	.	punct	O

The	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
cortisol	NN	nmod	O
was	VBD	auxpass	O
partially	RB	advmod	O
or	CC	advmod	O
totally	RB	advmod	O
prevented	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
concomitant	JJ	amod	O
incubation	NN	nmod	O
with	IN	case	O
equimolar	JJ	amod	O
amounts	NNS	nmod	O
of	IN	case	O
11-deoxycortisol	NN	nmod	O
and	CC	cc	O
RU	NN	conj	O
486	CD	nummod	O
but	CC	cc	O
not	RB	neg	O
of	IN	case	O
progesterone	NN	conj	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
NK	NN	compound	B-cell_type
effectors	NNS	nmod	I-cell_type
with	IN	case	O
a	DT	det	O
monoclonal	JJ	amod	B-protein
anti-human	JJ	amod	I-protein
corticosteroid-binding	JJ	amod	I-protein
globulin	NN	compound	I-protein
(	-LRB-	punct	I-protein
CBG	NN	compound	I-protein
)	-RRB-	punct	I-protein
antibody	NN	nmod	I-protein
produced	VBD	ROOT	O
an	DT	det	O
enhancement	NN	dobj	O
of	IN	case	O
the	DT	det	O
spontaneous	JJ	amod	O
NK	NN	compound	B-cell_type
activity	NN	nmod	O
and	CC	cc	O
a	DT	det	O
partial	JJ	amod	O
suppression	NN	conj	O
of	IN	case	O
cortisol-mediated	JJ	amod	O
effects	NNS	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
endogenous	JJ	amod	O
glucocorticoids	NNS	nsubj	O
play	VBP	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
NK	NN	nmod:npmod	O
cell-mediated	JJ	amod	O
cytotoxicity	NN	nmod	O
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
effect	NN	nsubj	O
of	IN	case	O
cortisol	NN	nmod	O
was	VBD	cop	O
additive	JJ	advcl	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
PgE2	NN	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
not	RB	neg	O
changed	VBN	conj	O
by	IN	case	O
phosphodiesterase	NN	compound	B-protein
inhibitors	NNS	nmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
conceivable	JJ	ROOT	O
that	IN	mark	O
the	DT	det	O
hormone	NN	nsubj	O
acts	VBZ	ccomp	O
at	IN	case	O
a	DT	det	O
level	NN	nmod	O
different	JJ	amod	O
from	IN	case	O
the	DT	det	O
adenylate	NN	compound	B-protein
cyclase	NN	compound	I-protein
-	HYPH	punct	O
phosphodiesterase	NN	compound	B-protein
system	NN	nmod	O
.	.	punct	O

Data	NNS	nsubj	O
obtained	VBN	acl	O
with	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
antiglucocorticoids	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
anti-CBG	JJ	amod	B-protein
antibody	NN	conj	I-protein
are	VBP	cop	O
compatible	JJ	ROOT	O
with	IN	case	O
a	DT	det	O
role	NN	nmod	O
both	DT	dep	O
of	IN	case	O
high-affinity	JJ	amod	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
of	IN	case	O
CBG	NN	conj	B-protein
in	IN	mark	O
mediating	VBG	advcl	O
cortisol	NN	compound	O
action	NN	dobj	O
on	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_type
NK	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
activity	NN	nmod	O
.	.	punct	O

Interaction	NN	ROOT	O
of	IN	case	O
cell-type-specific	JJ	amod	B-protein
nuclear	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
with	IN	case	O
immunoglobulin	NN	compound	B-DNA
VH	NN	compound	I-DNA
promoter	NN	compound	I-DNA
region	NN	compound	I-DNA
sequences	NNS	nmod	I-DNA
.	.	punct	O

All	DT	det	O
human	JJ	amod	B-DNA
and	CC	cc	I-DNA
murine	JJ	conj	I-DNA
immunoglobulin	NN	compound	I-DNA
heavy	JJ	amod	I-DNA
chain	NN	compound	I-DNA
variable	JJ	amod	I-DNA
region	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
VH	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
genes	NNS	nsubj	I-DNA
contain	VBP	ROOT	O
the	DT	det	O
sequence	NN	compound	O
ATGCAAAT	NN	dobj	O
approximately	RB	advmod	O
70	CD	nummod	O
nucleotides	NNS	dep	O
5	CD	nummod	O
'	''	punct	O
from	IN	case	O
the	DT	det	O
site	NN	nmod	O
of	IN	case	O
transcription	NN	compound	O
initiation	NN	nmod	O
.	.	punct	O

This	DT	det	O
octanucleotide	NN	nsubjpass	O
,	,	punct	O
in	IN	case	O
reverse	JJ	amod	O
orientation	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
light	JJ	amod	B-DNA
chain	NN	compound	I-DNA
variable	JJ	amod	I-DNA
region	NN	dep	I-DNA
(	-LRB-	punct	I-DNA
VL	NN	dep	I-DNA
)	-RRB-	punct	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
heavy	JJ	amod	I-DNA
chain	NN	compound	I-DNA
transcriptional	JJ	amod	I-DNA
enhancer	NN	conj	I-DNA
.	.	punct	O

Transfection	NN	compound	O
studies	NNS	nsubj	O
have	VBP	aux	O
established	VBN	ROOT	O
that	IN	mark	O
this	DT	det	O
octamer	NN	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
lymphoid-specific	JJ	amod	O
transcription	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Octamer-containing	JJ	amod	B-DNA
fragments	NNS	nsubjpass	I-DNA
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
to	TO	mark	O
bind	VB	xcomp	O
a	DT	det	O
factor	NN	dobj	O
present	JJ	amod	O
in	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
identical	JJ	amod	O
binding	NN	compound	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	parataxis	O
in	IN	case	O
both	CC	cc:preconj	O
B	NN	compound	B-cell_line
lymphoid	JJ	nmod	I-cell_line
and	CC	cc	I-cell_line
non-lymphoid	JJ	conj	I-cell_line
cells	NNS	dep	I-cell_line
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
establish	VBP	ROOT	O
that	IN	mark	O
nuclear	JJ	amod	O
extracts	NNS	nsubj	O
from	IN	case	O
distinct	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
differ	VBP	ccomp	O
in	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
interact	VB	acl	O
with	IN	case	O
octamer-containing	JJ	amod	B-DNA
fragments	NNS	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
also	RB	advmod	O
detected	VBN	ROOT	O
a	DT	det	O
DNA-protein	JJ	amod	O
interaction	NN	dobj	O
that	WDT	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
cell-type	JJ	amod	O
specificity	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-protein
expression	NN	nmod	O
,	,	punct	O
and	CC	cc	O
we	PRP	nsubj	O
have	VBP	aux	O
determined	VBN	conj	O
that	IN	mark	O
a	DT	det	O
sequence	NN	nsubj	O
upstream	JJ	amod	O
of	IN	case	O
the	DT	det	O
octamer	NN	nmod	O
participates	VBZ	ccomp	O
in	IN	case	O
an	DT	det	O
interaction	NN	nmod	O
with	IN	case	O
a	DT	det	O
nuclear	JJ	amod	B-protein
protein	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Preferential	JJ	amod	O
transcription	NN	ROOT	O
of	IN	case	O
HTLV-I	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
in	IN	case	O
cell-free	JJ	amod	O
extracts	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
producing	VBG	acl	O
HTLV-I	NN	compound	B-protein
viral	JJ	amod	I-protein
proteins	NNS	dobj	I-protein
.	.	punct	O

The	DT	det	O
promoters	NNS	nsubjpass	B-DNA
of	IN	case	O
the	DT	det	O
adenovirus	NN	compound	B-DNA
2	CD	nummod	I-DNA
major	JJ	amod	I-DNA
late	JJ	amod	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
the	DT	det	O
mouse	NN	compound	B-DNA
beta-globin	NN	compound	I-DNA
gene	NN	appos	I-DNA
,	,	punct	O
the	DT	det	O
mouse	NN	compound	B-DNA
immunoglobulin	NN	compound	I-DNA
VH	NN	compound	I-DNA
gene	NN	appos	I-DNA
and	CC	cc	O
the	DT	det	O
LTR	NN	conj	B-DNA
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
T-lymphotropic	JJ	amod	O
retrovirus	NN	compound	O
type	NN	nmod	O
I	CD	nummod	O
were	VBD	auxpass	O
tested	VBN	ROOT	O
for	IN	case	O
their	PRP$	nmod:poss	O
transcription	NN	compound	O
activities	NNS	nmod	O
in	IN	case	O
cell-free	JJ	amod	O
extracts	NNS	nmod	O
of	IN	case	O
four	CD	nummod	O
cell	NN	compound	O
lines	NNS	nmod	O
;	:	punct	O
HeLa	NN	dep	B-cell_line
,	,	punct	O
CESS	NN	conj	B-cell_line
(	-LRB-	punct	O
Epstein-Barr	JJ	amod	B-cell_line
virus-transformed	JJ	amod	I-cell_line
human	JJ	amod	I-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	appos	I-cell_line
)	-RRB-	punct	O
,	,	punct	O
MT-1	NN	compound	B-cell_line
(	-LRB-	punct	O
HTLV-I-infected	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	conj	I-cell_line
without	IN	case	O
viral	JJ	amod	O
protein	NN	compound	O
synthesis	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
MT-2	NN	conj	B-cell_line
(	-LRB-	punct	O
HTLV-I-infected	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	dep	I-cell_line
producing	VBG	acl	O
viral	JJ	amod	B-protein
proteins	NNS	dobj	I-protein
)	-RRB-	punct	O
.	.	punct	O

LTR	NN	nsubjpass	B-DNA
was	VBD	auxpass	O
preferentially	RB	advmod	O
transcribed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
extracts	NNS	nmod	O
of	IN	case	O
MT-2	NN	nmod	B-cell_line
although	IN	mark	O
the	DT	det	O
other	JJ	amod	O
three	CD	nummod	O
genes	NNS	nsubjpass	O
were	VBD	auxpass	O
transcribed	VBN	advcl	O
with	IN	case	O
relatively	RB	advmod	O
constant	JJ	amod	O
efficiencies	NNS	nmod	O
in	IN	case	O
different	JJ	amod	O
extracts	NNS	nmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
agree	VBP	ROOT	O
well	RB	advmod	O
with	IN	case	O
the	DT	det	O
previous	JJ	amod	O
in	FW	amod	O
vivo	FW	dep	O
studies	NNS	nmod	O
on	IN	case	O
the	DT	det	O
promoter	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
HTLV-I	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
.	.	punct	O

Mixing	NN	nsubj	O
of	IN	case	O
HeLa	NN	compound	O
and	CC	cc	O
MT-2	NN	conj	O
extracts	NNS	nmod	O
revealed	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
a	DT	det	O
LTR-specific	JJ	amod	O
stimulating	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
MT-2	NN	compound	O
extracts	NNS	nmod	O
.	.	punct	O

A	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	ROOT	I-protein
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
a	DT	det	O
conserved	VBN	amod	O
sequence	NN	compound	O
motif	NN	nmod	O
in	IN	case	O
transcriptional	JJ	amod	B-DNA
control	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Trans-acting	JJ	amod	B-protein
factors	NNS	nsubjpass	I-protein
that	WDT	nsubj	O
mediate	VBP	acl:relcl	O
B-cell	NN	compound	O
specific	JJ	amod	O
transcription	NN	dobj	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
have	VBP	aux	O
been	VBN	auxpass	O
postulated	VBN	ROOT	O
based	VBN	case	O
on	IN	case	O
an	DT	det	O
analysis	NN	nmod	O
of	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
exogenously	RB	advmod	O
introduced	VBN	amod	O
immunoglobulin	NN	compound	B-DNA
gene	NN	compound	I-DNA
recombinants	VBZ	nmod	I-DNA
in	IN	case	O
lymphoid	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
non-lymphoid	JJ	conj	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Two	CD	nummod	O
B-cell-specific	JJ	amod	O
,	,	punct	O
cis-acting	JJ	dep	B-DNA
transcriptional	JJ	amod	I-DNA
regulatory	JJ	amod	I-DNA
elements	NNS	nsubjpass	I-DNA
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
.	.	punct	O

One	CD	nummod	O
element	NN	nsubj	O
is	VBZ	cop	O
located	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
intron	NN	nmod	O
between	IN	case	O
the	DT	det	O
variable	JJ	nmod	O
(	-LRB-	punct	O
V	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
constant	JJ	amod	O
(	-LRB-	punct	O
C	NN	appos	O
)	-RRB-	punct	O
regions	NNS	conj	O
of	IN	case	O
both	CC	cc:preconj	O
heavy	JJ	amod	B-DNA
and	CC	cc	I-DNA
kappa	NN	conj	I-DNA
light-chain	JJ	conj	I-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
acts	VBZ	conj	O
as	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	O
enhancer	NN	nmod	O
.	.	punct	O

The	DT	det	O
second	JJ	amod	O
element	NN	nsubjpass	B-DNA
is	VBZ	auxpass	O
found	VBN	ROOT	O
upstream	RB	advmod	O
of	IN	case	O
both	CC	cc:preconj	O
heavy	JJ	amod	B-DNA
and	CC	cc	I-DNA
kappa	NN	nmod:npmod	I-DNA
light-chain	JJ	conj	I-DNA
gene	NN	compound	I-DNA
promoters	NNS	nmod	I-DNA
.	.	punct	O

This	DT	det	O
element	NN	nsubj	O
directs	VBZ	ROOT	O
lymphoid-specific	JJ	amod	O
transcription	NN	dobj	O
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
presence	NN	advcl	O
of	IN	case	O
viral	JJ	amod	B-DNA
enhancers	NNS	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
sought	VBN	ROOT	O
nuclear	JJ	amod	O
factors	NNS	dobj	O
that	WDT	nsubj	O
might	MD	aux	O
bind	VB	acl:relcl	O
specifically	RB	advmod	O
to	TO	case	O
these	DT	det	O
two	CD	nummod	O
regulatory	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
by	IN	case	O
application	NN	nmod	O
of	IN	case	O
a	DT	det	O
modified	VBN	amod	O
gel	NN	compound	O
electrophoresis	NN	compound	O
DNA	NN	compound	O
binding	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
the	DT	det	O
identification	NN	dobj	O
of	IN	case	O
a	DT	det	O
human	JJ	amod	B-protein
B-cell	NN	compound	I-protein
nuclear	JJ	amod	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
IgNF-A	NN	appos	B-protein
)	-RRB-	punct	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
DNA	NN	compound	B-DNA
sequences	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
upstream	JJ	amod	B-DNA
regions	NNS	nmod	I-DNA
of	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
mouse	NN	compound	B-DNA
heavy	NN	dep	I-DNA
and	CC	cc	I-DNA
kappa	NN	nmod:npmod	I-DNA
light-chain	JJ	conj	I-DNA
gene	NN	compound	I-DNA
promoters	NNS	nmod	I-DNA
and	CC	cc	O
also	RB	advmod	O
to	TO	case	O
the	DT	det	O
mouse	NN	compound	B-DNA
heavy-chain	NN	amod	I-DNA
gene	NN	compound	I-DNA
enhancer	NN	conj	I-DNA
.	.	punct	O

This	DT	det	O
sequence-specific	JJ	amod	O
binding	NN	nsubjpass	O
is	VBZ	auxpass	O
probably	RB	advmod	O
mediated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
highly	RB	advmod	O
conserved	VBN	amod	O
sequence	NN	compound	O
motif	NN	nmod	O
,	,	punct	O
ATTTGCAT	NN	appos	O
,	,	punct	O
present	JJ	amod	O
in	IN	case	O
all	DT	det	O
three	CD	nummod	O
transcriptional	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
a	DT	det	O
factor	NN	nsubj	O
showing	VBG	acl	O
similar	JJ	amod	O
binding	NN	compound	O
specificity	NN	dobj	O
to	TO	case	O
IgNF-A	NN	nmod	B-DNA
is	VBZ	cop	O
also	RB	advmod	O
present	JJ	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_line
HeLa	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
new	JJ	amod	O
world	NN	compound	O
primates	NNS	ROOT	O
as	IN	case	O
animal	NN	compound	O
models	NNS	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	O
resistance	NN	nmod	O
.	.	punct	O

Many	JJ	amod	O
New	NNP	compound	O
World	NN	compound	O
primate	JJ	compound	O
species	NNS	nsubj	O
have	VBP	aux	O
greatly	RB	advmod	O
increased	VBN	ROOT	O
plasma	NN	compound	O
cortisol	NN	compound	O
concentrations	NNS	dobj	O
,	,	punct	O
decreased	VBN	dep	O
plasma	NN	compound	O
cortisol	NN	compound	O
binding	NN	compound	O
globulin	NN	compound	O
capacity	NN	dobj	O
and	CC	cc	O
affinity	NN	conj	O
,	,	punct	O
marked	JJ	amod	O
resistance	NN	dobj	O
of	IN	case	O
the	DT	det	O
hypothalamic-pituitary-adrenal	JJ	amod	O
axis	NN	nmod	O
to	TO	case	O
suppression	NN	nmod	O
by	IN	case	O
dexamethasone	NN	nmod	O
,	,	punct	O
and	CC	cc	O
no	DT	neg	O
biological	JJ	amod	O
evidence	NN	conj	O
of	IN	case	O
glucocorticoid	NN	compound	O
excess	NN	nmod	O
.	.	punct	O

These	DT	det	O
primates	NNS	nsubj	O
also	RB	advmod	O
have	VBP	ROOT	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
circulating	VBG	amod	O
progesterone	NN	nmod	O
,	,	punct	O
estrogen	NN	conj	O
,	,	punct	O
mineralocorticoid	NN	conj	O
,	,	punct	O
androgen	NN	conj	O
and	CC	cc	O
vitamin	NN	compound	O
D	NN	conj	O
.	.	punct	O

The	DT	det	O
glucocorticoid	NN	compound	O
target	NN	compound	O
tissues	NNS	nsubj	O
that	WDT	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
examined	VBN	acl:relcl	O
(	-LRB-	punct	O
circulating	VBG	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
lymphocytes	NNS	dobj	I-cell_type
and	CC	cc	O
cultured	VBN	amod	B-cell_line
skin	NN	compound	I-cell_line
fibroblasts	NNS	conj	I-cell_line
)	-RRB-	punct	O
have	VBP	ROOT	O
normal	JJ	amod	O
concentrations	NNS	dobj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
with	IN	case	O
decreased	VBN	amod	O
affinity	NN	nmod	O
for	IN	case	O
dexamethasone	NN	nmod	O
.	.	punct	O

Transformation	NN	nsubj	O
of	IN	case	O
B-lymphocytes	NNS	nmod	B-cell_type
with	IN	case	O
the	DT	det	O
Epstein-Barr	JJ	amod	O
virus	NN	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
induction	NN	nmod	O
that	WDT	nsubj	O
is	VBZ	cop	O
less	JJR	acl:relcl	O
than	IN	case	O
that	DT	nmod	O
observed	VBN	acl	O
with	IN	case	O
cells	NNS	nmod	O
from	IN	case	O
Old	JJ	compound	O
World	NN	compound	O
primates	NNS	nmod	O
.	.	punct	O

The	DT	det	O
receptor	NN	nsubj	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
has	VBZ	ROOT	O
a	DT	det	O
low	JJ	amod	O
affinity	NN	dobj	O
for	IN	case	O
dexamethasone	NN	nmod	O
.	.	punct	O

The	DT	det	O
low	JJ	amod	O
affinity	NN	nsubj	O
leads	VBZ	ROOT	O
to	TO	case	O
an	DT	det	O
increased	VBN	amod	O
loss	NN	nmod	O
of	IN	case	O
specific	JJ	amod	O
bound	VBN	amod	O
ligand	NN	nmod	O
during	IN	case	O
thermal	JJ	amod	O
activation	NN	nmod	O
.	.	punct	O

Meroreceptor	NN	compound	O
generation	NN	nsubj	O
is	VBZ	cop	O
normal	JJ	ROOT	O
.	.	punct	O

The	DT	det	O
molecular	JJ	amod	O
weight	NN	nsubj	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
,	,	punct	O
determined	VBN	acl	O
by	IN	case	O
SDS-PAGE	NN	nmod	O
,	,	punct	O
is	VBZ	cop	O
similar	JJ	ROOT	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
Old	JJ	compound	O
World	NN	compound	O
primates	NNS	nmod	O
(	-LRB-	punct	O
approximately	RB	advmod	O
92	CD	nummod	O
,	,	punct	O
000	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
activation	NN	compound	O
pattern	NN	conj	O
per	FW	compound	O
se	FW	advmod	O
,	,	punct	O
examined	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
by	IN	mark	O
heating	VBG	advcl	O
cytosol	NN	dobj	O
and	CC	cc	O
performing	VBG	conj	O
phosphocellulose	NN	compound	O
chromatography	NN	conj	O
,	,	punct	O
appears	VBZ	dep	O
similar	JJ	xcomp	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
human	JJ	amod	O
controls	NNS	nmod	O
.	.	punct	O

The	DT	det	O
ratios	NNS	nsubj	O
of	IN	case	O
nuclear	JJ	nmod	O
to	TO	case	O
cytosolic	JJ	amod	B-protein
hormone-receptor-complexes	NNS	nmod	I-protein
and	CC	cc	O
of	IN	case	O
cytosolic	JJ	conj	O
activated	VBN	acl	O
to	TO	case	O
unactivated	JJ	amod	B-protein
receptor	NN	compound	I-protein
complexes	NNS	nmod	I-protein
in	IN	case	O
intact	JJ	amod	O
cells	NNS	nmod	O
are	VBP	cop	O
similar	JJ	ROOT	O
to	TO	case	O
Old	JJ	compound	O
World	NN	compound	O
primates	NNS	nmod	O
.	.	punct	O

Results	NNS	nsubj	O
from	IN	case	O
mixing	JJ	amod	O
studies	NNS	nmod	O
do	VBP	aux	O
not	RB	neg	O
support	VB	ROOT	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
a	DT	det	O
binding	VBG	amod	O
inhibitor	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
or	CC	cc	O
a	DT	det	O
deficient	JJ	amod	O
cytosolic	JJ	amod	O
positive	JJ	amod	O
modifier	NN	compound	O
(	-LRB-	punct	O
s	NNS	conj	O
)	-RRB-	punct	O
of	IN	case	O
binding	NN	nmod	O
underlies	VBZ	ccomp	O
the	DT	det	O
findings	NNS	dobj	O
in	IN	case	O
these	DT	det	O
primates	NNS	nmod	O
.	.	punct	O

The	DT	det	O
New	NNP	compound	O
World	NNP	compound	O
primates	NNS	nsubj	O
,	,	punct	O
unlike	IN	case	O
men	NNS	nmod	O
with	IN	case	O
the	DT	det	O
syndrome	NN	nmod	O
of	IN	case	O
primary	JJ	amod	O
cortisol	NN	compound	O
resistance	NN	nmod	O
,	,	punct	O
have	VBP	aux	O
compensated	VBN	ROOT	O
for	IN	case	O
their	PRP$	nmod:poss	O
condition	NN	nmod	O
with	IN	case	O
intra-adrenal	JJ	amod	O
and	CC	cc	O
mineralocorticoid	NN	conj	O
receptor	NN	compound	O
adaptations	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
unlike	IN	case	O
Old	JJ	compound	O
World	NN	compound	O
primates	NNS	nmod	O
,	,	punct	O
cortisol	NN	nsubj	O
in	IN	prep	O
New	NNP	compound	O
World	NN	compound	O
primates	NNS	pobj	O
has	VBZ	ROOT	O
only	RB	advmod	O
weak	JJ	amod	O
sodium-retaining	JJ	amod	O
potency	NN	dobj	O
because	IN	mark	O
the	DT	det	O
aldosterone	NN	compound	B-protein
receptor	NN	nsubj	I-protein
has	VBZ	advcl	O
a	DT	det	O
low	JJ	amod	O
affinity	NN	dobj	O
for	IN	case	O
cortisol	NN	nmod	O
.	.	punct	O

The	DT	det	O
common	JJ	amod	O
element	NN	ROOT	O
that	WDT	nsubj	O
would	MD	aux	O
explain	VB	acl:relcl	O
the	DT	det	O
apparent	JJ	amod	O
resistance	NN	dobj	O
to	TO	case	O
six	CD	nummod	O
steroid	NN	compound	O
hormones	NNS	nmod	O
in	IN	case	O
New	NNP	compound	O
World	NN	compound	O
primates	NNS	nmod	O

Acetylation	NN	ROOT	O
and	CC	cc	O
modulation	NN	conj	O
of	IN	case	O
erythroid	JJ	amod	B-protein
Kruppel-like	JJ	amod	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	O
EKLF	NN	appos	B-protein
)	-RRB-	punct	O
activity	NN	nmod	O
by	IN	case	O
interaction	NN	nmod	O
with	IN	case	O
histone	NN	compound	B-protein
acetyltransferases	NNS	nmod	I-protein
.	.	punct	O

Erythroid	JJ	amod	B-protein
Kruppel-like	JJ	amod	I-protein
factor	NN	nsubj	I-protein
(	-LRB-	punct	O
EKLF	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
red	JJ	amod	B-protein
cell-specific	JJ	amod	I-protein
transcriptional	JJ	amod	I-protein
activator	NN	ROOT	I-protein
that	WDT	nsubj	O
is	VBZ	cop	O
crucial	JJ	acl:relcl	O
for	IN	mark	O
consolidating	VBG	advcl	O
the	DT	det	O
switch	NN	dobj	O
to	TO	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
adult	JJ	amod	O
beta-globin	NN	compound	O
expression	NN	nmod	O
during	IN	case	O
erythroid	JJ	amod	O
ontogeny	NN	nmod	O
.	.	punct	O

EKLF	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
integrity	NN	nmod	O
of	IN	case	O
the	DT	det	O
chromatin	NN	compound	O
structure	NN	nmod	O
at	IN	case	O
the	DT	det	O
beta-like	JJ	amod	B-DNA
globin	NN	compound	I-DNA
locus	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
it	PRP	nsubj	O
interacts	VBZ	conj	O
with	IN	case	O
a	DT	det	O
positive-acting	JJ	amod	B-protein
factor	NN	nmod	I-protein
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

We	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
EKLF	NN	nsubj	B-protein
is	VBZ	cop	O
an	DT	det	O
acetylated	VBN	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	ccomp	I-protein
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
it	PRP	nsubj	O
interacts	VBZ	conj	O
in	FW	compound	O
vivo	FW	advmod	O
with	IN	case	O
CBP	NN	compound	B-protein
,	,	punct	O
p300	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
P/CAF	NN	conj	B-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
interactions	NNS	nsubj	O
with	IN	case	O
these	DT	det	O
histone	NN	compound	B-protein
acetyltransferases	NNS	nmod	I-protein
are	VBP	cop	O
not	RB	neg	O
equivalent	JJ	ROOT	O
,	,	punct	O
as	IN	case	O
CBP	NN	nsubj	B-protein
and	CC	cc	O
p300	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
P/CAF	NN	conj	B-protein
,	,	punct	O
utilize	VBP	advcl	O
EKLF	NN	dobj	B-protein
as	IN	case	O
a	DT	det	O
substrate	NN	nmod	O
for	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
acetylation	NN	nmod	O
within	IN	case	O
its	PRP$	nmod:poss	O
trans-activation	NN	compound	O
region	NN	nmod	O
.	.	punct	O

The	DT	det	O
functional	JJ	amod	O
effects	NNS	nsubj	O
of	IN	case	O
these	DT	det	O
interactions	NNS	nmod	O
are	VBP	ROOT	O
that	IN	mark	O
CBP	NN	nsubj	B-protein
and	CC	cc	O
p300	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
P/CAF	NN	conj	B-protein
,	,	punct	O
enhance	VBP	ccomp	O
EKLF	NN	nmod:poss	B-protein
's	POS	case	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
beta-globin	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
erythroid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
establish	VBP	ROOT	O
EKLF	NN	dobj	B-protein
as	IN	case	O
a	DT	det	O
tissue-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
that	WDT	nsubj	O
undergoes	VBZ	acl:relcl	O
post-translational	JJ	amod	O
acetylation	NN	dobj	O
and	CC	cc	O
suggest	VBP	conj	O
a	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
EKLF	NN	nsubj	B-protein
is	VBZ	cop	O
able	JJ	acl:relcl	O
to	TO	mark	O
alter	VB	xcomp	O
chromatin	NN	compound	O
structure	NN	dobj	O
and	CC	cc	O
induce	VB	conj	O
beta-globin	NN	compound	O
expression	NN	dobj	O
within	IN	case	O
the	DT	det	O
beta-like	JJ	amod	B-DNA
globin	NN	compound	I-DNA
cluster	NN	nmod	I-DNA
.	.	punct	O

Recognition	NN	ROOT	O
of	IN	case	O
herpes	NN	compound	B-protein
simplex	NN	compound	I-protein
virus	NN	compound	I-protein
type	NN	compound	I-protein
2	CD	nummod	I-protein
tegument	NN	amod	I-protein
proteins	NNS	nmod	I-protein
by	IN	case	O
CD4	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
infiltrating	VBG	acl	O
human	JJ	amod	O
genital	JJ	amod	O
herpes	NN	compound	O
lesions	NNS	dobj	O
.	.	punct	O

The	DT	det	O
local	JJ	amod	O
cellular	JJ	amod	O
immune	JJ	amod	O
response	NN	nsubj	O
to	TO	case	O
herpes	NN	compound	O
simplex	NN	compound	O
virus	NN	nmod	O
(	-LRB-	punct	O
HSV	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
important	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
recurrent	JJ	amod	O
HSV	NN	compound	O
infection	NN	nmod	O
.	.	punct	O

The	DT	det	O
antiviral	JJ	amod	O
functions	NNS	nsubj	O
of	IN	case	O
infiltrating	VBG	amod	B-cell_type
CD4-bearing	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
may	MD	aux	O
include	VB	ROOT	O
cytotoxicity	NN	dobj	O
,	,	punct	O
inhibition	NN	appos	O
of	IN	case	O
viral	JJ	amod	O
growth	NN	nmod	O
,	,	punct	O
lymphokine	NN	compound	O
secretion	NN	conj	O
,	,	punct	O
and	CC	cc	O
support	NN	conj	O
of	IN	case	O
humoral	JJ	amod	O
and	CC	cc	O
CD8	NN	conj	O
responses	NNS	nmod	O
.	.	punct	O

The	DT	det	O
antigens	NNS	nsubj	O
recognized	VBN	acl	O
by	IN	case	O
many	JJ	amod	O
HSV-specific	JJ	amod	B-cell_type
CD4	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
localizing	VBG	acl	O
to	TO	case	O
genital	JJ	amod	O
HSV-2	NN	compound	O
lesions	NNS	nmod	O
are	VBP	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

T	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
recognizing	VBG	acl	O
antigens	NNS	dobj	O
encoded	VBN	acl	O
within	IN	case	O
map	NN	compound	O
units	NNS	nmod	O
0.67	CD	compound	O
to	TO	dep	O
0.73	CD	dep	O
of	IN	case	O
HSV	NN	compound	B-DNA
DNA	NN	nmod	I-DNA
are	VBP	auxpass	O
frequently	RB	advmod	O
recovered	VBN	ROOT	O
from	IN	case	O
herpetic	JJ	amod	O
lesions	NNS	nmod	O
.	.	punct	O

Expression	NN	compound	O
cloning	VBG	nsubj	O
with	IN	case	O
this	DT	det	O
region	NN	nmod	O
of	IN	case	O
DNA	NN	nmod	O
now	RB	advmod	O
shows	VBZ	ROOT	O
that	IN	dobj	O
tegument	NN	amod	B-protein
protein	NN	dep	I-protein
VP22	NN	dep	B-protein
and	CC	cc	O
the	DT	det	O
viral	JJ	amod	B-protein
dUTPase	NN	conj	I-protein
,	,	punct	O
encoded	VBN	acl	O
by	IN	case	O
genes	NNS	nmod	B-DNA
UL49	NN	dep	I-DNA
and	CC	cc	I-DNA
UL50	NN	conj	I-DNA
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
are	VBP	cop	O
T-cell	NN	compound	B-protein
antigens	NNS	appos	I-protein
.	.	punct	O

Separate	JJ	amod	O
epitopes	NNS	nsubjpass	B-protein
in	IN	case	O
VP22	NN	nmod	B-protein
were	VBD	auxpass	O
defined	VBN	ROOT	O
for	IN	case	O
T-cell	NN	compound	B-cell_line
clones	NNS	nmod	I-cell_line
from	IN	case	O
each	DT	nmod	O
of	IN	case	O
three	CD	nummod	O
patients	NNS	nmod	O
.	.	punct	O

Reactivity	NN	nsubjpass	O
with	IN	case	O
the	DT	det	O
tegument	NN	amod	B-protein
protein	NN	nmod	I-protein
encoded	VBN	acl	O
by	IN	case	O
UL21	NN	nmod	B-DNA
was	VBD	auxpass	O
identified	VBN	ROOT	O
for	IN	case	O
an	DT	det	O
additional	JJ	amod	O
patient	NN	nmod	O
.	.	punct	O

Three	CD	nummod	O
new	JJ	amod	O
epitopes	NNS	nsubjpass	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
VP16	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
tegument	NN	amod	B-protein
protein	NN	appos	I-protein
associated	VBN	acl	O
with	IN	case	O
VP22	NN	nmod	B-protein
.	.	punct	O

Some	DT	det	O
tegument-specific	JJ	amod	B-cell_line
CD4	NN	compound	I-cell_line
T-cell	NN	compound	I-cell_line
clones	NNS	nsubj	I-cell_line
exhibited	VBD	ROOT	O
cytotoxic	JJ	amod	O
activity	NN	dobj	O
against	IN	case	O
HSV-infected	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
herpes	NN	compound	B-protein
simplex	NN	amod	I-protein
tegument	NN	amod	I-protein
proteins	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
processed	VBN	ccomp	O
for	IN	case	O
antigen	NN	compound	O
presentation	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	cc	O
are	VBP	cop	O
possible	JJ	amod	O
candidate	NN	compound	O
compounds	NNS	conj	O
for	IN	case	O
herpes	NN	compound	O
simplex	NN	compound	O
vaccines	NNS	nmod	O
.	.	punct	O

Fibrinogen	NN	nsubj	B-protein
activates	VBZ	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcription	NN	compound	I-protein
factors	NNS	dobj	I-protein
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
phagocytes	NNS	nmod	I-cell_type
.	.	punct	O

Adhesion	NN	nsubjpass	O
to	TO	case	O
extracellular	JJ	amod	O
matrices	NNS	nmod	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
modulate	VB	xcomp	O
leukocyte	NN	compound	O
activation	NN	dobj	O
,	,	punct	O
although	IN	mark	O
the	DT	det	O
mechanisms	NNS	nsubjpass	O
are	VBP	auxpass	O
not	RB	neg	O
fully	RB	advmod	O
understood	VBN	advcl	O
.	.	punct	O

Mononuclear	JJ	amod	B-cell_type
phagocytes	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
exposed	VBN	ROOT	O
to	TO	case	O
fibrinous	JJ	amod	O
provisional	JJ	amod	O
matrix	NN	nmod	O
throughout	IN	case	O
migration	NN	nmod	O
into	IN	case	O
inflammatory	JJ	amod	O
foci	NNS	nmod	O
,	,	punct	O
so	CC	advmod	O
this	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
undertaken	VBN	parataxis	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
fibrinogen	NN	nsubj	O
triggers	VBZ	ccomp	O
activation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

U937	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
differentiated	VBN	acl	O
with	IN	case	O
PMA	NN	nmod	O
in	IN	case	O
nonadherent	JJ	amod	B-cell_line
culture	NN	nmod	I-cell_line
were	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
express	VB	xcomp	O
two	CD	nummod	O
fibrinogen-binding	JJ	amod	B-protein
integrins	NNS	dobj	I-protein
,	,	punct	O
predominately	RB	advmod	O
CD11b/CD18	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
to	TO	case	O
a	DT	det	O
lesser	JJR	amod	O
extent	NN	nmod	O
,	,	punct	O
CD11c/CD18	NN	conj	B-protein
.	.	punct	O

Cells	NNS	nsubj	O
stimulated	VBN	acl	O
with	IN	case	O
fibrinogen	NN	nmod	B-protein
(	-LRB-	punct	O
10-100	CD	nummod	O
microg/ml	NN	appos	O
)	-RRB-	punct	O
/Mn2+	JJ	nsubjpass	O
(	-LRB-	punct	O
50	CD	nummod	O
microM	NN	dep	O
)	-RRB-	punct	O
for	IN	case	O
2	CD	nummod	O
h	NN	nmod	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nsubjpass	O
,	,	punct	O
minimal	JJ	amod	O
in	IN	case	O
unstimulated	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
was	VBD	auxpass	O
substantially	RB	advmod	O
up-regulated	VBN	ROOT	O
by	IN	case	O
fibrinogen	NN	nmod	B-protein
.	.	punct	O

Fibrinogen	NN	nsubj	B-protein
also	RB	advmod	O
caused	VBD	ROOT	O
activation	NN	dobj	O
of	IN	case	O
AP-1	NN	nmod	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
SP1	NN	conj	B-protein
or	CC	cc	O
cAMP	NN	compound	B-protein
response	NN	compound	I-protein
element-binding	JJ	amod	I-protein
protein	NN	compound	I-protein
(	-LRB-	punct	I-protein
CREB	NN	compound	I-protein
)	-RRB-	punct	I-protein
factors	NNS	conj	I-protein
.	.	punct	O

Blocking	NN	csubj	O
mAbs	NNS	dobj	B-protein
against	IN	case	O
CD18	NN	nmod	B-protein
and	CC	cc	O
CD11b	NN	conj	B-protein
abrogated	VBD	ROOT	O
fibrinogen	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	dobj	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
the	DT	det	O
effects	NNS	dobj	O
on	IN	case	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
,	,	punct	O
U937	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
transfected	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
plasmid	NN	nmod	O
containing	VBG	acl	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
enhancer	NN	dobj	I-DNA
(	-LRB-	punct	O
bearing	VBG	advcl	O
two	CD	nummod	O
NF-kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
)	-RRB-	punct	O
coupled	VBN	xcomp	O
to	TO	case	O
a	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyltransferase	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
CAT	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
reporter	NN	nmod	I-DNA
.	.	punct	O

Cells	NNS	nsubjpass	O
were	VBD	auxpass	O
subsequently	RB	advmod	O
stimulated	VBN	ROOT	O
with	IN	case	O
1	LS	nummod	O
)	-RRB-	punct	O
PMA	NN	nmod	O
for	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
,	,	punct	O
inducing	VBG	advcl	O
CAT	NN	compound	O
activity	NN	dobj	O
by	IN	case	O
2.6-fold	JJ	nmod	O
,	,	punct	O
2	LS	dep	O
)	-RRB-	punct	O
fibrinogen	NN	dep	B-protein
/Mn2+	JJ	dep	O
for	IN	case	O
2	CD	nummod	O
h	NN	nmod	O
,	,	punct	O
inducing	VBG	advcl	O
CAT	NN	compound	O
activity	NN	dobj	O
by	IN	case	O
3.2-fold	JJ	nmod	O
,	,	punct	O
or	CC	cc	O
3	LS	conj	O
)	-RRB-	punct	O
costimulation	NN	dobj	O
with	IN	case	O
fibrinogen	NN	nmod	B-protein
and	CC	cc	O
PMA	NN	conj	O
,	,	punct	O
inducing	VBG	advcl	O
5.7-fold	JJ	advmod	O
the	DT	det	O
CAT	NN	compound	O
activity	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
PMA	NN	nmod	O
alone	RB	advmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
contact	NN	nsubj	O
with	IN	case	O
fibrinogen-derived	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
may	MD	aux	O
contribute	VB	ccomp	O
to	TO	case	O
mononuclear	JJ	amod	O
phagocyte	NN	compound	O
activation	NN	nmod	O
by	IN	case	O
signaling	VBG	nmod	O
through	IN	case	O
CD11b/CD18	NN	nmod	B-protein
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
selective	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
transcriptional	JJ	amod	B-protein
regulatory	JJ	amod	I-protein
factors	NNS	nmod	I-protein
,	,	punct	O
including	VBG	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

Peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
and	CC	cc	I-cell_type
monocytes	NNS	conj	I-cell_type
and	CC	cc	O
B	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
derived	VBN	acl	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
lupus	NN	nmod	O
express	VBP	ROOT	O
estrogen	NN	compound	O
receptor	NN	compound	O
transcripts	NNS	dobj	O
similar	JJ	amod	O
to	TO	case	O
those	DT	nmod	O
of	IN	case	O
normal	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
identify	VB	dep	O
and	CC	cc	O
characterize	VB	conj	O
estrogen	NN	compound	B-RNA
receptor	NN	compound	I-RNA
(	-LRB-	punct	I-RNA
ER	NN	appos	I-RNA
)	-RRB-	punct	I-RNA
transcripts	NNS	dobj	I-RNA
expressed	VBN	acl	O
in	IN	case	O
immune	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
systemic	JJ	amod	O
lupus	NN	compound	O
erythematosus	NN	nmod	O
(	-LRB-	punct	O
SLE	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
healthy	JJ	amod	O
donors	NNS	conj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nsubjpass	I-cell_type
and	CC	cc	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
were	VBD	auxpass	O
prepared	VBN	dep	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
SLE	NN	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
6	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
healthy	JJ	amod	O
donors	NNS	conj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
8	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

T	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
separated	VBN	ROOT	O
into	IN	case	O
CD4	NN	nmod	B-cell_type
and	CC	cc	O
CD8	NN	conj	B-cell_type
.	.	punct	O

Some	DT	det	O
monocytes	NNS	nsubjpass	B-cell_type
and	CC	cc	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
were	VBD	auxpass	O
stimulated	VBN	ROOT	O
with	IN	case	O
estradiol	NN	nmod	O
,	,	punct	O
PMA	NN	conj	O
,	,	punct	O
and	CC	cc	O
ionomycin	NN	conj	O
.	.	punct	O

Epstein-Barr	JJ	amod	O
virus-transformed	JJ	amod	O
B	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nsubjpass	I-cell_line
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
7	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
B	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
hybridomas	NNS	conj	I-cell_line
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
2	CD	dep	O
)	-RRB-	punct	O
established	VBN	acl	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
SLE	NN	nmod	O
and	CC	cc	O
a	DT	det	O
healthy	JJ	amod	O
individual	NN	conj	O
were	VBD	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
B	NN	compound	O
cell	NN	compound	O
source	NN	nmod	O
.	.	punct	O

These	DT	det	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
for	IN	case	O
ER	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
by	IN	case	O
reverse	JJ	amod	O
transcription	NN	nmod:npmod	O
nested	JJ	amod	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
.	.	punct	O

Amplified	VBN	amod	O
cDNA	NN	nsubjpass	B-DNA
were	VBD	auxpass	O
sequenced	VBN	ROOT	O
by	IN	case	O
standard	JJ	amod	O
methods	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
all	DT	det	O
cells	NNS	nmod	O
tested	VBN	acl	O
,	,	punct	O
ER	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
was	VBD	auxpass	O
expressed	VBN	dep	O
without	IN	case	O
prior	JJ	amod	O
in	FW	amod	O
vitro	FW	dep	O
stimulation	NN	nmod	O
.	.	punct	O

Partial	JJ	amod	O
sequences	NNS	nsubj	O
from	IN	case	O
exons	NNS	nmod	B-DNA
1-8	CD	nummod	I-DNA
were	VBD	cop	O
nearly	RB	advmod	O
identical	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
published	VBN	amod	O
sequence	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-RNA
ER	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

There	EX	expl	O
were	VBD	ROOT	O
no	DT	neg	O
notable	JJ	amod	O
differences	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
ER	NN	compound	B-RNA
transcripts	NNS	nmod	I-RNA
between	IN	case	O
patients	NNS	nmod	O
and	CC	cc	O
healthy	JJ	amod	O
controls	NNS	conj	O
.	.	punct	O

Variant	JJ	amod	O
receptor	NN	compound	O
transcripts	NNS	nsubjpass	O
lacking	VBG	acl	O
exon	NN	dobj	B-DNA
5	CD	nummod	I-DNA
or	CC	cc	O
exon	NN	conj	B-DNA
7	CD	nummod	I-DNA
,	,	punct	O
which	WDT	nsubj	O
encodes	VBZ	acl:relcl	O
the	DT	det	O
hormone	NN	compound	B-protein
binding	NN	compound	I-protein
domain	NN	dobj	I-protein
,	,	punct	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
majority	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

Precise	JJ	amod	O
deletion	NN	nsubj	O
of	IN	case	O
the	DT	det	O
exons	NNS	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
they	PRP	nsubj	O
are	VBP	cop	O
alternatively	RB	advmod	O
spliced	VBN	amod	O
transcripts	NNS	ccomp	O
.	.	punct	O

Whether	IN	mark	O
the	DT	det	O
detected	VBN	amod	O
transcripts	NNS	nsubjpass	O
are	VBP	auxpass	O
translated	VBN	advcl	O
into	IN	case	O
functional	JJ	amod	B-protein
receptor	NN	compound	I-protein
proteins	NNS	nmod	I-protein
remains	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
determined	VBN	xcomp	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
stimulation	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
ER	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	dobj	O
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
variants	NNS	nmod	O
did	VBD	aux	O
not	RB	neg	O
correlate	VB	ROOT	O
with	IN	case	O
disease	NN	compound	O
activity	NN	nmod	O
or	CC	cc	O
medication	NN	conj	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Monocytes	NNS	nsubj	B-cell_type
,	,	punct	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
B	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
in	IN	case	O
patients	NNS	nmod	O
express	VBP	dep	O
transcripts	NNS	dobj	O
of	IN	case	O
the	DT	det	O
normal	JJ	amod	O
wild	JJ	amod	B-protein
type	NN	compound	I-protein
ER	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
hormone	NN	compound	B-protein
binding	NN	compound	I-protein
domain	NN	compound	I-protein
variants	NNS	conj	I-protein
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

DNA	NN	compound	O
damaging	NN	compound	O
agents	NNS	nsubj	O
induce	VBP	ROOT	O
expression	NN	dobj	O
of	IN	case	O
Fas	NN	compound	B-protein
ligand	NN	nmod	I-protein
and	CC	cc	O
subsequent	JJ	amod	O
apoptosis	NN	conj	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
via	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
and	CC	cc	O
AP-1	NN	conj	B-protein
.	.	punct	O

Apoptosis	NN	nsubj	O
induced	VBN	acl	O
by	IN	case	O
DNA	NN	compound	O
damage	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
stresses	NNS	conj	O
can	MD	aux	O
proceed	VB	ROOT	O
via	IN	case	O
expression	NN	nmod	O
of	IN	case	O
Fas	NN	compound	B-protein
ligand	NN	nmod	I-protein
(	-LRB-	punct	O
FasL	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
ligation	NN	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
receptor	NN	nmod	O
,	,	punct	O
Fas	NN	appos	O
(	-LRB-	punct	O
CD95	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
activation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
two	CD	nummod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
NF-kappa	NN	compound	I-protein
B	NN	dep	I-protein
and	CC	cc	I-protein
AP-1	NN	conj	I-protein
is	VBZ	auxpass	O
crucially	RB	advmod	O
involved	VBN	ccomp	O
in	IN	case	O
FasL	NN	compound	B-protein
expression	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
etoposide	NN	nmod	O
,	,	punct	O
teniposide	NN	conj	O
,	,	punct	O
and	CC	cc	O
UV	NN	compound	O
irradiation	NN	conj	O
.	.	punct	O

A	DT	det	O
nondegradable	JJ	amod	B-protein
mutant	NN	nsubj	I-protein
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
blocked	VBD	ROOT	O
both	CC	cc:preconj	O
FasL	NN	compound	B-protein
expression	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
induced	VBN	acl	O
by	IN	case	O
DNA	NN	compound	O
damage	NN	nmod	O
but	CC	cc	O
not	RB	cc	O
Fas	NN	compound	O
ligation	NN	conj	O
.	.	punct	O

These	DT	det	O
stimuli	NNS	nsubj	O
also	RB	advmod	O
induced	VBD	ROOT	O
the	DT	det	O
stress-activated	JJ	amod	O
kinase	NN	compound	O
pathway	NN	dobj	O
(	-LRB-	punct	O
SAPK/JNK	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
required	VBN	acl:relcl	O
for	IN	case	O
the	DT	det	O
maximal	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

A	DT	det	O
1.2	CD	nummod	O
kb	NN	compound	O
FasL	NN	compound	B-DNA
promoter	NN	nsubj	I-DNA
responded	VBD	ROOT	O
to	TO	case	O
DNA	NN	compound	O
damage	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
coexpression	NN	conj	O
with	IN	case	O
p65	NN	compound	B-protein
Rel	NN	nmod	I-protein
or	CC	cc	O
Fos/Jun	NN	conj	B-protein
.	.	punct	O

Mutations	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
relevant	JJ	amod	O
NF-kappa	NN	compound	B-DNA
B	NN	nmod	I-DNA
and	CC	cc	I-DNA
AP-1	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
eliminated	VBD	ROOT	O
these	DT	det	O
responses	NNS	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
activation	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
and	CC	cc	O
AP-1	NN	conj	B-protein
contributes	VBZ	ROOT	O
to	TO	case	O
stress-induced	JJ	amod	O
apoptosis	NN	nmod	O
via	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
FasL	NN	nmod	B-protein
.	.	punct	O

A	DT	det	O
small	JJ	amod	O
,	,	punct	O
nonpeptidyl	JJ	dep	O
mimic	NN	nsubj	O
of	IN	case	O
granulocyte-colony-stimulating	JJ	amod	B-protein
factor	NN	nmod	I-protein
[	-LRB-	punct	O
see	VB	ROOT	O
commetns	NNS	dobj	O
]	-RRB-	punct	O

A	DT	det	O
nonpeptidyl	JJ	compound	O
small	JJ	amod	O
molecule	NN	compound	O
SB	NN	nsubjpass	O
247464	CD	nummod	O
,	,	punct	O
capable	JJ	amod	O
of	IN	mark	O
activating	VBG	advcl	O
granulocyte-colony-stimulating	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	O
G-CSF	NN	appos	B-protein
)	-RRB-	punct	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	dobj	O
,	,	punct	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
high-throughput	JJ	amod	O
assay	NN	nmod	O
in	IN	case	O
cultured	VBN	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Like	IN	case	O
G-CSF	NN	nmod	B-protein
,	,	punct	O
SB	NN	nsubj	O
247464	CD	nummod	O
induced	VBD	ROOT	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
multiple	JJ	amod	B-protein
signaling	NN	compound	I-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
stimulated	VBD	conj	O
primary	JJ	amod	B-cell_type
murine	JJ	amod	I-cell_type
bone	NN	compound	I-cell_type
marrow	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
to	TO	mark	O
form	VB	xcomp	O
granulocytic	JJ	amod	B-cell_type
colonies	NNS	dobj	I-cell_type
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

It	PRP	nsubj	O
also	RB	advmod	O
elevated	VBD	ROOT	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
neutrophil	NN	compound	I-cell_type
counts	VBZ	dobj	O
in	IN	case	O
mice	NNS	nmod	O
.	.	punct	O

The	DT	det	O
extracellular	JJ	amod	O
domain	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
murine	JJ	amod	B-protein
G-CSF	NN	compound	I-protein
receptor	NN	nmod	I-protein
was	VBD	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
SB	NN	nmod	O
247464	CD	nummod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
compound	NN	nsubj	O
acts	VBZ	ccomp	O
by	IN	mark	O
oligomerizing	VBG	advcl	B-protein
receptor	NN	compound	I-protein
chains	NNS	dobj	I-protein
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
small	JJ	amod	O
molecule	NN	nsubj	O
can	MD	aux	O
activate	VB	ccomp	O
a	DT	det	O
receptor	NN	dobj	O
that	WDT	nsubj	O
normally	RB	advmod	O
binds	VBZ	acl:relcl	O
a	DT	det	O
relatively	RB	advmod	O
large	JJ	amod	O
protein	NN	compound	O
ligand	NN	dobj	O
.	.	punct	O

Minimal	JJ	amod	O
residual	JJ	amod	O
disease	NN	ROOT	O
in	IN	case	O
acute	JJ	amod	O
myelogenous	JJ	amod	O
leukemia	NN	nmod	O
with	IN	case	O
PML/RAR	NN	compound	B-protein
alpha	NN	nmod	I-protein
or	CC	cc	O
AML1/ETO	NN	compound	B-RNA
mRNA	NN	conj	I-RNA
and	CC	cc	O
phenotypic	JJ	amod	O
analysis	NN	conj	O
of	IN	case	O
possible	JJ	amod	O
T	NN	nmod	B-cell_type
and	CC	cc	I-cell_type
natural	JJ	amod	I-cell_type
killer	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
in	IN	case	O
bone	NN	compound	O
marrow	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
minimal	JJ	amod	O
residual	JJ	amod	O
disease	NN	dobj	O
(	-LRB-	punct	O
MRD	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
myeloid	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
AML	NN	appos	O
)	-RRB-	punct	O
who	WP	nsubj	O
have	VBP	acl:relcl	O
PML/RAR	NN	compound	B-protein
alpha	NN	dobj	I-protein
or	CC	cc	O
AML1/ETO	NN	conj	B-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
phenotypic	JJ	amod	O
analysis	NN	conj	O
of	IN	case	O
lymphocyte	NN	compound	B-cell_type
subsets	NNS	nmod	I-cell_type
involved	VBN	acl	O
in	IN	case	O
antitumor	NN	compound	O
immunity	NN	nmod	O
.	.	punct	O

Eight	CD	nummod	O
patients	NNS	nsubjpass	O
in	IN	case	O
long-term	JJ	nmod	O
(	-LRB-	punct	O
LT	NN	dep	O
;	:	punct	O
3	CD	compound	O
to	TO	dep	O
15	CD	nummod	O
years	NNS	dep	O
)	-RRB-	punct	O
and	CC	cc	O
15	CD	nummod	O
patients	NNS	conj	O
in	IN	case	O
short-term	JJ	amod	O
(	-LRB-	punct	O
ST	JJ	dep	O
;	:	punct	O
up	RB	advmod	O
to	TO	dep	O
3	CD	nummod	O
years	NNS	dep	O
)	-RRB-	punct	O
remission	NN	nmod	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
.	.	punct	O

Using	VBG	ROOT	O
the	DT	det	O
reverse	JJ	amod	O
transcription-polymerase	JJ	amod	O
chain	NN	compound	O
reaction	NN	compound	O
(	-LRB-	punct	O
RT	NN	appos	O
)	-RRB-	punct	O
assay	NN	dobj	O
,	,	punct	O
the	DT	det	O
limit	NN	nsubj	O
of	IN	case	O
detection	NN	nmod	O
was	VBD	cop	O
10	CD	compound	O
(	-LRB-	punct	O
-5	CD	appos	O
)	-RRB-	punct	O
to	TO	case	O
10	CD	compound	O
(	-LRB-	punct	O
-6	CD	appos	O
)	-RRB-	punct	O
for	IN	case	O
PML/RAR	NN	compound	B-RNA
alpha	NN	compound	I-RNA
transcript	NN	nmod	I-RNA
and	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-4	CD	appos	O
)	-RRB-	punct	O
to	TO	case	O
10	CD	dative	O
(	-LRB-	punct	O
-5	CD	appos	O
)	-RRB-	punct	O
for	IN	case	O
the	DT	det	O
AML1/ETO	NN	compound	B-RNA
transcript	NN	nmod	I-RNA
.	.	punct	O

Simultaneously	RB	advmod	O
,	,	punct	O
T	NN	compound	B-cell_type
lymphocyte	NN	compound	I-cell_type
subsets	NNS	nsubjpass	I-cell_type
and	CC	cc	O
NK	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
from	IN	case	O
the	DT	det	O
peripheral	JJ	amod	O
blood	NN	nmod	O
(	-LRB-	punct	O
PB	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
bone	NN	compound	O
marrow	NN	conj	O
(	-LRB-	punct	O
BM	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
by	IN	case	O
flow	NN	compound	O
cytometric	JJ	amod	O
analysis	NN	nmod	O
.	.	punct	O

Four	CD	nsubj	O
of	IN	case	O
the	DT	det	O
eight	CD	nummod	O
patients	NNS	nmod	O
in	IN	case	O
LT	NN	nmod	O
and	CC	cc	O
7	CD	conj	O
of	IN	case	O
the	DT	det	O
15	CD	nummod	O
patients	NNS	nmod	O
in	IN	case	O
ST	JJ	compound	O
remission	NN	nmod	O
were	VBD	cop	O
MRD-positive	JJ	ROOT	O
.	.	punct	O

Although	IN	mark	O
all	DT	det	O
MRD-positive	JJ	amod	O
patients	NNS	nsubj	O
in	IN	case	O
LT	NN	compound	O
remission	NN	nmod	O
are	VBP	cop	O
still	RB	advmod	O
until	IN	case	O
now	RB	advmod	O
event-free	JJ	advcl	O
,	,	punct	O
3	CD	appos	O
of	IN	case	O
the	DT	det	O
7	CD	nummod	O
MRD-positive	JJ	amod	O
(	-LRB-	punct	O
MRD+	JJ	dep	O
)	-RRB-	punct	O
patients	NNS	nmod	O
in	IN	case	O
ST	JJ	compound	O
remission	NN	nmod	O
soon	IN	advmod	O
relapsed	NN	ROOT	O
.	.	punct	O

The	DT	det	O
total	JJ	amod	O
populations	NNS	nsubj	O
of	IN	case	O
CD4	NN	nmod	B-protein
+	CC	cc	O
,	,	punct	O
CD8	NN	conj	B-protein
+	CC	cc	O
and	CC	cc	O
CD56	NN	conj	B-protein
+	CC	cc	O
[	-LRB-	punct	O
possible	JJ	amod	O
T-cell	NN	compound	B-cell_type
and	CC	cc	I-cell_type
natural	JJ	amod	I-cell_type
killer	NN	conj	I-cell_type
(	-LRB-	punct	I-cell_type
T/NK	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
populations	NNS	conj	I-cell_type
]	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
BM	NN	nmod	O
of	IN	case	O
ST	JJ	compound	O
patients	NNS	nmod	O
and	CC	cc	O
MRD+/LT	JJ	amod	O
patients	NNS	conj	O
were	VBD	cop	O
significantly	RB	advmod	O
(	-LRB-	punct	O
p	NN	intj	O
<	CD	dep	O
.01	CD	dep	O
)	-RRB-	punct	O
low	JJ	ROOT	O
.	.	punct	O

The	DT	det	O
CD8+	JJ	amod	B-cell_type
CD28+	JJ	amod	I-cell_type
population	NN	nsubj	I-cell_type
showed	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
tendency	NN	dobj	O
(	-LRB-	punct	O
p	NN	dep	O
<	CD	amod	O
.01-.02	CD	punct	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
T/NK	NN	compound	B-cell_type
subsets	NNS	nsubj	I-cell_type
in	IN	case	O
the	DT	det	O
BM	NN	nmod	O
of	IN	case	O
MRD-negative	JJ	amod	O
(	-LRB-	punct	O
MRD-	JJ	dep	O
)	-RRB-	punct	O
LT	NN	compound	O
(	-LRB-	punct	O
MRD-/LT	JJ	appos	O
)	-RRB-	punct	O
patients	NNS	nmod	O
showed	VBD	ROOT	O
similar	JJ	amod	O
numbers	NNS	dobj	O
of	IN	case	O
cells	NNS	nmod	O
as	IN	case	O
normal	JJ	amod	O
volunteers	NNS	nmod	O
.	.	punct	O

Basically	RB	advmod	O
,	,	punct	O
the	DT	det	O
total	JJ	amod	O
percentage	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
CD4+	JJ	amod	B-cell_type
,	,	punct	I-cell_type
CD8+	JJ	conj	I-cell_type
and	CC	cc	I-cell_type
CD56+	JJ	conj	I-cell_type
cell	NN	compound	I-cell_type
populations	NNS	nmod	I-cell_type
in	IN	case	O
the	DT	det	O
BM	NN	nmod	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
following	VBG	amod	O
order	NN	conj	O
:	:	punct	O
MRD-/LT	JJ	amod	O
patients	NNS	dep	O
,	,	punct	O
normal	JJ	amod	O
volunteers	NNS	conj	O
,	,	punct	O
MRD+/LT	JJ	amod	O
patients	NNS	conj	O
and	CC	cc	O
MRD+	JJ	conj	O
or	CC	cc	O
-/ST	JJ	conj	O
patients	NNS	dep	O
.	.	punct	O

The	DT	det	O
percentages	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
T/NK-cell	NN	compound	B-cell_type
subsets	NNS	nmod	I-cell_type
in	IN	case	O
the	DT	det	O
PB	NN	nmod	O
were	VBD	cop	O
not	RB	neg	O
significantly	RB	advmod	O
different	JJ	ROOT	O
among	IN	case	O
these	DT	det	O
groups	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
difference	NN	nsubj	O
of	IN	case	O
the	DT	det	O
possible	JJ	amod	O
T/NK-cell	JJ	compound	B-cell_type
phenotype	NN	nmod	O
in	IN	case	O
the	DT	det	O
BM	NN	nmod	O
may	MD	aux	O
strongly	RB	advmod	O
influence	VB	ROOT	O
clinical	JJ	amod	O
and	CC	cc	O
molecular	JJ	conj	O
remission	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
still	RB	advmod	O
remain	VBP	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
confirmed	VBN	xcomp	O
by	IN	case	O
further	JJ	amod	O
studies	NNS	nmod	O
of	IN	case	O
the	DT	det	O
functional	JJ	amod	O
anti-tumor	JJ	amod	O
immunity	NN	nmod	O
of	IN	case	O
T/NK	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
AML	NN	nmod	B-cell_type
in	IN	case	O
remission	NN	nmod	O
.	.	punct	O

Mycobacterium	FW	compound	O
tuberculosis	FW	nmod:npmod	O
mannose-capped	JJ	amod	O
lipoarabinomannan	NN	nsubj	O
can	MD	aux	O
induce	VB	ROOT	O
NF-kappaB	NN	compound	B-protein
-dependent	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
1	CD	nummod	I-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Tuberculosis	NN	nsubj	O
has	VBZ	aux	O
emerged	VBN	ROOT	O
as	IN	case	O
an	DT	det	O
epidemic	NN	nmod	O
,	,	punct	O
extended	VBN	advcl	O
by	IN	case	O
the	DT	det	O
large	JJ	amod	O
number	NN	nmod	O
of	IN	case	O
individuals	NNS	nmod	O
infected	VBN	acl	O
with	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
major	JJ	amod	O
goal	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
the	DT	det	O
mycobacterial	JJ	amod	O
cell	NN	compound	O
wall	NN	compound	O
component	NN	compound	O
mannose-capped	JJ	amod	O
lipoarabinomannan	NN	nsubj	O
(	-LRB-	punct	O
ManLAM	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
Mycobacterium	FW	compound	O
tuberculosis	FW	nmod	O
(	-LRB-	punct	O
M.	FW	compound	O
tuberculosis	FW	appos	O
)	-RRB-	punct	O
could	MD	aux	O
activate	VB	ccomp	O
transcription	NN	dobj	O
of	IN	case	O
HIV-1	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
cell	NN	compound	O
culture	NN	compound	O
system	NN	nmod	O
.	.	punct	O

These	DT	det	O
experiments	NNS	nsubj	O
are	VBP	cop	O
of	IN	case	O
prime	JJ	amod	O
importance	NN	ROOT	O
considering	VBG	acl	O
that	IN	mark	O
CD4	NN	compound	B-protein
-expressing	JJ	amod	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nsubj	I-cell_type
represent	VBP	ccomp	O
the	DT	det	O
major	JJ	amod	O
virus	NN	compound	O
reservoir	NN	dobj	O
in	IN	case	O
the	DT	det	O
peripheral	JJ	amod	O
blood	NN	nmod	O
of	IN	case	O
infected	JJ	amod	O
individuals	NNS	nmod	O
.	.	punct	O

Using	VBG	advcl	O
the	DT	det	O
1G5	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	dobj	I-cell_line
harbouring	VBG	acl	O
the	DT	det	O
luciferase	NN	compound	O
reporter	NN	compound	O
gene	NN	dobj	O
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
first	RB	advmod	O
found	VBN	ROOT	O
that	IN	mark	O
culture	NN	compound	O
protein	NN	compound	O
filtrates	NNS	nsubj	O
(	-LRB-	punct	O
CFP	NN	appos	O
)	-RRB-	punct	O
from	IN	case	O
M.	FW	compound	O
tuberculosis	FW	nmod	O
or	CC	cc	O
purified	VBN	amod	O
ManLAM	NN	conj	O
could	MD	aux	O
activate	VB	ccomp	O
HIV-1	NN	compound	B-DNA
LTR-dependent	JJ	amod	I-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
unlike	IN	case	O
similarly	RB	advmod	O
prepared	VBN	amod	O
CFP	NN	compound	O
extracts	NNS	nmod	O
devoid	JJ	amod	O
of	IN	case	O
ManLAM	NN	nmod	O
.	.	punct	O

The	DT	det	O
implication	NN	nsubjpass	O
of	IN	case	O
protein	NN	compound	B-protein
tyrosine	NN	compound	I-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	I-protein
s	NNS	nmod	I-protein
)	-RRB-	punct	I-protein
,	,	punct	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
A	NN	conj	I-protein
and/or	CC	cc	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	conj	I-protein
was	VBD	auxpass	O
highlighted	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
abrogation	NN	nmod	O
of	IN	case	O
the	DT	det	O
ManLAM-mediated	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
HIV-1	NN	compound	O
LTR-driven	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
using	VBG	acl	O
herbimycin	NN	compound	O
A	NN	dobj	O
and	CC	cc	O
H7	NN	conj	O
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
determined	VBN	ROOT	O
,	,	punct	O
using	VBG	xcomp	O
electrophoresis	NN	compound	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	dobj	O
,	,	punct	O
that	IN	mark	O
M.	FW	compound	O
tuberculosis	FW	compound	O
ManLAM	NN	nsubj	O
led	VBD	ccomp	O
to	TO	case	O
the	DT	det	O
nuclear	JJ	amod	O
translocation	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappaB	NN	nmod	I-protein
.	.	punct	O

M.	FW	compound	O
tuberculosis	FW	compound	O
ManLAM	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
clear	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
luciferase	NN	compound	B-DNA
gene	NN	nmod	I-DNA
placed	VBN	acl	O
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
wild-type	JJ	nmod	B-DNA
,	,	punct	I-DNA
but	CC	cc	I-DNA
not	RB	cc	I-DNA
the	DT	det	I-DNA
kappaB-mutated	JJ	amod	I-DNA
,	,	punct	I-DNA
HIV-1	NN	compound	I-DNA
LTR	NN	compound	I-DNA
region	NN	dep	I-DNA
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
the	DT	det	O
ManLAM-mediated	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
HIV-1	NN	compound	O
LTR	NN	compound	O
transcription	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
independent	JJ	xcomp	O
of	IN	case	O
the	DT	dep	O
autocrine	JJ	nmod	O
or	CC	cc	O
paracrine	JJ	conj	O
action	NN	dep	O
of	IN	case	O
endogenous	JJ	amod	B-protein
TNF-alpha	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
M.	FW	compound	O
tuberculosis	FW	nsubj	O
can	MD	aux	O
upregulate	VB	ccomp	O
HIV-1	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
could	MD	aux	O
thus	RB	advmod	O
have	VB	conj	O
the	DT	det	O
potential	NN	dobj	O
to	TO	mark	O
influence	VB	acl	O
the	DT	det	O
pathogenesis	NN	dobj	O
of	IN	case	O
HIV-1	NN	compound	O
infection	NN	nmod	O
.	.	punct	O

Human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
1	CD	nummod	I-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	compound	I-DNA
quasispecies	NNS	nsubj	O
differ	VBP	ROOT	O
in	IN	case	O
basal	JJ	amod	O
transcription	NN	nmod	O
and	CC	cc	O
nuclear	JJ	amod	O
factor	NN	compound	O
recruitment	NN	conj	O
in	IN	case	O
human	JJ	amod	B-cell_type
glial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	I-cell_type
lymphocytes	NNS	conj	I-cell_type
.	.	punct	O

The	DT	det	O
generation	NN	nsubj	O
of	IN	case	O
genomic	JJ	amod	O
diversity	NN	nmod	O
during	IN	case	O
the	DT	det	O
course	NN	nmod	O
of	IN	case	O
infection	NN	nmod	O
has	VBZ	ROOT	O
the	DT	det	O
potential	NN	dobj	O
to	TO	mark	O
affect	VB	acl	O
all	DT	det	O
aspects	NNS	dobj	O
of	IN	case	O
HIV-1	NN	compound	O
replication	NN	nmod	O
,	,	punct	O
including	VBG	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
proviral	JJ	amod	O
genome	NN	nmod	O
.	.	punct	O

To	TO	mark	O
gain	VB	advcl	O
a	DT	det	O
better	JJR	amod	O
understanding	NN	dobj	O
of	IN	case	O
the	DT	det	O
impact	NN	nmod	O
of	IN	case	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	compound	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
sequence	NN	compound	O
diversity	NN	nmod	O
on	IN	case	O
LTR-directed	JJ	amod	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
the	DT	det	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	nmod	O
(	-LRB-	punct	O
CNS	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
immune	JJ	amod	O
system	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
amplified	VBD	ROOT	O
and	CC	cc	O
cloned	VBN	conj	O
LTRs	NNS	dobj	B-DNA
from	IN	case	O
proviral	JJ	amod	O
DNA	NN	nmod	O
in	IN	case	O
HIV-1-infected	JJ	amod	O
peripheral	JJ	amod	O
blood	NN	nmod	O
.	.	punct	O

Sequence	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
nineteen	CD	nummod	O
LTRs	NNS	nmod	B-DNA
cloned	VBN	acl	O
from	IN	case	O
2	CD	nummod	O
adult	JJ	nmod	O
and	CC	cc	O
3	CD	nummod	O
pediatric	JJ	amod	O
patients	NNS	conj	O
revealed	VBD	ROOT	O
an	DT	det	O
average	NN	dobj	O
of	IN	case	O
33	CD	nummod	O
nucleotide	NN	compound	O
changes	NNS	nmod	O
(	-LRB-	punct	O
with	IN	case	O
respect	NN	dep	O
to	TO	case	O
the	DT	det	O
sequence	NN	nmod	O
of	IN	case	O
the	DT	det	O
LAI	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
)	-RRB-	punct	O
within	IN	case	O
the	DT	det	O
455-bp	JJ	amod	B-DNA
U3	NN	compound	I-DNA
region	NN	nmod	I-DNA
.	.	punct	O

Transient	JJ	amod	O
expression	NN	nsubj	O
analyses	NNS	nsubj	O
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
neuroglial	JJ	amod	O
and	CC	cc	O
lymphocytic	JJ	conj	O
origin	NN	nmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
some	DT	nsubj	O
of	IN	case	O
these	DT	det	O
LTRs	NNS	nmod	B-DNA
had	VBD	ccomp	O
activities	NNS	dobj	O
which	WDT	nsubj	O
varied	VBD	acl:relcl	O
significantly	RB	advmod	O
from	IN	case	O
the	DT	det	O
LAI	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
in	IN	case	O
U-373	NN	compound	B-cell_line
MG	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
(	-LRB-	punct	O
an	DT	det	O
astrocytoma	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	appos	I-cell_line
)	-RRB-	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
(	-LRB-	punct	O
a	DT	det	O
CD4-positive	JJ	amod	B-cell_line
lymphocyte	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	appos	I-cell_line
)	-RRB-	punct	O
.	.	punct	O

While	IN	mark	O
LTRs	NNS	nsubj	B-DNA
which	WDT	nsubj	O
demonstrated	VBD	acl:relcl	O
the	DT	det	O
highest	JJS	amod	O
activities	NNS	dobj	O
in	IN	case	O
U-373	NN	compound	B-cell_line
MG	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
also	RB	advmod	O
yielded	VBD	advcl	O
high	JJ	amod	O
activities	NNS	dobj	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
the	DT	det	O
LTRs	NNS	nsubj	B-DNA
were	VBD	cop	O
generally	RB	advmod	O
more	RBR	advmod	O
active	JJ	ROOT	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
when	WRB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
the	DT	det	O
LAI	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
.	.	punct	O

Differences	NNS	nsubj	O
in	IN	case	O
LTR	NN	compound	B-DNA
sequence	NN	nmod	I-DNA
also	RB	advmod	O
resulted	VBD	ROOT	O
in	IN	case	O
differences	NNS	nmod	O
in	IN	case	O
transcription	NN	compound	O
factor	NN	compound	O
recruitment	NN	nmod	O
to	TO	case	O
cis-acting	JJ	amod	B-DNA
sites	NNS	nmod	I-DNA
within	IN	case	O
the	DT	det	O
U3	NN	compound	B-DNA
region	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
LTR	NN	nmod	B-DNA
,	,	punct	O
as	IN	mark	O
demonstrated	VBN	advcl	O
by	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

In	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
naturally	RB	advmod	O
occurring	VBG	amod	O
sequence	NN	compound	O
variation	NN	nsubj	O
impacted	VBD	ROOT	O
transcription	NN	compound	B-protein
factor	NN	dobj	I-protein
binding	VBG	acl	O
to	TO	case	O
an	DT	det	O
activating	VBG	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
/	:	punct	O
cAMP	NN	compound	B-protein
response	NN	compound	I-protein
element	NN	compound	I-protein
binding	NN	compound	I-protein
(	-LRB-	punct	O
ATF	NN	compound	B-protein
/	:	punct	O
CREB	NN	compound	B-protein
)	-RRB-	punct	O
binding	NN	compound	O
site	NN	nmod	O
(	-LRB-	punct	O
located	JJ	dep	O
between	IN	case	O
the	DT	dep	O
LEF-1	NN	nmod	B-DNA
and	CC	cc	I-DNA
distal	JJ	amod	I-DNA
NF-kappaB	NN	compound	I-DNA
transcription	NN	compound	I-DNA
factor	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	conj	I-DNA
)	-RRB-	punct	O
that	WDT	mark	O
we	PRP	nsubj	O
identified	VBD	ccomp	O
in	IN	case	O
previous	JJ	amod	O
studies	NNS	nmod	O
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
LTR	NN	compound	B-DNA
sequence	NN	compound	I-DNA
changes	NNS	nsubj	O
can	MD	aux	O
significantly	RB	advmod	O
affect	VB	ccomp	O
basal	JJ	amod	O
LTR	NN	compound	O
function	NN	dobj	O
and	CC	cc	O
transcription	NN	compound	O
factor	NN	compound	O
recruitment	NN	conj	O
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
,	,	punct	O
in	IN	case	O
turn	NN	nmod	O
,	,	punct	O
alter	VBP	dep	O
the	DT	det	O
course	NN	dobj	O
of	IN	case	O
viral	JJ	amod	O
replication	NN	nmod	O
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
CNS	NN	nmod	O
and	CC	cc	O
immune	JJ	amod	O
system	NN	compound	O
origin	NN	conj	O
.	.	punct	O

HMG	NN	compound	B-protein
box	NN	ROOT	I-protein
containing	VBG	acl	I-protein
transcription	NN	compound	I-protein
factors	NNS	dobj	I-protein
in	IN	case	O
lymphocyte	NN	compound	B-cell_type
differentiation	NN	nmod	O
.	.	punct	O

The	DT	det	O
identification	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mammalian	JJ	amod	B-DNA
sex-determining	JJ	amod	I-DNA
gene	NN	compound	I-DNA
Sry	NN	nmod	I-DNA
has	VBZ	aux	O
led	VBN	ROOT	O
to	TO	prep	O
the	DT	det	O
discovery	NN	pobj	O
of	IN	prep	O
a	DT	det	O
large	JJ	amod	O
family	NN	pobj	O
of	IN	case	O
related	JJ	amod	O
(	-LRB-	punct	O
'	``	punct	O
HMG	NN	compound	B-protein
box	NN	compound	I-protein
'	''	punct	O
)	-RRB-	punct	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
that	WDT	nsubj	O
control	VBP	acl:relcl	O
developmental	JJ	amod	O
events	NNS	dobj	O
in	IN	case	O
yeast	NN	compound	O
,	,	punct	O
C.	FW	compound	O
elegans	FW	nmod	O
,	,	punct	O
Drosophila	NN	appos	O
and	CC	cc	O
vertebrates	NNS	conj	O
.	.	punct	O

In	IN	case	O
lymphocyte	NN	compound	B-cell_type
differentiation	NN	nmod	O
,	,	punct	O
several	JJ	amod	O
HMG	NN	compound	B-protein
box	NN	compound	I-protein
proteins	NNS	nsubj	I-protein
play	VBP	ROOT	O
a	DT	det	O
decisive	JJ	amod	O
role	NN	dobj	O
.	.	punct	O

Sox-4	NN	nsubj	B-protein
is	VBZ	cop	O
important	JJ	ROOT	O
for	IN	case	O
very	RB	advmod	O
early	JJ	amod	O
B-cell	NN	compound	O
differentiation	NN	nmod	O
,	,	punct	O
while	IN	mark	O
TCF-1	NN	nsubj	B-protein
/	:	punct	O
LEF-1	NN	nsubj	B-protein
play	VBP	advcl	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
early	JJ	amod	O
thymocyte	NN	compound	O
development	NN	nmod	O
.	.	punct	O

TCF/LEF	NN	compound	B-protein
proteins	NNS	nsubjpass	I-protein
have	VBP	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
constitute	VB	xcomp	O
a	DT	det	O
downstream	JJ	amod	O
component	NN	dobj	O
of	IN	case	O
the	DT	det	O
Wingless/Wnt	NN	compound	O
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

In	IN	case	O
flies	NNS	nmod	O
,	,	punct	O
this	DT	det	O
pathway	NN	nsubj	O
controls	VBZ	ROOT	O
segment	NN	compound	O
polarity	NN	dobj	O
;	:	punct	O
in	IN	prep	O
Xenopus	NN	pobj	O
it	PRP	nsubj	O
controls	VBZ	parataxis	O
the	DT	det	O
definition	NN	dobj	O
of	IN	case	O
the	DT	det	O
body	NN	compound	O
axis	NN	nmod	O
.	.	punct	O

Deregulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
pathway	NN	nmod	O
occurs	VBZ	ROOT	O
in	IN	case	O
several	JJ	amod	O
human	JJ	amod	B-cell_type
tumors	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
insights	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
events	NNS	nmod	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
TCF/LEF	NN	compound	B-protein
function	NN	nmod	O
in	IN	case	O
these	DT	det	O
organisms	NNS	nmod	O
may	MD	aux	O
eventually	RB	advmod	O
lead	VB	ROOT	O
to	TO	case	O
the	DT	det	O
understanding	NN	nmod	O
of	IN	case	O
the	DT	det	O
function	NN	nmod	O
of	IN	case	O
these	DT	det	O
HMG	NN	compound	B-protein
box	NN	compound	I-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
lymphoid	JJ	amod	O
development	NN	nmod	O

Transcriptional	JJ	amod	O
regulation	NN	ROOT	O
by	IN	case	O
C/EBP	NN	compound	B-protein
alpha	NN	nmod	I-protein
and	CC	cc	I-protein
-beta	NN	conj	I-protein
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
for	IN	case	O
the	DT	det	O
MRP14	NN	compound	B-protein
myeloid	JJ	amod	I-protein
calcium	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

Transcriptional	JJ	amod	O
regulation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
for	IN	case	O
the	DT	det	O
myeloid	JJ	amod	B-protein
calcium	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	nmod	I-protein
,	,	punct	O
MRP14	NN	appos	B-protein
,	,	punct	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_line
monocytic	JJ	amod	I-cell_line
leukemia	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
MRP14	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
not	RB	neg	O
expressed	VBN	ROOT	O
in	IN	case	O
monoblastic	JJ	amod	B-cell_line
ML-1	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
promonocytic	JJ	amod	B-cell_line
U-937	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
or	CC	cc	O
promyelocytic	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
the	DT	det	O
gene	NN	nsubjpass	O
was	VBD	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
monocytic	JJ	amod	B-cell_line
THP-1	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
in	IN	case	O
the	DT	det	O
HL-60	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
treated	VBN	acl	O
with	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
(	-LRB-	punct	O
VD3	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
MRP14	NN	nmod	B-protein
in	IN	case	O
VD3-treated	JJ	amod	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	cop	O
two-fold	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
THP-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Among	IN	case	O
several	JJ	amod	O
known	JJ	amod	O
transcription	NN	compound	B-DNA
factor	NN	compound	I-DNA
binding	NN	compound	I-DNA
motifs	NNS	ROOT	I-DNA
,	,	punct	O
nuclear	JJ	amod	B-protein
protein	NN	compound	I-protein
(	-LRB-	punct	I-protein
s	NNS	appos	I-protein
)	-RRB-	punct	I-protein
of	IN	case	O
VD3-treated	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	I-cell_line
THP-1	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
bound	VBD	acl	O
to	TO	case	O
the	DT	det	O
CCAAT/enhancer	NN	compound	B-DNA
binding	NN	compound	I-DNA
protein	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
C/EBP	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
-binding	JJ	amod	I-DNA
motif	NN	nmod	I-DNA
that	WDT	nsubj	O
was	VBD	cop	O
located	JJ	acl:relcl	O
in	IN	case	O
the	DT	det	O
upstream	JJ	amod	B-DNA
region	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
MRP14	NN	compound	B-DNA
gene	NN	nmod	I-DNA
(	-LRB-	punct	O
-81	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
as	IN	mark	O
evidenced	VBN	acl	O
by	IN	case	O
the	DT	det	O
competitive	JJ	amod	O
gel	NN	compound	O
mobility-shift	NN	amod	O
assay	NN	nmod	O
.	.	punct	O

An	DT	det	O
antibody	NN	nsubj	O
for	IN	case	O
C/EBP	NN	compound	B-protein
alpha	NN	nmod	I-protein
super-shifted	VBD	ROOT	O
the	DT	det	O
nucleoprotein	NN	compound	B-protein
complex	NN	dobj	I-protein
in	IN	case	O
THP-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
the	DT	det	O
VD3-treated	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
whereas	IN	dep	O
an	DT	det	O
antibody	NN	nsubj	O
for	IN	case	O
C/EBP	NN	compound	B-protein
beta	NN	nmod	I-protein
blocked	VBD	parataxis	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
the	DT	det	O
complex	NN	nmod	O
with	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
but	CC	cc	O
not	RB	neg	O
with	IN	case	O
that	DT	conj	O
of	IN	case	O
THP-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

An	DT	det	O
anti-C/EBP	JJ	amod	B-protein
delta	NN	compound	I-protein
antibody	NN	nsubj	I-protein
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
complex	NN	nmod	O
in	IN	case	O
either	DT	det	O
cell	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
C/EBP	NN	compound	B-protein
alpha	NN	nsubj	I-protein
and	CC	cc	I-protein
-beta	NN	conj	I-protein
were	VBD	cop	O
able	JJ	ccomp	O
to	TO	mark	O
bind	VB	xcomp	O
to	TO	case	O
the	DT	det	O
C/EBP	NN	compound	B-protein
motif	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
C/EBP	NN	compound	B-protein
alpha	NN	nsubj	I-protein
bound	VBD	conj	O
to	TO	case	O
the	DT	det	O
motif	NN	nmod	O
in	IN	case	O
THP-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
C/EBP	NN	compound	B-protein
beta	NN	conj	I-protein
bound	VBD	xcomp	O
to	TO	case	O
that	DT	nmod	O
in	IN	case	O
the	DT	det	O
VD3-treated	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
to	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
the	DT	det	O
C/EBP	NN	compound	B-protein
motif	NN	nmod	I-protein
,	,	punct	O
we	PRP	nsubj	O
transfected	VBD	ROOT	O
several	JJ	amod	O
constructed	VBN	amod	O
luciferase	NN	compound	B-DNA
reporter	NN	compound	I-DNA
DNAs	NNS	dobj	I-DNA
into	IN	case	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
THP-1	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

The	DT	det	O
luciferase	NN	compound	O
activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
C/EBP	NN	compound	B-protein
motif	NN	nmod	I-protein
in	IN	case	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	auxpass	O
increased	VBN	ROOT	O
by	IN	case	O
VD3	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

The	DT	det	O
C/EBP	NN	compound	B-protein
motif	NN	nsubjpass	I-protein
in	IN	case	O
the	DT	det	O
MRP14	NN	compound	B-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
to	TO	mark	O
function	VB	xcomp	O
as	IN	case	O
a	DT	det	O
regulatory	JJ	amod	O
region	NN	nmod	O
in	IN	case	O
VD3-treated	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	I-cell_line
THP-1	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
by	IN	case	O
the	DT	det	O
assay	NN	nmod	O
.	.	punct	O

Since	IN	mark	O
C/EBP	NN	compound	B-protein
beta	NN	nsubjpass	I-protein
was	VBD	auxpass	O
also	RB	advmod	O
detected	VBN	advcl	O
in	IN	case	O
VD3-untreated	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
by	IN	case	O
immunoblotting	NN	nmod	O
,	,	punct	O
VD3	NN	nsubj	O
activated	VBD	ROOT	O
C/EBP	NN	compound	B-protein
beta	NN	dobj	I-protein
to	TO	mark	O
bind	VB	xcomp	O
to	TO	case	O
the	DT	det	O
motif	NN	nmod	O
,	,	punct	O
probably	RB	advmod	O
through	IN	case	O
post-translational	JJ	amod	O
modification	NN	nmod	O
.	.	punct	O

Patients	NNS	nsubj	O
with	IN	case	O
high-risk	JJ	amod	O
myelodysplastic	JJ	amod	O
syndrome	NN	nmod	O
can	MD	aux	O
have	VB	ROOT	O
polyclonal	JJ	amod	O
or	CC	cc	O
clonal	JJ	conj	O
haemopoiesis	NN	dobj	O
in	IN	case	O
complete	JJ	amod	O
haematological	JJ	amod	O
remission	NN	nmod	O
.	.	punct	O

The	DT	det	O
clonality	NN	nsubjpass	O
of	IN	case	O
mature	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood-derived	JJ	amod	I-cell_type
myeloid	JJ	nmod	I-cell_type
and	CC	cc	I-cell_type
lymphoid	JJ	conj	I-cell_type
cells	NNS	dep	I-cell_type
and	CC	cc	O
bone	NN	compound	B-cell_type
marrow	NN	compound	I-cell_type
haemopoietic	JJ	amod	I-cell_type
progenitors	NNS	conj	I-cell_type
from	IN	case	O
18	CD	nummod	O
females	NNS	nmod	O
with	IN	case	O
myelodysplasia	NN	nmod	O
(	-LRB-	punct	O
MDS	NN	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
five	CD	nummod	O
refractory	JJ	amod	O
anaemia	NN	dep	O
,	,	punct	O
RA	NN	appos	O
;	:	punct	O
one	CD	nummod	O
RA	NN	dep	O
with	IN	case	O
ringed	JJ	amod	B-cell_type
sideroblasts	NNS	nmod	I-cell_type
,	,	punct	O
RARS	NN	appos	O
;	:	punct	O
three	CD	nummod	O
chronic	JJ	amod	O
myelomonocytic	JJ	amod	O
leukaemia	NN	dep	O
,	,	punct	O
CMML	NN	appos	O
;	:	punct	O
four	CD	nummod	O
RA	NN	dep	O
with	IN	case	O
excess	NN	nmod	O
of	IN	case	O
blasts	NNS	nmod	O
,	,	punct	O
RAEB	NN	appos	O
;	:	punct	O
five	CD	nummod	O
RAEB	NN	nsubjpass	O
in	IN	case	O
transformation	NN	nmod	O
,	,	punct	O
RAEB-t	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
by	IN	case	O
X-chromosome	NN	compound	B-DNA
inactivation	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
the	DT	det	O
human	JJ	amod	O
androgen-receptor	NN	compound	O
(	-LRB-	punct	O
HUMARA	NN	appos	O
)	-RRB-	punct	O
assay	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
analysed	VBD	ROOT	O
the	DT	det	O
clonal	JJ	amod	O
patterns	NNS	dobj	O
of	IN	case	O
highly	RB	advmod	B-cell_type
purified	VBN	amod	I-cell_type
immature	JJ	amod	I-cell_type
CD34+	JJ	amod	I-cell_type
38-	CD	nmod	I-cell_type
and	CC	cc	I-cell_type
committed	VBN	conj	I-cell_type
CD34+	JJ	amod	I-cell_type
38+	CD	compound	I-cell_type
marrow-derived	JJ	amod	I-cell_type
progenitors	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
CD16+	JJ	amod	B-cell_type
14-	CD	amod	I-cell_type
granulocytes	NNS	conj	I-cell_type
,	,	punct	O
CD14+	JJ	amod	B-cell_type
monocytes	NNS	conj	I-cell_type
,	,	punct	O
CD3+	JJ	amod	B-cell_type
T	NN	conj	I-cell_type
and	CC	cc	I-cell_type
CD19+	JJ	amod	I-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	conj	I-cell_type
from	IN	case	O
peripheral	JJ	amod	O
blood	NN	nmod	O
.	.	punct	O

In	IN	case	O
high-risk	JJ	amod	O
patients	NNS	nmod	O
(	-LRB-	punct	O
RAEB	NN	dep	O
,	,	punct	O
RAEB-t	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
clonality	NN	compound	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
before	IN	nmod	O
and	CC	cc	O
after	IN	case	O
intensive	JJ	amod	O
remission-induction	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

All	DT	det	O
patients	NNS	nsubj	O
,	,	punct	O
except	IN	case	O
one	CD	nmod	O
with	IN	case	O
RA	NN	nmod	O
,	,	punct	O
had	VBD	ROOT	O
predominance	NN	dobj	O
of	IN	case	O
a	DT	det	O
single	JJ	amod	O
clone	NN	nmod	O
in	IN	case	O
their	PRP$	nmod:poss	O
granulocytes	NNS	nmod	B-cell_type
and	CC	cc	O
monocytes	NNS	conj	B-cell_type
.	.	punct	O

The	DT	det	O
same	JJ	amod	O
clonal	JJ	amod	O
pattern	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
CD34+	JJ	amod	B-cell_type
progenitor	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
CD3+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nsubj	I-cell_type
were	VBD	cop	O
polyclonal	JJ	ROOT	O
or	CC	cc	O
oligoclonal	JJ	conj	O
in	IN	case	O
14/18	CD	nummod	O
patients	NNS	nmod	O
.	.	punct	O

X-chromosome	NN	compound	B-DNA
inactivation	NN	compound	O
patterns	NNS	nsubj	O
of	IN	case	O
CD19+	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	cop	O
highly	RB	advmod	O
concordant	JJ	ROOT	O
with	IN	case	O
CD3+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
except	IN	case	O
for	IN	case	O
two	CD	nummod	O
patients	NNS	nmod	O
(	-LRB-	punct	O
one	CD	nummod	O
RA	NN	dep	O
,	,	punct	O
one	CD	nummod	O
CMML	NN	appos	O
)	-RRB-	punct	O
with	IN	case	O
monoclonal	JJ	amod	B-cell_type
B	NN	nmod	I-cell_type
and	CC	cc	I-cell_type
polyclonal	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	conj	I-cell_type
,	,	punct	O
therefore	RB	advmod	O
suggesting	VBG	advcl	O
a	DT	det	O
clonal	JJ	amod	O
mutation	NN	dobj	O
in	IN	case	O
a	DT	det	O
progenitor	NN	nmod	B-cell_type
common	JJ	amod	O
to	TO	case	O
the	DT	det	O
myeloid	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
B-lymphoid	JJ	conj	I-cell_type
lineages	NNS	nmod	I-cell_type
or	CC	cc	O
the	DT	det	O
coexistence	NN	conj	O
of	IN	case	O
MDS	NN	nmod	O
and	CC	cc	O
a	DT	det	O
B-cell	NN	compound	O
disorder	NN	conj	O
in	IN	case	O
these	DT	det	O
particular	JJ	amod	O
patients	NNS	nmod	O
.	.	punct	O

After	IN	case	O
high-dose	JJ	amod	O
non-myeloablative	JJ	amod	O
chemotherapy	NN	nmod	O
,	,	punct	O
polyclonal	JJ	amod	O
haemopoiesis	NN	nsubjpass	O
was	VBD	auxpass	O
reinstalled	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
mature	JJ	amod	B-cell_type
myeloid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
immature	JJ	amod	O
and	CC	cc	O
committed	VBN	conj	B-cell_type
marrow	NN	compound	I-cell_type
progenitors	NNS	conj	I-cell_type
in	IN	case	O
three	CD	nmod	O
of	IN	case	O
four	CD	nummod	O
patients	NNS	nmod	O
achieving	VBG	acl	O
complete	JJ	amod	O
haematological	JJ	amod	O
remission	NN	dobj	O
.	.	punct	O

Therefore	RB	advmod	O
we	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
most	JJS	advmod	O
haematological	JJ	amod	O
remissions	NNS	nsubjpass	O
in	IN	case	O
MDS	NN	nmod	O
are	VBP	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
restoration	NN	nmod	O
of	IN	case	O
polyclonal	JJ	amod	O
haemopoiesis	NN	nmod	O
.	.	punct	O

Prominent	JJ	amod	O
sex	NN	compound	O
steroid	NN	compound	O
metabolism	NN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Steroid	NN	compound	O
metabolism	NN	nsubjpass	O
was	VBD	auxpass	O
investigated	VBN	ROOT	O
in	IN	case	O
cultured	VBN	amod	B-cell_line
human	JJ	amod	I-cell_line
B-lymphoblastoid	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
(	-LRB-	punct	O
B-LCL	NN	appos	B-cell_line
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
and	CC	cc	I-cell_type
B	NN	conj	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Gene	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
reverse-transcription	JJ	amod	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	compound	O
amplification	NN	nmod	O
(	-LRB-	punct	O
RT-PCR	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Appropriate	JJ	amod	O
sized	JJ	amod	O
transcripts	NNS	nsubjpass	B-RNA
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
cultured	VBN	amod	O
and	CC	cc	O
fresh	JJ	conj	O
peripheral	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
for	IN	case	O
CYP11A	NN	nmod	B-protein
,	,	punct	O
CYP17	NN	conj	B-protein
,	,	punct	O
HSD11L	NN	conj	B-protein
(	-LRB-	punct	O
11beta-hydroxysteroid	NN	compound	B-protein
dehydrogenase	NN	appos	I-protein
I	NN	nummod	I-protein
)	-RRB-	punct	O
,	,	punct	O
HSD17B1	NN	compound	B-protein
(	-LRB-	punct	O
17beta-hydroxysteroid	NN	compound	B-protein
dehydrogenase	NN	compound	I-protein
type	NN	appos	I-protein
I	CD	nummod	I-protein
)	-RRB-	punct	O
and	CC	cc	O
SRD5A1	NN	conj	B-protein
(	-LRB-	punct	O
5alpha-reductase	NN	appos	B-protein
I	CD	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

B-LCL	NN	nsubj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
T	NN	compound	B-cell_type
and	CC	cc	I-cell_type
B	NN	conj	I-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
expressed	VBD	ROOT	O
CYP11B	NN	dobj	B-protein
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
minimal	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
HSD3B1	NN	nmod	B-protein
and	CC	cc	O
HSD3B2	NN	conj	B-protein
(	-LRB-	punct	O
3beta-hydroxysteroid	NN	compound	B-protein
dehydrogenase	NN	appos	I-protein
I	CD	dep	I-protein
and	CC	cc	I-protein
II	CD	conj	I-protein
)	-RRB-	punct	O
in	IN	case	O
B-LCL	NN	compound	B-cell_line
and	CC	cc	O
T	NN	conj	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Transcripts	NNS	nsubjpass	O
for	IN	case	O
CYP19	NN	nmod	B-protein
and	CC	cc	O
HSD11K	NN	conj	B-protein
were	VBD	auxpass	O
not	RB	neg	O
detected	VBN	ROOT	O
.	.	punct	O

Corresponding	JJ	amod	O
enzymatic	JJ	amod	O
activity	NN	nsubj	O
was	VBD	cop	O
detectable	JJ	ROOT	O
only	RB	advmod	O
for	IN	case	O
17-hydroxysteroid	JJ	compound	B-protein
dehydrogenase	NN	nmod	I-protein
and	CC	cc	O
5alpha-reductase	NN	conj	B-protein
,	,	punct	O
respectively	RB	advmod	O
producing	VBG	advcl	O
testosterone	NN	dobj	O
and	CC	cc	O
5alpha-dihydrotestosterone	NN	conj	O
.	.	punct	O

Steroid	NN	compound	O
identities	NNS	nsubjpass	O
were	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
gas	NN	compound	O
chromatography/mass	NN	compound	O
spectrometry	NN	nmod	O
(	-LRB-	punct	O
GC/MS	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

One	CD	nummod	O
metabolite	NN	nsubj	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
deoxycorticosterone	NN	xcomp	O
was	VBD	auxpass	O
identified	VBN	ccomp	O
by	IN	case	O
GC/MS	NN	nmod	O
as	IN	case	O
6alpha-hydroxypregnanolone	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
sex	NN	compound	O
hormone	NN	compound	O
metabolism	NN	nsubj	O
,	,	punct	O
including	VBG	case	O
androgen	NN	compound	O
synthesis	NN	nmod	O
,	,	punct	O
occurs	VBZ	ccomp	O
in	IN	case	O
lymphocytes	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
may	MD	aux	O
modulate	VB	conj	O
immune	JJ	amod	O
response	NN	dobj	O
.	.	punct	O

Human	JJ	amod	B-cell_type
white	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
and	CC	cc	O
hair	NN	compound	O
follicles	NNS	conj	O
are	VBP	cop	O
good	JJ	amod	O
sources	NNS	ROOT	O
of	IN	case	O
mRNA	NN	nmod	B-RNA
for	IN	case	O
the	DT	det	O
pterin	NN	compound	B-protein
carbinolamine	NN	compound	I-protein
dehydratase/dimerization	NN	compound	I-protein
cofactor	NN	nmod	I-protein
of	IN	case	O
HNF1	NN	nmod	B-protein
for	IN	case	O
mutation	NN	compound	O
detection	NN	nmod	O
.	.	punct	O

Pterin	NN	compound	B-protein
carbinolamine	NN	compound	I-protein
dehydratase/dimerization	NN	compound	I-protein
cofactor	NN	nsubj	I-protein
of	IN	case	O
HNF1	NN	nmod	B-protein
(	-LRB-	punct	O
PCD/DCoH	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
protein	NN	ROOT	O
that	WDT	nsubj	O
has	VBZ	acl:relcl	O
a	DT	det	O
dual	JJ	amod	O
function	NN	dobj	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
a	DT	det	O
pterin	NN	compound	B-protein
4alpha-carbinolamine	NN	compound	I-protein
dehydratase	NN	ROOT	I-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
regeneration	NN	nmod	O
of	IN	case	O
the	DT	det	O
cofactor	NN	compound	B-protein
tetrahydrobiopterin	NN	nmod	I-protein
during	IN	case	O
the	DT	det	O
phenylalanine	NN	compound	O
hydroxylase-	NN	amod	O
catalyzed	VBD	amod	O
hydroxylation	NN	nmod	O
of	IN	case	O
phenylalanine	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
the	DT	det	O
dimerization	NN	compound	O
cofactor	NN	ROOT	O
of	IN	case	O
HNF1	NN	nmod	B-protein
that	WDT	nsubj	O
is	VBZ	cop	O
able	JJ	acl:relcl	O
to	TO	mark	O
activate	VB	xcomp	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
HNF1	NN	nmod	B-protein
.	.	punct	O

Deficiencies	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
gene	NN	nmod	O
for	IN	case	O
this	DT	det	O
dual	JJ	amod	B-protein
functional	JJ	amod	I-protein
protein	NN	nmod	I-protein
result	VBP	ROOT	O
in	IN	case	O
hyperphenylalaninemia	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
that	IN	mark	O
the	DT	det	O
PCD/DCoH	NN	compound	B-RNA
mRNA	NN	nsubj	I-RNA
is	VBZ	cop	O
present	JJ	acl:relcl	O
in	IN	case	O
human	JJ	amod	B-cell_type
white	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
hair	NN	compound	O
follicles	NNS	conj	O
.	.	punct	O

Taking	VBG	advcl	O
advantage	NN	dobj	O
of	IN	case	O
this	DT	det	O
finding	NN	nmod	O
,	,	punct	O
a	DT	det	O
sensitive	JJ	amod	O
,	,	punct	O
rapid	JJ	conj	O
and	CC	cc	O
convenient	JJ	conj	O
method	NN	nsubjpass	O
for	IN	case	O
screening	VBG	amod	O
mutations	NNS	nmod	O
occurring	VBG	acl	O
in	IN	case	O
the	DT	det	O
coding	VBG	amod	O
region	NN	nmod	O
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
described	VBN	ROOT	O
.	.	punct	O

Copyright	NN	dep	O
1998	CD	ROOT	O
Academic	NNP	compound	O
Press	NNP	dep	O
.	.	punct	O

Biochemical	JJ	amod	O
characterization	NN	ROOT	O
of	IN	case	O
the	DT	det	O
NF-Y	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
complex	NN	nmod	I-protein
during	IN	case	O
B	NN	compound	O
lymphocyte	NN	compound	O
development	NN	nmod	O
.	.	punct	O

The	DT	det	O
transcription	NN	compound	B-protein
factor	NN	nsubj	I-protein
,	,	punct	O
NF-Y	NN	appos	B-protein
,	,	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
tissue-specific	JJ	amod	O
major	JJ	amod	B-DNA
histocompatibility	NN	compound	I-DNA
complex	NN	compound	I-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
gene	NN	compound	I-DNA
transcription	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
the	DT	det	O
biochemical	JJ	amod	O
properties	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
heterotrimeric	JJ	amod	B-protein
NF-Y	NN	compound	I-protein
complex	NN	nmod	I-protein
have	VBP	aux	O
been	VBN	auxpass	O
characterized	VBN	ROOT	O
during	IN	case	O
stage-specific	JJ	amod	O
B-cell	NN	compound	O
development	NN	nmod	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
several	JJ	amod	O
class	NN	compound	B-cell_line
II-	NN	amod	I-cell_line
mutant	JJ	amod	I-cell_line
B-cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
,	,	punct	O
which	WDT	nsubj	O
represent	VBP	acl:relcl	O
distinct	JJ	amod	O
bare	JJ	amod	O
lymphocyte	NN	compound	O
syndrome	NN	compound	O
class	NN	compound	O
II	CD	nummod	O
genetic	JJ	amod	O
complementation	NN	compound	O
groups	NNS	dobj	O
.	.	punct	O

The	DT	det	O
NF-Y	NN	compound	B-protein
complex	NN	nsubj	I-protein
derived	VBN	acl	O
from	IN	case	O
class	NN	compound	B-cell_type
II+	JJ	amod	I-cell_type
mature	JJ	amod	I-cell_type
B-cells	NNS	nmod	I-cell_type
bound	VBN	ROOT	O
with	IN	case	O
high	JJ	amod	O
affinity	NN	nmod	O
to	TO	case	O
anion	NN	compound	B-protein
exchangers	NNS	nmod	I-protein
,	,	punct	O
and	CC	cc	O
eluted	VBN	conj	O
as	IN	case	O
an	DT	det	O
intact	JJ	amod	O
trimeric	JJ	amod	B-protein
complex	NN	nmod	I-protein
,	,	punct	O
whereas	IN	advmod	O
,	,	punct	O
NF-Y	NN	nmod	B-protein
derived	VBN	acl	O
from	IN	case	O
class	NN	compound	B-cell_type
II-	NN	amod	I-cell_type
plasma	NN	compound	I-cell_type
B-cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
from	IN	case	O
bare	JJ	amod	B-cell_line
lymphocyte	NN	compound	I-cell_line
syndrome	NN	compound	I-cell_line
group	NN	compound	I-cell_line
II	CD	nummod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
,	,	punct	O
RJ2.2.5	NN	appos	B-cell_line
and	CC	cc	O
RM3	NN	conj	B-cell_line
,	,	punct	O
dissociated	VBD	advcl	O
into	IN	case	O
discrete	JJ	amod	O
NF-YA	NN	nmod	B-protein
and	CC	cc	O
NF-YB	NN	conj	B-protein
:	:	punct	I-protein
C	NN	compound	I-protein
subunit	NN	compound	B-protein
fractions	NNS	dep	I-protein
.	.	punct	O

Recombination	NN	nsubj	O
of	IN	case	O
the	DT	det	O
MPC11	NN	compound	B-protein
plasma	NN	compound	I-protein
B-cell	NN	nmod	I-protein
derived	VBD	ROOT	I-protein
NF-Y	NN	compound	I-protein
A	NN	compound	I-protein
:	:	punct	I-protein
B	NN	compound	I-protein
:	:	punct	I-protein
C	NN	compound	I-protein
complex	NN	dobj	I-protein
with	IN	case	O
the	DT	det	O
low	JJ	amod	O
molecular	JJ	amod	O
mass	NN	compound	O
protein	NN	compound	O
fraction	NN	nmod	O
,	,	punct	O
NF-Y-associated	JJ	amod	B-protein
factors	NNS	conj	I-protein
(	-LRB-	punct	O
YAFs	NNS	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
derived	VBN	advcl	O
from	IN	case	O
mature	JJ	amod	O
A20	NN	compound	O
B-cell	NN	compound	O
nuclei	NNS	nmod	O
,	,	punct	O
conferred	VBD	conj	O
high	JJ	amod	O
affinity	NN	compound	O
anion	NN	compound	O
exchange	NN	dobj	O
binding	VBG	acl	O
to	TO	case	O
NF-Y	NN	nmod	B-protein
as	IN	case	O
an	DT	det	O
intact	JJ	amod	B-protein
trimeric	JJ	amod	I-protein
complex	NN	nmod	I-protein
.	.	punct	O

Recombination	NN	nsubj	O
of	IN	case	O
the	DT	det	O
native	JJ	amod	B-protein
NF-YA	NN	compound	I-protein
:	:	punct	I-protein
B	NN	compound	I-protein
:	:	punct	I-protein
C	NN	compound	I-protein
complex	NN	nmod	I-protein
with	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	B-protein
cofactor	NN	nmod	I-protein
,	,	punct	O
PC4	NN	appos	B-protein
,	,	punct	O
likewise	RB	advmod	O
conferred	VBN	ROOT	O
high	JJ	amod	B-protein
affinity	NN	compound	I-protein
NF-Y	NN	compound	I-protein
binding	NN	dobj	O
to	TO	case	O
anion	NN	compound	B-protein
exchangers	NNS	nmod	I-protein
,	,	punct	O
and	CC	cc	O
stabilized	VBD	conj	O
NF-Y	NN	compound	B-protein
interaction	NN	dobj	O
with	IN	case	O
CCAAT-box	NN	compound	B-DNA
DNA	NN	compound	I-DNA
motifs	NNS	nmod	I-DNA
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Interaction	NN	nsubjpass	O
between	IN	case	O
PC4	NN	nmod	B-protein
and	CC	cc	O
NF-Y	NN	conj	B-protein
was	VBD	auxpass	O
mapped	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
C-terminal	JJ	amod	B-protein
region	NN	nmod	I-protein
of	IN	case	O
PC4	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
the	DT	det	O
subunit	NN	compound	B-protein
interaction	NN	nsubj	I-protein
subdomain	NN	conj	I-protein
of	IN	case	O
the	DT	det	O
highly	RB	advmod	B-protein
conserved	VBN	amod	I-protein
DNA	NN	compound	I-protein
binding-subunit	JJ	amod	I-protein
interaction	NN	compound	I-protein
domain	NN	nmod	I-protein
(	-LRB-	punct	O
DBD	NN	appos	B-protein
)	-RRB-	punct	O
of	IN	case	O
NF-YA	NN	nmod	B-protein
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
class	NN	compound	B-cell_type
II+	JJ	amod	I-cell_type
mature	JJ	amod	I-cell_type
B-cells	NNS	compound	I-cell_type
NF-Y	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
the	DT	det	O
protein	NN	compound	O
cofactor	NN	nmod	O
,	,	punct	O
PC4	NN	appos	B-protein
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
play	VB	acl:relcl	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
NF-Y-mediated	JJ	amod	O
transcriptional	JJ	amod	O
control	NN	nmod	O
of	IN	case	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Arrest	NN	ROOT	O
of	IN	case	O
B	NN	compound	O
lymphocyte	NN	compound	O
terminal	JJ	amod	O
differentiation	NN	nmod	O
by	IN	case	O
CD40	NN	compound	O
signaling	NN	nmod	O
:	:	punct	O
mechanism	NN	dep	O
for	IN	case	O
lack	NN	nmod	O
of	IN	case	O
antibody-secreting	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
germinal	JJ	amod	O
centers	NNS	nmod	O
.	.	punct	O

Despite	IN	prep	O
extensive	JJ	amod	O
research	NN	pobj	O
,	,	punct	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
CD40	NN	compound	B-protein
signaling	NN	nmod	O
in	IN	case	O
B	NN	compound	O
cell	NN	compound	O
terminal	JJ	amod	O
differentiation	NN	nmod	O
remains	VBZ	ROOT	O
controversial	JJ	xcomp	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
CD40	NN	compound	B-protein
engagement	NN	nsubj	O
arrests	VBZ	ccomp	O
B	NN	compound	O
cell	NN	compound	O
differentiation	NN	dobj	O
prior	RB	case	O
to	TO	case	O
plasma	NN	compound	O
cell	NN	compound	O
formation	NN	nmod	O
.	.	punct	O

This	DT	det	O
arrest	NN	nsubjpass	O
is	VBZ	auxpass	O
manifested	VBN	ROOT	O
at	IN	case	O
a	DT	det	O
molecular	JJ	amod	O
level	NN	nmod	O
as	IN	case	O
a	DT	det	O
reduction	NN	nmod	O
in	IN	case	O
mRNA	NN	compound	O
levels	NNS	nmod	O
of	IN	case	O
secretory	JJ	amod	O
immunoglobulin	NN	compound	O
gene	NN	compound	O
products	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
mu	NN	compound	O
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
J	NN	compound	O
chain	NN	conj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
loss	NN	conj	O
of	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	B-protein
regulator	NN	nmod	I-protein
BLIMP-1	NN	dep	B-protein
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
inhibition	NN	nsubjpass	O
of	IN	case	O
B	NN	compound	O
cell	NN	compound	O
differentiation	NN	nmod	O
by	IN	case	O
CD40	NN	compound	B-protein
engagement	NN	nmod	O
could	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
overcome	VBN	ROOT	O
by	IN	case	O
either	CC	cc:preconj	O
mitogens	NNS	nmod	B-protein
or	CC	cc	O
cytokines	NNS	conj	B-protein
,	,	punct	O
but	CC	cc	O
could	MD	aux	O
be	VB	auxpass	O
reversed	VBN	conj	O
by	IN	case	O
antibodies	NNS	nmod	O
that	WDT	nsubj	O
interfere	VBP	acl:relcl	O
with	IN	case	O
the	DT	det	O
CD40	NN	compound	B-protein
/	:	punct	O
gp39	NN	compound	B-protein
interaction	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
secretory	JJ	amod	O
immunoglobulin	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
produced	VBN	ccomp	O
by	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
that	WDT	nsubjpass	O
are	VBP	auxpass	O
actively	RB	advmod	O
engaged	VBN	acl:relcl	O
by	IN	case	O
gp39-expressing	VBG	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
positively	RB	advmod	O
charged	JJ	amod	O
alpha-lipoic	JJ	amod	O
acid	NN	compound	O
analogue	NN	ROOT	O
with	IN	case	O
increased	VBN	amod	O
cellular	JJ	amod	O
uptake	NN	nmod	O
and	CC	cc	O
more	RBR	advmod	O
potent	JJ	amod	O
immunomodulatory	JJ	amod	O
activity	NN	conj	O
.	.	punct	O

alpha-Lipoic	JJ	amod	O
acid	NN	nsubjpass	O
(	-LRB-	punct	O
LA	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
taken	VBN	ROOT	O
up	RP	advmod	O
by	IN	case	O
cells	NNS	nmod	O
and	CC	cc	O
reduced	VBN	conj	O
to	TO	case	O
its	PRP$	nmod:poss	O
potent	JJ	amod	O
dithiol	NN	compound	O
form	NN	nmod	O
,	,	punct	O
dihydrolipoate	JJ	conj	O
(	-LRB-	punct	O
DHLA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
much	JJ	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
is	VBZ	auxpass	O
rapidly	RB	advmod	O
effluxed	VBN	parataxis	O
out	RP	advmod	O
from	IN	case	O
cells	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
improve	VB	advcl	O
retention	NN	dobj	O
in	IN	case	O
cells	NNS	nmod	O
,	,	punct	O
the	DT	det	O
LA	NN	compound	O
molecule	NN	nsubjpass	O
was	VBD	auxpass	O
modified	VBN	ROOT	O
to	TO	mark	O
confer	VB	xcomp	O
a	DT	det	O
positive	JJ	amod	O
charge	NN	dobj	O
at	IN	case	O
physiological	JJ	amod	O
pH	NN	nmod	O
.	.	punct	O

N	NN	nsubjpass	O
,	,	punct	O
N-dimethyl	NN	conj	O
,	,	punct	O
N'-2-amidoethyl-lipoate	NN	nsubjpass	O
was	VBD	auxpass	O
synthesized	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
protonated	JJ	amod	O
form	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
new	JJ	amod	O
molecule	NN	nmod	O
is	VBZ	auxpass	O
referred	VBN	ROOT	O
to	TO	prep	O
as	IN	case	O
LA-Plus	NN	nmod	O
.	.	punct	O

The	DT	det	O
uptake	NN	nsubj	O
of	IN	case	O
LA-Plus	NN	nmod	O
by	IN	case	O
human	JJ	amod	B-cell_type
Wurzburg	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	cop	O
higher	JJR	ROOT	O
compared	VBN	xcomp	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
LA	NN	nmod	O
.	.	punct	O

Several-fold	RB	amod	O
higher	JJR	amod	O
amounts	NNS	nsubjpass	O
of	IN	case	O
DHLA-Plus	NN	nmod	O
,	,	punct	O
the	DT	det	O
corresponding	JJ	amod	O
reduced	JJ	amod	O
form	NN	appos	O
of	IN	case	O
LA-Plus	NN	nmod	O
,	,	punct	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
LA-Plus	JJ	amod	O
treated	JJ	amod	O
cells	NNS	nmod	O
compared	VBN	case	O
to	TO	case	O
the	DT	det	O
amount	NN	advcl	O
of	IN	case	O
DHLA	NN	nmod	O
found	VBN	acl	O
in	IN	case	O
cells	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
LA	NN	nmod	O
.	.	punct	O

At	IN	case	O
100	CD	nummod	O
microM	NN	nmod	O
,	,	punct	O
LA	NN	nsubj	O
did	VBD	ROOT	O
not	RB	neg	O
but	CC	cc	O
LA-Plus	NN	nsubj	O
inhibited	VBD	conj	O
H2O2	NN	nmod:npmod	O
induced	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activation	NN	nsubj	O
and	CC	cc	O
NF-kappaB	NN	conj	B-protein
directed	VBD	conj	O
IL-2	NN	compound	B-protein
receptor	NN	compound	I-protein
expression	NN	dobj	O
.	.	punct	O

Both	CC	cc:preconj	O
LA	NN	nsubj	O
and	CC	cc	O
LA-Plus	NN	conj	O
synergised	VBD	ROOT	O
with	IN	case	O
selenium	NN	nmod	O
in	IN	mark	O
inhibiting	VBG	advcl	O
H2O2	NN	nmod:npmod	O
induced	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activation	NN	dobj	O
.	.	punct	O

At	IN	case	O
150	CD	nummod	O
microM	NN	amod	O
LA-Plus	NN	nsubj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
LA	NN	conj	O
,	,	punct	O
inhibited	VBD	ROOT	O
TNFalpha	NN	nmod:npmod	B-protein
induced	VBD	xcomp	O
NF-kappaB	NN	compound	B-protein
activation	NN	dobj	O
.	.	punct	O

At	IN	case	O
5	CD	nummod	O
microM	NN	amod	O
LA-Plus	NN	ROOT	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
LA	NN	conj	O
,	,	punct	O
protected	VBN	acl	O
against	IN	case	O
both	CC	cc:preconj	O
spontaneous	JJ	amod	O
and	CC	cc	O
etoposide	NN	conj	O
induced	VBD	conj	O
apoptosis	NN	nmod	O
in	IN	case	O
rat	NN	compound	B-cell_type
thymocytes	NNS	nmod	I-cell_type
.	.	punct	O

LA-Plus	NN	nsubj	O
is	VBZ	cop	O
thus	RB	advmod	O
an	DT	det	O
improved	JJ	amod	O
form	NN	ROOT	O
of	IN	case	O
LA	NN	nmod	O
with	IN	case	O
increased	VBN	amod	O
therapeutic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O

Copyright	NN	dep	O
1998	CD	ROOT	O
Academic	NNP	compound	O
Press	NNP	dep	O
.	.	punct	O

Carrier	NN	compound	O
identification	NN	ROOT	O
in	IN	case	O
X-linked	JJ	amod	O
immunodeficiency	NN	compound	O
diseases	NNS	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
Carrier	NN	compound	O
identification	NN	nsubjpass	O
in	IN	case	O
X-linked	JJ	amod	O
immunodeficiency	NN	compound	O
disorders	NNS	nmod	O
can	MD	aux	O
be	VB	auxpass	O
based	VBN	appos	O
on	IN	case	O
the	DT	det	O
demonstration	NN	nmod	O
of	IN	case	O
non-random	JJ	amod	O
X	NN	compound	O
inactivation	NN	nmod	O
(	-LRB-	punct	O
NRXI	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
affected	VBN	amod	B-cell_type
blood	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
lineages	NNS	nmod	I-cell_type
when	WRB	advmod	O
growth	NN	nsubj	O
is	VBZ	aux	O
impaired	JJ	advcl	O
in	IN	case	O
cells	NNS	nmod	O
expressing	VBG	acl	O
the	DT	det	O
abnormal	JJ	amod	B-DNA
gene	NN	dobj	I-DNA
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
utility	NN	dobj	O
of	IN	mark	O
seeking	VBG	acl	O
evidence	NN	dobj	O
of	IN	case	O
NRXI	NN	nmod	O
to	TO	mark	O
test	VB	advcl	O
the	DT	det	O
carrier	NN	compound	O
status	NN	dobj	O
of	IN	case	O
women	NNS	nmod	O
in	IN	case	O
families	NNS	nmod	O
affected	VBN	acl	O
by	IN	case	O
X-linked	JJ	amod	O
severe	JJ	amod	O
combined	JJ	amod	O
immunodeficiency	NN	nmod	O
(	-LRB-	punct	O
XSCID	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
X-linked	JJ	amod	O
hypogammaglobulinaemia	NN	conj	O
(	-LRB-	punct	O
XLH	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
to	TO	mark	O
identify	VB	advcl	O
as	IN	case	O
carriers	NNS	nmod	O
the	DT	det	O
mothers	NNS	dobj	O
of	IN	case	O
boys	NNS	nmod	O
with	IN	case	O
SCID	NN	nmod	O
or	CC	cc	O
hypogammaglobulinaemia	NN	conj	O
whose	WP$	nmod:poss	O
phenotype	NN	nsubj	O
suggested	VBD	acl:relcl	O
X-linkage	NN	dobj	O
and	CC	cc	O
to	TO	mark	O
infer	VB	conj	O
X-linkage	NN	dobj	O
in	IN	case	O
boys	NNS	nmod	O
with	IN	case	O
SCID	NN	nmod	O
or	CC	cc	O
hypogammaglobulinaemia	NN	conj	O
whose	WP$	nmod:poss	O
disease	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
clearly	RB	advmod	O
X-linked	JJ	acl:relcl	O
on	IN	case	O
the	DT	det	O
basis	NN	dep	O
either	CC	cc:preconj	O
of	IN	case	O
family	NN	compound	O
history	NN	nmod	O
or	CC	cc	O
clinical	JJ	amod	O
and	CC	cc	O
immunological	JJ	conj	O
characteristics	NNS	conj	O
.	.	punct	O

METHODOLOGY	NN	ROOT	O
:	:	punct	O
A	DT	det	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction-based	JJ	amod	O
method	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	dep	O
to	TO	mark	O
amplify	VB	xcomp	O
a	DT	det	O
polymorphic	JJ	amod	O
CAG	NN	compound	B-DNA
repeat	NN	dobj	I-DNA
in	IN	case	O
the	DT	det	O
first	JJ	amod	B-DNA
exon	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
androgen	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	nmod	I-DNA
after	IN	case	O
selective	JJ	amod	O
digestion	NN	nmod	O
of	IN	case	O
the	DT	det	O
active	JJ	amod	B-DNA
X	NN	compound	I-DNA
chromosome	NN	nmod	I-DNA
with	IN	case	O
a	DT	det	O
methylation-sensitive	JJ	amod	B-protein
enzyme	NN	nmod	I-protein
,	,	punct	O
HpaII	NN	appos	B-protein
to	TO	mark	O
distinguish	VB	acl	O
between	IN	case	O
the	DT	det	O
paternal	JJ	amod	B-DNA
and	CC	cc	I-DNA
maternal	JJ	conj	I-DNA
alleles	NNS	nmod	I-DNA
and	CC	cc	O
to	TO	mark	O
identify	VB	conj	O
their	PRP$	nmod:poss	O
methylation	NN	compound	O
status	NN	dobj	O
.	.	punct	O

RESULTS	NNS	dep	O
:	:	punct	O
Heterozygosity	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
24	CD	compound	O
of	IN	advmod	O
31	CD	nummod	O
female	JJ	amod	O
subjects	NNS	nmod	O
(	-LRB-	punct	O
77	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

As	IN	mark	O
anticipated	VBN	advcl	O
,	,	punct	O
NRXI	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
demonstrated	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
studied	VBN	acl	O
from	IN	case	O
obligate	JJ	amod	O
carriers	NNS	nmod	O
of	IN	case	O
XSCID	NN	nmod	O
and	CC	cc	O
an	DT	det	O
obligate	JJ	amod	O
carrier	NN	conj	O
of	IN	case	O
XLH	NN	nmod	O
but	CC	cc	O
not	RB	neg	O
on	IN	case	O
a	DT	det	O
carrier	NN	conj	O
of	IN	case	O
X-linked	JJ	amod	O
immunodeficiency	NN	nmod	O
with	IN	case	O
hyper-IgM	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
finding	NN	nsubj	O
of	IN	case	O
NRXI	NN	nmod	O
in	IN	case	O
the	DT	det	O
mother	NN	nmod	O
of	IN	case	O
a	DT	det	O
boy	NN	nmod	O
with	IN	case	O
a	DT	det	O
SCID	NN	compound	O
variant	NN	nmod	O
showed	VBD	ROOT	O
her	PRP	dobj	O
to	TO	aux	O
be	VB	cop	O
a	DT	det	O
carrier	NN	ccomp	O
of	IN	case	O
XSCID	NN	nmod	O
and	CC	cc	O
establishes	VBZ	conj	O
that	IN	mark	O
her	PRP$	poss	O
son	NN	nsubj	O
has	VBZ	ccomp	O
XSCID	NN	dobj	O
,	,	punct	O
not	RB	neg	O
otherwise	RB	advmod	O
evident	JJ	conj	O
from	IN	case	O
available	JJ	amod	O
data	NNS	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
This	DT	det	O
PCR	NN	compound	O
assay	NN	nsubj	O
provides	VBZ	dep	O
a	DT	det	O
rapid	JJ	amod	O
method	NN	dobj	O
for	IN	case	O
carrier	NN	compound	O
detection	NN	nmod	O
of	IN	case	O
X-linked	JJ	amod	O
immunodeficiencies	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
has	VBZ	aux	O
allowed	VBN	conj	O
us	PRP	dobj	O
to	TO	aux	O
expand	VB	xcomp	O
the	DT	det	O
phenotype	NN	dobj	O
of	IN	case	O
XSCID	NN	nmod	O

Leukocyte-endothelial	JJ	amod	O
interaction	NN	nsubjpass	O
is	VBZ	auxpass	O
augmented	VBN	ROOT	O
by	IN	case	O
high	JJ	amod	O
glucose	NN	compound	O
concentrations	NNS	nmod	O
and	CC	cc	O
hyperglycemia	NN	conj	O
in	IN	case	O
a	DT	det	O
NF-kB-dependent	JJ	compound	O
fashion	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
addressed	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
hyperglycemia	NN	nmod	O
in	IN	case	O
leukocyte-endothelium	JJ	compound	O
interaction	NN	nmod	O
under	IN	case	O
flow	NN	compound	O
conditions	NNS	nmod	O
by	IN	mark	O
exposing	VBG	advcl	O
human	JJ	amod	B-cell_type
umbilical	JJ	amod	I-cell_type
vein	NN	compound	I-cell_type
endothelial	JJ	amod	I-cell_type
cells	NNS	dobj	I-cell_type
for	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
to	TO	case	O
normal	JJ	nmod	O
(	-LRB-	punct	O
5	CD	nummod	O
mM	NN	dep	O
)	-RRB-	punct	O
,	,	punct	O
high	JJ	amod	O
concentration	NN	dobj	O
of	IN	case	O
glucose	NN	nmod	O
(	-LRB-	punct	O
30	CD	nummod	O
mM	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
advanced	JJ	amod	O
glycosylation	NN	compound	O
end	NN	compound	O
product-albumin	JJ	conj	B-protein
(	-LRB-	punct	O
100	CD	nummod	O
microg/ml	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
hyperglycemic	JJ	amod	O
(	-LRB-	punct	O
174-316	CD	nummod	O
mg/dl	NN	dep	O
)	-RRB-	punct	O
sera	NNS	conj	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
diabetes	NNS	nmod	O
and	CC	cc	O
abnormal	JJ	amod	O
hemoglobin	NN	compound	O
A1c	NN	conj	O
(	-LRB-	punct	O
8.1+/-1.4	CD	compound	O
%	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

At	IN	case	O
the	DT	det	O
end	NN	nmod	O
of	IN	case	O
incubation	NN	compound	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	auxpass	O
perfused	VBN	ROOT	O
with	IN	case	O
total	JJ	amod	O
leukocyte	NN	compound	O
suspension	NN	nmod	O
in	IN	case	O
a	DT	det	O
parallel	JJ	amod	O
plate	NN	compound	O
flow	NN	compound	O
chamber	NN	nmod	O
under	IN	case	O
laminar	JJ	compound	O
flow	NN	nmod	O
(	-LRB-	punct	O
1.5	CD	nummod	O
dyn/cm2	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Rolling	NN	amod	O
and	CC	cc	O
adherent	JJ	conj	B-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
by	IN	case	O
digital	JJ	amod	O
image	NN	compound	O
processing	NN	nmod	O
.	.	punct	O

Results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
30	CD	nummod	O
mM	NN	amod	O
glucose	NN	nsubj	O
significantly	RB	advmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	-LRB-	appos	O
0.01	CD	nummod	O
)	-RRB-	punct	O
increased	VBD	ccomp	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
adherent	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
to	TO	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
respect	NN	dep	O
to	TO	case	O
control	VB	nmod	O
(	-LRB-	punct	O
5	CD	compound	O
mM	NN	amod	O
glucose	NN	dep	O
;	:	punct	O
151+/-19	CD	nummod	O
versus	CC	cc	O
33+/-8	CD	conj	O
cells/mm2	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
similar	JJ	amod	O
response	NN	nsubjpass	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
endothelial	JJ	amod	O
stimulation	NN	nmod	O
with	IN	case	O
IL-1beta	NN	nmod	B-protein
,	,	punct	O
here	RB	advmod	O
used	VBN	advcl	O
as	IN	case	O
positive	JJ	amod	O
control	NN	nmod	O
(	-LRB-	punct	O
195+/-20	CD	nummod	O
cells/mm2	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
rolling	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
on	IN	case	O
endothelial	JJ	amod	O
surface	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
affected	VBN	ROOT	O
by	IN	case	O
high	JJ	amod	O
glucose	NN	compound	O
level	NN	nmod	O
.	.	punct	O

Stable	JJ	amod	O
adhesion	NN	nsubjpass	O
of	IN	case	O
leukocytes	NNS	nmod	B-cell_type
to	TO	case	O
glucose-treated	JJ	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
to	TO	case	O
IL-1beta-stimulated	JJ	amod	B-cell_type
endothelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	auxpass	O
preceded	VBN	ROOT	O
by	IN	case	O
short	JJ	amod	O
interaction	NN	nmod	O
of	IN	case	O
leukocytes	NNS	nmod	B-cell_type
with	IN	case	O
the	DT	det	O
endothelial	JJ	amod	O
surface	NN	nmod	O
.	.	punct	O

The	DT	det	O
distance	NN	nsubj	O
travelled	VBN	acl	O
by	IN	case	O
leukocytes	NNS	nmod	B-cell_type
before	IN	case	O
arrest	NN	nmod	O
on	IN	case	O
30	CD	compound	O
mM	NN	amod	O
glucose	NN	nmod	O
,	,	punct	O
or	CC	cc	O
on	IN	case	O
IL-1beta-treated	JJ	amod	B-cell_type
endothelial	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
was	VBD	cop	O
significantly	RB	advmod	O
(	-LRB-	punct	O
P	NN	dep	O
<	-LRB-	amod	O
0.01	CD	dep	O
)	-RRB-	punct	O
higher	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
observed	VBN	acl	O
for	IN	case	O
leukocytes	NNS	nmod	B-cell_type
adhering	VBG	acl	O
on	IN	case	O
control	JJ	compound	O
endothelium	NN	nmod	O
(	-LRB-	punct	O
30	CD	compound	O
mM	NN	amod	O
glucose	NN	dep	O
:	:	punct	O
76.7+/-3.5	CD	dep	O
;	:	punct	O
IL1beta	NN	dep	O
:	:	punct	O
69.7+/-4	NN	nummod	O
versus	CC	cc	O
5	CD	conj	O
mM	NN	amod	O
glucose	NN	nmod	O
:	:	punct	O
21.5+/-5	NN	nummod	O
microm	NN	dep	O
)	-RRB-	punct	O
.	.	punct	O

Functional	JJ	amod	O
blocking	NN	nsubj	O
of	IN	case	O
E-selectin	NN	nmod	B-protein
,	,	punct	O
intercellular	JJ	amod	B-protein
cell	NN	compound	I-protein
adhesion	NN	compound	I-protein
molecule-1	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
vascular	JJ	amod	B-protein
cell	NN	compound	I-protein
adhesion	NN	compound	I-protein
molecule-1	NN	conj	I-protein
on	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
the	DT	det	O
corresponding	JJ	amod	O
mouse	NN	compound	B-protein
mAb	NN	nmod	I-protein
significantly	RB	advmod	O
inhibited	VBD	ROOT	O
glucose-induced	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
leukocyte	NN	compound	O
adhesion	NN	nmod	O
(	-LRB-	punct	O
67+/-16	CD	dep	O
,	,	punct	O
83+/-12	NN	conj	O
,	,	punct	O
62+/-8	NN	nummod	O
versus	CC	cc	O
144+/-21	CD	conj	O
cells/	NN	compound	O
mm2	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Confocal	JJ	amod	O
fluorescence	NN	compound	O
microscopy	NN	compound	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
30	CD	nummod	O
mM	NN	amod	O
glucose	NN	nsubj	O
induced	VBD	ccomp	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
endothelial	JJ	amod	O
surface	NN	compound	O
expression	NN	nmod	O
of	IN	case	O
E-selectin	NN	nmod	B-protein
,	,	punct	O
intercellular	JJ	amod	B-protein
cell	NN	compound	I-protein
adhesion	NN	compound	I-protein
molecule-1	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
vascular	JJ	amod	B-protein
cell	NN	compound	I-protein
adhesion	NN	compound	I-protein
molecule-1	NN	conj	I-protein
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	nsubj	O
of	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
umbilical	JJ	amod	I-cell_type
vein	NN	compound	I-cell_type
endothelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
HUVEC	NN	appos	O
)	-RRB-	punct	O
exposed	VBN	acl	O
for	IN	case	O
1	CD	nummod	O
h	NN	nmod	O
to	TO	case	O
30	CD	compound	O
mM	NN	amod	O
glucose	NN	nmod	O
revealed	VBD	ROOT	O
an	DT	det	O
intense	JJ	amod	O
NF-kB	NN	compound	B-protein
activation	NN	dobj	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
HUVEC	NN	nmod	O
exposed	VBN	acl	O
to	TO	case	O
high	JJ	amod	O
glucose	NN	nmod	O
with	IN	case	O
the	DT	det	O
NF-kB	NN	compound	B-protein
inhibitors	NNS	nmod	I-protein
pyrrolidinedithiocarbamate	NN	dep	O
(	-LRB-	punct	O
100	CD	nummod	O
microM	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
tosyl-phe-chloromethylketone	NN	conj	O
(	-LRB-	punct	O
25	CD	nummod	O
microM	NN	appos	O
)	-RRB-	punct	O
significantly	RB	advmod	O
reduced	VBD	ROOT	O
(	-LRB-	punct	O
P	NN	dep	O
<	-LRB-	dep	O
0.05	CD	dep	O
)	-RRB-	punct	O
leukocyte	NN	compound	O
adhesion	NN	dobj	O
in	IN	case	O
respect	NN	dep	O
to	TO	case	O
HUVEC	NN	nmod	O
treated	VBN	acl	O
with	IN	case	O
glucose	NN	nmod	O
alone	RB	advmod	O
.	.	punct	O

A	DT	det	O
significant	JJ	amod	O
(	-LRB-	punct	O
P	NN	dep	O
<	-LRB-	dep	O
0.01	CD	dep	O
)	-RRB-	punct	O
inhibitory	JJ	amod	O
effect	NN	nsubjpass	O
on	IN	case	O
glucose-induced	JJ	amod	O
leukocyte	NN	compound	O
adhesion	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
after	IN	mark	O
blocking	VBG	advcl	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
activity	NN	dobj	O
with	IN	case	O
staurosporine	NN	nmod	O
(	-LRB-	punct	O
5	CD	nummod	O
nM	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

When	WRB	advmod	O
HUVEC	NN	nsubjpass	O
were	VBD	auxpass	O
treated	VBN	advcl	O
with	IN	case	O
specific	JJ	amod	O
antisense	JJ	amod	O
oligodesoxynucleotides	NNS	nmod	O
against	IN	case	O
PKCalpha	NN	compound	B-protein
and	CC	cc	I-protein
PKCepsilon	NN	conj	I-protein
isoforms	NNS	nmod	I-protein
before	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
30	CD	nummod	O
mM	NN	amod	O
glucose	NN	nmod	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
(	-LRB-	punct	O
P	NN	dep	O
<	-LRB-	amod	O
0.05	CD	dep	O
)	-RRB-	punct	O
reduction	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
adhesion	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
seen	VBN	ROOT	O
.	.	punct	O

Advanced	JJ	amod	O
glycosylation	NN	compound	O
end	VBP	compound	O
product-albumin	NN	nsubj	B-protein
significantly	RB	advmod	O
increased	VBD	ROOT	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
adhering	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
in	IN	case	O
respect	NN	dep	O
to	TO	case	O
native	JJ	amod	B-protein
albumin	NN	nmod	I-protein
used	VBN	acl	O
as	IN	case	O
control	NN	nmod	O
(	-LRB-	punct	O
110+/-16	CD	dep	O
versus	CC	cc	O
66+/-7	CD	conj	O
,	,	punct	O
P	NN	compound	O
<	-LRB-	appos	O
0.01	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Sera	NN	nsubj	O
from	IN	case	O
diabetic	JJ	amod	O
patients	NNS	nmod	O
significantly	RB	advmod	O
(	-LRB-	punct	O
P	NN	dep	O
<	-LRB-	amod	O
0.01	CD	nummod	O
)	-RRB-	punct	O
enhanced	VBD	ROOT	O
leukocyte	NN	compound	O
adhesion	NN	dobj	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
controls	NNS	nmod	O
,	,	punct	O
despite	IN	case	O
normal	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
IL-1beta	NN	nmod	B-protein
and	CC	cc	O
TNFalpha	NN	conj	B-protein
in	IN	case	O
these	DT	det	O
sera	NNS	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
high	JJ	amod	O
glucose	NN	compound	O
concentration	NN	nsubj	O
and	CC	cc	O
hyperglycemia	NN	conj	O
promote	VBP	ccomp	O
leukocyte	NN	compound	O
adhesion	NN	dobj	O
to	TO	case	O
the	DT	det	O
endothelium	NN	nmod	O
through	IN	case	O
upregulation	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
surface	NN	compound	O
expression	NN	nmod	O
of	IN	case	O
adhesive	JJ	amod	O
proteins	NNS	nmod	O
,	,	punct	O
possibly	RB	advmod	O
depending	VBG	advcl	O
on	IN	case	O
NF-kB	NN	compound	B-protein
activation	NN	nmod	O
.	.	punct	O

Ikaros	NN	ROOT	B-protein
in	IN	case	O
hemopoietic	JJ	amod	O
lineage	NN	compound	O
determination	NN	nmod	O
and	CC	cc	O
homeostasis	NN	conj	O
.	.	punct	O

Studies	NNS	nsubj	O
on	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nmod	O
that	WDT	nsubj	O
control	VBP	acl:relcl	O
hemopoietic	JJ	amod	O
differentiation	NN	dobj	O
have	VBP	aux	O
focused	VBN	ROOT	O
on	IN	case	O
signaling	VBG	compound	O
cascades	NNS	nmod	O
and	CC	cc	O
nuclear	JJ	amod	O
effectors	NNS	conj	O
that	WDT	nsubj	O
drive	VBP	acl:relcl	O
this	DT	det	O
complex	JJ	amod	O
developmental	JJ	amod	O
system	NN	dobj	O
in	IN	case	O
a	DT	det	O
regulated	VBN	amod	O
fashion	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
review	VBP	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
Ikaros	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
founding	VBG	amod	O
member	NN	appos	O
of	IN	case	O
a	DT	det	O
unique	JJ	amod	O
family	NN	nmod	O
of	IN	case	O
zinc	NN	compound	B-protein
finger	NN	compound	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
in	IN	case	O
this	DT	det	O
developmental	JJ	amod	O
process	NN	nmod	O
.	.	punct	O

Studies	NNS	nsubj	O
on	IN	case	O
an	DT	det	O
Ikaros	NN	compound	B-protein
null	NN	amod	O
mutation	NN	nmod	O
have	VBP	aux	O
revealed	VBN	ROOT	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
this	DT	det	O
factor	NN	nmod	O
in	IN	case	O
lymphoid	JJ	amod	O
cell	NN	compound	O
fate	NN	compound	O
determination	NN	nmod	O
and	CC	cc	O
at	IN	case	O
subsequent	JJ	amod	O
branch	NN	compound	O
points	NNS	conj	O
of	IN	case	O
the	DT	det	O
T	NN	compound	O
cell	NN	compound	O
differentiation	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

Differences	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
phenotypes	NNS	nmod	O
of	IN	case	O
a	DT	det	O
null	NN	nmod	O
and	CC	cc	O
a	DT	det	O
dominant	JJ	amod	B-DNA
negative	JJ	amod	I-DNA
(	-LRB-	punct	I-DNA
DN	JJ	dep	I-DNA
)	-RRB-	punct	I-DNA
Ikaros	NN	compound	I-DNA
mutation	NN	dep	I-DNA
provide	VBP	ROOT	O
insight	NN	dobj	O
into	IN	case	O
a	DT	det	O
regulatory	JJ	amod	O
network	NN	nmod	O
through	IN	case	O
which	WDT	nmod	O
Ikaros	NN	compound	B-protein
proteins	NNS	nsubj	I-protein
exert	VBP	acl:relcl	O
their	PRP$	nmod:poss	O
effects	NNS	dobj	O
in	IN	case	O
development	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
a	DT	det	O
comparative	JJ	amod	O
analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
hemopoietic	JJ	amod	B-cell_type
stem	NN	compound	I-cell_type
cell	NN	nmod	I-cell_type
and	CC	cc	O
precursor	NN	compound	O
compartment	NN	dep	O
resulting	VBG	acl	O
from	IN	case	O
the	DT	det	O
two	CD	nummod	O
Ikaros	NN	compound	B-DNA
mutations	NNS	nmod	I-DNA
reveals	VBZ	ROOT	O
a	DT	det	O
profound	JJ	amod	O
yet	RB	advmod	O
not	RB	dep	O
absolute	JJ	amod	O
requirement	NN	dobj	O
for	IN	case	O
Ikaros	NN	nmod	B-protein

Induction	NN	ROOT	O
of	IN	case	O
early	JJ	amod	B-protein
B	NN	compound	I-protein
cell	NN	compound	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
EBF	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
multiple	JJ	amod	B-DNA
B	NN	compound	I-DNA
lineage	NN	compound	I-DNA
genes	NNS	conj	I-DNA
by	IN	case	O
the	DT	det	O
basic	JJ	amod	B-protein
helix-loop-helix	JJ	amod	I-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
E12	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nsubjpass	I-protein
encoded	VBN	acl	O
by	IN	case	O
the	DT	det	O
E2A	NN	nmod	B-protein
and	CC	cc	O
early	JJ	amod	B-protein
B	NN	compound	I-protein
cell	NN	compound	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	O
EBF	NN	appos	B-protein
)	-RRB-	punct	O
genes	NNS	conj	O
are	VBP	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
proper	JJ	amod	O
development	NN	nmod	O
of	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
absence	NN	nsubj	O
of	IN	case	O
B	NN	compound	B-cell_type
lineage	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
E2A-	NN	amod	O
and	CC	cc	O
EBF-deficient	JJ	conj	O
mice	NNS	nmod	O
has	VBZ	aux	O
made	VBN	ROOT	O
it	PRP	nsubj	O
difficult	JJ	ccomp	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
function	NN	dobj	O
or	CC	cc	O
relationship	NN	conj	O
between	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
the	DT	det	O
identification	NN	dobj	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	O
model	NN	compound	O
system	NN	nmod	O
in	IN	case	O
which	WDT	nmod	O
the	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
E2A	NN	nmod	B-protein
and	CC	cc	O
EBF	NN	conj	B-protein
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
multiple	JJ	amod	O
B	NN	compound	O
lineage	NN	compound	O
traits	NNS	nmod	O
can	MD	aux	O
be	VB	auxpass	O
studied	VBN	acl:relcl	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
conversion	NN	nsubjpass	O
of	IN	case	O
70Z/3	NN	compound	B-cell_line
pre-B	JJ	amod	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
to	TO	case	O
cells	NNS	nmod	O
with	IN	case	O
a	DT	det	O
macrophage-like	JJ	amod	O
phenotype	NN	nmod	O
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
the	DT	det	O
loss	NN	nmod	O
of	IN	case	O
E2A	NN	nmod	B-protein
and	CC	cc	O
EBF	NN	conj	B-protein
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
ectopic	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
E2A	NN	compound	B-protein
protein	NN	compound	O
E12	NN	nmod	B-protein
in	IN	case	O
this	DT	det	O
macrophage	NN	compound	B-cell_line
line	NN	nmod	I-cell_line
results	VBZ	ccomp	O
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
many	JJ	amod	B-DNA
B	NN	compound	I-DNA
lineage	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
including	VBG	case	O
EBF	NN	nmod	B-protein
,	,	punct	O
IL7Ralpha	NN	conj	B-protein
,	,	punct	O
lambda5	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
Rag-1	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
ability	NN	conj	O
to	TO	mark	O
induce	VB	acl	O
kappa	NN	compound	B-protein
light	JJ	amod	I-protein
chain	NN	dobj	I-protein
in	IN	case	O
response	NN	dep	O
to	TO	case	O
mitogen	NN	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
EBF	NN	nmod	B-protein
may	MD	aux	O
be	VB	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
critical	JJ	amod	O
functions	NNS	nmod	O
of	IN	case	O
E12	NN	nmod	B-protein
in	IN	mark	O
regulating	VBG	acl	O
the	DT	det	O
B	NN	compound	O
lineage	NN	compound	O
phenotype	NN	dobj	O
since	IN	case	O
expression	NN	nmod	O
of	IN	case	O
EBF	NN	nmod	B-protein
alone	RB	advmod	O
leads	VBZ	conj	O
to	TO	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
E12	NN	compound	B-protein
-inducible	JJ	amod	O
traits	NNS	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
context	NN	dep	O
of	IN	case	O
this	DT	det	O
macrophage	NN	compound	B-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
E12	NN	nsubj	B-protein
induces	VBZ	ccomp	O
expression	NN	dobj	O
of	IN	case	O
EBF	NN	nmod	B-protein
and	CC	cc	O
together	RB	advmod	O
these	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nsubj	I-protein
coordinately	RB	advmod	O
regulate	VBP	conj	O
numerous	JJ	amod	O
B	NN	nmod:npmod	B-DNA
lineage-associated	JJ	amod	I-DNA
genes	NNS	dobj	I-DNA
.	.	punct	O

Activation-induced	JJ	amod	O
down-regulation	NN	ROOT	O
of	IN	case	O
retinoid	NN	compound	B-protein
receptor	NN	compound	I-protein
RXRalpha	NN	compound	I-protein
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Role	NN	ROOT	O
of	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
regulation	NN	nmod	O
.	.	punct	O

A	DT	det	O
5.4-kilobase	JJ	amod	B-RNA
mRNA	NN	nsubjpass	I-RNA
,	,	punct	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
is	VBZ	auxpass	O
down-regulated	VBN	ROOT	O
after	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBMCs	NNS	appos	B-cell_type
)	-RRB-	punct	O
with	IN	case	O
various	JJ	amod	O
T	NN	compound	O
cell-activating	JJ	amod	O
agents	NNS	nmod	O
,	,	punct	O
was	VBD	auxpass	O
isolated	VBN	conj	O
using	VBG	xcomp	O
an	DT	det	O
mRNA	NN	compound	O
differential	JJ	amod	O
display	NN	compound	O
method	NN	dobj	O
.	.	punct	O

Nucleotide	NN	compound	O
sequence	NN	compound	O
analysis	NN	nsubj	O
identified	VBD	ROOT	O
the	DT	det	O
5	CD	nummod	B-RNA
'	``	punct	I-RNA
end	NN	dobj	I-RNA
of	IN	case	O
this	DT	det	O
RNA	NN	nmod	B-RNA
as	IN	case	O
human	JJ	amod	B-RNA
retinoid	NN	compound	I-RNA
receptor	NN	compound	I-RNA
RXRalpha	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	advcl	O
the	DT	det	O
nucleotide	NN	compound	O
sequence	NN	dobj	O
of	IN	case	O
3.6	CD	nummod	B-DNA
kilobases	NNS	nmod	I-DNA
of	IN	case	O
this	DT	det	O
RNA	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
represents	VBZ	acl:relcl	O
the	DT	det	O
3	CD	nummod	B-RNA
'	``	punct	I-RNA
end	NN	dobj	I-RNA
of	IN	case	O
RXRalpha	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
,	,	punct	O
the	DT	det	O
sequence	NN	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
previously	RB	advmod	O
described	VBN	ROOT	O
.	.	punct	O

Activated	VBN	amod	O
PBMCs	NNS	nsubj	B-cell_type
also	RB	advmod	O
expressed	VBD	ROOT	O
lower	JJR	amod	O
levels	NNS	dobj	O
of	IN	case	O
RXRalpha	NN	compound	B-protein
protein	NN	nmod	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
DNA	NN	compound	O
binding	NN	compound	O
assay	NN	nsubj	O
showed	VBD	conj	O
that	IN	mark	O
the	DT	det	O
activation-induced	JJ	amod	O
loss	NN	nsubj	O
of	IN	case	O
RXRalpha	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
and	CC	cc	O
protein	NN	compound	O
expression	NN	conj	O
correlated	VBD	ccomp	O
with	IN	case	O
the	DT	det	O
loss	NN	nmod	O
of	IN	case	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
present	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
the	DT	det	O
transition	NN	nsubj	O
from	IN	case	O
G0/G1	NN	nmod	O
to	TO	case	O
S	NN	compound	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
results	VBZ	ccomp	O
in	IN	case	O
the	DT	det	O
down-regulation	NN	nmod	O
of	IN	case	O
RXRalpha	NN	compound	B-protein
expression	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
cell	NN	compound	O
cycle	NN	compound	O
inhibitors	NNS	nsubj	O
,	,	punct	O
which	WDT	nsubj	O
block	VBP	acl:relcl	O
the	DT	det	O
cells	NNS	dobj	O
in	IN	case	O
G1	NN	compound	O
phase	NN	nmod	O
,	,	punct	O
prevent	VBP	conj	O
this	DT	det	O
down-regulation	NN	dobj	O
.	.	punct	O

The	DT	det	O
decrease	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
levels	NNS	nmod	O
of	IN	case	O
RXRalpha	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
regulated	VBN	xcomp	O
at	IN	case	O
the	DT	det	O
post-transcriptional	JJ	amod	O
level	NN	nmod	O
and	CC	cc	O
involved	VBD	conj	O
new	JJ	amod	O
protein	NN	compound	O
synthesis	NN	dobj	O
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
levels	NNS	nsubjpass	O
of	IN	case	O
RXRalpha	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
T	NN	compound	O
lymphocytes	NNS	nmod	O
are	VBP	auxpass	O
coupled	VBN	ccomp	O
to	TO	case	O
cell	NN	compound	O
cycle	NN	compound	O
progression	NN	nmod	O
,	,	punct	O
and	CC	cc	O
there	EX	expl	O
is	VBZ	conj	O
tight	JJ	amod	O
regulatory	JJ	amod	O
control	NN	nsubj	O
of	IN	case	O
RXRalpha	NN	compound	B-protein
expression	NN	nmod	O
during	IN	case	O
the	DT	det	O
transition	NN	nmod	O
from	IN	case	O
G0/G1	NN	compound	O
to	TO	case	O
S	NN	compound	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
.	.	punct	O

Epidemiology	NN	ROOT	O
and	CC	cc	O
pathogenesis	NN	conj	O
of	IN	case	O
AIDS-related	JJ	amod	O
lymphomas	NNS	nmod	O
.	.	punct	O

Among	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
congenital	JJ	amod	O
and	CC	cc	O
acquired	VBN	conj	O
immunodeficiencies	NNS	nmod	O
,	,	punct	O
non-Hodgkin	JJ	amod	O
's	POS	case	O
lymphoma	NN	nsubj	O
(	-LRB-	punct	O
NHLs	NNS	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
the	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
tumors	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
setting	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
HIV	NN	appos	O
)	-RRB-	punct	O
infection	NN	nmod	O
,	,	punct	O
as	RB	mark	O
many	JJ	amod	O
as	IN	advmod	O
10	CD	nummod	O
%	NN	pobj	O
to	TO	quantmod	O
20	CD	nummod	O
%	NN	nsubj	O
of	IN	prep	O
people	NNS	pobj	O
ultimately	RB	advmod	O
developed	VBD	ROOT	O
NHLs	NNS	dobj	O
.	.	punct	O

These	DT	det	O
tumors	NNS	nsubj	O
are	VBP	cop	O
clinically	RB	advmod	O
aggressive	JJ	ROOT	O
,	,	punct	O
frequently	RB	advmod	O
involve	VBP	conj	O
extranodal	JJ	amod	O
sites	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
often	RB	advmod	O
exhibit	VBP	conj	O
unique	JJ	amod	O
features	NNS	dobj	O
that	WDT	nsubj	O
distinguish	VBP	acl:relcl	O
them	PRP	dobj	O
from	IN	case	O
NHL	NN	nmod	O
arising	VBG	acl	O
in	IN	case	O
individuals	NNS	nmod	O
with	IN	case	O
other	JJ	amod	O
forms	NNS	nmod	O
of	IN	case	O
immunosuppression	NN	nmod	O
.	.	punct	O

Important	JJ	advmod	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
HIV-associated	JJ	amod	O
NHL	NN	nmod	O
are	VBP	cop	O
cytokines	NNS	ROOT	B-protein
and	CC	cc	O
other	JJ	amod	O
factors	NNS	conj	O
that	WDT	nsubj	O
induce	VBP	acl:relcl	O
B-cell	NN	compound	O
proliferation	NN	dobj	O
and	CC	cc	O
increase	VB	conj	O
the	DT	det	O
likelihood	NN	dobj	O
of	IN	case	O
mutations	NNS	nmod	O
of	IN	case	O
c-myc	NN	nmod	B-DNA
,	,	punct	O
bcl-6	NN	conj	B-DNA
,	,	punct	O
and	CC	cc	O
other	JJ	amod	O
tumor-suppressor	JJ	compound	B-DNA
genes	NNS	conj	I-DNA
with	IN	case	O
carcinogenic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O

Specific	JJ	amod	O
forms	NNS	nsubjpass	O
of	IN	case	O
HIV-associated	JJ	amod	O
NHL	NN	nmod	O
are	VBP	auxpass	O
linked	VBN	ROOT	O
to	TO	case	O
expression	NN	nmod	O
of	IN	case	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
(	-LRB-	punct	I-protein
EBV	NN	compound	I-protein
)	-RRB-	punct	I-protein
-latent	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
;	:	punct	O
the	DT	det	O
newly	RB	advmod	O
described	VBN	amod	O
DNA	NN	compound	O
virus	NN	dep	O
,	,	punct	O
Karposi	NN	nmod:poss	O
's	POS	case	O
sarcoma-associated	JJ	amod	O
herpesvirus/human	JJ	amod	O
herpesvirus-8	NN	appos	O
(	-LRB-	punct	O
KSHV/HHV-8	NN	appos	O
)	-RRB-	punct	O
;	:	punct	O
and	CC	cc	O
perhaps	RB	advmod	O
HIV	NN	conj	O
.	.	punct	O

Elucidation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
factors	NNS	nmod	O
that	WDT	nsubj	O
contribute	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
high	JJ	amod	O
incidence	NN	nmod	O
of	IN	case	O
NHL	NN	nmod	O
among	IN	case	O
patients	NNS	nmod	O
infected	VBN	acl	O
with	IN	case	O
HIV	NN	nmod	O
provides	VBZ	ROOT	O
insights	NNS	dobj	O
into	IN	case	O
important	JJ	amod	O
elements	NNS	nmod	O
of	IN	case	O
lymphomagenesis	NN	nmod	O
.	.	punct	O

Matrix	NN	compound	B-protein
metalloproteinase	NN	compound	I-protein
expression	NN	ROOT	O
in	IN	case	O
human	JJ	amod	O
breast	NN	compound	O
cancer	NN	nmod	O
:	:	punct	O
an	DT	det	O
immunohistochemical	JJ	amod	O
study	NN	dep	O
including	VBG	case	O
correlation	NN	nmod	O
with	IN	case	O
cathepsin	NN	compound	B-protein
D	NN	nmod	I-protein
,	,	punct	O
type	NN	compound	B-protein
IV	CD	nummod	I-protein
collagen	NN	conj	I-protein
,	,	punct	O
laminin	NN	conj	B-protein
,	,	punct	O
fibronectin	NN	conj	B-protein
,	,	punct	O
EGFR	NN	conj	B-protein
,	,	punct	O
c-erbB-2	NN	amod	B-protein
oncoprotein	NN	conj	I-protein
,	,	punct	O
p53	NN	appos	B-protein
,	,	punct	O
steroid	NN	compound	O
receptors	NNS	compound	O
status	NN	conj	O
and	CC	cc	O
proliferative	JJ	amod	O
indices	NNS	conj	O
.	.	punct	O

Matrix	NN	compound	B-protein
metalloproteinase	NN	compound	I-protein
s	NNS	nsubj	O
(	-LRB-	punct	O
MMPs	NNS	appos	B-protein
)	-RRB-	punct	O
are	VBP	cop	O
a	DT	det	O
group	NN	ROOT	O
of	IN	case	O
enzymes	NNS	nmod	O
thought	VBN	acl	O
to	TO	mark	O
be	VB	cop	O
responsible	JJ	xcomp	O
for	IN	case	O
both	CC	cc:preconj	O
normal	JJ	amod	O
connective	JJ	amod	O
tissue	NN	compound	O
matrix	NN	compound	O
remodelling	VBG	nmod	O
and	CC	cc	O
accelerated	VBN	amod	O
breakdown	NN	conj	O
associated	VBN	acl	O
with	IN	prep	O
tumour	NN	compound	O
development	NN	pobj	O
.	.	punct	O

The	DT	det	O
current	JJ	amod	O
study	NN	nsubj	O
aimed	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
immunohistochemical	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
matrix	NN	compound	B-protein
metalloproteinase	NN	nmod	I-protein
3	CD	nummod	I-protein
(	-LRB-	punct	O
MMP-3	NN	dep	B-protein
,	,	punct	O
stromelysin-1	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
correlation	NN	nmod	O
with	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
Basement	NNP	compound	B-protein
Membrane	NNP	compound	I-protein
(	-LRB-	punct	I-protein
BM	NN	compound	I-protein
)	-RRB-	punct	I-protein
antigen	NN	compound	I-protein
(	-LRB-	punct	O
type	NN	compound	B-protein
IV	CD	nummod	I-protein
collagen	NN	nmod	I-protein
,	,	punct	O
laminin	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
fibronectin	NN	conj	B-protein
,	,	punct	O
cathepsin	NN	compound	B-protein
D	NN	conj	I-protein
,	,	punct	O
p53	NN	conj	B-protein
,	,	punct	O
c-erbB-2	NN	conj	B-protein
,	,	punct	O
proliferative	JJ	amod	O
activity	NN	conj	O
(	-LRB-	punct	O
Ki-67	NN	dep	B-protein
,	,	punct	O
PCNA	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
steroid	NN	compound	O
receptor	NN	compound	O
content	NN	conj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
to	IN	case	O
the	DT	det	O
other	JJ	amod	O
conventional	JJ	amod	O
clinicopathological	JJ	amod	O
parameters	NNS	conj	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
on	IN	case	O
a	DT	det	O
series	NN	nmod	O
of	IN	case	O
frozen	JJ	amod	O
and	CC	cc	O
paraffin	NN	conj	O
sections	NNS	nmod	O
from	IN	case	O
84	CD	nummod	O
breast	NN	compound	O
cancer	NN	compound	O
specimens	NNS	nmod	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
using	VBG	acl	O
the	DT	det	O
monoclonal	JJ	amod	B-protein
antibody	NN	compound	I-protein
MMP-3	NN	dobj	I-protein
(	-LRB-	punct	O
Ab-1	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Stromelysin-1	NN	nsubjpass	B-protein
(	-LRB-	punct	O
ST1	NN	appos	B-protein
)	-RRB-	punct	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
about	RB	advmod	O
10	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
epithelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
the	DT	det	O
control	NN	amod	O
groups	NNS	nmod	O
(	-LRB-	punct	O
cases	NNS	dep	O
of	IN	case	O
fibrocystic	JJ	amod	O
and	CC	cc	O
benign	JJ	conj	O
proliferative	JJ	amod	O
breast	NN	compound	O
disease	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
while	IN	mark	O
expression	NN	nsubjpass	O
(	-LRB-	punct	O
>	NN	dep	O
10	CD	nummod	O
%	NN	dep	O
of	IN	case	O
expression	NN	nmod	O
)	-RRB-	punct	O
was	VBD	auxpass	O
detected	VBN	advcl	O
in	IN	case	O
89.7	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
tumours	NNS	nmod	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
ST1	NN	nmod	B-protein
in	IN	case	O
carcinoma	NN	compound	O
cells	NNS	nmod	O
was	VBD	auxpass	O
strongly	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
its	PRP$	nmod:poss	O
presence	NN	nmod	O
in	IN	case	O
the	DT	det	O
stroma	NN	nmod	O
(	-LRB-	punct	O
p	NN	dep	O
<	-LRB-	dep	O
0.001	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
significantly	RB	advmod	O
positive	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
ST1	NN	compound	B-protein
expression	NN	nmod	O
,	,	punct	O
and	CC	cc	O
p53	NN	compound	B-protein
tumour	NN	compound	O
suppressor	NN	compound	O
gene	NN	compound	O
product	NN	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0.004	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
relationship	NN	nsubjpass	O
with	IN	case	O
c-erbB-2	NN	amod	B-protein
protein	NN	nmod	O
and	CC	cc	O
progesterone	NN	compound	O
receptor	NN	compound	O
status	NN	conj	O
was	VBD	auxpass	O
also	RB	advmod	O
indicated	VBN	conj	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
ST1	NN	compound	B-protein
expression	NN	nsubj	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
tissue	NN	nmod	O
is	VBZ	cop	O
irrespective	JJ	ccomp	O
of	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	O
matrix	NN	compound	O
component	NN	nmod	O
,	,	punct	O
the	DT	det	O
proteolytic	JJ	amod	B-protein
enzyme	NN	compound	I-protein
cathepsin	NN	compound	B-protein
D	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
growth	NN	compound	O
fraction	NN	conj	O
of	IN	case	O
the	DT	det	O
tumour	NN	nmod	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
it	PRP	nsubj	O
could	MD	aux	O
be	VB	cop	O
a	DT	det	O
potential	JJ	amod	O
new	JJ	amod	O
prognostic	JJ	amod	O
marker	NN	conj	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O

Use	NN	ROOT	O
of	IN	case	O
transfected	VBN	amod	B-cell_line
liver	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
to	TO	mark	O
evaluate	VB	acl	O
potential	JJ	amod	O
mechanisms	NNS	dobj	O
of	IN	case	O
alcohol-induced	JJ	amod	O
liver	NN	compound	O
injury	NN	nmod	O
[	-LRB-	punct	O
see	VB	dep	O
comments	NNS	dobj	O
]	-RRB-	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
increased	VBN	amod	O
activity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proinflammatory	JJ	amod	B-protein
cytokine	NN	nmod	I-protein
,	,	punct	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	appos	I-protein
(	-LRB-	punct	O
TNF	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
alcoholic	JJ	amod	O
liver	NN	compound	O
disease	NN	nmod	O
(	-LRB-	punct	O
ALD	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Hepatic	JJ	amod	O
neutrophil	NN	compound	O
infiltration	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
principal	JJ	amod	O
injurious	JJ	amod	O
manifestation	NN	ROOT	O
of	IN	case	O
ALD	NN	nmod	O
.	.	punct	O

TNF	NN	nsubj	B-protein
can	MD	aux	O
induce	VB	ROOT	O
cellular	JJ	amod	O
oxidative	JJ	amod	O
injury	NN	dobj	O
directly	RB	advmod	O
,	,	punct	O
and	CC	cc	O
indirectly	RB	advmod	O
by	IN	mark	O
inducing	VBG	advcl	O
neutrophil	NN	compound	O
chemotactic	JJ	amod	O
factor	NN	compound	O
(	-LRB-	punct	O
IL-8	NN	appos	B-protein
)	-RRB-	punct	O
production	NN	dobj	O
by	IN	case	O
hepatocytes	NNS	nmod	O
.	.	punct	O

IL-8	NN	nsubj	B-protein
activates	VBZ	ROOT	O
and	CC	cc	O
chemotactically	RB	advmod	O
attracts	VBZ	conj	O
neutrophils	NNS	dobj	O
to	TO	case	O
the	DT	det	O
liver	NN	nmod	O
where	WRB	advmod	O
they	PRP	nsubj	O
release	VBP	acl:relcl	O
oxidizing	VBG	amod	O
substances	NNS	dobj	O
.	.	punct	O

Patients	NNS	nsubj	O
with	IN	case	O
ALD	NN	nmod	O
also	RB	advmod	O
have	VBP	aux	O
decreased	VBN	ROOT	O
protective	JJ	amod	B-protein
factors	NNS	dobj	I-protein
for	IN	case	O
cellular	JJ	amod	O
oxidative	JJ	amod	O
injury	NN	nmod	O
.	.	punct	O

Manganous	JJ	amod	B-protein
superoxide	NN	compound	I-protein
dismutase	NN	nsubj	I-protein
(	-LRB-	punct	O
MnSOD	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
antioxidant	JJ	amod	B-protein
protective	JJ	amod	I-protein
factor	NN	ROOT	I-protein
.	.	punct	O

The	DT	det	O
objectives	NNS	nsubj	O
of	IN	case	O
these	DT	det	O
studies	NNS	nmod	O
were	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
mechanisms	NNS	dobj	O
for	IN	case	O
induction	NN	nmod	O
of	IN	case	O
an	DT	det	O
injurious	JJ	amod	B-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
IL-8	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
protective	JJ	amod	B-protein
factor	NN	conj	I-protein
(	-LRB-	punct	O
MnSOD	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
HepG2	NN	compound	B-cell_line
human	JJ	amod	I-cell_line
hepatoma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
the	DT	det	O
first	JJ	amod	O
set	NN	nmod	O
of	IN	case	O
experiments	NNS	nmod	O
,	,	punct	O
IL-8	NN	compound	B-DNA
gene	NN	compound	I-DNA
reporter	NN	compound	I-DNA
constructs	NNS	nsubjpass	I-DNA
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
transiently	RB	advmod	O
transfect	VB	xcomp	O
a	DT	det	O
derivative	JJ	dobj	O
(	-LRB-	punct	O
MVh2E1-9	NN	appos	B-cell_line
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
HepG2	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
which	WDT	nsubj	O
expresses	VBZ	acl:relcl	O
P-4502E1	NN	amod	B-protein
and	CC	cc	O
metabolizes	NNS	conj	O
ethanol	NN	dobj	O
.	.	punct	O

Inactivation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-DNA
and	CC	cc	I-DNA
3'NF-IL-6	JJ	conj	I-DNA
DNA	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
decreased	VBD	ROOT	O
IL-8	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcriptional	JJ	amod	O
activation	NN	dobj	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
TNF	NN	nmod	B-protein
while	IN	mark	O
inactivation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
5'NF-IL-6	JJ	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
increased	VBD	advcl	O
IL-8	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcriptional	JJ	amod	O
activity	NN	dobj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
TNF	NN	nmod	B-protein
.	.	punct	O

This	DT	det	O
system	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
useful	JJ	ROOT	O
to	TO	mark	O
assess	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
ethanol	NN	nmod	O
on	IN	case	O
TNF	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
hepatocyte	NN	compound	O
IL-8	NN	compound	B-protein
production	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
second	JJ	amod	O
set	NN	nmod	O
of	IN	case	O
experiments	NNS	nmod	O
,	,	punct	O
HepG2	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
cultured	VBN	ROOT	O
in	IN	case	O
25	CD	compound	O
to	TO	dep	O
100	CD	nummod	O
mmol	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
ethanol	NN	nmod	O
.	.	punct	O

Both	CC	cc:preconj	O
TNF	NN	nsubj	B-protein
and	CC	cc	O
ethanol	NN	conj	O
increased	VBD	ROOT	O
HepG2	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
MnSOD	NN	compound	B-protein
activity	NN	dobj	O
in	IN	case	O
short-term	JJ	amod	O
(	-LRB-	punct	O
72	CD	nummod	O
hr	NN	dep	O
)	-RRB-	punct	O
cultures	NNS	nmod	O
with	IN	case	O
ethanol	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
after	IN	case	O
long-term	JJ	amod	O
(	-LRB-	punct	O
10	CD	nummod	O
weeks	NNS	dep	O
)	-RRB-	punct	O
culture	NN	nmod	O
with	IN	case	O
ethanol	NN	nmod	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
induction	NN	nsubj	O
of	IN	case	O
MnSOD	NN	nmod	B-protein
by	IN	case	O
ethanol	NN	nmod	O
and	CC	cc	O
there	EX	expl	O
was	VBD	conj	O
a	DT	det	O
diminished	VBN	amod	O
induction	NN	nsubj	O
of	IN	case	O
MnSOD	NN	nmod	B-protein
in	IN	case	O
response	NN	dep	O
to	TO	case	O
TNF	NN	nmod	B-protein
.	.	punct	O

Further	JJ	amod	O
studies	NNS	nsubjpass	O
are	VBP	auxpass	O
needed	VBN	ROOT	O
to	TO	mark	O
assess	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
this	DT	det	O
diminished	VBN	amod	O
induction	NN	nmod	O
of	IN	case	O
MnSOD	NN	nmod	B-protein
with	IN	case	O
chronic	JJ	amod	O
ethanol	NN	compound	O
culture	NN	nmod	O
on	IN	case	O
HepG2	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
susceptibility	NN	nmod	O
to	TO	case	O
TNF	NN	compound	B-cell_line
cytotoxicity	NN	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
transfected	VBN	amod	O
liver	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nsubjpass	I-cell_line
can	MD	aux	O
be	VB	auxpass	O
used	VBN	ccomp	O
to	TO	mark	O
evaluate	VB	xcomp	O
mechanisms	NNS	dobj	O
for	IN	case	O
increased	VBN	amod	O
injurious	JJ	amod	B-protein
factors	NNS	nmod	I-protein
and	CC	cc	O
decreased	VBD	amod	O
protective	JJ	amod	B-protein
factors	NNS	conj	I-protein
in	IN	case	O
alcoholic	JJ	amod	O
liver	NN	compound	O
injury	NN	nmod	O
.	.	punct	O

Tissue	NN	compound	O
factor	NN	compound	O
transcription	NN	nsubj	O
driven	VBN	acl	O
by	IN	case	O
Egr-1	NN	nmod	B-protein
is	VBZ	cop	O
a	DT	det	O
critical	JJ	amod	O
mechanism	NN	ROOT	O
of	IN	case	O
murine	JJ	amod	B-protein
pulmonary	JJ	amod	I-protein
fibrin	NN	compound	I-protein
deposition	NN	nmod	O
in	IN	case	O
hypoxia	NN	nmod	O
.	.	punct	O

Local	JJ	amod	O
hypoxemia	NN	ROOT	O
and	CC	cc	O
stasis	NN	conj	O
trigger	NN	compound	O
thrombosis	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
previously	RB	advmod	O
that	IN	mark	O
in	IN	case	O
a	DT	det	O
murine	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
normobaric	JJ	amod	O
hypoxia	NN	compound	O
pulmonary	JJ	amod	O
fibrin	NN	compound	B-protein
deposition	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
result	NN	ccomp	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
tissue	NN	compound	B-protein
factor	NN	nmod	I-protein
,	,	punct	O
especially	RB	advmod	O
in	IN	case	O
oxygen-deprived	JJ	amod	B-protein
mononuclear	JJ	amod	I-protein
phagocytes	NNS	nmod	I-protein
(	-LRB-	punct	O
MPs	NNS	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
early-growth-response	JJ	amod	I-protein
gene	NN	compound	I-protein
product	NN	nsubjpass	I-protein
(	-LRB-	punct	O
Egr-1	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
rapidly	RB	advmod	O
activated	VBN	ccomp	O
in	IN	case	O
hypoxia	NN	nmod	O
,	,	punct	O
both	CC	cc:preconj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
and	CC	cc	O
is	VBZ	cop	O
responsible	JJ	conj	O
for	IN	case	O
transcription	NN	nmod	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
tissue	NN	compound	B-protein
factor	NN	nmod	I-protein
in	IN	case	O
hypoxic	JJ	amod	O
lung	NN	nmod	O
.	.	punct	O

MPs	NN	compound	B-protein
and	CC	cc	O
HeLa	NN	conj	B-cell_line
cells	NNS	nsubj	I-cell_line
subjected	VBN	ROOT	O
to	TO	case	O
hypoxia	NN	nmod	O
(	-LRB-	punct	O
pO2	NN	dep	O
approximately	RB	advmod	O
13	CD	nummod	O
torr	NN	appos	O
)	-RRB-	punct	O
had	VBD	conj	O
increased	VBN	amod	O
levels	NNS	dobj	O
of	IN	case	O
tissue	NN	compound	B-RNA
factor	NN	compound	I-RNA
transcripts	NNS	nmod	I-RNA
(	-LRB-	punct	O
approximately	RB	advmod	O
18-fold	RB	advmod	O
)	-RRB-	punct	O
and	CC	cc	O
an	DT	det	O
increased	VBN	amod	O
rate	NN	conj	O
of	IN	case	O
transcription	NN	nmod	O
(	-LRB-	punct	O
approximately	RB	advmod	O
15-fold	RB	appos	O
)	-RRB-	punct	O
,	,	punct	O
based	VBN	case	O
on	IN	case	O
nuclear	JJ	amod	O
run-on	JJ	amod	O
analysis	NN	nmod	O
.	.	punct	O

Gel-shift	JJ	amod	O
analysis	NN	nsubj	O
of	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
from	IN	case	O
hypoxic	JJ	amod	B-protein
MPs	NN	nmod	I-protein
and	CC	cc	O
HeLa	NN	conj	B-cell_line
cells	NNS	conj	I-cell_line
demonstrated	VBD	ROOT	O
increased	VBN	amod	O
DNA-binding	JJ	amod	O
activity	NN	dobj	O
at	IN	case	O
the	DT	det	O
serum	NN	compound	B-DNA
response	NN	compound	I-DNA
region	NN	nmod	I-DNA
(	-LRB-	punct	O
SRR	NN	dep	O
;	:	punct	O
-111/+14	CD	nummod	O
bp	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
tissue	NN	compound	B-DNA
factor	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
at	IN	case	O
Egr-1	NN	compound	B-DNA
motifs	NNS	nmod	I-DNA
.	.	punct	O

Using	VBG	advcl	O
32P-labeled	JJ	amod	O
Egr	NN	compound	O
consensus	NN	compound	O
oligonucleotide	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
induction	NN	dobj	O
of	IN	case	O
DNA-binding	JJ	amod	O
activity	NN	nmod	O
in	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
from	IN	case	O
hypoxic	JJ	amod	O
lung	NN	compound	O
and	CC	cc	O
HeLa	NN	conj	B-cell_line
cells	NNS	nmod	I-cell_line
because	IN	case	O
of	IN	mwe	O
activation	NN	nmod	O
of	IN	case	O
Egr-1	NN	nmod	B-protein
,	,	punct	O
by	IN	case	O
means	NNS	dep	O
of	IN	case	O
supershift	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

Transient	JJ	amod	O
transfection	NN	nsubj	O
of	IN	case	O
HeLa	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
chimeric	JJ	amod	B-DNA
plasmids	NNS	nmod	I-DNA
containing	VBG	acl	O
wild-type	JJ	amod	B-protein
or	CC	cc	I-protein
mutant	JJ	conj	I-protein
SRR	NN	dobj	I-protein
from	IN	case	O
the	DT	det	O
tissue	NN	compound	B-DNA
factor	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
showed	VBD	ROOT	O
that	IN	mark	O
intact	JJ	amod	B-DNA
Sp1	NN	compound	I-DNA
sites	NNS	nsubj	I-DNA
are	VBP	cop	O
necessary	JJ	ccomp	O
for	IN	case	O
basal	JJ	amod	O
promoter	NN	compound	O
activity	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
integrity	NN	nsubjpass	O
of	IN	case	O
Egr-1	NN	compound	B-DNA
sites	NNS	nmod	I-DNA
was	VBD	auxpass	O
required	VBN	advcl	O
for	IN	case	O
hypoxia-enhanced	JJ	amod	O
expression	NN	nmod	O
.	.	punct	O

A	DT	det	O
central	JJ	amod	O
role	NN	nsubjpass	O
for	IN	case	O
Egr-1	NN	nmod	B-protein
in	IN	case	O
hypoxia-mediated	JJ	amod	O
tissue	NN	compound	O
factor	NN	compound	O
expression	NN	nmod	O
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
experiments	NNS	nmod	O
with	IN	case	O
homozygous	JJ	amod	O
Egr-1	NN	compound	B-protein
null	NN	amod	O
mice	NNS	nmod	O
;	:	punct	O
wild-type	JJ	amod	O
mice	NNS	nsubj	O
subjected	VBN	acl	O
to	TO	case	O
oxygen	NN	compound	B-protein
deprivation	NN	nmod	I-protein
expressed	VBD	parataxis	I-protein
tissue	NN	compound	I-protein
factor	NN	dobj	I-protein
and	CC	cc	O
showed	VBD	conj	O
fibrin	NN	compound	B-protein
deposition	NN	dobj	O
,	,	punct	O
but	CC	cc	O
hypoxic	JJ	amod	O
homozygous	JJ	amod	O
Egr-1	NN	compound	B-protein
null	NN	amod	O
mice	NNS	nsubj	O
displayed	VBD	conj	O
neither	CC	cc:preconj	O
tissue	NN	compound	B-protein
factor	NN	dobj	I-protein
nor	CC	cc	O
fibrin	NN	conj	B-protein
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
delineate	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
biology	NN	dobj	O
for	IN	case	O
hypoxia-induced	JJ	amod	O
fibrin	NN	compound	B-protein
deposition	NN	nmod	O
,	,	punct	O
in	IN	case	O
which	WDT	nmod	O
oxygen	NN	nmod:npmod	O
deprivation-induced	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
Egr-1	NN	nmod	B-protein
,	,	punct	O
resulting	VBG	acl	O
in	IN	case	O
expression	NN	nmod	O
of	IN	case	O
tissue	NN	compound	B-protein
factor	NN	nmod	I-protein
,	,	punct	O
has	VBZ	acl:relcl	O
an	DT	det	O
unexpected	JJ	amod	O
and	CC	cc	O
central	JJ	conj	O
role	NN	dobj	O
.	.	punct	O

Kinetics	NNS	ROOT	O
of	IN	case	O
cytokine	NN	compound	O
and	CC	cc	O
NFAT	NN	conj	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_line
interleukin-2-dependent	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
lymphoblasts	NNS	nmod	I-cell_line
stimulated	VBN	acl	O
via	IN	case	O
T-cell	NN	compound	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
respond	VBP	ROOT	O
to	TO	case	O
mitogenic	JJ	nmod	O
or	CC	cc	O
antigenic	JJ	conj	O
stimulation	NN	dep	O
by	IN	case	O
proliferation	NN	nmod	O
and	CC	cc	O
by	IN	mark	O
turning	VBG	conj	O
on	IN	case	O
cytokine	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
have	VBP	aux	O
analysed	VBN	ROOT	O
the	DT	det	O
kinetics	NNS	dobj	O
and	CC	cc	O
nature	NN	conj	O
of	IN	case	O
cytokine	NN	compound	O
production	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood-derived	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphoblasts	NNS	nmod	I-cell_type
stimulated	VBN	acl	O
with	IN	case	O
anti-CD3	JJ	amod	B-protein
antibodies	NNS	nmod	I-protein
or	CC	cc	O
Lens	NN	compound	B-protein
culinaris	NN	compound	I-protein
lectin	NN	conj	I-protein
(	-LRB-	punct	O
LCL	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

T	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
purified	VBN	ROOT	O
from	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBMC	NNS	appos	B-cell_type
)	-RRB-	punct	O
and	CC	cc	O
primarily	RB	advmod	O
activated	VBN	conj	O
with	IN	case	O
anti-CD3	JJ	amod	B-protein
antibodies	NNS	nmod	I-protein
and	CC	cc	O
cultured	VBN	conj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
interleukin-2	NN	nmod	B-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Anti-CD3-restimulated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
(	-LRB-	punct	O
mainly	RB	advmod	O
CD8+	JJ	appos	O
)	-RRB-	punct	O
produced	VBD	ROOT	O
IL-2	NN	dobj	B-protein
,	,	punct	O
interferon-gamma	NN	conj	B-protein
(	-LRB-	punct	O
IFN-gamma	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
tumour	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	conj	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
low	JJ	amod	O
levels	NNS	conj	O
of	IN	case	O
IL-4	NN	nmod	B-RNA
and	CC	cc	I-RNA
IL-10	NN	conj	I-RNA
transcripts	NNS	dep	I-RNA
and	CC	cc	O
proteins	NNS	conj	O
.	.	punct	O

No	DT	neg	O
IL-6	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
LCL-stimulated	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
the	DT	det	O
cytokine	NN	compound	O
production	NN	compound	O
pattern	NN	nsubj	O
was	VBD	cop	O
very	RB	advmod	O
similar	JJ	ROOT	O
.	.	punct	O

Steady-state	JJ	amod	O
mRNA	NN	compound	O
levels	NNS	nsubj	O
of	IN	case	O
IL-2	NN	nmod	B-protein
,	,	punct	O
IL-10	NN	conj	B-protein
and	CC	cc	O
IFN-gamma	NN	conj	B-protein
peaked	VBD	ROOT	O
at	IN	case	O
3	CD	nummod	O
hr	NN	nmod	O
after	IN	case	O
anti-CD3	JJ	amod	O
stimulation	NN	nmod	O
and	CC	cc	O
declined	VBD	conj	O
rapidly	RB	advmod	O
thereafter	RB	advmod	O
.	.	punct	O

The	DT	det	O
kinetics	NNS	nsubj	O
of	IN	case	O
TNF-alpha	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nmod	O
was	VBD	cop	O
faster	RBR	ROOT	O
,	,	punct	O
being	VBG	xcomp	O
at	IN	case	O
its	PRP$	nmod:poss	O
peak	JJ	compound	O
level	NN	nmod	O
1	CD	nummod	O
hr	NN	dep	O
after	IN	case	O
stimulation	NN	nmod	O
.	.	punct	O

Anti-CD3-stimulated	JJ	amod	O
IL-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nsubjpass	O
was	VBD	auxpass	O
down-regulated	VBN	ROOT	O
by	IN	case	O
protein	NN	compound	O
synthesis	NN	compound	O
inhibitor	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
IL-10	NN	nsubjpass	B-DNA
,	,	punct	I-DNA
IFN-gamma	NN	conj	I-DNA
and	CC	cc	I-DNA
TNF-alpha	NN	conj	I-DNA
genes	NNS	dep	I-DNA
were	VBD	auxpass	O
readily	RB	advmod	O
induced	VBN	parataxis	O
independent	JJ	xcomp	O
of	IN	case	O
ongoing	JJ	amod	O
protein	NN	compound	O
synthesis	NN	nmod	O
.	.	punct	O

T-cell	NN	compound	B-protein
receptor	NN	compound	I-protein
stimulation	NN	nsubj	O
also	RB	advmod	O
induced	VBD	ROOT	O
a	DT	det	O
very	RB	advmod	O
rapid	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
c-jun	NN	compound	B-DNA
,	,	punct	I-DNA
c-fos	NN	conj	I-DNA
and	CC	cc	I-DNA
NFATc1	NN	conj	I-DNA
(	-LRB-	punct	I-DNA
NFATc	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
the	DT	det	O
gene	NN	compound	O
products	NNS	nsubjpass	O
of	IN	case	O
which	WDT	nmod	O
are	VBP	auxpass	O
involved	VBN	parataxis	O
in	IN	case	O
cytokine	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
the	DT	det	O
cytokines	NNS	nsubj	B-protein
synthesized	VBN	acl	O
by	IN	case	O
IL-2-dependent	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	cop	O
predominantly	RB	advmod	O
IL-2	NN	ROOT	B-protein
,	,	punct	O
IFN-gamma	NN	conj	B-protein
and	CC	cc	O
TNF-alpha	NN	conj	B-protein
.	.	punct	O

An	DT	det	O
animal	JJ	compound	O
model	NN	ROOT	O
to	TO	mark	O
study	VB	acl	O
local	JJ	amod	O
oxidation	NN	dobj	O
of	IN	case	O
LDL	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
biological	JJ	amod	O
effects	NNS	conj	O
in	IN	case	O
the	DT	det	O
arterial	JJ	amod	O
wall	NN	nmod	O
.	.	punct	O

Oxidized	VBN	amod	O
LDL	NN	nsubj	O
(	-LRB-	punct	O
oxLDL	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
atherosclerotic	JJ	amod	O
lesions	NNS	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
believed	VBN	conj	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
atherogenesis	NN	nmod	O
.	.	punct	O

Mainly	RB	advmod	O
on	IN	prep	O
the	DT	det	O
basis	NN	pobj	O
of	IN	case	O
cell	NN	compound	O
culture	NN	compound	O
studies	NNS	nmod	O
,	,	punct	O
oxLDL	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
produce	VB	xcomp	O
many	JJ	amod	O
biological	JJ	amod	O
effects	NNS	dobj	O
that	WDT	nsubj	O
influence	VBP	acl:relcl	O
the	DT	det	O
atherosclerotic	JJ	amod	O
process	NN	dobj	O
.	.	punct	O

To	TO	mark	O
study	VB	advcl	O
LDL	NN	compound	O
oxidation	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
established	VBN	ROOT	O
a	DT	det	O
model	NN	dobj	O
in	IN	case	O
which	WDT	nmod	O
Sprague-Dawley	NN	compound	O
rats	NNS	nsubjpass	O
are	VBP	auxpass	O
given	VBN	acl:relcl	O
a	DT	det	O
single	JJ	amod	O
injection	NN	dobj	O
of	IN	case	O
unmodified	JJ	amod	O
human	JJ	amod	O
LDL	NN	nmod	O
(	-LRB-	punct	O
>	NN	dep	O
or	CC	cc	O
=	JJ	conj	O
4	CD	nummod	O
mg/kg	NN	compound	O
body	NN	compound	O
weight	NN	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Within	IN	case	O
6	CD	nummod	O
hours	NNS	nmod	O
,	,	punct	O
an	DT	det	O
accumulation	NN	nsubjpass	O
of	IN	case	O
apolipoprotein	NN	compound	O
B	NN	nmod	O
and	CC	cc	O
epitopes	NNS	conj	B-protein
present	JJ	amod	O
on	IN	case	O
oxLDL	NN	nmod	O
are	VBP	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
arterial	JJ	amod	O
endothelium	NN	nmod	O
and	CC	cc	O
media	NNS	conj	O
.	.	punct	O

The	DT	det	O
presence	NN	nsubjpass	O
of	IN	case	O
oxLDL	NN	nmod	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
endothelium	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
endothelial	JJ	amod	O
expression	NN	conj	O
of	IN	case	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nmod	I-protein
.	.	punct	O

Injection	NN	nsubj	O
of	IN	case	O
LDL	NN	nmod	O
enriched	VBN	acl	O
with	IN	case	O
the	DT	det	O
antioxidant	JJ	amod	O
probucol	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
arterial	JJ	amod	O
accumulation	NN	nmod	O
of	IN	case	O
apolipoprotein	NN	compound	O
B	NN	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
oxLDL-specific	JJ	amod	O
epitopes	NNS	nmod	O
was	VBD	auxpass	O
reduced	VBN	conj	O
at	IN	case	O
24	CD	nummod	O
hours	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
this	DT	det	O
simple	JJ	amod	O
model	NN	nsubj	O
has	VBZ	ROOT	O
the	DT	det	O
potential	NN	dobj	O
to	TO	mark	O
analyze	VB	acl	O
the	DT	det	O
mechanisms	NNS	dobj	O
behind	RB	dep	O
and	CC	cc	O
biological	JJ	conj	O
effects	NNS	dobj	O
of	IN	case	O
LDL	NN	compound	O
oxidation	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Molecular	JJ	amod	O
mechanisms	NNS	ROOT	O
of	IN	case	O
promoter	NN	compound	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
gp34	NN	compound	B-DNA
gene	NN	nmod	I-DNA
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
trans-activated	VBN	acl:relcl	O
by	IN	case	O
an	DT	det	O
oncoprotein	NN	compound	B-protein
Tax	NN	nmod	I-protein
of	IN	case	O
human	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
I	CD	nummod	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
gp34	NN	compound	B-DNA
gene	NN	nmod	I-DNA
by	IN	case	O
the	DT	det	O
Tax	NN	compound	B-protein
oncoprotein	NN	nmod	I-protein
of	IN	case	O
human	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
I	CD	nummod	O
(	-LRB-	punct	O
HTLV-I	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

gp34	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
type	NN	compound	B-protein
II	CD	nummod	I-protein
transmembrane	JJ	compound	I-protein
molecule	NN	ROOT	I-protein
belonging	VBG	acl	O
to	TO	case	O
the	DT	det	O
tumor	NN	compound	O
necrosis	NN	compound	O
factor	NN	compound	O
family	NN	nmod	O
and	CC	cc	O
is	VBZ	auxpass	O
constitutively	RB	advmod	O
expressed	VBN	conj	O
on	IN	case	O
HTLV-I-producing	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
not	RB	cc	O
normal	JJ	amod	B-cell_type
resting	VBG	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

The	DT	det	O
transcriptional	JJ	amod	O
regulatory	JJ	amod	O
region	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
gp34	NN	compound	B-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
HTLV-I	NN	compound	O
Tax	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
Jurkat	NN	nmod	I-cell_line
,	,	punct	O
in	IN	case	O
which	WDT	nmod	O
endogenous	JJ	amod	O
gp34	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
induced	VBN	parataxis	O
by	IN	case	O
Tax	NN	nmod	B-protein
.	.	punct	O

Sequence	NN	compound	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
two	CD	nummod	O
NF-kappaB-like	JJ	amod	B-DNA
elements	NNS	nsubj	I-DNA
(	-LRB-	punct	O
1	CD	dep	O
and	CC	cc	O
2	CD	conj	O
)	-RRB-	punct	O
were	VBD	cop	O
present	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
regulatory	JJ	amod	B-DNA
region	NN	nmod	I-DNA
.	.	punct	O

Both	DT	det	O
NF-kappaB-like	JJ	amod	B-DNA
elements	NNS	nsubj	I-DNA
were	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
bind	VB	xcomp	O
to	TO	case	O
NF-kappaB	NN	nmod	B-protein
or	CC	cc	O
its	PRP$	nmod:poss	O
related	JJ	amod	O
factor	NN	compound	O
(	-LRB-	punct	O
s	NNS	conj	O
)	-RRB-	punct	O
in	IN	case	O
a	DT	det	O
Tax	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Chloramphenicol	NN	compound	B-protein
acetyltransferase	NN	compound	I-protein
assays	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
NF-kappaB-like	JJ	amod	B-DNA
element	NN	nsubj	I-DNA
1	CD	nummod	I-DNA
was	VBD	cop	O
Tax	NN	nmod:npmod	B-protein
-responsive	JJ	ccomp	O
,	,	punct	O
although	IN	mark	O
the	DT	det	O
activity	NN	nsubj	O
was	VBD	cop	O
lower	JJR	advcl	O
than	IN	case	O
that	IN	nmod	O
the	DT	det	O
native	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

NF-kappaB	NN	compound	B-protein
-like	JJ	amod	O
element	NN	compound	O
2	CD	nummod	O
elevated	JJ	amod	O
promoter	NN	compound	O
activity	NN	ROOT	O
when	WRB	advmod	O
combined	VBN	acl	O
with	IN	case	O
NF-kappaB-like	JJ	amod	B-DNA
element	NN	nmod	I-DNA
1	CD	nummod	I-DNA
,	,	punct	O
indicating	VBG	acl	O
cooperative	JJ	amod	O
function	NN	dobj	O
of	IN	case	O
the	DT	det	O
elements	NNS	nmod	O
for	IN	case	O
maximum	NN	amod	O
promoter	NN	compound	O
function	NN	nmod	O
.	.	punct	O

Unlike	IN	case	O
typical	JJ	amod	O
NF-kappaB	NN	compound	B-DNA
elements	NNS	nmod	I-DNA
,	,	punct	O
the	DT	det	O
NF-kappaB-like	JJ	amod	B-DNA
elements	NNS	nsubjpass	I-DNA
in	IN	case	O
gp34	NN	nmod	B-protein
were	VBD	auxpass	O
not	RB	neg	O
activated	VBN	ROOT	O
by	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
phorbol	NN	compound	O
ester	NN	nmod	O
despite	IN	case	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
-like	JJ	amod	O
binding	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

Chloramphenicol	NN	compound	B-protein
acetyltransferase	NN	compound	I-protein
reporter	NN	compound	O
assays	NNS	nsubj	O
using	VBG	acl	O
the	DT	det	O
region	NN	dobj	O
upstream	JJ	advmod	O
of	IN	case	O
the	DT	det	O
NF-kappaB-like	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
identified	VBD	ROOT	O
an	DT	det	O
upstream	JJ	amod	O
region	NN	dobj	O
that	WDT	nsubj	O
reduced	VBD	acl:relcl	O
transcription	NN	dobj	O
from	IN	case	O
cognate	JJ	nmod	B-DNA
and	CC	cc	I-DNA
noncognate	JJ	conj	I-DNA
core	NN	compound	I-DNA
promoters	NNS	dep	I-DNA
in	IN	case	O
a	DT	det	O
Tax-independent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
imply	VBP	ROOT	O
complex	JJ	amod	O
regulation	NN	dobj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
gp34	NN	compound	B-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
suggest	VBP	conj	O
implication	NN	dobj	O
of	IN	case	O
gp34	NN	nmod	B-protein
in	IN	case	O
proliferation	NN	nmod	O
of	IN	case	O
HTLV-I	NN	compound	O
infected	JJ	amod	O
T	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O

beta-Amyloid	JJ	compound	B-protein
fibrils	NNS	nsubj	I-protein
activate	VBP	ROOT	O
parallel	JJ	amod	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
pathways	NNS	dobj	O
in	IN	case	O
microglia	NNS	nmod	B-cell_type
and	CC	cc	O
THP1	NN	conj	B-cell_line
monocytes	NNS	dep	I-cell_line
.	.	punct	O

The	DT	det	O
senile	JJ	amod	O
plaques	NNS	nsubj	O
of	IN	prep	O
Alzheimer	NN	poss	O
's	POS	case	O
disease	NN	pobj	O
are	VBP	cop	O
foci	NNS	ROOT	O
of	IN	case	O
local	JJ	amod	O
inflammatory	JJ	amod	O
responses	NNS	nmod	O
,	,	punct	O
as	IN	mark	O
evidenced	VBN	advcl	O
by	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
acute	JJ	amod	B-protein
phase	NN	compound	I-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
oxidative	JJ	amod	O
damage	NN	conj	O
.	.	punct	O

Fibrillar	JJ	amod	B-protein
forms	NNS	nsubjpass	I-protein
of	IN	case	O
beta-amyloid	NN	nmod	B-protein
(	-LRB-	punct	O
Abeta	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
the	DT	det	O
primary	JJ	amod	O
constituents	NNS	acl:relcl	O
of	IN	prep	O
senile	JJ	amod	O
plaques	NNS	pobj	O
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
tyrosine	NN	compound	O
kinase-dependent	JJ	amod	O
signal	NN	compound	O
transduction	NN	compound	O
cascades	NNS	dobj	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
inflammatory	JJ	amod	O
responses	NNS	nmod	O
in	IN	case	O
microglia	NNS	nmod	B-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
downstream	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	nsubjpass	O
mediating	VBG	acl	O
Abeta	JJ	compound	B-protein
-induced	JJ	amod	O
inflammatory	JJ	amod	O
events	NNS	dobj	O
are	VBP	auxpass	O
not	RB	neg	O
well	RB	advmod	O
characterized	VBN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
exposure	NN	nsubj	O
of	IN	case	O
primary	JJ	amod	B-cell_type
rat	NN	compound	I-cell_type
microglia	NNS	nmod	I-cell_type
and	CC	cc	O
human	JJ	amod	B-cell_line
THP1	NN	compound	I-cell_line
monocytes	NNS	conj	I-cell_line
to	TO	case	O
fibrillar	JJ	amod	B-protein
Abeta	NNP	nmod	I-protein
results	VBZ	ccomp	O
in	IN	case	O
the	DT	det	O
tyrosine	NN	nmod:npmod	B-protein
kinase	NN	nmod:npmod	I-protein
-dependent	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
two	CD	nummod	O
parallel	JJ	amod	O
signal	NN	compound	O
transduction	NN	compound	O
cascades	NNS	nmod	O
involving	VBG	acl	O
members	NNS	dobj	O
of	IN	case	O
the	DT	det	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	I-protein
MAPK	NN	compound	I-protein
)	-RRB-	punct	I-protein
superfamily	NN	nmod	I-protein
.	.	punct	O

Abeta	NNP	nsubj	B-protein
stimulated	VBD	ROOT	O
the	DT	det	O
rapid	JJ	amod	O
,	,	punct	O
transient	JJ	dep	O
activation	NN	dobj	O
of	IN	case	O
extracellular	JJ	amod	B-protein
signal-regulated	JJ	amod	I-protein
kinase	NN	nmod	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
ERK1	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
ERK2	NN	conj	B-protein
in	IN	case	O
microglia	NNS	nmod	B-cell_type
and	CC	cc	O
ERK2	NN	conj	B-protein
in	IN	case	O
THP1	NN	compound	B-cell_line
monocytes	NNS	nmod	I-cell_line
.	.	punct	O

A	DT	det	O
second	JJ	amod	O
superfamily	NN	compound	B-protein
member	NN	nsubjpass	I-protein
,	,	punct	O
p38	NN	compound	B-protein
MAPK	NN	appos	I-protein
,	,	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
activated	VBN	ROOT	O
with	IN	case	O
similar	JJ	amod	O
kinetics	NNS	nmod	O
.	.	punct	O

Scavenger	NN	compound	B-protein
receptor	NN	nsubj	I-protein
and	CC	cc	O
receptor	NN	conj	B-protein
for	IN	case	I-protein
advanced	JJ	amod	I-protein
glycated	VBN	amod	I-protein
end	NN	compound	I-protein
products	NNS	compound	I-protein
(	-LRB-	punct	O
RAGE	NN	appos	B-protein
)	-RRB-	punct	O
ligands	NNS	nmod	O
failed	VBD	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
ERK	NN	compound	B-protein
and	CC	cc	O
p38	NN	conj	B-protein
MAPK	NN	dobj	I-protein
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
significant	JJ	amod	O
increases	NNS	nmod	O
in	IN	case	O
protein	NN	compound	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
,	,	punct	O
demonstrating	VBG	xcomp	O
that	IN	mark	O
scavenger	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
and	CC	cc	O
RAGE	NN	conj	B-protein
are	VBP	auxpass	O
not	RB	neg	O
linked	VBN	ccomp	O
to	TO	case	O
these	DT	det	O
pathways	NNS	nmod	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
the	DT	det	O
stress-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinases	NNS	nsubjpass	I-protein
(	-LRB-	punct	O
SAPKs	NNS	appos	B-protein
)	-RRB-	punct	O
were	VBD	auxpass	O
not	RB	neg	O
significantly	RB	advmod	O
activated	VBN	ROOT	O
in	IN	case	O
response	NN	nmod	O
to	IN	case	O
Abeta	NNP	nmod	B-protein
.	.	punct	O

Downstream	JJ	amod	O
effectors	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
MAPK	NN	compound	O
signal	NN	compound	O
transduction	NN	compound	O
cascades	NNS	nmod	O
include	VBP	ROOT	O
MAPKAP	NN	compound	B-protein
kinases	NNS	dobj	I-protein
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
RSK1	NN	nmod	B-protein
and	CC	cc	O
RSK2	NN	conj	B-protein
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
.	.	punct	O

Exposure	NN	nsubj	O
of	IN	case	O
microglia	NNS	nmod	B-cell_type
and	CC	cc	O
THP1	NN	conj	B-cell_line
monocytes	NNS	dep	I-cell_line
to	TO	case	O
Abeta	NN	nmod	B-protein
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
RSK1	NN	nmod	B-protein
and	CC	cc	O
RSK2	NN	conj	B-protein
and	CC	cc	O
phosphorylation	NN	conj	O
of	IN	case	O
cAMP	NN	compound	B-protein
response	NN	compound	I-protein
element-binding	JJ	amod	I-protein
protein	NN	nmod	I-protein
at	IN	case	O
Ser133	NN	nmod	O
,	,	punct	O
providing	VBG	advcl	O
a	DT	det	O
mechanism	NN	dobj	O
for	IN	case	O
Abeta	JJ	compound	B-protein
-induced	JJ	amod	O
changes	NNS	nmod	O
in	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O

Regulation	NN	ROOT	O
of	IN	case	O
cellular	JJ	amod	B-protein
retinoic	JJ	amod	I-protein
acid	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
CRABP	NN	appos	B-protein
II	CD	nummod	I-protein
)	-RRB-	punct	O
during	IN	case	O
human	JJ	amod	B-cell_type
monocyte	NN	compound	I-cell_type
differentiation	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Cellular	JJ	amod	B-protein
retinoic	JJ	amod	I-protein
acid	NN	compound	I-protein
binding	NN	compound	I-protein
proteins	NNS	nsubj	I-protein
(	-LRB-	punct	O
CRABP	NN	appos	B-protein
)	-RRB-	punct	O
are	VBP	cop	O
low	JJ	amod	B-protein
molecular	JJ	amod	I-protein
weight	NN	compound	I-protein
proteins	NNS	ROOT	I-protein
whose	WP$	nmod:poss	O
precise	JJ	amod	O
function	NN	nsubj	O
remains	VBZ	acl:relcl	O
unknown	JJ	xcomp	O
.	.	punct	O

They	PRP	nsubj	O
bind	VBP	ROOT	O
retinoids	NNS	dobj	O
and	CC	cc	O
may	MD	aux	O
thereby	RB	advmod	O
modulate	VB	conj	O
the	DT	det	O
intracellular	JJ	amod	O
steady-state	JJ	amod	O
concentration	NN	dobj	O
of	IN	case	O
retinoids	NNS	nmod	O
.	.	punct	O

Whereas	IN	mark	O
CRABP	NN	nsubjpass	B-protein
I	CD	nsubjpass	I-protein
is	VBZ	auxpass	O
ubiquitously	RB	advmod	O
expressed	VBN	advcl	O
,	,	punct	O
CRABP	NN	nsubjpass	B-protein
II	CD	nummod	I-protein
is	VBZ	auxpass	O
mainly	RB	advmod	O
detected	VBN	ROOT	O
in	IN	case	O
various	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
of	IN	case	O
the	DT	det	O
skin	NN	nmod	O
.	.	punct	O

By	IN	case	O
representative	JJ	amod	O
difference	NN	compound	O
analysis	NN	nmod	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
CRABP	NN	nsubjpass	B-protein
II	CD	nummod	I-protein
is	VBZ	auxpass	O
also	RB	advmod	O
strongly	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocyte-derived	JJ	amod	I-cell_type
macrophages	NNS	nmod	I-cell_type
(	-LRB-	punct	O
MAC	NN	appos	B-cell_type
)	-RRB-	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
freshly	RB	advmod	B-cell_type
isolated	VBN	amod	I-cell_type
monocytes	NNS	conj	I-cell_type
(	-LRB-	punct	O
MO	NN	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
CRABP	NN	compound	B-RNA
II	CD	nummod	I-RNA
mRNA	NN	nsubjpass	I-RNA
was	VBD	auxpass	O
gradually	RB	advmod	O
upregulated	VBN	ROOT	O
during	IN	case	O
differentiation	NN	nmod	O
from	IN	case	O
MO	NN	nmod	B-cell_type
to	TO	case	O
MAC	NN	nmod	B-cell_type
in	IN	case	O
the	DT	det	O
presence	NN	dep	O
of	IN	case	O
2	CD	compound	O
%	NN	amod	O
serum	NN	nmod	O
.	.	punct	O

Adherence	NN	nsubj	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
important	JJ	acl:relcl	O
for	IN	case	O
MO	NN	compound	B-cell_type
differentiation	NN	nmod	O
,	,	punct	O
induced	VBD	ROOT	O
CRABP	NN	compound	B-protein
II	CD	nummod	I-protein
expression	NN	dobj	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
addition	NN	nsubj	O
of	IN	case	O
10	CD	nummod	O
(	-LRB-	punct	O
-7	CD	compound	O
)	-RRB-	punct	O
M	NN	compound	O
retinoic	JJ	amod	O
acid	NN	nmod	O
inhibited	VBD	conj	O
the	DT	det	O
upregulation	NN	dobj	O
of	IN	case	O
CRABP	NN	compound	B-protein
II	CD	nummod	I-protein
expression	NN	nmod	O
during	IN	case	O
MO/MAC	JJ	compound	O
differentiation	NN	nmod	O
.	.	punct	O

As	IN	mark	O
MO	NN	nsubj	B-cell_type
can	MD	aux	O
differentiate	VB	advcl	O
along	IN	case	O
the	DT	det	O
classical	JJ	amod	O
pathway	NN	nmod	O
not	RB	neg	O
only	RB	cc:preconj	O
to	TO	case	O
MAC	NN	nmod	B-cell_type
but	CC	cc	O
also	RB	advmod	O
to	TO	case	O
dendritic	JJ	amod	O
cells	NNS	conj	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
CRABP	NN	nmod	B-protein
II	CD	nummod	I-protein
in	IN	case	O
MO-derived	JJ	amod	B-cell_type
dendritic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
cultured	VBN	acl	O
with	IN	case	O
10	CD	compound	O
%	NN	dep	O
FCS	NN	nmod	B-protein
,	,	punct	O
IL-4	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
GM-CSF	NN	conj	B-protein
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
MAC	NN	nmod	B-cell_type
,	,	punct	O
MO-derived	JJ	amod	B-cell_type
dendritic	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
showed	VBD	ROOT	O
an	DT	det	O
extremely	RB	advmod	O
low	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
CRABP	NN	nmod	B-protein
II	CD	nummod	I-protein
.	.	punct	O

From	IN	case	O
these	DT	det	O
results	NNS	nmod	O
we	PRP	nsubj	O
conclude	VBP	ROOT	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
that	IN	mark	O
the	DT	det	O
availability	NN	nsubj	O
and	CC	cc	O
the	DT	det	O
metabolism	NN	conj	O
of	IN	case	O
retinoids	NNS	nmod	O
may	MD	aux	O
be	VB	cop	O
different	JJ	ccomp	O
in	IN	case	O
MAC	NN	nmod	B-cell_type
compared	VBN	case	O
to	TO	case	O
MO	NN	compound	B-cell_type
and	CC	cc	O
dendritic	JJ	conj	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
(	-LRB-	punct	O
2	LS	conj	O
)	-RRB-	punct	O
that	WDT	mark	O
this	DT	nsubj	O
may	MD	aux	O
influence	VB	ccomp	O
differentiation	NN	dobj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
those	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

Transcription	NN	compound	B-protein
factor	NN	compound	I-protein
B-cell-specific	JJ	amod	I-protein
activator	NN	compound	I-protein
protein	NN	nsubjpass	I-protein
(	-LRB-	punct	O
BSAP	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
differentially	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
in	IN	case	O
subsets	NNS	conj	O
of	IN	case	O
B-cell	NN	compound	O
lymphomas	NNS	nmod	O
.	.	punct	O

The	DT	det	O
paired	JJ	amod	B-DNA
box	NN	compound	I-DNA
containing	VBG	amod	I-DNA
gene	NN	compound	I-DNA
PAX-5	NN	nsubj	B-DNA
encodes	VBZ	ROOT	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
BSAP	NN	dobj	B-protein
(	-LRB-	punct	O
B-cell-specific	JJ	amod	B-protein
activator	NN	compound	I-protein
protein	NN	appos	I-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
plays	VBZ	acl:relcl	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
B-lymphocyte	NN	compound	O
development	NN	nmod	O
.	.	punct	O

Despite	IN	case	O
its	PRP$	nmod:poss	O
known	JJ	amod	O
involvement	NN	nmod	O
in	IN	case	O
a	DT	det	O
rare	JJ	amod	O
subtype	NN	nmod	O
of	IN	case	O
non-Hodgkin	JJ	nmod:poss	O
's	POS	case	O
lymphoma	NN	nmod	O
(	-LRB-	punct	O
NHL	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
detailed	JJ	amod	O
examination	NN	nsubjpass	O
of	IN	case	O
BSAP	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
NHL	NN	nmod	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
previously	RB	advmod	O
reported	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
normal	JJ	amod	O
and	CC	cc	O
malignant	JJ	conj	O
lymphoid	JJ	amod	O
tissues	NNS	dobj	O
and	CC	cc	O
cell	NN	compound	B-cell_line
lines	NNS	conj	I-cell_line
,	,	punct	O
including	VBG	case	O
102	CD	nummod	O
cases	NNS	nmod	O
of	IN	case	O
B-cell	NN	compound	O
NHL	NN	nmod	O
,	,	punct	O
23	CD	nummod	O
cases	NNS	conj	O
of	IN	case	O
T-	NN	compound	O
and	CC	cc	O
null-cell	JJ	conj	O
NHL	NN	nmod	O
,	,	punct	O
and	CC	cc	O
18	CD	nummod	O
cases	NNS	conj	O
of	IN	case	O
Hodgkin	NN	nmod:poss	O
's	POS	case	O
disease	NN	nmod	O
.	.	punct	O

Normal	JJ	amod	O
lymphoid	JJ	amod	O
tissues	NNS	nsubj	O
showed	VBD	ROOT	O
strong	JJ	amod	O
nuclear	JJ	amod	O
BSAP	NN	compound	B-protein
expression	NN	dobj	O
in	IN	case	O
mantle	NN	compound	B-cell_type
zone	NN	compound	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
less	RBR	advmod	O
intense	JJ	amod	O
reactivity	NN	dobj	O
in	IN	case	O
follicular	JJ	amod	B-cell_type
center	NN	compound	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
no	DT	neg	O
expression	NN	conj	O
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
the	DT	det	O
T-cell-rich	JJ	amod	O
zones	NNS	nmod	O
.	.	punct	O

Monocytoid	NN	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
showed	VBD	ROOT	O
weak	JJ	amod	O
expression	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
plasma	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
and	CC	cc	O
extrafollicular	JJ	amod	B-cell_type
large	JJ	amod	I-cell_type
transformed	VBN	amod	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
were	VBD	cop	O
negative	JJ	parataxis	O
.	.	punct	O

Of	IN	case	O
the	DT	det	O
102	CD	nummod	O
B-cell	NN	compound	O
NHLs	NNS	nsubj	O
,	,	punct	O
83	CD	appos	O
(	-LRB-	punct	O
81	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
demonstrated	VBD	ROOT	O
BSAP	NN	compound	B-protein
expression	NN	dobj	O
.	.	punct	O

All	DT	nsubj	O
of	IN	case	O
the	DT	det	O
13	CD	nummod	O
(	-LRB-	punct	O
100	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
B-cell	NN	compound	O
chronic	JJ	amod	O
lymphocytic	JJ	amod	O
leukemias	NNS	nmod	O
(	-LRB-	punct	O
B-CLLs	NNS	appos	O
)	-RRB-	punct	O
,	,	punct	O
21	CD	appos	O
of	IN	case	O
(	-LRB-	punct	O
100	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
mantle	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
MCLs	NNS	appos	B-cell_type
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
20	CD	compound	O
of	IN	advmod	O
21	CD	nummod	O
(	-LRB-	punct	O
95	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
follicular	JJ	amod	O
lymphomas	NNS	conj	O
(	-LRB-	punct	O
FLs	NN	appos	O
)	-RRB-	punct	O
were	VBD	cop	O
positive	JJ	ROOT	O
.	.	punct	O

Moderate	JJ	amod	O
staining	NN	compound	O
intensities	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
most	JJS	amod	O
B-CLL	NN	nmod	O
and	CC	cc	O
FL	NN	conj	O
cases	NNS	dep	O
,	,	punct	O
whereas	IN	dep	O
most	JJS	amod	O
MCLs	NNS	nsubj	B-cell_type
showed	VBD	parataxis	O
strong	JJ	amod	O
reactions	NNS	dobj	O
,	,	punct	O
paralleling	VBG	advcl	O
the	DT	det	O
strong	JJ	amod	O
reactivity	NN	dobj	O
of	IN	case	O
nonmalignant	JJ	amod	B-cell_type
mantle	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Eight	CD	nsubj	O
of	IN	prep	O
12	CD	pobj	O
(	-LRB-	punct	O
67	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
marginal	JJ	amod	O
zone	NN	compound	O
lymphoma	NN	compound	O
cases	NNS	nsubj	O
showed	VBD	ROOT	O
negative	JJ	amod	O
or	CC	cc	O
low	JJ	conj	O
BSAP	NN	compound	B-protein
levels	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
17	CD	compound	O
of	IN	advmod	O
24	CD	nummod	O
(	-LRB-	punct	O
71	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
large	JJ	amod	O
B-cell	NN	compound	O
lymphomas	NNS	conj	O
displayed	VBD	acl	O
moderate	JJ	xcomp	O
to	TO	case	O
strong	JJ	amod	O
expression	NN	nmod	O
.	.	punct	O

None	NN	nsubj	O
of	IN	case	O
the	DT	det	O
23	CD	nummod	O
T-	NN	amod	O
and	CC	cc	O
null-cell	JJ	conj	O
lymphomas	NNS	nmod	O
reacted	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
BSAP	NN	compound	B-protein
antisera	NNS	nmod	O
,	,	punct	O
whereas	IN	mark	O
in	IN	case	O
Hodgkin	NN	nmod:poss	O
's	POS	case	O
disease	NN	nmod	O
,	,	punct	O
2	CD	compound	O
of	IN	advmod	O
4	CD	nummod	O
(	-LRB-	punct	O
50	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
nodular	JJ	amod	O
lymphocytic	JJ	amod	O
predominance	NN	dep	O
and	CC	cc	O
5	CD	compound	O
of	IN	advmod	O
14	CD	nummod	O
(	-LRB-	punct	O
36	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
classical	JJ	amod	O
cases	NNS	nsubj	O
showed	VBD	advcl	O
weak	JJ	amod	O
nuclear	JJ	amod	O
or	CC	cc	O
nucleolar	JJ	conj	O
BSAP	NN	compound	B-protein
reactions	NNS	dobj	O
in	IN	case	O
a	DT	det	O
fraction	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
a	DT	det	O
52-kD	JJ	amod	O
BSAP	NN	compound	B-protein
band	NN	dobj	O
in	IN	case	O
B-cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
non-B-cell	JJ	conj	B-cell_line
or	CC	cc	I-cell_line
plasma	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
BSAP	NN	compound	B-protein
expression	NN	nsubj	O
is	VBZ	cop	O
largely	RB	advmod	O
restricted	JJ	ccomp	O
to	TO	case	O
lymphomas	NNS	nmod	O
of	IN	case	O
B-cell	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
and	CC	cc	O
that	IN	mark	O
BSAP	NN	compound	B-protein
expression	NN	nsubj	O
varies	VBZ	conj	O
in	IN	case	O
B-cell	NN	compound	B-cell_type
subsets	NNS	nmod	I-cell_type
and	CC	cc	O
subtypes	NNS	conj	O
of	IN	case	O
B-cell	NN	compound	O
NHL	NN	nmod	O
.	.	punct	O

The	DT	det	O
high	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
BSAP	NN	nmod	B-protein
,	,	punct	O
especially	RB	advmod	O
those	DT	appos	O
found	VBN	acl	O
in	IN	case	O
large-cell	JJ	amod	B-cell_type
lymphomas	NNS	nmod	I-cell_type
and	CC	cc	O
in	IN	case	O
some	DT	det	O
follicular	JJ	amod	B-cell_type
lymphomas	NNS	conj	I-cell_type
,	,	punct	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
consequence	NN	ROOT	O
of	IN	case	O
deregulated	VBN	amod	O
gene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
a	DT	det	O
possible	JJ	amod	O
involvement	NN	dobj	O
of	IN	case	O
PAX-5	NN	nmod	B-DNA
in	IN	case	O
certain	JJ	amod	O
B-cell	NN	compound	O
malignancies	NNS	nmod	O
.	.	punct	O

This	DT	nsubj	O
is	VBZ	ROOT	O
a	DT	det	O
US	NNP	compound	O
government	NN	compound	O
work	NN	attr	O
.	.	punct	O

There	EX	expl	O
are	VBP	ROOT	O
no	DT	det	O
restrictions	NNS	attr	O
on	IN	prep	O
its	PRP$	poss	O
use	NN	pobj	O
.	.	punct	O

Mitogen	NN	ROOT	O
and	CC	cc	O
growth	NN	nmod:npmod	O
factor-induced	JJ	conj	O
activation	NN	dep	O
of	IN	case	O
a	DT	det	O
STAT-like	JJ	amod	B-protein
molecule	NN	nmod	I-protein
in	IN	case	O
channel	NN	compound	B-cell_type
catfish	JJ	amod	I-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	det	O
article	NN	nsubj	O
describes	VBZ	ROOT	O
the	DT	det	O
identification	NN	dobj	O
of	IN	case	O
a	DT	det	O
putative	JJ	amod	B-protein
STAT	NN	compound	I-protein
molecule	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
channel	NN	compound	O
catfish	NN	nmod	O
(	-LRB-	punct	O
Ictalurus	NN	compound	O
punctatus	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
first	JJ	amod	O
report	NN	appos	O
of	IN	case	O
such	PDT	predet	O
a	DT	det	O
molecule	NN	nmod	O
in	IN	case	O
a	DT	det	O
'lower	NN	nmod:poss	O
'	``	punct	O
vertebrate	NN	nmod	O
.	.	punct	O

A	DT	det	O
monoclonal	JJ	amod	B-protein
antibody	NN	nsubj	I-protein
against	IN	case	O
human	JJ	amod	B-protein
STAT6	NN	nmod	I-protein
recognizes	VBZ	ROOT	O
an	DT	det	O
approximately	RB	advmod	O
100	CD	nummod	B-protein
kDa	NN	compound	I-protein
molecule	NN	dobj	I-protein
that	WDT	nsubj	O
becomes	VBZ	acl:relcl	O
activated	VBN	xcomp	O
and	CC	cc	O
translocates	VBZ	conj	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
upon	IN	case	O
both	CC	cc:preconj	O
growth	NN	compound	O
factor	NN	nmod	O
and	CC	cc	O
mitogen	NN	compound	O
stimulation	NN	conj	O
of	IN	case	O
catfish	JJ	amod	O
leukocytes	NNS	nmod	O
.	.	punct	O

This	DT	det	O
presumed	JJ	amod	O
catfish	JJ	amod	B-protein
STAT	NN	nsubj	I-protein
binds	VBZ	ROOT	O
the	DT	det	O
mammalian	JJ	amod	B-DNA
interferon-gamma	NN	compound	I-DNA
activation	NN	compound	I-DNA
site	NN	dobj	I-DNA
,	,	punct	O
a	DT	det	O
known	JJ	amod	O
motif	NN	appos	O
of	IN	case	O
mammalian	JJ	amod	O
STAT	NN	compound	O
binding	NN	nmod	O
,	,	punct	O
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
electromobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

Purification	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proteins	NNS	nmod	O
present	JJ	amod	O
in	IN	case	O
these	DT	det	O
DNA	NN	compound	B-protein
complexes	NNS	nmod	I-protein
confirms	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
catfish	JJ	amod	O
reactive	JJ	amod	O
molecule	NN	nsubj	O
binds	VBZ	ccomp	O
to	TO	case	O
the	DT	det	O
interferon-gamma	NN	compound	B-DNA
activation	NN	compound	I-DNA
site	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
STAT	NN	compound	B-protein
molecules	NNS	nsubjpass	I-protein
have	VBP	aux	O
been	VBN	auxpass	O
highly	RB	advmod	O
conserved	VBN	ccomp	O
in	IN	case	O
vertebrate	NN	compound	O
evolution	NN	nmod	O
.	.	punct	O

Isolation	NN	ROOT	O
and	CC	cc	O
analysis	NN	conj	O
of	IN	case	O
a	DT	det	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
clone	NN	compound	I-cell_line
variant	NN	nmod	I-cell_line
exhibiting	VBG	acl	O
constitutively	RB	advmod	O
phosphorylated	VBN	amod	B-protein
Ser133	NN	compound	I-protein
cAMP	NN	compound	I-protein
response	NN	compound	I-protein
element-binding	JJ	amod	I-protein
protein	NN	dobj	I-protein
.	.	punct	O

In	IN	mark	O
driving	VBG	advcl	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
IL-2	NN	nsubj	B-protein
stimulates	VBZ	ROOT	O
a	DT	det	O
new	JJ	amod	O
program	NN	dobj	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
that	WDT	nsubj	O
includes	VBZ	acl:relcl	O
proliferating	VBG	amod	B-protein
cell	NN	compound	I-protein
nuclear	JJ	amod	I-protein
antigen	NN	dobj	I-protein
(	-LRB-	punct	O
PCNA	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
requisite	JJ	amod	O
processivity	NN	compound	O
factor	NN	appos	O
for	IN	case	O
DNA	NN	compound	B-protein
polymerase	NN	compound	I-protein
delta	NN	nmod	I-protein
.	.	punct	O

PCNA	NN	compound	B-protein
transcription	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
in	IN	case	O
part	NN	nmod	O
through	IN	case	O
tandem	JJ	amod	O
CRE	NN	compound	B-DNA
sequences	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
promoter	NN	nmod	B-protein
and	CC	cc	I-protein
CRE	NN	compound	I-protein
binding	NN	compound	I-protein
proteins	NNS	conj	I-protein
;	:	punct	O
IL-2	NN	nsubj	B-protein
stimulates	VBZ	parataxis	O
CREB	NN	compound	O
phosphorylation	NN	dobj	O
in	IN	case	O
the	DT	det	O
resting	VBG	amod	B-cell_line
cloned	VBN	amod	I-cell_line
T	NN	compound	I-cell_line
lymphocyte	NN	nmod	I-cell_line
,	,	punct	O
L2	NN	appos	B-cell_line
.	.	punct	O

After	IN	mark	O
culturing	VBG	advcl	O
L2	NN	compound	B-cell_line
cells	NNS	dobj	I-cell_line
for	IN	case	O
greater	JJR	advmod	O
than	IN	quantmod	O
91	CD	nummod	O
days	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
consistently	RB	advmod	O
isolate	VBP	ROOT	O
a	DT	det	O
stable	JJ	amod	O
variant	NN	dobj	O
that	WDT	nsubj	O
exhibits	VBZ	acl:relcl	O
constitutive	JJ	amod	O
CREB	NN	compound	O
phosphorylation	NN	dobj	O
.	.	punct	O

L2	NN	nsubjpass	B-cell_line
and	CC	cc	I-cell_line
L2	NN	conj	I-cell_line
variant	JJ	amod	I-cell_line
cells	NNS	conj	I-cell_line
were	VBD	auxpass	O
tested	VBN	ROOT	O
for	IN	case	O
IL-2	NN	compound	B-protein
responsiveness	NN	nmod	O
and	CC	cc	O
rapamycin	NN	compound	O
sensitivity	NN	conj	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
specific	JJ	amod	O
kinase	NN	compound	O
activity	NN	nmod	O
,	,	punct	O
PCNA	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
.	.	punct	O

In	IN	case	O
L2	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
IL-2	NN	nsubj	B-protein
stimulated	VBD	acl	O
and	CC	cc	O
rapamycin	NN	conj	O
inhibited	VBD	ROOT	O
the	DT	det	O
following	JJ	dobj	O
:	:	punct	O
cAMP-independent	JJ	amod	O
CREB	NN	compound	B-protein
kinase	NN	compound	I-protein
activity	NN	dep	O
,	,	punct	O
PCNA	NN	compound	O
expression	NN	conj	O
and	CC	cc	O
proliferation	NN	conj	O
.	.	punct	O

In	IN	case	O
L2	NN	compound	B-cell_line
variant	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
CREB	NN	compound	B-protein
kinase	NN	compound	I-protein
activity	NN	nsubj	O
was	VBD	cop	O
constitutively	RB	advmod	O
high	JJ	ROOT	O
;	:	punct	O
IL-2	NN	nsubj	B-protein
stimulated	VBD	acl	O
and	CC	cc	O
rapamycin	NN	conj	O
blocked	VBD	dep	O
PCNA	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
proliferation	NN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
IL-2	NN	nsubj	B-protein
induces	VBZ	ccomp	O
a	DT	det	O
rapamycin-sensitive	JJ	amod	O
,	,	punct	O
cAMP-independent	JJ	dep	O
CREB	NN	compound	B-protein
kinase	NN	compound	I-protein
activity	NN	dobj	O
in	IN	case	O
L2	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
phosphorylation	NN	nsubj	O
of	IN	case	O
CREB	NN	nmod	B-protein
alone	RB	advmod	O
is	VBZ	cop	O
not	RB	neg	O
sufficient	JJ	ROOT	O
to	TO	mark	O
drive	VB	xcomp	O
PCNA	NN	compound	B-protein
expression	NN	dobj	O
and	CC	cc	O
L2	NN	compound	O
cell	NN	compound	O
proliferation	NN	conj	O
in	IN	case	O
the	DT	det	O
absence	NN	dep	O
of	IN	case	O
IL-2	NN	nmod	B-protein
.	.	punct	O

Serotonin	NN	compound	O
derivative	NN	nsubj	O
,	,	punct	O
N-	NN	compound	O
(	-LRB-	punct	O
p-coumaroyl	NN	appos	O
)	-RRB-	punct	O
serotonin	NN	appos	O
,	,	punct	O
inhibits	VBZ	ROOT	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
TNF-alpha	NN	nmod	B-protein
,	,	punct	O
IL-1alpha	NN	conj	B-protein
,	,	punct	O
IL-1beta	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-6	NN	conj	B-protein
by	IN	case	O
endotoxin-stimulated	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
reported	VBN	ROOT	O
that	IN	mark	O
N-	NN	compound	O
(	-LRB-	punct	O
p-coumaroyl	NN	appos	O
)	-RRB-	punct	O
serotonin	NN	ccomp	O
(	-LRB-	punct	O
CS	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
derivatives	NNS	nsubj	O
with	IN	case	O
antioxidative	JJ	amod	O
activity	NN	nmod	O
are	VBP	cop	O
present	JJ	conj	O
in	IN	case	O
safflower	NN	compound	O
seeds	NNS	nmod	O
.	.	punct	O

As	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
species	NNS	nsubjpass	O
(	-LRB-	punct	O
ROS	NN	appos	O
)	-RRB-	punct	O
are	VBP	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
signaling	NN	nmod	O
of	IN	case	O
lipopolysaccharide	NN	nmod	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	parataxis	O
whether	IN	mark	O
CS	NN	nsubj	O
has	VBZ	ccomp	O
a	DT	det	O
suppressive	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
inflammatory	JJ	amod	B-protein
cytokine	NN	compound	I-protein
generation	NN	nmod	O
from	IN	case	O
human	JJ	amod	B-cell_type
monocyte	NN	compound	I-cell_type
s	NNS	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

CS	NN	nsubj	O
at	IN	case	O
50-200	CD	nummod	O
microM	NN	nmod	O
reduced	VBD	ROOT	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	dobj	I-protein
(	-LRB-	punct	O
TNF	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
interleukin-1	NN	appos	B-protein
(	-LRB-	punct	O
IL-1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
IL-6	NN	compound	B-protein
activities	NNS	conj	O
in	IN	case	O
the	DT	det	O
culture	NN	compound	O
supernatants	NNS	nmod	O
from	IN	case	O
LPS-stimulated	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
blood	NN	compound	I-cell_line
monocytes	NNS	nmod	I-cell_line
without	IN	case	O
cytotoxicity	NN	nmod	O
.	.	punct	O

ELISA	NN	compound	O
assay	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
production	NN	nsubjpass	O
of	IN	case	O
TNF-alpha	NN	nmod	B-protein
,	,	punct	O
IL-1alpha	NN	conj	B-protein
,	,	punct	O
IL-1beta	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-6	NN	conj	B-protein
was	VBD	auxpass	O
inhibited	VBN	ccomp	O
by	IN	case	O
CS	NN	nmod	O
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
LPS-induced	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
cytokine	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
was	VBD	auxpass	O
suppressed	VBN	ccomp	O
by	IN	case	O
CS	NN	nmod	O
.	.	punct	O

NF-kappaB	NN	compound	O
activation	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
inhibited	VBN	ROOT	O
by	IN	case	O
CS	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
CS	NN	nsubj	O
has	VBZ	ccomp	O
a	DT	det	O
suppressive	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
proinflammatory	JJ	amod	O
cytokine	NN	compound	O
production	NN	nmod	O
from	IN	case	O
monocytes	NNS	nmod	B-cell_type
,	,	punct	O
and	CC	cc	O
this	DT	det	O
effect	NN	nsubjpass	O
is	VBZ	auxpass	O
based	VBN	conj	O
in	IN	case	O
part	NN	nmod	O
on	IN	case	O
the	DT	det	O
suppression	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nmod	O
through	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
activation	NN	nmod	O
.	.	punct	O

Elevated	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
differentiation	NN	compound	B-RNA
inhibitory	JJ	amod	I-RNA
factor	NN	compound	I-RNA
nm23	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
monoblastic	JJ	amod	O
crisis	NN	nmod	O
of	IN	case	O
a	DT	det	O
patient	NN	nmod	O
with	IN	case	O
chronic	JJ	amod	O
myelogenous	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

Differentiation	NN	compound	B-protein
inhibitory	JJ	amod	I-protein
factor	NN	compound	I-protein
nm23	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
has	VBZ	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
expressed	VBN	xcomp	O
in	IN	case	O
high	JJ	amod	O
quantities	NNS	nmod	O
in	IN	case	O
acute	JJ	amod	O
myelogenous	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
AML	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
especially	RB	advmod	O
in	IN	case	O
acute	JJ	amod	O
monocytic	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
AML-M5	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
is	VBZ	auxpass	O
suggested	VBN	conj	O
as	IN	case	O
a	DT	det	O
new	JJ	amod	O
prognostic	JJ	amod	O
factor	NN	nmod	O
in	IN	case	O
AML-M5	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
an	DT	det	O
example	NN	dobj	O
of	IN	case	O
elevated	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
nm23	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
a	DT	det	O
patient	NN	nmod	O
with	IN	case	O
chronic	JJ	amod	O
myelogenous	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
CML	NN	appos	O
)	-RRB-	punct	O
who	WP	nsubj	O
developed	VBD	acl:relcl	O
monoblastic	JJ	amod	O
crisis	NN	dobj	O
.	.	punct	O

Relative	JJ	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
nm23-H1	NN	nmod	B-RNA
and	CC	cc	I-RNA
-H2	NN	conj	I-RNA
mRNA	NN	dep	I-RNA
extracted	VBN	acl	O
from	IN	case	O
the	DT	det	O
patient	NN	nmod:poss	O
's	POS	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
bone	NN	compound	B-cell_type
marrow	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
were	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
quantitative	JJ	amod	O
reverse	JJ	amod	O
transcriptase	NN	compound	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
.	.	punct	O

The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
nm23-H1	NN	amod	B-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
CML	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
at	IN	case	O
the	DT	det	O
chronic	JJ	amod	O
phase	NN	nmod	O
was	VBD	cop	O
as	RB	advmod	O
high	JJ	ROOT	O
as	IN	case	O
that	DT	nmod	O
in	IN	case	O
bone	NN	compound	B-cell_type
marrow	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
healthy	JJ	amod	O
volunteers	NNS	nmod	O
.	.	punct	O

The	DT	det	O
mRNA	NN	compound	O
level	NN	nsubj	O
of	IN	case	O
nm23-H2	NN	nmod	B-protein
was	VBD	cop	O
slightly	RB	advmod	O
below	IN	case	O
the	DT	det	O
normal	JJ	amod	O
level	NN	ROOT	O
.	.	punct	O

At	IN	case	O
blastic	JJ	amod	O
crisis	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
nm23-H1	NN	nmod	B-RNA
and	CC	cc	I-RNA
-H2	NN	conj	I-RNA
mRNA	NN	dep	I-RNA
was	VBD	aux	O
elevated	JJ	ROOT	O
to	TO	case	O
about	RB	advmod	O
three	CD	compound	O
to	TO	dep	O
nine	CD	nummod	O
times	NNS	nmod	O
of	IN	case	O
that	DT	nmod	O
at	IN	case	O
the	DT	det	O
chronic	JJ	amod	O
phase	NN	nmod	O
.	.	punct	O

Proliferated	VBN	amod	B-cell_type
blastic	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
were	VBD	cop	O
positive	JJ	ROOT	O
for	IN	case	O
non-specific	JJ	amod	B-protein
esterase	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
the	DT	det	O
serum	NN	compound	O
lysozyme	NN	compound	O
level	NN	nsubj	O
was	VBD	cop	O
elevated	JJ	conj	O
and	CC	cc	O
diagnosed	VBN	conj	O
as	IN	case	O
monoblastic	JJ	amod	O
crisis	NN	nmod	O
.	.	punct	O

The	DT	det	O
patient	NN	nsubj	O
received	VBD	ROOT	O
combined	JJ	amod	O
chemotherapy	NN	dobj	O
but	CC	cc	O
response	NN	conj	O
was	VBD	cop	O
partial	JJ	conj	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
are	VBP	cop	O
compatible	JJ	ROOT	O
with	IN	case	O
our	PRP$	nmod:poss	O
previous	JJ	amod	O
report	NN	nmod	O
that	IN	mark	O
nm23	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
overexpressed	VBN	ccomp	O
in	IN	case	O
monocytic	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

Increased	VBN	amod	O
transcription	NN	nsubj	O
decreases	VBZ	ROOT	O
the	DT	det	O
spontaneous	JJ	amod	O
mutation	NN	compound	O
rate	NN	dobj	O
at	IN	case	O
the	DT	det	O
thymidine	NN	compound	B-DNA
kinase	NN	compound	I-DNA
locus	NN	nmod	I-DNA
in	IN	case	O
human	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Transcription	NN	nsubj	O
increases	VBZ	ROOT	O
DNA	NN	compound	O
repair	NN	compound	O
efficiency	NN	dobj	O
and	CC	cc	O
modulates	VBZ	conj	O
the	DT	det	O
distribution	NN	dobj	O
of	IN	case	O
certain	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
DNA	NN	compound	O
damage	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
increased	VBN	amod	O
transcription	NN	compound	O
level	NN	nsubj	O
stimulates	VBZ	ROOT	O
spontaneous	JJ	amod	O
mutation	NN	compound	O
rate	NN	dobj	O
in	IN	case	O
yeast	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
explored	VBD	ROOT	O
whether	IN	mark	O
transcription	NN	compound	O
level	NN	nsubj	O
affects	VBZ	ccomp	O
spontaneous	JJ	amod	O
mutation	NN	compound	O
rate	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
first	RB	advmod	O
developed	VBD	ROOT	O
two	CD	nummod	O
thymidine	NN	compound	B-cell_line
kinase	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
tk	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
inducible	JJ	amod	I-cell_line
human	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dobj	I-cell_line
using	VBG	acl	O
the	DT	det	O
Gal4-Estrogen	NN	compound	O
receptor	NN	compound	O
system	NN	dobj	O
.	.	punct	O

In	IN	case	O
our	PRP$	nmod:poss	O
TK6i-G3	NN	nmod	B-cell_line
and	CC	cc	I-cell_line
G9	NN	conj	I-cell_line
tk	IN	cc	I-cell_line
heterozygous	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dep	I-cell_line
,	,	punct	O
the	DT	det	O
active	JJ	amod	O
tk	IN	compound	B-DNA
allele	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
linked	VBN	ROOT	O
to	TO	case	O
an	DT	det	O
inducible	JJ	amod	O
promoter	NN	compound	B-DNA
element	NN	nmod	I-DNA
.	.	punct	O

Tk	DT	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
is	VBZ	auxpass	O
induced	VBN	ROOT	O
following	VBG	case	O
treatment	NN	nmod	O
with	IN	case	O
estrogen	NN	nmod	O
.	.	punct	O

Spontaneous	JJ	amod	O
mutation	NN	compound	O
rate	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
decreased	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
after	IN	case	O
induction	NN	nmod	O
in	IN	case	O
contrast	NN	nmod	O
to	TO	case	O
the	DT	det	O
report	NN	nmod	O
in	IN	case	O
yeast	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
humans	NNS	nsubj	O
may	MD	aux	O
have	VB	aux	O
evolved	VBN	ROOT	O
different	JJ	amod	O
or	CC	cc	O
additional	JJ	conj	O
mechanisms	NNS	dobj	O
to	TO	mark	O
deal	VB	acl	O
with	IN	case	O
transcription	NN	nmod:npmod	O
related	JJ	amod	O
spontaneous	JJ	amod	O
mutagenesis	NN	nmod	O
.	.	punct	O

Copyright	NN	dep	O
1998	CD	nummod	O
Elsevier	NNP	compound	O
Science	NNP	compound	O
B.V	NNP	ROOT	O
.	.	punct	O

All	DT	det	O
rights	NNS	nsubj	O
reserved	VBN	ROOT	O
.	.	punct	O

Mutation	NN	ROOT	O
of	IN	case	O
BCL-6	NN	compound	B-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
normal	JJ	amod	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
somatic	JJ	amod	O
hypermutation	NN	nmod	O
of	IN	case	O
Ig	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Immunoglobulin	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
Ig	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
genes	NNS	nsubjpass	I-DNA
are	VBP	auxpass	O
hypermutated	VBN	ROOT	O
in	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
that	WDT	nsubj	O
are	VBP	cop	O
the	DT	det	O
precursors	NNS	acl:relcl	O
to	TO	case	O
memory	NN	compound	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
mutations	NNS	nsubjpass	O
are	VBP	auxpass	O
linked	VBN	ROOT	O
to	TO	case	O
transcription	NN	compound	O
initiation	NN	nmod	O
,	,	punct	O
but	CC	cc	O
non-Ig	JJ	amod	B-DNA
promoters	NNS	nsubj	I-DNA
are	VBP	cop	O
permissible	JJ	conj	O
for	IN	case	O
the	DT	det	O
mutation	NN	compound	O
process	NN	nmod	O
;	:	punct	O
thus	RB	advmod	O
,	,	punct	O
other	JJ	amod	O
genes	NNS	nsubj	O
expressed	VBN	acl	O
in	IN	mark	O
mutating	VBG	advcl	O
B	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
may	MD	aux	O
also	RB	advmod	O
be	VB	cop	O
subject	JJ	parataxis	O
to	TO	case	O
somatic	JJ	amod	O
hypermutation	NN	nmod	O
.	.	punct	O

Significant	JJ	amod	O
mutations	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
observed	VBN	ROOT	O
in	IN	case	O
c-MYC	NN	nmod	B-DNA
,	,	punct	I-DNA
S14	NN	conj	I-DNA
,	,	punct	I-DNA
or	CC	cc	I-DNA
alpha-fetoprotein	JJ	compound	I-DNA
(	-LRB-	punct	I-DNA
AFP	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
genes	NNS	conj	I-DNA
,	,	punct	O
but	CC	cc	O
BCL-6	NN	nsubjpass	B-protein
was	VBD	auxpass	O
highly	RB	advmod	O
mutated	VBN	conj	O
in	IN	case	O
a	DT	det	O
large	JJ	amod	O
proportion	NN	nmod	O
of	IN	case	O
memory	NN	compound	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
normal	JJ	amod	O
individuals	NNS	nmod	O
.	.	punct	O

The	DT	det	O
mutation	NN	compound	O
pattern	NN	nsubj	O
was	VBD	cop	O
similar	JJ	ROOT	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
Ig	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

CD28-mediated	JJ	amod	O
activation	NN	ROOT	O
in	IN	case	O
CD45RA+	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
CD45RO+	JJ	conj	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
enhanced	VBN	amod	O
levels	NNS	dep	O
of	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
intermediates	NNS	nmod	O
and	CC	cc	O
c-Rel	NN	compound	O
nuclear	JJ	amod	O
translocation	NN	conj	O
in	IN	case	O
CD45RA+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
analyzed	VBN	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
complete	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
(	-LRB-	punct	O
anti-CD3	NN	dep	O
plus	CC	cc	O
anti-CD28	NN	conj	O
)	-RRB-	punct	O
on	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
CD45RA+	JJ	nmod	B-cell_type
(	-LRB-	punct	I-cell_type
naive	JJ	dep	I-cell_type
)	-RRB-	punct	I-cell_type
and	CC	cc	I-cell_type
CD45RO+	JJ	amod	I-cell_type
(	-LRB-	punct	I-cell_type
memory/effector	NN	dep	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Long	JJ	amod	O
exposure	NN	nsubj	O
(	-LRB-	punct	O
24	CD	nummod	O
h	NN	appos	O
)	-RRB-	punct	O
induced	VBD	ROOT	O
stronger	JJR	amod	O
NF-kappaB	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	dobj	O
in	IN	case	O
CD45RA+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
than	IN	case	O
in	IN	case	O
CD45RO+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
c-Rel	NN	compound	I-protein
protein	NN	nmod	I-protein
indicated	VBD	ROOT	O
that	IN	mark	O
after	IN	case	O
anti-CD3+anti-CD28	NN	amod	O
stimulation	NN	nmod	O
the	DT	det	O
level	NN	nsubj	O
of	IN	case	O
c-Rel	NN	nmod	B-protein
was	VBD	cop	O
higher	JJR	ccomp	O
in	IN	case	O
CD45RA+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	B-protein
inhibitor	NN	compound	I-protein
IkappaBalpha	NN	nmod	B-protein
indicated	VBD	ROOT	O
that	IN	mark	O
anti-CD3+anti-CD28	NN	amod	O
stimulation	NN	nsubj	O
induced	VBD	ccomp	O
a	DT	det	O
long-lasting	JJ	amod	O
degradation	NN	dobj	O
in	IN	case	O
CD45RA+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
in	IN	case	O
CD45RO+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
the	DT	det	O
degradation	NN	compound	O
process	NN	nsubj	O
was	VBD	cop	O
more	RBR	advmod	O
rapid	JJ	conj	O
.	.	punct	O

Because	IN	mark	O
the	DT	det	O
CD28	NN	compound	B-protein
costimulus	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	advcl	O
to	TO	mark	O
induce	VB	xcomp	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
intermediates	NNS	nmod	O
(	-LRB-	punct	O
ROIs	NNS	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
intracellular	JJ	amod	O
ROI	NN	compound	O
levels	NNS	nsubjpass	O
in	IN	case	O
CD45RA+	JJ	nmod	B-cell_type
and	CC	cc	I-cell_type
CD45RO+	JJ	conj	I-cell_type
cells	NNS	dep	I-cell_type
were	VBD	auxpass	O
compared	VBN	ROOT	O
by	IN	case	O
flow	NN	compound	O
cytometry	NN	nmod	O
.	.	punct	O

ROIs	NNS	nsubjpass	O
were	VBD	auxpass	O
produced	VBN	ROOT	O
in	IN	case	O
both	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
more	RBR	advmod	O
strongly	RB	advmod	O
in	IN	case	O
CD45RA+	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
presented	VBN	acl	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
further	RB	advmod	O
emphasize	VBP	ROOT	O
the	DT	det	O
differences	NNS	dobj	O
between	IN	case	O
CD45RA+	JJ	nmod	B-cell_type
and	CC	cc	I-cell_type
CD45RO+	JJ	conj	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	dep	I-cell_type
in	IN	case	O
ROI-dependent	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O

Non-Hodgkin	NNP	nmod:poss	O
's	POS	case	O
lymphoma	NN	nsubj	O
involving	VBG	acl	O
bilateral	JJ	amod	O
breasts	NNS	dobj	O
[	-LRB-	punct	O
see	VB	ROOT	O
comments	NNS	dobj	O
]	-RRB-	punct	O

We	PRP	nsubj	O
describe	VBP	ROOT	O
here	RB	advmod	O
two	CD	nummod	O
cases	NNS	dobj	O
of	IN	case	O
diffuse	JJ	amod	O
large	JJ	amod	O
cell	NN	compound	O
type	NN	compound	O
non-Hodgkin	JJ	nmod:poss	O
's	POS	case	O
lymphoma	NN	nmod	O
affecting	VBG	acl	O
the	DT	det	O
bilateral	JJ	amod	O
breasts	NNS	dobj	O
.	.	punct	O

The	DT	det	O
contralateral	JJ	amod	O
tumor	NN	nsubj	O
in	IN	case	O
one	CD	nummod	O
case	NN	nmod	O
appeared	VBD	ROOT	O
17	CD	nummod	O
months	NNS	dobj	O
after	IN	case	O
the	DT	det	O
first	JJ	amod	O
mastectomy	NN	pobj	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
bilateral	JJ	amod	O
tumors	NNS	nsubj	O
occurred	VBD	parataxis	O
concurrently	RB	advmod	O
in	IN	case	O
the	DT	det	O
other	JJ	amod	O
patient	NN	nmod	O
who	WP	nsubj	O
was	VBD	cop	O
pregnant	JJ	acl:relcl	O
and	CC	cc	O
showed	VBD	conj	O
widespread	JJ	amod	O
dissemination	NN	dobj	O
at	IN	case	O
initial	JJ	amod	O
presentation	NN	nmod	O
.	.	punct	O

Lymphoma	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
from	IN	case	O
both	DT	det	O
cases	NNS	nmod	O
showed	VBD	ROOT	O
the	DT	det	O
mature	JJ	amod	O
B-cell	NN	compound	O
immunophenotype	NN	dobj	O
and	CC	cc	O
had	VBD	conj	O
rearrangements	NNS	dobj	O
of	IN	case	O
the	DT	det	O
BCL6	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Both	DT	det	O
patients	NNS	nsubj	O
developed	VBD	ROOT	O
progressive	JJ	amod	O
disease	NN	dobj	O
despite	IN	case	O
chemo-radiotherapy	NN	nmod	O
and	CC	cc	O
died	VBD	conj	O
of	IN	case	O
leukemic	JJ	amod	O
manifestations	NNS	nmod	O
.	.	punct	O

There	EX	expl	O
were	VBD	ROOT	O
no	DT	neg	O
apparent	JJ	amod	O
pathological	JJ	amod	O
features	NNS	nsubj	O
of	IN	case	O
lymphomas	NNS	nmod	O
of	IN	case	O
mucosa-associated	JJ	amod	O
lymphoid	JJ	amod	O
tissue	NN	compound	O
origin	NN	nmod	O

Biochemical	JJ	amod	O
characterization	NN	ROOT	O
of	IN	case	O
MIP-1	NN	compound	B-protein
alpha	NN	compound	I-protein
nuclear	JJ	amod	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

A	DT	det	O
family	NN	nsubjpass	O
of	IN	case	O
hematopoietic	JJ	amod	B-protein
specific	JJ	amod	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
,	,	punct	O
MIP-1	NN	compound	B-protein
alpha	NN	compound	I-protein
nuclear	JJ	amod	I-protein
protein	NN	compound	I-protein
(	-LRB-	punct	I-protein
MNP	NN	compound	I-protein
)	-RRB-	punct	I-protein
family	NN	appos	I-protein
,	,	punct	O
has	VBZ	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
.	.	punct	O

They	PRP	nsubjpass	O
are	VBP	auxpass	O
intimately	RB	advmod	O
involved	VBN	ROOT	O
in	IN	mark	O
regulating	VBG	advcl	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
the	DT	det	O
huMIP-1	NN	compound	B-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
,	,	punct	O
T-cells	NNS	conj	B-cell_type
,	,	punct	O
and	CC	cc	O
transformed	VBN	amod	B-cell_type
B-cells	NNS	conj	I-cell_type
.	.	punct	O

One	CD	nummod	O
member	NN	nsubj	O
of	IN	case	O
the	DT	det	O
family	NN	nmod	O
(	-LRB-	punct	O
MNP-1	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
promoter	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
and	CC	cc	O
B-cells	NNS	conj	B-cell_type
,	,	punct	O
while	IN	mark	O
another	DT	nsubjpass	O
(	-LRB-	punct	O
MNP-2	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
required	VBN	advcl	O
for	IN	case	O
full	JJ	amod	O
promotor	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
T-cells	NNS	nmod	B-cell_type
.	.	punct	O

A	DT	det	O
third	JJ	amod	O
member	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
family	NN	nmod	O
(	-LRB-	punct	O
MNP-3	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
PMA	NN	nmod:npmod	B-cell_line
induced	VBD	amod	I-cell_line
HL60	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
probably	RB	advmod	O
has	VBZ	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
monocyte	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
communication	NN	nmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
by	IN	case	O
two	CD	nummod	O
techniques	NNS	nmod	O
that	IN	mark	O
MNP-1	NN	nsubj	B-protein
and	CC	cc	O
MNP-2	NN	conj	B-protein
are	VBP	cop	O
distinct	JJ	acl:relcl	O
but	CC	cc	O
related	JJ	conj	O
factors	NNS	dep	O
,	,	punct	O
and	CC	cc	O
we	PRP	nsubj	O
present	VBP	conj	O
further	JJ	amod	O
evidence	NN	dobj	O
to	TO	mark	O
show	VB	advcl	O
that	IN	mark	O
MNP-1	NN	nsubj	B-protein
acts	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
heterodimer	NN	nmod	B-protein
.	.	punct	O

Bcl-3	NN	compound	B-protein
expression	NN	nsubjpass	O
and	CC	cc	O
nuclear	JJ	amod	O
translocation	NN	conj	O
are	VBP	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
granulocyte-macrophage	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	nmod	I-protein
and	CC	cc	O
erythropoietin	NN	conj	B-protein
in	IN	case	O
proliferating	VBG	amod	B-cell_type
human	JJ	amod	I-cell_type
erythroid	JJ	amod	I-cell_type
precursors	NNS	nmod	I-cell_type
.	.	punct	O

Bcl-3	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
proto-oncogene	NN	ROOT	B-DNA
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
chromosomal	JJ	amod	O
translocation	NN	compound	O
t	NN	nmod	B-DNA
(	-LRB-	punct	I-DNA
14	CD	dep	I-DNA
;	:	punct	I-DNA
19	CD	dep	I-DNA
)	-RRB-	punct	I-DNA
found	VBN	acl	O
in	IN	case	O
some	DT	det	O
patients	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
lymphocytic	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
shares	VBZ	ROOT	O
structural	JJ	amod	O
similarities	NNS	dobj	O
with	IN	prep	O
and	CC	cc	O
is	VBZ	cop	O
a	DT	det	O
member	NN	conj	O
of	IN	case	O
the	DT	det	O
IkappaB	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	O
proteins	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
involvement	NN	nsubjpass	O
of	IN	case	O
Bcl-3	NN	nmod	B-protein
in	IN	case	O
hematopoietic	JJ	amod	O
growth	NN	nmod:npmod	O
factor-stimulated	JJ	intj	O
erythroid	JJ	amod	O
proliferation	NN	nmod	O
and	CC	cc	O
differentiation	NN	conj	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
TF-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
an	DT	det	O
erythroleukemia	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nsubj	I-cell_line
,	,	punct	O
granulocyte-macrophage	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	appos	I-protein
(	-LRB-	punct	O
GM-CSF	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
erythropoietin	NN	conj	B-protein
(	-LRB-	punct	O
Epo	NN	appos	B-protein
)	-RRB-	punct	O
greatly	RB	advmod	O
enhanced	VBD	ROOT	O
Bcl-3	NN	compound	B-protein
expression	NN	dobj	O
at	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
protein	NN	compound	O
and	CC	cc	O
mRNA	NN	conj	O
levels	NNS	nmod	O
in	IN	case	O
association	NN	nmod	O
with	IN	case	O
stimulation	NN	nmod	O
of	IN	case	O
proliferation	NN	nmod	O
.	.	punct	O

Bcl-3	NN	compound	B-protein
protein	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
highly	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
early	JJ	amod	B-cell_type
burst-forming	JJ	amod	I-cell_type
unit-erythroid	JJ	compound	I-cell_type
(	-LRB-	punct	I-cell_type
BFU-E	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
-derived	JJ	amod	I-cell_type
erythroid	JJ	amod	I-cell_type
precursors	NNS	nmod	I-cell_type
(	-LRB-	punct	O
day	NN	appos	O
7	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
decreased	VBD	conj	O
during	IN	case	O
maturation	NN	nmod	O
(	-LRB-	punct	O
days	NNS	dep	O
10	CD	nummod	O
and	CC	cc	O
14	CD	conj	O
)	-RRB-	punct	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
Bcl-3	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
normal	JJ	amod	O
erythroid	JJ	amod	O
proliferation	NN	nmod	O
.	.	punct	O

In	IN	case	O
these	DT	det	O
hematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
Bcl-3	NN	nsubjpass	B-protein
was	VBD	auxpass	O
hyperphosphorylated	VBN	ROOT	O
.	.	punct	O

GM-CSF	NN	nsubj	B-protein
and	CC	cc	O
Epo	NN	conj	B-protein
modulated	VBD	ROOT	O
the	DT	det	O
subcellular	JJ	amod	O
localization	NN	dobj	O
of	IN	case	O
Bcl-3	NN	nmod	B-protein
.	.	punct	O

Upon	IN	case	O
stimulation	NN	nmod	O
of	IN	case	O
TF-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
GM-CSF	NN	nmod	B-protein
or	CC	cc	O
Epo	NN	conj	B-protein
,	,	punct	O
the	DT	det	O
nuclear	JJ	amod	O
translocation	NN	nsubjpass	O
of	IN	case	O
Bcl-3	NN	nmod	B-protein
was	VBD	auxpass	O
dramatically	RB	advmod	O
enhanced	VBN	ROOT	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
Bcl-3	NN	nmod	B-protein
in	IN	case	O
TF-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
by	IN	case	O
transient	JJ	amod	O
transfection	NN	nmod	O
along	IN	case	O
with	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
factors	NNS	nmod	I-protein
p50	NN	dep	I-protein
or	CC	cc	I-protein
p52	NN	conj	I-protein
resulted	VBD	ROOT	O
in	IN	case	O
significant	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
an	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus-type	JJ	compound	I-DNA
1	CD	nummod	I-DNA
(	-LRB-	punct	I-DNA
HIV-1	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
kappaB-TATA-luceriferase	JJ	compound	I-DNA
reporter	NN	compound	I-DNA
plasmid	NN	nmod	I-DNA
,	,	punct	O
demonstrating	VBG	xcomp	O
that	IN	mark	O
Bcl-3	NN	nsubj	B-protein
has	VBZ	ccomp	O
a	DT	det	O
positive	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
transactivation	NN	nmod	O
of	IN	case	O
kappaB-containing	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
erythroid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Stimulation	NN	nsubj	O
with	IN	case	O
GM-CSF	NN	nmod	B-protein
enhanced	VBD	ROOT	O
c-myb	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	dobj	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

Bcl-3	NN	nsubj	B-protein
in	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
of	IN	case	O
TF-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
bound	VBD	ROOT	O
to	TO	case	O
a	DT	det	O
kappaB	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
c-myb	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
together	RB	advmod	O
with	IN	case	O
NF-kappaB2/p52	NN	nmod	B-protein
and	CC	cc	O
this	DT	det	O
binding	NN	compound	O
activity	NN	conj	O
was	VBD	auxpass	O
enhanced	VBN	conj	O
by	IN	case	O
GM-CSF	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
cotransfection	NN	nsubj	O
of	IN	case	O
Bcl-3	NN	nmod	B-protein
with	IN	case	O
p52	NN	nmod	B-protein
or	CC	cc	O
p50	NN	conj	B-protein
in	IN	case	O
TF-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
resulted	VBD	ROOT	O
in	IN	case	O
significant	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
a	DT	det	O
c-myb	NN	compound	B-DNA
kappaB-TATA-luceriferase	JJ	compound	I-DNA
reporter	NN	compound	I-DNA
plasmid	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
Bcl-3	NN	nsubj	B-protein
may	MD	aux	O
participate	VB	ccomp	O
in	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
certain	JJ	amod	O
kappaB-containing	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
involved	VBN	acl	O
in	IN	case	O
hematopoiesis	NN	nmod	O
,	,	punct	O
including	VBG	case	O
c-myb	NN	nmod	B-DNA
.	.	punct	O

Copyright	NN	ROOT	O
1998	CD	nummod	O
by	IN	prep	O
The	NNP	det	O
American	NNP	compound	O
Society	NNP	pobj	O
of	IN	prep	O
Hematology	NNP	pobj	O
.	.	punct	O

5-Lipoxygenase	JJ	compound	B-protein
compartmentalization	NN	nsubjpass	O
in	IN	case	O
granulocytic	JJ	amod	O
cells	NNS	nmod	O
is	VBZ	auxpass	O
modulated	VBN	ROOT	O
by	IN	case	O
an	DT	det	O
internal	JJ	amod	B-protein
bipartite	JJ	amod	I-protein
nuclear	JJ	amod	I-protein
localizing	VBG	compound	I-protein
sequence	NN	nmod	I-protein
and	CC	cc	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
complex	NN	compound	I-protein
formation	NN	conj	O
.	.	punct	O

A	DT	det	O
region	NN	nsubj	O
of	IN	case	O
basic	JJ	amod	O
amino	NN	compound	O
acids	NNS	nmod	O
spanning	VBG	acl	O
residues	NNS	dobj	B-protein
639-656	CD	nummod	I-protein
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
5-lipoxygenase	NN	compound	I-protein
sequence	NN	nmod	I-protein
resembles	VBZ	ROOT	O
a	DT	det	O
consensus	NN	compound	B-protein
bipartite	JJ	amod	I-protein
nuclear	JJ	amod	I-protein
localizing	VBG	compound	I-protein
sequence	NN	dobj	I-protein
.	.	punct	O

A	DT	det	O
synthetic	JJ	amod	O
peptide	NN	nsubj	O
consisting	VBG	acl	O
of	IN	case	O
the	DT	det	O
Kaposi	NN	compound	B-protein
fibroblast	NN	compound	I-protein
growth	NN	compound	I-protein
factor	NN	compound	I-protein
signal	NN	compound	I-protein
sequence	NN	nmod	I-protein
fused	VBN	acl	O
to	TO	case	O
the	DT	det	O
5-lipoxygenase639-656	NN	amod	B-protein
bipartite	JJ	amod	I-protein
nuclear	JJ	amod	I-protein
localizing	NN	compound	I-protein
sequence	NN	nmod	I-protein
has	VBZ	ROOT	O
a	DT	det	O
prominent	JJ	amod	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
5-lipoxygenase	JJ	amod	B-protein
catalysis	NN	nmod	O
in	IN	case	O
granulocytic	JJ	amod	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
activated	VBN	acl	O
by	IN	case	O
calcium	NN	compound	O
ionophor	NN	compound	O
A23187	NN	nmod	O
.	.	punct	O

Recombinant	JJ	amod	O
5-lipoxygenase	NN	nsubjpass	B-protein
was	VBD	auxpass	O
not	RB	neg	O
affected	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
peptide	NN	nmod	O
.	.	punct	O

The	DT	det	O
peptide	NN	nsubj	O
also	RB	advmod	O
inhibited	VBD	ROOT	O
redistribution	NN	dobj	O
of	IN	case	O
5-lipoxygenase	NN	nmod	B-protein
from	IN	case	O
the	DT	det	O
cytosol	NN	nmod	O
to	TO	case	O
the	DT	det	O
nuclear	JJ	amod	O
membrane	NN	nmod	O
of	IN	case	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
stimulated	VBN	acl	O
by	IN	case	O
A23187	NN	nmod	O
.	.	punct	O

5-Lipoxygenase	JJ	compound	B-protein
protein	NN	nsubjpass	I-protein
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappaB	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF-kappaB	NN	compound	I-protein
)	-RRB-	punct	I-protein
p65	NN	compound	I-protein
subunit	NN	compound	I-protein
immunoprecipitate	VBP	amod	O
fractions	NNS	dobj	O
prepared	VBN	acl	O
from	IN	case	O
HL-60	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lysates	NNS	nmod	O
.	.	punct	O

The	DT	det	O
amount	NN	nsubjpass	O
of	IN	case	O
5-lipoxygenase	JJ	compound	B-protein
protein	NN	nmod	I-protein
coimmunoprecipitated	VBN	acl	O
by	IN	case	O
NF-kappaB	NN	compound	O
antiserum	NN	nmod	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
following	VBG	case	O
A23187	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

In	IN	case	O
cells	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
agents	NNS	nmod	O
that	WDT	nsubj	O
block	VBP	acl:relcl	O
5-lipoxygenase	NN	compound	B-protein
translocation	NN	dobj	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
,	,	punct	O
5-lipoxygenase	NN	compound	B-protein
protein	NN	nsubjpass	O
appearing	VBG	acl	O
in	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
immunoprecipitate	NN	nmod	O
was	VBD	auxpass	O
diminished	VBN	ROOT	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
implicate	VBP	ROOT	O
an	DT	det	O
internal	JJ	amod	B-protein
bipartite	JJ	amod	I-protein
nuclear	JJ	amod	I-protein
localizing	VBG	compound	I-protein
sequence	NN	dobj	I-protein
as	IN	case	O
a	DT	det	O
regulatory	JJ	amod	O
domain	NN	nmod	O
that	WDT	nsubj	O
modulates	VBZ	acl:relcl	O
5-lipoxygenase	NN	compound	B-protein
redistribution	NN	dobj	O
and	CC	cc	O
catalysis	NN	conj	O
in	IN	case	O
granulocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
molecular	JJ	amod	O
determinants	NNS	nsubjpass	O
which	WDT	nsubj	O
govern	VBP	acl:relcl	O
5-lipoxygenase	NN	dobj	O
and	CC	cc	O
NF-kappaB	NN	conj	O
redistribution	NN	dobj	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
coordinately	RB	advmod	O
controlled	VBN	ccomp	O
in	IN	case	O
granulocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Copyright	NN	dep	O
1998	CD	ROOT	O
Academic	NNP	compound	O
Press	NNP	dep	O
.	.	punct	O

Inhibition	NN	ROOT	O
of	IN	case	O
CD28/CD3-mediated	JJ	amod	O
costimulation	NN	nmod	O
of	IN	case	O
naive	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
memory	NN	conj	I-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
by	IN	case	O
intracellular	JJ	amod	O
incorporation	NN	nmod	O
of	IN	case	O
polyclonal	JJ	amod	B-protein
antibodies	NNS	nmod	I-protein
specific	JJ	amod	O
for	IN	case	O
the	DT	det	O
activator	NN	compound	B-protein
protein-1	NN	compound	I-protein
transcriptional	JJ	amod	I-protein
complex	NN	nmod	I-protein
.	.	punct	O

A	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
indirect	JJ	amod	O
methods	NNS	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
utilized	VBN	ROOT	O
in	IN	mark	O
demonstrating	VBG	advcl	O
activator	NN	compound	B-protein
protein-1	NN	compound	I-protein
transcription	NN	compound	O
factor	NN	compound	O
function	NN	dobj	O
in	IN	case	O
IL-2	NN	compound	O
promoter	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
there	EX	expl	O
has	VBZ	aux	O
been	VBN	ROOT	O
no	DT	neg	O
direct	JJ	amod	O
demonstration	NN	attr	O
that	IN	mark	O
activator	NN	compound	B-protein
protein-1	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
CD28-dependent	JJ	amod	O
costimulation	NN	nmod	O
of	IN	case	O
IL-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	nmod	O
in	IN	case	O
freshly	RB	advmod	O
isolated	VBN	amod	O
naive	JJ	dep	B-cell_type
and	CC	cc	I-cell_type
memory	NN	conj	I-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

To	TO	aux	O
address	VB	advcl	O
this	DT	det	O
issue	NN	dobj	O
,	,	punct	O
the	DT	det	O
method	NN	nsubjpass	O
of	IN	prep	O
scrape	NN	compound	O
loading	NN	pobj	O
was	VBD	auxpass	O
applied	VBN	ROOT	O
to	TO	case	O
purified	VBN	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Since	IN	mark	O
scrape	NN	compound	O
loading	NN	nsubj	O
relies	VBZ	advcl	O
on	IN	case	O
adherent	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
PB-T	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
immobilized	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
nonspecific	JJ	amod	O
cell	NN	compound	O
attachment	NN	compound	O
factor	NN	compound	O
poly-L-lysine	NN	nmod	O
.	.	punct	O

Cells	NNS	nsubj	O
scraped	VBD	ROOT	O
off	RP	advmod	O
poly-L-lysine	NN	dobj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
Ig	NN	compound	B-protein
FITC	NN	nmod	I-protein
efficiently	RB	advmod	O
incorporated	VBD	advcl	O
Ig	NN	dobj	O
,	,	punct	O
with	IN	prep	O
relatively	RB	advmod	O
uniform	NN	amod	O
fluorescence	NN	pobj	O
.	.	punct	O

T	NN	compound	O
cells	NNS	nsubj	O
retained	VBD	ROOT	O
their	PRP$	nmod:poss	O
physical	JJ	amod	O
parameters	NNS	dobj	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
forward	RB	amod	O
and	CC	cc	O
side	NN	conj	O
light	JJ	amod	O
scatter	NN	nmod	O
,	,	punct	O
and	CC	cc	O
functional	JJ	amod	O
activity	NN	conj	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
costimulation	NN	nmod	O
of	IN	case	O
proliferation	NN	nmod	O
and	CC	cc	O
IL-2	NN	compound	B-protein
production	NN	conj	O
after	IN	mark	O
being	VBG	auxpass	O
scraped	VBN	advcl	O
off	RP	case	O
this	DT	det	O
substrate	NN	nmod	O
.	.	punct	O

CD28/CD3-costimulated	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
produced	VBD	ROOT	O
intracellular	JJ	amod	O
IL-2	NN	dobj	B-protein
from	IN	case	O
all	DT	det	O
subsets	NNS	nmod	O
measured	VBN	xcomp	O
(	-LRB-	punct	O
CD4+	JJ	dep	B-cell_type
,	,	punct	O
CD4-	JJ	conj	B-cell_type
,	,	punct	O
CD45RO+	JJ	conj	B-cell_type
,	,	punct	O
and	CC	cc	O
CD45RO-	NN	conj	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

IL-2	NN	compound	B-protein
production	NN	nsubjpass	O
and	CC	cc	O
intracellular	JJ	amod	O
accumulation	NN	conj	O
in	IN	case	O
nonscraped	JJ	amod	O
PB-T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
activated	VBN	acl	O
with	IN	case	O
CD28/CD3	NN	compound	O
coligation	NN	nmod	O
were	VBD	auxpass	O
skewed	JJ	ROOT	O
favoring	VBG	xcomp	O
CD45RO+	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
CD4+	JJ	conj	I-cell_type
subsets	NNS	dobj	I-cell_type
,	,	punct	O
as	IN	mark	O
was	VBD	cop	O
IL-2	NN	compound	B-protein
production	NN	advcl	O
in	IN	case	O
scraped	JJ	amod	O
PB-T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
intracellular	JJ	amod	O
incorporation	NN	nsubj	O
of	IN	case	O
Abs	NN	nmod	O
specific	JJ	amod	O
for	IN	case	O
c-Fos	NN	compound	B-protein
and	CC	cc	I-protein
c-Jun	NN	conj	I-protein
family	NN	compound	I-protein
members	NNS	nmod	I-protein
by	IN	case	O
scrape	NN	compound	O
loading	NN	nmod	O
inhibited	VBD	ROOT	O
the	DT	det	O
production	NN	dobj	O
and	CC	cc	O
intracellular	JJ	amod	O
accumulation	NN	conj	O
of	IN	case	O
IL-2	NN	nmod	B-protein
within	IN	case	O
6	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
costimulation	NN	nmod	O
with	IN	case	O
PMA/ionomycin	NN	nmod	O
,	,	punct	O
or	CC	cc	O
costimulation	NN	conj	O
by	IN	case	O
CD28	NN	compound	O
and	CC	cc	O
CD3	NN	conj	O
ligation	NN	nmod	O
.	.	punct	O

Scrape	NN	compound	O
loading	VBG	nsubj	O
thus	RB	advmod	O
provides	VBZ	ROOT	O
an	DT	det	O
efficient	JJ	amod	O
mechanism	NN	dobj	O
for	IN	case	O
intracellular	JJ	amod	O
incorporation	NN	nmod	O
of	IN	case	O
macromolecules	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
first	JJ	amod	O
direct	JJ	amod	O
evidence	NN	conj	O
that	IN	mark	O
c-Fos	NN	nsubjpass	B-protein
and	CC	cc	O
c-Jun	NN	conj	B-protein
are	VBP	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
within	IN	case	O
its	PRP$	nmod:poss	O
correct	JJ	amod	O
chromosomal	JJ	amod	O
context	NN	nmod	O
,	,	punct	O
in	IN	case	O
resting	VBG	amod	O
human	JJ	amod	O
T	NN	compound	O
lymphocyte	NN	compound	O
subpopulations	NNS	nmod	O
.	.	punct	O

Differential	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
Nur77	NN	compound	B-protein
family	NN	compound	I-protein
members	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
T-lymphotropic	JJ	amod	I-cell_type
virus	NN	compound	I-cell_type
type	NN	compound	I-cell_type
1-infected	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
transactivation	NN	dep	O
of	IN	case	O
the	DT	det	O
TR3/nur77	JJ	compound	B-DNA
gene	NN	nmod	I-DNA
by	IN	case	O
Tax	NN	compound	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
differential	JJ	amod	O
expression	NN	dobj	O
and	CC	cc	O
regulation	NN	conj	O
of	IN	case	O
three	CD	nummod	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
Nur77	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
family	NN	nmod	I-protein
by	IN	case	O
the	DT	det	O
human	JJ	amod	O
T-lymphotropic	JJ	amod	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HTLV-1	NN	compound	O
)	-RRB-	punct	O
Tax	NN	compound	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
in	IN	case	O
both	CC	cc:preconj	O
HTLV-1-infected	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
Tax-expressing	JJ	amod	B-cell_line
JPX-9	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
TR3/nur77	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
highly	RB	advmod	O
expressed	VBN	ccomp	O
,	,	punct	O
whereas	IN	mark	O
neither	CC	cc:preconj	O
NOR-1	NN	nsubj	O
nor	CC	cc	O
NOT	NN	conj	O
expression	NN	dep	O
is	VBZ	cop	O
detectable	JJ	advcl	O
.	.	punct	O

Transient	JJ	amod	O
transfection	NN	compound	O
analysis	NN	nsubj	O
further	RB	advmod	O
confirmed	VBD	ROOT	O
the	DT	det	O
Tax	NN	compound	B-protein
transactivation	NN	dobj	O
of	IN	case	O
the	DT	det	O
TR3/nur77	JJ	compound	B-protein
promoter	NN	nmod	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
NOR-1	NN	compound	B-DNA
promoter	NN	conj	I-DNA
in	IN	case	O
different	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
a	DT	det	O
luciferase	NN	compound	B-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
driven	VBN	acl	O
by	IN	case	O
the	DT	det	O
NGFI-B	NN	nmod	B-DNA
(	-LRB-	punct	I-DNA
rat	NN	compound	I-DNA
homolog	NN	dep	I-DNA
of	IN	case	I-DNA
TR3/Nur77	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
response	NN	compound	I-DNA
element	NN	nmod	I-DNA
(	-LRB-	punct	O
NBRE	NN	appos	B-DNA
)	-RRB-	punct	O
provided	VBD	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
Tax	NN	compound	B-protein
-mediated	JJ	amod	O
transactivation	NN	nsubj	O
resulted	VBD	ccomp	O
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
a	DT	det	O
functional	JJ	amod	O
protein	NN	nmod	O
.	.	punct	O

Cotransfection	NN	compound	O
assays	NNS	nsubj	O
with	IN	case	O
the	DT	det	O
TR3/nur77	JJ	compound	B-DNA
promoter	NN	compound	I-DNA
sequence	NN	nmod	I-DNA
or	CC	cc	O
the	DT	det	O
NBRE	NN	compound	B-DNA
binding	NN	compound	O
motif	NN	conj	O
together	RB	advmod	O
with	IN	case	O
a	DT	det	O
series	NN	nmod	O
of	IN	case	O
Tax	NN	compound	B-protein
mutants	NNS	nmod	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
Tax	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
TR3/nur77	JJ	compound	B-protein
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
CREB/ATF-related	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Negative	JJ	amod	O
regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
heat	NN	compound	O
shock	NN	compound	O
transcriptional	JJ	amod	O
response	NN	nmod	O
by	IN	case	O
HSBP1	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
response	NN	dep	O
to	TO	case	O
stress	NN	nmod	O
,	,	punct	O
heat	NN	compound	B-protein
shock	NN	compound	I-protein
factor	NN	nsubj	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
HSF1	NN	appos	B-protein
)	-RRB-	punct	O
acquires	VBZ	ROOT	O
rapid	JJ	amod	O
DNA	NN	compound	O
binding	NN	dobj	O
and	CC	cc	O
transient	JJ	amod	O
transcriptional	JJ	amod	O
activity	NN	conj	O
while	IN	mark	O
undergoing	VBG	advcl	O
conformational	JJ	amod	O
transition	NN	dobj	O
from	IN	case	O
an	DT	det	O
inert	JJ	amod	O
non-DNA-binding	JJ	amod	B-protein
monomer	NN	nmod	I-protein
to	TO	case	O
active	JJ	amod	O
functional	JJ	amod	O
trimers	NNS	nmod	O
.	.	punct	O

Attenuation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
inducible	JJ	amod	O
transcriptional	JJ	amod	O
response	NN	nmod	O
occurs	VBZ	ROOT	O
during	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
or	CC	cc	O
upon	IN	case	O
recovery	NN	conj	O
at	IN	case	O
non-stress	JJ	amod	O
conditions	NNS	nmod	O
and	CC	cc	O
involves	VBZ	conj	O
dissociation	NN	dobj	O
of	IN	case	O
the	DT	det	O
HSF1	NN	compound	B-protein
trimer	NN	nmod	I-protein
and	CC	cc	O
loss	NN	conj	O
of	IN	case	O
activity	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
the	DT	det	O
hydrophobic	JJ	amod	B-protein
repeats	NNS	dobj	I-protein
of	IN	case	O
the	DT	det	O
HSF1	NN	compound	B-protein
trimerization	NN	compound	O
domain	NN	nmod	O
in	IN	case	O
the	DT	det	O
yeast	NN	compound	O
two-hybrid	JJ	amod	O
protein	NN	compound	O
interaction	NN	compound	O
assay	NN	nmod	O
to	TO	mark	O
identify	VB	advcl	O
heat	NN	compound	B-protein
shock	NN	compound	I-protein
factor	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	dobj	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
HSBP1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
novel	JJ	amod	O
,	,	punct	O
conserved	VBN	dep	O
,	,	punct	O
76-amino-acid	JJ	dep	B-protein
protein	NN	appos	I-protein
that	WDT	nsubj	O
contains	VBZ	acl:relcl	O
two	CD	nummod	O
extended	VBN	amod	O
arrays	NNS	dobj	O
of	IN	case	O
hydrophobic	JJ	amod	B-protein
repeats	NNS	nmod	I-protein
that	WDT	nsubj	O
interact	VBP	acl:relcl	O
with	IN	case	O
the	DT	det	O
HSF1	NN	compound	B-protein
heptad	NN	amod	I-protein
repeats	NNS	nmod	I-protein
.	.	punct	O

HSBP1	NN	nsubj	B-protein
is	VBZ	cop	O
nuclear-localized	JJ	ROOT	O
and	CC	cc	O
interacts	VBZ	conj	O
in	FW	compound	O
vivo	FW	advmod	O
with	IN	case	O
the	DT	det	O
active	JJ	amod	O
trimeric	JJ	amod	O
state	NN	nmod	O
of	IN	case	O
HSF1	NN	nmod	B-protein
that	WDT	nsubj	O
appears	VBZ	acl:relcl	O
during	IN	case	O
heat	NN	compound	O
shock	NN	nmod	O
.	.	punct	O

During	IN	case	O
attenuation	NN	nmod	O
of	IN	case	O
HSF1	NN	nmod	B-protein
to	TO	case	O
the	DT	det	O
inert	JJ	amod	O
monomer	NN	nmod	O
,	,	punct	O
HSBP1	NN	nsubj	B-protein
associates	VBZ	ROOT	O
with	IN	case	O
Hsp70	NN	nmod	O
.	.	punct	O

HSBP1	NN	nsubj	B-protein
negatively	RB	advmod	O
affects	VBZ	ROOT	O
HSF1	NN	compound	B-protein
DNA-binding	JJ	amod	O
activity	NN	dobj	O
,	,	punct	O
and	CC	cc	O
overexpression	NN	nsubj	O
of	IN	case	O
HSBP1	NN	nmod	B-protein
in	IN	case	O
mammalian	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
represses	VBZ	conj	O
the	DT	det	O
transactivation	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
HSF1	NN	nmod	B-protein
.	.	punct	O

To	TO	mark	O
establish	VB	advcl	O
a	DT	det	O
biological	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
HSBP1	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
homologous	JJ	amod	O
Caenorhabditis	NN	compound	B-protein
elegans	NN	compound	I-protein
protein	NN	nsubjpass	I-protein
was	VBD	auxpass	O
overexpressed	VBN	ROOT	O
in	IN	case	O
body	NN	compound	B-cell_type
wall	NN	compound	I-cell_type
muscle	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
was	VBD	auxpass	O
shown	VBN	conj	O
to	TO	mark	O
block	VB	xcomp	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
heat	NN	compound	O
shock	NN	compound	O
response	NN	nmod	O
from	IN	case	O
a	DT	det	O
heat	NN	compound	B-DNA
shock	NN	compound	I-DNA
promoter-reporter	JJ	amod	I-DNA
construct	NN	nmod	I-DNA
.	.	punct	O

Alteration	NN	nsubj	O
in	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
HSBP1	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
C.	FW	compound	O
elegans	FW	nmod	O
has	VBZ	ROOT	O
severe	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
survival	NN	nmod	O
of	IN	case	O
the	DT	det	O
animals	NNS	nmod	O
after	IN	case	O
thermal	JJ	amod	O
and	CC	cc	O
chemical	JJ	conj	O
stress	NN	nmod	O
,	,	punct	O
consistent	JJ	advcl	O
with	IN	case	O
a	DT	det	O
role	NN	nmod	O
for	IN	case	O
HSBP1	NN	nmod	B-protein
as	IN	case	O
a	DT	det	O
negative	JJ	amod	O
regulator	NN	nmod	O
of	IN	case	O
the	DT	det	O
heat	NN	compound	O
shock	NN	compound	O
response	NN	nmod	O
.	.	punct	O

Long-range	JJ	amod	O
transcriptional	JJ	amod	O
regulation	NN	ROOT	O
of	IN	case	O
cytokine	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Most	JJS	amod	O
studies	NNS	nsubj	O
on	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
have	VBP	aux	O
involved	VBN	ROOT	O
the	DT	det	O
functional	JJ	amod	O
analysis	NN	dobj	O
of	IN	case	O
proximal	JJ	amod	B-DNA
promoters	NNS	nmod	I-DNA
.	.	punct	O

Recent	JJ	amod	O
work	NN	nsubj	O
has	VBZ	aux	O
identified	VBN	ROOT	O
distal	JJ	amod	B-DNA
elements	NNS	dobj	I-DNA
that	WDT	nsubj	O
mediate	VBP	acl:relcl	O
long-range	JJ	amod	O
cytokine	NN	compound	O
gene	NN	compound	O
regulation	NN	dobj	O
and	CC	cc	O
has	VBZ	aux	O
implicated	VBN	conj	O
chromatin	NN	compound	O
reorganization	NN	dobj	O
in	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	B-DNA
gene	NN	compound	I-DNA
loci	NNS	nmod	I-DNA
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
have	VBP	aux	O
begun	VBN	ROOT	O
to	TO	mark	O
elucidate	VB	xcomp	O
the	DT	det	O
basis	NN	dobj	O
for	IN	case	O
cell-specificity	JJ	amod	O
and	CC	cc	O
high-level	JJ	conj	O
expression	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

A	DT	det	O
signaling	NN	compound	O
complex	NN	nsubj	O
of	IN	case	O
Ca2+-calmodulin-dependent	NN	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
IV	CD	nummod	I-protein
and	CC	cc	O
protein	NN	compound	B-protein
phosphatase	NN	compound	I-protein
2A	NN	conj	I-protein
[	-LRB-	punct	O
see	VB	ROOT	O
comments	NNS	dobj	O
]	-RRB-	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
results	VBZ	ROOT	O
in	IN	case	O
a	DT	det	O
rapid	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
intracellular	JJ	amod	O
calcium	NN	compound	O
concentration	NN	nmod	O
(	-LRB-	punct	O
[	-LRB-	punct	O
Ca2+	NN	dep	O
]	-RRB-	punct	O
i	LS	appos	O
)	-RRB-	punct	O
that	WDT	nsubj	O
parallels	VBZ	acl:relcl	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
Ca2+-calmodulin-dependent	NN	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
IV	CD	nummod	I-protein
(	-LRB-	punct	O
CaMKIV	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
nuclear	JJ	amod	B-protein
enzyme	NN	appos	I-protein
that	WDT	nsubj	O
can	MD	aux	O
phosphorylate	VB	acl:relcl	O
and	CC	cc	O
activate	VBP	conj	O
the	DT	det	O
cyclic	JJ	amod	B-protein
adenosine	NN	compound	I-protein
monophosphate	NN	compound	I-protein
(	-LRB-	punct	I-protein
cAMP	NN	compound	I-protein
)	-RRB-	punct	I-protein
response	NN	compound	I-protein
element-binding	JJ	amod	I-protein
protein	NN	dobj	I-protein
(	-LRB-	punct	O
CREB	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
inactivation	NN	nsubj	O
of	IN	case	O
CaMKIV	NNP	nmod	B-protein
occurs	VBZ	ROOT	O
despite	IN	case	O
the	DT	det	O
sustained	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
[	-LRB-	punct	O
Ca2+	NN	nmod	O
]	-RRB-	punct	O
i	NN	dep	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	acl:relcl	O
for	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

A	DT	det	O
stable	JJ	amod	O
and	CC	cc	O
stoichiometric	JJ	conj	O
complex	NN	nsubjpass	O
of	IN	case	O
CaMKIV	NN	nmod	B-protein
with	IN	case	O
protein	NN	compound	B-protein
serine-threonine	NN	compound	I-protein
phosphatase	NN	compound	I-protein
2A	NN	nmod	I-protein
(	-LRB-	punct	O
PP2A	NN	appos	B-protein
)	-RRB-	punct	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
which	WDT	nmod	O
PP2A	NN	nsubj	B-protein
dephosphorylates	VBZ	ccomp	O
CaMKIV	NN	dobj	B-protein
and	CC	cc	O
functions	VBZ	conj	O
as	IN	case	O
a	DT	det	O
negative	JJ	amod	O
regulator	NN	nmod	O
of	IN	case	O
CaMKIV	NN	compound	B-protein
signaling	NN	nmod	O
.	.	punct	O

In	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
PP2A	NN	compound	B-protein
activity	NN	nmod	O
by	IN	case	O
small	JJ	amod	O
t	NN	compound	O
antigen	NN	nmod	O
enhanced	VBD	ROOT	O
activation	NN	dobj	O
of	IN	case	O
CREB	NN	compound	B-protein
-mediated	JJ	amod	O
transcription	NN	nmod	O
by	IN	case	O
CaMKIV	NNP	nmod	B-protein
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
reveal	VBP	ROOT	O
an	DT	det	O
intracellular	JJ	amod	O
signaling	NN	compound	O
mechanism	NN	dobj	O
whereby	WRB	advmod	O
a	DT	det	O
protein	NN	compound	B-protein
serine-threonine	NN	compound	I-protein
kinase	NN	nsubjpass	I-protein
(	-LRB-	punct	O
CaMKIV	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
regulated	VBN	acl:relcl	O
by	IN	case	O
a	DT	det	O
tightly	RB	advmod	O
associated	VBN	amod	O
protein	NN	compound	B-protein
serine-threonine	NN	compound	I-protein
phosphatase	NN	nmod	I-protein
(	-LRB-	punct	O
PP2A	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Hypoxia	NN	nsubj	O
down-regulates	VBZ	ROOT	O
MCP-1	NN	compound	B-protein
expression	NN	dobj	O
:	:	punct	O
implications	NNS	dep	O
for	IN	case	O
macrophage	NN	compound	O
distribution	NN	nmod	O
in	IN	case	O
tumors	NNS	nmod	O
.	.	punct	O

Monocyte	NN	compound	B-protein
chemoattractant	NN	compound	I-protein
protein	NN	nsubj	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
MCP-1	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
likely	JJ	ROOT	O
to	TO	mark	O
contribute	VB	xcomp	O
to	TO	case	O
the	DT	det	O
macrophage	NN	compound	B-cell_type
infiltrate	NN	nmod	I-cell_type
in	IN	case	O
human	JJ	amod	O
ovarian	JJ	amod	O
carcinomas	NNS	nmod	O
.	.	punct	O

Although	IN	mark	O
MCP-1	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
predominantly	RB	advmod	O
expressed	VBN	advcl	O
by	IN	case	O
the	DT	det	O
tumor	NN	compound	O
parenchyma	NN	nmod	O
,	,	punct	O
macrophages	NNS	nsubj	O
accumulate	VBP	ROOT	O
at	IN	case	O
highest	JJS	amod	O
density	NN	nmod	O
in	IN	case	O
necrotic	JJ	amod	O
regions	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	acl:relcl	O
with	IN	case	O
low	JJ	amod	O
oxygen	NN	compound	O
tensions	NNS	nmod	O
.	.	punct	O

Tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	nsubj	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
can	MD	aux	O
stimulate	VB	ROOT	O
MCP-1	NN	compound	B-protein
production	NN	dobj	O
and	CC	cc	O
is	VBZ	cop	O
also	RB	advmod	O
present	JJ	conj	O
within	IN	case	O
ovarian	JJ	amod	O
carcinomas	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
hypoxia	NN	nmod	O
both	CC	cc:preconj	O
on	IN	case	O
MCP-1	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
ovarian	JJ	amod	B-cell_line
cancer	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
and	CC	cc	O
monocyte	NN	compound	O
migration	NN	conj	O
.	.	punct	O

Hypoxia	NN	nsubj	O
down-regulated	VBD	ROOT	O
TNF-alpha-induced	JJ	amod	B-RNA
MCP-1	NN	compound	I-RNA
mRNA	NN	dobj	I-RNA
and	CC	cc	O
protein	NN	compound	O
production	NN	conj	O
by	IN	case	O
ovarian	JJ	amod	B-cell_type
cancer	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
was	VBD	auxpass	O
mimicked	VBN	ROOT	O
by	IN	case	O
cobalt	NN	compound	O
chloride	NN	nmod	O
and	CC	cc	O
desferrioxamine	NN	conj	O
,	,	punct	O
consistent	JJ	advcl	O
with	IN	case	O
a	DT	det	O
specific	JJ	amod	O
oxygen-sensing	JJ	amod	O
mechanism	NN	nmod	O
.	.	punct	O

Unlike	IN	case	O
antioxidants	NNS	nmod	O
,	,	punct	O
hypoxia	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
inhibit	VB	ROOT	O
nuclear	JJ	amod	O
factor	NN	compound	O
KB	NN	compound	O
mobilization	NN	dobj	O
.	.	punct	O

Monocyte	NN	compound	O
migration	NN	nsubjpass	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
MCP-1	NN	nmod	B-protein
was	VBD	auxpass	O
also	RB	advmod	O
diminished	VBN	ROOT	O
under	IN	case	O
hypoxic	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O

Down-regulation	NN	nsubj	O
of	IN	case	O
MCP-1	NN	compound	B-protein
expression	NN	nmod	O
and	CC	cc	O
the	DT	det	O
inhibition	NN	conj	O
of	IN	case	O
monocyte	NN	compound	O
migration	NN	nmod	O
are	VBP	cop	O
independent	JJ	amod	O
effects	NNS	ROOT	O
of	IN	case	O
hypoxia	NN	nmod	O
that	WDT	nsubj	O
may	MD	aux	O
contribute	VB	acl:relcl	O
to	TO	case	O
the	DT	det	O
distribution	NN	nmod	O
of	IN	case	O
macrophages	NNS	nmod	B-cell_type
within	IN	case	O
ovarian	JJ	amod	O
tumors	NNS	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
inflammatory	JJ	amod	O
bowel	NN	compound	O
disease	NN	nmod	O
[	-LRB-	punct	O
see	VB	ROOT	O
comments	NNS	dobj	O
]	-RRB-	punct	O

BACKGROUND	NN	dep	O
:	:	punct	O
Expression	NN	nsubjpass	O
of	IN	case	O
pro-inflammatory	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
is	VBZ	auxpass	O
increased	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
intestinal	JJ	amod	O
lamina	NN	compound	O
propria	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
inflammatory	JJ	amod	O
bowel	NN	compound	O
disease	NN	nmod	O
(	-LRB-	punct	O
IBD	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	nsubj	I-protein
(	-LRB-	punct	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
controls	VBZ	ROOT	O
transcription	NN	dobj	O
of	IN	case	O
inflammation	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

On	IN	case	O
activation	NN	nmod	O
,	,	punct	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
rapidly	RB	advmod	O
released	VBN	ROOT	O
from	IN	case	O
its	PRP$	nmod:poss	O
cytoplasmic	JJ	amod	B-protein
inhibitor	NN	nmod	I-protein
(	-LRB-	punct	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
,	,	punct	O
transmigrates	NNS	conj	O
into	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
,	,	punct	O
and	CC	cc	O
binds	VBZ	conj	O
to	TO	case	O
DNA	NN	compound	B-DNA
response	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
in	IN	case	O
gene	NN	compound	O
promoter	NN	compound	O
regions	NNS	nmod	O
.	.	punct	O

AIMS	NNS	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
whether	IN	mark	O
increased	VBN	amod	O
activation	NN	nsubj	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
is	VBZ	cop	O
important	JJ	ccomp	O
in	IN	case	O
IBD	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
be	VB	auxpass	O
down-regulated	VBN	conj	O
by	IN	case	O
anti-inflammatory	JJ	amod	O
treatment	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Activation	NN	nsubjpass	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
was	VBD	auxpass	O
determined	VBN	dep	O
by	IN	case	O
western	NN	compound	O
blot	NN	compound	O
assessment	NN	nmod	O
and	CC	cc	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	conj	O
in	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
of	IN	case	O
colonic	JJ	amod	O
biopsy	NN	compound	O
samples	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
lamina	NN	compound	B-cell_type
propria	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Nuclear	JJ	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
p65	NN	nmod	B-protein
are	VBP	auxpass	O
increased	VBN	appos	O
in	IN	case	O
lamina	NN	compound	O
propria	NN	compound	O
biopsy	NN	compound	O
specimens	NNS	nmod	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
Crohn	NN	nmod:poss	O
's	POS	case	O
disease	NN	nmod	O
in	IN	case	O
comparison	NN	nmod	O
with	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
ulcerative	JJ	amod	O
colitis	NN	nmod	O
and	CC	cc	O
controls	NNS	conj	O
.	.	punct	O

Increased	VBN	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
lamina	NN	compound	B-cell_type
propria	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
active	JJ	amod	O
IBD	NN	nmod	O
.	.	punct	O

Corticosteroids	NNS	nsubj	O
strongly	RB	advmod	O
inhibit	VBP	ROOT	O
intestinal	JJ	amod	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
activation	NN	dobj	O
in	IN	case	O
IBD	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vitro	FW	advmod	O
by	IN	mark	O
stabilising	VBG	advcl	O
the	DT	det	O
cytosolic	JJ	amod	B-protein
inhibitor	NN	compound	I-protein
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	dobj	O
against	IN	case	O
activation	NN	nmod	O
induced	JJ	amod	O
degradation	NN	dobj	O
.	.	punct	O

CONCLUSIONS	NNS	nsubjpass	O
:	:	punct	O
In	IN	case	O
both	DT	det	O
IBDs	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
particularly	RB	advmod	O
Crohn	NN	nmod:poss	O
's	POS	case	O
disease	NN	conj	O
,	,	punct	O
increased	VBN	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
may	MD	aux	O
be	VB	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
inflammatory	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
activation	NN	nmod	O
may	MD	aux	O
represent	VB	ROOT	O
a	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
steroids	NNS	nsubj	O
exert	VBP	acl:relcl	O
an	DT	det	O
anti-inflammatory	JJ	amod	O
effect	NN	dobj	O
in	IN	case	O
IBD	NN	nmod	O

Insufficient	JJ	amod	O
glycemic	JJ	amod	O
control	NN	nsubj	O
increases	VBZ	ROOT	O
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	compound	I-protein
binding	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
isolated	VBN	acl	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
type	NN	compound	O
1	CD	nummod	O
diabetes	NNS	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
redox-sensitive	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	nsubjpass	I-protein
nuclear	JJ	amod	I-protein
factor-kappa	NN	compound	I-protein
B	NN	dep	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
believed	VBN	dep	O
to	TO	mark	O
contribute	VB	xcomp	O
to	TO	case	O
late	JJ	amod	O
diabetic	JJ	amod	O
complications	NNS	nmod	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
unknown	JJ	ROOT	O
whether	IN	mark	O
NF-kappa	NN	compound	B-protein
B	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
influenced	VBN	ccomp	O
by	IN	case	O
glycemic	JJ	amod	O
control	NN	nmod	O
.	.	punct	O

RESEARCH	NNP	compound	O
DESIGN	NN	nsubj	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
whether	IN	mark	O
NF-kappa	NN	compound	B-protein
B	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
activated	VBN	ccomp	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
insufficient	JJ	amod	O
glycemic	JJ	amod	O
control	NN	nmod	O
(	-LRB-	punct	O
HbA1c	NN	amod	O
>	NN	dep	O
10	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
,	,	punct	O
we	PRP	nsubj	O
developed	VBD	ROOT	O
a	DT	det	O
tissue	NN	compound	O
culture-independent	JJ	amod	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	compound	O
(	-LRB-	punct	O
EMSA	NN	compound	O
)	-RRB-	punct	O
-based	JJ	amod	O
semiquantitative	JJ	amod	O
detection	NN	compound	O
system	NN	dobj	O
that	WDT	nsubj	O
allowed	VBD	acl:relcl	O
us	PRP	dobj	O
to	TO	mark	O
determine	VB	xcomp	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	dobj	O
in	IN	case	O
ex	FW	case	O
vivo-isolated	JJ	amod	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBMCs	NNS	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
included	VBD	ROOT	O
43	CD	nummod	O
patients	NNS	dobj	O
with	IN	case	O
type	NN	compound	O
1	CD	nummod	O
diabetes	NNS	nmod	O
in	IN	case	O
this	DT	det	O
cross-sectional	JJ	amod	O
study	NN	nmod	O
.	.	punct	O

10	CD	nsubj	O
of	IN	case	O
those	DT	nmod	O
received	VBD	ROOT	O
the	DT	det	O
antioxidant	JJ	amod	O
thioctic	JJ	amod	O
acid	NN	dobj	O
(	-LRB-	punct	O
600	CD	nummod	O
mg/day	NN	compound	O
p.o.	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
2	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Monocytes	NNS	nsubj	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
HbA1c	NN	compound	O
levels	NNS	nmod	O
>	NN	advmod	O
10	CD	nummod	O
%	NN	nsubj	O
demonstrated	VBD	dep	O
significantly	RB	advmod	O
higher	JJR	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
binding	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
an	DT	det	O
EMSA	NN	nmod	O
and	CC	cc	O
a	DT	det	O
stronger	JJR	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
staining	NN	conj	O
in	IN	case	O
immunohistochemistry	NN	nmod	O
than	IN	case	O
monocytes	NNS	nmod	B-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
HbA1c	NN	compound	O
levels	NNS	nmod	O
of	IN	case	O
6-8	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

The	DT	det	O
increase	NN	nsubj	O
in	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
plasmatic	JJ	amod	O
markers	NNS	nmod	O
of	IN	case	O
lipid	NN	compound	O
peroxidation	NN	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
the	DT	det	O
antioxidant	JJ	amod	O
thioctic	JJ	amod	O
acid	NN	nmod	O
decreased	VBD	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
binding	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Hyperglycemia	NN	nsubj	O
induces	VBZ	dep	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	O
factor	NN	compound	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
ex	FW	case	O
vivo-isolated	JJ	amod	O
PBMCs	NNS	nmod	B-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
type	NN	compound	O
1	CD	nummod	O
diabetes	NNS	nmod	O
.	.	punct	O

NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nsubj	O
is	VBZ	cop	O
at	IN	advmod	O
least	JJS	mwe	O
partially	RB	advmod	O
dependent	JJ	ROOT	O
on	IN	case	O
oxidative	JJ	amod	O
stress	NN	nmod	O
,	,	punct	O
since	IN	mark	O
the	DT	det	O
antioxidant	JJ	amod	O
thioctic	JJ	amod	O
acid	NN	nsubj	O
significantly	RB	advmod	O
lowered	VBD	advcl	O
the	DT	det	O
extent	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
binding	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

Synergistic	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
MAP	NN	compound	B-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
ERK1/2	NN	appos	B-protein
)	-RRB-	punct	O
by	IN	case	O
erythropoietin	NN	nmod	B-protein
and	CC	cc	O
stem	NN	compound	B-protein
cell	NN	compound	I-protein
factor	NN	conj	I-protein
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
expanded	VBN	amod	O
erythropoiesis	NN	nmod	O
.	.	punct	O

Stem	NN	compound	B-protein
cell	NN	compound	I-protein
factor	NN	nsubj	I-protein
(	-LRB-	punct	O
SCF	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
erythropoietin	NN	conj	B-protein
(	-LRB-	punct	O
EPO	NN	appos	B-protein
)	-RRB-	punct	O
work	NN	ROOT	O
synergistically	RB	advmod	O
to	TO	mark	O
support	VB	advcl	O
erythropoiesis	NN	dobj	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanism	NN	nsubj	O
for	IN	case	O
this	DT	det	O
synergism	NN	nmod	O
is	VBZ	cop	O
unknown	JJ	conj	O
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
purified	VBN	amod	B-cell_line
human	JJ	amod	I-cell_line
erythroid	JJ	amod	I-cell_line
colony-forming	JJ	amod	I-cell_line
cells	NNS	dobj	I-cell_line
(	-LRB-	punct	O
ECFC	NNS	appos	B-cell_line
)	-RRB-	punct	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
SCF	NN	nsubj	B-protein
and	CC	cc	O
EPO	NN	conj	B-protein
synergistically	RB	advmod	O
activate	VBP	ccomp	O
MAP	NN	compound	B-protein
kinase	NN	dobj	I-protein
(	-LRB-	punct	O
MAPK	NN	dep	B-protein
,	,	punct	O
ERK1/2	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
correlates	VBZ	acl:relcl	O
with	IN	case	O
the	DT	det	O
cell	NN	compound	O
growth	NN	nmod	O
and	CC	cc	O
thus	RB	advmod	O
may	MD	aux	O
be	VB	cop	O
responsible	JJ	conj	O
for	IN	case	O
the	DT	det	O
synergistic	JJ	amod	O
effects	NNS	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
with	IN	case	O
PD98059	NN	nmod	O
and	CC	cc	O
wortmannin	NN	conj	O
,	,	punct	O
inhibitors	NNS	nsubj	O
of	IN	case	O
MEK	NN	nmod	B-protein
and	CC	cc	O
PI-3	NN	compound	B-protein
kinase	NN	conj	I-protein
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
inhibited	VBD	ROOT	O
the	DT	det	O
synergistic	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
MAPK	NN	nmod	B-protein
and	CC	cc	O
also	RB	advmod	O
the	DT	det	O
cell	NN	compound	O
growth	NN	conj	O
,	,	punct	O
further	RB	advmod	O
supporting	VBG	advcl	O
this	DT	det	O
conclusion	NN	dobj	O
.	.	punct	O

Wortmannin	NN	nsubj	O
only	RB	advmod	O
inhibits	VBZ	ROOT	O
MAPK	NN	compound	B-protein
activation	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
EPO	NN	nmod	B-protein
but	CC	cc	O
not	RB	neg	O
that	IN	conj	O
by	IN	case	O
SCF	NN	nmod	B-protein
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
SCF	NN	nsubj	B-protein
and	CC	cc	O
EPO	NN	conj	B-protein
may	MD	aux	O
activate	VB	ccomp	O
MAPK	NN	dobj	B-protein
through	IN	case	O
different	JJ	amod	O
pathways	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
would	MD	aux	O
facilitate	VB	acl:relcl	O
synergy	NN	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
EPO	NN	nsubj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
SCF	NN	conj	B-protein
,	,	punct	O
led	VBD	ROOT	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
STAT5	NN	nmod	B-protein
,	,	punct	O
whereas	IN	dep	O
SCF	NN	nsubj	B-protein
and	CC	cc	O
wortmannin	NN	conj	O
had	VBD	parataxis	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
EPO	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
STAT5	NN	compound	B-protein
activation	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
STAT5	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
not	RB	neg	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
synergistic	JJ	amod	O
action	NN	nmod	O
of	IN	case	O
SCF	NN	nmod	B-protein
and	CC	cc	O
EPO	NN	conj	B-protein
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
the	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
synergistic	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
MAPK	NN	nmod	B-protein
by	IN	case	O
SCF	NN	nmod	B-protein
and	CC	cc	O
EPO	NN	conj	B-protein
is	VBZ	cop	O
essential	JJ	ccomp	O
for	IN	case	O
expanded	VBN	amod	O
erythropoiesis	NN	nmod	O
.	.	punct	O

Copyright	NN	ROOT	O
1998	CD	nummod	O
by	IN	prep	O
The	NNP	det	O
American	NNP	compound	O
Society	NNP	pobj	O
of	IN	prep	O
Hematology	NNP	pobj	O
.	.	punct	O

The	DT	det	O
molecular	JJ	amod	O
and	CC	cc	O
phenotypic	JJ	conj	O
profile	NN	nsubj	O
of	IN	case	O
primary	JJ	amod	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	compound	O
lymphoma	NN	nmod	O
identifies	VBZ	ROOT	O
distinct	JJ	amod	O
categories	NNS	dobj	O
of	IN	case	O
the	DT	det	O
disease	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
consistent	JJ	conj	O
with	IN	case	O
histogenetic	JJ	amod	O
derivation	NN	nmod	O
from	IN	case	O
germinal	JJ	amod	B-cell_type
center-related	JJ	amod	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Primary	JJ	amod	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	compound	O
lymphoma	NN	nsubj	O
(	-LRB-	punct	O
PCNSL	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
cause	NN	ROOT	O
of	IN	case	O
morbidity	NN	nmod	O
and	CC	cc	O
mortality	NN	conj	O
among	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
HIV	NN	compound	O
)	-RRB-	punct	O
-infected	JJ	amod	O
individuals	NNS	nmod	O
.	.	punct	O

The	DT	det	O
precise	JJ	amod	O
histogenetic	JJ	amod	O
derivation	NN	nsubjpass	O
and	CC	cc	O
the	DT	det	O
molecular	JJ	amod	O
pathogenesis	NN	conj	O
of	IN	case	O
PCNSL	NN	nmod	O
is	VBZ	auxpass	O
poorly	RB	advmod	O
understood	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
an	DT	det	O
attempt	NN	nmod	O
to	TO	mark	O
clarify	VB	acl	O
the	DT	det	O
histogenesis	NN	dobj	O
and	CC	cc	O
pathogenesis	NN	conj	O
of	IN	case	O
these	DT	det	O
lymphomas	NNS	nmod	O
,	,	punct	O
49	CD	nummod	O
PCNSL	NN	nsubjpass	O
(	-LRB-	punct	O
26	CD	nummod	O
acquired	VBD	amod	O
immunodeficiency	NN	compound	O
syndrome	NN	dep	O
[	-LRB-	punct	O
AIDS	NN	dep	O
]	-RRB-	punct	O
-related	JJ	dep	O
and	CC	cc	O
23	CD	conj	O
AIDS-unrelated	JJ	conj	O
)	-RRB-	punct	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
for	IN	case	O
multiple	JJ	amod	O
biologic	JJ	amod	O
markers	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
known	VBN	acl:relcl	O
to	TO	mark	O
bear	VB	xcomp	O
histogenetic	JJ	amod	O
and	CC	cc	O
pathogenetic	JJ	conj	O
significance	NN	dobj	O
for	IN	case	O
mature	JJ	amod	O
B-cell	NN	compound	O
neoplasms	NNS	nmod	O
.	.	punct	O

PCNSL	NN	nsubj	O
associated	VBD	ROOT	O
frequently	RB	advmod	O
(	-LRB-	punct	O
50.0	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
with	IN	case	O
mutations	NNS	nmod	O
of	IN	case	O
BCL-6	NN	compound	B-DNA
5	CD	nummod	I-DNA
'	``	punct	I-DNA
noncoding	JJ	compound	I-DNA
regions	NNS	nmod	I-DNA
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
regarded	VBN	acl:relcl	O
as	IN	case	O
a	DT	det	O
marker	NN	nmod	O
of	IN	case	O
B-cell	NN	compound	O
transition	NN	nmod	O
through	IN	case	O
the	DT	det	O
germinal	JJ	amod	O
center	NN	nmod	O
(	-LRB-	punct	O
GC	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
BCL-6	NN	compound	B-protein
protein	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
restricted	JJ	acl:relcl	O
to	TO	case	O
GC	NN	compound	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
throughout	IN	case	O
physiologic	JJ	amod	O
B-cell	NN	compound	O
maturation	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
100	CD	nummod	O
%	NN	amod	O
AIDS-unrelated	JJ	amod	O
PCNSL	NN	nmod	O
and	CC	cc	O
in	IN	case	O
56.2	CD	nummod	O
%	NN	amod	O
AIDS-related	JJ	amod	O
cases	NNS	conj	O
.	.	punct	O

Notably	RB	advmod	O
,	,	punct	O
among	IN	case	O
AIDS-related	JJ	amod	O
PCNSL	NN	nmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
BCL-6	NN	nmod	B-protein
was	VBD	cop	O
mutually	RB	advmod	O
exclusive	JJ	ROOT	O
with	IN	case	O
expression	NN	nmod	O
of	IN	case	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	nmod:npmod	I-protein
(	-LRB-	punct	I-protein
EBV	NN	nmod:npmod	I-protein
)	-RRB-	punct	I-protein
-encoded	JJ	amod	I-protein
latent	JJ	amod	I-protein
membrane	NN	compound	I-protein
protein	NN	compound	I-protein
(	-LRB-	punct	I-protein
LMP	NN	nmod	I-protein
)	-RRB-	punct	I-protein
-1	CD	nummod	I-protein
and	CC	cc	O
,	,	punct	O
with	IN	case	O
few	JJ	amod	O
exceptions	NNS	nmod	O
,	,	punct	O
also	RB	advmod	O
of	IN	case	O
BCL-2	NN	nmod	B-protein
.	.	punct	O

All	DT	nsubj	O
but	CC	cc	O
one	CD	nummod	O
PCNSL	NN	nsubj	O
expressed	VBD	ROOT	O
hMSH2	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
among	IN	case	O
mature	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
selectively	RB	advmod	O
stains	VBZ	acl:relcl	O
GC	NN	compound	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
PCNSL	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
frequently	RB	advmod	O
related	JJ	ccomp	O
to	TO	case	O
GC	NN	compound	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
may	MD	aux	O
be	VB	auxpass	O
segregated	VBN	conj	O
into	IN	case	O
two	CD	nummod	O
major	JJ	amod	O
biologic	JJ	amod	O
categories	NNS	nmod	O
based	VBN	case	O
on	IN	case	O
the	DT	det	O
expression	NN	compound	O
pattern	NN	nmod	O
of	IN	case	O
BCL-6	NN	nmod	B-protein
,	,	punct	O
LMP-1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
BCL-2	NN	conj	B-protein
.	.	punct	O

BCL-6	NN	nsubj	B-protein
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
/	:	punct	O
LMP-1	NN	compound	B-protein
(	-LRB-	punct	O
-	:	punct	O
)	-RRB-	punct	O
/	:	punct	O
BCL-2	NN	compound	B-protein
(	-LRB-	punct	O
-	:	punct	O
)	-RRB-	punct	O
PCNSL	NN	nsubj	O
occur	VBP	ROOT	O
both	CC	cc:preconj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
absence	NN	dep	O
of	IN	case	O
HIV	NN	compound	O
infection	NN	conj	O
and	CC	cc	O
consistently	RB	advmod	O
display	VBP	conj	O
a	DT	det	O
large	JJ	amod	O
noncleaved	JJ	amod	O
cell	NN	compound	O
morphology	NN	dobj	O
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
BCL-6	NN	compound	B-protein
(	-LRB-	punct	O
-	:	punct	O
)	-RRB-	punct	O
/	:	punct	O
LMP-1	NN	compound	B-protein
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
/	:	punct	O
BCL-2	NN	conj	B-protein
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
PCNSL	NN	nsubj	O
are	VBP	aux	O
restricted	JJ	ROOT	O
to	TO	case	O
HIV-infected	JJ	amod	O
hosts	NNS	nmod	O
and	CC	cc	O
are	VBP	auxpass	O
represented	VBN	conj	O
by	IN	case	O
lymphomas	NNS	nmod	O
with	IN	case	O
immunoblastic	JJ	amod	O
features	NNS	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
are	VBP	cop	O
relevant	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
and	CC	cc	O
histogenesis	NN	conj	O
of	IN	case	O
PCNSL	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
be	VB	cop	O
helpful	JJ	conj	O
to	TO	mark	O
segregate	VB	xcomp	O
distinct	JJ	amod	O
biologic	JJ	amod	O
and	CC	cc	O
prognostic	JJ	conj	O
categories	NNS	dobj	O
of	IN	case	O
these	DT	det	O
lymphomas	NNS	nmod	O
.	.	punct	O

Copyright	NN	ROOT	O
1998	CD	nummod	O
by	IN	prep	O
The	NNP	det	O
American	NNP	compound	O
Society	NNP	pobj	O
of	IN	prep	O
Hematology	NNP	pobj	O
.	.	punct	O

Antioxidant	JJ	amod	O
regulation	NN	ROOT	O
of	IN	case	O
phorbol	NN	nmod:npmod	O
ester-induced	JJ	amod	O
adhesion	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
T-cells	NNS	nmod	I-cell_line
to	TO	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Regulation	NN	nsubjpass	O
of	IN	case	O
adhesion	NN	compound	O
molecule	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
function	NN	conj	O
by	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
species	NNS	nmod	O
via	IN	case	O
specific	JJ	amod	O
redox	NN	compound	O
sensitive	JJ	amod	O
mechanisms	NNS	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
clinically	RB	advmod	O
safe	JJ	amod	O
antioxidants	NNS	nmod	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
adhesion	NN	compound	O
molecule	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
endothelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
ECV	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
adherence	NN	conj	O
of	IN	case	O
human	JJ	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
to	TO	case	O
ECV	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
thiol	NN	compound	O
antioxidant	NN	dep	O
,	,	punct	O
alpha-lipoate	NN	conj	O
,	,	punct	O
at	IN	case	O
clinically	RB	advmod	O
relevant	JJ	amod	O
doses	NNS	nsubj	O
down-regulated	VBD	ROOT	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	compound	O
(	-LRB-	punct	O
PMA	NN	compound	O
)	-RRB-	punct	O
-induced	JJ	amod	O
adhesion	NN	compound	O
molecule	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
cell-cell	JJ	amod	O
adhesion	NN	conj	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
PMA-induced	JJ	amod	O
ICAM-1	NN	nmod	O
and	CC	cc	O
VCAM-1	NN	conj	O
expression	NN	dep	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
PMA-induced	JJ	amod	O
adhesion	NN	conj	O
of	IN	case	O
Jurkat	NN	compound	B-cell_line
T-cells	NNS	nmod	I-cell_line
to	TO	case	O
ECV	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
alpha-lipoate	NN	nmod	O
was	VBD	cop	O
dose	NN	nmod:npmod	O
dependent	JJ	ROOT	O
(	-LRB-	punct	O
50-250	CD	nummod	O
microM	NN	dep	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubj	O
was	VBD	cop	O
significant	JJ	ROOT	O
for	IN	case	O
ICAM-1	NN	nmod	B-protein
(	-LRB-	punct	O
p	NN	compound	O
<	CD	appos	O
.01	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
VCAM-1	NN	conj	B-protein
(	-LRB-	punct	O
p	NN	appos	O
<	CD	dep	O
.01	CD	nummod	O
)	-RRB-	punct	O
expression	NN	conj	O
in	IN	case	O
cells	NNS	nmod	O
pretreated	VBN	acl	O
with	IN	case	O
100	CD	nummod	O
microM	NN	compound	O
alpha-lipoate	NN	nmod	O
compared	VBN	case	O
to	TO	case	O
PMA-activated	JJ	amod	B-cell_type
untreated	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
PMA-induced	JJ	amod	O
adhesion	NN	compound	O
molecule	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
cell-cell	JJ	amod	O
adhesion	NN	conj	O
was	VBD	auxpass	O
more	RBR	advmod	O
pronounced	JJ	ROOT	O
when	WRB	advmod	O
a	DT	det	O
combination	NN	nsubjpass	O
of	IN	case	O
antioxidants	NNS	nmod	O
,	,	punct	O
alpha-lipoate	NN	conj	O
and	CC	cc	O
alpha-tocopherol	NN	conj	O
,	,	punct	O
were	VBD	auxpass	O
used	VBN	advcl	O
compared	VBN	case	O
to	TO	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
either	DT	nmod	O
of	IN	case	O
these	DT	det	O
antioxidant	NN	nmod	O
alone	RB	advmod	O
.	.	punct	O

The	DT	det	O
regulation	NN	nsubj	O
of	IN	case	O
adhesion	NN	compound	O
molecule	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
function	NN	conj	O
by	IN	case	O
low	JJ	amod	O
concentration	NN	nmod	O
of	IN	case	O
antioxidants	NNS	nmod	O
investigated	VBN	acl	O
does	VBZ	aux	O
not	RB	neg	O
appear	VB	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
NF-kappaB	NN	nmod:npmod	B-protein
regulated	JJ	xcomp	O
or	CC	cc	O
transcription	NN	nmod:npmod	O
dependent	JJ	conj	O
because	IN	mark	O
no	DT	neg	O
change	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
mRNA	NN	compound	O
response	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	advcl	O
.	.	punct	O

Protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nsubjpass	I-protein
(	-LRB-	punct	O
PKC	NN	appos	B-protein
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	ROOT	O
to	TO	mark	O
regulate	VB	xcomp	O
PMA-induced	JJ	amod	O
adhesion	NN	compound	O
molecule	NN	compound	O
expression	NN	dobj	O
by	IN	case	O
post-transcriptional	JJ	amod	O
stabilization	NN	nmod	O
of	IN	case	O
adhesion	NN	compound	B-RNA
molecule	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

Alpha-lipoate	JJ	amod	O
pretreatment	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
influence	VB	ROOT	O
the	DT	det	O
response	NN	dobj	O
of	IN	case	O
PKC	NN	compound	B-protein
activity	NN	nmod	O
to	TO	case	O
PMA	NN	nmod	O
.	.	punct	O

Oxidants	NNS	nsubjpass	O
are	VBP	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
adhesion	NN	compound	O
processes	NNS	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
ECV	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
PMA	NN	nmod	O
induced	JJ	ROOT	O
generation	NN	dobj	O
of	IN	case	O
intracellular	JJ	amod	O
oxidants	NNS	nmod	O
.	.	punct	O

Alpha-lipoate	NN	amod	O
(	-LRB-	punct	O
100	CD	nummod	O
or	CC	cc	O
250	CD	conj	O
microM	NN	dep	O
)	-RRB-	punct	O
treatment	NN	nsubj	O
decreased	VBD	ROOT	O
PMA-induced	JJ	amod	O
generation	NN	dobj	O
of	IN	case	O
intracellular	JJ	amod	O
oxidants	NNS	nmod	O
.	.	punct	O

The	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
low	JJ	amod	O
concentration	NN	nmod	O
of	IN	case	O
alpha-lipaote	JJ	nmod	O
alone	RB	advmod	O
or	CC	cc	O
in	IN	case	O
combination	NN	conj	O
with	IN	case	O
alpha-tocopherol	NN	nmod	O
on	IN	case	O
agonist-induced	JJ	amod	O
adhesion	NN	compound	O
processes	NNS	nmod	O
observed	VBN	acl	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
of	IN	case	O
potential	JJ	amod	O
therapeutic	JJ	amod	O
value	NN	ROOT	O
.	.	punct	O

Binding	NN	nsubj	O
of	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
to	TO	case	O
CD4	NN	compound	B-protein
and	CC	cc	I-protein
CXCR4	NN	conj	I-protein
receptors	NNS	nmod	I-protein
differentially	RB	advmod	O
regulates	VBZ	ROOT	O
expression	NN	dobj	O
of	IN	case	O
inflammatory	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
activates	VBZ	conj	O
the	DT	det	O
MEK	NN	compound	B-protein
/ERK	NN	compound	O
signaling	NN	compound	O
pathway	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
binding	NN	nsubj	O
of	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
virions	NNS	nmod	O
to	TO	case	O
CD4	NN	compound	B-protein
receptors	NNS	nmod	I-protein
stimulates	VBZ	ccomp	O
association	NN	dobj	O
of	IN	case	O
Lck	NN	nmod	B-protein
with	IN	case	O
Raf-1	NN	nmod	B-protein
and	CC	cc	O
results	VBZ	conj	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
Raf-1	NN	compound	B-protein
kinase	NN	nmod	O
in	IN	case	O
a	DT	det	O
Ras-independent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
HIV-1	NN	compound	B-protein
envelope	NN	compound	I-protein
glycoproteins	NNS	nsubj	I-protein
of	IN	case	O
both	CC	cc:preconj	O
T-cell-tropic	JJ	nmod	O
and	CC	cc	O
macrophagetropic	JJ	conj	O
strains	NNS	dep	O
rapidly	RB	advmod	O
activate	VBP	ccomp	O
the	DT	det	O
ERK/mitogen-activated	JJ	amod	O
protein	NN	compound	O
(	-LRB-	punct	O
MAP	NN	compound	O
)	-RRB-	punct	O
kinase	NN	compound	O
pathway	NN	dobj	O
and	CC	cc	O
the	DT	det	O
binding	NN	conj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
(	-LRB-	punct	O
AP-1	NN	dep	B-protein
,	,	punct	O
NF-kappaB	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
C/EBP	NN	conj	B-protein
)	-RRB-	punct	O
and	CC	cc	O
stimulate	VBP	conj	O
expression	NN	dobj	O
of	IN	case	O
cytokine	NN	nmod	B-DNA
and	CC	cc	I-DNA
chemokine	NN	conj	I-DNA
genes	NNS	dep	I-DNA
.	.	punct	O

The	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
this	DT	det	O
signaling	NN	compound	O
pathway	NN	nmod	O
requires	VBZ	ROOT	O
functional	JJ	amod	O
CD4	NN	compound	B-protein
receptors	NNS	dobj	I-protein
and	CC	cc	O
is	VBZ	cop	O
independent	JJ	conj	O
of	IN	mark	O
binding	VBG	nmod	O
to	TO	case	O
CXCR4	NN	nmod	B-protein
.	.	punct	O

Binding	NN	nsubj	O
of	IN	case	O
the	DT	det	O
natural	JJ	amod	O
ligand	NN	compound	O
stromal	JJ	amod	B-protein
cell-derived	JJ	amod	I-protein
factor	NN	nmod	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
SDF-1	NN	appos	B-protein
)	-RRB-	punct	O
to	TO	case	O
CXCR4	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
inhibits	VBZ	acl:relcl	O
entry	NN	dobj	O
of	IN	case	O
T-cell-tropic	JJ	amod	O
HIV-1	NN	nmod	O
,	,	punct	O
activates	VBZ	ROOT	O
also	RB	advmod	O
the	DT	det	O
ERK/	NN	amod	O
MAP	NN	compound	B-protein
kinase	NN	compound	I-protein
pathway	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
SDF-1	NN	nsubj	B-protein
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
the	DT	det	O
CD4-mediated	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
cytokine	NN	compound	B-DNA
and	CC	cc	I-DNA
chemokine	NN	conj	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
provide	VBP	ROOT	O
firm	JJ	compound	O
molecular	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
binding	NN	nsubj	O
of	IN	case	O
HIV-1	NN	compound	B-protein
envelope	NN	compound	I-protein
glycoproteins	NNS	nmod	I-protein
to	TO	case	O
CD4	NN	compound	B-protein
receptor	NN	nmod	I-protein
initiates	VBZ	ccomp	O
a	DT	det	O
signaling	NN	compound	O
pathway	NN	compound	O
(	-LRB-	punct	O
s	NNS	dobj	O
)	-RRB-	punct	O
independent	JJ	amod	O
of	IN	case	O
the	DT	det	O
binding	NN	nmod	O
to	TO	case	O
the	DT	det	O
chemokine	NN	compound	B-protein
receptor	NN	nmod	I-protein
that	WDT	nsubj	O
leads	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
aberrant	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
inflammatory	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
may	MD	aux	O
contribute	VB	conj	O
significantly	RB	advmod	O
to	TO	case	O
HIV-1	NN	compound	O
replication	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
to	TO	case	O
deregulation	NN	conj	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

Antigen	NN	compound	O
receptor	NN	compound	O
signaling	NN	nsubj	O
induces	VBZ	ROOT	O
MAP	NN	compound	O
kinase-mediated	JJ	amod	O
phosphorylation	NN	dobj	O
and	CC	cc	O
degradation	NN	conj	O
of	IN	case	O
the	DT	det	O
BCL-6	NN	compound	B-protein
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
bcl-6	JJ	compound	B-DNA
proto-oncogene	NN	nsubj	I-DNA
encodes	VBZ	ROOT	O
a	DT	det	O
POZ/zinc	NN	compound	B-protein
finger	NN	compound	I-protein
transcriptional	JJ	amod	I-protein
repressor	NN	dobj	I-protein
expressed	VBN	acl	O
in	IN	case	O
germinal	JJ	amod	B-cell_type
center	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
GC	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
B	NN	compound	I-cell_type
and	CC	cc	I-cell_type
T	NN	conj	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
required	VBN	conj	O
for	IN	case	O
GC	NN	compound	O
formation	NN	nmod	O
and	CC	cc	O
antibody	NN	compound	O
affinity	NN	compound	O
maturation	NN	conj	O
.	.	punct	O

Deregulation	NN	nsubjpass	O
of	IN	case	O
bcl-6	JJ	compound	B-DNA
expression	NN	nmod	O
by	IN	case	O
chromosomal	JJ	amod	O
rearrangements	NNS	nmod	O
and	CC	cc	O
point	NN	compound	O
mutations	NNS	conj	O
of	IN	case	O
the	DT	det	O
bcl-6	NN	compound	B-DNA
promoter	NN	compound	I-DNA
region	NN	nmod	I-DNA
are	VBP	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
B-cell	NN	compound	O
lymphoma	NN	nmod	O
.	.	punct	O

The	DT	det	O
signals	NNS	nsubjpass	O
regulating	VBG	acl	O
bcl-6	JJ	compound	B-DNA
expression	NN	dobj	O
are	VBP	auxpass	O
not	RB	neg	O
known	VBN	ROOT	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
antigen	NN	compound	O
receptor	NN	compound	O
activation	NN	nsubj	O
leads	VBZ	ccomp	O
to	TO	case	O
BCL-6	NN	compound	B-protein
phosphorylation	NN	nmod	O
by	IN	case	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
MAPK	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Phosphorylation	NN	nsubj	O
,	,	punct	O
in	IN	case	O
turn	NN	nmod	O
,	,	punct	O
targets	VBZ	ROOT	O
BCL-6	NN	dobj	B-protein
for	IN	case	O
rapid	JJ	amod	O
degradation	NN	nmod	O
by	IN	case	O
the	DT	det	O
ubiquitin	NN	compound	B-protein
/	:	punct	O
proteasome	NN	compound	B-protein
pathway	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
BCL-6	NN	compound	B-protein
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
directly	RB	advmod	O
controlled	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
antigen	NN	compound	O
receptor	NN	nmod	O
via	IN	case	O
MAPK	NN	compound	B-protein
activation	NN	nmod	O
.	.	punct	O

This	DT	det	O
signaling	NN	compound	O
pathway	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
crucial	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
B-cell	NN	compound	O
differentiation	NN	nmod	O
and	CC	cc	O
antibody	NN	compound	O
response	NN	conj	O
and	CC	cc	O
has	VBZ	conj	O
implications	NNS	dobj	O
for	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
other	JJ	amod	O
POZ/zinc	NN	compound	B-protein
finger	NN	compound	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
in	IN	case	O
other	JJ	amod	O
tissues	NNS	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
differentially	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
and	CC	cc	O
tissues	NNS	conj	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

Cytosolic	JJ	amod	B-protein
glucocorticoid	NN	compound	I-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
binding	NN	compound	O
studies	NNS	nsubj	O
on	IN	case	O
immune	JJ	amod	O
tissues	NNS	nmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
thymus	NN	nsubj	O
exhibits	VBZ	ccomp	O
three	CD	compound	O
to	TO	dep	O
four	CD	nummod	O
times	NNS	nmod:npmod	O
higher	JJR	amod	O
levels	NNS	dobj	O
of	IN	case	O
GR	NN	compound	B-protein
protein	NN	nmod	I-protein
than	IN	case	O
the	DT	det	O
spleen	NN	nmod	O
.	.	punct	O

High	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
GR	NN	nmod	B-protein
are	VBP	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
the	DT	det	O
exquisite	JJ	amod	O
sensitivity	NN	nmod	O
of	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
to	TO	case	O
glucocorticoid	NN	compound	O
exposure	NN	nmod	O
.	.	punct	O

Nevertheless	RB	advmod	O
,	,	punct	O
whole	JJ	amod	O
cell	NN	compound	O
binding	NN	compound	O
studies	NNS	nsubj	O
reveal	VBP	ROOT	O
similar	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
GR	NN	nmod	B-protein
in	IN	case	O
immature	JJ	amod	B-cell_type
thymic	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
more	RBR	advmod	O
mature	JJ	amod	O
,	,	punct	O
splenic	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	conj	I-cell_type
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
whole	JJ	amod	O
cell	NN	compound	O
binding	NN	compound	O
techniques	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
neutrophils	NNS	nsubj	B-cell_type
(	-LRB-	punct	O
which	WDT	nsubj	O
represent	VBP	acl:relcl	O
roughly	RB	advmod	O
30	CD	nummod	O
%	NN	dobj	O
of	IN	case	O
splenic	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
)	-RRB-	punct	O
exhibit	VBP	ccomp	O
higher	JJR	amod	O
GR	NN	dobj	B-protein
than	IN	case	O
both	CC	cc:preconj	O
T	NN	compound	B-cell_type
and	CC	cc	I-cell_type
B	NN	conj	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
further	RBR	advmod	O
contradicting	NN	amod	O
results	NNS	dobj	O
from	IN	case	O
cytosolic	JJ	amod	O
binding	NN	compound	O
studies	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
address	VB	advcl	O
these	DT	det	O
inconsistencies	NNS	dobj	O
,	,	punct	O
GR	NN	compound	B-protein
protein	NN	nsubjpass	I-protein
was	VBD	auxpass	O
assessed	VBN	ROOT	O
in	IN	case	O
immune	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	I-cell_type
tissues	NNS	conj	I-cell_type
using	VBG	xcomp	O
cytosolic	JJ	amod	O
radioligand	NN	compound	O
binding	NN	dobj	O
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
analysis	NN	ROOT	O
,	,	punct	O
and	CC	cc	O
immunocytochemistry	NN	conj	O
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
previous	JJ	amod	O
cytosolic	JJ	amod	O
receptor	NN	compound	O
binding	NN	compound	O
studies	NNS	nmod	O
on	IN	case	O
immune	JJ	amod	O
tissue	NN	compound	O
homogenates	NNS	nmod	O
,	,	punct	O
thymic	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
higher	JJR	amod	O
levels	NNS	dobj	O
of	IN	case	O
GR	NN	nmod	B-protein
than	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
isolated	VBN	acl	O
from	IN	case	O
the	DT	det	O
spleen	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
neutrophils	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
fewer	JJR	amod	O
GR	NN	dobj	B-protein
than	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
and	CC	cc	O
monocytes	NNS	conj	B-cell_type
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
a	DT	det	O
meaningful	JJ	amod	O
relationship	NN	dobj	O
between	IN	case	O
receptor	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
known	JJ	amod	O
sensitivity	NN	conj	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

Functional	JJ	amod	O
replacement	NN	ROOT	O
of	IN	case	O
the	DT	det	O
mouse	NN	compound	B-DNA
E2A	NN	compound	I-DNA
gene	NN	nmod	I-DNA
with	IN	case	O
a	DT	det	O
human	JJ	amod	B-DNA
HEB	NN	compound	I-DNA
cDNA	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
mammalian	JJ	amod	B-DNA
E2A	NN	nsubj	I-DNA
,	,	punct	I-DNA
HEB	NN	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
E2-2	NN	compound	I-DNA
genes	NNS	conj	I-DNA
encode	VBP	ROOT	O
a	DT	det	O
unique	JJ	amod	O
class	NN	dobj	O
of	IN	case	O
basic	JJ	amod	B-protein
helix-loop-helix	JJ	amod	I-protein
(	-LRB-	punct	I-protein
bHLH	JJ	intj	I-protein
)	-RRB-	punct	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
that	WDT	nsubjpass	O
are	VBP	auxpass	O
evolutionarily	RB	advmod	O
conserved	VBN	acl:relcl	O
and	CC	cc	O
essential	JJ	conj	O
for	IN	case	O
embryonic	JJ	amod	O
and	CC	cc	O
postnatal	JJ	conj	O
development	NN	nmod	O
.	.	punct	O

While	IN	mark	O
the	DT	det	O
structural	JJ	amod	O
and	CC	cc	O
functional	JJ	conj	O
similarities	NNS	nsubjpass	O
among	IN	case	O
the	DT	det	O
gene	NN	compound	B-protein
products	NNS	nmod	I-protein
are	VBP	auxpass	O
well	RB	advmod	O
demonstrated	VBN	advcl	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
clear	JJ	ROOT	O
why	WRB	advmod	O
deletion	NN	nsubj	O
of	IN	case	O
E2A	NN	nmod	B-DNA
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
HEB	NN	conj	B-DNA
or	CC	cc	O
E2-2	NN	conj	B-DNA
,	,	punct	O
leads	VBZ	ccomp	O
to	TO	case	O
a	DT	det	O
complete	JJ	amod	O
arrest	NN	nmod	O
in	IN	case	O
B-lymphocyte	NN	compound	O
development	NN	nmod	O
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
basis	NN	dobj	O
of	IN	case	O
the	DT	det	O
functional	JJ	amod	O
specificity	NN	nmod	O
between	IN	case	O
E2A	NN	nmod	B-DNA
and	CC	cc	O
HEB	NN	conj	B-DNA
/	:	punct	O
E2-2	NN	dep	B-DNA
in	IN	case	O
mammalian	JJ	amod	O
development	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
generated	VBD	ROOT	O
and	CC	cc	O
tested	VBD	conj	O
a	DT	det	O
panel	NN	dobj	O
of	IN	case	O
E2A	NN	compound	B-DNA
knockin	NN	compound	O
mutations	NNS	nmod	O
including	VBG	case	O
subtle	JJ	amod	O
mutations	NNS	nmod	O
in	IN	case	O
the	DT	dep	O
E12	NN	nmod	B-DNA
and	CC	cc	I-DNA
E47	NN	conj	I-DNA
exons	NNS	dep	I-DNA
and	CC	cc	O
substitution	NN	conj	O
of	IN	case	O
both	CC	cc:preconj	O
E12	NN	nmod	B-DNA
and	CC	cc	I-DNA
E47	NN	conj	I-DNA
exons	NNS	nmod	I-DNA
with	IN	case	O
a	DT	det	O
human	JJ	amod	B-DNA
HEB	NN	compound	I-DNA
cDNA	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
alternatively	RB	advmod	O
spliced	VBN	amod	O
E12	NN	nsubj	B-protein
and	CC	cc	I-protein
E47	NN	conj	I-protein
bHLH	JJ	amod	I-protein
proteins	NNS	conj	I-protein
of	IN	case	O
the	DT	det	O
E2A	NN	compound	B-DNA
gene	NN	nmod	I-DNA
play	VBP	ccomp	O
similar	JJ	amod	O
and	CC	cc	O
additive	JJ	conj	O
roles	NNS	dobj	O
in	IN	mark	O
supporting	VBG	advcl	O
B	NN	compound	B-cell_type
lymphopoiesis	NN	dobj	I-cell_type
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
HEB	NN	nsubj	B-DNA
driven	VBN	acl	O
by	IN	case	O
the	DT	det	O
endogenous	JJ	amod	B-DNA
E2A	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
can	MD	aux	O
functionally	RB	advmod	O
replace	VB	ccomp	O
E2A	NN	dobj	B-DNA
in	IN	mark	O
supporting	VBG	advcl	O
B-cell	NN	compound	O
commitment	NN	dobj	O
and	CC	cc	O
differentiation	NN	conj	O
toward	IN	case	O
completion	NN	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
the	DT	det	O
postnatal	JJ	amod	O
lethality	NN	nsubjpass	O
associated	VBN	acl	O
with	IN	case	O
E2A	NN	compound	B-DNA
disruption	NN	nmod	O
is	VBZ	auxpass	O
fully	RB	advmod	O
rescued	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
HEB	NN	nmod	B-DNA
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
functional	JJ	amod	O
divergence	NN	nsubjpass	O
among	IN	case	O
E12	NN	nmod	B-DNA
,	,	punct	O
E47	NN	conj	B-DNA
,	,	punct	O
and	CC	cc	O
HEB	NN	conj	B-DNA
in	IN	case	O
different	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
is	VBZ	auxpass	O
partially	RB	advmod	O
defined	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
context	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Biased	VBN	amod	O
dependency	NN	ROOT	O
of	IN	case	O
CD80	NN	nmod	B-protein
versus	CC	cc	O
CD86	NN	conj	B-protein
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
regulating	VBG	acl	O
the	DT	det	O
human	JJ	amod	B-DNA
IL-2	NN	compound	I-DNA
promoter	NN	dobj	I-DNA
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	case	O
the	DT	det	O
signals	NNS	nmod	O
obtained	VBN	acl	O
by	IN	case	O
ligation	NN	nmod	O
of	IN	case	O
the	DT	det	O
TCR	NN	nmod	O
,	,	punct	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
need	VBP	ROOT	O
additional	JJ	amod	O
,	,	punct	O
co-stimulatory	JJ	dep	O
signals	NNS	nsubjpass	O
to	TO	mark	O
be	VB	auxpass	O
activated	VBN	ccomp	O
.	.	punct	O

One	CD	nummod	O
such	JJ	amod	O
co-stimulatory	JJ	amod	O
signal	NN	nsubjpass	O
is	VBZ	auxpass	O
delivered	VBN	ROOT	O
when	WRB	advmod	O
CD28	NN	nsubj	B-protein
on	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
binds	VBZ	advcl	O
to	TO	case	O
CD80	NN	nmod	B-protein
or	CC	cc	O
CD86	NN	conj	B-protein
on	IN	case	O
antigen-presenting	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
APC	NN	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
CD80	NN	nmod	B-protein
and	CC	cc	O
CD86	NN	conj	B-protein
to	TO	mark	O
co-stimulate	VB	acl	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
activated	VBN	acl	O
by	IN	case	O
superantigen	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
the	DT	det	O
Raji	NN	compound	B-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lymphoma	NN	dobj	I-cell_line
,	,	punct	O
which	WDT	nsubj	O
express	VBP	acl:relcl	O
similar	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
CD80	NN	nmod	B-protein
and	CC	cc	O
CD86	NN	conj	B-protein
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
that	IN	mark	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	nsubjpass	O
was	VBD	auxpass	O
mainly	RB	advmod	O
co-stimulated	VBN	ccomp	O
by	IN	case	O
CD80	NN	nmod	B-protein
.	.	punct	O

To	TO	mark	O
further	RB	advmod	O
characterize	VB	advcl	O
the	DT	det	O
consequences	NNS	dobj	O
of	IN	case	O
this	DT	det	O
biased	VBN	amod	O
co-stimulatory	JJ	amod	O
dependency	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
employed	VBD	ROOT	O
a	DT	det	O
well-defined	JJ	amod	O
system	NN	dobj	O
of	IN	case	O
transfected	VBN	amod	O
CHO	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
expressing	VBG	acl	O
human	JJ	amod	B-protein
MHC	NN	compound	I-protein
class	NN	dobj	I-protein
II	CD	nummod	I-protein
together	RB	advmod	O
with	IN	case	O
CD80	NN	nmod	B-protein
,	,	punct	O
CD86	NN	conj	B-protein
or	CC	cc	O
CD80	NN	conj	B-protein
and	CC	cc	O
CD86	NN	conj	B-protein
.	.	punct	O

Proliferation	NN	nsubj	O
of	IN	case	O
freshly	RB	advmod	O
prepared	VBN	amod	O
CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
required	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
either	CC	cc:preconj	O
CD80	NN	nmod	B-protein
or	CC	cc	O
CD86	NN	conj	B-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
IL-2	NN	compound	B-protein
production	NN	nsubj	O
reached	VBD	ROOT	O
only	RB	advmod	O
suboptimal	JJ	amod	O
levels	NNS	dobj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
CD86	NN	nmod	B-protein
but	CC	cc	O
optimal	JJ	amod	O
levels	NNS	conj	O
with	IN	case	O
CD80	NN	nmod	B-protein
.	.	punct	O

To	TO	mark	O
analyze	VB	ROOT	O
IL-2	NN	compound	B-protein
transcriptional	JJ	amod	O
activity	NN	dobj	O
in	IN	case	O
CD80	NN	nmod	B-protein
and	CC	cc	O
CD86	NN	conj	B-protein
co-stimulated	VBD	parataxis	O
T	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
we	PRP	nsubj	O
used	VBD	parataxis	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	dobj	I-cell_line
transfected	VBN	acl	O
with	IN	case	O
luciferase	NN	compound	B-DNA
reporter	NN	compound	I-DNA
gene	NN	compound	I-DNA
constructs	NNS	nmod	I-DNA
.	.	punct	O

CD80	NN	nsubj	B-protein
induced	VBD	ROOT	O
higher	JJR	amod	O
levels	NNS	dobj	O
of	IN	case	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
-enhancer	JJ	compound	O
activity	NN	nmod	O
compared	VBN	case	O
to	TO	case	O
CD86	NN	nmod	B-protein
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
activity	NN	nsubj	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
regulating	VBG	acl	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter-enhancer	JJ	amod	I-DNA
region	NN	dobj	I-DNA
including	VBG	case	O
activation	NN	compound	B-protein
protein-1	NN	nmod	I-protein
,	,	punct	O
CD28	NN	compound	B-DNA
response	NN	compound	I-DNA
element	NN	conj	I-DNA
and	CC	cc	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappaB	NN	conj	I-protein
were	VBD	cop	O
4-8	CD	nummod	O
times	NNS	nmod:npmod	O
higher	JJR	ROOT	O
after	IN	case	O
CD80	NN	nmod	B-protein
compared	VBN	advcl	O
to	TO	case	O
CD86	NN	compound	B-protein
ligation	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
eventual	JJ	amod	O
appearance	NN	nsubj	O
of	IN	case	O
CD80	NN	nmod	B-protein
on	IN	case	O
recently	RB	advmod	O
activated	VBN	amod	O
CD86+	JJ	amod	B-cell_type
APC	NN	nmod	I-cell_type
is	VBZ	cop	O
important	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
superinduction	NN	nmod	O
of	IN	case	O
IL-2	NN	compound	B-protein
production	NN	nmod	O
and	CC	cc	O
to	TO	mark	O
support	VB	conj	O
vigorous	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	dobj	O
.	.	punct	O

Duplication	NN	ROOT	O
of	IN	case	O
the	DT	det	O
DR3	NN	compound	B-DNA
gene	NN	nmod	I-DNA
on	IN	case	O
human	JJ	amod	B-DNA
chromosome	NN	compound	I-DNA
1p36	NN	nmod	I-DNA
and	CC	cc	O
its	PRP$	nmod:poss	O
deletion	NN	conj	O
in	IN	case	O
human	JJ	amod	B-cell_type
neuroblastoma	NN	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-DNA
DR3	NN	compound	I-DNA
gene	NN	nsubj	I-DNA
,	,	punct	O
whose	WP$	nmod:poss	O
product	NN	nsubjpass	O
is	VBZ	auxpass	O
also	RB	advmod	O
known	VBN	acl:relcl	O
as	IN	case	O
Wsl-1/APO-3/TRAMP/LARD	NN	nmod	B-protein
,	,	punct	O
encodes	VBZ	ROOT	O
a	DT	det	O
tumor	NN	compound	B-protein
necrosis	NN	nmod:npmod	I-protein
factor-related	JJ	amod	I-protein
receptor	NN	dobj	I-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
expressed	VBN	acl:relcl	O
primarily	RB	advmod	O
on	IN	case	O
the	DT	det	O
surface	NN	nmod	O
of	IN	case	O
thymocytes	NNS	nmod	B-cell_type
and	CC	cc	O
lymphocytes	NNS	conj	B-cell_type
.	.	punct	O

DR3	NN	nsubj	B-protein
is	VBZ	cop	O
capable	JJ	ROOT	O
of	IN	mark	O
inducing	VBG	advcl	O
both	CC	cc:preconj	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
when	WRB	advmod	O
overexpressed	VBN	advcl	O
in	IN	case	O
mammalian	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
although	IN	mark	O
its	PRP$	nmod:poss	O
ligand	NN	nsubjpass	O
has	VBZ	aux	O
not	RB	neg	O
yet	RB	advmod	O
been	VBN	auxpass	O
identified	VBN	advcl	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
the	DT	det	O
DR3	NN	compound	B-DNA
gene	NN	compound	I-DNA
locus	NN	nsubj	I-DNA
is	VBZ	cop	O
tandemly	RB	ccomp	O
duplicated	JJ	xcomp	O
on	IN	case	O
human	JJ	amod	B-DNA
chromosome	NN	compound	I-DNA
band	NN	nmod	I-DNA
1p36.2-p36.3	CD	dep	I-DNA
and	CC	cc	O
that	IN	mark	O
these	DT	det	O
genes	NNS	nsubjpass	O
are	VBP	auxpass	O
hemizygously	RB	advmod	O
deleted	VBN	conj	O
and/or	CC	cc	O
translocated	VBN	conj	O
to	TO	case	O
another	DT	det	O
chromosome	NN	nmod	O
in	IN	case	O
neuroblastoma	NN	compound	B-cell_line
(	-LRB-	punct	I-cell_line
NB	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
with	IN	case	O
amplified	VBN	amod	O
MYCN	NNP	nmod	O
.	.	punct	O

Duplication	NN	nsubjpass	O
of	IN	case	O
at	IN	advmod	O
least	JJS	nmod:npmod	O
a	DT	det	O
portion	NN	nmod	O
of	IN	case	O
the	DT	det	O
DR3	NN	compound	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
including	VBG	case	O
the	DT	dep	O
extracellular	JJ	nmod	B-protein
and	CC	cc	I-protein
transmembrane	JJ	conj	I-protein
regions	NNS	dep	I-protein
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
cytoplasmic	JJ	amod	B-protein
domain	NN	conj	I-protein
,	,	punct	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
by	IN	case	O
both	DT	cc:preconj	O
fluorescence	NN	compound	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nmod	O
and	CC	cc	O
genomic	JJ	amod	O
Southern	NN	compound	O
blotting	NN	conj	O
.	.	punct	O

In	IN	case	O
most	JJS	amod	O
NB	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
both	CC	cc:preconj	O
the	DT	det	O
DR3	NN	nsubjpass	B-DNA
and	CC	cc	I-DNA
the	DT	det	I-DNA
DR3L	NN	compound	I-DNA
sequences	NNS	conj	I-DNA
are	VBP	auxpass	O
simultaneously	RB	advmod	O
deleted	VBN	ROOT	O
and/or	CC	cc	O
translocated	VBN	conj	O
to	TO	case	O
another	DT	det	O
chromosome	NN	nmod	B-DNA
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
DR3/	NN	amod	B-protein
Wsl-1	NN	compound	I-protein
protein	NN	compound	I-protein
expression	NN	nsubj	O
is	VBZ	cop	O
quite	RB	advmod	O
variable	JJ	ROOT	O
among	IN	case	O
these	DT	det	O
NB	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
with	IN	case	O
very	RB	advmod	O
low	JJ	amod	O
or	CC	cc	O
undetectable	JJ	conj	O
levels	NNS	nmod	O
in	IN	case	O
7	CD	compound	O
of	IN	advmod	O
17	CD	nummod	O
NB	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line

Differential	JJ	amod	O
protection	NN	ROOT	O
of	IN	case	O
normal	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
malignant	JJ	conj	I-cell_type
human	JJ	amod	I-cell_type
myeloid	JJ	amod	I-cell_type
progenitors	NNS	nmod	I-cell_type
(	-LRB-	punct	O
CFU-GM	NN	appos	B-cell_type
)	-RRB-	punct	O
from	IN	case	O
Ara-C	NN	compound	O
toxicity	NN	nmod	O
using	VBG	acl	O
cycloheximide	NN	dobj	O
.	.	punct	O

Cycloheximide	NN	nsubjpass	O
,	,	punct	O
a	DT	det	O
reversible	JJ	amod	O
protein	NN	compound	O
synthesis	NN	compound	O
inhibitor	NN	appos	O
,	,	punct	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
block	VB	xcomp	O
DNA	NN	compound	O
replication	NN	dobj	O
in	IN	case	O
normal	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	mark	O
preventing	VBG	advcl	O
synthesis	NN	dobj	O
of	IN	case	O
a	DT	det	O
labile	JJ	amod	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
animal	NN	compound	O
systems	NNS	nmod	O
,	,	punct	O
cycloheximide	NN	nsubj	O
protects	VBZ	ROOT	O
normal	JJ	amod	B-cell_type
cells	NNS	dobj	I-cell_type
from	IN	case	O
cytotoxic	JJ	amod	O
S-phase	NN	compound	O
specific	JJ	amod	O
agents	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
cytosine	NN	compound	O
arabinoside	NN	nmod	O
(	-LRB-	punct	O
Ara-C	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Malignant	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
appear	VBP	ROOT	O
not	RB	neg	O
to	TO	mark	O
be	VB	cop	O
susceptible	JJ	xcomp	O
to	TO	case	O
cycloheximide-induced	JJ	amod	O
cycle	NN	compound	O
arrest	NN	nmod	O
and	CC	cc	O
,	,	punct	O
subsequently	RB	advmod	O
,	,	punct	O
may	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
protected	VBN	conj	O
from	IN	case	O
Ara-C	NN	compound	O
cytotoxicity	NN	nmod	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
cycloheximide	NN	nmod	O
on	IN	case	O
granulocyte/macrophage	JJ	amod	B-cell_type
progenitors	NNS	nmod	I-cell_type
(	-LRB-	punct	O
CFU-GM	NN	appos	B-cell_type
)	-RRB-	punct	O
after	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
Ara-C	NN	compound	O
exposure	NN	nmod	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
using	VBG	xcomp	O
normal	JJ	amod	O
human	JJ	amod	O
bone	NN	compound	O
marrow	NN	dobj	O
,	,	punct	O
malignant	JJ	amod	B-cell_type
progenitors	NNS	conj	I-cell_type
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
myelogenous	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
CML	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
clonogenic	JJ	amod	B-cell_line
cells	NNS	conj	I-cell_line
from	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
acute	JJ	amod	I-cell_line
nonlymphocytic	JJ	amod	I-cell_line
leukemia	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
HL-60	NN	dep	I-cell_line
and	CC	cc	I-cell_line
KG-1	NN	conj	I-cell_line
.	.	punct	O

Mononuclear	JJ	amod	B-cell_line
or	CC	cc	I-cell_line
clonogenic	JJ	conj	I-cell_line
cells	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
incubated	VBN	ROOT	O
for	IN	case	O
one	CD	nummod	O
hour	NN	nmod	O
with	IN	case	O
cycloheximide	NN	nmod	O
,	,	punct	O
followed	VBN	advcl	O
by	IN	case	O
the	DT	det	O
addition	NN	nmod	O
,	,	punct	O
for	IN	case	O
three	CD	nummod	O
or	CC	cc	O
17	CD	conj	O
hours	NNS	nmod	O
,	,	punct	O
of	IN	case	O
Ara-C	NN	nmod	O
before	IN	mark	O
being	VBG	auxpass	O
plated	VBN	advcl	O
in	IN	case	O
a	DT	det	O
methylcellulose	JJ	amod	O
culture	NN	compound	O
system	NN	nmod	O
.	.	punct	O

CFU-GM	NN	compound	O
survival	NN	nsubj	O
was	VBD	auxpass	O
significantly	RB	advmod	O
increase	VB	ROOT	O
if	IN	mark	O
normal	JJ	amod	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
treated	VBN	advcl	O
with	IN	case	O
cycloheximide	NN	nmod	O
before	IN	case	O
Ara-C	NN	compound	O
exposure	NN	nmod	O
.	.	punct	O

Similar	JJ	amod	O
cycloheximide	NN	compound	O
pretreatment	NN	nsubj	O
of	IN	case	O
CML	NN	compound	B-cell_type
progenitors	NNS	nmod	I-cell_type
and	CC	cc	O
clonogenic	JJ	amod	B-cell_line
HL-60	NN	compound	I-cell_line
and	CC	cc	I-cell_line
KG-1	NN	conj	I-cell_line
cells	NNS	conj	I-cell_line
failed	VBD	ROOT	O
to	TO	mark	O
protect	VB	xcomp	O
CFU-GM	NN	dobj	B-cell_type
from	IN	case	O
Ara-C-induced	JJ	amod	O
cytotoxicity	NN	nmod	O
.	.	punct	O

Primary	JJ	amod	O
cortisol	NN	compound	O
resistance	NN	ROOT	O
accompanied	VBN	acl	O
by	IN	case	O
a	DT	det	O
reduction	NN	nmod	O
in	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
two	CD	nummod	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
same	JJ	amod	O
family	NN	nmod	O
.	.	punct	O

This	DT	det	O
report	NN	ROOT	O
describes	VBZ	amod	O
studies	NNS	dobj	O
of	IN	prep	O
a	DT	det	O
man	NN	pobj	O
suspected	VBN	acl	O
of	IN	prep	O
having	VBG	pcomp	O
primary	JJ	amod	O
cortisol	NN	compound	O
resistance	NN	dobj	O
.	.	punct	O

This	DT	det	O
conclusion	NN	nsubjpass	O
is	VBZ	auxpass	O
based	VBN	ROOT	O
on	IN	case	O
his	PRP$	nmod:poss	O
high	JJ	amod	O
plasma	NN	compound	O
cortisol	NN	compound	O
levels	NNS	nmod	O
and	CC	cc	O
high	JJ	amod	O
24-h	JJ	amod	O
urinary	JJ	amod	O
17-hydroxycorticosteroid	NN	compound	O
and	CC	cc	O
cortisol	NN	conj	O
excretion	NN	conj	O
,	,	punct	O
plus	CC	cc	O
the	DT	det	O
fact	NN	conj	O
that	IN	mark	O
he	PRP	nsubj	O
had	VBD	relcl	O
no	DT	det	O
manifestations	NNS	dobj	O
of	IN	case	O
Cushing	NN	nmod:poss	O
's	POS	case	O
syndrome	NN	nmod	O
.	.	punct	O

Among	IN	case	O
family	NN	compound	O
members	NNS	nmod	O
tested	VBN	acl	O
,	,	punct	O
his	PRP$	poss	O
mother	NN	nsubj	O
also	RB	advmod	O
had	VBD	ROOT	O
hypercortisolemia	NN	dobj	O
.	.	punct	O

Both	CC	det	O
mother	NN	nsubj	O
and	CC	cc	O
son	NN	conj	O
had	VBD	ROOT	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
unbound	JJ	amod	O
plasma	NN	compound	O
cortisol	NN	nmod	O
,	,	punct	O
but	CC	cc	O
their	PRP$	nmod:poss	O
plasma	NN	compound	O
ACTH	NN	compound	O
concentrations	NNS	nsubj	O
were	VBD	cop	O
within	IN	case	O
the	DT	det	O
normal	JJ	amod	O
range	NN	conj	O
.	.	punct	O

Both	DT	nsubj	O
were	VBD	cop	O
partially	RB	advmod	O
resistant	JJ	ROOT	O
to	TO	case	O
dexamethasone	NN	compound	O
adrenal	JJ	amod	O
suppression	NN	nmod	O
,	,	punct	O
and	CC	cc	O
both	DT	nsubj	O
had	VBD	conj	O
mild	JJ	amod	O
hypertension	NN	dobj	O
without	IN	case	O
hypokalemia	NN	nmod	O
.	.	punct	O

To	TO	mark	O
study	VB	advcl	O
this	DT	det	O
apparent	JJ	amod	O
end-organ	JJ	amod	O
resistance	NN	dobj	O
to	TO	case	O
cortisol	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	dobj	I-protein
in	IN	case	O
peripheral	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Using	VBG	advcl	O
whole	JJ	amod	O
cell	NN	compound	O
assays	NNS	dobj	O
,	,	punct	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
in	IN	case	O
both	DT	det	O
patients	NNS	nmod	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
have	VB	aux	O
reduced	VBN	xcomp	O
total	JJ	amod	O
binding	NN	compound	O
capacity	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
these	DT	det	O
two	CD	nummod	O
patients	NNS	nsubj	O
,	,	punct	O
members	NNS	appos	O
of	IN	case	O
the	DT	det	O
same	JJ	amod	O
family	NN	nmod	O
,	,	punct	O
have	VBP	ccomp	O
primary	JJ	amod	O
cortisol	NN	compound	O
resistance	NN	dobj	O
accompanied	VBN	acl	O
by	IN	case	O
a	DT	det	O
reduced	VBN	amod	O
number	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

[	-LRB-	punct	O
Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
and	CC	cc	O
response	NN	conj	O
to	TO	case	O
polychemotherapy	NN	nmod	O
in	IN	case	O
acute	JJ	amod	O
lymphatic	JJ	amod	O
leukemia	NN	nmod	O
]	-RRB-	punct	O

Glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
quantified	VBN	ROOT	O
in	IN	case	O
leukemic	JJ	amod	B-cell_type
blasts	NNS	nmod	I-cell_type
from	IN	case	O
peripheral	JJ	amod	O
blood	NN	nmod	O
of	IN	case	O
86	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

The	DT	det	O
subsequent	JJ	amod	O
achievement	NN	nsubjpass	O
of	IN	case	O
complete	JJ	amod	O
remission	NN	nmod	O
after	IN	case	O
combination	NN	compound	O
chemotherapy	NN	nmod	O
was	VBD	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
high	JJ	amod	O
receptor	NN	compound	O
levels	NNS	nmod	O
.	.	punct	O

Forty-seven	CD	nsubj	O
of	IN	case	O
50	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
containing	VBG	acl	O
more	JJR	amod	O
than	IN	mwe	O
6	CD	dep	O
,	,	punct	O
000	CD	nummod	O
receptor	NN	compound	O
sites	NNS	dobj	O
and	CC	cc	O
22	CD	compound	O
of	IN	advmod	O
36	CD	nummod	O
patients	NNS	conj	O
with	IN	case	O
cells	NNS	nmod	O
containing	VBG	acl	O
less	JJR	amod	O
than	IN	case	O
6	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
receptor	NN	compound	O
sites	NNS	dobj	O
achieved	VBD	ROOT	O
remission	NN	dobj	O
.	.	punct	O

The	DT	det	O
study	NN	nsubj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
may	MD	aux	O
predict	VB	ROOT	O
response	NN	dobj	O
to	TO	case	O
combination	NN	compound	O
chemotherapy	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

Specific	JJ	amod	O
uptake	NN	ROOT	O
of	IN	case	O
1	CD	nmod	O
,	,	punct	O
25-dihydroxycholecalciferol	NN	conj	O
by	IN	case	O
human	JJ	amod	B-cell_type
chronic	JJ	amod	I-cell_type
myeloid	JJ	amod	I-cell_type
leukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
mononuclear	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
preparations	NNS	dobj	I-cell_line
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
myeloid	JJ	amod	O
leukemia	NN	nmod	O
[	-LRB-	punct	O
CML	NN	appos	O
]	-RRB-	punct	O
for	IN	case	O
binding	NN	nmod	O
of	IN	dep	O
and	CC	cc	O
response	NN	conj	O
to	TO	case	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxycholecalciferol	NN	conj	O
[	-LRB-	punct	O
1	CD	dep	O
,	,	punct	O
25-	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
]	-RRB-	punct	O
.	.	punct	O

Whole	JJ	amod	O
cells	NNS	nsubj	O
specifically	RB	advmod	O
took	VBD	ROOT	O
up	RP	prt	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
-1	CD	dep	O
,	,	punct	O
25-	CD	compound	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	dobj	O
with	IN	case	O
high	JJ	amod	O
affinity	NN	nmod	O
(	-LRB-	punct	O
Kd	NN	compound	O
3.6	CD	nummod	O
X	NN	compound	O
10	CD	nummod	O
(	-LRB-	punct	O
-11	CD	dep	O
)	-RRB-	punct	O
M	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
low	JJ	amod	O
capacity	NN	conj	O
.	.	punct	O

Subcellular	JJ	amod	O
fractionation	NN	nsubj	O
of	IN	case	O
labeled	VBN	amod	B-cell_line
cells	NNS	nmod	I-cell_line
showed	VBD	ROOT	O
that	IN	mark	O
binding	NN	nsubj	O
was	VBD	cop	O
restricted	JJ	ccomp	O
to	TO	case	O
cytosols	NNS	nmod	O
and	CC	cc	O
nuclei	NNS	conj	O
.	.	punct	O

Sucrose	NN	compound	O
gradient	NN	compound	O
centrifugation	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	O
preincubated	VBN	acl	O
with	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
-1	CD	dep	O
,	,	punct	O
25-	CD	compound	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
revealed	VBD	ROOT	O
a	DT	det	O
single	JJ	amod	O
3.6S	CD	compound	O
peak	NN	dobj	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
totally	RB	advmod	O
displaced	VBN	acl:relcl	O
with	IN	case	O
100-fold	JJ	amod	O
excess	JJ	amod	O
nonradioactive	JJ	amod	O
hormone	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
were	VBD	cop	O
unable	JJ	ROOT	O
to	TO	mark	O
demonstrate	VB	xcomp	O
specific	JJ	amod	O
binding	NN	dobj	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
by	IN	mark	O
postlabeling	VBG	advcl	O
standard	JJ	amod	O
cytosol	NN	compound	O
preparations	NNS	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
cytosols	NNS	nsubj	O
prepared	VBN	acl	O
from	IN	case	O
a	DT	det	O
mixture	NN	nmod	O
of	IN	case	O
CML	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
1	CD	nummod	B-cell_line
,	,	punct	I-cell_line
25-	CD	conj	I-cell_line
(	-LRB-	punct	I-cell_line
OH	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
2D3	NN	compound	I-cell_line
receptor-positive	JJ	amod	I-cell_line
T47D	NN	compound	I-cell_line
(	-LRB-	punct	O
human	JJ	amod	O
breast	NN	compound	O
cancer	NN	appos	O
)	-RRB-	punct	O
cells	NNS	nsubj	O
had	VBD	ROOT	O
less	JJR	advmod	O
than	IN	advmod	O
10	CD	nummod	O
%	NN	dobj	O
of	IN	case	O
the	DT	det	O
binding	NN	nmod	O
measured	VBN	acl	O
in	IN	case	O
T47D	NN	compound	B-cell_line
cytosol	NN	nmod	O
alone	RB	advmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
levels	NNS	nsubjpass	O
of	IN	case	O
binding	NN	nmod	O
in	IN	case	O
T47D	NN	compound	B-cell_line
cytosols	NNS	nmod	O
were	VBD	auxpass	O
not	RB	neg	O
reduced	VBN	ROOT	O
if	IN	mark	O
the	DT	det	O
receptors	NNS	nsubjpass	O
were	VBD	auxpass	O
occupied	VBN	advcl	O
with	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
-1	CD	dep	O
,	,	punct	O
25-	CD	compound	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
prior	RB	case	O
to	TO	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
the	DT	det	O
CML	NN	compound	B-cell_line
cytosols	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
CML	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
appear	VBP	ROOT	O
to	TO	mark	O
contain	VB	xcomp	O
both	CC	cc:preconj	O
the	DT	det	O
receptor	NN	dobj	O
for	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
and	CC	cc	O
an	DT	det	O
unknown	JJ	amod	O
substance	NN	conj	O
which	WDT	nsubj	O
prevents	VBZ	acl:relcl	O
its	PRP$	nmod:poss	O
detection	NN	dobj	O
following	VBG	case	O
the	DT	det	O
preparation	NN	nmod	O
of	IN	case	O
cytosol	NN	nmod	O
.	.	punct	O

Cells	NNS	nsubj	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
CML	NN	nmod	O
in	IN	case	O
the	DT	det	O
chronic	JJ	amod	O
phase	NN	nmod	O
specifically	RB	advmod	O
bound	VBD	ROOT	O
more	RBR	amod	O
1	CD	nummod	O
,	,	punct	O
25-	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	compound	O
[	-LRB-	punct	O
18.0	CD	nummod	O
+/-	CC	cc	O
3.2	CD	conj	O
(	-LRB-	punct	O
S.E.	NN	compound	O
)	-RRB-	punct	O
fmol/10	NN	compound	O
(	-LRB-	punct	O
7	CD	nummod	O
)	-RRB-	punct	O
cells	NNS	dobj	O
]	-RRB-	punct	O
than	IN	mark	O
did	VBD	advcl	O
those	DT	nsubj	O
in	IN	case	O
acute	JJ	amod	O
myeloid	JJ	amod	O
transformation	NN	nmod	O
[	-LRB-	punct	O
7.2	CD	nummod	O
+/-	CC	cc	O
1.5	CD	conj	O
]	-RRB-	punct	O
or	CC	cc	O
than	IN	conj	O
did	VBD	conj	O
cells	NNS	nmod	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
myeloid	JJ	amod	O
leukemia	NN	nmod	O
[	-LRB-	punct	O
2.6	CD	dep	O
+/-	CC	cc	O
0.8	CD	conj	O
]	-RRB-	punct	O
.	.	punct	O

Only	JJ	amod	O
cells	NNS	nsubj	O
from	IN	case	O
the	DT	det	O
first	JJ	amod	O
group	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
responded	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
addition	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
by	IN	mark	O
differentiating	VBG	advcl	O
along	IN	case	O
the	DT	det	O
monocyte-macrophage	JJ	amod	O
pathway	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
differentiation-induction	JJ	compound	O
effect	NN	nsubj	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
is	VBZ	cop	O
likely	JJ	ccomp	O
to	TO	mark	O
depend	VB	xcomp	O
on	IN	case	O
adequate	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
receptor	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
intact	JJ	amod	B-cell_type
cells	NNS	nsubjpass	I-cell_type
rather	RB	cc	O
than	IN	mwe	O
cytosol	NN	compound	O
preparations	NNS	conj	O
should	MD	aux	O
be	VB	auxpass	O
studied	VBN	conj	O
before	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
a	DT	det	O
particular	JJ	amod	O
tissue	NN	nmod	O
are	VBP	auxpass	O
designated	VBN	ccomp	O
as	IN	case	O
receptor	NN	compound	O
negative	JJ	nmod	O
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
position	NN	nmod	O
on	IN	case	O
dexamethasone	NN	compound	O
binding	NN	nmod	O
by	IN	case	O
mouse	NN	compound	B-cell_line
and	CC	cc	I-cell_line
human	JJ	conj	I-cell_line
lymphoid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
:	:	punct	O
correlation	NN	dep	O
between	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
dexamethasone	NN	compound	O
binding	NN	nmod	O
during	IN	case	O
S	NN	compound	O
phase	NN	nmod	O
and	CC	cc	O
dexamethasone	NN	compound	O
sensitivity	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
determined	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
position	NN	nmod	O
on	IN	case	O
the	DT	det	O
amount	NN	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
specifically	RB	advmod	O
bound	VBN	acl:relcl	O
by	IN	case	O
mouse	NN	nmod	B-cell_line
and	CC	cc	I-cell_line
human	JJ	amod	I-cell_line
lymphoid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

Cell	NN	compound	B-cell_line
lines	NNS	nsubjpass	I-cell_line
that	WDT	nsubj	O
were	VBD	cop	O
either	CC	cc:preconj	O
sensitive	JJ	acl:relcl	O
or	CC	cc	O
resistant	JJ	conj	O
to	TO	case	O
growth	NN	compound	O
inhibition	NN	nmod	O
by	IN	case	O
dexamethasone	NN	nmod	O
were	VBD	auxpass	O
compared	VBN	ROOT	O
.	.	punct	O

Exponentially	RB	advmod	B-cell_type
growing	VBG	amod	I-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
separated	VBN	ROOT	O
by	IN	case	O
centrifugal	NN	amod	O
elutriation	NN	nmod	O
into	IN	case	O
fractions	NNS	nmod	O
that	WDT	nsubj	O
corresponded	VBD	acl:relcl	O
to	TO	case	O
different	JJ	amod	O
positions	NNS	nmod	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
.	.	punct	O

The	DT	det	O
cell	NN	compound	O
cycle	NN	compound	O
phase	NN	compound	O
distribution	NN	nsubjpass	O
of	IN	case	O
each	DT	det	O
fraction	NN	nmod	O
was	VBD	auxpass	O
estimated	VBN	ROOT	O
by	IN	case	O
flow	NN	compound	O
cytometry	NN	nmod	O
and	CC	cc	O
autoradiography	NN	conj	O
.	.	punct	O

The	DT	det	O
amount	NN	nsubj	O
of	IN	case	O
dexamethasone	NN	nmod	O
bound	VBD	nsubjpass	O
per	IN	case	O
cell	NN	nmod	O
in	IN	case	O
each	DT	det	O
fraction	NN	nmod	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
whole	JJ	amod	O
cell	NN	compound	O
binding	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

In	IN	case	O
three	CD	nummod	O
dexamethasone-sensitive	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
(	-LRB-	punct	O
two	CD	nummod	O
mouse	NN	dep	O
and	CC	cc	O
one	CD	nummod	O
human	JJ	conj	O
)	-RRB-	punct	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
amount	NN	nsubj	O
of	IN	case	O
dexamethasone	NN	nmod	O
bound	VBD	ccomp	O
per	IN	case	O
cell	NN	nmod	O
increased	VBD	amod	O
2-4-fold	RB	advmod	O
between	IN	case	O
G1	NN	compound	O
phase	NN	nmod	O
and	CC	cc	O
S	NN	compound	O
phase	NN	conj	O
,	,	punct	O
and	CC	cc	O
then	RB	advmod	O
decreased	VBD	conj	O
during	IN	case	O
G2/M	NN	compound	O
phase	NN	nmod	O
.	.	punct	O

Results	NNS	nsubj	O
were	VBD	auxpass	O
the	DT	det	O
same	JJ	nsubjpass	O
when	WRB	advmod	O
the	DT	det	O
amount	NN	nsubj	O
of	IN	prep	O
dexamethasone	NN	pobj	O
bound	VBD	advcl	O
per	IN	case	O
milligram	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-protein
protein	NN	nmod	I-protein
was	VBD	auxpass	O
measured	VBN	ROOT	O
.	.	punct	O

Binding	NN	compound	O
affinity	NN	nsubj	O
was	VBD	cop	O
the	DT	det	O
same	JJ	ROOT	O
during	IN	case	O
G1	NN	compound	O
phase	NN	nmod	O
and	CC	cc	O
S	NN	compound	O
phase	NN	conj	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
proportion	NN	nsubj	O
of	IN	case	O
bound	VBN	amod	O
dexamethasone	NN	nmod	O
that	WDT	nsubj	O
translocated	VBD	acl:relcl	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
was	VBD	cop	O
greater	JJR	conj	O
during	IN	case	O
S	NN	compound	O
phase	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
amount	NN	nsubj	O
of	IN	case	O
dexamethasone	NN	nmod	O
bound	VBD	ccomp	O
per	IN	case	O
cell	NN	nmod	O
by	IN	case	O
three	CD	nummod	O
dexamethasone-resistant	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
(	-LRB-	punct	O
two	CD	nummod	O
mouse	NN	dep	O
and	CC	cc	O
one	CD	nummod	O
human	JJ	conj	O
)	-RRB-	punct	O
did	VBD	aux	O
not	RB	neg	O
increase	VB	ccomp	O
during	IN	case	O
S	NN	compound	O
phase	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
cell	NN	compound	O
cycle	NN	compound	O
changes	NNS	nsubj	O
in	IN	case	O
dexamethasone	NN	compound	O
binding	NN	nmod	O
are	VBP	cop	O
not	RB	neg	O
simply	RB	advmod	O
related	JJ	ccomp	O
to	TO	case	O
changes	NNS	nmod	O
in	IN	case	O
cell	NN	compound	B-protein
protein	NN	nmod	I-protein
or	CC	cc	O
cell	NN	compound	O
volume	NN	conj	O
during	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
.	.	punct	O

An	DT	det	O
increase	NN	nsubjpass	O
in	IN	case	O
dexamethasone	NN	compound	O
binding	NN	nmod	O
during	IN	case	O
S	NN	compound	O
phase	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
dexamethasone	NN	nmod	O
to	TO	mark	O
inhibit	VB	xcomp	O
cell	NN	compound	O
growth	NN	dobj	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
failure	NN	nsubj	O
of	IN	case	O
dexamethasone	NN	compound	O
binding	NN	nmod	O
to	TO	mark	O
increase	VB	acl	O
during	IN	case	O
S	NN	compound	O
phase	NN	nmod	O
might	MD	aux	O
represent	VB	conj	O
a	DT	det	O
new	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
dexamethasone	NN	compound	O
resistance	NN	nmod	O
in	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Presence	NN	ROOT	O
and	CC	cc	O
steroid	NN	compound	O
inducibility	NN	conj	O
of	IN	case	O
glutamine	NN	compound	B-protein
synthetase	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
leukemic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Glutamine	NN	compound	B-protein
synthetase	NN	nsubj	I-protein
(	-LRB-	punct	O
EC	NN	appos	O
6.3.1.2	NN	nummod	O
;	:	punct	O
GS	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
lymphoblasts	NNS	nmod	B-cell_type
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
ALL	NN	appos	O
)	-RRB-	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
normal	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	conj	I-cell_type
.	.	punct	O

In	IN	case	O
16	CD	nummod	O
out	IN	advmod	O
of	IN	advmod	O
20	CD	nummod	O
ALL	NN	compound	O
patients	NNS	nsubj	O
studied	VBD	ROOT	O
exposure	NN	dobj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
to	TO	case	O
physiological	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
increased	VBN	amod	O
enzyme	NN	compound	B-protein
activity	NN	conj	O
above	IN	case	O
the	DT	det	O
control	NN	compound	O
levels	NNS	nmod	O
.	.	punct	O

The	DT	det	O
increase	NN	nsubj	O
was	VBD	cop	O
specific	JJ	ROOT	O
for	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
ligands	NNS	nmod	O
.	.	punct	O

A	DT	det	O
direct	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
the	DT	det	O
magnitude	NN	nmod	O
of	IN	case	O
glucocorticoid-mediated	JJ	amod	O
increase	NN	nmod	O
of	IN	case	O
GS	NN	compound	O
activity	NN	nmod	O
and	CC	cc	O
the	DT	det	O
cellular	JJ	amod	O
levels	NNS	conj	O
of	IN	case	O
specific	JJ	amod	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
assayed	VBN	acl	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
cell	NN	compound	B-cell_type
specimen	NN	nmod	I-cell_type
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
basal	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
enzyme	NN	nmod	B-protein
measured	VBN	acl	O
in	IN	case	O
cells	NNS	nmod	O
prior	JJ	case	O
to	TO	case	O
exposure	NN	nmod	O
to	TO	case	O
dexamethasone	NN	nmod	O
correlated	VBD	ROOT	O
negatively	RB	advmod	O
with	IN	case	O
receptor	NN	compound	O
density	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
steroid-inducible	JJ	amod	B-protein
GS	NN	nmod	I-protein
in	IN	case	O
ALL	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
may	MD	aux	O
prove	VB	ccomp	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
marker	NN	xcomp	O
for	IN	case	O
functional	JJ	amod	B-protein
receptor	NN	compound	I-protein
sites	NNS	nmod	I-protein
.	.	punct	O

Binding	NN	ROOT	O
of	IN	case	O
progestins	NNS	nmod	O
to	TO	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Correlation	NN	ROOT	O
to	TO	case	O
their	PRP$	nmod:poss	O
glucocorticoid-like	JJ	amod	O
effects	NNS	nmod	O
on	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
functions	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
physiological	JJ	amod	O
and	CC	cc	O
synthetic	JJ	conj	O
progestins	NNS	nmod	O
were	VBD	auxpass	O
tested	VBN	ROOT	O
for	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
compete	VB	acl	O
with	IN	case	O
[	-LRB-	punct	O
3H	NN	intj	O
]	-RRB-	punct	O
dexamethasone	NN	nmod	O
for	IN	case	O
the	DT	det	O
binding	NN	nmod	O
to	TO	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
of	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
and	CC	cc	O
their	PRP$	nmod:poss	O
ability	NN	conj	O
to	TO	mark	O
elicit	VB	acl	O
glucocorticoid-like	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
the	DT	det	O
same	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

As	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
the	DT	det	O
reference	NN	compound	O
compound	NN	compound	O
dexamethasone	NN	nmod	O
(	-LRB-	punct	O
relative	JJ	amod	O
receptor	NN	compound	O
binding	NN	compound	O
affinity	NN	dep	O
defined	VBN	acl	O
as	IN	case	O
100	CD	nummod	O
%	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
two	CD	nummod	O
potent	JJ	amod	O
synthetic	JJ	amod	O
progestins	NNS	appos	O
with	IN	case	O
a	DT	det	O
pregnane-type	JJ	amod	O
structure	NN	nmod	O
,	,	punct	O
megestrol	NN	compound	O
acetate	NN	conj	O
and	CC	cc	O
medroxyprogesterone	NN	compound	O
acetate	NN	conj	O
,	,	punct	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
display	VB	xcomp	O
a	DT	det	O
considerable	JJ	amod	O
binding	NN	compound	O
affinity	NN	dobj	O
towards	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
(	-LRB-	punct	O
46	CD	nummod	O
and	CC	cc	O
42	CD	conj	O
%	NN	dep	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
relative	JJ	amod	O
binding	NN	compound	O
affinity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
naturally	RB	advmod	O
occurring	VBG	amod	O
ligand	NN	nmod	O
,	,	punct	O
cortisol	NN	appos	O
,	,	punct	O
to	TO	case	O
the	DT	det	O
receptor	NN	nmod	O
was	VBD	cop	O
clearly	RB	advmod	O
lower	JJR	ROOT	O
(	-LRB-	punct	O
25	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
effective	JJ	amod	O
binding	NN	nsubjpass	O
of	IN	case	O
medroxyprogesterone	NN	compound	O
acetate	NN	nmod	O
to	TO	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
direct	JJ	amod	O
binding	NN	compound	O
studies	NNS	nmod	O
utilizing	VBG	acl	O
a	DT	det	O
tritiated	JJ	amod	O
derivative	NN	dobj	O
of	IN	case	O
this	DT	det	O
steroid	NN	nmod	O
.	.	punct	O

No	DT	neg	O
evidence	NN	nsubjpass	O
for	IN	case	O
the	DT	det	O
existence	NN	nmod	O
of	IN	case	O
a	DT	det	O
specific	JJ	amod	O
progesterone	NN	compound	B-protein
receptor	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
was	VBD	auxpass	O
obtained	VBN	ROOT	O
as	IN	mark	O
judged	VBN	advcl	O
by	IN	case	O
the	DT	det	O
results	NNS	nmod	O
of	IN	case	O
competition	NN	compound	O
experiments	NNS	nmod	O
where	WRB	advmod	O
a	DT	det	O
progesterone	NN	compound	O
receptor-specific	JJ	amod	O
ligand	NN	nsubjpass	O
[	-LRB-	punct	O
3H	NN	appos	O
]	-RRB-	punct	O
Org	NNP	appos	O
2058	CD	nummod	O
was	VBD	auxpass	O
used	VBN	acl:relcl	O
.	.	punct	O

Medroxyprogesterone	NN	compound	O
acetate	NN	nsubj	O
and	CC	cc	O
megestrol	NN	compound	O
acetate	NN	conj	O
also	RB	advmod	O
induced	VBD	ROOT	O
glucocorticoid-like	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
the	DT	det	O
lymphocyte	NN	compound	B-cell_type
functions	NNS	nmod	O
.	.	punct	O

These	DT	nsubj	O
included	VBD	ROOT	O
inhibition	NN	dobj	O
of	IN	case	O
the	DT	det	O
proliferative	JJ	amod	O
responses	NNS	nmod	O
to	TO	case	O
the	DT	det	O
T-cell	NN	compound	B-protein
mitogens	NNS	nmod	I-protein
concanavalin	NN	compound	B-protein
A	NN	dep	I-protein
and	CC	cc	O
phytohaemagglutinin	NN	conj	B-protein
and	CC	cc	O
an	DT	det	O
enhanced	VBN	amod	O
accumulation	NN	conj	O
of	IN	case	O
immunoglobulin	NN	compound	B-cell_type
secreting	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
pokeweed	NN	compound	B-cell_line
mitogen-stimulated	JJ	amod	I-cell_line
cultures	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
progestin	NN	compound	O
effect	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
through	IN	case	O
a	DT	det	O
radiosensitive	JJ	amod	O
(	-LRB-	punct	O
suppressor	NN	dep	O
)	-RRB-	punct	O
subpopulation	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
synthetic	JJ	amod	O
progestins	NNS	nsubj	O
related	JJ	acl	O
structurally	RB	advmod	O
to	TO	case	O
19-nortestosterone	NN	nmod	O
,	,	punct	O
norethisterone	NN	conj	O
and	CC	cc	O
d-norgestrel	NN	conj	O
,	,	punct	O
were	VBD	cop	O
virtually	RB	advmod	O
devoid	JJ	ROOT	O
of	IN	case	O
binding	NN	compound	O
affinity	NN	nmod	O
towards	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
nor	CC	cc	O
did	VBD	aux	O
they	PRP	nsubj	O
measurably	RB	advmod	O
influence	VB	conj	O
the	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
lymphocyte	NN	compound	B-cell_type
functions	NNS	dobj	O
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
certain	JJ	amod	O
progestins	NNS	nsubj	O
in	IN	case	O
common	JJ	amod	O
clinical	JJ	amod	O
use	NN	nmod	O
probably	RB	advmod	O
possess	VBP	ccomp	O
inherent	JJ	amod	O
glucocorticoid	NN	compound	O
activity	NN	dobj	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
side	JJ	amod	O
effects	NNS	nsubjpass	O
attributable	JJ	amod	O
to	TO	case	O
this	DT	det	O
character	NN	nmod	O
(	-LRB-	punct	O
e.g.	FW	dep	O
suppression	NN	dep	O
of	IN	case	O
the	DT	det	O
pituitary-adrenal	JJ	amod	O
axis	NN	nmod	O
)	-RRB-	punct	O
might	MD	aux	O
be	VB	auxpass	O
expected	VBN	ccomp	O
when	WRB	advmod	O
these	DT	det	O
compounds	NNS	nsubjpass	O
are	VBP	auxpass	O
used	VBN	advcl	O
in	IN	case	O
pharmacological	JJ	amod	O
doses	NNS	nmod	O
.	.	punct	O

Metabolic	JJ	amod	O
and	CC	cc	O
ultrastructural	JJ	conj	O
aspects	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
lysis	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	B-cell_type
lymphocytic	JJ	amod	I-cell_type
leukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

Human	JJ	amod	B-cell_type
chronic	JJ	amod	I-cell_type
lymphocytic	JJ	amod	I-cell_type
leukemia	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
CLL	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nsubjpass	I-cell_type
like	IN	case	O
prothymocytes	NNS	nmod	B-cell_type
and	CC	cc	O
immunoactivated	VBN	amod	B-cell_type
T-lymphocytes	NNS	conj	I-cell_type
are	VBP	auxpass	O
readily	RB	advmod	O
lysed	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
by	IN	case	O
pharmacological	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
cortisol	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nsubj	I-cell_type
and	CC	cc	O
thymocytes	NNS	conj	B-cell_type
are	VBP	aux	O
unaffected	JJ	parataxis	O
by	IN	case	O
the	DT	det	O
hormone	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
metabolic	JJ	amod	O
and	CC	cc	O
ultrastructural	JJ	conj	O
aspects	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
cortisol-induced	JJ	amod	O
killing	NN	compound	O
process	NN	nmod	O
of	IN	case	O
CLL	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
are	VBP	auxpass	O
recorded	VBN	ROOT	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
lysis	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
temperature	NN	nmod:npmod	O
dependent	JJ	xcomp	O
and	CC	cc	O
was	VBD	auxpass	O
detected	VBN	conj	O
only	RB	advmod	O
after	IN	case	O
6	CD	compound	O
to	TO	dep	O
8	CD	nummod	O
hr	NN	compound	O
incubation	NN	nmod	O
with	IN	case	O
cortisol	NN	nmod	O
by	IN	case	O
means	NNS	nmod	O
of	IN	case	O
the	DT	det	O
trypan	NN	compound	O
blue	JJ	amod	O
exclusion	NN	compound	O
test	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
30	CD	nummod	O
min	NN	nsubj	O
of	IN	case	O
incubation	NN	nmod	O
with	IN	case	O
cortisol	NN	nmod	O
at	IN	case	O
either	CC	cc:preconj	O
37	CD	nummod	O
degrees	NNS	nmod	O
or	CC	cc	O
4	CD	nummod	O
degrees	NNS	conj	O
followed	VBN	acl	O
by	IN	case	O
the	DT	det	O
removal	NN	nmod	O
of	IN	case	O
the	DT	det	O
hormone	NN	nmod	B-protein
was	VBD	cop	O
still	RB	advmod	O
sufficient	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
the	DT	det	O
lytic	JJ	amod	O
process	NN	dobj	O
.	.	punct	O

Ultrastructural	JJ	amod	O
studies	NNS	nsubj	O
demonstrated	VBD	ROOT	O
sequential	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
,	,	punct	O
including	VBG	case	O
swelling	NN	nmod	O
of	IN	case	O
mitochondria	NN	nmod	O
and	CC	cc	O
cytoplasmic	JJ	amod	O
decompartmentalization	NN	conj	O
,	,	punct	O
followed	VBN	advcl	O
by	IN	case	O
loss	NN	nmod	O
of	IN	case	O
surface	NN	nmod	O
microvilli	JJ	conj	O
with	IN	case	O
the	DT	det	O
appearance	NN	nmod	O
of	IN	case	O
``	``	punct	O
holes	NNS	nmod	O
''	''	punct	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	O
membrane	NN	nmod	O
,	,	punct	O
and	CC	cc	O
subsequent	JJ	amod	O
condensation	NN	conj	O
of	IN	case	O
nuclear	JJ	amod	B-DNA
chromatin	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
large	JJ	amod	O
holes	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
membrane	NN	compound	O
appearing	NN	nmod	O
after	IN	case	O
6	CD	nummod	O
hr	NN	nmod	O
of	IN	case	O
incubation	NN	nmod	O
with	IN	case	O
the	DT	det	O
hormone	NN	nmod	B-protein
may	MD	aux	O
be	VB	cop	O
the	DT	det	O
cause	NN	ROOT	O
for	IN	case	O
the	DT	det	O
penetration	NN	nmod	O
of	IN	case	O
the	DT	det	O
viable	JJ	amod	O
stain	NN	nmod	O
into	IN	case	O
the	DT	det	O
dead	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
as	IN	mark	O
seen	VBN	advcl	O
by	IN	case	O
light	JJ	amod	O
microscopy	NN	nmod	O
.	.	punct	O

Addition	NN	nsubj	O
of	IN	case	O
metabolic	JJ	amod	O
inhibitors	NNS	nmod	O
including	VBG	case	O
actinomycin	NN	compound	O
D	NN	nmod	O
,	,	punct	O
puromycin	NN	conj	O
,	,	punct	O
and	CC	cc	O
cycloheximide	NN	conj	O
following	VBG	case	O
administration	NN	nmod	O
of	IN	case	O
cortisol	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
lysis	NN	nmod	O
.	.	punct	O

An	DT	det	O
excess	NN	nsubjpass	O
of	IN	prep	O
an	DT	det	O
antagonist	NN	pobj	O
such	JJ	amod	O
as	IN	prep	O
cortexolone	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
the	DT	det	O
cortisol-induced	JJ	amod	O
cytolysis	NN	dobj	O
of	IN	case	O
the	DT	det	O
CLL	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
glucocorticoid-induced	JJ	amod	O
lysis	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-cell_line
CLL	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
is	VBZ	cop	O
similar	JJ	ccomp	O
to	TO	case	O
the	DT	det	O
phenomenon	NN	nmod	O
observed	VBN	acl	O
in	IN	case	O
rat	NN	compound	B-cell_type
or	CC	cc	I-cell_type
murine	JJ	conj	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
is	VBZ	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
interaction	NN	nmod	O
of	IN	case	O
the	DT	det	O
steroid	NN	compound	O
molecule	NN	nmod	O
with	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
resulting	VBG	amod	O
complex	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
specific	JJ	amod	O
gene	NN	compound	B-DNA
(	-LRB-	punct	O
s	NNS	dobj	O
)	-RRB-	punct	O
the	DT	det	O
products	NNS	dobj	O
of	IN	case	O
which	WDT	nsubj	O
eventually	RB	advmod	O
cause	VBP	acl:relcl	O
cytolysis	NN	dobj	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
in	IN	case	O
lymphoid	JJ	amod	O
tumors	NNS	nmod	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
a	DT	det	O
range	NN	nsubj	O
of	IN	case	O
levels	NNS	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
numbers	NNS	nmod	O
seen	VBN	acl	O
in	IN	case	O
the	DT	det	O
various	JJ	amod	O
subclasses	NNS	nmod	O
of	IN	case	O
acute	JJ	amod	O
lymphatic	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
ALL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
variability	NN	nsubjpass	O
can	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
explained	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
known	JJ	amod	O
correlation	NN	nmod	O
between	IN	case	O
active	JJ	amod	O
cell	NN	compound	O
proliferation	NN	nmod	O
and	CC	cc	O
an	DT	det	O
increase	NN	conj	O
in	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
receptors	NNS	nmod	O
,	,	punct	O
since	IN	mark	O
the	DT	det	O
tumors	NNS	nsubj	O
with	IN	case	O
the	DT	det	O
highest	JJS	amod	O
growth	NN	compound	O
fraction	NN	nmod	O
(	-LRB-	punct	O
i.e.	FW	dep	O
,	,	punct	O
Burkitt	NN	nmod:poss	O
's	POS	case	O
lymphoma	NN	dep	O
and	CC	cc	O
T-cell	NN	compound	O
leukemia	NN	conj	O
)	-RRB-	punct	O
tend	VBP	advcl	O
to	TO	mark	O
have	VB	xcomp	O
lower	JJR	amod	O
average	JJ	amod	O
receptor	NN	compound	O
numbers	NNS	dobj	O
than	IN	mark	O
do	VBP	advcl	O
tumors	NNS	dobj	O
with	IN	case	O
lower	JJR	amod	O
growth	NN	compound	O
fractions	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
common	JJ	amod	O
ALL	NN	nmod	O
.	.	punct	O

All	DT	det	O
clinical	JJ	amod	O
specimens	NNS	nsubj	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
lymphatic	JJ	amod	O
leukemia	NN	nmod	O
have	VBP	ROOT	O
some	DT	det	O
measurable	JJ	amod	O
level	NN	dobj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
;	:	punct	O
therefore	RB	advmod	O
,	,	punct	O
the	DT	det	O
resistance	NN	nsubjpass	O
seen	VBN	acl	O
in	FW	compound	O
vivo	FW	advmod	O
can	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
explained	VBN	parataxis	O
by	IN	case	O
the	DT	det	O
lack	NN	nmod	O
of	IN	case	O
receptors	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
there	EX	expl	O
has	VBZ	aux	O
been	VBN	ROOT	O
a	DT	det	O
positive	JJ	amod	O
correlation	NN	attr	O
,	,	punct	O
in	IN	prep	O
our	PRP$	poss	O
hands	NNS	pobj	O
,	,	punct	O
with	IN	case	O
receptor	NN	compound	O
level	NN	nmod	O
and	CC	cc	O
prognosis	NN	conj	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
models	NNS	nmod	O
,	,	punct	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
proposed	VBN	ROOT	O
that	IN	mark	O
perhaps	RB	advmod	O
the	DT	det	O
high	JJ	amod	B-cell_line
receptor	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nsubj	I-cell_line
(	-LRB-	punct	O
i.e.	FW	dep	O
,	,	punct	O
common	JJ	amod	O
ALL	NN	dep	O
of	IN	case	O
childhood	NN	nmod	O
)	-RRB-	punct	O
have	VBP	ccomp	O
relative	JJ	amod	O
stability	NN	dobj	O
of	IN	case	O
their	PRP$	nmod:poss	O
genetic	JJ	amod	O
material	NN	nmod	O
making	VBG	acl	O
glucocorticoid-resistant	JJ	amod	O
mutations	NNS	nsubj	O
less	RBR	advmod	O
likely	JJ	advmod	O
to	TO	mark	O
occur	VB	xcomp	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
than	IN	case	O
in	IN	case	O
low-receptor	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
(	-LRB-	punct	O
i.e.	FW	dep	O
,	,	punct	O
T-cell	NN	compound	O
leukemia	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
greater	JJR	amod	O
genetic	JJ	amod	O
variability	NN	nsubj	O
in	IN	case	O
the	DT	det	O
low-receptor	JJ	amod	B-cell_line
lines	NNS	nmod	I-cell_line
could	MD	aux	O
account	VB	ROOT	O
for	IN	case	O
the	DT	det	O
earlier	JJR	amod	O
emergence	NN	nmod	O
of	IN	case	O
clinical	JJ	amod	O
glucocorticoid	NN	compound	O
resistance	NN	nmod	O
in	IN	case	O
these	DT	det	O
patients	NNS	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Tumor	NN	compound	O
histology	NN	ROOT	O
and	CC	cc	O
steroid	NN	compound	B-protein
receptors	NNS	conj	I-protein
in	IN	case	O
breast	NN	compound	O
carcinoma	NN	nmod	O
]	-RRB-	punct	O

In	IN	case	O
Specimens	NNP	nmod	O
of	IN	case	O
115	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
4	CD	nummod	O
tumorparameters	NNS	nmod	O
(	-LRB-	punct	O
tumorsize	VB	dep	O
,	,	punct	O
tumorboder	NN	conj	O
,	,	punct	O
nucleargrade	NN	conj	O
,	,	punct	O
lymphocytic	JJ	amod	O
stromal	JJ	amod	O
reaction	NN	appos	O
)	-RRB-	punct	O
3	CD	nummod	O
features	NNS	nsubjpass	O
of	IN	case	O
regional	JJ	amod	O
lymphnodes	NNS	nmod	O
(	-LRB-	punct	O
sinushistiocytosis	NN	dep	O
,	,	punct	O
T-cellreaction	NN	conj	O
,	,	punct	O
lymphnode	NN	amod	O
metastases	NNS	appos	O
)	-RRB-	punct	O
and	CC	cc	O
estrogen	NN	compound	B-protein
and	CC	cc	I-protein
progesteron	NN	conj	I-protein
receptors	NNS	conj	I-protein
were	VBD	auxpass	O
determined	VBN	ROOT	O
.	.	punct	O

A	DT	det	O
strong	JJ	amod	O
sinushistiocytosis	NN	nsubjpass	O
and	CC	cc	O
T-cellreaction	NN	conj	O
could	MD	aux	O
be	VB	auxpass	O
verified	VBN	ROOT	O
mainly	RB	advmod	O
in	IN	case	O
metastases	NNS	nmod	O
in	IN	case	O
free	JJ	amod	O
lymphnodes	NNS	nmod	O
.	.	punct	O

The	DT	det	O
steroid	NN	compound	B-protein
receptor	NN	compound	I-protein
content	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
correlate	VB	ROOT	O
with	IN	case	O
histological	JJ	amod	O
parameters	NNS	nmod	O

Aldosterone-receptor	NN	compound	B-protein
deficiency	NN	ROOT	O
in	IN	case	O
pseudohypoaldosteronism	NN	nmod	O
.	.	punct	O

Pseudohypoaldosteronism	NN	nsubj	O
,	,	punct	O
a	DT	det	O
syndrome	NN	appos	O
characterized	VBN	acl	O
by	IN	case	O
salt	NN	compound	O
wasting	NN	nmod	O
and	CC	cc	O
failure	NN	conj	O
to	TO	case	O
thrive	VB	nmod	O
,	,	punct	O
usually	RB	advmod	O
presents	VBZ	ROOT	O
in	IN	case	O
infancy	NN	nmod	O
as	IN	case	O
high	JJ	amod	O
urinary	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
sodium	NN	nmod	O
despite	IN	case	O
hyponatremia	NN	nmod	O
,	,	punct	O
hyperkalemia	NN	conj	O
,	,	punct	O
hyperreninemia	NN	conj	O
,	,	punct	O
and	CC	cc	O
elevated	JJ	amod	O
aldosterone	NN	compound	O
levels	NNS	conj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
this	DT	det	O
syndrome	NN	dobj	O
for	IN	case	O
the	DT	det	O
possibility	NN	nmod	O
of	IN	case	O
abnormal	JJ	amod	B-protein
Type	NN	compound	I-protein
I	CD	nummod	I-protein
or	CC	cc	O
``	``	punct	B-protein
mineralocorticoid-like	JJ	amod	I-protein
''	''	punct	I-protein
receptors	NNS	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
have	VBP	acl:relcl	O
intrinsic	JJ	amod	O
steroid	NN	compound	O
specificity	NN	dobj	O
indistinguishable	JJ	amod	O
from	IN	case	O
that	DT	nmod	O
of	IN	case	O
renal	JJ	amod	B-protein
mineralocorticoid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
are	VBP	auxpass	O
found	VBN	conj	O
in	IN	case	O
many	JJ	amod	O
tissues	NNS	nmod	O
and	CC	cc	O
cells	NNS	conj	B-cell_type
,	,	punct	O
including	VBG	case	O
mononuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
studied	VBN	ROOT	O
three	CD	nummod	O
patients	NNS	dobj	O
with	IN	case	O
pseudohypoaldosteronism	NN	nmod	O
:	:	punct	O
the	DT	det	O
28-year-old	JJ	amod	O
index	NN	compound	O
case	NN	dep	O
in	IN	case	O
Melbourne	NN	nmod	O
(	-LRB-	punct	O
Patient	NN	appos	O
1	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
two	CD	nummod	O
siblings	NNS	conj	O
in	IN	prep	O
Munich	NNP	pobj	O
,	,	punct	O
eight	CD	conj	O
and	CC	cc	O
two	CD	nummod	O
years	NNS	conj	O
of	IN	prep	O
age	NN	pobj	O
(	-LRB-	punct	O
Patients	NNS	appos	O
2	CD	nummod	O
and	CC	cc	O
3	CD	conj	O
)	-RRB-	punct	O
;	:	punct	O
clinically	RB	advmod	O
,	,	punct	O
Patient	NN	nsubj	O
3	CD	nummod	O
had	VBD	parataxis	O
a	DT	det	O
less	RBR	advmod	O
severe	JJ	amod	O
case	NN	dobj	O
than	IN	prep	O
his	PRP$	poss	O
sister	NN	pobj	O
.	.	punct	O

Percoll-separated	JJ	amod	B-cell_type
control	NN	compound	I-cell_type
monocytes	NNS	nsubj	I-cell_type
bound	VBD	ROOT	O
[	-LRB-	punct	O
3H	NN	ccomp	O
]	-RRB-	punct	O
aldosterone	NN	dep	O
with	IN	case	O
high	JJ	amod	O
affinity	NN	nmod	O
(	-LRB-	punct	O
Kd	NN	dep	O
approximately	RB	advmod	O
3	CD	nummod	O
nM	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
limited	JJ	amod	O
capacity	NN	conj	O
(	-LRB-	punct	O
150	CD	compound	O
to	TO	dep	O
600	CD	nummod	O
sites	NNS	dep	O
per	IN	case	O
cell	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

On	IN	case	O
repeated	VBN	amod	O
examination	NN	nmod	O
,	,	punct	O
no	DT	neg	O
[	-LRB-	punct	O
3H	NN	dep	O
]	-RRB-	punct	O
aldosterone	NN	compound	O
binding	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
from	IN	case	O
Patients	NNS	nmod	O
1	CD	nummod	O
and	CC	cc	O
2	CD	conj	O
;	:	punct	O
in	IN	case	O
Patient	NN	nmod	O
3	CD	nummod	O
,	,	punct	O
the	DT	det	O
levels	NNS	nsubj	O
were	VBD	cop	O
62	CD	nummod	O
sites	NNS	nmod	O
per	IN	case	O
cell	NN	nmod	O
,	,	punct	O
more	JJR	advmod	O
than	IN	mwe	O
2	CD	nummod	O
S.D.	NNP	conj	O
below	IN	case	O
those	DT	nmod	O
of	IN	case	O
the	DT	det	O
control	NN	nmod	O
.	.	punct	O

Levels	NNS	nsubj	O
in	IN	prep	O
the	DT	det	O
parents	NNS	pobj	O
of	IN	prep	O
the	DT	det	O
Munich	NNP	compound	O
patients	NNS	pobj	O
(	-LRB-	punct	O
first	JJ	amod	O
cousins	NNS	appos	O
)	-RRB-	punct	O
were	VBD	cop	O
normal	JJ	ROOT	O
.	.	punct	O

It	PRP	nsubj	O
appears	VBZ	ROOT	O
that	IN	mark	O
pseudohypoaldosteronism	NN	nsubjpass	O
is	VBZ	auxpass	O
caused	VBN	ccomp	O
by	IN	case	O
a	DT	det	O
Type	NN	compound	O
I	CD	nummod	O
receptor	NN	compound	O
defect	NN	nmod	O
,	,	punct	O
that	IN	mark	O
the	DT	det	O
defect	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
complete	JJ	ccomp	O
or	CC	cc	O
partial	JJ	conj	O
,	,	punct	O
that	IN	mark	O
transmission	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
autosomal	JJ	amod	O
recessive	JJ	ccomp	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
study	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
pseudohypoaldosteronism	NN	nmod	O
may	MD	aux	O
indicate	VB	conj	O
physiologic	JJ	amod	O
roles	NNS	dobj	O
for	IN	case	O
Type	NN	compound	B-protein
I	CD	nummod	I-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
nonepithelial	JJ	amod	O
tissues	NNS	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	O
inhibition	NN	ROOT	O
of	IN	case	O
urokinase-like	JJ	amod	B-protein
plasminogen	NN	compound	I-protein
activators	NNS	nmod	I-protein
in	IN	case	O
cultured	VBN	amod	B-cell_line
human	JJ	amod	I-cell_line
lymphoblasts	NNS	nmod	I-cell_line
.	.	punct	O

Two	CD	nummod	O
human	JJ	amod	B-cell_line
lymphoblast	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nsubj	I-cell_line
,	,	punct	O
LICR-LON-HMy2	NN	appos	B-cell_line
(	-LRB-	punct	O
HMy2	NN	compound	B-cell_line
cells	NNS	appos	I-cell_line
)	-RRB-	punct	O
and	CC	cc	O
GM4672A	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
are	VBP	cop	O
moderately	RB	advmod	O
growth	NN	ROOT	O
inhibited	VBN	acl	O
by	IN	case	O
dexamethasone	NN	nmod	O
(	-LRB-	punct	O
1	CD	dep	O
,	,	punct	O
4-pregnadien-9-fluoro-16	JJ	compound	O
alpha-methyl-11	NN	compound	O
beta	NN	conj	O
,	,	punct	O
17	CD	nummod	O
alpha	NN	conj	O
,	,	punct	O
21-triol-3	NN	conj	O
,	,	punct	O
20-dione	NN	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
Dex	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Both	DT	det	O
cell	NN	compound	O
types	NNS	nsubj	O
secrete	VBP	ROOT	O
a	DT	det	O
urokinase	NN	compound	B-protein
(	-LRB-	punct	I-protein
UK	NN	compound	I-protein
)	-RRB-	punct	I-protein
-like	JJ	amod	I-protein
plasminogen	NN	compound	I-protein
activator	NN	dobj	I-protein
(	-LRB-	punct	O
PA	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
HMy2	NN	compound	B-cell_line
and	CC	cc	I-cell_line
GM4672A	NN	conj	I-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
Dex	NN	nmod	O
for	IN	case	O
1-4	CD	nummod	O
days	NNS	nmod	O
inhibits	VBZ	ROOT	O
extracellular	JJ	amod	O
PA	NN	compound	B-protein
activity	NN	dobj	O
in	IN	case	O
a	DT	det	O
concentration-dependent	JJ	amod	O
manner	NN	nmod	O
,	,	punct	O
being	VBG	cop	O
half-maximal	JJ	conj	O
at	IN	case	O
approximately	RB	advmod	O
1	CD	nummod	O
X	NN	compound	O
10	CD	nummod	O
(	-LRB-	punct	O
-9	CD	nummod	O
)	-RRB-	punct	O
M	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
PA	NN	nmod	B-protein
in	IN	case	O
both	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
is	VBZ	cop	O
specific	JJ	ROOT	O
for	IN	case	O
active	JJ	amod	O
glucocorticoids	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
this	DT	det	O
specificity	NN	nsubj	O
parallels	VBZ	conj	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
various	JJ	amod	O
steroids	NNS	nmod	O
to	TO	mark	O
bind	VB	acl	O
to	TO	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

HMy2	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
PA	NN	nsubj	B-protein
is	VBZ	cop	O
fully	RB	advmod	O
suppressible	JJ	ROOT	O
by	IN	case	O
Dex	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
up	IN	advmod	O
to	IN	quantmod	O
one	CD	nummod	O
third	NN	advcl	O
of	IN	case	O
the	DT	det	O
activator	NN	nmod	O
expressed	VBN	acl	O
by	IN	case	O
GM4672A	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
is	VBZ	cop	O
resistant	JJ	conj	O
to	TO	case	O
glucocorticoid	NN	compound	O
inhibition	NN	nmod	O
.	.	punct	O

Mixing	JJ	amod	O
experiments	NNS	nsubj	O
using	VBG	acl	O
a	DT	det	O
UK	NN	compound	O
standard	NN	dobj	O
and	CC	cc	O
conditioned	JJ	amod	O
media	NNS	conj	O
from	IN	case	O
Dex-treated	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
suggest	VBP	ROOT	O
an	DT	det	O
absence	NN	dobj	O
of	IN	case	O
glucocorticoid-inducible	JJ	amod	B-protein
inhibitors	NNS	nmod	I-protein
to	TO	case	O
UK	NN	nmod	B-protein
or	CC	cc	O
plasmin	NN	conj	B-protein
in	IN	case	O
both	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
conditioned	JJ	amod	O
media	NNS	nsubj	O
from	IN	case	O
Dex-treated	JJ	amod	B-cell_line
GM4672A	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
inhibits	VBZ	ROOT	O
a	DT	det	O
portion	NN	dobj	O
of	IN	case	O
the	DT	det	O
homologous	JJ	amod	O
cellular	JJ	amod	O
activator	NN	nmod	O
in	IN	case	O
conditioned	JJ	amod	O
media	NNS	nmod	O
from	IN	case	O
control	JJ	amod	O
GM4672A	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
low	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
glucocorticoid-inducible	JJ	amod	B-protein
inhibitors	NNS	nmod	I-protein
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	prep	O
,	,	punct	O
but	CC	cc	O
can	MD	aux	O
not	RB	neg	O
fully	RB	advmod	O
account	VB	conj	O
for	IN	nmod	O
,	,	punct	O
Dex	NN	compound	O
inhibition	NN	dobj	O
of	IN	case	O
GM4672A	NNP	compound	B-protein
PA	NN	compound	I-protein
activity	NN	nmod	O
.	.	punct	O

Glucocorticoid-inducible	JJ	amod	B-protein
inhibitors	NNS	nsubj	I-protein
in	IN	case	O
HMy2	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
are	VBP	cop	O
either	RB	cc:preconj	O
totally	RB	advmod	O
absent	JJ	ROOT	O
or	CC	cc	O
are	VBP	cop	O
present	JJ	conj	O
at	IN	case	O
undetectable	JJ	amod	O
levels	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
regulation	NN	nsubj	O
of	IN	case	O
UK-like	JJ	amod	B-protein
PAs	NN	nmod	I-protein
in	IN	case	O
HMy2	NN	compound	B-cell_line
and	CC	cc	I-cell_line
GM4672A	NN	conj	I-cell_line
cells	NNS	nmod	I-cell_line
differs	VBZ	ROOT	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
the	DT	det	O
extent	NN	nmod	O
to	TO	case	O
which	WDT	nmod	O
glucocorticoids	NNS	nsubj	O
inhibit	VBP	acl:relcl	O
constitutively	RB	advmod	B-protein
expressed	VBN	amod	I-protein
activator	NN	compound	I-protein
levels	NNS	dobj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
possible	JJ	amod	O
contribution	NN	conj	O
of	IN	case	O
glucocorticoid-inducible	JJ	amod	B-protein
inhibitors	NNS	nmod	I-protein
to	TO	case	O
the	DT	det	O
regulatory	JJ	amod	O
process	NN	nmod	O
in	IN	case	O
GM4672A	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Characterization	NN	ROOT	O
of	IN	case	O
aldosterone	NN	compound	O
binding	NN	compound	O
sites	NNS	nmod	O
in	IN	case	O
circulating	VBG	amod	B-cell_type
human	JJ	amod	I-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
.	.	punct	O

Aldosterone	NN	compound	O
binding	NN	compound	O
sites	NNS	nsubjpass	O
in	IN	case	O
human	JJ	amod	B-cell_line
mononuclear	JJ	amod	I-cell_line
leukocytes	NNS	nmod	I-cell_line
were	VBD	auxpass	O
characterized	VBN	ROOT	O
after	IN	case	O
separation	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
from	IN	case	O
blood	NN	nmod	O
by	IN	case	O
a	DT	det	O
Percoll	NN	compound	O
gradient	NN	nmod	O
.	.	punct	O

After	IN	prep	O
washing	NN	pobj	O
and	CC	cc	O
resuspension	NN	conj	O
in	IN	case	O
RPMI-1640	NN	compound	O
medium	NN	nmod	O
,	,	punct	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
incubated	VBN	ROOT	O
at	IN	case	O
37	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
for	IN	case	O
1	CD	nummod	O
h	NN	nmod	O
with	IN	case	O
different	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	nmod	O
]	-RRB-	punct	O
aldosterone	NN	dep	O
plus	CC	cc	O
a	DT	det	O
100-fold	JJ	amod	O
concentration	NN	conj	O
of	IN	case	O
RU-26988	NN	nmod	O
(	-LRB-	punct	O
11	CD	nummod	O
alpha	NN	dep	O
,	,	punct	O
17	CD	nummod	O
alpha-dihydroxy-17	NN	cc	O
beta-propynylandrost-1	NN	conj	O
,	,	punct	O
4	CD	conj	O
,	,	punct	O
6-trien-3-one	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
with	IN	nmod	O
or	CC	cc	O
without	IN	case	O
an	DT	det	O
excess	NN	nmod	O
of	IN	case	O
unlabeled	JJ	amod	O
aldosterone	NN	nmod	O
.	.	punct	O

Aldosterone	NN	nsubj	O
binds	VBZ	ROOT	O
to	TO	case	O
a	DT	det	O
single	JJ	amod	O
class	NN	nmod	O
of	IN	case	O
receptors	NNS	nmod	O
with	IN	case	O
an	DT	det	O
affinity	NN	nmod	O
of	IN	case	O
2.7	CD	nummod	O
+/-	CC	cc	O
0.5	CD	conj	O
nM	NN	nmod	O
(	-LRB-	punct	O
means	NNS	dep	O
+/-	CC	cc	O
SD	NN	conj	O
,	,	punct	O
n	NN	nsubj	O
=	JJ	amod	O
14	CD	dobj	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
capacity	NN	conj	O
of	IN	case	O
290	CD	nummod	O
+/-	CC	cc	O
108	CD	conj	O
sites/cell	NNS	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
14	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
specificity	NN	compound	O
data	NNS	nsubj	O
show	VBP	ROOT	O
a	DT	det	O
hierarchy	NN	dobj	O
of	IN	case	O
affinity	NN	nmod	O
of	IN	case	O
desoxycorticosterone	NN	nmod	O
=	JJ	amod	O
corticosterone	NN	dobj	O
=	JJ	amod	O
aldosterone	NN	dobj	O
greater	JJR	amod	O
than	IN	case	O
hydrocortisone	NN	nmod	O
greater	JJR	amod	O
than	IN	case	O
dexamethasone	NN	nmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
mononuclear	JJ	amod	B-cell_type
leukocytes	NNS	nsubj	I-cell_type
could	MD	aux	O
be	VB	cop	O
useful	JJ	ccomp	O
for	IN	mark	O
studying	VBG	advcl	O
the	DT	det	O
physiological	JJ	amod	O
significance	NN	dobj	O
of	IN	case	O
these	DT	det	O
mineralocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
their	PRP$	nmod:poss	O
regulation	NN	conj	O
in	IN	case	O
humans	NNS	nmod	O
.	.	punct	O

Mineralocorticoid	NN	compound	B-protein
and	CC	cc	I-protein
glucocorticoid	NN	conj	I-protein
receptors	NNS	ROOT	I-protein
in	IN	case	O
circulating	VBG	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
primary	JJ	amod	O
hyperaldosteronism	NN	nmod	O
.	.	punct	O

Mineralocorticoid	NN	compound	B-protein
and	CC	cc	I-protein
glucocorticoid	NN	conj	I-protein
receptors	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
measured	VBN	ROOT	O
in	IN	case	O
circulating	VBG	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
in	IN	case	O
5	CD	nummod	O
patients	NNS	nmod	O
affected	VBN	acl	O
by	IN	case	O
Conn	NN	nmod:poss	O
's	POS	case	O
syndrome	NN	nmod	O
(	-LRB-	punct	O
3	CD	nummod	O
cases	NNS	dep	O
of	IN	case	O
bilateral	JJ	amod	O
adrenal	JJ	amod	O
hyperplasia	NN	nmod	O
and	CC	cc	O
2	CD	nummod	O
cases	NNS	conj	O
of	IN	case	O
adenoma	NN	nmod	O
plus	CC	cc	O
unilateral	JJ	amod	O
hyperplasia	NN	conj	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
number	NN	nsubj	O
of	IN	case	O
the	DT	det	O
binding	VBG	amod	O
sites	NNS	nmod	O
per	IN	case	O
cell	NN	nmod	O
resulted	VBD	ROOT	O
significantly	RB	advmod	O
lower	JJR	xcomp	O
(	-LRB-	punct	O
189	CD	dep	O
+/-	CC	cc	O
114	CD	conj	O
,	,	punct	O
mean	NN	conj	O
+/-	CC	cc	O
SD	NN	conj	O
)	-RRB-	punct	O
,	,	punct	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
the	DT	det	O
normal	JJ	amod	O
controls	NNS	nmod	O
(	-LRB-	punct	O
298	CD	dep	O
+/-	CC	cc	O
105	CD	conj	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
affinity	NN	nsubjpass	O
of	IN	case	O
aldosterone	NN	nmod	O
for	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
not	RB	neg	O
different	JJ	xcomp	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
healthy	JJ	amod	O
control	NN	compound	O
subjects	NNS	nmod	O
.	.	punct	O

The	DT	det	O
capacity	NN	nsubj	O
and	CC	cc	O
the	DT	det	O
affinity	NN	conj	O
of	IN	case	O
dexamethasone	NN	nmod	O
for	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
ranged	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
normal	JJ	amod	O
values	NNS	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
possible	JJ	amod	O
down-regulation	NN	dobj	O
of	IN	case	O
mineralocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
humans	NNS	nmod	O
.	.	punct	O

Short-term	JJ	amod	O
and	CC	cc	O
long-term	JJ	conj	O
effects	NNS	ROOT	O
of	IN	case	O
estrogen	NN	nmod	O
on	IN	case	O
lymphoid	JJ	amod	O
tissues	NNS	nmod	O
and	CC	cc	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
with	IN	case	O
some	DT	det	O
remarks	NNS	nmod	O
on	IN	case	O
the	DT	det	O
significance	NN	nmod	O
for	IN	case	O
carcinogenesis	NN	nmod	O
.	.	punct	O

Estrogens	NNS	nsubjpass	O
have	VBP	aux	O
long	RB	advmod	O
been	VBN	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
regulating	VBG	advcl	O
the	DT	det	O
immune	JJ	amod	O
system	NN	dobj	O
.	.	punct	O

The	DT	det	O
difference	NN	nsubjpass	O
in	IN	case	O
some	DT	det	O
types	NNS	nmod	O
of	IN	case	O
immune	JJ	amod	O
responses	NNS	nmod	O
between	IN	case	O
males	NNS	nmod	O
and	CC	cc	O
females	NNS	conj	O
is	VBZ	auxpass	O
well-known	JJ	ROOT	O
,	,	punct	O
as	IN	mark	O
is	VBZ	cop	O
the	DT	det	O
pronounced	JJ	amod	O
thymic	JJ	amod	O
involution	NN	advcl	O
induced	VBN	acl	O
by	IN	case	O
exogenous	JJ	amod	O
estrogens	NNS	nmod	O
.	.	punct	O

Estrogens	NNS	nsubj	O
stimulate	VBP	ROOT	O
some	DT	det	O
aspects	NNS	dobj	O
of	IN	prep	O
macrophage	NN	compound	B-cell_type
activity	NN	pobj	O
and	CC	cc	O
,	,	punct	O
depending	VBG	case	O
on	IN	case	O
dose	NN	advcl	O
and	CC	cc	O
mitogen	NN	conj	B-protein
,	,	punct	O
inhibit	VBP	conj	O
or	CC	cc	O
stimulate	VB	conj	O
lymphocyte	NN	compound	O
proliferative	JJ	amod	O
response	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Another	DT	det	O
example	NN	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
estrogen	NN	compound	O
effect	NN	attr	O
on	IN	case	O
the	DT	det	O
delayed	VBN	amod	O
type	NN	compound	O
hypersensitivity	NN	compound	O
response	NN	nmod	O
.	.	punct	O

A	DT	det	O
broad	JJ	amod	O
review	NN	nsubjpass	O
is	VBZ	auxpass	O
given	VBN	ROOT	O
of	IN	case	O
such	JJ	amod	O
estrogen	NN	compound	O
effects	NNS	nmod	O
on	IN	case	O
lymphoid	JJ	amod	B-cell_type
tissue	NN	nmod	I-cell_type
and	CC	cc	O
immune	JJ	amod	O
response	NN	conj	O
.	.	punct	O

Most	JJS	nsubj	O
of	IN	prep	O
the	DT	det	O
studies	NNS	pobj	O
published	VBN	csubj	O
so	RB	advmod	O
far	RB	advmod	O
are	VBP	ROOT	O
phenomenological	JJ	acomp	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
recent	JJ	amod	O
description	NN	nsubj	O
of	IN	case	O
estrogen	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
and	CC	cc	O
in	IN	case	O
some	DT	det	O
lymphocyte	NN	compound	B-cell_line
subpopulations	NNS	conj	I-cell_line
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
a	DT	det	O
deeper	JJR	compound	O
understanding	NN	conj	O
of	IN	case	O
regulating	VBG	amod	O
factors	NNS	nmod	O
in	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
,	,	punct	O
open	VBP	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
of	IN	case	O
a	DT	det	O
more	RBR	advmod	O
detailed	JJ	amod	O
understanding	NN	nmod	O
of	IN	case	O
the	DT	det	O
estrogen	NN	compound	O
mechanism	NN	nmod	O
of	IN	case	O
interference	NN	nmod	O
.	.	punct	O

Estrogen	NN	compound	O
effects	NNS	nsubj	O
in	IN	case	O
adults	NNS	nmod	O
are	VBP	cop	O
reversible	JJ	ROOT	O
.	.	punct	O

After	IN	mark	O
treating	VBG	advcl	O
neonatal	JJ	amod	O
mice	NNS	dobj	O
with	IN	case	O
the	DT	det	O
synthetic	JJ	amod	O
estrogen	NN	compound	O
diethylstilbestrol	NN	nmod	O
(	-LRB-	punct	O
DES	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
disturbances	NNS	nsubjpass	O
are	VBP	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
lymphocyte	NN	compound	B-cell_line
populations	NNS	nmod	I-cell_line
and	CC	cc	O
lymphocyte	NN	compound	B-cell_type
functions	NNS	conj	O
which	WDT	nsubj	O
are	VBP	cop	O
permanent	JJ	acl:relcl	O
and	CC	cc	O
irreversible	JJ	conj	O
.	.	punct	O

Lymphocytes	NNS	nsubj	B-cell_type
from	IN	case	O
adult	JJ	nmod	O
,	,	punct	O
neonatally	RB	advmod	O
DES-treated	JJ	amod	O
female	JJ	amod	O
mice	NNS	conj	O
have	VBP	ROOT	O
a	DT	det	O
reduced	VBN	amod	O
mitogen	NN	compound	O
response	NN	dobj	O
to	TO	case	O
ConA	NN	nmod	B-protein
and	CC	cc	O
LPS	NN	conj	B-protein
(	-LRB-	punct	O
T	NN	dep	B-protein
and	CC	cc	I-protein
B	NN	conj	I-protein
cell	NN	compound	I-protein
mitogen	NN	conj	I-protein
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
delayed	VBN	amod	O
type	NN	compound	O
hypersensitivity	NN	compound	O
response	NN	nsubjpass	O
is	VBZ	auxpass	O
depressed	VBN	conj	O
.	.	punct	O

A	DT	det	O
detailed	JJ	amod	O
analysis	NN	nsubj	O
demonstrated	VBD	ROOT	O
a	DT	det	O
decreased	VBN	amod	O
T	NN	compound	B-cell_type
helper	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
population	NN	dobj	O
.	.	punct	O

The	DT	det	O
activity	NN	nsubjpass	O
of	IN	case	O
Natural	NNP	amod	B-cell_type
Killer	NNP	compound	I-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
permanently	RB	advmod	O
reduced	VBN	ROOT	O
and	CC	cc	O
this	DT	det	O
functional	JJ	amod	O
impairment	NN	nsubj	O
is	VBZ	cop	O
related	JJ	conj	O
to	TO	case	O
a	DT	det	O
decreased	VBN	amod	O
number	NN	nmod	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
,	,	punct	O
in	IN	case	O
turn	NN	nmod	O
determined	VBN	acl	O
at	IN	case	O
the	DT	det	O
bone	NN	compound	O
marrow	NN	compound	O
level	NN	nmod	O
.	.	punct	O

The	DT	det	O
same	JJ	amod	O
animals	NNS	nsubj	O
have	VBP	ROOT	O
an	DT	det	O
increased	VBN	amod	O
sensitivity	NN	dobj	O
to	TO	case	O
chemical	JJ	amod	O
carcinogens	NNS	nmod	O
(	-LRB-	punct	O
methylcholanthrene	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
they	PRP	nsubj	O
spontaneously	RB	advmod	O
develop	VBP	conj	O
epithelial	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
the	DT	det	O
uterine	JJ	amod	O
cervix	NNS	nmod	O
which	WDT	nsubj	O
morphologically	RB	advmod	O
are	VBP	cop	O
similar	JJ	acl:relcl	O
to	TO	case	O
adenocarcinoma	NN	nmod	O
.	.	punct	O

The	DT	det	O
association	NN	nsubj	O
between	IN	case	O
estrogen-associated	JJ	amod	O
malignancy	NN	nmod	O
and	CC	cc	O
estrogen	NN	conj	O
effects	NNS	dep	O
in	IN	case	O
lymphocyte	NN	compound	B-cell_type
functions	NNS	nmod	O
deserves	VBZ	ROOT	O
further	JJ	amod	O
study	NN	dobj	O
.	.	punct	O

Drugs	NNS	ROOT	O
affecting	VBG	acl	O
the	DT	det	O
hormonal	JJ	amod	O
receptors	NNS	dobj	O
of	IN	case	O
normal	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
leukaemic	JJ	conj	I-cell_type
peripheral	JJ	amod	I-cell_type
leucocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
authors	NNS	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
behaviour	NN	dobj	O
of	IN	case	O
steroid	NN	compound	O
hormone	NN	compound	O
uptake	NN	nmod	O
in	IN	case	O
leukaemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
CML	NN	dep	B-cell_line
,	,	punct	O
CLL	NN	conj	B-cell_line
,	,	punct	O
AML	NN	conj	B-cell_line
,	,	punct	O
ALL	NN	appos	B-cell_line
)	-RRB-	punct	O
,	,	punct	O
in	IN	case	O
basal	JJ	amod	O
conditions	NNS	nmod	O
and	CC	cc	O
after	IN	case	O
incubation	NN	conj	O
with	IN	case	O
drugs	NNS	nmod	O
which	WDT	nsubj	O
modify	VBP	acl:relcl	O
the	DT	det	O
cellular	JJ	amod	O
concentration	NN	dobj	O
of	IN	case	O
cAMP	NN	nmod	O
,	,	punct	O
PGE	NN	conj	O
and	CC	cc	O
PGF	NN	conj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
demonstrated	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
in	IN	case	O
leukaemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
an	DT	det	O
alteration	NN	nmod	O
in	IN	case	O
the	DT	det	O
incorporation	NN	nmod	O
of	IN	case	O
steroid	NN	compound	O
hormones	NNS	nmod	O
.	.	punct	O

This	DT	det	O
alteration	NN	nsubjpass	O
was	VBD	auxpass	O
scarcely	RB	advmod	O
modified	VBN	ROOT	O
by	IN	case	O
incubation	NN	nmod	O
with	IN	case	O
theophylline	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
increases	VBZ	acl:relcl	O
cellular	JJ	amod	O
concentration	NN	dobj	O
of	IN	case	O
cAMP	NN	nmod	O
.	.	punct	O

On	IN	prep	O
the	DT	det	O
other	JJ	amod	O
hand	NN	pobj	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
moderately	RB	advmod	O
counteracted	VBN	ROOT	O
by	IN	case	O
thioproline	NN	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
evidently	RB	advmod	O
inhibited	VBN	conj	O
by	IN	case	O
flurbiprofen	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
also	RB	advmod	O
reduced	VBD	acl:relcl	O
cellular	JJ	amod	O
concentrations	NNS	dobj	O
of	IN	case	O
prostaglandins	NNS	nmod	O
,	,	punct	O
particularly	RB	advmod	O
PGE2	NN	appos	O
,	,	punct	O
with	IN	case	O
the	DT	det	O
exception	NN	nmod	O
of	IN	case	O
PGF2	NN	nmod	O
which	WDT	nsubj	O
showed	VBD	acl:relcl	O
a	DT	det	O
poor	JJ	amod	O
response	NN	dobj	O
.	.	punct	O

Differences	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
behavior	NN	nmod	O
of	IN	case	O
hormonal	JJ	amod	O
uptake	NN	nmod	O
of	IN	case	O
CML	NN	nmod	B-cell_line
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
AML	NN	nmod	B-cell_line
,	,	punct	I-cell_line
CLL	NN	conj	I-cell_line
and	CC	cc	I-cell_line
ALL	NN	conj	I-cell_line
peripheral	JJ	amod	I-cell_line
leucocytes	NNS	conj	I-cell_line
.	.	punct	O

Human	JJ	amod	O
breast	NN	compound	O
cancer	NN	ROOT	O
and	CC	cc	O
impaired	JJ	amod	O
NK	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
function	NN	conj	O
.	.	punct	O

Recent	JJ	amod	O
advances	NNS	nsubj	O
in	IN	case	O
tumor	NN	compound	O
immunology	NN	nmod	O
have	VBP	aux	O
led	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
discovery	NN	nmod	O
of	IN	case	O
a	DT	det	O
new	JJ	amod	O
lymphoid	JJ	amod	B-cell_type
cell	NN	nmod	I-cell_type
with	IN	case	O
unique	JJ	amod	O
antitumor	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

Natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
NK	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nsubj	I-cell_type
form	VBP	ROOT	O
an	DT	det	O
antitumor	JJ	amod	O
surveillance	NN	compound	O
system	NN	dobj	O
and	CC	cc	O
appear	VBP	conj	O
to	TO	mark	O
be	VB	cop	O
vital	JJ	xcomp	O
in	IN	mark	O
preventing	VBG	advcl	O
tumor	NN	compound	O
growth	NN	dobj	O
and	CC	cc	O
metastasis	NN	conj	O
in	IN	case	O
animal	NN	compound	O
models	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
studied	VBD	ROOT	O
NK	NN	compound	B-cell_type
activity	NN	dobj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
benign	JJ	amod	O
and	CC	cc	O
malignant	JJ	conj	O
breast	NN	compound	O
disease	NN	nmod	O
,	,	punct	O
using	VBG	advcl	O
a	DT	det	O
chromium-51	NN	compound	O
release	NN	compound	O
microtiter	NN	compound	O
cytotoxicity	NN	compound	O
assay	NN	dobj	O
with	IN	case	O
K562	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
as	IN	case	O
targets	NNS	nmod	O
.	.	punct	O

Compared	VBN	case	O
with	IN	case	O
benign	JJ	amod	O
controls	NNS	nmod	O
,	,	punct	O
patients	NNS	nsubj	O
with	IN	case	O
malignancies	NNS	nmod	O
had	VBD	aux	O
significantly	RB	advmod	O
depressed	VBN	ROOT	O
NK	NN	compound	B-cell_type
-mediated	JJ	amod	O
lysis	NN	dobj	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.01	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
lysis	NN	nsubj	O
in	IN	case	O
those	DT	nmod	O
with	IN	case	O
advanced	JJ	amod	O
disease	NN	nmod	O
(	-LRB-	punct	O
stages	NNS	appos	O
II	CD	nummod	O
,	,	punct	O
III	CD	conj	O
,	,	punct	O
and	CC	cc	O
IV	CD	conj	O
)	-RRB-	punct	O
was	VBD	cop	O
significantly	RB	advmod	O
less	JJR	ROOT	O
than	IN	case	O
in	IN	case	O
those	DT	nmod	O
with	IN	case	O
limited	JJ	amod	O
disease	NN	nmod	O
(	-LRB-	punct	O
stage	NN	appos	O
I	CD	dep	O
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.01	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

NK	NN	compound	B-cell_type
activity	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
correlated	VBN	ROOT	O
to	TO	case	O
estrogen	NN	nmod	O
or	CC	cc	O
progesterone	NN	compound	O
receptor	NN	compound	O
states	NNS	conj	O
.	.	punct	O

Positive	JJ	amod	O
correlation	NN	nsubj	O
of	IN	case	O
a	DT	det	O
depressed	JJ	amod	O
natural	JJ	amod	O
killer	NN	compound	O
activity	NN	nmod	O
with	IN	case	O
the	DT	det	O
extent	NN	nmod	O
of	IN	case	O
tumor	NN	nmod	O
spread	NN	acl	O
supports	VBZ	ROOT	O
the	DT	det	O
concept	NN	dobj	O
of	IN	case	O
an	DT	det	O
NK	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
immune	JJ	amod	O
surveillance	NN	compound	O
system	NN	nmod	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
and	CC	cc	O
emphasizes	VBZ	conj	O
its	PRP$	nmod:poss	O
importance	NN	dobj	O
in	IN	case	O
this	DT	det	O
malignancy	NN	nmod	O
.	.	punct	O

Immunosuppressive	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
serum	NN	compound	O
progesterone	NN	nmod	O
during	IN	case	O
pregnancy	NN	nmod	O
depends	VBZ	ROOT	O
on	IN	case	O
the	DT	det	O
progesterone	NN	compound	O
binding	NN	compound	O
capacity	NN	nmod	O
of	IN	case	O
the	DT	det	O
lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

Cytotoxic	JJ	amod	O
activity	NN	nsubjpass	O
and	CC	cc	O
progesterone	NN	compound	O
binding	NN	compound	O
capacity	NN	conj	O
of	IN	case	O
the	DT	det	O
lymphocytes	NNS	nmod	B-cell_type
,	,	punct	O
together	RB	advmod	O
with	IN	case	O
serum	NN	compound	O
progesterone	NN	compound	O
concentrations	NNS	nmod	O
,	,	punct	O
were	VBD	auxpass	O
determined	VBN	ROOT	O
in	IN	case	O
women	NNS	nmod	O
with	IN	case	O
normal	JJ	amod	O
pregnancy	NN	nmod	O
or	CC	cc	O
with	IN	case	O
a	DT	det	O
clinical	JJ	amod	O
diagnosis	NN	conj	O
of	IN	case	O
threatened	VBN	amod	O
abortion	NN	nmod	O
or	CC	cc	O
threatened	VBD	amod	O
premature	JJ	amod	O
labour	NN	conj	O
.	.	punct	O

The	DT	det	O
lymphocytes	NNS	nsubj	O
of	IN	case	O
women	NNS	nmod	O
with	IN	case	O
threatened	VBN	amod	O
abortion	NN	nmod	O
or	CC	cc	O
threatened	VBD	amod	O
premature	JJ	amod	O
labour	NN	conj	O
showed	VBD	ROOT	O
significantly	RB	advmod	O
higher	JJR	amod	O
cytotoxic	JJ	amod	O
activity	NN	dobj	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.001	CD	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
significantly	RB	advmod	O
lower	JJR	amod	O
progesterone	NN	compound	O
binding	NN	compound	O
capacity	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.001	CD	nmod	O
)	-RRB-	punct	O
than	IN	mark	O
did	VBD	advcl	O
lymphocytes	NNS	dobj	B-cell_type
obtained	VBN	acl	O
from	IN	case	O
the	DT	det	O
healthy	JJ	amod	O
pregnant	JJ	amod	O
women	NNS	nmod	O
.	.	punct	O

Significant	JJ	amod	O
inverse	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
progesterone	NN	compound	O
binding	NN	compound	O
capacity	NN	nmod	O
and	CC	cc	O
cytotoxic	JJ	amod	O
activity	NN	conj	O
of	IN	case	O
the	DT	det	O
lymphocytes	NNS	nmod	B-cell_type
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.001	CD	nmod	O
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
progesterone	NN	compound	O
concentration	NN	nsubj	O
of	IN	case	O
the	DT	det	O
pregnancy	NN	compound	O
serum	NN	nmod	O
appeared	VBD	conj	O
to	TO	mark	O
have	VB	xcomp	O
no	DT	neg	O
influence	NN	dobj	O
on	IN	case	O
the	DT	det	O
other	JJ	amod	O
two	CD	nummod	O
parameters	NNS	nmod	O
.	.	punct	O

The	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
intact	JJ	amod	O
progesterone	NN	compound	O
binding	NN	compound	O
capacity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
lymphocytes	NNS	nmod	B-cell_type
is	VBZ	cop	O
an	DT	det	O
essential	JJ	amod	O
factor	NN	ccomp	O
for	IN	case	O
the	DT	det	O
manifestation	NN	nmod	O
of	IN	case	O
the	DT	det	O
blocking	NN	amod	O
effect	NN	nmod	O
exerted	VBN	acl	O
by	IN	case	O
pregnancy	NN	compound	O
serum	NN	nmod	O
on	IN	case	O
lymphocyte	NN	compound	B-cell_type
cytotoxicity	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Serum	NN	compound	O
sex	NN	compound	O
steroid	NN	compound	O
and	CC	cc	O
peptide	NN	compound	O
hormone	NN	compound	O
concentrations	NNS	conj	O
,	,	punct	O
and	CC	cc	O
endometrial	JJ	amod	O
estrogen	NN	conj	O
and	CC	cc	O
progestin	NN	conj	O
receptor	NN	compound	O
levels	NNS	ROOT	O
during	IN	case	O
administration	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-protein
leukocyte	NN	compound	I-protein
interferon	NN	nmod	I-protein
.	.	punct	O

Five	CD	nummod	O
normally	RB	advmod	O
cycling	VBG	amod	O
healthy	JJ	amod	O
women	NNS	nsubjpass	O
were	VBD	auxpass	O
given	VBN	ROOT	O
daily	RB	advmod	O
subcutaneous	JJ	amod	O
injections	NNS	dobj	O
of	IN	case	O
human	JJ	amod	B-protein
leukocyte	NN	compound	I-protein
interferon	NN	nmod	I-protein
(	-LRB-	punct	O
3	CD	nummod	O
X	NN	compound	O
10	CD	nummod	O
(	-LRB-	punct	O
6	CD	appos	O
)	-RRB-	punct	O
units/day	NN	advmod	O
)	-RRB-	punct	O
from	IN	prep	O
the	DT	det	O
3rd	NN	pobj	O
through	IN	prep	O
23rd	JJ	amod	O
day	NN	pobj	O
of	IN	prep	O
the	DT	det	O
menstrual	JJ	amod	O
cycle	NN	pobj	O
,	,	punct	O
and	CC	cc	O
serum	NN	compound	O
steroid	NN	conj	O
and	CC	cc	O
peptide	NN	compound	O
hormone	NN	compound	O
concentrations	NNS	dep	O
monitored	VBN	acl	O
at	IN	case	O
3-day	JJ	amod	O
intervals	NNS	nmod	O
during	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
and	CC	cc	O
the	DT	det	O
preceding	JJ	amod	O
control	NN	compound	O
cycle	NN	conj	O
.	.	punct	O

Concentrations	NNS	nsubjpass	O
of	IN	case	O
cytosol	NN	nmod	B-protein
and	CC	cc	I-protein
nuclear	JJ	amod	I-protein
estrogen	NN	compound	I-protein
receptors	NNS	conj	I-protein
(	-LRB-	punct	O
ERC	NN	dep	B-protein
and	CC	cc	O
ERN	NN	conj	B-protein
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
and	CC	cc	O
progestin	NN	compound	B-protein
receptors	NNS	conj	I-protein
(	-LRB-	punct	O
PRC	NN	dep	B-protein
and	CC	cc	O
PRN	NN	conj	B-protein
)	-RRB-	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
measured	VBN	ROOT	O
from	IN	case	O
endometrial	JJ	amod	O
biopsies	NNS	nmod	O
taken	VBN	acl	O
on	IN	prep	O
the	DT	det	O
24th	JJ	amod	O
day	NN	pobj	O
of	IN	prep	O
the	DT	det	O
control	NN	nmod	O
and	CC	cc	O
treatment	NN	conj	O
cycle	NN	pobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
an	DT	det	O
extensive	JJ	amod	O
monitoring	NN	nsubjpass	O
of	IN	case	O
clinical	JJ	amod	O
chemical	NN	nmod	O
and	CC	cc	O
hematological	JJ	conj	O
tests	NNS	dep	O
from	IN	case	O
the	DT	det	O
blood	NN	compound	O
samples	NNS	nmod	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
.	.	punct	O

Serum	NN	compound	O
estradiol	NN	nsubjpass	O
and	CC	cc	O
progesterone	NN	conj	O
concentrations	NNS	dep	O
were	VBD	auxpass	O
significantly	RB	advmod	O
decreased	VBN	ROOT	O
during	IN	case	O
the	DT	det	O
treatment	NN	compound	O
cycle	NN	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
interferon	NN	nsubj	B-protein
interacts	VBZ	ccomp	O
in	FW	compound	O
vivo	FW	advmod	O
with	IN	case	O
the	DT	det	O
function	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
FSH	NN	nmod	O
and	CC	cc	O
LH	NN	conj	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
changes	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
serum	NN	compound	O
peptide	NN	compound	O
hormone	NN	compound	O
concentrations	NNS	nmod	O
measured	VBN	acl	O
(	-LRB-	punct	O
FSH	NN	dep	O
,	,	punct	O
LH	NN	conj	O
,	,	punct	O
prolactin	NN	conj	O
,	,	punct	O
insulin	NN	conj	O
,	,	punct	O
growth	NN	compound	O
hormone	NN	conj	O
and	CC	cc	O
TSH	NN	conj	O
)	-RRB-	punct	O
;	:	punct	O
neither	DT	nsubj	O
were	VBD	cop	O
the	DT	det	O
levels	NNS	dep	O
of	IN	case	O
endometrial	JJ	amod	B-protein
ERC	NN	nmod	I-protein
,	,	punct	I-protein
ERN	NN	conj	I-protein
,	,	punct	I-protein
PRC	NN	conj	I-protein
and	CC	cc	I-protein
PRN	NN	conj	I-protein
affected	VBN	acl	O
by	IN	case	O
interferon	NN	compound	B-protein
administration	NN	nmod	O
.	.	punct	O

As	IN	mark	O
expected	VBN	advcl	O
,	,	punct	O
interferon	NN	compound	B-protein
administration	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
decreased	VBN	amod	O
leukocyte	NN	compound	B-cell_type
counts	NNS	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
an	DT	det	O
increasing	VBG	amod	O
tendency	NN	nsubj	O
in	IN	case	O
the	DT	det	O
activities	NNS	nmod	O
of	IN	case	O
serum	NN	compound	B-protein
alkaline	NN	compound	I-protein
phosphatase	NN	nmod	I-protein
and	CC	cc	O
gamma-glutamyltransferase	NN	conj	B-protein
during	IN	case	O
the	DT	det	O
interferon	NN	compound	B-protein
therapy	NN	nmod	O
shows	VBZ	ROOT	O
that	IN	mark	O
interferon	NN	nsubj	B-protein
may	MD	aux	O
slightly	RB	advmod	O
interfere	VB	ccomp	O
with	IN	case	O
the	DT	det	O
liver	NN	compound	O
function	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
one	CD	nsubj	O
of	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
by	IN	case	O
which	WDT	nmod	O
interferon	NN	compound	B-protein
treatment	NN	nsubj	O
may	MD	aux	O
affect	VB	acl:relcl	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
hormone-dependent	JJ	amod	O
neoplasms	NNS	nmod	O
could	MD	aux	O
be	VB	cop	O
the	DT	det	O
interaction	NN	ccomp	O
with	IN	case	O
production	NN	nmod	O
and/or	CC	cc	O
function	NN	conj	O
of	IN	case	O
circulating	VBG	amod	O
hormonal	JJ	amod	O
compounds	NNS	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
level	NN	ROOT	O
in	IN	case	O
the	DT	det	O
blood	NN	compound	B-cell_type
leukocytes	NNS	nmod	I-cell_type
in	IN	case	O
different	JJ	amod	O
acute	JJ	amod	O
diseases	NNS	nmod	O
]	-RRB-	punct	O

Content	NN	nsubjpass	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
cytosol	NN	nmod	O
of	IN	case	O
blood	NN	compound	B-cell_type
leukocytes	NNS	nmod	I-cell_type
,	,	punct	O
concentration	NN	nsubjpass	O
of	IN	case	O
cortisol	NN	nmod	O
and	CC	cc	O
amount	NN	conj	O
of	IN	case	O
leukocytes	NNS	nmod	B-cell_type
in	IN	case	O
blood	NN	nmod	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
20	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
impairments	NNS	nmod	O
within	IN	case	O
the	DT	det	O
second	JJ	amod	O
day	NN	nmod	O
of	IN	case	O
the	DT	det	O
disease	NN	nmod	O
.	.	punct	O

Content	NN	nsubjpass	O
of	IN	case	O
receptors	NNS	nmod	O
in	IN	case	O
cytosol	NN	nmod	O
of	IN	case	O
blood	NN	compound	O
leukocytes	NNS	nmod	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
using	VBG	xcomp	O
3H-triamcinolone	NN	compound	O
acetonide	NN	dobj	O
.	.	punct	O

Distinct	JJ	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
amount	NN	nmod	O
of	IN	case	O
the	DT	det	O
leukocyte	NN	compound	B-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
poisoning	NN	nmod	O
by	IN	case	O
dichlorethane	NN	nmod	O
and	CC	cc	O
hypnotic	JJ	conj	O
drugs	NNS	dep	O
under	IN	case	O
conditions	NNS	nmod	O
of	IN	case	O
acute	JJ	amod	O
myocardial	JJ	amod	O
infarction	NN	nmod	O
.	.	punct	O

In	IN	case	O
acute	JJ	amod	O
pancreatitis	NN	compound	O
content	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
leukocyte	NN	compound	B-protein
receptors	NNS	nmod	I-protein
was	VBD	auxpass	O
not	RB	neg	O
altered	VBN	ROOT	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

Concentration	NN	nsubjpass	O
of	IN	case	O
endogenous	JJ	amod	O
cortisol	NN	nmod	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
in	IN	case	O
blood	NN	nmod	O
of	IN	case	O
all	PDT	det:predet	O
the	DT	det	O
patients	NNS	nmod	O
,	,	punct	O
except	IN	case	O
of	IN	case	O
the	DT	det	O
cases	NNS	nmod	O
of	IN	case	O
acetate	NN	compound	O
intoxication	NN	nmod	O
.	.	punct	O

Reverse	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
between	IN	case	O
concentration	NN	nmod	O
of	IN	case	O
cortisol	NN	nmod	O
in	IN	case	O
blood	NN	nmod	O
and	CC	cc	O
content	NN	conj	O
of	IN	case	O
glucocorticoid	NN	compound	O
receptors	NNS	nmod	O
in	IN	case	O
leukocytes	NNS	nmod	B-cell_type
.	.	punct	O

But	CC	cc	O
in	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
pancreatitis	NN	nmod	O
the	DT	det	O
decrease	NN	nsubjpass	O
in	IN	case	O
content	NN	nmod	O
of	IN	case	O
leukocyte	NN	compound	B-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
was	VBD	auxpass	O
not	RB	neg	O
observed	VBN	ROOT	O
although	IN	mark	O
there	EX	expl	O
was	VBD	advcl	O
an	DT	det	O
increase	NN	nsubj	O
in	IN	case	O
cortisol	NN	compound	O
concentration	NN	nmod	O
in	IN	case	O
blood	NN	nmod	O
.	.	punct	O

The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
immunological	JJ	amod	O
processes	NNS	nmod	O
under	IN	case	O
conditions	NNS	nmod	O
of	IN	case	O
purulent	JJ	amod	O
complications	NNS	nmod	O
and	CC	cc	O
possibility	NN	conj	O
to	TO	mark	O
regulate	VB	acl	O
the	DT	det	O
metabolism	NN	dobj	O
in	IN	case	O
leukocytes	NNS	nmod	B-cell_type

Therapeutic	JJ	amod	O
concentrations	NNS	nsubj	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
suppress	VBP	ROOT	O
the	DT	det	O
antimicrobial	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
without	IN	mark	O
impairing	VBG	advcl	O
their	PRP$	nmod:poss	O
responsiveness	NN	dobj	O
to	TO	case	O
gamma	NN	compound	B-protein
interferon	NN	nmod	I-protein
.	.	punct	O

By	IN	mark	O
exposing	VBG	advcl	O
human	JJ	amod	B-cell_type
blood-derived	JJ	amod	I-cell_type
macrophages	NNS	dobj	I-cell_type
and	CC	cc	I-cell_type
alveolar	JJ	amod	I-cell_type
macrophages	NNS	conj	I-cell_type
in	FW	compound	O
vitro	FW	advmod	O
to	TO	case	O
dexamethasone	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
in	IN	case	O
these	DT	det	O
studies	NNS	nmod	O
that	IN	mark	O
glucocorticoids	NNS	nsubj	O
markedly	RB	advmod	O
suppress	VBP	ccomp	O
the	DT	det	O
antimicrobial	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
macrophages	NNS	nmod	B-cell_type
but	CC	cc	O
not	RB	cc	O
macrophage	NN	conj	B-cell_type
activation	NN	dep	O
by	IN	case	O
lymphokines	NNS	nmod	B-cell_type
.	.	punct	O

As	RB	mark	O
little	JJ	mwe	O
as	IN	prep	O
2.5	CD	compound	O
X	NN	compound	O
10	CD	nummod	O
(	-LRB-	punct	O
-8	CD	appos	O
)	-RRB-	punct	O
mol/liter	NN	nsubj	O
of	IN	case	O
dexamethasone	NN	nmod	O
prevented	VBD	ROOT	O
macrophages	NNS	dobj	B-cell_type
from	IN	mark	O
inhibiting	VBG	advcl	O
germination	NN	dobj	O
of	IN	prep	O
Aspergillus	NN	compound	O
spores	NNS	pobj	O
or	CC	cc	O
from	IN	conj	O
eliminating	VBG	pcomp	O
ingested	VBN	amod	O
bacteria	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
Listeria	NNP	nmod	O
,	,	punct	O
Nocardia	NNP	conj	O
,	,	punct	O
or	CC	cc	O
Salmonella	NNP	conj	O
.	.	punct	O

Damage	NN	compound	O
to	TO	dep	O
macrophage	NN	compound	B-cell_type
function	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
progesterone	NN	nmod	O
and	CC	cc	O
appeared	VBD	conj	O
to	TO	mark	O
be	VB	auxpass	O
receptor-mediated	JJ	xcomp	O
.	.	punct	O

In	IN	case	O
accordance	NN	dep	O
with	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
observations	NNS	nmod	O
,	,	punct	O
dexamethasone	NN	nsubj	O
required	VBD	ROOT	O
24-36	CD	nummod	O
h	NN	dobj	O
to	TO	mark	O
suppress	VB	xcomp	O
antimicrobial	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

While	IN	mark	O
glucocorticoids	NNS	nsubj	O
interfered	VBN	advcl	O
with	IN	case	O
base-line	NN	amod	O
activity	NN	nmod	O
of	IN	case	O
macrophages	NNS	nmod	B-cell_type
,	,	punct	O
dexamethasone	NN	compound	O
concentrations	NNS	nsubj	O
comparable	JJ	amod	O
to	TO	case	O
drug	NN	compound	O
levels	NNS	nmod	O
in	IN	case	O
patients	NNS	nmod	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
macrophage	NN	compound	B-cell_type
activation	NN	nmod	O
.	.	punct	O

Proliferating	VBG	amod	O
lymphocytes	NNS	nsubj	B-cell_type
and	CC	cc	O
gamma-interferon	NN	conj	B-protein
thus	RB	advmod	O
increased	VBD	ROOT	O
the	DT	det	O
antimicrobial	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
phagocytes	NNS	nmod	B-cell_type
exposed	VBN	acl	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
over	IN	case	O
that	DT	nmod	O
of	IN	case	O
control	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

Macrophage	NN	compound	O
activation	NN	nsubj	O
and	CC	cc	O
correction	NN	conj	O
of	IN	case	O
the	DT	det	O
dexamethasone	NN	compound	O
effect	NN	nmod	O
by	IN	case	O
gamma-interferon	NN	nmod	B-protein
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
was	VBD	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
pathogen	NN	nmod	O
.	.	punct	O

The	DT	det	O
lymphokine	NN	nsubj	B-protein
enhanced	VBD	ROOT	O
the	DT	det	O
antimicrobial	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
dexamethasone-treated	JJ	amod	B-cell_line
macrophages	NNS	nmod	I-cell_line
against	IN	case	O
Listeria	NNP	nmod	O
and	CC	cc	O
Salmonella	NNP	conj	O
but	CC	cc	O
not	RB	conj	O
against	IN	case	O
Aspergillus	NNP	conj	O
or	CC	cc	O
Nocardia	NNP	conj	O
.	.	punct	O

Dexamethasone-induced	JJ	amod	O
damage	NN	ROOT	O
to	IN	case	O
the	DT	det	O
antimicrobial	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
in	FW	amod	O
vitro	FW	dep	O
parallels	VBZ	compound	O
observations	NNS	nmod	O
that	IN	mark	O
glucocorticoids	NNS	nsubj	O
render	VBP	ccomp	O
laboratory	JJ	amod	O
animals	NNS	dobj	O
susceptible	JJ	amod	O
to	TO	case	O
listeriosis	NN	nmod	O
and	CC	cc	O
aspergillosis	NN	conj	O
by	IN	case	O
damaging	VBG	amod	O
resident	JJ	amod	O
macrophages	NNS	nmod	B-cell_line
.	.	punct	O

Suppression	NN	nsubjpass	O
of	IN	case	O
macrophage	NN	compound	B-cell_type
antimicrobial	JJ	amod	O
activity	NN	nmod	O
should	MD	aux	O
thus	RB	advmod	O
be	VB	auxpass	O
considered	VBN	ROOT	O
when	WRB	advmod	O
treating	VBG	amod	O
patients	NNS	advcl	O
with	IN	case	O
glucocorticoids	NNS	nmod	O
;	:	punct	O
its	PRP$	nmod:poss	O
prevention	NN	nsubj	O
by	IN	case	O
gamma-interferon	NN	nmod	B-protein
might	MD	aux	O
be	VB	cop	O
beneficial	JJ	parataxis	O
for	IN	prep	O
some	DT	nmod	O
but	CC	cc	O
not	RB	cc	O
all	DT	det	O
pathogens	NNS	pobj	O
.	.	punct	O

Interleukin	NN	compound	B-protein
2	CD	nummod	I-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
Tac	NN	compound	B-protein
antigen	NN	appos	I-protein
)	-RRB-	punct	O
expression	NN	ROOT	O
in	IN	case	O
HTLV-I-associated	JJ	amod	O
adult	JJ	amod	O
T-cell	NN	compound	B-cell_type
leukemia	NN	nmod	O
.	.	punct	O

Interleukin-2	NN	nsubj	B-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
lymphokine	NN	ROOT	B-protein
synthesized	VBN	acl	O
by	IN	case	O
some	DT	det	O
T-cells	NNS	nmod	B-cell_type
following	VBG	case	O
activation	NN	nmod	O
.	.	punct	O

Resting	VBG	amod	O
T-cells	NNS	nsubj	B-cell_type
do	VBP	aux	O
not	RB	neg	O
express	VB	ROOT	O
IL-2	NN	compound	B-protein
receptors	NNS	dobj	I-protein
,	,	punct	O
but	CC	cc	O
receptors	NNS	nsubjpass	O
are	VBP	auxpass	O
rapidly	RB	advmod	O
expressed	VBN	conj	O
on	IN	case	O
T-cells	NNS	nmod	B-cell_type
following	VBG	case	O
interaction	NN	nmod	O
of	IN	case	O
antigens	NNS	nmod	O
,	,	punct	O
mitogens	NNS	conj	O
,	,	punct	O
or	CC	cc	O
monoclonal	JJ	amod	B-protein
antibodies	NNS	conj	I-protein
with	IN	case	O
the	DT	det	O
antigen-specific	JJ	amod	B-protein
T-cell	NN	compound	I-protein
receptor	NN	compound	I-protein
complex	NN	nmod	I-protein
.	.	punct	O

Using	VBG	advcl	O
anti-Tac	NN	amod	B-protein
,	,	punct	O
a	DT	det	O
monoclonal	JJ	amod	B-protein
antibody	NN	dobj	I-protein
that	WDT	nsubj	O
recognizes	VBZ	acl:relcl	O
the	DT	det	O
IL-2	NN	compound	B-protein
receptor	NN	dobj	I-protein
,	,	punct	O
the	DT	det	O
receptor	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
purified	VBN	ROOT	O
and	CC	cc	O
shown	VBN	conj	O
to	TO	aux	O
be	VB	cop	O
a	DT	det	O
Mr	NNP	compound	O
33	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
peptide	NN	xcomp	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
posttranslationally	RB	advmod	O
glycosylated	VBN	acl:relcl	O
to	IN	prep	O
a	DT	det	O
Mr	NNP	compound	O
55	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
mature	JJ	amod	O
form	NN	pobj	O
.	.	punct	O

Normal	JJ	amod	O
resting	VBG	amod	O
T-cells	NNS	nsubj	B-cell_type
and	CC	cc	O
most	RBS	advmod	O
leukemic	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
populations	NNS	conj	I-cell_line
do	VBP	aux	O
not	RB	neg	O
express	VB	ROOT	O
IL-2	NN	compound	B-protein
receptors	NNS	dobj	I-protein
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
of	IN	case	O
the	DT	det	O
11	CD	nummod	O
patients	NNS	nmod	O
examined	VBN	parataxis	O
who	WP	nsubj	O
had	VBD	ccomp	O
human	JJ	amod	O
T-cell	NN	compound	O
lymphotropic	JJ	amod	O
virus-associated	JJ	amod	O
adult	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	dobj	O
expressed	VBD	conj	O
the	DT	det	O
Tac	NN	compound	B-protein
antigen	NN	dobj	I-protein
.	.	punct	O

In	IN	case	O
human	JJ	amod	B-cell_type
T-cell	NN	compound	I-cell_type
lymphotropic	JJ	amod	I-cell_type
virus-I	NN	compound	I-cell_type
infected	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
the	DT	det	O
Mr	NNP	compound	O
42	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
long	JJ	amod	O
open	JJ	amod	B-protein
reading	NN	compound	I-protein
frame	NN	compound	I-protein
protein	NN	nsubj	I-protein
encoded	VBN	acl	O
in	IN	case	O
part	NN	nmod	O
by	IN	case	O
the	DT	det	O
pX	NN	amod	B-DNA
region	NN	nmod	I-DNA
of	IN	case	O
this	DT	det	O
virus	NN	nmod	O
may	MD	aux	O
act	VB	ROOT	O
as	IN	case	O
a	DT	det	O
transacting	VBG	amod	B-protein
transcriptional	JJ	amod	I-protein
activator	NN	nmod	I-protein
that	WDT	nsubj	O
induces	VBZ	acl:relcl	O
IL-2	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	compound	I-DNA
transcription	NN	dobj	O
,	,	punct	O
thus	RB	advmod	O
providing	VBG	advcl	O
an	DT	det	O
explanation	NN	dobj	O
for	IN	case	O
the	DT	det	O
constant	JJ	amod	O
association	NN	nmod	O
of	IN	case	O
IL-2	NN	compound	B-protein
receptor	NN	compound	I-protein
expression	NN	nmod	O
with	IN	case	O
adult	JJ	amod	O
T-cell	NN	compound	O
lymphotropic	JJ	amod	O
virus-I	NN	compound	O
infection	NN	nmod	O
of	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
constant	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
large	JJ	amod	O
numbers	NNS	nmod	O
of	IN	case	O
IL-2	NN	compound	B-protein
receptors	NNS	nmod	I-protein
which	WDT	nsubj	O
may	MD	aux	O
be	VB	cop	O
aberrant	JJ	acl:relcl	O
may	MD	aux	O
play	VB	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
uncontrolled	JJ	amod	O
growth	NN	nmod	O
of	IN	case	O
adult	JJ	amod	B-cell_type
T-cell	NN	compound	I-cell_type
leukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Two	CD	nummod	O
patients	NNS	nsubjpass	O
with	IN	case	O
Tac-positive	JJ	amod	O
adult	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
anti-Tac	NN	nmod	B-protein
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
had	VBD	ROOT	O
6-	CD	nummod	O
and	CC	cc	O
3-mo	JJ	conj	O
remissions	NNS	dobj	O
of	IN	case	O
his	PRP$	poss	O
leukemia	NN	nmod	O
following	VBG	case	O
two	CD	nummod	O
courses	NNS	nmod	O
of	IN	case	O
therapy	NN	nmod	O
with	IN	case	O
this	DT	det	O
monoclonal	JJ	amod	B-protein
antibody	NN	nmod	I-protein
directed	VBN	acl	O
toward	IN	case	O
this	DT	det	O
growth	NN	compound	B-protein
factor	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Lymphocyte	NN	compound	B-cell_type
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
binding	NN	ROOT	O
in	IN	case	O
depressed	JJ	amod	O
patients	NNS	nmod	O
with	IN	case	O
hypercortisolemia	NN	nmod	O
.	.	punct	O

Despite	IN	case	O
elevated	JJ	amod	O
levels	NNS	ROOT	O
of	IN	case	O
serum	NN	nmod	O
and	CC	cc	O
urinary	JJ	amod	O
cortisol	NN	conj	O
,	,	punct	O
patients	NNS	appos	O
with	IN	case	O
depressive	JJ	amod	O
illness	NN	compound	O
manifest	NN	amod	O
none	NN	nmod	O
of	IN	case	O
the	DT	det	O
clinical	JJ	amod	O
stigmata	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	O
excess	NN	nmod	O
.	.	punct	O

This	DT	det	O
hypercortisolemia	NN	nsubj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
clinical	JJ	amod	O
effects	NNS	nmod	O
suggests	VBZ	ROOT	O
a	DT	det	O
state	NN	dobj	O
of	IN	case	O
hormone	NN	compound	O
resistance	NN	nmod	O
and	CC	cc	O
could	MD	aux	O
be	VB	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
alterations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Earlier	JJR	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
small	JJ	amod	O
doses	NNS	nsubj	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
cause	VBP	ccomp	O
a	DT	det	O
decrease	NN	dobj	O
in	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
binding	NN	nmod	O
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

White	JJ	amod	O
cells	NNS	nsubjpass	O
from	IN	case	O
depressed	JJ	amod	O
patients	NNS	nmod	O
with	IN	case	O
significant	JJ	amod	O
hypercortisolemia	NN	nmod	O
would	MD	aux	O
be	VB	auxpass	O
expected	VBN	ROOT	O
to	TO	aux	O
show	VB	xcomp	O
a	DT	det	O
similar	JJ	amod	O
change	NN	dobj	O
in	IN	case	O
receptor	NN	compound	O
concentration	NN	nmod	O
if	IN	mark	O
peripheral	JJ	amod	O
tissues	NNS	nsubjpass	O
are	VBP	auxpass	O
adequately	RB	advmod	O
exposed	VBN	advcl	O
to	TO	nmod	O
and	CC	cc	O
sensitive	JJ	conj	O
to	TO	case	O
the	DT	det	O
hormone	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
compared	VBD	ROOT	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	intj	O
]	-RRB-	punct	O
dexamethasone	NN	nmod	O
to	TO	case	O
lymphocytes	NNS	nmod	B-cell_type
from	IN	case	O
normal	JJ	amod	O
subjects	NNS	nmod	O
and	CC	cc	O
depressed	JJ	amod	O
patients	NNS	conj	O
with	IN	case	O
hypercortisolemia	NN	nmod	O
.	.	punct	O

Lymphocytes	NNS	nsubj	B-cell_type
from	IN	case	O
normal	JJ	amod	O
subjects	NNS	nmod	O
had	VBD	ROOT	O
a	DT	det	O
mean	NN	amod	O
receptor	NN	compound	O
concentration	NN	dobj	O
of	IN	case	O
10.2	CD	nummod	O
+/-	CC	cc	O
0.66	CD	conj	O
fm/10	NN	nmod	O
(	-LRB-	punct	O
6	CD	nummod	O
)	-RRB-	punct	O
cells	NNS	dep	O
(	-LRB-	punct	O
S.E.M.	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
dissociation	NN	compound	O
constant	NN	conj	O
of	IN	case	O
4.8	CD	nummod	O
+/-	CC	cc	O
0.47	CD	conj	O
nM	NN	nmod	O
.	.	punct	O

Lymphocytes	NNS	nsubj	B-cell_type
from	IN	case	O
depressed	JJ	amod	O
patients	NNS	nmod	O
with	IN	case	O
abnormal	JJ	amod	O
0800	CD	nummod	O
h	NN	compound	O
serum	NN	compound	O
cortisol	NN	nmod	O
after	IN	case	O
dexamethasone	NN	nmod	O
had	VBD	ROOT	O
a	DT	det	O
mean	NN	amod	O
receptor	NN	compound	O
concentration	NN	dobj	O
of	IN	case	O
8.8	CD	nummod	O
+/-	CC	cc	O
0.75	CD	conj	O
fm/10	NN	compound	O
(	-LRB-	punct	O
6	CD	appos	O
)	-RRB-	punct	O
cells	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
was	VBD	cop	O
not	RB	neg	O
significantly	RB	advmod	O
different	JJ	acl:relcl	O
from	IN	case	O
that	DT	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
from	IN	case	O
normal	JJ	amod	O
subjects	NNS	nmod	O
or	CC	cc	O
from	IN	case	O
depressed	JJ	amod	O
subjects	NNS	conj	O
with	IN	case	O
normal	JJ	amod	O
post-dexamethasone	JJ	amod	O
cortisol	NN	compound	O
levels	NNS	nmod	O
(	-LRB-	punct	O
9.4	CD	nummod	O
+/-	CC	cc	O
0.95	CD	conj	O
fm/10	NN	dep	O
(	-LRB-	punct	O
6	CD	nummod	O
)	-RRB-	punct	O
cells	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

Lymphocytes	NNS	nsubj	B-cell_type
from	IN	case	O
depressed	JJ	amod	O
patients	NNS	nmod	O
with	IN	case	O
elevated	JJ	amod	O
urinary	JJ	amod	O
free	JJ	amod	O
cortisol	NN	compound	O
excretion	NN	nmod	O
(	-LRB-	punct	O
UFC	NN	appos	O
)	-RRB-	punct	O
also	RB	advmod	O
had	VBD	ROOT	O
normal	JJ	amod	O
receptor	NN	compound	O
concentration	NN	dobj	O
and	CC	cc	O
binding	NN	compound	O
affinity	NN	conj	O
for	IN	case	O
dexamethasone	NN	nmod	O
.	.	punct	O

The	DT	det	O
lack	NN	nsubj	O
of	IN	case	O
a	DT	det	O
change	NN	nmod	O
in	IN	case	O
lymphocyte	NN	compound	B-cell_type
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
concentration	NN	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
cortisol	NN	compound	O
excess	NN	nmod	O
suggests	VBZ	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
hypercortisolemia	NN	nsubj	O
in	IN	case	O
depressive	JJ	amod	O
illness	NN	nmod	O
represents	VBZ	ccomp	O
a	DT	det	O
state	NN	dobj	O
of	IN	case	O
peripheral	JJ	amod	O
glucocorticoid	NN	compound	O
resistance	NN	nmod	O
.	.	punct	O

Structure	NN	ROOT	O
and	CC	cc	O
regulation	NN	conj	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
hormone	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nsubj	I-protein
is	VBZ	cop	O
an	DT	det	O
intracellular	JJ	amod	B-protein
protein	NN	ROOT	I-protein
which	WDT	nsubj	O
possesses	VBZ	acl:relcl	O
three	CD	nummod	O
distinct	JJ	amod	O
domains	NNS	dobj	O
,	,	punct	O
one	CD	appos	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
agonist	NN	nmod	O
and	CC	cc	O
antagonist	NN	conj	O
steroids	NNS	dobj	O
,	,	punct	O
one	CD	appos	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
DNA	NN	dobj	O
,	,	punct	O
and	CC	cc	O
one	CD	conj	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
anti-receptor	JJ	amod	B-protein
antibodies	NNS	dobj	I-protein
and	CC	cc	O
is	VBZ	auxpass	O
required	VBN	conj	O
for	IN	case	O
glucocorticoid	NN	compound	O
modulation	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

In	IN	case	O
intact	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
receptor	NN	compound	O
number	NN	nsubj	O
,	,	punct	O
affinity	NN	conj	O
and	CC	cc	O
activity	NN	conj	O
can	MD	aux	O
change	VB	ROOT	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
factors	NNS	nmod	O
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
receptor	NN	nmod	O
,	,	punct	O
or	CC	cc	O
that	WDT	nsubj	O
act	VBP	conj	O
indirectly	RB	advmod	O
through	IN	case	O
ill-defined	JJ	amod	O
mechanisms	NNS	nmod	O
which	WDT	nsubj	O
may	MD	aux	O
include	VB	acl:relcl	O
resumption	NN	dobj	O
or	CC	cc	O
arrest	NN	conj	O
of	IN	case	O
cell	NN	compound	O
cycling	NN	nmod	O
and	CC	cc	O
variations	NNS	conj	O
in	IN	case	O
intracellular	JJ	amod	O
calcium	NN	compound	O
ion	NN	compound	O
concentrations	NNS	nmod	O
.	.	punct	O

Some	DT	nsubj	O
of	IN	case	O
these	DT	det	O
factors	NNS	nmod	O
appear	VBP	ROOT	O
to	TO	mark	O
exert	VB	xcomp	O
their	PRP$	nmod:poss	O
effect	NN	dobj	O
by	IN	mark	O
controlling	VBG	advcl	O
critical	JJ	amod	O
receptor	NN	compound	O
properties	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
ATP-dependent	JJ	amod	O
phosphorylation	NN	nmod	O
,	,	punct	O
integrity	NN	appos	O
of	IN	case	O
thiol	NN	compound	B-protein
groups	NNS	nmod	I-protein
,	,	punct	O
and	CC	cc	O
exposure	NN	conj	O
of	IN	case	O
key	JJ	amod	B-protein
amino	NN	compound	I-protein
acid	NN	compound	I-protein
residues	NNS	nmod	I-protein
.	.	punct	O

Glucocorticoid	NN	compound	O
agonists	NNS	nsubj	O
promote	VBP	ROOT	O
the	DT	det	O
'transformation	NN	dobj	O
'	''	punct	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
into	IN	case	O
the	DT	det	O
DNA-binding	JJ	amod	O
state	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
competent	JJ	acl:relcl	O
for	IN	mark	O
modulating	VBG	advcl	O
gene	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Glucocorticoid	NN	compound	O
antagonists	NNS	nsubj	O
are	VBP	cop	O
steroids	NNS	ROOT	O
that	WDT	nsubj	O
interact	VBP	ccomp	O
with	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
but	CC	cc	O
either	CC	cc:preconj	O
fail	VBP	conj	O
to	TO	mark	O
produce	VB	xcomp	O
a	DT	det	O
stable	JJ	amod	B-protein
complex	NN	dobj	I-protein
or	CC	cc	O
produce	VBP	conj	O
a	DT	det	O
stable	JJ	amod	B-protein
but	CC	cc	I-protein
inefficient	JJ	conj	I-protein
complex	NN	dobj	I-protein
.	.	punct	O

Although	IN	mark	O
substituent	JJ	compound	O
groups	NNS	nsubjpass	O
that	WDT	nsubj	O
confer	VBP	acl:relcl	O
agonist	NN	dobj	O
or	CC	cc	O
antagonist	NN	conj	O
activity	NN	conj	O
to	TO	case	O
the	DT	det	O
steroid	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	advcl	O
,	,	punct	O
the	DT	det	O
molecular	JJ	amod	O
determinants	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
difference	NN	nmod	O
at	IN	case	O
the	DT	det	O
receptor	NN	compound	O
level	NN	nmod	O
remain	VBP	ROOT	O
unknown	JJ	xcomp	O
.	.	punct	O

Most	JJS	advmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	amod	O
vivo	FW	dep	O
data	NNS	nsubjpass	O
on	IN	case	O
receptor	NN	compound	O
regulation	NN	nmod	O
can	MD	aux	O
be	VB	auxpass	O
accommodated	VBN	ROOT	O
by	IN	mark	O
postulating	VBG	advcl	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
an	DT	det	O
intracellular	JJ	amod	O
cycle	NN	nmod	O
that	WDT	nsubj	O
involves	VBZ	acl:relcl	O
five	CD	nummod	O
states	NNS	dobj	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
.	.	punct	O

The	DT	det	O
active	JJ	amod	O
free	JJ	amod	O
receptor	NN	nsubjpass	O
is	VBZ	auxpass	O
phosphorylated	VBN	ROOT	O
,	,	punct	O
reduced	VBN	conj	O
,	,	punct	O
and	CC	cc	O
presumably	RB	advmod	O
oligomeric	JJ	conj	O
(	-LRB-	punct	O
state	NN	compound	O
A	NN	dep	O
)	-RRB-	punct	O
.	.	punct	O

Following	VBG	case	O
binding	NN	nmod	O
of	IN	case	O
an	DT	det	O
agonist	NN	nmod	O
(	-LRB-	punct	O
state	NN	compound	O
B	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
it	PRP	nsubj	O
can	MD	aux	O
become	VB	ROOT	O
transformed	VBN	xcomp	O
by	IN	agent	O
dissociation	NN	pobj	O
into	IN	prep	O
its	PRP$	nmod:poss	O
subunits	NNS	pobj	O
and	CC	cc	O
dephosphorylation	NN	conj	O
(	-LRB-	punct	O
state	NN	compound	O
C	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
transformed	VBN	amod	B-protein
receptor	NN	nsubj	I-protein
then	RB	advmod	O
interacts	VBZ	ROOT	O
with	IN	case	O
chromatin	NN	nmod	B-DNA
(	-LRB-	punct	O
state	NN	compound	O
D	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Dissociation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
steroid	NN	nmod	O
and	CC	cc	O
oxidation	NN	conj	O
of	IN	case	O
receptor	NN	compound	B-protein
thiol	NN	compound	I-protein
group	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
lead	VBP	ROOT	O
to	TO	case	O
the	DT	det	O
inactive	JJ	amod	O
receptor	NN	compound	O
form	NN	nmod	O
(	-LRB-	punct	O
state	NN	compound	O
E	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Reduction	NN	nsubj	O
and	CC	cc	O
rephosphorylation	NN	conj	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
enable	VBP	ROOT	O
it	PRP	dobj	O
to	TO	mark	O
bind	VB	xcomp	O
steroids	NNS	dobj	O
again	RB	advmod	O
so	IN	mark	O
that	IN	mark	O
the	DT	det	O
cycle	NN	nsubjpass	O
is	VBZ	auxpass	O
closed	VBN	advcl	O
.	.	punct	O

Thermodynamics	NNS	ROOT	O
of	IN	case	O
steroid	NN	compound	O
binding	NN	nmod	O
to	TO	case	O
the	DT	det	O
human	JJ	amod	B-protein
glucocorticoid	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
thermodynamics	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
with	IN	case	O
their	PRP$	nmod:poss	O
receptor	NN	nmod	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
cytosol	NN	nmod	O
from	IN	case	O
human	JJ	amod	B-cell_type
lymphoblastoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
rate	NN	compound	O
and	CC	cc	O
affinity	NN	conj	O
constants	NNS	nsubjpass	O
of	IN	case	O
dexamethasone	NN	nmod	O
and	CC	cc	O
cortisol	NN	conj	O
between	IN	case	O
0	CD	nummod	O
degree	NN	nmod	O
and	CC	cc	O
25	CD	nummod	O
degrees	NNS	compound	O
C	NN	conj	O
were	VBD	auxpass	O
calculated	VBN	ROOT	O
by	IN	case	O
curve-fitting	JJ	advcl	O
from	IN	case	O
time-course	JJ	amod	O
and	CC	cc	O
equilibrium	NN	conj	O
kinetics	NNS	nmod	O
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
were	VBD	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
a	DT	det	O
simple	JJ	amod	O
reversible	JJ	amod	O
bimolecular	JJ	amod	O
interaction	NN	nmod	O
.	.	punct	O

Arrhenius	NN	nsubj	O
and	CC	cc	O
Va	NNP	conj	O
n't	RB	conj	O
Hoff	NNP	conj	O
plots	NNS	conj	O
were	VBD	cop	O
curvilinear	JJ	ROOT	O
for	IN	case	O
both	DT	det	O
steroids	NNS	nmod	O
.	.	punct	O

At	IN	case	O
equilibrium	NN	nmod	O
,	,	punct	O
the	DT	det	O
solution	NN	nsubj	O
for	IN	case	O
the	DT	det	O
equation	NN	compound	O
delta	NN	compound	O
G	NN	nmod	O
=	JJ	amod	O
delta	NN	compound	O
H	NN	compound	O
-	HYPH	punct	O
T	NN	compound	O
X	NN	compound	O
delta	NN	compound	O
S	NN	dobj	O
(	-LRB-	punct	O
eqn.	NN	appos	O
1	CD	nummod	O
)	-RRB-	punct	O
was	VBD	cop	O
(	-LRB-	punct	O
in	IN	case	O
kJ	NN	compound	O
X	NN	compound	O
mol-1	NN	nsubj	O
)	-RRB-	punct	O
-47	CD	nummod	O
=	JJ	ROOT	O
36	CD	compound	O
-	HYPH	punct	O
83	CD	dobj	O
(	-LRB-	punct	O
dexamethasone	NN	dep	O
)	-RRB-	punct	O
and	CC	cc	O
-42	CD	nsubj	O
=	JJ	conj	O
-9	CD	compound	O
-	SYM	punct	O
33	CD	nummod	O
(	-LRB-	punct	O
cortisol	NN	dobj	O
)	-RRB-	punct	O
at	IN	case	O
0	CD	nummod	O
degree	NN	compound	O
C	NN	nmod	O
.	.	punct	O

Enthalpy	NN	nmod	O
and	CC	cc	O
entropy	JJ	conj	O
changes	NNS	nsubj	O
decreased	VBD	ROOT	O
quasi-linearly	RB	advmod	O
with	IN	case	O
temperature	NN	nmod	O
such	JJ	case	O
that	IN	nmod	O
,	,	punct	O
at	IN	case	O
25	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
,	,	punct	O
the	DT	det	O
respective	JJ	amod	O
values	NNS	nsubj	O
were	VBD	cop	O
-50	CD	nummod	O
=	JJ	advcl	O
-75	CD	nsubj	O
+	CC	cc	O
25	CD	conj	O
and	CC	cc	O
-43	CD	conj	O
=	JJ	dep	O
-48	CD	dep	O
+	CC	cc	O
5	CD	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
for	IN	case	O
both	DT	det	O
steroids	NNS	nmod	O
,	,	punct	O
the	DT	det	O
interaction	NN	nsubj	O
was	VBD	cop	O
entropy-driven	JJ	ROOT	O
at	IN	case	O
low	JJ	amod	O
temperature	NN	nmod	O
and	CC	cc	O
became	VBD	cop	O
entirely	RB	advmod	O
enthalpy-driven	JJ	conj	O
at	IN	case	O
20	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
.	.	punct	O

Thermodynamic	JJ	amod	O
values	NNS	nsubjpass	O
for	IN	case	O
the	DT	det	O
transition	NN	compound	O
state	NN	nmod	O
were	VBD	auxpass	O
calculated	VBN	ROOT	O
from	IN	prep	O
the	DT	det	O
rate	NN	compound	O
constants	NNS	pobj	O
.	.	punct	O

For	IN	prep	O
the	DT	det	O
forward	JJ	amod	O
reaction	NN	pobj	O
,	,	punct	O
eqn.	NN	nsubj	O
(	-LRB-	punct	O
1	CD	appos	O
)	-RRB-	punct	O
gave	VBD	ROOT	O
45	CD	dative	O
=	JJ	amod	O
84	CD	nummod	O
-	SYM	punct	O
39	CD	dep	O
(	-LRB-	punct	O
dexamethasone	NN	dobj	O
)	-RRB-	punct	O
and	CC	cc	O
46	CD	nsubj	O
=	JJ	conj	O
60	CD	nummod	O
-	SYM	punct	O
14	CD	nummod	O
(	-LRB-	punct	O
cortisol	NN	dep	O
)	-RRB-	punct	O
at	IN	case	O
0	CD	nummod	O
degree	NN	compound	O
C	NN	nmod	O
,	,	punct	O
and	CC	cc	O
44	CD	nsubj	O
=	JJ	conj	O
24	CD	dep	O
+	CC	cc	O
20	CD	dep	O
(	-LRB-	punct	O
dexamethasone	NN	dep	O
)	-RRB-	punct	O
and	CC	cc	O
46	CD	nsubj	O
=	JJ	conj	O
28	CD	dep	O
+	CC	cc	O
18	CD	dep	O
(	-LRB-	punct	O
cortisol	NN	dep	O
)	-RRB-	punct	O
at	IN	case	O
25	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
fit	VBP	ROOT	O
quite	RB	advmod	O
well	RB	advmod	O
with	IN	case	O
a	DT	det	O
two-step	JJ	amod	O
model	NN	nmod	O
[	-LRB-	punct	O
Ross	NNP	dep	O
&	CC	cc	O
Subramanian	NNP	conj	O
(	-LRB-	punct	O
1981	CD	dep	O
)	-RRB-	punct	O
Biochemistry	NNP	conj	O
20	CD	nummod	O
,	,	punct	O
3096-3102	CD	nummod	O
]	-RRB-	punct	O
proposed	VBN	acl	O
for	IN	case	O
ligand-protein	JJ	amod	O
interactions	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
involves	VBZ	acl:relcl	O
a	DT	det	O
partial	JJ	amod	O
immobilization	NN	dobj	O
of	IN	case	O
the	DT	det	O
reacting	VBG	amod	O
species	NNS	nmod	O
governed	VBN	acl	O
by	IN	agent	O
hydrophobic	JJ	amod	O
forces	NNS	pobj	O
,	,	punct	O
followed	VBN	acl	O
by	IN	case	O
stabilization	NN	nmod	O
of	IN	case	O
the	DT	det	O
complex	NN	nmod	O
by	IN	case	O
short-range	JJ	amod	O
interactions	NNS	nmod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
this	DT	det	O
model	NN	nmod	O
,	,	punct	O
an	DT	det	O
analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
transition-state	NN	amod	O
thermodynamics	NNS	nmod	O
led	VBD	ROOT	O
to	TO	prep	O
the	DT	det	O
conclusion	NN	pobj	O
that	WDT	mark	O
no	RB	neg	O
more	JJR	amod	O
than	IN	quantmod	O
half	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
steroid	NN	compound	O
molecular	JJ	amod	O
area	NN	nmod	O
is	VBZ	auxpass	O
engaged	VBN	acl	O
in	IN	case	O
the	DT	det	O
binding	NN	compound	O
process	NN	nmod	O
.	.	punct	O

Cell	NN	compound	O
cycle-related	JJ	amod	O
changes	NNS	ROOT	O
in	IN	case	O
number	NN	nmod	O
of	IN	case	O
T-lymphocyte	NN	compound	B-protein
receptors	NNS	nmod	I-protein
for	IN	case	O
glucocorticoids	NNS	nmod	O
and	CC	cc	O
insulin	NN	conj	O
.	.	punct	O

Enriched	JJ	amod	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
T-lymphocytes	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
stimulated	VBN	ROOT	O
with	IN	case	O
PHA	NN	nmod	O
and	CC	cc	O
examined	VBN	conj	O
for	IN	case	O
variations	NNS	nmod	O
in	IN	case	O
insulin	NN	nmod	O
and	CC	cc	O
glucocorticoid	NN	compound	O
(	-LRB-	punct	O
dexamethasone	NN	appos	O
)	-RRB-	punct	O
receptor	NN	compound	O
numbers	NNS	dep	O
during	IN	case	O
the	DT	det	O
early	JJ	amod	O
phases	NNS	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
.	.	punct	O

Cells	NNS	nsubjpass	O
in	IN	case	O
G0	NN	nmod	O
,	,	punct	O
G1a	NN	conj	O
and	CC	cc	O
G1b	NN	conj	O
phases	NNS	dep	O
,	,	punct	O
where	WRB	advmod	O
the	DT	det	O
G1a	NN	compound	O
-	HYPH	punct	O
G1b	NN	compound	O
transition	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
Interleukin	NN	compound	B-protein
2	CD	nummod	I-protein
dependent	JJ	amod	O
event	NN	dep	O
,	,	punct	O
were	VBD	auxpass	O
quantitated	VBN	ROOT	O
by	IN	case	O
flow	NN	compound	O
cytometry	NN	nmod	O
.	.	punct	O

Few	JJ	nsubjpass	O
but	CC	cc	O
significant	JJ	conj	O
numbers	NNS	dep	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
2700/cell	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
no	DT	neg	O
insulin	NN	compound	B-protein
receptors	NNS	dep	I-protein
(	-LRB-	punct	O
-1/cell	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
resting	VBG	amod	O
(	-LRB-	punct	O
G0	NN	compound	O
)	-RRB-	punct	O
phase	NN	nmod	O
.	.	punct	O

As	IN	mark	O
cells	NNS	nsubj	O
entered	VBD	advcl	O
the	DT	det	O
G1a	NN	compound	O
phase	NN	dobj	O
the	DT	det	O
specific	JJ	amod	O
binding	NN	nsubj	O
of	IN	case	O
dexamethasone	NN	nmod	O
increased	VBD	csubj	O
and	CC	cc	O
of	IN	case	O
insulin	NN	conj	O
took	VBD	ROOT	O
place	NN	dobj	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
specific	JJ	amod	O
binding	NN	nsubj	O
further	RB	advmod	O
increased	VBD	advcl	O
as	IN	case	O
T-cells	NNS	nmod	B-cell_type
entered	VBD	ROOT	O
the	DT	det	O
G1b	NN	compound	O
phase	NN	dobj	O
(	-LRB-	punct	O
as	IN	mark	O
measured	VBN	advcl	O
at	IN	case	O
44	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
incubation	NN	nmod	O
and	CC	cc	O
using	VBG	conj	O
hydroxyurea-treated	JJ	amod	B-cell_line
cells	NNS	dobj	I-cell_line
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
major	JJ	amod	O
changes	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
specific	JJ	amod	O
binding	NN	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
took	VBD	parataxis	O
place	NN	dobj	O
during	IN	case	O
the	DT	det	O
period	NN	nmod	O
16	CD	compound	O
-	SYM	punct	O
20	CD	nummod	O
h	NN	dep	O
after	IN	case	O
stimulation	NN	nmod	O
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
these	DT	det	O
findings	NNS	nmod	O
,	,	punct	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
both	DT	cc:preconj	O
receptor	NN	compound	O
types	NNS	nsubjpass	O
(	-LRB-	punct	O
cell	NN	compound	B-protein
membrane	NN	dep	I-protein
and	CC	cc	I-protein
cytoplasmic	JJ	amod	I-protein
receptors	NNS	conj	I-protein
)	-RRB-	punct	O
are	VBP	aux	O
being	VBG	auxpass	O
formed	VBN	ccomp	O
and	CC	cc	O
increased	VBD	conj	O
at	IN	case	O
G1	NN	compound	O
phase	NN	nmod	O
prior	RB	case	O
to	TO	mwe	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
G1	NN	compound	O
phase	NN	nmod	O
in	IN	case	O
immunoregulation	NN	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
and	CC	cc	O
cortico-sensitivity	NN	conj	O
in	IN	case	O
a	DT	det	O
human	JJ	amod	B-cell_line
clonal	JJ	amod	I-cell_line
monocytic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
CM-SM	NN	appos	B-cell_line
.	.	punct	O

CM-SM	NN	nsubj	B-cell_line
is	VBZ	cop	O
a	DT	det	O
clonal	JJ	amod	B-cell_line
line	NN	ROOT	I-cell_line
of	IN	case	O
human	JJ	amod	B-cell_type
precursor	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
phagocytes	NNS	nmod	I-cell_type
inducible	JJ	amod	O
to	TO	case	O
macrophage	NN	compound	B-cell_type
differentiation	NN	nmod	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
the	DT	det	O
tumor	NN	compound	O
promoter	NN	compound	O
phorbol	NN	compound	O
ester	NN	nmod	O
12-O-tetradecanoyl-phorbol-13-acetate	CD	nummod	O
(	-LRB-	punct	O
TPA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Untreated	JJ	amod	O
CM-SM	NN	compound	O
cells	NNS	nsubj	O
contain	VBP	ROOT	O
single	JJ	amod	O
class	NN	dobj	O
,	,	punct	O
high-affinity	JJ	conj	O
(	-LRB-	punct	O
KD	NN	dep	O
=	JJ	amod	O
4.0	CD	nummod	O
X	NN	compound	O
10	CD	nummod	O
(	-LRB-	punct	O
-9	CD	nummod	O
)	-RRB-	punct	O
M	NN	dep	O
)	-RRB-	punct	O
glucocorticoid-specific	JJ	amod	O
receptor	NN	compound	O
sites	NNS	dep	O
(	-LRB-	punct	O
approximately	RB	advmod	O
60	CD	nummod	O
,	,	punct	O
000	CD	conj	O
per	IN	case	O
cell	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
a	DT	det	O
whole	JJ	amod	O
cell	NN	compound	O
assay	NN	nmod	O
,	,	punct	O
at	IN	case	O
37	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
,	,	punct	O
using	VBG	advcl	O
[	-LRB-	punct	O
3H	NN	dobj	O
]	-RRB-	punct	O
triamcinolone	NN	compound	O
acetonide	NN	dep	O
(	-LRB-	punct	O
TA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Exposure	NN	nsubj	O
of	IN	case	O
CM-SM	NN	nmod	B-cell_line
to	TO	case	O
dexamethasone	NN	nmod	O
(	-LRB-	punct	O
DEX	NN	appos	O
)	-RRB-	punct	O
produced	VBD	ROOT	O
a	DT	det	O
progressive	JJ	amod	O
,	,	punct	O
dose-	NN	dep	O
and	CC	cc	O
time-related	JJ	conj	O
series	NN	dobj	O
of	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
CM-SM	NN	compound	B-cell_line
cell	NN	compound	O
growth	NN	nmod	O
,	,	punct	O
saturation	NN	compound	O
density	NN	conj	O
,	,	punct	O
morphology	NN	conj	O
,	,	punct	O
and	CC	cc	O
functional	JJ	amod	O
properties	NNS	conj	O
,	,	punct	O
with	IN	case	O
half-maximal	JJ	amod	O
effects	NNS	nmod	O
at	IN	case	O
about	RB	advmod	O
10	CD	nummod	O
(	-LRB-	punct	O
-9	CD	dep	O
)	-RRB-	punct	O
M	NN	nmod	O
for	IN	case	O
DEX	NN	nmod	O
.	.	punct	O

TA-receptor	NN	amod	O
sites	NNS	nsubj	O
rapidly	RB	advmod	O
decreased	VBD	ROOT	O
(	-LRB-	punct	O
about	IN	advmod	O
70	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
after	IN	case	O
DEX	NN	compound	O
treatment	NN	nmod	O
,	,	punct	O
without	IN	case	O
any	DT	det	O
apparent	JJ	amod	O
change	NN	nmod	O
in	IN	case	O
steroid	NN	compound	O
specificity	NN	nmod	O
and	CC	cc	O
affinity	NN	conj	O
.	.	punct	O

After	IN	case	O
5	CD	nummod	O
days	NNS	nmod	O
in	IN	case	O
culture	NN	nmod	O
with	IN	case	O
a	DT	det	O
saturating	JJ	amod	O
concentration	NN	nmod	O
(	-LRB-	punct	O
3.6	CD	nummod	O
X	NN	compound	O
10	CD	nummod	O
(	-LRB-	punct	O
-8	CD	compound	O
)	-RRB-	punct	O
M	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
hormone	NN	nmod	O
,	,	punct	O
the	DT	det	O
cells	NNS	nsubj	O
reached	VBD	ROOT	O
a	DT	det	O
saturation	NN	compound	O
density	NN	dobj	O
of	IN	case	O
about	RB	advmod	O
9.0	CD	nummod	O
X	NN	compound	O
10	CD	nummod	O
(	-LRB-	punct	O
6	CD	appos	O
)	-RRB-	punct	O
viable	JJ	amod	O
cells/ml	NNS	nmod	O
(	-LRB-	punct	O
about	RB	advmod	O
4.0	CD	nummod	O
X	NN	compound	O
10	CD	nummod	O
(	-LRB-	punct	O
6	CD	appos	O
)	-RRB-	punct	O
viable	JJ	amod	O
cells/ml	NNS	nmod	O
in	IN	case	O
the	DT	det	O
controls	NNS	nmod	O
)	-RRB-	punct	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
modal	JJ	amod	O
volume	NN	nsubj	O
of	IN	case	O
the	DT	det	O
resulting	VBG	amod	O
cell	NN	compound	B-cell_line
population	NN	nmod	I-cell_line
was	VBD	cop	O
approximately	RB	advmod	O
60	CD	nummod	O
%	NN	advcl	O
,	,	punct	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
the	DT	det	O
volume	NN	nmod	O
of	IN	case	O
untreated	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

DEX-treated	JJ	amod	B-cell_line
cells	NNS	nsubj	I-cell_line
appeared	VBD	ROOT	O
less	RBR	advmod	O
differentiated	VBN	xcomp	O
than	IN	case	O
controls	NNS	nmod	O
,	,	punct	O
as	IN	mark	O
assessed	VBN	advcl	O
by	IN	case	O
combined	JJ	amod	O
morphologic	JJ	nmod	O
,	,	punct	O
antigenic	JJ	conj	O
,	,	punct	O
and	CC	cc	O
cytoenzymatic	JJ	amod	O
analyses	NNS	conj	O
.	.	punct	O

DEX	NN	nsubj	O
almost	RB	advmod	O
completely	RB	advmod	O
inhibited	VBD	ROOT	O
TPA	NN	compound	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
following	VBG	amod	O
macrophage	NN	compound	B-cell_type
functions	NNS	nmod	O
:	:	punct	O
adherency	NN	dep	O
to	TO	case	O
the	DT	det	O
culture	NN	compound	O
plate	NN	nmod	O
,	,	punct	O
expression	NN	dobj	O
of	IN	case	O
lysosomal	JJ	amod	B-protein
enzymes	NNS	nmod	I-protein
,	,	punct	O
Fc	NN	compound	B-protein
and	CC	cc	I-protein
C3	NN	conj	I-protein
receptors	NNS	conj	I-protein
,	,	punct	O
and	CC	cc	O
stimulation	NN	conj	O
of	IN	case	O
phagocytosis	NN	nmod	O
.	.	punct	O

After	IN	case	O
removal	NN	nmod	O
of	IN	case	O
DEX	NN	nmod	O
,	,	punct	O
the	DT	det	O
cells	NNS	nsubj	O
,	,	punct	O
within	IN	case	O
a	DT	det	O
few	JJ	amod	O
passages	NNS	nmod	O
,	,	punct	O
returned	VBD	ROOT	O
to	IN	prep	O
a	DT	det	O
state	NN	pobj	O
apparently	RB	advmod	O
identical	JJ	amod	O
to	TO	case	O
the	DT	det	O
untreated	JJ	amod	O
controls	NNS	nmod	O
and	CC	cc	O
could	MD	aux	O
be	VB	auxpass	O
induced	VBN	conj	O
to	TO	case	O
macrophage	NN	compound	B-cell_type
differentiation	NN	nmod	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
TPA	NN	nmod	O
.	.	punct	O

Acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	ROOT	O
in	IN	case	O
children	NNS	nmod	O
:	:	punct	O
current	JJ	amod	O
status	NN	dep	O
,	,	punct	O
controversies	NNS	conj	O
,	,	punct	O
and	CC	cc	O
future	JJ	amod	O
perspective	NN	conj	O
.	.	punct	O

Disease-free	JJ	amod	O
survival	NN	nsubj	O
(	-LRB-	punct	O
DFS	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
childhood	NN	compound	O
ALL	NN	nmod	O
is	VBZ	ROOT	O
60	CD	nummod	O
%	NN	attr	O
,	,	punct	O
and	CC	cc	O
survival	NN	nsubj	O
in	IN	case	O
good	JJ	amod	O
,	,	punct	O
average	JJ	conj	O
,	,	punct	O
and	CC	cc	O
poor	JJ	amod	O
prognostic	JJ	amod	O
groups	NNS	nmod	O
defined	VBN	acl	O
by	IN	case	O
initial	JJ	amod	O
WBC	NN	nmod	O
and	CC	cc	O
age	NN	conj	O
is	VBZ	conj	O
90	CD	attr	O
,	,	punct	O
60	CD	conj	O
,	,	punct	O
and	CC	cc	O
45	CD	nummod	O
%	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Additional	JJ	amod	O
immunological	JJ	nsubjpass	O
,	,	punct	O
morphological	JJ	conj	O
,	,	punct	O
biochemical	JJ	conj	O
,	,	punct	O
cytokinetic	JJ	conj	O
,	,	punct	O
and	CC	cc	O
cytogenetic	JJ	amod	O
factors	NNS	conj	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
,	,	punct	O
illustrating	VBG	xcomp	O
the	DT	det	O
heterogeneity	NN	dobj	O
of	IN	case	O
ALL	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
derivation	NN	conj	O
from	IN	case	O
malignant	JJ	amod	B-cell_line
clones	NNS	nmod	I-cell_line
at	IN	case	O
various	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
differentiation	NN	nmod	O
and	CC	cc	O
with	IN	case	O
varying	VBG	amod	O
rates	NNS	conj	O
of	IN	case	O
proliferation	NN	nmod	O
.	.	punct	O

Of	IN	case	O
biologic	JJ	amod	O
importance	NN	nmod	O
,	,	punct	O
these	DT	det	O
factors	NNS	nsubj	O
may	MD	aux	O
refine	VB	ROOT	O
further	RB	advmod	O
the	DT	det	O
characteristic	JJ	amod	O
features	NNS	dobj	O
of	IN	case	O
clinically-determined	JJ	amod	O
prognostic	JJ	amod	O
groups	NNS	nmod	O
.	.	punct	O

Multivariate	JJ	compound	O
analysis	NN	nsubjpass	O
of	IN	case	O
large	JJ	amod	O
prospective	JJ	amod	O
trials	NNS	nmod	O
with	IN	case	O
homogeneous	JJ	amod	O
therapy	NN	nmod	O
will	MD	aux	O
be	VB	auxpass	O
required	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
independent	JJ	amod	O
prognostic	JJ	amod	O
importance	NN	dobj	O
of	IN	case	O
these	DT	det	O
factors	NNS	nmod	O
.	.	punct	O

Current	JJ	amod	O
treatment	NN	compound	O
strategies	NNS	nsubj	O
in	IN	case	O
ALL	NN	nmod	O
include	VBP	ROOT	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
tailoring	NN	compound	O
therapy	NN	dobj	O
and	CC	cc	O
its	PRP$	nmod:poss	O
intensity	NN	conj	O
to	TO	case	O
prognostic	JJ	amod	O
groups	NNS	nmod	O
;	:	punct	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
multiple-drug	JJ	amod	O
combinations	NNS	dep	O
in	IN	case	O
induction	NN	nmod	O
;	:	punct	O
(	-LRB-	punct	O
3	LS	dep	O
)	-RRB-	punct	O
early	JJ	amod	O
use	NN	dep	O
of	IN	case	O
intrathecal	JJ	amod	O
(	-LRB-	punct	O
IT	NN	appos	O
)	-RRB-	punct	O
methotrexate	NN	nmod	O
(	-LRB-	punct	O
MTX	NN	appos	O
)	-RRB-	punct	O
;	:	punct	O
(	-LRB-	punct	O
4	LS	dep	O
)	-RRB-	punct	O
CNS	NN	compound	O
prophylaxis	NN	conj	O
with	IN	case	O
IT	NN	compound	O
MTX	NN	nmod	O
alone	RB	advmod	O
in	IN	case	O
good	JJ	amod	O
prognosis	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
combined	JJ	amod	O
cranial	JJ	amod	O
radiation	NN	conj	O
(	-LRB-	punct	O
CXRT	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
1800	CD	nummod	O
rads	NNS	conj	O
plus	CC	cc	O
IT	NN	compound	O
MTX	NN	conj	O
,	,	punct	O
in	IN	case	O
average	JJ	amod	O
and	CC	cc	O
poor	JJ	conj	O
prognosis	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

Current	JJ	amod	O
studies	NNS	nsubj	O
show	VBP	ROOT	O
a	DT	det	O
CNS	NN	compound	O
relapse	NN	compound	O
rate	NN	dobj	O
of	IN	case	O
5	CD	nummod	O
%	NN	nmod	O
in	IN	case	O
all	DT	det	O
prognostic	JJ	amod	O
groups	NNS	nmod	O
.	.	punct	O

Late	JJ	amod	O
neuropsychological	JJ	amod	O
defects	NNS	nsubj	O
caused	VBN	acl	O
by	IN	case	O
cranial	JJ	amod	O
XRT	NN	nmod	O
and	CC	cc	O
IT	NN	compound	O
MTX	NN	conj	O
have	VBP	aux	O
prompted	VBN	ROOT	O
programs	NNS	dobj	O
designed	VBN	acl	O
to	TO	aux	O
reduce	VB	xcomp	O
the	DT	det	O
potential	JJ	amod	O
late	JJ	amod	O
toxicity	NN	dobj	O
of	IN	case	O
CNS	NN	compound	O
prophylaxis	NN	nmod	O
.	.	punct	O

More	RBR	advmod	O
pronounced	JJ	advcl	O
in	IN	prep	O
younger	JJR	amod	O
children	NNS	pobj	O
,	,	punct	O
these	DT	det	O
abnormalities	NNS	nsubj	O
include	VBP	ROOT	O
decreased	VBN	amod	O
IQ	NN	dobj	O
,	,	punct	O
visual-motor	JJ	amod	O
incoordination	NN	conj	O
,	,	punct	O
poor	JJ	amod	O
performance	NN	conj	O
in	IN	case	O
mathematics	NN	nmod	O
,	,	punct	O
and	CC	cc	O
memory	NN	compound	O
dysfunction	NN	conj	O
.	.	punct	O

Until	IN	prep	O
1980	CD	pobj	O
,	,	punct	O
more	RBR	advmod	O
intensive	JJ	amod	O
induction	NN	nsubj	O
,	,	punct	O
consolidation	NN	conj	O
,	,	punct	O
and	CC	cc	O
maintenance	NN	compound	O
therapy	NN	conj	O
had	VBD	aux	O
failed	VBN	ROOT	O
to	TO	mark	O
prolong	VB	xcomp	O
DFS	NN	dobj	O
in	IN	prep	O
children	NNS	pobj	O
with	IN	case	O
a	DT	det	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O

In	IN	case	O
West	NNP	compound	O
Germany	NNP	nmod	O
(	-LRB-	punct	O
Berlin-Frankfurt-Muenster	NN	compound	O
protocol	NN	appos	O
)	-RRB-	punct	O
a	DT	det	O
70	CD	compound	O
to	TO	dep	O
75	CD	nummod	O
%	NN	amod	O
DFS	NN	nsubjpass	O
is	VBZ	auxpass	O
seen	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
patients	NNS	nmod	O
regardless	RB	advmod	O
of	IN	case	O
initial	JJ	amod	O
WBC	NN	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
effective	JJ	amod	O
therapy	NN	nsubj	O
will	MD	aux	O
override	VB	ccomp	O
prognostic	JJ	amod	O
factors	NNS	dobj	O
.	.	punct	O

Ultra-high-dose	NN	amod	O
MTX	NN	nsubj	O
,	,	punct	O
without	IN	case	O
cranial	JJ	amod	O
radiation	NN	nmod	O
,	,	punct	O
is	VBZ	aux	O
also	RB	advmod	O
showing	VBG	ROOT	O
promise	NN	dobj	O
in	IN	case	O
poor	JJ	amod	O
prognosis	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

Other	JJ	amod	O
issues	NNS	nsubj	O
include	VBP	ROOT	O
the	DT	det	O
optimal	JJ	amod	O
duration	NN	dobj	O
of	IN	case	O
therapy	NN	nmod	O
,	,	punct	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
testicular	JJ	amod	O
biopsies	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
prophylactic	JJ	amod	O
testicular	JJ	amod	O
radiation	NN	conj	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
prognostic	JJ	amod	O
factors	NNS	nsubj	O
lose	VBP	ccomp	O
their	PRP$	nmod:poss	O
significance	NN	dobj	O
after	IN	case	O
2	CD	nummod	O
years	NNS	nmod	O
of	IN	prep	O
continuous	JJ	amod	O
complete	JJ	amod	O
remission	NN	pobj	O
and	CC	cc	O
that	IN	mark	O
2	CD	nummod	O
years	NNS	nsubj	O
of	IN	case	O
maintenance	NN	compound	O
therapy	NN	nmod	O
is	VBZ	cop	O
adequate	JJ	conj	O
.	.	punct	O

Bilateral	JJ	amod	O
open-wedge	JJ	amod	O
testicular	JJ	amod	O
biopsies	NNS	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
occult	JJ	amod	O
testicular	JJ	amod	O
disease	NN	dobj	O
in	IN	case	O
8	CD	compound	O
to	TO	dep	O
10	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
males	NNS	nmod	O
.	.	punct	O

A	DT	det	O
unified	JJ	amod	O
approach	NN	nsubj	O
to	TO	case	O
children	NNS	nmod	O
with	IN	case	O
leukemia/lymphoma	NN	nmod	O
,	,	punct	O
a	DT	det	O
group	NN	appos	O
with	IN	case	O
a	DT	det	O
particularly	RB	advmod	O
poor	JJ	amod	O
prognosis	NN	nmod	O
,	,	punct	O
utilizing	VBG	acl	O
NHL-type	NN	amod	O
therapy	NN	dobj	O
may	MD	aux	O
be	VB	cop	O
more	RBR	advmod	O
effective	JJ	ROOT	O
than	IN	case	O
conventional	JJ	amod	O
ALL	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
400	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

Glucocorticoid	NN	compound	B-protein
receptor	NN	ROOT	I-protein
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
sensitivity	NN	conj	O
to	TO	case	O
steroid	NN	compound	O
hormones	NNS	nmod	O
in	IN	case	O
human	JJ	amod	O
lymphoproliferative	JJ	amod	O
diseases	NNS	nmod	O
and	CC	cc	O
myeloid	JJ	amod	O
leukemia	NN	conj	O
.	.	punct	O

The	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
quantitation	NN	nsubjpass	O
by	IN	case	O
a	DT	det	O
whole-cell	JJ	amod	O
assay	NN	nmod	O
and/or	CC	cc	O
cytosol	NN	compound	O
technique	NN	conj	O
and	CC	cc	O
the	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
sensitivity	NN	conj	O
to	TO	case	O
steroids	NNS	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
assessed	VBN	ROOT	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
normal	JJ	amod	O
donors	NNS	nmod	O
and	CC	cc	O
patients	NNS	conj	O
with	IN	case	O
chronic	JJ	amod	O
lymphatic	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
CLL	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	conj	O
(	-LRB-	punct	O
ALL	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
lymphosarcoma	JJ	compound	O
cell	NN	compound	O
leukemia	NN	conj	O
(	-LRB-	punct	O
LSCL	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
acute	JJ	amod	O
nonlymphatic	JJ	amod	O
leukemia	NN	conj	O
(	-LRB-	punct	O
ANLL	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
chronic	JJ	amod	O
myeloid	JJ	amod	O
leukemia	NN	conj	O
(	-LRB-	punct	O
CML	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Within	IN	case	O
the	DT	det	O
lymphoproliferative	JJ	amod	O
diseases	NNS	nmod	O
,	,	punct	O
ALL	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
exhibited	VBD	ROOT	O
the	DT	det	O
highest	JJS	amod	O
GR	NN	compound	B-protein
concentration	NN	dobj	O
(	-LRB-	punct	O
regardless	RB	dep	O
of	IN	case	O
the	DT	det	O
method	NN	nmod	O
used	VBN	acl	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
highest	JJS	amod	O
in	FW	amod	O
vitro	FW	dep	O
inhibition	NN	conj	O
of	IN	case	O
spontaneous	JJ	amod	O
[	-LRB-	punct	O
3H	NN	dep	O
]	-RRB-	punct	O
thymidine	NN	nmod	O
(	-LRB-	punct	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
TdR	NN	appos	O
)	-RRB-	punct	O
uptake	NN	dep	O
by	IN	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

A	DT	det	O
significant	JJ	amod	O
relationship	NN	nsubjpass	O
between	IN	case	O
GR	NN	compound	B-protein
concentration	NN	nmod	O
(	-LRB-	punct	O
whole-cell	JJ	amod	O
assay	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
sensitivity	NN	conj	O
to	TO	case	O
dexamethasone	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
contrary	NN	nmod	O
,	,	punct	O
CLL	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
presented	VBD	ROOT	O
the	DT	det	O
highest	JJS	amod	O
sensitivity	NN	dobj	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
in	IN	case	O
PHA-stimulated	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
cultures	NNS	nmod	I-cell_line
.	.	punct	O

Cells	NNS	nsubj	O
from	IN	case	O
the	DT	det	O
only	JJ	advmod	O
two	CD	nummod	O
ALL	NN	compound	O
patients	NNS	nmod	O
who	WP	nsubj	O
did	VBD	aux	O
not	RB	neg	O
undergo	VB	acl:relcl	O
a	DT	det	O
remission	NN	dobj	O
after	IN	mark	O
glucocorticoid-inclusive	JJ	amod	O
chemotherapy	NN	nsubj	O
had	VBD	ROOT	O
both	CC	cc:preconj	O
the	DT	det	O
lowest	JJS	amod	O
in	FW	amod	O
vitro	FW	dep	O
sensitivity	NN	dobj	O
to	TO	case	O
dexamethasone	NN	nmod	O
and	CC	cc	O
the	DT	det	O
lowest	JJS	amod	O
GR	NN	compound	O
concentration	NN	conj	O
with	IN	case	O
whole-cell	JJ	amod	O
assay	NN	nmod	O
.	.	punct	O

Concerning	VBG	case	O
myeloid	JJ	amod	O
leukemia	NN	nmod	O
,	,	punct	O
ANLL	NN	compound	O
patients	NNS	nsubj	O
had	VBD	ROOT	O
GR	NN	compound	B-protein
concentrations	NNS	dobj	O
slightly	RB	advmod	O
higher	JJR	amod	O
than	IN	case	O
those	DT	nmod	O
found	VBN	acl	O
in	IN	case	O
the	DT	det	O
ALL	NN	compound	O
group	NN	nmod	O
but	CC	cc	O
exhibited	VBD	conj	O
the	DT	det	O
lowest	JJS	amod	O
degree	NN	dobj	O
of	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
spontaneous	JJ	amod	O
[	-LRB-	punct	O
3H	NN	dep	O
]	-RRB-	punct	O
TdR	NN	compound	O
uptake	NN	nmod	O
by	IN	case	O
dexamethasone	NN	nmod	O
(	-LRB-	punct	O
stimulatory	JJ	amod	O
effects	NNS	nsubj	O
occurred	VBD	conj	O
in	IN	case	O
some	DT	det	O
cases	NNS	nmod	O
)	-RRB-	punct	O
.	.	punct	O

CML	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
exhibited	VBD	ROOT	O
an	DT	det	O
inhibition	NN	compound	O
degree	NN	dobj	O
by	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
glucocorticoids	NNS	nmod	O
significantly	RB	advmod	O
higher	JJR	amod	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
ANLL	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
but	CC	cc	O
not	RB	neg	O
different	JJ	conj	O
from	IN	case	O
that	DT	nmod	O
of	IN	case	O
lymphoproliferative	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

No	DT	neg	O
clear	JJ	amod	O
relationship	NN	nsubjpass	O
among	IN	case	O
GR	NN	compound	O
pattern	NN	nmod	O
,	,	punct	O
in	FW	amod	O
vitro	FW	dep	O
cell	NN	compound	O
sensitivity	NN	conj	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
clinicohematologic	JJ	amod	O
parameters	NNS	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
myeloid	JJ	amod	O
leukemia-bearing	JJ	amod	O
patients	NNS	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
corticosensitivity	NN	conj	O
of	IN	case	O
peanut-positive	JJ	amod	B-cell_line
and	CC	cc	I-cell_line
peanut-negative	JJ	conj	I-cell_line
human	JJ	amod	I-cell_line
thymocyte	NN	compound	I-cell_line
subpopulations	NNS	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
6	CD	nummod	O
human	JJ	amod	O
thymus	NN	compound	O
glands	NNS	nmod	O
,	,	punct	O
the	DT	det	O
immature	JJ	amod	O
subset	NN	nsubjpass	O
of	IN	case	O
thymocytes	NNS	nmod	B-cell_type
was	VBD	auxpass	O
separated	VBN	ROOT	O
from	IN	case	O
the	DT	det	O
more	RBR	advmod	O
mature	JJ	amod	O
one	NN	nmod	O
,	,	punct	O
by	IN	case	O
differential	JJ	amod	O
peanut	NN	compound	O
lectin	NN	compound	O
agglutination	NN	nmod	O
.	.	punct	O

These	DT	det	O
2	CD	nummod	O
cell	NN	compound	O
subpopulations	NNS	nsubjpass	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
for	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
content	NN	nmod	O
by	IN	mark	O
using	VBG	advcl	O
a	DT	det	O
whole	JJ	amod	O
cell	NN	compound	O
assay	NN	dobj	O
,	,	punct	O
with	IN	case	O
(	-LRB-	punct	O
3H	NN	compound	O
)	-RRB-	punct	O
-triamcinolone	NN	compound	O
acetonide	NN	nmod	O
as	IN	case	O
tracer	NN	nmod	O
.	.	punct	O

The	DT	det	O
unagglutinated	JJ	amod	B-cell_type
thymocytes	NNS	nsubj	I-cell_type
(	-LRB-	punct	O
peanut	NN	compound	O
negative	JJ	appos	O
)	-RRB-	punct	O
contained	VBD	ROOT	O
about	IN	advmod	O
2	CD	compound	O
times	NNS	nummod	O
more	JJR	advmod	O
receptor	NN	compound	O
sites	NNS	dobj	O
per	IN	case	O
cell	NN	nmod	O
than	IN	cc	O
agglutinated	VBN	dep	O
(	-LRB-	punct	O
peanut	NN	compound	O
positive	JJ	amod	O
)	-RRB-	punct	O
ones	NNS	dep	O
(	-LRB-	punct	O
7650	CD	nummod	O
+/-	CC	cc	O
1550	CD	conj	O
S.D.	NNP	compound	O
verus	NN	dep	O
3195	CD	nummod	O
+/-	CC	cc	O
896	CD	conj	O
S.D.	NNP	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
affinity	NN	nsubj	O
for	IN	case	O
steroid	NN	nmod	O
was	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
both	DT	det	O
cell	NN	compound	O
subsets	NNS	nmod	O
,	,	punct	O
as	IN	mark	O
was	VBD	cop	O
the	DT	det	O
stereospecificity	NN	advcl	O
for	IN	case	O
glucocorticoids	NNS	nmod	O
,	,	punct	O
the	DT	det	O
time-course	NN	conj	O
of	IN	case	O
steroid-receptor	JJ	amod	O
association	NN	nmod	O
,	,	punct	O
and	CC	cc	O
cytoplasmic	JJ	conj	O
to	TO	case	O
nuclear	JJ	amod	O
translocation	NN	nmod	O
.	.	punct	O

Despite	IN	case	O
the	DT	det	O
greater	JJR	amod	O
number	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
sites	NNS	nmod	O
,	,	punct	O
the	DT	det	O
peanut-negative	JJ	amod	B-cell_line
thymocyte	NN	compound	I-cell_line
subpopulation	NN	nsubj	I-cell_line
did	VBD	aux	O
not	RB	neg	O
differ	VB	ROOT	O
from	IN	case	O
the	DT	det	O
peanut-positive	JJ	amod	B-cell_line
one	CD	nmod	O
in	IN	case	O
its	PRP$	nmod:poss	O
sensitivity	NN	nmod	O
to	TO	case	O
the	DT	det	O
inhibitory	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
triamcinolone	NN	compound	O
acetonide	NN	nmod	O
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
measurements	NNS	nmod	O
of	IN	case	O
the	DT	det	O
incorporation	NN	nmod	O
of	IN	case	O
radiolabeled	VBN	amod	O
precursors	NNS	nmod	O
of	IN	case	O
protein	NN	nmod	O
and	CC	cc	O
DNA	NN	conj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
peanut-negative	JJ	amod	B-cell_line
subset	NN	nsubj	I-cell_line
appeared	VBD	ROOT	O
more	RBR	advmod	O
resistant	JJ	xcomp	O
in	FW	compound	O
vitro	FW	advmod	O
to	TO	case	O
the	DT	det	O
steroid-induced	JJ	amod	O
cell	NN	compound	O
lysis	NN	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
the	DT	det	O
peanut-positive	JJ	amod	B-cell_line
one	CD	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
glucocorticoid	NN	compound	O
receptor	NN	compound	O
density	NN	nsubjpass	O
and	CC	cc	O
corticosensitivity	NN	conj	O
are	VBP	auxpass	O
not	RB	neg	O
directly	RB	advmod	O
correlated	VBN	ccomp	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
number	NN	nsubj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
sites	NNS	nmod	O
may	MD	aux	O
be	VB	cop	O
dependent	JJ	conj	O
on	IN	case	O
the	DT	det	O
degree	NN	nmod	O
of	IN	case	O
immunologic	JJ	amod	O
maturation	NN	nmod	O

Defective	JJ	amod	O
binding	NN	ROOT	O
and	CC	cc	O
function	NN	conj	O
of	IN	case	O
1	CD	nummod	B-protein
,	,	punct	I-protein
25-dihydroxyvitamin	NN	dep	I-protein
D3	NN	compound	I-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
peripheral	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
end-organ	JJ	amod	O
resistance	NN	nmod	O
to	TO	case	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D	NN	nmod	O
.	.	punct	O

Lectin-induced	JJ	amod	O
DNA	NN	compound	O
synthesis	NN	nsubjpass	O
by	IN	case	O
peripheral	JJ	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
17	CD	nummod	O
normal	JJ	amod	O
donors	NNS	nmod	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
(	-LRB-	punct	O
40-60	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
by	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
(	-LRB-	punct	O
1	CD	dep	O
,	,	punct	O
25	CD	appos	O
[	-LRB-	punct	O
OH	NN	dep	O
]	-RRB-	punct	O
2D3	NN	appos	O
)	-RRB-	punct	O
at	IN	case	O
physiological	JJ	amod	O
concentrations	NNS	nmod	O
(	-LRB-	punct	O
10	CD	nummod	O
(	-LRB-	punct	O
-10	CD	dep	O
)	-RRB-	punct	O
-10	CD	nummod	O
(	-LRB-	punct	O
-9	CD	nummod	O
)	-RRB-	punct	O
M	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
lymphocytes	NNS	nsubj	B-cell_type
acquire	VBP	ROOT	O
specific	JJ	amod	O
receptors	NNS	dobj	O
for	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
upon	IN	case	O
activation	NN	nmod	O
by	IN	case	O
the	DT	det	O
lectins	NNS	nmod	B-protein
.	.	punct	O

This	DT	det	O
process	NN	nsubj	O
precedes	VBZ	ROOT	O
the	DT	det	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
studied	VBD	ROOT	O
lymphocytes	NNS	dobj	B-cell_type
from	IN	case	O
six	CD	nummod	O
patients	NNS	nmod	O
from	IN	case	O
four	CD	nummod	O
different	JJ	amod	O
kindreds	NNS	nmod	O
with	IN	case	O
the	DT	det	O
syndrome	NN	nmod	O
of	IN	case	O
hereditary	JJ	amod	O
end-organ	JJ	amod	O
resistance	NN	nmod	O
to	TO	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D	NN	nmod	O
(	-LRB-	punct	O
the	DT	det	O
so-called	JJ	amod	O
vitamin	NN	compound	O
D-dependent	JJ	amod	O
rickets	NN	compound	O
type	NN	appos	O
II	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
five	CD	nummod	O
patients	NNS	nmod	O
(	-LRB-	punct	O
three	CD	nummod	O
kindreds	NNS	dep	O
)	-RRB-	punct	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
did	VBD	aux	O
not	RB	neg	O
acquire	VB	ROOT	O
receptors	NNS	dobj	O
for	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
upon	IN	case	O
phytohemagglutinin-induced	JJ	amod	O
activation	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
normal	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
the	DT	det	O
mitogenic	JJ	amod	O
stimulation	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
patients	NNS	nmod:poss	O
'	POS	case	O
lymphocytes	NNS	nmod	B-cell_type
by	IN	case	O
phytohemagglutinin	NN	nmod	B-protein
and	CC	cc	O
concanavalin	NN	compound	O
A	NN	conj	O
was	VBD	auxpass	O
not	RB	neg	O
inhibited	VBN	ROOT	O
by	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
.	.	punct	O

Activated	VBN	amod	O
lymphocytes	NNS	nsubj	B-cell_type
of	IN	case	O
the	DT	det	O
sixth	JJ	amod	O
patient	NN	nmod	O
from	IN	case	O
a	DT	det	O
fourth	JJ	advmod	O
kindred	VBN	nmod	O
exhibited	VBD	ROOT	O
normal	JJ	amod	O
binding	NN	dobj	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	pobj	O
]	-RRB-	punct	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	dep	O
)	-RRB-	punct	O
2D3	NN	nmod	O
but	CC	cc	O
the	DT	det	O
hormone	NN	conj	O
failed	VBD	advcl	O
to	TO	mark	O
inhibit	VB	xcomp	O
the	DT	det	O
mitogenic	JJ	amod	O
stimulation	NN	dobj	O
.	.	punct	O

A	DT	det	O
similar	JJ	amod	O
pattern	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
vitamin	NN	compound	O
D	NN	compound	O
effector	NN	compound	O
system	NN	nmod	O
was	VBD	auxpass	O
previously	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
fibroblasts	NNS	nmod	O
cultured	VBN	acl	O
from	IN	case	O
skin	NN	compound	O
biopsies	NNS	nmod	O
of	IN	case	O
the	DT	det	O
same	JJ	amod	O
group	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
.	.	punct	O

The	DT	det	O
conclusions	NNS	nsubj	O
from	IN	case	O
these	DT	det	O
findings	NNS	nmod	O
are	VBP	auxpass	O
:	:	punct	O
(	-LRB-	punct	O
a	LS	dep	O
)	-RRB-	punct	O
the	DT	det	O
inhibition	NN	nsubjpass	O
of	IN	case	O
mitogenic	JJ	amod	O
stimulation	NN	nmod	O
by	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
specific	JJ	amod	B-protein
functional	JJ	amod	I-protein
receptors	NNS	nmod	I-protein
to	TO	case	O
the	DT	det	O
hormone	NN	nmod	O
;	:	punct	O
and	CC	cc	O
(	-LRB-	punct	O
b	LS	dep	O
)	-RRB-	punct	O
the	DT	det	O
receptors	NNS	nsubjpass	O
for	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
are	VBP	auxpass	O
probably	RB	advmod	O
controlled	VBN	conj	O
genetically	RB	advmod	O
by	IN	case	O
the	DT	det	O
same	JJ	amod	O
mechanisms	NNS	nmod	O
as	IN	case	O
the	DT	det	O
effector	NN	compound	O
system	NN	nmod	O
in	IN	case	O
well-characterized	JJ	amod	O
target	NN	compound	O
organs	NNS	nmod	O
of	IN	case	O
the	DT	det	O
hormone	NN	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
intestine	NN	nmod	O
and	CC	cc	O
kidney	NN	conj	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
of	IN	case	O
mononuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
from	IN	case	O
myasthenia	NN	compound	O
gravis	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
to	TO	mark	O
analyse	JJ	xcomp	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
binding	NN	dobj	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
leukocytes	NNS	nmod	I-cell_type
(	-LRB-	punct	O
MNL	NNS	appos	B-cell_type
)	-RRB-	punct	O
from	IN	case	O
39	CD	nummod	O
myasthenia	NN	compound	O
gravis	NN	compound	O
(	-LRB-	punct	O
MG	NN	appos	O
)	-RRB-	punct	O
patients	NNS	nmod	O
(	-LRB-	punct	O
unoperated	JJ	amod	O
patients	NNS	dep	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
13	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
thymectomized	JJ	amod	O
patients	NNS	conj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
14	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
patients	NNS	conj	O
receiving	VBG	acl	O
glucocorticoids	NNS	dobj	O
:	:	punct	O
thymectomized	VBN	dep	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
11	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
unoperated	JJ	conj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
6	CD	dobj	O
]	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
whole	JJ	amod	O
cell	NN	compound	O
binding	NN	compound	O
assay	NN	nsubjpass	O
with	IN	case	O
3	CD	nummod	O
(	-LRB-	punct	O
H	NN	compound	O
)	-RRB-	punct	O
dexamethasone	NN	nmod	O
was	VBD	auxpass	O
used	VBN	ROOT	O
.	.	punct	O

GR	NN	compound	B-protein
mean	NN	compound	O
values	NNS	nsubj	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
in	IN	case	O
the	DT	det	O
MNL	NN	nmod	B-cell_type
of	IN	case	O
MG	NN	compound	O
patients	NNS	nmod	O
(	-LRB-	punct	O
thymectomized	VBN	dep	O
or	CC	cc	O
not	RB	conj	O
)	-RRB-	punct	O
not	RB	neg	O
receiving	VBG	xcomp	O
glucocorticoid	NN	dobj	O
than	IN	case	O
in	IN	case	O
the	DT	det	O
MNL	NN	nmod	B-cell_type
of	IN	case	O
healthy	JJ	amod	O
donors	NNS	nmod	O
.	.	punct	O

Affinity	NN	nsubj	O
was	VBD	cop	O
within	IN	case	O
the	DT	det	O
normal	JJ	amod	O
range	NN	ROOT	O
.	.	punct	O

Sex	NN	nsubj	O
,	,	punct	O
age	NN	conj	O
or	CC	cc	O
clinical	JJ	conj	O
forms	NNS	dep	O
of	IN	case	O
illness	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
influence	VB	ROOT	O
the	DT	det	O
results	NNS	dobj	O
.	.	punct	O

In	IN	case	O
patients	NNS	nmod	O
receiving	VBG	acl	O
prednisone	NN	dobj	O
(	-LRB-	punct	O
Pd	NN	appos	O
)	-RRB-	punct	O
the	DT	det	O
GR	NN	compound	B-protein
values	NNS	nsubj	O
were	VBD	cop	O
significantly	RB	advmod	O
lower	JJR	ROOT	O
than	IN	case	O
in	IN	case	O
MG	NN	compound	O
patients	NNS	nmod	O
without	IN	case	O
Pd	NN	compound	O
therapy	NN	nmod	O
,	,	punct	O
independent	JJ	xcomp	O
of	IN	case	O
Pd	NN	compound	O
dose	NN	nmod	O
or	CC	cc	O
time	NN	conj	O
of	IN	prep	O
administration	NN	pobj	O
.	.	punct	O

No	DT	neg	O
differences	NNS	nsubjpass	O
in	IN	case	O
receptor	NN	compound	O
binding	NN	nmod	O
between	IN	case	O
normal	JJ	amod	O
subjects	NNS	nmod	O
and	CC	cc	O
MG	NN	compound	O
patients	NNS	conj	O
receiving	VBG	acl	O
Pd	NN	dobj	O
have	VBP	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
.	.	punct	O

Immunological	JJ	amod	O
interference	NN	ROOT	O
of	IN	case	O
high	JJ	amod	O
dose	NN	compound	O
corticosteroids	NNS	nmod	O
.	.	punct	O

High-dose	JJ	amod	O
corticosteroids	NNS	nsubj	O
(	-LRB-	punct	O
HDC	NN	appos	O
)	-RRB-	punct	O
will	MD	aux	O
influence	VB	ROOT	O
cellular	JJ	dobj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
humoral	JJ	amod	O
participants	NNS	conj	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

The	DT	det	O
lymphoid	JJ	amod	O
tissue	NN	nsubj	O
will	MD	aux	O
decrease	VB	ROOT	O
in	IN	case	O
size	NN	nmod	O
and	CC	cc	O
weight	NN	conj	O
after	IN	case	O
prolonged	JJ	amod	O
treatment	NN	nmod	O
with	IN	case	O
HDC	NN	nmod	O
.	.	punct	O

Lymphocyte	NN	compound	O
functions	NNS	nsubj	O
will	MD	aux	O
be	VB	auxpass	O
impaired	JJ	ROOT	O
.	.	punct	O

Reduced	VBN	amod	O
synthesis	NN	nsubjpass	O
of	IN	case	O
B-	NN	nmod	B-cell_type
as	RB	cc	I-cell_type
well	RB	mwe	I-cell_type
as	IN	mwe	I-cell_type
T-lymphocytes	NNS	conj	I-cell_type
will	MD	aux	O
be	VB	auxpass	O
seen	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nsubjpass	O
on	IN	case	O
B-cell	NN	compound	B-cell_type
function	NN	nmod	O
can	MD	aux	O
be	VB	auxpass	O
observed	VBN	ROOT	O
both	CC	dep	O
as	IN	case	O
decreased	VBN	amod	O
serum	NN	compound	O
levels	NNS	nmod	O
of	IN	case	O
immunoglobulins	NNS	nmod	B-protein
and	CC	cc	O
as	IN	case	O
impaired	JJ	amod	O
binding	NN	conj	O
of	IN	case	O
antibodies	NNS	nmod	B-protein
and	CC	cc	O
complement	NN	conj	O
to	TO	case	O
the	DT	det	O
cellular	JJ	amod	O
surface	NN	nmod	O
.	.	punct	O

Reduced	VBN	amod	O
T-cell	NN	compound	B-cell_type
function	NN	nsubjpass	O
indicated	VBN	acl	O
by	IN	case	O
impaired	JJ	amod	O
stimulation	NN	nmod	O
by	IN	case	O
PHA	NN	nmod	B-protein
and	CC	cc	O
porkweed	NN	conj	B-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
by	IN	case	O
impaired	JJ	amod	O
lymphokinin	NN	compound	O
effects	NNS	nmod	O
on	IN	case	O
leukocyte	NN	compound	B-cell_type
migration	NN	compound	O
inhibition	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
.	.	punct	O

Reduced	VBN	amod	O
lymphocyte	NN	compound	O
adherence	NN	nsubjpass	O
to	TO	case	O
antigen	NN	nmod	O
and	CC	cc	O
suppressed	VBD	conj	O
lymphocyte	NN	compound	O
reaction	NN	dobj	O
have	VBP	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

Humoral	JJ	amod	O
factors	NNS	nsubj	O
involved	VBN	acl	O
in	IN	case	O
chemotaxis	NN	nmod	O
,	,	punct	O
opsonisation	NN	conj	O
,	,	punct	O
phagocytosis	NN	conj	O
,	,	punct	O
vascular	JJ	amod	O
permeability	NN	nsubj	O
leading	VBG	acl	O
to	TO	case	O
leakage	NN	nmod	O
of	IN	case	O
fluid	NN	nmod	O
and	CC	cc	O
cells	NNS	conj	O
and	CC	cc	O
factors	NNS	conj	O
involved	VBN	acl	O
in	IN	case	O
lysis	NN	nmod	O
of	IN	case	O
antigens	NNS	nmod	O
are	VBP	cop	O
impaired	JJ	ROOT	O
.	.	punct	O

This	DT	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
explained	VBN	ROOT	O
partly	RB	advmod	O
by	IN	case	O
the	DT	det	O
observed	VBN	amod	O
reduced	VBN	amod	O
complement	NN	compound	O
activation	NN	nmod	O
via	IN	case	O
the	DT	det	O
alternative	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
classical	JJ	amod	O
pathway	NN	conj	O
in	IN	case	O
association	NN	nmod	O
with	IN	case	O
HDC	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O

Acute	JJ	amod	O
processes	NNS	nsubjpass	O
with	IN	case	O
increased	VBN	amod	O
vascular	JJ	amod	O
permeability	NN	nmod	O
and	CC	cc	O
accumulation	NN	conj	O
of	IN	case	O
leukocytes	NNS	nmod	B-cell_type
as	IN	case	O
impairing	VBG	amod	O
factors	NNS	nmod	O
could	MD	aux	O
be	VB	auxpass	O
influenced	VBN	ROOT	O
beneficially	RB	advmod	O
by	IN	case	O
HDC	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O

This	DT	det	O
positive	JJ	amod	O
effect	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
seen	VBN	ROOT	O
in	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
septic	JJ	amod	O
shock	NN	nmod	O
or	CC	cc	O
rejection	NN	conj	O
of	IN	case	O
a	DT	det	O
transplant	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
if	IN	mark	O
sepsis	NN	nsubjpass	O
or	CC	cc	O
rejection	NN	conj	O
is	VBZ	auxpass	O
not	RB	neg	O
rapidly	RB	advmod	O
reversed	VBN	advcl	O
,	,	punct	O
complications	NNS	nsubj	O
such	JJ	case	O
as	IN	mwe	O
multisystem	JJ	compound	O
organ	NN	compound	O
failure	NN	nmod	O
and	CC	cc	O
bacteremia	NN	conj	O
are	VBP	cop	O
prone	VBN	ROOT	O
to	TO	aux	O
appear	VB	xcomp	O
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
human	JJ	amod	B-protein
leukemic	JJ	amod	I-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
using	VBG	acl	O
affinity	NN	compound	O
labeling	NN	dobj	O
and	CC	cc	O
anti-human	JJ	amod	B-protein
glucocorticoid	NN	compound	I-protein
receptor	NN	compound	I-protein
antibodies	NNS	conj	I-protein
.	.	punct	O

Antisera	NNS	nsubjpass	O
raised	VBN	acl	O
against	IN	case	O
human	JJ	amod	B-protein
lymphoid	JJ	amod	I-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
were	VBD	auxpass	O
used	VBN	ROOT	O
in	IN	case	O
combination	NN	nmod	O
with	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	O
receptor	NN	compound	O
affinity	NN	compound	O
label	NN	nmod	O
[	-LRB-	punct	O
3H	NN	appos	O
]	-RRB-	punct	O
dexamethasone	NN	compound	O
21-mesylate	NN	dep	O
[	-LRB-	punct	O
(	-LRB-	punct	O
3H	NN	intj	O
]	-RRB-	punct	O
DM	NN	appos	O
)	-RRB-	punct	O
to	TO	mark	O
identify	VB	advcl	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	dobj	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
B-lymphoblastoid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
IM-9	NN	dep	B-cell_line
and	CC	cc	O
the	DT	det	O
human	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
leukemic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
CEM-C7	NN	conj	B-cell_line
.	.	punct	O

Antisera	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
following	VBG	case	O
immunization	NN	nmod	O
of	IN	prep	O
New	NNP	compound	O
Zealand	NNP	compound	O
White	NNP	pobj	O
rabbits	VBZ	conj	O
with	IN	prep	O
[	-LRB-	punct	B-protein
3H	NN	pobj	I-protein
]	-RRB-	punct	I-protein
triamcinolone	NN	compound	I-protein
acetonide	NN	pobj	I-protein
[	-LRB-	punct	I-protein
(	-LRB-	punct	I-protein
3H	NN	compound	I-protein
]	-RRB-	punct	I-protein
TA	NN	compound	I-protein
)	-RRB-	punct	I-protein
-glucocorticoid	NN	amod	I-protein
receptor	NN	compound	I-protein
complexes	NNS	appos	I-protein
partially	RB	advmod	O
purified	VBN	acl	O
by	IN	case	O
two-stage	JJ	amod	O
DNA-cellulose	JJ	amod	O
chromatography	NN	nmod	O
.	.	punct	O

The	DT	det	O
presence	NN	nsubjpass	O
of	IN	case	O
anti-human	JJ	amod	B-protein
glucocorticoid	NN	compound	I-protein
receptor	NN	compound	I-protein
antibodies	NNS	nmod	I-protein
was	VBD	auxpass	O
verified	VBN	ROOT	O
by	IN	case	O
:	:	punct	O
(	-LRB-	punct	O
a	LS	det	O
)	-RRB-	punct	O
adsorption	NN	nmod	O
of	IN	case	O
[	-LRB-	punct	B-protein
3H	NN	compound	I-protein
]	-RRB-	punct	I-protein
TA-receptor-antibody	NN	compound	I-protein
complexes	NNS	nmod	I-protein
to	TO	case	O
Protein	NN	compound	B-protein
A	NN	nmod	I-protein
;	:	punct	O
(	-LRB-	punct	O
b	LS	dep	O
)	-RRB-	punct	O
a	DT	det	O
shift	NN	dep	O
to	IN	case	O
higher	JJR	amod	O
apparent	JJ	amod	O
molecular	JJ	amod	O
weight	NN	nmod	O
in	IN	case	O
the	DT	det	O
elution	NN	compound	O
position	NN	nmod	O
from	IN	case	O
Sephacryl	NN	compound	O
S300	NN	nmod	O
of	IN	case	O
[	-LRB-	punct	B-protein
3H	NN	intj	I-protein
]	-RRB-	punct	I-protein
TA-receptor	NN	compound	I-protein
complexes	NNS	nmod	I-protein
incubated	VBN	acl	O
with	IN	case	O
immune	JJ	amod	O
serum	NN	nmod	O
;	:	punct	O
and	CC	cc	O
(	-LRB-	punct	O
c	LS	conj	O
)	-RRB-	punct	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
immune	JJ	amod	O
serum	NN	nmod	O
to	TO	case	O
displace	NN	acl	O
[	-LRB-	punct	B-protein
3H	NN	dep	I-protein
]	-RRB-	punct	I-protein
TA-receptor	NN	compound	I-protein
complexes	NNS	dep	I-protein
on	IN	case	O
sucrose	NN	compound	O
gradients	NNS	nmod	O
.	.	punct	O

These	DT	det	O
antibodies	NNS	nsubj	B-protein
also	RB	advmod	O
recognized	VBD	ROOT	O
rat	NN	compound	O
liver	NN	dobj	O
and	CC	cc	O
murine	JJ	amod	B-protein
S49	NN	compound	I-protein
cell	NN	compound	I-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	conj	I-protein
.	.	punct	O

Sodium	NN	nmod:npmod	O
dodecyl	NN	nmod:npmod	O
sulfate-polyacrylamide	JJ	amod	O
gel	NN	compound	O
electrophoresis	NN	nsubj	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
DM-labeled	JJ	amod	O
IM-9	NN	compound	O
cytosol	NN	nmod	O
identified	VBD	ROOT	O
a	DT	det	O
major	JJ	amod	O
competable	JJ	amod	O
band	NN	dobj	O
with	IN	case	O
a	DT	det	O
molecular	JJ	amod	O
weight	NN	nmod	O
of	IN	case	O
approximately	RB	advmod	O
90	CD	nummod	O
,	,	punct	O
000	CD	nmod	O
,	,	punct	O
three	CD	nummod	O
minor	JJ	amod	O
competable	JJ	amod	O
components	NNS	conj	O
with	IN	case	O
molecular	JJ	amod	O
weights	NNS	nmod	O
of	IN	case	O
approximately	RB	advmod	O
78	CD	nummod	O
,	,	punct	O
000	CD	nmod	O
,	,	punct	O
approximately	RB	advmod	O
51	CD	nummod	O
,	,	punct	O
000	CD	conj	O
,	,	punct	O
and	CC	cc	O
approximately	RB	advmod	O
38	CD	conj	O
,	,	punct	O
500	CD	conj	O
,	,	punct	O
and	CC	cc	O
at	IN	case	O
least	JJS	nmod:npmod	O
21	CD	nummod	O
other	JJ	amod	O
noncompetable	JJ	amod	O
components	NNS	conj	O
.	.	punct	O

Following	VBG	case	O
immunoprecipitation	NN	nmod	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
DM-labeled	JJ	amod	O
cytosol	NN	nmod	O
with	IN	case	O
immune	JJ	amod	O
serum	NN	nmod	O
,	,	punct	O
only	RB	advmod	O
the	DT	det	O
Mr	NNP	nsubjpass	O
90	CD	nummod	O
,	,	punct	O
000	CD	conj	O
and	CC	cc	O
78	CD	conj	O
,	,	punct	O
000	CD	nummod	O
components	NNS	nsubjpass	O
were	VBD	auxpass	O
seen	VBN	ROOT	O
.	.	punct	O

Sodium	NN	nmod:npmod	O
dodecyl	NN	nmod:npmod	O
sulfate-polyacrylamide	JJ	amod	O
gel	NN	compound	O
electrophoresis	NN	nsubj	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	intj	O
]	-RRB-	punct	O
DM-labeled	JJ	amod	O
CEM-C7	NN	compound	O
cytosol	NN	nmod	O
revealed	VBD	ROOT	O
a	DT	det	O
larger	JJR	amod	O
number	NN	dobj	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
DM-labeled	JJ	amod	O
components	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
after	IN	case	O
immunoprecipitation	NN	nsubjpass	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	intj	O
]	-RRB-	punct	O
DM-labeled	JJ	amod	O
CEM-C7	NN	compound	O
cytosol	NN	nmod	O
,	,	punct	O
a	DT	det	O
predominant	JJ	amod	O
competable	JJ	amod	O
component	NN	appos	O
with	IN	case	O
a	DT	det	O
molecular	JJ	amod	O
weight	NN	nmod	O
of	IN	case	O
90	CD	nummod	O
,	,	punct	O
000	CD	nmod	O
was	VBD	auxpass	O
easily	RB	advmod	O
identified	VBN	ROOT	O
.	.	punct	O

This	DT	det	O
component	NN	nsubjpass	O
was	VBD	auxpass	O
markedly	RB	advmod	O
diminished	VBN	ROOT	O
when	WRB	advmod	O
cytosols	NNS	nsubjpass	O
from	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-cell_line
receptor-deficient	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
ICR-27	NN	nmod	B-cell_line
were	VBD	auxpass	O
used	VBN	advcl	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
combination	NN	nsubj	O
of	IN	case	O
affinity	NN	compound	O
labeling	NN	nmod	O
and	CC	cc	O
anti-human	JJ	amod	B-protein
glucocorticoid	NN	compound	I-protein
receptor	NN	compound	I-protein
antibodies	NNS	conj	I-protein
is	VBZ	cop	O
capable	JJ	ROOT	O
of	IN	mark	O
providing	VBG	advcl	O
direct	JJ	amod	O
physical	JJ	amod	O
identification	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-protein
lymphoid	JJ	amod	I-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Effect	NN	ROOT	O
of	IN	case	O
thymosin	NN	nmod	O
on	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
activity	NN	nmod	O
and	CC	cc	O
glucocorticoid	NN	compound	O
sensitivity	NN	conj	O
of	IN	case	O
human	JJ	amod	B-cell_type
thymocytes	NNS	nmod	I-cell_type
.	.	punct	O

Incubation	NN	nsubj	O
with	IN	case	O
thymosin	NN	compound	O
fraction	NN	nmod	O
5	CD	nummod	O
,	,	punct	O
(	-LRB-	punct	O
TMS	NN	compound	O
F5	NN	dep	O
at	IN	case	O
300	CD	nummod	O
micrograms/ml	NNS	nmod	O
)	-RRB-	punct	O
a	DT	det	O
partially	RB	advmod	O
purified	VBN	amod	O
thymic	JJ	amod	O
factor	NN	nsubj	O
,	,	punct	O
reduced	VBD	ROOT	O
the	DT	det	O
steroid	NN	compound	O
binding	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-cell_type
infant	JJ	compound	I-cell_type
thymocytes	NNS	nmod	I-cell_type
from	IN	case	O
9.6	CD	nummod	O
+/-	CC	cc	O
2.1	CD	conj	O
fmole/ml	NN	nmod	O
to	TO	case	O
5.0	CD	nummod	O
+/-	CC	cc	O
2.0	CD	conj	O
fmole/ml	NN	nmod	O
.	.	punct	O

The	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
activity	NN	nsubjpass	O
in	IN	case	O
normal	JJ	amod	O
infant	JJ	amod	O
thymocytes	NNS	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
2	CD	nummod	O
,	,	punct	O
146	CD	conj	O
+/-	CC	cc	O
726	CD	conj	O
(	-LRB-	punct	O
s.d.	NN	dep	O
)	-RRB-	punct	O
sites	NNS	xcomp	O
per	IN	case	O
cell	NN	nmod	O
with	IN	case	O
dissociation	NN	compound	O
constant	NN	nmod	O
of	IN	case	O
1.4	CD	nummod	O
+/-	CC	cc	O
0.6	CD	conj	O
X	NN	compound	O
10	CD	nummod	O
(	-LRB-	punct	O
-8	CD	nummod	O
)	-RRB-	punct	O
M	NN	nmod	O
.	.	punct	O

TMS	NN	compound	O
F5	NN	nsubj	O
also	RB	advmod	O
increased	VBD	ROOT	O
the	DT	det	O
resistance	NN	dobj	O
of	IN	case	O
human	JJ	amod	O
thymocytes	NNS	nmod	O
to	TO	case	O
the	DT	det	O
cytolytic	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
(	-LRB-	punct	O
2.5	CD	nummod	O
X	NN	compound	O
10	CD	nummod	O
(	-LRB-	punct	O
-8	CD	compound	O
)	-RRB-	punct	O
M	NN	appos	O
)	-RRB-	punct	O
to	TO	case	O
168.6	CD	nummod	O
+/-	CC	cc	O
30.2	CD	conj	O
%	NN	nmod	O
of	IN	case	O
control	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.01	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	prep	O
animals	NNS	pobj	O
,	,	punct	O
medullary	JJ	nsubj	B-cell_type
and	CC	cc	I-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
are	VBP	cop	O
more	RBR	advmod	O
resistant	JJ	ROOT	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
than	IN	case	O
immature	JJ	amod	B-cell_type
thymic	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
thymosin	NN	nsubj	O
can	MD	aux	O
induce	VB	ccomp	O
changes	NNS	dobj	O
consistent	JJ	amod	O
with	IN	case	O
differentiation	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
thymocytes	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
results	NNS	nsubj	O
are	VBP	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
a	DT	det	O
physiological	JJ	amod	O
role	NN	nmod	O
of	IN	case	O
thymosin	NN	nmod	O
in	IN	case	O
intrathymic	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
maturation	NN	nmod	O
in	IN	case	O
man	NN	nmod	O
.	.	punct	O

Incubation	NN	nsubj	O
of	IN	case	O
a	DT	det	O
human	JJ	amod	B-cell_line
malignant	JJ	amod	I-cell_line
thymus	NN	nmod	I-cell_line
derived	VBN	acl	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	dobj	I-cell_line
(	-LRB-	punct	O
MOLT	NN	appos	B-cell_line
3	CD	nummod	I-cell_line
)	-RRB-	punct	O
with	IN	case	O
TMS	NN	compound	O
F5	NN	nmod	O
also	RB	advmod	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
significant	JJ	amod	O
reduction	NN	nmod	O
of	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
steroid	NN	compound	O
binding	NN	compound	O
sites	NNS	nmod	O
to	TO	case	O
44.2	CD	nmod	O
+/-	CC	cc	O
15.3	CD	conj	O
%	NN	conj	O
of	IN	case	O
control	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.05	CD	nmod	O
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
TMS	NN	compound	O
F5	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
significantly	RB	advmod	O
reduce	VB	conj	O
the	DT	det	O
glucocorticoid	NN	compound	O
sensitivity	NN	dobj	O
of	IN	case	O
MOLT	NN	compound	B-cell_line
3	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Specific	JJ	amod	B-protein
high-affinity	JJ	amod	I-protein
receptors	NNS	ROOT	I-protein
for	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	dep	O
D3	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
presence	NN	dep	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
and	CC	cc	O
induction	NN	conj	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
following	VBG	case	O
activation	NN	nmod	O
.	.	punct	O

Human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nsubj	I-cell_type
have	VBP	ROOT	O
high	JJ	amod	O
affinity	NN	compound	O
binding	NN	compound	O
sites	NNS	dobj	O
for	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-	CD	compound	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	nmod	O
(	-LRB-	punct	O
Kd	NN	compound	O
0.14	CD	nummod	O
nM	NN	dep	O
,	,	punct	O
sedimentation	NN	compound	O
coefficient	NN	amod	O
3.7S	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Resting	VBG	amod	B-cell_type
human	JJ	amod	I-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nsubj	I-cell_type
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
do	VBP	aux	O
not	RB	neg	O
have	VB	ROOT	O
a	DT	det	O
demonstrable	JJ	amod	O
1	CD	dep	B-protein
,	,	punct	I-protein
25-	CD	compound	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	compound	I-protein
receptor	NN	dobj	I-protein
.	.	punct	O

After	IN	case	O
activation	NN	nsubj	O
with	IN	case	O
phytohemagglutinin	NN	intj	B-protein
the	DT	det	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
exhibit	VBP	ROOT	O
the	DT	det	O
receptor	NN	dobj	O
within	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
,	,	punct	O
and	CC	cc	O
this	DT	det	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
blocked	VBN	conj	O
by	IN	case	O
cycloheximide	NN	nmod	O
.	.	punct	O

The	DT	det	O
receptor	NN	nsubj	O
in	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
has	VBZ	ROOT	O
a	DT	det	O
sedimentation	NN	compound	O
coefficient	NN	dobj	O
of	IN	case	O
3.7S	CD	nmod	O
and	CC	cc	O
a	DT	det	O
high	JJ	amod	O
affinity	NN	conj	O
(	-LRB-	punct	O
Kd	NN	dep	O
0.10	CD	nummod	O
nM	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
the	DT	det	O
ligand	NN	nmod	O
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
chronic	JJ	amod	O
glucocorticoid	NN	compound	O
excess	NN	nmod	O
in	IN	case	O
man	NN	nmod	O
on	IN	case	O
insulin	NN	nmod	O
binding	NN	acl	O
to	TO	case	O
circulating	VBG	amod	B-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
differences	NNS	dep	O
between	IN	case	O
endogenous	JJ	amod	O
and	CC	cc	O
exogenous	JJ	conj	O
hypercorticism	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
measured	VBD	ROOT	O
[	-LRB-	punct	O
125I	NN	dobj	O
]	-RRB-	punct	O
insulin	NN	dep	O
binding	VBG	acl	O
to	TO	case	O
circulating	VBG	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
or	CC	cc	I-cell_type
erythrocytes	NNS	conj	I-cell_type
from	IN	case	O
16	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
glucocorticoid	NN	compound	O
excess	NN	nmod	O
,	,	punct	O
9	CD	appos	O
chronically	RB	advmod	O
treated	VBN	acl	O
with	IN	case	O
prednisone	NN	nmod	O
and	CC	cc	O
7	CD	conj	O
with	IN	case	O
adrenocortical	JJ	amod	O
hyperfunction	NN	nmod	O
.	.	punct	O

With	IN	case	O
monocytes	NNS	nmod	B-cell_type
,	,	punct	O
[	-LRB-	punct	O
125I	NN	dep	O
]	-RRB-	punct	O
insulin	NN	compound	O
binding	NN	nsubjpass	O
was	VBD	auxpass	O
iincreased	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
patients	NNS	nmod	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
binding	VBG	amod	O
data	NNS	nmod	O
indicated	VBD	ROOT	O
that	IN	dobj	O
increased	VBN	amod	O
binding	NN	dep	O
in	IN	case	O
patients	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
prednisone	NN	nmod	O
was	VBD	cop	O
due	JJ	case	O
to	TO	case	O
an	DT	det	O
ncrease	NN	nmod	O
in	IN	case	O
receptor	NN	compound	O
concentration	NN	nmod	O
,	,	punct	O
whereas	IN	mark	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
adrenocortical	JJ	amod	O
hyperfunction	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
was	VBD	cop	O
due	JJ	case	O
to	TO	case	O
an	DT	det	O
increase	NN	dep	O
in	IN	case	O
receptor	NN	compound	O
affinity	NN	nmod	O
.	.	punct	O

With	IN	case	O
erythrocytes	NNS	nmod	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
adrenocortical	JJ	amod	O
hyperfunction	NN	nmod	O
there	EX	expl	O
was	VBD	ROOT	O
an	DT	det	O
increase	NN	nsubj	O
in	IN	case	O
receptor	NN	compound	O
affinity	NN	nmod	O
and	CC	cc	O
a	DT	det	O
decrease	NN	conj	O
in	IN	case	O
receptor	NN	compound	O
concentration	NN	nmod	O
,	,	punct	O
so	IN	mark	O
that	IN	mark	O
the	DT	det	O
binding	NN	nsubj	O
of	IN	case	O
[	-LRB-	punct	O
125I	NN	nmod	O
]	-RRB-	punct	O
insulin	NN	nsubj	O
was	VBD	cop	O
normal	JJ	advcl	O
.	.	punct	O

The	DT	det	O
disparity	NN	nsubj	O
of	IN	case	O
results	NNS	nmod	O
between	IN	case	O
endogenous	JJ	amod	O
and	CC	cc	O
exogenous	JJ	conj	O
hypercorticism	NN	nmod	O
,	,	punct	O
between	IN	case	O
the	DT	det	O
two	CD	nummod	O
cell	NN	compound	O
types	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
between	IN	case	O
the	DT	det	O
present	JJ	amod	O
studies	NNS	conj	O
and	CC	cc	O
previous	JJ	amod	O
studies	NNS	conj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
glucocorticoid	NN	compound	O
excess	NN	nmod	O
on	IN	case	O
the	DT	det	O
insulin	NN	compound	B-protein
receptor	NN	nmod	I-protein
are	VBP	cop	O
extremely	RB	advmod	O
complex	JJ	ccomp	O
and	CC	cc	O
wide-ranging	JJ	conj	O
and	CC	cc	O
that	IN	mark	O
in	IN	case	O
this	DT	det	O
condition	NN	nmod	O
,	,	punct	O
extrapolations	NNS	nsubj	O
in	IN	case	O
humans	NNS	nmod	O
from	IN	case	O
data	NNS	nmod	O
with	IN	case	O
circulating	VBG	amod	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
liver	NN	nmod	O
and	CC	cc	O
muscle	NN	conj	O
may	MD	aux	O
not	RB	neg	O
be	VB	cop	O
appropriate	JJ	conj	O
.	.	punct	O

Reduced	VBN	amod	O
level	NN	ROOT	O
of	IN	case	O
cellular	JJ	amod	B-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
anorexia	NN	compound	O
nervosa	NN	nmod	O
.	.	punct	O

Specific	JJ	amod	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
measured	VBN	ROOT	O
in	IN	case	O
circulating	VBG	amod	O
mononuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
from	IN	case	O
12	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
anorexia	NN	compound	O
nervosa	NN	nmod	O
and	CC	cc	O
21	CD	nummod	O
healthy	JJ	amod	O
control	NN	compound	O
subjects	NNS	conj	O
.	.	punct	O

Cells	NNS	nsubjpass	O
from	IN	case	O
patients	NNS	nmod	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
contain	VB	xcomp	O
a	DT	det	O
significantly	RB	amod	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0.01	CD	dep	O
)	-RRB-	punct	O
lower	JJR	amod	O
level	NN	dobj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
3830	CD	nummod	O
+/-	CC	cc	O
210	CD	conj	O
sites/cell	NNS	dep	O
,	,	punct	O
mean	NN	appos	O
+/-	CC	cc	O
SE	NN	conj	O
)	-RRB-	punct	O
than	IN	case	O
those	DT	nmod	O
from	IN	case	O
controls	NNS	nmod	O
(	-LRB-	punct	O
4930	CD	nummod	O
+/-	CC	cc	O
250	CD	conj	O
sites/cell	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
partial	JJ	amod	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
defect	NN	nsubj	O
may	MD	aux	O
well	RB	advmod	O
explain	VB	ROOT	O
the	DT	det	O
abnormal	JJ	amod	O
cortisol	NN	compound	O
metabolism	NN	dobj	O
and	CC	cc	O
glucocorticoid	NN	compound	O
resistance	NN	conj	O
commonly	RB	advmod	O
found	VBN	acl	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
anorexia	NN	compound	O
nervosa	NN	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
presence	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
well	RB	advmod	O
established	VBN	ROOT	O
,	,	punct	O
but	CC	cc	O
factors	NNS	nsubjpass	O
affecting	VBG	acl	O
its	PRP$	nmod:poss	O
regulation	NN	dobj	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
described	VBN	conj	O
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
competitive	JJ	amod	O
binding	NN	compound	O
whole	JJ	amod	O
cell	NN	compound	O
assay	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
-dexamethasone	NN	nmod	O
at	IN	case	O
24	CD	nummod	O
and	CC	cc	O
37	CD	conj	O
degrees	NNS	compound	O
C	NN	nmod	O
in	IN	case	O
untreated	JJ	amod	O
normal	JJ	amod	O
subjects	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
healthy	JJ	amod	O
subjects	NNS	conj	O
taking	VBG	acl	O
various	JJ	amod	O
glucocorticoid	NN	compound	O
preparations	NNS	dobj	O
.	.	punct	O

At	IN	case	O
24	CD	nummod	O
degrees	NNS	compound	O
C	NN	compound	O
normal	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
lymphocytes	NNS	nsubj	I-cell_type
had	VBD	ROOT	O
6000	CD	nummod	O
binding	VBG	amod	O
sites/cell	NNS	dobj	O
and	CC	cc	O
a	DT	det	O
dissociation	NN	compound	O
constant	NN	conj	O
of	IN	case	O
4	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-9	CD	dep	O
)	-RRB-	punct	O
M	NN	nmod	O
.	.	punct	O

The	DT	det	O
administration	NN	nsubj	O
of	IN	case	O
1	CD	nummod	O
mg	NN	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
,	,	punct	O
5	CD	nummod	O
mg	NN	appos	O
of	IN	case	O
prednisone	NN	nmod	O
,	,	punct	O
and	CC	cc	O
37.5	CD	nummod	O
mg	NN	conj	O
of	IN	case	O
cortisone	NN	compound	O
acetate	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
30	CD	compound	O
%	NN	amod	O
decrease	NN	nmod	O
in	IN	case	O
binding	VBG	amod	O
sites	NNS	nmod	O
after	IN	case	O
1	CD	nummod	O
week	NN	nmod	O
with	IN	case	O
no	DT	neg	O
change	NN	nmod	O
in	IN	case	O
binding	NN	compound	O
affinity	NN	nmod	O
.	.	punct	O

No	DT	neg	O
changes	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
binding	VBG	amod	O
sites	NNS	nmod	O
was	VBD	auxpass	O
noted	VBN	ROOT	O
before	IN	case	O
1	CD	nummod	O
week	NN	nmod	O
and	CC	cc	O
the	DT	det	O
diminished	VBN	amod	O
number	NN	nsubj	O
persisted	VBD	conj	O
for	IN	case	O
1	CD	nummod	O
week	NN	nmod	O
after	IN	case	O
discontinuation	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

Lymphocytes	NNS	nsubj	B-cell_type
from	IN	case	O
hospitalized	VBN	amod	O
patients	NNS	nmod	O
taking	VBG	acl	O
40-60	CD	nummod	O
mg	NN	dobj	O
of	IN	case	O
dexamethasone	NN	nmod	O
daily	RB	advmod	O
demonstrated	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
change	NN	dobj	O
in	IN	case	O
number	NN	nmod	O
of	IN	case	O
binding	VBG	amod	O
sites	NNS	nmod	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
seen	VBN	acl:relcl	O
in	IN	case	O
normal	JJ	amod	O
subjects	NNS	nmod	O
taking	VBG	acl	O
1	CD	nummod	O
mg	NN	dobj	O
of	IN	case	O
dexamethasone	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
binding	NN	compound	O
assays	NNS	nsubjpass	O
were	VBD	auxpass	O
carried	VBN	advcl	O
out	RP	prt	O
at	IN	case	O
physiologic	JJ	amod	O
temperature	NN	nmod	O
there	EX	expl	O
was	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
decrease	NN	nsubj	O
in	IN	case	O
number	NN	nmod	O
of	IN	case	O
binding	VBG	amod	O
sites	NNS	nmod	O
after	IN	case	O
dexamethasone	NN	compound	O
administration	NN	nmod	O
,	,	punct	O
and	CC	cc	O
in	IN	prep	O
addition	NN	pobj	O
,	,	punct	O
there	EX	expl	O
was	VBD	conj	O
a	DT	det	O
two-fold	JJ	amod	O
increase	NN	nsubj	O
in	IN	case	O
binding	NN	compound	O
affinity	NN	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	O
administration	NN	nsubj	O
results	VBZ	ROOT	O
in	IN	case	O
a	DT	det	O
time-dependent	JJ	amod	O
decrease	NN	nmod	O
in	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
lymphocyte	NN	compound	O
glucocorticoid	NN	compound	O
binding	NN	compound	O
sites	NNS	nmod	O
that	WDT	nsubj	O
is	VBZ	cop	O
independent	JJ	acl:relcl	O
of	IN	case	O
the	DT	det	O
type	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	nmod	O
administered	VBN	acl	O
.	.	punct	O

This	DT	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
first	JJ	amod	O
in	FW	amod	O
vivo	FW	dep	O
demonstration	NN	attr	O
that	IN	mark	O
glucocorticoids	NNS	nsubj	O
modulate	VBP	ccomp	O
their	PRP$	nmod:poss	O
own	JJ	amod	O
receptors	NNS	dobj	O
in	IN	case	O
man	NN	nmod	O
.	.	punct	O

Immunoglobulin	NN	compound	O
localization	NN	ROOT	O
in	IN	case	O
benign	JJ	amod	O
and	CC	cc	O
malignant	JJ	conj	O
lesions	NNS	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
mammary	JJ	amod	O
gland	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
direct	JJ	amod	O
imunofluorescence	NN	dobj	O
,	,	punct	O
lesions	NNS	nsubjpass	O
from	IN	case	O
266	CD	nummod	O
human	JJ	amod	O
breast	NN	compound	O
specimens	NNS	nmod	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
IgA	NN	nmod	O
,	,	punct	O
IgM	NN	conj	O
,	,	punct	O
or	CC	cc	O
IgG	NN	compound	O
localization	NN	conj	O
.	.	punct	O

The	DT	det	O
lesions	NNS	nsubj	O
included	VBD	ROOT	O
benign	JJ	amod	O
elements	NNS	dobj	O
from	IN	case	O
66	CD	nummod	O
subcutaneous	JJ	amod	O
mastectomy	NN	compound	O
specimens	NNS	nmod	O
in	IN	case	O
which	WDT	nmod	O
the	DT	det	O
absence	NN	nsubjpass	O
of	IN	case	O
simultaneous	JJ	amod	O
breast	NN	compound	O
malignancy	NN	nmod	O
was	VBD	auxpass	O
documented	VBN	acl:relcl	O
,	,	punct	O
primary	JJ	amod	O
breast	NN	compound	O
carcinomas	NNS	conj	O
from	IN	case	O
153	CD	nummod	O
mastectomy	NN	compound	O
specimens	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
47	CD	nummod	O
biopsies	NNS	conj	O
containing	VBG	acl	O
metastatic	JJ	amod	O
breast	NN	compound	O
cancer	NN	dobj	O
.	.	punct	O

A	DT	det	O
statistically	RB	advmod	O
significant	JJ	amod	O
association	NN	nsubjpass	O
of	IN	case	O
IgA	NN	nmod	B-protein
and	CC	cc	O
IgM	NN	conj	B-protein
with	IN	case	O
benign	JJ	amod	O
lesions	NNS	nmod	O
was	VBD	auxpass	O
contrasted	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
association	NN	nmod	O
of	IN	case	O
IgG	NN	nmod	B-protein
with	IN	case	O
malignant	JJ	amod	O
lesions	NNS	nmod	O
.	.	punct	O

In	IN	case	O
both	CC	cc:preconj	O
primary	JJ	amod	O
and	CC	cc	O
metastatic	JJ	conj	O
lesions	NNS	nmod	O
,	,	punct	O
IgG	NN	compound	B-protein
localization	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
estrogen-receptor-poor	JJ	amod	O
primary	JJ	amod	O
cancers	NNS	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
estrogen-receptor-rich	JJ	amod	O
primary	JJ	amod	O
cancers	NNS	nmod	O
.	.	punct	O

Among	IN	case	O
primary	JJ	amod	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O
,	,	punct	O
IgG	NN	compound	B-protein
localization	NN	nsubj	O
in	IN	case	O
the	DT	det	O
tumor	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
relative	JJ	amod	O
lymphopenia	NN	nmod	O
.	.	punct	O

A	DT	det	O
shorter	JJR	amod	O
disease-free	JJ	amod	O
interval	NN	nsubjpass	O
was	VBD	auxpass	O
noted	VBN	ROOT	O
in	IN	case	O
association	NN	nmod	O
with	IN	case	O
IgG	NN	compound	B-protein
localization	NN	nmod	O
among	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
breast	NN	compound	O
lesions	NNS	nmod	O
.	.	punct	O

No	DT	neg	O
statistically	RB	advmod	O
significant	JJ	amod	O
association	NN	nsubj	O
between	IN	case	O
stage	NN	nmod	O
of	IN	case	O
disease	NN	nmod	O
and	CC	cc	O
immunoglobulin	NN	compound	O
presence	NN	conj	O
was	VBD	cop	O
demonstrable	JJ	ROOT	O
.	.	punct	O

Moderate-to-severe	CD	compound	O
intraductal	JJ	amod	O
epithelial	JJ	amod	O
hyperplasias	NN	nsubjpass	O
were	VBD	auxpass	O
more	RBR	advmod	O
often	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
immunoglobulin	NN	compound	B-protein
G	NN	compound	I-protein
localization	NN	nmod	O
that	WDT	nsubj	O
were	VBD	cop	O
other	JJ	amod	O
benign	JJ	amod	O
lesions	NNS	acl:relcl	O

Correlation	NN	ROOT	O
of	IN	case	O
steroid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
with	IN	case	O
histologic	JJ	amod	O
differentiation	NN	nmod	O
in	IN	case	O
mammary	JJ	amod	O
carcinoma	NN	nmod	O
.	.	punct	O

A	DT	det	O
Singapore	NNP	compound	O
experience	NN	ROOT	O
.	.	punct	O

Cancer	NN	nsubj	O
of	IN	case	O
the	DT	det	O
breast	NN	nmod	O
is	VBZ	ROOT	O
the	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
tumor	NN	attr	O
in	IN	prep	O
females	NNS	pobj	O
in	IN	prep	O
Singapore	NNP	pobj	O
,	,	punct	O
with	IN	prep	O
the	DT	det	O
rate	NN	pobj	O
of	IN	prep	O
20.7	CD	pobj	O
per	IN	prep	O
100	CD	pobj	O
,	,	punct	O
000	CD	pobj	O
per	IN	prep	O
year	NN	pobj	O
(	-LRB-	punct	O
1977	CD	nummod	O
estimate	NN	parataxis	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
predicted	VBN	ccomp	O
to	TO	mark	O
increase	VB	xcomp	O
to	IN	case	O
29.8	CD	nummod	O
per	IN	case	O
100	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
women	NNS	dobj	O
per	IN	prep	O
year	NN	pobj	O
by	IN	prep	O
1995	CD	pobj	O
.	.	punct	O

A	DT	det	O
detailed	JJ	amod	O
histopathologic	JJ	amod	O
review	NN	nsubjpass	O
of	IN	case	O
50	CD	nummod	O
primary	JJ	amod	O
breast	NN	compound	O
cancer	NN	compound	O
tumors	NNS	nmod	O
analyzed	VBN	acl	O
for	IN	case	O
estrogen	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
ER	NN	appos	B-protein
)	-RRB-	punct	O
level	NN	nmod	O
was	VBD	auxpass	O
carried	VBN	ROOT	O
out	RP	advmod	O
and	CC	cc	O
a	DT	det	O
variety	NN	conj	O
of	IN	case	O
morphologic	JJ	amod	O
features	NNS	nmod	O
correlated	VBD	acl	O
with	IN	case	O
ER	NN	nmod	B-protein
results	VBZ	conj	O
to	TO	mark	O
identify	VB	xcomp	O
any	DT	det	O
factors	NNS	dobj	O
that	WDT	nsubj	O
will	MD	aux	O
improve	VB	acl:relcl	O
the	DT	det	O
management	NN	dobj	O
and	CC	cc	O
prognosis	NN	conj	O
for	IN	prep	O
breast	NN	compound	O
cancer	NN	pobj	O
.	.	punct	O

Cytosol	NN	nsubjpass	O
was	VBD	auxpass	O
incubated	VBN	ROOT	O
with	IN	case	O
3H-estradiol	NN	nmod	O
in	IN	case	O
the	DT	dep	O
presence	NN	nmod	O
and	CC	cc	O
absence	NN	conj	O
of	IN	case	O
cold	JJ	amod	O
diethylstilbestrol	NN	nmod	O
,	,	punct	O
and	CC	cc	O
bound	VBD	amod	O
and	CC	cc	O
free	JJ	amod	O
hormone	NN	nsubjpass	O
were	VBD	auxpass	O
separated	VBN	conj	O
by	IN	case	O
Dextran-coated	JJ	amod	O
charcoal	NN	compound	O
method	NN	nmod	O
.	.	punct	O

Tumors	NNS	nsubjpass	O
binding	VBG	acl	O
more	JJR	amod	O
than	IN	mwe	O
5	CD	compound	O
fmol/mg	NN	compound	O
cytosol	NN	compound	B-protein
protein	NN	nmod	I-protein
were	VBD	auxpass	O
classified	VBN	ROOT	O
as	IN	case	O
ER	NN	compound	B-protein
-positive	JJ	nmod	O
.	.	punct	O

Progesterone	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
PR	NN	appos	B-protein
)	-RRB-	punct	O
level	NN	nsubjpass	O
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
in	IN	case	O
some	DT	det	O
specimens	NNS	nmod	O
with	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
a	DT	det	O
similar	JJ	amod	O
method	NN	nmod	O
.	.	punct	O

Most	JJS	nsubj	O
of	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
were	VBD	ROOT	O
Chinese	JJ	acomp	O
(	-LRB-	punct	O
90	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Three	CD	nummod	O
patients	NNS	nsubj	O
were	VBD	ccomp	O
Malays	NNP	attr	O
,	,	punct	O
one	CD	nsubj	O
was	VBD	ROOT	O
Indian	JJ	acomp	O
,	,	punct	O
and	CC	cc	O
one	CD	nsubj	O
was	VBD	conj	O
European	NNP	acomp	O
in	IN	prep	O
this	DT	det	O
series	NN	pobj	O
.	.	punct	O

Results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
there	EX	expl	O
was	VBD	ccomp	O
strong	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
ER	NN	compound	B-protein
level	NN	nmod	O
,	,	punct	O
age	NN	conj	O
,	,	punct	O
and	CC	cc	O
histologic	JJ	amod	O
grade	NN	conj	O
of	IN	case	O
the	DT	det	O
tumors	NNS	nmod	O
.	.	punct	O

No	DT	neg	O
correlation	NN	nsubj	O
existed	VBD	ROOT	O
between	IN	case	O
absence	NN	nmod	O
or	CC	cc	O
presence	NN	conj	O
of	IN	case	O
lymph	NN	compound	O
node	NN	compound	O
metastases	NNS	nmod	O
and	CC	cc	O
ER	NN	conj	B-protein
.	.	punct	O

Although	IN	mark	O
there	EX	expl	O
was	VBD	advcl	O
a	DT	det	O
trend	NN	nsubj	O
for	IN	case	O
ER	NN	compound	B-protein
-positive	JJ	amod	O
tumors	NNS	nmod	O
to	TO	mark	O
have	VB	acl	O
a	DT	det	O
low-grade	JJ	amod	O
lymphocytic	JJ	amod	O
infiltration	NN	dobj	O
,	,	punct	O
the	DT	det	O
difference	NN	nsubj	O
was	VBD	cop	O
not	RB	neg	O
statistically	RB	advmod	O
significant	JJ	ROOT	O
.	.	punct	O

Mononuclear	JJ	amod	B-cell_type
cells	NNS	ROOT	I-cell_type
infiltrating	VBG	acl	O
human	JJ	amod	O
mammary	JJ	amod	O
carcinomas	NNS	dobj	O
:	:	punct	O
immunohistochemical	JJ	amod	O
analysis	NN	dep	O
with	IN	case	O
monoclonal	JJ	amod	B-protein
antibodies	NNS	nmod	I-protein
.	.	punct	O

Breast	NN	compound	O
carcinomas	NNS	nsubjpass	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
immunoperoxidase	NN	compound	O
technique	NN	nmod	O
using	VBG	acl	O
antisera	NNS	dobj	O
specific	JJ	amod	O
for	IN	case	O
lymphocyte	NN	compound	B-cell_type
subsets	NNS	nmod	I-cell_type
,	,	punct	O
monocytes	NNS	conj	B-cell_type
,	,	punct	O
NK	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
and	CC	cc	O
major	JJ	amod	B-protein
histocompatibility	NN	compound	I-protein
antigens	NNS	conj	I-protein
(	-LRB-	punct	O
HLA-A	NN	dep	B-protein
,	,	punct	O
-B	NN	conj	B-protein
,	,	punct	O
-C	NN	nummod	O
;	:	punct	O
Ia-like	NN	amod	B-protein
)	-RRB-	punct	O
.	.	punct	O

Sixty-four	CD	nsubj	O
per	IN	case	O
cent	NN	nmod	O
of	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
had	VBD	ROOT	O
a	DT	det	O
moderate	JJ	amod	O
or	CC	cc	O
strong	JJ	conj	O
mononuclear	JJ	amod	O
cell	NN	compound	O
infiltration	NN	dobj	O
,	,	punct	O
77	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
without	IN	case	O
mononuclear	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
infiltration	NN	nmod	O
had	VBD	parataxis	O
receptors	NNS	dobj	O
for	IN	case	O
estrogens	NNS	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
51	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
with	IN	case	O
infiltration	NN	nmod	O
.	.	punct	O

The	DT	det	O
majority	NN	nsubj	O
of	IN	case	O
the	DT	det	O
infiltrating	VBG	amod	B-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	cop	O
T	NN	compound	B-cell_type
cells	NNS	ROOT	I-cell_type
;	:	punct	O
generally	RB	advmod	O
the	DT	det	O
OKT8	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
were	VBD	cop	O
predominant	JJ	dep	O
.	.	punct	O

The	DT	det	O
Leu	NN	compound	O
3A/OKT8	NN	compound	O
cell	NN	compound	O
ratio	NN	nsubj	O
was	VBD	cop	O
not	RB	neg	O
related	JJ	ROOT	O
to	TO	case	O
histological	JJ	amod	O
type	NN	nmod	O
,	,	punct	O
tumor	NN	compound	O
size	NN	conj	O
,	,	punct	O
age	NN	appos	O
of	IN	case	O
the	DT	det	O
patient	NN	nmod	O
or	CC	cc	O
presence	NN	conj	O
of	IN	case	O
metastases	NNS	nmod	O
.	.	punct	O

Some	DT	nsubj	O
of	IN	case	O
the	DT	det	O
T	NN	compound	O
cells	NNS	nmod	O
had	VBD	ROOT	O
the	DT	det	O
Ia	NN	compound	B-protein
antigen	NN	dobj	I-protein
and	CC	cc	O
were	VBD	auxpass	O
thus	RB	advmod	O
probably	RB	advmod	O
activated	VBN	conj	O
.	.	punct	O

The	DT	det	O
B	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
were	VBD	cop	O
either	CC	cc:preconj	O
absent	JJ	ROOT	O
or	CC	cc	O
less	RBR	advmod	O
numerous	JJ	conj	O
than	IN	case	O
the	DT	det	O
T	NN	compound	O
cells	NNS	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
relation	NN	nsubj	O
between	IN	prep	O
their	PRP$	nmod:poss	O
distribution	NN	pobj	O
and	CC	cc	O
the	DT	det	O
various	JJ	amod	O
parameters	NNS	conj	O
studied	VBN	acl	O
.	.	punct	O

A	DT	det	O
few	JJ	amod	O
monocytes	NNS	nsubj	B-cell_type
were	VBD	cop	O
heterogeneous	JJ	ROOT	O
according	VBG	case	O
to	IN	case	O
their	PRP$	nmod:poss	O
markers	NNS	nmod	O
(	-LRB-	punct	O
OKM	NN	appos	B-protein
I	CD	nummod	I-protein
and	CC	cc	O
acid	NN	compound	O
phosphatase	NN	conj	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
6	CD	nummod	O
cases	NNS	nmod	O
only	RB	advmod	O
there	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
strong	JJ	amod	O
infiltration	NN	nsubj	O
of	IN	case	O
mononuclear	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
positive	JJ	amod	O
for	IN	case	O
acid	NN	compound	B-protein
phosphatase	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
number	NN	nsubj	O
of	IN	case	O
the	DT	det	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	cop	O
also	RB	advmod	O
low	JJ	ROOT	O
.	.	punct	O

Only	RB	advmod	O
a	DT	det	O
few	JJ	amod	O
mononuclear	JJ	amod	O
infiltrating	VBG	amod	O
cells	NNS	nsubj	O
had	VBD	ROOT	O
receptors	NNS	dobj	O
for	IN	case	O
transferrin	NN	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
positive	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
the	DT	det	O
inflammatory	JJ	amod	O
infiltration	NN	nmod	O
and	CC	cc	O
the	DT	det	O
presence	NN	conj	O
of	IN	case	O
HLA	NN	compound	B-protein
class-I	NN	compound	I-protein
antigens	NNS	nmod	I-protein
on	IN	case	O
tumor	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
s	NNS	nmod	O
.	.	punct	O

Some	DT	nsubj	O
of	IN	case	O
the	DT	det	O
antisera	NNS	nmod	O
specific	JJ	amod	O
for	IN	case	O
lymphocyte	NN	compound	B-cell_type
subsets	NNS	nmod	I-cell_type
also	RB	advmod	O
stained	VBD	ROOT	O
the	DT	det	O
breast	NN	compound	B-cell_type
carcinoma	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
.	.	punct	O

The	DT	det	O
great	JJ	amod	O
variations	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
subsets	NNS	nmod	O
of	IN	case	O
mononuclear	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
breast	NN	compound	O
carcinomas	NNS	nmod	O
may	MD	aux	O
correspond	VB	ROOT	O
to	TO	case	O
various	JJ	amod	O
systems	NNS	nmod	O
of	IN	case	O
defense	NN	nmod	O
against	IN	case	O
neoplasm	NN	nmod	O
.	.	punct	O

A	DT	det	O
case	NN	ROOT	O
of	IN	case	O
male	JJ	amod	O
pseudohermaphroditism	NN	nmod	O
with	IN	case	O
normal	JJ	amod	O
androgen	NN	compound	B-protein
receptor	NN	compound	I-protein
binding	NN	nmod	O
and	CC	cc	O
47	CD	conj	O
,	,	punct	O
XYY	NN	compound	O
karyotype	NN	conj	O
.	.	punct	O

A	DT	det	O
case	NN	nsubjpass	O
of	IN	case	O
male	JJ	amod	O
pseudohermaphroditism	NN	nmod	O
with	IN	case	O
47	CD	nummod	O
,	,	punct	O
XYY	NN	compound	O
karyotype	NN	conj	O
in	IN	case	O
blood	NN	nmod	O
and	CC	cc	O
cutaneous	JJ	amod	B-cell_type
fibroblasts	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
described	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
plasma	NN	compound	O
testosterone	NN	compound	O
response	NN	nsubj	O
to	TO	case	O
HCG	NN	compound	O
stimulation	NN	nmod	O
was	VBD	cop	O
slightly	RB	advmod	O
below	IN	case	O
the	DT	det	O
normal	JJ	amod	O
range	NN	ROOT	O
on	IN	case	O
two	CD	nummod	O
occasions	NNS	nmod	O
suggesting	VBG	acl	O
a	DT	det	O
deficit	NN	dobj	O
of	IN	case	O
gonadal	JJ	amod	O
function	NN	nmod	O
.	.	punct	O

A	DT	det	O
study	NN	nsubj	O
of	IN	case	O
the	DT	det	O
receptors	NNS	nmod	O
for	IN	case	O
dihydrotestosterone	NN	nmod	O
in	IN	case	O
fibroblasts	NNS	nmod	B-cell_type
of	IN	case	O
genital	JJ	nmod	O
and	CC	cc	O
nongenital	JJ	conj	O
skin	NN	dep	O
showed	VBD	ROOT	O
a	DT	det	O
normal	JJ	amod	O
concentration	NN	dobj	O
of	IN	case	O
receptors	NNS	nmod	O
in	IN	case	O
genital	JJ	amod	O
skin	NN	nmod	O
;	:	punct	O
5-alpha-reductase	NN	compound	B-protein
activity	NN	nsubj	O
in	IN	case	O
fibroblasts	NNS	nmod	B-cell_type
of	IN	case	O
the	DT	det	O
genital	JJ	amod	O
skin	NN	nmod	O
was	VBD	cop	O
low	JJ	conj	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
plasma	NN	compound	O
relationship	NN	compound	O
testosterone/dihydrotestosterone	NN	nsubj	O
under	IN	case	O
HCG	NN	compound	O
stimulation	NN	nmod	O
was	VBD	cop	O
normal	JJ	conj	O
.	.	punct	O

The	DT	det	O
diagnostic	JJ	amod	O
possibility	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
complete	JJ	amod	O
testicular	JJ	amod	O
feminization	NN	compound	O
syndrome	NN	nmod	O
with	IN	case	O
normal	JJ	amod	O
receptors	NNS	nmod	O
for	IN	case	O
dihydrotestosterone	NN	nmod	O
is	VBZ	auxpass	O
commented	VBN	ROOT	O
on	RP	prt	O
.	.	punct	O

1	LS	dep	O
,	,	punct	O
25-Dihydroxyvitamin	CD	nummod	O
D3	NN	nsubj	O
inhibits	VBZ	ROOT	O
antigen-induced	JJ	amod	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	dobj	O
.	.	punct	O

The	DT	det	O
proliferative	JJ	amod	O
response	NN	nsubjpass	O
of	IN	case	O
murine	JJ	amod	B-cell_type
spleen	NN	nmod	I-cell_type
and	CC	cc	I-cell_type
thymus	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
to	TO	case	O
antigen	NN	nmod	B-protein
but	CC	cc	O
not	RB	neg	O
to	TO	case	O
lectin	NN	conj	B-protein
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
active	JJ	amod	O
metabolite	NN	nmod	O
of	IN	case	O
vitamin	NN	compound	O
D3	NN	nmod	O
,	,	punct	O
1	CD	nummod	O
,	,	punct	O
25-	CD	compound	O
(	-LRB-	punct	O
OH	NN	dep	O
)	-RRB-	punct	O
2D3	NN	appos	O
.	.	punct	O

To	TO	mark	O
directly	RB	advmod	O
examine	VB	advcl	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
on	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	nmod	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
other	JJ	amod	O
complicating	NN	amod	O
interactions	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
utilized	VBD	ROOT	O
a	DT	det	O
panel	NN	dobj	O
of	IN	case	O
cloned	VBN	amod	O
Ia-restricted	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
hybridomas	NNS	nmod	I-cell_line
that	WDT	nsubj	O
secrete	VBP	acl:relcl	O
IL	NN	dobj	B-protein
2	CD	nummod	I-protein
on	IN	case	O
activation	NN	nmod	O
by	IN	case	O
cloned	VBN	amod	O
Ia-bearing	JJ	amod	B-cell_type
stimulator	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
TA3	NN	appos	B-cell_type
)	-RRB-	punct	O
or	CC	cc	O
when	WRB	advmod	O
stimulated	VBN	conj	O
by	IN	case	O
mitogen	NN	nmod	O
.	.	punct	O

Physiologic	JJ	amod	O
concentrations	NNS	nsubj	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-	CD	compound	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	nmod	O
(	-LRB-	punct	O
0.01	CD	compound	O
to	TO	dep	O
0.1	CD	nummod	O
nm	NN	appos	O
)	-RRB-	punct	O
inhibited	VBD	ROOT	O
the	DT	det	O
antigen-induced	JJ	amod	O
secretion	NN	dobj	O
of	IN	case	O
IL	NN	nmod	O
2	CD	nummod	O
by	IN	case	O
several	JJ	nmod	O
of	IN	case	O
these	DT	det	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
hybridomas	NNS	nmod	I-cell_line
.	.	punct	O

This	DT	det	O
inhibition	NN	nsubj	O
was	VBD	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
concentration	NN	nmod	O
of	IN	case	O
the	DT	det	O
free	JJ	amod	O
hormone	NN	nmod	O
and	CC	cc	O
could	MD	aux	O
be	VB	auxpass	O
overcome	VBN	conj	O
by	IN	mark	O
increasing	VBG	advcl	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
Ia-bearing	JJ	amod	B-cell_line
stimulator	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
used	VBN	acl	O
.	.	punct	O

Pretreatment	NN	nsubj	O
of	IN	case	O
the	DT	det	O
T	NN	compound	B-cell_line
hybridoma	NN	nmod	I-cell_line
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
TA3	NN	compound	B-cell_line
stimulator	NN	compound	I-cell_line
cell	NN	conj	I-cell_line
with	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
activation	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
are	VBP	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
the	DT	det	O
finding	NN	nmod	O
that	IN	mark	O
specific	JJ	amod	O
1	CD	nummod	B-protein
,	,	punct	I-protein
25-	CD	compound	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	compound	I-protein
receptors	NNS	nsubj	I-protein
are	VBP	cop	O
present	JJ	ccomp	O
on	IN	case	O
the	DT	det	O
T	NN	compound	O
cell	NN	compound	O
hybridomas	NNS	nmod	O
but	CC	cc	O
are	VBP	aux	O
lacking	VBG	conj	O
in	IN	case	O
TA3	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

1	LS	nummod	O
,	,	punct	O
25-	CD	appos	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nsubj	O
failed	VBD	ROOT	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
to	TO	mark	O
inhibit	VB	xcomp	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
hybridomas	NNS	nmod	I-cell_line
by	IN	case	O
lectin	NN	nmod	B-protein
or	CC	cc	O
by	IN	case	O
an	DT	det	O
anti-Thy-1	NN	amod	B-protein
antibody	NN	conj	I-protein
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
1	CD	nummod	O
,	,	punct	O
25-	CD	compound	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nsubj	O
may	MD	aux	O
be	VB	aux	O
interfering	VBG	ccomp	O
with	IN	case	O
early	JJ	amod	O
events	NNS	nmod	O
of	IN	case	O
antigen-induced	JJ	amod	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	nmod	O
,	,	punct	O
perhaps	RB	advmod	O
by	IN	mark	O
hindering	VBG	advcl	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
recognition	NN	dobj	O
of	IN	case	O
the	DT	det	O
relevant	JJ	amod	O
antigen	NN	nmod	O
on	IN	case	O
stimulator	NN	compound	O
cell	NN	compound	O
surfaces	NNS	nmod	O
.	.	punct	O

This	DT	det	O
system	NN	nsubj	O
should	MD	aux	O
prove	VB	ROOT	O
useful	JJ	xcomp	O
in	IN	mark	O
studying	VBG	advcl	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
by	IN	case	O
which	WDT	nmod	O
1	CD	nummod	O
,	,	punct	O
25-	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nsubj	O
acts	VBZ	acl:relcl	O
to	TO	mark	O
inhibit	VB	xcomp	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	dobj	O
and	CC	cc	O
subsequent	JJ	amod	O
IL	NN	compound	B-protein
2	CD	nummod	I-protein
production	NN	conj	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
and	CC	cc	O
steroid	NN	compound	O
sensitivity	NN	conj	O
in	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
neoplastic	JJ	conj	O
human	JJ	amod	O
lymphoid	JJ	amod	O
tissues	NNS	nmod	O
:	:	punct	O
a	DT	det	O
review	NN	dep	O
.	.	punct	O

The	DT	det	O
determination	NN	nsubjpass	O
of	IN	case	O
estrogen	NN	compound	B-protein
and	CC	cc	I-protein
progesterone	NN	conj	I-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
useful	JJ	xcomp	O
in	IN	mark	O
predicting	VBG	advcl	O
the	DT	det	O
response	NN	dobj	O
to	TO	case	O
endocrine	JJ	amod	O
therapy	NN	nmod	O
.	.	punct	O

Given	VBN	case	O
their	PRP$	nmod:poss	O
well-known	JJ	amod	O
inhibitory	JJ	amod	O
effects	NNS	nmod	O
on	IN	case	O
lymphoid	JJ	amod	O
tissue	NN	nmod	O
,	,	punct	O
glucocorticoids	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
used	VBN	ROOT	O
widely	RB	advmod	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
leukemia	NN	nmod	O
.	.	punct	O

Given	VBN	prep	O
these	DT	det	O
facts	NNS	pobj	O
,	,	punct	O
over	IN	prep	O
the	DT	det	O
last	JJ	amod	O
10	CD	nummod	O
years	NNS	pobj	O
,	,	punct	O
several	JJ	amod	O
investigators	NNS	nsubj	O
have	VBP	aux	O
measured	VBN	ROOT	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
neoplastic	JJ	conj	O
lymphoid	JJ	amod	O
tissue	NN	nmod	O
to	TO	mark	O
see	VB	advcl	O
whether	IN	mark	O
their	PRP$	nmod:poss	O
number	NN	nsubj	O
correlated	VBD	ccomp	O
with	IN	case	O
glucocorticoid	NN	compound	O
responsiveness	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
or	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

No	DT	neg	O
clear	JJ	amod	O
correlation	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
established	VBN	ROOT	O
between	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
action	NN	conj	O
of	IN	case	O
steroids	NNS	nmod	O
in	IN	case	O
normal	JJ	nmod	O
and	CC	cc	O
neoplastic	JJ	conj	O
lymphoid	JJ	amod	O
tissue	NN	dep	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
attempts	VBZ	ROOT	O
to	TO	mark	O
correlate	VB	xcomp	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
levels	NNS	dobj	O
in	IN	case	O
acute	JJ	amod	O
lymphocytic	JJ	amod	O
leukemia	NN	nmod	O
to	TO	case	O
in	FW	amod	O
vivo	FW	dep	O
steroid	NN	compound	O
responsiveness	NN	nmod	O
and	CC	cc	O
immunological	JJ	amod	O
type	NN	conj	O
using	VBG	xcomp	O
the	DT	det	O
whole-cell-binding	JJ	amod	O
assay	NN	dobj	O
for	IN	case	O
receptor	NN	compound	O
determination	NN	nmod	O
and	CC	cc	O
selecting	VBG	conj	O
the	DT	det	O
patients	NNS	dobj	O
according	VBG	case	O
to	IN	case	O
age	NN	nmod	O
and	CC	cc	O
immunological	JJ	amod	O
criteria	NNS	conj	O
have	VBP	aux	O
been	VBN	cop	O
more	RBR	advmod	O
successful	JJ	conj	O
.	.	punct	O

[	-LRB-	punct	O
Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
in	IN	case	O
normal	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
]	-RRB-	punct	O

Glucocorticoid	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
GC	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
receptors	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
intact	JJ	amod	O
lymphocytes	NNS	nmod	B-cell_type
from	IN	case	O
11	CD	nummod	O
donors	NNS	nmod	O
.	.	punct	O

GC	NN	compound	O
binding	NN	compound	O
parameters	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
highly	RB	advmod	O
reproducible	JJ	xcomp	O
in	IN	case	O
repeated	VBN	amod	O
experiments	NNS	nmod	O
with	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
GC	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
in	IN	case	O
donors	NNS	nmod:poss	O
'	POS	case	O
lymphocytes	NNS	nmod	B-cell_type
could	MD	aux	O
be	VB	auxpass	O
distributed	VBN	ccomp	O
into	IN	case	O
two	CD	nummod	O
different	JJ	amod	O
classes	NNS	nmod	O
similarly	RB	advmod	O
to	TO	case	O
the	DT	det	O
pattern	NN	nmod	O
seen	VBN	acl	O
in	IN	case	O
skin	NN	compound	B-cell_type
fibroblasts	NNS	nmod	I-cell_type
.	.	punct	O

Human	JJ	amod	B-cell_type
lymphocytes	NNS	nsubj	I-cell_type
are	VBP	cop	O
an	DT	det	O
adequate	JJ	amod	O
object	NN	ROOT	O
for	IN	mark	O
studying	VBG	advcl	O
genetically	RB	advmod	O
determined	VBN	amod	O
variability	NN	dobj	O
of	IN	case	O
GC	NN	compound	B-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
its	PRP$	nmod:poss	O
clinical	JJ	amod	O
importance	NN	conj	O
.	.	punct	O

Specific	JJ	amod	O
estrogen	NN	compound	B-protein
binding	NN	compound	I-protein
sites	NNS	ROOT	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
thymic	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

The	DT	det	O
binding	NN	nsubjpass	O
of	IN	case	O
estrogen	NN	nmod	O
in	IN	case	O
preparations	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	I-cell_type
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
by	IN	case	O
splenic	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
thymic	JJ	conj	I-cell_type
cells	NNS	conj	I-cell_type
is	VBZ	auxpass	O
demonstrated	VBN	ROOT	O
by	IN	case	O
three	CD	nummod	O
different	JJ	amod	O
approaches	NNS	nmod	O
(	-LRB-	punct	O
Dextran-coated	JJ	amod	O
charcoal	NN	compound	O
method	NN	dep	O
,	,	punct	O
whole	JJ	amod	O
cell	NN	compound	O
assay	NN	conj	O
,	,	punct	O
and	CC	cc	O
gel	NN	compound	O
filtration	NN	conj	O
on	IN	prep	O
a	DT	det	O
sepharose	NN	pobj	O
4B	NN	compound	O
column	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Scatchard	NN	poss	O
's	POS	case	O
analysis	NN	nsubj	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
-moxestrol	NN	nmod	O
(	-LRB-	punct	O
R2858	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
-estradiol	NN	amod	O
binding	NN	conj	O
proves	VBZ	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
a	DT	det	O
single	JJ	amod	O
class	NN	nmod	O
of	IN	case	O
receptor	NN	compound	B-protein
sites	NNS	nmod	I-protein
having	VBG	acl	O
a	DT	det	O
dissociation	NN	compound	O
constant	NN	dobj	O
of	IN	case	O
0.18-2.4	CD	nummod	O
X	NN	compound	O
10	CD	nummod	O
(	-LRB-	punct	O
-9	CD	dep	O
)	-RRB-	punct	O
M	NN	nmod	O
.	.	punct	O

Physicochemical	JJ	amod	O
properties	NNS	nsubj	O
of	IN	prep	O
the	DT	det	O
binder	NN	pobj	O
,	,	punct	O
including	VBG	case	O
binding	NN	compound	O
capacity	NN	nmod	O
and	CC	cc	O
steroid	NN	compound	O
specificity	NN	conj	O
,	,	punct	O
are	VBP	cop	O
quite	RB	advmod	O
similar	JJ	ROOT	O
to	TO	case	O
those	DT	nmod	O
reported	VBN	acl	O
for	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
of	IN	case	O
small	JJ	amod	O
mammalian	JJ	amod	O
species	NNS	nmod	O
or	CC	cc	O
human	JJ	amod	O
thymoma	NN	conj	O
.	.	punct	O

Administration	NN	ROOT	O
of	IN	case	O
fibroblast	NN	compound	B-protein
interferon	NN	nmod	I-protein
to	TO	case	O
patients	NNS	nmod	O
with	IN	case	O
advanced	JJ	amod	O
breast	NN	compound	O
cancer	NN	nmod	O
:	:	punct	O
possible	JJ	amod	O
effects	NNS	dep	O
on	IN	case	O
skin	NN	compound	O
metastasis	NN	nmod	O
and	CC	cc	O
on	IN	case	O
hormone	NN	compound	B-protein
receptors	NNS	conj	I-protein
.	.	punct	O

Eleven	CD	amod	O
patients	NNS	nsubj	O
with	IN	case	O
metastasized	JJ	amod	O
breast	NN	compound	O
cancer	NN	nmod	O
received	VBD	ROOT	O
8	CD	nummod	O
intramuscular	JJ	amod	O
injections	NNS	dobj	O
of	IN	case	O
6	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
6	CD	dep	O
)	-RRB-	punct	O
units	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-protein
fibroblast	NN	compound	I-protein
interferon	NN	nmod	I-protein
over	IN	case	O
a	DT	det	O
period	NN	nmod	O
of	IN	case	O
40	CD	nummod	O
days	NNS	nmod	O
.	.	punct	O

The	DT	det	O
injections	NNS	nsubj	O
did	VBD	aux	O
not	RB	neg	O
cause	VB	ROOT	O
local	JJ	amod	O
irritation	NN	dobj	O
or	CC	cc	O
inflammation	NN	conj	O
.	.	punct	O

Fever	NNP	nsubj	O
occurred	VBD	ROOT	O
in	IN	prep	O
only	RB	advmod	O
1	CD	pobj	O
of	IN	case	O
the	DT	det	O
11	CD	nummod	O
patients	NNS	nmod	O
.	.	punct	O

Although	IN	mark	O
several	JJ	amod	O
types	NNS	nsubjpass	O
of	IN	case	O
metastases	NNS	nmod	O
were	VBD	auxpass	O
monitored	VBN	advcl	O
,	,	punct	O
only	RB	advmod	O
skin	NN	compound	O
nodules	NNS	nsubj	O
consistently	RB	advmod	O
(	-LRB-	punct	O
10	CD	nummod	O
out	IN	cc	O
of	IN	case	O
11	CD	nummod	O
patients	NNS	appos	O
)	-RRB-	punct	O
exhibited	VBD	ROOT	O
changes	NNS	dobj	O
that	WDT	nsubj	O
were	VBD	cop	O
suggestive	JJ	acl:relcl	O
of	IN	case	O
a	DT	det	O
therapeutic	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
the	DT	det	O
treatment	NN	compound	O
regimen	NNS	nmod	O
:	:	punct	O
either	CC	cc:preconj	O
a	DT	det	O
simple	JJ	amod	O
decrease	NN	dep	O
in	IN	case	O
size	NN	nmod	O
of	IN	case	O
some	DT	det	O
nodules	NNS	nmod	O
or	CC	cc	O
central	JJ	amod	O
necrosis	NN	conj	O
accompanied	VBN	acl	O
by	IN	case	O
an	DT	det	O
inflammatory	JJ	amod	O
reaction	NN	nmod	O
.	.	punct	O

NK-activity	NN	nsubjpass	O
of	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
leukocytes	NNS	nmod	I-cell_type
was	VBD	auxpass	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
after	IN	case	O
administration	NN	nmod	O
of	IN	case	O
the	DT	det	O
first	JJ	amod	O
dose	NN	nmod	O
;	:	punct	O
the	DT	det	O
effect	NN	nsubj	O
of	IN	case	O
subsequent	JJ	amod	O
injections	NNS	nmod	O
was	VBD	cop	O
less	RBR	advmod	O
clear	JJ	parataxis	O
.	.	punct	O

Receptors	NNS	nsubjpass	O
for	IN	case	O
estrogens	NNS	nmod	O
and	CC	cc	O
progestogens	NNS	conj	O
were	VBD	auxpass	O
increased	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
tumor	NN	compound	O
biopsies	NNS	nmod	O
of	IN	case	O
2	CD	compound	O
out	IN	advmod	O
of	IN	advmod	O
2	CD	nummod	O
and	CC	cc	O
5	CD	conj	O
out	IN	advmod	O
of	IN	advmod	O
6	CD	nummod	O
patients	NNS	nmod	O
tested	VBN	acl	O
respectively	RB	advmod	O
.	.	punct	O

Decreased	VBN	amod	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
binding	NN	ROOT	O
in	IN	case	O
adrenal	JJ	amod	O
insufficiency	NN	nmod	O
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
glucocorticoid	NN	compound	O
deficiency	NN	nmod	O
on	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
,	,	punct	O
we	PRP	nsubj	O
examine	VBP	ROOT	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	nmod	O
]	-RRB-	punct	O
dexamethasone	NN	dep	O
to	TO	case	O
lymphocytes	NNS	nmod	B-cell_type
in	IN	case	O
normal	JJ	amod	O
subjects	NNS	nmod	O
and	CC	cc	O
patients	NNS	conj	O
with	IN	case	O
adrenal	JJ	amod	O
insufficiency	NN	nmod	O
before	IN	nmod	O
and	CC	cc	O
after	IN	conj	O
glucocorticoid	NN	compound	O
replacement	NN	compound	O
therapy	NN	dep	O
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
whole	JJ	amod	O
cell	NN	compound	O
competitive	JJ	amod	O
binding	NN	compound	O
assay	NN	dobj	O
,	,	punct	O
normal	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
lymphocytes	NNS	nsubj	I-cell_type
had	VBD	ROOT	O
5977	CD	dobj	O
+/-	CC	cc	O
1487	CD	conj	O
(	-LRB-	punct	O
mean	NN	intj	O
+/-	CC	cc	O
SD	NN	conj	O
)	-RRB-	punct	O
binding	NN	compound	O
sites/cell	NNS	dep	O
and	CC	cc	O
a	DT	det	O
dissociation	NN	compound	O
constant	NN	conj	O
of	IN	case	O
10	CD	nummod	O
+/-	CC	cc	O
2	CD	conj	O
nM	NN	nmod	O
.	.	punct	O

Lymphocytes	NNS	nsubj	B-cell_type
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
untreated	JJ	amod	O
adrenal	JJ	amod	O
insufficiency	NN	nmod	O
had	VBD	ROOT	O
fewer	JJR	amod	O
binding	VBG	amod	B-protein
sites	NNS	dobj	I-protein
(	-LRB-	punct	O
3364	CD	nummod	O
+/-322	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
2-fold	JJ	amod	O
increase	NN	conj	O
in	IN	case	O
binding	NN	compound	O
affinity	NN	nmod	O
(	-LRB-	punct	O
5.4	CD	nummod	O
+/-	CC	cc	O
0.9	CD	conj	O
mM	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
administration	NN	nsubj	O
of	IN	case	O
conventional	JJ	amod	O
replacement	NN	compound	O
doses	NNS	nmod	O
of	IN	case	O
cortisone	NN	compound	O
acetate	NN	nmod	O
for	IN	case	O
6	CD	nummod	O
months	NNS	nmod	O
caused	VBD	ROOT	O
no	DT	neg	O
change	NN	dobj	O
in	IN	case	O
receptor	NN	compound	O
number	NN	nmod	O
,	,	punct	O
but	CC	cc	O
was	VBD	auxpass	O
associated	VBN	conj	O
with	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
binding	NN	compound	O
affinity	NN	nmod	O
toward	IN	case	O
normal	JJ	nmod	O
.	.	punct	O

After	IN	case	O
long	JJ	amod	O
term	NN	compound	O
glucocorticoid	NN	compound	O
replacement	NN	compound	O
therapy	NN	nmod	O
,	,	punct	O
binding	VBG	compound	O
parameters	NNS	nsubj	O
were	VBD	cop	O
similar	JJ	ROOT	O
to	TO	case	O
those	DT	nmod	O
in	IN	case	O
patients	NNS	nmod	O
before	IN	case	O
treatment	NN	nmod	O
.	.	punct	O

The	DT	det	O
physiological	JJ	amod	O
implications	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
decreased	VBN	amod	O
receptor	NN	compound	O
number	NN	nmod	O
and	CC	cc	O
increased	VBN	amod	O
binding	NN	compound	O
affinity	NN	conj	O
in	IN	case	O
adrenal	JJ	amod	O
insufficiency	NN	nmod	O
remain	VBP	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
elucidated	VBN	xcomp	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
concentrations	NNS	ROOT	O
and	CC	cc	O
terminal	JJ	amod	O
transferase	NN	compound	B-protein
activity	NN	conj	O
as	IN	case	O
indicators	NNS	nmod	O
of	IN	case	O
prognosis	NN	nmod	O
in	IN	case	O
acute	JJ	amod	O
non-lymphocytic	JJ	amod	O
leukaemia	NN	nmod	O
.	.	punct	O

Activity	NN	nsubjpass	O
of	IN	case	O
terminal	JJ	amod	B-protein
deoxynucleotidyl	NN	compound	I-protein
transferase	NN	nmod	I-protein
(	-LRB-	punct	O
TdT	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
adenosine	NN	compound	B-protein
deaminase	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
5'nucleotidase	NN	conj	B-protein
and	CC	cc	O
the	DT	det	O
cellular	JJ	amod	O
concentration	NN	conj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
(	-LRB-	punct	I-protein
dexamethasone	NN	compound	I-protein
)	-RRB-	punct	I-protein
receptor	NN	nmod	I-protein
were	VBD	auxpass	O
determined	VBN	ROOT	O
in	IN	case	O
25	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
non-lymphocytic	JJ	amod	O
leukaemia	NN	nmod	O
.	.	punct	O

All	DT	det	O
patients	NNS	nsubjpass	O
were	VBD	auxpass	O
treated	VBN	ROOT	O
according	VBG	case	O
to	IN	case	O
a	DT	det	O
common	JJ	amod	O
protocol	NN	nmod	O
.	.	punct	O

Increased	VBN	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
TdT	NN	nmod	B-protein
(	-LRB-	punct	O
greater	JJR	dep	O
than	IN	case	O
0.1	CD	nummod	O
unit/microgram	JJ	compound	O
DNA	NN	nmod	O
)	-RRB-	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
11	CD	nummod	O
patients	NNS	nmod	O
.	.	punct	O

This	DT	det	O
group	NN	nsubjpass	O
of	IN	case	O
patients	NNS	nmod	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
higher	JJR	amod	O
remission	NN	compound	O
and	CC	cc	O
survival	NN	conj	O
rates	NNS	dobj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0.06	CD	dobj	O
)	-RRB-	punct	O
compared	VBN	case	O
with	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
low	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
TdT	NN	nmod	O
.	.	punct	O

The	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
concentration	NN	ROOT	O
of	IN	case	O
the	DT	det	O
leukaemic	JJ	amod	B-cell_type
blast	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
ranged	VBD	acl	O
from	IN	case	O
0	CD	compound	O
to	TO	dep	O
0.94	CD	nummod	O
fmol/microgram	NN	compound	O
DNA	NN	nmod	O
.	.	punct	O

Thirteen	CD	nummod	O
patients	NNS	nsubj	O
had	VBD	ROOT	O
blast	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
with	IN	case	O
a	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
concentration	NN	nmod	O
over	IN	case	O
0.22	CD	nummod	O
fmol/microgram	NN	compound	O
DNA	NN	nmod	O
.	.	punct	O

These	DT	det	O
patients	NNS	nsubj	O
had	VBD	aux	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
remission	NN	compound	O
and	CC	cc	O
survival	NN	conj	O
rates	NNS	dobj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0.006	CD	dobj	O
)	-RRB-	punct	O
compared	VBN	case	O
with	IN	case	O
those	DT	advcl	O
with	IN	case	O
a	DT	det	O
low	JJ	amod	O
receptor	NN	compound	O
concentration	NN	nmod	O
.	.	punct	O

This	DT	det	O
finding	NN	nsubjpass	O
can	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
explained	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
difference	NN	nmod	O
in	IN	case	O
sensitivity	NN	nmod	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
since	IN	mark	O
these	DT	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
used	VBN	advcl	O
as	IN	case	O
therapeutic	JJ	amod	O
agents	NNS	nmod	O
.	.	punct	O

Adenosine	NN	compound	B-protein
deaminase	NN	nsubj	I-protein
and	CC	cc	O
5'nucleotidase	NN	compound	B-protein
activities	NNS	conj	O
both	CC	appos	O
varied	VBD	ROOT	O
within	IN	case	O
two	CD	nummod	O
orders	NNS	nmod	O
of	IN	case	O
magnitude	NN	nmod	O
.	.	punct	O

No	DT	neg	O
correlation	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
activities	NNS	nmod	O
of	IN	case	O
these	DT	det	O
enzymes	NNS	nmod	O
and	CC	cc	O
remission	NN	conj	O
or	CC	cc	O
survival	NN	conj	O
rate	NN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
measurements	NNS	nsubj	O
of	IN	case	O
TdT	NN	compound	B-protein
activity	NN	nmod	O
and	CC	cc	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
concentration	NN	conj	O
yield	VBP	ccomp	O
valuable	JJ	amod	O
prognostic	JJ	amod	O
information	NN	dobj	O
in	IN	case	O
acute	JJ	amod	O
non-lymphocytic	JJ	amod	O
leukaemia	NN	nmod	O

[	-LRB-	punct	O
3H	NN	ROOT	O
]	-RRB-	punct	O
cortivazol	NN	appos	O
:	:	punct	O
a	DT	det	O
unique	JJ	amod	O
high	JJ	amod	O
affinity	NN	compound	O
ligand	NN	appos	O
for	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Cortivazol	NN	nsubj	O
(	-LRB-	punct	O
CVZ	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
deacylcortivazol	NN	conj	O
(	-LRB-	punct	O
DAC	NN	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
pyrazolosteroids	NNS	ROOT	O
with	IN	case	O
potent	JJ	amod	O
glucocorticoid	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

In	IN	case	O
previous	JJ	amod	O
work	NN	nmod	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
DAC	NN	nsubj	O
is	VBZ	cop	O
40-fold	RB	advmod	O
more	RBR	advmod	O
potent	JJ	ccomp	O
than	IN	case	O
dexamethasone	NN	nmod	O
(	-LRB-	punct	O
DEX	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
lysing	VBG	amod	O
leukemic	JJ	amod	B-cell_type
lymphoblasts	NNS	nmod	I-cell_type
.	.	punct	O

To	TO	mark	O
assess	VB	advcl	O
the	DT	det	O
interaction	NN	dobj	O
between	IN	case	O
these	DT	det	O
atypical	JJ	amod	O
steroids	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	conj	I-protein
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	intj	O
]	-RRB-	punct	O
CVZ	NN	nmod	O
to	TO	case	O
cytosol	NN	nmod	O
from	IN	case	O
glucocorticoid-sensitive	JJ	amod	B-cell_line
and	CC	cc	I-cell_line
-resistant	JJ	conj	I-cell_line
variants	NNS	nmod	I-cell_line
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
leukemic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
CEM	NN	compound	B-cell_line
C7	NN	nmod	I-cell_line
.	.	punct	O

In	IN	case	O
glucocorticoid-sensitive	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
[	-LRB-	punct	O
3H	NN	nsubj	O
]	-RRB-	punct	O
CVZ	NN	nsubj	O
causes	VBZ	ROOT	O
a	DT	det	O
2-fold	JJ	amod	O
induction	NN	dobj	O
of	IN	case	O
glutamine	NN	compound	B-protein
synthetase	NN	nmod	I-protein
and	CC	cc	O
binds	VBZ	conj	O
to	TO	case	O
a	DT	det	O
protein	NN	nmod	O
in	IN	case	O
the	DT	det	O
4.6	CD	nummod	O
S	NN	compound	O
region	NN	nmod	O
of	IN	case	O
high	JJ	amod	O
salt	NN	compound	O
sucrose	NN	compound	O
gradients	NNS	nmod	O
.	.	punct	O

On	IN	case	O
DEAE-cellulose	JJ	amod	O
chromatography	NN	nmod	O
,	,	punct	O
[	-LRB-	punct	B-protein
3H	NN	nsubj	I-protein
]	-RRB-	punct	I-protein
CVZ-receptor	NN	compound	I-protein
complexes	NNS	nsubj	I-protein
show	VBP	ROOT	O
a	DT	det	O
shift	NN	dobj	O
from	IN	case	O
high	JJ	amod	O
(	-LRB-	punct	O
0.25	CD	compound	O
M	NN	compound	O
KP	NN	nmod	O
)	-RRB-	punct	O
to	TO	case	O
low	JJ	amod	O
salt	NN	compound	O
(	-LRB-	punct	O
0.09	CD	compound	O
M	NN	compound	O
KP	NN	appos	O
)	-RRB-	punct	O
eluting	NN	amod	O
forms	NNS	dobj	O
upon	IN	case	O
activation	NN	nmod	O
.	.	punct	O

CVZ	NN	nsubj	O
competes	NNS	ROOT	O
for	IN	case	O
a	DT	det	O
97	CD	nummod	O
,	,	punct	O
000-dalton	CD	dep	O
protein	NN	nmod	O
labeled	VBN	acl	O
by	IN	case	O
[	-LRB-	punct	O
3H	NN	nmod	O
]	-RRB-	punct	O
dexamethasone	NN	nsubj	O
mesylate	NN	amod	O
.	.	punct	O

Scatchard	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
binding	NN	nmod	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	intj	O
]	-RRB-	punct	O
CVZ	NN	nmod	O
in	IN	case	O
glucocorticoid-sensitive	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
revealed	VBD	ROOT	O
a	DT	det	O
curvilinear	JJ	amod	O
plot	NN	dobj	O
which	WDT	nsubj	O
resolved	VBD	acl:relcl	O
into	IN	prep	O
high	JJ	amod	O
(	-LRB-	punct	O
0.4	CD	nummod	O
nM	NN	dep	O
)	-RRB-	punct	O
and	CC	cc	O
low	JJ	conj	O
(	-LRB-	punct	O
11	CD	nummod	O
nM	NN	dep	O
)	-RRB-	punct	O
affinity	NN	compound	O
components	NNS	pobj	O
.	.	punct	O

The	DT	det	O
receptor	NN	compound	O
concentration	NN	nsubj	O
of	IN	case	O
the	DT	det	O
low	JJ	amod	O
affinity	NN	compound	O
site	NN	nmod	O
(	-LRB-	punct	O
0.30	CD	nummod	O
pmol/mg	NN	compound	O
protein	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
approximately	RB	advmod	O
twice	RB	ROOT	O
that	DT	dobj	O
of	IN	case	O
the	DT	det	O
high	JJ	amod	B-protein
affinity	NN	compound	I-protein
site	NN	nmod	I-protein
(	-LRB-	punct	O
0.14	CD	nummod	O
pmol/mg	NN	compound	O
protein	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Dissociation	NN	compound	O
experiments	NNS	nsubj	O
with	IN	case	O
dilution	NN	nmod	O
and/or	CC	cc	O
excess	VB	amod	O
unlabeled	JJ	amod	O
CVZ	NN	conj	O
supported	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
independent	JJ	amod	O
sites	NNS	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
binding	NN	nsubj	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	nmod	O
]	-RRB-	punct	O
DEX	NN	nsubj	O
to	TO	case	O
C7	NN	compound	O
cytosol	NN	nmod	O
revealed	VBD	ROOT	O
a	DT	det	O
single	JJ	amod	O
class	NN	dobj	O
of	IN	case	O
binding	VBG	amod	O
sites	NNS	nmod	O
(	-LRB-	punct	O
Kd	NN	dep	O
=	JJ	amod	O
1.9	CD	nummod	O
nM	NN	dep	O
;	:	punct	O
receptor	NN	compound	O
concentration	NN	dep	O
,	,	punct	O
0.46	CD	nummod	O
pmol/mg	NN	compound	O
protein	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Examination	NN	nsubj	O
of	IN	case	O
the	DT	det	O
binding	NN	nmod	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	intj	O
]	-RRB-	punct	O
CVZ	NN	nmod	O
using	VBG	acl	O
10	CD	nummod	O
(	-LRB-	punct	O
-5	CD	dep	O
)	-RRB-	punct	O
M	NN	dep	O
DEX	NN	dobj	O
as	IN	case	O
the	DT	det	O
competing	VBG	amod	O
ligand	NN	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
DEX	NN	nsubj	O
binds	VBZ	ccomp	O
only	RB	advmod	O
to	TO	case	O
the	DT	det	O
low	JJ	amod	O
affinity	NN	compound	O
site	NN	nmod	O
detected	VBN	acl	O
by	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
CVZ	NN	nmod	O
.	.	punct	O

In	IN	case	O
cytosol	NN	nmod	O
from	IN	case	O
a	DT	det	O
glucocorticoid-resistant	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
with	IN	case	O
virtually	RB	advmod	O
no	DT	nummod	O
[	-LRB-	punct	O
3H	NN	dep	O
]	-RRB-	punct	O
DEX	NN	compound	O
binding	NN	nmod	O
,	,	punct	O
[	-LRB-	punct	O
3H	NN	dep	O
]	-RRB-	punct	O
CVZ	NN	nsubj	O
detected	VBD	ROOT	O
a	DT	det	O
single	JJ	amod	O
high	JJ	amod	B-protein
affinity	NN	compound	I-protein
binding	NN	compound	I-protein
site	NN	dobj	I-protein
that	WDT	nsubj	O
was	VBD	cop	O
similar	JJ	acl:relcl	O
in	IN	case	O
dissociation	NN	compound	O
constant	NN	nmod	O
(	-LRB-	punct	O
0.8	CD	nummod	O
nM	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
receptor	NN	compound	O
concentration	NN	conj	O
(	-LRB-	punct	O
0.13	CD	nummod	O
pmol/mg	NN	compound	O
protein	NN	appos	O
)	-RRB-	punct	O
to	TO	case	O
the	DT	det	O
high	JJ	amod	B-protein
affinity	NN	compound	I-protein
site	NN	nmod	I-protein
detected	VBN	acl	O
in	IN	case	O
the	DT	det	O
glucocorticoid-sensitive	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
C7	NN	nmod	B-cell_line
.	.	punct	O

A	DT	det	O
controlled	JJ	amod	O
pore	NN	nsubj	O
glass	NN	ROOT	O
bead	NN	compound	O
assay	NN	dobj	O
for	IN	case	O
the	DT	det	O
measurement	NN	nmod	O
of	IN	case	O
cytoplasmic	JJ	amod	B-protein
and	CC	cc	I-protein
nuclear	JJ	conj	I-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

An	DT	det	O
assay	NN	nsubjpass	O
for	IN	case	O
the	DT	det	O
quantitation	NN	nmod	O
of	IN	case	O
cytoplasmic	JJ	amod	B-protein
and	CC	cc	I-protein
nuclear	JJ	conj	I-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
lymphoid	JJ	amod	O
tissue	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
developed	VBN	ROOT	O
using	VBG	xcomp	O
controlled	JJ	amod	O
pore	NN	compound	O
glass	NN	compound	O
(	-LRB-	punct	O
CPG	NN	appos	O
)	-RRB-	punct	O
beads	NNS	dobj	O
.	.	punct	O

Soluble	JJ	amod	O
receptor	NN	nsubjpass	B-protein
--	:	punct	I-protein
3H-steroid	NN	amod	I-protein
complex	NN	appos	I-protein
(	-LRB-	punct	O
cytosol	NN	dep	O
or	CC	cc	O
nuclear	JJ	amod	O
extract	NN	conj	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
adsorbed	VBN	ROOT	O
quantitatively	RB	advmod	O
within	IN	case	O
the	DT	det	O
crevasses	NNS	nmod	O
of	IN	case	O
porous	JJ	amod	O
glass	NN	compound	O
beads	NNS	nmod	O
.	.	punct	O

Excess	JJ	nsubj	O
labeled	VBN	ROOT	O
steroid	NN	dobj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
most	RBS	advmod	O
non-specifically	RB	advmod	O
bound	VBN	amod	O
steroid	NN	nsubjpass	O
is	VBZ	auxpass	O
easily	RB	advmod	O
washed	VBN	conj	O
away	RB	advmod	O
,	,	punct	O
leaving	VBG	advcl	O
the	DT	det	O
hormone-receptor	NN	compound	B-protein
complex	NN	dobj	I-protein
retained	VBN	acl	O
by	IN	agent	O
the	DT	det	O
beads	NNS	pobj	O
.	.	punct	O

Bound	VBN	amod	O
3H-steroid	NN	nsubjpass	O
is	VBZ	auxpass	O
eluted	VBN	ROOT	O
with	IN	case	O
ethanol	NN	nmod	O
and	CC	cc	O
measured	VBN	conj	O
for	IN	case	O
radioactivity	NN	nmod	O
.	.	punct	O

This	DT	det	O
procedure	NN	nsubj	O
which	WDT	nsubj	O
is	VBZ	cop	O
simple	JJ	ROOT	O
,	,	punct	O
rapid	JJ	conj	O
,	,	punct	O
and	CC	cc	O
highly	RB	advmod	O
reproducible	JJ	nsubjpass	O
is	VBZ	auxpass	O
carried	VBN	conj	O
out	RP	prt	O
using	VBG	xcomp	O
frozen	JJ	amod	O
samples	NNS	dobj	O
(	-LRB-	punct	O
stable	JJ	dep	O
for	IN	case	O
many	JJ	amod	O
months	NNS	nmod	O
)	-RRB-	punct	O
containing	VBG	xcomp	O
as	RB	advmod	O
few	JJ	nummod	O
as	IN	case	O
1	CD	compound	O
X	NN	compound	O
10	CD	nummod	O
(	-LRB-	punct	O
7	CD	nummod	O
)	-RRB-	punct	O
cells	NNS	dobj	O
.	.	punct	O

A	DT	det	O
comparison	NN	nsubj	O
of	IN	case	O
the	DT	det	O
CPG	NN	compound	O
assay	NN	nmod	O
to	TO	case	O
dextran	NN	nmod	O
coated	VBD	amod	O
charcoal	NN	dobj	O
and	CC	cc	O
a	DT	det	O
whole	JJ	amod	O
cell	NN	compound	O
assay	NN	conj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
CPG	NN	nsubj	O
and	CC	cc	O
dextran	NN	conj	O
coated	VBD	ccomp	O
charcoal	NN	nsubj	O
give	VBP	amod	O
equivalent	JJ	amod	O
measurements	NNS	dobj	O
of	IN	case	O
cytosolic	JJ	amod	B-protein
receptor	NN	compound	I-protein
concentration	NN	nmod	O
,	,	punct	O
while	IN	mark	O
the	DT	dep	O
CPG	NN	nsubj	O
and	CC	cc	O
whole	JJ	amod	O
cell	NN	compound	O
assays	NNS	conj	O
provide	VBP	advcl	O
equivalent	JJ	amod	O
values	NNS	dobj	O
for	IN	case	O
total	JJ	amod	O
receptor	NN	compound	O
content	NN	nmod	O
.	.	punct	O

Plasmacytoid	NN	compound	O
blast	NN	compound	O
crisis	NN	ROOT	O
in	IN	case	O
B-cell	NN	compound	B-cell_type
chronic	JJ	amod	O
lymphocytic	JJ	amod	O
leukemia	NN	nmod	O
:	:	punct	O
effect	NN	dep	O
of	IN	case	O
estradiol	NN	nmod	O
on	IN	case	O
growth	NN	nmod	O
and	CC	cc	O
differentiation	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Evolution	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
case	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	O
lymphocytic	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
CLL	NN	appos	O
)	-RRB-	punct	O
into	IN	case	O
blast	NN	compound	O
crisis	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
characterized	VBN	xcomp	O
by	IN	case	O
three	CD	nummod	O
unusual	JJ	amod	O
features	NNS	nmod	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
the	DT	det	O
phenotype	NN	nsubj	O
of	IN	case	O
the	DT	det	O
emerging	VBG	amod	B-cell_type
blast	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	cop	O
that	IN	mark	O
of	IN	case	O
pre-plasmacytoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
plasma	NN	compound	O
cell	NN	compound	O
morphology	NN	nmod	O
and	CC	cc	O
an	DT	det	O
immunological	JJ	amod	O
phenotype	NN	conj	O
corresponding	VBG	acl	O
partially	RB	advmod	O
with	IN	case	O
CLL-	NN	nmod	B-cell_type
or	CC	cc	I-cell_type
intermediate	JJ	conj	I-cell_type
B-cells	NNS	dep	I-cell_type
,	,	punct	O
partially	RB	advmod	O
with	IN	case	O
plasma	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
terminal	JJ	amod	B-protein
transferase	NN	dep	I-protein
-	:	punct	O
,	,	punct	O
common	JJ	amod	O
acute	JJ	amod	B-protein
lymphocytic	JJ	amod	I-protein
leukemia	NN	compound	I-protein
antigen	NN	appos	I-protein
-	:	punct	O
,	,	punct	O
Ia+	NN	conj	B-protein
,	,	punct	O
surface	NN	compound	B-protein
immunoglobulin	NN	compound	I-protein
heavy	JJ	amod	I-protein
chains	NNS	conj	I-protein
-	:	punct	O
,	,	punct	O
surface	NN	compound	B-protein
kappa	NN	compound	I-protein
light	NN	amod	I-protein
chains	NNS	conj	I-protein
+	CC	cc	O
,	,	punct	O
intracytoplasmic	JJ	amod	B-protein
immunoglobulin	NN	compound	I-protein
A+	NN	conj	I-protein
and	CC	cc	I-protein
G+	NN	conj	I-protein
,	,	punct	O
BA-1+	NN	conj	B-protein
,	,	punct	O
polyclonal	JJ	amod	O
gammaglobulin	NN	compound	O
production	NN	appos	O
)	-RRB-	punct	O
;	:	punct	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
cytogenetic	JJ	amod	O
analysis	NN	nsubj	O
of	IN	case	O
spontaneous	JJ	amod	O
metaphases	NNS	nmod	O
revealed	VBD	advcl	O
that	IN	mark	O
in	IN	case	O
addition	NN	dep	O
to	TO	case	O
the	DT	det	O
typical	JJ	amod	O
CLL	NN	compound	O
abnormality	NN	nmod	O
,	,	punct	O
trisomy	JJ	ccomp	O
12	CD	dobj	O
,	,	punct	O
in	IN	case	O
all	DT	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
,	,	punct	O
an	DT	det	O
additional	JJ	amod	O
translocation	NN	appos	O
between	IN	case	O
chromosomes	NNS	nmod	B-DNA
14	CD	nummod	I-DNA
and	CC	cc	I-DNA
17	CD	conj	I-DNA
was	VBD	cop	O
present	JJ	ccomp	O
in	IN	case	O
40	CD	nummod	O
%	NN	nmod	O
with	IN	case	O
a	DT	det	O
presumptive	JJ	amod	O
breakpoint	NN	nmod	O
on	IN	case	O
chromosome	NN	nmod	B-DNA
14	CD	nummod	I-DNA
(	-LRB-	punct	O
q12-3	NN	dep	O
)	-RRB-	punct	O
never	RB	neg	O
described	VBN	advcl	O
before	IN	case	O
(	-LRB-	punct	O
commonly	RB	advmod	O
q32	NN	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
(	-LRB-	punct	O
3	LS	dep	O
)	-RRB-	punct	O
the	DT	det	O
progression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
disease	NN	nmod	O
was	VBD	auxpass	O
associated	VBN	conj	O
with	IN	case	O
a	DT	det	O
striking	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
by	IN	case	O
the	DT	det	O
transformed	VBN	amod	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
specific	JJ	amod	O
binding	VBG	amod	O
sites	NNS	nmod	O
for	IN	case	O
estradiol	NN	nmod	O
(	-LRB-	punct	O
E2	NN	appos	O
)	-RRB-	punct	O
due	JJ	case	O
to	TO	mwe	O
an	DT	det	O
actual	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
total	JJ	amod	O
cellular	JJ	amod	B-protein
receptor	NN	compound	I-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
not	RB	neg	O
to	TO	case	O
a	DT	det	O
change	NN	conj	O
in	IN	case	O
receptor	NN	compound	O
affinity	NN	nmod	O
for	IN	case	O
E2	NN	nmod	O
.	.	punct	O

The	DT	det	O
functional	JJ	amod	O
status	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
steroid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
nuclear	JJ	amod	O
transfer	NN	nmod	O
of	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	B-protein
hormone-receptor	NN	compound	I-protein
complex	NN	nmod	I-protein
upon	IN	case	O
temperature	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Since	IN	mark	O
the	DT	det	O
rise	NN	nsubj	O
in	IN	case	O
E2-receptor	NN	amod	B-protein
display	NN	nmod	O
paralleled	VBD	advcl	O
a	DT	det	O
large	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
the	DT	det	O
proliferative	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
a	DT	det	O
change	NN	dobj	O
in	IN	case	O
their	PRP$	nmod:poss	O
maturation	NN	compound	O
status	NN	nmod	O
the	DT	det	O
question	NN	nsubjpass	O
was	VBD	auxpass	O
raised	VBN	ROOT	O
as	IN	mark	O
to	TO	mwe	O
whether	IN	mark	O
the	DT	det	O
E2-receptor	NN	nsubjpass	B-protein
should	MD	aux	O
be	VB	auxpass	O
considered	VBN	advcl	O
as	IN	case	O
a	DT	det	O
physiological	JJ	amod	O
marker	NN	nmod	O
of	IN	case	O
growth	NN	compound	O
rate	NN	nmod	O
or	CC	cc	O
of	IN	case	O
cellular	JJ	amod	O
differentiation	NN	conj	O
.	.	punct	O

Exposure	NN	nsubj	O
of	IN	case	O
the	DT	det	O
patient	NN	nmod:poss	O
's	POS	case	O
blast	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
E2	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
resulted	VBD	ROOT	O
in	IN	case	O
cessation	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
growth	NN	nmod	O
following	VBG	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
one	CD	nummod	O
mitosis	NN	nmod	O
after	IN	case	O
addition	NN	nmod	O
of	IN	case	O
the	DT	det	O
inducer	NN	nmod	O
as	IN	mark	O
seen	VBN	advcl	O
from	IN	case	O
the	DT	det	O
replacement	NN	nmod	O
of	IN	case	O
the	DT	det	O
large	JJ	amod	B-cell_type
blasts	NNS	nmod	I-cell_type
by	IN	case	O
small	JJ	amod	O
CLL-like	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
without	IN	case	O
definite	JJ	amod	O
signs	NNS	nmod	O
of	IN	case	O
alteration	NN	nmod	O
of	IN	case	O
the	DT	det	O
differentiation	NN	compound	O
status	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
suggests	VBZ	ROOT	O
the	DT	det	O
association	NN	dobj	O
of	IN	case	O
E2-receptor	NN	compound	B-protein
expression	NN	nmod	O
with	IN	case	O
control	NN	nmod	O
of	IN	case	O
growth	NN	nmod	O
rather	RB	cc	O
than	IN	mwe	O
cell	NN	compound	O
maturation	NN	conj	O
.	.	punct	O

Multiple	JJ	amod	O
forms	NNS	ROOT	O
and	CC	cc	O
fragments	NNS	conj	O
of	IN	case	O
cytosolic	JJ	amod	B-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
from	IN	case	O
human	JJ	amod	B-cell_type
leukemic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
normal	JJ	amod	B-cell_type
lymphocytes	NNS	conj	I-cell_type
.	.	punct	O

Therapy	NN	nsubj	O
with	IN	case	O
glucocorticoids	NNS	nmod	O
is	VBZ	cop	O
generally	RB	advmod	O
more	RBR	advmod	O
effective	JJ	ROOT	O
in	IN	case	O
acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	nmod	O
than	IN	case	O
in	IN	case	O
other	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
human	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
have	VBP	aux	O
not	RB	neg	O
revealed	VBN	ROOT	O
any	DT	det	O
consistent	JJ	amod	O
relationship	NN	dobj	O
between	IN	case	O
clinical	JJ	amod	O
responsiveness	NN	nmod	O
and	CC	cc	O
the	DT	det	O
cellular	JJ	amod	O
or	CC	cc	O
cytosolic	JJ	conj	O
concentration	NN	conj	O
of	IN	case	O
glucocorticoid-binding	JJ	amod	B-protein
sites	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
objectives	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
were	VBD	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
there	EX	expl	O
are	VBP	ccomp	O
intrinsic	JJ	amod	O
structural	JJ	amod	O
differences	NNS	nsubj	O
among	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
various	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
normal	JJ	amod	B-cell_type
lymphocytes	NNS	conj	I-cell_type
and	CC	cc	O
to	TO	mark	O
investigate	VB	conj	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
endogenous	JJ	amod	B-protein
peptidases	NNS	nmod	I-protein
in	IN	case	O
receptor	NN	compound	O
degradation	NN	nmod	O
.	.	punct	O

Cytosols	NNS	nsubjpass	O
were	VBD	auxpass	O
prepared	VBN	ROOT	O
from	IN	case	O
fresh	JJ	amod	B-cell_type
or	CC	cc	I-cell_type
rapidly	RB	advmod	I-cell_type
frozen	JJ	conj	I-cell_type
leukocytes	NNS	nmod	I-cell_type
from	IN	case	O
6	CD	nummod	O
healthy	JJ	amod	O
adults	NNS	nmod	O
and	CC	cc	O
35	CD	nummod	O
high-risk	JJ	compound	O
leukemia	NN	compound	O
patients	NNS	conj	O
(	-LRB-	punct	O
median	JJ	amod	O
white	JJ	amod	O
blood	NN	compound	O
cell	NN	compound	O
count	NN	dep	O
,	,	punct	O
150	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
cells/microliter	NN	appos	O
;	:	punct	O
median	JJ	amod	O
age	NN	conj	O
,	,	punct	O
13	CD	nummod	O
years	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

Receptors	NNS	nsubjpass	O
were	VBD	auxpass	O
labeled	VBN	ROOT	O
with	IN	prep	O
[	-LRB-	punct	O
3H	NN	pobj	O
]	-RRB-	punct	O
triamcinolone	NN	compound	O
acetonide	NN	pobj	O
and	CC	cc	O
quantitated	VBN	conj	O
by	IN	case	O
charcoal-dextran	JJ	amod	O
treatment	NN	nmod	O
or	CC	cc	O
Sephadex	NN	compound	O
LH-20	NN	compound	O
chromatography	NN	conj	O
.	.	punct	O

Mean	NN	amod	O
and	CC	cc	O
median	JJ	conj	O
cytosolic	JJ	amod	O
receptor	NN	compound	O
concentrations	NNS	nsubj	O
in	IN	case	O
12	CD	nummod	O
acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	compound	O
specimens	NNS	nmod	O
lacking	VBG	acl	O
the	DT	det	O
standard	JJ	amod	O
B-cell	NN	dobj	O
or	CC	cc	O
T-cell	NN	compound	O
markers	NNS	conj	O
(	-LRB-	punct	O
``	``	punct	O
null	JJ	amod	O
cells	NNS	appos	O
''	''	punct	O
)	-RRB-	punct	O
were	VBD	cop	O
approximately	RB	advmod	O
4-fold	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
in	IN	case	O
23	CD	nummod	O
other	JJ	amod	O
leukemic	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
specimens	NNS	nmod	I-cell_type
.	.	punct	O

No	DT	neg	O
other	JJ	amod	O
consistent	JJ	amod	O
differences	NNS	nsubjpass	O
in	IN	case	O
receptor	NN	compound	O
content	NN	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

Agarose	NN	amod	O
filtration	NN	nsubj	O
and	CC	cc	O
ultracentrifugation	NN	conj	O
in	IN	case	O
hypotonic	JJ	amod	O
buffers	NNS	nmod	O
containing	VBG	acl	O
20	CD	nummod	O
mM	NN	amod	O
Na2MoO4	NN	dobj	O
revealed	VBD	ROOT	O
complexes	NNS	dobj	O
of	IN	case	O
similar	JJ	amod	O
size	NN	nmod	O
and	CC	cc	O
shape	NN	conj	O
in	IN	case	O
all	DT	det	O
clinical	JJ	amod	O
specimens	NNS	nmod	O
tested	VBN	acl	O
and	CC	cc	O
two	CD	nummod	O
established	JJ	amod	O
leukemic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

They	PRP	nsubj	O
had	VBD	ROOT	O
Stokes	NNP	compound	O
radii	NN	dobj	O
(	-LRB-	punct	O
Rs	NN	appos	O
)	-RRB-	punct	O
of	IN	prep	O
8.1	CD	compound	O
+/-	CC	cc	O
0.5	CD	conj	O
(	-LRB-	punct	O
S.D.	NNP	compound	O
)	-RRB-	punct	O
nm	NN	pobj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
50	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
sedimentation	NN	compound	O
coefficients	NNS	dobj	O
of	IN	case	O
9.5	CD	pobj	O
+/-	CC	cc	O
0.3S	CD	conj	O
(	-LRB-	punct	O
n	NN	nmod	O
=	JJ	amod	O
40	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
molecular	JJ	amod	O
weights	NNS	conj	O
of	IN	case	O
approximately	RB	advmod	O
330	CD	nummod	O
,	,	punct	O
000	CD	nmod	O
,	,	punct	O
and	CC	cc	O
axial	JJ	amod	O
ratios	NNS	conj	O
(	-LRB-	punct	O
a/b	JJ	appos	O
)	-RRB-	punct	O
of	IN	case	O
approximately	RB	advmod	O
12	CD	nmod	O
.	.	punct	O

In	IN	case	O
hypertonic	NN	nmod	O
,	,	punct	O
molybdate-free	JJ	amod	O
buffer	NN	nmod	O
,	,	punct	O
these	DT	det	O
oligomeric	JJ	amod	B-protein
complexes	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
dissociated	VBN	ROOT	O
into	IN	case	O
subunits	NNS	nmod	O
with	IN	case	O
Rs	NNS	nmod	O
of	IN	case	O
5.9	CD	nummod	O
+/-	CC	cc	O
0.3	CD	conj	O
nm	NN	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
12	CD	dobj	O
)	-RRB-	punct	O
and	CC	cc	O
a/b	NN	conj	O
of	IN	case	O
11	CD	compound	O
to	TO	dep	O
12	CD	nmod	O
,	,	punct	O
as	IN	mark	O
observed	VBN	advcl	O
previously	RB	advmod	O
for	IN	case	O
other	JJ	amod	O
receptors	NNS	nmod	O
.	.	punct	O

Fragmentation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
oligomer	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
subunit	NN	conj	B-protein
was	VBD	cop	O
evident	JJ	ROOT	O
in	IN	case	O
some	DT	det	O
cytosols	NNS	nmod	O
.	.	punct	O

High	JJ	amod	O
activities	NNS	nsubjpass	O
of	IN	case	O
peptidases	NNS	nmod	B-protein
of	IN	case	O
various	JJ	amod	O
specificities	NNS	nmod	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
leukemic	JJ	amod	O
cell	NN	compound	O
cytosols	NNS	nmod	O
,	,	punct	O
as	IN	case	O
in	IN	case	O
other	JJ	amod	O
cytosols	NNS	nmod	O
,	,	punct	O
by	IN	case	O
fluorometric	JJ	amod	O
assays	NNS	nmod	O
with	IN	case	O
derivatives	NNS	nmod	O
of	IN	case	O
7-amino-4-methylcoumarin	NN	nmod	O
.	.	punct	O

Receptor	NN	compound	O
cleavage	NN	nsubj	O
by	IN	case	O
these	DT	nmod	O
and	CC	cc	O
other	JJ	amod	O
endogenous	JJ	amod	B-protein
enzymes	NNS	conj	I-protein
may	MD	aux	O
account	VB	ROOT	O
for	IN	case	O
previous	JJ	amod	O
observations	NNS	nmod	O
of	IN	case	O
``	``	punct	O
abnormal	JJ	amod	O
''	''	punct	O
receptors	NNS	nmod	O
in	IN	case	O
cytosols	NNS	nmod	O
from	IN	case	O
some	DT	det	O
leukemic	JJ	amod	B-cell_type
specimens	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
intrinsic	JJ	amod	O
structural	JJ	amod	O
defects	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
receptors	NNS	nmod	O
are	VBP	cop	O
unlikely	JJ	advmod	O
explanations	NNS	ccomp	O
for	IN	case	O
the	DT	det	O
unresponsiveness	NN	nmod	O
of	IN	case	O
some	DT	det	O
types	NNS	nmod	O
of	IN	case	O
leukemia	NN	nmod	O
to	TO	case	O
steroid	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
number	NN	ROOT	O
and	CC	cc	O
intracellular	JJ	amod	O
water	NN	compound	O
space	NN	conj	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	dep	O
elucidate	VB	advcl	O
the	DT	det	O
relationship	NN	dobj	O
between	IN	case	O
cell	NN	compound	O
water	NN	compound	O
content	NN	nmod	O
and	CC	cc	O
number	NN	conj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
,	,	punct	O
eleven	CD	amod	O
normal	JJ	amod	O
and	CC	cc	O
malignant	JJ	conj	B-cell_type
lymphoid	JJ	dep	I-cell_type
or	CC	cc	I-cell_type
myelomonocytic	JJ	conj	I-cell_type
cell	NN	compound	I-cell_type
types	NNS	nsubjpass	I-cell_type
originating	VBG	acl	O
from	IN	case	O
mouse	NN	nmod	O
,	,	punct	O
rat	NN	conj	O
and	CC	cc	O
man	NN	conj	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
cellular	JJ	amod	O
water	NN	compound	O
space	NN	nsubjpass	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
with	IN	case	O
3H2O	NN	nmod	O
,	,	punct	O
and	CC	cc	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
number	NN	nsubjpass	O
was	VBD	auxpass	O
measured	VBN	conj	O
in	IN	case	O
a	DT	det	O
whole-cell	JJ	amod	O
binding	NN	compound	O
assay	NN	nmod	O
with	IN	case	O
[	-LRB-	punct	O
3H	NN	nmod	O
]	-RRB-	punct	O
dexamethasone	NN	dep	O
at	IN	case	O
30	CD	nummod	O
and	CC	cc	O
37	CD	conj	O
degrees	NNS	compound	O
C	NN	nmod	O
.	.	punct	O

The	DT	det	O
intracellular	JJ	amod	O
water	NN	compound	O
phase	NN	compound	O
concentration	NN	nsubj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
around	IN	advmod	O
40	CD	nummod	O
nmol/l	NN	compound	O
cell	NN	compound	O
water	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
dependence	NN	nsubj	O
of	IN	case	O
receptor	NN	compound	O
affinity	NN	nmod	O
on	IN	case	O
temperature	NN	nmod	O
were	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
normal	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
malignant	JJ	conj	I-cell_type
rodent	NN	dep	I-cell_type
and	CC	cc	I-cell_type
human	JJ	conj	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
comparisons	NNS	nsubjpass	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
levels	NNS	nmod	O
are	VBP	auxpass	O
best	RBS	advmod	O
made	VBN	ccomp	O
on	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
intracellular	JJ	amod	B-protein
receptor	NN	compound	I-protein
concentrations	NNS	nmod	O
.	.	punct	O

Covalent	JJ	amod	O
labeling	NN	ROOT	O
of	IN	case	O
rat	NN	compound	B-cell_type
thymocyte	NN	nmod	I-cell_type
and	CC	cc	O
human	JJ	amod	B-protein
lymphoid	JJ	amod	I-protein
glucocorticoid	NN	compound	I-protein
receptor	NN	conj	I-protein
.	.	punct	O

Lymphoid	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
contain	VBP	ROOT	O
specific	JJ	amod	O
receptors	NNS	dobj	B-protein
for	IN	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
[	-LRB-	punct	O
3H	NN	dobj	O
]	-RRB-	punct	O
dexamethasone-21-mesylate	JJ	ccomp	O
to	TO	aux	O
label	VB	xcomp	O
covalently	RB	advmod	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	dobj	I-protein
in	IN	case	O
rat	NN	compound	B-cell_type
thymic	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
in	IN	case	O
neoplastic	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
obtained	VBN	acl	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	nmod	O
and	CC	cc	O
malignant	JJ	amod	O
lymphoma	NN	conj	O
.	.	punct	O

The	DT	det	O
covalently	RB	advmod	O
labeled	VBN	amod	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
identified	VBN	ROOT	O
by	IN	case	O
polyacrylamide	NN	compound	O
gel	NN	compound	O
electrophoresis	NN	nmod	O
(	-LRB-	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
0.1	CD	nummod	O
%	NN	compound	O
sodium	NN	compound	O
dodecyl	NN	compound	O
sulfate	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
cytosolic	JJ	amod	O
fractions	NNS	nmod	O
prepared	VBN	acl	O
from	IN	case	O
rat	NN	compound	B-cell_type
thymic	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
[	-LRB-	punct	O
3H	NN	nsubj	O
]	-RRB-	punct	O
-dexamethasone-21-mesylate	NN	dep	O
labels	NNS	ROOT	O
a	DT	det	O
protein	NN	dobj	O
(	-LRB-	punct	O
Mr	NN	appos	O
approximately	RB	advmod	O
equal	JJ	amod	O
to	IN	case	O
95	CD	nummod	O
,	,	punct	O
000	CD	nmod	O
)	-RRB-	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
identified	VBN	acl:relcl	O
as	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
by	IN	case	O
the	DT	det	O
following	VBG	amod	O
criteria	NNS	nmod	O
:	:	punct	O
(	-LRB-	punct	O
a	LS	dep	O
)	-RRB-	punct	O
labeling	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
moiety	NN	nmod	O
is	VBZ	auxpass	O
inhibited	VBN	parataxis	O
by	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
a	DT	det	O
100-fold	JJ	amod	O
molar	JJ	amod	O
excess	NN	nmod	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
dexamethasone	NN	nmod	O
and	CC	cc	O
triamcinolone	NN	compound	O
acetonide	NN	conj	O
;	:	punct	O
and	CC	cc	O
(	-LRB-	punct	O
b	LS	dep	O
)	-RRB-	punct	O
the	DT	det	O
covalently	RB	advmod	O
labeled	VBN	amod	O
Mr	NNP	appos	O
approximately	RB	advmod	O
equal	JJ	amod	O
to	IN	case	O
95	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
protein	NN	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	conj	O
(	-LRB-	punct	O
by	IN	mark	O
heating	VBG	advcl	O
at	IN	case	O
20	CD	nummod	O
degrees	NNS	nmod	O
for	IN	case	O
30	CD	nummod	O
min	NN	nmod	O
)	-RRB-	punct	O
to	TO	case	O
a	DT	det	O
form	NN	nmod	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
DNA-cellulose	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
intact	JJ	amod	B-cell_type
thymocytes	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
dexamethasone-21-mesylate	NN	nmod	O
,	,	punct	O
an	DT	det	O
Mr	NN	nsubjpass	O
approximately	RB	advmod	O
equal	JJ	amod	O
to	IN	case	O
95	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
moiety	NN	nmod	O
is	VBZ	auxpass	O
also	RB	advmod	O
labeled	VBN	acl:relcl	O
covalently	RB	advmod	O
.	.	punct	O

Approximately	RB	advmod	O
35	CD	nummod	O
%	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
can	MD	aux	O
be	VB	auxpass	O
labeled	VBN	ROOT	O
covalently	RB	advmod	O
when	WRB	advmod	O
intact	JJ	amod	O
thymocytes	NNS	nsubjpass	B-cell_type
are	VBP	auxpass	O
treated	VBN	advcl	O
with	IN	case	O
100	CD	nummod	O
nM	NN	nmod	O
[	-LRB-	punct	O
3H	NN	appos	O
]	-RRB-	punct	O
dexamethasone-21-mesylate	NN	advcl	O
for	IN	case	O
30	CD	nummod	O
min	NN	nmod	O
at	IN	case	O
4	CD	nummod	O
degrees	NNS	nmod	O
.	.	punct	O

Neoplastic	JJ	amod	B-cell_type
cells	NNS	nsubjpass	I-cell_type
from	IN	case	O
acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	nmod	O
and	CC	cc	O
malignant	JJ	amod	O
lymphoma	NN	conj	O
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
dexamethasone-21-mesylate	NN	nmod	O
.	.	punct	O

In	IN	case	O
all	DT	det	O
samples	NNS	nmod	O
,	,	punct	O
an	DT	det	O
Mr	NN	nsubjpass	O
approximately	RB	advmod	O
equal	JJ	amod	O
to	IN	case	O
95	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
moiety	NN	nmod	O
was	VBD	auxpass	O
labeled	VBN	ROOT	O
covalently	RB	advmod	O
;	:	punct	O
labeling	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	parataxis	O
by	IN	case	O
excess	JJ	amod	O
glucocorticoid	NN	nmod	O
.	.	punct	O

Smaller	JJR	amod	B-protein
moieties	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
also	RB	advmod	O
identified	VBN	ROOT	O
by	IN	case	O
competition	NN	compound	O
experiments	NNS	nmod	O
;	:	punct	O
these	DT	nsubj	O
may	MD	aux	O
represent	VB	parataxis	O
proteolytic	JJ	amod	B-protein
fragments	NNS	dobj	I-protein
of	IN	case	O
the	DT	det	O
Mr	NN	nmod	O
approximately	RB	advmod	O
equal	JJ	advmod	O
to	IN	case	O
95	CD	nummod	O
,	,	punct	O
000	CD	nummod	O
receptor	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
in	IN	case	O
rat	NN	compound	B-cell_type
and	CC	cc	I-cell_type
human	JJ	conj	I-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
[	-LRB-	punct	O
3H	NN	nsubjpass	O
]	-RRB-	punct	O
dexamethasone-21-mesylate	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
label	VB	xcomp	O
covalently	RB	advmod	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	dobj	I-protein
.	.	punct	O

The	DT	det	O
association	NN	ROOT	O
of	IN	case	O
cytosol	NN	compound	O
oestrogen	NN	nmod	B-protein
and	CC	cc	I-protein
progesterone	NN	compound	I-protein
receptors	NNS	conj	I-protein
with	IN	case	O
histological	JJ	amod	O
features	NNS	nmod	O
of	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
and	CC	cc	O
early	JJ	amod	O
recurrence	NN	conj	O
of	IN	case	O
disease	NN	nmod	O
.	.	punct	O

Two	CD	nummod	O
hundred	CD	dep	O
and	CC	cc	O
eighty-eight	JJ	conj	O
primary	JJ	amod	O
breast	NN	compound	O
tumours	NNS	nsubjpass	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
presence	NN	nmod	O
or	CC	cc	O
absence	NN	conj	O
of	IN	case	O
oestrogen	NN	nmod	B-protein
(	-LRB-	punct	I-protein
REc	NNS	appos	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	I-protein
progesterone	NN	compound	I-protein
(	-LRB-	punct	I-protein
RPc	NN	appos	I-protein
)	-RRB-	punct	I-protein
receptors	NNS	conj	I-protein
.	.	punct	O

Analysis	NNP	nsubj	O
has	VBZ	aux	O
shown	VBN	ROOT	O
a	DT	det	O
relative	JJ	amod	O
interdependence	NN	dobj	O
between	IN	case	O
the	DT	det	O
steroid	NN	compound	B-protein
receptor	NN	compound	I-protein
status	NN	nmod	O
of	IN	case	O
primary	JJ	amod	O
breast	NN	compound	O
cancer	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
prognostic	JJ	amod	O
variables	NNS	conj	O
such	JJ	case	O
as	IN	mwe	O
histological	JJ	amod	O
grade	NN	nmod	O
,	,	punct	O
lymphocytic	JJ	amod	O
infiltration	NN	conj	O
and	CC	cc	O
tumour	NN	compound	O
elastosis	NN	conj	O
.	.	punct	O

There	EX	expl	O
were	VBD	ROOT	O
significant	JJ	amod	O
associations	NNS	attr	O
between	IN	case	O
epithelial	JJ	amod	O
cellularity	NN	nmod	O
,	,	punct	O
stromal	JJ	amod	O
fibrosis	NN	conj	O
and	CC	cc	O
the	DT	det	O
value	NN	conj	O
of	IN	case	O
REc	NNS	nmod	B-protein
in	IN	case	O
those	DT	det	O
tumours	NNS	nmod	O
in	IN	case	O
which	WDT	nmod	O
the	DT	det	O
receptor	NN	nsubj	O
was	VBD	cop	O
present	JJ	acl:relcl	O
.	.	punct	O

Cellularity	NN	nsubjpass	O
and	CC	cc	O
fibrosis	NN	conj	O
were	VBD	auxpass	O
unrelated	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
presence	NN	nmod	O
or	CC	cc	O
absence	NN	conj	O
of	IN	case	O
oestrogen	NN	compound	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
neither	CC	cc:preconj	O
the	DT	dep	O
presence	NN	nsubj	O
or	CC	cc	O
absence	NN	conj	O
nor	CC	cc	O
the	DT	det	O
value	NN	conj	O
of	IN	case	O
RPc	NNS	nmod	B-protein
could	MD	aux	O
be	VB	cop	O
related	JJ	ROOT	O
to	TO	case	O
cellularity	NN	nmod	O
or	CC	cc	O
fibrosis	NN	conj	O
.	.	punct	O

The	DT	det	O
value	NN	nsubjpass	O
of	IN	case	O
REc	NNS	compound	B-protein
and	CC	cc	O
RPc	NN	conj	B-protein
analysis	NN	nmod	O
as	IN	case	O
an	DT	det	O
indicator	NN	nmod	O
of	IN	case	O
prognosis	NN	nmod	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
sub-group	NN	amod	O
of	IN	advmod	O
175	CD	nummod	O
patients	NNS	nmod	O
receiving	VBG	acl	O
no	DT	neg	O
additional	JJ	amod	O
treatment	NN	dobj	O
following	VBG	case	O
mastectomy	NN	nmod	O
.	.	punct	O

Overall	JJ	amod	O
relapse-free	JJ	amod	O
survival	NN	nsubj	O
(	-LRB-	punct	O
RFS	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
no	RB	neg	O
different	JJ	ROOT	O
for	IN	case	O
those	DT	det	O
patients	NNS	nmod	O
with	IN	case	O
receptors	NNS	nmod	O
compared	VBN	case	O
to	TO	case	O
those	DT	nmod	O
without	IN	case	O
them	PRP	nmod	O
(	-LRB-	punct	O
REc	NNS	compound	B-protein
P	NN	nsubj	O
=	JJ	dep	O
0.11	CD	dobj	O
,	,	punct	O
RPc	NN	compound	O
P	NN	nsubj	O
=	JJ	parataxis	O
0.7	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
difference	NN	nsubj	O
in	IN	case	O
RFS	NN	nmod	O
of	IN	case	O
receptor	NN	nmod	O
positive	JJ	dep	O
and	CC	cc	O
negative	JJ	conj	O
tumours	NNS	attr	O
when	WRB	advmod	O
the	DT	det	O
axillary	JJ	amod	O
node	NN	compound	O
status	NN	nsubjpass	O
was	VBD	auxpass	O
taken	VBN	advcl	O
into	IN	prep	O
account	NN	pobj	O
.	.	punct	O

Clinical	JJ	amod	O
implications	NNS	ROOT	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

Normal	JJ	amod	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
contain	VBP	ROOT	O
glucocorticoid	NN	compound	B-protein
receptor	NN	dobj	I-protein
.	.	punct	O

A	DT	det	O
variety	NN	nsubj	O
of	IN	case	O
stimuli	NNS	nmod	O
that	WDT	nsubj	O
activate	VBP	acl:relcl	O
these	DT	det	O
cells	NNS	dobj	O
also	RB	advmod	O
induce	VBP	ROOT	O
increases	NNS	dobj	O
in	IN	case	O
receptor	NN	compound	O
concentration	NN	nmod	O
.	.	punct	O

Similar	JJ	amod	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
can	MD	aux	O
be	VB	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
ALL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Absence	NN	ROOT	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
usually	RB	advmod	O
found	VBN	dep	O
in	IN	case	O
treated	VBN	amod	O
patients	NNS	nmod	O
)	-RRB-	punct	O
predicts	VBZ	compound	O
lack	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	O
responsiveness	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
in	IN	case	O
our	PRP$	nmod:poss	O
hands	NNS	nmod	O
,	,	punct	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
levels	NNS	nsubj	O
correlate	VBP	ROOT	O
with	IN	case	O
the	DT	det	O
duration	NN	nmod	O
of	IN	case	O
complete	JJ	amod	O
remission	NN	nmod	O
in	IN	case	O
ALL	NN	nmod	O
(	-LRB-	punct	O
though	IN	mark	O
not	RB	neg	O
in	IN	case	O
other	JJ	amod	O
forms	NNS	advcl	O
of	IN	case	O
leukemia	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
association	NN	nsubj	O
is	VBZ	cop	O
independent	JJ	ROOT	O
of	IN	case	O
cell	NN	compound	O
type	NN	nmod	O
,	,	punct	O
age	NN	conj	O
,	,	punct	O
sex	NN	conj	O
,	,	punct	O
or	CC	cc	O
initial	JJ	amod	O
leukocyte	NN	compound	B-cell_type
count	NN	conj	O
.	.	punct	O

The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
receptor	NN	nmod	O
shows	VBZ	ROOT	O
a	DT	det	O
negative	JJ	amod	O
correlation	NN	dobj	O
with	IN	case	O
increasing	VBG	amod	O
aggressiveness	NN	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	nmod	O
(	-LRB-	punct	O
null-cell	JJ	compound	O
leukemia	NN	dep	O
greater	JJR	amod	O
than	IN	case	O
T-cell	NN	compound	O
leukemia	NN	nmod	O
greater	JJR	amod	O
than	IN	case	O
Burkitt	NN	nmod:poss	O
's	POS	case	O
lymphoma	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Corticosteroid-mediated	JJ	amod	O
immunoregulation	NN	ROOT	O
in	IN	prep	O
man	NN	pobj	O
.	.	punct	O

Glucocorticoids	NNS	nsubj	O
have	VBP	ROOT	O
profound	JJ	amod	O
and	CC	cc	O
complex	JJ	conj	O
effects	NNS	dobj	O
on	IN	case	O
the	DT	det	O
human	JJ	amod	O
immune	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
precise	JJ	amod	O
mechanisms	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
corticosteroid-induced	JJ	amod	O
immunoregulation	NN	nmod	O
in	IN	case	O
man	NN	nmod	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
precisely	RB	advmod	O
defined	VBN	ROOT	O
.	.	punct	O

Intracytoplasmic	JJ	amod	B-protein
corticosteroid-specific	JJ	amod	I-protein
receptors	NNS	nsubj	I-protein
appear	VBP	ROOT	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
common	JJ	amod	O
pathway	NN	xcomp	O
for	IN	case	O
steroid-induced	JJ	amod	O
changes	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
variations	NNS	nsubj	O
of	IN	case	O
receptor	NN	compound	O
parameters	NNS	nmod	O
do	VBP	aux	O
not	RB	neg	O
account	VB	conj	O
for	IN	case	O
the	DT	det	O
multifaceted	JJ	amod	O
effects	NNS	nmod	O
on	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

Human	JJ	amod	B-cell_type
circulating	VBG	amod	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
redistribute	VBP	ROOT	O
out	IN	case	O
of	IN	case	O
the	DT	det	O
intravascular	JJ	amod	O
compartment	NN	nmod	O
following	VBG	case	O
treatment	NN	nmod	O
with	IN	case	O
corticosteroids	NNS	nmod	O
.	.	punct	O

Although	IN	mark	O
certain	JJ	amod	O
components	NNS	nsubjpass	O
at	IN	case	O
this	DT	det	O
redistribution	NN	compound	O
phenomenon	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
well-characterized	JJ	advcl	O
,	,	punct	O
the	DT	det	O
importance	NN	nsubj	O
of	IN	case	O
this	DT	det	O
compartmental	JJ	amod	O
cellular	JJ	amod	O
shift	NN	nmod	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
of	IN	case	O
corticosteroid-induced	JJ	amod	O
immunoregulation	NN	nmod	O
are	VBP	cop	O
less	RBR	advmod	O
well-defined	JJ	ROOT	O
.	.	punct	O

Recent	JJ	amod	O
observations	NNS	nsubj	O
that	IN	mark	O
activated	VBN	amod	B-cell_type
lymphocytes	NNS	nsubj	I-cell_type
may	MD	aux	O
be	VB	cop	O
sensitive	JJ	acl:relcl	O
to	TO	case	O
the	DT	det	O
lytic	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
under	IN	case	O
certain	JJ	amod	O
situations	NNS	nmod	O
the	DT	det	O
elimination	NN	nsubj	O
of	IN	case	O
selected	VBN	amod	O
subsets	NNS	nmod	O
of	IN	case	O
cells	NNS	nmod	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
relevant	JJ	amod	O
mechanism	NN	ccomp	O
of	IN	case	O
corticosteroid-mediated	JJ	amod	O
immunoregulation	NN	nmod	O
in	IN	case	O
man	NN	nmod	O
.	.	punct	O

Corticosteroid-mediated	JJ	amod	O
effects	NNS	nsubj	O
on	IN	case	O
monocyte	NN	compound	B-cell_type
function	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
mechanism	NN	ROOT	O
of	IN	case	O
drug-induced	JJ	amod	B-cell_type
immunoregulation	NN	nmod	I-cell_type
in	IN	case	O
monocyte-dependent	JJ	amod	B-cell_type
responses	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
some	DT	det	O
experimental	JJ	amod	O
conditions	NNS	nmod	O
,	,	punct	O
corticosteroids	NNS	nsubj	O
inhibit	VBP	ROOT	O
Interleukin	NN	compound	B-protein
1	CD	nummod	I-protein
production	NN	dobj	O
by	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

The	DT	det	O
immunoregulatory	JJ	amod	O
effects	NNS	nsubj	O
of	IN	case	O
corticosteroids	NNS	nmod	O
on	IN	case	O
lymphocyte	NN	compound	B-cell_type
immune	JJ	amod	O
responses	NNS	nmod	O
are	VBP	cop	O
complex	JJ	ROOT	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
corticosteroids	NNS	nsubj	O
appear	VBP	ROOT	O
to	TO	mark	O
selectively	RB	advmod	O
affect	VB	xcomp	O
early	JJ	amod	O
immunoregulatory	JJ	amod	O
events	NNS	dobj	O
as	IN	mark	O
opposed	VBN	advcl	O
to	IN	mark	O
altering	VBG	advcl	O
an	DT	det	O
established	JJ	amod	O
response	NN	dobj	O
.	.	punct	O

Multiple	JJ	amod	O
sites	NNS	nsubjpass	O
of	IN	case	O
steroid-induced	JJ	amod	O
modulations	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
responses	NNS	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
defined	VBN	ROOT	O
.	.	punct	O

Human	JJ	amod	B-cell_line
lymphoid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	ROOT	I-cell_line
and	CC	cc	O
glucocorticoids	NNS	conj	O
:	:	punct	O
II	CD	dep	O
.	.	punct	O

Whole	JJ	amod	O
cell	NN	ROOT	O
and	CC	cc	O
cytoplasmic	JJ	amod	O
binding	NN	compound	O
properties	NNS	conj	O
of	IN	case	O
lymphoblastoid	JJ	intj	B-cell_line
,	,	punct	I-cell_line
leukaemia	NN	nmod	I-cell_line
and	CC	cc	I-cell_line
lymphoma	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

The	DT	det	O
glucocorticoid	NN	compound	O
binding	NN	compound	O
properties	NNS	nsubjpass	O
of	IN	case	O
18	CD	nummod	O
human	JJ	amod	B-cell_line
lymphoid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
(	-LRB-	punct	O
HLCL	NN	appos	B-cell_line
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
specificity	NN	nsubjpass	O
of	IN	case	O
steroid	NN	compound	O
binding	NN	nmod	O
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
with	IN	case	O
various	JJ	amod	O
glucocorticoid	NN	compound	O
agonists	NNS	nmod	O
and	CC	cc	O
antagonists	NNS	conj	O
.	.	punct	O

A	DT	det	O
gradation	NN	nsubjpass	O
in	IN	case	O
whole	JJ	amod	O
cell	NN	nmod	O
and	CC	cc	O
cytoplasmic	JJ	amod	O
glucocorticoid	NN	compound	O
binding	NN	compound	O
capacity	NN	conj	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
different	JJ	amod	O
cell	NN	compound	O
line	NN	compound	O
types	NNS	nmod	O
:	:	punct	O
lymphoblastoid	JJ	dep	B-cell_line
greater	JJR	amod	O
than	IN	case	O
lymphoma	NN	nmod	B-cell_line
greater	JJR	amod	O
than	IN	case	O
leukaemia	NN	nmod	B-cell_line
.	.	punct	O

The	DT	det	O
cytoplasmic	JJ	amod	B-protein
receptors	NNS	nsubj	I-protein
of	IN	case	O
leukaemia	NN	nmod	B-cell_line
and	CC	cc	I-cell_line
lymphoblastoid	JJ	amod	I-cell_line
lines	NNS	conj	I-cell_line
appeared	VBD	ROOT	O
to	TO	mark	O
contain	VB	xcomp	O
both	CC	cc:preconj	O
proteinaceous	JJ	amod	O
and	CC	cc	O
phospholipid	JJ	conj	O
components	NNS	dobj	O
.	.	punct	O

Cytoplasmic	JJ	amod	B-protein
steroid-receptor	JJ	amod	I-protein
complexes	NNS	nsubj	I-protein
exhibited	VBD	ROOT	O
a	DT	det	O
wide	JJ	amod	O
range	NN	dobj	O
of	IN	case	O
sedimentation	NN	compound	O
coefficients	NNS	nmod	O
(	-LRB-	punct	O
8.5-11.3S	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
low	JJ	amod	O
ionic	JJ	amod	O
strength	NN	compound	O
buffer	NN	nmod	O
but	CC	cc	O
there	EX	expl	O
was	VBD	conj	O
no	DT	neg	O
correlation	NN	nsubj	O
with	IN	case	O
cell	NN	compound	O
line	NN	compound	O
type	NN	nmod	O
or	CC	cc	O
glucocorticoid	NN	compound	O
sensitivity	NN	conj	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
these	DT	det	O
complexes	NNS	nmod	O
by	IN	case	O
heat	NN	nmod	O
(	-LRB-	punct	O
37	CD	nummod	O
degrees	NNS	compound	O
C	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
exposure	NN	conj	O
to	TO	case	O
high	JJ	amod	O
ionic	JJ	amod	O
strength	NN	compound	O
buffer	NN	nmod	O
(	-LRB-	punct	O
0.3	CD	compound	O
M	NN	compound	O
NaCl	NN	appos	O
)	-RRB-	punct	O
induced	VBD	ROOT	O
nuclear	JJ	amod	O
binding	NN	dobj	O
of	IN	case	O
steroid	NN	nmod	O
but	CC	cc	O
only	RB	advmod	O
complexes	NNS	conj	O
in	IN	case	O
high	JJ	amod	O
ionic	JJ	amod	O
strength	NN	compound	O
buffer	NN	compound	O
manifested	VBN	amod	O
changes	NNS	dobj	O
in	IN	case	O
sedimentation	NN	compound	O
coefficient	NN	nmod	O
.	.	punct	O

No	DT	neg	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
between	IN	case	O
the	DT	det	O
level	NN	nmod	O
or	CC	cc	O
nature	NN	conj	O
of	IN	case	O
glucocorticoid	NN	compound	O
binding	NN	nmod	O
and	CC	cc	O
the	DT	det	O
cytolethal	NN	conj	O
or	CC	cc	O
cytostatic	JJ	conj	O
responsiveness	NN	dep	O
of	IN	case	O
HLCL	NN	nmod	B-cell_line
to	TO	case	O
glucocorticoid	NN	compound	O
treatment	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

The	DT	det	O
resistance	NN	nsubjpass	O
to	TO	case	O
cytolethal	NN	amod	O
effects	NNS	nmod	O
can	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
ascribed	VBN	ROOT	O
to	TO	case	O
a	DT	det	O
failure	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
to	TO	mark	O
take	VB	acl	O
up	RP	advmod	O
and	CC	cc	O
bind	VBP	conj	O
steroid	NN	dobj	O
or	CC	cc	O
to	TO	case	O
significant	JJ	amod	O
differences	NNS	conj	O
in	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
species	NNS	nmod	O
of	IN	case	O
cytoplasmic	JJ	amod	B-protein
receptors	NNS	nmod	I-protein
present	JJ	amod	O
.	.	punct	O

The	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	ROOT	O
by	IN	case	O
which	WDT	nmod	O
glucocorticoids	NNS	nsubj	O
achieve	VBP	acl:relcl	O
cytolethal	NN	amod	O
responses	NNS	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type

CD28	NN	compound	B-protein
-mediated	JJ	amod	O
activation	NN	ROOT	O
in	IN	case	O
CD45RA+	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
CD45RO+	JJ	conj	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
enhanced	VBN	amod	O
levels	NNS	dep	O
of	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
intermediates	NNS	nmod	O
and	CC	cc	O
c-Rel	NN	compound	B-protein
nuclear	JJ	amod	O
translocation	NN	conj	O
in	IN	case	O
CD45RA+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
analyzed	VBN	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
complete	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
(	-LRB-	punct	O
anti-CD3	NN	dep	B-protein
plus	CC	cc	O
anti-CD28	NN	conj	B-protein
)	-RRB-	punct	O
on	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
CD45RA+	JJ	nmod	B-cell_type
(	-LRB-	punct	I-cell_type
naive	JJ	dep	I-cell_type
)	-RRB-	punct	I-cell_type
and	CC	cc	I-cell_type
CD45RO+	JJ	amod	I-cell_type
(	-LRB-	punct	I-cell_type
memory/effector	NN	dep	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Long	JJ	amod	O
exposure	NN	nsubj	O
(	-LRB-	punct	O
24	CD	nummod	O
h	NN	appos	O
)	-RRB-	punct	O
induced	VBD	ROOT	O
stronger	JJR	amod	O
NF-kappaB	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	dobj	O
in	IN	case	O
CD45RA+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
than	IN	case	O
in	IN	case	O
CD45RO+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
c-Rel	NN	compound	I-protein
protein	NN	nmod	I-protein
indicated	VBD	ROOT	O
that	IN	mark	O
after	IN	case	O
anti-CD3+anti-CD28	NN	amod	O
stimulation	NN	nmod	O
the	DT	det	O
level	NN	nsubj	O
of	IN	case	O
c-Rel	NN	nmod	B-protein
was	VBD	cop	O
higher	JJR	ccomp	O
in	IN	case	O
CD45RA+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	O
inhibitor	NN	compound	O
IkappaBalpha	NN	nmod	B-protein
indicated	VBD	ROOT	O
that	IN	mark	O
anti-CD3+anti-CD28	NN	amod	O
stimulation	NN	nsubj	O
induced	VBD	ccomp	O
a	DT	det	O
long-lasting	JJ	amod	O
degradation	NN	dobj	O
in	IN	case	O
CD45RA+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
in	IN	case	O
CD45RO+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
the	DT	det	O
degradation	NN	compound	O
process	NN	nsubj	O
was	VBD	cop	O
more	RBR	advmod	O
rapid	JJ	conj	O
.	.	punct	O

Because	IN	mark	O
the	DT	det	O
CD28	NN	compound	O
costimulus	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	advcl	O
to	TO	mark	O
induce	VB	xcomp	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
intermediates	NNS	nmod	O
(	-LRB-	punct	O
ROIs	NNS	appos	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
intracellular	JJ	amod	O
ROI	NN	compound	O
levels	NNS	nsubjpass	O
in	IN	case	O
CD45RA+	JJ	nmod	B-cell_type
and	CC	cc	I-cell_type
CD45RO+	JJ	conj	I-cell_type
cells	NNS	dep	I-cell_type
were	VBD	auxpass	O
compared	VBN	ROOT	O
by	IN	case	O
flow	NN	compound	O
cytometry	NN	nmod	O
.	.	punct	O

ROIs	NNS	nsubjpass	O
were	VBD	auxpass	O
produced	VBN	ROOT	O
in	IN	case	O
both	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
more	RBR	advmod	O
strongly	RB	advmod	O
in	IN	case	O
CD45RA+	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
presented	VBN	acl	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
further	RB	advmod	O
emphasize	VBP	ROOT	O
the	DT	det	O
differences	NNS	dobj	O
between	IN	case	O
CD45RA+	JJ	nmod	B-cell_type
and	CC	cc	I-cell_type
CD45RO+	JJ	conj	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	dep	I-cell_type
in	IN	case	O
ROI-dependent	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O

Ikaros	NN	ROOT	B-protein
in	IN	case	O
hemopoietic	JJ	amod	B-cell_line
lineage	NN	compound	I-cell_line
determination	NN	nmod	O
and	CC	cc	O
homeostasis	NN	conj	O
.	.	punct	O

Studies	NNS	nsubj	O
on	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nmod	O
that	WDT	nsubj	O
control	VBP	acl:relcl	O
hemopoietic	JJ	amod	O
differentiation	NN	dobj	O
have	VBP	aux	O
focused	VBN	ROOT	O
on	IN	case	O
signaling	VBG	compound	O
cascades	NNS	nmod	O
and	CC	cc	O
nuclear	JJ	amod	O
effectors	NNS	conj	O
that	WDT	nsubj	O
drive	VBP	acl:relcl	O
this	DT	det	O
complex	JJ	amod	O
developmental	JJ	amod	O
system	NN	dobj	O
in	IN	case	O
a	DT	det	O
regulated	VBN	amod	O
fashion	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
review	VBP	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
Ikaros	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
founding	VBG	amod	O
member	NN	appos	O
of	IN	case	O
a	DT	det	O
unique	JJ	amod	O
family	NN	nmod	O
of	IN	case	O
zinc	NN	compound	B-protein
finger	NN	compound	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
in	IN	case	O
this	DT	det	O
developmental	JJ	amod	O
process	NN	nmod	O
.	.	punct	O

Studies	NNS	nsubj	O
on	IN	case	O
an	DT	det	O
Ikaros	NN	compound	B-protein
null	NN	amod	O
mutation	NN	nmod	O
have	VBP	aux	O
revealed	VBN	ROOT	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
this	DT	det	O
factor	NN	nmod	O
in	IN	case	O
lymphoid	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
fate	NN	compound	O
determination	NN	nmod	O
and	CC	cc	O
at	IN	case	O
subsequent	JJ	amod	O
branch	NN	compound	O
points	NNS	conj	O
of	IN	case	O
the	DT	det	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
differentiation	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

Differences	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
phenotypes	NNS	nmod	O
of	IN	case	O
a	DT	det	O
null	NN	nmod	O
and	CC	cc	O
a	DT	det	O
dominant	JJ	amod	O
negative	JJ	amod	O
(	-LRB-	punct	O
DN	JJ	dep	O
)	-RRB-	punct	O
Ikaros	NN	compound	O
mutation	NN	dep	O
provide	VBP	ROOT	O
insight	NN	dobj	O
into	IN	case	O
a	DT	det	O
regulatory	JJ	amod	O
network	NN	nmod	O
through	IN	case	O
which	WDT	nmod	O
Ikaros	NN	compound	B-protein
proteins	NNS	nsubj	I-protein
exert	VBP	acl:relcl	O
their	PRP$	nmod:poss	O
effects	NNS	dobj	O
in	IN	case	O
development	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
a	DT	det	O
comparative	JJ	amod	O
analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
hemopoietic	JJ	amod	B-cell_type
stem	NN	compound	I-cell_type
cell	NN	nmod	I-cell_type
and	CC	cc	O
precursor	NN	compound	O
compartment	NN	dep	O
resulting	VBG	acl	O
from	IN	case	O
the	DT	det	O
two	CD	nummod	O
Ikaros	NN	compound	B-protein
mutations	NNS	nmod	O
reveals	VBZ	ROOT	O
a	DT	det	O
profound	JJ	amod	O
yet	RB	advmod	O
not	RB	dep	O
absolute	JJ	amod	O
requirement	NN	dobj	O
for	IN	case	O
Ikaros	NN	nmod	B-protein
in	IN	case	O
the	DT	dep	O
production	NN	nmod	O
and	CC	cc	O
differentiation	NN	conj	O
of	IN	case	O
these	DT	det	O
populations	NNS	nmod	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
p65	NN	nmod	O
and	CC	cc	O
c-Jun	NN	conj	O
substitutes	VBZ	ROOT	O
for	IN	case	O
B7-1	NN	compound	O
costimulation	NN	nmod	O
by	IN	mark	O
targeting	VBG	advcl	O
the	DT	det	O
CD28RE	NN	dobj	B-DNA
within	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
Rel	NN	compound	B-protein
and	CC	cc	O
activation	NN	compound	B-protein
protein-1	NN	nmod	I-protein
(	-LRB-	punct	O
AP-1	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
in	IN	case	O
B7-1-	NN	nmod	B-cell_type
and	CC	cc	I-cell_type
leukocyte	NN	nmod:npmod	I-cell_type
function-associated	JJ	amod	I-cell_type
Ag-3	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
LFA.	NN	compound	I-cell_type
3	CD	nummod	I-cell_type
)	-RRB-	punct	I-cell_type
-costimulated	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
has	VBZ	aux	O
been	VBN	auxpass	O
evaluated	VBN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
overexpression	NN	nsubj	O
of	IN	case	O
c-Jun	NN	nmod	B-protein
but	CC	cc	O
not	RB	cc	O
c-Fos	NN	conj	B-protein
increases	VBZ	ccomp	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
B7-1-	JJ	nmod	B-cell_type
and	CC	cc	I-cell_type
LFA-3-costimulated	JJ	amod	I-cell_type
Jurkat	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Cotransfection	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
c-Jun	NN	nmod	O
and	CC	cc	O
c-Fos	NN	conj	O
substitutes	VBZ	ROOT	O
for	IN	case	O
B7-1	NN	compound	O
costimulation	NN	nmod	O
in	IN	mark	O
driving	VBG	advcl	O
an	DT	det	O
activation	NN	compound	B-DNA
protein-1	NN	compound	I-DNA
response	NN	compound	I-DNA
element	NN	dobj	I-DNA
but	CC	cc	O
not	RB	neg	O
for	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	conj	I-DNA
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
Rel	NN	compound	B-protein
proteins	NNS	nmod	I-protein
demonstrated	VBD	ROOT	O
that	IN	mark	O
p65-expressing	JJ	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
cells	NNS	nsubj	I-cell_line
transcribed	VBN	ccomp	O
equally	RB	advmod	O
well	RB	advmod	O
a	DT	det	O
nuclear	JJ	amod	B-DNA
factor	NN	compound	I-DNA
kappabeta	NN	compound	I-DNA
reporter	NN	compound	I-DNA
construct	NN	dobj	I-DNA
when	WRB	advmod	O
costimulated	VBN	advcl	O
with	IN	case	O
B7-1	NN	nmod	B-protein
or	CC	cc	O
LFA-3	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
transcription	NN	nsubj	O
of	IN	case	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
or	CC	cc	O
CD28	NN	compound	B-DNA
response	NN	compound	I-DNA
element	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
CD28RE	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
-driven	JJ	amod	I-DNA
reporters	NNS	nmod	I-DNA
was	VBD	cop	O
superior	JJ	conj	O
in	IN	case	O
B7-1-costimulated	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Combined	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
c-Jun	NN	nmod	B-protein
and	CC	cc	O
p65	NN	conj	B-protein
induced	VBD	ROOT	O
vigorous	JJ	amod	O
transcription	NN	dobj	O
of	IN	case	O
IL-2	NN	compound	B-DNA
promoter-	NN	nmod	I-DNA
and	CC	cc	I-DNA
CD28RE-driven	JJ	conj	I-DNA
reporter	NN	compound	I-DNA
constructs	NNS	dep	I-DNA
in	IN	case	O
both	CC	cc:preconj	O
LFA-3-	NN	amod	B-cell_type
and	CC	cc	I-cell_type
B7-1-costimulated	JJ	conj	I-cell_type
Jurkat	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Mutating	VBG	csubj	O
the	DT	det	O
CD28RE	NN	dobj	B-DNA
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
upstream	JJ	amod	B-DNA
nuclear	JJ	amod	I-DNA
factor	NN	compound	I-DNA
kappabeta-binding	JJ	amod	I-DNA
site	NN	conj	I-DNA
in	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
reduced	VBD	ROOT	O
B7-1	NN	compound	B-protein
-driven	JJ	amod	O
transcription	NN	dobj	O
>	NN	dep	O
90	CD	nummod	O
%	NN	npadvmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
implicates	VBZ	ROOT	O
a	DT	det	O
major	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
CD28RE	NN	nmod	B-DNA
in	IN	case	O
the	DT	det	O
integration	NN	nmod	O
of	IN	case	O
p65	NN	nmod:npmod	B-protein
/	:	punct	O
c-Jun	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
transcription	NN	nmod	O
within	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
transition	NN	nsubj	O
from	IN	case	O
an	DT	det	O
autocrine	JJ	amod	O
LFA-3	NN	compound	B-protein
-driven	JJ	amod	O
immune	JJ	amod	O
response	NN	nmod	O
to	TO	case	O
a	DT	det	O
B7	NN	nmod	O
--	:	punct	O
induced	VBD	ccomp	O
paracrine	JJ	amod	O
immune	JJ	amod	O
response	NN	dobj	O
involves	VBZ	ccomp	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
c-Jun	NN	nmod	B-protein
and	CC	cc	O
p65	NN	conj	B-protein
,	,	punct	O
which	WDT	nsubj	O
target	VBP	acl:relcl	O
the	DT	det	O
CD28RE	NN	compound	B-DNA
region	NN	dobj	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Defects	NNS	nsubj	O
in	IN	case	O
actin-cap	NN	amod	O
formation	NN	nmod	O
in	IN	case	O
Vav-deficient	JJ	amod	O
mice	NNS	nmod	O
implicate	VBP	ROOT	O
an	DT	det	O
actin	NN	compound	O
requirement	NN	dobj	O
for	IN	case	O
lymphocyte	NN	compound	O
signal	NN	compound	O
transduction	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Antigen-receptor	NN	compound	O
interactions	NNS	nsubj	O
on	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
result	VBP	dep	O
in	IN	case	O
local	JJ	amod	O
clustering	NN	nmod	O
of	IN	case	O
actin	NN	nmod	B-protein
,	,	punct	O
receptors	NNS	conj	O
and	CC	cc	O
signaling	VBG	compound	O
molecules	NNS	conj	O
into	IN	case	O
an	DT	det	O
asymmetric	JJ	amod	O
membrane	NN	compound	O
structure	NN	nmod	O
termed	VBN	acl	O
a	DT	det	O
cap	NN	xcomp	O
.	.	punct	O

Although	IN	mark	O
actin	NN	compound	O
polymerization	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	advcl	O
to	TO	mark	O
be	VB	auxpass	O
required	VBN	xcomp	O
,	,	punct	O
the	DT	det	O
mechanisms	NNS	nsubj	O
underlying	VBG	acl	O
cap	NN	compound	O
formation	NN	dobj	O
are	VBP	cop	O
unclear	JJ	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
studied	VBN	ROOT	O
the	DT	det	O
events	NNS	dobj	O
underlying	VBG	acl	O
cap	NN	compound	O
formation	NN	dobj	O
using	VBG	acl	O
mice	NNS	dobj	O
bearing	VBG	acl	O
a	DT	det	O
null	JJ	amod	O
mutation	NN	dobj	O
in	IN	case	O
vav	NN	nmod	B-DNA
(	-LRB-	punct	O
vav	NN	compound	B-DNA
-/-	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
gene	NN	appos	O
that	WDT	nsubj	O
encodes	VBZ	acl:relcl	O
a	DT	det	O
guanine-nucleotide	NN	amod	B-protein
exchange	NN	compound	I-protein
factor	NN	dobj	I-protein
for	IN	case	O
the	DT	det	O
GTPase	NN	compound	B-protein
Rac	NN	nmod	I-protein
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Lymphocytes	NNS	nsubj	B-cell_type
from	IN	case	O
vav	NN	compound	B-DNA
-/-	JJ	compound	O
mice	NNS	nmod	O
failed	VBD	dep	O
to	TO	mark	O
form	VB	xcomp	O
T-cell	NN	compound	O
receptor	NN	compound	O
caps	NNS	dobj	O
following	VBG	case	O
activation	NN	nmod	O
and	CC	cc	O
had	VBD	conj	O
a	DT	det	O
defective	JJ	amod	O
actin	NN	compound	O
cytoskeleton	NN	dobj	O
.	.	punct	O

The	DT	det	O
vav-/-	JJ	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
were	VBD	cop	O
deficient	JJ	ROOT	O
in	IN	case	O
interleukin-2	NN	compound	O
(	-LRB-	punct	O
IL-2	NN	appos	O
)	-RRB-	punct	O
production	NN	nmod	O
and	CC	cc	O
proliferation	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
peak	NN	nsubjpass	O
of	IN	case	O
Ca2+	NN	compound	O
mobilization	NN	nmod	O
was	VBD	auxpass	O
reduced	VBN	conj	O
although	IN	case	O
of	IN	case	O
normal	JJ	amod	O
duration	NN	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
Jun	NN	compound	B-protein
N-terminal	JJ	amod	I-protein
kinase	NN	nmod	I-protein
or	CC	cc	O
stress-activated	JJ	amod	B-protein
kinase	NN	conj	I-protein
(	-LRB-	punct	O
JNK	NN	dep	B-protein
or	CC	cc	O
SAPK	NN	conj	B-protein
)	-RRB-	punct	O
and	CC	cc	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	conj	I-protein
(	-LRB-	punct	O
MAPK	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
induction	NN	conj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-ATc1	NN	nmod	B-DNA
and	CC	cc	I-DNA
egr-1	NN	compound	I-DNA
genes	NNS	conj	I-DNA
was	VBD	cop	O
normal	JJ	ROOT	O
.	.	punct	O

Despite	IN	case	O
the	DT	det	O
reduced	VBN	amod	O
Ca2+	NN	compound	O
mobilization	NN	nmod	O
,	,	punct	O
translocation	NN	nsubj	O
of	IN	case	O
cytoplasmic	JJ	amod	B-protein
NF-ATc	NN	nmod	I-protein
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
was	VBD	cop	O
normal	JJ	ROOT	O
,	,	punct	O
reflecting	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
lower	JJR	amod	O
levels	NNS	nsubj	O
of	IN	case	O
Ca2+	NN	nmod	O
in	IN	case	O
vav-/-	JJ	compound	B-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	cop	O
still	RB	advmod	O
sufficient	JJ	ccomp	O
to	TO	mark	O
activate	VB	xcomp	O
calcineurin	NN	dobj	B-protein
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
with	IN	case	O
cytochalasin	NN	compound	O
D	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
blocks	VBZ	acl:relcl	O
actin	NN	compound	O
polymerization	NN	dobj	O
,	,	punct	O
inhibited	VBD	ROOT	O
cap	NN	compound	O
formation	NN	dobj	O
and	CC	cc	O
produced	VBN	conj	O
defects	NNS	dobj	O
in	IN	case	O
signaling	NN	nmod	O
and	CC	cc	O
IL-2	NN	compound	O
transcriptional	JJ	amod	O
induction	NN	conj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
antigen-receptor	JJ	compound	O
signaling	NN	nmod	O
that	WDT	nsubj	O
were	VBD	cop	O
nearly	RB	advmod	O
identical	JJ	acl:relcl	O
to	TO	case	O
those	DT	nmod	O
seen	VBN	acl	O
in	IN	case	O
vav-/-	JJ	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
transfection	NN	compound	O
studies	NNS	nmod	O
,	,	punct	O
either	CC	cc:preconj	O
constitutively	RB	advmod	O
active	JJ	amod	O
Vav	NN	nsubj	B-protein
or	CC	cc	O
Rac	NN	conj	B-protein
could	MD	aux	O
complement	VB	ROOT	O
constitutively	RB	advmod	O
active	JJ	amod	O
calcineurin	NN	dobj	B-protein
to	TO	mark	O
activate	VB	xcomp	O
NF-AT-dependent	JJ	amod	O
transcription	NN	dobj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	appos	O
that	IN	mark	O
Vav	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
cap	NN	compound	O
formation	NN	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
correlation	NN	nsubj	O
between	IN	case	O
cap	NN	compound	O
formation	NN	nmod	O
,	,	punct	O
IL-2	NN	compound	O
production	NN	conj	O
and	CC	cc	O
proliferation	NN	conj	O
supports	VBZ	ROOT	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
an	DT	det	O
actin-dependent	JJ	amod	O
pathway	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
source	NN	ccomp	O
of	IN	case	O
specialized	VBN	amod	O
growth	NN	compound	O
regulatory	JJ	amod	O
signals	NNS	nmod	O
.	.	punct	O

CD14	NN	compound	B-protein
-dependent	JJ	amod	O
activation	NN	ROOT	O
of	IN	case	O
human	JJ	amod	B-cell_type
endothelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
Bacteroides	NNPS	compound	O
fragilis	JJR	compound	O
outer	JJ	amod	O
membrane	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
capacity	NN	dobj	O
of	IN	case	O
isolated	VBN	amod	O
Bacteriodes	NNPS	compound	O
fragilis	JJR	compound	O
outer	JJ	amod	O
membrane	NN	nmod	O
,	,	punct	O
B.	FW	compound	O
fragilis	FW	appos	O
NCTC9343	JJ	compound	O
lipopolysaccharide	NN	conj	O
(	-LRB-	punct	O
LPS	NN	appos	O
;	:	punct	O
endotoxin	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
B.	FW	compound	O
fragilis	FW	conj	O
NCTC9343	JJ	compound	O
capsular	JJ	conj	O
polysaccharides	NNS	conj	O
to	TO	mark	O
activate	VB	xcomp	O
human	JJ	amod	O
umbilical	JJ	amod	O
vein	NN	compound	O
endothelial	JJ	amod	O
cell	NN	compound	O
(	-LRB-	punct	O
HUVEC	NN	compound	O
)	-RRB-	punct	O
monolayers	NNS	dobj	O
.	.	punct	O

To	TO	mark	O
assess	VB	advcl	O
HUVEC	NN	compound	O
activation	NN	dobj	O
,	,	punct	O
E-selectin	NN	compound	B-protein
expression	NN	nsubjpass	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
enzyme-linked	JJ	amod	O
immunosorbent	JJ	amod	O
assay	NN	nmod	O
(	-LRB-	punct	O
ELISA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	conj	O
for	IN	case	O
E-selectin-specific	JJ	amod	B-RNA
mRNA	NN	nmod	I-RNA
,	,	punct	O
and	CC	cc	O
electrophoretic	JJ	amod	O
gel	NN	compound	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	conj	O
(	-LRB-	punct	O
EMSA	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	appos	I-protein
necessary	JJ	amod	O
for	IN	case	O
E-selectin	NN	compound	B-DNA
gene	NN	compound	I-DNA
activation	NN	nmod	O
.	.	punct	O

Exposure	NN	nsubj	O
of	IN	case	O
HUVECs	NNS	nmod	B-cell_type
to	IN	case	O
B.	FW	compound	O
fragilis	FW	compound	O
outer	JJ	amod	O
membrane	NN	compound	O
fractions	NNS	nmod	O
,	,	punct	O
separated	VBN	acl	O
from	IN	case	O
other	JJ	amod	O
components	NNS	nmod	O
of	IN	case	O
the	DT	det	O
B.	NNP	compound	O
fragilis	JJR	compound	O
cell	NN	compound	O
wall	NN	nmod	O
by	IN	case	O
isopycnic	JJ	nmod	O
,	,	punct	O
sucrose	NN	compound	O
gradient	NN	compound	O
centrifugation	NN	conj	O
,	,	punct	O
significantly	RB	advmod	O
increased	VBD	ROOT	O
surface	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
E-selectin	NN	nmod	B-protein
and	CC	cc	O
induced	VBD	conj	O
functional	JJ	amod	O
endothelial	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
-dependent	JJ	amod	O
leukocyte	NN	compound	O
adhesion	NN	dobj	O
.	.	punct	O

B.	FW	compound	O
fragilis	FW	compound	O
outer	JJ	amod	O
membranes	NNS	nsubj	O
induced	VBD	ROOT	O
translocation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
to	TO	case	O
HUVEC	NN	compound	O
nuclei	NNS	nmod	O
and	CC	cc	O
accumulation	NN	conj	O
of	IN	case	O
E-selectin	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
HUVEC	NN	compound	O
cytoplasm	NN	nmod	O
.	.	punct	O

E-selectin	NN	compound	O
expression	NN	nsubjpass	O
induced	VBN	acl	O
by	IN	case	O
B.	FW	compound	O
fragilis	FW	compound	O
outer	JJ	amod	O
membranes	NNS	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
blocked	VBN	ROOT	O
by	IN	case	O
polymixin	NN	compound	O
B	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
E-selectin	NN	compound	O
expression	NN	nsubjpass	O
induced	VBN	acl	O
by	IN	case	O
outer	JJ	amod	O
membrane	NN	compound	O
fractions	NNS	nmod	O
purified	VBN	acl	O
from	IN	case	O
E.	FW	compound	O
coli	FW	nmod	O
was	VBD	auxpass	O
competitively	RB	advmod	O
inhibited	VBN	ROOT	O
by	IN	case	O
polymixin	NN	compound	O
B	NN	nmod	O
.	.	punct	O

Neither	CC	cc:preconj	O
purified	VBN	amod	O
B.	NNP	compound	O
fragilis	FW	compound	O
LPS	NN	nsubj	O
,	,	punct	O
a	DT	det	O
prominent	JJ	amod	O
constituent	NN	appos	O
of	IN	case	O
the	DT	det	O
outer	JJ	amod	O
membrane	NN	nmod	O
,	,	punct	O
nor	CC	cc	O
purified	VBN	amod	O
B.	NNP	compound	O
fragilis	FW	compound	O
capsular	JJ	nsubj	O
polysaccharides	NNS	ROOT	O
induced	VBD	dep	O
HUVEC	NN	compound	O
activation	NN	dobj	O
.	.	punct	O

Two	CD	nummod	O
different	JJ	amod	O
monoclonal	JJ	amod	B-protein
antibodies	NNS	nsubj	I-protein
directed	VBN	acl	O
against	IN	case	O
human	JJ	amod	B-protein
CD14	NN	nmod	I-protein
completely	RB	advmod	O
inhibited	VBD	ROOT	O
B.	NNP	compound	O
fragilis	FW	compound	O
outer	IN	amod	O
membrane-induced	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	dobj	O
,	,	punct	O
E-selectin	NN	compound	O
transcription	NN	conj	O
,	,	punct	O
and	CC	cc	O
E-selectin	NN	compound	O
surface	NN	compound	O
expression	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
outer	JJ	amod	O
membrane	NN	compound	O
component	NN	nsubj	O
of	IN	case	O
the	DT	det	O
B.	NNP	compound	O
fragilis	FW	compound	O
cell	NN	compound	O
wall	NN	nmod	O
contains	VBZ	ccomp	O
a	DT	det	O
proinflammatory	JJ	amod	O
factor	NN	compound	O
(	-LRB-	punct	O
s	NNS	dobj	O
)	-RRB-	punct	O
,	,	punct	O
that	WDT	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
LPS	NN	parataxis	O
,	,	punct	O
which	WDT	nsubj	O
induces	VBZ	acl:relcl	O
human	JJ	amod	B-cell_type
endothelial	JJ	amod	I-cell_type
cell	NN	compound	I-cell_type
activation	NN	dobj	O
by	IN	case	O
a	DT	det	O
soluble	JJ	amod	O
CD14	NN	compound	B-protein
-dependent	JJ	amod	O
mechanism	NN	nmod	O
.	.	punct	O

NF-kappaB	NN	nsubj	B-protein
protects	VBZ	ROOT	O
HIV-1-infected	JJ	amod	O
myeloid	JJ	amod	B-cell_type
cells	NNS	dobj	I-cell_type
from	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

HIV-1	NN	compound	O
infection	NN	nsubj	O
of	IN	case	O
primary	JJ	amod	B-cell_type
monocytic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
myeloid	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
results	VBZ	ROOT	O
in	IN	case	O
sustained	JJ	amod	O
NF-kappaB	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
NF-kappaB	NN	compound	O
induction	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
protecting	VBG	advcl	O
cells	NNS	dobj	O
from	IN	case	O
programmed	VBN	amod	O
cell	NN	compound	O
death	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
sought	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
whether	IN	mark	O
constitutive	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activity	NN	nsubj	O
in	IN	case	O
chronically	RB	advmod	O
HIV-1-infected	JJ	amod	O
promonocytic	JJ	amod	B-cell_line
U937	NN	nmod	I-cell_line
(	-LRB-	punct	I-cell_line
U9-IIIB	NN	appos	I-cell_line
)	-RRB-	punct	I-cell_line
and	CC	cc	I-cell_line
myeloblastic	JJ	amod	I-cell_line
PLB-985	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
PLB-IIIB	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
cells	NNS	conj	I-cell_line
affects	VBZ	ccomp	O
apoptotic	JJ	amod	O
signaling	NN	dobj	O
.	.	punct	O

TNFalpha	NN	nsubj	B-protein
and	CC	cc	O
cycloheximide	NN	conj	O
caused	VBD	ROOT	O
infected	JJ	amod	O
cells	NNS	dobj	O
to	TO	mark	O
undergo	VB	xcomp	O
apoptosis	NN	dobj	O
more	RBR	advmod	O
rapidly	RB	advmod	O
than	IN	case	O
parental	JJ	amod	B-cell_line
U937	NN	nmod	I-cell_line
and	CC	cc	O
PLB-985	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
TNFalpha	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
NF-kappaB	NN	compound	O
activation	NN	nmod	O
using	VBG	acl	O
the	DT	det	O
antioxidant	JJ	amod	O
N-acetylcysteine	NN	dobj	O
(	-LRB-	punct	O
NAC	NN	appos	O
)	-RRB-	punct	O
resulted	VBD	ROOT	O
in	IN	case	O
increased	VBN	amod	O
apoptosis	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
U937	NN	nmod	B-cell_line
and	CC	cc	I-cell_line
U9-IIIB	NN	conj	I-cell_line
cells	NNS	dep	I-cell_line
,	,	punct	O
while	IN	mark	O
preactivation	NN	nsubj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
with	IN	case	O
the	DT	det	O
non-apoptotic	JJ	amod	B-protein
inducer	NN	compound	I-protein
IL-1beta	NN	nmod	I-protein
caused	VBD	advcl	O
a	DT	det	O
relative	JJ	amod	O
decrease	NN	dobj	O
in	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
constitutive	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activity	NN	nmod	O
in	IN	case	O
U9-IIIB	NN	nmod	B-cell_line
and	CC	cc	I-cell_line
PLB-IIIB	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
also	RB	advmod	O
induced	VBD	ROOT	O
apoptosis	NN	dobj	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
NF-kappaB	NN	nsubj	B-cell_type
protects	VBZ	ccomp	I-cell_type
cells	NNS	dobj	I-cell_type
from	IN	case	O
a	DT	det	O
persistent	JJ	amod	O
apoptotic	JJ	amod	O
signal	NN	nmod	O
.	.	punct	O

TNFalpha	NN	compound	B-protein
plus	CC	cc	O
NAC	NN	conj	O
treatment	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
marked	JJ	amod	O
decrease	NN	nmod	O
in	IN	case	O
Bcl-2	NN	compound	B-protein
protein	NN	compound	I-protein
levels	NNS	nmod	O
in	IN	case	O
HIV-1-infected	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
coupled	VBN	acl	O
with	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
Bax	NN	compound	B-protein
protein	NN	nmod	I-protein
compared	VBN	case	O
to	TO	case	O
uninfected	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
difference	NN	nsubj	O
in	IN	case	O
susceptibility	NN	nmod	O
to	TO	case	O
TNFalpha	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
apoptosis	NN	nmod	O
may	MD	aux	O
relate	VB	ccomp	O
to	TO	case	O
the	DT	det	O
differences	NNS	nmod	O
in	IN	case	O
relative	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
Bcl-2	NN	nmod	B-protein
and	CC	cc	O
Bax	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
protective	JJ	amod	O
role	NN	nsubjpass	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	mark	O
blocking	VBG	acl	O
TNFalpha-	NN	amod	O
and	CC	cc	O
HIV-1-induced	JJ	conj	O
apoptosis	NN	dobj	O
was	VBD	auxpass	O
supported	VBN	ROOT	O
by	IN	case	O
studies	NNS	nmod	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
engineered	VBN	acl	O
to	TO	mark	O
express	VB	xcomp	O
IkappaB	NN	compound	B-protein
alpha	NN	compound	I-protein
repressor	NN	compound	I-protein
mutants	NNS	dobj	I-protein
(	-LRB-	punct	O
TD-IkappaB	NN	appos	B-protein
)	-RRB-	punct	O
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
a	DT	det	O
tetracycline-responsive	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Cells	NNS	nsubj	O
underwent	VBD	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
TNFalpha	NN	nmod	B-protein
only	RB	advmod	O
when	WRB	advmod	O
NF-kappaB	NN	compound	O
activation	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	advcl	O
by	IN	case	O
TD-IkappaB	NN	compound	B-protein
expression	NN	nmod	O
.	.	punct	O

As	IN	mark	O
was	VBD	auxpass	O
observed	VBN	advcl	O
for	IN	case	O
the	DT	det	O
U9-IIIB	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
TNFalpha	NN	compound	B-protein
treatment	NN	nsubj	O
also	RB	advmod	O
induced	VBD	ROOT	O
a	DT	det	O
marked	JJ	amod	O
decrease	NN	dobj	O
in	IN	case	O
Bcl-2	NN	compound	B-protein
protein	NN	compound	I-protein
levels	NNS	nmod	O
in	IN	case	O
TD-IkappaB	NN	compound	B-cell_type
expressing	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
experiments	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
apoptotic	JJ	amod	O
signaling	NN	nsubjpass	O
is	VBZ	auxpass	O
perturbed	VBN	ccomp	O
in	IN	case	O
HIV-1-infected	JJ	amod	O
U9-IIIB	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
indicate	VBP	conj	O
that	IN	mark	O
NF-kappaB	NN	compound	O
activation	NN	nsubj	O
may	MD	aux	O
play	VB	ccomp	O
an	DT	det	O
additional	JJ	amod	O
protective	JJ	amod	O
role	NN	dobj	O
against	IN	case	O
HIV-1-induced	JJ	amod	O
apoptosis	NN	nmod	O
in	IN	case	O
myeloid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Human	JJ	amod	B-cell_type
normal	JJ	amod	I-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
B-lymphocytes	NNS	nsubj	I-cell_type
are	VBP	cop	O
deficient	JJ	ROOT	O
in	IN	case	O
DNA-dependent	JJ	amod	O
protein	NN	compound	O
kinase	NN	compound	O
activity	NN	nmod	O
due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
a	DT	det	O
variant	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
the	DT	det	O
Ku86	NN	compound	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
heterodimeric	JJ	amod	O
Ku	NN	compound	B-protein
protein	NN	nsubj	I-protein
,	,	punct	O
which	WDT	nsubj	O
comprises	VBZ	acl:relcl	O
a	DT	det	O
86	CD	nummod	B-protein
kDa	NN	dobj	I-protein
(	-LRB-	punct	I-protein
Ku86	NN	appos	I-protein
)	-RRB-	punct	I-protein
amd	VBD	ROOT	O
a	DT	det	O
70	CD	nummod	B-protein
kDa	NN	compound	I-protein
(	-LRB-	punct	I-protein
Ku70	NN	appos	I-protein
)	-RRB-	punct	I-protein
subunits	NNS	dobj	I-protein
,	,	punct	O
is	VBZ	cop	O
an	DT	det	O
abundant	JJ	amod	O
nuclear	JJ	amod	B-protein
DNA-binding	JJ	amod	I-protein
protein	NN	conj	I-protein
which	WDT	nsubj	O
binds	VBZ	acl:relcl	O
in	FW	compound	O
vitro	FW	advmod	O
to	TO	case	O
DNA	NN	compound	B-DNA
termini	NNS	nmod	I-DNA
without	IN	case	O
sequence	NN	compound	O
specificity	NN	nmod	O
.	.	punct	O

Ku	NNP	nsubj	B-protein
is	VBZ	cop	O
the	DT	det	O
DNA-targeting	JJ	amod	B-protein
component	NN	ROOT	I-protein
of	IN	case	O
the	DT	det	O
large	JJ	amod	O
catalytic	JJ	amod	B-protein
sub-unit	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
DNA-dependent	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
complex	NN	nmod	I-protein
(	-LRB-	punct	O
DNA-PK	NN	compound	B-protein
[	-LRB-	punct	I-protein
CS	NN	dep	I-protein
]	-RRB-	punct	I-protein
)	-RRB-	punct	O
,	,	punct	O
that	WDT	nsubj	O
plays	VBZ	acl:relcl	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
mammalian	JJ	amod	O
double-strand	JJ	amod	O
break	NN	amod	O
repair	NN	nmod	O
and	CC	cc	O
lymphoid	JJ	amod	O
V	NN	compound	O
(	-LRB-	punct	O
D	NN	compound	O
)	-RRB-	punct	O
J	NN	compound	O
recombination	NN	conj	O
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
the	DT	det	O
major	JJ	amod	B-protein
Ku	NN	compound	I-protein
x	NN	cc	I-protein
DNA	NN	compound	I-protein
complex	NN	nmod	I-protein
usually	RB	advmod	O
detected	VBN	acl	O
in	IN	case	O
cell	NN	compound	O
line	NN	compound	O
extracts	NNS	nmod	O
,	,	punct	O
a	DT	det	O
second	JJ	amod	O
complex	NN	nsubjpass	O
with	IN	case	O
faster	JJR	amod	O
electrophoretic	JJ	amod	O
mobility	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ccomp	O
in	IN	case	O
normal	JJ	amod	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	compound	I-cell_type
(	-LRB-	punct	O
PBL	NN	appos	B-cell_type
)	-RRB-	punct	O
extracts	NNS	nmod	O
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
this	DT	det	O
faster	RBR	amod	B-protein
migrating	VBG	amod	I-protein
complex	NN	nmod	I-protein
was	VBD	aux	O
restricted	JJ	ROOT	O
to	TO	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
among	IN	case	O
the	DT	det	O
circulating	VBG	amod	B-cell_type
lymphocyte	NN	compound	I-cell_type
population	NN	nmod	I-cell_type
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
B	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
express	VBP	ccomp	O
a	DT	det	O
variant	JJ	amod	O
form	NN	dobj	O
of	IN	case	O
the	DT	det	O
Ku86	NN	compound	B-protein
protein	NN	nmod	I-protein
with	IN	case	O
an	DT	det	O
apparent	JJ	amod	O
molecular	JJ	amod	O
weight	NN	nmod	O
of	IN	case	O
69	CD	nummod	O
kDa	NN	nmod	O
,	,	punct	O
and	CC	cc	O
not	RB	neg	O
the	DT	det	O
86	CD	nummod	B-protein
kDa-	JJ	compound	I-protein
full-length	JJ	amod	I-protein
protein	NN	conj	I-protein
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
heterodimer	NN	compound	B-protein
Ku70/variant-Ku86	NN	nsubj	I-protein
binds	VBZ	advcl	O
to	TO	case	O
DNA-ends	NN	nmod	B-DNA
,	,	punct	O
this	DT	det	O
altered	JJ	amod	O
form	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Ku	NN	compound	B-protein
heterodimer	NN	nmod	I-protein
has	VBZ	ROOT	O
a	DT	det	O
decreased	VBN	amod	O
ability	NN	dobj	O
to	TO	mark	O
recruit	VB	acl	O
the	DT	det	O
catalytic	JJ	amod	B-protein
component	NN	dobj	I-protein
of	IN	case	O
the	DT	det	O
complex	NN	nmod	O
,	,	punct	O
DNA-PK	NN	appos	B-protein
(	-LRB-	punct	I-protein
CS	NN	appos	I-protein
)	-RRB-	punct	I-protein
,	,	punct	O
which	WDT	nsubj	O
contributes	VBZ	acl:relcl	O
to	TO	case	O
an	DT	det	O
absence	NN	nmod	O
of	IN	case	O
detectable	JJ	amod	O
DNA-PK	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
provide	VBP	ROOT	O
a	DT	det	O
molecular	JJ	amod	O
basis	NN	dobj	O
for	IN	case	O
the	DT	det	O
increased	VBN	amod	O
sensitivity	NN	nmod	O
of	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	mark	O
ionizing	VBG	acl	O
radiation	NN	dobj	O
and	CC	cc	O
identify	VB	conj	O
a	DT	det	O
new	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
regulation	NN	nmod	O
of	IN	case	O
DNA-PK	NN	compound	O
activity	NN	nmod	O
that	WDT	nsubj	O
operates	VBZ	acl:relcl	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Co-stimulation	NN	nsubj	O
of	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
IL-2	NN	nmod	B-protein
and	CC	cc	O
anti-CD3	JJ	conj	B-protein
monoclonal	JJ	amod	I-protein
antibodies	NNS	dep	I-protein
induces	VBZ	ROOT	O
phosphorylation	NN	dobj	O
of	IN	case	O
CREB	NN	nmod	B-protein
.	.	punct	O

Phosphorylation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
cAMP-response	NN	compound	B-protein
element	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	compound	I-protein
CREB	NN	nmod	I-protein
within	IN	case	O
1	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
CD2	NN	nmod	B-protein
but	CC	cc	O
not	RB	cc	O
CD3	NN	compound	B-protein
cross-linking	NN	conj	O
of	IN	case	O
human	JJ	amod	B-cell_type
PBMC	NN	nmod	I-cell_type
was	VBD	auxpass	O
recently	RB	advmod	O
demonstrated	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
absence	NN	nsubjpass	O
of	IN	case	O
P-CREB	NN	nmod	B-protein
following	VBG	case	O
CD3	NN	compound	O
cross-linking	NN	nmod	O
was	VBD	auxpass	O
unexpected	JJ	ROOT	O
,	,	punct	O
as	IN	mark	O
other	JJ	amod	O
laboratories	NNS	nsubj	O
reported	VBD	advcl	O
increased	VBN	amod	O
phosphorylation	NN	dobj	O
of	IN	case	O
CREB	NN	nmod	B-protein
following	VBG	case	O
CD3	NN	compound	O
cross-linking	NN	nmod	O
of	IN	case	O
the	DT	det	O
Jurkat	NN	compound	B-cell_line
lymphocyte	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

Due	JJ	case	O
to	TO	mwe	O
Jurkat	NN	compound	B-cell_line
T-cells	NNS	nsubj	I-cell_line
being	VBG	cop	O
IL-2-independent	JJ	advcl	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
postulated	VBN	ROOT	O
that	IN	mark	O
IL-2	NN	nsubj	B-protein
might	MD	aux	O
provide	VB	ccomp	O
a	DT	det	O
necessary	JJ	amod	O
co-stimulus	NN	dobj	O
for	IN	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
CREB	NN	nmod	B-protein
in	IN	case	O
primary	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
P-CREB	NN	nsubjpass	B-protein
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
following	VBG	case	O
co-stimulation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
PBMC	NN	nmod	I-cell_type
through	IN	case	O
the	DT	det	O
IL-2	NN	nmod	B-protein
and	CC	cc	I-protein
CD2	NN	conj	I-protein
or	CC	cc	I-protein
CD3	NN	conj	I-protein
receptors	NNS	dep	I-protein
.	.	punct	O

IL-2	NN	nsubj	B-protein
did	VBD	aux	O
not	RB	neg	O
further	RB	advmod	O
augment	VB	ROOT	O
phosphorylation	NN	dobj	O
of	IN	case	O
CREB	NN	nmod	B-protein
following	VBG	case	O
CD2	NN	compound	O
cross-linking	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
while	IN	mark	O
neither	CC	cc:preconj	O
IL-2	NN	nsubj	B-protein
nor	CC	cc	O
CD3	NN	compound	O
cross-linking	NN	conj	O
alone	RB	advmod	O
induced	VBD	amod	O
P-CREB	NN	nsubjpass	B-protein
,	,	punct	O
a	DT	det	O
4.5-fold	JJ	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
CREB	NN	nmod	B-protein
within	IN	case	O
1	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
IL-2/CD3	NN	compound	O
co-stimulation	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

Phosphorylation	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
cAMP	NN	nmod	O
,	,	punct	O
and	CC	cc	O
inhibition	NN	nsubj	O
of	IN	case	O
PKA	NN	compound	O
signaling	NN	nmod	O
had	VBD	conj	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
P-CREB	NN	nmod	B-protein
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
signal	NN	compound	O
transduction	NN	nmod	O
through	IN	case	O
p56lck	NN	nmod	B-protein
or	CC	cc	O
p59fyn	NN	conj	B-protein
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
PTK	NN	compound	O
signaling	NN	nmod	O
reduced	VBD	ROOT	O
phosphorylation	NN	compound	O
50	CD	nummod	O
%	NN	dobj	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
inhibiting	VBG	nsubj	O
PKC	NN	compound	O
signaling	NN	dobj	O
with	IN	case	O
calphostin	NN	compound	O
C	NN	nmod	O
further	RB	advmod	O
increased	VBD	ROOT	O
P-CREB	JJ	compound	O
levels	NNS	dobj	O
3-fold	RB	advmod	O
over	IN	case	O
that	DT	nmod	O
observed	VBN	acl	O
in	IN	case	O
IL-2/CD3	NN	compound	B-cell_type
co-stimulated	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
not	RB	neg	O
pretreated	VBN	xcomp	O
with	IN	case	O
a	DT	det	O
PKC	NN	compound	O
inhibitor	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
previous	JJ	amod	O
studies	NNS	nsubjpass	O
performed	VBN	acl	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
exogenous	JJ	amod	B-protein
IL-2	NN	nmod	I-protein
,	,	punct	O
no	DT	neg	O
increase	NN	nsubjpass	O
in	IN	case	O
binding	NN	nmod	O
of	IN	case	O
CREB	NN	nmod	B-protein
to	TO	case	O
a	DT	det	O
32P-labeled	JJ	amod	O
oligonucleotide	NN	compound	O
probe	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
by	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
IL-2	NN	compound	B-protein
and	CC	cc	O
CD3	NN	conj	B-protein
signaling	NN	compound	O
pathways	NNS	nsubj	O
provide	VBP	ccomp	O
a	DT	det	O
necessary	JJ	amod	O
and	CC	cc	O
co-operative	JJ	conj	O
stimulus	NN	dobj	O
promoting	VBG	acl	O
phosphorylation	NN	dobj	O
of	IN	case	O
CREB	NN	nmod	B-protein
following	VBG	case	O
receptor	NN	compound	O
cross-linking	NN	nmod	O
.	.	punct	O

HIV-1	NN	compound	O
infection	NN	nsubj	O
induces	VBZ	ROOT	O
a	DT	det	O
selective	JJ	amod	O
reduction	NN	dobj	O
in	IN	case	O
STAT5	NN	compound	O
protein	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

HIV-1	NN	compound	O
infection	NN	nsubjpass	O
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
qualitative	JJ	amod	O
and	CC	cc	O
quantitative	JJ	conj	O
defects	NNS	nmod	O
in	IN	case	O
CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Loss	NN	nsubjpass	O
of	IN	case	O
immune	JJ	amod	O
function	NN	nmod	O
in	IN	case	O
HIV	NN	compound	O
patients	NNS	nmod	O
is	VBZ	auxpass	O
usually	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
profound	JJ	amod	O
dysregulation	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	B-protein
production	NN	nmod	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
whether	IN	mark	O
cytokine	NN	compound	B-protein
signaling	NN	compound	O
defects	NNS	nsubj	O
occur	VBP	ccomp	O
during	IN	case	O
HIV	NN	compound	O
infection	NN	nmod	O
,	,	punct	O
PHA	NN	compound	B-cell_type
blasts	NNS	nsubjpass	I-cell_type
from	IN	case	O
healthy	JJ	amod	O
human	JJ	amod	O
donors	NNS	nmod	O
were	VBD	auxpass	O
infected	VBN	ROOT	O
with	IN	case	O
two	CD	nummod	O
strains	NNS	nmod	O
of	IN	case	O
HIV-1	NN	nmod	O
and	CC	cc	O
screened	VBN	conj	O
for	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
STAT	NN	compound	B-protein
proteins	NNS	nmod	I-protein
used	VBN	acl	O
in	IN	case	O
cytokine	NN	compound	B-protein
signaling	NN	nmod	O
.	.	punct	O

A	DT	det	O
selective	JJ	amod	O
decrease	NN	nsubjpass	O
in	IN	case	O
STAT5B	NN	nmod	B-protein
was	VBD	auxpass	O
seen	VBN	ROOT	O
8	CD	nummod	O
days	NNS	nmod	O
after	IN	case	O
infection	NN	nmod	O
with	IN	case	O
the	DT	det	O
BZ167	NN	compound	O
dual-tropic	JJ	amod	O
HIV	NN	compound	O
isolate	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
with	IN	case	O
the	DT	det	O
Ba-L	NN	conj	O
,	,	punct	O
M-tropic	JJ	amod	O
strain	NN	conj	O
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
these	DT	det	O
findings	NNS	nmod	O
,	,	punct	O
purified	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
from	IN	case	O
HIV-infected	JJ	amod	O
patients	NNS	nmod	O
in	IN	case	O
different	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
disease	NN	nmod	O
were	VBD	auxpass	O
also	RB	advmod	O
tested	VBN	ROOT	O
for	IN	case	O
STAT	NN	compound	O
expression	NN	nmod	O
;	:	punct	O
decreases	VBZ	nsubjpass	O
in	IN	case	O
STAT5A	NN	nmod	B-protein
,	,	punct	O
STAT5B	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
STAT1alpha	NN	conj	B-protein
were	VBD	auxpass	O
observed	VBN	parataxis	O
in	IN	case	O
all	DT	det	O
patients	NNS	nmod	O
.	.	punct	O

The	DT	det	O
reduction	NN	nsubj	O
in	IN	case	O
STATs	NNS	nmod	B-protein
seen	VBN	acl	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vitro	FW	advmod	O
after	IN	case	O
HIV	NN	compound	O
infection	NN	nmod	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
loss	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
function	NN	nmod	O
in	IN	case	O
HIV	NN	compound	O
disease	NN	nmod	O
.	.	punct	O

Transcription	NN	compound	B-protein
factors	NNS	ROOT	I-protein
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
monocyte	NN	compound	B-cell_type
/	:	punct	O
macrophage	NN	dep	B-cell_type
differentiation	NN	dobj	O
.	.	punct	O

Although	IN	mark	O
all	PDT	det:predet	O
the	DT	det	O
cells	NNS	nsubj	O
in	IN	case	O
an	DT	det	O
organism	NN	nmod	O
contain	VBP	advcl	O
the	DT	det	O
same	JJ	amod	O
genetic	JJ	amod	O
information	NN	dobj	O
,	,	punct	O
differences	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	O
phenotype	NN	nmod	O
arise	VBP	ROOT	O
from	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
lineage-specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

During	IN	case	O
myelopoiesis	NN	nmod	O
,	,	punct	O
external	JJ	amod	O
differentiating	VBG	amod	O
signals	NNS	nsubj	O
regulate	VBP	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
a	DT	det	O
set	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
combined	JJ	amod	O
action	NN	nsubj	O
of	IN	case	O
these	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
subsequently	RB	advmod	O
determines	VBZ	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
myeloid-specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
the	DT	det	O
generation	NN	conj	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
and	CC	cc	O
macrophages	NNS	conj	B-cell_type
.	.	punct	O

In	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
PU.1	NN	nsubj	I-protein
has	VBZ	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
this	DT	det	O
process	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
review	VBP	ROOT	O
the	DT	det	O
contribution	NN	dobj	O
of	IN	case	O
several	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
to	TO	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
macrophage	NN	compound	B-cell_type
development	NN	nmod	O

Transcription	NN	compound	B-protein
factor	NN	compound	I-protein
LKLF	NN	nsubj	I-protein
is	VBZ	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
program	NN	xcomp	O
T	NN	compound	O
cell	NN	compound	O
quiescence	NN	dobj	O
via	IN	case	O
a	DT	det	O
c-Myc	NN	compound	O
--	:	punct	O
dependent	JJ	amod	O
pathway	NN	nmod	O
.	.	punct	O

T	NN	compound	B-cell_type
lymphocytes	NNS	nsubj	I-cell_type
circulate	VBP	ROOT	O
in	IN	case	O
a	DT	det	O
quiescent	JJ	amod	O
state	NN	nmod	O
until	IN	mark	O
they	PRP	nsubj	O
encounter	VBP	advcl	O
cognate	JJ	amod	B-protein
antigen	NN	dobj	I-protein
bound	VBD	acl	O
to	TO	case	O
the	DT	det	O
surface	NN	nmod	O
of	IN	case	O
an	DT	det	O
antigen-presenting	JJ	amod	B-cell_type
cell	NN	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
molecular	JJ	amod	O
pathways	NNS	nsubj	O
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
T	NN	compound	O
cell	NN	compound	O
quiescence	NN	dobj	O
remain	VBP	ROOT	O
largely	RB	advmod	O
unknown	JJ	xcomp	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
forced	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
lung	NN	compound	B-protein
Kruppel-like	JJ	amod	I-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
LKLF	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
program	VB	xcomp	O
a	DT	det	O
quiescent	JJ	amod	O
phenotype	NN	dobj	O
characterized	VBN	acl	O
by	IN	case	O
decreased	VBN	amod	O
proliferation	NN	nmod	O
,	,	punct	O
reduced	VBD	amod	O
cell	NN	compound	O
size	NN	conj	O
and	CC	cc	O
protein	NN	compound	O
synthesis	NN	conj	O
and	CC	cc	O
decreased	VBD	amod	O
surface	NN	compound	O
expression	NN	conj	O
of	IN	case	O
activation	NN	compound	O
markers	NNS	nmod	O
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
LKLF-deficient	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
produced	VBN	acl	O
by	IN	case	O
gene	NN	compound	O
targeting	NN	nmod	O
showed	VBD	ROOT	O
increased	VBN	amod	O
proliferation	NN	dobj	O
,	,	punct	O
increased	VBN	amod	O
cell	NN	compound	O
size	NN	conj	O
and	CC	cc	O
enhanced	VBN	amod	O
expression	NN	conj	O
of	IN	case	O
surface	NN	compound	O
activation	NN	compound	O
markers	NNS	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

LKLF	NNS	nsubj	B-protein
appeared	VBD	ROOT	O
to	TO	case	O
function	VB	xcomp	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
by	IN	mark	O
decreasing	VBG	advcl	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
proto-oncogene	NN	nmod	B-DNA
encoding	VBG	acl	O
c-Myc	NN	dobj	B-protein
.	.	punct	O

Forced	VBN	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
LKLF	NN	nmod	B-protein
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
markedly	RB	advmod	O
decreased	VBN	amod	O
c-Myc	NN	compound	B-protein
expression	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
many	JJ	amod	O
effects	NNS	nsubjpass	O
of	IN	case	O
LKLF	NN	compound	B-protein
expression	NN	nmod	O
were	VBD	auxpass	O
mimicked	VBN	ROOT	O
by	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
dominant-negative	JJ	amod	B-protein
MadMyc	NN	compound	I-protein
protein	NN	nmod	I-protein
and	CC	cc	O
rescued	VBN	conj	O
by	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
c-Myc	NN	nmod	B-protein
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
LKLF	NN	nsubj	B-protein
is	VBZ	cop	O
both	CC	cc:preconj	O
necessary	JJ	ROOT	O
and	CC	cc	O
sufficient	JJ	conj	O
to	TO	case	O
program	NN	compound	O
quiescence	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
functions	NNS	conj	O
,	,	punct	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
by	IN	mark	O
negatively	RB	advmod	O
regulating	VBG	advcl	O
a	DT	det	O
c-Myc	NN	compound	O
--	:	punct	O
dependent	JJ	amod	O
pathway	NN	dobj	O
.	.	punct	O

HTLV-1	NN	compound	B-protein
p12	NN	compound	I-protein
(	-LRB-	punct	I-protein
I	NN	compound	I-protein
)	-RRB-	punct	I-protein
protein	NN	nsubj	I-protein
enhances	VBZ	ROOT	O
STAT5	NN	compound	O
activation	NN	dobj	O
and	CC	cc	O
decreases	VBZ	conj	O
the	DT	det	O
interleukin-2	NN	compound	B-protein
requirement	NN	dobj	O
for	IN	case	O
proliferation	NN	nmod	O
of	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
p12	NN	compound	B-protein
(	-LRB-	punct	I-protein
I	NN	compound	I-protein
)	-RRB-	punct	I-protein
protein	NN	nsubj	I-protein
,	,	punct	O
encoded	VBN	acl	O
by	IN	case	O
the	DT	det	O
pX	NN	amod	B-DNA
open	JJ	amod	I-DNA
reading	NN	compound	I-DNA
frame	NN	nmod	I-DNA
I	CD	dep	I-DNA
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
T-lymphotropic	JJ	amod	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
(	-LRB-	punct	O
HTLV-1	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
hydrophobic	JJ	amod	B-protein
protein	NN	ROOT	I-protein
that	WDT	nsubj	O
localizes	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
endoplasmic	JJ	amod	O
reticulum	NN	nmod	O
and	CC	cc	O
the	DT	det	O
Golgi	NNP	conj	O
.	.	punct	O

Although	IN	mark	O
p12	NN	nsubj	B-protein
(	-LRB-	punct	I-protein
I	NN	appos	I-protein
)	-RRB-	punct	I-protein
contains	VBZ	advcl	O
4	CD	nummod	O
minimal	JJ	amod	O
proline-rich	JJ	dobj	O
,	,	punct	O
src	NN	compound	B-protein
homology	NN	compound	I-protein
3-binding	JJ	amod	I-protein
motifs	NNS	conj	I-protein
(	-LRB-	punct	O
PXXP	NNS	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
characteristic	JJ	appos	O
commonly	RB	advmod	O
found	VBN	acl	O
in	IN	case	O
proteins	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
signaling	NN	compound	O
pathways	NNS	nmod	O
,	,	punct	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
known	VBN	ROOT	O
whether	IN	mark	O
p12	NN	nsubj	B-protein
(	-LRB-	punct	I-protein
I	NN	appos	I-protein
)	-RRB-	punct	I-protein
has	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	mark	O
modulating	VBG	acl	O
intracellular	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	dobj	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
p12	NN	nsubj	B-protein
(	-LRB-	punct	I-protein
I	NN	appos	I-protein
)	-RRB-	punct	I-protein
binds	VBZ	ccomp	O
to	TO	case	O
the	DT	det	O
cytoplasmic	JJ	amod	B-protein
domain	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
interleukin-2	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	I-protein
IL-2R	NN	compound	I-protein
)	-RRB-	punct	I-protein
beta	NN	compound	I-protein
chain	NN	nmod	I-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
recruitment	NN	nmod	O
of	IN	case	O
the	DT	dep	O
Jak1	NN	nmod	B-protein
and	CC	cc	I-protein
Jak3	NN	conj	I-protein
kinases	NNS	dep	I-protein
.	.	punct	O

As	IN	case	O
a	DT	det	O
result	NN	nmod	O
of	IN	case	O
this	DT	det	O
interaction	NN	nmod	O
,	,	punct	O
p12	NN	nsubj	B-protein
(	-LRB-	punct	I-protein
I	NN	appos	I-protein
)	-RRB-	punct	I-protein
increases	VBZ	ROOT	O
signal	NN	compound	B-protein
transducers	NNS	dobj	I-protein
and	CC	cc	I-protein
activators	NNS	compound	I-protein
of	IN	amod	I-protein
transcription	NN	compound	I-protein
5	CD	nummod	I-protein
(	-LRB-	punct	O
STAT5	NN	appos	B-protein
)	-RRB-	punct	O
DNA	NN	compound	O
binding	NN	conj	O
and	CC	cc	O
transcriptional	JJ	amod	O
activity	NN	conj	O
and	CC	cc	O
this	DT	det	O
effect	NN	nsubj	O
depends	VBZ	conj	O
on	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
IL-2R	NN	compound	B-protein
beta	NN	nmod	I-protein
and	CC	cc	I-protein
gamma	NN	compound	I-protein
(	-LRB-	punct	I-protein
c	NN	appos	I-protein
)	-RRB-	punct	I-protein
chains	NNS	dep	I-protein
and	CC	cc	O
Jak3	NN	conj	B-protein
.	.	punct	O

Transduction	NN	nsubj	O
of	IN	case	O
primary	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
peripheral	JJ	amod	I-cell_line
blood	NN	compound	I-cell_line
mononuclear	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
(	-LRB-	punct	O
PBMCs	NNS	appos	B-cell_type
)	-RRB-	punct	O
with	IN	case	O
a	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
type	NN	compound	I-DNA
1-based	JJ	amod	I-DNA
retroviral	JJ	amod	I-DNA
vector	NN	nmod	I-DNA
expressing	NN	acl	O
p12	NN	dobj	B-protein
(	-LRB-	punct	I-protein
I	NN	appos	I-protein
)	-RRB-	punct	I-protein
also	RB	advmod	O
resulted	VBD	ROOT	O
in	IN	case	O
increased	VBN	amod	O
STAT5	NN	compound	B-protein
phosphorylation	NN	nmod	O
and	CC	cc	O
DNA	NN	compound	O
binding	NN	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
p12	NN	nsubj	B-protein
(	-LRB-	punct	I-protein
I	NN	appos	I-protein
)	-RRB-	punct	I-protein
could	MD	aux	O
increase	VB	ROOT	O
proliferation	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-cell_type
PBMCs	NNS	nmod	I-cell_type
only	RB	advmod	O
after	IN	case	O
stimulation	NN	nmod	O
of	IN	case	O
T-cell	NN	compound	B-protein
receptors	NNS	nmod	I-protein
by	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
with	IN	case	O
low	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
alphaCD3	NN	nmod	B-protein
and	CC	cc	I-protein
alphaCD28	JJ	amod	I-protein
antibodies	NNS	conj	I-protein
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
proliferative	JJ	amod	O
advantage	NN	nsubj	O
of	IN	case	O
p12	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
I	NN	nmod:npmod	I-cell_type
)	-RRB-	punct	I-cell_type
-transduced	JJ	amod	I-cell_type
PBMCs	NNS	nmod	I-cell_type
was	VBD	cop	O
evident	JJ	ROOT	O
mainly	RB	advmod	O
at	IN	case	O
low	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
IL-2	NN	nmod	B-protein
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
p12	NN	nsubj	B-protein
(	-LRB-	punct	I-protein
I	NN	appos	I-protein
)	-RRB-	punct	I-protein
may	MD	aux	O
confer	VB	ccomp	O
a	DT	det	O
proliferative	JJ	amod	O
advantage	NN	dobj	O
on	IN	case	O
HTLV-1-infected	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
suboptimal	JJ	amod	O
antigen	NN	compound	O
stimulation	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
this	DT	det	O
event	NN	nsubj	O
may	MD	aux	O
account	VB	conj	O
for	IN	case	O
the	DT	det	O
clonal	JJ	amod	O
proliferation	NN	nmod	O
of	IN	case	O
infected	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

(	-LRB-	punct	O
Blood.	NNP	ROOT	O
2001	CD	nummod	O
;	:	punct	O
98	CD	nummod	O
:	:	punct	O
823-829	CD	nummod	O
)	-RRB-	punct	O

Single	JJ	amod	O
dose	NN	compound	O
intranasal	JJ	amod	O
administration	NN	nsubj	O
of	IN	case	O
retinal	JJ	amod	B-protein
autoantigen	NN	nmod	I-protein
generates	VBZ	ROOT	O
a	DT	det	O
rapid	JJ	amod	O
accumulation	NN	dobj	O
and	CC	cc	O
cell	NN	compound	O
activation	NN	conj	O
in	IN	mark	O
draining	VBG	acl	O
lymph	NN	compound	O
node	NN	dobj	O
and	CC	cc	O
spleen	NN	conj	O
:	:	punct	O
implications	NNS	dep	O
for	IN	case	O
tolerance	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O

BACKGROUND/AIMS	NN	ROOT	O
:	:	punct	O
A	DT	det	O
single	JJ	amod	O
intranasal	JJ	amod	O
delivery	NN	nsubj	O
of	IN	case	O
retinal	JJ	amod	B-protein
autoantigen	NN	nmod	I-protein
suppresses	VBZ	dep	O
effectively	RB	advmod	O
experimental	JJ	amod	O
autoimmune	JJ	amod	O
uveoretinitis	NN	dobj	O
(	-LRB-	punct	O
EAU	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

To	TO	case	O
further	RB	advmod	O
unravel	VB	amod	O
underlying	VBG	amod	O
mechanisms	NNS	nmod	O
the	DT	det	O
authors	NNS	nsubj	O
wished	VBD	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
,	,	punct	O
firstly	RB	advmod	O
,	,	punct	O
the	DT	det	O
kinetics	NNS	dobj	O
of	IN	case	O
antigen	NN	compound	O
delivery	NN	nmod	O
and	CC	cc	O
,	,	punct	O
secondly	RB	advmod	O
,	,	punct	O
the	DT	det	O
early	JJ	amod	O
cellular	JJ	amod	O
responses	NNS	appos	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
initial	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
nasal	JJ	amod	O
mucosal	JJ	amod	O
tolerance	NN	compound	O
induction	NN	nmod	O
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
Flow	NN	compound	O
cytometry	NN	nsubjpass	O
,	,	punct	O
cell	NN	compound	O
proliferation	NN	compound	O
assays	NNS	conj	O
,	,	punct	O
and	CC	cc	O
microscopy	NN	conj	O
were	VBD	auxpass	O
used	VBN	dep	O
to	TO	mark	O
track	VB	xcomp	O
antigen	NN	dobj	B-protein
following	VBG	case	O
a	DT	det	O
single	JJ	amod	O
,	,	punct	O
intranasal	JJ	amod	O
dose	NN	nmod	O
of	IN	case	O
Alexa-488	NN	nmod	B-protein
labelled	JJ	ROOT	I-protein
retinal	JJ	amod	I-protein
antigen	NN	dobj	I-protein
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
A	DT	det	O
rapid	JJ	amod	O
accumulation	NN	nsubjpass	O
of	IN	case	O
antigen	NN	nmod	B-protein
within	IN	case	O
both	CC	cc:preconj	O
superficial	JJ	amod	O
cervical	JJ	amod	O
lymph	NN	compound	O
nodes	NNS	nmod	O
(	-LRB-	punct	O
SCLN	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
spleen	NN	conj	O
was	VBD	auxpass	O
observed	VBN	dep	O
after	IN	case	O
30	CD	nummod	O
minutes	NNS	nmod	O
.	.	punct	O

Significant	JJ	amod	O
proliferative	JJ	amod	O
responses	NNS	nsubjpass	O
to	TO	case	O
IRBP	NN	nmod	O
were	VBD	auxpass	O
elicited	VBN	ROOT	O
by	IN	case	O
48	CD	nummod	O
hours	NNS	nmod	O
indicating	VBG	acl	O
that	IN	mark	O
systemic	JJ	amod	O
priming	NN	nsubj	O
of	IN	case	O
naive	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
retinal	JJ	amod	B-protein
antigen	NN	nmod	I-protein
had	VBD	aux	O
occurred	VBN	ccomp	O
.	.	punct	O

Cell	NN	compound	O
activation	NN	nsubjpass	O
was	VBD	auxpass	O
further	RB	advmod	O
confirmed	VBN	ROOT	O
by	IN	case	O
immunoprecipitation	NN	compound	O
studies	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
demonstrated	VBD	acl:relcl	O
phosphorylation	NN	dobj	O
of	IN	case	O
STAT4	NN	nmod	B-protein
but	CC	cc	O
not	RB	cc	O
STAT6	NN	conj	B-protein
in	IN	case	O
both	CC	cc:preconj	O
lymph	NN	compound	O
nodes	NNS	nmod	O
and	CC	cc	O
spleen	NN	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
at	IN	case	O
24	CD	nummod	O
hours	NNS	nmod	O
,	,	punct	O
STAT4	NN	compound	O
heterodimerisation	NN	nsubjpass	O
with	IN	case	O
STAT	NN	nmod	B-protein
3	CD	nummod	I-protein
was	VBD	auxpass	O
only	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
spleen	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
results	NNS	nsubj	O
provide	VBP	appos	O
novel	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
following	VBG	case	O
a	DT	det	O
single	JJ	amod	O
intranasal	JJ	amod	O
application	NN	compound	O
rapid	JJ	amod	O
transfer	NN	nsubj	O
of	IN	case	O
antigen	NN	nmod	B-protein
occurs	VBZ	acl:relcl	O
.	.	punct	O

Resulting	VBG	amod	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	nsubj	O
develops	VBZ	ROOT	O
consequent	JJ	dobj	O
to	TO	case	O
differential	JJ	amod	O
cell	NN	nmod	O
signalling	NN	acl	O
in	IN	case	O
SCLN	NN	nmod	O
and	CC	cc	O
spleen	NN	conj	O
.	.	punct	O

Further	JJ	amod	O
understanding	NN	nsubj	O
of	IN	case	O
these	DT	det	O
underlying	VBG	amod	O
cellular	JJ	amod	O
mechanisms	NNS	nmod	O
,	,	punct	O
in	IN	case	O
particular	JJ	nmod	O
as	IN	mark	O
is	VBZ	auxpass	O
inferred	VBN	advcl	O
by	IN	case	O
the	DT	det	O
results	NNS	nmod	O
the	DT	det	O
contribution	NN	dep	O
of	IN	case	O
local	JJ	amod	O
versus	CC	cc	O
systemic	JJ	conj	O
tolerance	NN	compound	O
induction	NN	nmod	O
,	,	punct	O
may	MD	aux	O
assist	VB	ROOT	O
in	IN	case	O
strategies	NNS	nmod	O
to	TO	mark	O
clinically	RB	advmod	O
apply	VB	xcomp	O
mucosal	JJ	amod	O
tolerance	NN	compound	O
therapy	NN	dobj	O
successfully	RB	advmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	compound	I-protein
)	-RRB-	punct	I-protein
-18	CD	nummod	I-protein
receptor	NN	compound	I-protein
alpha	NN	compound	I-protein
chain	NN	compound	I-protein
expression	NN	nmod	O
on	IN	case	O
CD4	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
during	IN	case	O
T	NN	compound	O
helper	NN	compound	O
(	-LRB-	punct	O
Th	NN	compound	O
)	-RRB-	punct	O
1/Th2	CD	compound	O
differentiation	NN	nmod	O
.	.	punct	O

Critical	JJ	amod	O
downregulatory	JJ	amod	O
role	NN	ROOT	O
of	IN	case	O
IL-4	NN	nmod	B-protein
.	.	punct	O

Interleukin	NN	nsubjpass	B-protein
(	-LRB-	punct	I-protein
IL	NN	appos	I-protein
)	-RRB-	punct	I-protein
-18	CD	nummod	I-protein
has	VBZ	aux	O
been	VBN	auxpass	O
well	RB	advmod	O
characterized	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
costimulatory	JJ	amod	B-protein
factor	NN	nmod	I-protein
for	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
IL-12-mediated	JJ	amod	B-protein
interferon	NN	compound	I-protein
(	-LRB-	punct	I-protein
IFN	NN	compound	I-protein
)	-RRB-	punct	I-protein
-gamma	NN	compound	I-protein
production	NN	nmod	O
by	IN	case	O
T	NN	compound	B-cell_type
helper	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
Th	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
1	CD	nummod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
can	MD	aux	O
induce	VB	conj	O
IL-4	NN	compound	O
production	NN	dobj	O
and	CC	cc	O
thus	RB	advmod	O
facilitate	VBP	conj	O
the	DT	det	O
differentiation	NN	dobj	O
of	IN	case	O
Th2	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
by	IN	case	O
which	WDT	nmod	O
IL-18	NN	nsubj	B-protein
might	MD	aux	O
regulate	VB	acl:relcl	O
these	DT	det	O
diametrically	RB	advmod	O
distinct	JJ	amod	O
immune	JJ	amod	O
responses	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
analyzed	VBN	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
IL-18	NN	compound	B-protein
receptor	NN	compound	I-protein
alpha	NN	compound	I-protein
chain	NN	dep	I-protein
(	-LRB-	punct	O
IL-18Ralpha	NN	appos	B-protein
)	-RRB-	punct	O
expression	NN	nmod	O
.	.	punct	O

The	DT	det	O
majority	NN	nsubj	O
of	IN	case	O
peripheral	JJ	amod	B-cell_type
CD4	NN	nmod	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
constitutively	RB	advmod	O
expressed	VBD	ROOT	O
the	DT	det	O
IL-18Ralpha	NN	dobj	B-protein
.	.	punct	O

Upon	IN	case	O
antigen	NN	compound	O
stimulation	NN	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
IL-12	NN	nmod	B-protein
,	,	punct	O
marked	JJ	amod	O
enhancement	NN	nsubjpass	O
of	IN	case	O
IL-18Ralpha	NN	compound	B-protein
expression	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

IL-12	NN	compound	B-protein
-mediated	JJ	amod	O
upregulation	NN	nsubj	O
of	IN	case	O
IL-18Ralpha	NN	nmod	B-protein
required	VBD	ROOT	O
IFN-gamma	NN	dobj	B-protein
.	.	punct	O

Activated	VBN	amod	B-cell_type
CD4	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
that	WDT	nsubj	O
expressed	VBD	acl:relcl	O
low	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
IL-18Ralpha	NN	nmod	B-protein
could	MD	aux	O
produce	VB	ROOT	O
IFN-gamma	NN	dobj	B-protein
when	WRB	advmod	O
stimulated	VBN	advcl	O
with	IN	case	O
the	DT	det	O
combination	NN	nmod	O
of	IN	case	O
IL-12	NN	nmod	B-protein
and	CC	cc	O
IL-18	NN	conj	B-protein
,	,	punct	O
while	IN	mark	O
CD4	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nsubj	I-cell_type
which	WDT	nsubj	O
expressed	VBD	acl:relcl	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
IL-18Ralpha	NN	nmod	B-protein
could	MD	aux	O
respond	VB	advcl	O
to	TO	case	O
IL-18	NN	nmod	B-protein
alone	RB	advmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
T	NN	compound	O
cell	NN	compound	O
stimulation	NN	nsubj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
IL-4	NN	nmod	B-protein
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
downregulation	NN	nmod	O
of	IN	case	O
IL-18Ralpha	NN	compound	B-protein
expression	NN	nmod	O
.	.	punct	O

Both	CC	cc:preconj	O
IL-4	NN	nsubj	B-cell_type
(	-LRB-	punct	I-cell_type
-/	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
-	:	punct	I-cell_type
and	CC	cc	I-cell_type
signal	NN	compound	I-cell_type
transducer	NN	compound	I-cell_type
and	CC	cc	I-cell_type
activator	NN	conj	I-cell_type
of	IN	amod	I-cell_type
transcription	NN	nmod	I-cell_type
(	-LRB-	punct	I-cell_type
Stat	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
6	CD	nummod	I-cell_type
(	-LRB-	punct	I-cell_type
-/	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
-	:	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
expressed	VBD	ROOT	O
higher	JJR	amod	O
levels	NNS	dobj	O
of	IN	case	O
IL-18Ralpha	NN	nmod	B-protein
after	IN	case	O
TCR	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
from	IN	case	O
Stat6	NN	compound	O
(	-LRB-	punct	O
-/	NN	appos	O
)	-RRB-	punct	O
-	:	punct	O
mice	NNS	nmod	O
produced	VBD	ROOT	O
more	JJR	amod	O
IFN-gamma	NN	dobj	B-protein
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
IL-18	NN	nmod	B-protein
than	IN	case	O
wild-type	JJ	amod	O
controls	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
positive/negative	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
IL-18Ralpha	NN	nmod	B-protein
by	IN	case	O
the	DT	det	O
major	JJ	amod	O
inductive	JJ	amod	O
cytokines	NNS	nmod	B-protein
(	-LRB-	punct	O
IL-12	NN	dep	B-protein
and	CC	cc	O
IL-4	NN	conj	B-protein
)	-RRB-	punct	O
determines	VBZ	ROOT	O
the	DT	det	O
capacity	NN	dobj	O
of	IN	case	O
IL-18	NN	nmod	B-protein
to	TO	mark	O
polarize	VB	acl	O
an	DT	det	O
immune	JJ	amod	O
response	NN	dobj	O
.	.	punct	O

Glucocorticoid-regulated	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	ROOT	I-protein
.	.	punct	O

Glucocorticoids	NNS	nsubj	O
are	VBP	cop	O
the	DT	det	O
most	RBS	advmod	O
effective	JJ	amod	O
antiinflammatory	JJ	amod	O
drugs	NNS	ROOT	O
used	VBN	acl	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
asthma	NN	nmod	O
.	.	punct	O

They	PRP	nsubj	O
act	VBP	ROOT	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
a	DT	det	O
specific	JJ	amod	O
receptor	NN	nmod	O
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
that	WDT	mark	O
,	,	punct	O
upon	IN	case	O
activation	NN	nmod	O
,	,	punct	O
translocates	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	O
and	CC	cc	O
either	DT	cc:preconj	O
increases	NNS	conj	O
(	-LRB-	punct	O
transactivates	NNS	appos	O
)	-RRB-	punct	O
or	CC	cc	O
decreases	NNS	compound	O
(	-LRB-	punct	O
transrepresses	NNS	appos	O
)	-RRB-	punct	O
gene	NN	compound	O
expression	NN	conj	O
.	.	punct	O

Inhibition	NN	nsubjpass	O
of	IN	case	O
pro-inflammatory	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
such	JJ	case	O
as	IN	mwe	O
activator	NN	compound	B-protein
protein	NN	compound	I-protein
(	-LRB-	punct	I-protein
AP	NN	nmod	I-protein
)	-RRB-	punct	I-protein
-1	CD	nummod	I-protein
,	,	punct	O
signal	NN	compound	B-protein
transducers	NNS	conj	I-protein
and	CC	cc	I-protein
activators	NNS	compound	I-protein
of	IN	amod	I-protein
transcription	NN	conj	I-protein
(	-LRB-	punct	O
STATs	NNS	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	conj	I-protein
(	-LRB-	punct	O
NFAT	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-kappa	NN	compound	I-protein
B	NN	conj	I-protein
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
major	JJ	amod	O
action	NN	xcomp	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

Acetylation	NN	nsubj	O
of	IN	case	O
histones	NNS	nmod	B-protein
allows	VBZ	ROOT	O
unwinding	NN	xcomp	O
of	IN	case	O
the	DT	det	O
local	JJ	amod	B-DNA
DNA	NN	compound	I-DNA
structure	NN	nmod	I-DNA
and	CC	cc	O
enables	VBZ	conj	O
RNA	NN	compound	B-protein
polymerase	NN	dobj	I-protein
II	CD	nummod	I-protein
to	TO	mark	O
enhance	VB	xcomp	O
gene	NN	compound	O
transcription	NN	dobj	O
.	.	punct	O

Histone	NN	compound	O
acetylation	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
balance	NN	nmod	O
between	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
histone	NN	compound	B-protein
acetyltransferases	NNS	nmod	I-protein
(	-LRB-	punct	O
HATs	NNS	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
histone	NN	compound	B-protein
deacetylases	NNS	conj	I-protein
(	-LRB-	punct	O
HDACs	NNS	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

GR	NN	nsubj	B-protein
acts	VBZ	ROOT	O
as	IN	case	O
a	DT	det	O
direct	JJ	amod	O
inhibitor	NN	nmod	O
of	IN	case	O
NF-kappa	NN	nmod:npmod	O
B-induced	JJ	amod	O
HAT	NN	compound	O
activity	NN	nmod	O
and	CC	cc	O
also	RB	advmod	O
by	IN	mark	O
recruiting	VBG	conj	O
HDAC2	NN	dobj	B-protein
to	TO	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B/HAT	NN	compound	I-protein
complex	NN	nmod	I-protein
.	.	punct	O

A	DT	det	O
sub-group	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
glucocorticoid-insensitive	JJ	amod	O
asthma	NN	nmod	O
have	VBP	ROOT	O
an	DT	det	O
inability	NN	dobj	O
to	TO	mark	O
induce	VB	acl	O
histone	NN	compound	O
acetylation	NN	dobj	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
dexamethasone	NN	nmod	O
suggesting	VBG	acl	O
reduced	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
a	DT	det	O
GR-specific	JJ	amod	B-protein
HAT	NN	nmod	I-protein
.	.	punct	O

This	DT	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
pharmacological	JJ	amod	O
manipulation	NN	nsubj	O
of	IN	case	O
specific	JJ	amod	O
histone	NN	compound	O
acetylation	NN	compound	O
status	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
potentially	RB	advmod	O
useful	JJ	amod	O
approach	NN	ccomp	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
inflammatory	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

Identification	NN	nsubj	O
of	IN	case	O
the	DT	det	O
precise	JJ	amod	O
mechanism	NN	nmod	O
by	IN	case	O
which	WDT	nmod	O
activated	VBN	amod	B-protein
GR	NN	nsubj	I-protein
recruits	VBZ	acl:relcl	O
HDAC2	NN	dobj	B-protein
may	MD	aux	O
reveal	VB	ROOT	O
new	JJ	amod	O
targets	NNS	dobj	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
drugs	NNS	nmod	O
that	WDT	nsubj	O
may	MD	aux	O
dissociate	VB	acl:relcl	O
the	DT	det	O
antiinflammatory	JJ	amod	O
actions	NNS	dobj	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
from	IN	case	O
their	PRP$	nmod:poss	O
side	JJ	amod	O
effects	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
largely	RB	advmod	O
due	JJ	case	O
to	TO	mwe	O
gene	NN	compound	O
induction	NN	acl:relcl	O
.	.	punct	O

Copyright	NNP	compound	O
Academic	NNP	compound	O
Press	NNP	ROOT	O
.	.	punct	O

Differential	JJ	amod	O
ultraviolet-B-induced	JJ	amod	O
immunomodulation	NN	ROOT	O
in	IN	case	O
XPA	NN	nmod	O
,	,	punct	O
XPC	NN	conj	O
,	,	punct	O
and	CC	cc	O
CSB	NN	compound	O
DNA	NN	nmod:npmod	O
repair-deficient	JJ	amod	O
mice	NNS	conj	O
.	.	punct	O

Ultraviolet	NN	compound	O
B	NN	compound	O
irradiation	NN	nsubj	O
has	VBZ	ROOT	O
serious	JJ	amod	O
consequences	NNS	dobj	O
for	IN	case	O
cellular	JJ	amod	O
immunity	NN	nmod	O
and	CC	cc	O
can	MD	aux	O
suppress	VB	conj	O
the	DT	det	O
rejection	NN	dobj	O
of	IN	case	O
skin	NN	compound	O
tumors	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
resistance	NN	conj	O
to	TO	case	O
infectious	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

DNA	NN	compound	O
damage	NN	nsubj	O
plays	VBZ	ROOT	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
these	DT	det	O
immunomodulatory	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
ultraviolet	JJ	amod	O
B	NN	nmod	O
,	,	punct	O
as	IN	mark	O
impaired	JJ	amod	O
repair	NN	nsubjpass	O
of	IN	case	O
ultraviolet-B-induced	JJ	amod	O
DNA	NN	compound	O
damage	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	advcl	O
to	TO	mark	O
cause	VB	xcomp	O
suppression	NN	dobj	O
of	IN	case	O
cellular	JJ	amod	O
immunity	NN	nmod	O
.	.	punct	O

Ultraviolet-B-induced	JJ	amod	O
DNA	NN	compound	O
damage	NN	nsubjpass	O
is	VBZ	auxpass	O
repaired	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
nucleotide	NN	compound	O
excision	NN	compound	O
repair	NN	compound	O
mechanism	NN	nmod	O
very	RB	advmod	O
efficiently	RB	advmod	O
.	.	punct	O

Nucleotide	NN	compound	O
excision	NN	compound	O
repair	NN	nsubj	O
comprises	VBZ	ROOT	O
two	CD	nummod	O
subpathways	NNS	dobj	O
:	:	punct	O
transcription-coupled	JJ	amod	O
and	CC	cc	O
global	JJ	conj	O
genome	NN	compound	O
repair	NN	appos	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
the	DT	det	O
immunologic	JJ	amod	O
consequences	NNS	nsubjpass	O
of	IN	case	O
specific	JJ	amod	O
nucleotide	NN	compound	O
excision	NN	compound	O
repair	NN	compound	O
defects	NNS	nmod	O
in	IN	case	O
three	CD	nummod	O
mouse	NN	compound	O
models	NNS	nmod	O
,	,	punct	O
XPA	NN	appos	O
,	,	punct	O
XPC	NN	conj	O
,	,	punct	O
and	CC	cc	O
CSB	NN	compound	O
mutant	JJ	amod	O
mice	NNS	conj	O
,	,	punct	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

XPA	NN	compound	O
mice	NNS	nsubj	O
carry	VBP	ROOT	O
a	DT	det	O
total	JJ	amod	O
nucleotide	NN	compound	O
excision	NN	compound	O
repair	NN	compound	O
defect	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
XPC	NN	nsubj	O
and	CC	cc	O
CSB	NN	conj	O
mice	NNS	dep	O
only	RB	advmod	O
lack	VBP	parataxis	O
global	JJ	amod	O
genome	NN	dobj	O
and	CC	cc	O
transcription-coupled	JJ	amod	O
nucleotide	NN	compound	O
excision	NN	compound	O
repair	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
cellular	JJ	amod	O
immune	JJ	amod	O
parameters	NNS	nsubj	O
in	IN	case	O
XPA	NN	nmod	O
,	,	punct	O
XPC	NN	conj	O
,	,	punct	O
and	CC	cc	O
CSB	NN	compound	O
mice	NNS	conj	O
are	VBP	cop	O
normal	JJ	ccomp	O
compared	VBN	case	O
with	IN	case	O
their	PRP$	nmod:poss	O
wild-type	JJ	amod	O
(	-LRB-	punct	O
control	JJ	dep	O
)	-RRB-	punct	O
littermates	NNS	nmod	O
.	.	punct	O

This	DT	nsubj	O
may	MD	aux	O
indicate	VB	ROOT	O
that	IN	mark	O
the	DT	det	O
reported	VBN	amod	O
altered	JJ	amod	O
cellular	JJ	amod	O
responses	NNS	nsubj	O
in	IN	case	O
xeroderma	NN	compound	O
pigmentosum	NN	compound	O
patients	NNS	nmod	O
are	VBP	cop	O
not	RB	neg	O
constitutive	JJ	ccomp	O
but	CC	cc	O
could	MD	aux	O
be	VB	cop	O
due	JJ	case	O
to	TO	mwe	O
external	JJ	amod	O
factors	NNS	conj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
ultraviolet	JJ	nmod	O
B	NN	dobj	O
.	.	punct	O

Upon	IN	case	O
exposure	NN	nmod	O
to	TO	mark	O
ultraviolet	JJ	acl	O
B	NN	dobj	O
,	,	punct	O
only	RB	advmod	O
XPA	NN	compound	O
mice	NNS	nsubj	O
are	VBP	cop	O
very	RB	advmod	O
sensitive	JJ	ROOT	O
to	TO	case	O
ultraviolet-B-induced	JJ	amod	O
inhibition	NN	nmod	O
of	IN	case	O
Th1-mediated	JJ	amod	O
contact	NN	compound	O
hypersensitivity	NN	compound	O
responses	NNS	nmod	O
and	CC	cc	O
interferon-gamma	NN	compound	B-protein
production	NN	conj	O
in	IN	case	O
skin	NN	nmod	O
draining	NN	acl	O
lymph	NN	compound	O
nodes	NNS	dobj	O
.	.	punct	O

Lipopolysaccharide-stimulated	JJ	amod	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	nsubjpass	I-protein
and	CC	cc	O
interleukin-10	NN	conj	B-protein
production	NN	dep	O
are	VBP	auxpass	O
significantly	RB	advmod	O
augmented	JJ	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
XPA	NN	compound	O
and	CC	cc	O
CSB	NN	conj	O
mice	NNS	nmod	O
after	IN	mark	O
ultraviolet	JJ	advcl	O
B	NN	compound	O
exposure	NN	dobj	O
.	.	punct	O

Lymph	NN	compound	O
node	NN	compound	O
cell	NN	compound	O
numbers	NNS	nsubjpass	O
were	VBD	auxpass	O
increased	VBN	ROOT	O
very	RB	advmod	O
significantly	RB	advmod	O
in	IN	case	O
XPA	NN	nmod	O
,	,	punct	O
mildly	RB	advmod	O
increased	VBN	advcl	O
in	IN	case	O
CSB	NN	nmod	O
,	,	punct	O
and	CC	cc	O
not	RB	neg	O
in	IN	case	O
XPC	NN	compound	O
mice	NNS	conj	O
.	.	punct	O

In	IN	case	O
general	JJ	amod	O
XPC	NN	compound	O
mice	NNS	nsubj	O
do	VBP	aux	O
not	RB	neg	O
exhibit	VB	ROOT	O
any	DT	det	O
indication	NN	dobj	O
of	IN	case	O
enhanced	VBN	amod	O
ultraviolet	JJ	amod	O
B	NN	compound	O
susceptibility	NN	nmod	O
with	IN	case	O
regard	NN	nmod	O
to	TO	case	O
the	DT	det	O
immune	JJ	amod	O
parameters	NNS	nmod	O
analyzed	VBN	acl	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
global	JJ	amod	O
genome	NN	compound	O
repair	NN	nsubjpass	O
and	CC	cc	O
transcription-coupled	JJ	amod	O
repair	NN	conj	O
are	VBP	auxpass	O
needed	VBN	ccomp	O
to	TO	mark	O
prevent	VB	xcomp	O
immunomodulation	NN	dobj	O
by	IN	case	O
ultraviolet	JJ	amod	O
B	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
transcription-coupled	JJ	amod	O
repair	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
major	JJ	amod	O
DNA	NN	nsubj	O
repair	NN	advcl	O
subpathway	NN	dobj	O
of	IN	case	O
nucleotide	NN	compound	O
excision	NN	compound	O
repair	NN	dobj	O
that	WDT	nsubj	O
prevents	VBZ	acl:relcl	O
the	DT	det	O
acute	JJ	amod	O
ultraviolet-B-induced	JJ	amod	O
effects	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
erythema	NN	nmod	O
.	.	punct	O

Biomechanical	JJ	amod	O
strain	NN	nsubj	O
induces	VBZ	ROOT	O
class	NN	dative	O
a	DT	det	O
scavenger	NN	amod	B-protein
receptor	NN	compound	I-protein
expression	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocyte/macrophages	NNS	nmod	I-cell_type
and	CC	cc	O
THP-1	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
:	:	punct	O
a	DT	det	O
potential	JJ	amod	O
mechanism	NN	dep	O
of	IN	case	O
increased	VBN	amod	O
atherosclerosis	NN	nmod	O
in	IN	case	O
hypertension	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	nsubjpass	O
:	:	punct	O
Although	IN	mark	O
hypertension	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
risk	NN	compound	O
factor	NN	advcl	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
atherosclerosis	NN	nmod	O
,	,	punct	O
the	DT	det	O
mechanisms	NNS	nsubjpass	O
for	IN	case	O
this	DT	det	O
interaction	NN	nmod	O
are	VBP	auxpass	O
incompletely	RB	advmod	O
described	VBN	ROOT	O
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
suggested	VBN	ROOT	O
that	IN	mark	O
biomechanical	JJ	amod	O
strain	NN	nsubj	O
regulates	VBZ	ccomp	O
macrophage	NN	compound	O
phenotype	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
biomechanical	JJ	amod	O
strain	NN	nsubj	O
can	MD	aux	O
induce	VB	ccomp	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
class	NN	compound	B-protein
A	NN	compound	I-protein
scavenger	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
SRA	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
important	JJ	amod	O
lipoprotein	NN	compound	B-protein
receptor	NN	appos	I-protein
in	IN	case	O
atherogenesis	NN	nmod	O
.	.	punct	O

METHODS	NNS	nsubjpass	O
AND	CC	cc	O
RESULTS	NNS	conj	O
:	:	punct	O
Human	JJ	amod	B-cell_type
monocyte/macrophages	NNS	nsubjpass	I-cell_type
or	CC	cc	O
THP-1	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
were	VBD	auxpass	O
cultured	VBN	dep	O
in	IN	case	O
a	DT	det	O
device	NN	nmod	O
that	WDT	nsubj	O
imposes	VBZ	acl:relcl	O
uniform	VBP	amod	O
biaxial	JJ	amod	O
cyclic	JJ	amod	O
1-Hz	JJ	nummod	O
strains	NNS	dobj	O
of	IN	prep	O
0	CD	nummod	O
%	NN	pobj	O
,	,	punct	O
1	CD	nummod	O
%	NN	appos	O
,	,	punct	O
2	CD	nummod	O
%	NN	appos	O
,	,	punct	O
or	CC	cc	O
3	CD	nummod	O
%	NN	conj	O
,	,	punct	O
and	CC	cc	O
SRA	NN	compound	B-protein
expression	NN	nsubjpass	O
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
.	.	punct	O

Mechanical	JJ	amod	O
strains	NNS	nsubj	O
induced	VBD	ROOT	O
SRA	NN	compound	B-RNA
mRNA	NN	dobj	I-RNA
(	-LRB-	punct	O
3.5+/-0.6-fold	CD	dep	O
at	IN	case	O
3	CD	nummod	O
%	NN	compound	O
strain	NN	nmod	O
for	IN	case	O
48	CD	nummod	O
hours	NNS	nmod	O
,	,	punct	O
P	NN	compound	O
<	-LRB-	appos	O
0.01	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
SRA	NN	compound	B-protein
protein	NN	conj	I-protein
in	IN	case	O
THP-1	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
an	DT	det	O
amplitude-dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

This	DT	det	O
induction	NN	nsubjpass	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
augmented	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
class	NN	compound	B-protein
B	NN	compound	I-protein
scavenger	NN	compound	I-protein
receptor	NN	nmod	I-protein
CD36	NN	dep	I-protein
(	-LRB-	punct	O
2.8+/-0.3-fold	CD	dep	O
,	,	punct	O
P	NN	appos	O
<	-LRB-	compound	O
0.001	CD	dep	O
)	-RRB-	punct	O
but	CC	cc	O
not	RB	neg	O
by	IN	case	O
increased	VBN	amod	O
peroxisome	NN	nmod:npmod	B-protein
proliferator-activated	JJ	amod	I-protein
receptor-gamma	NN	compound	I-protein
expression	NN	conj	O
.	.	punct	O

To	TO	mark	O
evaluate	VB	advcl	O
this	DT	det	O
effect	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
apolipoprotein	NN	compound	O
E	NN	compound	O
(	-LRB-	punct	O
-/-	CD	appos	O
)	-RRB-	punct	O
mice	NNS	nsubjpass	O
were	VBD	auxpass	O
randomly	RB	advmod	O
assigned	VBN	ROOT	O
to	TO	aux	O
receive	VB	xcomp	O
standard	JJ	amod	O
chow	NN	dobj	O
,	,	punct	O
a	DT	det	O
high-cholesterol	JJ	amod	O
diet	NN	conj	O
,	,	punct	O
or	CC	cc	O
a	DT	det	O
high-cholesterol	JJ	amod	O
diet	NN	conj	O
with	IN	case	O
hypertension	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
angiotensin	NN	compound	O
II	CD	nummod	O
infusion	NN	nmod	O
for	IN	case	O
8	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

Immunohistochemistry	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
among	IN	case	O
macrophages	NNS	nmod	B-cell_type
in	IN	case	O
atherosclerotic	JJ	amod	O
lesions	NNS	nmod	O
of	IN	case	O
the	DT	det	O
aorta	NN	nmod	O
,	,	punct	O
the	DT	det	O
proportion	NN	nsubj	O
of	IN	case	O
macrophages	NNS	nmod	B-cell_type
with	IN	case	O
SRA	NN	compound	B-protein
expression	NN	nmod	O
was	VBD	cop	O
highest	JJS	ccomp	O
in	IN	case	O
hypertensive	JJ	amod	O
animals	NNS	nmod	O
on	IN	case	O
a	DT	det	O
high-cholesterol	JJ	amod	O
diet	NN	nmod	O
(	-LRB-	punct	O
43.9+/-0.7	CD	nummod	O
%	NN	dep	O
,	,	punct	O
versus	CC	cc	O
12.0+/-2.0	CD	nummod	O
%	NN	conj	O
for	IN	case	O
normotensive	JJ	amod	O
animals	NNS	nmod	O
on	IN	case	O
a	DT	det	O
high-cholesterol	JJ	amod	O
diet	NN	nmod	O
and	CC	cc	O
4.7+/-4.7	NN	nummod	O
%	NN	conj	O
for	IN	prep	O
animals	NNS	pobj	O
on	IN	prep	O
standard	JJ	amod	O
chow	NN	pobj	O
;	:	punct	O
P	NN	compound	O
<	-LRB-	compound	O
0.001	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Biomechanical	JJ	amod	O
strain	NN	nsubj	O
induces	VBZ	dep	O
SRA	RB	compound	B-protein
expression	NN	dobj	O
by	IN	case	O
monocyte/macrophages	NNS	nmod	B-cell_type
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
novel	JJ	amod	O
mechanism	NN	dobj	O
for	IN	case	O
promotion	NN	nmod	O
of	IN	case	O
atherosclerosis	NN	nmod	O
in	IN	case	O
hypertensive	JJ	amod	O
patients	NNS	nmod	O
.	.	punct	O

High	JJ	amod	O
glucose	NN	nsubj	O
induces	VBZ	ROOT	O
MCP-1	NN	compound	O
expression	NN	dobj	O
partly	RB	advmod	O
via	IN	case	O
tyrosine	NN	compound	O
kinase-AP-1	NN	compound	O
pathway	NN	nmod	O
in	IN	case	O
peritoneal	JJ	amod	B-cell_type
mesothelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
High	JJ	amod	O
glucose	NN	nsubjpass	O
in	IN	case	O
peritoneal	JJ	amod	O
dialysis	NN	compound	O
solutions	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	dep	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
peritoneal	JJ	amod	O
fibrosis	NN	nmod	O
in	IN	case	O
chronic	JJ	amod	O
ambulatory	JJ	amod	O
peritoneal	JJ	amod	O
dialysis	NN	compound	O
(	-LRB-	punct	O
CAPD	NN	appos	O
)	-RRB-	punct	O
patients	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
mechanisms	NNS	nsubj	O
are	VBP	cop	O
not	RB	neg	O
very	RB	advmod	O
clear	JJ	ROOT	O
.	.	punct	O

Peritoneal	JJ	amod	B-cell_type
macrophages	NNS	nsubj	I-cell_type
seem	VBP	ROOT	O
to	TO	mark	O
participate	VB	xcomp	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
peritoneal	JJ	amod	O
fibrosis	NN	nmod	O
and	CC	cc	O
monocyte	NN	compound	B-protein
chemoattractant	NN	compound	I-protein
protein-1	NN	conj	I-protein
(	-LRB-	punct	O
MCP-1	NN	appos	B-protein
)	-RRB-	punct	O
plays	VBZ	conj	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
recruitment	NN	nmod	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
toward	IN	case	O
the	DT	det	O
peritoneal	JJ	amod	O
cavity	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
effect	NN	nmod	O
of	IN	case	O
high	JJ	amod	O
glucose	NN	nmod	O
on	IN	case	O
MCP-1	NN	compound	B-protein
expression	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	conj	O
in	IN	case	O
human	JJ	amod	B-cell_type
peritoneal	JJ	amod	I-cell_type
mesothelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Mesothelial	JJ	amod	B-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
cultured	VBN	ROOT	O
with	IN	case	O
glucose	NN	nmod	O
(	-LRB-	punct	O
5	CD	compound	O
to	TO	dep	O
100	CD	nummod	O
mmol/L	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
mannitol	NN	conj	O
chronically	RB	advmod	O
for	IN	case	O
up	RB	advmod	O
to	TO	quantmod	O
seven	CD	nummod	O
days	NNS	nmod	O
.	.	punct	O

MCP-1	NN	compound	B-protein
expression	NN	nsubjpass	O
of	IN	case	O
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
and	CC	cc	O
enzyme-linked	JJ	amod	O
immunosorbent	JJ	amod	O
assay	NN	conj	O
(	-LRB-	punct	O
ELISA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Chemotactic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
high-glucose-conditioned	JJ	amod	O
culture	NN	compound	O
supernatant	NN	nmod	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
chemotactic	JJ	amod	O
assay	NN	nmod	O
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
roles	NNS	dobj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	compound	I-protein
activator	NN	compound	B-protein
protein-1	NN	nmod	I-protein
(	-LRB-	punct	O
AP-1	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	conj	I-protein
(	-LRB-	punct	O
NF-kappaB	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	conj	O
(	-LRB-	punct	O
EMSA	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Glucose	NN	nsubj	O
induced	VBD	dep	O
MCP-1	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	dobj	O
in	IN	case	O
a	DT	det	O
time-	NN	amod	O
and	CC	cc	O
dose-dependent	JJ	conj	O
manner	NN	nmod	O
.	.	punct	O

MCP-1	NN	compound	B-protein
protein	NN	nsubjpass	I-protein
in	IN	case	O
cell	NN	compound	O
culture	NN	nmod	O
supernant	NN	dep	O
was	VBD	auxpass	O
also	RB	advmod	O
increased	VBN	ROOT	O
.	.	punct	O

Equivalent	JJ	amod	O
concentrations	NNS	nsubj	O
of	IN	case	O
mannitol	NN	nmod	O
had	VBD	ROOT	O
no	DT	neg	O
significant	JJ	amod	O
effect	NN	dobj	O
.	.	punct	O

High-glucose-conditioned	JJ	amod	O
supernatant	NN	nsubj	O
possessed	VBD	ROOT	O
an	DT	det	O
increased	VBN	amod	O
chemotactic	JJ	amod	O
activity	NN	dobj	O
for	IN	case	O
monocytes	NNS	nmod	B-cell_type
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
neutralized	VBN	acl:relcl	O
by	IN	case	O
anti-MCP-1	JJ	amod	B-protein
antibody	NN	nmod	I-protein
.	.	punct	O

EMSA	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
glucose	NN	nsubj	O
increased	VBD	ccomp	O
the	DT	det	O
AP-1	NN	compound	B-protein
binding	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
a	DT	det	O
time-	NN	amod	O
and	CC	cc	O
dose-dependent	JJ	conj	O
manner	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
NF-kappaB	NN	conj	B-protein
.	.	punct	O

Curcumin	NN	nsubj	O
,	,	punct	O
an	DT	det	O
inhibitor	NN	appos	O
of	IN	case	O
AP-1	NN	nmod	B-protein
,	,	punct	O
dose-dependently	RB	advmod	O
suppressed	VBD	ROOT	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
MCP-1	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
by	IN	case	O
high	JJ	amod	O
glucose	NN	nmod	O
.	.	punct	O

Tyrosine	NN	compound	O
kinase	NN	compound	O
inhibitors	NNS	nsubj	O
such	JJ	case	O
as	IN	mwe	O
genistein	NN	nmod	O
(	-LRB-	punct	O
12.5	CD	compound	O
to	TO	dep	O
50	CD	nummod	O
micromol/L	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
herbimycin	NN	compound	O
A	NN	conj	O
(	-LRB-	punct	O
0.1	CD	compound	O
to	TO	dep	O
1	CD	nummod	O
micromol/L	NN	appos	O
)	-RRB-	punct	O
inhibited	VBD	ROOT	O
the	DT	det	O
high-glucose-induced	JJ	amod	O
MCP-1	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	dobj	O
in	IN	case	O
a	DT	det	O
dose-dependent	JJ	amod	O
manner	NN	nmod	O
,	,	punct	O
and	CC	cc	O
also	RB	advmod	O
suppressed	VBD	conj	O
the	DT	det	O
high-glucose-induced	JJ	amod	O
AP-1	NN	compound	B-protein
binding	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
:	:	punct	O
High	JJ	amod	O
glucose	NN	nsubj	O
induced	VBD	dep	O
mesothelial	JJ	amod	O
MCP-1	NN	compound	B-protein
expression	NN	dobj	O
partly	RB	advmod	O
via	IN	case	O
the	DT	det	O
tyrosine	NN	compound	O
kinase-	NN	compound	O
AP-1	NN	compound	B-protein
pathway	NN	nmod	O
.	.	punct	O

Signal	NN	compound	O
thresholds	NNS	ROOT	O
and	CC	cc	O
modular	JJ	amod	O
synergy	NN	conj	O
during	IN	case	O
expression	NN	nmod	O
of	IN	case	O
costimulatory	JJ	amod	O
molecules	NNS	nmod	O
in	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
analyzed	VBD	ROOT	O
intracellular	JJ	amod	O
pathways	NNS	dobj	O
modulating	VBG	acl	O
surface	NN	compound	O
densities	NNS	dobj	O
of	IN	case	O
CD80	NN	nmod	B-protein
and	CC	cc	O
CD86	NN	conj	B-protein
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
activated	VBN	acl	O
through	IN	case	O
ligation	NN	nmod	O
of	IN	case	O
the	DT	det	O
Ag	NN	compound	B-protein
receptor	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
the	DT	det	O
adhesion	NN	compound	B-protein
molecule	NN	conj	I-protein
CD54	NN	dep	B-protein
.	.	punct	O

Whereas	IN	mark	O
B	NN	compound	B-protein
cell	NN	compound	I-protein
Ag	NN	compound	I-protein
receptor	NN	dep	I-protein
(	-LRB-	punct	O
BCR	NN	appos	B-protein
)	-RRB-	punct	O
cross-linking	NN	nsubj	O
alone	RB	advmod	O
stimulated	VBD	advcl	O
increased	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
CD86	NN	nmod	B-protein
,	,	punct	O
up-regulation	NN	nsubj	O
of	IN	case	O
CD80	NN	nmod	B-protein
required	VBD	ROOT	O
dual	JJ	amod	O
stimulation	NN	dobj	O
with	IN	case	O
anti-IgM	JJ	nmod	B-protein
and	CC	cc	O
anti-CD54	JJ	conj	B-protein
.	.	punct	O

The	DT	det	O
principal	JJ	amod	O
downstream	JJ	amod	O
component	NN	nsubj	O
contributed	VBN	acl	O
by	IN	case	O
BCR	NN	compound	B-protein
signaling	NN	nmod	O
,	,	punct	O
toward	IN	case	O
both	CC	cc:preconj	O
CD80	NN	compound	B-protein
and	CC	cc	O
CD86	NN	conj	B-protein
induction	NN	nmod	O
,	,	punct	O
was	VBD	cop	O
the	DT	det	O
elevated	JJ	amod	O
concentration	NN	ROOT	O
of	IN	case	O
free	JJ	amod	O
cytoplasmic	JJ	amod	O
Ca	NN	nmod	O
(	-LRB-	punct	O
2+	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
recruited	VBN	acl	O
by	IN	case	O
way	NN	nmod	O
of	IN	prep	O
capacitative	JJ	amod	O
influx	NN	pobj	O
.	.	punct	O

This	DT	det	O
alone	RB	nsubj	O
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
generate	VB	xcomp	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
CD86	NN	compound	B-protein
levels	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
CD80	NN	compound	B-protein
enhancement	NN	nsubj	O
required	VBD	ROOT	O
the	DT	det	O
concerted	JJ	amod	O
action	NN	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
intracellular	JJ	amod	O
Ca	NN	compound	O
(	-LRB-	punct	O
2+	NN	appos	O
)	-RRB-	punct	O
concentration	NN	nmod	O
and	CC	cc	O
CD54-initiated	JJ	amod	O
pathways	NNS	conj	O
.	.	punct	O

The	DT	det	O
nexus	NN	nsubjpass	O
between	IN	case	O
anti-IgM	JJ	amod	O
and	CC	cc	O
anti-CD54	JJ	conj	O
stimulation	NN	nmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
context	NN	dep	O
of	IN	case	O
CD80	NN	compound	B-protein
regulation	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
to	TO	mark	O
involve	VB	xcomp	O
a	DT	det	O
self-propagating	JJ	amod	O
process	NN	dobj	O
of	IN	case	O
sequential	JJ	amod	O
synergy	NN	nmod	O
.	.	punct	O

The	DT	det	O
first	JJ	amod	O
step	NN	nsubj	O
involved	VBN	ROOT	O
amplified	VBN	amod	O
accumulation	NN	dobj	O
of	IN	case	O
intracellular	JJ	amod	O
cAMP	NN	nmod	O
,	,	punct	O
as	IN	case	O
a	DT	det	O
result	NN	nmod	O
of	IN	case	O
cross-talk	NN	nmod	O
between	IN	case	O
BCR	NN	compound	B-protein
-mobilized	JJ	amod	O
Ca	NN	nmod	O
(	-LRB-	punct	O
2+	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
CD54-derived	JJ	amod	O
signals	NNS	conj	O
.	.	punct	O

This	DT	nsubj	O
then	RB	advmod	O
facilitated	VBD	ROOT	O
a	DT	det	O
second	JJ	amod	O
synergistic	JJ	amod	O
interaction	NN	dobj	O
between	IN	case	O
Ca	NN	nmod	O
(	-LRB-	punct	O
2+	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
cAMP	NN	conj	O
,	,	punct	O
culminating	VBG	advcl	O
in	IN	case	O
CD80	NN	compound	B-protein
expression	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
of	IN	case	O
distinct	JJ	amod	O
signal	NN	compound	O
transducer	NN	compound	O
requirements	NNS	nmod	O
,	,	punct	O
with	IN	case	O
the	DT	det	O
added	VBN	amod	O
consequences	NNS	nmod	O
of	IN	case	O
cross-talk	NN	nmod	O
,	,	punct	O
offers	VBZ	ROOT	O
an	DT	det	O
explanation	NN	dobj	O
for	IN	case	O
variable	JJ	amod	O
modulation	NN	nmod	O
of	IN	case	O
costimulatory	JJ	amod	O
molecule	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
diverse	JJ	amod	O
physiological	JJ	amod	O
stimuli	NNS	nmod	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
also	RB	advmod	O
reveal	VBP	ROOT	O
how	WRB	advmod	O
concentration	NN	compound	O
threshold	NN	compound	O
barriers	NNS	dobj	O
for	IN	prep	O
recruitment	NN	pobj	O
of	IN	prep	O
individual	JJ	amod	O
second	JJ	amod	O
messengers	NNS	pobj	O
can	MD	aux	O
be	VB	auxpass	O
overcome	VBN	ccomp	O
by	IN	case	O
constructive	JJ	amod	O
convergence	NN	nmod	O
of	IN	case	O
signaling	VBG	compound	O
modules	NNS	nmod	O
.	.	punct	O

The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	nmod	O
in	IN	case	O
neoplastic	JJ	amod	O
transformation	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
review	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
focus	VBP	ROOT	O
on	IN	case	O
new	JJ	amod	O
data	NNS	nmod	O
from	IN	case	O
basic	JJ	amod	O
,	,	punct	O
translational	JJ	conj	O
and	CC	cc	O
clinical	JJ	conj	O
research	NN	nmod	O
relating	VBG	acl	O
to	TO	case	O
the	DT	det	O
Epstein-Barr	JJ	amod	O
virus	NN	nmod	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Beside	IN	case	O
its	PRP$	nmod:poss	O
well-known	JJ	amod	O
tropism	NN	nmod	O
for	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
epithelial	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
EBV	NN	nsubj	O
also	RB	advmod	O
infects	VBZ	ROOT	O
T	NN	compound	B-cell_type
lymphocytes	NNS	dobj	I-cell_type
,	,	punct	O
monocytes	NNS	conj	B-cell_type
and	CC	cc	O
granulocytes	NNS	conj	B-cell_type
.	.	punct	O

After	IN	case	O
primary	JJ	amod	O
infection	NN	nmod	O
,	,	punct	O
EBV	NN	nsubj	O
persists	VBZ	ROOT	O
throughout	IN	case	O
the	DT	det	O
life	NN	compound	O
span	NN	nmod	O
in	IN	case	O
resting	VBG	amod	B-cell_type
memory	NN	compound	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
from	IN	mark	O
where	WRB	advmod	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
reactivated	VBN	advcl	O
upon	IN	case	O
breakdown	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	O
immunity	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
neoplastic	JJ	amod	O
transformation	NN	nmod	O
,	,	punct	O
the	DT	det	O
EBV-encoded	JJ	amod	B-DNA
latent	JJ	amod	I-DNA
membrane	NN	compound	I-DNA
protein	NN	compound	I-DNA
1	CD	nummod	I-DNA
(	-LRB-	punct	I-DNA
LMP1	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
oncogene	NN	nsubj	I-DNA
represents	VBZ	ROOT	O
the	DT	det	O
major	JJ	amod	O
driving	NN	compound	O
force	NN	dobj	O
.	.	punct	O

LMP1	NN	nsubj	B-protein
acts	VBZ	ROOT	O
like	IN	case	O
a	DT	det	O
constitutively	RB	advmod	B-protein
activated	VBN	amod	I-protein
receptor	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
receptor	NN	compound	I-protein
family	NN	nmod	I-protein
and	CC	cc	O
allows	VBZ	conj	O
the	DT	det	O
amplification	NN	dobj	O
or	CC	cc	O
bypassing	NN	conj	O
of	IN	case	O
physiological	JJ	amod	O
regulatory	JJ	amod	O
signals	NNS	nmod	O
through	IN	case	O
direct	JJ	amod	O
and	CC	cc	O
indirect	JJ	conj	O
interactions	NNS	nmod	O
with	IN	case	O
proteins	NNS	nmod	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
receptor-associated	JJ	amod	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
TRAF	NN	compound	I-protein
)	-RRB-	punct	I-protein
family	NN	nmod	I-protein
.	.	punct	O

TRAF2	NN	compound	B-protein
-mediated	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activation	NN	nsubj	O
,	,	punct	O
AP-1	NN	compound	B-protein
induction	NN	nsubj	O
and	CC	cc	O
JAK3	NN	compound	B-protein
/	:	punct	O
STAT	NN	compound	B-protein
activation	NN	conj	O
may	MD	aux	O
result	VB	ROOT	O
in	IN	case	O
sustained	JJ	amod	O
proliferation	NN	nmod	O
leading	VBG	acl	O
to	TO	case	O
lymphoma	NN	nmod	B-cell_line
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
LMP1	NN	nmod	B-protein
to	TO	mark	O
suppress	VB	acl	O
germinal	JJ	amod	O
center	NN	compound	O
formation	NN	dobj	O
and	CC	cc	O
its	PRP$	nmod:poss	O
capacity	NN	conj	O
to	TO	mark	O
mediate	VB	acl	O
its	PRP$	nmod:poss	O
own	JJ	amod	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
shed	VBD	ROOT	O
new	JJ	amod	O
light	NN	dobj	O
on	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
EBV-associated	JJ	amod	O
latency	NN	compound	O
type	NN	compound	O
II	CD	nummod	O
lymphoproliferations	NNS	nmod	O
like	IN	case	O
Hodgkin	NN	nmod:poss	O
's	POS	case	O
disease	NN	nmod	O
and	CC	cc	O
angioimmunoblastic	JJ	amod	O
lymphadenopathy	NN	conj	O
.	.	punct	O

The	DT	det	O
carboxy	NN	compound	B-protein
terminus	NN	nsubj	I-protein
of	IN	case	O
LMP1	NN	nmod	B-protein
is	VBZ	cop	O
also	RB	advmod	O
a	DT	det	O
reliable	JJ	amod	O
marker	NN	ROOT	O
for	IN	case	O
individual	JJ	amod	O
EBV	NN	compound	O
strain	NN	compound	O
identification	NN	nmod	O
and	CC	cc	O
thus	RB	advmod	O
offers	VBZ	conj	O
new	JJ	amod	O
possibilities	NNS	dobj	O
in	IN	mark	O
tracing	VBG	acl	O
the	DT	det	O
molecular	JJ	amod	O
events	NNS	dobj	O
leading	VBG	acl	O
to	TO	case	O
posttransplant	JJ	amod	O
lymphoproliferative	JJ	amod	O
disorders	NNS	nmod	O
(	-LRB-	punct	O
PTLDs	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

Cytotoxic	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nsubj	I-cell_type
directed	VBN	acl	O
against	IN	case	O
well-characterized	JJ	amod	O
epitopes	NNS	nmod	O
of	IN	case	O
EBV	NN	compound	B-DNA
latency	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
represent	VBP	ROOT	O
an	DT	det	O
already	RB	advmod	O
successful	JJ	amod	O
and	CC	cc	O
promising	JJ	conj	O
therapeutic	JJ	amod	O
approach	NN	dobj	O
to	TO	case	O
EBV-associated	JJ	amod	B-cell_line
lymphomas	NNS	nmod	I-cell_line
,	,	punct	O
in	IN	case	O
particular	JJ	amod	O
PTLDs	NNS	nmod	O

Interferon-alpha	NN	nsubj	B-protein
drives	VBZ	ROOT	O
T	NN	nmod:npmod	O
cell-mediated	JJ	amod	O
immunopathology	NN	dobj	O
in	IN	case	O
the	DT	det	O
intestine	NN	nmod	O
.	.	punct	O

The	DT	det	O
ability	NN	nsubjpass	O
of	IN	case	O
interferon	NN	compound	B-protein
(	-LRB-	punct	I-protein
IFN	NN	compound	I-protein
)	-RRB-	punct	I-protein
-alpha	NN	nmod	I-protein
to	TO	mark	O
induce	VB	acl	O
autoimmunity	NN	dobj	O
and	CC	cc	O
exacerbate	VB	conj	O
Th1	NN	compound	O
diseases	NNS	nsubjpass	O
is	VBZ	auxpass	O
well	RB	advmod	O
known	VBN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
recently	RB	advmod	O
described	VBN	ROOT	O
enhanced	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
IFN-alpha	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
mucosa	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
celiac	JJ	amod	O
disease	NN	nmod	O
(	-LRB-	punct	O
CD	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
gluten-sensitive	JJ	amod	O
Th1-mediated	JJ	amod	O
enteropathy	NN	appos	O
,	,	punct	O
characterized	VBN	acl	O
by	IN	case	O
villous	JJ	amod	O
atrophy	NN	nmod	O
and	CC	cc	O
crypt	NN	amod	O
cell	NN	compound	O
hyperplasia	NN	conj	O
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
from	IN	case	O
this	DT	det	O
laboratory	NN	nmod	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	nsubj	O
in	IN	case	O
explant	JJ	amod	O
cultures	NNS	nmod	O
of	IN	case	O
human	JJ	amod	O
fetal	JJ	amod	O
gut	NN	nmod	O
can	MD	aux	O
also	RB	advmod	O
result	VB	ccomp	O
in	IN	case	O
villous	JJ	amod	O
atrophy	NN	nmod	O
and	CC	cc	O
crypt	NN	amod	O
cell	NN	compound	O
hyperplasia	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	ROOT	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
examined	VBD	parataxis	O
changes	NNS	dobj	O
that	WDT	nsubj	O
take	VBP	acl:relcl	O
place	NN	dobj	O
in	IN	case	O
explant	JJ	amod	O
cultures	NNS	nmod	O
of	IN	case	O
human	JJ	amod	O
fetal	JJ	amod	O
gut	NN	nmod	O
after	IN	case	O
activation	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
anti-CD3	NN	nmod	B-protein
and/or	CC	cc	O
IFN-alpha	NN	conj	B-protein
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
activation	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
anti-CD3	NN	nmod	B-protein
alone	RB	advmod	O
elicits	VBZ	ccomp	O
a	DT	det	O
small	JJ	amod	O
IFN-gamma	NN	compound	B-protein
and	CC	cc	O
TNF-alpha	NN	conj	B-protein
response	NN	dobj	O
with	IN	case	O
no	DT	neg	O
tissue	NN	compound	O
injury	NN	nmod	O
.	.	punct	O

Similarly	RB	advmod	O
,	,	punct	O
no	DT	neg	O
changes	NNS	nsubjpass	O
are	VBP	auxpass	O
seen	VBN	ROOT	O
in	IN	case	O
explants	NNS	nmod	O
cultured	VBN	acl	O
with	IN	case	O
IFN-alpha	NN	nmod	B-protein
alone	RB	advmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
addition	NN	nsubj	O
of	IN	case	O
IFN-alpha	NN	nmod	B-protein
with	IN	case	O
anti-CD3	JJ	amod	B-protein
results	VBZ	ROOT	O
in	IN	case	O
enhanced	VBN	amod	O
Th1	NN	compound	O
response	NN	nmod	O
and	CC	cc	O
crypt	NN	amod	O
cell	NN	compound	O
hyperplasia	NN	conj	O
.	.	punct	O

This	DT	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
enhanced	VBN	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
STAT1	NN	nmod	B-protein
,	,	punct	O
STAT3	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
Fyn	NN	conj	B-protein
,	,	punct	I-protein
a	DT	det	I-protein
Src	NN	compound	I-protein
homology	NN	compound	I-protein
tyrosine	NN	compound	I-protein
kinase	NN	appos	I-protein
,	,	punct	O
which	WDT	nsubj	O
interacts	VBZ	acl:relcl	O
with	IN	case	O
both	CC	cc:preconj	O
TCR	NN	nmod	O
and	CC	cc	O
IFN-alpha	NN	conj	O
signal	NN	compound	O
components	NNS	dep	O
.	.	punct	O

Together	RB	advmod	O
these	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
IFN-alpha	NN	nsubj	B-protein
can	MD	aux	O
facilitate	VB	ccomp	O
activation	NN	dobj	O
of	IN	case	O
Th1-reactive	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
the	DT	det	O
gut	NN	preconj	O
and	CC	cc	O
drive	VB	conj	O
immunopathology	NN	nmod	O
.	.	punct	O

Suppression	NN	ROOT	O
of	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	compound	I-protein
production	NN	nmod	O
by	IN	case	O
cAMP	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
:	:	punct	O
dissociation	NN	dep	O
with	IN	case	O
mRNA	NN	compound	O
level	NN	nmod	O
and	CC	cc	O
independent	JJ	conj	O
of	IN	case	O
interleukin-10	NN	nmod	B-protein
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Elevation	NN	nsubj	O
of	IN	case	O
cellular	JJ	amod	O
cAMP	NN	nmod	O
inhibits	VBZ	dep	O
lipopolysaccharide	NN	compound	O
(	-LRB-	punct	O
LPS	NN	nmod:npmod	O
)	-RRB-	punct	O
-stimulated	JJ	amod	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	compound	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
production	NN	dobj	O
and	CC	cc	O
increases	VBZ	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	nmod	I-protein
)	-RRB-	punct	I-protein
-10	CD	nummod	I-protein
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

TNF-alpha	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nsubj	O
obligates	VBZ	ROOT	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappaB	NN	nmod	I-protein
(	-LRB-	punct	O
NF-kappaB	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Exogenous	JJ	amod	O
IL-10	NN	nsubj	B-protein
inhibits	VBZ	ROOT	O
NF-kappaB	NN	dobj	B-protein
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
and	CC	cc	O
thus	RB	advmod	O
attenuates	VBZ	conj	O
TNF-alpha	NN	compound	B-protein
production	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
endogenous	JJ	amod	O
IL-10	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
activation	NN	nmod	O
and	CC	cc	O
TNF-alpha	NN	compound	B-protein
production	NN	conj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
by	IN	case	O
cAMP	NN	nmod	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Human	JJ	amod	B-cell_type
monocytes	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
stimulated	VBN	ROOT	O
with	IN	case	O
Escherichia	FW	compound	O
coli	FW	compound	O
LPS	NN	nmod	O
(	-LRB-	punct	O
100	CD	nummod	O
ng/ml	NN	appos	O
)	-RRB-	punct	O
with	IN	nmod	O
and	CC	cc	O
without	IN	conj	O
forskolin	NN	nmod	O
(	-LRB-	punct	O
FSK	NN	dep	O
,	,	punct	O
50	CD	nummod	O
microM	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
dibutyryl	NN	compound	O
cyclic	JJ	amod	O
AMP	NN	conj	O
(	-LRB-	punct	O
dbcAMP	NN	dep	O
,	,	punct	O
100	CD	nummod	O
microM	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Cytokine	NN	compound	B-protein
(	-LRB-	punct	O
TNF-alpha	NN	dep	B-protein
and	CC	cc	O
IL-10	NN	conj	B-protein
)	-RRB-	punct	O
release	NN	nsubjpass	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
immunoassay	NN	nmod	O
.	.	punct	O

TNF-alpha	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
was	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
reverse	JJ	amod	O
transcription	NN	compound	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
,	,	punct	O
and	CC	cc	O
NF-kappaB	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
assessed	VBN	conj	O
by	IN	case	O
gel	NN	compound	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
cAMP-elevating	JJ	amod	O
agents	NNS	nsubj	O
inhibited	VBD	dep	O
LPS-stimulated	JJ	amod	O
TNF-alpha	NN	compound	B-protein
release	NN	dobj	O
(	-LRB-	punct	O
0.77	CD	nummod	O
+/-	CC	cc	O
0.13	CD	conj	O
ng/10	RB	compound	O
(	-LRB-	punct	O
6	CD	nummod	O
)	-RRB-	punct	O
cells	NNS	nmod	O
in	IN	case	O
LPS	NN	nmod	O
+	CC	cc	O
dbcAMP	NN	conj	O
and	CC	cc	O
0.68	CD	nummod	O
+/-	CC	cc	O
0.19	CD	conj	O
ng/10	JJ	compound	O
(	-LRB-	punct	O
6	CD	dep	O
)	-RRB-	punct	O
cells	NNS	conj	O
in	IN	case	O
LPS	NN	nmod	O
+	CC	cc	O
FSK	NN	conj	O
,	,	punct	O
both	DT	cc:preconj	O
P	NN	compound	O
<	:	dep	O
0.05	CD	dep	O
vs	CC	cc	O
1.61	CD	nummod	O
+/-	CC	cc	O
0.34	CD	conj	O
ng/10	RB	dep	O
(	-LRB-	punct	O
6	CD	dep	O
)	-RRB-	punct	O
cells	NNS	nmod	O
in	IN	case	O
LPS	NN	nmod	O
alone	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
cAMP	NN	nsubj	O
enhanced	VBD	ROOT	O
LPS-stimulated	JJ	amod	O
IL-10	NN	compound	B-protein
release	NN	dobj	O
(	-LRB-	punct	O
100	CD	nummod	O
+/-	CC	cc	O
21.5	CD	conj	O
pg/10	NN	compound	O
(	-LRB-	punct	O
6	CD	dep	O
)	-RRB-	punct	O
cells	NNS	nmod	O
in	IN	case	O
LPS	NN	nmod	O
+	CC	cc	O
dbcAMP	NN	conj	O
and	CC	cc	O
110	CD	nummod	O
+/-	CC	cc	O
25.2	CD	conj	O
pg/10	NN	compound	O
(	-LRB-	punct	O
6	CD	dep	O
)	-RRB-	punct	O
cells	NNS	conj	O
in	IN	case	O
LPS	NN	nmod	O
+	CC	cc	O
FSK	NN	conj	O
,	,	punct	O
both	DT	cc:preconj	O
P	NN	nsubj	O
<	:	advcl	O
0.05	CD	dep	O
vs	CC	cc	O
53.3	CD	nummod	O
+/-	CC	cc	O
12.8	CD	conj	O
pg/10	NN	conj	O
(	-LRB-	punct	O
6	CD	dep	O
)	-RRB-	punct	O
cells	NNS	dep	O
in	IN	case	O
LPS	NN	nmod	O
alone	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

Neither	CC	cc:preconj	O
TNF-alpha	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nsubjpass	O
nor	CC	cc	O
NF-kappaB	NN	compound	B-protein
activation	NN	conj	O
stimulated	VBN	acl	O
by	IN	case	O
LPS	NN	nmod	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
cAMP-elevating	JJ	amod	O
agents	NNS	nmod	O
.	.	punct	O

Neutralization	NN	nsubj	O
of	IN	case	O
IL-10	NN	nmod	B-protein
with	IN	case	O
a	DT	det	O
specific	JJ	amod	O
antibody	NN	nmod	B-protein
did	VBD	aux	O
not	RB	neg	O
attenuate	VB	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
cAMP-elevating	JJ	amod	O
agents	NNS	nmod	O
on	IN	case	O
TNF-alpha	NN	compound	B-protein
production	NN	nmod	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
The	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
cAMP	NN	nsubj	O
inhibits	VBZ	ccomp	O
LPS-stimulated	JJ	amod	O
TNF-alpha	NN	compound	B-protein
production	NN	dobj	O
through	IN	case	O
a	DT	det	O
posttranscriptional	JJ	amod	O
mechanism	NN	nmod	O
that	WDT	nsubj	O
is	VBZ	cop	O
independent	JJ	acl:relcl	O
of	IN	case	O
endogenous	JJ	amod	O
IL-10	NN	nmod	B-protein
.	.	punct	O

Copyright	NN	dep	O
2001	CD	nummod	O
Academic	NNP	compound	O
Press	NNP	ROOT	O
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
p21	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
CIP1/WAF1	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
promoter	NN	nmod	I-DNA
by	IN	case	O
bone	NN	compound	B-protein
morphogenetic	JJ	amod	I-protein
protein-2	NN	nmod	I-protein
in	IN	case	O
mouse	NN	compound	O
B	NN	compound	B-cell_line
lineage	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

BMPs	NNS	nsubj	B-protein
exert	VBP	ROOT	O
a	DT	det	O
negative	JJ	amod	O
growth	NN	compound	O
effect	NN	dobj	O
on	IN	case	O
various	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cells	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
reported	VBN	ROOT	O
that	IN	mark	O
BMP-2	NN	nsubj	B-protein
inhibited	VBD	ccomp	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
HS-72	NN	compound	B-cell_line
mouse	NN	compound	I-cell_line
hybridoma	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
by	IN	mark	O
inducing	VBG	advcl	O
p21	NN	compound	O
(	-LRB-	punct	O
CIP1/WAF1	NN	appos	O
)	-RRB-	punct	O
expression	NN	dobj	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
BMP-2	NN	nsubj	B-protein
activated	VBD	ccomp	O
the	DT	det	O
mouse	NN	compound	O
p21	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
CIP1/WAF1	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
promoter	NN	dobj	I-DNA
in	IN	case	O
HS-72	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
a	DT	det	O
29-base	NN	compound	B-DNA
pair	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
b	LS	appos	I-DNA
)	-RRB-	punct	I-DNA
region	NN	nsubj	I-DNA
of	IN	case	O
the	DT	det	O
promoter	NN	nmod	O
(	-LRB-	punct	O
-1928/-1900	NN	dep	O
relative	JJ	amod	O
to	TO	case	O
the	DT	det	O
TATA	NN	compound	B-DNA
box	NN	nmod	I-DNA
)	-RRB-	punct	O
,	,	punct	O
conserved	VBN	acl	O
between	IN	case	O
mice	NNS	nmod	O
and	CC	cc	O
humans	NNS	conj	O
,	,	punct	O
was	VBD	cop	O
responsive	JJ	conj	O
to	TO	case	O
BMP-2	NN	nmod	B-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
expression	NN	conj	O
of	IN	case	O
Smad1	NN	nmod	B-protein
,	,	punct	O
Smad4	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
constitutively	RB	advmod	O
active	JJ	amod	O
mutants	NNS	conj	O
of	IN	case	O
BMP	NN	compound	B-protein
type	NN	compound	I-protein
I	CD	nummod	I-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
an	DT	det	O
oligonucleotide	NN	nsubjpass	O
containing	VBG	acl	O
the	DT	det	O
29-b	JJ	amod	B-DNA
region	NN	dobj	I-DNA
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
associated	VBN	xcomp	O
with	IN	case	O
Smad4	NN	nmod	B-protein
and	CC	cc	O
phosphorylated	VBN	amod	B-protein
Smad1	NN	conj	I-protein
in	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
extract	NN	nmod	O
of	IN	case	O
BMP-2	NN	compound	B-protein
-stimulated	JJ	amod	O
HS-72	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggested	VBD	ROOT	O
that	IN	mark	O
BMP-2	NN	nsubj	B-protein
might	MD	aux	O
activate	VB	ccomp	O
p21	NN	compound	O
(	-LRB-	punct	O
CIP1/WAF1	NN	appos	O
)	-RRB-	punct	O
transcription	NN	dobj	O
by	IN	mark	O
inducing	VBG	advcl	O
a	DT	det	O
binding	NN	dobj	O
of	IN	case	O
Smad4	NN	nmod	B-protein
and	CC	cc	O
Smad1	NN	conj	B-protein
to	TO	case	O
the	DT	det	O
29-b	JJ	amod	B-DNA
region	NN	nmod	I-DNA
in	IN	case	O
HS-72	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Dendritic	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
development	NN	ROOT	O
from	IN	case	O
common	JJ	amod	O
myeloid	JJ	amod	B-cell_type
progenitors	NNS	nmod	I-cell_type
.	.	punct	O

Dendritic	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
(	-LRB-	punct	O
DCs	NNS	appos	B-cell_type
)	-RRB-	punct	O
are	VBP	cop	O
professional	JJ	amod	O
antigen-presenting	JJ	amod	B-cell_type
cells	NNS	ROOT	I-cell_type
which	WDT	nsubj	O
both	DT	cc:preconj	O
initiate	VBP	acl:relcl	O
adaptive	JJ	amod	O
immune	JJ	amod	O
responses	NNS	dobj	O
and	CC	cc	O
control	VBP	conj	O
tolerance	NN	dobj	O
to	TO	case	O
self-antigens	NNS	nmod	B-protein
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
these	DT	det	O
different	JJ	amod	O
effects	NNS	nsubj	O
on	IN	case	O
responder	NN	compound	O
cells	NNS	nmod	O
depend	VBP	ccomp	O
on	IN	case	O
subsets	NNS	nmod	O
of	IN	case	O
DCs	NNS	nmod	B-cell_type
arising	VBG	acl	O
from	IN	case	O
either	CC	cc:preconj	O
myeloid	JJ	nmod	O
or	CC	cc	O
lymphoid	JJ	conj	O
hematopoietic	JJ	amod	O
origins	NNS	dep	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
model	NN	nmod	O
,	,	punct	O
CD8	NN	compound	B-cell_type
alpha+	NN	compound	I-cell_type
Mac-1-	NN	compound	I-cell_type
DCs	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
supposed	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
of	IN	case	O
lymphoid	JJ	xcomp	O
while	IN	mark	O
CD8	NN	compound	B-cell_type
alpha-	NN	amod	I-cell_type
Mac-1+	JJ	amod	I-cell_type
DCs	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
supposed	VBN	advcl	O
to	TO	mark	O
be	VB	cop	O
of	IN	case	O
myeloid	JJ	amod	O
origin	NN	xcomp	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
summarize	VBP	ROOT	O
our	PRP$	nmod:poss	O
findings	NNS	dobj	O
that	IN	mark	O
both	CC	cc:preconj	O
CD8	NN	compound	B-cell_type
alpha+	NN	nsubj	I-cell_type
and	CC	cc	I-cell_type
CD8	NN	compound	I-cell_type
alpha-	NN	amod	I-cell_type
DCs	NNS	conj	I-cell_type
can	MD	aux	O
arise	VB	ccomp	O
from	IN	case	O
clonogenic	JJ	amod	B-cell_type
common	JJ	amod	I-cell_type
myeloid	JJ	amod	I-cell_type
progenitors	NNS	nmod	I-cell_type
(	-LRB-	punct	O
CMPs	NNS	appos	B-cell_type
)	-RRB-	punct	O
in	IN	case	O
both	CC	cc:preconj	O
thymus	NN	nmod	O
and	CC	cc	O
spleen	NN	conj	O
.	.	punct	O

Therefore	RB	advmod	O
CD8	NN	compound	B-protein
alpha	NN	compound	I-protein
expression	NN	compound	O
DCs	NNS	nsubj	B-cell_type
does	VBZ	aux	O
not	RB	neg	O
indicate	VB	ROOT	O
a	DT	det	O
lymphoid	JJ	amod	O
origin	NN	dobj	O
and	CC	cc	O
differences	NNS	conj	O
among	IN	case	O
CD8	NN	compound	B-cell_type
alpha+	NN	nmod	I-cell_type
and	CC	cc	I-cell_type
CD8	NN	compound	I-cell_type
alpha-	NN	amod	I-cell_type
DCs	NNS	conj	I-cell_type
might	MD	aux	O
rather	RB	advmod	O
reflect	VB	conj	O
maturation	NN	compound	O
status	NN	dobj	O
than	IN	case	O
ontogeny	NN	nmod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
transplantation	NN	compound	O
studies	NNS	nmod	O
,	,	punct	O
it	PRP	nsubj	O
seems	VBZ	ROOT	O
likely	JJ	xcomp	O
that	IN	mark	O
most	JJS	nsubjpass	O
of	IN	case	O
the	DT	det	O
DCs	NNS	nmod	B-cell_type
in	IN	case	O
secondary	JJ	amod	O
lymphoid	JJ	amod	O
organs	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
substantial	JJ	amod	O
fraction	NN	conj	O
of	IN	case	O
thymic	JJ	amod	B-cell_type
DCs	NNS	nmod	I-cell_type
are	VBP	auxpass	O
myeloid-derived	JJ	ccomp	O
.	.	punct	O

Macrophage	NN	compound	O
stimulation	NN	nsubj	O
with	IN	case	O
Murabutide	NN	nmod	O
,	,	punct	O
an	DT	det	O
HIV-suppressive	JJ	amod	O
muramyl	NN	compound	O
peptide	NN	compound	O
derivative	NN	appos	O
,	,	punct	O
selectively	RB	advmod	O
activates	VBZ	ROOT	O
extracellular	JJ	amod	B-protein
signal-regulated	JJ	amod	I-protein
kinases	NNS	dobj	I-protein
1	CD	nummod	I-protein
and	CC	cc	I-protein
2	CD	conj	I-protein
,	,	punct	O
C/EBPbeta	NN	conj	B-protein
and	CC	cc	O
STAT1	NN	conj	B-protein
:	:	punct	O
role	NN	dep	O
of	IN	case	O
CD14	NN	nmod	B-protein
and	CC	cc	O
Toll-like	JJ	amod	B-protein
receptors	NNS	conj	I-protein
2	CD	nummod	I-protein
and	CC	cc	I-protein
4	CD	conj	I-protein
.	.	punct	O

The	DT	det	O
smallest	JJS	amod	O
unit	NN	nsubj	O
of	IN	case	O
bacterial	JJ	amod	O
peptidoglycans	NNS	nmod	O
known	VBN	acl	O
to	TO	mark	O
be	VB	auxpass	O
endowed	JJ	xcomp	O
with	IN	case	O
biological	JJ	amod	O
activities	NNS	nmod	O
is	VBZ	cop	O
muramyl	NN	compound	O
dipeptide	NN	ROOT	O
(	-LRB-	punct	O
MDP	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
clinically	RB	advmod	O
acceptable	JJ	amod	O
synthetic	JJ	amod	O
derivative	NN	nsubjpass	O
of	IN	case	O
MDP	NN	nmod	O
,	,	punct	O
namely	RB	advmod	O
murabutide	NN	appos	O
(	-LRB-	punct	O
MB	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
present	VB	xcomp	O
interesting	JJ	amod	O
pharmacological	JJ	amod	O
properties	NNS	dobj	O
and	CC	cc	O
to	TO	mark	O
suppress	VB	conj	O
HIV-1	NN	compound	O
replication	NN	dobj	O
in	IN	case	O
monocyte-derived	JJ	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
(	-LRB-	punct	O
MDM	NN	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
addressed	VBN	ROOT	O
the	DT	det	O
signaling	NN	compound	O
events	NNS	dobj	O
activated	VBN	acl	O
in	IN	case	O
MDM	NN	nmod	B-cell_type
following	VBG	case	O
stimulation	NN	nmod	O
with	IN	case	O
either	CC	cc:preconj	O
MB	NN	nmod	O
or	CC	cc	O
the	DT	det	O
potent	JJ	amod	O
immunostimulant	JJ	amod	O
LPS	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
examined	VBD	ROOT	O
whether	IN	mark	O
signaling	NN	nsubj	O
by	IN	case	O
muramyl	NN	compound	O
peptides	NNS	nmod	O
involves	VBZ	ccomp	O
the	DT	det	O
use	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
receptors	NNS	nmod	I-protein
,	,	punct	O
including	VBG	case	O
CD14	NN	nmod	B-protein
and	CC	cc	O
Toll-like	JJ	amod	B-protein
receptor	NN	conj	I-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
TLR2	NN	appos	B-protein
)	-RRB-	punct	O
or	CC	cc	O
TLR4	NN	conj	B-protein
that	WDT	nsubjpass	O
are	VBP	auxpass	O
known	VBN	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
signal-transducing	JJ	amod	B-protein
receptors	NNS	xcomp	I-protein
for	IN	case	O
other	JJ	amod	O
bacterial	JJ	amod	O
cell	NN	compound	O
wall	NN	compound	O
components	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
,	,	punct	O
unlike	IN	case	O
LPS	NN	nmod	O
,	,	punct	O
the	DT	det	O
safe	JJ	amod	O
immunomodulator	NN	compound	O
MB	NN	nsubj	O
selectively	RB	advmod	O
activates	VBZ	ccomp	O
extracellular	JJ	amod	B-protein
signal-regulated	JJ	amod	I-protein
kinases	NNS	dobj	I-protein
(	-LRB-	punct	I-protein
Erk	NN	appos	I-protein
)	-RRB-	punct	I-protein
1/2	CD	nummod	I-protein
,	,	punct	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
detectable	JJ	amod	O
Jun	NN	compound	B-protein
N-terminal	JJ	amod	I-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
JNK	NN	appos	B-protein
)	-RRB-	punct	O
or	CC	cc	O
p38	NN	nmod:npmod	B-protein
mitogen-activated	JJ	amod	I-protein
kinase	NN	compound	I-protein
activation	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
STAT1	NN	compound	B-protein
activation	NN	nsubjpass	O
but	CC	cc	O
weak	JJ	conj	O
or	CC	cc	O
no	DT	neg	O
activation	NN	conj	O
of	IN	case	O
STAT3	NN	nmod	B-protein
or	CC	cc	O
STAT5	NN	conj	B-protein
respectively	RB	advmod	O
,	,	punct	O
could	MD	aux	O
be	VB	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
MB-stimulated	JJ	amod	B-cell_type
MDM	NN	nmod	I-cell_type
.	.	punct	O

Using	VBG	advcl	O
MonoMac6	NN	amod	B-cell_line
cells	NNS	dobj	I-cell_line
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
high	JJ	amod	O
C/EBPbeta	NN	dobj	B-protein
and	CC	cc	O
AP-1	NN	conj	B-protein
but	CC	cc	O
weaker	JJR	conj	O
and	CC	cc	O
transient	JJ	conj	O
NF-kappaB	NN	compound	B-protein
activation	NN	conj	O
by	IN	case	O
MB	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
truncated	VBN	amod	O
form	NN	nsubjpass	O
of	IN	case	O
C/EBPbeta	NN	nmod	B-protein
,	,	punct	O
known	VBN	acl	O
to	TO	mark	O
repress	VB	xcomp	O
HIV-1	NN	compound	O
transcription	NN	dobj	O
,	,	punct	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
extracts	NNS	nmod	O
from	IN	case	O
MB-treated	JJ	amod	B-cell_line
THP-1	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
neither	CC	cc:preconj	O
MB	NN	nsubj	O
nor	CC	cc	O
MDP	NN	conj	O
were	VBD	cop	O
able	JJ	ROOT	O
to	TO	mark	O
transduce	VB	xcomp	O
signals	NNS	dobj	O
via	IN	case	O
CD14	NN	nmod	B-protein
and	CC	cc	O
TLR2	NN	conj	B-protein
or	CC	cc	I-protein
4	CD	conj	I-protein
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
present	VBP	ROOT	O
major	JJ	amod	O
differences	NNS	dobj	O
in	IN	case	O
the	DT	det	O
early	JJ	amod	O
cell	NN	compound	O
activation	NN	compound	O
process	NN	nmod	O
between	IN	case	O
LPS	NN	nmod	O
and	CC	cc	O
muramyl	NN	compound	O
peptides	NNS	conj	O
,	,	punct	O
and	CC	cc	O
strongly	RB	advmod	O
argue	VBP	conj	O
for	IN	case	O
the	DT	det	O
implication	NN	nmod	O
of	IN	case	O
co-receptors	NNS	nmod	B-protein
other	JJ	amod	O
than	IN	case	O
TLR2	NN	nmod	B-protein
and	CC	cc	O
TLR4	NN	conj	B-protein
in	IN	mark	O
mediating	VBG	acl	O
the	DT	det	O
signaling	NN	compound	O
events	NNS	dobj	O
induced	VBN	acl	O
by	IN	case	O
defined	VBN	amod	O
subunits	NNS	nmod	O
of	IN	case	O
bacterial	JJ	amod	O
peptidoglycans	NNS	nmod	O
.	.	punct	O

Nuclear	JJ	amod	B-protein
peroxisome	NN	nmod:npmod	I-protein
proliferator-activated	JJ	amod	I-protein
receptors	NNS	nsubj	I-protein
alpha	NN	dep	I-protein
and	CC	cc	I-protein
gamma	NN	conj	I-protein
have	VBP	aux	O
opposing	VBG	ROOT	O
effects	NNS	dobj	O
on	IN	case	O
monocyte	NN	compound	O
chemotaxis	NN	nmod	O
in	IN	case	O
endometriosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
peroxisome	NN	compound	B-protein
proliferator-activated	JJ	amod	I-protein
receptors	NNS	nsubj	I-protein
(	-LRB-	punct	I-protein
PPARs	NNS	appos	I-protein
)	-RRB-	punct	I-protein
alpha	NN	dep	I-protein
and	CC	cc	I-protein
gamma	NN	conj	I-protein
are	VBP	cop	O
nuclear	JJ	amod	B-protein
receptors	NNS	ROOT	I-protein
that	WDT	nsubj	O
play	VBP	acl:relcl	O
important	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
inflammatory	JJ	amod	O
diseases	NNS	nmod	O
like	IN	case	O
ulcerative	JJ	amod	O
colitis	NN	nmod	O
and	CC	cc	O
arthritis	NN	conj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
possible	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
PPARs	NNS	nmod	B-protein
in	IN	case	O
macrophage	NN	compound	O
attraction	NN	nmod	O
into	IN	case	O
the	DT	det	O
peritoneal	JJ	amod	O
cavity	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
endometriosis	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
identified	VBD	ROOT	O
PPAR-alpha	NN	dobj	B-RNA
and	CC	cc	I-RNA
-gamma	NN	conj	I-RNA
messenger	NN	compound	O
RNA	NN	dep	O
by	IN	case	O
RT-PCR	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
by	IN	case	O
immunoblotting	NN	nmod	O
of	IN	case	O
lysates	NNS	nmod	O
of	IN	case	O
peritoneal	JJ	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
and	CC	cc	O
monocytic	JJ	amod	B-cell_line
U937	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

Using	VBG	advcl	O
immunocytochemistry	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
localized	VBD	ROOT	O
PPAR-alpha	NN	dobj	B-protein
and	CC	cc	I-protein
-gamma	NN	conj	I-protein
within	IN	case	O
the	DT	det	O
nuclei	NNS	nmod	O
of	IN	case	O
both	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

Monocyte	NN	compound	O
chemotactic	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
peritoneal	JJ	amod	O
fluid	NN	nmod	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
endometriosis	NN	nmod	O
was	VBD	auxpass	O
quantified	VBN	ROOT	O
in	IN	case	O
Boyden	NNP	compound	O
chambers	NNS	nmod	O
.	.	punct	O

Migration	NN	nsubjpass	O
of	IN	case	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	auxpass	O
increased	VBN	ROOT	O
by	IN	case	O
WY	NN	nmod	O
14643	CD	nummod	O
and	CC	cc	O
reduced	VBN	conj	O
by	IN	case	O
rosiglitazone	NN	nmod	O
.	.	punct	O

Peritoneal	JJ	amod	O
fluid	NN	ROOT	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
endometriosis	NN	compound	O
activated	VBD	amod	O
U937	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
transiently	RB	advmod	O
transfected	VBN	acl	O
with	IN	case	O
a	DT	det	O
PPAR-alpha/GAL4	JJ	amod	B-DNA
luciferase	NN	compound	I-DNA
reporter	NN	nmod	I-DNA
.	.	punct	O

By	IN	prep	O
contrast	NN	pobj	O
,	,	punct	O
peritoneal	JJ	amod	O
fluid	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
cause	VB	ROOT	O
significant	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
PPAR-gamma/GAL4	JJ	amod	B-DNA
constructs	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
U937	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
transiently	RB	advmod	O
transfected	VBN	acl	O
with	IN	case	O
a	DT	det	O
PPAR	NN	compound	B-DNA
response	NN	compound	I-DNA
element	NN	compound	I-DNA
luciferase	NN	compound	I-DNA
reporter	NN	nmod	I-DNA
showed	VBD	ROOT	O
disease	NN	compound	O
stage-dependent	JJ	amod	O
up-regulation	NN	dobj	O
when	WRB	advmod	O
treated	VBN	advcl	O
with	IN	case	O
peritoneal	JJ	amod	O
fluid	NN	nmod	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
endometriosis	NN	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
peritoneal	JJ	amod	O
fluid	NN	nmod	O
from	IN	case	O
healthy	JJ	amod	O
controls	NNS	nmod	O
down-regulated	VBD	ROOT	O
PPAR	NN	compound	O
response	NN	compound	O
element	NN	compound	O
transactivation	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
peritoneal	JJ	amod	O
fluid	NN	nsubj	O
of	IN	case	O
endometriosis	NN	compound	O
patients	NNS	nmod	O
contains	VBZ	ccomp	O
activators	NNS	dobj	O
of	IN	case	O
PPAR-alpha	NN	nmod	B-protein
that	WDT	nsubj	O
stimulate	VBP	acl:relcl	O
macrophage	NN	compound	O
chemotaxis	NN	dobj	O
.	.	punct	O

Inhibitors	NNS	nsubjpass	O
of	IN	case	O
PPAR-alpha	NN	nmod	B-protein
or	CC	cc	O
activators	NNS	conj	O
of	IN	case	O
PPAR-gamma	NN	nmod	B-protein
could	MD	aux	O
be	VB	auxpass	O
developed	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
inflammation	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
endometriosis	NN	nmod	O
.	.	punct	O

Long-term-impaired	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
and	CC	cc	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	conj	I-protein
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
trauma	NN	amod	O
patients	NNS	nmod	O
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-kappa	NN	compound	I-protein
B	NN	compound	I-protein
expression	NN	nsubjpass	O
and	CC	cc	O
dimer	NN	compound	O
characteristics	NNS	conj	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBMCs	NNS	appos	B-cell_type
)	-RRB-	punct	O
of	IN	case	O
major-trauma	NN	amod	O
patients	NNS	nmod	O
and	CC	cc	O
healthy	JJ	amod	O
controls	NNS	conj	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
PBMCs	NNS	nmod	B-cell_type
on	IN	case	O
days	NNS	nmod	O
1	CD	nummod	O
,	,	punct	O
3	CD	conj	O
,	,	punct	O
5	CD	conj	O
,	,	punct	O
and	CC	cc	O
10	CD	conj	O
after	IN	case	O
trauma	NN	nmod	O
revealed	VBD	ROOT	O
that	IN	mark	O
expression	NN	nsubjpass	O
of	IN	case	O
both	DT	cc:preconj	O
p65p50	JJ	amod	B-protein
heterodimers	NNS	nmod	I-protein
and	CC	cc	O
p50p50	JJ	compound	B-protein
homodimers	NNS	conj	I-protein
was	VBD	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ccomp	O
compared	VBN	case	O
with	IN	case	O
that	DT	nmod	O
in	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
lipopolysaccharide	NN	compound	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
stimulation	NN	nsubj	O
of	IN	case	O
PBMCs	NNS	nmod	B-cell_type
induced	VBD	ROOT	O
NF-kappa	NN	compound	O
B	NN	compound	O
translocation	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
throughout	IN	prep	O
the	DT	det	O
survey	NN	pobj	O
,	,	punct	O
p65p50	JJ	amod	O
activation	NN	nsubj	O
remained	VBD	ROOT	O
significantly	RB	advmod	O
lower	JJR	xcomp	O
in	IN	case	O
trauma	NN	compound	O
patients	NNS	nmod	O
than	IN	case	O
in	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

After	IN	case	O
LPS	NN	compound	O
stimulation	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
the	DT	det	O
p65p50/p50p50	NN	compound	O
ratio	NN	nsubj	O
was	VBD	cop	O
significantly	RB	advmod	O
lower	JJR	ROOT	O
in	IN	case	O
PBMCs	NNS	nmod	B-cell_type
from	IN	case	O
trauma	NN	amod	O
patients	NNS	nmod	O
than	IN	case	O
from	IN	case	O
healthy	JJ	amod	O
controls	NNS	nmod	O
.	.	punct	O

The	DT	det	O
ex	FW	amod	O
vivo	FW	dep	O
expression	NN	nsubj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
was	VBD	cop	O
higher	JJR	ROOT	O
in	IN	case	O
PBMCs	NNS	nmod	B-cell_type
of	IN	case	O
controls	NNS	nmod	O
than	IN	case	O
of	IN	case	O
trauma	NN	amod	O
patients	NNS	nmod	O
.	.	punct	O

LPS	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
induce	VB	ROOT	O
I	NN	compound	O
kappa	NN	compound	O
B	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
PBMCs	NNS	nmod	B-cell_type
from	IN	case	O
trauma	NN	amod	O
patients	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
strong	JJ	amod	O
induction	NN	nsubjpass	O
was	VBD	auxpass	O
obtained	VBN	conj	O
with	IN	case	O
staphylococci	NNS	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
this	DT	det	O
defect	NN	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
universal	JJ	ccomp	O
and	CC	cc	O
depends	VBZ	conj	O
on	IN	case	O
the	DT	det	O
nature	NN	nmod	O
of	IN	case	O
the	DT	det	O
activating	VBG	amod	O
signal	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
no	DT	neg	O
direct	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	advcl	O
between	IN	case	O
levels	NNS	nmod	O
of	IN	case	O
interleukin-10	NN	nmod	B-protein
or	CC	cc	O
transforming	VBG	amod	B-protein
growth	NN	compound	I-protein
factor-beta	NN	conj	I-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
,	,	punct	O
these	DT	det	O
immunosuppressive	JJ	amod	B-protein
cytokines	NNS	nsubj	I-protein
were	VBD	auxpass	O
significantly	RB	advmod	O
elevated	JJ	ROOT	O
in	IN	case	O
trauma	NN	compound	O
patients	NNS	nmod	O
by	IN	case	O
10	CD	nummod	O
days	NNS	nmod	O
after	IN	case	O
admission	NN	nmod	O
.	.	punct	O

The	DT	det	O
long-term	JJ	amod	O
low-basal	JJ	amod	O
and	CC	cc	O
LPS-induced	JJ	conj	O
nuclear	JJ	amod	O
translocation	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
recalled	VBD	ROOT	O
long-term	JJ	amod	O
immunoparalysis	NN	dobj	O
observed	VBN	acl	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
severe	JJ	amod	O
inflammatory	JJ	amod	O
stress	NN	nmod	O
such	JJ	case	O
as	IN	mwe	O
trauma	NN	nmod	O
.	.	punct	O

Hepatic	JJ	amod	O
ischemia-reperfusion	NN	compound	O
injury	NN	ROOT	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
morbidity	NN	nsubj	O
associated	VBN	acl	O
with	IN	case	O
liver	NN	compound	O
transplantation	NN	nmod	O
and	CC	cc	O
major	JJ	amod	O
hepatic	JJ	amod	O
resections	NNS	conj	O
is	VBZ	cop	O
partly	RB	advmod	O
a	DT	det	O
result	NN	appos	O
of	IN	case	O
ischemia-reperfusion	JJ	amod	O
injury	NN	nmod	O
.	.	punct	O

DATA	NNP	compound	O
SOURCES	NNP	nsubjpass	O
:	:	punct	O
The	DT	det	O
entire	JJ	amod	O
world	NN	compound	O
literature	NN	nsubjpass	O
on	IN	prep	O
the	DT	det	O
subject	NN	pobj	O
was	VBD	auxpass	O
searched	VBN	ROOT	O
via	IN	prep	O
Medline	NNP	pobj	O
.	.	punct	O

Keywords	NNP	nsubj	O
included	VBD	ROOT	O
reperfusion	NN	compound	O
injury	NN	dobj	O
,	,	punct	O
transplantation	NN	conj	O
,	,	punct	O
liver	NN	compound	O
resection	NN	conj	O
,	,	punct	O
nitric	JJ	amod	O
oxide	NN	conj	O
,	,	punct	O
endothelin	NN	conj	O
,	,	punct	O
cytokines	NNS	conj	B-protein
,	,	punct	O
Kupffer	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
ischemic/ischaemic	JJ	amod	O
preconditioning	NN	conj	O
,	,	punct	O
and	CC	cc	O
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	conj	I-protein
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
An	DT	det	O
imbalance	NN	nsubj	O
between	IN	case	O
endothelin	NN	nmod	O
and	CC	cc	O
nitric	JJ	amod	O
oxide	NN	compound	O
levels	NNS	conj	O
results	VBZ	dep	O
in	IN	case	O
failure	NN	nmod	O
of	IN	case	O
the	DT	det	O
hepatic	JJ	amod	O
microcirculation	NN	nmod	O
at	IN	case	O
the	DT	det	O
onset	NN	nmod	O
of	IN	case	O
reperfusion	NN	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
liver	NN	nmod	O
promotes	VBZ	ROOT	O
proinflammatory	JJ	amod	B-protein
cytokine	NN	dobj	I-protein
and	CC	cc	O
adhesion	NN	compound	B-protein
molecule	NN	compound	I-protein
synthesis	NN	conj	O
.	.	punct	O

These	DT	det	O
result	VBP	ROOT	O
in	IN	case	O
oxygen-derived	JJ	amod	O
free	JJ	amod	O
radical	JJ	amod	O
production	NN	nmod	O
and	CC	cc	O
neutrophil	NN	compound	O
recruitment	NN	conj	O
,	,	punct	O
further	RB	advmod	O
contributing	VBG	advcl	O
to	TO	case	O
cellular	JJ	amod	O
injury	NN	nmod	O
.	.	punct	O

Various	JJ	amod	O
therapeutic	JJ	amod	O
modalities	NNS	nsubjpass	O
acting	VBG	acl	O
on	IN	prep	O
the	DT	det	O
above	JJ	amod	O
mediators	NNS	pobj	O
have	VBP	aux	O
been	VBN	auxpass	O
successfully	RB	advmod	O
used	VBN	ROOT	O
to	TO	mark	O
attenuate	VB	xcomp	O
reperfusion	NN	compound	O
injury	NN	dobj	O
in	IN	case	O
animal	NN	compound	O
models	NNS	nmod	O
of	IN	case	O
hepatic	JJ	amod	O
transplantation	NN	nmod	O
and	CC	cc	O
resection	NN	conj	O
.	.	punct	O

Application	NN	nsubj	O
of	IN	case	O
the	DT	det	O
knowledge	NN	nmod	O
gained	VBN	ROOT	O
from	IN	case	O
animal	NN	compound	O
models	NNS	nmod	O
of	IN	case	O
hepatic	JJ	amod	O
ischemia-reperfusion	NN	nmod	O
to	TO	case	O
the	DT	det	O
clinical	JJ	amod	O
setting	NN	nmod	O
will	MD	aux	O
improve	VB	conj	O
the	DT	det	O
outcome	NN	dobj	O
of	IN	prep	O
hepatic	JJ	amod	O
surgery	NN	pobj	O
.	.	punct	O

Down-regulation	NN	ROOT	O
of	IN	case	O
IL-12	NN	compound	B-DNA
p40	NN	compound	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
Plasmodium	NN	compound	O
berghei-infected	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
that	WDT	nsubj	O
causes	VBZ	acl:relcl	O
suppression	NN	dobj	O
of	IN	case	O
IL-12	NN	compound	B-DNA
p40	NN	compound	I-DNA
gene	NN	compound	I-DNA
induction	NN	nmod	O
during	IN	case	O
Plasmodium	NN	compound	O
berghei	NN	compound	O
infection	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
IL-12	NN	nsubj	B-protein
together	RB	advmod	O
with	IN	case	O
IFN-gamma	NN	nmod	B-protein
plays	VBZ	advcl	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
protection	NN	nmod	O
against	IN	case	O
pathogenic	JJ	amod	O
infection	NN	nmod	O
,	,	punct	O
the	DT	det	O
IL-12	NN	compound	B-protein
p70	NN	compound	I-protein
protein	NN	compound	I-protein
production	NN	nsubj	O
of	IN	case	O
infected	JJ	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
is	VBZ	cop	O
lower	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
by	IN	case	O
the	DT	det	O
uninfected	JJ	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
showed	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
that	IN	mark	O
the	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
IL-12	NN	compound	B-DNA
p40	NN	compound	I-DNA
gene	NN	nmod	I-DNA
but	CC	cc	O
not	RB	cc	O
IL-12	NN	compound	B-DNA
p35	NN	compound	I-DNA
gene	NN	conj	I-DNA
in	IN	case	O
macrophages	NNS	nmod	B-cell_type
of	IN	case	O
P.	FW	compound	O
berghei-infected	JJ	amod	O
mice	NNS	nmod	O
was	VBD	auxpass	O
profoundly	RB	advmod	O
inhibited	VBN	ccomp	O
.	.	punct	O

The	DT	det	O
inhibition	NN	nsubjpass	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
interaction	NN	nmod	O
with	IN	case	O
macrophages	NNS	nmod	B-cell_type
that	WDT	nsubj	O
had	VBD	aux	O
contacted	VBN	acl:relcl	O
with	IN	case	O
P.	FW	compound	B-cell_type
berghei-infected	JJ	amod	I-cell_type
erythrocytes	NNS	nmod	I-cell_type
and	CC	cc	O
was	VBD	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
a	DT	det	O
soluble	JJ	amod	O
factor	NN	nmod	O
,	,	punct	O
IL-10	NN	appos	B-protein
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
comparable	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
uninfected	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
infected	JJ	conj	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
IFN-regulatory	JJ	amod	B-DNA
factor-1	NN	compound	I-DNA
gene	NN	nmod	I-DNA
was	VBD	cop	O
comparable	JJ	ROOT	O
in	IN	case	O
transcription	NN	compound	O
level	NN	nmod	O
in	IN	case	O
uninfected	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
infected	JJ	conj	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
while	IN	mark	O
the	DT	det	O
unidentified	JJ	amod	O
complex	NN	compound	O
formation	NN	nsubjpass	O
of	IN	case	O
IFN-regulatory	JJ	amod	B-protein
factor-1	NN	nmod	I-protein
was	VBD	auxpass	O
observed	VBN	advcl	O
in	IN	case	O
infected	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
the	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
IL-12	NN	compound	B-DNA
p40	NN	compound	I-DNA
gene	NN	compound	I-DNA
induction	NN	nmod	O
appeared	VBD	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
regulated	VBN	xcomp	O
at	IN	case	O
transcriptional	JJ	amod	O
regulation	NN	compound	O
level	NN	nmod	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
.	.	punct	O

The	DT	det	O
Friend	NN	nsubj	B-protein
of	IN	case	I-protein
GATA	NN	compound	I-protein
proteins	NNS	nmod	I-protein
U-shaped	VBN	dep	O
,	,	punct	O
FOG-1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
FOG-2	NN	conj	B-protein
function	VBP	ROOT	O
as	IN	case	O
negative	JJ	amod	O
regulators	NNS	nmod	O
of	IN	case	O
blood	NN	nmod	O
,	,	punct	O
heart	NN	conj	O
,	,	punct	O
and	CC	cc	O
eye	NN	compound	O
development	NN	conj	O
in	IN	case	O
Drosophila	FW	nmod	O
.	.	punct	O

Friend	NN	nsubj	B-protein
of	IN	case	I-protein
GATA	NN	compound	I-protein
(	-LRB-	punct	I-protein
FOG	NN	appos	I-protein
)	-RRB-	punct	I-protein
proteins	NNS	nmod	I-protein
regulate	VBP	ROOT	O
GATA	NN	nmod:npmod	O
factor-activated	JJ	amod	O
gene	NN	compound	O
transcription	NN	dobj	O
.	.	punct	O

During	IN	case	O
vertebrate	NN	amod	O
hematopoiesis	NN	nmod	O
,	,	punct	O
FOG	NN	compound	B-protein
and	CC	cc	I-protein
GATA	NN	conj	I-protein
proteins	NNS	nsubj	I-protein
cooperate	VBP	ROOT	O
to	TO	mark	O
promote	VB	xcomp	O
erythrocyte	NN	dobj	O
and	CC	cc	O
megakaryocyte	NN	conj	O
differentiation	NN	dep	O
.	.	punct	O

The	DT	det	O
Drosophila	FW	compound	B-protein
FOG	NN	compound	I-protein
homologue	NN	nsubjpass	I-protein
U-shaped	JJ	amod	I-protein
(	-LRB-	punct	O
Ush	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
similarly	RB	advmod	O
in	IN	case	O
the	DT	det	O
blood	NN	compound	O
cell	NN	compound	O
anlage	NN	nmod	O
during	IN	case	O
embryogenesis	NN	nmod	O
.	.	punct	O

During	IN	case	O
hematopoiesis	NN	nmod	O
,	,	punct	O
the	DT	det	O
acute	JJ	amod	O
myeloid	JJ	amod	O
leukemia	NN	compound	O
1	CD	nummod	O
homologue	NN	nsubjpass	O
Lozenge	NNP	dep	B-cell_type
and	CC	cc	I-cell_type
Glial	JJ	conj	I-cell_type
cells	NNS	compound	I-cell_type
missing	VBG	conj	O
are	VBP	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
crystal	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
plasmatocytes	NNS	conj	B-cell_type
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
additional	JJ	amod	O
factors	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
predicted	VBN	ROOT	O
to	TO	mark	O
control	VB	xcomp	O
crystal	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
Ush	NNP	nsubjpass	B-protein
is	VBZ	auxpass	O
expressed	VBN	ccomp	O
in	IN	case	O
hemocyte	NN	compound	B-cell_type
precursors	NNS	nmod	I-cell_type
and	CC	cc	O
plasmatocytes	NNS	conj	B-cell_type
throughout	IN	case	O
embryogenesis	NN	nmod	O
and	CC	cc	O
larval	JJ	compound	O
development	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
GATA	NN	compound	B-protein
factor	NN	compound	I-protein
Serpent	NNP	nsubj	I-protein
is	VBZ	cop	O
essential	JJ	conj	O
for	IN	case	O
Ush	NNP	compound	B-protein
embryonic	JJ	amod	O
expression	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
loss	NN	nsubj	O
of	IN	case	O
ush	JJ	compound	O
function	NN	nmod	O
results	VBZ	ROOT	O
in	IN	case	O
an	DT	det	O
overproduction	NN	nmod	O
of	IN	case	O
crystal	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
whereas	IN	dep	O
forced	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
Ush	NNP	nmod	B-protein
reduces	VBZ	parataxis	O
this	DT	det	O
cell	NN	compound	O
population	NN	dobj	O
.	.	punct	O

Murine	JJ	amod	B-protein
FOG-1	NN	nsubj	I-protein
and	CC	cc	I-protein
FOG-2	NN	conj	I-protein
also	RB	advmod	O
can	MD	aux	O
repress	VB	ROOT	O
crystal	JJ	amod	O
cell	NN	compound	O
production	NN	dobj	O
,	,	punct	O
but	CC	cc	O
a	DT	det	O
mutant	JJ	amod	O
version	NN	nsubj	O
of	IN	case	O
FOG-2	NN	nmod	B-protein
lacking	VBG	acl	O
a	DT	det	O
conserved	VBN	amod	O
motif	NN	dobj	O
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
the	DT	det	O
corepressor	NN	compound	B-protein
C-terminal	JJ	amod	I-protein
binding	NN	compound	I-protein
protein	NN	dobj	I-protein
fails	VBZ	conj	O
to	TO	mark	O
affect	VB	xcomp	O
the	DT	det	O
cell	NN	compound	O
lineage	NN	dobj	O
.	.	punct	O

The	DT	det	O
GATA	NN	compound	B-protein
factor	NN	compound	I-protein
Pannier	NN	nsubjpass	I-protein
(	-LRB-	punct	O
Pnr	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
eye	NN	compound	O
and	CC	cc	O
heart	NN	conj	O
development	NN	nmod	O
in	IN	case	O
Drosophila	FW	nmod	O
.	.	punct	O

When	WRB	advmod	O
Ush	NNP	nsubjpass	B-protein
,	,	punct	O
FOG-1	NN	conj	B-protein
,	,	punct	O
FOG-2	NN	conj	B-protein
,	,	punct	O
or	CC	cc	O
mutant	JJ	amod	B-protein
FOG-2	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
coexpressed	VBN	advcl	O
with	IN	case	O
Pnr	NN	nmod	B-protein
during	IN	case	O
these	DT	det	O
developmental	JJ	amod	O
processes	NNS	nmod	O
,	,	punct	O
severe	JJ	amod	O
eye	NN	nsubj	O
and	CC	cc	O
heart	NN	compound	O
phenotypes	NNS	conj	O
result	VBP	ROOT	O
,	,	punct	O
consistent	JJ	xcomp	O
with	IN	case	O
a	DT	det	O
conserved	VBN	amod	O
negative	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
Pnr	NN	compound	B-protein
function	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
fly	NN	nsubj	O
and	CC	cc	O
mouse	NN	conj	O
FOG	NN	compound	B-protein
proteins	NNS	dep	I-protein
function	VBP	ccomp	O
similarly	RB	advmod	O
in	IN	case	O
three	CD	nummod	O
distinct	JJ	amod	O
cellular	JJ	amod	O
contexts	NNS	nmod	O
in	IN	case	O
Drosophila	FW	nmod	O
,	,	punct	O
but	CC	cc	O
may	MD	aux	O
use	VB	conj	O
different	JJ	amod	O
mechanisms	NNS	dobj	O
to	TO	mark	O
regulate	VB	xcomp	O
genetic	JJ	amod	O
events	NNS	dobj	O
in	IN	case	O
blood	NN	nmod	O
vs	CC	cc	O
.	.	punct	O
cardial	JJ	ROOT	B-cell_line
or	CC	cc	I-cell_line
eye	NN	conj	I-cell_line
cell	NN	compound	I-cell_line
lineages	NNS	dep	I-cell_line

The	DT	det	O
RING	NN	compound	B-protein
finger	NN	compound	I-protein
protein	NN	nsubj	I-protein
Siah-1	NN	dep	B-protein
regulates	VBZ	ROOT	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	B-protein
coactivator	NN	compound	I-protein
OBF-1	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
transcriptional	JJ	amod	B-protein
coactivator	NN	nsubjpass	I-protein
OBF-1	NN	dep	B-protein
,	,	punct	O
which	WDT	nsubj	O
interacts	VBZ	acl:relcl	O
with	IN	case	O
Oct-1	NN	nmod	B-protein
and	CC	cc	O
Oct-2	NN	conj	B-protein
and	CC	cc	O
the	DT	det	O
octamer	NN	compound	B-DNA
site	NN	compound	I-DNA
DNA	NN	conj	I-DNA
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
critical	JJ	xcomp	O
for	IN	case	O
development	NN	nmod	O
of	IN	case	O
a	DT	det	O
normal	JJ	amod	O
immune	JJ	amod	O
response	NN	nmod	O
and	CC	cc	O
the	DT	det	O
formation	NN	conj	O
of	IN	case	O
germinal	JJ	amod	O
centers	NNS	nmod	O
in	IN	case	O
secondary	JJ	amod	O
lymphoid	JJ	amod	O
organs	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
the	DT	det	O
RING	NN	compound	B-protein
finger	NN	compound	I-protein
protein	NN	dobj	I-protein
Siah-1	NN	dep	B-protein
as	IN	case	O
a	DT	det	O
protein	NN	nmod	O
interacting	VBG	acl	O
specifically	RB	advmod	O
with	IN	case	O
OBF-1	NN	nmod	B-protein
.	.	punct	O

This	DT	det	O
interaction	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
C-terminal	JJ	amod	B-protein
part	NN	nmod	O
of	IN	case	O
Siah-1	NN	nmod	B-protein
and	CC	cc	O
by	IN	case	O
residues	NNS	conj	O
in	IN	case	O
the	DT	det	O
N-terminus	NN	nmod	B-protein
of	IN	case	O
OBF-1	NN	nmod	B-protein
,	,	punct	O
partly	RB	advmod	O
distinct	JJ	advcl	O
from	IN	case	O
the	DT	det	O
residues	NNS	nmod	O
required	VBN	acl	O
for	IN	case	O
formation	NN	nmod	O
of	IN	case	O
a	DT	det	O
complex	NN	nmod	O
with	IN	case	O
the	DT	det	O
Oct	NN	compound	B-protein
POU	NN	compound	I-protein
domains	NNS	nmod	I-protein
and	CC	cc	O
the	DT	det	O
DNA	NN	conj	O
.	.	punct	O

Interaction	NN	nsubj	O
between	IN	case	O
Siah-1	NN	nmod	B-protein
and	CC	cc	O
OBF-1	NN	conj	B-protein
leads	VBZ	ROOT	O
to	TO	case	O
downregulation	NN	nmod	O
of	IN	case	O
OBF-1	NN	compound	O
protein	NN	compound	O
level	NN	nmod	O
but	CC	cc	O
not	RB	cc	O
mRNA	NN	conj	O
,	,	punct	O
and	CC	cc	O
to	TO	case	O
a	DT	det	O
corresponding	JJ	amod	O
reduction	NN	conj	O
in	IN	case	O
octamer	NN	nmod:npmod	O
site-dependent	JJ	amod	O
transcription	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
ubiquitin-proteasome	JJ	amod	O
pathway	NN	nmod	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
leads	VBZ	ROOT	O
to	TO	case	O
elevated	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
OBF-1	NN	compound	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
in	IN	case	O
immunized	JJ	amod	O
mice	NNS	nmod	O
,	,	punct	O
OBF-1	NN	compound	B-protein
protein	NN	compound	I-protein
amounts	NNS	nsubjpass	O
are	VBP	auxpass	O
dramatically	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	B-cell_type
activated	VBN	amod	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
without	IN	case	O
concomitant	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
OBF-1	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
Siah-1	NN	nsubj	B-protein
is	VBZ	cop	O
part	NN	ccomp	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	O
regulatory	JJ	amod	O
loop	NN	nmod	O
controlling	VBG	acl	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
OBF-1	NN	compound	B-protein
protein	NN	nmod	I-protein
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
beta-catenin	NN	nsubj	O
--	:	punct	O
TCF-1	NN	compound	O
pathway	NN	nsubj	O
ensures	VBZ	ROOT	O
CD4	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
CD8	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
thymocyte	NN	compound	I-cell_type
survival	NN	dobj	O
.	.	punct	O

The	DT	det	O
association	NN	nsubj	O
of	IN	case	O
trans-acting	JJ	amod	B-protein
T	NN	compound	I-protein
cell	NN	compound	I-protein
factors	NNS	nmod	I-protein
(	-LRB-	punct	O
TCFs	NNS	appos	B-protein
)	-RRB-	punct	O
or	CC	cc	O
lymphoid	JJ	amod	B-protein
enhancer	NN	compound	I-protein
factor	NN	conj	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
LEF-1	NN	appos	B-protein
)	-RRB-	punct	O
with	IN	case	O
their	PRP$	nmod:poss	O
coactivator	NN	compound	O
beta-catenin	NN	nmod	O
mediates	VBZ	ROOT	O
transient	JJ	amod	O
transcriptional	JJ	amod	O
responses	NNS	dobj	O
to	TO	case	O
extracellular	JJ	amod	O
Wnt	NN	compound	O
signals	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
T	NN	compound	O
cell	NN	compound	O
maturation	NN	nsubj	O
depends	VBZ	ccomp	O
on	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
the	DT	det	O
beta-catenin	NN	compound	B-protein
--	:	punct	I-protein
binding	NN	compound	I-protein
domain	NN	nmod	I-protein
in	IN	case	O
TCF-1	NN	nmod	B-protein
.	.	punct	O

This	DT	det	O
domain	NN	nsubj	O
is	VBZ	cop	O
necessary	JJ	ROOT	O
to	TO	mark	O
mediate	VB	xcomp	O
the	DT	det	O
survival	NN	dobj	O
of	IN	case	O
immature	JJ	amod	O
CD4	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
CD8	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
double-positive	JJ	amod	I-cell_type
(	-LRB-	punct	I-cell_type
DP	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
thymocytes	NNS	nmod	I-cell_type
.	.	punct	O

Accelerated	VBN	amod	O
spontaneous	JJ	amod	O
thymocyte	NN	compound	O
death	NN	nsubj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
TCF-1	NN	nmod	B-protein
correlates	VBZ	ROOT	O
with	IN	case	O
aberrantly	RB	advmod	O
low	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
anti-apoptotic	JJ	amod	B-protein
protein	NN	compound	I-protein
Bcl-x	NN	nmod	B-protein
(	-LRB-	punct	I-protein
L	NN	appos	I-protein
)	-RRB-	punct	I-protein
.	.	punct	O

Increasing	VBG	amod	O
anti-apoptotic	JJ	amod	O
effectors	NNS	nsubj	O
in	IN	case	O
thymocytes	NNS	nmod	B-cell_type
by	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
a	DT	det	O
Bcl-2	NN	compound	B-DNA
transgene	NN	nmod	I-DNA
rescued	VBD	ROOT	O
TCF-1-deficient	JJ	amod	B-cell_type
DP	NN	compound	I-cell_type
thymocytes	NNS	dobj	I-cell_type
from	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
TCF-1	NN	nsubj	B-protein
,	,	punct	O
upon	IN	case	O
association	NN	nmod	O
with	IN	case	O
beta-catenin	NN	nmod	O
,	,	punct	O
transiently	RB	advmod	O
ensures	VBZ	ROOT	O
the	DT	det	O
survival	NN	dobj	O
of	IN	case	O
immature	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
which	WDT	nsubj	O
enables	VBZ	acl:relcl	O
them	PRP	dobj	O
to	TO	aux	O
generate	VB	xcomp	O
and	CC	cc	O
edit	VB	conj	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	I-protein
TCR	NN	compound	I-protein
)	-RRB-	punct	I-protein
alpha	NN	compound	I-protein
chains	NNS	dobj	I-protein
and	CC	cc	O
attempt	NN	conj	O
TCR	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
positive	JJ	amod	O
selection	NN	dobj	O
.	.	punct	O

TRAIL/Apo2L	JJ	amod	B-protein
ligand	NN	nsubj	I-protein
selectively	RB	advmod	O
induces	VBZ	ROOT	O
apoptosis	NN	dobj	O
and	CC	cc	O
overcomes	VBZ	compound	O
drug	NN	compound	O
resistance	NN	conj	O
in	IN	case	O
multiple	JJ	amod	O
myeloma	NN	nmod	O
:	:	punct	O
therapeutic	JJ	amod	O
applications	NNS	dobj	O
.	.	punct	O

Multiple	JJ	amod	O
myeloma	NN	nsubj	O
(	-LRB-	punct	O
MM	NN	appos	O
)	-RRB-	punct	O
remains	VBZ	ROOT	O
incurable	JJ	amod	O
and	CC	cc	O
novel	JJ	conj	O
treatments	NNS	nsubjpass	O
are	VBP	auxpass	O
urgently	RB	advmod	O
needed	VBN	advcl	O
.	.	punct	O

Preclinical	JJ	amod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	amod	O
vivo	FW	dep	O
evaluations	NNS	nsubjpass	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
to	TO	mark	O
assess	VB	xcomp	O
the	DT	det	O
potential	JJ	amod	O
therapeutic	JJ	amod	O
applications	NNS	dobj	O
of	IN	case	O
human	JJ	amod	O
recombinant	JJ	amod	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
TNF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-related	JJ	amod	I-protein
apoptosis-inducing	JJ	amod	I-protein
ligand/Apo2	NN	compound	I-protein
ligand	NN	nmod	I-protein
(	-LRB-	punct	O
TRAIL/Apo2L	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
MM	NN	nmod	O
.	.	punct	O

TRAIL/Apo2L	NN	ROOT	B-protein
potently	RB	advmod	O
induced	VBD	amod	O
apoptosis	NN	dobj	O
of	IN	case	O
MM	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
patients	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
majority	NN	conj	O
of	IN	case	O
MM	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
including	VBG	case	O
cells	NNS	nmod	O
sensitive	JJ	amod	O
or	CC	cc	O
resistant	JJ	conj	O
to	TO	case	O
dexamethasone	NN	nmod	O
(	-LRB-	punct	O
Dex	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
doxorubicin	NN	conj	O
(	-LRB-	punct	O
Dox	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
melphalan	NN	conj	O
,	,	punct	O
and	CC	cc	O
mitoxantrone	NN	conj	O
.	.	punct	O

TRAIL/Apo2L	NN	nsubj	B-protein
also	RB	advmod	O
overcame	VBD	ROOT	O
the	DT	det	O
survival	NN	compound	O
effect	NN	dobj	O
of	IN	case	O
interleukin	NN	nmod	B-protein
6	CD	nummod	I-protein
on	IN	case	O
MM	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	conj	O
the	DT	det	O
survival	NN	dobj	O
of	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	nmod	I-cell_type
and	CC	cc	I-cell_type
bone	NN	compound	I-cell_type
marrow	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
and	CC	cc	O
purified	VBN	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
from	IN	case	O
healthy	JJ	amod	O
donors	NNS	nmod	O
.	.	punct	O

The	DT	det	O
status	NN	nsubj	O
of	IN	case	O
the	DT	det	O
TRAIL	NN	compound	B-protein
receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
assessed	VBN	dep	O
by	IN	case	O
immunoblotting	NN	nmod	O
and	CC	cc	O
flow	NN	compound	O
cytometry	NN	conj	O
)	-RRB-	punct	O
could	MD	aux	O
not	RB	neg	O
predict	VB	ROOT	O
TRAIL	NN	compound	O
sensitivity	NN	dobj	O
of	IN	case	O
MM	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
anti-MM	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
TRAIL/Apo2L	NN	nmod	B-protein
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
in	IN	case	O
nu/xid/bg	NN	amod	O
mice	NNS	nmod	O
xenografted	VBN	acl	O
with	IN	case	O
human	JJ	amod	B-cell_type
MM	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
;	:	punct	O
TRAIL	NN	nsubjpass	B-protein
(	-LRB-	punct	O
500	CD	nummod	O
microg	NN	appos	O
intraperitoneally	RB	advmod	O
daily	RB	amod	O
for	IN	case	O
14	CD	nummod	O
days	NNS	nmod	O
)	-RRB-	punct	O
was	VBD	auxpass	O
well	RB	advmod	O
tolerated	VBN	parataxis	O
and	CC	cc	O
significantly	RB	advmod	O
suppressed	VBD	conj	O
the	DT	det	O
growth	NN	dobj	O
of	IN	prep	O
plasmacytomas	NNS	pobj	B-cell_type
.	.	punct	O

Dox	NNP	nsubj	O
up-regulated	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
TRAIL	NN	compound	B-protein
receptor	NN	compound	I-protein
death	NN	compound	B-protein
receptor	NN	nmod	I-protein
5	CD	nummod	I-protein
(	-LRB-	punct	O
DR5	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
synergistically	RB	advmod	O
enhanced	VBD	conj	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
TRAIL	NN	nmod	B-protein
not	RB	neg	O
only	RB	cc:preconj	O
against	IN	case	O
MM	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
sensitive	JJ	amod	O
to	TO	nmod	O
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
against	IN	case	O
those	DT	conj	O
resistant	JJ	amod	O
to	TO	dep	O
,	,	punct	O
Dex-	NN	amod	O
or	CC	cc	O
Dox-induced	JJ	conj	O
apoptosis	NN	nmod	O
.	.	punct	O

Nuclear	JJ	amod	O
factor	NN	compound	O
(	-LRB-	punct	O
NF	NN	compound	O
)	-RRB-	punct	O
-kappaB	NN	compound	O
inhibitors	NNS	nsubj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
SN50	NN	nmod	O
(	-LRB-	punct	O
a	DT	det	O
cell-permeable	JJ	amod	O
inhibitor	NN	dep	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
translocation	NN	nmod	O
and	CC	cc	O
transcriptional	JJ	amod	O
activity	NN	conj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
)	-RRB-	punct	O
or	CC	cc	O
the	DT	det	O
proteasome	NN	compound	O
inhibitor	NN	compound	O
PS-341	NN	conj	O
,	,	punct	O
enhanced	VBD	ROOT	O
the	DT	det	O
proapoptotic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
TRAIL/Apo2L	NN	nmod	B-protein
against	IN	case	O
TRAIL-sensitive	JJ	amod	B-cell_type
MM	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
whereas	IN	dep	O
SN50	NN	nsubj	O
reversed	VBD	parataxis	O
the	DT	det	O
TRAIL	NN	compound	O
resistance	NN	dobj	O
of	IN	case	O
ARH-77	NN	nmod	B-cell_type
and	CC	cc	I-cell_type
IM-9	NN	conj	I-cell_type
MM	NN	compound	I-cell_type
cells	NNS	dep	I-cell_type
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
normal	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
not	RB	neg	O
sensitized	VBN	ROOT	O
to	TO	case	O
TRAIL	NN	nmod	B-protein
by	IN	case	O
either	CC	cc:preconj	O
Dox	NN	nmod	O
,	,	punct	O
SN50	NN	conj	O
,	,	punct	O
or	CC	cc	O
PS-341	NN	conj	O
.	.	punct	O

These	DT	det	O
preclinical	JJ	amod	O
studies	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
TRAIL/Apo2L	NN	nsubj	B-protein
can	MD	aux	O
overcome	VB	ccomp	O
conventional	JJ	amod	O
drug	NN	compound	O
resistance	NN	dobj	O
and	CC	cc	O
provide	VBP	conj	O
the	DT	det	O
basis	NN	dobj	O
for	IN	case	O
clinical	JJ	amod	O
trials	NNS	nmod	O
of	IN	case	O
TRAIL	NN	nmod:npmod	B-protein
-based	JJ	amod	O
treatment	NN	compound	O
regimens	VBZ	nmod	O
to	TO	mark	O
improve	VB	xcomp	O
outcome	NN	dobj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
MM	NN	nmod	O
.	.	punct	O

(	-LRB-	punct	O
Blood.	NNP	ROOT	O
2001	CD	nummod	O
;	:	punct	O
98	CD	nummod	O
:	:	punct	O
795-804	CD	nummod	O
)	-RRB-	punct	O

CD28	NN	compound	B-protein
costimulation	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
not	RB	neg	O
only	RB	cc:preconj	O
to	TO	mark	O
induce	VB	advcl	O
IL-12	NN	compound	B-protein
receptor	NN	dobj	I-protein
but	CC	cc	O
also	RB	advmod	O
to	TO	mark	O
render	VB	conj	O
janus	NN	compound	B-protein
kinases/STAT4	NN	dobj	I-protein
responsive	JJ	amod	O
to	TO	case	O
IL-12	NN	compound	B-protein
stimulation	NN	nmod	O
in	IN	case	O
TCR-triggered	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
resting	VBG	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
for	IN	case	O
the	DT	det	O
acquisition	NN	nmod	O
of	IN	case	O
various	JJ	amod	O
functions	NNS	nmod	O
depends	VBZ	ROOT	O
on	IN	mark	O
whether	IN	mark	O
CD28	NN	compound	O
costimulatory	JJ	amod	O
signals	NNS	nsubjpass	O
are	VBP	auxpass	O
provided	VBN	advcl	O
upon	IN	case	O
T	NN	compound	O
cell	NN	compound	O
receptor	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
how	WRB	advmod	O
CD28	NN	compound	O
costimulation	NN	nsubj	O
functions	VBZ	ccomp	O
to	TO	mark	O
allow	VB	xcomp	O
TCR	NN	nmod:npmod	B-protein
-triggered	JJ	amod	O
resting	VBG	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
to	TO	mark	O
acquire	VB	xcomp	O
IL-12	NN	compound	B-protein
responsiveness	NN	dobj	O
.	.	punct	O

When	WRB	advmod	O
T	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
stimulated	VBN	advcl	O
with	IN	case	O
low	JJ	amod	O
doses	NNS	nmod	O
of	IN	case	O
anti-CD3	JJ	amod	B-protein
mAb	NN	nmod	I-protein
,	,	punct	O
CD28	NN	compound	O
costimulation	NN	nsubjpass	O
was	VBD	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
optimal	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
IL-12	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
IL-12R	NN	appos	B-protein
)	-RRB-	punct	O
expression	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
stimulation	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
high	JJ	amod	O
doses	NNS	nmod	O
of	IN	case	O
anti-CD3	NN	nmod	B-protein
alone	RB	advmod	O
induced	VBD	ROOT	O
comparable	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
IL-12R	NN	compound	B-protein
expression	NN	nmod	O
to	TO	case	O
those	DT	nmod	O
induced	VBN	acl	O
upon	IN	case	O
CD28	NN	compound	O
costimulation	NN	nmod	O
.	.	punct	O

Nevertheless	RB	advmod	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
substantial	JJ	amod	O
difference	NN	nsubj	O
in	IN	case	O
IL-12	NN	compound	B-protein
responsiveness	NN	nmod	O
between	IN	case	O
these	DT	det	O
two	CD	nummod	O
groups	NNS	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
compared	VBN	case	O
to	TO	case	O
anti-CD28-costimulated	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
that	WDT	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
costimulated	VBN	acl:relcl	O
with	IN	case	O
anti-CD28	NN	nmod	B-protein
exhibited	VBD	parataxis	O
decreased	VBN	amod	O
levels	NNS	dobj	O
of	IN	case	O
Janus	NN	compound	B-protein
kinases	NNS	compound	I-protein
(	-LRB-	punct	O
JAK	NN	appos	B-protein
)	-RRB-	punct	O
JAK2/TYK2	NN	nmod	B-protein
and	CC	cc	O
STAT4	NN	compound	B-protein
phosphorylation	NN	conj	O
and	CC	cc	O
IFN-y	NN	compound	O
production	NN	conj	O
following	VBG	case	O
IL-12	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
STAT6	NN	compound	O
phosphorylation	NN	nsubjpass	O
following	VBG	case	O
IL-4	NN	compound	O
stimulation	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
decreased	VBN	ROOT	O
in	IN	case	O
anti-CD28-uncostimulated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
resutls	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
CD28	NN	compound	O
costimulation	NN	nsubj	O
not	RB	neg	O
only	RB	cc:preconj	O
contributes	VBZ	ccomp	O
to	TO	mark	O
up-regulating	VBG	xcomp	O
IL-12R	NN	compound	B-protein
expression	NN	dobj	O
but	CC	cc	O
is	VBZ	auxpass	O
also	RB	advmod	O
required	VBN	conj	O
to	TO	mark	O
render	VB	xcomp	O
JAKs/STAT4	NN	dobj	B-protein
responsive	JJ	amod	O
to	TO	case	O
IL-12	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

Constitutively	RB	advmod	O
activated	VBN	amod	O
Akt-1	NN	nsubj	B-protein
is	VBZ	cop	O
vital	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
survival	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
monocyte-differentiated	JJ	amod	I-cell_type
macrophages	NNS	nmod	I-cell_type
.	.	punct	O

Role	NN	ROOT	O
of	IN	case	O
Mcl-1	NN	nmod	B-protein
,	,	punct	O
independent	JJ	amod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-kappaB	NN	nmod	I-protein
,	,	punct	O
Bad	NN	conj	B-protein
,	,	punct	O
or	CC	cc	O
caspase	NN	compound	O
activation	NN	conj	O
.	.	punct	O

Recent	JJ	amod	O
data	NNS	nsubj	O
from	IN	case	O
mice	NNS	nmod	O
deficient	JJ	amod	O
for	IN	case	O
phosphatase	NN	nmod	B-protein
and	CC	cc	O
tensin	NN	compound	B-DNA
homologue	NN	conj	I-DNA
deleted	VBN	acl	O
from	IN	case	O
chromosome	NN	nmod	B-DNA
10	CD	nummod	I-DNA
or	CC	cc	O
src	NN	conj	B-protein
homology	NN	compound	I-protein
2	CD	nummod	I-protein
domain-containing	JJ	amod	I-protein
5	CD	nummod	I-protein
'	``	punct	I-protein
inositol	NN	compound	I-protein
phosphatase	NN	dep	I-protein
,	,	punct	O
phosphatases	NNS	appos	B-protein
that	WDT	nsubj	O
negatively	RB	advmod	O
regulate	VBP	acl:relcl	O
the	DT	det	O
phosphatidylinositol	NN	compound	B-protein
3-kinase	NN	compound	I-protein
(	-LRB-	punct	O
PI3K	NN	appos	B-protein
)	-RRB-	punct	O
pathway	NN	dobj	O
,	,	punct	O
revealed	VBD	ROOT	O
an	DT	det	O
increased	VBN	amod	O
number	NN	dobj	O
of	IN	case	O
macrophages	NNS	nmod	B-cell_type
in	IN	case	O
these	DT	det	O
animals	NNS	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
an	DT	det	O
essential	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
the	DT	det	O
PI3K	NN	compound	B-protein
pathway	NN	nmod	O
for	IN	case	O
macro-phage	JJ	amod	B-cell_type
survival	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
focused	VBD	ROOT	O
on	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
the	DT	det	O
PI3K-regulated	JJ	amod	B-protein
serine/threonine	NN	compound	I-protein
kinase	NN	compound	I-protein
Akt-1	NN	nmod	B-protein
in	IN	mark	O
modulating	VBG	advcl	O
macrophage	NN	compound	B-cell_type
survival	NN	dobj	O
.	.	punct	O

Akt-1	NN	nsubjpass	B-protein
was	VBD	auxpass	O
constitutively	RB	advmod	O
activated	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
and	CC	cc	O
addition	NN	conj	O
of	IN	case	O
the	DT	det	O
PI3K	NN	compound	B-protein
inhibitor	NN	nmod	O
,	,	punct	O
LY294002	NN	appos	O
,	,	punct	O
suppressed	VBD	conj	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
Akt-1	NN	nmod	B-protein
and	CC	cc	O
induced	VBD	amod	O
cell	NN	compound	O
death	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
suppression	NN	nsubj	O
of	IN	case	O
Akt-1	NN	nmod	B-protein
by	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
PI3K	NN	nmod	B-protein
or	CC	cc	O
a	DT	det	O
dominant	JJ	amod	B-protein
negative	JJ	amod	I-protein
(	-LRB-	punct	I-protein
DN	JJ	dep	I-protein
)	-RRB-	punct	I-protein
Akt-1	NN	conj	I-protein
resulted	VBD	ROOT	O
in	IN	case	O
loss	NN	nmod	O
of	IN	case	O
mitochondrial	JJ	amod	O
transmembrane	JJ	amod	O
potential	NN	nmod	O
,	,	punct	O
activation	NN	appos	O
of	IN	case	O
caspases-9	NN	nmod	B-protein
and	CC	cc	I-protein
-3	CD	conj	I-protein
,	,	punct	O
and	CC	cc	O
DNA	NN	compound	O
fragmentation	NN	conj	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
PI3K	NN	compound	B-protein
inhibition	NN	nmod	O
were	VBD	auxpass	O
reversed	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
ectopic	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
constitutively	RB	advmod	O
activated	VBN	amod	O
Akt-1	NN	nmod	B-protein
or	CC	cc	O
Bcl-x	NN	conj	B-protein
(	-LRB-	punct	I-protein
L	NN	appos	I-protein
)	-RRB-	punct	I-protein
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
PI3K	NN	compound	B-protein
/Akt-1	NN	compound	O
pathway	NN	nmod	O
either	CC	advmod	O
by	IN	case	O
LY294002	NN	compound	O
or	CC	cc	O
DN	JJ	conj	B-protein
Akt-1	NN	nmod	I-protein
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
constitutive	JJ	amod	O
or	CC	cc	O
inducible	JJ	conj	O
activation	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-kappaB	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
after	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
the	DT	det	O
PI3K	NN	compound	B-protein
/	:	punct	O
Akt-1	NN	compound	B-protein
pathway	NN	nmod	O
,	,	punct	O
a	DT	det	O
marked	JJ	amod	O
decrease	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
antiapoptotic	JJ	amod	B-protein
molecule	NN	compound	I-protein
Mcl-1	NN	nmod	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
other	JJ	amod	O
Bcl-2	NN	compound	B-protein
family	NN	compound	I-protein
members	NNS	conj	I-protein
was	VBD	auxpass	O
observed	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
Mcl-1	NN	nsubj	B-protein
rescued	VBD	conj	O
macrophages	NNS	dobj	B-cell_type
from	IN	case	O
LY294002-induced	JJ	amod	O
cell	NN	compound	O
death	NN	nmod	O
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
Mcl-1	NN	nmod	B-protein
by	IN	case	O
antisense	JJ	amod	O
oligonucleotides	NNS	nmod	O
,	,	punct	O
also	RB	advmod	O
resulted	VBD	ROOT	O
in	IN	case	O
macrophage	NN	compound	B-cell_type
apoptosis	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
constitutive	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
Akt-1	NN	nmod	B-protein
regulates	VBZ	ccomp	O
macrophage	NN	compound	B-cell_type
survival	NN	dobj	O
through	IN	case	O
Mcl-1	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
independent	JJ	acl:relcl	O
of	IN	case	O
caspases	NNS	nmod	B-protein
,	,	punct	O
NF-kappaB	NN	conj	B-protein
,	,	punct	O
or	CC	cc	O
Bad	NN	conj	B-protein
.	.	punct	O

GRbeta	NN	compound	O
expression	NN	ROOT	O
in	IN	case	O
nasal	JJ	amod	B-cell_type
polyp	RB	compound	I-cell_type
inflammatory	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
its	PRP$	nmod:poss	O
relationship	NN	conj	O
to	TO	case	O
the	DT	det	O
anti-inflammatory	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
intranasal	JJ	amod	O
fluticasone	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Nasal	JJ	amod	O
polyposis	NN	compound	O
disease	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
inflammatory	JJ	amod	O
disorder	NN	dep	O
with	IN	case	O
intense	JJ	amod	O
eosinophilic	JJ	amod	O
infiltration	NN	nmod	O
of	IN	case	O
respiratory	JJ	amod	O
mucosa	NN	nmod	O
that	WDT	nsubj	O
is	VBZ	cop	O
often	RB	advmod	O
difficult	JJ	acl:relcl	O
to	TO	mark	O
control	VB	xcomp	O
with	IN	case	O
topical	JJ	amod	O
steroids	NNS	nmod	O
.	.	punct	O

Recent	JJ	amod	O
evidence	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
overexpression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
splice	NN	compound	I-protein
variant	JJ	amod	I-protein
GRbeta	NN	nmod	B-protein
in	IN	case	O
inflammatory	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
might	MD	aux	O
contribute	VB	ccomp	O
to	TO	case	O
steroid	NN	compound	O
insensitivity	NN	nmod	O
in	IN	case	O
diseases	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
asthma	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
purposes	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
investigation	NN	nmod	O
were	VBD	appos	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
nasal	JJ	amod	B-cell_type
polyp	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
NP	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
inflammatory	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
overexpress	VBP	ccomp	O
GRbeta	NN	dobj	B-protein
and	CC	cc	O
to	TO	mark	O
examine	VB	conj	O
whether	IN	mark	O
GRbeta	NN	compound	B-protein
overexpression	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
insensitivity	NN	nmod	O
to	TO	case	O
the	DT	det	O
potent	JJ	amod	O
topical	JJ	amod	O
steroid	NN	compound	O
fluticasone	NN	compound	O
propionate	NN	nmod	O
(	-LRB-	punct	O
FP	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Biopsies	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
from	IN	case	O
10	CD	nummod	O
subjects	NNS	nmod	O
with	IN	case	O
NPs	NNS	nmod	O
before	IN	nmod	O
and	CC	cc	O
4	CD	nummod	O
weeks	NNS	nmod	O
after	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
intranasal	JJ	amod	O
FP	NN	nmod	O
.	.	punct	O

Middle	JJ	nsubj	O
turbinates	NNS	ROOT	O
biopsies	NNS	dobj	O
from	IN	case	O
6	CD	nummod	O
healthy	JJ	amod	O
,	,	punct	O
nonallergic	JJ	dep	O
subjects	NNS	nmod	O
served	VBD	acl	O
as	IN	case	O
normal	JJ	amod	O
controls	NNS	nmod	O
.	.	punct	O

Biopsies	NNS	nsubjpass	O
were	VBD	auxpass	O
immunostained	VBN	ROOT	O
for	IN	case	O
inflammatory	JJ	amod	O
cell	NN	compound	O
markers	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
GRbeta	NN	conj	B-protein
and	CC	cc	O
probed	VBN	conj	O
for	IN	case	O
various	JJ	amod	O
cytokine	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

The	DT	det	O
anti-inflammatory	JJ	amod	O
response	NN	nsubjpass	O
to	TO	case	O
FP	NN	nmod	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
relation	NN	nmod	O
to	TO	case	O
pretreatment	NN	amod	O
levels	NNS	nmod	O
of	IN	case	O
GRbeta	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
total	JJ	amod	O
numbers	NNS	nsubjpass	O
of	IN	case	O
inflammatory	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	auxpass	O
increased	VBN	appos	O
in	IN	case	O
NPs	NNS	nmod	B-cell_type
.	.	punct	O

The	DT	det	O
percentage	NN	nsubjpass	O
of	IN	case	O
inflammatory	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
expressing	VBG	acl	O
GRbeta	NN	dobj	B-protein
was	VBD	auxpass	O
also	RB	advmod	O
increased	VBN	ROOT	O
(	-LRB-	punct	O
40.5	CD	nummod	O
%	NN	dep	O
+/-	CC	cc	O
19.2	CD	nummod	O
%	NN	conj	O
vs	CC	cc	O
16.1	CD	nummod	O
%	NN	conj	O
+/-	CC	cc	O
4.0	CD	nummod	O
%	NN	conj	O
,	,	punct	O
P	NN	compound	O
=.009	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

GRbeta	NN	compound	B-protein
expression	NN	nsubj	O
in	IN	case	O
NPs	NNS	nmod	B-cell_type
was	VBD	cop	O
almost	RB	advmod	O
exclusive	JJ	ROOT	O
to	TO	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
eosinophils	NNS	conj	B-cell_type
,	,	punct	O
and	CC	cc	O
macrophages	NNS	conj	B-cell_type
.	.	punct	O

An	DT	det	O
inverse	JJ	amod	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
between	IN	case	O
the	DT	det	O
baseline	NN	compound	O
inflammatory	JJ	amod	O
cell	NN	compound	O
GRbeta	NN	compound	B-protein
expression	NN	nmod	O
and	CC	cc	O
the	DT	det	O
reduction	NN	conj	O
after	IN	case	O
FP	NN	compound	O
treatment	NN	nmod	O
in	IN	case	O
EG2-positive	JJ	amod	B-cell_type
eosinophils	NNS	nmod	I-cell_type
,	,	punct	O
CD4-positive	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	conj	I-cell_type
,	,	punct	O
endothelial	JJ	amod	O
VCAM-1	NN	compound	B-protein
expression	NN	conj	O
,	,	punct	O
and	CC	cc	O
IL-4	NN	compound	B-cell_type
mRNA-positive	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

NPs	NNS	nsubj	B-cell_type
that	WDT	nsubj	O
were	VBD	cop	O
``	``	punct	O
FP-insensitive	JJ	acl:relcl	O
''	''	punct	O
in	IN	case	O
terms	NNS	nmod	O
of	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
eosinophil	NN	compound	B-cell_type
numbers	NNS	nmod	O
(	-LRB-	punct	O
major	JJ	amod	B-protein
basic	JJ	amod	I-protein
protein	NN	compound	I-protein
-positive	JJ	appos	O
)	-RRB-	punct	O
had	VBD	ROOT	O
a	DT	det	O
significantly	RB	advmod	O
greater	JJR	amod	O
percentage	NN	dobj	O
of	IN	case	O
GRbeta-positive	JJ	amod	B-cell_type
inflammatory	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
a	DT	det	O
higher	JJR	amod	O
ratio	NN	appos	O
of	IN	case	O
GRbeta-positive/GRalpha-positive	NN	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
increased	VBN	amod	O
numbers	NNS	conj	O
of	IN	case	O
GRbeta-positive	JJ	amod	B-cell_type
eosinophils	NNS	nmod	I-cell_type
and	CC	cc	O
macrophages	NNS	conj	B-cell_type
in	IN	case	O
comparison	NN	nmod	O
with	IN	case	O
those	DT	nmod	O
that	WDT	nsubj	O
were	VBD	cop	O
``	``	punct	O
FP-sensitive.	NN	conj	O
''	''	punct	O

``	``	punct	B-cell_type
FP-insensitive	JJ	amod	I-cell_type
''	''	punct	I-cell_type
NPs	NNS	nsubj	I-cell_type
also	RB	advmod	O
demonstrated	VBD	ROOT	O
a	DT	det	O
higher	JJR	amod	O
percentage	NN	dobj	O
of	IN	case	O
IL-5-positive	JJ	amod	B-cell_type
inflammatory	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
expressing	VBG	acl	O
GRbeta	NN	dobj	B-protein
before	IN	nmod	O
and	CC	cc	O
after	IN	conj	O
FP	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
GRbeta	NN	compound	B-protein
expression	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
marker	NN	xcomp	O
of	IN	case	O
steroid	NN	compound	O
insensitivity	NN	nmod	O
in	IN	case	O
NPs	NNS	nmod	B-cell_type
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
GRbeta	NN	nmod	B-protein
by	IN	case	O
NP	NN	compound	B-cell_type
inflammatory	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
particularly	RB	advmod	O
T	NN	compound	B-cell_type
cells	NNS	appos	I-cell_type
and	CC	cc	O
eosinophils	NNS	conj	B-cell_type
,	,	punct	O
might	MD	aux	O
render	VB	ROOT	O
them	PRP	nsubj	O
resistant	JJ	ccomp	O
to	TO	case	O
suppression	NN	nmod	O
by	IN	case	O
topical	JJ	amod	O
steroids	NNS	nmod	O
and	CC	cc	O
thereby	RB	advmod	O
contribute	VBP	conj	O
to	TO	case	O
persistent	JJ	amod	O
NP	NN	compound	B-cell_type
inflammation	NN	nmod	O
.	.	punct	O

Transcriptional	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
galectin-10	NN	nmod	B-protein
(	-LRB-	punct	O
eosinophil	NN	compound	B-protein
Charcot-Leyden	NN	compound	I-protein
crystal	NN	amod	I-protein
protein	NN	appos	I-protein
)	-RRB-	punct	O
:	:	punct	O
a	DT	det	O
GC	NN	compound	B-DNA
box	NN	nsubj	I-DNA
(	-LRB-	punct	O
-44	CD	compound	O
to	TO	dep	O
-50	CD	appos	O
)	-RRB-	punct	O
controls	VBZ	ROOT	O
butyric	JJ	amod	O
acid	NN	compound	O
induction	NN	dobj	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Galectin-10	NN	nsubj	B-protein
(	-LRB-	punct	O
gal-10	NN	appos	B-protein
,	,	punct	O
also	RB	advmod	O
known	VBN	acl	O
as	IN	case	O
Charcot-Leyden	NN	compound	B-protein
crystal	NN	amod	I-protein
protein	NN	nmod	I-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
galectin	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	O
beta-galactoside	NN	amod	B-protein
binding	NN	compound	I-protein
proteins	NNS	nmod	I-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
expressed	VBN	acl:relcl	O
uniquely	RB	advmod	O
in	IN	case	O
eosinophilic	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
basophilic	JJ	conj	I-cell_type
leukocytes	NNS	nmod	I-cell_type
.	.	punct	O

To	TO	mark	O
gain	VB	advcl	O
a	DT	det	O
better	JJR	amod	O
understanding	NN	dobj	O
of	IN	case	O
galectin	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
present	VBP	ROOT	O
an	DT	det	O
analysis	NN	dobj	O
of	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
encoding	NN	acl	O
gal-10	NN	dobj	B-protein
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
minimal	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
revealed	VBD	ROOT	O
nine	CD	nummod	O
consensus-binding	JJ	amod	B-DNA
sites	NNS	dobj	I-DNA
for	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
,	,	punct	O
including	VBG	case	O
several	JJ	nmod	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
also	RB	advmod	O
found	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
minimal	JJ	amod	B-DNA
promoters	NNS	nmod	I-DNA
of	IN	case	O
galectins	NNS	nmod	B-DNA
-1	CD	nummod	I-DNA
,	,	punct	I-DNA
-2	CD	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
-3	CD	conj	I-DNA
.	.	punct	O

The	DT	det	O
decrease	NN	nsubj	O
in	IN	case	O
gal-10	NN	amod	O
promoter	NN	compound	O
activity	NN	nmod	O
after	IN	case	O
disruption	NN	nmod	O
of	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
GC	NN	compound	B-DNA
box	NN	nmod	I-DNA
(	-LRB-	punct	O
-44	CD	nummod	O
to	TO	dep	O
-50	CD	appos	O
)	-RRB-	punct	O
or	CC	cc	O
the	DT	det	O
Oct	NN	compound	B-DNA
site	NN	conj	I-DNA
(	-LRB-	punct	O
-255	CD	nummod	O
to	TO	dep	O
-261	CD	appos	O
)	-RRB-	punct	O
suggests	VBZ	ROOT	O
that	IN	mark	O
these	DT	det	O
sites	NNS	nsubj	O
,	,	punct	O
along	IN	case	O
with	IN	case	O
the	DT	det	O
previously	RB	advmod	O
characterized	VBN	amod	O
GATA	NN	nmod	B-DNA
and	CC	cc	I-DNA
EoTF	JJ	compound	I-DNA
sites	NNS	conj	I-DNA
,	,	punct	O
are	VBP	cop	O
necessary	JJ	ccomp	O
for	IN	case	O
full	JJ	amod	O
promoter	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

By	IN	case	O
supershift	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
binding	NN	dobj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
Sp1	NN	dep	B-protein
and	CC	cc	O
Oct1	NN	conj	B-protein
to	TO	case	O
the	DT	det	O
consensus	NN	compound	B-DNA
GC	NN	compound	I-DNA
box	NN	nmod	I-DNA
and	CC	cc	O
the	DT	det	O
Oct	NN	compound	B-DNA
site	NN	conj	I-DNA
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Similar	JJ	advmod	O
to	TO	case	O
gal-1	NN	nmod	B-DNA
,	,	punct	O
gal-10	NN	amod	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
butyric	JJ	amod	O
acid	NN	nmod	O
,	,	punct	O
an	DT	det	O
effect	NN	appos	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
lost	VBN	acl:relcl	O
upon	IN	case	O
ablation	NN	nmod	O
of	IN	case	O
the	DT	det	O
GC	NN	compound	B-DNA
box	NN	nmod	I-DNA
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
AML3	NN	compound	O
binding	NN	dobj	O
to	TO	case	O
the	DT	det	O
consensus	NN	compound	B-DNA
AML	NN	compound	I-DNA
site	NN	nmod	I-DNA
and	CC	cc	O
YY1	NN	compound	B-protein
binding	VBG	conj	I-protein
to	TO	case	O
the	DT	det	O
Inr	NN	compound	B-DNA
sequence	NN	nmod	I-DNA
,	,	punct	O
both	DT	det	O
elements	NNS	dobj	O
functioning	VBG	acl	O
as	IN	case	O
silencers	NNS	nmod	O
in	IN	case	O
the	DT	det	O
gal-10	NN	amod	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Tumour-stromal	JJ	amod	O
interactions	NNS	ROOT	O
.	.	punct	O

Role	NN	ROOT	O
of	IN	case	O
the	DT	det	O
stroma	NN	nmod	O
in	IN	case	O
mammary	JJ	amod	O
development	NN	nmod	O
.	.	punct	O

Mammary	JJ	amod	O
development	NN	nsubj	O
depends	VBZ	ROOT	O
on	IN	case	O
branching	VBG	amod	O
morphogenesis	NN	nmod	O
,	,	punct	O
namely	RB	advmod	O
the	DT	det	O
bifurcation	NN	appos	O
and	CC	cc	O
extension	NN	conj	O
of	IN	case	O
ductal	JJ	amod	O
growth	NN	compound	O
points	NNS	nmod	O
(	-LRB-	punct	O
end	NN	compound	O
buds	NNS	appos	O
)	-RRB-	punct	O
and	CC	cc	O
secretory	JJ	amod	O
lobules	NNS	conj	O
into	IN	case	O
a	DT	det	O
more	JJR	amod	O
or	CC	cc	O
less	RBR	conj	O
fatty	JJ	amod	O
stroma	NN	nmod	O
.	.	punct	O

Because	IN	mark	O
breast	NN	compound	O
carcinomas	NNS	nsubj	O
are	VBP	cop	O
overwhelmingly	RB	advmod	O
ductal	JJ	advcl	O
in	IN	case	O
origin	NN	nmod	O
,	,	punct	O
this	DT	det	O
review	NN	nsubj	O
focuses	VBZ	ROOT	O
on	IN	case	O
stromal	JJ	amod	O
influences	NNS	nmod	O
guiding	VBG	acl	O
postnatal	JJ	amod	O
ductal	JJ	amod	O
development	NN	dobj	O
and	CC	cc	O
there	EX	expl	O
is	VBZ	conj	O
only	RB	advmod	O
the	DT	det	O
briefest	JJS	amod	O
account	NN	nsubj	O
of	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
embryonic	JJ	amod	O
stroma	NN	nmod	O
(	-LRB-	punct	O
mesenchyme	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
stroma	NN	nsubjpass	O
as	IN	case	O
the	DT	det	O
necessary	JJ	amod	O
target	NN	nmod	O
for	IN	case	O
endocrine	JJ	amod	O
mammogens	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
source	NN	conj	O
of	IN	case	O
stimulatory	JJ	amod	O
growth	NN	compound	O
factors	NNS	nmod	O
is	VBZ	auxpass	O
described	VBN	ROOT	O
and	CC	cc	O
the	DT	det	O
importance	NN	nsubjpass	O
of	IN	case	O
mammary	JJ	amod	O
epithelium-induced	JJ	amod	O
modifications	NNS	nmod	O
of	IN	case	O
the	DT	det	O
periductal	JJ	amod	O
stroma	NN	nmod	O
is	VBZ	auxpass	O
emphasized	VBN	conj	O
.	.	punct	O

Evidence	NN	nsubjpass	O
is	VBZ	auxpass	O
presented	VBN	ROOT	O
that	IN	mark	O
if	IN	mark	O
they	PRP	nsubj	O
are	VBP	advcl	O
to	TO	aux	O
grow	VB	xcomp	O
,	,	punct	O
end	VB	compound	O
buds	NNS	nsubj	O
must	MD	aux	O
condition	VB	ccomp	O
proximal	JJ	amod	O
fatty	JJ	amod	O
stroma	NN	dobj	O
by	IN	mark	O
recruiting	VBG	advcl	O
white	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
inducing	VBG	xcomp	O
stromal	JJ	amod	O
cell	NN	compound	O
division	NN	dobj	O
and	CC	cc	O
,	,	punct	O
possibly	RB	advmod	O
,	,	punct	O
estrogen	NN	compound	B-protein
receptors	NNS	conj	I-protein
.	.	punct	O

The	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
fibrous	JJ	amod	O
stromal	JJ	amod	O
tunic	NN	nmod	O
around	IN	case	O
the	DT	det	O
end	NN	compound	O
bud	NN	nmod	O
is	VBZ	auxpass	O
described	VBN	ROOT	O
and	CC	cc	O
its	PRP$	nmod:poss	O
likely	JJ	amod	O
role	NN	nsubjpass	O
as	IN	case	O
a	DT	det	O
complex	JJ	amod	O
ductal	JJ	amod	O
morphogen	NN	nmod	O
is	VBZ	auxpass	O
discussed	VBN	conj	O
;	:	punct	O
a	DT	det	O
possible	JJ	amod	O
role	NN	nsubjpass	O
in	IN	case	O
growth	NN	compound	O
inhibition	NN	nmod	O
is	VBZ	auxpass	O
also	RB	advmod	O
considered	VBN	parataxis	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
signals	NNS	nsubj	O
governing	VBG	advcl	O
fibrotic	JJ	amod	O
induction	NN	dobj	O
,	,	punct	O
ductal	JJ	amod	O
morphogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
growth	NN	compound	O
inhibition	NN	conj	O
are	VBP	cop	O
unknown	JJ	ROOT	O
,	,	punct	O
a	DT	det	O
role	NN	nsubj	O
for	IN	case	O
transforming	VBG	amod	O
growth	NN	compound	B-protein
factor-beta	NN	nmod	I-protein
is	VBZ	cop	O
highly	RB	advmod	O
likely	JJ	parataxis	O
and	CC	cc	O
is	VBZ	auxpass	O
discussed	VBN	conj	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
a	DT	det	O
need	NN	nsubjpass	O
for	IN	prep	O
new	JJ	amod	O
conceptual	JJ	amod	O
and	CC	cc	O
experimental	JJ	conj	O
approaches	NNS	pobj	O
to	TO	mark	O
understanding	VBG	acl	O
stromal-epithelial	JJ	amod	O
signaling	NN	dobj	O
is	VBZ	auxpass	O
discussed	VBN	ROOT	O
.	.	punct	O

Adipophilin	NNP	nsubj	B-protein
is	VBZ	ROOT	O
a	DT	det	O
sensitive	JJ	amod	O
marker	NN	attr	O
for	IN	case	O
lipid	NN	compound	O
loading	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

Adipophilin	NNP	nsubjpass	B-protein
,	,	punct	O
a	DT	det	O
marker	NN	nsubjpass	O
of	IN	case	O
lipid	NN	compound	O
accumulation	NN	nmod	O
initially	RB	advmod	O
described	VBN	acl	O
in	IN	case	O
adipocytes	NNS	nmod	B-cell_type
,	,	punct	O
was	VBD	auxpass	O
recently	RB	advmod	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
induced	VBN	xcomp	O
in	IN	case	O
macrophage	NN	compound	B-cell_type
foam	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
even	RB	advmod	O
freshly	RB	advmod	B-cell_type
isolated	VBN	amod	I-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nsubj	I-cell_type
express	VBP	ccomp	O
adipophilin	NN	dobj	B-protein
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
amount	NN	nsubj	O
of	IN	case	O
adipophilin	NN	compound	B-protein
protein	NN	nmod	I-protein
is	VBZ	cop	O
variable	JJ	conj	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
from	IN	case	O
different	JJ	amod	O
healthy	JJ	amod	O
individuals	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
physiological	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
adipophilin	NN	nmod	B-protein
does	VBZ	aux	O
not	RB	neg	O
correlate	VB	ROOT	O
with	IN	case	O
the	DT	det	O
levels	NNS	nmod	O
of	IN	case	O
free	JJ	amod	O
fatty	JJ	amod	O
acids	NNS	nmod	O
,	,	punct	O
cholesterylesters	NNS	conj	O
or	CC	cc	O
free	JJ	amod	O
cholesterol	NN	conj	O
.	.	punct	O

Enzymatically	RB	advmod	B-protein
modified	VBN	amod	I-protein
low-density	JJ	amod	I-protein
lipoprotein	NN	nsubj	I-protein
(	-LRB-	punct	O
E-LDL	NN	appos	B-protein
)	-RRB-	punct	O
induces	VBZ	ROOT	O
rapid	JJ	amod	O
foam	NN	compound	O
cell	NN	compound	O
formation	NN	dobj	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
and	CC	cc	O
upregulates	VBZ	conj	O
adipophilin	NN	compound	B-protein
mRNA	NN	dobj	O
and	CC	cc	O
protein	NN	conj	O
within	IN	case	O
2	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
incubation	NN	nmod	O
.	.	punct	O

This	DT	det	O
rapid	JJ	amod	O
induction	NN	nsubjpass	O
of	IN	case	O
adipophilin	NN	nmod	B-protein
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
significant	JJ	amod	O
increase	NN	nmod	O
of	IN	case	O
free	JJ	amod	O
fatty	JJ	amod	O
acids	NNS	nmod	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
incubated	VBN	acl	O
with	IN	case	O
E-LDL	NN	nmod	B-protein
.	.	punct	O

Adipophilin	NNP	nsubj	B-protein
facilitates	VBZ	ROOT	O
the	DT	det	O
uptake	NN	dobj	O
of	IN	prep	O
free	JJ	amod	O
fatty	JJ	amod	O
acids	NNS	pobj	O
,	,	punct	O
and	CC	cc	O
here	RB	advmod	O
we	PRP	nsubj	O
demonstrate	VBP	conj	O
that	IN	mark	O
free	JJ	amod	O
fatty	JJ	amod	O
acids	NNS	compound	O
increase	VBP	nsubj	O
is	VBZ	cop	O
related	JJ	ccomp	O
to	TO	case	O
the	DT	det	O
early	JJ	amod	O
upregulation	NN	nmod	O
of	IN	case	O
adipophilin	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
blood	NN	compound	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

Fatty	JJ	amod	O
acids	NNS	nsubj	O
are	VBP	cop	O
ligands	NNS	ROOT	O
for	IN	case	O
peroxisome	NN	compound	B-protein
proliferator-activated	JJ	amod	I-protein
receptor-gamma	NN	nmod	I-protein
(	-LRB-	punct	O
PPARgamma	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
upregulation	NN	nsubj	O
of	IN	case	O
adipophilin	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
by	IN	case	O
PPARgamma	NN	compound	B-protein
agonists	NNS	nmod	O
like	IN	case	O
15d-PGJ	NN	nmod	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
ciglitazone	NN	conj	O
indicates	VBZ	conj	O
that	IN	mark	O
PPARgamma	NN	nsubj	B-protein
may	MD	aux	O
mediate	VB	ccomp	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
adipophilin	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

Constitutive	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
MHC	NN	compound	B-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
melanoma	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
results	VBZ	ROOT	O
from	IN	case	O
the	DT	det	O
transcription	NN	nmod	O
of	IN	case	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
transactivator	NN	nmod	I-DNA
abnormally	RB	advmod	O
initiated	VBN	acl	O
from	IN	case	O
its	PRP$	nmod:poss	O
B	NN	compound	B-DNA
cell-specific	JJ	amod	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
melanoma	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
two	CD	nummod	O
different	JJ	amod	O
patterns	NNS	nsubjpass	O
of	IN	case	O
MHC	NN	compound	O
class	NN	compound	O
II	CD	nummod	O
expression	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
described	VBN	ROOT	O
,	,	punct	O
either	CC	cc:preconj	O
an	DT	det	O
IFN	NN	compound	O
gamma-inducible	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
HLA-DR	NN	nmod	B-DNA
and	CC	cc	O
HLA-DP	NN	conj	B-DNA
,	,	punct	O
with	IN	case	O
a	DT	det	O
faint	JJ	amod	O
or	CC	cc	O
null	JJ	conj	O
expression	NN	nmod	O
of	IN	case	O
HLA-DQ	NN	nmod	B-DNA
,	,	punct	O
resembling	VBG	xcomp	O
that	IN	xcomp	O
described	VBN	acl	O
for	IN	case	O
melanocytes	NNS	nmod	B-cell_type
,	,	punct	O
or	CC	cc	O
a	DT	det	O
constitutive	JJ	amod	O
expression	NN	conj	O
,	,	punct	O
i.e.	FW	advmod	O
,	,	punct	O
IFN-gamma	NN	nmod:npmod	O
independent	JJ	amod	O
,	,	punct	O
of	IN	case	O
all	DT	det	O
three	CD	nummod	O
HLA-D	NN	compound	B-DNA
isotypes	NNS	nmod	I-DNA
.	.	punct	O

As	IN	mark	O
this	DT	det	O
latter	JJ	amod	O
phenotype	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	advcl	O
with	IN	case	O
a	DT	det	O
more	RBR	advmod	O
rapid	JJ	amod	O
progression	NN	nmod	O
of	IN	case	O
melanoma	NN	compound	O
tumors	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
analyzed	VBN	ROOT	O
in	IN	case	O
different	JJ	amod	O
melanoma	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
leading	VBG	acl	O
to	TO	case	O
this	DT	det	O
abnormal	JJ	amod	O
pattern	NN	nmod	O
of	IN	case	O
MHC	NN	compound	O
class	NN	compound	O
II	CD	nummod	O
expression	NN	nmod	O
.	.	punct	O

In	IN	case	O
agreement	NN	nmod	O
with	IN	case	O
the	DT	det	O
evidence	NN	nmod	O
of	IN	case	O
a	DT	det	O
coordinate	JJ	amod	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
HLA-D	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
these	DT	det	O
cell	NN	compound	O
lines	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	advcl	O
the	DT	det	O
constitutive	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
CIITA	NN	compound	B-RNA
(	-LRB-	punct	I-RNA
class	NN	compound	I-RNA
II	CD	nummod	I-RNA
transactivator	NN	appos	I-RNA
)	-RRB-	punct	I-RNA
transcripts	NNS	nmod	I-RNA
,	,	punct	O
CIITA	NN	nsubjpass	B-protein
being	VBG	auxpass	O
known	VBN	ROOT	O
as	IN	case	O
the	DT	det	O
master	JJ	amod	O
switch	NN	nmod	O
of	IN	case	O
MHC	NN	compound	O
class	NN	compound	O
II	CD	nummod	O
expression	NN	nmod	O
.	.	punct	O

Unexpectedly	RB	advmod	O
,	,	punct	O
these	DT	det	O
transcripts	NNS	nsubj	O
initiate	VBP	ROOT	O
from	IN	case	O
promoter	NN	nmod	B-DNA
III	CD	nummod	I-DNA
of	IN	case	O
the	DT	det	O
CIITA	NN	compound	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
a	DT	det	O
promoter	NN	appos	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
mainly	RB	advmod	O
used	VBN	acl:relcl	O
constitutively	RB	advmod	O
in	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	det	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
further	RB	advmod	O
shown	VBN	ROOT	O
to	TO	mark	O
occur	VB	xcomp	O
through	IN	case	O
factor	NN	compound	O
(	-LRB-	punct	O
s	NNS	nmod	O
)	-RRB-	punct	O
acting	VBG	acl	O
on	IN	case	O
the	DT	det	O
enhancer	NN	nmod	O
located	JJ	amod	O
upstream	RB	advmod	O
of	IN	case	O
CIITA	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
III	CD	nummod	I-DNA
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
previously	RB	advmod	O
described	VBN	acl:relcl	O
in	IN	case	O
epithelioid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
as	IN	case	O
an	DT	det	O
IFN-gamma-response	JJ	amod	O
sequence	NN	nmod	O
.	.	punct	O

The	DT	det	O
hypothesis	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
general	JJ	amod	O
abnormality	NN	nmod	O
of	IN	case	O
the	DT	det	O
IFN-gamma	NN	compound	O
transduction	NN	compound	O
pathway	NN	nmod	O
was	VBD	auxpass	O
dismissed	VBN	ROOT	O
.	.	punct	O

Constitutive	JJ	amod	O
transcription	NN	nsubjpass	O
of	IN	case	O
CIITA	NN	nmod	B-DNA
from	IN	case	O
promoter	NN	nmod	B-DNA
III	CD	nummod	I-DNA
having	VBG	acl	O
been	VBN	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
unrelated	JJ	amod	O
melanoma	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	parataxis	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
this	DT	det	O
phenomenon	NN	nsubj	O
might	MD	aux	O
not	RB	neg	O
be	VB	cop	O
a	DT	det	O
random	JJ	amod	O
event	NN	ccomp	O
,	,	punct	O
but	CC	cc	O
could	MD	aux	O
be	VB	auxpass	O
linked	VBN	conj	O
to	TO	case	O
the	DT	det	O
neoplasic	JJ	amod	O
state	NN	nmod	O
of	IN	case	O
the	DT	det	O
melanoma	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type

Caspase	NN	compound	B-protein
-mediated	JJ	amod	O
calcineurin	NN	compound	O
activation	NN	nsubj	O
contributes	VBZ	ROOT	O
to	TO	case	O
IL-2	NN	compound	B-protein
release	NN	nmod	O
during	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Calcineurin	NN	nsubj	B-protein
,	,	punct	O
a	DT	det	O
Ca	NN	compound	B-protein
(	-LRB-	punct	I-protein
2+	NN	dep	I-protein
)	-RRB-	punct	I-protein
/calmodulin-dependent	JJ	amod	I-protein
Ser/Thr	NN	compound	I-protein
phosphatase	NN	compound	I-protein
(	-LRB-	punct	I-protein
protein	NN	compound	I-protein
phosphatase	NN	compound	I-protein
2B	NN	appos	I-protein
)	-RRB-	punct	I-protein
,	,	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
IL-2	NN	compound	O
production	NN	nmod	O
during	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
previously	RB	advmod	O
reported	VBN	ROOT	O
that	IN	mark	O
IL-2	NN	compound	B-protein
release	NN	nsubj	O
in	IN	case	O
activated	VBN	amod	O
Jurkat	NN	compound	B-cell_line
T	NN	nmod	I-cell_line
requires	VBZ	ccomp	O
caspase-like	JJ	amod	O
activity	NN	dobj	O
(	-LRB-	punct	O
Posmantur	NNP	dep	O
et	FW	dep	O
al.	FW	dep	O
(	-LRB-	punct	O
1998	CD	dep	O
)	-RRB-	punct	O
Exp.	NNP	compound	O
Cell.	NNP	compound	O
Res.	NNP	dep	O
244	CD	nummod	O
,	,	punct	O
302-309	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
the	DT	det	O
60-kDa	JJ	amod	B-protein
catalytic	JJ	amod	I-protein
subunit	NN	nsubjpass	I-protein
of	IN	case	O
calcineurin	NN	compound	B-protein
A	NN	nmod	I-protein
(	-LRB-	punct	O
Cn	NN	compound	B-protein
A	NN	appos	I-protein
)	-RRB-	punct	O
was	VBD	auxpass	O
partially	RB	advmod	O
cleaved	VBN	ccomp	O
to	TO	case	O
a	DT	det	O
45-kDa	JJ	amod	B-protein
form	NN	nmod	O
in	IN	case	O
phytohemagglutinin	NN	compound	O
A	NN	nmod	O
(	-LRB-	punct	O
PHA	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
phorbol	NN	compound	O
ester	NN	conj	O
+	CC	cc	O
ionomycin	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
+	CC	cc	O
I	NN	conj	O
)	-RRB-	punct	O
-activated	JJ	amod	O
Jurkat	NN	compound	B-cell_line
cells	NNS	dep	I-cell_line
.	.	punct	O

In	IN	case	O
parallel	NN	nmod	O
,	,	punct	O
proteolytic	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
upstream	JJ	amod	O
caspases	NNS	nmod	B-protein
(	-LRB-	punct	O
caspase-8	NN	dep	O
and	CC	cc	O
-9	CD	conj	O
)	-RRB-	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
effector	NN	compound	B-protein
caspase-3	NN	conj	I-protein
was	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
.	.	punct	O

Cn	NN	compound	B-protein
A	NN	compound	I-protein
cleavage	NN	nsubj	O
was	VBD	auxpass	O
caspase	NN	nsubjpass	O
mediated	VBN	ROOT	O
,	,	punct	O
since	IN	mark	O
it	PRP	nsubj	O
was	VBD	cop	O
inhibitable	JJ	advcl	O
by	IN	case	O
pan-caspase	JJ	amod	O
inhibitor	NN	compound	O
Cbz-Asp-CH	NN	nmod	O
(	-LRB-	punct	O
2	LS	nummod	O
)	-RRB-	punct	O
OC	NN	compound	O
(	-LRB-	punct	O
O	NN	appos	O
)	-RRB-	punct	O
-2	CD	nummod	O
,	,	punct	O
6-dichlorobenzene	NN	dep	O
(	-LRB-	punct	O
Z-D-DCB	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Cn	NN	compound	B-protein
A	NN	compound	I-protein
cleavage	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
when	WRB	advmod	O
purified	VBN	amod	O
calcineurin	NN	nsubjpass	B-protein
was	VBD	auxpass	O
digested	VBN	advcl	O
in	FW	compound	O
vitro	FW	advmod	O
with	IN	case	O
caspase-3	NN	nmod	B-protein
.	.	punct	O

Truncated	VBN	amod	B-protein
Cn	NNP	compound	I-protein
A	NN	nsubjpass	I-protein
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
enhanced	VBN	amod	O
phosphatase	NN	compound	O
activity	NN	nmod	O
and	CC	cc	O
reduced	VBN	amod	O
calmodulin	NN	compound	O
sensitivity	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
in	IN	case	O
PHA	NN	nmod	O
or	CC	cc	O
P	NN	conj	O
+	CC	cc	O
I-activated	JJ	conj	O
Jurkat	NN	compound	B-cell_line
cells	NNS	dep	I-cell_line
,	,	punct	O
dephosphorylation	NN	appos	O
of	IN	case	O
calcineurin	NN	compound	B-protein
substrate	NN	compound	O
NFATc	NN	nmod	B-protein
(	-LRB-	punct	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	dep	I-protein
known	VBN	acl	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
in	IN	case	O
transactivation	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
suppressed	VBN	ROOT	O
by	IN	case	O
Z-D-DCB	NN	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
caspase-mediated	JJ	amod	O
cleavage	NN	nsubj	O
of	IN	case	O
Cn	NN	compound	B-protein
A	NN	nmod	I-protein
contributes	VBZ	ccomp	O
to	TO	case	O
IL-2	NN	compound	O
production	NN	nmod	O
during	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Copyright	NN	dep	O
2001	CD	nummod	O
Academic	NNP	compound	O
Press	NNP	ROOT	O
.	.	punct	O

Maturation	NN	ROOT	O
of	IN	case	O
human	JJ	amod	B-cell_type
dendritic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
as	IN	case	O
sulfasalazine	NN	compound	O
target	NN	nmod	O
.	.	punct	O

AIM	NN	ROOT	O
:	:	punct	O
Sulfasalazine	NN	nsubj	O
,	,	punct	O
a	DT	det	O
nonsteroidal	JJ	amod	O
anti-inflammatory	JJ	amod	O
drug	NN	appos	O
,	,	punct	O
is	VBZ	cop	O
effective	JJ	appos	O
in	IN	mark	O
treating	VBG	advcl	O
some	DT	det	O
autoimmune	JJ	amod	O
diseases	NNS	dobj	O
,	,	punct	O
but	CC	cc	O
its	PRP$	nmod:poss	O
mechanism	NN	nsubj	O
of	IN	case	O
action	NN	nmod	O
is	VBZ	cop	O
unclear	JJ	conj	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
dendritic	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
could	MD	aux	O
be	VB	cop	O
a	DT	det	O
possible	JJ	amod	O
target	NN	ccomp	O
of	IN	case	O
the	DT	det	O
drug	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
sulfasalazine	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
metabolites	NNS	conj	O
,	,	punct	O
aminosalicylate	NN	conj	O
and	CC	cc	O
sulfapyridine	NN	conj	O
,	,	punct	O
on	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
maturation	NN	nmod	O
(	-LRB-	punct	O
terminal	JJ	amod	O
differentiation	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
human	JJ	amod	B-cell_type
myeloid	JJ	amod	I-cell_type
dendritic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
prepared	VBD	ROOT	O
immature	JJ	amod	B-cell_type
dendritic	JJ	amod	I-cell_type
cells	NNS	dobj	I-cell_type
by	IN	mark	O
incubating	VBG	advcl	O
CD14-positive	JJ	amod	B-cell_type
cells	NNS	dobj	I-cell_type
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
granulocyte-	NN	amod	B-protein
macrophage	NN	compound	I-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	nmod	I-protein
and	CC	cc	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	conj	I-protein
)	-RRB-	punct	I-protein
-4	CD	nummod	I-protein
.	.	punct	O

The	DT	det	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
matured	VBN	ROOT	O
by	IN	case	O
addition	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	I-protein
TNF	NN	appos	I-protein
)	-RRB-	punct	I-protein
-a	NN	nummod	I-protein
,	,	punct	O
IL-1	NN	compound	B-protein
beta	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
prostaglandin	NN	compound	B-protein
E2	NN	conj	I-protein
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
sulfasalazine	NN	nmod	O
or	CC	cc	O
its	PRP$	nmod:poss	O
metabolites	NNS	conj	O
--	:	punct	O
aminosalicylate	VBP	conj	O
and	CC	cc	O
sulfapyridine	NN	conj	O
,	,	punct	O
or	CC	cc	O
their	PRP$	nmod:poss	O
combinations	NNS	conj	O
.	.	punct	O

We	PRP	nsubj	O
quantified	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
drugs	NNS	nmod	O
on	IN	case	O
the	DT	det	O
dendritic	JJ	amod	O
cell	NN	compound	O
characteristics	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
stimulation	NN	nmod	O
of	IN	case	O
autologous	JJ	amod	O
and	CC	cc	O
allogeneic	JJ	conj	O
pan-T	JJ	conj	O
cell	NN	compound	O
proliferation	NN	nmod	O
,	,	punct	O
surface	NN	compound	O
marker	NN	compound	O
phenotype	NN	conj	O
,	,	punct	O
IL-12	NN	compound	O
p40	NN	compound	O
subunit	NN	compound	O
secretion	NN	conj	O
,	,	punct	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Dendritic	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
treated	VBN	acl	O
with	IN	case	O
sulfasalazine	NN	nmod	O
(	-LRB-	punct	O
1.25	CD	nummod	O
micromol/L	NN	dep	O
or	CC	cc	O
2.5	CD	nummod	O
micromol/L	NN	conj	O
)	-RRB-	punct	O
could	MD	aux	O
not	RB	neg	O
stimulate	VB	dep	O
T	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
(	-LRB-	punct	O
p	NN	dep	O
<	CD	amod	O
0.028	CD	dep	O
,	,	punct	O
two-sided	JJ	amod	O
paired	JJ	amod	O
t-test	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
distinction	NN	nmod	O
to	TO	case	O
drug-free	JJ	amod	O
maturing	VBG	amod	O
dendritic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
2.5	CD	nummod	O
micromol/L	NN	amod	O
sulfasalazine	NN	nsubj	O
upregulated	VBD	ROOT	O
the	DT	det	O
levels	NNS	dobj	O
of	IN	case	O
CD14	NN	nmod	B-protein
and	CC	cc	O
CD68	NN	conj	B-protein
and	CC	cc	O
downregulated	VBD	conj	O
the	DT	det	O
levels	NNS	dobj	O
of	IN	case	O
CD40	NN	nmod	B-protein
,	,	punct	O
CD80	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
CD83	NN	conj	B-protein
(	-LRB-	punct	O
for	IN	case	O
all	DT	det	O
CD	NN	compound	O
markers	NNS	nmod	O
,	,	punct	O
p	NN	dep	O
<	CD	appos	O
0.03	CD	nummod	O
for	IN	case	O
difference	NN	nmod	O
between	IN	case	O
measurements	NNS	nmod	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
and	CC	cc	O
the	DT	det	O
presence	NN	conj	O
of	IN	case	O
sulfasalazine	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

From	IN	case	O
concentration-dependent	JJ	amod	O
changes	NNS	nmod	O
in	IN	case	O
CD83	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
an	DT	det	O
apparent	JJ	amod	O
ID50	NN	compound	O
>	NN	advmod	O
>	NN	amod	O
1.5	CD	nummod	O
micromol/L	NN	amod	O
sulfasalazine	NN	dobj	O
.	.	punct	O

The	DT	det	O
apparent	JJ	amod	O
ID50	NN	compound	O
value	NN	nsubj	O
for	IN	case	O
aminosalicylate-inhibited	JJ	amod	O
maturation	NN	nmod	O
was	VBD	cop	O
4	CD	nummod	O
micromol/L	NN	ROOT	O
.	.	punct	O

Sulfapyridine	NNP	nsubj	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
.	.	punct	O

At	IN	case	O
1.25	CD	nummod	O
micromol/L	NN	nmod	O
,	,	punct	O
sulfasalazine	NN	nsubj	O
largely	RB	advmod	O
inhibited	VBD	ROOT	O
NF-kB	NN	compound	O
activation	NN	dobj	O
in	IN	case	O
dendritic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Maturing	VBG	amod	B-cell_type
human	JJ	amod	I-cell_type
dendritic	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
are	VBP	cop	O
hundred-fold	RB	advmod	O
more	RBR	advmod	O
sensitive	JJ	appos	O
to	TO	case	O
sulfasalazine	NN	nmod	O
than	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
NK	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
and	CC	cc	O
the	DT	det	O
most	RBS	advmod	O
sensitive	JJ	amod	O
human	JJ	amod	O
cells	NNS	conj	O
described	VBN	acl	O
so	RB	advmod	O
far	RB	advmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
dendritic	JJ	amod	O
cell	NN	compound	O
maturation	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
target	NN	ROOT	O
of	IN	case	O
sulfasalazine	NN	nmod	O
.	.	punct	O

Because	IN	case	O
of	IN	mwe	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
dendritic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
(	-LRB-	punct	O
auto	NN	compound	O
)	-RRB-	punct	O
immunity	NN	nmod	O
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
their	PRP$	nmod:poss	O
maturation	NN	nmod	O
might	MD	aux	O
provide	VB	ROOT	O
a	DT	det	O
target	NN	dobj	O
for	IN	case	O
further	JJ	amod	O
optimization	NN	nmod	O
of	IN	case	O
sulfasalazine	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O

Defective	JJ	amod	O
function	NN	ROOT	O
of	IN	case	O
the	DT	det	O
proteasome	NN	nmod	B-protein
in	IN	case	O
autoimmunity	NN	nmod	O
:	:	punct	O
involvement	NN	dep	O
of	IN	case	O
impaired	JJ	amod	O
NF-kappaB	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Type	NN	compound	O
1	CD	nummod	O
diabetes	NNS	nsubjpass	O
(	-LRB-	punct	O
also	RB	advmod	O
known	VBN	dep	O
as	IN	case	O
insulin-dependent	JJ	amod	O
diabetes	NNS	compound	O
mellitus	NN	nmod	O
or	CC	cc	O
juvenile-onset	JJ	compound	O
diabetes	NNS	conj	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
usually	RB	advmod	O
caused	VBN	ROOT	O
by	IN	case	O
T	NN	nmod:npmod	O
cell-mediated	JJ	amod	O
autoimmunity	NN	nmod	O
,	,	punct	O
with	IN	case	O
a	DT	det	O
prediabetic	JJ	amod	O
state	NN	nmod	O
characterized	VBN	acl	O
by	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
autoantibodies	NNS	nmod	B-protein
specific	JJ	amod	O
for	IN	case	O
proteins	NNS	nmod	O
expressed	VBN	acl	O
by	IN	case	O
pancreatic	JJ	amod	B-cell_type
beta	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
nonobese	JJ	amod	O
patient	NN	nsubj	O
with	IN	case	O
diabetes	NNS	compound	O
(	-LRB-	punct	O
NOD	NN	appos	O
)	-RRB-	punct	O
mouse	NN	nmod	O
is	VBZ	cop	O
a	DT	det	O
spontaneous	JJ	amod	O
model	NN	ROOT	O
of	IN	case	O
type	NN	compound	O
1	CD	nummod	O
diabetes	VBZ	nmod	O
with	IN	case	O
a	DT	det	O
strong	JJ	amod	O
genetic	JJ	amod	O
component	NN	nmod	O
that	WDT	nsubj	O
maps	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
major	JJ	amod	B-DNA
histocompatibility	NN	compound	I-DNA
complex	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
MHC	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
region	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
genome	NN	nmod	B-DNA
.	.	punct	O

A	DT	det	O
specific	JJ	amod	O
proteasome	NN	compound	B-protein
defect	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
NOD	NN	compound	O
mouse	NN	nmod	O
in	IN	case	O
select	JJ	amod	O
lymphocytic	JJ	amod	B-cell_line
and	CC	cc	I-cell_line
monocytic	JJ	conj	I-cell_line
lineages	NNS	nmod	I-cell_line
that	WDT	nsubj	O
results	VBZ	acl:relcl	O
from	IN	case	O
down-regulation	NN	nmod	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
proteasome	NN	compound	B-protein
subunit	NN	compound	I-protein
LMP2	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
encoded	VBN	acl:relcl	O
by	IN	case	O
a	DT	det	O
gene	NN	nmod	O
in	IN	case	O
the	DT	det	O
MHC	NN	compound	B-DNA
genomic	JJ	amod	I-DNA
region	NN	nmod	I-DNA
.	.	punct	O

This	DT	det	O
defect	NN	nsubj	O
prevents	VBZ	ROOT	O
the	DT	det	O
proteolytic	JJ	amod	O
processing	NN	dobj	O
required	VBN	acl	O
for	IN	case	O
the	DT	det	O
production	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
nuclear	JJ	amod	I-protein
factor-kappaB	NN	nmod	I-protein
(	-LRB-	punct	O
NF-kappaB	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
plays	VBZ	acl:relcl	O
important	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
immune	JJ	amod	O
and	CC	cc	O
inflammatory	JJ	conj	O
responses	NNS	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
increases	VBZ	conj	O
the	DT	det	O
susceptibility	NN	dobj	O
of	IN	case	O
the	DT	det	O
affected	VBN	amod	O
cells	NNS	nmod	O
to	TO	case	O
apoptosis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	nmod	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
novel	JJ	amod	O
role	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
proteasome	NN	nmod	B-protein
in	IN	case	O
dysfunction	NN	nmod	O
in	IN	case	O
autoimmunity	NN	nmod	O
is	VBZ	auxpass	O
presented	VBN	ROOT	O
and	CC	cc	O
documented	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
both	CC	cc:preconj	O
tissue	NN	xcomp	O
and	CC	cc	O
developmental	JJ	amod	O
stage	NN	conj	O
specific	JJ	amod	O
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
a	DT	det	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
proteasome	NN	nmod	B-protein
as	IN	case	O
a	DT	det	O
step	NN	nmod	O
in	IN	case	O
disease	NN	compound	O
pathogenesis	NN	nmod	O
and	CC	cc	O
tissue	NN	compound	O
targeting	NN	conj	O
.	.	punct	O

Down-regulation	NN	ROOT	O
of	IN	case	O
TDT	NN	compound	O
transcription	NN	nmod	O
in	IN	case	O
CD4	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
CD8	NN	conj	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
thymocytes	NNS	nmod	I-cell_type
by	IN	case	O
Ikaros	NN	compound	B-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
direct	JJ	amod	O
competition	NN	nmod	O
with	IN	case	O
an	DT	det	O
Ets	NN	compound	B-protein
activator	NN	nmod	I-protein
.	.	punct	O

Ikaros	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
unique	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
lymphopoiesis	NN	nmod	O
that	WDT	nsubj	O
associates	VBZ	acl:relcl	O
with	IN	case	O
pericentromeric	JJ	amod	B-DNA
heterochromatin	NN	nmod	I-DNA
and	CC	cc	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	conj	O
in	IN	case	O
heritable	JJ	amod	O
gene	NN	compound	O
inactivation	NN	nmod	O
.	.	punct	O

Binding	NN	nsubj	O
and	CC	cc	O
competition	NN	conj	O
experiments	NNS	dep	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
Ikaros	NN	compound	B-protein
dimers	NNS	nsubj	I-protein
compete	VBP	ccomp	O
with	IN	case	O
an	DT	det	O
Ets	NN	compound	B-protein
activator	NN	nmod	I-protein
for	IN	case	O
occupancy	NN	nmod	O
of	IN	case	O
the	DT	det	O
lymphocyte-specific	JJ	amod	B-DNA
TdT	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Mutations	NNS	nsubj	O
that	WDT	nsubj	O
selectively	RB	advmod	O
disrupt	VBP	acl:relcl	O
Ikaros	NN	compound	O
binding	NN	dobj	O
to	TO	case	O
an	DT	det	O
integrated	VBN	amod	B-DNA
TdT	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
promoter	NN	compound	O
function	NN	nmod	O
in	IN	case	O
a	DT	det	O
CD4	NN	compound	B-cell_line
(	-LRB-	punct	I-cell_line
+	CC	cc	I-cell_line
)	-RRB-	punct	I-cell_line
CD8	NN	appos	I-cell_line
(	-LRB-	punct	I-cell_line
+	CC	cc	I-cell_line
)	-RRB-	punct	I-cell_line
thymocyte	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
these	DT	det	O
mutations	NNS	nsubj	O
abolished	VBD	ROOT	O
down-regulation	NN	dobj	O
on	IN	case	O
differentiation	NN	nmod	O
,	,	punct	O
providing	VBG	advcl	O
evidence	NN	dobj	O
that	IN	mark	O
Ikaros	NN	nsubj	B-protein
plays	VBZ	ccomp	O
a	DT	det	O
direct	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
repression	NN	nmod	O
.	.	punct	O

Reduced	VBN	amod	O
access	NN	nsubj	O
to	TO	case	O
restriction	NN	compound	O
enzyme	NN	compound	O
cleavage	NN	nmod	O
suggested	VBD	ROOT	O
that	IN	mark	O
chromatin	NN	compound	O
alterations	NNS	nsubj	O
accompany	VBP	ccomp	O
down-regulation	NN	dobj	O
.	.	punct	O

The	DT	det	O
Ikaros-dependent	JJ	amod	O
down-regulation	NN	amod	O
event	NN	nsubj	O
and	CC	cc	O
the	DT	det	O
observed	VBN	amod	O
chromatin	NN	compound	O
alterations	NNS	conj	O
appear	VBP	ROOT	O
to	TO	mark	O
precede	VB	xcomp	O
pericentromeric	JJ	amod	O
repositioning	NN	dobj	O
.	.	punct	O

Current	JJ	amod	O
models	NNS	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
functions	NNS	nsubjpass	O
of	IN	case	O
Ikaros	NN	nmod	B-protein
should	MD	aux	O
be	VB	auxpass	O
disrupted	VBN	ccomp	O
by	IN	case	O
a	DT	det	O
small	JJ	amod	O
isoform	NN	nmod	B-protein
that	WDT	nsubj	O
retains	VBZ	acl:relcl	O
the	DT	det	O
dimerization	NN	compound	B-protein
domain	NN	dobj	I-protein
and	CC	cc	O
lacks	VBZ	conj	O
the	DT	det	O
DNA-binding	JJ	amod	B-protein
domain	NN	dobj	I-protein
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
CD4	NN	nmod	B-cell_line
(	-LRB-	punct	I-cell_line
+	CC	dep	I-cell_line
)	-RRB-	punct	I-cell_line
CD8	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
+	CC	cc	I-cell_line
)	-RRB-	punct	I-cell_line
thymocyte	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
overexpression	NN	nsubj	O
of	IN	case	O
a	DT	det	O
small	JJ	amod	B-protein
Ikaros	NN	compound	I-protein
isoform	NN	nmod	I-protein
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
differentiation	NN	nmod	O
or	CC	cc	O
on	IN	case	O
the	DT	dep	O
pericentromeric	JJ	amod	O
targeting	NN	conj	O
and	CC	cc	O
DNA-binding	JJ	amod	O
properties	NNS	conj	O
of	IN	case	O
Ikaros	NN	nmod	B-protein
.	.	punct	O

Rather	RB	ROOT	O
,	,	punct	O
the	DT	det	O
small	JJ	amod	O
isoform	NN	appos	B-protein
assembled	VBN	acl	O
into	IN	case	O
multimeric	JJ	amod	B-protein
complexes	NNS	nmod	I-protein
with	IN	case	O
DNA-bound	JJ	amod	B-protein
Ikaros	NN	nmod	I-protein
at	IN	case	O
the	DT	det	O
pericentromeric	JJ	amod	O
foci	NNS	nmod	O
.	.	punct	O

The	DT	det	O
capacity	NN	nsubj	O
for	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
multimer	NN	compound	O
formation	NN	nmod	O
suggests	VBZ	ROOT	O
that	IN	mark	O
interactions	NNS	nsubj	O
between	IN	case	O
Ikaros	NN	compound	B-protein
dimers	NNS	nmod	I-protein
bound	VBD	ccomp	O
to	TO	case	O
the	DT	det	O
TdT	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
and	CC	cc	O
those	DT	nsubj	O
bound	VBN	acl	O
to	TO	case	O
pericentromeric	JJ	amod	B-DNA
repeat	NN	compound	I-DNA
sequences	NNS	nmod	I-DNA
may	MD	aux	O
contribute	VB	conj	O
to	TO	case	O
the	DT	det	O
pericentromeric	JJ	amod	O
repositioning	NN	nmod	O
of	IN	case	O
the	DT	det	O
inactive	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Type	NN	compound	B-protein
I	CD	nummod	I-protein
interferons	NNS	ROOT	I-protein
and	CC	cc	O
IL-12	NN	conj	B-protein
:	:	punct	O
convergence	NN	dep	O
and	CC	cc	O
cross-regulation	NN	conj	O
among	IN	case	O
mediators	NNS	nmod	O
of	IN	case	O
cellular	JJ	amod	O
immunity	NN	nmod	O
.	.	punct	O

Therapeutic	JJ	amod	O
use	NN	nsubj	O
of	IN	case	O
type	NN	compound	B-protein
I	CD	nummod	I-protein
IFN	NN	nmod	I-protein
(	-LRB-	punct	O
IFN-alpha/beta	NN	appos	B-protein
)	-RRB-	punct	O
has	VBZ	aux	O
become	VBN	ROOT	O
common	JJ	acomp	O
.	.	punct	O

Many	JJ	nsubjpass	O
of	IN	case	O
the	DT	det	O
diverse	JJ	amod	O
diseases	NNS	nmod	O
targeted	VBN	acl	O
are	VBP	auxpass	O
marked	VBN	ROOT	O
by	IN	case	O
pathogenetic	JJ	amod	O
abnormalities	NNS	nmod	O
in	IN	case	O
cell-mediated	JJ	amod	O
immunity	NN	nmod	O
(	-LRB-	punct	O
CMI	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
these	DT	det	O
cellular	JJ	amod	O
immune	JJ	amod	O
responses	NNS	nmod	O
either	CC	cc:preconj	O
causing	VBG	acl	O
injury	NN	dobj	O
to	TO	case	O
the	DT	det	O
host	NN	nmod	O
,	,	punct	O
lacking	VBG	xcomp	O
sufficient	JJ	amod	O
vigor	NN	dobj	O
for	IN	case	O
virus	NN	nmod	O
or	CC	cc	O
tumor	NN	compound	O
clearance	NN	conj	O
,	,	punct	O
or	CC	cc	O
both	DT	conj	O
.	.	punct	O

In	IN	case	O
general	JJ	nmod	O
,	,	punct	O
therapeutic	JJ	amod	O
efficacy	NN	nsubjpass	O
is	VBZ	auxpass	O
limited	JJ	ROOT	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	ROOT	O
thus	RB	advmod	O
notable	JJ	acomp	O
that	IN	mark	O
the	DT	det	O
pleiotropic	JJ	amod	O
effects	NNS	nsubj	O
of	IN	case	O
type	NN	compound	B-protein
I	CD	nummod	I-protein
IFN	NN	nmod	I-protein
on	IN	case	O
CMI	NN	nmod	O
remain	VBP	ccomp	O
poorly	RB	advmod	O
understood	VBN	xcomp	O
.	.	punct	O

We	PRP	nsubj	O
characterized	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
type	NN	compound	B-protein
I	CD	nummod	I-protein
IFN	NN	nmod	I-protein
on	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
IL-12	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
central	JJ	amod	B-protein
immunoregulatory	JJ	amod	I-protein
cytokine	NN	appos	I-protein
of	IN	case	O
the	DT	det	O
CD4	NN	nmod	B-protein
(	-LRB-	punct	I-protein
+	CC	cc	I-protein
)	-RRB-	punct	I-protein
T	NN	compound	I-protein
cell	NN	compound	I-protein
arm	NN	dep	I-protein
of	IN	case	O
CMI	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
type	NN	compound	B-protein
I	CD	nummod	I-protein
IFN	NN	nsubj	I-protein
are	VBP	cop	O
potent	JJ	amod	O
inhibitors	NNS	ccomp	O
of	IN	case	O
IL-12	NN	compound	O
production	NN	nmod	O
by	IN	case	O
human	JJ	amod	B-cell_type
monocytes/macrophages	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
underlying	VBG	amod	O
mechanism	NN	nsubj	O
involves	VBZ	ROOT	O
transcriptional	JJ	amod	O
inhibition	NN	dobj	O
of	IN	case	O
the	DT	det	O
IL-12p40	NN	compound	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
marked	VBN	acl	O
by	IN	case	O
down-regulation	NN	nmod	O
of	IN	case	O
PU.1	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
at	IN	case	O
the	DT	det	O
upstream	JJ	amod	B-DNA
Ets	NN	compound	I-DNA
site	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
IL-12p40	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Type	NN	compound	B-protein
I	CD	nummod	I-protein
IFN	NN	nsubjpass	I-protein
have	VBP	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
able	JJ	xcomp	O
to	TO	mark	O
substitute	VB	xcomp	O
for	IN	case	O
IL-12	NN	nmod	B-protein
in	IN	mark	O
driving	VBG	advcl	O
IFN-gamma	NN	compound	O
production	NN	dobj	O
from	IN	case	O
T	NN	compound	B-cell_type
and	CC	cc	I-cell_type
NK	NN	conj	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
IFN-alpha/beta	NN	nmod	B-protein
to	TO	mark	O
suppress	VB	acl	O
IL-12	NN	compound	O
production	NN	dobj	O
while	IN	mark	O
up-regulating	VBG	advcl	O
IFN-gamma	NN	compound	O
production	NN	dobj	O
suggests	VBZ	ROOT	O
a	DT	det	O
possible	JJ	amod	O
mechanistic	JJ	amod	O
basis	NN	dobj	O
for	IN	case	O
the	DT	det	O
difficulties	NNS	nmod	O
of	IN	mark	O
employing	VBG	acl	O
these	DT	det	O
cytokines	NNS	dobj	B-protein
in	IN	case	O
diseases	NNS	nmod	O
involving	VBG	acl	O
abnormalities	NNS	dobj	O
of	IN	case	O
CMI	NN	nmod	O
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod:npmod	I-protein
suppressive	JJ	amod	O
and	CC	cc	O
inhibitor-kappaB	NN	conj	B-protein
stimulatory	JJ	amod	O
effects	NNS	ROOT	O
of	IN	case	O
troglitazone	NN	nmod	O
in	IN	case	O
obese	JJ	amod	O
patients	NNS	nmod	O
with	IN	case	O
type	NN	compound	O
2	CD	nummod	O
diabetes	NNS	nmod	O
:	:	punct	O
evidence	NN	dep	O
of	IN	case	O
an	DT	det	O
antiinflammatory	JJ	amod	O
action	NN	nmod	O
?	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
recently	RB	advmod	O
that	IN	mark	O
troglitazone	NN	nsubj	O
exerts	VBZ	ccomp	O
an	DT	det	O
anti-inflammatory	JJ	amod	O
effect	NN	dobj	O
,	,	punct	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
experimental	JJ	amod	O
animals	NNS	conj	O
.	.	punct	O

To	TO	mark	O
test	VB	advcl	O
these	DT	det	O
properties	NNS	dobj	O
in	IN	case	O
humans	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
troglitazone	NN	nmod	O
on	IN	case	O
the	DT	det	O
proinflammatory	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
nuclear	JJ	amod	I-protein
factor-kappaB	NN	nmod	I-protein
and	CC	cc	O
its	PRP$	nmod:poss	O
inhibitory	JJ	amod	B-protein
protein	NN	compound	I-protein
IkappaB	NN	conj	I-protein
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
MNC	NN	appos	B-cell_type
)	-RRB-	punct	O
and	CC	cc	O
plasma	NN	compound	B-protein
soluble	JJ	amod	I-protein
intracellular	JJ	amod	I-protein
adhesion	NN	compound	I-protein
molecule-1	NN	conj	I-protein
,	,	punct	O
monocyte	NN	compound	B-protein
chemoattractant	NN	compound	I-protein
protein-1	NN	appos	I-protein
,	,	punct	O
plasminogen	NN	compound	B-protein
activator	NN	compound	I-protein
inhibitor-1	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
C-reactive	JJ	amod	B-protein
protein	NN	conj	I-protein
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
examined	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
troglitazone	NN	nmod	O
on	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
species	NNS	compound	O
generation	NN	nmod	O
,	,	punct	O
p47	NN	compound	O
(	-LRB-	punct	O
phox	NN	compound	O
)	-RRB-	punct	O
subunit	NN	compound	O
expression	NN	conj	O
,	,	punct	O
9-hydroxyoctadecadienoic	JJ	amod	O
acid	NN	conj	O
(	-LRB-	punct	O
9-HODE	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
13-HODE	NN	conj	O
,	,	punct	O
o-tyrosine	NN	conj	O
,	,	punct	O
and	CC	cc	O
m-tyrosine	NN	conj	O
in	IN	case	O
obese	JJ	amod	O
patients	NNS	nmod	O
with	IN	case	O
type	NN	compound	O
2	CD	nummod	O
diabetes	NNS	nmod	O
.	.	punct	O

Seven	CD	nummod	O
obese	JJ	amod	O
patients	NNS	nsubjpass	O
with	IN	case	O
type	NN	compound	O
2	CD	nummod	O
diabetes	NNS	nmod	O
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
troglitazone	NN	nmod	O
(	-LRB-	punct	O
400	CD	nummod	O
mg/day	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
4	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

Blood	NN	compound	O
samples	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
at	IN	case	O
weekly	JJ	amod	O
intervals	NNS	nmod	O
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor-kappaB	NN	compound	I-protein
binding	NN	compound	O
activity	NN	nsubjpass	O
in	IN	case	O
MNC	NN	compound	B-cell_type
nuclear	JJ	amod	O
extracts	NNS	nmod	O
was	VBD	auxpass	O
significantly	RB	advmod	O
inhibited	VBN	ROOT	O
after	IN	case	O
troglitazone	NN	compound	O
treatment	NN	nmod	O
at	IN	case	O
week	NN	nmod	O
1	CD	nummod	O
and	CC	cc	O
continued	VBD	conj	O
to	TO	mark	O
be	VB	auxpass	O
inhibited	VBN	xcomp	O
up	RB	advmod	O
to	TO	prep	O
week	VB	pobj	O
4	CD	nummod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
IkappaB	NN	compound	O
protein	NN	compound	O
levels	NNS	nsubj	O
increased	VBD	ROOT	O
significantly	RB	advmod	O
after	IN	case	O
troglitazone	NN	compound	O
treatment	NN	nmod	O
at	IN	case	O
week	NN	nmod	O
1	CD	nummod	O
,	,	punct	O
and	CC	cc	O
this	DT	det	O
increase	NN	conj	O
persisted	VBD	acl	O
throughout	IN	case	O
the	DT	det	O
study	NN	nmod	O
.	.	punct	O

Plasma	NN	compound	B-protein
monocyte	NN	compound	I-protein
chemoattractant	NN	compound	I-protein
protein-1	NN	nsubj	I-protein
and	CC	cc	O
soluble	JJ	amod	B-protein
intracellular	JJ	amod	I-protein
adhesion	NN	compound	I-protein
molecule-1	NN	compound	I-protein
concentrations	NNS	conj	O
did	VBD	aux	O
not	RB	neg	O
decrease	VB	ROOT	O
significantly	RB	advmod	O
after	IN	case	O
troglitazone	NN	compound	O
treatment	NN	nmod	O
,	,	punct	O
although	IN	mark	O
there	EX	expl	O
was	VBD	advcl	O
a	DT	det	O
trend	NN	nsubj	O
toward	IN	prep	O
inhibition	NN	pobj	O
.	.	punct	O

Reactive	JJ	amod	O
oxygen	NN	compound	O
species	NNS	compound	O
generation	NN	nsubj	O
by	IN	case	O
polymorphonuclear	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
MNC	NN	conj	B-cell_type
,	,	punct	O
p47	NN	compound	B-protein
(	-LRB-	punct	I-protein
phox	NN	compound	I-protein
)	-RRB-	punct	I-protein
subunit	NN	compound	I-protein
protein	NN	compound	I-protein
quantities	NNS	conj	O
,	,	punct	O
plasminogen	NN	compound	B-protein
activator	NN	compound	I-protein
inhibitor-1	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
C-reactive	JJ	amod	B-protein
protein	NN	compound	I-protein
levels	NNS	conj	O
decreased	VBD	ROOT	O
significantly	RB	advmod	O
after	IN	case	O
troglitazone	NN	compound	O
intake	NN	nmod	O
.	.	punct	O

13-HODE/linoleic	JJ	amod	O
acid	NN	nsubj	O
and	CC	cc	O
9-HODE/linoleic	CD	amod	O
acid	NN	compound	O
ratios	NNS	conj	O
also	RB	advmod	O
decreased	VBD	ROOT	O
after	IN	case	O
troglitazone	NN	compound	O
intake	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
o-tyrosine/phenylalanine	NN	compound	O
and	CC	cc	O
m-tyrosine/phenylalanine	NN	conj	O
ratios	NNS	nsubj	O
did	VBD	aux	O
not	RB	neg	O
change	VB	ROOT	O
significantly	RB	advmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
troglitazone	NN	nsubj	O
has	VBZ	ccomp	O
profound	JJ	amod	O
antiinflammatory	JJ	amod	O
effects	NNS	dobj	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
antioxidant	JJ	amod	O
effects	NNS	nmod	O
in	IN	case	O
obese	JJ	amod	O
type	NN	compound	O
2	CD	nummod	O
diabetics	NNS	nmod	O
;	:	punct	O
these	DT	det	O
effects	NNS	nsubj	O
may	MD	aux	O
be	VB	cop	O
relevant	JJ	parataxis	O
to	TO	case	O
the	DT	det	O
recently	RB	advmod	O
described	VBN	amod	O
beneficial	JJ	amod	O
antiatherosclerotic	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
troglitazone	NN	nmod	O
at	IN	case	O
the	DT	det	O
vascular	JJ	amod	O
level	NN	nmod	O
.	.	punct	O

OX40	NN	compound	O
stimulation	NN	nsubj	O
by	IN	case	O
gp34/OX40	NN	compound	B-protein
ligand	NN	nmod	I-protein
enhances	VBZ	ROOT	O
productive	JJ	amod	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
infection	NN	dobj	O
.	.	punct	O

OX40	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
TNF	NN	compound	I-protein
)	-RRB-	punct	I-protein
receptor	NN	compound	I-protein
superfamily	NN	nmod	I-protein
and	CC	cc	O
known	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
costimulatory	JJ	amod	B-protein
molecule	NN	xcomp	I-protein
expressed	VBN	acl	O
on	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
costimulation	NN	nmod	O
of	IN	case	O
OX40	NN	nmod	B-protein
in	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
infection	NN	nmod	O
by	IN	case	O
its	PRP$	nmod:poss	O
natural	JJ	amod	O
ligand	NN	nmod	O
,	,	punct	O
gp34	NN	appos	B-protein
,	,	punct	O
the	DT	det	O
OX40-transfected	JJ	amod	B-cell_line
ACH-2	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	appos	I-cell_line
,	,	punct	I-cell_line
ACH-2/OX40	NN	appos	I-cell_line
,	,	punct	O
chronically	RB	advmod	O
infected	VBN	acl	O
with	IN	case	O
HIV-1	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
cocultured	VBN	ROOT	O
with	IN	case	O
paraformaldehyde	NN	compound	O
(	-LRB-	punct	O
PFA	NN	compound	O
)	-RRB-	punct	O
-fixed	JJ	amod	O
gp34-transfected	JJ	amod	B-cell_line
mouse	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	I-cell_line
SV-T2/gp34	NN	appos	I-cell_line
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
HIV-1	NN	compound	O
production	NN	nsubjpass	O
was	VBD	auxpass	O
strongly	RB	advmod	O
induced	VBN	ccomp	O
.	.	punct	O

This	DT	nsubjpass	O
was	VBD	auxpass	O
followed	VBN	ROOT	O
by	IN	case	O
apparent	JJ	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
both	DT	det	O
processes	NNS	nsubjpass	O
were	VBD	auxpass	O
specifically	RB	advmod	O
inhibited	VBN	conj	O
by	IN	case	O
the	DT	det	O
gp34	NN	nmod:npmod	B-protein
-specific	JJ	amod	O
neutralizing	VBG	amod	B-protein
monoclonal	JJ	amod	I-protein
antibody	NN	nmod	I-protein
5A8	NN	dep	I-protein
.	.	punct	O

Endogenous	JJ	amod	O
TNF	NN	compound	B-protein
alpha	NN	nsubjpass	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
TNF-beta	NN	compound	B-protein
production	NN	conj	O
were	VBD	auxpass	O
not	RB	neg	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
enhanced	VBN	amod	O
HIV-1	NN	compound	O
production	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
enhanced	VBN	amod	O
HIV-1	NN	compound	O
transcription	NN	nsubj	O
in	IN	case	O
gp34	NN	compound	B-protein
-stimulated	JJ	amod	O
ACH-2/OX40	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
site	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
the	DT	det	O
OX40-gp34	NN	compound	O
interaction	NN	nsubj	O
activated	VBD	conj	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
consisting	VBG	acl	O
of	IN	case	O
p50	NN	compound	B-protein
and	CC	cc	I-protein
p65	NN	conj	I-protein
subunits	NNS	nmod	I-protein
.	.	punct	O

When	WRB	advmod	O
primary	JJ	amod	O
activated	VBN	amod	O
CD4	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
acutely	RB	advmod	O
infected	VBN	acl	O
with	IN	case	O
HIV-1	NN	nmod	O
(	-LRB-	punct	O
NL4-3	NN	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
CXCR4-using	JJ	amod	B-cell_line
T-cell-line-tropic	JJ	appos	I-cell_line
)	-RRB-	punct	O
were	VBD	auxpass	O
cocultured	VBN	ROOT	O
with	IN	case	O
PFA-fixed	JJ	amod	O
gp34	NN	nmod	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
human	JJ	amod	I-cell_type
T-cell	NN	compound	I-cell_type
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1-bearing	JJ	amod	O
MT-2	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
or	CC	cc	O
SV-T2/gp34	NN	compound	B-cell_line
cells	NNS	conj	I-cell_line
,	,	punct	O
HIV-1	NN	compound	O
production	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
markedly	RB	advmod	O
enhanced	VBN	parataxis	O
.	.	punct	O

The	DT	det	O
enhancement	NN	nsubjpass	O
was	VBD	auxpass	O
again	RB	advmod	O
significantly	RB	advmod	O
inhibited	VBN	ROOT	O
by	IN	case	O
5A8	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
first	RB	advmod	O
shows	VBZ	ROOT	O
that	IN	mark	O
OX40-gp34	NN	compound	O
interaction	NN	nsubj	O
stimulates	VBZ	ccomp	O
HIV-1	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
suggests	VBZ	conj	O
that	IN	mark	O
OX40	NN	compound	O
triggering	NN	nsubj	O
by	IN	case	O
gp34	NN	nmod	B-protein
may	MD	aux	O
play	VB	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
enhancing	VBG	advcl	O
HIV-1	NN	compound	O
production	NN	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
acutely	RB	advmod	O
and	CC	advmod	O
latently	RB	advmod	O
infected	JJ	amod	O
CD4	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Troglitazone	NN	nsubj	O
,	,	punct	O
a	DT	det	O
PPARgamma	NN	compound	O
ligand	NN	appos	O
,	,	punct	O
inhibits	VBZ	ROOT	O
osteopontin	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes/macrophage	NN	amod	I-cell_type
THP-1	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Peroxizome	NN	compound	B-protein
proliferator-activated	JJ	amod	I-protein
receptor-gamma	NN	nsubj	I-protein
(	-LRB-	punct	O
PPARgamma	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
receptor	NN	compound	I-protein
family	NN	nmod	I-protein
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
adipocyte	NN	compound	O
differentiation	NN	dobj	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
liganded	JJ	amod	B-protein
PPARgamma	NN	nsubj	I-protein
not	RB	neg	O
only	RB	cc:preconj	O
promotes	VBZ	ccomp	O
differentiation	NN	dobj	O
but	CC	cc	O
also	RB	advmod	O
inhibits	VBZ	conj	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
macrophages	NNS	nmod	B-cell_type
.	.	punct	O

Osteopontin	NN	nsubjpass	B-protein
,	,	punct	O
a	DT	det	O
component	NN	appos	O
of	IN	case	O
extracellular	JJ	amod	O
matrix	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
synthesized	VBN	ROOT	O
by	IN	case	O
macrophages	NNS	nmod	B-cell_type
in	IN	case	O
atherosclerotic	JJ	amod	O
plaques	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
whether	IN	mark	O
PPARgamma	NN	compound	B-protein
ligand	NN	nsubj	O
regulates	VBZ	ccomp	O
osteopontin	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
THP-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
a	DT	det	O
cell	NN	compound	O
line	NN	appos	O
derived	VBN	acl	O
from	IN	case	O
human	JJ	amod	B-cell_type
monocytic	JJ	amod	I-cell_type
leukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
which	WDT	nsubj	O
can	MD	aux	O
differentiate	VB	acl:relcl	O
to	TO	case	O
macrophage	NN	nmod	B-cell_type
upon	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
phorbol	NN	compound	O
ester	NN	compound	O
PMA	NN	nmod	O
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
osteopontin	NN	compound	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
markedly	RB	advmod	O
induced	VBN	ccomp	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
PMA	NN	nmod	O
.	.	punct	O

Troglitazone	NN	nsubj	O
,	,	punct	O
a	DT	det	O
PPARgamma	NN	compound	B-protein
ligand	NN	appos	O
,	,	punct	O
dramatically	RB	advmod	O
attenuated	VBD	ROOT	O
the	DT	det	O
PMA-induced	JJ	amod	O
osteopontin	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Transient	JJ	amod	O
transfection	NN	compound	O
assays	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
osteopontin	NN	compound	I-DNA
promoter/luciferase	NN	compound	I-DNA
construct	NN	nmod	I-DNA
which	WDT	nsubj	O
contains	VBZ	acl:relcl	O
a	DT	det	O
5'-flanking	JJ	amod	B-DNA
region	NN	dobj	I-DNA
between	IN	case	O
-1500	CD	nmod	O
and	CC	cc	O
+87	CD	conj	O
relative	JJ	case	O
to	TO	case	O
the	DT	det	O
transcription	NN	compound	B-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
demonstrate	VBP	ROOT	O
that	IN	mark	O
either	CC	det	O
treatment	NN	nsubj	O
with	IN	case	O
troglitazone	NN	nmod	O
or	CC	cc	O
cotransfection	NN	conj	O
of	IN	case	O
PPARgamma	NN	compound	B-DNA
expression	NN	compound	I-DNA
vector	NN	nmod	I-DNA
inhibits	VBZ	ccomp	O
osteopontin	NN	compound	O
promoter	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
troglitazone	NN	nsubj	O
reduces	VBZ	ccomp	O
osteopontin	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
at	IN	case	O
transcriptional	JJ	amod	O
level	NN	nmod	O
through	IN	case	O
PPARgamma	NN	compound	B-protein
activation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
suggest	VBP	conj	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
troglitazone	NN	nmod	O
in	IN	mark	O
inhibiting	VBG	acl	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
macrophages	NNS	nmod	B-cell_type
to	TO	mark	O
produce	VB	acl	O
extracellular	JJ	amod	O
matrix	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
particularly	RB	advmod	O
relevant	JJ	acl:relcl	O
to	TO	case	O
atherosclerotic	JJ	amod	O
plaque	NN	compound	O
formation	NN	nmod	O
.	.	punct	O

Transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	I-protein
B	NN	nsubj	I-protein
regulates	VBZ	ROOT	O
Ig	NN	compound	B-protein
lambda	NN	compound	I-protein
light	JJ	amod	O
chain	NN	compound	O
gene	NN	compound	O
rearrangement	NN	dobj	O
.	.	punct	O

The	DT	det	O
tissue-	NN	amod	O
and	CC	cc	O
stage-specific	JJ	conj	O
assembly	NN	nsubjpass	O
of	IN	case	O
Ig	NN	compound	B-DNA
and	CC	cc	I-DNA
TCR	NN	conj	I-DNA
genes	NNS	nmod	I-DNA
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
common	JJ	amod	O
V	NN	compound	B-protein
(	-LRB-	punct	I-protein
D	NN	compound	I-protein
)	-RRB-	punct	I-protein
J	NN	compound	I-protein
recombinase	NN	compound	I-protein
complex	NN	nmod	I-protein
in	IN	case	O
precursor	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Directed	JJ	amod	O
alterations	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
accessibility	NN	nmod	O
of	IN	case	O
V	NN	compound	B-DNA
,	,	punct	I-DNA
D	NN	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
J	NN	compound	I-DNA
gene	NN	compound	I-DNA
segments	NNS	nmod	I-DNA
target	VBP	ROOT	O
the	DT	det	O
recombinase	NN	dobj	B-protein
to	TO	case	O
specific	JJ	amod	O
Ag	NN	compound	B-DNA
receptor	NN	compound	I-DNA
loci	NNS	nmod	I-DNA
.	.	punct	O

Accessibility	NN	nsubjpass	O
within	IN	case	O
a	DT	det	O
given	VBN	amod	O
locus	NN	nmod	B-DNA
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
functional	JJ	amod	O
interaction	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
with	IN	case	O
cognate	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
and	CC	cc	O
correlates	VBZ	conj	O
with	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
unrearranged	JJ	amod	O
gene	NN	compound	B-DNA
segments	NNS	nmod	I-DNA
.	.	punct	O

As	IN	mark	O
demonstrated	VBN	advcl	O
in	IN	case	O
our	PRP$	nmod:poss	O
prior	JJ	amod	O
studies	NNS	nmod	O
,	,	punct	O
rearrangement	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
Igkappa	NNP	compound	B-DNA
locus	NN	nmod	I-DNA
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
inducible	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
NF-kappaB	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
the	DT	det	O
Igkappa	NNP	compound	B-DNA
locus	NN	nmod	I-DNA
,	,	punct	O
known	JJ	amod	O
transcriptional	JJ	amod	B-DNA
control	NN	compound	I-DNA
elements	NNS	nsubj	I-DNA
in	IN	case	O
the	DT	det	O
Iglambda	NNP	compound	B-DNA
locus	NN	nmod	I-DNA
lack	NN	ROOT	O
functional	JJ	amod	O
NF-kappaB	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
this	DT	det	O
observation	NN	nmod	O
,	,	punct	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
assembled	VBN	amod	O
Iglambda	NNP	compound	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
mature	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
NF-kappaB	NN	nmod:npmod	B-protein
independent	JJ	xcomp	O
.	.	punct	O

Nonetheless	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
now	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
specific	JJ	amod	O
repression	NN	nsubj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
inhibits	VBZ	ccomp	O
germline	NN	compound	O
transcription	NN	dobj	O
and	CC	cc	O
recombination	NN	conj	O
of	IN	case	O
Iglambda	NN	compound	B-DNA
gene	NN	compound	I-DNA
segments	NNS	nmod	I-DNA
in	IN	case	O
precursor	NN	compound	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Molecular	JJ	amod	O
analyses	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
block	NN	nsubj	O
in	IN	case	O
NF-kappaB	NN	nmod	B-protein
impairs	VBZ	ccomp	O
Iglambda	NN	compound	O
rearrangement	NN	dobj	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
recombinase	NN	compound	B-protein
accessibility	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
activities	NNS	nsubj	O
of	IN	case	O
known	JJ	amod	O
Iglambda	NNP	compound	B-DNA
promoter	NN	nmod	I-DNA
and	CC	cc	O
enhancer	NN	compound	B-DNA
elements	NNS	conj	I-DNA
are	VBP	aux	O
unaffected	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
cellular	JJ	amod	O
background	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
expand	VBP	ROOT	O
the	DT	det	O
range	NN	dobj	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
action	NN	nmod	O
in	IN	case	O
precursor	NN	compound	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
beyond	IN	case	O
Igkappa	NNP	nmod	B-protein
to	TO	mark	O
include	VB	advcl	O
the	DT	det	O
control	NN	dobj	O
of	IN	case	O
recombinational	JJ	amod	O
accessibility	NN	nmod	O
at	IN	case	O
both	CC	det	O
L	NN	compound	B-DNA
chain	NN	compound	I-DNA
loci	NNS	nmod	I-DNA
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
strongly	RB	advmod	O
suggest	VBP	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	O
Iglambda	NN	compound	B-DNA
regulatory	JJ	amod	I-DNA
element	NN	nmod	I-DNA
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
either	CC	cc:preconj	O
directly	RB	advmod	O
or	CC	advmod	O
indirectly	RB	advmod	O
activated	VBN	acl:relcl	O
by	IN	case	O
NF-kappaB	NN	nmod	B-protein
during	IN	case	O
the	DT	det	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
B	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
.	.	punct	O

Transcription	NN	compound	B-protein
factor	NN	compound	I-protein
STAT5A	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
substrate	NN	ROOT	O
of	IN	case	O
Bruton	NNP	nmod:poss	B-protein
's	POS	case	I-protein
tyrosine	NN	compound	I-protein
kinase	NN	nmod	I-protein
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

STAT5A	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
molecular	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
differentiation	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
lymphohematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
STAT5A	NN	nsubj	B-protein
can	MD	aux	O
serve	VB	ccomp	O
as	IN	case	O
a	DT	det	O
functional	JJ	amod	O
substrate	NN	nmod	O
of	IN	case	O
Bruton	NNP	nmod:poss	B-protein
's	POS	case	I-protein
tyrosine	NN	compound	I-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
BTK	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Purified	VBN	amod	B-protein
recombinant	JJ	amod	I-protein
BTK	NN	nsubj	I-protein
was	VBD	cop	O
capable	JJ	ROOT	O
of	IN	case	O
directly	RB	advmod	O
binding	VBG	amod	O
purified	VBN	amod	B-protein
recombinant	JJ	amod	I-protein
STAT5A	NN	nmod	I-protein
with	IN	case	O
high	JJ	amod	O
affinity	NN	nmod	O
(	-LRB-	punct	O
K	NN	dep	O
(	-LRB-	punct	O
d	NN	appos	O
)	-RRB-	punct	O
=	JJ	dep	O
44	CD	nummod	O
nm	NN	dobj	O
)	-RRB-	punct	O
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
surface	NN	compound	O
plasmon	JJ	amod	O
resonance	NN	nmod	O
using	VBG	acl	O
a	DT	det	O
BIAcore	NN	compound	O
biosensor	NN	compound	O
system	NN	dobj	O
.	.	punct	O

BTK	NN	nsubj	B-protein
was	VBD	cop	O
also	RB	advmod	O
capable	JJ	ROOT	O
of	IN	case	O
tyrosine-phosphorylating	NN	amod	O
ectopically	RB	advmod	O
expressed	VBN	amod	O
recombinant	JJ	amod	B-protein
STAT5A	NN	nmod	I-protein
on	IN	case	O
Tyr	NN	nmod	O
(	-LRB-	punct	O
694	CD	appos	O
)	-RRB-	punct	O
both	CC	cc:preconj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
in	FW	compound	O
vivo	FW	advmod	O
in	IN	case	O
a	DT	det	O
Janus	NN	compound	B-protein
kinase	NN	compound	I-protein
3	CD	nummod	I-protein
-independent	JJ	amod	O
fashion	NN	nmod	O
.	.	punct	O

BTK	NN	nsubj	B-protein
phosphorylated	VBD	ROOT	O
the	DT	det	O
Y665F	NN	amod	B-protein
,	,	punct	I-protein
Y668F	NN	conj	I-protein
,	,	punct	I-protein
and	CC	cc	I-protein
Y682F	NN	conj	I-protein
,	,	punct	I-protein
Y683F	NN	compound	I-protein
mutants	NNS	dobj	I-protein
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
Y694F	NN	amod	B-protein
mutant	NN	conj	I-protein
of	IN	case	O
STAT5A	NN	nmod	B-protein
.	.	punct	O

STAT5A	NN	compound	O
mutations	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
Src	NN	compound	B-protein
homology	NN	nmod	I-protein
2	CD	nummod	I-protein
(	-LRB-	punct	I-protein
SH2	NN	appos	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	I-protein
SH3	NN	compound	I-protein
domains	NNS	conj	I-protein
did	VBD	aux	O
not	RB	neg	O
alter	VB	ROOT	O
the	DT	det	O
BTK	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
.	.	punct	O

Recombinant	JJ	amod	B-protein
BTK	NN	compound	I-protein
proteins	NNS	nsubj	I-protein
with	IN	case	O
mutant	JJ	amod	O
pleckstrin	NN	compound	O
homology	NN	nmod	O
,	,	punct	O
SH2	NN	conj	B-protein
,	,	punct	I-protein
or	CC	cc	I-protein
SH3	NN	compound	I-protein
domains	NNS	conj	I-protein
were	VBD	cop	O
capable	JJ	ROOT	O
of	IN	mark	O
phosphorylating	VBG	advcl	O
STAT5A	NN	dobj	B-protein
,	,	punct	O
whereas	IN	dep	O
recombinant	JJ	amod	B-protein
BTK	NN	compound	I-protein
proteins	NNS	nsubj	I-protein
with	IN	case	O
SH1/kinase	NN	compound	O
domain	NN	compound	O
mutations	NNS	nmod	O
were	VBD	parataxis	O
not	RB	neg	O
.	.	punct	O

In	IN	case	O
pull-down	JJ	amod	O
experiments	NNS	nmod	O
,	,	punct	O
only	RB	advmod	O
full-length	JJ	amod	B-protein
BTK	NN	nsubj	I-protein
and	CC	cc	O
its	PRP$	nmod:poss	O
SH1/kinase	NN	compound	B-protein
domain	NN	conj	I-protein
(	-LRB-	punct	O
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
pleckstrin	NN	compound	O
homology	NN	conj	O
,	,	punct	O
SH2	NN	conj	B-protein
,	,	punct	I-protein
or	CC	cc	I-protein
SH3	NN	compound	I-protein
domains	NNS	conj	I-protein
)	-RRB-	punct	O
were	VBD	cop	O
capable	JJ	ROOT	O
of	IN	mark	O
binding	VBG	advcl	O
STAT5A	NN	dobj	B-protein
.	.	punct	O

Ectopically	RB	advmod	O
expressed	VBN	advcl	O
BTK	NN	compound	B-protein
kinase	NN	compound	I-protein
domain	NN	nsubj	I-protein
was	VBD	cop	O
capable	JJ	ROOT	O
of	IN	case	O
tyrosine-phosphorylating	JJ	amod	O
STAT5A	NN	nmod	B-protein
both	CC	cc:preconj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

BTK	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nsubj	O
of	IN	case	O
ectopically	RB	advmod	O
expressed	VBN	amod	O
wild	JJ	amod	O
type	NN	nmod	O
(	-LRB-	punct	O
but	CC	cc	O
not	RB	neg	O
Tyr	NN	compound	B-protein
(	-LRB-	punct	I-protein
694	CD	nummod	I-protein
)	-RRB-	punct	I-protein
mutant	JJ	conj	I-protein
)	-RRB-	punct	O
STAT5A	NN	nsubj	B-protein
enhanced	VBD	ROOT	O
its	PRP$	nmod:poss	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

In	IN	case	O
BTK	NN	compound	B-protein
-competent	JJ	amod	O
chicken	NN	compound	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
anti-IgM-stimulated	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
STAT5	NN	compound	B-protein
protein	NN	nmod	I-protein
was	VBD	auxpass	O
prevented	VBN	ROOT	O
by	IN	case	O
pretreatment	NN	nmod	O
with	IN	case	O
the	DT	det	O
BTK	NN	compound	B-protein
inhibitor	NN	compound	O
LFM-A13	NN	nmod	O
but	CC	cc	O
not	RB	neg	O
by	IN	case	O
pretreatment	NN	conj	O
with	IN	case	O
the	DT	det	O
JAK3	NN	compound	O
inhibitor	NN	compound	O
HI-P131	NN	nmod	O
.	.	punct	O

B	NN	compound	O
cell	NN	compound	O
antigen	NN	compound	O
receptor	NN	compound	O
ligation	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
enhanced	VBN	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
STAT5	NN	nmod	B-protein
in	IN	case	O
BTK	NN	compound	B-protein
-deficient	JJ	amod	O
chicken	NN	compound	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
reconstituted	VBN	acl	O
with	IN	case	O
wild	JJ	amod	B-protein
type	NN	compound	I-protein
human	JJ	amod	I-protein
BTK	NN	nmod	I-protein
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
BTK	NN	compound	B-protein
-deficient	JJ	amod	O
chicken	NN	compound	O
B	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
reconstituted	VBN	acl	O
with	IN	case	O
kinase-inactive	JJ	amod	B-protein
mutant	JJ	amod	I-protein
BTK	NN	nmod	I-protein
.	.	punct	O

Similarly	RB	advmod	O
,	,	punct	O
anti-IgM	JJ	amod	O
stimulation	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
enhanced	VBN	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
STAT5A	NN	nmod	B-protein
in	IN	case	O
BTK	NN	compound	B-protein
-competent	JJ	amod	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
wild	JJ	amod	O
type	NN	compound	O
mice	NNS	nmod	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
BTK	NN	compound	B-protein
-deficient	JJ	amod	O
B	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
from	IN	case	O
XID	NN	compound	O
mice	NNS	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
to	TO	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
XID	NN	compound	O
mice	NNS	nmod	O
,	,	punct	O
B	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
from	IN	case	O
JAK3	NN	compound	O
knockout	JJ	compound	O
mice	NNS	nmod	O
showed	VBD	ROOT	O
a	DT	det	O
normal	JJ	amod	O
STAT5A	NN	compound	O
phosphorylation	NN	compound	O
response	NN	dobj	O
to	TO	case	O
anti-IgM	JJ	amod	O
stimulation	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
provide	VBP	ROOT	O
unprecedented	JJ	amod	O
experimental	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
BTK	NN	nsubj	B-protein
plays	VBZ	acl:relcl	O
a	DT	det	O
nonredundant	JJ	amod	O
and	CC	cc	O
pivotal	JJ	conj	O
role	NN	dobj	O
in	IN	case	O
B	NN	compound	O
cell	NN	compound	O
antigen	NN	nmod:npmod	O
receptor-mediated	JJ	amod	O
STAT5A	NN	compound	O
activation	NN	nmod	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type

Role	NN	ROOT	O
of	IN	case	O
T-bet	NN	nmod	B-protein
in	IN	case	O
commitment	NN	nmod	O
of	IN	case	O
TH1	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
before	IN	case	O
IL-12	NN	compound	B-protein
-dependent	JJ	amod	O
selection	NN	nmod	O
.	.	punct	O

How	WRB	advmod	O
cytokines	NNS	nsubj	B-protein
control	VBP	csubj	O
differentiation	NN	dobj	O
of	IN	case	O
helper	NN	compound	B-cell_type
T	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
TH	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	cop	O
controversial	JJ	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
T-bet	NN	nsubj	B-protein
,	,	punct	O
without	IN	case	O
apparent	JJ	amod	O
assistance	NN	nmod	O
from	IN	case	O
interleukin	NN	nmod	B-protein
12	CD	nummod	I-protein
(	-LRB-	punct	I-protein
IL-12	NN	appos	I-protein
)	-RRB-	punct	I-protein
/	:	punct	O
STAT4	NN	conj	B-protein
,	,	punct	O
specifies	VBZ	ccomp	O
TH1	NN	compound	B-cell_type
effector	NN	compound	O
fate	NN	dobj	O
by	IN	mark	O
targeting	VBG	advcl	O
chromatin	NN	compound	O
remodeling	NN	dobj	O
to	TO	case	O
individual	JJ	amod	O
interferon-gamma	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
IFN-gamma	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
alleles	NNS	nmod	I-DNA
and	CC	cc	O
by	IN	mark	O
inducing	VBG	conj	O
IL-12	NN	compound	B-DNA
receptor	NN	compound	I-DNA
beta2	NN	compound	I-DNA
expression	NN	dobj	O
.	.	punct	O

Subsequently	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
appears	VBZ	ROOT	O
that	IN	mark	O
IL-12	NN	nsubj	B-protein
/	:	punct	O
STAT4	NN	conj	B-protein
serves	VBZ	ccomp	O
two	CD	nummod	O
essential	JJ	amod	O
functions	NNS	dobj	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
TH1	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
as	IN	case	O
growth	NN	compound	B-protein
signal	NN	advcl	I-protein
,	,	punct	O
inducing	VBG	acl	O
survival	NN	dobj	O
and	CC	cc	O
cell	NN	compound	O
division	NN	conj	O
;	:	punct	O
and	CC	cc	O
as	IN	case	O
trans-activator	NN	conj	B-protein
,	,	punct	O
prolonging	VBG	acl	O
IFN-gamma	NN	compound	B-protein
synthesis	NN	dobj	O
through	IN	case	O
a	DT	det	O
genetic	JJ	amod	O
interaction	NN	nmod	O
with	IN	case	O
the	DT	det	O
coactivator	NN	nmod	B-protein
,	,	punct	O
CREB-binding	JJ	amod	B-protein
protein	NN	appos	I-protein
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
cytokine	NN	nsubj	B-protein
does	VBZ	aux	O
not	RB	neg	O
simply	RB	advmod	O
induce	VB	ccomp	O
TH	NN	compound	O
fate	NN	compound	O
choice	NN	dobj	O
but	CC	cc	O
instead	RB	advmod	O
may	MD	aux	O
act	VB	conj	O
as	IN	case	O
an	DT	det	O
essential	JJ	amod	O
secondary	JJ	amod	O
stimulus	NN	nmod	O
that	WDT	nsubj	O
mediates	VBZ	acl:relcl	O
selective	JJ	amod	O
survival	NN	dobj	O
of	IN	case	O
a	DT	det	O
lineage	NN	nmod	O
.	.	punct	O

Stat6	NN	nsubj	B-protein
is	VBZ	cop	O
necessary	JJ	ROOT	O
and	CC	cc	O
sufficient	JJ	conj	O
for	IN	case	O
IL-4	NN	nmod:poss	O
's	POS	case	O
role	NN	nmod	O
in	IN	case	O
Th2	NN	compound	O
differentiation	NN	nmod	O
and	CC	cc	O
cell	NN	compound	O
expansion	NN	conj	O
.	.	punct	O

IL-4	NN	nsubj	B-protein
plays	VBZ	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
differentiation	NN	nmod	O
of	IN	case	O
T	NN	nmod:npmod	O
CR-stimulated	JJ	amod	B-cell_type
naive	JJ	amod	I-cell_type
CD4	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
the	DT	det	O
Th2	NN	compound	O
phenotype	NN	nmod	O
.	.	punct	O

In	IN	case	O
response	NN	dep	O
to	TO	case	O
IL-4	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
IL-4R	NN	nsubj	B-protein
activates	VBZ	ROOT	O
a	DT	det	O
set	NN	dobj	O
of	IN	case	O
phosphotyrosine	NN	compound	B-protein
binding	NN	compound	I-protein
domain-containing	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
including	VBG	case	O
insulin	NN	compound	B-protein
receptor	NN	compound	I-protein
substrate	NN	nmod	I-protein
1/2	CD	nummod	I-protein
,	,	punct	O
Shc	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-4R	NN	compound	B-protein
interacting	NN	amod	I-protein
protein	NN	conj	I-protein
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
Stat6	NN	conj	B-protein
.	.	punct	O

Stat6	NN	nsubjpass	B-protein
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
required	VBN	xcomp	O
for	IN	case	O
Th2	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
the	DT	det	O
roles	NNS	dobj	O
of	IN	case	O
the	DT	det	O
phosphotyrosine	NN	compound	B-protein
binding	NN	compound	I-protein
adaptors	NNS	nmod	I-protein
in	IN	case	O
Th2	NN	compound	O
differentiation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
prepared	VBD	ROOT	O
a	DT	det	O
retrovirus	NN	dobj	O
containing	VBG	acl	O
a	DT	det	O
mutant	NN	dobj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
(	-LRB-	punct	I-protein
h	NN	dep	I-protein
)	-RRB-	punct	I-protein
IL-4R	NN	compound	I-protein
alpha-chain	NN	nmod	I-protein
,	,	punct	O
Y497F	NN	appos	B-protein
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
unable	JJ	acl:relcl	O
to	TO	mark	O
recruit	VB	xcomp	O
these	DT	det	O
adaptors	NNS	dobj	O
.	.	punct	O

The	DT	det	O
mutant	JJ	amod	B-protein
hIL-4Ralpha	NN	nsubjpass	I-protein
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
wild-type	JJ	amod	B-protein
(	-LRB-	punct	I-protein
WT	JJ	dep	I-protein
)	-RRB-	punct	I-protein
hIL-4Ralpha	NN	conj	I-protein
,	,	punct	O
was	VBD	auxpass	O
introduced	VBN	ROOT	O
into	IN	case	O
naive	JJ	amod	B-cell_type
CD4	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Upon	IN	case	O
hIL-4	NN	compound	O
stimulation	NN	nmod	O
,	,	punct	O
Y497F	NN	nsubj	B-protein
worked	VBD	ROOT	O
as	RB	advmod	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
WT	JJ	compound	B-protein
hIL-4Ralpha	NN	conj	I-protein
in	IN	mark	O
driving	VBG	advcl	O
Th2	NN	compound	O
differentiation	NN	dobj	O
,	,	punct	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
Gata3	NN	compound	O
up-regulation	NN	nmod	O
and	CC	cc	O
IL-4	NN	compound	O
production	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
IL-4-driven	JJ	amod	O
cell	NN	compound	O
expansion	NN	nsubj	O
was	VBD	cop	O
also	RB	advmod	O
normal	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
infected	VBN	acl	O
with	IN	case	O
Y497F	NN	nmod	B-protein
,	,	punct	O
although	IN	mark	O
cells	NNS	nsubj	O
infected	VBN	acl	O
with	IN	case	O
Y497F	NN	nmod	B-protein
were	VBD	cop	O
not	RB	neg	O
capable	JJ	advcl	O
of	IN	mark	O
phosphorylating	VBG	advcl	O
insulin	NN	compound	B-protein
receptor	NN	compound	I-protein
substrate	NN	dobj	I-protein
2	CD	nummod	I-protein
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
signal	NN	compound	O
pathway	NN	nsubj	O
mediated	VBN	acl	O
by	IN	case	O
Y497	NN	nmod	B-protein
is	VBZ	cop	O
dispensable	JJ	ccomp	O
for	IN	case	O
both	CC	cc:preconj	O
IL-4	NN	nmod:npmod	B-protein
-driven	JJ	amod	O
Th2	NN	compound	O
differentiation	NN	nmod	O
and	CC	cc	O
cell	NN	compound	O
expansion	NN	conj	O
.	.	punct	O

Both	CC	cc:preconj	O
WT	NNP	nsubj	B-protein
and	CC	cc	I-protein
Y497F	NN	compound	I-protein
hIL-4Ralpha	NN	conj	I-protein
lose	VBP	ROOT	O
the	DT	det	O
ability	NN	dobj	O
to	TO	mark	O
drive	VB	acl	O
Th2	NN	compound	O
differentiation	NN	dobj	O
and	CC	cc	O
cell	NN	compound	O
expansion	NN	conj	O
in	IN	case	O
Stat6-knockout	JJ	amod	B-cell_type
CD4	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
constitutively	RB	advmod	O
activated	VBN	amod	O
form	NN	nsubj	O
of	IN	case	O
Stat6	NN	nmod	B-protein
introduced	VBN	acl	O
into	IN	case	O
CD4	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
resulted	VBD	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
Th2	NN	compound	O
differentiation	NN	nmod	O
and	CC	cc	O
enhanced	VBN	amod	O
cell	NN	compound	O
expansion	NN	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
activated	VBN	amod	B-protein
Stat6	NN	nsubj	I-protein
is	VBZ	cop	O
necessary	JJ	ROOT	O
and	CC	cc	O
sufficient	JJ	conj	O
to	TO	mark	O
mediate	VB	xcomp	O
both	CC	cc:preconj	O
IL-4	NN	nmod:npmod	B-protein
-driven	JJ	amod	O
Th2	NN	compound	O
differentiation	NN	dobj	O
and	CC	cc	O
cell	NN	compound	O
expansion	NN	conj	O
in	IN	case	O
CD4	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
effect	NN	ROOT	O
of	IN	case	O
HIV-1	NN	compound	B-protein
regulatory	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
on	IN	case	O
cellular	JJ	amod	O
genes	NNS	nmod	O
:	:	punct	O
derepression	NN	dep	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
by	IN	case	O
Tat	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
HIV-infected	JJ	amod	O
individuals	NNS	compound	O
dysregulation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
is	VBZ	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
severe	JJ	amod	O
disorders	NNS	nmod	O
of	IN	case	O
the	DT	det	O
cytokine	NN	compound	O
network	NN	nmod	O
.	.	punct	O

Increase	NN	compound	O
secretion	NN	nsubj	O
of	IN	case	O
IL-2	NN	nmod	B-protein
,	,	punct	O
the	DT	dep	O
major	JJ	amod	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
growth	NN	appos	O
and	CC	cc	O
differentiation	NN	compound	O
cytokine	NN	conj	B-protein
,	,	punct	O
may	MD	aux	O
play	VB	ROOT	O
a	DT	det	O
decisive	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
sensitization	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
for	IN	case	O
activation	NN	nmod	O
induced	JJ	amod	O
apoptosis	NN	conj	O
and	CC	cc	O
indirect	JJ	amod	O
death	NN	conj	O
of	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
through	IN	case	O
augmented	JJ	amod	O
virus	NN	compound	O
replication	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
cause	NN	dobj	O
of	IN	case	O
enhanced	VBN	amod	O
IL-2	NN	compound	O
secretion	NN	nmod	O
and	CC	cc	O
found	VBD	conj	O
that	IN	mark	O
the	DT	det	O
HIV	NN	compound	B-protein
Tat	NN	nsubj	I-protein
induces	VBZ	ccomp	O
this	DT	det	O
effect	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
increased	VBN	amod	O
IL-2	NN	compound	O
secretion	NN	nsubj	O
is	VBZ	cop	O
due	JJ	case	O
to	TO	case	O
Tat	NN	nmod:npmod	B-protein
-enhanced	JJ	amod	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activation	NN	ccomp	O
.	.	punct	O

Tat	NN	compound	B-protein
derepresses	NNS	ROOT	O
and	CC	cc	O
activates	VBZ	conj	O
the	DT	det	O
distal	JJ	amod	B-DNA
AP-1	NN	compound	I-DNA
site	NN	dobj	I-DNA
(	-LRB-	punct	O
position	NN	appos	B-DNA
-185	CD	compound	I-DNA
to	TO	dep	I-DNA
-177	CD	nummod	I-DNA
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
nonstimulated	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
a	DT	det	O
repressor	NN	compound	O
complex	NN	nsubjpass	O
containing	VBG	acl	O
NF-IL6	NN	dobj	B-protein
,	,	punct	O
JunB	NN	conj	B-protein
,	,	punct	O
c-Fos	NN	conj	B-protein
and	CC	cc	O
Fra-1	NN	conj	B-protein
is	VBZ	auxpass	O
formed	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
AP-1	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
IL-2/d	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
site	NN	nmod	I-DNA
and	CC	cc	O
represses	VBZ	conj	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	dobj	O
.	.	punct	O

After	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
a	DT	det	O
heterodimeric	JJ	amod	B-protein
activator	NN	nsubj	I-protein
containing	VBG	acl	O
p65	NN	dobj	B-protein
and	CC	cc	O
c-Jun	NN	conj	B-protein
binds	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
AP-1	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
IL-2/d	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

HIV	NN	compound	B-protein
Tat	NN	nsubj	I-protein
enhances	VBZ	ROOT	O
activation	NN	dobj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
and	CC	cc	O
consequently	RB	advmod	O
,	,	punct	O
activates	VBZ	conj	O
the	DT	det	O
AP-1	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
IL-2/d	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
site	NN	dobj	I-DNA
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
for	IN	case	O
a	DT	det	O
novel	JJ	amod	O
mechanism	NN	nmod	O
by	IN	case	O
which	WDT	nmod	O
HIV	NN	compound	B-protein
Tat	NN	nsubj	I-protein
dysregulates	VBZ	acl:relcl	O
IL-2	NN	compound	O
production	NN	dobj	O
and	CC	cc	O
therefore	RB	advmod	O
may	MD	aux	O
contribute	VB	conj	O
to	TO	case	O
the	DT	det	O
HIV-1	NN	compound	O
infection	NN	nmod	O
in	IN	case	O
a	DT	det	O
way	NN	nmod	O
yet	RB	advmod	O
to	TO	aux	O
be	VB	auxpass	O
clarified	VBN	acl	O
.	.	punct	O

Transforming	VBG	amod	B-protein
growth	NN	compound	I-protein
factor-beta1	NN	nsubj	I-protein
interferes	VBZ	ROOT	O
with	IN	case	O
thrombopoietin-induced	JJ	amod	O
signal	NN	compound	O
transduction	NN	nmod	O
in	IN	case	O
megakaryoblastic	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
erythroleukemic	JJ	conj	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
Thrombopoietin	NN	nsubjpass	B-protein
(	-LRB-	punct	O
TPO	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
transforming	VBG	amod	B-protein
growth	NN	compound	I-protein
factor-beta	NN	conj	I-protein
(	-LRB-	punct	I-protein
1	CD	appos	I-protein
)	-RRB-	punct	I-protein
(	-LRB-	punct	O
TGF-beta	NN	appos	B-protein
(	-LRB-	punct	I-protein
1	CD	appos	I-protein
)	-RRB-	punct	I-protein
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	dep	O
to	TO	mark	O
exert	VB	xcomp	O
opposite	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
proliferation	NN	nmod	O
and	CC	cc	O
megakaryocytic	JJ	amod	O
differentiation	NN	conj	O
of	IN	case	O
hematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

To	TO	mark	O
determine	VB	ROOT	O
whether	IN	mark	O
TGF-beta	NN	nsubj	B-protein
(	-LRB-	punct	I-protein
1	CD	appos	I-protein
)	-RRB-	punct	I-protein
interferes	VBZ	ccomp	O
directly	RB	advmod	O
with	IN	case	O
TPO	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
signal	NN	compound	O
transduction	NN	nmod	O
in	IN	case	O
hematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
we	PRP	nsubj	O
compared	VBD	parataxis	O
the	DT	det	O
regulatory	JJ	amod	O
effects	NNS	dobj	O
in	IN	case	O
the	DT	det	O
TPO	NN	compound	B-protein
-responsive	JJ	amod	O
cell	NN	compound	O
lines	NNS	nmod	O
Mo-7e	NN	dep	O
and	CC	cc	O
HEL	NN	conj	O
.	.	punct	O

MATERIALS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
The	DT	det	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
stimulated	VBN	dep	O
by	IN	case	O
100	CD	nummod	O
ng/mL	NN	compound	O
TPO	NN	nmod	B-protein
and/or	CC	cc	O
100	CD	nummod	O
ng/mL	NN	compound	O
TGF-beta1	NN	conj	B-protein
and	CC	cc	O
analyzed	VBN	conj	O
for	IN	case	O
proliferation	NN	nmod	O
(	-LRB-	punct	O
3H	NN	compound	O
thymidine	NN	compound	O
incorporation	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
viability	NN	conj	O
(	-LRB-	punct	O
trypan	NN	amod	O
blue	JJ	amod	O
exclusion	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
protein	NN	compound	O
expression	NN	conj	O
and	CC	cc	O
phosphorylation	NN	conj	O
(	-LRB-	punct	O
Western	NN	compound	O
blot	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
TPO	NN	nsubj	B-protein
enhanced	VBD	ROOT	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
Mo-7e	JJ	compound	B-cell_line
cells	NNS	nmod	I-cell_line
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
3H-thymidine	NN	amod	O
incorporation	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
TGF-beta1	NN	nsubj	B-protein
suppressed	VBD	parataxis	O
baseline	NN	compound	O
cell	NN	compound	O
growth	NN	dobj	O
and	CC	cc	O
antagonized	VBD	conj	O
the	DT	det	O
proliferative	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
TPO	NN	nmod	B-protein
.	.	punct	O

TPO	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
proliferation	NN	nsubjpass	O
also	RB	advmod	O
was	VBD	auxpass	O
reduced	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
specific	JJ	amod	O
inhibitor	NN	nmod	O
of	IN	case	O
the	DT	det	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	O
MAPK	NN	appos	B-protein
)	-RRB-	punct	O
pathway	NN	nmod	O
(	-LRB-	punct	O
PD098059	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
inhibits	VBZ	acl:relcl	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
MAPK	NN	compound	B-protein
extracellular	JJ	amod	I-protein
signal-regulated	JJ	amod	I-protein
kinases	NNS	nmod	I-protein
(	-LRB-	punct	O
ERK	NN	appos	B-protein
)	-RRB-	punct	O
ERK1	NN	dep	B-protein
and	CC	cc	O
ERK2	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
AG490	NN	conj	O
,	,	punct	O
an	DT	det	O
inhibitor	NN	appos	O
of	IN	case	O
Janus	NN	compound	B-protein
kinase-2	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
completely	RB	advmod	O
blocked	VBD	acl:relcl	O
TPO	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
proliferation	NN	dobj	O
.	.	punct	O

As	IN	mark	O
demonstrated	VBN	advcl	O
by	IN	case	O
Western	NN	compound	O
blotting	NN	nmod	O
,	,	punct	O
TGF-beta1	NN	nsubj	B-protein
reduced	VBD	ROOT	O
the	DT	det	O
TPO	NN	compound	B-protein
-stimulated	JJ	amod	O
ERK1	NN	compound	B-protein
/	:	punct	O
ERK2	NN	conj	B-protein
and	CC	cc	O
STAT5	NN	conj	O
phosphorylation	NN	dobj	O
in	IN	case	O
Mo-7e	JJ	nmod	B-cell_line
and	CC	cc	I-cell_line
HEL	NN	conj	I-cell_line
cells	NNS	dep	I-cell_line
.	.	punct	O

This	DT	det	O
effect	NN	nsubjpass	O
was	VBD	auxpass	O
completely	RB	advmod	O
reversed	VBN	ROOT	O
by	IN	case	O
preincubation	NN	nmod	O
with	IN	case	O
a	DT	det	O
tyrosine	NN	compound	O
phosphatase	NN	compound	O
inhibitor	NN	nmod	O
(	-LRB-	punct	O
Na3VO4	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
suggests	VBZ	acl:relcl	O
that	IN	mark	O
TGF-beta1	NN	nsubj	B-protein
activated	VBD	ccomp	O
a	DT	det	O
phosphatase	NN	dobj	B-protein
.	.	punct	O

Although	IN	mark	O
STAT3	NN	nsubjpass	B-protein
also	RB	advmod	O
was	VBD	auxpass	O
activated	VBN	advcl	O
by	IN	case	O
TPO	NN	nmod	B-protein
,	,	punct	O
STAT3	NN	compound	B-protein
activation	NN	nsubj	O
remained	VBD	ROOT	O
unaltered	JJ	xcomp	O
by	IN	case	O
TGF-beta1	NN	nmod	B-protein
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
TGF-beta1	NN	nsubj	B-protein
modulates	VBZ	ccomp	O
TPO	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
megakaryocytic	JJ	amod	O
proliferation	NN	nmod	O
by	IN	mark	O
interfering	VBG	advcl	O
with	IN	case	O
TPO	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
signal	NN	compound	O
transduction	NN	nmod	O
,	,	punct	O
particularly	RB	advmod	O
by	IN	mark	O
reducing	VBG	advcl	O
the	DT	det	O
activities	NNS	dobj	O
of	IN	case	O
MAPK	NN	nmod	B-protein
ERK1/ERK2	NN	dep	I-protein
and	CC	cc	I-protein
STAT5	NN	conj	I-protein
.	.	punct	O

Invariant	JJ	amod	B-protein
chain	NN	nsubj	I-protein
induces	VBZ	ROOT	O
B	NN	compound	O
cell	NN	compound	O
maturation	NN	dobj	O
by	IN	mark	O
activating	VBG	advcl	O
a	DT	det	O
TAF	NN	compound	B-protein
(	-LRB-	punct	I-protein
II	CD	intj	I-protein
)	-RRB-	punct	I-protein
105-NF-kappaB	NN	amod	I-protein
-dependent	JJ	amod	O
transcription	NN	compound	O
program	NN	dobj	O
.	.	punct	O

Early	JJ	amod	O
stages	NNS	nsubj	O
of	IN	case	O
B	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
occur	VBP	ROOT	O
in	IN	case	O
the	DT	det	O
bone	NN	compound	O
marrow	NN	nmod	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
formation	NN	nmod	O
of	IN	case	O
immature	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

From	IN	prep	O
there	EX	pcomp	O
these	DT	det	O
immature	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
migrate	VBP	ROOT	O
to	TO	case	O
the	DT	det	O
spleen	NN	nmod	O
where	WRB	advmod	O
they	PRP	nsubj	O
differentiate	VBP	ccomp	O
to	TO	case	O
mature	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	det	O
final	JJ	amod	O
maturation	NN	compound	O
step	NN	nsubj	O
is	VBZ	cop	O
crucial	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	mark	O
become	VB	xcomp	O
responsive	JJ	xcomp	O
to	TO	case	O
antigens	NNS	nmod	B-protein
and	CC	cc	O
to	TO	mark	O
participate	VB	conj	O
in	IN	case	O
the	DT	det	O
immune	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
invariant	JJ	amod	B-protein
chain	NN	nsubjpass	I-protein
(	-LRB-	punct	O
Ii	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
major	JJ	amod	B-protein
histocompatibility	NN	compound	I-protein
complex	NN	compound	I-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
chaperone	NN	appos	I-protein
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
c-Rel	NN	dep	B-protein
and	CC	cc	O
p65/RelA	NN	conj	B-protein
,	,	punct	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
final	JJ	amod	O
antigen-independent	JJ	amod	O
differentiation	NN	compound	O
stage	NN	nmod	O
of	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
the	DT	det	O
spleen	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
a	DT	det	O
possible	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
Ii	NN	compound	B-protein
-dependent	JJ	amod	O
B	NN	compound	O
cell	NN	compound	O
maturation	NN	nmod	O
and	CC	cc	O
the	DT	det	O
NF-kappaB	NN	compound	O
pathway	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
studies	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Ii	NN	compound	B-protein
-induced	JJ	amod	O
B	NN	compound	O
cell	NN	compound	O
maturation	NN	nsubj	O
involves	VBZ	ccomp	O
activation	NN	dobj	O
of	IN	case	O
transcription	NN	nmod	O
mediated	VBN	acl	O
by	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
p65/RelA	NN	compound	I-protein
homodimer	NN	nmod	I-protein
and	CC	cc	O
requires	VBZ	conj	O
the	DT	det	O
B	NN	compound	B-protein
cell-enriched	JJ	amod	I-protein
coactivator	NN	compound	I-protein
TBP-associated	JJ	amod	B-protein
factor	NN	dobj	I-protein
(	-LRB-	punct	I-protein
II	CD	appos	I-protein
)	-RRB-	punct	I-protein
105	CD	nummod	I-protein
.	.	punct	O

Androgens	NNS	nsubj	O
indirectly	RB	advmod	O
accelerate	VBP	ROOT	O
thymocyte	NN	compound	B-cell_type
apoptosis	NN	dobj	O
.	.	punct	O

Apoptotic	JJ	amod	O
processes	NNS	nsubjpass	O
,	,	punct	O
or	CC	cc	O
the	DT	det	O
disturbance	NN	conj	O
of	IN	case	O
the	DT	det	O
natural	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
these	DT	det	O
processes	NNS	nmod	O
,	,	punct	O
may	MD	aux	O
be	VB	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
autoimmune	JJ	amod	O
diseases	NNS	nmod	O
(	-LRB-	punct	O
AID	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Women	NNS	nsubj	O
are	VBP	ROOT	O
,	,	punct	O
in	IN	prep	O
general	JJ	pobj	O
,	,	punct	O
more	RBR	advmod	O
susceptible	JJ	acomp	O
than	IN	mark	O
men	NNS	nsubj	O
to	TO	aux	O
develop	VB	advcl	O
AID	NN	dobj	O
like	IN	case	O
rheumatoid	JJ	amod	O
arthritis	NN	nmod	O
.	.	punct	O

Androgens	NNS	nsubj	O
and	CC	cc	O
glucocorticoids	NNS	conj	O
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
oestrogens	NNS	nmod	O
,	,	punct	O
have	VBP	ROOT	O
favourable	JJ	amod	O
effects	NNS	dobj	O
in	IN	case	O
AID	NN	compound	O
models	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
human	JJ	amod	O
AID	NN	conj	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
that	IN	mark	O
glucocorticoids	NNS	nsubj	O
(	-LRB-	punct	O
GC	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
used	VBN	acl	O
for	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
AID	NN	nmod	O
,	,	punct	O
increase	VBP	ccomp	O
apoptosis	NN	dobj	O
in	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
resulting	VBG	acl	O
in	IN	case	O
decreased	VBN	amod	O
numbers	NNS	nmod	O
of	IN	case	O
CD4+	JJ	amod	B-cell_type
CD8+	JJ	amod	I-cell_type
thymocytes	NNS	nmod	I-cell_type
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
asked	VBN	ROOT	O
whether	IN	mark	O
androgens	NNS	nsubj	O
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
oestrogens	NNS	nmod	O
,	,	punct	O
exert	VBP	ccomp	O
their	PRP$	nmod:poss	O
favourable	JJ	amod	O
effects	NNS	dobj	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
AID	NN	nmod	O
by	IN	case	O
a	DT	det	O
mechanism	NN	nmod	O
comparable	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
described	VBN	acl	O
for	IN	case	O
GC	NN	nmod	O
by	IN	mark	O
eliminating	VBG	advcl	O
the	DT	det	O
apoptosis	NN	compound	O
prone	NN	compound	O
CD4+	JJ	amod	B-cell_type
CD8+	JJ	amod	I-cell_type
population	NN	dobj	I-cell_type
in	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
both	DT	cc:preconj	O
androgens	NNS	nsubj	O
and	CC	cc	O
oestrogens	NNS	conj	O
proved	VBD	advcl	O
thymolytic	JJ	xcomp	O
,	,	punct	O
a	DT	det	O
significantly	RB	advmod	O
decreased	VBN	amod	O
percentage	NN	nsubjpass	O
of	IN	case	O
CD4+	JJ	amod	B-cell_type
CD8+	JJ	amod	I-cell_type
thymocytes	NNS	nmod	I-cell_type
was	VBD	auxpass	O
observed	VBN	ROOT	O
by	IN	case	O
flow	NN	compound	O
cytometry	NN	nmod	O
after	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
mice	NNS	nmod	O
with	IN	case	O
the	DT	det	O
androgen	NN	compound	O
methyltestosterone	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
with	IN	case	O
the	DT	det	O
oestrogen	NN	compound	O
ethinylestradiol	NN	conj	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
whether	IN	mark	O
the	DT	det	O
observed	VBN	amod	O
thymolytic	JJ	amod	O
effects	NNS	nsubj	O
were	VBD	cop	O
due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
presence	NN	ccomp	O
of	IN	case	O
hormone	NN	compound	B-protein
receptors	NNS	nmod	I-protein
on	IN	case	O
thymocytes	NNS	nmod	B-cell_type
,	,	punct	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
isolated	VBN	ROOT	O
from	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
and	CC	cc	O
incubated	VBN	conj	O
with	IN	case	O
androgens	NNS	nmod	O
or	CC	cc	O
oestrogens	NNS	conj	O
to	TO	mark	O
measure	VB	xcomp	O
apoptosis	NN	dobj	O
.	.	punct	O

Several	JJ	amod	O
techniques	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
thymocyte	NN	compound	B-cell_type
apoptosis	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
but	CC	cc	O
no	DT	neg	O
enhanced	VBN	amod	O
apoptotic	JJ	amod	O
signal	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	conj	O
.	.	punct	O

Using	VBG	advcl	O
the	DT	det	O
very	RB	advmod	O
sensitive	JJ	amod	O
TUNEL	NN	compound	O
assay	NN	dobj	O
,	,	punct	O
no	DT	neg	O
direct	JJ	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
androgens	NNS	nmod	O
on	IN	case	O
thymocytes	NNS	nmod	B-cell_type
in	FW	compound	O
vitro	FW	advmod	O
could	MD	aux	O
be	VB	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

This	DT	nsubj	O
is	VBZ	ROOT	O
in	IN	prep	O
sharp	JJ	amod	O
contrast	NN	pobj	O
to	TO	case	O
the	DT	det	O
high	JJ	amod	O
signal	NN	nmod	O
observed	VBN	acl	O
with	IN	case	O
GC	NN	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
upon	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
androgen	NN	compound	O
treatment	NN	nmod	O
,	,	punct	O
other	JJ	amod	O
cells	NNS	nsubjpass	O
containing	VBG	acl	O
androgen	NN	compound	B-protein
receptors	NNS	dobj	I-protein
than	IN	case	O
thymocytes	NNS	nmod	B-cell_type
are	VBP	auxpass	O
probably	RB	advmod	O
involved	VBN	ROOT	O
in	IN	mark	O
inducing	VBG	advcl	O
the	DT	det	O
increase	NN	dobj	O
in	IN	case	O
thymic	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

To	TO	mark	O
study	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
androgen	NN	compound	B-protein
receptor	NN	nmod	I-protein
on	IN	case	O
thymocyte	NN	compound	B-cell_type
apoptosis	NN	nmod	O
,	,	punct	O
androgen	NN	compound	B-protein
receptor	NN	compound	I-protein
mutant	NN	compound	O
(	-LRB-	punct	O
Tfm/Y	NN	appos	O
)	-RRB-	punct	O
mice	NNS	nsubjpass	O
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
androgens	NNS	nmod	O
.	.	punct	O

No	DT	neg	O
alterations	NNS	nsubjpass	O
of	IN	case	O
thymocyte	NN	compound	B-cell_type
subpopulations	NNS	nmod	I-cell_type
were	VBD	auxpass	O
seen	VBN	ROOT	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
changes	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
percentage	NN	nmod	O
of	IN	case	O
CD4+	JJ	amod	B-cell_type
CD8+	JJ	amod	I-cell_type
thymocytes	NNS	nmod	I-cell_type
after	IN	case	O
administration	NN	nmod	O
of	IN	case	O
androgens	NNS	nmod	O
depend	VBP	ccomp	O
on	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
functional	JJ	amod	O
androgen	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
androgens	NNS	nsubj	O
indirectly	RB	advmod	O
accelerate	VBP	ccomp	O
thymocyte	NN	compound	B-cell_type
apoptosis	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Inhibition	NN	ROOT	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
AP-1	NN	dep	B-protein
and	CC	cc	O
NF-kappaB	NN	conj	B-protein
in	IN	case	O
CD4	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
peroxisome	NN	compound	B-protein
proliferator-activated	JJ	amod	I-protein
receptor	NN	compound	I-protein
gamma	NN	compound	I-protein
ligands	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
peroxisome	NN	compound	B-protein
proliferator-activated	JJ	amod	I-protein
receptor	NN	compound	I-protein
gamma	NN	nsubj	I-protein
(	-LRB-	punct	O
PPARgamma	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
hormone	NN	compound	I-protein
receptor	NN	compound	I-protein
superfamily	NN	nmod	I-protein
,	,	punct	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
adipocyte	NN	compound	O
differentiation	NN	nmod	O
and	CC	cc	O
glucose	NN	compound	O
homeostasis	NN	conj	O
.	.	punct	O

PPARgamma	NN	nsubjpass	B-protein
has	VBZ	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
recently	RB	advmod	O
to	TO	mark	O
regulate	VB	xcomp	O
macrophage	NN	compound	O
activation	NN	dobj	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
mitogens	NNS	nmod	B-protein
and	CC	cc	O
inflammation	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
PPARgamma	NN	nsubjpass	B-protein
to	TO	mark	O
be	VB	auxpass	O
preferentially	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
nuclei	NNS	nmod	O
of	IN	case	O
resting	VBG	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
to	TO	mark	O
increase	VB	conj	O
upon	IN	case	O
activation	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
either	CC	cc:preconj	O
anti-CD3	JJ	nmod	B-protein
and	CC	cc	O
anti-CD28	NN	conj	B-protein
or	CC	cc	O
phorbol	NN	compound	O
myristyl	NN	compound	O
acetate	NN	conj	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
found	VBD	ROOT	O
the	DT	det	O
PPARgamma	NN	compound	B-protein
ligand	NN	compound	I-protein
ciglitizone	NN	dobj	O
to	TO	mark	O
attenuate	VB	xcomp	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	mark	O
inhibiting	VBG	advcl	O
cytokine	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
anti-CD3	JJ	conj	B-protein
and	CC	cc	O
anti-CD28	JJ	amod	B-protein
or	CC	cc	O
PMA-induced	JJ	conj	O
proliferative	JJ	amod	O
responses	NNS	conj	O
.	.	punct	O

Inhibition	NN	nsubjpass	O
of	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
proliferative	JJ	amod	O
response	NN	nmod	O
and	CC	cc	O
inflammatory	JJ	amod	O
cytokine	NN	compound	O
expression	NN	conj	O
in	IN	case	O
CD4	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
the	DT	det	O
activated	VBN	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
AP1	NN	dep	B-protein
and	CC	cc	O
NF-kappaB	NN	conj	B-protein
.	.	punct	O

PPARgamma	NN	compound	B-protein
ligands	NNS	nsubj	I-protein
also	RB	advmod	O
strongly	RB	advmod	O
inhibited	VBD	ROOT	O
SEA-induced	JJ	amod	O
Vbeta3	NN	compound	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
,	,	punct	O
together	RB	advmod	O
with	IN	case	O
previous	JJ	amod	O
findings	NNS	nmod	O
of	IN	case	O
the	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
PPARgamma	NN	compound	B-protein
ligands	NNS	nmod	I-protein
on	IN	case	O
activated	VBN	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
,	,	punct	O
provide	VBP	ROOT	O
clear	JJ	amod	O
evidence	NN	dobj	O
for	IN	case	O
PPARgamma	NN	nmod	B-protein
as	IN	case	O
a	DT	det	O
negative	JJ	amod	B-protein
regulator	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
inflammatory	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
macrophage	NN	nmod	B-cell_type
and	CC	cc	O
T	NN	conj	B-cell_type
cells	NNS	dep	I-cell_type
.	.	punct	O

PPARgamma	NN	nsubj	B-protein
may	MD	aux	O
thus	RB	advmod	O
be	VB	cop	O
a	DT	det	O
potential	JJ	amod	O
therapeutic	JJ	amod	O
target	NN	ROOT	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
autoimmunity	NN	nmod	O
.	.	punct	O

A	DT	det	O
prominent	JJ	amod	O
role	NN	ROOT	O
for	IN	case	O
activator	NN	compound	B-protein
protein-1	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
2B4	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
CD244	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
NK	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
glycoprotein	NN	compound	I-protein
2B4	NN	nsubjpass	I-protein
(	-LRB-	punct	O
CD244	NN	appos	B-protein
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
Ig	NN	compound	B-protein
superfamily	NN	nmod	I-protein
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
NK	NN	compound	B-cell_type
and	CC	cc	O
T	NN	conj	B-cell_type
lymphocyte	NN	compound	I-cell_type
functions	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
recently	RB	advmod	O
identified	VBN	ROOT	O
CD48	NN	dobj	B-protein
as	IN	case	O
the	DT	det	O
high	JJ	amod	B-protein
affinity	NN	compound	I-protein
counterreceptor	NN	nmod	I-protein
for	IN	case	O
2B4	NN	nmod	B-protein
in	IN	case	O
both	CC	cc:preconj	O
mice	NNS	nmod	O
and	CC	cc	O
humans	NNS	conj	O
.	.	punct	O

The	DT	det	O
cytoplasmic	JJ	amod	B-protein
domain	NN	nsubj	I-protein
of	IN	case	O
2B4	NN	nmod	B-protein
associates	VBZ	ROOT	O
with	IN	case	O
src	NN	compound	B-protein
homology	NN	compound	I-protein
2	CD	nummod	I-protein
domain-containing	JJ	amod	I-protein
protein	NN	nmod	I-protein
or	CC	cc	O
signaling	VBG	compound	B-protein
lymphocyte	NN	compound	I-protein
activation	NN	compound	I-protein
molecule-associated	JJ	amod	I-protein
protein	NN	conj	I-protein
,	,	punct	O
whose	WP$	nmod:poss	O
mutation	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
underlying	JJ	amod	O
genetic	JJ	amod	O
defect	NN	acl:relcl	O
in	IN	case	O
the	DT	det	O
X-linked	JJ	amod	O
lymphoproliferative	JJ	amod	O
syndrome	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
cloning	NN	dobj	O
and	CC	cc	O
characterization	NN	conj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
2B4	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
h2B4	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Through	IN	case	O
primer	NN	compound	O
extension	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
transcription	NN	nsubj	O
of	IN	case	O
the	DT	det	O
h2B4	NN	amod	B-DNA
gene	NN	nmod	I-DNA
initiates	VBZ	ccomp	O
at	IN	case	O
multiple	JJ	amod	O
start	NN	compound	O
sites	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
isolated	VBD	ROOT	O
h2B4	NN	amod	B-DNA
genomic	JJ	amod	I-DNA
clones	NNS	nsubj	I-DNA
and	CC	cc	O
PCR	NN	conj	O
amplified	VBD	ccomp	O
the	DT	det	O
5	CD	nummod	B-DNA
'	''	punct	I-DNA
untranslated	JJ	amod	I-DNA
region	NN	dobj	I-DNA
containing	VBG	acl	O
the	DT	det	O
promoter	NN	compound	B-DNA
elements	NNS	dobj	I-DNA
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
functional	JJ	amod	O
AP-1	NN	compound	B-DNA
site	NN	dobj	I-DNA
that	WDT	nsubj	O
lies	VBZ	acl:relcl	O
between	IN	case	O
(	-LRB-	punct	O
-106	CD	nummod	O
to	TO	dep	O
-100	CD	nmod	O
)	-RRB-	punct	O
through	IN	case	O
transient	JJ	amod	O
transfection	NN	compound	O
analysis	NN	nmod	O
in	IN	case	O
YT	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
a	DT	det	O
human	JJ	amod	B-cell_line
NK	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	appos	I-cell_line
.	.	punct	O

EMSAs	NNS	nsubj	O
with	IN	case	O
Abs	NN	nmod	B-protein
specific	JJ	amod	O
for	IN	case	O
various	JJ	amod	O
protein	NN	compound	B-protein
factors	NNS	nmod	I-protein
of	IN	case	O
the	DT	det	O
AP-1	NN	compound	B-protein
family	NN	nmod	I-protein
revealed	VBD	ROOT	O
that	IN	mark	O
multiple	JJ	amod	O
members	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
Jun	NN	compound	B-protein
family	NN	nmod	I-protein
are	VBP	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
h2B4	NN	amod	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
AP-1	NN	compound	B-DNA
site	NN	nmod	I-DNA
not	RB	neg	O
only	RB	cc:preconj	O
abolishes	VBZ	ROOT	O
protein/DNA	NN	compound	O
interactions	NNS	dobj	O
but	CC	cc	O
also	RB	advmod	O
promoter	NN	compound	O
activity	NN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
a	DT	det	O
significant	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
AP-1	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
h2B4	NN	amod	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Functional	JJ	amod	O
correction	NN	nsubj	O
of	IN	case	O
FA-C	JJ	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
FANCC	NN	nmod	B-protein
suppresses	VBZ	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
interferon	NN	compound	B-DNA
gamma-inducible	JJ	amod	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Because	IN	mark	O
hematopoietic	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
derived	VBN	acl	O
from	IN	case	O
Fanconi	JJ	amod	O
anemia	NN	compound	O
(	-LRB-	punct	O
FA	NN	appos	O
)	-RRB-	punct	O
patients	NNS	nmod	O
of	IN	case	O
the	DT	det	O
C-complementation	NN	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
FA-C	NN	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
hypersensitive	JJ	advcl	O
to	TO	case	O
the	DT	det	O
inhibitory	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
interferon	NN	compound	B-protein
gamma	NN	nmod	I-protein
(	-LRB-	punct	O
IFNgamma	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
products	NNS	nsubjpass	O
of	IN	case	O
certain	JJ	amod	O
IFNgamma-inducible	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
known	VBN	acl	O
to	TO	mark	O
influence	VB	xcomp	O
hematopoietic	JJ	amod	O
cell	NN	compound	O
survival	NN	dobj	O
were	VBD	auxpass	O
quantified	VBN	ROOT	O
.	.	punct	O

High	JJ	amod	O
constitutive	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
IFNgamma-inducible	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
IFN-stimulated	JJ	amod	B-protein
gene	NN	compound	I-protein
factor	NN	compound	I-protein
3	CD	nummod	I-protein
gamma	NN	compound	I-protein
subunit	NN	appos	I-protein
(	-LRB-	punct	O
ISGF3gamma	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
IFN	NN	compound	B-protein
regulatory	JJ	amod	I-protein
factor-1	NN	conj	I-protein
(	-LRB-	punct	O
IRF-1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
cyclin-dependent	JJ	amod	B-protein
kinase	NN	compound	I-protein
inhibitor	NN	compound	I-protein
p21	NN	conj	I-protein
(	-LRB-	punct	O
WAF1	NN	appos	B-protein
)	-RRB-	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
FANCC	NN	compound	B-protein
mutant	JJ	amod	O
B	NN	compound	B-cell_type
lymphoblasts	NNS	nmod	I-cell_type
,	,	punct	O
low-density	JJ	amod	B-cell_type
bone	NN	compound	I-cell_type
marrow	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
murine	JJ	amod	B-cell_type
embryonic	JJ	amod	I-cell_type
fibroblasts	NNS	conj	I-cell_type
.	.	punct	O

Paradoxically	RB	advmod	O
,	,	punct	O
these	DT	det	O
cells	NNS	nsubj	O
do	VBP	aux	O
not	RB	neg	O
activate	VB	ROOT	B-protein
signal	NN	compound	I-protein
transducer	NN	dobj	I-protein
and	CC	cc	I-protein
activator	NN	compound	I-protein
of	IN	amod	I-protein
transcription	NN	conj	I-protein
(	-LRB-	punct	I-protein
STAT	NN	appos	I-protein
)	-RRB-	punct	I-protein
1	CD	nummod	I-protein
properly	RB	advmod	O
.	.	punct	O

In	IN	case	O
an	DT	det	O
attempt	NN	nmod	O
to	TO	mark	O
clarify	VB	acl	O
mechanisms	NNS	dobj	O
by	IN	case	O
which	WDT	nmod	O
FA-C	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
overexpress	VBP	acl:relcl	O
IFNgamma-inducible	JJ	amod	B-DNA
genes	NNS	dobj	I-DNA
in	IN	case	O
the	DT	det	O
face	NN	nmod	O
of	IN	case	O
defective	JJ	amod	O
STAT1	NN	compound	O
phosphorylation	NN	nmod	O
,	,	punct	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
reasoned	VBN	ROOT	O
that	IN	mark	O
decreased	VBN	amod	O
levels	NNS	nsubj	O
of	IN	case	O
activated	VBN	amod	B-protein
STAT1	NN	nmod	I-protein
might	MD	aux	O
result	VB	ccomp	O
in	IN	case	O
reduced	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
a	DT	det	O
hematopoietic	JJ	amod	B-protein
IFNgamma-responsive	JJ	amod	I-protein
protein	NN	nmod	I-protein
that	WDT	nsubj	O
normally	RB	advmod	O
modulates	VBZ	acl:relcl	O
expression	NN	dobj	O
of	IN	case	O
other	JJ	amod	O
IFNgamma-responsive	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Levels	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
IFNgamma	NN	compound	B-protein
-inducible	JJ	amod	O
factor	NN	compound	O
IFN	NN	compound	B-protein
consensus	NN	compound	I-protein
sequence	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
ICSBP	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
negative	JJ	amod	B-protein
trans-acting	JJ	amod	I-protein
regulator	NN	appos	I-protein
of	IN	case	O
some	DT	det	O
IFNgamma-inducible	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
were	VBD	auxpass	O
quantified	VBN	ROOT	O
.	.	punct	O

ICSBP	NN	compound	B-protein
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
reduced	VBN	ROOT	O
in	IN	case	O
FA-C	NN	compound	B-cell_type
B	NN	compound	I-cell_type
lymphoblasts	NNS	nmod	I-cell_type
and	CC	cc	O
MEFs	NNS	conj	B-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
enforced	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
ICSBP	NN	nmod	B-protein
failed	VBD	ROOT	O
to	TO	mark	O
down-regulate	VB	xcomp	O
IRF-1	NN	dobj	B-protein
,	,	punct	O
ISGF3gamma	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
p21	NN	conj	B-protein
(	-LRB-	punct	I-protein
WAF1	NN	appos	I-protein
)	-RRB-	punct	I-protein
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
FANCC	NN	compound	B-protein
protein	NN	nsubj	I-protein
functions	VBZ	ROOT	O
to	TO	mark	O
modulate	VB	xcomp	O
expression	NN	dobj	O
of	IN	case	O
a	DT	det	O
family	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
that	WDT	mark	O
in	IN	case	O
normal	JJ	amod	O
cells	NNS	nmod	O
are	VBP	cop	O
inducible	JJ	acl:relcl	O
only	RB	advmod	O
by	IN	case	O
specific	JJ	amod	O
environmental	JJ	amod	O
cues	NNS	nmod	O
for	IN	case	O
apoptosis	NN	nmod	O
or	CC	cc	O
mitogenic	JJ	amod	O
inhibition	NN	conj	O
,	,	punct	O
but	CC	cc	O
it	PRP	nsubj	O
does	VBZ	conj	O
so	RB	advmod	O
independently	RB	advmod	O
of	IN	case	O
the	DT	det	O
classic	JJ	amod	O
IFN-STAT1	NN	compound	O
pathway	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
not	RB	neg	O
the	DT	det	O
direct	JJ	amod	O
result	NN	conj	O
of	IN	case	O
reduced	VBN	amod	O
ICSBP	NN	compound	B-protein
expression	NN	nmod	O
.	.	punct	O

A	DT	det	O
genetic	JJ	amod	O
investigation	NN	ROOT	O
of	IN	case	O
E2A	NN	compound	O
function	NN	nmod	O
in	IN	case	O
lymphocyte	NN	compound	O
development	NN	nmod	O
.	.	punct	O

Lymphocytes	NNS	nsubjpass	B-cell_type
are	VBP	auxpass	O
derived	VBN	ROOT	O
from	IN	case	O
hematopoietic	JJ	amod	B-cell_type
stem	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
HSC	NN	appos	B-cell_type
)	-RRB-	punct	O
following	VBG	case	O
a	DT	det	O
series	NN	nmod	O
of	IN	case	O
regulated	VBN	amod	O
differentiation	NN	compound	O
events	NNS	nmod	O
.	.	punct	O

Multipotent	JJ	amod	B-cell_type
HSCs	NNS	nsubj	I-cell_type
become	VBP	ROOT	O
committed	VBN	xcomp	O
to	TO	case	O
the	DT	det	O
B	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lineage	NN	nmod	I-cell_line
in	IN	case	O
bone	NN	compound	O
marrow	NN	nmod	O
and	CC	cc	O
the	DT	det	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lineage	NN	conj	I-cell_line
in	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
after	IN	mark	O
receiving	VBG	advcl	O
appropriate	JJ	amod	O
signals	NNS	dobj	O
from	IN	case	O
the	DT	det	O
corresponding	JJ	amod	O
microenvironment	NN	nmod	O
.	.	punct	O

These	DT	det	O
committed	VBN	amod	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
must	MD	aux	O
then	RB	advmod	O
undergo	VB	ROOT	O
V	NN	compound	O
(	-LRB-	punct	O
D	NN	compound	O
)	-RRB-	punct	O
J	NN	compound	O
recombination	NN	dobj	O
at	IN	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
gene	NN	nmod	I-DNA
or	CC	cc	O
T	NN	compound	B-DNA
cell	NN	compound	I-DNA
receptor	NN	compound	I-DNA
gene	NN	compound	I-DNA
locus	NN	conj	I-DNA
resulting	VBG	acl	O
in	IN	case	O
clonal	JJ	amod	O
production	NN	nmod	O
of	IN	case	O
functional	JJ	amod	O
B	NN	nmod	B-cell_type
or	CC	cc	I-cell_type
T	NN	conj	I-cell_type
lymphocytes	NNS	dep	I-cell_type
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Lymphocyte	NN	compound	O
commitment	NN	nsubjpass	O
and	CC	cc	O
differentiation	NN	conj	O
are	VBP	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
programmed	VBN	amod	O
gene	NN	compound	O
expression	NN	nmod	O
or	CC	cc	O
repression	NN	compound	O
events	NNS	conj	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
driven	VBN	acl:relcl	O
by	IN	case	O
lineage	NN	nmod	B-protein
and	CC	cc	I-protein
stage	NN	conj	I-protein
specific	JJ	amod	I-protein
transcription	NN	compound	I-protein
factors	NNS	conj	I-protein
.	.	punct	O

The	DT	det	O
basic-helix-loop-helix	JJ	amod	B-protein
(	-LRB-	punct	I-protein
bHLH	JJ	appos	I-protein
)	-RRB-	punct	I-protein
transcription	NN	compound	I-protein
factors	NNS	nsubjpass	I-protein
encoded	VBN	acl	O
by	IN	case	O
the	DT	det	O
E2A	NN	compound	B-DNA
gene	NN	nmod	I-DNA
are	VBP	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
several	JJ	amod	O
differentiation	NN	compound	O
events	NNS	nmod	O
during	IN	case	O
B	NN	nmod	O
and	CC	cc	O
T	NN	conj	O
cell	NN	compound	O
development	NN	dep	O
,	,	punct	O
including	VBG	case	O
lineage	NN	compound	O
commitment	NN	nmod	O
,	,	punct	O
initiation	NN	dep	O
of	IN	case	O
V	NN	compound	O
(	-LRB-	punct	O
D	NN	compound	O
)	-RRB-	punct	O
J	NN	compound	O
recombination	NN	nmod	O
,	,	punct	O
and	CC	cc	O
antigen	NN	compound	O
receptor	NN	nmod:npmod	O
mediated	JJ	amod	O
proliferation	NN	conj	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

Several	JJ	amod	O
recent	JJ	amod	O
reviews	NNS	nsubj	O
have	VBP	aux	O
provided	VBN	ROOT	O
a	DT	det	O
comprehensive	JJ	amod	O
discussion	NN	dobj	O
of	IN	case	O
biochemical	JJ	amod	O
,	,	punct	O
cellular	JJ	conj	O
,	,	punct	O
and	CC	cc	O
genetic	JJ	conj	O
research	NN	nmod	O
on	IN	case	O
E2A	NN	compound	O
function	NN	nmod	O
in	IN	case	O
lymphocyte	NN	compound	O
development	NN	nmod	O
(	-LRB-	punct	O
1	CD	dep	O
,	,	punct	O
2	CD	amod	O
)	-RRB-	punct	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
only	RB	advmod	O
discuss	VBP	ROOT	O
some	DT	dobj	O
of	IN	case	O
the	DT	det	O
genetic	JJ	amod	O
approaches	NNS	nmod	O
our	PRP$	nmod:poss	O
laboratory	NN	appos	O
(	-LRB-	punct	O
except	IN	mark	O
where	WRB	advmod	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
noted	VBN	advcl	O
)	-RRB-	punct	O
has	VBZ	aux	O
undertaken	VBN	advcl	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
molecular	JJ	amod	O
pathways	NNS	dobj	O
mediated	VBN	acl	O
by	IN	case	O
E2A	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
in	IN	case	O
lymphocyte	NN	compound	O
development	NN	nmod	O

D609	NN	nsubj	O
inhibits	VBZ	ROOT	O
ionizing	VBG	xcomp	O
radiation-induced	JJ	amod	O
oxidative	JJ	amod	O
damage	NN	dobj	O
by	IN	mark	O
acting	VBG	advcl	O
as	IN	case	O
a	DT	det	O
potent	JJ	amod	O
antioxidant	NN	nmod	O
.	.	punct	O

Tricyclodecan-9-yl-xanthogenate	NN	nsubjpass	O
(	-LRB-	punct	O
D609	NN	appos	O
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
extensively	RB	advmod	O
studied	VBN	ROOT	O
in	IN	case	O
biological	JJ	amod	O
systems	NNS	nmod	O
and	CC	cc	O
exhibits	VBZ	conj	O
a	DT	det	O
variety	NN	dobj	O
of	IN	case	O
biological	JJ	amod	O
functions	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
antiviral	JJ	nmod	O
,	,	punct	O
antitumor	NN	conj	O
,	,	punct	O
and	CC	cc	O
anti-inflammatory	JJ	conj	O
activities	NNS	dep	O
.	.	punct	O

Most	JJS	nsubjpass	O
of	IN	prep	O
these	DT	det	O
activities	NNS	pobj	O
have	VBP	aux	O
been	VBN	auxpass	O
largely	RB	advmod	O
attributed	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
D609	NN	nmod	O
on	IN	case	O
phosphatidylcholine-specific	JJ	amod	O
phospholipase	NN	compound	B-protein
C	NN	nmod	I-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
as	IN	case	O
a	DT	det	O
xanthate	JJ	compound	O
derivative	NN	nmod	O
,	,	punct	O
D609	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
strong	JJ	amod	O
electrolyte	NN	ROOT	O
and	CC	cc	O
readily	RB	advmod	O
dissociates	VBZ	conj	O
to	TO	mark	O
xanthate	VB	acl	O
anions	NNS	dobj	O
and	CC	cc	O
cations	NNS	conj	O
of	IN	prep	O
alkali	JJ	amod	O
metals	NNS	pobj	O
in	IN	prep	O
solution	NN	pobj	O
.	.	punct	O

Xanthate	NN	compound	O
anions	NNS	nsubj	O
and	CC	cc	O
protonated	VBD	amod	O
xanthic	JJ	amod	O
acid	NN	conj	O
contain	VBP	ROOT	O
a	DT	det	O
free	JJ	amod	O
thiol	NN	compound	O
moiety	NN	dobj	O
and	CC	cc	O
are	VBP	cop	O
highly	RB	advmod	O
reductive	JJ	conj	O
.	.	punct	O

This	DT	nsubj	O
implies	VBZ	ROOT	O
that	IN	mark	O
D609	NN	nsubj	O
and	CC	cc	O
other	JJ	amod	O
xanthate	NN	compound	O
derivatives	NNS	conj	O
may	MD	aux	O
function	VB	ccomp	O
as	IN	case	O
potent	JJ	amod	O
antioxidants	NNS	nmod	O
.	.	punct	O

Indeed	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
D609	NN	nsubj	O
inhibited	VBD	ccomp	O
the	DT	det	O
Fenton	NNP	compound	O
reaction-induced	JJ	amod	O
oxidation	NN	dobj	O
of	IN	case	O
dihydrorhodamine	NN	nmod	O
123	CD	nummod	O
in	IN	case	O
a	DT	det	O
dose-dependent	JJ	amod	O
manner	NN	nmod	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
pyrrolidinedithiocarbamate	NN	nmod	O
,	,	punct	O
a	DT	det	O
well	RB	advmod	O
known	JJ	amod	O
antioxidant	NN	appos	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
D609	NN	nsubj	O
inhibited	VBD	ROOT	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
the	DT	det	O
alpha-phenyl-tert-butylnitrone-free	NN	amod	O
radical	JJ	amod	O
spin	NN	compound	O
adducts	NNS	nmod	O
and	CC	cc	O
lipid	NN	compound	O
peroxidation	NN	conj	O
of	IN	case	O
synaptosomal	JJ	amod	O
membranes	NNS	nmod	O
by	IN	case	O
the	DT	det	O
Fenton	NNP	compound	O
reagents	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
preincubation	NN	nsubj	O
of	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
with	IN	case	O
D609	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
significant	JJ	amod	O
diminution	NN	nmod	O
of	IN	case	O
ionizing	VBG	amod	O
radiation	NN	nmod	O
(	-LRB-	punct	O
IR	NN	intj	O
)	-RRB-	punct	O
-induced	JJ	dep	O
1	CD	nummod	O
)	-RRB-	punct	O
production	NN	conj	O
of	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
species	NNS	nmod	O
;	:	punct	O
2	LS	dep	O
)	-RRB-	punct	O
decrease	NN	dep	O
in	IN	case	O
intracellular	JJ	amod	O
reduced	VBN	amod	O
glutathione	NN	nmod	O
;	:	punct	O
3	LS	nummod	O
)	-RRB-	punct	O
oxidative	JJ	amod	O
damage	NN	dep	O
to	IN	case	O
proteins	NNS	nmod	O
and	CC	cc	O
lipids	NNS	conj	O
;	:	punct	O
and	CC	cc	O
4	LS	conj	O
)	-RRB-	punct	O
activation	NN	conj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod	I-protein
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
D609	NN	nsubjpass	O
(	-LRB-	punct	O
50	CD	nummod	O
mg/kg	NN	appos	O
i.v.	NN	amod	O
)	-RRB-	punct	O
was	VBD	auxpass	O
administered	VBN	advcl	O
to	TO	case	O
mice	NNS	nmod	O
10	CD	nummod	O
min	NN	dep	O
prior	JJ	case	O
to	TO	case	O
total	JJ	amod	O
body	NN	compound	O
IR	NN	nmod	O
(	-LRB-	punct	O
6.5	CD	nummod	O
and	CC	cc	O
8.5	CD	conj	O
Gy	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
it	PRP	nsubj	O
protected	VBD	ROOT	O
the	DT	det	O
mice	NNS	dobj	O
from	IN	case	O
IR-induced	JJ	amod	O
lethality	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
D609	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
antioxidant	NN	ccomp	O
and	CC	cc	O
has	VBZ	conj	O
the	DT	det	O
ability	NN	dobj	O
to	TO	mark	O
inhibit	VB	acl	O
IR-induced	JJ	amod	O
cellular	JJ	amod	O
oxidative	JJ	amod	O
stress	NN	dobj	O
.	.	punct	O

Inhibition	NN	ROOT	O
of	IN	case	O
AP-1	NN	nmod	B-protein
by	IN	case	O
the	DT	det	O
glucocorticoid-inducible	JJ	amod	O
protein	NN	compound	B-protein
GILZ	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
immunosuppressive	JJ	amod	O
effects	NNS	nsubj	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
arise	VBP	ROOT	O
largely	RB	advmod	O
by	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
ascribed	VBN	acl:relcl	O
to	TO	case	O
interference	NN	nmod	O
between	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
and	CC	cc	O
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
such	JJ	case	O
as	IN	mwe	O
AP-1	NN	nmod	B-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
by	IN	case	O
competition	NN	conj	O
for	IN	prep	O
common	JJ	amod	O
coactivators	NNS	pobj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
glucocorticoid-induced	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
interleukin-2	NN	compound	O
mRNA	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
activated	VBN	amod	B-cell_type
normal	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
required	VBD	ccomp	O
new	JJ	amod	O
protein	NN	compound	O
synthesis	NN	dobj	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
this	DT	det	O
phenomenon	NN	nsubj	O
is	VBZ	cop	O
secondary	JJ	ccomp	O
to	TO	case	O
expression	NN	nmod	O
of	IN	case	O
glucocorticoid-regulated	JJ	amod	O
genes	NNS	nmod	B-DNA
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
prominent	JJ	amod	O
glucocorticoid-induced	JJ	amod	O
genes	NNS	nmod	B-DNA
is	VBZ	cop	O
glucocorticoid-induced	JJ	amod	B-DNA
leucine	NN	compound	I-DNA
zipper	NN	ROOT	I-DNA
(	-LRB-	punct	O
GILZ	NN	appos	B-DNA
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	acl:relcl	O
to	TO	mark	O
inhibit	VB	xcomp	O
activation-induced	JJ	amod	O
up-regulation	NN	dobj	O
of	IN	case	O
Fas	NN	compound	B-RNA
ligand	NN	compound	I-RNA
(	-LRB-	punct	I-RNA
FasL	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

Indeed	RB	advmod	O
,	,	punct	O
transient	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
GILZ	NN	nmod	B-DNA
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
blocked	VBD	ROOT	O
induction	NN	dobj	O
of	IN	case	O
a	DT	det	O
reporter	NN	compound	B-DNA
construct	NN	nmod	I-DNA
driven	VBN	acl	O
by	IN	case	O
the	DT	det	O
FasL	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

This	DT	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
accounted	VBN	ROOT	O
for	IN	case	O
by	IN	case	O
GILZ	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
inhibition	NN	nmod	O
of	IN	case	O
Egr-2	NN	nmod	B-protein
and	CC	cc	O
Egr-3	NN	conj	B-protein
,	,	punct	O
NFAT/AP-1	NN	compound	B-protein
-inducible	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
a	DT	det	O
regulatory	JJ	amod	B-DNA
element	NN	dobj	I-DNA
in	IN	case	O
the	DT	det	O
FasL	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
and	CC	cc	O
up-regulate	VBP	conj	O
FasL	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

GILZ	NN	nsubj	B-protein
also	RB	advmod	O
potently	RB	advmod	O
inhibited	VBD	ROOT	O
AP-1-driven	JJ	amod	B-DNA
and	CC	cc	I-DNA
IL-2	NN	nmod:npmod	I-DNA
promoter-driven	JJ	conj	I-DNA
reporter	NN	compound	I-DNA
constructs	NNS	dobj	I-DNA
,	,	punct	O
and	CC	cc	O
recombinant	JJ	amod	O
GILZ	NN	nsubj	B-protein
specifically	RB	advmod	O
interacted	VBD	conj	O
with	IN	case	O
c-Fos	NN	nmod	B-protein
and	CC	cc	O
c-Jun	NN	conj	B-protein
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
inhibited	VBD	conj	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
active	JJ	amod	B-protein
AP-1	NN	nmod	I-protein
to	TO	case	O
its	PRP$	nmod:poss	O
target	NN	compound	O
DNA	NN	nmod	O
.	.	punct	O

Whereas	IN	mark	O
homodimerization	NN	nsubj	O
of	IN	case	O
GILZ	NN	nmod	B-protein
required	VBD	advcl	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
its	PRP$	nmod:poss	O
leucine	NN	compound	B-protein
zipper	NN	nmod	I-protein
,	,	punct	O
the	DT	det	O
interaction	NN	nsubj	O
with	IN	case	O
c-Fos	NN	nmod	B-protein
and	CC	cc	O
c-Jun	NN	conj	B-protein
occurred	VBD	ROOT	O
through	IN	case	O
the	DT	det	O
N-terminal	JJ	amod	B-protein
60-amino	JJ	compound	B-protein
acid	NN	compound	I-protein
region	NN	nmod	I-protein
of	IN	case	O
GILZ	NN	nmod	B-protein
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
GILZ	NN	nsubj	B-protein
represents	VBZ	ROOT	O
a	DT	det	O
glucocorticoid-induced	JJ	amod	O
gene	NN	compound	O
product	NN	dobj	O
that	WDT	nsubj	O
can	MD	aux	O
inhibit	VB	acl:relcl	O
a	DT	det	O
variety	NN	dobj	O
of	IN	case	O
activation-induced	JJ	amod	O
events	NNS	nmod	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
by	IN	case	O
direct	JJ	amod	O
interference	NN	nmod	O
with	IN	case	O
AP-1	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
is	VBZ	cop	O
therefore	RB	advmod	O
a	DT	det	O
candidate	NN	conj	O
for	IN	case	O
a	DT	det	O
mediator	NN	nmod	O
of	IN	case	O
glucocorticoid-induced	JJ	amod	O
immunosuppression	NN	nmod	O
.	.	punct	O

Pharmacokinetic	JJ	amod	O
differences	NNS	ROOT	O
between	IN	case	O
a	DT	det	O
T	NN	compound	O
cell-tolerizing	JJ	nmod	O
and	CC	cc	O
a	DT	det	O
T	NN	nmod:npmod	O
cell-activating	JJ	amod	O
peptide	NN	conj	O
.	.	punct	O

Vaccination	NN	nsubj	O
with	IN	case	O
a	DT	det	O
peptide	NN	nmod	O
representing	VBG	acl	O
a	DT	det	O
CTL	NN	compound	O
epitope	NN	dobj	O
from	IN	case	O
the	DT	det	O
human	JJ	amod	O
papillomavirus	NN	compound	O
(	-LRB-	punct	O
HPV	NN	appos	O
)	-RRB-	punct	O
16	CD	nummod	O
E7	NN	compound	B-protein
protein	NN	nmod	I-protein
induces	VBZ	ROOT	O
a	DT	det	O
specific	JJ	amod	O
CTL	NN	compound	O
response	NN	dobj	O
that	WDT	nsubj	O
prevents	VBZ	acl:relcl	O
the	DT	det	O
outgrowth	NN	dobj	O
of	IN	case	O
HPV16	NN	compound	O
E7-expressing	JJ	amod	O
tumors	NNS	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
vaccination	NN	nsubj	O
with	IN	case	O
a	DT	det	O
peptide	NN	nmod	O
encoding	VBG	acl	O
an	DT	det	O
adenovirus	NN	compound	O
type	NN	compound	O
5	CD	nummod	O
(	-LRB-	punct	O
Ad5	NN	appos	O
)	-RRB-	punct	O
E1A	NN	compound	O
CTL	NN	compound	O
epitope	NN	dobj	O
results	VBZ	ROOT	O
in	IN	case	O
CTL	NN	compound	O
tolerance	NN	nmod	O
and	CC	cc	O
enhanced	VBN	amod	O
growth	NN	conj	O
of	IN	case	O
an	DT	det	O
Ad5	NN	compound	O
E1A-expressing	JJ	amod	O
tumor	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
unclear	JJ	ROOT	O
why	WRB	advmod	O
these	DT	det	O
peptides	NNS	nsubj	O
induce	VBP	ccomp	O
such	JJ	amod	O
opposite	JJ	amod	O
effects	NNS	dobj	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
a	DT	det	O
difference	NN	nsubj	O
in	IN	case	O
pharmacokinetics	NNS	nmod	O
can	MD	aux	O
explain	VB	ccomp	O
the	DT	det	O
functional	JJ	amod	O
contrasts	NNS	dobj	O
,	,	punct	O
tritiated	VBD	amod	O
Ad5	NN	compound	O
E1A	NN	compound	O
and	CC	cc	O
HPV16	NN	conj	O
E7	NN	compound	O
peptides	NNS	nsubjpass	O
were	VBD	auxpass	O
injected	VBN	ROOT	O
into	IN	case	O
mice	NNS	nmod	O
.	.	punct	O

Results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
tolerizing	NN	compound	O
peptide	NN	nsubj	O
spread	VBN	acl	O
through	IN	prep	O
the	DT	det	O
body	NN	pobj	O
16	CD	nummod	O
times	NNS	cc	O
faster	RBR	ccomp	O
than	IN	case	O
the	DT	det	O
activating	VBG	amod	O
peptide	NN	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
cleared	VBN	conj	O
at	IN	advmod	O
least	JJS	nmod:npmod	O
2	CD	compound	O
times	NNS	nummod	O
faster	RBR	xcomp	O
.	.	punct	O

The	DT	det	O
HPV16	NN	compound	O
E7	NN	compound	O
peptide	NN	compound	O
kinetics	NNS	nsubj	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
kinetics	NNS	nmod	O
of	IN	case	O
HPV16	NN	nmod:npmod	B-protein
E7	NN	nmod:npmod	I-protein
-specific	JJ	amod	O
CTL	NN	compound	O
induction	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
Ad5	NN	compound	O
E1A	NN	compound	O
peptide	NN	compound	O
injection	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
physical	JJ	amod	O
deletion	NN	nmod	O
of	IN	mark	O
preexisting	VBG	acl	O
Ad5	NN	compound	B-protein
E1A	NN	compound	I-protein
-specific	JJ	amod	O
CTLs	NNS	dobj	B-protein
within	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
after	IN	case	O
injection	NN	nmod	O
.	.	punct	O

This	DT	det	O
tolerization	NN	nsubj	O
occurred	VBD	ROOT	O
at	IN	prep	O
the	DT	det	O
time	NN	pobj	O
when	WRB	advmod	O
the	DT	det	O
peptide	NN	nsubj	O
reached	VBD	advcl	O
its	PRP$	nmod:poss	O
maximum	JJ	amod	O
peptide	NN	compound	O
concentration	NN	dobj	O
in	IN	case	O
the	DT	det	O
organs	NNS	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
ubiquitous	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
tolerizing	NN	amod	O
Ad5	NN	compound	O
E1A	NN	compound	O
peptide	NN	nmod	O
within	IN	case	O
a	DT	det	O
short	JJ	amod	O
period	NN	nmod	O
of	IN	case	O
time	NN	nmod	O
causes	VBZ	ccomp	O
activation-induced	JJ	amod	O
cell	NN	compound	O
death	NN	dobj	O
of	IN	case	O
Ad5	NN	compound	B-protein
E1A	NN	compound	I-protein
-specific	JJ	amod	O
CTLs	NNS	nmod	B-protein
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
information	NN	nsubj	O
on	IN	case	O
the	DT	det	O
pharmacokinetics	NNS	nmod	O
of	IN	case	O
peptides	NNS	nmod	O
is	VBZ	cop	O
vital	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
safety	NN	nmod	O
and	CC	cc	O
efficacy	NN	conj	O
of	IN	prep	O
peptide-based	JJ	amod	O
vaccines	NNS	pobj	O
.	.	punct	O

Smad3	NN	nsubj	B-protein
and	CC	cc	O
Smad4	NN	conj	B-protein
mediate	VBP	ROOT	O
transforming	VBG	amod	B-protein
growth	NN	nmod:npmod	I-protein
factor-beta1	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
IgA	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
murine	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Transforming	VBG	amod	B-protein
growth	NN	compound	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
TGF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-beta1	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
well	RB	advmod	O
established	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
critical	JJ	amod	O
IgA	NN	compound	B-protein
isotype	NN	compound	I-protein
switching	NN	compound	I-protein
factor	NN	nmod	I-protein
and	CC	cc	O
Smad	NN	compound	B-protein
molecules	NNS	nsubjpass	I-protein
have	VBP	aux	O
been	VBN	auxpass	O
reported	VBN	conj	O
to	TO	mark	O
act	VB	xcomp	O
as	IN	case	O
transducers	NNS	nmod	B-protein
and	CC	cc	O
transcriptional	JJ	amod	B-protein
factors	NNS	conj	I-protein
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
TGF-beta1	NN	compound	B-protein
-targeted	JJ	amod	O
genes	NNS	nmod	B-DNA
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
Smad	NN	compound	B-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
TGF-beta1	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
IgA	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

First	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
TGF-beta1	NN	nsubj	B-protein
significantly	RB	advmod	O
increases	VBZ	ccomp	O
endogenous	JJ	amod	B-RNA
germ-line	NN	compound	I-RNA
(	-LRB-	punct	I-RNA
GL	NN	intj	I-RNA
)	-RRB-	punct	I-RNA
alpha	NN	compound	I-RNA
transcripts	NNS	dobj	I-RNA
by	IN	case	O
LPS-stimulated	JJ	amod	O
CH12.LX.4933	NN	nmod	B-cell_line
(	-LRB-	punct	I-cell_line
mu	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
+	CC	nummod	I-cell_line
)	-RRB-	punct	I-cell_line
)	-RRB-	punct	I-cell_line
B	NN	compound	I-cell_line
lymphoma	NN	compound	I-cell_line
cells	NNS	dep	I-cell_line
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
its	PRP$	nmod:poss	O
signaling	NN	compound	O
mechanisms	NNS	dobj	O
,	,	punct	O
the	DT	det	O
lymphoma	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nsubjpass	I-cell_line
was	VBD	auxpass	O
transfected	VBN	ROOT	O
with	IN	case	O
pFL3	NN	nmod	B-DNA
that	WDT	nsubj	O
contains	VBZ	acl:relcl	O
the	DT	det	O
TGF-beta-responsive	JJ	amod	B-DNA
element	NN	dobj	I-DNA
of	IN	case	O
the	DT	det	O
GLalpha	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
stimulated	VBN	conj	O
with	IN	case	O
TGF-beta1	NN	nmod	B-protein
.	.	punct	O

Similar	JJ	advcl	O
to	TO	case	O
endogenous	JJ	amod	B-RNA
GLalpha	NN	compound	I-RNA
transcripts	NNS	nmod	I-RNA
,	,	punct	O
TGF-beta1	NN	nsubj	B-protein
induces	VBZ	ROOT	O
GLalpha	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	dobj	O
and	CC	cc	O
overexpression	NN	nsubj	O
of	IN	case	O
Smad3	NN	nmod	B-protein
markedly	RB	advmod	O
enhances	VBZ	conj	O
the	DT	det	O
promoter	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

This	DT	det	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
further	RB	advmod	O
augmented	VBN	ROOT	O
by	IN	case	O
cotransfected	VBN	amod	B-protein
Smad4	NN	nmod	I-protein
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
Smad7	NN	nsubj	B-protein
substantially	RB	advmod	O
abrogates	VBZ	ROOT	O
the	DT	det	O
synergistic	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
Smad3/4	NN	nmod	B-protein
on	IN	case	O
GLalpha	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
overexpression	NN	nsubj	O
of	IN	case	O
Smad3/4	NN	nmod	B-protein
enhances	VBZ	ROOT	O
TGF-beta1	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
endogenous	JJ	amod	B-RNA
GLalpha	NN	compound	I-RNA
transcripts	NNS	dobj	I-RNA
in	IN	case	O
normal	JJ	amod	B-cell_type
spleen	NN	compound	I-cell_type
B	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
s	NNS	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	dep	O
of	IN	case	O
TGF-beta1	NN	nmod	B-protein
,	,	punct	O
overexpression	NN	nsubj	O
of	IN	case	O
Smad3/4	NN	nmod	B-protein
selectively	RB	advmod	O
increases	VBZ	ROOT	O
both	CC	cc:preconj	O
surface	NN	compound	O
IgA	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
IgA	NN	compound	O
production	NN	conj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
from	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
Smad3	NN	nsubj	B-protein
,	,	punct	O
Smad4	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
Smad7	NN	conj	B-protein
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
serve	VBP	ccomp	O
as	IN	case	O
mediators	NNS	nmod	O
linking	VBG	acl	O
TGF-beta1	NN	dobj	B-protein
to	TO	case	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
IgA	NN	compound	B-DNA
switching	NN	compound	I-DNA
related	JJ	amod	I-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
regulation	NN	conj	O
of	IN	case	O
IgA	NN	compound	O
class	NN	compound	O
switching	NN	nmod	O
.	.	punct	O

The	DT	det	O
translesion	NN	compound	B-protein
DNA	NN	compound	I-protein
polymerase	NN	compound	I-protein
zeta	NN	nsubj	I-protein
plays	VBZ	ROOT	O
a	DT	det	O
major	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
Ig	NN	compound	O
and	CC	cc	O
bcl-6	JJ	conj	O
somatic	JJ	amod	O
hypermutation	NN	nmod	O
.	.	punct	O

Ig	NN	compound	O
somatic	JJ	amod	O
mutations	NNS	nsubjpass	O
would	MD	aux	O
be	VB	auxpass	O
introduced	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
polymerase	NN	nmod	B-protein
(	-LRB-	punct	O
pol	NN	appos	B-protein
)	-RRB-	punct	O
while	IN	mark	O
repairing	VBG	advcl	O
DNA	NN	dobj	O
outside	IN	case	O
main	JJ	amod	O
DNA	NN	compound	O
replication	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
constitutively	RB	advmod	O
express	VBP	ccomp	O
the	DT	det	O
translesion	NN	compound	B-protein
pol	NN	compound	I-protein
zeta	NN	dobj	I-protein
,	,	punct	O
which	WDT	nsubj	O
effectively	RB	advmod	O
extends	VBZ	acl:relcl	O
DNA	NN	compound	O
past	IN	amod	O
mismatched	VBN	amod	O
bases	NNS	dobj	O
(	-LRB-	punct	O
mispair	JJ	amod	O
extender	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
pol	NN	compound	B-protein
eta	NN	conj	I-protein
,	,	punct	O
which	WDT	nsubj	O
bypasses	VBZ	acl:relcl	O
DNA	NN	compound	O
lesions	NNS	dobj	O
in	IN	case	O
an	DT	det	O
error-free	JJ	amod	O
fashion	NN	nmod	O
.	.	punct	O

Upon	IN	case	O
B	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	dep	I-protein
(	-LRB-	punct	O
BCR	NN	appos	B-protein
)	-RRB-	punct	O
engagement	NN	nmod	O
and	CC	cc	O
coculture	NN	conj	O
with	IN	case	O
activated	VBN	amod	B-cell_type
CD4+	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
these	DT	det	O
lymphocytes	NNS	nsubj	B-cell_type
upregulated	VBD	ROOT	O
pol	NN	compound	B-protein
zeta	NN	dobj	I-protein
,	,	punct	O
downregulated	VBD	conj	O
pol	NN	compound	B-protein
eta	NN	dobj	I-protein
,	,	punct	O
and	CC	cc	O
mutated	VBD	conj	O
the	DT	det	O
Ig	NN	compound	B-DNA
and	CC	cc	I-DNA
bcl-6	JJ	conj	I-DNA
genes	NNS	dobj	I-DNA
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
pol	NN	compound	B-protein
zeta	NN	compound	I-protein
REV3	NN	compound	B-protein
catalytic	JJ	amod	I-protein
subunit	NN	nmod	I-protein
by	IN	case	O
specific	JJ	amod	O
phosphorothioate-modified	JJ	amod	O
oligonucleotides	NNS	nmod	O
impaired	VBD	ROOT	O
Ig	NN	compound	O
and	CC	cc	O
bcl-6	JJ	conj	O
hypermutation	NN	dobj	O
and	CC	cc	O
UV	NN	nmod:npmod	O
damage-induced	JJ	amod	O
DNA	NN	compound	O
mutagenesis	NN	conj	O
,	,	punct	O
without	IN	mark	O
affecting	VBG	advcl	O
cell	NN	compound	O
cycle	NN	dobj	O
or	CC	cc	O
viability	NN	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
pol	NN	compound	B-protein
zeta	NN	nsubj	I-protein
plays	VBZ	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
Ig	NN	compound	O
and	CC	cc	O
bcl-6	JJ	conj	O
hypermutation	NN	nmod	O
,	,	punct	O
perhaps	RB	advmod	O
facilitated	VBN	advcl	O
by	IN	case	O
the	DT	det	O
downregulation	NN	nmod	O
of	IN	case	O
pol	NN	compound	B-protein
eta	NN	nmod	I-protein
.	.	punct	O

Molecular	JJ	amod	O
mechanism	NN	ROOT	O
of	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
progression	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
oncogene	NN	compound	B-protein
product	NN	compound	I-protein
Tax	NN	nmod	I-protein
of	IN	case	O
human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
I	CD	nummod	O
.	.	punct	O

The	DT	det	O
trans-activator	NN	compound	B-protein
protein	NN	compound	I-protein
Tax	NN	nsubj	I-protein
of	IN	case	O
human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
I	CD	nummod	O
(	-LRB-	punct	O
HTLV-I	NN	appos	O
)	-RRB-	punct	O
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
adult	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	nmod	O
through	IN	advmod	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
ability	NN	appos	O
to	TO	mark	O
stimulate	VB	acl	O
cell	NN	compound	O
growth	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
reported	VBD	ROOT	O
that	IN	mark	O
Tax	NN	nsubj	B-protein
induced	VBD	ccomp	O
cell	NN	compound	O
cycle	NN	compound	O
progression	NN	dobj	O
from	IN	case	O
G0/G1	NN	compound	O
phase	NN	nmod	O
to	TO	case	O
S	NN	nmod	O
and	CC	cc	O
G2/M	NN	conj	O
phases	NNS	dep	O
in	IN	case	O
human	JJ	amod	B-cell_line
T-cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
Kit	NN	compound	I-cell_line
225	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

To	TO	mark	O
elucidate	VB	advcl	O
molecular	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
Tax	NN	compound	B-protein
-induced	JJ	amod	O
cell	NN	compound	O
cycle	NN	compound	O
progression	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
systematically	RB	advmod	O
examined	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
Tax	NN	nmod	B-protein
on	IN	case	O
biochemical	JJ	amod	O
events	NNS	nmod	O
associated	VBN	acl	O
with	IN	case	O
cell	NN	compound	O
cycle	NN	compound	O
progression	NN	nmod	O
.	.	punct	O

Introduction	NN	nsubj	O
of	IN	case	O
Tax	NN	nmod	B-protein
into	IN	case	O
resting	VBG	amod	B-cell_line
Kit	NN	compound	I-cell_line
225	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
induced	VBD	ROOT	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
G1/S	NN	compound	O
transition	NN	compound	O
regulation	NN	compound	O
cascade	NN	nmod	O
consisting	VBG	acl	O
of	IN	case	O
activation	NN	nmod	O
of	IN	case	O
cyclin	NN	compound	B-protein
dependent	JJ	amod	I-protein
kinase	NN	nmod	I-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
CDK2	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
CDK4	NN	conj	B-protein
,	,	punct	O
phosphorylation	NN	appos	O
of	IN	case	O
the	DT	det	O
Rb	NN	compound	B-protein
family	NN	compound	I-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
an	DT	det	O
increase	NN	conj	O
in	IN	case	O
free	JJ	amod	O
E2F	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
kinase	NN	compound	O
activation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
result	VB	xcomp	O
from	IN	case	O
Tax	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
for	IN	case	O
cell	NN	compound	B-protein
cycle	NN	compound	I-protein
regulatory	JJ	amod	I-protein
molecules	NNS	nmod	I-protein
including	VBG	case	O
cyclin	NN	compound	B-protein
D2	NN	nmod	I-protein
,	,	punct	O
cyclin	NN	compound	B-protein
E	NN	conj	I-protein
,	,	punct	O
E2F1	NN	conj	B-protein
,	,	punct	O
CDK2	NN	conj	B-protein
,	,	punct	O
CDK4	NN	conj	B-protein
and	CC	cc	O
CDK6	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
Tax	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
reduction	NN	conj	O
of	IN	case	O
CDK	NN	compound	B-protein
inhibitors	NNS	compound	I-protein
p19	NN	nmod	I-protein
(	-LRB-	punct	O
INK4d	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
p27	NN	conj	B-protein
(	-LRB-	punct	I-protein
Kip1	NN	appos	I-protein
)	-RRB-	punct	I-protein
.	.	punct	O

These	DT	det	O
modulations	NNS	nsubj	O
by	IN	case	O
Tax	NN	nmod	B-protein
always	RB	advmod	O
paralleled	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
Tax	NN	nmod	B-protein
to	TO	mark	O
activate	VB	acl	O
the	DT	det	O
NF-kappaB	NN	compound	O
transcription	NN	compound	O
pathway	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
the	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
Tax	NN	compound	B-protein
-mediated	JJ	amod	O
trans-activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
genes	NNS	nmod	O
for	IN	case	O
cell	NN	compound	B-protein
cycle	NN	compound	I-protein
regulatory	JJ	amod	I-protein
molecules	NNS	nmod	I-protein
in	IN	case	O
Tax	NN	compound	B-protein
-induced	JJ	amod	O
cell	NN	compound	O
cycle	NN	compound	O
progression	NN	nmod	O
.	.	punct	O

Cot	NN	compound	B-protein
kinase	NN	nsubj	I-protein
induces	VBZ	ROOT	O
cyclooxygenase-2	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
through	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	nmod	I-protein
.	.	punct	O

Cyclooxygenase-2	NN	nsubjpass	B-protein
(	-LRB-	punct	O
COX-2	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
upon	IN	case	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	compound	I-protein
triggering	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
Cot	NN	compound	B-protein
kinase	NN	nsubj	I-protein
,	,	punct	O
a	DT	det	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
kinase	NN	compound	I-protein
kinase	NN	appos	I-protein
involved	VBN	acl	O
in	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
up-regulates	VBZ	ccomp	O
COX-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
COX-2	NN	compound	O
promoter	NN	compound	O
activity	NN	nmod	O
by	IN	case	O
Cot	NN	compound	B-protein
kinase	NN	nmod	I-protein
occurred	VBD	ROOT	O
mainly	RB	advmod	O
through	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	nmod	I-protein
(	-LRB-	punct	O
NFAT	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
distal	JJ	nmod	B-DNA
(	-LRB-	punct	I-DNA
-105/-97	CD	dep	I-DNA
)	-RRB-	punct	I-DNA
and	CC	cc	O
proximal	JJ	amod	B-DNA
(	-LRB-	punct	I-DNA
-76/-61	JJ	nummod	I-DNA
)	-RRB-	punct	I-DNA
NFAT	NN	compound	B-DNA
response	NN	compound	I-DNA
elements	NNS	dep	I-DNA
in	IN	case	O
the	DT	det	O
COX-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
abolished	VBD	ROOT	O
the	DT	det	O
activation	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
Cot	NN	compound	B-protein
kinase	NN	nmod	I-protein
.	.	punct	O

Even	RB	advmod	O
more	RBR	advmod	O
,	,	punct	O
coexpression	NN	nsubj	O
of	IN	case	O
a	DT	det	O
dominant	JJ	amod	O
negative	JJ	amod	O
version	NN	nmod	O
of	IN	case	O
NFAT	NN	nmod	B-protein
inhibited	VBD	ROOT	O
Cot	NN	compound	B-protein
kinase	NN	nmod:npmod	I-protein
-mediated	JJ	amod	O
COX-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activation	NN	dobj	O
,	,	punct	O
whereas	IN	mark	O
cotransfection	NN	nsubj	O
of	IN	case	O
a	DT	det	O
constitutively	RB	advmod	O
active	JJ	amod	O
version	NN	nmod	O
of	IN	case	O
the	DT	det	O
calcium-dependent	JJ	amod	B-protein
phosphatase	NN	compound	I-protein
calcineurin	NN	nmod	I-protein
synergizes	VBZ	advcl	O
with	IN	case	O
Cot	NN	compound	B-protein
kinase	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
up-regulation	NN	nmod	O
of	IN	case	O
COX-2	NN	nmod:npmod	B-DNA
promoter	NN	nmod:npmod	I-DNA
-driven	JJ	amod	O
transcription	NN	nmod	O
.	.	punct	O

Strikingly	RB	advmod	O
,	,	punct	O
Cot	NN	compound	B-protein
kinase	NN	nsubj	I-protein
increased	VBD	ROOT	O
transactivation	NN	dobj	O
mediated	VBN	acl	O
by	IN	case	O
a	DT	det	O
GAL4-NFAT	NN	compound	B-protein
fusion	NN	compound	I-protein
protein	NN	nmod	I-protein
containing	VBG	acl	O
the	DT	det	O
N-terminal	JJ	amod	B-protein
transactivation	NN	compound	I-protein
domain	NN	dobj	I-protein
of	IN	case	O
NFATp	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
phorbol	NN	compound	O
ester	NN	nmod	O
plus	CC	cc	O
calcium	NN	compound	O
ionophore	NN	compound	O
A23187	NN	conj	O
,	,	punct	O
Cot	NN	compound	B-protein
kinase	NN	nsubj	I-protein
increases	VBZ	ROOT	O
both	CC	cc:preconj	O
COX-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	dobj	O
and	CC	cc	O
NFAT	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
transactivation	NN	conj	O
in	IN	case	O
a	DT	det	O
cyclosporin	NN	compound	O
A-independent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Cot	NN	compound	B-protein
kinase	NN	nsubj	I-protein
up-regulates	VBZ	ccomp	O
COX-2	NN	nmod:npmod	B-DNA
promoter	NN	nmod:npmod	I-DNA
-driven	JJ	amod	O
transcription	NN	dobj	O
through	IN	case	O
the	DT	det	O
NFAT	NN	compound	B-DNA
response	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
,	,	punct	O
being	VBG	cop	O
the	DT	det	O
Cot	NN	nmod:npmod	B-protein
kinase	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
NFAT	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
transactivation	NN	advcl	O
presumably	RB	advmod	O
implicated	VBN	acl	O
in	IN	case	O
this	DT	det	O
up-regulation	NN	nmod	O
.	.	punct	O

Positive	JJ	amod	O
and	CC	cc	O
negative	JJ	conj	O
roles	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
trans-acting	JJ	amod	B-protein
T	NN	compound	I-protein
cell	NN	compound	I-protein
factor-1	NN	nmod	I-protein
for	IN	case	O
the	DT	det	O
acquisition	NN	nmod	O
of	IN	case	O
distinct	JJ	amod	O
Ly-49	NN	compound	B-protein
MHC	NN	compound	I-protein
class	NN	compound	I-protein
I	CD	nummod	I-protein
receptors	NNS	nmod	I-protein
by	IN	case	O
NK	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Members	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
Ly-49	NN	compound	B-DNA
gene	NN	compound	I-DNA
family	NN	compound	I-DNA
code	NN	nmod	O
for	IN	case	O
class	NN	compound	B-protein
I	CD	nummod	I-protein
MHC-specific	JJ	amod	I-protein
receptors	NNS	nmod	I-protein
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
NK	NN	compound	O
cell	NN	compound	O
function	NN	dobj	O
.	.	punct	O

Due	JJ	case	O
to	TO	mwe	O
a	DT	det	O
combinatorial	JJ	amod	O
distribution	NN	nmod	O
of	IN	case	O
Ly-49	NN	compound	B-protein
receptors	NNS	nmod	I-protein
,	,	punct	O
NK	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
display	VBP	ROOT	O
considerable	JJ	amod	O
clonal	JJ	amod	O
heterogeneity	NN	dobj	O
.	.	punct	O

The	DT	det	O
acquisition	NN	nsubj	O
of	IN	case	O
one	CD	nummod	O
Ly-49	NN	compound	B-protein
receptor	NN	nmod	I-protein
,	,	punct	O
Ly-49A	NN	nsubj	B-protein
is	VBZ	cop	O
strictly	RB	advmod	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	B-protein
trans-acting	JJ	amod	I-protein
factor	NN	compound	I-protein
T	NN	compound	B-protein
cell-specific	JJ	amod	I-protein
factor-1	NN	nmod	I-protein
(	-LRB-	punct	O
TCF-1	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Indeed	RB	advmod	O
,	,	punct	O
TCF-1	NN	nsubj	B-protein
binds	VBZ	ROOT	O
to	TO	case	O
two	CD	nummod	O
sites	NNS	nmod	O
in	IN	case	O
the	DT	det	O
Ly-49a	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
and	CC	cc	O
regulates	VBZ	conj	O
its	PRP$	nmod:poss	O
activity	NN	dobj	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
Ly-49a	NN	compound	B-DNA
gene	NN	nsubj	I-DNA
is	VBZ	cop	O
a	DT	det	O
direct	JJ	amod	O
TCF-1	NN	compound	B-protein
target	NN	ccomp	O
.	.	punct	O

TCF-1	NN	compound	B-protein
deficiency	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
altered	JJ	amod	O
usage	NN	nmod	O
of	IN	case	O
additional	JJ	amod	O
Ly-49	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
using	VBG	advcl	O
TCF-1	NN	compound	B-protein
beta	NN	dobj	I-protein
(	-LRB-	punct	I-protein
2	LS	nummod	I-protein
)	-RRB-	punct	I-protein
-microglobulin	JJ	amod	I-protein
double-deficient	JJ	amod	O
mice	NNS	dep	O
,	,	punct	O
that	IN	mark	O
these	DT	det	O
repertoire	NN	compound	O
alterations	NNS	nsubj	O
are	VBP	cop	O
not	RB	neg	O
due	JJ	case	O
to	TO	mwe	O
Ly-49/MHC	NN	amod	O
class	NN	compound	O
I	CD	nummod	O
interactions	NNS	ccomp	O
.	.	punct	O

Our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
rather	RB	advmod	O
suggest	VBP	ROOT	O
a	DT	det	O
TCF-1	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
,	,	punct	O
cell	NN	compound	O
autonomous	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
acquisition	NN	nmod	O
of	IN	case	O
multiple	JJ	amod	O
Ly-49	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Besides	IN	case	O
reduced	VBN	amod	O
receptor	NN	compound	O
usage	NN	nmod	O
(	-LRB-	punct	O
Ly-49A	NN	dep	B-protein
and	CC	cc	I-protein
D	NN	conj	I-protein
)	-RRB-	punct	O
,	,	punct	O
we	PRP	nsubj	O
also	RB	advmod	O
observed	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
(	-LRB-	punct	O
Ly-49C	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
significantly	RB	advmod	O
expanded	VBN	conj	O
(	-LRB-	punct	O
Ly-49G	NN	dep	B-protein
and	CC	cc	I-protein
I	NN	conj	I-protein
)	-RRB-	punct	O
receptor	NN	compound	O
usage	NN	dep	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
TCF-1	NN	nmod	B-protein
.	.	punct	O

These	DT	det	O
effects	NNS	nsubj	O
did	VBD	aux	O
not	RB	neg	O
in	IN	case	O
all	DT	det	O
cases	NNS	nsubj	O
correlate	VBP	ROOT	O
with	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
TCF	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
respective	JJ	amod	O
proximal	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
besides	IN	case	O
TCF-1	NN	compound	B-protein
binding	NN	nmod	O
to	TO	case	O
the	DT	det	O
proximal	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
,	,	punct	O
Ly-49	NN	compound	O
acquisition	NN	nsubjpass	O
may	MD	aux	O
also	RB	advmod	O
be	VB	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
TCF-1	NN	compound	B-protein
binding	NN	nmod	O
to	TO	case	O
more	RBR	advmod	O
distant	JJ	amod	O
cis-acting	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
and/or	CC	cc	O
by	IN	mark	O
regulating	VBG	advcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
additional	JJ	amod	O
trans-acting	JJ	amod	B-DNA
factors	NNS	nmod	I-DNA
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
the	DT	det	O
observed	VBN	amod	O
differential	JJ	amod	O
,	,	punct	O
positive	JJ	conj	O
or	CC	cc	O
negative	JJ	conj	O
role	NN	nmod	O
of	IN	case	O
TCF-1	NN	nmod	B-protein
for	IN	case	O
Ly-49	NN	compound	B-protein
receptor	NN	compound	I-protein
acquisition	NN	nmod	O
,	,	punct	O
reporter	NN	compound	O
gene	NN	compound	O
assays	NNS	nsubj	O
revealed	VBD	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
an	DT	det	O
inducing	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
a	DT	det	O
repressing	JJ	amod	O
TCF	NN	compound	B-DNA
site	NN	conj	I-DNA
in	IN	case	O
certain	JJ	amod	O
proximal	JJ	amod	O
Ly-49	NN	compound	B-DNA
promoters	NNS	nmod	I-DNA
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
reveal	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
TCF-1	NN	nmod	B-protein
for	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
the	DT	det	O
NK	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	compound	I-protein
repertoire	NN	nmod	O
.	.	punct	O

Ligation	NN	nsubj	O
of	IN	case	O
CD11b	NN	nmod	B-protein
and	CC	cc	O
CD11c	NN	compound	B-protein
beta	NN	conj	I-protein
(	-LRB-	punct	I-protein
2	CD	appos	I-protein
)	-RRB-	punct	I-protein
integrins	NNS	nmod	B-protein
by	IN	case	O
antibodies	NNS	nmod	B-protein
or	CC	cc	O
soluble	JJ	amod	B-protein
CD23	NN	conj	I-protein
induces	VBZ	ROOT	O
macrophage	NN	compound	B-protein
inflammatory	JJ	amod	I-protein
protein	NN	compound	I-protein
1alpha	NN	dobj	I-protein
(	-LRB-	punct	O
MIP-1alpha	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
MIP-1beta	NN	compound	B-protein
production	NN	conj	O
in	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
monocytes	NNS	nmod	I-cell_type
through	IN	case	O
a	DT	det	O
pathway	NN	nmod	O
dependent	JJ	amod	O
on	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod	I-protein
.	.	punct	O

Chemokines	NNS	nsubj	B-protein
and	CC	cc	O
adhesion	NN	compound	B-protein
molecules	NNS	conj	I-protein
such	JJ	case	O
as	IN	mwe	O
integrins	NNS	nmod	B-protein
play	VBP	ROOT	O
a	DT	det	O
major	JJ	amod	O
part	NN	dobj	O
in	IN	case	O
the	DT	det	O
trafficking	NN	pobj	O
,	,	punct	O
extravasation	NN	conj	O
,	,	punct	O
and	CC	cc	O
recruitment	NN	nmod	O
of	IN	case	O
leukocytes	NNS	nmod	B-cell_type
to	TO	case	O
inflammatory	JJ	amod	O
sites	NNS	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
beta	NN	compound	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
integrin	NN	compound	O
engagement	NN	nmod	O
on	IN	case	O
chemokine	NN	compound	O
production	NN	nmod	O
by	IN	case	O
freshly	RB	advmod	B-cell_type
isolated	VBN	amod	I-cell_type
human	JJ	amod	I-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
ligation	NN	nsubj	O
of	IN	case	O
CD11b	NN	nmod	B-protein
or	CC	cc	O
CD11c	NN	conj	B-protein
but	CC	cc	O
not	RB	neg	O
CD11a	NN	compound	B-protein
alpha	NN	compound	I-protein
chains	NNS	conj	I-protein
of	IN	case	O
beta	NN	nmod	B-protein
(	-LRB-	punct	I-protein
2	CD	appos	I-protein
)	-RRB-	punct	I-protein
integrins	NNS	conj	I-protein
by	IN	case	O
antibodies	NNS	nmod	B-protein
or	CC	cc	O
soluble	JJ	amod	B-protein
CD23	NN	compound	I-protein
(	-LRB-	punct	I-protein
sCD23	NN	appos	I-protein
)	-RRB-	punct	I-protein
fusion	NN	compound	I-protein
proteins	NNS	conj	I-protein
rapidly	RB	advmod	O
induced	VBD	ccomp	O
transcription	NN	dobj	O
and	CC	cc	O
secretion	NN	conj	O
of	IN	case	O
interleukin	NN	nmod	B-protein
8	CD	nummod	I-protein
,	,	punct	O
macrophage	NN	compound	B-protein
inflammatory	JJ	amod	I-protein
protein	NN	compound	I-protein
(	-LRB-	punct	I-protein
MIP	NN	appos	I-protein
)	-RRB-	punct	I-protein
1alpha	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
MIP-1beta	NN	conj	B-protein
.	.	punct	O

Because	IN	mark	O
the	DT	det	O
promoters	NNS	nsubj	B-DNA
of	IN	case	O
these	DT	det	O
chemokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
contain	VBP	advcl	O
kappaB	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
,	,	punct	O
we	PRP	nsubj	O
assessed	VBD	ROOT	O
the	DT	det	O
possible	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod	I-protein
(	-LRB-	punct	O
NF-kappaB	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	mark	O
controlling	VBG	advcl	O
induction	NN	dobj	O
of	IN	case	O
the	DT	det	O
genes	NNS	nmod	O
through	IN	case	O
beta	NN	compound	O
(	-LRB-	punct	O
2	LS	nummod	O
)	-RRB-	punct	O
integrin	NN	compound	O
engagement	NN	nmod	O
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
sCD23	NN	nsubj	B-protein
or	CC	cc	O
antibodies	NNS	conj	B-protein
to	TO	case	O
CD11b	NN	nmod	B-protein
or	CC	cc	O
to	TO	case	O
CD11c	NN	conj	B-protein
up-regulated	JJ	ccomp	O
DNA-binding	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
.	.	punct	O

Activation	NN	nsubjpass	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
degradation	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
cytosolic	JJ	amod	B-protein
inhibitor	NN	compound	I-protein
IkappaB-alpha	NN	nmod	I-protein
.	.	punct	O

Blockade	NN	nsubj	O
of	IN	case	O
depletion	NN	nmod	O
of	IN	case	O
IkappaB-alpha	NN	nmod	B-protein
by	IN	case	O
proteasome	NN	compound	O
inhibitors	NNS	nmod	O
(	-LRB-	punct	O
proteasome	NN	compound	O
inhibitor	NN	appos	O
I	CD	nummod	O
or	CC	cc	O
acetyl-leucinyl-leucinyl-norleucinal	JJ	conj	O
)	-RRB-	punct	O
led	VBD	ROOT	O
to	TO	case	O
concomitant	JJ	amod	O
inhibition	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	compound	O
DNA-binding	JJ	amod	O
activity	NN	nmod	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
MIP-1alpha	NN	nmod	B-RNA
and	CC	cc	I-RNA
MIP-1beta	NN	conj	I-RNA
messenger	NN	compound	I-RNA
RNA	NN	dep	I-RNA
induced	VBN	acl	O
by	IN	case	O
beta	NN	compound	O
(	-LRB-	punct	O
2	LS	nummod	O
)	-RRB-	punct	O
integrin	NN	compound	O
ligation	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
triggering	NN	nsubj	O
of	IN	case	O
CD11b	NN	compound	B-protein
or	CC	cc	O
CD11c	NN	compound	B-protein
beta	NN	conj	I-protein
(	-LRB-	punct	I-protein
2	LS	dep	I-protein
)	-RRB-	punct	I-protein
integrin	NN	nmod	O
on	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
monocytes	NNS	nmod	I-cell_type
provides	VBZ	ccomp	O
activation	NN	compound	O
signals	NNS	dobj	O
leading	VBG	acl	O
to	TO	case	O
nuclear	JJ	amod	O
translocation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
and	CC	cc	O
subsequent	JJ	amod	O
secretion	NN	conj	O
of	IN	case	O
MIP-1alpha	NN	nmod	B-protein
and	CC	cc	O
MIP-1beta	NN	conj	B-protein
that	WDT	nsubj	O
may	MD	aux	O
have	VB	acl:relcl	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
recruitment	NN	nmod	O
of	IN	case	O
other	JJ	amod	O
inflammatory	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
during	IN	case	O
initiation	NN	nmod	O
of	IN	case	O
an	DT	det	O
inflammatory	JJ	amod	O
response	NN	nmod	O

Synergistic	JJ	amod	O
transcriptional	JJ	amod	O
activation	NN	ROOT	O
of	IN	case	O
human	JJ	amod	B-DNA
Acyl-coenzyme	NN	compound	I-DNA
A	NN	nmod	I-DNA
:	:	punct	I-DNA
cholesterol	NN	dep	I-DNA
acyltransterase-1	NN	compound	I-DNA
gene	NN	dobj	I-DNA
by	IN	case	O
interferon-gamma	NN	nmod	B-protein
and	CC	cc	O
all-trans-retinoic	JJ	amod	O
acid	NN	compound	O
THP-1	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Acyl-coenzyme	JJ	compound	B-protein
A	NN	ROOT	I-protein
:	:	punct	I-protein
cholesterol	NN	compound	I-protein
acyltransferase	NN	nsubj	I-protein
(	-LRB-	punct	O
ACAT	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
intracellular	JJ	amod	B-protein
enzyme	NN	dep	I-protein
involved	VBN	acl	O
in	IN	case	O
cellular	JJ	amod	O
cholesterol	NN	compound	O
homeostasis	NN	nmod	O
and	CC	cc	O
in	IN	case	O
atherosclerotic	JJ	amod	O
foam	NN	compound	O
cell	NN	compound	O
formation	NN	conj	O
.	.	punct	O

Human	JJ	amod	B-DNA
ACAT-1	NN	compound	I-DNA
gene	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
two	CD	nummod	O
promoters	NNS	dobj	B-DNA
(	-LRB-	punct	O
P1	NN	dep	B-DNA
and	CC	cc	O
P7	NN	conj	B-DNA
)	-RRB-	punct	O
,	,	punct	O
each	DT	det	O
located	JJ	appos	O
in	IN	case	O
a	DT	det	O
different	JJ	amod	O
chromosome	NN	nmod	B-DNA
(	-LRB-	punct	I-DNA
1	CD	dep	I-DNA
and	CC	cc	I-DNA
7	CD	conj	I-DNA
)	-RRB-	punct	I-DNA
(	-LRB-	punct	O
Li	NNP	compound	O
,	,	punct	O
B.	NNP	compound	O
L.	NNP	dep	O
,	,	punct	O
Li	NNP	compound	O
,	,	punct	O
X.	NNP	compound	O
L.	NNP	dep	O
,	,	punct	O
Duan	NNP	compound	O
,	,	punct	O
Z.	NNP	compound	O
J.	NNP	conj	O
,	,	punct	O
Lee	NNP	conj	O
,	,	punct	O
O.	NNP	conj	O
,	,	punct	O
Lin	NNP	compound	O
,	,	punct	O
S.	NNP	conj	O
,	,	punct	O
Ma	NNP	compound	O
,	,	punct	O
Z.	NNP	compound	O
M.	NNP	conj	O
,	,	punct	O
Chang	NNP	compound	O
,	,	punct	O
C.	NNP	appos	O
C.	NNP	conj	O
,	,	punct	O
Yang	NNP	compound	O
,	,	punct	O
X.	NNP	compound	O
Y.	NNP	conj	O
,	,	punct	O
Park	NNP	compound	O
,	,	punct	O
J.	NNP	compound	O
P.	NNP	conj	O
,	,	punct	O
Mohandas	NNP	compound	O
,	,	punct	O
T.	NNP	compound	O
K.	NNP	conj	O
,	,	punct	O
Noll	NNP	compound	O
,	,	punct	O
W.	NNP	conj	O
,	,	punct	O
Chan	NNP	compound	O
,	,	punct	O
L.	NNP	conj	O
,	,	punct	O
and	CC	cc	O
Chang	NNP	compound	O
,	,	punct	O
T.	NNP	compound	O
Y.	NNP	conj	O
(	-LRB-	punct	O
1999	CD	nummod	O
)	-RRB-	punct	O
J.	NNP	compound	O
Biol	NNP	compound	O
Chem.	NNP	appos	O
274	CD	nummod	O
,	,	punct	O
11060-11071	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Interferon-gamma	NN	nsubj	B-protein
(	-LRB-	punct	O
IFN-gamma	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
cytokine	NN	appos	B-protein
that	WDT	nsubj	O
exerts	VBZ	acl:relcl	O
many	JJ	amod	O
pro-atherosclerotic	JJ	amod	O
effects	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
causes	VBZ	ROOT	O
up-regulation	NN	dobj	O
of	IN	case	O
ACAT-1	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
human	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
monocyte-derived	JJ	amod	I-cell_type
macrophages	NNS	nmod	I-cell_type
and	CC	cc	O
macrophage-like	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	conj	O
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
nature	NN	dobj	O
of	IN	case	O
this	DT	det	O
observation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
within	IN	case	O
the	DT	det	O
ACAT-1	NN	compound	B-DNA
P1	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
a	DT	det	O
159-base	JJ	amod	B-DNA
pair	NN	compound	I-DNA
core	NN	compound	I-DNA
region	NN	dobj	I-DNA
.	.	punct	O

This	DT	det	O
region	NN	nsubj	O
contains	VBZ	ROOT	O
4	CD	nummod	O
Sp1	NN	compound	B-DNA
elements	NNS	dobj	I-DNA
and	CC	cc	O
an	DT	det	O
IFN-gamma	NN	compound	B-DNA
activated	JJ	amod	I-DNA
sequence	NN	conj	I-DNA
(	-LRB-	punct	O
GAS	NN	appos	B-DNA
)	-RRB-	punct	O
that	WDT	nsubj	O
overlaps	VBZ	acl:relcl	O
with	IN	case	O
the	DT	det	O
second	JJ	amod	O
Sp1	NN	compound	B-DNA
element	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
the	DT	det	O
monocytic	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
line	NN	compound	I-cell_type
THP-1	NN	compound	I-cell_type
cell	NN	nmod	I-cell_type
,	,	punct	O
the	DT	det	O
combination	NN	nsubj	O
of	IN	case	O
IFN-gamma	NN	nmod	B-protein
and	CC	cc	O
all-trans-retinoic	JJ	amod	O
acid	NN	conj	O
(	-LRB-	punct	O
a	DT	det	O
known	JJ	amod	O
differentiation	NN	compound	O
agent	NN	appos	O
)	-RRB-	punct	O
enhances	VBZ	ROOT	O
the	DT	det	O
ACAT-1	NN	compound	B-DNA
P1	NN	compound	I-DNA
promoter	NN	dobj	I-DNA
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
P7	NN	compound	B-DNA
promoter	NN	conj	I-DNA
.	.	punct	O

Additional	JJ	amod	O
experiments	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
all-trans-retinoic	JJ	amod	O
acid	NN	nsubj	O
causes	VBZ	ccomp	O
large	JJ	amod	O
induction	NN	dobj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
STAT1	NN	nmod	I-protein
,	,	punct	O
while	IN	mark	O
IFN-gamma	NN	nsubj	B-protein
causes	VBZ	advcl	O
activation	NN	dobj	O
of	IN	case	O
STAT1	NN	nmod	B-protein
such	JJ	mark	O
that	IN	mark	O
it	PRP	nsubj	O
binds	VBZ	advcl	O
to	TO	case	O
the	DT	det	O
GAS/Sp1	NN	compound	B-DNA
site	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
ACAT-1	NN	compound	B-DNA
P1	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Our	PRP$	nmod:poss	O
work	NN	nsubj	O
provides	VBZ	ROOT	O
a	DT	det	O
molecular	JJ	amod	O
mechanism	NN	dobj	O
to	TO	mark	O
account	VB	acl	O
for	IN	case	O
the	DT	det	O
effect	NN	nmod	O
of	IN	case	O
IFN-gamma	NN	nmod	B-protein
in	IN	mark	O
causing	VBG	acl	O
transcriptional	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
ACAT-1	NN	nmod	B-protein
in	IN	case	O
macrophage-like	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Inhaled	VBN	amod	O
nitric	JJ	amod	O
oxide	NN	nsubj	O
down-regulates	VBZ	ROOT	O
intrapulmonary	JJ	amod	O
nitric	JJ	amod	O
oxide	NN	compound	O
production	NN	dobj	O
in	IN	case	O
lipopolysaccharide-induced	JJ	amod	O
acute	JJ	amod	O
lung	NN	compound	O
injury	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
examine	VB	dep	O
whether	IN	mark	O
inhaled	VBN	amod	O
nitric	JJ	amod	O
oxide	NN	nsubj	O
(	-LRB-	punct	O
NO	NN	appos	O
)	-RRB-	punct	O
affected	VBD	ccomp	O
the	DT	det	O
intrapulmonary	JJ	amod	O
production	NN	dobj	O
of	IN	case	O
NO	NN	nmod	O
,	,	punct	O
reactive	JJ	amod	O
oxygen	NN	compound	O
species	NNS	conj	O
,	,	punct	O
and	CC	cc	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	conj	I-protein
in	IN	case	O
a	DT	det	O
lipopolysaccharide	NN	compound	O
(	-LRB-	punct	O
LPS	NN	compound	O
)	-RRB-	punct	O
-induced	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
acute	JJ	amod	O
lung	NN	compound	O
injury	NN	nmod	O
.	.	punct	O

DESIGN	NN	ROOT	O
:	:	punct	O
Prospective	JJ	amod	O
,	,	punct	O
randomized	VBN	conj	O
,	,	punct	O
laboratory	JJ	dep	O
study	NN	appos	O
.	.	punct	O

SETTING	NN	ROOT	O
:	:	punct	O
Experimental	JJ	amod	O
laboratory	NN	appos	O
at	IN	prep	O
a	DT	det	O
biomedical	JJ	amod	O
institute	NN	pobj	O
.	.	punct	O

SUBJECTS	NNS	ROOT	O
:	:	punct	O
Twenty	CD	nummod	O
male	JJ	amod	O
rabbits	NNS	dep	O
weighing	VBG	acl	O
2.5-3.5	CD	nummod	O
kg	NN	dobj	O
.	.	punct	O

INTERVENTIONS	NNS	ROOT	O
:	:	punct	O
Saline	NN	nsubjpass	O
or	CC	cc	O
LPS	NN	conj	O
(	-LRB-	punct	O
5	CD	nummod	O
mg/kg	NN	dep	O
of	IN	case	O
body	NN	compound	O
weight	NN	nmod	O
)	-RRB-	punct	O
was	VBD	auxpass	O
administered	VBN	dep	O
intravenously	RB	advmod	O
with	IN	nmod	O
or	CC	cc	O
without	IN	case	O
NO	NN	compound	O
inhalation	NN	nmod	O
(	-LRB-	punct	O
10	CD	nummod	O
ppm	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
each	DT	det	O
group	NN	nmod	O
of	IN	case	O
five	CD	nummod	O
rabbits	NNS	nmod	O
.	.	punct	O

MEASUREMENTS	NNS	nsubj	O
AND	CC	cc	O
MAIN	JJ	conj	O
RESULTS	NNS	dep	O
:	:	punct	O
LPS	NN	nsubj	O
increased	VBD	ROOT	O
the	DT	det	O
lung	NN	compound	O
leak	NN	compound	O
index	NN	dobj	O
,	,	punct	O
the	DT	det	O
neutrophils	NNS	appos	B-cell_type
and	CC	cc	O
NO	NN	compound	O
levels	NNS	conj	O
in	IN	case	O
bronchoalveolar	JJ	amod	O
lavage	NN	compound	O
fluid	NN	nmod	O
,	,	punct	O
and	CC	cc	O
NO	NN	compound	O
levels	NNS	conj	O
produced	VBN	acl	O
by	IN	case	O
resting	VBG	amod	O
and	CC	cc	O
stimulated	VBN	conj	O
alveolar	JJ	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
.	.	punct	O

Inhaled	VBN	amod	O
NO	NN	nsubj	O
decreased	VBD	ROOT	O
the	DT	det	O
lung	NN	compound	O
leak	NN	compound	O
index	NN	dobj	O
,	,	punct	O
the	DT	det	O
neutrophils	NNS	appos	B-cell_type
and	CC	cc	O
NO	NN	compound	O
levels	NNS	conj	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
nitrite	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
the	DT	det	O
lavage	NN	compound	O
fluid	NN	nmod	O
,	,	punct	O
and	CC	cc	O
NO	NN	conj	O
produced	VBN	acl	O
by	IN	case	O
the	DT	det	O
resting	VBG	amod	O
and	CC	cc	O
stimulated	VBN	conj	O
alveolar	JJ	amod	B-cell_type
macrophages	NNS	nmod	I-cell_type
.	.	punct	O

Inhaled	VBN	amod	O
NO	NN	nsubj	O
also	RB	advmod	O
blocked	VBD	ROOT	O
the	DT	det	O
activities	NNS	dobj	O
of	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
species	NNS	nmod	O
and	CC	cc	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	conj	I-protein
binding	VBG	acl	O
to	TO	case	O
DNA	NN	nmod	O
in	IN	case	O
lavage	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
in	IN	case	O
alveolar	JJ	amod	B-cell_type
macrophages	NNS	conj	I-cell_type
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
Inhaled	VBN	amod	O
NO	NN	nsubj	O
attenuates	VBZ	ROOT	O
LPS-induced	JJ	amod	O
acute	JJ	amod	O
lung	NN	compound	O
injury	NN	dobj	O
,	,	punct	O
possibly	RB	advmod	O
by	IN	mark	O
decreasing	VBG	advcl	O
NO	NN	compound	O
production	NN	dobj	O
in	IN	prep	O
the	DT	det	O
lungs	NNS	pobj	O
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubj	O
of	IN	mark	O
reducing	VBG	acl	O
NO	NN	compound	O
production	NN	dobj	O
resulting	VBG	acl	O
from	IN	case	O
inhaled	VBN	amod	O
NO	NN	nmod	O
may	MD	aux	O
involve	VB	ROOT	O
,	,	punct	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
the	DT	det	O
activities	NNS	appos	O
of	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
species	NNS	nmod	O
and/or	CC	cc	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	conj	I-protein
.	.	punct	O

Treatment	NN	ROOT	O
of	IN	case	O
allergic	JJ	amod	O
airway	NN	compound	O
inflammation	NN	nmod	O
and	CC	cc	O
hyperresponsiveness	NN	conj	O
by	IN	case	O
antisense-induced	JJ	amod	O
local	JJ	amod	O
blockade	NN	nmod	O
of	IN	case	O
GATA-3	NN	compound	B-DNA
expression	NN	nmod	O
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
in	IN	case	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
have	VBP	aux	O
revealed	VBN	ROOT	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
a	DT	det	O
dominant	JJ	amod	O
negative	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
GATA-3	NN	nmod	I-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
can	MD	aux	O
prevent	VB	ccomp	O
T	NN	compound	B-cell_type
helper	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
type	NN	compound	I-cell_type
2	CD	nummod	I-cell_type
(	-LRB-	punct	O
Th2	NN	compound	B-cell_type
)	-RRB-	punct	O
-mediated	JJ	amod	O
allergic	JJ	amod	O
airway	NN	compound	O
inflammation	NN	dobj	O
in	IN	case	O
mice	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
remains	VBZ	ROOT	O
unclear	JJ	xcomp	O
whether	IN	mark	O
GATA-3	NN	nsubj	B-protein
plays	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
effector	NN	compound	O
phase	NN	nmod	O
of	IN	case	O
allergic	JJ	amod	O
airway	NN	compound	O
inflammation	NN	nmod	O
and	CC	cc	O
whether	IN	mark	O
antagonizing	VBG	advcl	O
the	DT	det	O
expression	NN	dobj	O
and/or	CC	cc	O
function	NN	conj	O
of	IN	case	O
GATA-3	NN	nmod	B-DNA
can	MD	aux	O
be	VB	auxpass	O
used	VBN	conj	O
for	IN	case	O
the	DT	det	O
therapy	NN	nmod	O
of	IN	case	O
allergic	JJ	amod	O
airway	NN	compound	O
inflammation	NN	nmod	O
and	CC	cc	O
hyperresponsiveness	NN	conj	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	mark	O
locally	RB	advmod	O
antagonizing	VBG	acl	O
GATA-3	NN	compound	B-protein
function	NN	dobj	O
in	IN	case	O
a	DT	det	O
murine	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
asthma	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
could	MD	aux	O
suppress	VB	ROOT	O
GATA-3	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	compound	I-protein
)	-RRB-	punct	I-protein
-4	CD	nummod	I-protein
-producing	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	case	O
an	DT	det	O
antisense	JJ	amod	O
phosphorothioate	NN	compound	O
oligonucleotide	NN	nmod	O
overlapping	VBG	acl	O
the	DT	det	O
translation	NN	compound	B-DNA
start	NN	compound	I-DNA
site	NN	dobj	I-DNA
of	IN	case	O
GATA-3	NN	nmod	B-DNA
,	,	punct	O
whereas	IN	mark	O
nonsense	NN	amod	O
control	NN	compound	O
oligonucleotides	NNS	nsubj	O
were	VBD	cop	O
virtually	RB	advmod	O
inactive	JJ	advcl	O
.	.	punct	O

In	IN	case	O
a	DT	det	O
murine	JJ	amod	O
model	NN	nmod	O
of	IN	case	O
asthma	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
allergic	JJ	amod	O
pulmonary	JJ	amod	O
inflammation	NN	nmod	O
and	CC	cc	O
hyperresponsiveness	NN	conj	O
in	IN	case	O
ovalbumin	NN	compound	O
(	-LRB-	punct	O
OVA	NN	compound	O
)	-RRB-	punct	O
-sensitized	JJ	amod	O
mice	NNS	nmod	O
,	,	punct	O
local	JJ	amod	O
intranasal	JJ	amod	O
administration	NN	nsubj	O
of	IN	case	O
fluorescein	NN	compound	O
isothiocyanate-labeled	JJ	amod	O
GATA-3	NN	compound	O
antisense	JJ	amod	O
oligonucleotides	NNS	nmod	O
led	VBD	ROOT	O
to	TO	case	O
DNA	NN	compound	O
uptake	NN	nmod	O
in	IN	case	O
lung	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
associated	VBN	acl	O
with	IN	case	O
a	DT	det	O
reduction	NN	nmod	O
of	IN	case	O
intracellular	JJ	amod	O
GATA-3	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Such	JJ	amod	O
intrapulmonary	JJ	amod	O
blockade	NN	nsubj	O
of	IN	case	O
GATA-3	NN	compound	O
expression	NN	nmod	O
caused	VBD	ROOT	O
an	DT	det	O
abrogation	NN	dobj	O
of	IN	case	O
signs	NNS	nmod	O
of	IN	case	O
lung	NN	compound	O
inflammation	NN	nmod	O
including	VBG	case	O
infiltration	NN	nmod	O
of	IN	case	O
eosinophils	NNS	nmod	B-cell_type
and	CC	cc	O
Th2	NN	compound	B-cell_type
cytokine	NN	compound	O
production	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
treatment	NN	nsubj	O
with	IN	case	O
antisense	JJ	amod	O
but	CC	cc	O
not	RB	cc	O
nonsense	NN	conj	O
oligonucleotides	NNS	nmod	O
induced	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
reduction	NN	dobj	O
of	IN	case	O
airway	NN	compound	O
hyperresponsiveness	NN	nmod	O
in	IN	case	O
OVA-sensitized	JJ	amod	O
mice	NNS	nmod	O
to	TO	case	O
levels	NNS	nmod	O
comparable	JJ	amod	O
to	TO	case	O
saline-treated	JJ	amod	O
control	NN	compound	O
mice	NNS	nmod	O
,	,	punct	O
as	IN	mark	O
assessed	VBN	advcl	O
by	IN	case	O
both	CC	cc:preconj	O
enhanced	VBN	amod	O
pause	NN	compound	O
(	-LRB-	punct	O
PenH	NN	appos	O
)	-RRB-	punct	O
responses	NNS	nmod	O
and	CC	cc	O
pulmonary	JJ	amod	O
resistance	NN	conj	O
determined	VBN	acl	O
by	IN	case	O
body	NN	compound	O
plethysmography	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
GATA-3	NN	nmod	B-DNA
in	IN	case	O
the	DT	det	O
effector	NN	compound	O
phase	NN	nmod	O
of	IN	case	O
a	DT	det	O
murine	JJ	amod	O
asthma	NN	compound	O
model	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
local	JJ	amod	O
delivery	NN	nsubj	O
of	IN	case	O
GATA-3	NN	compound	O
antisense	JJ	amod	O
oligonucleotides	NNS	nmod	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
novel	JJ	amod	O
approach	NN	ccomp	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
airway	NN	compound	O
hyperresponsiveness	NN	nmod	O
such	JJ	case	O
as	IN	mwe	O
in	IN	case	O
asthma	NN	nmod	O
.	.	punct	O

This	DT	det	O
approach	NN	nsubj	O
has	VBZ	ROOT	O
the	DT	det	O
potential	JJ	amod	O
advantage	NN	dobj	O
of	IN	mark	O
suppressing	VBG	acl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
various	JJ	amod	O
proinflammatory	JJ	amod	B-protein
Th2	NN	compound	I-protein
cytokines	NNS	nmod	I-protein
simultaneously	RB	advmod	O
rather	RB	advmod	O
than	IN	mwe	O
suppressing	VBG	advcl	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
a	DT	det	O
single	JJ	amod	O
cytokine	NN	nmod	B-protein
.	.	punct	O

T	NN	compound	O
helper-cell	JJ	compound	O
phenotype	NN	nsubj	O
regulates	VBZ	ROOT	O
atherosclerosis	NN	dobj	O
in	IN	case	O
mice	NNS	nmod	O
under	IN	case	O
conditions	NNS	nmod	O
of	IN	case	O
mild	JJ	amod	O
hypercholesterolemia	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
T	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
implicated	VBN	dep	O
in	IN	case	O
atherosclerosis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	conj	O
about	IN	case	O
the	DT	det	O
genetic	JJ	amod	O
control	NN	nmod	O
or	CC	cc	O
molecular	JJ	amod	O
pathways	NNS	conj	O
,	,	punct	O
especially	RB	advmod	O
under	IN	case	O
conditions	NNS	nmod	O
of	IN	case	O
mild	JJ	amod	O
hypercholesterolemia	NN	nmod	O
.	.	punct	O

METHODS	NNS	nsubj	O
AND	CC	cc	O
RESULTS	NNS	conj	O
:	:	punct	O
BALB/c	NN	compound	O
mice	NNS	dep	O
,	,	punct	O
making	VBG	acl	O
a	DT	det	O
CD4+	JJ	amod	O
Th2	NN	compound	O
(	-LRB-	punct	O
IL-4+	NN	amod	O
)	-RRB-	punct	O
cell	NN	compound	O
response	NN	dobj	O
,	,	punct	O
express	VBP	ROOT	O
both	CC	cc:preconj	O
MHC	NN	compound	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
antigens	NNS	dobj	I-protein
(	-LRB-	punct	O
IA	NN	dep	B-protein
(	-LRB-	punct	I-protein
d	NN	appos	I-protein
)	-RRB-	punct	I-protein
,	,	punct	O
IE	NN	conj	B-protein
(	-LRB-	punct	I-protein
d	NN	appos	I-protein
)	-RRB-	punct	I-protein
)	-RRB-	punct	O
and	CC	cc	O
are	VBP	cop	O
atherosclerosis-resistant	JJ	conj	O
.	.	punct	O

C57Bl/6	NN	compound	O
mice	NNS	nsubj	O
produce	VBP	ROOT	O
a	DT	det	O
CD4+	JJ	amod	O
Th1	NN	compound	O
(	-LRB-	punct	O
interferon	NN	compound	O
[	-LRB-	punct	O
IFN	NN	compound	O
]	-RRB-	punct	O
gamma+	NN	compound	O
)	-RRB-	punct	O
response	NN	dobj	O
,	,	punct	O
express	VBP	conj	O
IA	NN	dobj	B-protein
(	-LRB-	punct	I-protein
b	LS	appos	I-protein
)	-RRB-	punct	I-protein
but	CC	cc	O
no	DT	neg	O
IE	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
are	VBP	cop	O
atherosclerosis-prone	NN	conj	O
.	.	punct	O

To	TO	mark	O
evaluate	VB	advcl	O
T	NN	compound	O
helper-cell	JJ	compound	O
phenotype	NN	dobj	O
in	IN	case	O
fatty	JJ	amod	O
streak	NN	amod	O
formation	NN	nmod	O
,	,	punct	O
wild-type	JJ	amod	O
C57Bl/6	NN	compound	O
mice	NNS	intj	O
(	-LRB-	punct	O
IA	NN	compound	O
(	-LRB-	punct	O
b	LS	appos	O
)	-RRB-	punct	O
+IE-	NN	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
transgenic	JJ	amod	O
mice	NNS	conj	O
,	,	punct	O
either	CC	cc:preconj	O
AB	NN	nsubjpass	O
(	-LRB-	punct	O
o	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
IA	NN	compound	O
(	-LRB-	punct	O
b	LS	compound	O
)	-RRB-	punct	O
-IE-	NN	conj	O
;	:	punct	O
ABEalpha	NN	dep	O
,	,	punct	O
IA-IE	NN	compound	O
(	-LRB-	punct	O
k	NN	appos	O
)	-RRB-	punct	O
+	CC	cc	O
;	:	punct	O
or	CC	cc	O
BL	NN	conj	O
:	:	punct	O
TG	NN	dep	O
:	:	punct	O
Ealpha	NN	appos	O
,	,	punct	O
IA	NN	appos	O
(	-LRB-	punct	O
b	LS	appos	O
)	-RRB-	punct	O
+IE	NN	dep	O
(	-LRB-	punct	O
k	NN	appos	O
)	-RRB-	punct	O
+	CC	cc	O
,	,	punct	O
were	VBD	auxpass	O
fed	VBN	ROOT	O
a	DT	det	O
high-cholesterol	JJ	amod	O
diet	NN	dobj	O
for	IN	prep	O
16	CD	nummod	O
weeks	NNS	pobj	O
and	CC	cc	O
evaluated	VBN	conj	O
histomorphometrically	RB	advmod	O
for	IN	case	O
aortic	JJ	amod	O
lesions	NNS	nmod	O
.	.	punct	O

Lesion	NN	compound	O
size	NN	nsubjpass	O
in	IN	case	O
AB	NN	nmod	O
(	-LRB-	punct	O
o	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
ABEalpha	NN	conj	O
,	,	punct	O
and	CC	cc	O
BL	NN	conj	O
:	:	punct	O
TG	NN	appos	O
:	:	punct	O
Ealpha	NN	compound	O
strains	NNS	nsubjpass	O
was	VBD	auxpass	O
decreased	VBN	ROOT	O
by	IN	case	O
54	CD	nummod	O
%	NN	nmod	O
,	,	punct	O
79	CD	nummod	O
%	NN	conj	O
,	,	punct	O
and	CC	cc	O
82	CD	nummod	O
%	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
compared	VBN	case	O
with	IN	case	O
wild-type	JJ	advcl	O
,	,	punct	O
correlating	VBG	advcl	O
with	IN	case	O
decreased	VBN	amod	O
Th1	NN	nmod	B-cell_type
and	CC	cc	O
increased	VBD	amod	O
Th2	NN	compound	B-cell_type
expression	NN	conj	O
and	CC	cc	O
suggesting	VBG	conj	O
that	IN	mark	O
T	NN	compound	O
helper-cell	JJ	compound	O
phenotype	NN	nsubj	O
is	VBZ	cop	O
important	JJ	ccomp	O
in	IN	case	O
fatty	JJ	amod	O
lesion	NN	compound	O
development	NN	nmod	O
.	.	punct	O

Decreasing	VBG	amod	O
Th1	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
by	IN	case	O
antibodies	NNS	nmod	B-protein
(	-LRB-	punct	O
alpha-CD4	NN	appos	B-protein
)	-RRB-	punct	O
or	CC	cc	O
cytokines	NNS	conj	B-protein
(	-LRB-	punct	O
IL-4	NN	appos	B-protein
)	-RRB-	punct	O
also	RB	advmod	O
caused	VBD	ROOT	O
>	NN	amod	O
/=80	NN	compound	O
%	NN	compound	O
reductions	NNS	dobj	O
in	IN	prep	O
lesion	NN	compound	O
size	NN	pobj	O
.	.	punct	O

Immunohistology	NN	nsubj	O
revealed	VBD	ROOT	O
IFN-gamma	NN	dobj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
IL-4	NN	conj	B-protein
,	,	punct	O
colocalized	VBD	advcl	O
with	IN	case	O
activated	VBN	amod	O
macrophages	NNS	nmod	B-cell_type
.	.	punct	O

Confirming	VBG	csubj	O
these	DT	det	O
findings	NNS	dobj	O
in	IN	case	O
a	DT	det	O
different	JJ	amod	O
mouse	NN	compound	O
strain	NN	nmod	O
,	,	punct	O
BALB/c	NN	compound	O
Stat	NN	compound	O
6	CD	nummod	O
knockout	JJ	amod	O
mice	NNS	conj	O
(	-LRB-	punct	O
Th2	NN	compound	O
cell-deficient	JJ	appos	O
)	-RRB-	punct	O
developed	VBD	ROOT	O
aortic	JJ	amod	O
lesions	NNS	dobj	O
comparable	JJ	amod	O
to	TO	case	O
C57Bl/6	NN	compound	O
mice	NNS	nmod	O
on	IN	case	O
the	DT	det	O
same	JJ	amod	O
diet	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
mildly	RB	advmod	O
hypercholesterolemic	JJ	amod	O
C57Bl/6	NN	compound	O
mice	NNS	dep	O
,	,	punct	O
presence	NN	appos	O
of	IN	case	O
IA	NN	nmod	B-protein
(	-LRB-	punct	I-protein
b	NN	appos	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	O
absence	NN	conj	O
of	IN	case	O
IE	JJ	amod	B-protein
regulated	JJ	amod	O
CD4+	JJ	amod	O
T	NN	compound	O
helper-cell	JJ	compound	O
phenotype	NN	nmod	O
;	:	punct	O
fatty	JJ	amod	O
lesions	NNS	nsubj	O
were	VBD	cop	O
proportional	JJ	appos	O
to	TO	case	O
IFNgamma+	JJ	amod	B-cell_type
Th1	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
both	CC	cc:preconj	O
C57Bl/6	NN	nmod	O
and	CC	cc	O
BALB/c	NN	conj	O
strains	NNS	dep	O
.	.	punct	O

IFN-gamma	NN	nsubj	B-protein
may	MD	aux	O
participate	VB	ROOT	O
through	IN	case	O
macrophage	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
IL-4	NN	nsubj	B-protein
may	MD	aux	O
act	VB	parataxis	O
to	TO	mark	O
limit	VB	xcomp	O
Th1-cell	NN	compound	O
response	NN	dobj	O
.	.	punct	O

Requirement	NN	ROOT	O
for	IN	case	O
p38	NN	compound	B-protein
and	CC	cc	O
p44/p42	JJ	conj	B-protein
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinases	NNS	nmod	I-protein
in	IN	case	O
RAGE	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	compound	I-protein
transcriptional	JJ	amod	O
activation	NN	nmod	O
and	CC	cc	O
cytokine	NN	compound	O
secretion	NN	conj	O
.	.	punct	O

Advanced	JJ	amod	O
glycation	NN	compound	O
end	NN	compound	O
product	NN	compound	O
(	-LRB-	punct	O
AGE	NN	appos	O
)	-RRB-	punct	O
activation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
signal-transducing	JJ	amod	B-protein
receptor	NN	nmod	I-protein
for	IN	case	I-protein
AGE	NN	nmod	I-protein
(	-LRB-	punct	O
RAGE	NN	appos	B-protein
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
linked	VBN	ROOT	O
to	TO	case	O
a	DT	det	O
proinflammatory	JJ	amod	O
phenotypic	JJ	amod	O
change	NN	nmod	O
within	IN	case	O
cells	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
precise	JJ	amod	O
intracellular	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	nsubjpass	O
involved	VBN	acl	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
elucidated	VBN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
here	RB	advmod	O
that	IN	dobj	O
human	JJ	amod	O
serum	NN	compound	O
albumin	NN	dep	O
modified	VBN	acl	O
with	IN	case	O
N	NN	compound	O
(	-LRB-	punct	O
varepsilon	NN	nmod	O
)	-RRB-	punct	O
-	:	punct	O
(	-LRB-	punct	O
carboxymethyl	NN	compound	O
)	-RRB-	punct	O
lysine	NN	nmod	O
(	-LRB-	punct	O
CML	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
major	JJ	amod	O
AGE	NN	compound	O
adduct	NN	appos	O
that	WDT	nsubj	O
progressively	RB	advmod	O
accumulates	VBZ	acl:relcl	O
with	IN	case	O
aging	NN	nmod	O
,	,	punct	O
diabetes	NNS	conj	O
,	,	punct	O
and	CC	cc	O
renal	JJ	amod	O
failure	NN	conj	O
,	,	punct	O
induced	VBD	amod	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF	NN	nmod:npmod	I-protein
)	-RRB-	punct	I-protein
-kappaB	NN	nmod:npmod	I-protein
-driven	JJ	amod	O
reporter	NN	compound	O
gene	NN	compound	O
expression	NN	conj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytic	JJ	amod	I-cell_type
THP-1	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
NF-kappaB	NN	compound	O
response	NN	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
synthetic	JJ	amod	O
peptide	NN	nmod	O
corresponding	VBG	acl	O
to	TO	case	O
the	DT	det	O
putative	JJ	amod	B-protein
ligand-binding	JJ	amod	I-protein
domain	NN	nmod	I-protein
of	IN	case	O
RAGE	NN	nmod	B-protein
,	,	punct	O
with	IN	case	O
anti-	NN	amod	O
RAGE	NN	compound	B-protein
antiserum	NN	nmod	O
,	,	punct	O
and	CC	cc	O
by	IN	case	O
coexpression	NN	conj	O
of	IN	case	O
truncated	VBN	amod	B-protein
receptors	NNS	nmod	I-protein
lacking	VBG	acl	O
the	DT	det	O
intracellular	JJ	amod	B-protein
domain	NN	dobj	I-protein
.	.	punct	O

Signal	NN	compound	O
transduction	NN	nsubj	O
from	IN	case	O
RAGE	NN	nmod	B-protein
to	TO	case	O
NF-kappaB	NN	nmod	B-protein
involved	VBD	ROOT	O
the	DT	det	O
generation	NN	dobj	O
of	IN	case	O
reactive	JJ	amod	O
oxygen	NN	compound	O
species	NNS	nmod	O
,	,	punct	O
since	IN	mark	O
reporter	NN	compound	O
gene	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
blocked	VBN	advcl	O
with	IN	case	O
the	DT	det	O
antioxidant	JJ	amod	O
N-acetyl-L-cysteine	NN	nmod	O
.	.	punct	O

CML-modified	JJ	amod	B-protein
albumin	NN	nsubj	I-protein
produced	VBD	ROOT	O
rapid	JJ	amod	O
transient	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
,	,	punct	O
extracellular	JJ	amod	B-protein
signal-regulated	JJ	amod	I-protein
kinase	NN	conj	I-protein
1	CD	nummod	I-protein
and	CC	cc	I-protein
2	CD	conj	I-protein
,	,	punct	O
and	CC	cc	O
p38	NN	compound	B-protein
mitogen-activated	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	conj	I-protein
(	-LRB-	punct	O
MAPK	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
c-Jun	NN	compound	B-protein
NH	NN	compound	I-protein
(	-LRB-	punct	I-protein
2	CD	nummod	I-protein
)	-RRB-	punct	I-protein
-terminal	JJ	amod	I-protein
kinase	NN	conj	I-protein
.	.	punct	O

RAGE	NN	compound	B-protein
-mediated	JJ	amod	O
NF-kappaB	NN	compound	O
activation	NN	nsubjpass	O
was	VBD	auxpass	O
suppressed	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
selective	JJ	amod	O
p38	NN	compound	B-protein
MAPK	NN	compound	I-protein
inhibitor	NN	compound	O
SB203580	NN	nmod	O
and	CC	cc	O
by	IN	case	O
coexpression	NN	conj	O
of	IN	case	O
a	DT	det	O
kinase-dead	JJ	amod	O
p38	NN	compound	O
dominant-negative	JJ	amod	O
mutant	NN	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
by	IN	case	O
CML-modified	JJ	amod	B-protein
albumin	NN	nmod	I-protein
increased	VBD	ROOT	O
secretion	NN	dobj	O
of	IN	case	O
proinflammatory	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
(	-LRB-	punct	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	compound	I-protein
,	,	punct	O
interleukin-1beta	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
monocyte	NN	compound	B-protein
chemoattractant	NN	compound	I-protein
protein-1	NN	conj	I-protein
)	-RRB-	punct	O
severalfold	NN	nmod	O
,	,	punct	O
and	CC	cc	O
inhibition	NN	nsubj	O
of	IN	case	O
p38	NN	compound	B-protein
MAPK	NN	nmod	I-protein
blocked	VBD	conj	O
these	DT	det	O
increases	NNS	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
p38	NN	compound	B-protein
MAPK	NN	compound	I-protein
activation	NN	nsubj	O
mediates	VBZ	ccomp	O
RAGE	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
NF-kappaB	NN	compound	B-protein
-dependent	JJ	amod	O
secretion	NN	dobj	O
of	IN	case	O
proinflammatory	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
accelerated	VBN	amod	O
inflammation	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
consequence	NN	ccomp	O
of	IN	case	O
cellular	JJ	amod	O
activation	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
this	DT	det	O
receptor	NN	nmod	O
.	.	punct	O

Antigen-receptor	JJ	compound	O
cross-linking	NN	nsubj	O
and	CC	cc	O
lipopolysaccharide	NN	conj	O
trigger	NN	ROOT	O
distinct	JJ	amod	O
phosphoinositide	NN	compound	B-protein
3-kinase	NN	compound	I-protein
-dependent	JJ	amod	O
pathways	NNS	dobj	O
to	TO	case	O
NF-kappa	NN	compound	O
B	NN	compound	O
activation	NN	nmod	O
in	IN	case	O
primary	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
NF-kappaB/Rel	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nsubj	I-protein
play	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
B	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
,	,	punct	O
differentiation	NN	conj	O
and	CC	cc	O
function	NN	conj	O
.	.	punct	O

Nuclear	JJ	amod	B-protein
NF-kappaB	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
engagement	NN	nmod	O
of	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
BCR	NN	nmod	B-protein
or	CC	cc	O
CD40	NN	conj	B-protein
or	CC	cc	O
by	IN	case	O
stimulation	NN	conj	O
with	IN	case	O
lipopolysaccharide	NN	nmod	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Despite	IN	case	O
the	DT	det	O
importance	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
to	TO	case	O
B	NN	compound	O
cell	NN	compound	O
function	NN	nmod	O
,	,	punct	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
signaling	NN	compound	O
pathways	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
NF-kappaB	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
we	PRP	nsubj	O
address	VBP	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
phosphoinositide	NN	compound	B-protein
3'-kinase	NN	nmod	I-protein
(	-LRB-	punct	O
PI	NN	compound	B-protein
3-kinase	NN	appos	I-protein
)	-RRB-	punct	O
in	IN	case	O
BCR	NN	nmod	B-protein
-	:	punct	O
and	CC	cc	O
LPS-induced	JJ	conj	O
NF-kappaB	NN	compound	O
activation	NN	conj	O
using	VBG	acl	O
populations	NNS	dobj	O
of	IN	case	O
primary	JJ	amod	B-cell_type
murine	NN	amod	I-cell_type
resting	VBG	amod	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Using	VBG	advcl	O
the	DT	det	O
specific	JJ	amod	O
pharmacological	JJ	amod	O
inhibitors	NNS	dobj	O
of	IN	case	O
PI	NN	compound	B-protein
3-kinase	NN	nmod	I-protein
,	,	punct	O
Wortmannin	NN	appos	O
and	CC	cc	O
LY294002	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
PI	NN	compound	B-protein
3-kinase	NN	compound	I-protein
activity	NN	nsubj	O
is	VBZ	cop	O
vital	JJ	ccomp	O
for	IN	case	O
BCR	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
NF-kappaB	NN	compound	B-protein
DNA-binding	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
this	DT	nsubjpass	O
is	VBZ	auxpass	O
achieved	VBN	ccomp	O
via	IN	case	O
protein	NN	nmod:npmod	B-protein
kinase	NN	nmod:npmod	I-protein
C	NN	nmod:npmod	I-protein
-dependent	JJ	amod	O
degradation	NN	nmod	O
of	IN	case	O
IkappaBalpha	NN	nmod	B-protein
.	.	punct	O

Similar	JJ	amod	O
analyses	NNS	nsubj	O
reveal	VBP	ROOT	O
that	IN	mark	O
PI	NN	compound	B-protein
3-kinase	NN	nsubj	I-protein
is	VBZ	cop	O
also	RB	advmod	O
critical	JJ	ccomp	O
in	IN	mark	O
triggering	VBG	advcl	O
NF-kappaB	NN	compound	B-protein
DNA-binding	JJ	amod	O
activity	NN	dobj	O
and	CC	cc	O
IkappaBalpha	NN	compound	B-protein
degradation	NN	conj	O
following	VBG	case	O
LPS	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
a	DT	det	O
PKC	NN	compound	O
inhibitor	NN	nsubj	O
which	WDT	nsubj	O
blocked	VBD	acl:relcl	O
the	DT	det	O
BCR	NN	compound	B-protein
-induced	JJ	amod	O
IkappaBalpha	NN	compound	B-protein
degradation	NN	dobj	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
degradation	NN	nmod	O
of	IN	case	O
IkappaBalpha	NN	nmod	B-protein
after	IN	case	O
LPS	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
PI	NN	compound	B-protein
3-kinase	NN	nmod	I-protein
in	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
two	CD	nummod	O
distinct	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Tetramer-guided	JJ	amod	O
epitope	NN	compound	O
mapping	NN	ROOT	O
:	:	punct	O
rapid	JJ	amod	O
identification	NN	dep	O
and	CC	cc	O
characterization	NN	conj	O
of	IN	case	O
immunodominant	JJ	amod	B-cell_type
CD4+	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
epitopes	NNS	nmod	I-cell_type
from	IN	case	O
complex	JJ	amod	O
antigens	NNS	nmod	B-protein
.	.	punct	O

T	NN	compound	O
cell	NN	compound	O
responses	NNS	nsubj	O
to	TO	case	O
Ags	NNS	nmod	B-protein
involve	VBP	ROOT	O
recognition	NN	dobj	O
of	IN	case	O
selected	VBN	amod	O
peptide	NN	compound	B-protein
epitopes	NNS	nmod	I-protein
contained	VBN	acl	O
within	IN	case	O
the	DT	det	O
antigenic	JJ	amod	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
describe	VBP	ROOT	O
a	DT	det	O
new	JJ	amod	O
approach	NN	dobj	O
for	IN	case	O
direct	JJ	amod	O
identification	NN	nmod	O
of	IN	case	O
CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
epitopes	NNS	nmod	I-cell_type
of	IN	case	O
complex	JJ	compound	O
Ags	NNS	nmod	B-protein
that	WDT	nsubj	O
uses	VBZ	acl:relcl	O
human	JJ	amod	B-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
tetramers	NNS	dobj	I-protein
to	TO	mark	O
identify	VB	xcomp	O
reactive	JJ	amod	O
cells	NNS	dobj	O
.	.	punct	O

With	IN	prep	O
a	DT	det	O
panel	NN	pobj	O
of	IN	case	O
60	CD	nummod	O
overlapping	VBG	amod	O
peptides	NNS	nmod	O
covering	VBG	acl	O
the	DT	det	O
entire	JJ	amod	O
sequence	NN	dobj	O
of	IN	case	O
the	DT	det	O
VP16	NN	compound	B-protein
protein	NN	nmod	I-protein
,	,	punct	O
a	DT	det	O
major	JJ	amod	O
Ag	NN	appos	B-protein
for	IN	case	O
HSV-2	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
generated	VBD	ROOT	O
a	DT	det	O
panel	NN	dobj	O
of	IN	case	O
class	NN	compound	B-protein
II	CD	nummod	I-protein
MHC	NN	compound	I-protein
tetramers	NNS	nmod	I-protein
loaded	VBN	acl	O
with	IN	case	O
peptide	NN	compound	O
pools	NNS	nmod	O
that	WDT	nsubjpass	O
were	VBD	auxpass	O
used	VBN	acl:relcl	O
to	TO	mark	O
stain	VB	xcomp	O
peripheral	JJ	amod	B-cell_type
lymphocytes	NNS	dobj	I-cell_type
of	IN	case	O
an	DT	det	O
HSV-2	NN	compound	O
infected	JJ	amod	O
individual	NN	nmod	O
.	.	punct	O

With	IN	case	O
this	DT	det	O
approach	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
identified	VBD	ROOT	O
four	CD	nummod	O
new	JJ	amod	O
DRA1*0101/DRB1*0401-	NN	dobj	O
and	CC	cc	O
two	CD	nummod	O
DRA1*0101/DRB1*0404-restricted	JJ	amod	O
,	,	punct	O
VP16-specific	JJ	amod	B-protein
epitopes	NNS	conj	I-protein
.	.	punct	O

By	IN	prep	O
using	VBG	pcomp	O
tetramers	NNS	dobj	B-protein
to	TO	aux	O
sort	VB	xcomp	O
individual	JJ	amod	O
cells	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
easily	RB	advmod	O
obtained	VBD	ROOT	O
a	DT	det	O
large	JJ	amod	O
number	NN	dobj	O
of	IN	case	O
clones	NNS	nmod	O
specific	JJ	amod	O
to	TO	case	O
these	DT	det	O
epitopes	NNS	nmod	B-protein
.	.	punct	O

Although	IN	mark	O
DRA1*0101/DRB1*0401	NN	nsubj	O
and	CC	cc	O
DRA1*0101/DRB1*0404	NN	conj	O
are	VBP	cop	O
structurally	RB	advmod	O
very	RB	advmod	O
similar	JJ	amod	O
,	,	punct	O
nonoverlapping	JJ	dep	O
VP16	NN	compound	B-protein
epitopes	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
identified	VBN	ROOT	O
,	,	punct	O
illustrating	VBG	xcomp	O
high	JJ	amod	O
selectivity	NN	dobj	O
of	IN	case	O
individual	JJ	amod	O
allele	NN	compound	O
polymorphisms	NNS	nmod	O
within	IN	case	O
common	JJ	amod	O
MHC	NN	compound	O
variants	NNS	nmod	O
.	.	punct	O

This	DT	det	O
rapid	JJ	amod	O
approach	NN	nsubjpass	O
to	TO	mark	O
detecting	VBG	acl	O
CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
epitopes	NNS	dobj	I-cell_type
from	IN	case	O
complex	JJ	compound	O
Ags	NNS	nmod	B-protein
can	MD	aux	O
be	VB	auxpass	O
applied	VBN	ROOT	O
to	TO	case	O
any	DT	det	O
known	JJ	amod	O
Ag	NN	nmod	B-protein
that	WDT	nsubj	O
gives	VBZ	acl:relcl	O
a	DT	det	O
T	NN	compound	O
cell	NN	compound	O
response	NN	dobj	O
.	.	punct	O

Localized	JJ	amod	O
pancreatic	JJ	amod	O
NF-kappaB	NN	compound	O
activation	NN	ROOT	O
and	CC	cc	O
inflammatory	JJ	amod	O
response	NN	conj	O
in	IN	case	O
taurocholate-induced	JJ	amod	O
pancreatitis	NN	nmod	O
.	.	punct	O

Transcription	NN	compound	B-protein
factor	NN	compound	I-protein
nuclear	JJ	amod	I-protein
factor-kappaB	NN	nsubjpass	I-protein
(	-LRB-	punct	O
NF-kappaB	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
activated	VBN	ROOT	O
in	IN	case	O
cerulein	NN	compound	O
pancreatitis	NN	nmod	O
and	CC	cc	O
mediates	VBZ	conj	O
cytokine	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
transcription	NN	compound	O
factor	NN	compound	O
activation	NN	nmod	O
in	IN	case	O
other	JJ	amod	O
models	NNS	nmod	O
of	IN	case	O
pancreatitis	NN	nmod	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
established	VBN	ROOT	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
upregulation	NN	dobj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
and	CC	cc	O
inflammatory	JJ	amod	B-protein
molecules	NNS	conj	I-protein
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
correlation	NN	conj	O
with	IN	case	O
local	JJ	amod	O
pancreatic	JJ	amod	O
injury	NN	nmod	O
,	,	punct	O
in	IN	case	O
a	DT	det	O
model	NN	nmod	O
of	IN	case	O
severe	JJ	amod	O
pancreatitis	NN	nmod	O
.	.	punct	O

Rats	NNS	nsubj	O
received	VBD	ROOT	O
intraductal	JJ	amod	O
infusion	NN	dobj	O
of	IN	case	O
taurocholate	NN	nmod	O
or	CC	cc	O
saline	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
pancreatic	JJ	amod	O
head	NN	nsubjpass	O
and	CC	cc	O
tail	NN	conj	O
were	VBD	auxpass	O
analyzed	VBN	conj	O
separately	RB	advmod	O
.	.	punct	O

NF-kappaB	NN	compound	B-protein
and	CC	cc	O
activator	NN	compound	B-protein
protein-1	NN	compound	I-protein
(	-LRB-	punct	O
AP-1	NN	appos	B-protein
)	-RRB-	punct	O
activation	NN	nsubjpass	O
were	VBD	auxpass	O
assessed	VBN	ROOT	O
by	IN	case	O
gel	NN	compound	O
shift	NN	compound	O
assay	NN	nmod	O
,	,	punct	O
and	CC	cc	O
mRNA	NN	compound	O
expression	NN	nsubjpass	O
of	IN	case	O
interleukin-6	NN	nmod	B-RNA
,	,	punct	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	conj	I-protein
,	,	punct	O
KC	NN	conj	O
,	,	punct	O
monocyte	NN	compound	B-protein
chemoattractant	NN	compound	I-protein
protein-1	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
inducible	JJ	amod	B-protein
nitric	JJ	amod	I-protein
oxide	NN	compound	I-protein
synthase	NN	conj	I-protein
was	VBD	auxpass	O
assessed	VBN	conj	O
by	IN	case	O
semiquantitative	JJ	amod	O
RT-PCR	NN	nmod	O
.	.	punct	O

Morphological	JJ	amod	O
damage	NN	nsubj	O
and	CC	cc	O
trypsin	NN	compound	O
activation	NN	conj	O
were	VBD	cop	O
much	RB	advmod	O
greater	JJR	ROOT	O
in	IN	case	O
the	DT	det	O
pancreatic	JJ	amod	O
head	NN	nmod	O
than	IN	case	O
tail	NN	nmod	O
,	,	punct	O
in	IN	case	O
parallel	NN	nmod	O
with	IN	case	O
a	DT	det	O
stronger	JJR	amod	O
activation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-RNA
and	CC	cc	I-RNA
cytokine	NN	conj	I-RNA
mRNA	NN	dep	I-RNA
.	.	punct	O

Saline	NN	compound	O
infusion	NN	nsubj	O
mildly	RB	advmod	O
affected	VBD	ROOT	O
these	DT	det	O
parameters	NNS	dobj	O
.	.	punct	O

AP-1	NN	nsubjpass	B-protein
was	VBD	auxpass	O
strongly	RB	advmod	O
activated	VBN	ROOT	O
in	IN	case	O
both	CC	det	O
pancreatic	JJ	amod	O
segments	NNS	nmod	O
after	IN	case	O
either	CC	cc:preconj	O
taurocholate	VB	nmod	O
or	CC	cc	O
saline	NN	compound	O
infusion	NN	conj	O
.	.	punct	O

NF-kappaB	NN	compound	B-protein
inhibition	NN	nsubj	O
with	IN	case	O
N-acetylcysteine	NN	nmod	O
ameliorated	VBD	ROOT	O
the	DT	det	O
local	JJ	amod	O
inflammatory	JJ	amod	O
response	NN	dobj	O
.	.	punct	O

Correlation	NN	nsubj	O
between	IN	case	O
localized	JJ	amod	O
NF-kappaB	NN	compound	B-protein
activation	NN	nmod	O
,	,	punct	O
cytokine	NN	compound	O
upregulation	NN	conj	O
,	,	punct	O
and	CC	cc	O
tissue	NN	compound	O
damage	NN	conj	O
suggests	VBZ	ROOT	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
the	DT	det	O
inflammatory	JJ	amod	O
response	NN	nmod	O
of	IN	case	O
acute	JJ	amod	O
pancreatitis	NN	nmod	O
.	.	punct	O

CD45	NN	compound	B-protein
tyrosine	NN	compound	I-protein
phosphatase	NN	nsubj	I-protein
controls	VBZ	ROOT	O
common	JJ	amod	O
gamma-chain	NN	amod	B-protein
cytokine	NN	compound	I-protein
-mediated	JJ	amod	O
STAT	NN	dobj	B-protein
and	CC	cc	O
extracellular	JJ	amod	O
signal-related	JJ	amod	O
kinase	NN	compound	O
phosphorylation	NN	conj	O
in	IN	case	O
activated	VBN	amod	B-cell_type
human	JJ	amod	I-cell_type
lymphoblasts	NNS	nmod	I-cell_type
:	:	punct	O
inhibition	NN	dep	O
of	IN	case	O
proliferation	NN	nmod	O
without	IN	case	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
objective	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
test	VB	xcomp	O
whether	IN	mark	O
CD45	NN	compound	O
signals	NNS	nsubj	O
can	MD	aux	O
influence	VB	ccomp	O
signaling	NN	compound	O
processes	NNS	dobj	O
in	IN	case	O
activated	VBN	amod	B-cell_type
human	JJ	amod	I-cell_type
lymphoblasts	NNS	nmod	I-cell_type
.	.	punct	O

To	IN	case	O
this	DT	det	O
end	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
generated	VBD	ROOT	O
lymphoblasts	NNS	dobj	B-cell_type
which	WDT	nsubj	O
proliferate	VBP	acl:relcl	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
common	JJ	amod	O
gamma-chain	NN	amod	B-protein
cytokines	NNS	nmod	I-protein
,	,	punct	O
but	CC	cc	O
readily	RB	advmod	O
undergo	VBP	conj	O
apoptosis	NN	dobj	O
after	IN	case	O
cytokine	NN	compound	O
withdrawal	NN	nmod	O
.	.	punct	O

In	IN	case	O
experiments	NNS	nmod	O
with	IN	case	O
the	DT	det	O
CD45R0	NN	compound	B-protein
mAb	NN	compound	I-protein
UCHL-1	NN	nmod	I-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
control	VB	conj	B-protein
CD45	NN	compound	I-protein
mAbs	NNS	dobj	I-protein
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
significant	JJ	amod	O
inhibition	NN	dobj	O
of	IN	case	O
proliferation	NN	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
pan-CD45	JJ	compound	B-protein
mAb	NN	compound	I-protein
GAP8.3	NN	nsubj	I-protein
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
most	RBS	advmod	O
effective	JJ	acl:relcl	O
in	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
OKT-3-mediated	JJ	amod	O
proliferation	NN	nmod	O
in	IN	case	O
quiescent	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
was	VBD	cop	O
ineffective	JJ	ROOT	O
in	IN	case	O
lymphoblasts	NNS	nmod	B-cell_type
.	.	punct	O

Addition	NN	nsubj	O
of	IN	case	O
CD3	NN	compound	B-protein
mAb	NN	compound	I-protein
OKT-3	NN	nmod	I-protein
had	VBD	ROOT	O
no	DT	neg	O
influence	NN	dobj	O
on	IN	case	O
IL-2-mediated	JJ	amod	O
proliferation	NN	nmod	O
(	-LRB-	punct	O
with	IN	nmod	O
or	CC	cc	O
without	IN	case	O
UCHL-1	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
after	IN	case	O
addition	NN	nmod	O
of	IN	case	O
OKT-3	NN	nmod	B-protein
to	TO	case	O
IL-4	NN	compound	B-protein
-	:	punct	O
and	CC	cc	O
IL-7	NN	nmod:npmod	B-protein
-stimulated	JJ	amod	O
proliferation	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
UCHL-1	NN	compound	B-protein
signals	NNS	nsubj	O
could	MD	aux	O
not	RB	neg	O
significantly	RB	advmod	O
alter	VB	ROOT	O
cellular	JJ	amod	O
proliferation	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
did	VBD	aux	O
not	RB	neg	O
find	VB	ROOT	O
induction	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
following	VBG	case	O
CD45R0	NN	compound	O
signaling	NN	nmod	O
.	.	punct	O

In	IN	case	O
Western	NN	compound	O
blots	NNS	nmod	O
using	VBG	acl	O
mAbs	NNS	dobj	B-protein
detecting	VBG	acl	O
phosphorylated	VBN	amod	B-protein
STAT-3	NN	dobj	I-protein
,	,	punct	I-protein
STAT-5	NN	conj	I-protein
,	,	punct	I-protein
STAT-6	NN	conj	I-protein
,	,	punct	O
or	CC	cc	O
extracellular	JJ	amod	B-protein
signal-related	JJ	amod	I-protein
kinase	NN	conj	I-protein
1/2	CD	nummod	I-protein
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
CD45R0	NN	compound	O
signaling	NN	nsubj	O
could	MD	aux	O
effectively	RB	advmod	O
diminish	VB	ccomp	O
phosphorylation	NN	dobj	O
of	IN	case	O
these	DT	det	O
intracellular	JJ	amod	O
signaling	NN	compound	O
components	NNS	nmod	O
.	.	punct	O

Using	VBG	advcl	O
RT-PCR	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
CD45R0	NN	compound	O
signaling	NN	nsubj	O
inhibited	VBD	ccomp	O
IL-2	NN	compound	O
mRNA	NN	compound	O
production	NN	dobj	O
without	IN	case	O
major	JJ	amod	O
influence	NN	nmod	O
on	IN	case	O
IL-13	NN	nmod	B-protein
,	,	punct	O
IL-5	NN	conj	B-protein
,	,	punct	O
or	CC	cc	O
IFN-gamma	NN	conj	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	dep	O
.	.	punct	O

Costimulation	NN	nsubj	O
with	IN	case	O
OKT-3	NN	nmod	B-protein
and	CC	cc	O
IL-2	NN	conj	B-protein
optimally	RB	advmod	O
induced	VBD	ROOT	O
secretion	NN	dobj	O
of	IN	case	O
IFN-gamma	NN	nmod	B-protein
,	,	punct	O
TNF-alpha	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-5	NN	conj	B-protein
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
decreased	VBN	acl:relcl	O
by	IN	case	O
CD45	NN	compound	O
signals	NNS	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
illustrate	VBP	ROOT	O
that	IN	mark	O
CD45R0	NN	compound	O
signals	NNS	nsubj	O
control	VBP	ccomp	O
early	JJ	amod	O
cytokine	NN	nmod:npmod	O
receptor-associated	JJ	amod	O
signaling	NN	compound	O
processes	NNS	dobj	O
and	CC	cc	O
mRNA	NN	conj	O
and	CC	cc	O
DNA	NN	compound	O
synthesis	NN	conj	O
in	IN	case	O
activated	VBN	amod	B-cell_type
human	JJ	amod	I-cell_type
lymphoblasts	NNS	nmod	I-cell_type
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
CD45	NN	compound	B-protein
epitopes	NNS	nmod	I-protein
(	-LRB-	punct	O
GAP8.3	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
active	JJ	acl:relcl	O
and	CC	cc	O
critical	JJ	conj	O
for	IN	case	O
signaling	NN	nmod	O
in	IN	case	O
quiescent	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
but	CC	cc	O
are	VBP	cop	O
nonfunctional	JJ	conj	O
in	IN	case	O
activated	VBN	amod	B-cell_type
human	JJ	amod	I-cell_type
lymphoblasts	NNS	nmod	I-cell_type
.	.	punct	O

Pax5	NN	nsubj	B-DNA
determines	VBZ	ROOT	O
the	DT	det	O
identity	NN	dobj	O
of	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
the	DT	det	O
beginning	NN	nmod	O
to	IN	case	O
the	DT	det	O
end	NN	nmod	O
of	IN	case	O
B-lymphopoiesis	NN	nmod	O
.	.	punct	O

Despite	IN	prep	O
being	VBG	pcomp	O
one	CD	attr	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
intensively	RB	advmod	O
studied	VBN	amod	O
cell	NN	compound	O
types	NNS	nmod	O
,	,	punct	O
the	DT	det	O
molecular	JJ	amod	O
basis	NN	nsubj	O
of	IN	case	O
B	NN	compound	O
cell	NN	compound	O
specification	NN	nmod	O
is	VBZ	cop	O
largely	RB	advmod	O
unknown	JJ	ROOT	O
.	.	punct	O

The	DT	det	O
Pax5	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
encoding	VBG	acl	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
BSAP	NN	dobj	I-protein
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
progression	NN	nmod	O
of	IN	case	O
B-lymphopoiesis	NN	nmod	O
beyond	IN	case	O
the	DT	det	O
pro-B	JJ	amod	O
cell	NN	compound	O
stage	NN	nmod	O
.	.	punct	O

Pax5-deficient	JJ	amod	B-cell_type
pro-B	JJ	amod	I-cell_type
cells	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
not	RB	neg	O
yet	RB	advmod	O
committed	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
B-lymphoid	JJ	amod	B-cell_type
lineage	NN	nmod	I-cell_type
,	,	punct	O
but	CC	cc	O
instead	RB	advmod	O
have	VBP	conj	O
a	DT	det	O
broad	JJ	amod	O
lymphomyeloid	JJ	compound	O
developmental	JJ	amod	O
potential	NN	dobj	O
.	.	punct	O

Pax5	NN	nsubj	B-DNA
appears	VBZ	ROOT	O
to	TO	mark	O
mediate	VB	xcomp	O
B-lineage	JJ	amod	O
commitment	NN	dobj	O
by	IN	mark	O
repressing	VBG	advcl	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
non-B-lymphoid	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
by	IN	mark	O
simultaneously	RB	advmod	O
activating	VBG	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
B-lineage-specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Pax5	NN	nsubj	B-DNA
thus	RB	advmod	O
functions	VBZ	ROOT	O
both	CC	cc:preconj	O
as	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	O
repressor	NN	dobj	O
and	CC	cc	O
activator	NN	conj	O
,	,	punct	O
depending	VBG	case	O
on	IN	case	O
its	PRP$	nmod:poss	O
interactions	NNS	nmod	O
with	IN	case	O
corepressors	NNS	nmod	B-protein
of	IN	case	O
the	DT	det	O
Groucho	NN	compound	B-protein
protein	NN	compound	I-protein
family	NN	nmod	I-protein
or	CC	cc	O
with	IN	case	O
positive	JJ	amod	O
regulators	NNS	conj	O
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
TATA-binding	JJ	amod	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

Once	RB	mark	O
committed	VBN	advcl	O
to	TO	case	O
the	DT	det	O
B-lineage	NN	nmod	B-cell_type
,	,	punct	O
B	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
require	VBP	ROOT	O
Pax5	NN	compound	B-DNA
function	NN	dobj	O
to	TO	mark	O
maintain	VB	xcomp	O
their	PRP$	nmod:poss	O
B-lymphoid	JJ	amod	O
identity	NN	dobj	O
throughout	IN	case	O
B	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O

Partners	NNS	ROOT	O
in	IN	case	O
transcription	NN	nmod	O
:	:	punct	O
NFAT	NN	dep	B-protein
and	CC	cc	O
AP-1	NN	conj	B-protein
.	.	punct	O

Combinatorial	JJ	amod	O
regulation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
powerful	JJ	amod	O
mechanism	NN	ROOT	O
that	WDT	nsubj	O
enables	VBZ	acl:relcl	O
tight	JJ	amod	O
control	NN	dobj	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
via	IN	case	O
integration	NN	nmod	O
of	IN	case	O
multiple	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	nmod	O
that	WDT	nsubj	O
induce	VBP	acl:relcl	O
different	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	dobj	I-protein
required	VBN	acl	O
for	IN	case	O
enhanceosome	NN	compound	O
assembly	NN	nmod	O
.	.	punct	O

The	DT	det	O
four	CD	nummod	O
calcium-regulated	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nsubj	I-protein
of	IN	case	O
the	DT	det	O
NFAT	NN	compound	B-protein
family	NN	nmod	I-protein
act	VBP	ROOT	O
synergistically	RB	advmod	O
with	IN	case	O
AP-1	NN	compound	B-protein
(	-LRB-	punct	I-protein
Fos/Jun	NN	compound	I-protein
)	-RRB-	punct	I-protein
proteins	NNS	nmod	I-protein
on	IN	case	O
composite	JJ	amod	O
DNA	NN	compound	O
elements	NNS	nmod	O
which	WDT	nsubj	O
contain	VBP	acl:relcl	O
adjacent	JJ	amod	O
NFAT	NN	compound	B-DNA
and	CC	cc	I-DNA
AP-1	NN	conj	I-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
,	,	punct	O
where	WRB	advmod	O
they	PRP	nsubj	O
form	VBP	advcl	O
highly	RB	advmod	O
stable	JJ	amod	O
ternary	JJ	amod	O
complexes	NNS	dobj	O
to	TO	mark	O
regulate	VB	xcomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
diverse	JJ	amod	O
inducible	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O

Concomitant	JJ	amod	O
induction	NN	nsubj	O
of	IN	case	O
NFAT	NN	nmod	B-protein
and	CC	cc	O
AP-1	NN	conj	B-protein
requires	VBZ	ROOT	O
concerted	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
different	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	nmod	O
:	:	punct	O
calcium/calcineurin	NN	dep	O
,	,	punct	O
which	WDT	nsubj	O
promotes	VBZ	acl:relcl	O
NFAT	NN	compound	O
dephosphorylation	NN	dobj	O
,	,	punct	O
nuclear	JJ	amod	O
translocation	NN	conj	O
and	CC	cc	O
activation	NN	conj	O
;	:	punct	O
and	CC	cc	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
(	-LRB-	punct	I-protein
PKC	NN	appos	I-protein
)	-RRB-	punct	I-protein
/Ras	NN	conj	I-protein
,	,	punct	O
which	WDT	nsubj	O
promotes	VBZ	acl:relcl	O
the	DT	det	O
synthesis	NN	dobj	O
,	,	punct	O
phosphorylation	NN	conj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
Fos	NN	compound	B-protein
and	CC	cc	I-protein
Jun	NN	conj	I-protein
families	NNS	nmod	I-protein
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

A	DT	det	O
fifth	JJ	amod	O
member	NN	nsubj	O
of	IN	case	O
the	DT	det	O
NFAT	NN	compound	B-protein
family	NN	nmod	I-protein
,	,	punct	O
NFAT5	NN	appos	B-protein
,	,	punct	O
controls	VBZ	ROOT	O
the	DT	det	O
cellular	JJ	amod	O
response	NN	dobj	O
to	TO	case	O
osmotic	JJ	amod	O
stress	NN	nmod	O
,	,	punct	O
by	IN	case	O
a	DT	det	O
mechanism	NN	nmod	O
that	WDT	nsubj	O
requires	VBZ	acl:relcl	O
dimer	NN	compound	O
formation	NN	dobj	O
and	CC	cc	O
is	VBZ	cop	O
independent	JJ	conj	O
of	IN	case	O
calcineurin	NN	nmod	B-protein
or	CC	cc	O
of	IN	case	O
interaction	NN	conj	O
with	IN	case	O
AP-1	NN	nmod	B-protein
.	.	punct	O

Pharmacological	JJ	amod	O
interference	NN	nsubj	O
with	IN	case	O
theNFAT	NNP	nmod	O
:	:	punct	O
AP-1	NN	compound	O
interaction	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
useful	JJ	ROOT	O
in	IN	case	O
selective	JJ	amod	O
manipulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

Balanced	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
NFAT	NN	nmod	B-protein
and	CC	cc	O
AP-1	NN	conj	B-protein
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
required	VBN	xcomp	O
for	IN	case	O
productive	JJ	amod	O
immune	JJ	amod	O
responses	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
NFAT	NN	nmod	O
:	:	punct	O
AP-1	NN	compound	O
interactions	NNS	nsubj	O
in	IN	case	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
and	CC	cc	O
biological	JJ	amod	O
processes	NNS	conj	O
remains	VBZ	conj	O
to	TO	mark	O
be	VB	auxpass	O
understood	VBN	xcomp	O
.	.	punct	O

Cytokine	NN	compound	O
production	NN	nsubj	O
by	IN	case	O
Vgamma	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
-T-cell	NN	compound	I-cell_type
subsets	NNS	nmod	I-cell_type
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
factor	NN	ROOT	O
determining	VBG	acl	O
CD4	NN	dobj	O
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
-Th-cell	NN	compound	O
phenotype	NN	dep	O
and	CC	cc	O
susceptibility	NN	conj	O
of	IN	case	O
BALB/c	NN	compound	O
mice	NNS	nmod	O
to	TO	case	O
coxsackievirus	VB	compound	O
B3-induced	JJ	amod	O
myocarditis	NN	nmod	O
.	.	punct	O

Two	CD	nummod	O
coxsackievirus	NN	compound	O
B3	NN	compound	O
(	-LRB-	punct	O
CVB3	NN	appos	O
)	-RRB-	punct	O
variants	NNS	nsubj	O
(	-LRB-	punct	O
H3	NN	dep	O
and	CC	cc	O
H310A1	NN	conj	O
)	-RRB-	punct	O
differ	VBP	ROOT	O
by	IN	case	O
a	DT	det	O
single	JJ	amod	O
amino	NN	compound	O
acid	NN	compound	O
mutation	NN	nmod	O
in	IN	case	O
the	DT	det	O
VP2	NN	compound	B-protein
capsid	NN	compound	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

H3	NN	nsubj	O
induces	VBZ	ROOT	O
severe	JJ	amod	O
myocarditis	NN	dobj	O
in	IN	case	O
BALB/c	NN	compound	O
mice	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
H310A1	NN	nsubj	O
is	VBZ	cop	O
amyocarditic	JJ	conj	O
.	.	punct	O

Infection	NN	nsubj	O
with	IN	case	O
H3	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
H310A1	NN	conj	O
,	,	punct	O
preferentially	RB	advmod	O
activates	VBZ	ROOT	O
Vgamma4	NN	amod	B-cell_type
Vdelta4	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
strongly	RB	advmod	O
positive	JJ	acl:relcl	O
for	IN	case	O
gamma	NN	compound	B-protein
interferon	NN	nmod	I-protein
(	-LRB-	punct	O
IFN-gamma	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
Vgamma1	NN	compound	B-cell_type
Vdelta4	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
increased	VBN	parataxis	O
in	IN	case	O
both	CC	cc:preconj	O
H3	NN	nmod	O
and	CC	cc	O
H310A1	NN	nmod:npmod	O
virus-infected	JJ	amod	O
animals	NNS	conj	O
.	.	punct	O

Depletion	NN	nsubj	O
of	IN	case	O
Vgamma1	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
using	VBG	acl	O
monoclonal	JJ	amod	B-protein
anti-Vgamma1	NN	compound	I-protein
antibody	NN	dobj	I-protein
enhanced	VBD	ROOT	O
myocarditis	NN	dobj	O
and	CC	cc	O
CD4	NN	conj	O
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
-	:	punct	O
,	,	punct	O
IFN-gamma	NN	compound	B-protein
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
-cell	JJ	compound	O
responses	NNS	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
H3-	NN	nmod	O
and	CC	cc	O
H310A1-infected	JJ	conj	O
mice	NNS	dep	O
yet	RB	advmod	O
decreased	VBD	conj	O
the	DT	det	O
CD4	NN	compound	O
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
-	:	punct	O
,	,	punct	O
IL-4	NN	compound	O
(	-LRB-	punct	O
+	CC	dep	O
)	-RRB-	punct	O
-cell	JJ	amod	O
response	NN	dobj	O
.	.	punct	O

Depleting	VBG	advcl	O
Vgamma4	NN	dobj	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nsubj	I-cell_type
suppressed	VBD	ROOT	O
myocarditis	NN	compound	O
and	CC	cc	O
reduced	VBD	amod	O
CD4	NN	conj	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
IFN-gamma	NN	conj	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	dobj	I-cell_type
but	CC	cc	O
increased	VBN	amod	O
CD4	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
IL-4	NN	dep	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
cytokine	NN	compound	O
production	NN	nmod	O
by	IN	case	O
Vgamma1	NN	nmod	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
and	CC	cc	I-cell_type
Vgamma4	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
was	VBD	auxpass	O
investigated	VBN	ROOT	O
by	IN	mark	O
adoptively	RB	advmod	O
transferring	VBG	advcl	O
these	DT	det	O
cells	NNS	dobj	O
isolated	VBN	acl	O
from	IN	case	O
H3-infected	JJ	amod	O
BALB/c	NN	compound	O
Stat4	NN	compound	O
knockout	NN	nmod	O
(	-LRB-	punct	O
Stat4ko	NN	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
defective	JJ	dep	O
in	IN	case	O
IFN-gamma	NN	compound	B-protein
expression	NN	nmod	O
)	-RRB-	punct	O
or	CC	cc	O
BALB/c	NN	compound	O
Stat6ko	NN	compound	O
(	-LRB-	punct	O
defective	JJ	dep	O
in	IN	case	O
IL-4	NN	compound	O
expression	NN	nmod	O
)	-RRB-	punct	O
mice	NNS	conj	O
into	IN	case	O
H3	NN	nmod:npmod	O
virus-infected	JJ	amod	O
wild-type	JJ	amod	O
BALB/c	NN	compound	O
recipients	NNS	nmod	O
.	.	punct	O

Vgamma4	NN	compound	B-cell_type
and	CC	cc	I-cell_type
Vgamma1	NN	conj	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
from	IN	case	O
Stat4ko	JJ	compound	O
mice	NNS	nmod	O
expressed	VBD	ROOT	O
IL-4	NN	dobj	B-protein
but	CC	cc	O
no	DT	conj	O
or	CC	cc	O
minimal	JJ	conj	O
IFN-gamma	NN	conj	B-protein
,	,	punct	O
whereas	IN	dep	O
these	DT	det	O
cell	NN	compound	O
populations	NNS	nsubj	O
derived	VBN	acl	O
from	IN	case	O
Stat6ko	NN	compound	O
mice	NNS	nmod	O
expressed	VBD	parataxis	O
IFN-gamma	NN	dobj	B-protein
but	CC	cc	O
no	DT	neg	O
IL-4	NN	conj	B-protein
.	.	punct	O

Stat4ko	JJ	compound	B-cell_type
Vgamma1	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nsubj	I-cell_type
(	-LRB-	punct	I-cell_type
IL-4	NN	dep	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	nummod	I-cell_type
)	-RRB-	punct	I-cell_type
)	-RRB-	punct	O
suppress	VBP	ROOT	O
myocarditis	NN	dobj	O
.	.	punct	O

Stat6ko	NN	compound	B-cell_type
Vgamma1	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nsubj	I-cell_type
(	-LRB-	punct	I-cell_type
IFN-gamma	NN	dep	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	appos	I-cell_type
)	-RRB-	punct	I-cell_type
)	-RRB-	punct	I-cell_type
were	VBD	cop	O
not	RB	neg	O
inhibitory	JJ	ROOT	O
.	.	punct	O

Stat6ko	NN	compound	B-cell_type
Vgamma4	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nsubj	I-cell_type
(	-LRB-	punct	I-cell_type
IFN-gamma	NN	dep	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	appos	I-cell_type
)	-RRB-	punct	I-cell_type
)	-RRB-	punct	I-cell_type
significantly	RB	advmod	O
enhanced	VBD	ROOT	O
myocarditis	NN	dobj	O
.	.	punct	O

Stat4ko	JJ	nummod	B-cell_type
Vgamma4	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	ROOT	I-cell_type
(	-LRB-	punct	I-cell_type
IL-4	NN	dep	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	nummod	I-cell_type
)	-RRB-	punct	I-cell_type
)	-RRB-	punct	I-cell_type
neither	CC	cc:preconj	O
inhibited	VBD	amod	O
nor	CC	cc	O
enhanced	VBN	conj	O
disease	NN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
distinct	JJ	amod	O
gammadelta-T-cell	NN	compound	B-cell_type
subsets	NNS	nsubj	I-cell_type
control	VBP	ccomp	O
myocarditis	NN	compound	O
susceptibility	NN	dobj	O
and	CC	cc	O
bias	VBZ	conj	O
the	DT	det	O
CD4	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
-Th-cell	NN	compound	I-cell_type
response	NN	dobj	O
.	.	punct	O

The	DT	det	O
cytokines	NNS	nsubj	B-protein
produced	VBN	acl	O
by	IN	case	O
the	DT	det	O
Vgamma	NN	compound	B-cell_type
subpopulation	NN	nmod	I-cell_type
have	VBP	ROOT	O
a	DT	det	O
significant	JJ	amod	O
influence	NN	dobj	O
on	IN	case	O
the	DT	det	O
CD4	NN	compound	B-protein
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
-Th-cell	NN	compound	O
phenotype	NN	nmod	O
.	.	punct	O

Plasmin	NN	compound	B-protein
-induced	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
and	CC	cc	O
tissue	NN	compound	B-protein
factor	NN	conj	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
involves	VBZ	ROOT	O
AP-1	NN	compound	B-protein
and	CC	cc	O
IKKbeta	NN	conj	B-protein
-mediated	JJ	amod	O
NF-kappaB	NN	compound	O
activation	NN	dobj	O
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
plasmin	NN	nsubj	B-protein
activates	VBZ	ccomp	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
monocytes	NNS	dobj	I-cell_type
in	IN	case	O
terms	NNS	nmod	O
of	IN	case	O
lipid	NN	compound	O
mediator	NN	compound	O
release	NN	nmod	O
and	CC	cc	O
chemotactic	JJ	amod	O
migration	NN	conj	O
.	.	punct	O

Here	RB	advmod	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
plasmin	NN	nsubj	B-protein
induces	VBZ	ccomp	O
proinflammatory	JJ	amod	B-protein
cytokine	NN	compound	I-protein
release	NN	dobj	O
and	CC	cc	O
tissue	NN	compound	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	O
TF	NN	appos	B-protein
)	-RRB-	punct	O
expression	NN	conj	O
by	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

Plasmin	NNP	nsubj	B-protein
0.043	CD	quantmod	O
to	TO	quantmod	O
1.43	CD	nummod	O
CTA	NNP	compound	O
U/mL	NN	dobj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
active	JJ	amod	B-protein
site-blocked	JJ	amod	I-protein
plasmin	NN	conj	I-protein
,	,	punct	O
triggered	VBD	ROOT	O
concentration-dependent	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
mRNA	NN	nmod	O
for	IN	case	O
interleukin-1alpha	NN	nmod	B-protein
(	-LRB-	punct	O
IL-1alpha	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
IL-1beta	NN	conj	B-protein
,	,	punct	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	conj	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
TF	NN	conj	B-protein
with	IN	case	O
maximum	JJ	amod	O
responses	NNS	nmod	O
after	IN	case	O
4	CD	nummod	O
hours	NNS	nmod	O
.	.	punct	O

Plasmin	NN	compound	B-protein
-mediated	JJ	amod	O
mRNA	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
concentration-dependent	JJ	amod	O
manner	NN	nmod	O
by	IN	case	O
the	DT	det	O
lysine	NN	compound	O
analogue	NN	compound	O
trans-4-	NN	compound	O
(	-LRB-	punct	O
aminomethyl	NN	appos	O
)	-RRB-	punct	O
cyclohexane-1-carboxylic	JJ	amod	O
acid	NN	nmod	O
(	-LRB-	punct	O
t-AMCA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Increases	NNS	nsubjpass	O
in	IN	case	O
mRNA	NN	compound	O
levels	NNS	nmod	O
were	VBD	auxpass	O
followed	VBN	ROOT	O
by	IN	case	O
concentration-	NN	nmod	O
and	CC	cc	O
time-dependent	JJ	conj	O
release	NN	dep	O
of	IN	case	O
IL-1alpha	NN	nmod	B-protein
,	,	punct	O
IL-1beta	NN	conj	B-protein
and	CC	cc	O
TNF-alpha	NN	conj	B-protein
and	CC	cc	O
by	IN	case	O
TF	NN	compound	B-protein
expression	NN	conj	O
on	IN	case	O
monocyte	NN	compound	O
surfaces	NNS	nmod	O
.	.	punct	O

Neither	DT	cc:preconj	O
cytokines	NNS	nsubjpass	B-protein
nor	CC	cc	O
TF	NN	conj	B-protein
could	MD	aux	O
be	VB	auxpass	O
detected	VBN	ROOT	O
when	WRB	advmod	O
monocytes	NNS	nsubjpass	B-cell_type
were	VBD	auxpass	O
preincubated	VBN	advcl	O
with	IN	case	O
actinomycin	NN	compound	O
D	NN	nmod	O
or	CC	cc	O
cycloheximide	NN	conj	O
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
indicated	VBD	ROOT	O
plasmin	NN	compound	B-protein
-induced	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
;	:	punct	O
DNA-binding	JJ	amod	B-protein
complexes	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
composed	VBN	parataxis	O
of	IN	case	O
p50	NN	nmod	B-protein
,	,	punct	O
p65	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
c-Rel	NN	conj	B-protein
,	,	punct	O
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
supershift	NN	compound	O
experiments	NNS	nmod	O
.	.	punct	O

Nuclear	JJ	amod	O
translocation	NN	nsubj	O
of	IN	case	O
NF-kappaB/Rel	NN	compound	B-protein
proteins	NNS	nmod	I-protein
coincided	VBD	ROOT	O
with	IN	case	O
IkappaBalpha	NN	compound	O
degradation	NN	nmod	O
.	.	punct	O

At	IN	case	O
variance	NN	nmod	O
with	IN	case	O
endotoxic	JJ	amod	O
lipopolysaccharide	NN	nmod	O
,	,	punct	O
plasmin	NN	nsubj	B-protein
elicited	VBD	ROOT	O
the	DT	det	O
rapid	JJ	amod	O
degradation	NN	dobj	O
of	IN	case	O
another	DT	det	O
cytoplasmic	JJ	amod	B-protein
NF-kappaB	NN	compound	I-protein
inhibitor	NN	nmod	I-protein
,	,	punct	I-protein
p105	NN	appos	I-protein
.	.	punct	O

Proteolysis	NN	nsubj	O
of	IN	case	O
NF-kappaB	NN	compound	O
inhibitors	NNS	nmod	O
was	VBD	cop	O
apparently	RB	advmod	O
due	JJ	case	O
to	TO	mwe	O
transient	JJ	amod	O
activation	NN	ROOT	O
of	IN	case	O
IkappaB	NN	compound	B-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	I-protein
IKK	NN	compound	I-protein
)	-RRB-	punct	I-protein
beta	NN	nmod	I-protein
that	WDT	nsubj	O
reached	VBD	acl:relcl	O
maximum	NN	compound	O
activity	NN	dobj	O
at	IN	case	O
1	CD	nummod	O
hour	NN	nmod	O
after	IN	case	O
plasmin	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
AP-1	NN	compound	O
binding	NN	nsubjpass	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
in	IN	case	O
plasmin	NN	compound	B-protein
-treated	JJ	amod	O
monocytes	NNS	nmod	B-cell_type
,	,	punct	O
with	IN	case	O
most	JJS	amod	O
complexes	NNS	nmod	O
composed	VBN	acl	O
of	IN	case	O
JunD	NN	nmod	B-protein
,	,	punct	O
c-Fos	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
FosB	NN	conj	B-protein
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
further	RB	advmod	O
substantiate	VBP	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
plasmin	NN	nmod	B-protein
as	IN	case	O
a	DT	det	O
proinflammatory	JJ	amod	O
activator	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
and	CC	cc	O
reveal	VBP	conj	O
an	DT	det	O
important	JJ	amod	O
new	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
the	DT	det	O
plasminogen-plasmin	JJ	amod	O
system	NN	nmod	O
and	CC	cc	O
inflammation	NN	conj	O
.	.	punct	O

(	-LRB-	punct	O
Blood.	NNP	ROOT	O
2001	CD	nummod	O
;	:	punct	O
97	CD	dep	O
:	:	punct	O
3941-3950	CD	nummod	O
)	-RRB-	punct	O

STAT3	NN	nsubj	B-protein
is	VBZ	cop	O
constitutively	RB	advmod	O
active	JJ	ROOT	O
in	IN	case	O
some	DT	det	O
patients	NNS	nmod	O
with	IN	case	O
Polycythemia	NN	compound	O
rubra	NN	compound	O
vera	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
Polycythemia	NN	compound	O
vera	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
clonal	JJ	amod	O
stem	NN	compound	O
cell	NN	compound	O
disorder	NN	dep	O
characterized	VBN	acl	O
by	IN	case	O
hyperproliferation	NN	nmod	O
of	IN	case	O
the	DT	det	O
erythroid	JJ	amod	B-cell_type
,	,	punct	I-cell_type
myeloid	JJ	conj	I-cell_type
,	,	punct	I-cell_type
and	CC	cc	I-cell_type
megakaryocytic	JJ	conj	I-cell_type
lineages	NNS	nmod	I-cell_type
.	.	punct	O

While	IN	mark	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	advcl	O
that	IN	mark	O
progenitor	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
of	IN	case	O
P.	FW	compound	O
vera	FW	compound	O
patients	NNS	nmod	O
are	VBP	cop	O
hypersensitive	JJ	ccomp	O
to	TO	case	O
several	JJ	amod	O
growth	NN	compound	O
factors	NNS	nmod	O
including	VBG	case	O
erythropoietin	NN	nmod	B-protein
,	,	punct	O
insulin-like	JJ	amod	B-protein
growth	NN	compound	I-protein
factor-1	NN	conj	I-protein
,	,	punct	O
thrombopoietin	NN	conj	B-protein
,	,	punct	O
interleukin-3	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
granulocyte/monocyte	NN	compound	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	conj	I-protein
,	,	punct	O
the	DT	det	O
molecular	JJ	amod	O
pathogenesis	NN	appos	O
of	IN	case	O
this	DT	det	O
disease	NN	nmod	O
remains	VBZ	ROOT	O
unknown	JJ	xcomp	O
.	.	punct	O

Growth	NN	compound	O
factor	NN	compound	O
hypersensitivity	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
therefore	RB	advmod	O
investigated	VBD	ROOT	O
a	DT	det	O
common	JJ	amod	O
downstream	JJ	amod	O
effector	NN	dobj	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
,	,	punct	O
the	DT	det	O
signal	NN	compound	B-protein
transducers	NNS	appos	I-protein
and	CC	cc	I-protein
activators	NNS	compound	I-protein
of	IN	amod	I-protein
transcription	NN	conj	I-protein
(	-LRB-	punct	O
STATs	NNS	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
constitutive	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
STAT	NN	compound	B-protein
factors	NNS	nmod	I-protein
could	MD	aux	O
explain	VB	ROOT	O
the	DT	det	O
increased	VBN	amod	O
proliferation	NN	dobj	O
of	IN	case	O
P.	FW	compound	B-cell_type
vera	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
absence	NN	dep	O
of	IN	case	O
growth	NN	compound	O
factor	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Peripheral	JJ	amod	B-cell_type
granulocytes	NNS	nsubjpass	I-cell_type
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
P.	FW	compound	O
vera	NN	nmod	O
and	CC	cc	O
from	IN	case	O
healthy	JJ	amod	O
volunteers	NNS	conj	O
were	VBD	auxpass	O
assayed	VBN	ROOT	O
for	IN	case	O
STAT1	NN	nmod	B-protein
,	,	punct	I-protein
3	CD	conj	I-protein
,	,	punct	I-protein
and	CC	cc	I-protein
5	CD	nummod	I-protein
DNA	NN	compound	O
binding	NN	conj	O
by	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Four	CD	nsubj	O
of	IN	case	O
14	CD	nummod	O
P.	FW	compound	O
vera	FW	compound	O
patients	NNS	nmod	O
analyzed	VBN	acl	O
showed	VBD	appos	O
constitutive	JJ	amod	O
STAT3	NN	compound	O
DNA	NN	compound	O
binding	NN	dobj	O
in	IN	case	O
unstimulated	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
granulocytes	NNS	nmod	I-cell_type
,	,	punct	O
while	IN	mark	O
none	NN	nsubj	O
of	IN	case	O
the	DT	det	O
17	CD	nummod	O
healthy	JJ	amod	O
volunteers	NNS	nmod	O
tested	VBN	acl	O
did	VBD	advcl	O
.	.	punct	O

None	NN	nsubj	O
of	IN	case	O
the	DT	det	O
subjects	NNS	nmod	O
showed	VBD	ROOT	O
constitutive	JJ	amod	O
STAT1	NN	dobj	B-protein
or	CC	cc	O
STAT5	NN	conj	B-protein
activity	NN	dep	O
.	.	punct	O

Western	NN	compound	O
blotting	NN	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
three	CD	nummod	O
patients	NNS	nmod	O
,	,	punct	O
STAT3	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
constitutively	RB	advmod	O
phosphorylated	VBN	ccomp	O
on	IN	case	O
Tyr	NN	nmod	O
705	CD	nummod	O
,	,	punct	O
whereas	IN	dep	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
unphosphorylated	JJ	parataxis	O
in	IN	case	O
the	DT	det	O
other	JJ	amod	O
patients	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
controls	NNS	conj	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
constitutive	JJ	amod	O
STAT3	NN	compound	B-protein
activity	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
correlate	VB	ROOT	O
with	IN	case	O
the	DT	det	O
duration	NN	nmod	O
of	IN	case	O
disease	NN	nmod	O
or	CC	cc	O
the	DT	det	O
treatment	NN	compound	O
regimen	NNS	conj	O
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
recently	RB	advmod	O
diagnosed	VBN	amod	O
patient	NN	nmod	O
and	CC	cc	O
in	IN	case	O
two	CD	nummod	O
patients	NNS	conj	O
treated	VBN	acl	O
only	RB	advmod	O
with	IN	case	O
phlebotomy	NN	nmod	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	appos	O
that	IN	mark	O
constitutive	JJ	amod	O
phosphorylation	NN	nsubj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
STAT3	NN	nmod	B-protein
is	VBZ	cop	O
not	RB	neg	O
a	DT	det	O
secondary	JJ	amod	O
event	NN	ccomp	O
induced	VBN	acl	O
by	IN	case	O
mutagenizing	VBG	amod	O
agents	NNS	nmod	O
or	CC	cc	O
by	IN	case	O
prolonged	JJ	amod	O
hyperproliferation	NN	conj	O
of	IN	case	O
hematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
but	CC	cc	O
rather	RB	advmod	O
represents	VBZ	conj	O
a	DT	det	O
primary	JJ	amod	O
molecular	JJ	amod	O
aberration	NN	dobj	O
.	.	punct	O

Constitutively	RB	advmod	B-protein
active	JJ	amod	I-protein
STAT3	NN	nsubj	I-protein
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
growth	NN	compound	O
factor	NN	compound	O
hypersensitivity	NN	nmod	O
of	IN	case	O
P.	FW	compound	B-cell_type
vera	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
phosphorylation	NN	compound	B-protein
sites	NNS	nmod	I-protein
for	IN	case	O
Bruton	NNP	nmod:poss	B-protein
's	POS	case	I-protein
tyrosine	NN	compound	I-protein
kinase	NN	nmod	I-protein
within	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	B-protein
regulator	NN	compound	I-protein
BAP/TFII-I	NNP	nmod	I-protein
.	.	punct	O

Bruton	NNP	nmod:poss	B-protein
's	POS	case	I-protein
tyrosine	NN	compound	I-protein
kinase	NN	nsubj	I-protein
(	-LRB-	punct	O
Btk	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
Tec	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	I-protein
cytosolic	JJ	amod	I-protein
kinases	NNS	nmod	I-protein
,	,	punct	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
development	NN	nmod	O
and	CC	cc	O
function	NN	conj	O
.	.	punct	O

BAP/TFII-I	NN	nsubjpass	B-protein
,	,	punct	O
a	DT	det	O
protein	NN	appos	O
implicated	VBN	acl	O
in	IN	case	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
Btk	NN	nmod	B-protein
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
is	VBZ	auxpass	O
transiently	RB	advmod	O
phosphorylated	VBN	conj	O
on	IN	case	O
tyrosine	NN	nmod	O
following	VBG	case	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
receptor	NN	compound	O
engagement	NN	nmod	O
.	.	punct	O

BAP/TFII-I	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
substrate	NN	ROOT	O
for	IN	case	O
Btk	NN	nmod	B-protein
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
is	VBZ	auxpass	O
hyperphosphorylated	VBN	conj	O
on	IN	case	O
tyrosine	NN	nmod	O
upon	IN	case	O
coexpression	NN	nmod	O
with	IN	case	O
Btk	NN	nmod	B-protein
in	IN	case	O
mammalian	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
an	DT	det	O
effort	NN	nmod	O
to	TO	mark	O
understand	VB	acl	O
the	DT	det	O
physiologic	JJ	amod	O
consequences	NNS	dobj	O
of	IN	case	O
BAP/TFII-I	NN	compound	B-protein
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
following	VBG	case	O
B	NN	compound	O
cell	NN	compound	O
receptor	NN	compound	O
stimulation	NN	nmod	O
,	,	punct	O
site-directed	JJ	amod	O
mutagenesis	NN	nsubjpass	O
and	CC	cc	O
phosphopeptide	NN	compound	O
mapping	NN	conj	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
locate	VB	xcomp	O
the	DT	det	O
predominant	JJ	amod	O
sites	NNS	dobj	O
of	IN	case	O
BAP/TFII-I	NN	compound	B-protein
phosphorylation	NN	nmod	O
by	IN	case	O
Btk	NN	nmod	B-protein
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

These	DT	det	O
residues	NNS	nsubjpass	O
,	,	punct	O
Tyr248	NN	appos	O
,	,	punct	O
Tyr357	NN	conj	O
,	,	punct	O
and	CC	cc	O
Tyr462	NN	conj	O
,	,	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
major	JJ	amod	O
sites	NNS	xcomp	O
for	IN	case	O
Btk	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
BAP/TFII-I	NN	nmod	B-protein
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Residues	NNS	nsubjpass	O
Tyr357	NN	dep	O
and	CC	cc	O
Tyr462	NN	conj	O
are	VBP	auxpass	O
contained	VBN	ROOT	O
within	IN	case	O
the	DT	det	O
loop	NN	compound	B-protein
regions	NNS	nmod	I-protein
of	IN	case	O
adjacent	JJ	amod	O
helix-loop-helix-like	JJ	amod	B-protein
repeats	NNS	nmod	I-protein
within	IN	case	O
BAP/TFII-I	NN	nmod	B-protein
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
either	CC	cc:preconj	O
Tyr248	NN	nmod	O
,	,	punct	O
Tyr357	NN	conj	O
,	,	punct	O
or	CC	cc	O
Tyr462	NN	conj	O
to	TO	case	O
phenylalanine	NN	nmod	O
reduced	VBD	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
a	DT	det	O
c-fos	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
relative	JJ	case	O
to	TO	case	O
wild-type	JJ	amod	B-DNA
BAP/TFII-I	NN	nmod	I-DNA
in	IN	case	O
transfected	VBN	amod	O
COS-7	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
consistent	JJ	xcomp	O
with	IN	case	O
the	DT	det	O
interpretation	NN	nmod	O
that	IN	mark	O
phosphorylation	NN	nsubj	O
at	IN	case	O
these	DT	det	O
sites	NNS	nmod	O
contributes	VBZ	ccomp	O
to	TO	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
.	.	punct	O

Phosphorylation	NN	nsubj	O
of	IN	case	O
BAP/TFII-I	NN	nmod	B-protein
by	IN	case	O
Btk	NN	nmod	B-protein
may	MD	aux	O
link	VB	ROOT	O
engagement	NN	dobj	O
of	IN	case	O
receptors	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
surface	NN	compound	O
immunoglobulin	NN	nmod	B-protein
to	TO	case	O
modulation	NN	nmod	O
of	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
interferon	NN	compound	B-protein
consensus	NN	compound	I-protein
sequence	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	nmod	I-protein
induces	VBZ	ROOT	O
potent	JJ	amod	O
immunity	NN	dobj	O
against	IN	case	O
BCR/ABL-induced	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

Mice	NNS	nsubj	O
deficient	JJ	amod	O
in	IN	case	O
the	DT	det	O
interferon	NN	compound	B-protein
consensus	NN	compound	I-protein
sequence	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
ICSBP	NN	appos	B-protein
)	-RRB-	punct	O
develop	VBP	ROOT	O
a	DT	det	O
disease	NN	dobj	O
resembling	VBG	acl	O
chronic	JJ	amod	O
myeloid	JJ	amod	O
leukemia	NN	xcomp	O
(	-LRB-	punct	O
CML	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubjpass	O
in	IN	case	O
humans	NNS	nmod	O
is	VBZ	auxpass	O
caused	VBN	acl:relcl	O
by	IN	case	O
the	DT	det	O
BCR/ABL	NN	compound	B-protein
oncoprotein	NN	nmod	I-protein
.	.	punct	O

Interferon-alpha	NN	nsubj	B-protein
(	-LRB-	punct	O
IFN-alpha	NN	appos	B-protein
)	-RRB-	punct	O
induces	VBZ	ROOT	O
ICSBP	NN	compound	B-protein
expression	NN	dobj	O
and	CC	cc	O
is	VBZ	cop	O
an	DT	det	O
effective	JJ	amod	O
therapy	NN	conj	O
for	IN	case	O
CML	NN	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
examined	VBD	ROOT	O
whether	IN	mark	O
enforced	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
ICSBP	NN	nmod	B-protein
might	MD	aux	O
antagonize	VB	ccomp	O
BCR/ABL-induced	JJ	amod	O
leukemia	NN	dobj	O
;	:	punct	O
results	NNS	nsubj	O
demonstrated	VBD	parataxis	O
that	IN	mark	O
ICSBP-modified	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
generated	VBD	ccomp	O
a	DT	det	O
protective	JJ	amod	O
CD8	NN	compound	O
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
cytotoxic	JJ	amod	O
T-cell	NN	compound	O
response	NN	dobj	O
against	IN	case	O
BCR/ABL-transformed	JJ	amod	B-cell_type
BaF3	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
a	DT	det	O
murine	JJ	amod	O
leukemia	NN	compound	O
model	NN	nmod	O
.	.	punct	O

ICSBP	NN	compound	B-protein
expression	NN	nsubj	O
represents	VBZ	ROOT	O
a	DT	det	O
novel	JJ	amod	O
means	NNS	dobj	O
of	IN	mark	O
stimulating	VBG	acl	O
a	DT	det	O
host	NN	compound	O
immune	JJ	amod	O
response	NN	dobj	O
to	TO	case	O
BCR/ABL	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
leukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
a	DT	det	O
potential	JJ	amod	O
strategy	NN	conj	O
for	IN	case	O
immunotherapy	NN	nmod	O
of	IN	case	O
CML	NN	nmod	O
.	.	punct	O

(	-LRB-	punct	O
Blood.	NNP	ROOT	O
2001	CD	nummod	O
;	:	punct	O
97	CD	dep	O
:	:	punct	O
3491-3497	CD	appos	O
)	-RRB-	punct	O

A	DT	det	O
transcriptional	JJ	amod	O
block	NN	ROOT	O
in	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
at	IN	case	O
the	DT	det	O
-150	CD	nummod	B-DNA
AP-1	NN	compound	I-DNA
site	NN	nmod	I-DNA
in	IN	case	O
effector	NN	compound	B-cell_type
CD8+	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Both	CC	cc:preconj	O
CD4+	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
CD8+	JJ	conj	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
that	WDT	nsubj	O
produce	VBP	acl:relcl	O
IL-2	NN	dobj	B-protein
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
Ag	NN	compound	O
recognition	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
isolated	VBN	ROOT	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
most	JJS	amod	O
effector	NN	compound	B-cell_type
CD8+	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
recovered	VBN	acl	O
after	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
Ag	NN	nmod	B-protein
do	VBP	aux	O
not	RB	neg	O
produce	VB	ROOT	O
sufficient	JJ	amod	O
IL-2	NN	dobj	B-protein
to	TO	mark	O
sustain	VB	xcomp	O
growth	NN	dobj	O
,	,	punct	O
and	CC	cc	O
depend	VB	conj	O
on	IN	case	O
CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
helper	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
for	IN	case	O
this	DT	det	O
obligate	JJ	amod	O
growth	NN	compound	O
factor	NN	nmod	O
.	.	punct	O

IL-2	NN	compound	O
expression	NN	nsubjpass	O
in	IN	case	O
CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
primarily	RB	advmod	O
controlled	VBN	ROOT	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
transcription	NN	nmod	O
,	,	punct	O
but	CC	cc	O
mechanisms	NNS	nsubjpass	O
restricting	VBG	acl	O
IL-2	NN	compound	O
production	NN	dobj	O
in	IN	case	O
CD8+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
elucidated	VBN	conj	O
.	.	punct	O

To	TO	mark	O
evaluate	VB	advcl	O
transcriptional	JJ	amod	O
regulation	NN	dobj	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
CD8+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
we	PRP	nsubj	O
stably	RB	advmod	O
transfected	VBD	ROOT	O
reporter	NN	compound	B-DNA
genes	NNS	dobj	I-DNA
into	IN	case	O
Ag	NN	compound	B-protein
-specific	JJ	amod	O
CD8+	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
clones	NNS	nmod	I-cell_line
.	.	punct	O

CD28+	JJ	amod	B-cell_type
CD8	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
unable	JJ	amod	O
to	TO	mark	O
transcribe	VB	xcomp	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	dobj	I-DNA
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
antigenic	JJ	amod	O
stimulation	NN	nmod	O
had	VBD	ROOT	O
a	DT	det	O
block	NN	dobj	O
in	IN	case	O
transactivation	NN	nmod	O
of	IN	case	O
the	DT	det	O
-150	CD	nummod	B-DNA
CD28	NN	compound	I-DNA
response	NN	compound	I-DNA
element	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
CD28RE	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
/AP-1	NN	compound	I-DNA
site	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
,	,	punct	O
but	CC	cc	O
did	VBD	aux	O
transactivate	VB	conj	O
the	DT	det	O
composite	JJ	amod	O
NFAT/AP-1	NN	dobj	B-DNA
and	CC	cc	I-DNA
OCT/AP-1	NN	conj	I-DNA
sites	NNS	dep	I-DNA
,	,	punct	O
and	CC	cc	O
a	DT	det	O
consensus	NN	compound	B-DNA
AP-1	NN	compound	I-DNA
motif	NN	conj	I-DNA
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
nonconsensus	JJ	amod	B-DNA
-150	CD	nummod	I-DNA
AP-1	NN	compound	I-DNA
site	NN	nmod	I-DNA
to	TO	case	O
a	DT	det	O
consensus	NN	compound	B-DNA
AP-1	NN	compound	I-DNA
site	NN	nmod	I-DNA
,	,	punct	O
or	CC	cc	O
insertion	NN	conj	O
of	IN	case	O
a	DT	det	O
CD28RE/AP-1	NN	compound	B-DNA
consensus	NN	compound	I-DNA
site	NN	nmod	I-DNA
upstream	RB	advmod	O
of	IN	case	O
the	DT	det	O
native	JJ	amod	O
-150	CD	nummod	B-DNA
CD28RE/AP-1	NN	compound	I-DNA
site	NN	nmod	I-DNA
restored	VBD	ROOT	O
transactivation	NN	dobj	O
of	IN	case	O
the	DT	det	O
altered	JJ	amod	O
promoter	NN	nmod	B-DNA
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
defect	NN	nsubj	O
at	IN	case	O
the	DT	det	O
-150	CD	nummod	B-DNA
site	NN	nmod	I-DNA
may	MD	aux	O
reflect	VB	ccomp	O
the	DT	det	O
absence	NN	dobj	O
or	CC	cc	O
inactivity	NN	conj	O
of	IN	case	O
a	DT	det	O
required	VBN	amod	O
factor	NN	nmod	O
rather	RB	cc	O
than	IN	mwe	O
repression	NN	conj	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Stem	NN	compound	B-protein
cell	NN	compound	I-protein
factor	NN	nsubj	I-protein
and	CC	cc	O
interleukin-3	NN	conj	B-protein
induce	VBP	ROOT	O
stepwise	NN	amod	O
generation	NN	dobj	O
of	IN	case	O
erythroid	JJ	amod	B-cell_type
precursor	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
a	DT	det	O
basic	JJ	amod	O
fibroblast	NN	compound	B-protein
growth	NN	compound	I-protein
factor	NN	nmod:npmod	I-protein
-dependent	JJ	amod	O
hematopoietic	JJ	amod	B-cell_line
stem	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	I-cell_line
A-6	NN	appos	I-cell_line
.	.	punct	O

A	DT	det	O
m	NN	amod	O
ultipotent	JJ	amod	B-cell_type
immature	JJ	amod	I-cell_type
myeloid	JJ	amod	I-cell_type
cell	NN	compound	I-cell_type
population	NN	nsubjpass	I-cell_type
was	VBD	auxpass	O
produced	VBN	ROOT	O
from	IN	case	O
a	DT	det	O
basic	JJ	amod	B-protein
fibroblast	NN	compound	I-protein
growth	NN	compound	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	O
bFGF	NN	compound	B-protein
)	-RRB-	punct	O
-dependent	JJ	amod	O
hematopoietic	JJ	amod	B-cell_line
stem	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	I-cell_line
A-6	NN	appos	I-cell_line
,	,	punct	O
when	WRB	advmod	O
cultured	VBN	advcl	O
with	IN	case	O
stem	NN	compound	B-protein
cell	NN	compound	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
SCF	NN	appos	B-protein
)	-RRB-	punct	O
replacing	VBG	acl	O
bFGF	NN	dobj	B-protein
.	.	punct	O

Those	DT	det	O
cells	NNS	nsubj	O
were	VBD	cop	O
positive	JJ	ROOT	O
for	IN	case	O
stem	NN	compound	B-protein
cell	NN	compound	I-protein
markers	NNS	nmod	I-protein
,	,	punct	O
c-kit	NN	appos	B-protein
and	CC	cc	O
CD34	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
a	DT	det	O
myeloid	JJ	amod	B-protein
cell	NN	compound	I-protein
marker	NN	conj	I-protein
,	,	punct	I-protein
F4/80	NNP	advmod	I-protein
.	.	punct	O

Some	DT	det	O
cell	NN	compound	O
fractions	NNS	nsubj	O
were	VBD	cop	O
also	RB	advmod	O
positive	JJ	ROOT	O
for	IN	case	O
Mac-1	NN	nmod	B-protein
,	,	punct	I-protein
a	DT	det	I-protein
macrophage	NN	compound	I-protein
marker	NN	appos	I-protein
or	CC	cc	O
Gr-1	NN	conj	B-protein
,	,	punct	I-protein
a	DT	det	I-protein
granulocytic	JJ	amod	I-protein
maker	NN	conj	I-protein
,	,	punct	O
but	CC	cc	O
negative	JJ	conj	O
for	IN	case	O
an	DT	det	O
erythroid	JJ	amod	B-protein
marker	NN	compound	I-protein
TER119	NN	nmod	I-protein
.	.	punct	O

They	PRP	nsubj	O
also	RB	advmod	O
showed	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
mRNA	NN	nmod	O
for	IN	case	O
the	DT	det	O
myeloid-specific	JJ	amod	B-protein
PU.1	NN	nmod	I-protein
but	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
that	DT	conj	O
for	IN	case	O
the	DT	det	O
erythroid-specific	JJ	amod	B-protein
GATA-1	NN	nmod	I-protein
.	.	punct	O

Among	IN	case	O
various	JJ	amod	O
cytokines	NNS	nmod	B-protein
,	,	punct	O
interleukin-3	NN	nsubj	B-protein
(	-LRB-	punct	O
IL-3	NN	appos	B-protein
)	-RRB-	punct	O
induced	VBD	ROOT	O
erythroid	JJ	amod	B-cell_type
precursor	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
that	WDT	nsubj	O
expressed	VBD	acl:relcl	O
the	DT	det	O
erythroid-specific	JJ	amod	B-protein
GATA-1	NN	dobj	I-protein
and	CC	cc	O
beta-major	JJ	amod	B-protein
globin	NN	conj	I-protein
.	.	punct	O

The	DT	det	O
quantitative	JJ	amod	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
erythroid	JJ	amod	B-cell_type
precursor	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
newly	RB	advmod	O
produced	VBN	ccomp	O
from	IN	case	O
the	DT	det	O
immature	JJ	amod	B-cell_type
myeloid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
cultivation	NN	nmod	O
with	IN	case	O
IL-3	NN	nmod	B-protein
.	.	punct	O

SCF	NN	nsubj	B-protein
and	CC	cc	O
IL-3	NN	conj	B-protein
induced	VBD	ROOT	O
stepwise	NN	amod	O
generation	NN	dobj	O
of	IN	case	O
erythroid	JJ	amod	B-cell_type
precursor	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
an	DT	det	O
A-6	NN	amod	B-cell_line
hematopoietic	JJ	amod	I-cell_line
stem	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

Copyright	NN	dep	O
2001	CD	nummod	O
Academic	NNP	compound	O
Press	NNP	ROOT	O
.	.	punct	O

Distinct	JJ	amod	O
BMI-1	NN	nsubj	B-protein
and	CC	cc	O
EZH2	NN	compound	B-protein
expression	NN	compound	O
patterns	NNS	conj	O
in	IN	case	O
thymocytes	NNS	nmod	B-cell_type
and	CC	cc	O
mature	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
suggest	VBP	ROOT	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
Polycomb	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
human	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

BMI-1	NN	compound	B-protein
and	CC	cc	O
EZH2	NN	compound	B-protein
Polycomb-group	NN	compound	B-protein
(	-LRB-	punct	I-protein
PcG	NN	appos	I-protein
)	-RRB-	punct	I-protein
proteins	NNS	nsubj	I-protein
belong	VBP	ROOT	O
to	TO	case	O
two	CD	nummod	O
distinct	JJ	amod	O
protein	NN	compound	O
complexes	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
hematopoiesis	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
unique	JJ	amod	O
PcG-specific	JJ	amod	O
antisera	NNS	dobj	O
and	CC	cc	O
triple	JJ	amod	O
immunofluorescence	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
mature	JJ	amod	B-cell_type
resting	VBG	amod	I-cell_type
peripheral	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
expressed	VBD	ccomp	O
BMI-1	NN	dobj	B-protein
,	,	punct	O
whereas	IN	dep	O
dividing	VBG	compound	B-cell_type
blasts	NNS	nsubj	I-cell_type
were	VBD	cop	O
EZH2	NN	parataxis	O
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
.	.	punct	O

By	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
subcapsular	JJ	amod	B-cell_type
immature	JJ	amod	I-cell_type
double-negative	JJ	amod	I-cell_type
(	-LRB-	punct	I-cell_type
DN	JJ	dep	I-cell_type
)	-RRB-	punct	I-cell_type
(	-LRB-	punct	I-cell_type
CD4	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
-	:	punct	I-cell_type
)	-RRB-	punct	I-cell_type
/CD8	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
-	:	punct	I-cell_type
)	-RRB-	punct	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
in	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
coexpressed	VBD	ROOT	O
BMI-1	NN	dobj	B-protein
and	CC	cc	O
EZH2	NN	conj	B-protein
or	CC	cc	O
were	VBD	cop	O
BMI-1	NN	nmod:npmod	O
single	JJ	amod	O
positive	JJ	conj	O
.	.	punct	O

Their	PRP$	poss	O
descendants	NNS	nsubj	O
,	,	punct	O
double-positive	JJ	amod	B-cell_type
(	-LRB-	punct	I-cell_type
DP	NN	dep	I-cell_type
;	:	punct	I-cell_type
CD4	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
/CD8	JJ	appos	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
)	-RRB-	punct	I-cell_type
cortical	JJ	amod	I-cell_type
thymocytes	NNS	appos	I-cell_type
,	,	punct	O
expressed	VBD	ROOT	O
EZH2	NN	dobj	B-protein
without	IN	case	O
BMI-1	NN	nmod	B-protein
.	.	punct	O

Most	JJS	amod	O
EZH2	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
DN	JJ	compound	I-cell_type
and	CC	cc	I-cell_type
DP	NN	conj	I-cell_type
thymocytes	NNS	nsubj	I-cell_type
were	VBD	aux	O
dividing	VBG	ROOT	O
,	,	punct	O
while	IN	mark	O
DN	JJ	amod	B-cell_type
BMI-1	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
/EZH2	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
-	:	punct	I-cell_type
)	-RRB-	punct	I-cell_type
thymocytes	NNS	nsubj	I-cell_type
were	VBD	cop	O
resting	VBG	advcl	O
and	CC	cc	O
proliferation	NN	nsubjpass	O
was	VBD	auxpass	O
occasionally	RB	advmod	O
noted	VBN	conj	O
in	IN	case	O
DN	JJ	amod	B-cell_type
BMI-1	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	dep	I-cell_type
)	-RRB-	punct	I-cell_type
/EZH2	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	dep	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Maturation	NN	nsubj	O
of	IN	case	O
DP	NN	compound	B-cell_type
cortical	JJ	amod	I-cell_type
thymocytes	NNS	nmod	I-cell_type
to	TO	case	O
single-positive	JJ	amod	B-cell_type
(	-LRB-	punct	I-cell_type
CD4	NN	dep	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
/CD8	JJ	nmod	I-cell_type
(	-LRB-	punct	I-cell_type
-	:	nummod	I-cell_type
)	-RRB-	punct	I-cell_type
or	CC	cc	O
CD8	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
/CD4	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
-	:	nummod	I-cell_type
)	-RRB-	punct	I-cell_type
)	-RRB-	punct	I-cell_type
medullar	JJ	amod	I-cell_type
thymocytes	NNS	conj	I-cell_type
correlated	VBD	ROOT	O
with	IN	case	O
decreased	VBN	amod	O
detectability	NN	nmod	O
of	IN	case	O
EZH2	NN	nmod	B-protein
and	CC	cc	O
continued	VBD	conj	O
relative	JJ	amod	O
absence	NN	dobj	O
of	IN	case	O
BMI-1	NN	nmod	B-protein
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
BMI-1	NN	compound	B-protein
and	CC	cc	O
EZH2	NN	conj	B-protein
expression	NN	nsubj	O
in	IN	case	O
mature	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	cop	O
mutually	RB	advmod	O
exclusive	JJ	ccomp	O
and	CC	cc	O
linked	VBN	conj	O
to	TO	case	O
proliferation	NN	compound	O
status	NN	nmod	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
this	DT	det	O
pattern	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
yet	RB	advmod	O
established	VBN	conj	O
in	IN	case	O
thymocytes	NNS	nmod	B-cell_type
of	IN	case	O
the	DT	det	O
cortex	NN	nmod	O
and	CC	cc	O
medulla	NN	conj	O
.	.	punct	O

T	NN	nmod:npmod	B-cell_type
cell	NN	nmod:npmod	I-cell_type
stage-specific	JJ	amod	O
PcG	NN	compound	O
expression	NN	compound	O
profiles	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
PcG	NN	compound	B-DNA
genes	NNS	nsubj	I-DNA
contribute	VBP	ccomp	O
to	TO	case	O
regulation	NN	nmod	O
of	IN	case	O
T	NN	compound	O
cell	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

They	PRP	nsubj	O
probably	RB	advmod	O
reflect	VBP	ROOT	O
stabilization	NN	dobj	O
of	IN	case	O
cell	NN	nmod:npmod	O
type-specific	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
irreversibility	NN	conj	O
of	IN	case	O
lineage	NN	compound	O
choice	NN	nmod	O
.	.	punct	O

The	DT	det	O
difference	NN	nsubj	O
in	IN	case	O
PcG	NN	compound	O
expression	NN	nmod	O
between	IN	case	O
medullar	JJ	amod	B-cell_type
thymocytes	NNS	nmod	I-cell_type
and	CC	cc	O
mature	JJ	amod	B-cell_type
interfollicular	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
indicates	VBZ	ROOT	O
that	IN	mark	O
additional	JJ	amod	O
maturation	NN	compound	O
processes	NNS	nsubj	O
occur	VBP	ccomp	O
after	IN	case	O
thymocyte	NN	compound	O
transportation	NN	nmod	O
from	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
.	.	punct	O

Stepwise	JJ	amod	O
lineage	NN	compound	O
restriction	NN	ROOT	O
of	IN	case	O
progenitors	NNS	nmod	B-cell_type
in	IN	case	O
lympho-myelopoiesis	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
has	VBZ	aux	O
long	RB	advmod	O
been	VBN	cop	O
controversial	JJ	ROOT	O
whether	IN	mark	O
hematopoiesis	NN	compound	O
progresses	NNS	ccomp	O
through	IN	case	O
ordered	VBN	amod	O
stages	NNS	nmod	O
of	IN	case	O
determination	NN	nmod	O
as	IN	case	O
in	IN	case	O
embryonic	JJ	amod	O
development	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
is	VBZ	cop	O
due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
absence	NN	ROOT	O
of	IN	case	O
a	DT	det	O
methodology	NN	nmod	O
capable	JJ	amod	O
of	IN	mark	O
exactly	RB	advmod	O
determining	VBG	advcl	O
the	DT	det	O
developmental	JJ	amod	O
potential	NN	dobj	O
of	IN	case	O
hematopoietic	JJ	amod	B-cell_type
stem/progenitor	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
multilineage	NN	compound	O
progenitor	NN	compound	O
(	-LRB-	punct	O
MLP	NN	appos	O
)	-RRB-	punct	O
assay	NN	nsubj	O
enabled	VBD	ROOT	O
us	PRP	dobj	O
to	TO	mark	O
discriminate	VB	xcomp	O
among	IN	case	O
seven	CD	nummod	O
types	NNS	nmod	O
of	IN	case	O
hematopoietic	JJ	amod	O
progenitors	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
multipotent	JJ	amod	O
progenitor	NN	compound	O
p-MTB	NN	acl:relcl	O
(	-LRB-	punct	O
capable	JJ	dep	O
of	IN	mark	O
generating	VBG	advcl	O
myeloid	JJ	amod	B-cell_type
,	,	punct	I-cell_type
T	NN	conj	I-cell_type
and	CC	cc	I-cell_type
B	NN	conj	I-cell_type
cells	NNS	dobj	I-cell_type
)	-RRB-	punct	O
,	,	punct	O
bipotent	JJ	amod	O
progenitors	NNS	appos	O
p-MT	NN	dep	O
,	,	punct	O
p-MB	NN	conj	O
and	CC	cc	O
p-TB	NN	conj	O
,	,	punct	O
and	CC	cc	O
unipotent	JJ	amod	O
progenitors	NNS	compound	O
p-M	NN	conj	O
,	,	punct	O
p-T	NN	conj	O
and	CC	cc	O
p-B	NN	conj	O
.	.	punct	O

Among	IN	case	O
these	DT	det	O
seven	CD	nummod	O
types	NNS	nmod	O
,	,	punct	O
the	DT	det	O
p-TB	NN	amod	O
type	NN	compound	O
progenitor	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
absent	JJ	xcomp	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
process	NN	nsubj	O
of	IN	case	O
lineage	NN	compound	O
commitment	NN	nmod	O
proceeds	VBZ	ccomp	O
through	IN	case	O
an	DT	det	O
ordered	VBN	nmod	O
but	CC	cc	O
not	RB	cc	O
random	JJ	amod	O
process	NN	dep	O
.	.	punct	O

By	IN	prep	O
extending	VBG	pcomp	O
the	DT	det	O
area	NN	dobj	O
of	IN	prep	O
investigation	NN	pobj	O
to	TO	mark	O
include	VB	advcl	O
the	DT	det	O
erythroid	JJ	amod	B-cell_type
lineage	NN	dobj	I-cell_type
,	,	punct	O
more	RBR	advmod	O
convincing	VBG	amod	O
evidence	NN	nsubjpass	O
for	IN	case	O
the	DT	det	O
ordered	VBN	amod	O
process	NN	nmod	O
was	VBD	auxpass	O
obtained	VBN	ROOT	O
.	.	punct	O

Detailed	JJ	amod	O
and	CC	cc	O
exact	JJ	conj	O
illustration	NN	nsubj	O
of	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
hematopoiesis	NN	nmod	O
will	MD	aux	O
provide	VB	ROOT	O
an	DT	det	O
opportunity	NN	dobj	O
to	TO	case	O
revive	JJ	amod	O
hematopoiesis	NN	nmod	O
as	IN	case	O
one	CD	nmod	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
fascinating	JJ	amod	O
targets	NNS	nmod	O
of	IN	case	O
research	NN	nmod	O
in	IN	prep	O
developmental	JJ	amod	O
biology	NN	pobj	O

Epstein-Barr	JJ	amod	O
Virus	NNP	nsubj	O
and	CC	cc	O
its	PRP$	nmod:poss	O
glycoprotein-350	NN	conj	B-protein
upregulate	VBP	ROOT	O
IL-6	NN	dobj	B-protein
in	IN	case	O
human	JJ	amod	B-cell_type
B-lymphocytes	NNS	nmod	I-cell_type
via	IN	case	O
CD21	NN	nmod	B-protein
,	,	punct	O
involving	VBG	advcl	O
activation	NN	dobj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
and	CC	cc	O
different	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	conj	O
.	.	punct	O

Epstein-Barr	JJ	amod	O
virus	NN	nsubj	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
ubiquitous	JJ	amod	O
and	CC	cc	O
highly	RB	advmod	O
immunotropic	JJ	conj	O
gamma	NN	compound	O
herpesvirus	NN	ROOT	O
that	WDT	nsubj	O
infects	VBZ	acl:relcl	O
more	JJR	amod	O
than	IN	quantmod	O
90	CD	nummod	O
%	NN	dobj	O
of	IN	case	O
humans	NNS	nmod	O
worldwide	VBP	advmod	O
.	.	punct	O

Its	PRP$	nmod:poss	O
pathogenicity	NN	nsubj	O
leads	VBZ	ROOT	O
to	TO	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
diseases	NNS	nmod	O
including	VBG	case	O
tumors	NNS	nmod	O
that	WDT	nsubj	O
result	VBP	acl:relcl	O
from	IN	case	O
EBV	NN	nmod:poss	O
's	POS	case	O
ability	NN	nmod	O
to	TO	mark	O
readily	RB	advmod	O
transform	VB	acl	O
B-lymphocytes	NNS	dobj	B-cell_type
and	CC	cc	O
,	,	punct	O
to	TO	case	O
a	DT	det	O
lesser	JJR	amod	O
extent	NN	conj	O
,	,	punct	O
epithelial	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

EBV	NN	nsubj	O
utilizes	VBZ	ROOT	O
CD21/CR2	NN	dobj	B-protein
as	IN	case	O
its	PRP$	nmod:poss	O
receptor	NN	nmod	O
on	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	mark	O
initiate	VB	advcl	O
the	DT	det	O
infection	NN	compound	O
process	NN	dobj	O
.	.	punct	O

EBV	NN	nsubj	O
binds	VBZ	ROOT	O
to	TO	case	O
CR2	NN	nmod	B-protein
through	IN	case	O
its	PRP$	nmod:poss	O
major	JJ	amod	B-protein
envelope	NN	compound	I-protein
glycoprotein-350	NN	nmod	I-protein
(	-LRB-	punct	O
gp350	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
is	VBZ	cop	O
also	RB	advmod	O
a	DT	det	O
remarkable	JJ	amod	O
immunomodulating	NN	amod	O
agent	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
had	VBD	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
EBV	NN	nsubj	O
is	VBZ	cop	O
capable	JJ	ccomp	O
of	IN	mark	O
modulating	VBG	advcl	O
the	DT	det	O
synthesis	NN	dobj	O
of	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
while	IN	mark	O
both	CC	cc:preconj	O
purified	VBN	amod	O
recombinant	JJ	amod	B-protein
gp350	NN	nsubj	I-protein
(	-LRB-	punct	O
rgp350	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
EBV	NN	conj	O
upregulate	VBP	advcl	O
IL-6	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
synthesis	NN	dobj	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
EBV-induced	JJ	amod	O
IL-6	NN	compound	O
gene	NN	compound	O
activation	NN	nsubj	O
occurs	VBZ	ccomp	O
for	IN	case	O
a	DT	det	O
significantly	RB	advmod	O
longer	JJR	amod	O
period	NN	nmod	O
of	IN	case	O
time	NN	nmod	O
(	-LRB-	punct	O
i.e.	FW	advmod	O
12	CD	nummod	O
hours	NNS	dep	O
for	IN	case	O
EBV	NN	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
6	CD	nummod	O
hours	NNS	nmod	O
for	IN	case	O
rgp350	NN	nmod	B-protein
)	-RRB-	punct	O
.	.	punct	O

Moreover	RB	ROOT	O
,	,	punct	O
the	DT	det	O
half-life	NN	nsubj	O
of	IN	case	O
EBV-induced	JJ	amod	O
IL-6	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
was	VBD	cop	O
also	RB	advmod	O
significantly	RB	advmod	O
longer	JJR	intj	O
(	-LRB-	punct	O
10	CD	nummod	O
hours	NNS	dep	O
)	-RRB-	punct	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
mRNA	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
rgp350	NN	nmod	B-protein
(	-LRB-	punct	O
about	RB	advmod	O
6	CD	nummod	O
hours	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

Both	CC	cc:preconj	O
EBV	NN	nsubj	O
and	CC	cc	O
gp350	NN	conj	B-protein
enhance	VBP	ROOT	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
band-shift	NN	amod	O
and	CC	cc	O
augment	VBP	conj	O
NF-kappaB	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
a	DT	det	O
CAT	NN	compound	B-DNA
reporter	NN	compound	I-DNA
plasmid	NN	nmod	I-DNA
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
while	IN	mark	O
the	DT	det	O
activation	NN	nsubjpass	O
of	IN	case	O
IL-6	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
gp350	NN	nmod	B-protein
is	VBZ	auxpass	O
mediated	VBN	advcl	O
primarily	RB	advmod	O
by	IN	case	O
the	DT	det	O
protein	NN	compound	O
kinase	NN	compound	O
C	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
EBV	NN	nsubj	O
can	MD	aux	O
mediate	VB	ccomp	O
its	PRP$	nmod:poss	O
effects	NNS	dobj	O
through	IN	case	O
multiple	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O

To	TO	prep	O
our	PRP$	poss	O
knowledge	NN	pobj	O
this	DT	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
first	JJ	amod	O
report	NN	attr	O
showing	VBG	acl	O
that	IN	mark	O
the	DT	det	O
binding	NN	nsubj	O
of	IN	case	O
a	DT	det	O
herpesvirus	NN	compound	B-protein
envelope	NN	compound	I-protein
glycoprotein	NN	nmod	I-protein
to	TO	case	O
CR2	NN	nmod	B-protein
on	IN	case	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
results	VBZ	ccomp	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
leading	VBG	acl	O
to	TO	case	O
the	DT	det	O
upregulation	NN	nmod	O
of	IN	case	O
IL-6	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
these	DT	det	O
lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

Copyright	NN	dep	O
2001	CD	nummod	O
Academic	NNP	compound	O
Press	NNP	ROOT	O
.	.	punct	O

Gene-	NN	ROOT	O
and	CC	cc	O
tissue-specificity	NN	conj	O
of	IN	case	O
mutation	NN	nmod	O
in	IN	case	O
Big	NNP	compound	O
Blue	NNP	compound	O
rats	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
the	DT	det	O
hepatocarcinogen	NN	compound	O
N-hydroxy-2-acetylaminofluorene	NN	nmod	O
.	.	punct	O

In	IN	case	O
a	DT	det	O
previous	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
treating	VBG	csubj	O
transgenic	JJ	amod	O
Big	NNP	compound	O
Blue	NNP	compound	O
rats	NNS	dobj	O
with	IN	case	O
the	DT	det	O
hepatocarcinogen	NN	compound	O
N-hydroxy-2-acetylaminofluorene	NN	nmod	O
(	-LRB-	punct	O
N-OH-AAF	NN	appos	O
)	-RRB-	punct	O
produced	VBD	ccomp	O
the	DT	det	O
same	JJ	amod	O
major	JJ	amod	O
DNA	NN	compound	O
adduct	NN	dobj	O
in	IN	case	O
the	DT	det	O
target	NN	compound	O
liver	NN	nmod	O
and	CC	cc	O
the	DT	det	O
nontarget	NN	compound	B-cell_type
spleen	NN	compound	I-cell_type
lymphocytes	NNS	conj	I-cell_type
and	CC	cc	O
bone	NN	compound	B-cell_type
marrow	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
induced	VBD	amod	O
lacI	NN	compound	B-cell_type
mutants	NNS	dobj	I-cell_type
in	IN	case	O
the	DT	det	O
liver	NN	nmod	O
,	,	punct	O
and	CC	cc	O
induced	VBN	conj	O
much	RB	advmod	O
lower	JJR	amod	O
frequencies	NNS	dobj	O
of	IN	case	O
l	NN	amod	O
acI	NN	compound	B-cell_type
and	CC	cc	I-cell_type
hprt	NN	conj	I-cell_type
mutants	NNS	nmod	I-cell_type
in	IN	case	O
spleen	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
sequence	NN	compound	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
conducted	VBN	ROOT	O
on	IN	case	O
lacI	NN	compound	B-DNA
DNA	NN	nmod	I-DNA
and	CC	cc	O
hprt	NN	amod	B-DNA
cDNA	NN	conj	I-DNA
from	IN	case	O
the	DT	det	O
mutants	NNS	nmod	O
,	,	punct	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
mutational	JJ	amod	O
specificity	NN	dobj	O
of	IN	case	O
N-OH-AAF	NN	nmod	O
in	IN	case	O
the	DT	det	O
rat	NN	nmod	O
.	.	punct	O

All	PDT	predet	O
the	DT	det	O
mutation	NN	compound	O
spectra	NNS	nsubj	O
from	IN	case	O
N-OH-AAF-treated	JJ	amod	O
rats	NNS	nmod	O
differed	VBD	ROOT	O
significantly	RB	advmod	O
from	IN	case	O
corresponding	VBG	amod	O
mutation	NN	compound	O
profiles	NNS	nmod	O
from	IN	case	O
untreated	JJ	amod	O
animals	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0.02	CD	dobj	O
to	TO	case	O
P	NN	nmod	O
<	-LRB-	dep	O
0.0001	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

Although	IN	mark	O
there	EX	expl	O
were	VBD	advcl	O
similarities	NNS	nsubj	O
among	IN	case	O
the	DT	det	O
mutational	JJ	amod	O
patterns	NNS	nmod	O
derived	VBN	acl	O
from	IN	case	O
N-OH-AAF-treated	JJ	amod	O
rats	NNS	nmod	O
(	-LRB-	punct	O
e.g.	FW	dep	O
,	,	punct	O
G	NN	compound	O
:	:	punct	O
C	NN	dep	O
--	:	punct	O
>	NN	amod	O
T	NN	appos	O
:	:	punct	O
A	DT	det	O
transversion	NN	nsubj	O
was	VBD	ccomp	O
the	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
mutation	NN	attr	O
in	IN	case	O
all	DT	det	O
mutation	NN	compound	O
sets	NNS	nmod	O
)	-RRB-	punct	O
,	,	punct	O
there	EX	expl	O
were	VBD	ROOT	O
significant	JJ	amod	O
differences	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
patterns	NNS	nmod	O
of	IN	case	O
basepair	NN	compound	O
substitution	NN	nmod	O
and	CC	cc	O
frameshift	NN	compound	O
mutation	NN	conj	O
between	IN	case	O
the	DT	dep	O
liver	NN	nmod	O
and	CC	cc	O
spleen	NN	conj	B-cell_type
lymphocyte	NN	compound	I-cell_type
lacI	NN	compound	I-cell_type
mutants	NNS	dep	I-cell_type
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0.02	CD	dobj	O
)	-RRB-	punct	O
and	CC	cc	O
between	IN	case	O
the	DT	det	O
spleen	NN	compound	B-cell_type
lymphocyte	NN	compound	I-cell_type
lacI	NN	conj	B-cell_type
and	CC	cc	I-cell_type
hprt	NN	conj	I-cell_type
mutants	NNS	dep	I-cell_type
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0.04	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Also	RB	advmod	O
,	,	punct	O
multiplex	JJ	amod	O
PCR	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
genomic	JJ	amod	B-DNA
DNA	NN	nmod	I-DNA
from	IN	case	O
the	DT	det	O
hprt	NN	amod	B-cell_type
mutants	NNS	nmod	I-cell_type
indicated	VBD	ROOT	O
that	IN	mark	O
12	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
mutants	NNS	nmod	O
from	IN	case	O
treated	VBN	amod	O
rats	NNS	nmod	O
had	VBD	ccomp	O
major	JJ	amod	O
deletions	NNS	dobj	O
in	IN	case	O
the	DT	det	O
hprt	NN	amod	B-DNA
gene	NN	nmod	I-DNA
;	:	punct	O
no	DT	neg	O
corresponding	JJ	amod	O
incidence	NN	nsubj	O
of	IN	case	O
large	JJ	amod	O
deletions	NNS	nmod	O
was	VBD	cop	O
evident	JJ	parataxis	O
among	IN	case	O
lacI	NN	compound	O
mutations	NNS	nmod	O
.	.	punct	O

All	PDT	det:predet	O
the	DT	det	O
mutation	NN	compound	O
profiles	NNS	nsubj	O
reflect	VBP	ROOT	O
the	DT	det	O
general	JJ	amod	O
mutational	JJ	amod	O
specificity	NN	dobj	O
of	IN	case	O
the	DT	det	O
major	JJ	amod	O
DNA	NN	compound	O
adduct	NN	nmod	O
formed	VBN	acl	O
by	IN	case	O
N-OH-AAF	NN	nmod	O
.	.	punct	O

The	DT	det	O
differences	NNS	nsubjpass	O
between	IN	case	O
N-OH-AAF	NN	amod	O
mutation	NN	nmod	O
in	IN	case	O
the	DT	det	O
endogenous	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
and	CC	cc	O
transgene	NN	conj	B-DNA
can	MD	aux	O
be	VB	auxpass	O
partially	RB	advmod	O
explained	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
structures	NNS	nmod	O
of	IN	case	O
the	DT	det	O
two	CD	nummod	O
genes	NNS	nmod	O
.	.	punct	O

The	DT	det	O
tissue-specificity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
mutation	NN	compound	O
spectra	NNS	nmod	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	mark	O
targeting	VBG	xcomp	O
tumor	NN	compound	O
formation	NN	dobj	O
to	TO	case	O
the	DT	det	O
liver	NN	nmod	O
.	.	punct	O

Environ.	NNP	compound	O
Mol.	NNP	compound	O
Mutagen.	NNP	ROOT	O
37	CD	nummod	O
:	:	punct	O
203-214	CD	nummod	O
,	,	punct	O
2001	CD	appos	O
.	.	punct	O

Published	VBN	compound	O
2001	CD	nummod	O
Wiley-Liss	NNP	compound	O
,	,	punct	O
Inc	NNP	ROOT	O
.	.	punct	O

Caspase	NN	compound	B-protein
-dependent	JJ	amod	O
cleavage	NN	nsubj	O
of	IN	case	O
the	DT	det	O
hematopoietic	JJ	amod	B-protein
specific	JJ	amod	I-protein
adaptor	NN	compound	I-protein
protein	NN	compound	I-protein
Gads	NNS	nmod	I-protein
alters	VBZ	ROOT	O
signalling	VBG	xcomp	O
from	IN	case	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Gads	NNS	nsubj	B-protein
is	VBZ	ROOT	O
a	DT	det	O
SH2	NN	compound	B-protein
and	CC	cc	I-protein
SH3	NN	conj	I-protein
domain	NN	compound	I-protein
-containing	JJ	conj	O
,	,	punct	O
hematopoietic-specific	JJ	amod	B-protein
adaptor	NN	compound	I-protein
protein	NN	attr	I-protein
that	WDT	nsubj	O
functions	VBZ	relcl	O
in	IN	mark	O
signalling	NN	advcl	O
from	IN	case	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Gads	NNS	nsubj	B-protein
acts	VBZ	ROOT	O
by	IN	prep	O
linking	VBG	pcomp	O
SLP-76	NN	dobj	B-protein
,	,	punct	O
bound	VBN	advcl	O
by	IN	case	O
the	DT	det	O
carboxy-terminal	JJ	amod	B-protein
Gads	NNS	compound	I-protein
SH3	NN	compound	I-protein
domain	NN	nmod	I-protein
,	,	punct	O
to	TO	case	O
tyrosine	NN	compound	B-protein
phosphorylated	JJ	amod	I-protein
LAT	NN	nmod	I-protein
which	WDT	nsubj	O
contains	VBZ	acl:relcl	O
binding	VBG	amod	O
sites	NNS	dobj	O
for	IN	case	O
the	DT	det	O
Gads	NN	compound	B-protein
SH2	NN	compound	I-protein
domain	NN	nmod	I-protein
.	.	punct	O

Gads	NNP	nsubjpass	B-protein
is	VBZ	auxpass	O
distinguished	VBN	ROOT	O
from	IN	case	O
Grb2	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
closely	RB	advmod	O
related	JJ	amod	O
Grap	NN	compound	B-protein
protein	NN	conj	I-protein
by	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
a	DT	det	O
120	CD	nummod	B-protein
amino	NN	compound	I-protein
acid	NN	compound	I-protein
unique	JJ	amod	I-protein
region	NN	nmod	I-protein
between	IN	case	O
the	DT	det	O
SH2	NN	compound	B-protein
domain	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
carboxy	JJ	compound	B-protein
terminal	JJ	amod	I-protein
SH3	NN	compound	I-protein
domain	NN	conj	I-protein
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
unique	JJ	amod	O
region	NN	nsubj	O
of	IN	case	O
Gads	NNP	nmod	B-protein
contains	VBZ	ccomp	O
a	DT	det	O
capase	NN	compound	B-protein
cleavage	NN	compound	I-protein
site	NN	dobj	I-protein
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
apoptosis	NN	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
results	VBZ	ROOT	O
in	IN	case	O
detectable	JJ	amod	O
Gads	NNS	compound	B-protein
cleavage	NN	nmod	O
by	IN	case	O
60	CD	nummod	O
min	NN	nmod	O
.	.	punct	O

Gads	JJ	compound	B-protein
cleavage	NN	nsubjpass	O
is	VBZ	auxpass	O
blocked	VBN	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
by	IN	mark	O
treating	VBG	advcl	O
cells	NNS	dobj	O
with	IN	case	O
a	DT	det	O
caspase	NN	compound	O
3	CD	nummod	O
inhibitor	NN	nmod	O
.	.	punct	O

A	DT	det	O
putative	JJ	amod	B-protein
caspase	NN	compound	I-protein
3	CD	nummod	I-protein
cleavage	NN	compound	I-protein
site	NN	nsubjpass	I-protein
was	VBD	auxpass	O
identified	VBN	ROOT	O
within	IN	case	O
the	DT	det	O
unique	JJ	amod	O
region	NN	nmod	O
and	CC	cc	O
mutation	NN	conj	O
of	IN	case	O
this	DT	det	O
site	NN	nmod	O
prevented	VBD	conj	O
Gads	NNS	compound	B-protein
cleavage	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
and	CC	cc	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
Gads	JJ	compound	B-protein
cleavage	NN	compound	O
products	NNS	nsubj	O
retained	VBD	ROOT	O
the	DT	det	O
predicted	VBN	amod	O
binding	NN	compound	O
specificity	NN	dobj	O
for	IN	case	O
SLP-76	NN	nmod	B-protein
and	CC	cc	O
LAT	NN	conj	B-protein
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Gads	JJ	compound	B-protein
cleavage	NN	compound	O
products	NNS	nmod	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
inhibited	VBD	ROOT	O
NFAT	NN	compound	O
activation	NN	dobj	O
following	VBG	case	O
TCR	NN	compound	O
cross	NN	compound	O
linking	VBG	advcl	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
cleavage	NN	nsubj	O
of	IN	case	O
Gads	NNS	nmod	B-protein
in	FW	compound	O
vivo	FW	advmod	O
could	MD	aux	O
function	VB	ccomp	O
to	TO	mark	O
alter	VB	xcomp	O
signalling	NN	xcomp	O
downstream	RB	advmod	O
of	IN	case	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	nmod	I-protein
by	IN	mark	O
disrupting	VBG	advcl	O
cross	JJ	compound	O
talk	NN	dobj	O
between	IN	case	O
SLP-76	NN	nmod	B-protein
and	CC	cc	O
LAT	NN	conj	B-protein
.	.	punct	O

Targeting	NN	ROOT	O
of	IN	case	O
p300	NN	nmod	B-protein
to	TO	case	O
the	DT	det	O
interleukin-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
via	IN	case	O
CREB-Rel	NN	compound	O
cross-talk	NN	nmod	O
during	IN	case	O
mitogen	NN	nmod	B-protein
and	CC	cc	O
oncogenic	JJ	amod	O
molecular	JJ	amod	O
signaling	NN	conj	O
in	IN	case	O
activated	VBN	amod	B-cell_type
T-cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
explore	VBP	ROOT	O
the	DT	det	O
mechanisms	NNS	dobj	O
of	IN	case	O
targeting	NN	nmod	O
of	IN	case	O
p300	NN	nmod	B-protein
to	TO	case	O
the	DT	det	O
interleukin-2	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
IL-2	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
response	NN	dep	O
to	TO	case	O
mitogenic	JJ	amod	O
and	CC	cc	O
oncogenic	JJ	conj	O
molecular	JJ	amod	O
signals	NNS	nmod	O
.	.	punct	O

Recruitment	NN	nsubj	O
of	IN	case	O
p300	NN	nmod	B-protein
by	IN	case	O
cAMP-responsive	JJ	amod	B-protein
element-binding	JJ	amod	I-protein
protein-Rel	NN	amod	I-protein
cross-talk	NN	nmod	O
at	IN	case	O
the	DT	det	O
composite	JJ	amod	B-protein
CD28	NN	compound	I-protein
response	NN	compound	I-protein
element	NN	compound	I-protein
(	-LRB-	punct	O
CD28RE	NN	compound	B-protein
)	-RRB-	punct	O
-	:	punct	O
TRE	NN	compound	B-DNA
element	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
promoter	NN	compound	O
inducibility	NN	nmod	O
during	IN	case	O
T-cell	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
CD28RE-TRE	NN	nsubj	B-DNA
is	VBZ	cop	O
the	DT	det	O
exclusive	JJ	amod	O
target	NN	conj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_type
T-cell	NN	compound	I-cell_type
lymphotropic	JJ	amod	O
virus	NN	compound	O
type	NN	compound	O
I	CD	nummod	O
oncoprotein	NN	compound	B-protein
Tax	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
intrinsic	JJ	amod	O
histone	NN	compound	O
acetyltransferase	NN	compound	O
activity	NN	nsubj	O
of	IN	case	O
p300	NN	nmod	B-protein
is	VBZ	cop	O
dispensable	JJ	ROOT	O
for	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
the	DT	det	O
N-terminal	JJ	amod	B-protein
743	CD	nummod	I-protein
residues	NNS	nsubj	I-protein
contain	VBP	conj	O
the	DT	det	O
minimal	JJ	amod	O
structural	JJ	amod	O
requirements	NNS	dobj	O
for	IN	case	O
synergistic	JJ	amod	O
transactivation	NN	nmod	O
of	IN	case	O
the	DT	det	O
CD28RE-TRE	NN	nmod	B-DNA
,	,	punct	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	appos	I-DNA
,	,	punct	O
and	CC	cc	O
endogenous	JJ	amod	O
IL-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	conj	O
.	.	punct	O

Mutational	JJ	amod	O
analysis	NN	nsubj	O
of	IN	case	O
p300	NN	nmod	B-protein
reveals	VBZ	ROOT	O
differential	JJ	amod	O
structural	JJ	amod	O
requirements	NNS	dobj	O
for	IN	case	O
the	DT	det	O
N-terminal	JJ	amod	O
p300	NN	compound	O
module	NN	nmod	O
by	IN	case	O
individual	JJ	amod	O
cis-elements	NNS	nmod	B-DNA
within	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
p300	NN	compound	B-protein
assembles	NNS	ccomp	O
at	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
to	TO	mark	O
form	VB	acl	O
an	DT	det	O
enhanceosome-like	JJ	amod	O
signal	NN	compound	O
transduction	NN	compound	O
target	NN	dobj	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
centrally	RB	advmod	O
integrated	VBN	acl:relcl	O
at	IN	case	O
the	DT	det	O
CD28RE-TRE	JJ	compound	B-DNA
element	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
through	IN	case	O
specific	JJ	amod	O
protein	NN	nmod:npmod	O
module-targeted	JJ	amod	O
associations	NNS	nmod	O
in	IN	case	O
activated	VBN	amod	B-cell_type
T-cells	NNS	nmod	I-cell_type
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
cytokine	NN	compound	O
production	NN	nmod	O
in	IN	case	O
T-cell	NN	compound	B-cell_type
responses	NNS	nmod	O
to	TO	case	O
inhalant	JJ	amod	O
allergen	NN	nmod	O
:	:	punct	O
GATA-3	NN	compound	B-protein
expression	NN	nsubj	O
distinguishes	VBZ	dep	O
between	IN	case	O
Th1-	NN	nmod	O
and	CC	cc	O
Th2-polarized	JJ	conj	O
immunity	NN	dep	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
precise	JJ	amod	O
nature	NN	nsubj	O
of	IN	case	O
allergen-specific	JJ	amod	O
cytokine	NN	compound	O
responses	NNS	nmod	O
in	IN	case	O
atopics	NNS	nmod	O
versus	CC	cc	O
non-atopics	NN	conj	O
,	,	punct	O
in	IN	case	O
particular	JJ	amod	O
the	DT	det	O
'Th1	NN	amod	O
polarity	NN	appos	O
'	''	punct	O
of	IN	case	O
responses	NNS	nmod	O
in	IN	case	O
non-atopics	NN	nmod	O
,	,	punct	O
remains	VBZ	appos	O
controversial	JJ	xcomp	O
.	.	punct	O

This	DT	nsubj	O
is	VBZ	cop	O
due	JJ	acomp	O
in	IN	case	O
part	NN	nmod	O
to	TO	case	O
the	DT	det	O
relative	JJ	amod	O
insensitivity	NN	ROOT	O
of	IN	case	O
cytokine	NN	compound	O
detection	NN	compound	O
systems	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
associated	VBN	amod	O
variations	NNS	conj	O
in	IN	case	O
kinetics	NNS	nmod	O
of	IN	case	O
cytokine	NN	compound	O
production	NN	nmod	O
and	CC	cc	O
catabolism	NN	conj	O
in	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
culture	NN	compound	O
systems	NNS	nmod	O
.	.	punct	O

As	IN	case	O
an	DT	det	O
alternative	NN	nmod	O
to	TO	case	O
cytokine	NN	compound	O
measurement	NN	nmod	O
,	,	punct	O
this	DT	det	O
study	NN	nsubj	O
focuses	VBZ	ROOT	O
on	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
GATA-3	NN	nmod	I-protein
for	IN	case	O
analysis	NN	nmod	O
of	IN	case	O
allergen-specific	JJ	amod	O
Th	NN	compound	O
cell	NN	compound	O
responses	NNS	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Cord	NN	compound	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
were	VBD	cop	O
Th1-	NN	dep	O
or	CC	cc	O
Th2-polarized	JJ	conj	O
by	IN	case	O
culture	NN	nmod	O
in	IN	case	O
IL-12-	NN	nmod	O
or	CC	cc	O
IL-4-employing	JJ	amod	O
established	JJ	amod	O
methods	NNS	conj	O
;	:	punct	O
PBMC	NN	nsubjpass	B-cell_type
from	IN	case	O
house	NN	compound	O
dust	NN	amod	O
mite	JJ	compound	O
(	-LRB-	punct	O
HDM	NN	compound	O
)	-RRB-	punct	O
-sensitive	JJ	amod	O
atopics	NNS	nmod	O
and	CC	cc	O
controls	NNS	conj	O
were	VBD	auxpass	O
stimulated	VBN	parataxis	O
overnight	RB	advmod	O
with	IN	case	O
HDM	NN	nmod	O
;	:	punct	O
cytokine	NN	compound	O
production	NN	nsubjpass	O
was	VBD	auxpass	O
measured	VBN	parataxis	O
by	IN	case	O
ELISA	NN	nmod	O
and	CC	cc	O
GATA-3	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	conj	O
by	IN	case	O
PCR	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Cytokine	NN	nmod:npmod	B-protein
-driven	JJ	amod	O
Th2	NN	compound	O
polarization	NN	nsubjpass	O
of	IN	case	O
naive	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
associated	VBN	dep	O
with	IN	case	O
marked	JJ	amod	O
upregulation	NN	nmod	O
of	IN	case	O
GATA-3	NN	compound	B-protein
expression	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
a	DT	det	O
reciprocal	JJ	amod	O
expression	NN	compound	O
pattern	NN	nsubj	O
accompanies	VBZ	parataxis	O
differentiation	NN	dobj	O
towards	IN	case	O
the	DT	det	O
Th1	NN	compound	O
cytokine	NN	compound	O
phenotype	NN	nmod	O
.	.	punct	O

In	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
HDM	NN	compound	O
skin	NN	compound	O
prick	VBP	compound	O
test-positive	JJ	amod	O
(	-LRB-	punct	O
HDM-SPT+/HDM-IgE+	NN	dep	O
)	-RRB-	punct	O
volunteers	NNS	nmod	O
,	,	punct	O
overnight	JJ	amod	O
stimulation	NN	nsubj	O
results	VBZ	ROOT	O
in	IN	case	O
marked	JJ	amod	O
upregulation	NN	nmod	O
of	IN	case	O
GATA-3	NN	compound	B-protein
expression	NN	nmod	O
,	,	punct	O
compared	VBN	case	O
to	TO	case	O
an	DT	det	O
equally	RB	advmod	O
marked	JJ	amod	O
downregulation	NN	advcl	O
of	IN	case	O
expression	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
SPT-/IgE-	JJ	compound	O
subjects	NNS	nmod	O
.	.	punct	O

In	IN	case	O
subjects	NNS	nmod	O
who	WP	nsubj	O
are	VBP	cop	O
HDM-SPT+	NN	acl:relcl	O
but	CC	cc	O
IgE-	NN	conj	O
,	,	punct	O
GATA-3	NN	compound	B-protein
expression	NN	compound	O
levels	NNS	nsubj	O
remained	VBD	ROOT	O
relatively	RB	advmod	O
stable	JJ	xcomp	O
during	IN	case	O
culture	NN	nmod	O
with	IN	case	O
HDM	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Upregulation	NN	nsubj	O
of	IN	case	O
GATA-3	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
PBMC	NN	nmod	B-cell_type
is	VBZ	cop	O
a	DT	det	O
hallmark	NN	dep	O
of	IN	case	O
the	DT	det	O
early	JJ	amod	O
phase	NN	nmod	O
of	IN	case	O
Th2	NN	compound	O
recall	NN	compound	O
responses	NNS	nmod	O
to	TO	case	O
specific	JJ	amod	O
allergen	NN	nmod	O
in	IN	case	O
atopics	NNS	nmod	O
.	.	punct	O

The	DT	det	O
reciprocal	JJ	amod	O
expression	NN	compound	O
pattern	NN	nsubj	O
observed	VBN	acl	O
in	IN	case	O
HDM-specific	JJ	amod	O
recall	NN	compound	O
responses	NNS	nmod	O
of	IN	case	O
non-atopics	NN	nmod	O
provides	VBZ	ROOT	O
independent	JJ	amod	O
confirmation	NN	dobj	O
of	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	mark	O
underlying	VBG	acl	O
Th1-like	JJ	amod	O
immunity	NN	dobj	O
in	IN	case	O
these	DT	det	O
subjects	NNS	nmod	O
.	.	punct	O

The	DT	det	O
parallel	JJ	amod	O
findings	NNS	nsubj	O
in	IN	case	O
neonatal	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
same	JJ	amod	O
approach	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
utilized	VBN	ccomp	O
for	IN	mark	O
monitoring	VBG	advcl	O
the	DT	det	O
progress	NN	dobj	O
of	IN	case	O
allergen-specific	JJ	amod	O
Th1/Th2	NN	compound	O
memory	NN	compound	O
development	NN	nmod	O
during	IN	case	O
early	JJ	amod	O
childhood	NN	nmod	O
,	,	punct	O
and	CC	cc	O
hence	RB	conj	O
in	IN	case	O
assessment	NN	nmod	O
of	IN	case	O
risk	NN	nmod	O
for	IN	case	O
future	JJ	amod	O
allergic	JJ	amod	O
disease	NN	nmod	O
.	.	punct	O

Copyright	NN	compound	O
2001	CD	nummod	O
S.	NNP	compound	O
Karger	NNP	compound	O
AG	NNP	ROOT	O
,	,	punct	O
Basel	NNP	appos	O

The	DT	det	O
heat	NN	compound	O
shock	NN	compound	O
response	NN	nsubj	O
reduces	VBZ	ROOT	O
myelin	JJ	compound	B-protein
oligodendrocyte	NN	compound	I-protein
glycoprotein	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
experimental	JJ	amod	O
autoimmune	JJ	amod	O
encephalomyelitis	NN	dobj	O
in	IN	case	O
mice	NNS	nmod	O
.	.	punct	O

The	DT	det	O
stress	NN	compound	O
response	NN	nsubj	O
(	-LRB-	punct	O
SR	NN	appos	O
)	-RRB-	punct	O
can	MD	aux	O
block	VB	ROOT	O
inflammatory	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
by	IN	mark	O
preventing	VBG	advcl	O
activation	NN	dobj	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
(	-LRB-	punct	O
NF-kappaB	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

As	IN	mark	O
inflammatory	JJ	amod	O
gene	NN	compound	O
expression	NN	nsubj	O
contributes	VBZ	advcl	O
to	TO	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
demyelinating	VBG	amod	O
diseases	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
the	DT	det	O
SR	NN	nmod	O
on	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
the	DT	det	O
demyelinating	VBG	amod	O
disease	NN	compound	O
experimental	JJ	amod	O
autoimmune	JJ	amod	O
encephalomyelitis	NN	nmod	O
(	-LRB-	punct	O
EAE	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

EAE	NN	nsubjpass	O
was	VBD	auxpass	O
actively	RB	advmod	O
induced	VBN	ROOT	O
in	IN	case	O
C57BL/6	NN	compound	O
mice	NNS	nmod	O
using	VBG	advcl	O
an	DT	det	O
encephalitogenic	JJ	amod	O
myelin	JJ	compound	B-protein
oligodendrocyte	NN	compound	I-protein
glycoprotein	NN	compound	I-protein
(	-LRB-	punct	O
MOG	NN	compound	B-protein
(	-LRB-	punct	I-protein
35-55	CD	nummod	I-protein
)	-RRB-	punct	I-protein
)	-RRB-	punct	O
peptide	NN	dobj	O
.	.	punct	O

Whole	JJ	amod	O
body	NN	compound	O
hyperthermia	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
a	DT	det	O
heat	NN	compound	O
shock	NN	compound	O
response	NN	dobj	O
(	-LRB-	punct	O
HSR	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
immunized	VBN	amod	O
mice	NNS	nmod	O
2	CD	nummod	O
days	NNS	dep	O
after	IN	case	O
the	DT	det	O
booster	NN	compound	O
MOG	NN	compound	O
(	-LRB-	punct	O
35-55	CD	nummod	O
)	-RRB-	punct	O
peptide	NN	compound	O
injection	NN	nmod	O
.	.	punct	O

The	DT	det	O
HSR	NN	nsubj	O
reduced	VBD	ROOT	O
the	DT	det	O
incidence	NN	dobj	O
of	IN	case	O
EAE	NN	nmod	O
by	IN	case	O
70	CD	nummod	O
%	NN	nmod	O
,	,	punct	O
delayed	VBN	amod	O
disease	NN	compound	O
onset	NN	conj	O
by	IN	case	O
6	CD	nummod	O
days	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
attenuated	VBD	amod	O
disease	NN	compound	O
severity	NN	conj	O
.	.	punct	O

The	DT	det	O
HSR	NN	nsubj	O
attenuated	VBD	ROOT	O
leukocyte	NN	compound	B-cell_type
infiltration	NN	dobj	O
into	IN	case	O
CNS	NN	nmod	O
assessed	VBN	acl	O
by	IN	case	O
quantitation	NN	nmod	O
of	IN	case	O
perivascular	JJ	amod	O
infiltrates	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
by	IN	case	O
reduced	VBN	amod	O
staining	NN	conj	O
for	IN	case	O
CD4	NN	compound	B-protein
and	CC	cc	O
CD25	NN	conj	B-protein
immunopositive	JJ	amod	O
T-cells	NNS	nmod	B-cell_type
.	.	punct	O

T-cell	NN	compound	O
activation	NN	nsubjpass	O
,	,	punct	O
assessed	VBN	acl	O
by	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
interferon	NN	compound	B-protein
gamma	NN	nmod	I-protein
(	-LRB-	punct	O
IFNgamma	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
MOG	NN	nmod	B-protein
(	-LRB-	punct	I-protein
35-55	CD	appos	I-protein
)	-RRB-	punct	I-protein
,	,	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
decreased	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
HSR	NN	nmod	O
.	.	punct	O

The	DT	det	O
HSR	NN	nsubj	O
reduced	VBD	amod	O
inflammatory	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
the	DT	det	O
brain	NN	nmod	O
that	WDT	nsubj	O
normally	RB	advmod	O
occurs	VBZ	acl:relcl	O
during	IN	case	O
EAE	NN	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
early	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
RANTES	NN	nmod	B-protein
(	-LRB-	punct	O
regulated	VBN	dep	B-protein
on	IN	case	I-protein
activation	NN	nmod	I-protein
of	IN	case	I-protein
normal	JJ	amod	I-protein
T-cell	NN	nmod	I-protein
expressed	VBN	acl	I-protein
and	CC	cc	I-protein
secreted	VBN	conj	I-protein
)	-RRB-	punct	O
expression	NN	ROOT	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
later	JJ	amod	O
expression	NN	conj	O
of	IN	case	O
the	DT	det	O
inducible	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
nitric	JJ	amod	B-protein
oxide	NN	compound	I-protein
synthase	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
early	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappaB	NN	nmod	B-protein
was	VBD	auxpass	O
also	RB	advmod	O
blocked	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
HSR	NN	nmod	O
.	.	punct	O

The	DT	det	O
finding	NN	nsubj	O
that	IN	mark	O
the	DT	det	O
SR	JJ	nsubj	O
reduces	VBZ	ccomp	O
inflammation	NN	dobj	O
in	IN	case	O
the	DT	det	O
brain	NN	nmod	O
and	CC	cc	O
the	DT	det	O
clinical	JJ	amod	O
severity	NN	conj	O
of	IN	case	O
EAE	NN	nmod	O
opens	VBZ	ROOT	O
a	DT	det	O
novel	JJ	amod	O
therapeutic	JJ	amod	O
approach	NN	dobj	O
for	IN	case	O
prevention	NN	nmod	O
of	IN	case	O
autoimmune	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
detection	NN	ROOT	O
of	IN	case	O
intracellular	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	nmod	O
in	IN	case	O
developing	VBG	amod	O
thymocytes	NNS	nmod	B-cell_type
.	.	punct	O

Information	NN	nsubjpass	O
regarding	VBG	case	O
the	DT	det	O
intracellular	JJ	amod	O
signaling	NN	compound	O
processes	NNS	nmod	O
that	WDT	nsubj	O
occur	VBP	acl:relcl	O
during	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
has	VBZ	aux	O
largely	RB	advmod	O
been	VBN	auxpass	O
obtained	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
transgenic	JJ	amod	O
mouse	NN	compound	O
models	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
although	IN	mark	O
providing	VBG	csubj	O
invaluable	JJ	amod	O
information	NN	dobj	O
are	VBP	cop	O
time	NN	compound	O
consuming	JJ	acl:relcl	O
and	CC	cc	O
costly	JJ	advmod	O
.	.	punct	O

To	IN	case	O
this	DT	det	O
end	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
developed	VBN	ROOT	O
a	DT	det	O
novel	JJ	amod	O
system	NN	dobj	O
that	WDT	nsubj	O
facilitates	VBZ	acl:relcl	O
the	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
analysis	NN	dobj	O
of	IN	case	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	nmod	O
during	IN	case	O
T-lymphocyte	NN	compound	B-cell_type
development	NN	nmod	O
.	.	punct	O

This	DT	det	O
approach	NN	nsubj	O
uses	VBZ	ROOT	O
reporter-plasmids	NNS	dobj	B-DNA
for	IN	case	O
the	DT	det	O
detection	NN	nmod	O
of	IN	case	O
intracellular	JJ	amod	O
signals	NNS	nmod	O
mediated	VBN	acl	O
by	IN	case	O
the	DT	det	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
or	CC	cc	O
cyclic	JJ	amod	B-protein
AMP-dependent	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	conj	I-protein
.	.	punct	O

Reporter-plasmids	NNS	nsubjpass	B-DNA
are	VBP	auxpass	O
transfected	VBN	ROOT	O
into	IN	case	O
thymocytes	NNS	nmod	B-cell_type
in	IN	case	O
fetal	JJ	amod	O
thymic	JJ	amod	O
organ	NN	compound	O
culture	NN	nmod	O
by	IN	case	O
accelerated	VBN	amod	O
DNA/particle	JJ	compound	O
bombardment	NN	nmod	O
(	-LRB-	punct	O
gene	NN	compound	O
gun	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
activation	NN	nsubjpass	O
of	IN	case	O
a	DT	det	O
signaling	NN	compound	O
pathway	NN	nmod	O
is	VBZ	auxpass	O
determined	VBN	conj	O
in	IN	case	O
the	DT	det	O
form	NN	nmod	O
of	IN	case	O
a	DT	det	O
standard	JJ	amod	O
luciferase	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
this	DT	det	O
powerful	JJ	amod	O
technique	NN	nsubj	O
preserves	NNS	ROOT	O
the	DT	det	O
structural	JJ	amod	O
integrity	NN	dobj	O
of	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
,	,	punct	O
and	CC	cc	O
will	MD	aux	O
provide	VB	conj	O
an	DT	det	O
invaluable	JJ	amod	O
tool	NN	dobj	O
to	TO	mark	O
study	VB	xcomp	O
how	WRB	advmod	O
thymocytes	NNS	nsubj	B-cell_type
respond	VBP	ccomp	O
to	TO	case	O
normal	JJ	amod	O
environmental	JJ	amod	O
stimuli	NNS	nmod	O
encountered	VBN	acl	O
during	IN	case	O
differentiation	NN	nmod	O
within	IN	case	O
the	DT	det	O
thymic	JJ	amod	O
milieu	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
this	DT	det	O
method	NN	nsubj	O
allows	VBZ	ROOT	O
for	IN	case	O
the	DT	det	O
monitoring	NN	nmod	O
of	IN	case	O
signals	NNS	nmod	O
that	WDT	nsubj	O
occur	VBP	acl:relcl	O
in	IN	case	O
a	DT	det	O
biological	JJ	amod	O
time	NN	compound	O
frame	NN	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
during	IN	conj	O
differentiation	NN	pobj	O
,	,	punct	O
and	CC	cc	O
within	IN	case	O
the	DT	det	O
natural	JJ	amod	O
environment	NN	nmod	O
of	IN	case	O
differentiating	VBG	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Core-binding	JJ	amod	B-protein
factor	NN	compound	I-protein
beta	NN	nsubj	I-protein
(	-LRB-	punct	O
CBFbeta	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
CBFbeta-smooth	JJ	compound	B-protein
muscle	NN	compound	I-protein
myosin	NN	compound	I-protein
heavy	JJ	amod	I-protein
chain	NN	conj	I-protein
,	,	punct	O
rescues	VBZ	ROOT	O
definitive	JJ	amod	O
hematopoiesis	NN	dobj	O
in	IN	case	O
CBFbeta	NN	compound	B-protein
-deficient	JJ	amod	O
embryonic	JJ	amod	B-cell_type
stem	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Core-binding	JJ	amod	B-protein
factor	NN	compound	I-protein
beta	NN	nsubj	I-protein
(	-LRB-	punct	O
CBFbeta	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
the	DT	det	O
non-DNA-binding	JJ	amod	B-protein
subunit	NN	ROOT	I-protein
of	IN	case	O
the	DT	det	O
heterodimeric	JJ	amod	B-protein
CBFs	NNS	nmod	I-protein
.	.	punct	O

Genes	NNS	nsubjpass	B-DNA
encoding	VBG	acl	I-DNA
CBFbeta	NN	dobj	I-DNA
(	-LRB-	punct	O
CBFB	NN	appos	B-DNA
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
one	CD	conj	O
of	IN	case	O
the	DT	det	O
DNA-binding	JJ	amod	B-protein
CBFalpha	NN	compound	I-protein
subunits	NNS	nmod	I-protein
,	,	punct	I-protein
Runx1	NN	appos	I-protein
(	-LRB-	punct	O
also	RB	advmod	O
known	VBN	acl	O
as	IN	case	O
CBFalpha2	NN	nmod	B-protein
,	,	punct	O
AML1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
PEBP2alphaB	NN	conj	B-protein
)	-RRB-	punct	O
,	,	punct	O
are	VBP	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
normal	JJ	amod	O
hematopoiesis	NN	nmod	O
and	CC	cc	O
are	VBP	cop	O
also	RB	advmod	O
frequent	JJ	amod	O
targets	NNS	conj	O
of	IN	case	O
chromosomal	JJ	amod	O
translocations	NNS	nmod	O
in	IN	case	O
acute	JJ	amod	O
leukemias	NNS	nmod	O
in	IN	case	O
humans	NNS	nmod	O
.	.	punct	O

Homozygous	JJ	amod	O
disruption	NN	nsubj	O
of	IN	case	O
either	CC	cc:preconj	O
the	DT	dep	O
Runx1	NN	compound	B-DNA
or	CC	cc	I-DNA
Cbfb	NN	conj	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
mice	NNS	nmod	O
results	VBZ	ROOT	O
in	IN	case	O
embryonic	JJ	amod	O
lethality	NN	nmod	O
at	IN	case	O
midgestation	NN	nmod	O
due	JJ	case	O
to	TO	mwe	O
hemorrhaging	NN	advcl	O
in	IN	case	O
the	DT	det	O
central	JJ	amod	O
nervous	JJ	amod	O
system	NN	nmod	O
,	,	punct	O
and	CC	cc	O
severely	RB	advmod	O
impairs	VBZ	conj	O
fetal	JJ	amod	O
liver	NN	compound	O
hematopoiesis	NN	dobj	O
.	.	punct	O

Results	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
show	VBP	ROOT	O
that	IN	mark	O
Cbfb-deficient	JJ	amod	O
mouse	NN	compound	O
embryonic	JJ	amod	B-cell_type
stem	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
ES	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nsubj	I-cell_type
can	MD	aux	O
differentiate	VB	ccomp	O
into	IN	case	O
primitive	JJ	amod	B-cell_type
erythroid	JJ	amod	I-cell_type
colonies	NNS	nmod	I-cell_type
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
but	CC	cc	O
are	VBP	aux	O
impaired	JJ	conj	O
in	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
produce	VB	acl	O
definitive	JJ	amod	O
erythroid	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
myeloid	JJ	conj	I-cell_type
colonies	NNS	dobj	I-cell_type
,	,	punct	O
mimicking	VBG	advcl	O
the	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
defect	NN	dobj	O
.	.	punct	O

Definitive	JJ	amod	O
hematopoiesis	NN	nsubjpass	O
is	VBZ	auxpass	O
restored	VBN	ROOT	O
by	IN	case	O
ectopic	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
full-length	JJ	amod	B-DNA
Cbfb	NNP	compound	I-DNA
transgenes	NNS	nmod	I-DNA
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
by	IN	case	O
a	DT	det	O
transgene	NN	conj	O
encoding	VBG	acl	O
only	RB	advmod	O
the	DT	det	O
heterodimerization	NN	compound	B-protein
domain	NN	dobj	I-protein
of	IN	case	O
CBFbeta	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
CBFbeta	NN	compound	B-protein
-	HYPH	punct	O
smooth	JJ	amod	B-protein
muscle	NN	compound	I-protein
myosin	NN	compound	I-protein
heavy	JJ	amod	I-protein
chain	NN	compound	I-protein
(	-LRB-	punct	I-protein
SMMHC	NN	compound	I-protein
)	-RRB-	punct	I-protein
fusion	NN	compound	I-protein
protein	NN	nsubj	I-protein
generated	VBN	acl	O
by	IN	case	O
the	DT	det	O
inv	NN	nmod	B-protein
(	-LRB-	punct	I-protein
16	CD	dep	I-protein
)	-RRB-	punct	I-protein
associated	VBN	acl	O
with	IN	case	O
acute	JJ	amod	B-cell_line
myeloid	JJ	amod	I-cell_line
leukemias	NNS	nmod	I-cell_line
(	-LRB-	punct	O
M4Eo	NN	appos	B-cell_line
)	-RRB-	punct	O
can	MD	aux	O
not	RB	neg	O
rescue	VB	ROOT	O
definitive	JJ	amod	O
hematopoiesis	NN	dobj	O
by	IN	case	O
Cbfb-deficient	JJ	amod	B-cell_type
ES	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Sequences	NNS	nsubj	O
responsible	JJ	amod	O
for	IN	case	O
the	DT	det	O
inability	NN	nmod	O
of	IN	case	O
CBFbeta	NN	nmod	B-protein
-SMMHC	VBP	amod	O
to	TO	mark	O
rescue	VB	acl	O
definitive	JJ	amod	O
hematopoiesis	NN	dobj	O
reside	NN	ROOT	O
in	IN	case	O
the	DT	det	O
SMMHC	NN	compound	B-protein
portion	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
fusion	NN	compound	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

Results	NNS	nsubj	O
also	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
CBFbeta-SMMHC	NN	amod	B-protein
fusion	NN	compound	I-protein
protein	NN	nsubj	I-protein
transdominantly	RB	advmod	O
inhibits	VBZ	ccomp	O
definitive	JJ	amod	O
hematopoiesis	NN	dobj	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
to	TO	case	O
the	DT	det	O
same	JJ	amod	O
extent	NN	conj	O
as	IN	case	O
homozygous	JJ	amod	O
loss	NN	nmod	O
of	IN	case	O
Runx1	NN	nmod	B-protein
or	CC	cc	O
Cbfb	NNP	conj	B-protein
.	.	punct	O

CBFbeta-SMMHC	NN	nsubj	B-protein
preferentially	RB	advmod	O
inhibits	VBZ	ROOT	O
the	DT	det	O
differentiation	NN	dobj	O
of	IN	case	O
myeloid	JJ	amod	B-cell_type
lineage	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
while	IN	mark	O
increasing	VBG	advcl	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
blastlike	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O

The	DT	det	O
latency	NN	compound	O
pattern	NN	ROOT	O
of	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	compound	O
infection	NN	nmod	O
and	CC	cc	O
viral	JJ	amod	O
IL-10	NN	compound	B-protein
expression	NN	conj	O
in	IN	case	O
cutaneous	JJ	amod	B-cell_type
natural	JJ	amod	I-cell_type
killer/T-cell	NN	compound	I-cell_type
lymphomas	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
nasal	JJ	amod	B-cell_type
type	NN	nsubjpass	I-cell_type
,	,	punct	I-cell_type
extranodal	JJ	amod	I-cell_type
natural	JJ	amod	I-cell_type
killer	NN	nsubjpass	I-cell_type
or	CC	cc	I-cell_type
T	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
NK/T	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
-cell	JJ	compound	I-cell_type
lymphoma	NN	conj	I-cell_type
is	VBZ	auxpass	O
usually	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
latent	JJ	amod	O
Epstein-Barr	JJ	amod	O
virus	NN	compound	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
infection	NN	nmod	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
elucidate	VB	advcl	O
the	DT	det	O
EBV	NN	compound	O
gene	NN	compound	O
expression	NN	compound	O
patterns	NNS	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
eight	CD	nummod	O
patients	NNS	dobj	O
with	IN	case	O
cutaneous	JJ	amod	O
EBV-related	JJ	amod	O
NK/T-cell	JJ	compound	O
lymphomas	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
six	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
a	DT	det	O
NK-cell	NN	amod	O
phenotype	NN	nmod	O
and	CC	cc	O
two	CD	nummod	O
patients	NNS	conj	O
with	IN	case	O
a	DT	det	O
T-cell	NN	compound	O
phenotype	NN	nmod	O
.	.	punct	O

The	DT	det	O
implication	NN	nsubjpass	O
of	IN	case	O
EBV	NN	nmod	O
in	IN	case	O
the	DT	det	O
skin	NN	compound	O
lesions	NNS	nmod	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
EBV-DNA	NN	nmod	B-DNA
,	,	punct	O
EBV-encoded	JJ	amod	B-RNA
nuclear	JJ	amod	I-RNA
RNA	NN	conj	I-RNA
(	-LRB-	punct	O
EBER	NN	appos	B-RNA
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
clonality	NN	conj	O
of	IN	case	O
EBV-DNA	NN	compound	B-DNA
fragments	NNS	nmod	I-DNA
containing	VBG	acl	O
the	DT	det	O
terminal	JJ	amod	B-DNA
repeats	NNS	dobj	I-DNA
.	.	punct	O

Transcripts	NNS	nsubjpass	O
of	IN	case	O
EBV-encoded	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
were	VBD	auxpass	O
screened	VBN	ROOT	O
by	IN	case	O
reverse	JJ	amod	O
transcription-	NN	amod	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
(	-LRB-	punct	O
RT-PCR	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
confirmed	VBN	conj	O
by	IN	case	O
Southern	NN	compound	O
blot	NN	compound	O
hybridization	NN	nmod	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
EBV-related	JJ	amod	B-protein
antigens	NNS	nmod	I-protein
was	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
immunostaining	NN	nmod	O
using	VBG	acl	O
paraffin-embedded	JJ	amod	O
tissue	NN	compound	O
sections	NNS	dobj	O
and	CC	cc	O
cell	NN	compound	O
pellets	NNS	conj	O
of	IN	case	O
EBV-positive	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Our	PRP$	nmod:poss	O
study	NN	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
all	DT	det	O
samples	NNS	nsubj	O
from	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
contained	VBD	ccomp	O
EBV	NN	compound	B-RNA
nuclear	JJ	amod	I-RNA
antigen	NN	compound	I-RNA
(	-LRB-	punct	I-RNA
EBNA	NN	appos	I-RNA
)	-RRB-	punct	I-RNA
-1	CD	nummod	I-RNA
mRNA	NN	dobj	I-RNA
which	WDT	nsubjpass	O
was	VBD	auxpass	O
transcribed	VBN	acl:relcl	O
using	VBG	xcomp	O
the	DT	det	O
Q	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
,	,	punct	O
whereas	IN	dep	O
both	CC	cc:preconj	O
the	DT	det	O
Q	NN	compound	B-DNA
promoter	NN	nsubjpass	I-DNA
and	CC	cc	O
another	DT	det	O
upstream	JJ	amod	B-DNA
promoter	NN	conj	I-DNA
(	-LRB-	punct	O
Cp/Wp	NN	appos	B-DNA
)	-RRB-	punct	O
were	VBD	auxpass	O
used	VBN	advcl	O
in	IN	case	O
EBV-positive	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
B95.8	NN	appos	B-cell_line
,	,	punct	O
Raji	NN	conj	B-cell_line
and	CC	cc	O
Jiyoye	NNP	conj	B-cell_line
.	.	punct	O

Latent	JJ	amod	B-RNA
membrane	NN	compound	I-RNA
protein-1	NN	compound	I-RNA
(	-LRB-	punct	I-RNA
LMP-1	NN	appos	I-RNA
)	-RRB-	punct	I-RNA
mRNA	NN	nsubjpass	I-RNA
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
seven	CD	nummod	O
of	IN	case	O
eight	CD	nummod	O
patients	NNS	nmod	O
and	CC	cc	O
all	DT	det	O
cell	NN	compound	B-cell_line
lines	NNS	conj	I-cell_line
,	,	punct	O
whereas	IN	dep	O
EBNA-2	NN	compound	B-RNA
transcripts	NNS	nsubjpass	I-RNA
were	VBD	auxpass	O
found	VBN	parataxis	O
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Immunostaining	NN	nsubj	O
showed	VBD	ROOT	O
no	DT	neg	O
LMP-1	NN	dobj	B-protein
,	,	punct	I-protein
EBNA-2	NN	conj	I-protein
or	CC	cc	I-protein
ZEBRA	NN	conj	I-protein
antigens	NNS	dep	I-protein
in	IN	case	O
the	DT	det	O
paraffin-embedded	JJ	amod	O
tissue	NN	compound	O
sections	NNS	nmod	O
,	,	punct	O
although	IN	mark	O
they	PRP	nsubj	O
were	VBD	cop	O
positive	JJ	advcl	O
in	IN	case	O
the	DT	det	O
cell	NN	compound	B-cell_line
line	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Latent	JJ	amod	B-RNA
BHRF1	NN	compound	I-RNA
transcripts	NNS	nsubjpass	I-RNA
encoding	VBG	acl	O
bcl-2	NN	compound	B-RNA
homologue	NN	dobj	I-RNA
and	CC	cc	O
BCRF1	NN	compound	B-RNA
transcripts	NNS	conj	I-RNA
encoding	VBG	acl	O
viral	JJ	amod	B-protein
interleukin	NN	dobj	I-protein
(	-LRB-	punct	I-protein
vIL	NN	appos	I-protein
)	-RRB-	punct	I-protein
-10	CD	nummod	I-protein
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
one	CD	nmod	O
and	CC	cc	O
two	CD	conj	O
of	IN	case	O
eight	CD	nummod	O
patients	NNS	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

A	DT	det	O
patient	NN	nsubj	O
with	IN	case	O
NK-cell	NN	amod	O
lymphoma	NN	nmod	O
expressing	VBG	acl	O
both	DT	det	O
transcripts	NNS	dobj	O
died	VBD	ROOT	O
of	IN	case	O
rapid	JJ	amod	O
progression	NN	nmod	O
of	IN	case	O
the	DT	det	O
illness	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
restricted	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
latency-associated	JJ	amod	B-DNA
EBV	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
and	CC	cc	O
the	DT	det	O
production	NN	conj	O
of	IN	case	O
vIL-10	NN	nmod	B-RNA
and	CC	cc	I-RNA
bcl-2	NN	conj	I-RNA
homologue	NN	dep	I-RNA
may	MD	aux	O
favour	VB	amod	O
tumour	NN	compound	O
growth	NN	ccomp	O
,	,	punct	O
evading	VBG	acl	O
the	DT	det	O
host	NN	compound	O
immune	JJ	amod	O
surveillance	NN	dobj	O
.	.	punct	O

Copyright	NN	compound	O
2001	CD	nummod	O
Cancer	NNP	compound	O
Research	NNP	compound	O
Campaign	NNP	ROOT	O
.	.	punct	O

Oxidized	VBN	amod	O
alkyl	NN	compound	O
phospholipids	NNS	nsubj	O
are	VBP	cop	O
specific	JJ	ROOT	O
,	,	punct	O
high	JJ	amod	O
affinity	NN	compound	O
peroxisome	NN	compound	O
proliferator-activated	JJ	amod	O
receptor	NN	compound	O
gamma	NN	compound	O
ligands	NNS	dep	O
and	CC	cc	O
agonists	NNS	conj	O
.	.	punct	O

Synthetic	JJ	amod	O
high	JJ	amod	O
affinity	NN	compound	O
peroxisome	NN	compound	O
proliferator-activated	JJ	amod	O
receptor	NN	compound	O
(	-LRB-	punct	O
PPAR	NN	appos	O
)	-RRB-	punct	O
agonists	NNS	nsubjpass	O
are	VBP	auxpass	O
known	VBN	ROOT	O
,	,	punct	O
but	CC	cc	O
biologic	JJ	amod	O
ligands	NNS	nsubj	O
are	VBP	cop	O
of	IN	case	O
low	JJ	amod	O
affinity	NN	conj	O
.	.	punct	O

Oxidized	VBN	amod	B-protein
low	JJ	amod	I-protein
density	NN	compound	I-protein
lipoprotein	NN	nsubj	I-protein
(	-LRB-	punct	O
oxLDL	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
inflammatory	JJ	ROOT	O
and	CC	cc	O
signals	NNS	conj	O
through	IN	case	O
PPARs	NNS	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
showed	VBD	ROOT	O
,	,	punct	O
by	IN	case	O
phospholipase	NN	compound	O
A	NN	compound	O
(	-LRB-	punct	O
1	LS	appos	O
)	-RRB-	punct	O
digestion	NN	dobj	O
,	,	punct	O
that	IN	mark	O
PPARgamma	NN	compound	O
agonists	NNS	nsubj	O
in	IN	case	O
oxLDL	NN	nmod	B-protein
arise	NN	acl:relcl	O
from	IN	case	O
the	DT	det	O
small	JJ	amod	O
pool	NN	nmod	O
of	IN	case	O
alkyl	NN	compound	O
phosphatidylcholines	NNS	nmod	O
in	IN	case	O
LDL	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
identified	VBD	ROOT	O
an	DT	det	O
abundant	JJ	amod	O
oxidatively	RB	advmod	O
fragmented	JJ	amod	O
alkyl	NN	compound	O
phospholipid	NN	dobj	O
in	IN	case	O
oxLDL	NN	nmod	B-protein
,	,	punct	O
hexadecyl	JJ	compound	O
azelaoyl	NN	compound	O
phosphatidylcholine	NN	appos	O
(	-LRB-	punct	O
azPC	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
as	IN	case	O
a	DT	det	O
high	JJ	amod	O
affinity	NN	compound	O
ligand	NN	nmod	O
and	CC	cc	O
agonist	NN	conj	O
for	IN	case	O
PPARgamma	NN	nmod	B-protein
.	.	punct	O

[	-LRB-	punct	O
(	-LRB-	punct	O
3	LS	nummod	O
)	-RRB-	punct	O
H	NN	nsubj	O
]	-RRB-	punct	O
azPC	NNS	nsubj	O
bound	VBD	ROOT	O
recombinant	JJ	amod	B-protein
PPARgamma	NN	dobj	I-protein
with	IN	case	O
an	DT	det	O
affinity	NN	nmod	O
(	-LRB-	punct	O
K	NN	dep	O
(	-LRB-	punct	O
d	NN	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
(	-LRB-	punct	O
app	NN	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
approximately	RB	advmod	O
40	CD	nummod	O
nm	NN	dep	O
)	-RRB-	punct	O
that	WDT	nsubj	O
was	VBD	cop	O
equivalent	JJ	acl:relcl	O
to	TO	case	O
rosiglitazone	NN	nmod	O
(	-LRB-	punct	O
BRL49653	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
competition	NN	nsubj	O
with	IN	case	O
rosiglitazone	NN	nmod	O
showed	VBD	conj	O
that	IN	mark	O
binding	NN	nsubj	O
occurred	VBD	ccomp	O
in	IN	case	O
the	DT	det	O
ligand-binding	JJ	amod	B-protein
pocket	NN	nmod	I-protein
.	.	punct	O

azPC	NNS	nsubj	O
induced	VBD	ROOT	O
PPRE	NN	compound	O
reporter	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
,	,	punct	O
as	IN	mark	O
did	VBD	aux	O
rosiglitazone	NN	advcl	O
,	,	punct	O
with	IN	case	O
a	DT	det	O
half-maximal	JJ	amod	O
effect	NN	nmod	O
at	IN	case	O
100	CD	nummod	O
nm	NN	nmod	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
PPARalpha	NN	nmod	B-protein
or	CC	cc	O
PPARgamma	NN	conj	B-protein
revealed	VBD	ROOT	O
that	IN	mark	O
azPC	NNS	nsubj	O
was	VBD	cop	O
a	DT	det	O
specific	JJ	amod	O
PPARgamma	NN	compound	O
agonist	NN	ccomp	O
.	.	punct	O

The	DT	det	O
scavenger	NN	compound	B-protein
receptor	NN	compound	I-protein
CD36	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
encoded	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
PPRE-responsive	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
azPC	NN	nsubj	O
enhanced	VBD	conj	O
expression	NN	dobj	O
of	IN	case	O
CD36	NN	nmod	B-protein
in	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
anti-CD36	NN	nsubj	B-protein
inhibited	VBD	ccomp	O
azPC	JJ	compound	O
uptake	NN	dobj	O
,	,	punct	O
and	CC	cc	O
it	PRP	nsubj	O
inhibited	VBD	conj	O
PPRE	NN	compound	O
reporter	NN	compound	O
induction	NN	dobj	O
.	.	punct	O

Results	NNS	nsubj	O
with	IN	case	O
a	DT	det	O
small	JJ	amod	O
molecule	NN	compound	O
phospholipid	JJ	compound	B-protein
flippase	NN	compound	I-protein
mimetic	JJ	nmod	I-protein
suggest	VBP	ROOT	O
azPC	NN	nsubj	O
acts	VBZ	ccomp	O
intracellularly	RB	advmod	O
and	CC	cc	O
that	IN	mark	O
cellular	JJ	amod	O
azPC	JJ	compound	O
accumulation	NN	nsubj	O
was	VBD	cop	O
efficient	JJ	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
certain	JJ	amod	O
alkyl	NN	compound	O
phospholipid	JJ	amod	O
oxidation	NN	compound	O
products	NNS	nsubj	O
in	IN	case	O
oxLDL	NN	nmod	B-protein
are	VBP	cop	O
specific	JJ	ROOT	O
,	,	punct	O
high	JJ	amod	O
affinity	NN	compound	O
extracellular	JJ	amod	O
ligands	NNS	dep	O
and	CC	cc	O
agonists	NNS	conj	O
for	IN	case	O
PPARgamma	NN	nmod	B-protein
that	WDT	nsubj	O
induce	VBP	acl:relcl	O
PPAR-responsive	JJ	amod	B-DNA
genes	NNS	dobj	I-DNA

Regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
MAT2B	NN	compound	I-DNA
gene	NN	nmod	I-DNA
encoding	VBG	acl	O
the	DT	det	O
regulatory	JJ	amod	B-protein
beta	NN	compound	I-protein
subunit	NN	dobj	I-protein
of	IN	case	O
methionine	NN	compound	B-protein
adenosyltransferase	NN	nmod	I-protein
,	,	punct	O
MAT	NN	appos	B-protein
II	CD	nummod	I-protein
.	.	punct	O

Methionine	NN	compound	B-protein
adenosyltransferase	NN	nsubj	I-protein
(	-LRB-	punct	O
MAT	NN	appos	B-protein
)	-RRB-	punct	O
catalyzes	VBZ	ROOT	O
the	DT	det	O
biosynthesis	NN	dobj	O
of	IN	case	O
S-adenosylmethionine	NN	nmod	B-protein
(	-LRB-	punct	O
AdoMet	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
key	JJ	amod	O
molecule	NN	appos	O
in	IN	case	O
transmethylation	NN	compound	O
reactions	NNS	nmod	O
and	CC	cc	O
polyamine	NN	compound	O
biosynthesis	NN	conj	O
.	.	punct	O

The	DT	det	O
MAT	NNP	compound	B-protein
II	CD	nummod	I-protein
isozyme	NN	nsubj	I-protein
consists	VBZ	ROOT	O
of	IN	case	O
a	DT	det	O
catalytic	JJ	amod	B-protein
alpha2	NN	nmod	I-protein
and	CC	cc	I-protein
a	DT	det	I-protein
regulatory	JJ	amod	I-protein
beta	NN	compound	I-protein
subunit	NN	conj	I-protein
.	.	punct	O

Down-regulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
MAT	NN	compound	B-protein
II	CD	nummod	I-protein
beta	NN	compound	I-protein
subunit	NN	compound	I-protein
expression	NN	nmod	O
causes	VBZ	ROOT	O
a	DT	det	O
6-10-fold	JJ	nummod	O
increase	NN	dobj	O
in	IN	case	O
intracellular	JJ	amod	O
AdoMet	NN	compound	B-protein
levels	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
the	DT	det	O
beta	NN	compound	B-protein
subunit	NN	compound	I-protein
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	acl:relcl	O
,	,	punct	O
we	PRP	nsubj	O
cloned	VBD	ROOT	O
the	DT	det	O
MAT2B	NN	compound	B-DNA
gene	NN	dobj	I-DNA
,	,	punct	O
determined	VBD	conj	O
its	PRP$	nmod:poss	O
organization	NN	dobj	O
,	,	punct	O
characterized	VBD	conj	O
its	PRP$	nmod:poss	O
5'-flanking	JJ	amod	B-DNA
sequences	NNS	dobj	I-DNA
,	,	punct	O
and	CC	cc	O
elucidated	VBD	conj	O
the	DT	det	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	amod	O
vivo	FW	dep	O
regulation	NN	dobj	O
of	IN	case	O
its	PRP$	nmod:poss	O
promoter	NN	nmod	B-DNA
.	.	punct	O

Transcription	NN	nsubj	O
of	IN	case	O
the	DT	det	O
MAT2B	NN	compound	B-DNA
gene	NN	nmod	I-DNA
initiates	VBZ	ROOT	O
at	IN	case	O
position	NN	nmod	O
-203	CD	nummod	O
relative	JJ	case	O
to	TO	case	O
the	DT	det	O
translation	NN	compound	B-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
.	.	punct	O

Promoter	NN	compound	B-DNA
deletion	NN	compound	I-DNA
analysis	NN	nsubj	I-DNA
defined	VBD	ROOT	O
a	DT	det	O
minimal	JJ	amod	B-DNA
promoter	NN	dobj	I-DNA
between	IN	case	O
positions	NNS	nmod	B-DNA
+52	CD	dep	I-DNA
and	CC	cc	I-DNA
+93	CD	nummod	I-DNA
base	NN	compound	O
pairs	NNS	conj	O
,	,	punct	O
a	DT	det	O
GC-rich	JJ	amod	B-DNA
region	NN	appos	I-DNA
.	.	punct	O

Inclusion	NN	nsubj	O
of	IN	case	O
the	DT	det	O
sequences	NNS	nmod	O
between	IN	case	O
-4	CD	nmod	O
and	CC	cc	O
+52	CD	conj	O
enhanced	VBN	ROOT	O
promoter	NN	compound	O
activity	NN	dobj	O
;	:	punct	O
this	DT	nsubj	O
was	VBD	cop	O
primarily	RB	advmod	O
because	IN	case	O
of	IN	mwe	O
an	DT	det	O
Sp1	NN	compound	B-DNA
recognition	NN	compound	I-DNA
site	NN	parataxis	I-DNA
at	IN	case	O
+9/+15	NN	nmod	O
.	.	punct	O

The	DT	det	O
inclusion	NN	nsubj	O
of	IN	case	O
sequences	NNS	nmod	O
up	RP	amod	O
to	TO	case	O
position	NN	nmod	O
-115	CD	nummod	O
provided	VBD	ROOT	O
full	JJ	amod	O
activity	NN	dobj	O
;	:	punct	O
this	DT	nsubjpass	O
was	VBD	auxpass	O
attributed	VBN	parataxis	O
to	TO	case	O
a	DT	det	O
TATA	NN	nmod	B-DNA
at	IN	case	O
-32	CD	nmod	O
.	.	punct	O

The	DT	det	O
Sp1	NN	compound	B-DNA
site	NN	nsubj	I-DNA
at	IN	case	O
position	NN	compound	O
+9	NN	nmod	O
was	VBD	cop	O
key	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
protein.DNA	NN	compound	O
complexes	NNS	nmod	O
.	.	punct	O

Mutation	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
Sp1	NN	compound	B-DNA
site	NN	nmod	I-DNA
at	IN	case	O
+9	NN	nmod	O
and	CC	cc	O
the	DT	det	O
TATA	NN	conj	B-DNA
at	IN	case	O
-32	CD	nmod	O
reduced	VBD	ROOT	O
promoter	NN	compound	O
activity	NN	dobj	O
to	TO	case	O
its	PRP$	nmod:poss	O
minimal	JJ	amod	O
level	NN	nmod	O
.	.	punct	O

Supershift	NN	compound	O
assays	NNS	nsubj	O
showed	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
of	IN	case	O
the	DT	det	O
anti-Sp1	NN	compound	B-protein
antibody	NN	nmod	I-protein
on	IN	case	O
complex	JJ	compound	O
formation	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
anti-Sp3	NN	compound	B-protein
antibody	NN	nsubj	I-protein
had	VBD	parataxis	O
a	DT	det	O
strong	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
protein.DNA	NN	compound	O
complex	NN	compound	O
formation	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
Sp3	NN	nsubj	B-protein
is	VBZ	cop	O
one	CD	ccomp	O
of	IN	case	O
the	DT	det	O
main	JJ	amod	O
factors	NNS	nmod	O
binding	VBG	acl	O
to	TO	case	O
this	DT	det	O
Sp1	NN	compound	B-DNA
site	NN	nmod	I-DNA
.	.	punct	O

Chromatin	NN	compound	O
immunoprecipitation	NN	compound	O
assays	NNS	nsubj	O
supported	VBD	ROOT	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
Sp1	NN	nmod	B-protein
and	CC	cc	O
Sp3	NN	conj	B-protein
in	IN	case	O
complexes	NNS	nmod	O
formed	VBN	acl	O
on	IN	case	O
the	DT	det	O
MAT2B	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
5'-untranslated	JJ	amod	B-DNA
sequences	NNS	nsubj	I-DNA
play	VBP	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
regulating	VBG	advcl	O
the	DT	det	O
MAT2B	NN	compound	B-DNA
gene	NN	dobj	I-DNA
and	CC	cc	O
identifies	VBZ	conj	O
the	DT	det	O
Sp1	NN	compound	B-DNA
site	NN	dobj	I-DNA
at	IN	case	O
+9	NN	nmod	O
as	IN	case	O
a	DT	det	O
potential	JJ	amod	O
target	NN	nmod	O
for	IN	mark	O
modulating	VBG	acl	O
MAT2B	NN	compound	O
expression	NN	dobj	O
,	,	punct	O
a	DT	det	O
process	NN	dobj	O
that	WDT	nsubj	O
can	MD	aux	O
have	VB	acl:relcl	O
a	DT	det	O
major	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
intracellular	JJ	amod	O
AdoMet	NN	compound	B-protein
levels	NNS	nmod	O
.	.	punct	O

Molecular	JJ	amod	O
pathogenesis	NN	ROOT	O
of	IN	case	O
influenza	NN	compound	O
A	NN	compound	O
virus	NN	compound	O
infection	NN	nmod	O
and	CC	cc	O
virus-induced	JJ	amod	O
regulation	NN	conj	O
of	IN	case	O
cytokine	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
.	.	punct	O

Despite	IN	case	O
vaccines	NNS	nsubj	O
and	CC	cc	O
antiviral	JJ	amod	O
substances	NNS	compound	O
influenza	NN	conj	O
still	RB	advmod	O
causes	VBZ	ROOT	O
significant	JJ	amod	O
morbidity	NN	dobj	O
and	CC	cc	O
mortality	NN	compound	O
world	NN	conj	O
wide	RB	conj	O
.	.	punct	O

Better	JJR	amod	O
understanding	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nmod	O
of	IN	case	O
influenza	NN	compound	O
virus	NN	compound	O
replication	NN	nmod	O
,	,	punct	O
pathogenesis	NN	conj	O
and	CC	cc	O
host	NN	compound	O
immune	JJ	amod	O
responses	NNS	conj	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
more	RBR	advmod	O
efficient	JJ	amod	O
means	NNS	nmod	O
of	IN	case	O
prevention	NN	nmod	O
and	CC	cc	O
treatment	NN	conj	O
of	IN	case	O
influenza	NN	nmod	O
.	.	punct	O

Influenza	NN	compound	O
A	NN	compound	O
virus	NN	nsubj	O
,	,	punct	O
which	WDT	nsubj	O
replicates	VBZ	acl:relcl	O
in	IN	case	O
epithelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
leukocytes	NNS	conj	B-cell_type
,	,	punct	O
regulates	VBZ	ROOT	O
host	NN	compound	O
cell	NN	nmod:npmod	O
transcriptional	JJ	dobj	O
and	CC	cc	O
translational	JJ	amod	O
systems	NNS	conj	O
and	CC	cc	O
activates	VBZ	conj	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
downregulates	VBZ	conj	O
apoptotic	JJ	amod	O
pathways	NNS	dobj	O
.	.	punct	O

Influenza	NN	compound	O
A	NN	compound	O
virus	NN	compound	O
infection	NN	nsubj	O
results	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
chemotactic	JJ	amod	O
(	-LRB-	punct	O
RANTES	NN	dep	B-protein
,	,	punct	O
MIP-1	NN	compound	B-protein
alpha	NN	conj	I-protein
,	,	punct	O
MCP-1	NN	conj	B-protein
,	,	punct	O
MCP-3	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IP-10	NN	conj	B-protein
)	-RRB-	punct	O
,	,	punct	O
pro-inflammatory	JJ	conj	O
(	-LRB-	punct	O
IL-1	NN	compound	B-protein
beta	NN	dep	I-protein
,	,	punct	O
IL-6	NN	conj	B-protein
,	,	punct	O
IL-18	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
TNF-alpha	NN	conj	B-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
antiviral	JJ	amod	B-protein
(	-LRB-	punct	I-protein
IFN-alpha/beta	NN	dep	I-protein
)	-RRB-	punct	I-protein
cytokines	NNS	nmod	I-protein
.	.	punct	O

Cytokine	NN	compound	O
gene	NN	compound	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	O
AP-1	NN	conj	B-protein
,	,	punct	O
STAT	NN	conj	B-protein
and	CC	cc	O
IRF	NN	compound	B-protein
signal	NN	compound	I-protein
transducing	VBG	compound	I-protein
molecules	NNS	conj	I-protein
in	IN	case	O
influenza	NN	compound	O
A	NN	compound	O
virus-infected	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
of	IN	mark	O
upregulating	VBG	acl	O
cytokine	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
,	,	punct	O
influenza	NN	compound	O
A	NN	compound	O
virus	NN	compound	O
infection	NN	nsubj	O
activates	VBZ	ROOT	O
caspase-1	NN	compound	B-protein
enzyme	NN	dobj	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
proteolytic	JJ	amod	O
processing	NN	nmod	O
of	IN	case	O
proIL-1	NN	compound	B-protein
beta	NN	nmod	I-protein
and	CC	cc	O
proIL-18	NN	conj	B-protein
into	IN	case	O
their	PRP$	nmod:poss	O
biologically	RB	advmod	O
active	JJ	amod	O
forms	NNS	nmod	O
.	.	punct	O

Influenza	NN	compound	O
A	NN	compound	O
virus-induced	JJ	amod	O
IFN-alpha/beta	NN	nsubj	B-protein
is	VBZ	cop	O
essential	JJ	ROOT	O
in	IN	case	O
host	NN	nmod:poss	O
's	POS	case	O
antiviral	JJ	amod	O
defence	NN	nmod	O
by	IN	mark	O
activating	VBG	advcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
antiviral	JJ	amod	B-DNA
Mx	NN	nmod	I-DNA
,	,	punct	O
PKR	NN	appos	B-DNA
and	CC	cc	I-DNA
oligoadenylate	NN	compound	I-DNA
synthetase	NN	compound	I-DNA
genes	NNS	conj	I-DNA
.	.	punct	O

IFN-alpha/beta	NN	nsubj	B-protein
also	RB	advmod	O
prolongs	VBZ	ROOT	O
T	NN	compound	O
cell	NN	compound	O
survival	NN	dobj	O
,	,	punct	O
upregulates	VBZ	conj	O
IL-12	NN	compound	O
and	CC	cc	O
IL-18	NN	conj	O
receptor	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
together	RB	advmod	O
with	IN	case	O
IL-18	NN	nmod	B-protein
stimulates	VBZ	conj	O
NK	NN	compound	B-cell_type
and	CC	cc	I-cell_type
T	NN	conj	I-cell_type
cell	NN	compound	I-cell_type
IFN-gamma	NN	compound	O
production	NN	dobj	O
and	CC	cc	O
the	DT	det	O
development	NN	conj	O
of	IN	case	O
Th1-type	JJ	amod	O
immune	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

Comparison	NN	ROOT	O
of	IN	case	O
hprt	NN	nmod	O
and	CC	cc	O
lacI	NN	conj	O
mutant	JJ	amod	O
frequency	NN	dep	O
with	IN	case	O
DNA	NN	compound	O
adduct	NN	compound	O
formation	NN	nmod	O
in	IN	case	O
N-hydroxy-2-acetylaminofluorene-treated	JJ	amod	O
Big	NNP	compound	O
Blue	NNP	compound	O
rats	NNS	nmod	O
.	.	punct	O

N-Hydroxy-2-acetylaminofluorene	NN	nsubj	O
(	-LRB-	punct	O
N-OH-AAF	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
the	DT	det	O
proximate	NN	compound	O
carcinogenic	JJ	amod	O
metabolite	NN	ROOT	O
of	IN	case	O
the	DT	det	O
powerful	JJ	amod	O
rat	NN	compound	O
liver	NN	compound	O
carcinogen	NN	compound	O
2-acetylaminofluorene	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
transgenic	JJ	amod	O
Big	NNP	compound	O
Blue	NNP	compound	O
(	-LRB-	punct	O
R	NN	compound	O
)	-RRB-	punct	O
rats	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
examine	VB	xcomp	O
the	DT	det	O
relationship	NN	dobj	O
between	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
mutagenicity	NN	nmod	O
and	CC	cc	O
DNA	NN	compound	O
adduct	NN	compound	O
formation	NN	conj	O
by	IN	case	O
N-OH-AAF	NN	nmod	O
in	IN	case	O
the	DT	det	O
target	NN	compound	O
liver	NN	nmod	O
compared	VBN	case	O
with	IN	case	O
that	DT	nmod	O
in	IN	case	O
nontarget	NN	compound	O
tissues	NNS	nmod	O
.	.	punct	O

Male	JJ	amod	O
rats	NNS	nsubjpass	O
were	VBD	auxpass	O
given	VBN	ROOT	O
one	CD	dobj	O
,	,	punct	O
two	CD	conj	O
,	,	punct	O
or	CC	cc	O
four	CD	nummod	O
doses	NNS	conj	O
of	IN	case	O
25	CD	compound	O
mg	NN	compound	O
N-OH-AAF/kg	NN	compound	O
body	NN	compound	O
weight	NN	nmod	O
by	IN	prep	O
i.p.	RB	dep	O
injection	NN	dobj	O
at	IN	case	O
4-day	JJ	amod	O
intervals	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
groups	NNS	nsubjpass	O
of	IN	case	O
treated	VBN	amod	O
and	CC	cc	O
control	JJ	conj	O
rats	NNS	nmod	O
were	VBD	auxpass	O
euthanized	VBN	conj	O
up	RB	advmod	O
to	TO	quantmod	O
10	CD	nummod	O
weeks	NNS	nmod	O
after	IN	case	O
beginning	VBG	pcomp	O
the	DT	det	O
dosing	NN	dobj	O
.	.	punct	O

Mutant	JJ	amod	O
frequencies	NNS	nsubjpass	O
were	VBD	auxpass	O
measured	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
spleen	NN	compound	B-DNA
lymphocyte	NN	compound	I-DNA
hprt	NN	compound	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
lacI	NN	compound	O
mutant	JJ	amod	O
frequencies	NNS	nsubjpass	O
were	VBD	auxpass	O
determined	VBN	conj	O
in	IN	case	O
the	DT	det	O
liver	NN	compound	O
and	CC	cc	O
spleen	NN	conj	O
lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

At	IN	prep	O
6	CD	nummod	O
weeks	NNS	pobj	O
after	IN	prep	O
beginning	VBG	pcomp	O
the	DT	det	O
dosing	NN	dobj	O
,	,	punct	O
the	DT	det	O
hprt	NN	amod	O
mutant	JJ	amod	O
frequency	NN	prep	O
in	IN	case	O
spleen	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
from	IN	case	O
the	DT	det	O
four-dose	JJ	amod	O
group	NN	nmod	O
was	VBD	ROOT	O
16.5	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-6	CD	attr	O
)	-RRB-	punct	O
compared	VBN	prep	O
with	IN	case	O
3.2	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-6	CD	nmod	O
)	-RRB-	punct	O
in	IN	case	O
control	JJ	amod	O
animals	NNS	nmod	O
.	.	punct	O

Also	RB	advmod	O
at	IN	case	O
6	CD	nummod	O
weeks	NNS	nmod	O
,	,	punct	O
rats	NNS	nsubj	O
given	VBN	ROOT	O
one	CD	dobj	O
,	,	punct	O
two	CD	conj	O
,	,	punct	O
or	CC	cc	O
four	CD	nummod	O
doses	NNS	nsubj	O
of	IN	case	O
N-OH-AAF	NN	nmod	O
had	VBD	conj	O
lacI	NN	compound	O
mutant	JJ	amod	O
frequencies	NNS	dobj	O
in	IN	case	O
the	DT	det	O
liver	NN	nmod	O
of	IN	case	O
97.6	CD	nmod	O
,	,	punct	O
155.6	CD	conj	O
,	,	punct	O
and	CC	cc	O
406.8	CD	conj	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-6	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
compared	VBN	case	O
with	IN	case	O
a	DT	det	O
control	JJ	amod	O
frequency	NN	advcl	O
of	IN	case	O
25.7	CD	nmod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-6	CD	appos	O
)	-RRB-	punct	O
;	:	punct	O
rats	NNS	nsubj	O
given	VBN	parataxis	O
four	CD	nummod	O
doses	NNS	dobj	O
had	VBD	conj	O
lacI	NN	compound	O
mutant	JJ	amod	O
frequencies	NNS	dobj	O
in	IN	case	O
spleen	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
of	IN	case	O
55.8	CD	nmod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-6	CD	appos	O
)	-RRB-	punct	O
compared	VBN	case	O
with	IN	case	O
a	DT	det	O
control	JJ	amod	O
frequency	NN	advcl	O
of	IN	case	O
20.4	CD	nmod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-6	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Additional	JJ	amod	O
rats	NNS	nsubjpass	O
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
for	IN	case	O
DNA	NN	compound	O
adduct	NN	compound	O
formation	NN	nmod	O
in	IN	case	O
the	DT	det	O
liver	NN	nmod	O
,	,	punct	O
spleen	NN	compound	B-cell_type
lymphocytes	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
bone	NN	compound	O
marrow	NN	conj	O
by	IN	case	O
(	-LRB-	punct	O
32	CD	nummod	O
)	-RRB-	punct	O
P-postlabeling	NN	nmod	O
.	.	punct	O

Adduct	NN	compound	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
conducted	VBN	ROOT	O
1	CD	nummod	O
day	NN	npadvmod	O
after	IN	case	O
one	CD	pobj	O
,	,	punct	O
two	CD	npadvmod	O
,	,	punct	O
and	CC	cc	O
four	CD	nummod	O
treatments	NNS	conj	O
with	IN	case	O
N-OH-AAF	NN	nmod	O
,	,	punct	O
5	CD	nummod	O
days	NNS	nmod	O
after	IN	case	O
one	CD	nummod	O
treatment	NN	nmod	O
,	,	punct	O
and	CC	cc	O
9	CD	nummod	O
days	NNS	npadvmod	O
after	IN	prep	O
two	CD	nummod	O
treatments	NNS	pobj	O
.	.	punct	O

N-	NN	compound	O
(	-LRB-	punct	O
Deoxyguanosin-8-yl	NN	appos	O
)	-RRB-	punct	O
-2-aminofluorene	NN	nsubj	O
was	VBD	cop	O
the	DT	det	O
major	JJ	amod	O
DNA	NN	compound	O
adduct	NN	ROOT	O
identified	VBN	acl	O
in	IN	case	O
all	PDT	det:predet	O
the	DT	det	O
tissues	NNS	nmod	O
examined	VBN	acl	O
.	.	punct	O

Adduct	NN	compound	O
concentrations	NNS	nsubj	O
increased	VBD	ROOT	O
with	IN	case	O
total	JJ	amod	O
dose	NN	nmod	O
to	TO	case	O
maximum	NN	compound	O
values	NNS	nmod	O
in	IN	case	O
samples	NNS	nmod	O
taken	VBN	advcl	O
1	CD	nummod	O
day	NN	npadvmod	O
after	IN	case	O
two	CD	nummod	O
doses	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
remained	VBD	conj	O
essentially	RB	advmod	O
the	DT	det	O
same	JJ	advmod	O
after	IN	case	O
four	CD	nummod	O
doses	NNS	nmod	O
.	.	punct	O

In	IN	case	O
samples	NNS	nmod	O
taken	VBN	acl	O
after	IN	case	O
four	CD	nummod	O
doses	NNS	nmod	O
,	,	punct	O
adduct	NN	compound	O
levels	NNS	nsubj	O
were	VBD	cop	O
103	CD	nummod	O
,	,	punct	O
28	CD	conj	O
,	,	punct	O
and	CC	cc	O
7	CD	conj	O
fmol/microg	NN	ROOT	O
of	IN	case	O
DNA	NN	nmod	O
in	IN	case	O
liver	NN	nmod	O
,	,	punct	O
spleen	NN	compound	B-cell_type
lymphocytes	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
bone	NN	compound	O
marrow	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
extent	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
DNA	NN	compound	O
adduct	NN	compound	O
formation	NN	nmod	O
and	CC	cc	O
mutant	JJ	amod	O
induction	NN	conj	O
correlates	VBZ	ccomp	O
with	IN	case	O
the	DT	det	O
organ	NN	compound	O
specificity	NN	nmod	O
for	IN	case	O
N-OH-AAF	NN	amod	O
carcinogenesis	NN	nmod	O
in	IN	case	O
the	DT	det	O
rat	NN	nmod	O
.	.	punct	O

Environ.	NNP	compound	O
Mol.	NNP	compound	O
Mutagen.	NNP	ROOT	O
37	CD	nummod	O
:	:	punct	O
195-202	CD	nummod	O
,	,	punct	O
2001	CD	appos	O
.	.	punct	O

Published	VBN	compound	O
2001	CD	nummod	O
Wiley-Liss	NNP	compound	O
,	,	punct	O
Inc	NNP	ROOT	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
Mad1	NN	nmod	B-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
leads	VBZ	ROOT	O
to	TO	case	O
reduced	VBN	amod	O
thymic	JJ	amod	O
cellularity	NN	nmod	O
and	CC	cc	O
impaired	JJ	amod	O
mitogen-induced	JJ	amod	O
proliferation	NN	conj	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
Mad1	NN	compound	B-protein
function	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
transgenic	JJ	amod	O
mice	NNS	nsubjpass	O
were	VBD	auxpass	O
generated	VBN	ROOT	O
that	WDT	nsubj	O
express	VBP	ccomp	O
a	DT	det	O
Mad1	NN	compound	B-DNA
transgene	NN	dobj	I-DNA
in	IN	case	O
T	NN	compound	B-cell_type
lineage	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
proximal	JJ	amod	B-DNA
lck	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Thymus	NN	compound	O
size	NN	nsubjpass	O
in	IN	case	O
lck-Mad1	NN	amod	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
is	VBZ	auxpass	O
drastically	RB	advmod	O
reduced	VBN	ROOT	O
although	IN	mark	O
representation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
various	JJ	amod	O
thymocyte	NN	compound	B-cell_type
sub	NN	compound	I-cell_type
populations	NNS	nmod	I-cell_type
appears	VBZ	advcl	O
normal	JJ	xcomp	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
more	RBR	advmod	O
closely	RB	advmod	O
any	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
Mad1	NN	compound	O
expression	NN	nmod	O
on	IN	case	O
thymocytes	NNS	nmod	B-cell_type
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
thymic	JJ	amod	O
selection	NN	dobj	O
using	VBG	acl	O
MHC	NN	compound	O
class	NN	compound	O
I-restricted	JJ	amod	O
H-Y-TCR	NN	compound	O
transgenic	JJ	amod	O
mice	NNS	dobj	O
.	.	punct	O

Mad1	NN	compound	O
expression	NN	nsubj	O
in	FW	compound	O
vivo	FW	advmod	O
reduces	VBZ	ROOT	O
the	DT	det	O
efficiency	NN	dobj	O
of	IN	case	O
positive	JJ	amod	O
selection	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
thymocytes	NNS	nsubj	B-cell_type
and	CC	cc	O
splenic	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
from	IN	case	O
lck-Mad1	JJ	amod	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
display	VBP	ROOT	O
a	DT	det	O
profound	JJ	amod	O
proliferative	JJ	amod	O
defect	NN	dobj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
activation	NN	nmod	O
with	IN	case	O
either	CC	cc:preconj	O
PMA/Ionomycin	NN	nmod	O
or	CC	cc	O
immobilized	VBN	amod	B-protein
anti-CD3/CD28	NN	compound	I-protein
antibody	NN	conj	I-protein
.	.	punct	O

This	DT	det	O
proliferative	JJ	amod	O
defect	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
reversed	VBN	ROOT	O
by	IN	case	O
addition	NN	nmod	O
of	IN	case	O
exogenous	JJ	amod	B-protein
IL-2	NN	nmod	I-protein
and	CC	cc	O
is	VBZ	cop	O
p53-independent	JJ	conj	O
.	.	punct	O

The	DT	det	O
growth	NN	compound	O
inhibition	NN	nsubjpass	O
caused	VBN	acl	O
by	IN	case	O
Mad1	NN	nmod	B-protein
is	VBZ	auxpass	O
overcome	VBN	ROOT	O
by	IN	case	O
expression	NN	nmod	O
of	IN	case	O
active	JJ	amod	B-protein
c-Myc	NN	nmod	I-protein
.	.	punct	O

Differential	JJ	amod	O
requirement	NN	ROOT	O
for	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
PU.1	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
generation	NN	nmod	O
of	IN	case	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
versus	CC	cc	O
B	NN	compound	B-cell_type
and	CC	cc	I-cell_type
T	NN	conj	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

PU.1	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
Ets	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
required	VBN	acl	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
various	JJ	amod	O
lymphoid	JJ	nmod	B-cell_line
and	CC	cc	I-cell_line
myeloid	JJ	conj	I-cell_line
cell	NN	compound	I-cell_line
lineages	NNS	dep	I-cell_line
,	,	punct	O
but	CC	cc	O
its	PRP$	nmod:poss	O
role	NN	nsubjpass	O
in	IN	case	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
NK	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
cell	NN	compound	I-cell_type
development	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
known	VBN	conj	O
.	.	punct	O

The	DT	det	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
PU.1	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
expressed	VBN	ccomp	O
in	IN	case	O
NK	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
that	IN	mark	O
,	,	punct	O
on	IN	case	O
cell	NN	compound	O
transfer	NN	nmod	O
into	IN	case	O
alymphoid	JJ	amod	O
Rag2/gammac	NN	compound	O
(	-LRB-	punct	O
-/-	JJ	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	O
,	,	punct	O
hematopoietic	JJ	amod	B-cell_type
progenitors	NNS	nsubj	I-cell_type
of	IN	case	O
PU.1	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
-/-	JJ	compound	I-cell_type
)	-RRB-	punct	I-cell_type
fetal	JJ	amod	I-cell_type
liver	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
could	MD	aux	O
generate	VB	conj	O
functional	JJ	amod	O
NK	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
but	CC	cc	O
not	RB	cc	O
B	NN	compound	B-cell_type
or	CC	cc	I-cell_type
T	NN	conj	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Nevertheless	RB	advmod	O
,	,	punct	O
the	DT	det	O
numbers	NNS	nsubjpass	O
of	IN	case	O
bone	NN	compound	B-cell_type
marrow	NN	compound	I-cell_type
NK	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
precursors	NNS	nmod	I-cell_type
and	CC	cc	O
splenic	JJ	amod	B-cell_type
mature	JJ	amod	I-cell_type
NK	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
were	VBD	auxpass	O
reduced	VBN	ROOT	O
compared	VBN	case	O
to	TO	case	O
controls	NNS	advcl	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
PU.1	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
-/-	JJ	compound	I-cell_type
)	-RRB-	punct	I-cell_type
NK	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
displayed	VBD	ROOT	O
reduced	VBN	amod	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
receptors	NNS	nmod	O
for	IN	case	O
stem	NN	compound	B-protein
cell	NN	compound	I-protein
factor	NN	nmod	I-protein
and	CC	cc	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	conj	I-protein
)	-RRB-	punct	I-protein
-7	CD	nummod	I-protein
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
nonredundant	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
PU.1	NN	nmod	B-protein
in	IN	mark	O
regulating	VBG	acl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
these	DT	det	O
cytokine	NN	compound	B-DNA
receptor	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
during	IN	case	O
NK	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
.	.	punct	O

PU.1	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
-/-	JJ	compound	I-cell_type
)	-RRB-	punct	I-cell_type
NK	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
also	RB	advmod	O
showed	VBD	ROOT	O
defective	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
inhibitory	JJ	amod	O
and	CC	cc	O
activating	VBG	conj	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
Ly49	NN	compound	B-protein
family	NN	nmod	I-protein
and	CC	cc	O
failed	VBD	conj	O
to	TO	mark	O
proliferate	VB	xcomp	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
IL-2	NN	nmod	B-protein
and	CC	cc	O
IL-12	NN	conj	B-protein
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
despite	IN	case	O
the	DT	det	O
less	RBR	advmod	O
stringent	JJ	amod	O
requirement	NN	nmod	O
for	IN	case	O
PU.1	NN	nmod	B-protein
in	IN	case	O
NK	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
compared	VBN	case	O
to	TO	case	O
B	NN	nmod	B-cell_type
and	CC	cc	I-cell_type
T	NN	conj	I-cell_type
cells	NNS	dep	I-cell_type
,	,	punct	O
PU.1	NN	nsubj	B-protein
regulates	VBZ	ROOT	O
NK	NN	compound	O
cell	NN	dobj	O
differentiation	NN	dep	O
and	CC	cc	O
homeostasis	NN	conj	O
.	.	punct	O

Benzene-extracted	JJ	amod	O
components	NNS	nsubj	O
are	VBP	cop	O
important	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
major	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
diesel	NN	compound	O
exhaust	NN	compound	O
particles	NNS	nmod	O
:	:	punct	O
effect	NN	dep	O
on	IN	case	O
interleukin-8	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
bronchial	JJ	amod	I-cell_type
epithelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Epidemiologic	JJ	amod	O
and	CC	cc	O
experimental	JJ	conj	O
studies	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
diesel	NN	compound	O
exhaust	NN	compound	O
particles	NNS	nsubj	O
(	-LRB-	punct	O
DEPs	NNS	appos	O
)	-RRB-	punct	O
may	MD	aux	O
be	VB	cop	O
related	JJ	ccomp	O
to	TO	mark	O
increasing	VBG	advcl	O
respiratory	JJ	amod	O
mortality	NN	dobj	O
and	CC	cc	O
morbidity	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
DEPs	NNS	nsubj	O
augmented	VBD	ccomp	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
inflammatory	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
by	IN	case	O
human	JJ	amod	B-cell_type
airway	NN	compound	I-cell_type
epithelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

To	TO	mark	O
better	RBR	advmod	O
understand	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
of	IN	case	O
their	PRP$	nmod:poss	O
proinflammatory	JJ	amod	O
activities	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
several	JJ	amod	O
components	NNS	nmod	O
extracted	VBN	acl	O
from	IN	case	O
DEPs	NNS	nmod	O
on	IN	case	O
interleukin	NN	compound	O
(	-LRB-	punct	O
IL	NN	compound	O
)	-RRB-	punct	O
-8	CD	nummod	O
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_line
bronchial	JJ	amod	I-cell_line
epithelial	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
BEAS-2B	NN	nmod	I-cell_line
and	CC	cc	O
normal	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
airway	NN	compound	I-cell_type
epithelial	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
obtained	VBN	acl	O
from	IN	case	O
very	RB	advmod	O
peripheral	JJ	amod	O
airways	NNS	nmod	O
by	IN	case	O
an	DT	det	O
ultrathin	JJ	amod	O
bronchoscope	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
used	VBD	ROOT	O
several	JJ	amod	O
agents	NNS	dobj	O
active	JJ	amod	O
on	IN	case	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	nmod	O
in	IN	case	O
cytokine	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
protein	NN	compound	O
kinase	NN	compound	O
C	NN	compound	O
inhibitor	NN	compound	O
staurosporin	NN	nmod	O
,	,	punct	O
antioxidant	JJ	amod	O
agents	NNS	conj	O
including	VBG	case	O
N-acetyl	JJ	amod	O
cysteine	NN	nmod	O
(	-LRB-	punct	O
NAC	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
pyrrolidine	NN	compound	O
dithiocarbamate	NN	conj	O
(	-LRB-	punct	O
PDTC	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
p38	NN	compound	B-protein
mitogen-activated	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	O
MAPK	NN	appos	B-protein
)	-RRB-	punct	O
inhibitor	NN	compound	O
SB203580	NN	conj	O
.	.	punct	O

Benzene-extracted	JJ	amod	O
components	NNS	nsubj	O
showed	VBD	ROOT	O
effects	NNS	dobj	O
mimicking	VBG	acl	O
DEPs	NNS	dobj	O
on	IN	case	O
IL-8	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
release	NN	dep	O
of	IN	case	O
several	JJ	amod	O
cytokines	NNS	nmod	B-protein
(	-LRB-	punct	O
IL-8	NN	dep	B-protein
;	:	punct	O
granulocyte	NN	compound	B-protein
macrophage	NN	nmod:npmod	I-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	conj	I-protein
;	:	punct	O
and	CC	cc	O
regulated	VBN	conj	O
on	IN	case	O
activation	NN	nmod	O
,	,	punct	O
normal	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
expressed	VBD	acl	O
and	CC	cc	O
secreted	VBN	conj	O
)	-RRB-	punct	O
and	CC	cc	O
nuclear	JJ	amod	O
factor	NN	compound	O
(	-LRB-	punct	O
NF	NN	compound	O
)	-RRB-	punct	O
-kappa	NN	compound	O
B	NN	compound	O
activation	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
found	VBD	ROOT	O
that	IN	mark	O
NAC	NN	nsubj	O
,	,	punct	O
PDTC	NN	conj	O
,	,	punct	O
and	CC	cc	O
SB203580	NN	conj	O
suppressed	VBD	ccomp	O
the	DT	det	O
activities	NNS	dobj	O
of	IN	case	O
DEPs	NNS	nmod	O
and	CC	cc	O
their	PRP$	nmod:poss	O
benzene	NN	compound	O
extracts	NNS	conj	O
,	,	punct	O
suggesting	VBG	advcl	O
the	DT	det	O
roles	NNS	dobj	O
of	IN	case	O
oxidants-mediated	JJ	amod	O
NF-kappa	NN	compound	O
B	NN	compound	O
activation	NN	nmod	O
and	CC	cc	O
p38MAPK	NN	compound	B-protein
pathways	NNS	conj	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
benzo	NN	nsubj	O
[	-LRB-	punct	O
a	DT	det	O
]	-RRB-	punct	O
pyrene	NN	dep	O
,	,	punct	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
important	JJ	amod	O
compounds	NNS	nmod	O
included	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
benzene	NN	compound	O
component	NN	nmod	O
,	,	punct	O
replicated	VBD	conj	O
the	DT	det	O
activities	NNS	dobj	O
shown	VBN	acl	O
by	IN	case	O
DEPs	NNS	nmod	O
.	.	punct	O

The	DT	det	O
nuclear	JJ	amod	B-protein
receptor	NN	compound	I-protein
PPAR	NN	compound	I-protein
gamma	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
expressed	VBN	ROOT	O
by	IN	case	O
mouse	NN	compound	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
PPAR	NN	compound	O
gamma	NN	compound	O
agonists	NNS	nsubj	O
induce	VBP	conj	O
apoptosis	NN	dobj	O
.	.	punct	O

Peroxisome	NN	compound	B-protein
proliferator-activated	JJ	amod	I-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	I-protein
PPAR	NN	compound	I-protein
)	-RRB-	punct	I-protein
-gamma	NN	nsubj	I-protein
is	VBZ	cop	O
a	DT	det	O
nuclear	JJ	amod	B-protein
hormone	NN	compound	I-protein
receptor	NN	ROOT	I-protein
that	WDT	nsubj	O
serves	VBZ	acl:relcl	O
as	IN	case	O
a	DT	det	O
trans	JJ	amod	O
factor	NN	nmod	O
to	TO	mark	O
regulate	VB	xcomp	O
lipid	NN	compound	O
metabolism	NN	dobj	O
.	.	punct	O

Intense	JJ	amod	O
interest	NN	nsubjpass	O
is	VBZ	auxpass	O
focused	VBN	ROOT	O
on	IN	case	O
PPAR-gamma	NN	nmod	B-protein
and	CC	cc	O
its	PRP$	nmod:poss	O
ligands	NNS	conj	O
owing	VBG	acl	O
to	TO	case	O
its	PRP$	nmod:poss	O
putative	JJ	amod	O
role	NN	nmod	O
in	IN	case	O
adipocyte	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

Little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
about	IN	case	O
the	DT	det	O
functions	NNS	nmod	O
of	IN	case	O
PPAR-gamma	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
,	,	punct	O
especially	RB	advmod	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
naive	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
activated	VBN	conj	I-cell_type
ovalbumin-specific	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
from	IN	case	O
DO11.10-transgenic	JJ	amod	O
mice	NNS	nmod	O
express	VBP	ccomp	O
PPAR-gamma	NN	dobj	B-RNA
mRNA	NN	dep	O
and	CC	cc	O
protein	NN	conj	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
determine	VB	advcl	O
the	DT	det	O
function	NN	dobj	O
of	IN	case	O
PPAR-gamma	NN	nmod	B-protein
,	,	punct	O
T	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
stimulated	VBN	ROOT	O
with	IN	case	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	nmod	O
and	CC	cc	O
ionomycin	NN	conj	O
or	CC	cc	O
antigen	NN	conj	O
and	CC	cc	O
antigen-presenting	JJ	conj	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Simultaneous	JJ	amod	O
exposure	NN	nsubj	O
to	TO	case	O
PPAR-gamma	NN	compound	O
ligands	NNS	nmod	O
(	-LRB-	punct	O
e.g.	FW	advmod	O
15-deoxy-Delta	NN	dep	O
(	-LRB-	punct	O
12	CD	nummod	O
,	,	punct	O
14	CD	nummod	O
)	-RRB-	punct	O
-prostaglandin	NN	compound	O
J	NN	dep	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
troglitazone	NN	appos	O
)	-RRB-	punct	O
showed	VBD	ROOT	O
drastic	JJ	amod	O
inhibition	NN	dobj	O
of	IN	case	O
proliferation	NN	nmod	O
and	CC	cc	O
significant	JJ	amod	O
decreases	NNS	conj	O
in	IN	case	O
cell	NN	compound	O
viability	NN	nmod	O
.	.	punct	O

The	DT	det	O
decrease	NN	nsubj	O
in	IN	case	O
cell	NN	compound	O
viability	NN	nmod	O
was	VBD	cop	O
due	JJ	ROOT	O
to	TO	case	O
apoptosis	NN	nmod	O
of	IN	case	O
the	DT	det	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
occurred	VBD	conj	O
only	RB	advmod	O
when	WRB	advmod	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
treated	VBN	advcl	O
with	IN	case	O
PPAR-gamma	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
not	RB	cc	O
PPAR-alpha	NN	compound	O
agonists	NNS	conj	O
,	,	punct	O
revealing	VBG	xcomp	O
specificity	NN	dobj	O
of	IN	case	O
this	DT	det	O
response	NN	nmod	O
for	IN	case	O
PPAR-gamma	NN	nmod	B-protein
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
PPAR-gamma	NN	compound	O
agonists	NNS	nsubj	O
play	VBP	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
regulating	VBG	advcl	O
T	NN	nmod:npmod	O
cell-mediated	JJ	amod	O
immune	JJ	amod	O
responses	NNS	dobj	O
by	IN	mark	O
inducing	VBG	advcl	O
apoptosis	NN	dobj	O
.	.	punct	O

T	NN	compound	O
cell	NN	compound	O
death	NN	nsubj	O
via	IN	case	O
PPAR-gamma	NN	compound	O
ligation	NN	nmod	O
may	MD	aux	O
act	VB	ROOT	O
as	IN	case	O
a	DT	det	O
potent	JJ	amod	O
anti-inflammatory	JJ	amod	O
signal	NN	nmod	O
in	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
,	,	punct	O
and	CC	cc	O
ligands	NNS	nsubjpass	O
could	MD	aux	O
possibly	RB	advmod	O
be	VB	auxpass	O
used	VBN	conj	O
to	TO	mark	O
control	VB	xcomp	O
disorders	NNS	dobj	O
in	IN	case	O
which	WDT	nmod	O
excessive	JJ	amod	O
inflammation	NN	nsubj	O
occurs	VBZ	acl:relcl	O
.	.	punct	O

Suppression	NN	ROOT	O
of	IN	case	O
lung	NN	compound	O
inflammation	NN	nmod	O
in	IN	case	O
rats	NNS	nmod	O
by	IN	case	O
prevention	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	compound	O
activation	NN	nmod	O
in	IN	case	O
the	DT	det	O
liver	NN	nmod	O
.	.	punct	O

Activation	NN	nsubjpass	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
and	CC	cc	O
production	NN	conj	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
-dependent	JJ	amod	O
chemokines	NNS	nmod	B-protein
are	VBP	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
neutrophilic	JJ	amod	O
lung	NN	compound	O
inflammation	NN	nmod	O
.	.	punct	O

Calpain-1	NN	compound	O
inhibitor	NN	nsubj	O
(	-LRB-	punct	O
CI-1	NN	appos	O
)	-RRB-	punct	O
blocks	VBZ	ROOT	O
activation	NN	dobj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
by	IN	mark	O
preventing	VBG	advcl	O
proteolysis	NN	dobj	O
of	IN	case	O
the	DT	det	O
inhibitory	JJ	amod	O
protein	NN	compound	O
IkappaB-alpha	NN	nmod	B-protein
by	IN	case	O
the	DT	det	O
ubiquitin/proteasome	NN	amod	O
pathway	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
hypothesized	VBD	ROOT	O
that	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
proteasome	NN	compound	O
function	NN	nmod	O
with	IN	case	O
CI-1	NN	nmod	O
would	MD	aux	O
block	VB	ccomp	O
NF-kappaB	NN	compound	O
activation	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
after	IN	case	O
intraperitoneal	JJ	amod	O
(	-LRB-	punct	O
i.p.	RB	dep	O
)	-RRB-	punct	O
treatment	NN	nmod	O
with	IN	case	O
bacterial	JJ	amod	O
lipopolysaccharide	NN	nmod	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
NF-kappaB	NN	compound	O
inhibition	NN	nsubjpass	O
would	MD	aux	O
be	VB	auxpass	O
associated	VBN	conj	O
with	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
chemokine	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
attenuation	NN	conj	O
of	IN	case	O
neutrophilic	JJ	amod	O
alveolitis	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
treated	VBD	ROOT	O
rats	NNS	dobj	O
with	IN	case	O
a	DT	det	O
single	JJ	nmod	O
i.p.	IN	cc	O
injection	NN	conj	O
of	IN	case	O
CI-1	NN	nmod	O
(	-LRB-	punct	O
10	CD	nummod	O
mg/kg	NN	appos	O
)	-RRB-	punct	O
two	CD	nummod	O
hours	NNS	dep	O
prior	JJ	case	O
to	TO	mwe	O
i.p.	RB	mwe	O
LPS	NN	nmod	O
(	-LRB-	punct	O
7	CD	nummod	O
mg/kg	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
Cl-1	NN	nmod	O
prevented	VBD	ROOT	O
degradation	NN	dobj	O
of	IN	case	O
IkappaB-alpha	NN	nmod	B-protein
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
liver	NN	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
LPS	NN	nmod	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
Cl-1	NN	compound	O
treatment	NN	nsubj	O
had	VBD	parataxis	O
no	DT	neg	O
detected	VBN	amod	O
effect	NN	dobj	O
on	IN	case	O
NF-kappaB	NN	compound	O
activation	NN	nmod	O
in	IN	case	O
lung	NN	compound	O
tissue	NN	nmod	O
.	.	punct	O

CI-1	NN	compound	O
treatment	NN	nsubj	O
prior	RB	case	O
to	TO	case	O
LPS	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
40	CD	nummod	O
%	NN	nmod:npmod	O
lower	JJR	amod	O
MIP-2	NN	compound	O
concentration	NN	nmod	O
in	IN	case	O
lung	NN	compound	O
lavage	NN	compound	O
fluid	NN	nmod	O
compared	VBN	case	O
to	TO	case	O
rats	NNS	advcl	O
treated	VBN	acl	O
with	IN	case	O
vehicle	NN	nmod	O
prior	RB	case	O
to	TO	case	O
LPS	NN	nmod	O
(	-LRB-	punct	O
502	CD	nummod	O
+/-	CC	cc	O
112	CD	conj	O
pg/ml	NN	dep	O
vs.	CC	cc	O
859	CD	compound	O
+/-144	CD	nmod	O
pg/ml	NN	dep	O
,	,	punct	O
P	NN	compound	O
<	-LRB-	appos	O
0.05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
CI-1	NN	compound	O
treatment	NN	nsubj	O
substantially	RB	advmod	O
inhibited	VBD	ROOT	O
LPS-induced	JJ	amod	O
neutrophilic	JJ	amod	O
alveolitis	NN	dobj	O
(	-LRB-	punct	O
2.7+	NN	appos	O
/-	.	punct	O
1.2	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
5	CD	ROOT	O
)	-RRB-	punct	O
vs.	CC	cc	O
43.7	CD	nummod	O
+/-	CC	cc	O
12.2	CD	conj	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
5	CD	dep	O
)	-RRB-	punct	O
lung	NN	compound	B-cell_type
lavage	NN	compound	I-cell_type
neutrophils	NNS	conj	I-cell_type
,	,	punct	O
P	NN	compound	O
<	-LRB-	appos	O
0.01	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
NF-kappaB	NN	compound	O
inhibition	NN	nsubj	O
in	IN	case	O
the	DT	det	O
liver	NN	nmod	O
can	MD	aux	O
alter	VB	ccomp	O
lung	NN	compound	O
inflammation	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
systemic	JJ	amod	O
LPS	NN	compound	O
treatment	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
a	DT	det	O
liver-lung	JJ	amod	O
interaction	NN	nsubj	O
contributes	VBZ	ccomp	O
to	TO	case	O
the	DT	det	O
inflammatory	JJ	amod	O
response	NN	nmod	O
of	IN	case	O
the	DT	det	O
lung	NN	nmod	O
.	.	punct	O

Notch1	NN	nsubj	B-protein
regulates	VBZ	ROOT	O
maturation	NN	dobj	O
of	IN	case	O
CD4+	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
CD8+	JJ	conj	I-cell_type
thymocytes	NNS	nmod	I-cell_type
by	IN	mark	O
modulating	VBG	advcl	O
TCR	NN	compound	O
signal	NN	compound	O
strength	NN	dobj	O
.	.	punct	O

Notch	NN	compound	O
signaling	NN	nsubj	O
regulates	VBZ	ROOT	O
cell	NN	compound	O
fate	NN	compound	O
decisions	NNS	dobj	O
in	IN	case	O
multiple	JJ	amod	O
lineages	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
in	IN	case	O
this	DT	det	O
report	NN	nmod	O
that	IN	mark	O
retroviral	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
activated	VBN	amod	O
Notch1	NN	nmod	B-protein
in	IN	case	O
mouse	NN	compound	B-cell_type
thymocytes	NNS	nmod	I-cell_type
abrogates	VBZ	ccomp	O
differentiation	NN	dobj	O
of	IN	case	O
immature	JJ	amod	B-cell_type
CD4+CD8+	JJ	compound	I-cell_type
thymocytes	NNS	nmod	I-cell_type
into	IN	case	O
both	CC	cc:preconj	O
CD4	NN	nmod	B-cell_type
and	CC	cc	I-cell_type
CD8	NN	conj	I-cell_type
mature	JJ	amod	I-cell_type
single-positive	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	dep	I-cell_type
.	.	punct	O

The	DT	det	O
ability	NN	nsubjpass	O
of	IN	case	O
Notch1	NN	nmod	B-protein
to	TO	mark	O
inhibit	VB	acl	O
T	NN	compound	O
cell	NN	compound	O
development	NN	dobj	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
with	IN	case	O
both	CC	cc:preconj	O
normal	JJ	nmod	B-cell_type
and	CC	cc	I-cell_type
TCR	NN	conj	I-cell_type
transgenic	JJ	amod	I-cell_type
thymocytes	NNS	dep	I-cell_type
.	.	punct	O

Notch1	JJ	nmod:npmod	B-protein
-mediated	JJ	amod	O
developmental	JJ	amod	O
arrest	NN	nsubj	O
was	VBD	cop	O
dose	NN	nmod:npmod	O
dependent	JJ	ROOT	O
and	CC	cc	O
was	VBD	auxpass	O
associated	VBN	conj	O
with	IN	case	O
impaired	JJ	amod	O
thymocyte	NN	compound	O
responses	NNS	nmod	O
to	TO	case	O
TCR	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

Notch1	NN	nsubj	B-protein
also	RB	advmod	O
inhibited	VBD	ROOT	O
TCR-mediated	JJ	amod	O
signaling	NN	dobj	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
constitutively	RB	advmod	O
active	JJ	amod	O
Notch1	NN	nsubj	B-protein
abrogates	VBZ	ccomp	O
CD4+	JJ	amod	O
and	CC	cc	O
CD8+	JJ	conj	O
maturation	NN	dobj	O
by	IN	mark	O
interfering	VBG	advcl	O
with	IN	case	O
TCR	NN	compound	O
signal	NN	compound	O
strength	NN	nmod	O
and	CC	cc	O
provide	VBP	conj	O
an	DT	det	O
explanation	NN	dobj	O
for	IN	case	O
the	DT	det	O
physiological	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
Notch	NN	compound	O
expression	NN	nmod	O
during	IN	case	O
thymocyte	NN	compound	O
development	NN	nmod	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
SART3	NN	compound	B-protein
antigen	NN	nmod	I-protein
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
CTLs	NNS	nmod	B-cell_type
by	IN	case	O
SART3-derived	JJ	amod	O
peptides	NNS	nmod	O
in	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
recently	RB	advmod	O
reported	VBD	ROOT	O
the	DT	det	O
SART3	NN	compound	B-protein
tumour-rejection	NN	compound	I-protein
antigen	NN	dobj	I-protein
as	IN	mark	O
possessing	VBG	advcl	O
tumour	NN	compound	O
epitopes	NNS	dobj	O
capable	JJ	amod	O
of	IN	mark	O
inducing	VBG	advcl	O
HLA-class	NN	amod	B-cell_type
I-restricted	JJ	amod	I-cell_type
cytotoxic	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	dobj	I-cell_type
(	-LRB-	punct	O
CTLs	NNS	appos	B-cell_type
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
investigated	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
SART3	NN	compound	B-protein
antigen	NN	nmod	I-protein
in	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
to	TO	mark	O
explore	VB	advcl	O
an	DT	det	O
appropriate	JJ	amod	O
molecule	NN	dobj	O
for	IN	case	O
use	NN	nmod	O
in	IN	case	O
specific	JJ	amod	O
immunotherapy	NN	nmod	O
of	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

The	DT	det	O
SART3	NN	compound	B-protein
antigen	NN	nsubjpass	I-protein
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
all	DT	nmod	O
of	IN	case	O
the	DT	det	O
breast	NN	compound	B-cell_line
cancer	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
tested	VBN	acl	O
,	,	punct	O
30	CD	compound	O
of	IN	advmod	O
40	CD	nummod	O
(	-LRB-	punct	O
75	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
breast	NN	compound	O
cancer	NN	compound	O
tissue	NN	compound	O
samples	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
0	CD	conj	O
of	IN	case	O
3	CD	nummod	O
non-tumourous	JJ	amod	O
breast	NN	compound	O
tissue	NN	compound	O
samples	NNS	nmod	O
.	.	punct	O

SART3	NN	nsubj	O
derived	VBD	ROOT	O
peptides	NNS	dobj	O
at	IN	case	O
positions	NNS	nmod	B-DNA
109-118	CD	nummod	I-DNA
and	CC	cc	I-DNA
315-323	CD	conj	I-DNA
induced	VBD	amod	O
HLA-A24	NN	compound	O
restricted	JJ	amod	O
CTLs	NNS	dobj	B-cell_type
that	WDT	nsubj	O
reacted	VBD	acl:relcl	O
to	TO	case	O
breast	NN	compound	B-cell_type
cancer	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
the	DT	det	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBMCs	NNS	appos	B-cell_type
)	-RRB-	punct	O
of	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
the	DT	det	O
SART3	NN	compound	B-protein
antigen	NN	nsubj	I-protein
and	CC	cc	O
its	PRP$	nmod:poss	O
peptides	NNS	conj	O
could	MD	aux	O
be	VB	cop	O
an	DT	det	O
appropriate	JJ	amod	O
molecule	NN	ROOT	O
for	IN	case	O
use	NN	nmod	O
in	IN	case	O
specific	JJ	amod	O
immunotherapy	NN	nmod	O
of	IN	case	O
the	DT	det	O
majority	NN	nmod	O
of	IN	case	O
HLA-A24-positive	JJ	amod	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O

Autostimulation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
Epstein-Barr	JJ	amod	O
virus	NN	compound	O
BRLF1	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
through	IN	case	O
consensus	NN	compound	O
Sp1	NN	nmod	B-DNA
and	CC	cc	I-DNA
Sp3	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	conj	I-DNA
.	.	punct	O

As	IN	case	O
an	DT	det	O
essential	JJ	amod	O
step	NN	nmod	O
in	IN	case	O
the	DT	det	O
lytic	JJ	amod	O
cascade	NN	nmod	O
,	,	punct	O
the	DT	det	O
Rta	NN	compound	O
homologues	NNS	nsubj	O
of	IN	case	O
gammaherpesviruses	NNS	nmod	O
all	DT	advmod	O
activate	VBP	ROOT	O
their	PRP$	nmod:poss	O
own	JJ	amod	O
expression	NN	dobj	O
.	.	punct	O

Consistent	JJ	advcl	O
with	IN	case	O
this	DT	det	O
biologic	JJ	amod	O
function	NN	nmod	O
,	,	punct	O
the	DT	det	O
Epstein-Barr	JJ	amod	O
virus	NN	compound	O
(	-LRB-	punct	O
EBV	NN	compound	O
)	-RRB-	punct	O
Rta	NN	compound	B-protein
protein	NN	nsubj	I-protein
powerfully	RB	advmod	O
stimulates	VBZ	ROOT	O
the	DT	det	O
promoter	NN	dobj	B-DNA
of	IN	case	O
its	PRP$	nmod:poss	O
own	JJ	amod	O
gene	NN	nmod	O
,	,	punct	O
Rp	NN	appos	B-DNA
,	,	punct	O
in	IN	case	O
EBV-positive	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
transient-transfection	JJ	amod	O
reporter-based	JJ	amod	O
assays	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
RpCAT	NN	nmod	B-DNA
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
Rta	NN	nmod	B-protein
by	IN	case	O
deletional	JJ	amod	O
and	CC	cc	O
site-directed	JJ	conj	O
mutagenesis	NN	nmod	O
.	.	punct	O

Two	CD	nummod	O
cognate	JJ	amod	B-DNA
Sp1	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	nsubj	I-DNA
located	JJ	amod	O
at	IN	case	O
-279	CD	nmod	O
and	CC	cc	O
-45	CD	conj	O
relative	JJ	case	O
to	TO	case	O
the	DT	det	O
transcriptional	JJ	amod	B-DNA
start	NN	compound	I-DNA
site	NN	nmod	I-DNA
proved	VBD	ROOT	O
crucial	JJ	xcomp	O
for	IN	case	O
Rta-mediated	JJ	amod	O
activation	NN	nmod	O
.	.	punct	O

Previously	RB	advmod	O
described	VBN	advcl	O
binding	VBG	amod	O
sites	NNS	nsubjpass	O
for	IN	case	O
the	DT	det	O
cellular	JJ	amod	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
Zif268	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
viral	JJ	amod	B-protein
transactivator	NN	compound	I-protein
ZEBRA	NN	conj	I-protein
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
dispensable	JJ	xcomp	O
for	IN	case	O
activation	NN	nmod	O
of	IN	case	O
RpCAT	NN	nmod	B-DNA
by	IN	case	O
Rta	NN	nmod	B-protein
.	.	punct	O

Gel	NN	compound	O
shift	NN	compound	O
analysis	NN	nsubj	O
,	,	punct	O
using	VBG	acl	O
extracts	NNS	dobj	O
of	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
latency	NN	nmod	O
or	CC	cc	O
induced	VBN	conj	O
into	IN	case	O
the	DT	det	O
lytic	JJ	amod	O
cycle	NN	nmod	O
,	,	punct	O
identified	VBD	ROOT	O
Sp1	NN	dobj	B-protein
and	CC	cc	O
Sp3	NN	conj	B-protein
as	IN	case	O
the	DT	det	O
predominant	JJ	amod	O
cellular	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
bound	VBN	acl	O
to	TO	case	O
Rp	NN	nmod	B-DNA
near	IN	case	O
-45	CD	nmod	O
.	.	punct	O

During	IN	case	O
the	DT	det	O
lytic	JJ	amod	O
cycle	NN	nmod	O
,	,	punct	O
ZEBRA	NN	nsubj	B-protein
bound	VBD	ROOT	O
Rp	NN	dobj	B-DNA
near	IN	case	O
the	DT	det	O
Sp1/Sp3	NN	compound	B-DNA
site	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
binding	NN	nsubj	O
of	IN	case	O
Sp1	NN	nmod	B-protein
and	CC	cc	O
Sp3	NN	conj	B-protein
to	TO	case	O
Rp	NN	nmod	B-DNA
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
reporter	NN	compound	O
activities	NNS	nmod	O
in	IN	case	O
the	DT	det	O
mutagenesis	NN	compound	O
study	NN	nmod	O
,	,	punct	O
establishing	VBG	xcomp	O
a	DT	det	O
direct	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
Rp	NN	nmod	B-DNA
by	IN	case	O
Rta	NN	nmod	B-protein
and	CC	cc	O
DNA	NN	conj	O
binding	NN	dep	O
by	IN	case	O
Sp1	NN	nmod	B-protein
and/or	CC	cc	O
Sp3	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
relative	JJ	amod	O
abundance	NN	nsubjpass	O
or	CC	cc	O
functional	JJ	amod	O
state	NN	conj	O
of	IN	case	O
the	DT	dep	O
cellular	JJ	amod	O
Sp1	NN	nmod	B-protein
and	CC	cc	O
Sp3	NN	conj	B-protein
transcription	NN	compound	B-protein
factors	NNS	dep	I-protein
may	MD	aux	O
be	VB	auxpass	O
altered	VBN	ROOT	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
stimuli	NNS	nmod	O
that	WDT	nsubj	O
induce	VBP	acl:relcl	O
the	DT	det	O
BRLF1	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
and	CC	cc	O
thereby	RB	advmod	O
contribute	VB	conj	O
to	TO	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
viral	JJ	amod	O
lytic	JJ	amod	O
cycle	NN	nmod	O
.	.	punct	O

Gene	NN	compound	O
transfer	NN	nsubj	O
of	IN	case	O
antisense	JJ	amod	O
hypoxia	NN	compound	B-protein
inducible	JJ	amod	I-protein
factor-1	NN	compound	I-protein
alpha	NN	nmod	I-protein
enhances	VBZ	ROOT	O
the	DT	det	O
therapeutic	JJ	amod	O
efficacy	NN	dobj	O
of	IN	case	O
cancer	NN	compound	O
immunotherapy	NN	nmod	O
.	.	punct	O

Solid	JJ	amod	O
tumors	NNS	nsubj	O
meet	VBP	ROOT	O
their	PRP$	nmod:poss	O
demands	NNS	dobj	O
for	IN	case	O
nascent	JJ	amod	O
blood	NN	compound	O
vessels	NNS	nmod	O
and	CC	cc	O
increased	VBN	amod	O
glycolysis	NN	conj	O
,	,	punct	O
to	TO	mark	O
combat	VB	advcl	O
hypoxia	NN	dobj	O
,	,	punct	O
by	IN	mark	O
activating	VBG	advcl	O
multiple	JJ	amod	O
genes	NNS	dobj	O
involved	VBN	acl	O
in	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
glucose	NN	compound	O
metabolism	NN	conj	O
.	.	punct	O

Hypoxia	NN	compound	B-protein
inducible	JJ	amod	I-protein
factor-1	NN	nsubj	I-protein
(	-LRB-	punct	O
HIF-1	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
constitutively	RB	advmod	O
expressed	VBN	amod	O
basic	JJ	amod	O
helix-loop-helix	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	ROOT	I-protein
,	,	punct	O
formed	VBN	acl	O
by	IN	case	O
the	DT	det	O
assembly	NN	nmod	O
of	IN	case	O
HIF-1alpha	NN	nmod	B-protein
and	CC	cc	O
HIF-1beta	NN	conj	B-protein
(	-LRB-	punct	O
Arnt	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
stablized	VBN	acl:relcl	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
hypoxia	NN	nmod	O
,	,	punct	O
and	CC	cc	O
rapidly	RB	advmod	O
degraded	VBN	conj	O
under	IN	case	O
normoxic	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O

It	PRP	nsubj	O
activates	VBZ	ROOT	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	O
important	JJ	amod	O
for	IN	mark	O
maintaining	VBG	advcl	O
oxygen	NN	compound	O
homeostasis	NN	dobj	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
engineered	VBN	amod	O
down-regulation	NN	nsubj	O
of	IN	case	O
HIF-1alpha	NN	nmod	B-protein
by	IN	case	O
intratumoral	JJ	amod	O
gene	NN	compound	O
transfer	NN	nmod	O
of	IN	case	O
an	DT	det	O
antisense	JJ	amod	B-DNA
HIF-1alpha	NN	compound	I-DNA
plasmid	NN	nmod	I-DNA
leads	VBZ	ccomp	O
to	TO	case	O
the	DT	det	O
down-regulation	NN	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-DNA
,	,	punct	O
and	CC	cc	O
decreased	VBN	amod	O
tumor	NN	compound	O
microvessel	NN	compound	O
density	NN	conj	O
.	.	punct	O

Antisense	JJ	amod	O
HIF-1alpha	NN	compound	O
monotherapy	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
complete	JJ	amod	O
and	CC	cc	O
permanent	JJ	conj	O
rejection	NN	nmod	O
of	IN	case	O
small	JJ	amod	O
(	-LRB-	punct	O
0.1	CD	nummod	O
cm	NN	nmod	O
in	IN	case	O
diameter	NN	amod	O
)	-RRB-	punct	O
EL-4	NN	compound	O
tumors	NNS	dep	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
unusual	JJ	acl:relcl	O
for	IN	case	O
an	DT	det	O
anti-angiogenic	JJ	amod	O
agent	NN	nmod	O
where	WRB	advmod	O
transient	JJ	amod	O
suppression	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	O
growth	NN	nmod	O
is	VBZ	cop	O
the	DT	det	O
norm	NN	acl:relcl	O
.	.	punct	O

It	PRP	nsubj	O
induced	VBD	ROOT	O
NK	NN	nmod:npmod	B-cell_type
cell	NN	nmod:npmod	I-cell_type
-dependent	JJ	amod	O
rejection	NN	dobj	O
of	IN	case	O
tumors	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
failed	VBD	conj	O
to	TO	mark	O
stimulate	VB	xcomp	O
systemic	JJ	amod	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
-mediated	JJ	amod	O
anti-tumor	JJ	amod	O
immunity	NN	dobj	O
,	,	punct	O
and	CC	cc	O
synergized	VBD	conj	O
with	IN	case	O
B7-1-mediated	JJ	amod	O
immunotherapy	NN	nmod	O
to	TO	mark	O
cause	VB	xcomp	O
the	DT	det	O
NK	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
and	CC	cc	O
CD8	NN	nmod:npmod	B-cell_type
T	NN	nmod:npmod	I-cell_type
cell	NN	nmod:npmod	I-cell_type
-dependent	JJ	amod	O
rejection	NN	dobj	O
of	IN	case	O
larger	JJR	amod	O
EL-4	NN	compound	O
tumors	NNS	nmod	O
(	-LRB-	punct	O
0.4	CD	nummod	O
cm	NN	dep	O
in	IN	case	O
diameter	NN	nmod	O
)	-RRB-	punct	O
that	WDT	nsubj	O
were	VBD	cop	O
refractory	JJ	acl:relcl	O
to	TO	case	O
monotherapies	NNS	nmod	O
.	.	punct	O

Mice	NNS	nsubj	O
cured	VBN	acl	O
of	IN	case	O
their	PRP$	nmod:poss	O
tumors	NNS	nmod	O
by	IN	case	O
combination	NN	compound	O
therapy	NN	nmod	O
resisted	VBD	ROOT	O
a	DT	det	O
rechallenge	NN	dobj	O
with	IN	case	O
parental	JJ	amod	B-cell_type
tumor	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
indicating	VBG	advcl	O
systemic	JJ	amod	O
antitumor	NN	compound	O
immunity	NN	nsubjpass	O
had	VBD	aux	O
been	VBN	auxpass	O
achieved	VBN	conj	O
.	.	punct	O

In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
whilst	IN	nsubj	O
intensive	JJ	amod	O
investigations	NNS	nsubj	O
are	VBP	cop	O
in	IN	case	O
progress	NN	advcl	O
to	TO	mark	O
target	VB	acl	O
the	DT	det	O
many	JJ	amod	O
HIF-1	NN	compound	B-protein
effectors	NNS	dobj	O
,	,	punct	O
the	DT	det	O
results	NNS	nsubj	O
herein	RB	advmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
blocking	VBG	csubj	O
hypoxia-inducible	JJ	amod	O
pathways	NNS	dobj	O
and	CC	cc	O
enhancing	VBG	conj	O
NK-mediated	JJ	amod	O
antitumor	NN	compound	O
immunity	NN	dobj	O
by	IN	mark	O
targeting	VBG	advcl	O
HIF-1	NN	dobj	B-protein
itself	PRP	dep	O
may	MD	aux	O
be	VB	cop	O
advantageous	JJ	ccomp	O
,	,	punct	O
especially	RB	advmod	O
when	WRB	advmod	O
combined	VBN	advcl	O
with	IN	case	O
cancer	NN	compound	O
immunotherapy	NN	nmod	O
.	.	punct	O

Runx2	NN	ROOT	B-DNA
:	:	punct	O
a	DT	det	O
novel	JJ	amod	O
oncogenic	JJ	amod	O
effector	NN	dep	O
revealed	VBN	acl	O
by	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
complementation	NN	nmod	O
and	CC	cc	O
retroviral	JJ	amod	O
tagging	NN	conj	O
.	.	punct	O

The	DT	det	O
Runx2	NN	compound	B-DNA
(	-LRB-	punct	O
Cbfa1	NN	compound	B-DNA
,	,	punct	O
Pebp2alphaA	NN	appos	B-DNA
,	,	punct	O
Aml3	NN	appos	B-DNA
)	-RRB-	punct	O
gene	NN	nsubjpass	O
was	VBD	auxpass	O
previously	RB	advmod	O
identified	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
frequent	JJ	amod	O
target	NN	nmod	O
for	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
by	IN	case	O
proviral	JJ	amod	O
insertion	NN	nmod	O
in	IN	case	O
T-cell	NN	compound	O
lymphomas	NNS	nmod	O
of	IN	case	O
CD2-MYC	NN	compound	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
recently	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
over-expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
full-length	NN	nmod	O
,	,	punct	O
most	RBS	advmod	O
highly	RB	advmod	O
expressed	VBD	amod	O
Runx2	NN	compound	B-DNA
isoform	NN	dep	O
in	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
perturbs	NNS	ccomp	O
T-cell	NN	compound	O
development	NN	dobj	O
,	,	punct	O
leads	VBZ	ccomp	O
to	TO	case	O
development	NN	nmod	O
of	IN	case	O
spontaneous	JJ	amod	O
lymphomas	NNS	nmod	O
at	IN	case	O
low	JJ	amod	O
frequency	NN	nmod	O
and	CC	cc	O
is	VBZ	cop	O
strongly	RB	advmod	O
synergistic	JJ	conj	O
with	IN	case	O
Myc	NNP	nmod	B-protein
.	.	punct	O

To	TO	mark	O
gain	VB	advcl	O
further	JJ	amod	O
insight	NN	dobj	O
into	IN	case	O
the	DT	det	O
relationship	NN	nmod	O
of	IN	case	O
Runx2	NN	nmod	B-DNA
to	TO	case	O
other	JJ	amod	O
lymphomagenic	JJ	amod	O
pathways	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
tested	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	mark	O
combining	VBG	acl	O
the	DT	det	O
CD2-Runx2	NN	compound	B-DNA
transgene	NN	dobj	I-DNA
either	CC	cc:preconj	O
with	IN	case	O
a	DT	det	O
Pim1	NN	compound	B-DNA
transgene	NN	compound	I-DNA
(	-LRB-	punct	O
E	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
mu	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
-Pim1	CD	nmod	I-DNA
)	-RRB-	punct	O
or	CC	cc	O
with	IN	case	O
the	DT	det	O
p53	NN	compound	B-DNA
null	NN	amod	O
genotype	NN	conj	O
,	,	punct	O
as	IN	mark	O
each	DT	nsubj	O
of	IN	prep	O
these	DT	det	O
displays	NNS	advcl	O
independent	JJ	amod	O
synergy	NN	dobj	O
with	IN	prep	O
Myc	NNP	pobj	B-protein
.	.	punct	O

In	IN	case	O
both	DT	det	O
cases	NNS	nmod	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
synergistic	JJ	amod	O
tumour	NN	compound	O
development	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
Runx2	NN	nsubj	B-protein
appeared	VBD	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
a	DT	det	O
dominant	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
tumour	NN	compound	O
phenotype	NN	nmod	O
in	IN	case	O
each	DT	det	O
case	NN	nmod	O
,	,	punct	O
with	IN	case	O
most	JJS	amod	O
tumours	NNS	advcl	O
conforming	VBG	acl	O
to	TO	prep	O
the	DT	det	O
CD3	NN	pobj	O
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
,	,	punct	O
CD8	NN	conj	O
(	-LRB-	punct	O
+	CC	advmod	O
)	-RRB-	punct	O
,	,	punct	O
CD4	NN	compound	O
(	-LRB-	punct	O
+/-	CC	cc	O
)	-RRB-	punct	O
phenotype	NN	conj	O
seen	VBN	acl	O
in	IN	case	O
CD2-Runx2	NN	amod	O
mice	NNS	nmod	O
.	.	punct	O

Neonatal	JJ	amod	O
infection	NN	nsubj	O
of	IN	case	O
CD2-Runx2	NN	amod	O
mice	NNS	nmod	O
with	IN	case	O
Moloney	NN	compound	O
murine	JJ	amod	O
leukaemia	NN	compound	O
virus	NN	nmod	O
(	-LRB-	punct	O
Moloney	NN	compound	O
MLV	NN	appos	O
)	-RRB-	punct	O
also	RB	advmod	O
led	VBD	ROOT	O
to	TO	case	O
a	DT	det	O
dramatic	JJ	amod	O
acceleration	NN	nmod	O
of	IN	case	O
tumour	NN	compound	O
onset	NN	nmod	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
known	JJ	amod	O
Moloney	NN	compound	B-DNA
MLV	NN	compound	I-DNA
target	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
these	DT	det	O
lymphomas	NNS	nmod	O
showed	VBD	ROOT	O
a	DT	det	O
high	JJ	amod	O
frequency	NN	dobj	O
of	IN	case	O
rearrangement	NN	nmod	O
at	IN	case	O
c-Myc	NN	nmod	B-DNA
or	CC	cc	O
N-Myc	NN	conj	B-DNA
(	-LRB-	punct	O
82	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
significant	JJ	amod	O
number	NN	conj	O
at	IN	case	O
Pim1	NN	nmod	B-DNA
or	CC	cc	O
Pim2	NN	conj	B-DNA
(	-LRB-	punct	O
23	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
at	IN	case	O
Pal1/Gfi1	NN	conj	B-DNA
(	-LRB-	punct	O
18	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Runx2	NN	nsubj	B-protein
makes	VBZ	ccomp	O
a	DT	det	O
distinct	JJ	amod	O
contribution	NN	dobj	O
to	TO	case	O
T-cell	NN	compound	O
lymphoma	NN	compound	O
development	NN	nmod	O
which	WDT	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
coincide	VB	acl:relcl	O
with	IN	case	O
any	DT	nmod	O
of	IN	case	O
the	DT	det	O
oncogene	NN	compound	O
complementation	NN	compound	O
groups	NNS	nmod	O
previously	RB	advmod	O
identified	VBN	acl	O
by	IN	case	O
retroviral	JJ	amod	O
tagging	NN	nmod	O
.	.	punct	O

The	DT	det	O
involvement	NN	ROOT	O
of	IN	case	O
TNF-alpha	NN	compound	B-protein
-related	JJ	amod	O
apoptosis-inducing	JJ	amod	O
ligand	NN	nmod	O
in	IN	case	O
the	DT	det	O
enhanced	VBN	amod	O
cytotoxicity	NN	nmod	O
of	IN	case	O
IFN-beta	NN	compound	B-protein
-stimulated	JJ	amod	O
human	JJ	amod	B-cell_type
dendritic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
tumor	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

TNF-alpha	NN	compound	B-protein
-related	JJ	amod	O
apoptosis-inducing	JJ	amod	O
ligand	NN	nsubjpass	O
(	-LRB-	punct	O
TRAIL	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
its	PRP$	nmod:poss	O
preferential	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
not	RB	cc	O
normal	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Dendritic	JJ	amod	B-cell_type
cells	NNS	nsubjpass	I-cell_type
(	-LRB-	punct	O
DCs	NNS	appos	B-cell_type
)	-RRB-	punct	O
,	,	punct	O
besides	IN	case	O
their	PRP$	nmod:poss	O
role	NN	nmod	O
as	IN	case	O
APCs	NNS	nmod	O
,	,	punct	O
now	RB	advmod	O
have	VBP	aux	O
been	VBN	auxpass	O
demonstrated	VBN	ROOT	O
to	TO	mark	O
exert	VB	xcomp	O
cytotoxicity	NN	dobj	O
or	CC	cc	O
cytostasis	NN	conj	O
on	IN	case	O
some	DT	det	O
tumor	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
human	JJ	amod	B-cell_type
CD34	NN	nsubj	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
stem	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
-derived	JJ	amod	O
DCs	NNS	conj	B-cell_type
(	-LRB-	punct	O
CD34DCs	NN	appos	B-cell_type
)	-RRB-	punct	O
and	CC	cc	O
human	JJ	amod	B-cell_type
CD14	NN	conj	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
monocyte	NN	compound	I-cell_type
-derived	JJ	amod	O
DCs	NNS	dep	B-cell_type
(	-LRB-	punct	O
MoDCs	NN	appos	B-cell_type
)	-RRB-	punct	O
express	VBP	ccomp	O
TRAIL	NN	dobj	O
and	CC	cc	O
exhibit	VBP	conj	O
cytotoxicity	NN	dobj	O
to	IN	case	O
some	DT	det	O
types	NNS	nmod	O
of	IN	case	O
tumor	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
partially	RB	advmod	O
through	IN	case	O
TRAIL	NN	nmod	O
.	.	punct	O

Moderate	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
TRAIL	NN	nmod	O
appeared	VBD	ROOT	O
on	IN	case	O
CD34DCs	NN	nmod	B-cell_type
from	IN	case	O
the	DT	det	O
8th	JJ	amod	O
day	NN	nmod	O
of	IN	case	O
culture	NN	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
also	RB	advmod	O
seen	VBN	conj	O
on	IN	case	O
freshly	RB	advmod	B-cell_type
isolated	VBN	amod	I-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
level	NN	nsubj	O
of	IN	case	O
TRAIL	NN	compound	O
expression	NN	nmod	O
remained	VBD	ROOT	O
constant	JJ	xcomp	O
until	IN	case	O
DC	NN	compound	O
maturation	NN	nmod	O
.	.	punct	O

TRAIL	NN	compound	O
expression	NN	nsubjpass	O
on	IN	case	O
immature	JJ	amod	B-cell_type
CD34DCs	NN	nmod	I-cell_type
or	CC	cc	O
MoDCs	NN	conj	B-cell_type
was	VBD	auxpass	O
greatly	RB	advmod	O
up-regulated	VBN	ROOT	O
after	IN	case	O
IFN-beta	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
IFN-beta	NN	nsubj	B-protein
could	MD	aux	O
strikingly	RB	advmod	O
enhance	VB	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
CD34DCs	NN	nmod	B-cell_type
or	CC	cc	O
MoDCs	NN	conj	B-cell_type
to	TO	mark	O
kill	VB	acl	O
TRAIL-sensitive	JJ	amod	O
tumor	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
,	,	punct	O
but	CC	cc	O
LPS	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
have	VB	conj	O
such	PDT	det:predet	O
an	DT	det	O
effect	NN	dobj	O
.	.	punct	O

The	DT	det	O
up-regulation	NN	nsubj	O
of	IN	case	O
TRAIL	NN	nmod	O
on	IN	case	O
IFN-beta	NN	compound	B-protein
-stimulated	JJ	amod	O
DCs	NNS	nmod	B-cell_type
partially	RB	advmod	O
contributed	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
increased	VBN	amod	O
cytotoxicity	NN	nmod	O
of	IN	case	O
DCS	NN	nmod	B-cell_type
:	:	punct	O
Pretreatment	NN	nsubj	O
of	IN	case	O
TRAIL-sensitive	JJ	amod	O
tumor	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
caspase-3	NN	compound	O
inhibitor	NN	nmod	O
could	MD	aux	O
significantly	RB	advmod	O
increase	VB	parataxis	O
their	PRP$	nmod:poss	O
resistance	NN	dobj	O
to	TO	case	O
the	DT	det	O
cytotoxicity	NN	nmod	O
of	IN	case	O
IFN-beta	NN	compound	B-protein
-stimulated	JJ	amod	O
DCS	NN	nmod	B-cell_type
:	:	punct	O
In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
NF-kappaB	NN	compound	O
inhibitor	NN	nsubj	O
could	MD	aux	O
significantly	RB	advmod	O
increase	VB	parataxis	O
the	DT	det	O
sensitivity	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
the	DT	det	O
killing	NN	nmod	O
by	IN	case	O
nonstimulated	JJ	amod	O
or	CC	cc	O
LPS-stimulated	JJ	conj	O
DCS	NN	nmod	B-cell_type
:	:	punct	O
Our	PRP$	nmod:poss	O
studies	NNS	nsubj	O
demonstrate	VBP	parataxis	O
that	IN	mark	O
IFN-beta	NN	compound	B-protein
-stimulated	JJ	amod	O
DCs	NNS	nsubj	B-cell_type
are	VBP	cop	O
functionally	RB	advmod	O
cytotoxic	JJ	ccomp	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
an	DT	det	O
innate	JJ	amod	O
mechanism	NN	nsubj	O
of	IN	case	O
DC-mediated	JJ	amod	O
antitumor	NN	compound	O
immunity	NN	nmod	O
might	MD	aux	O
exist	VB	ROOT	O
in	FW	compound	O
vivo	FW	advmod	O
in	IN	case	O
which	WDT	nmod	O
DCs	NNS	nsubj	B-cell_type
act	VBP	ccomp	O
as	IN	case	O
effectors	NNS	nmod	O
to	TO	mark	O
directly	RB	advmod	O
kill	VB	xcomp	O
tumor	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
partially	RB	advmod	O
via	IN	case	O
TRAIL	NN	nmod	O
.	.	punct	O

Subsequently	RB	advmod	O
,	,	punct	O
DCs	NNS	nsubj	B-cell_type
act	VBP	ROOT	O
as	IN	case	O
APCs	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
uptake	NN	nmod	O
,	,	punct	O
processing	NN	conj	O
,	,	punct	O
and	CC	cc	O
presentation	NN	conj	O
of	IN	case	O
apoptotic	JJ	amod	B-protein
tumor	NN	compound	I-protein
Ags	NNS	nmod	I-protein
to	TO	case	O
cross-prime	JJ	amod	O
CD8	NN	nmod	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
CTL	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Tumor	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
regulate	VBP	ROOT	O
the	DT	det	O
lytic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
tumor-specific	JJ	amod	B-cell_type
cytotoxic	JJ	amod	I-cell_type
t	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
by	IN	mark	O
modulating	VBG	advcl	O
the	DT	det	O
inhibitory	JJ	amod	O
natural	JJ	amod	O
killer	NN	compound	O
receptor	NN	compound	O
function	NN	dobj	O
.	.	punct	O

Tumor-infiltrating	JJ	amod	B-cell_type
p58+	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
from	IN	case	O
a	DT	det	O
renal	JJ	amod	O
tumor	NN	nmod	O
were	VBD	auxpass	O
specifically	RB	advmod	O
expanded	VBN	ROOT	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
tumor	NN	compound	O
cell	NN	compound	O
stimulation	NN	nmod	O
and	CC	cc	O
cloned	VBN	conj	O
.	.	punct	O

These	DT	det	O
p58+	JJ	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
express	VB	xcomp	O
a	DT	det	O
memory	NN	compound	B-cell_type
phenotype	NN	dobj	I-cell_type
and	CC	cc	O
corresponded	VBD	conj	O
to	TO	case	O
clonal	JJ	amod	O
TCRBV3	NN	compound	O
T-cell	NN	compound	O
expansion	NN	nmod	O
.	.	punct	O

Functionally	RB	advmod	O
,	,	punct	O
p58	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	intj	I-cell_type
)	-RRB-	punct	I-cell_type
CTLs	NNS	nsubj	I-cell_type
displayed	VBD	ROOT	O
a	DT	det	O
low	JJ	amod	O
lytic	JJ	amod	O
activity	NN	dobj	O
for	IN	case	O
HLA-A2	NN	nmod	B-cell_type
tumor	NN	dep	I-cell_type
and	CC	cc	I-cell_type
normal	JJ	amod	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
this	DT	det	O
lytic	JJ	amod	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
after	IN	case	O
blockade	NN	nmod	O
of	IN	case	O
p58	NN	nmod	B-protein
with	IN	case	O
specific	JJ	amod	O
monoclonal	JJ	amod	B-protein
antibodies	NNS	nmod	I-protein
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
stimulation	NN	nsubjpass	O
by	IN	case	O
tumor	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	auxpass	O
required	VBN	ccomp	O
to	TO	mark	O
trigger	VB	xcomp	O
the	DT	det	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
p58	NN	nmod	B-protein
on	IN	case	O
the	DT	det	O
lytic	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
antigen-specific	JJ	amod	B-cell_type
CTLs	NNS	nmod	I-cell_type
and	CC	cc	O
that	IN	mark	O
stimulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
inhibitory	JJ	amod	O
function	NN	nmod	O
of	IN	case	O
p58	NN	nmod	B-protein
by	IN	case	O
tumor	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
correlated	VBD	conj	O
with	IN	case	O
an	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	O
factor-kappaB	NN	compound	O
activation	NN	nmod	O
in	IN	case	O
p58+	NN	compound	B-cell_type
tumor-specific	JJ	amod	I-cell_type
CTLS	NN	nmod	I-cell_type
.	.	punct	O

T-cell	NN	compound	B-protein
factor-1	NN	compound	I-protein
expression	NN	nsubj	O
during	IN	case	O
human	JJ	amod	B-cell_type
natural	JJ	amod	I-cell_type
killer	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
development	NN	nmod	O
and	CC	cc	O
in	IN	case	O
circulating	VBG	amod	O
CD56	NN	conj	B-protein
(	-LRB-	punct	I-protein
+	CC	cc	I-protein
)	-RRB-	punct	I-protein
bright	JJ	ROOT	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
.	.	punct	O

Transcription	NN	compound	B-protein
factors	NNS	nsubj	I-protein
are	VBP	cop	O
essential	JJ	ROOT	O
to	TO	mark	O
govern	VB	xcomp	O
differentiation	NN	dobj	O
along	IN	case	O
the	DT	det	O
lymphoid	JJ	amod	B-cell_type
lineage	NN	nmod	I-cell_type
from	IN	case	O
uncommitted	JJ	amod	B-cell_type
hematopoietic	JJ	amod	I-cell_type
stem	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Although	IN	mark	O
many	JJ	nsubj	O
of	IN	case	O
these	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
have	VBP	advcl	O
putative	JJ	amod	O
roles	NNS	dobj	O
based	VBN	case	O
on	IN	case	O
murine	JJ	amod	O
knockout	JJ	compound	O
experiments	NNS	nmod	O
,	,	punct	O
their	PRP$	nmod:poss	O
function	NN	nsubjpass	O
in	IN	case	O
human	JJ	amod	O
lymphoid	JJ	amod	O
development	NN	nmod	O
is	VBZ	auxpass	O
less	RBR	advmod	O
known	VBN	ROOT	O
and	CC	cc	O
was	VBD	auxpass	O
studied	VBN	conj	O
further	RB	advmod	O
.	.	punct	O

Transcription	NN	compound	O
factor	NN	compound	O
expression	NN	nsubjpass	O
in	IN	case	O
fresh	JJ	amod	O
and	CC	cc	O
cultured	VBD	conj	O
adult	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
bone	NN	compound	I-cell_type
marrow	NN	nmod	I-cell_type
and	CC	cc	I-cell_type
umbilical	JJ	amod	I-cell_type
cord	NN	compound	I-cell_type
blood	NN	compound	I-cell_type
progenitors	NNS	conj	I-cell_type
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
fresh	JJ	amod	B-cell_type
CD34	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
Lin	NNP	compound	I-cell_type
(	-LRB-	punct	I-cell_type
-	:	punct	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nsubj	I-cell_type
that	WDT	nsubj	O
are	VBP	cop	O
human	JJ	amod	O
leukocyte	NN	compound	O
antigen	NN	compound	O
(	-LRB-	punct	O
HLA	NN	compound	O
)	-RRB-	punct	O
-DR	NN	acl:relcl	O
(	-LRB-	punct	O
-	:	punct	O
)	-RRB-	punct	O
or	CC	cc	O
CD38	NN	conj	O
(	-LRB-	punct	O
-	:	punct	O
)	-RRB-	punct	O
constitutively	RB	advmod	O
express	VBP	ccomp	O
GATA-3	NN	dobj	B-protein
but	CC	cc	O
not	RB	cc	O
T-cell	NN	compound	B-protein
factor-1	NN	conj	I-protein
(	-LRB-	punct	O
TCF-1	NN	appos	B-protein
)	-RRB-	punct	O
or	CC	cc	O
Id-3	NN	conj	B-protein
.	.	punct	O

Culture	NN	nsubj	O
with	IN	case	O
the	DT	det	O
murine	JJ	amod	B-cell_line
fetal	JJ	amod	I-cell_line
liver	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
AFT024	NN	nmod	I-cell_line
and	CC	cc	O
defined	VBN	amod	O
cytokines	NNS	conj	B-protein
was	VBD	cop	O
capable	JJ	ROOT	O
of	IN	mark	O
inducing	VBG	advcl	O
TCF-1	NN	compound	B-RNA
mRNA	NN	dobj	I-RNA
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
no	DT	neg	O
T-cell	NN	compound	B-DNA
receptor	NN	compound	I-DNA
gene	NN	compound	I-DNA
rearrangement	NN	nsubjpass	O
was	VBD	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
cultured	VBN	amod	O
progeny	NN	nmod	O
.	.	punct	O

Id-3	NN	nsubjpass	B-protein
,	,	punct	O
a	DT	det	O
basic	JJ	amod	B-protein
helix	NN	compound	I-protein
loop	NN	compound	I-protein
helix	NN	compound	I-protein
factor	NN	appos	I-protein
with	IN	case	O
dominant	JJ	amod	O
negative	JJ	amod	O
function	NN	nmod	O
for	IN	case	O
T-cell	NN	compound	O
differentiation	NN	compound	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
,	,	punct	O
also	RB	advmod	O
was	VBD	auxpass	O
upregulated	VBN	ROOT	O
and	CC	cc	O
may	MD	aux	O
explain	VB	conj	O
unsuccessful	JJ	amod	O
T-cell	NN	compound	O
maturation	NN	dobj	O
.	.	punct	O

To	TO	mark	O
better	RBR	advmod	O
understand	VB	advcl	O
the	DT	det	O
developmental	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
natural	JJ	amod	B-cell_type
killer	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
NK	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
derived	VBN	acl	O
from	IN	case	O
progenitors	NNS	nmod	B-cell_type
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
NK	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
subsets	NNS	dobj	I-cell_type
circulating	VBG	acl	O
in	IN	case	O
blood	NN	nmod	O
.	.	punct	O

CD56	NN	nsubj	B-cell_type
(	-LRB-	punct	I-cell_type
+bright	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
CD56	NN	conj	B-cell_type
(	-LRB-	punct	I-cell_type
+dim	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
,	,	punct	O
NK	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
constitutively	RB	advmod	O
express	VBP	ROOT	O
TCF-1	NN	dobj	B-protein
by	IN	case	O
reverse	JJ	amod	O
transcriptase	NN	compound	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
and	CC	cc	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	conj	O
.	.	punct	O

The	DT	det	O
TCF-1	NN	compound	B-protein
isoform	NN	nsubj	I-protein
found	VBN	acl	O
in	IN	case	O
CD56	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+bright	NN	intj	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
which	WDT	nsubj	O
express	VBP	acl:relcl	O
lectin	NN	dobj	B-protein
but	CC	cc	O
not	RB	cc	O
immunoglobulin	NN	compound	B-protein
class	NN	compound	I-protein
I	CD	nummod	I-protein
recognizing	VBG	amod	O
inhibitory	JJ	amod	B-protein
receptors	NNS	dep	I-protein
,	,	punct	O
was	VBD	cop	O
identical	JJ	ROOT	O
to	TO	case	O
that	DT	nmod	O
induced	VBN	acl	O
in	IN	case	O
NK	NN	compound	O
cell	NN	compound	O
differentiation	NN	compound	O
culture	NN	nmod	O
and	CC	cc	O
was	VBD	cop	O
distinctly	RB	advmod	O
different	JJ	conj	O
from	IN	case	O
isoforms	NNS	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
TCF-1	NN	nsubj	B-protein
does	VBZ	aux	O
not	RB	neg	O
target	VB	advcl	O
human	JJ	amod	B-DNA
killer	NN	compound	I-DNA
immunoglobulin	NN	compound	I-DNA
receptor	NN	compound	I-DNA
genes	NNS	dobj	I-DNA
,	,	punct	O
TCF-1	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
uniquely	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
circulating	VBG	amod	O
CD56	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+bright	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
NK	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
specific	JJ	amod	O
TCF-1	NN	compound	B-protein
isoforms	NNS	nsubj	I-protein
may	MD	aux	O
play	VB	conj	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
regulating	VBG	advcl	O
NK	NN	compound	O
differentiation	NN	dobj	O
from	IN	case	O
a	DT	det	O
common	JJ	amod	O
NK/T-cell	JJ	compound	B-cell_type
progenitor	NN	nmod	I-cell_type
.	.	punct	O

Transcriptional	JJ	amod	O
activation	NN	ROOT	O
by	IN	case	O
a	DT	det	O
matrix	NN	nmod	B-protein
associating	VBG	case	I-protein
region-binding	JJ	amod	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

contextual	JJ	amod	O
requirements	NNS	ROOT	O
for	IN	case	O
the	DT	det	O
function	NN	nmod	O
of	IN	case	O
bright	NN	nmod	B-protein
.	.	punct	O

Bright	NN	compound	B-protein
(	-LRB-	punct	O
B	NN	compound	B-protein
cell	NN	compound	I-protein
regulator	NN	nsubj	I-protein
of	IN	case	I-protein
IgH	NN	compound	I-protein
transcription	NN	nmod	I-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
-specific	JJ	ROOT	O
,	,	punct	O
matrix	NN	conj	B-protein
associating	VBG	case	I-protein
region-binding	JJ	amod	I-protein
protein	NN	nmod	I-protein
that	WDT	nsubj	O
transactivates	VBZ	acl:relcl	O
gene	NN	compound	O
expression	NN	dobj	O
from	IN	case	O
the	DT	det	O
IgH	NN	compound	B-DNA
intronic	JJ	amod	I-DNA
enhancer	NN	nmod	I-DNA
(	-LRB-	punct	O
E	NN	compound	B-DNA
mu	NN	appos	I-DNA
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
Bright	NNP	nsubj	B-protein
has	VBZ	ccomp	O
multiple	JJ	amod	O
contextual	JJ	amod	O
requirements	NNS	dobj	O
to	TO	mark	O
function	VB	xcomp	O
as	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	B-protein
activator	NN	nmod	I-protein
.	.	punct	O

Bright	NN	nsubj	B-protein
can	MD	aux	O
not	RB	neg	O
transactivate	VB	ROOT	O
via	IN	prep	O
out	IN	prep	O
of	IN	case	O
context	NN	amod	O
,	,	punct	O
concatenated	VBD	amod	B-protein
binding	VBG	compound	I-protein
sites	NNS	dobj	I-protein
.	.	punct	O

Transactivation	NN	nsubj	O
is	VBZ	cop	O
maximal	JJ	ROOT	O
on	IN	case	O
integrated	VBN	amod	O
substrates	NNS	nmod	O
.	.	punct	O

Two	CD	nsubjpass	O
of	IN	case	O
the	DT	det	O
three	CD	nummod	O
previously	RB	advmod	O
identified	VBN	amod	O
binding	VBG	compound	B-DNA
sites	NNS	nmod	I-DNA
in	IN	case	O
E	NN	compound	B-DNA
mu	NN	nmod	I-DNA
are	VBP	auxpass	O
required	VBN	ROOT	O
for	IN	prep	O
full	JJ	amod	O
Bright	JJ	compound	B-protein
transactivation	NN	pobj	O
.	.	punct	O

The	DT	det	O
Bright	JJ	compound	B-protein
DNA	NN	compound	I-protein
binding	NN	compound	I-protein
domain	NN	nsubj	I-protein
defined	VBD	ROOT	O
a	DT	det	O
new	JJ	amod	O
family	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
includes	VBZ	acl:relcl	O
SWI1	NN	dobj	B-protein
,	,	punct	O
a	DT	det	O
component	NN	appos	O
of	IN	case	O
the	DT	det	O
SWI.SNF	NN	compound	B-protein
complex	NN	nmod	I-protein
shown	VBN	acl	O
to	TO	mark	O
have	VB	xcomp	O
high	JJ	amod	O
mobility	NN	compound	O
group-like	JJ	amod	O
DNA	NN	compound	O
binding	NN	compound	O
characteristics	NNS	dobj	O
.	.	punct	O

Similar	JJ	ROOT	O
to	TO	case	O
one	CD	nummod	O
group	NN	nmod	O
of	IN	case	O
high	JJ	amod	B-protein
mobility	NN	compound	I-protein
group	NN	compound	I-protein
box	NN	compound	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
Bright	NN	compound	B-protein
distorts	NNS	compound	O
E	NN	compound	B-DNA
mu	NN	compound	I-DNA
binding	NN	compound	I-DNA
site	NN	compound	I-DNA
-containing	JJ	amod	O
DNA	NN	appos	O
on	IN	case	O
binding	NN	nmod	O
,	,	punct	O
supporting	VBG	advcl	O
the	DT	det	O
concept	NN	dobj	O
that	IN	mark	O
it	PRP	nsubj	O
mediates	VBZ	relcl	O
E	NN	compound	B-DNA
mu	NN	compound	I-DNA
remodeling	NN	dobj	O
.	.	punct	O

Transfection	NN	compound	O
studies	NNS	nsubj	O
further	RB	advmod	O
implicate	VBP	ROOT	O
Bright	NNP	dobj	B-protein
in	IN	mark	O
facilitating	VBG	advcl	O
spatially	RB	advmod	O
separated	VBN	amod	O
promoter-enhancer	JJ	amod	O
interactions	NNS	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
transient	JJ	nmod	O
and	CC	cc	O
stable	JJ	conj	O
assays	NNS	dep	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
overexpression	NN	nsubj	O
of	IN	case	O
Bright	NNP	nmod	B-protein
leads	VBZ	ccomp	O
to	TO	case	O
enhanced	VBN	amod	O
DNase	NN	compound	O
I	CD	nummod	O
sensitivity	NN	nmod	O
of	IN	case	O
the	DT	det	O
endogenous	JJ	amod	O
E	NN	compound	B-DNA
mu	NN	compound	I-DNA
matrix	NN	nmod	O
associating	NN	case	O
regions	NNS	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
further	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
Bright	NNP	nsubj	B-protein
may	MD	aux	O
contribute	VB	ccomp	O
to	TO	case	O
increased	VBN	amod	O
gene	NN	compound	O
expression	NN	nmod	O
by	IN	mark	O
remodeling	VBG	advcl	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
locus	NN	dobj	I-DNA
during	IN	case	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
development	NN	nmod	O
.	.	punct	O

Analysis	NN	ROOT	O
of	IN	case	O
BCL-6	NN	compound	O
mutations	NNS	nmod	O
in	IN	case	O
classic	JJ	amod	O
Hodgkin	NN	compound	O
disease	NN	nmod	O
of	IN	case	O
the	DT	dep	O
B-	NN	nmod	B-cell_type
and	CC	cc	I-cell_type
T-cell	NN	conj	I-cell_type
type	NN	dep	I-cell_type
.	.	punct	O

BCL-6	NN	nsubj	B-DNA
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
germinal	JJ	amod	O
center	NN	compound	O
formation	NN	nmod	O
and	CC	cc	O
thus	RB	advmod	O
for	IN	case	O
affinity	NN	compound	O
maturation	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
Ig	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
genes	NNS	nmod	I-DNA
by	IN	case	O
somatic	JJ	amod	O
mutations	NNS	nmod	O
.	.	punct	O

The	DT	det	O
5'-noncoding	JJ	amod	B-DNA
region	NN	nsubj	I-DNA
of	IN	case	O
the	DT	det	O
BCL-6	NN	compound	B-DNA
gene	NN	nmod	I-DNA
is	VBZ	cop	O
even	RB	advmod	O
a	DT	det	O
target	NN	ROOT	O
for	IN	case	O
the	DT	det	O
mutation	NN	compound	O
machinery	NN	nmod	O
.	.	punct	O

Translocations	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
BCL-6	NN	compound	B-DNA
gene	NN	nmod	I-DNA
to	TO	case	O
heterologous	JJ	amod	B-DNA
promoters	NNS	nmod	I-DNA
and	CC	cc	O
mutations	NNS	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
5'-noncoding	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
region	NN	nmod	I-DNA
were	VBD	auxpass	O
reported	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
potential	JJ	amod	O
mechanisms	NNS	xcomp	O
for	IN	mark	O
deregulating	VBG	acl	O
BCL-6	NN	compound	B-DNA
expression	NN	dobj	O
and	CC	cc	O
for	IN	mark	O
playing	VBG	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
genesis	NN	nmod	O
of	IN	case	O
non-Hodgkin	JJ	amod	O
lymphoma	NN	nmod	O
.	.	punct	O

In	IN	case	O
line	NN	nmod	O
with	IN	case	O
this	DT	det	O
hypothesis	NN	nmod	O
is	VBZ	cop	O
the	DT	det	O
observation	NN	ROOT	O
that	IN	mark	O
B-cell	NN	compound	O
lymphoma	NN	nsubj	O
with	IN	case	O
somatic	JJ	amod	O
mutations	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
diffuse	JJ	amod	O
large	JJ	amod	O
B-cell	NN	compound	O
lymphoma	NN	nmod	O
and	CC	cc	O
follicular	JJ	amod	O
lymphoma	NN	conj	O
,	,	punct	O
also	RB	advmod	O
carry	VBP	ccomp	O
BCL-6	NN	compound	O
mutations	NNS	dobj	O
,	,	punct	O
some	DT	nsubj	O
of	IN	case	O
which	WDT	nmod	O
are	VBP	cop	O
recurrently	RB	advmod	O
detectable	JJ	parataxis	O
.	.	punct	O

Classic	JJ	compound	O
Hodgkin	NN	compound	O
disease	NN	nsubjpass	O
(	-LRB-	punct	O
cHD	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
also	RB	advmod	O
derived	VBN	ROOT	O
from	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
high	JJ	amod	O
loads	NNS	nmod	O
of	IN	case	O
somatic	JJ	amod	O
mutations	NNS	nmod	O
and	CC	cc	O
thus	RB	advmod	O
a	DT	det	O
further	JJ	amod	O
candidate	NN	conj	O
for	IN	case	O
BCL-6	NN	compound	O
mutations	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
the	DT	dep	O
presence	NN	dobj	O
and	CC	cc	O
potential	JJ	conj	O
role	NN	dep	O
of	IN	case	O
BCL-6	NN	compound	O
mutations	NNS	nmod	O
in	IN	case	O
cHD	NN	nmod	O
,	,	punct	O
the	DT	det	O
5'-noncoding	JJ	amod	B-DNA
BCL-6	NN	compound	I-DNA
proportion	NN	nsubjpass	O
of	IN	case	O
single	JJ	amod	B-cell_type
Hodgkin	NN	nmod	I-cell_type
and	CC	cc	I-cell_type
Reed-Sternberg	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
HRS	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	conj	I-cell_type
from	IN	case	O
6	CD	nummod	O
cases	NNS	nmod	O
of	IN	case	O
cHD	NN	nmod	O
and	CC	cc	O
6	CD	nummod	O
cases	NNS	conj	O
of	IN	case	O
HD-derived	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
.	.	punct	O

All	DT	det	O
B-cell-derived	JJ	amod	O
HD	NN	compound	O
cases	NNS	nsubj	O
and	CC	cc	O
cell	NN	compound	O
lines	NNS	conj	O
harbored	VBD	ROOT	O
BCL-6	NN	compound	O
mutations	NNS	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
both	CC	cc:preconj	O
T-cell-derived	JJ	amod	O
HD	NN	compound	O
cases	NNS	nsubj	O
and	CC	cc	O
cell	NN	compound	O
lines	NNS	conj	O
were	VBD	cop	O
devoid	JJ	ROOT	O
of	IN	case	O
BCL-6	NN	compound	O
mutations	NNS	nmod	O
.	.	punct	O

With	IN	prep	O
only	RB	advmod	O
one	CD	nummod	O
exception	NN	pobj	O
,	,	punct	O
there	EX	expl	O
were	VBD	cop	O
no	DT	neg	O
lymphoma-specific	JJ	amod	O
recurrent	JJ	amod	O
BCL-6	NN	compound	O
mutations	NNS	nsubj	O
detected	VBN	acl	O
,	,	punct	O
and	CC	cc	O
BCL-6	NN	compound	B-protein
protein	NN	nsubj	I-protein
was	VBD	cop	O
absent	JJ	ROOT	O
from	IN	case	O
the	DT	det	O
HRS	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
most	JJS	amod	O
cases	NNS	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
(	-LRB-	punct	O
1	LS	dep	O
)	-RRB-	punct	O
somatic	JJ	amod	O
BCL-6	NN	compound	O
mutations	NNS	nsubj	O
are	VBP	aux	O
restricted	JJ	ROOT	O
to	TO	case	O
cHD	NN	compound	O
cases	NNS	nmod	O
of	IN	case	O
B-cell	NN	compound	B-cell_type
origin	NN	nmod	O
,	,	punct	O
and	CC	cc	O
(	-LRB-	punct	O
2	LS	dep	O
)	-RRB-	punct	O
the	DT	det	O
BCL-6	NN	compound	O
mutations	NNS	nsubj	O
represent	VBP	conj	O
mostly	RB	advmod	O
irrelevant	JJ	amod	O
somatic	JJ	amod	O
base	NN	compound	O
substitutions	NNS	dobj	O
without	IN	case	O
consequences	NNS	nmod	O
for	IN	case	O
BCL-6	NN	compound	B-protein
protein	NN	compound	I-protein
expression	NN	nmod	O
and	CC	cc	O
the	DT	det	O
pathogenesis	NN	conj	O
of	IN	case	O
cHD	NN	nmod	O
.	.	punct	O

Gadd45gamma	NN	nsubj	B-DNA
is	VBZ	cop	O
dispensable	JJ	ROOT	O
for	IN	case	O
normal	JJ	amod	O
mouse	NN	compound	O
development	NN	nmod	O
and	CC	cc	O
T-cell	NN	compound	O
proliferation	NN	conj	O
.	.	punct	O

Gadd45gamma	NN	nsubjpass	B-DNA
,	,	punct	O
a	DT	det	O
family	NN	compound	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
growth	NN	compound	B-DNA
arrest	NN	nmod	I-DNA
and	CC	cc	I-DNA
DNA	NN	nmod:npmod	I-DNA
damage-inducible	JJ	amod	I-DNA
gene	NN	compound	I-DNA
family	NN	conj	I-DNA
45	CD	nummod	I-DNA
(	-LRB-	punct	O
Gadd45	NN	appos	B-DNA
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	auxpass	O
strongly	RB	advmod	O
induced	VBN	ROOT	O
by	IN	case	O
interleukin-2	NN	nmod	B-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

While	IN	mark	O
in	IN	case	O
most	JJS	amod	O
tissues	NNS	nmod	O
all	DT	det	O
Gadd45	NN	compound	B-DNA
family	NN	compound	I-DNA
members	NNS	nsubjpass	I-DNA
are	VBP	auxpass	O
expressed	VBN	advcl	O
,	,	punct	O
Gadd45gamma	NN	nsubj	B-DNA
is	VBZ	cop	O
the	DT	det	O
only	JJ	amod	O
member	NN	ROOT	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	acl:relcl	O
by	IN	case	O
IL-2	NN	nmod	B-protein
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
IL-2	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
Gadd45gamma	NN	nmod	B-DNA
is	VBZ	cop	O
dependent	JJ	ccomp	O
on	IN	case	O
a	DT	det	O
signaling	NN	compound	O
pathway	NN	nmod	O
mediated	VBN	acl	O
by	IN	case	O
the	DT	det	O
tyrosine	NN	compound	B-protein
kinase	NN	compound	I-protein
Jak3	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
Stat5a	NN	dep	B-protein
and	CC	cc	O
Stat5b	NN	conj	B-protein
(	-LRB-	punct	O
signal	NN	compound	B-protein
transducer	NN	dep	I-protein
and	CC	cc	I-protein
activator	NN	conj	I-protein
of	IN	amod	I-protein
transcription	NN	nmod	I-protein
)	-RRB-	punct	O
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
with	IN	case	O
ectopically	RB	advmod	O
overexpressed	VBN	amod	O
Gadd45gamma	NN	nmod	B-DNA
in	IN	case	O
various	JJ	amod	O
cell	NN	compound	O
lines	NNS	nmod	O
implicated	VBD	ROOT	O
its	PRP$	nmod:poss	O
function	NN	dobj	O
in	IN	case	O
negative	JJ	amod	O
growth	NN	compound	O
control	NN	nmod	O
.	.	punct	O

To	TO	mark	O
analyze	VB	advcl	O
the	DT	det	O
physiological	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
Gadd45gamma	NN	nmod	B-DNA
we	PRP	nsubj	O
used	VBD	ROOT	O
homologous	JJ	amod	O
recombination	NN	dobj	O
to	TO	mark	O
generate	VB	xcomp	O
mice	NNS	dobj	O
lacking	VBG	acl	O
Gadd45gamma	NN	dobj	B-DNA
.	.	punct	O

Gadd45gamma	NN	compound	B-DNA
-deficient	JJ	amod	O
mice	NNS	nsubj	O
develop	VBP	ROOT	O
normally	RB	advmod	O
,	,	punct	O
are	VBP	cop	O
indistinguishable	JJ	parataxis	O
from	IN	case	O
their	PRP$	nmod:poss	O
littermates	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
are	VBP	cop	O
fertile	JJ	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
hematopoiesis	NN	nsubj	O
in	IN	case	O
mice	NNS	nmod	O
lacking	VBG	acl	O
Gadd45gamma	NN	dobj	B-DNA
is	VBZ	cop	O
not	RB	neg	O
impaired	JJ	amod	O
and	CC	cc	O
Gadd45gamma	NN	nmod:npmod	B-DNA
-deficient	JJ	amod	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nsubj	I-cell_type
show	VBP	ROOT	O
normal	JJ	amod	O
responses	NNS	dobj	O
to	TO	case	O
IL-2	NN	nmod	B-protein
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
Gadd45gamma	NN	nsubj	B-DNA
is	VBZ	cop	O
not	RB	neg	O
essential	JJ	ccomp	O
for	IN	case	O
normal	JJ	amod	O
mouse	NN	compound	O
development	NN	nmod	O
and	CC	cc	O
hematopoiesis	NN	conj	O
,	,	punct	O
possibly	RB	advmod	O
due	JJ	case	O
to	TO	mwe	O
functional	JJ	amod	O
redundancy	NN	nmod	O
among	IN	case	O
the	DT	det	O
Gadd45	NN	compound	B-DNA
family	NN	compound	I-DNA
members	NNS	nmod	I-DNA
.	.	punct	O

Gadd45gamma	NN	nsubj	B-DNA
is	VBZ	cop	O
also	RB	advmod	O
dispensable	JJ	ROOT	O
for	IN	case	O
IL-2	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
T-cell	NN	compound	O
proliferation	NN	nmod	O
.	.	punct	O

Decreased	VBN	amod	O
expression	NN	ROOT	O
of	IN	case	O
c-myc	NN	compound	B-DNA
family	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
thymuses	NNS	nmod	O
from	IN	case	O
myasthenia	NN	compound	O
gravis	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

The	DT	det	O
thymus	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
critical	JJ	amod	O
organ	NN	ROOT	O
for	IN	case	O
the	DT	det	O
elimination	NN	nmod	O
of	IN	case	O
autoreactive	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
apoptosis-associated	JJ	amod	O
genes	NNS	nmod	O
,	,	punct	O
bcl-xL	NN	appos	B-DNA
,	,	punct	O
bad	JJ	conj	B-DNA
,	,	punct	O
caspase-3	NN	conj	B-DNA
,	,	punct	O
and	CC	cc	O
c-myc	NN	compound	B-DNA
family	NN	compound	I-DNA
genes	NNS	conj	I-DNA
in	IN	case	O
myasthenia	NN	compound	O
gravis	NN	compound	O
(	-LRB-	punct	O
MG	NN	appos	O
)	-RRB-	punct	O
thymuses	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
observed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
mRNA	NN	compound	O
levels	NNS	nsubjpass	O
of	IN	case	O
myc	NN	compound	B-DNA
family	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
c-myc	NN	appos	B-DNA
and	CC	cc	O
max	NN	conj	B-DNA
,	,	punct	O
were	VBD	auxpass	O
markedly	RB	advmod	O
reduced	VBN	ccomp	O
in	IN	case	O
MG	NNP	compound	O
thymuses	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
c-myc	NN	compound	B-DNA
-mediated	JJ	amod	O
signaling	NN	nsubj	O
is	VBZ	cop	O
abnormal	JJ	ccomp	O
in	IN	case	O
MG	NNP	compound	O
thymuses	NNS	nmod	O
.	.	punct	O

The	DT	det	O
levels	NNS	ROOT	O
of	IN	case	O
molecules	NNS	nmod	O
whose	WP$	nmod:poss	O
expressions	NNS	nsubjpass	O
are	VBP	auxpass	O
associated	VBN	acl:relcl	O
with	IN	case	O
myc	NN	nmod	B-DNA
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
STAM	NN	nmod	B-protein
,	,	punct	O
prothymosin-alpha	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
NFkappaB	NN	conj	B-protein

Immunohistochemical	JJ	amod	O
detection	NN	ROOT	O
of	IN	case	O
interferon-gamma-producing	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
dermatophytosis	NN	nmod	O
.	.	punct	O

Skin	NN	compound	O
lesions	NNS	nsubjpass	O
of	IN	case	O
dermatophytosis	NN	nmod	O
are	VBP	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
result	NN	xcomp	O
of	IN	case	O
a	DT	det	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
-dependent	JJ	amod	O
inflammatory	JJ	amod	O
response	NN	nmod	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	acl:relcl	O
by	IN	case	O
various	JJ	amod	O
cytokines	NNS	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
whether	IN	mark	O
IFN-gamma-positive	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
(	-LRB-	punct	O
as	IN	case	O
expression	NN	nmod	O
of	IN	case	O
Th1	NN	compound	B-cell_type
response	NN	nmod	O
)	-RRB-	punct	O
were	VBD	cop	O
present	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
skin	NN	compound	O
lesions	NNS	nmod	O
of	IN	case	O
dermatophytosis	NN	nmod	O
in	FW	compound	O
situ	FW	advmod	O
by	IN	case	O
immunohistochemical	JJ	amod	O
techniques	NNS	nmod	O
.	.	punct	O

Mixtures	NNS	nsubjpass	O
of	IN	case	O
CD4-positive	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
CD8-positive	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
present	JJ	xcomp	O
in	IN	case	O
the	DT	det	O
dermal	JJ	amod	O
infiltrates	NNS	nmod	O
of	IN	case	O
the	DT	det	O
lesions	NNS	nmod	O
.	.	punct	O

Considerable	JJ	amod	O
numbers	NNS	nsubjpass	O
of	IN	case	O
CD1a-positive	JJ	compound	B-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
upper	JJ	amod	O
dermis	NN	nmod	O
and	CC	cc	O
epidermis	JJ	conj	O
.	.	punct	O

A	DT	det	O
marked	JJ	amod	O
accumulation	NN	nsubjpass	O
of	IN	case	O
CD68-positive	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
upper	JJ	amod	O
dermis	NN	nmod	O
.	.	punct	O

IFN-gamma-positive	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
were	VBD	cop	O
present	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
upper	JJ	amod	O
dermis	NN	nmod	O
of	IN	case	O
the	DT	det	O
lesions	NNS	nmod	O
.	.	punct	O

The	DT	det	O
pattern	NN	nsubj	O
of	IN	case	O
IFN-gamma	NN	compound	B-protein
staining	NN	nmod	O
appeared	VBD	ROOT	O
to	TO	mark	O
be	VB	cop	O
intracellular	JJ	xcomp	O
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
staining	NN	nsubjpass	O
was	VBD	auxpass	O
considered	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
highly	RB	advmod	O
specific	JJ	xcomp	O
because	IN	mark	O
it	PRP	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
completely	RB	advmod	O
blocked	VBN	advcl	O
by	IN	case	O
preabsorption	NN	nmod	O
with	IN	case	O
recombinant	JJ	amod	B-protein
IFN-gamma	NN	nmod	I-protein
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
the	DT	det	O
skin	NN	compound	O
lesions	NNS	nsubjpass	O
of	IN	case	O
dermatophytosis	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
a	DT	det	O
Th1	NN	compound	B-cell_type
response	NN	nmod	O
.	.	punct	O

Th1	NN	compound	B-cell_type
response	NN	nsubjpass	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
characterized	VBN	acl:relcl	O
by	IN	case	O
IFN-gamma	NN	compound	B-protein
release	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
thought	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
in	IN	case	O
the	DT	det	O
host	NN	compound	O
defense	NN	nmod	O
against	IN	case	O
dermatophytes	NNS	nmod	O
and	CC	cc	O
to	TO	mark	O
reflect	VB	conj	O
cutaneous	JJ	amod	O
reaction	NN	dobj	O
in	IN	case	O
dermatophytosis	NN	nmod	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
helix-loop-helix	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
E2A	NN	appos	B-protein
and	CC	cc	O
Id3	NN	conj	B-protein
,	,	punct	O
by	IN	case	O
the	DT	det	O
Ras	NN	compound	B-protein
-	HYPH	punct	O
ERK	NN	compound	B-protein
MAPK	NN	compound	B-protein
cascade	NN	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	O
MAPK	NN	appos	B-protein
)	-RRB-	punct	O
pathways	NNS	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
cellular	JJ	amod	O
differentiation	NN	nmod	O
and/or	CC	cc	O
proliferation	NN	conj	O
in	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
types	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
developing	VBG	amod	B-cell_type
thymocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
basic	JJ	amod	B-protein
helix-loop-helix	JJ	amod	I-protein
(	-LRB-	punct	I-protein
bHLH	JJ	dep	I-protein
)	-RRB-	punct	I-protein
proteins	NNS	nsubj	I-protein
E12	NN	dep	B-protein
and	CC	cc	O
E47	NN	conj	B-protein
and	CC	cc	O
an	DT	det	O
inhibitor	NN	compound	B-protein
HLH	JJ	compound	I-protein
protein	NN	conj	I-protein
,	,	punct	O
Id3	NN	conj	B-protein
,	,	punct	O
play	VB	ROOT	O
key	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
thymocyte	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
E2A	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	nsubjpass	O
is	VBZ	auxpass	O
lowered	VBN	ccomp	O
in	IN	case	O
primary	JJ	amod	B-cell_type
immature	JJ	amod	I-cell_type
thymocytes	NNS	nmod	I-cell_type
consequent	JJ	advcl	O
to	TO	case	O
T	NN	compound	O
cell	NN	compound	O
receptor	NN	compound	O
(	-LRB-	punct	O
TCR	NN	compound	O
)	-RRB-	punct	O
-mediated	JJ	amod	O
ligation	NN	nmod	O
.	.	punct	O

Whereas	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
E2A	NN	compound	O
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
are	VBP	cop	O
unaltered	JJ	advcl	O
,	,	punct	O
Id3	NN	compound	B-RNA
transcripts	NNS	nsubjpass	I-RNA
are	VBP	auxpass	O
rapidly	RB	advmod	O
induced	VBN	ROOT	O
upon	IN	case	O
signaling	NN	nmod	O
from	IN	case	O
the	DT	det	O
TCR	NN	nmod	B-protein
.	.	punct	O

Activation	NN	nsubjpass	O
of	IN	case	O
Id3	NN	compound	O
transcription	NN	nmod	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
dose-dependent	JJ	amod	O
manner	NN	nmod	O
by	IN	case	O
the	DT	det	O
extracellular	JJ	amod	O
signal-regulated	JJ	amod	O
kinase	NN	compound	O
(	-LRB-	punct	O
ERK	NN	compound	B-protein
)	-RRB-	punct	O
MAPK	NN	compound	B-protein
module	NN	nmod	O
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
directly	RB	advmod	O
connect	VBP	ROOT	O
the	DT	det	O
ERK	NN	compound	B-protein
MAPK	NN	compound	B-protein
cascade	NN	dobj	O
and	CC	cc	O
HLH	JJ	compound	B-protein
proteins	NNS	conj	I-protein
in	IN	case	O
a	DT	det	O
linear	JJ	amod	O
pathway	NN	nmod	O
.	.	punct	O

Retinoic	JJ	amod	O
acid	NN	nsubj	O
up-regulates	VBZ	ROOT	O
myeloid	JJ	amod	O
ICAM-3	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
function	NN	conj	O
in	IN	case	O
a	DT	det	O
cell-specific	JJ	amod	O
fashion	NN	nmod	O
--	:	punct	O
evidence	NN	dep	O
for	IN	case	O
retinoid	NN	compound	O
signaling	NN	compound	O
pathways	NNS	nmod	O
in	IN	case	O
the	DT	det	O
mast	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
lineage	NN	nmod	I-cell_type
.	.	punct	O

Investigation	NN	nsubj	O
of	IN	case	O
mast	NN	compound	O
cell	NN	compound	O
responsiveness	NN	nmod	O
toward	IN	case	O
retinoic	JJ	amod	O
acid	NN	nmod	O
(	-LRB-	punct	O
RA	NN	appos	O
)	-RRB-	punct	O
revealed	VBD	ROOT	O
selective	JJ	amod	O
promotion	NN	dobj	O
of	IN	case	O
ICAM-3	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
mast	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
HMC-1	NN	nmod	I-cell_line
.	.	punct	O

This	DT	det	O
process	NN	nsubj	O
was	VBD	cop	O
dose-	NN	ROOT	O
and	CC	cc	O
time-dependent	JJ	conj	O
and	CC	cc	O
detectable	JJ	conj	O
by	IN	case	O
flow	NN	compound	O
cytometry	NN	nmod	O
,	,	punct	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	conj	O
,	,	punct	O
ELISA	NN	conj	O
,	,	punct	O
and	CC	cc	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	conj	O
.	.	punct	O

ICAM-3	NN	compound	B-protein
modulation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
cell-type	JJ	nmod:npmod	O
dependent	JJ	xcomp	O
,	,	punct	O
detectable	JJ	dep	O
also	RB	advmod	O
for	IN	case	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
monocytes	NNS	conj	B-cell_type
but	CC	cc	O
not	RB	cc	O
U-937	NN	conj	B-cell_line
and	CC	cc	O
only	RB	advmod	O
weakly	RB	conj	O
for	IN	case	O
KU812	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Terminally	RB	advmod	B-cell_type
differentiated	VBN	amod	I-cell_type
skin	NN	compound	I-cell_type
mast	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
also	RB	advmod	O
failed	VBD	ROOT	O
to	TO	mark	O
up-modulate	VB	xcomp	O
their	PRP$	nmod:poss	O
ICAM-3	NN	dobj	B-protein
,	,	punct	O
suggesting	VBG	xcomp	O
the	DT	det	O
requirement	NN	dobj	O
for	IN	case	O
some	DT	det	O
degree	NN	nmod	O
of	IN	case	O
immaturity	NN	nmod	O
for	IN	prep	O
the	DT	det	O
process	NN	pobj	O
.	.	punct	O

RA-mediated	JJ	amod	O
effects	NNS	nsubj	O
on	IN	case	O
ICAM-1	NN	compound	B-protein
expression	NN	nmod	O
,	,	punct	O
studied	VBN	acl	O
in	IN	case	O
parallel	NN	nmod	O
,	,	punct	O
were	VBD	cop	O
clearly	RB	advmod	O
distinct	JJ	ROOT	O
from	IN	case	O
those	DT	nmod	O
on	IN	case	O
ICAM-3	NN	nmod	B-protein
.	.	punct	O

Investigation	NN	nsubj	O
of	IN	case	O
retinoid	NN	compound	B-protein
receptor	NN	compound	I-protein
expression	NN	nmod	O
,	,	punct	O
known	VBN	acl	O
to	TO	mark	O
mediate	VB	xcomp	O
intracellular	JJ	amod	O
RA	NN	compound	O
signaling	NN	dobj	O
,	,	punct	O
revealed	VBD	ROOT	O
presence	NN	dobj	O
of	IN	case	O
RAR	NN	compound	B-RNA
alpha	NN	nmod	I-RNA
,	,	punct	I-RNA
RAR	NN	compound	I-RNA
gamma	NN	conj	I-RNA
,	,	punct	I-RNA
RXR	NN	compound	I-RNA
beta	NN	conj	I-RNA
,	,	punct	I-RNA
and	CC	cc	I-RNA
RXR	NN	compound	I-RNA
gamma	NN	compound	I-RNA
transcripts	NNS	conj	I-RNA
in	IN	case	O
all	DT	det	O
cell	NN	compound	O
lines	NNS	nmod	O
studied	VBN	acl	O
,	,	punct	O
and	CC	cc	O
HMC-1	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
were	VBD	cop	O
the	DT	det	O
only	JJ	amod	O
line	NN	conj	O
lacking	VBG	acl	O
RXR	NN	compound	B-protein
alpha	NN	dobj	I-protein
.	.	punct	O

RAR	NN	compound	B-protein
beta	NN	nsubjpass	I-protein
,	,	punct	O
not	RB	neg	O
expressed	VBN	acl	O
at	IN	case	O
baseline	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
RA	NN	nmod	O
in	IN	case	O
a	DT	det	O
fashion	NN	nmod	O
obviously	RB	advmod	O
correlating	VBG	acl	O
with	IN	case	O
ICAM-3	NN	compound	B-protein
up-regulation	NN	nmod	O
.	.	punct	O

Increased	VBN	amod	O
ICAM-3	NN	compound	B-protein
expression	NN	nsubj	O
was	VBD	cop	O
of	IN	case	O
functional	JJ	amod	O
significance	NN	nsubjpass	O
,	,	punct	O
such	JJ	det:predet	O
that	IN	det	O
processes	NNS	nsubj	O
stimulated	VBN	acl	O
or	CC	cc	O
co-stimulated	VBN	conj	O
via	IN	case	O
ICAM-3	NN	nmod	B-protein
(	-LRB-	punct	O
homotypic	JJ	amod	O
aggregation	NN	dep	O
,	,	punct	O
IL-8	NN	compound	O
secretion	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
clearly	RB	advmod	O
enhanced	VBN	ROOT	O
upon	IN	case	O
RA	NN	compound	O
pretreatment	NN	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
RA	NN	nsubj	O
may	MD	aux	O
contribute	VB	ccomp	O
via	IN	case	O
hitherto	RB	compound	O
unrecognized	JJ	amod	O
pathways	NNS	nmod	O
to	TO	case	O
immune	JJ	amod	O
function	NN	nmod	O
and	CC	cc	O
host	NN	compound	O
defense	NN	conj	O
.	.	punct	O

CD28	NN	ROOT	B-protein
and	CC	cc	O
T	NN	conj	B-cell_type
cell	NN	compound	I-cell_type
co-stimulation	NN	dep	O
.	.	punct	O

Over	IN	prep	O
the	DT	det	O
last	JJ	amod	O
decade	NN	pobj	O
the	DT	det	O
concept	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
co-stimulation	NN	nmod	O
has	VBZ	aux	O
emerged	VBN	ROOT	O
to	TO	aux	O
take	VB	xcomp	O
a	DT	det	O
central	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
exact	JJ	amod	O
definition	NN	nsubj	O
of	IN	case	O
co-stimulation	NN	nmod	O
is	VBZ	ROOT	O
still	RB	advmod	O
unclear	JJ	acomp	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
review	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
re-examine	VBP	ROOT	O
the	DT	det	O
concept	NN	dobj	O
of	IN	prep	O
co-stimulation	NN	pobj	O
.	.	punct	O

We	PRP	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
while	IN	mark	O
co-stimulation	NN	nsubj	O
is	VBZ	cop	O
important	JJ	advcl	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ccomp	O
little	JJ	amod	O
evidence	NN	nsubj	O
to	TO	case	O
link	VB	compound	O
co-stimulation	NN	nmod	O
with	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
anergy	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
then	RB	advmod	O
suggest	VBP	ROOT	O
a	DT	det	O
framework	NN	dobj	O
for	IN	prep	O
studying	VBG	pcomp	O
co-stimulation	NN	dobj	O
.	.	punct	O

Focusing	VBG	advcl	O
on	IN	prep	O
recent	JJ	amod	O
advances	NNS	pobj	O
in	IN	case	O
our	PRP$	nmod:poss	O
understanding	NN	nmod	O
of	IN	case	O
CD28	NN	nmod	B-protein
,	,	punct	O
we	PRP	nsubj	O
discuss	VBP	ROOT	O
four	CD	nummod	O
areas	NNS	dobj	O
of	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	nmod	O
where	WRB	advmod	O
co-stimulation	NN	nsubj	O
may	MD	aux	O
play	VB	acl:relcl	O
a	DT	det	O
role	NN	dobj	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
activator	NN	compound	B-protein
protein-1	NN	nmod	I-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
in	IN	case	O
CD8+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
exposed	VBN	acl	O
to	TO	case	O
peripheral	JJ	amod	B-protein
self-antigens	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
transcriptional	JJ	amod	O
events	NNS	nsubj	O
that	WDT	nsubj	O
control	VBP	acl:relcl	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
tolerance	NN	dobj	O
to	TO	case	O
peripheral	JJ	amod	B-protein
self	NN	compound	I-protein
Ags	NNS	nmod	I-protein
are	VBP	cop	O
still	RB	advmod	O
unknown	JJ	ROOT	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
regulation	NN	dobj	O
of	IN	case	O
AP-1	NN	compound	B-protein
-	:	punct	O
and	CC	cc	O
NF-kappa	NN	nmod:npmod	B-protein
B	NN	nmod:npmod	I-protein
-mediated	JJ	amod	O
transcription	NN	nmod	O
during	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
induction	NN	nmod	O
of	IN	case	O
tolerance	NN	nmod	O
to	TO	case	O
a	DT	det	O
self	NN	compound	B-protein
Ag	NN	nmod	I-protein
expressed	VBD	acl	O
exclusively	RB	advmod	O
on	IN	case	O
hepatocytes	NNS	nmod	B-cell_type
.	.	punct	O

Naive	JJ	amod	B-cell_type
CD8	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
Desire	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
Des	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
isolated	VBN	acl	O
from	IN	case	O
the	DT	det	O
Des	NN	compound	O
TCR-transgenic	JJ	amod	O
mice	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
specific	JJ	acl:relcl	O
for	IN	case	O
the	DT	det	O
H-2K	NN	compound	B-protein
(	-LRB-	punct	I-protein
b	LS	compound	I-protein
)	-RRB-	punct	I-protein
class	NN	compound	I-protein
I	CD	nummod	I-protein
Ag	NN	nmod	I-protein
were	VBD	auxpass	O
transferred	VBN	ROOT	O
into	IN	case	O
Alb-K	NNS	compound	O
(	-LRB-	punct	O
b	LS	compound	O
)	-RRB-	punct	O
-transgenic	JJ	amod	O
mice	NNS	nmod	O
that	WDT	nsubj	O
express	VBP	acl:relcl	O
the	DT	det	O
H-2K	NN	compound	B-protein
(	-LRB-	punct	I-protein
b	LS	appos	I-protein
)	-RRB-	punct	I-protein
Ag	NN	dobj	I-protein
on	IN	case	O
hepatocytes	NNS	nmod	B-cell_type
only	RB	advmod	O
.	.	punct	O

Tolerance	NN	nsubj	O
develops	VBZ	ROOT	O
in	IN	case	O
these	DT	det	O
mice	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ccomp	O
that	IN	mark	O
the	DT	det	O
self-reactive	JJ	amod	B-cell_type
CD8	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
Des	NN	dep	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
transiently	RB	advmod	O
activated	VBN	ccomp	O
,	,	punct	O
then	RB	advmod	O
became	VBD	ROOT	O
unresponsive	JJ	acomp	O
and	CC	cc	O
were	VBD	auxpass	O
further	RB	advmod	O
deleted	VBN	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
CD8	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
Des	NN	appos	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
activated	VBN	acl	O
in	FW	compound	O
vivo	FW	advmod	O
with	IN	case	O
APCs	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
express	VBP	acl:relcl	O
high	JJ	amod	O
AP-1	NN	dobj	B-protein
and	CC	cc	O
high	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcriptional	JJ	amod	O
activity	NN	conj	O
,	,	punct	O
the	DT	det	O
unresponsive	JJ	amod	O
CD8	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
Des	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
expressed	VBD	ROOT	O
no	DT	neg	O
AP-1	NN	dobj	B-protein
and	CC	cc	O
only	RB	advmod	O
weak	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcriptional	JJ	amod	O
activity	NN	conj	O
.	.	punct	O

The	DT	det	O
differences	NNS	nsubj	O
in	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcriptional	JJ	amod	O
activity	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
generation	NN	nmod	O
of	IN	case	O
distinct	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
complexes	NNS	nmod	I-protein
.	.	punct	O

Indeed	RB	advmod	O
,	,	punct	O
in	FW	amod	O
vivo	FW	dep	O
primed	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
predominantly	RB	advmod	O
express	VBP	ROOT	O
p50/p50	NN	compound	B-protein
and	CC	cc	I-protein
p65/p50	NN	conj	I-protein
dimers	NNS	dobj	I-protein
,	,	punct	O
whereas	IN	dep	O
these	DT	det	O
p50-containing	JJ	amod	B-protein
complexes	NNS	nsubj	I-protein
are	VBP	cop	O
barely	RB	advmod	O
detectable	JJ	parataxis	O
in	IN	case	O
tolerant	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
that	WDT	nsubj	O
express	VBP	acl:relcl	O
p65-	NN	amod	B-protein
and	CC	cc	I-protein
c-Rel-containing	JJ	conj	I-protein
complexes	NNS	dobj	I-protein
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
fine	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
complex	NN	compound	I-protein
formation	NN	nmod	O
may	MD	aux	O
determine	VB	ccomp	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
fate	NN	dobj	O
.	.	punct	O

Transcriptional	JJ	amod	O
regulation	NN	ROOT	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
.	.	punct	O

Lymphocytes	NNS	nsubjpass	B-cell_type
have	VBP	aux	O
been	VBN	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
many	JJ	amod	O
cellular	JJ	amod	O
processes	NNS	dobj	O
,	,	punct	O
including	VBG	case	O
lineage	NN	compound	O
commitment	NN	nmod	O
,	,	punct	O
differentiation	NN	conj	O
,	,	punct	O
proliferation	NN	conj	O
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

The	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nsubjpass	I-protein
that	WDT	nsubj	O
mediate	VBP	acl:relcl	O
these	DT	det	O
processes	NNS	dobj	O
are	VBP	auxpass	O
often	RB	advmod	O
expressed	VBN	ROOT	O
broadly	RB	advmod	O
in	IN	case	O
many	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

The	DT	det	O
emerging	VBG	amod	O
theme	NN	nsubj	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
cell-type-specific	JJ	amod	O
regulation	NN	nmod	O
,	,	punct	O
affecting	VBG	advcl	O
not	RB	neg	O
only	RB	cc:preconj	O
the	DT	det	O
functional	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
but	CC	cc	O
also	RB	advmod	O
their	PRP$	nmod:poss	O
access	NN	conj	O
to	TO	case	O
appropriate	VB	amod	O
regions	NNS	nmod	O
of	IN	case	O
DNA	NN	nmod	O
.	.	punct	O

Existence	NN	ROOT	O
of	IN	case	O
retinoic	JJ	amod	B-protein
acid-receptor	JJ	amod	I-protein
-independent	JJ	amod	O
retinoid	NN	compound	B-protein
X-receptor	NN	compound	I-protein
-dependent	JJ	amod	O
pathway	NN	nmod	O
in	IN	case	O
myeloid	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
function	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
reported	VBD	ROOT	O
that	IN	mark	O
ER-27191	NN	nsubj	O
(	-LRB-	punct	O
4-	CD	appos	O
[	-LRB-	punct	O
4	CD	dep	O
,	,	punct	O
5	CD	conj	O
,	,	punct	O
7	CD	dep	O
,	,	punct	O
8	CD	conj	O
,	,	punct	O
9	CD	conj	O
,	,	punct	O
10-hexahydro-7	CD	conj	O
,	,	punct	O
7	CD	conj	O
,	,	punct	O
10	CD	conj	O
,	,	punct	O
10-tetramethyl-1-	JJ	appos	O
(	-LRB-	punct	O
3-pyridylmethyl	JJ	appos	O
)	-RRB-	punct	O
anthra	NN	dep	O
[	-LRB-	punct	O
1	CD	nummod	O
,	,	punct	O
2-b	JJ	conj	O
]	-RRB-	punct	O
pyrrol-3-yl	NN	dep	O
]	-RRB-	punct	O
benzoic	JJ	amod	O
acid	NN	dep	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
antagonist	NN	nsubj	O
of	IN	case	O
retinoic	JJ	amod	B-protein
acid	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
RAR	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
ER-35795	NN	conj	O
(	-LRB-	punct	O
(	-LRB-	punct	O
2E	NN	dep	O
,	,	punct	O
4E	NN	conj	O
,	,	punct	O
6E	NN	appos	O
)	-RRB-	punct	O
-7-	NN	punct	O
[	-LRB-	punct	O
1-	CD	compound	O
(	-LRB-	punct	O
1-methylethyl	JJ	appos	O
)	-RRB-	punct	O
-8-chloro-1	NN	dep	O
,	,	punct	O
2	CD	conj	O
,	,	punct	O
3	CD	conj	O
,	,	punct	O
4-tetrahydroquinolin-6-yl	NN	conj	O
]	-RRB-	punct	O
-6-fluoro-3-methyl-2	CD	dep	O
,	,	punct	O
4	CD	conj	O
,	,	punct	O
6-nonatrienoic	JJ	amod	O
acid	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
retinoid	NN	compound	B-protein
X	NN	compound	I-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
RXR	NN	appos	B-protein
)	-RRB-	punct	O
-specific	JJ	amod	O
agonist	NN	dobj	O
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
these	DT	det	O
compounds	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
whether	IN	mark	O
distinct	JJ	amod	O
RAR	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
and	CC	cc	O
RXR	NN	nmod:npmod	B-protein
-dependent	JJ	conj	O
pathways	NNS	nsubj	O
operate	VBP	ccomp	O
to	TO	mark	O
mediate	VB	xcomp	O
the	DT	det	O
diverse	JJ	amod	O
activities	NNS	dobj	O
of	IN	case	O
retinoids	NNS	nmod	O
,	,	punct	O
particularly	RB	advmod	O
,	,	punct	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
the	DT	det	O
RXR	NN	compound	B-protein
pathway	NN	nmod	O
on	IN	case	O
cellular	JJ	amod	O
function	NN	nmod	O
.	.	punct	O

ER-27191	NN	nsubj	O
completely	RB	advmod	O
antagonized	VBD	ROOT	O
HL60	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
differentiation	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
all-trans-retinoic	JJ	amod	O
acid	NN	nmod	O
(	-LRB-	punct	O
atRA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
differentiation	NN	nsubjpass	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
ER-35795	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
antagonized	VBN	ROOT	O
at	IN	case	O
all	RB	nmod	O
by	IN	case	O
the	DT	det	O
RAR	NN	compound	B-protein
antagonist	NN	nmod	O
,	,	punct	O
but	CC	cc	O
was	VBD	auxpass	O
inhibited	VBN	conj	O
by	IN	case	O
an	DT	det	O
RXR	NN	compound	B-protein
homodimer	NN	compound	I-protein
antagonist	NN	nmod	O
(	-LRB-	punct	O
LGD100754	NN	dep	O
,	,	punct	O
(	-LRB-	punct	O
2E	NN	dep	O
,	,	punct	O
4E	NN	conj	O
,	,	punct	O
6Z	NN	appos	O
)	-RRB-	punct	O
-7-	NN	dep	O
(	-LRB-	punct	O
3-n-propoxy-5	CD	dep	O
,	,	punct	O
6	CD	amod	O
,	,	punct	O
7	CD	conj	O
,	,	punct	O
8-tetrahydro-5	NN	conj	O
,	,	punct	O
5	CD	conj	O
,	,	punct	O
8	CD	conj	O
,	,	punct	O
8-tetramethylnaphthalen-2-yl	NN	appos	O
)	-RRB-	punct	O
-3-methylocta-2	NN	amod	O
,	,	punct	O
4	CD	dep	O
,	,	punct	O
6-trienoic	JJ	amod	O
acid	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Its	PRP$	nmod:poss	O
agonistic	JJ	amod	O
action	NN	nsubjpass	O
on	IN	case	O
RXR/RAR	NN	compound	B-protein
heterodimer	NN	nmod	I-protein
,	,	punct	O
on	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
neutralized	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
RAR	NN	compound	B-protein
antagonist	NN	nmod	O
.	.	punct	O

During	IN	case	O
HL60	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
differentiation	NN	nmod	O
,	,	punct	O
atRA	NN	nsubj	O
induced	VBD	ROOT	O
RARbeta	NN	compound	B-RNA
mRNA	NN	dobj	I-RNA
,	,	punct	O
while	IN	mark	O
the	DT	det	O
RXR	NN	nsubj	B-protein
had	VBD	advcl	O
no	DT	neg	O
effect	NN	dobj	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
a	DT	det	O
functional	JJ	amod	O
RXR	NN	compound	B-protein
-pathway	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
seen	VBN	ROOT	O
in	IN	case	O
lipopolysaccharide-induced	JJ	amod	O
inhibition	NN	nmod	O
of	IN	case	O
mouse	NN	compound	B-cell_type
splenocyte	NN	compound	I-cell_type
proliferation	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
strongly	RB	advmod	O
suggest	VBP	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
a	DT	det	O
pharmacological	JJ	amod	O
RXR	NN	compound	B-protein
-dependent	JJ	amod	O
pathway	NN	nmod	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	acl:relcl	O
by	IN	case	O
a	DT	det	O
ligand	NN	nmod	O
that	WDT	nsubj	O
can	MD	aux	O
bind	VB	acl:relcl	O
to	TO	case	O
RXR	NN	nmod	B-protein
.	.	punct	O

Targeting	VBG	csubj	O
Src	NN	compound	B-protein
homology	NN	compound	I-protein
2	CD	nummod	I-protein
domain-containing	JJ	amod	I-protein
tyrosine	NN	compound	I-protein
phosphatase	NN	dobj	I-protein
(	-LRB-	punct	O
SHP-1	NN	appos	B-protein
)	-RRB-	punct	O
into	IN	case	O
lipid	NN	compound	O
rafts	NNS	nmod	O
inhibits	VBZ	ROOT	O
CD3	NN	compound	B-protein
-induced	JJ	amod	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	dobj	O
.	.	punct	O

To	TO	mark	O
study	VB	advcl	O
the	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
protein	NN	compound	B-protein
tyrosine	NN	compound	I-protein
phosphatases	NNS	nsubj	I-protein
(	-LRB-	punct	O
PTPs	NNS	appos	B-protein
)	-RRB-	punct	O
regulate	VBP	acl:relcl	O
CD3	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
distribution	NN	dobj	O
of	IN	case	O
PTPs	NN	nmod	B-protein
in	IN	case	O
subdomains	NNS	nmod	O
of	IN	case	O
plasma	NN	compound	O
membrane	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
the	DT	det	O
bulk	JJ	amod	O
PTP	NN	compound	B-protein
activity	NN	nsubj	O
associated	VBN	acl	O
with	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
membrane	NN	nmod	O
is	VBZ	cop	O
present	JJ	ccomp	O
outside	IN	case	O
the	DT	det	O
lipid	NN	compound	O
rafts	NNS	nmod	O
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
sucrose	NN	compound	O
density	NN	compound	O
gradient	NN	compound	O
sedimentation	NN	nmod	O
.	.	punct	O

In	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
approximately	RB	advmod	O
5	CD	nummod	O
--	:	punct	O
10	CD	nummod	O
%	NN	nsubjpass	O
of	IN	case	O
Src	NN	compound	B-protein
homology	NN	compound	I-protein
2	CD	nummod	I-protein
domain-containing	JJ	amod	I-protein
tyrosine	NN	compound	I-protein
phosphatase	NN	nmod	I-protein
(	-LRB-	punct	O
SHP-1	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
constitutively	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
plasma	NN	compound	O
membrane	NN	nmod	O
,	,	punct	O
and	CC	cc	O
nearly	RB	advmod	O
50	CD	nummod	O
%	NN	nsubjpass	O
of	IN	case	O
SHP-2	NN	nmod	B-protein
is	VBZ	auxpass	O
translocated	VBN	conj	O
to	TO	case	O
plasma	NN	compound	O
membrane	NN	nmod	O
after	IN	case	O
vanadate	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

Similar	JJ	advcl	O
to	TO	case	O
transmembrane	JJ	amod	B-protein
PTP	NN	nmod	I-protein
,	,	punct	O
CD45	NN	appos	B-protein
,	,	punct	O
the	DT	det	O
membrane-associated	JJ	amod	O
populations	NNS	nsubjpass	O
of	IN	case	O
SHP-1	NN	nmod	B-protein
and	CC	cc	O
SHP-2	NN	conj	B-protein
are	VBP	auxpass	O
essentially	RB	advmod	O
excluded	VBN	ROOT	O
from	IN	case	O
lipid	NN	compound	O
rafts	NNS	nmod	O
,	,	punct	O
where	WRB	advmod	O
other	JJ	amod	O
signaling	VBG	amod	B-protein
molecules	NNS	nsubj	I-protein
such	JJ	case	O
as	IN	mwe	O
Lck	NN	nmod	B-protein
,	,	punct	I-protein
linker	NN	nsubjpass	I-protein
for	IN	case	I-protein
activation	NN	nmod	I-protein
of	IN	case	I-protein
T	NN	compound	I-protein
cells	NNS	nmod	I-protein
,	,	punct	O
and	CC	cc	O
CD3	NN	compound	B-protein
zeta	NN	conj	I-protein
are	VBP	auxpass	O
enriched	VBN	acl:relcl	O
.	.	punct	O

We	PRP	nsubj	O
further	RB	advmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
CD3	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nsubj	O
of	IN	case	O
these	DT	det	O
substrates	NNS	nmod	O
is	VBZ	cop	O
largely	RB	advmod	O
restricted	JJ	ccomp	O
to	TO	case	O
lipid	NN	compound	O
rafts	NNS	nmod	O
,	,	punct	O
unless	IN	mark	O
PTPs	NNS	nsubjpass	B-protein
are	VBP	auxpass	O
inhibited	VBN	advcl	O
.	.	punct	O

It	PRP	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
a	DT	det	O
restricted	JJ	amod	O
partition	NN	nsubj	O
of	IN	case	O
PTPs	NN	nmod	B-protein
among	IN	case	O
membrane	NN	compound	O
subdomains	NNS	nmod	O
may	MD	aux	O
regulate	VB	ccomp	O
protein	NN	compound	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
membrane	NN	nmod	O
.	.	punct	O

To	TO	mark	O
test	VB	advcl	O
this	DT	det	O
hypothesis	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
targeted	VBD	ROOT	O
SHP-1	NN	dobj	B-protein
into	IN	case	O
lipid	NN	compound	O
rafts	NNS	nmod	O
by	IN	mark	O
using	VBG	advcl	O
the	DT	det	O
N-terminal	JJ	amod	B-protein
region	NN	dobj	I-protein
of	IN	case	I-protein
Lck	NN	nmod	I-protein
(	-LRB-	punct	O
residues	NNS	dep	B-protein
1	CD	nummod	I-protein
--	:	punct	I-protein
14	CD	nummod	I-protein
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
Lck/SHP-1	JJ	compound	B-protein
chimera	NN	nmod	I-protein
inside	IN	case	O
lipid	NN	compound	O
rafts	NNS	nmod	O
profoundly	RB	advmod	O
inhibits	VBZ	ccomp	O
CD3	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
of	IN	case	O
CD3	NN	compound	B-protein
zeta/epsilon	NN	nmod	I-protein
,	,	punct	O
IL-2	NN	compound	O
generation	NN	conj	O
,	,	punct	O
and	CC	cc	O
nuclear	JJ	amod	O
mobilization	NN	conj	O
of	IN	case	O
NF-AT	NN	nmod	B-protein
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
exclusion	NN	nsubj	O
of	IN	case	O
PTPs	NN	nmod	B-protein
from	IN	case	O
lipid	NN	compound	O
rafts	NNS	nmod	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
mechanism	NN	ccomp	O
that	WDT	nsubj	O
potentiates	VBZ	acl:relcl	O
TCR	NN	compound	B-protein
/	:	punct	O
CD3	NN	compound	B-protein
activation	NN	dobj	O

An	DT	det	O
instructive	JJ	amod	O
component	NN	ROOT	O
in	IN	case	O
T	NN	compound	B-cell_type
helper	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
type	NN	compound	I-cell_type
2	CD	nummod	I-cell_type
(	-LRB-	punct	O
Th2	NN	appos	B-cell_type
)	-RRB-	punct	O
development	NN	nmod	O
mediated	VBN	acl	O
by	IN	case	O
GATA-3	NN	nmod	B-protein
.	.	punct	O

Although	IN	mark	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	nsubj	I-protein
)	-RRB-	punct	I-protein
-12	CD	nummod	I-protein
and	CC	cc	O
IL-4	NN	conj	B-protein
polarize	VBP	advcl	O
naive	JJ	amod	B-cell_type
CD4	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
toward	IN	case	O
T	NN	compound	O
helper	NN	compound	O
cell	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
(	-LRB-	punct	O
Th1	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
Th2	NN	compound	O
phenotypes	NNS	conj	O
,	,	punct	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
known	VBN	ROOT	O
whether	IN	mark	O
cytokines	NNS	nsubj	B-protein
instruct	VBP	ccomp	O
the	DT	det	O
developmental	JJ	amod	O
fate	NN	dobj	O
in	IN	case	O
uncommitted	JJ	amod	B-cell_type
progenitors	NNS	nmod	I-cell_type
or	CC	cc	O
select	JJ	conj	O
for	IN	case	O
outgrowth	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
that	WDT	nsubj	O
have	VBP	aux	O
stochastically	RB	advmod	O
committed	VBN	acl:relcl	O
to	TO	case	O
a	DT	det	O
particular	JJ	amod	O
fate	NN	nmod	O
.	.	punct	O

To	TO	mark	O
distinguish	VB	advcl	O
these	DT	det	O
instructive	JJ	amod	O
and	CC	cc	O
selective	JJ	conj	O
models	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
surface	NN	compound	O
affinity	NN	compound	O
matrix	NN	compound	O
technology	NN	dobj	O
to	TO	mark	O
isolate	VB	xcomp	O
committed	VBN	amod	B-cell_type
progenitors	NNS	dobj	I-cell_type
based	VBN	case	O
on	IN	case	O
cytokine	NN	compound	O
secretion	NN	compound	O
phenotype	NN	nmod	O
and	CC	cc	O
developed	VBD	conj	O
retroviral-based	JJ	amod	O
tagging	NN	compound	O
approaches	NNS	dobj	O
to	TO	mark	O
directly	RB	advmod	O
monitor	VB	xcomp	O
individual	JJ	amod	O
progenitor	NN	compound	O
fate	NN	compound	O
decisions	NNS	dobj	O
at	IN	case	O
the	DT	det	O
clonal	JJ	amod	O
and	CC	cc	O
population	NN	conj	O
levels	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
observe	VBP	ROOT	O
IL-4	NN	compound	B-protein
-dependent	JJ	amod	O
redirection	NN	dobj	O
of	IN	case	O
phenotype	NN	nmod	O
in	IN	case	O
cells	NNS	nmod	O
that	WDT	nsubj	O
have	VBP	aux	O
already	RB	advmod	O
committed	VBN	acl:relcl	O
to	TO	case	O
a	DT	det	O
non-IL-4-producing	JJ	amod	O
fate	NN	nmod	O
,	,	punct	O
inconsistent	JJ	dep	O
with	IN	case	O
predictions	NNS	nmod	O
of	IN	case	O
the	DT	det	O
selective	JJ	amod	O
model	NN	nmod	O
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
retroviral	JJ	amod	O
tagging	NN	nsubj	O
of	IN	case	O
naive	JJ	amod	B-cell_type
progenitors	NNS	nmod	I-cell_type
with	IN	case	O
the	DT	det	O
Th2-specific	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
GATA-3	NN	nmod	I-protein
provided	VBD	ROOT	O
direct	JJ	amod	O
evidence	NN	dobj	O
for	IN	case	O
instructive	JJ	amod	O
differentiation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
no	DT	neg	O
evidence	NN	conj	O
for	IN	case	O
the	DT	det	O
selective	JJ	amod	O
outgrowth	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
committed	VBN	acl	O
to	TO	case	O
either	CC	cc:preconj	O
the	DT	det	O
Th1	NN	compound	O
or	CC	cc	O
Th2	NN	conj	O
fate	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
would	MD	aux	O
seem	VB	ROOT	O
to	TO	mark	O
exclude	VB	xcomp	O
selection	NN	dobj	O
as	IN	case	O
an	DT	det	O
exclusive	JJ	amod	O
mechanism	NN	nmod	O
in	IN	case	O
Th1	NN	nmod	B-cell_type
/	:	punct	O
Th2	NN	compound	B-cell_type
differentiation	NN	conj	O
,	,	punct	O
and	CC	cc	O
support	VBP	conj	O
an	DT	det	O
instructive	JJ	amod	O
model	NN	dobj	O
of	IN	case	O
cytokine-driven	JJ	amod	O
transcriptional	JJ	amod	O
programming	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
fate	NN	compound	O
decisions	NNS	nmod	O
.	.	punct	O

In	IN	case	O
vitro-activated	JJ	amod	O
human	JJ	amod	B-cell_type
lupus	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
express	VBP	ROOT	O
normal	JJ	amod	O
estrogen	NN	compound	B-protein
receptor	NN	compound	I-protein
proteins	NNS	dobj	I-protein
which	WDT	nsubj	O
bind	VBP	acl:relcl	O
to	TO	case	O
the	DT	det	O
estrogen	NN	compound	B-protein
response	NN	compound	I-protein
element	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
estrogen	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
ERalpha	NN	compound	B-protein
,	,	punct	O
ERbeta	NN	appos	B-protein
)	-RRB-	punct	O
transcripts	NNS	nsubjpass	O
are	VBP	auxpass	O
expressed	VBN	ccomp	O
in	IN	case	O
SLE	NN	nmod	B-cell_type
and	CC	cc	I-cell_type
normal	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
T	NN	compound	O
cell	NN	compound	O
nuclear	JJ	amod	O
extracts	NNS	nsubjpass	O
from	IN	case	O
female	JJ	amod	O
lupus	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
normal	JJ	amod	O
donors	NNS	conj	O
were	VBD	auxpass	O
tested	VBN	ROOT	O
for	IN	case	O
biologically	RB	advmod	O
active	JJ	amod	O
ER	NN	compound	B-protein
proteins	NNS	nmod	I-protein
capable	JJ	amod	O
of	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
the	DT	det	O
human	JJ	amod	B-DNA
estrogen	NN	compound	I-DNA
response	NN	compound	I-DNA
element	NN	nmod	I-DNA
(	-LRB-	punct	O
hERE	NN	appos	B-DNA
)	-RRB-	punct	O
by	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

When	WRB	advmod	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
stimulated	VBN	advcl	O
with	IN	case	O
17beta-estradiol	NN	nmod	O
(	-LRB-	punct	O
E2	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
PMA	NN	conj	O
and	CC	cc	O
ionomycin	NN	conj	O
,	,	punct	O
two	CD	nummod	O
major	JJ	amod	O
retarded	VBN	amod	O
bands	NNS	nsubj	O
in	IN	case	O
T	NN	compound	O
cell	NN	compound	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
exhibited	VBD	ROOT	O
a	DT	det	O
migration	NN	compound	O
pattern	NN	dobj	O
similar	JJ	amod	O
to	TO	case	O
slow	VB	amod	O
migrating	VBG	amod	O
protein-ERE	JJ	compound	B-protein
complexes	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	O
breast	NN	compound	O
cancer	NN	compound	O
cell	NN	compound	O
extracts	NNS	nmod	O
.	.	punct	O

T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
cultured	VBN	acl	O
only	RB	advmod	O
with	IN	case	O
E2	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
have	VB	ROOT	O
these	DT	det	O
complexes	NNS	dobj	O
.	.	punct	O

The	DT	det	O
formation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
complexes	NNS	nmod	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
competition	NN	nmod	O
with	IN	case	O
the	DT	det	O
hERE	NN	compound	O
cold	JJ	amod	O
oligonucleotide	NN	nmod	O
and	CC	cc	O
partially	RB	advmod	O
with	IN	case	O
anti-ERalpha	NN	compound	B-protein
antibodies	NNS	conj	I-protein
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
notable	JJ	amod	O
difference	NN	nsubj	O
in	IN	case	O
the	DT	det	O
migration	NN	compound	O
pattern	NN	nmod	O
of	IN	case	O
ERE-binding	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
between	IN	case	O
the	DT	det	O
SLE	NN	nmod	O
and	CC	cc	O
normal	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
extracts	NNS	conj	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	dobj	O
activated	VBN	amod	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	dep	I-cell_type
,	,	punct	O
whether	IN	mark	O
lupus-derived	JJ	nsubj	O
or	CC	cc	O
normal-derived	JJ	conj	O
,	,	punct	O
contain	VBP	acl:relcl	O
biologically	RB	advmod	O
active	JJ	amod	O
ERalpha	NN	compound	B-protein
proteins	NNS	dobj	I-protein
.	.	punct	O

Other	JJ	amod	O
factors	NNS	nsubj	O
may	MD	aux	O
be	VB	cop	O
responsible	JJ	ROOT	O
for	IN	case	O
differential	JJ	amod	O
sensitivity	NN	nmod	O
of	IN	case	O
lupus	NN	compound	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
estrogen	NN	nmod	O
.	.	punct	O

Mechanism	NN	ROOT	O
of	IN	case	O
the	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
protease	NN	compound	O
inhibitor	NN	nmod	O
on	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	compound	I-protein
production	NN	nmod	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

If	IN	mark	O
the	DT	det	O
inflammatory	JJ	amod	O
response	NN	nsubj	O
becomes	VBZ	advcl	O
excessive	JJ	acomp	O
or	CC	cc	O
uncontrolled	VBN	conj	O
by	IN	case	O
some	DT	det	O
stimuli	NNS	nmod	O
,	,	punct	O
inappropriate	JJ	amod	O
inflammatory	JJ	amod	O
responses	NNS	nsubj	O
occur	VBP	ROOT	O
.	.	punct	O

Monocytes	NNS	nsubj	B-cell_type
are	VBP	cop	O
extremely	RB	advmod	O
important	JJ	amod	O
cells	NNS	nsubj	O
for	IN	mark	O
regulating	VBG	advcl	O
the	DT	det	O
cytokine	NN	compound	O
network	NN	dobj	O
and	CC	cc	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	conj	I-protein
(	-LRB-	punct	O
TNFalpha	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
interleukin-	NN	amod	B-protein
(	-LRB-	punct	I-protein
IL	NN	conj	I-protein
)	-RRB-	punct	I-protein
10	CD	nummod	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
mainly	RB	advmod	O
synthesized	VBN	acl:relcl	O
by	IN	case	O
monocytes	NNS	nmod	B-cell_type
,	,	punct	O
are	VBP	cop	O
representative	JJ	amod	O
cytokines	NNS	ROOT	B-protein
that	WDT	nsubj	O
play	VBP	acl:relcl	O
a	DT	det	O
central	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
cytokine	NN	compound	O
network	NN	nmod	O
.	.	punct	O

Protease	NN	compound	O
inhibitors	NNS	nsubjpass	O
such	JJ	case	O
as	IN	mwe	O
gabexate	NN	compound	O
mesilate	NN	nmod	O
(	-LRB-	punct	O
GM	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
ulinastatin	NN	conj	O
(	-LRB-	punct	O
UTI	NN	appos	O
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
various	JJ	amod	O
beneficial	JJ	amod	O
effects	NNS	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
leukocytes	NNS	nmod	B-cell_type
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanism	NN	nsubj	O
for	IN	case	O
this	DT	nmod	O
has	VBZ	conj	O
yet	RB	advmod	O
to	TO	mark	O
be	VB	auxpass	O
fully	RB	advmod	O
elucidated	VBN	xcomp	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
the	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
protease	NN	compound	O
inhibitors	NNS	nmod	O
on	IN	case	O
the	DT	det	O
proinflammatory	JJ	amod	O
cytokine	NN	compound	O
production	NN	nmod	O
of	IN	case	O
lipopolysaccharide-	NN	compound	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
stimulated	JJ	amod	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

LPS-stimulated	JJ	amod	O
monocytes	NNS	nsubjpass	B-cell_type
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
GM	NNP	nmod	O
or	CC	cc	O
UTI	NNP	conj	O
.	.	punct	O

The	DT	det	O
value	NN	nsubjpass	O
of	IN	case	O
TNFalpha	NN	nmod	B-protein
and	CC	cc	O
IL-10	NN	conj	B-protein
in	IN	case	O
the	DT	det	O
culture	NN	compound	O
medium	NN	nmod	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
was	VBD	auxpass	O
measured	VBN	ROOT	O
and	CC	cc	O
each	DT	det	O
mRNA	NN	compound	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
assayed	VBN	conj	O
.	.	punct	O

The	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
protease	NN	compound	O
inhibitors	NNS	nmod	O
on	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
intracellular	JJ	amod	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nmod	I-protein
(	-LRB-	punct	O
PKC	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	conj	I-protein
(	-LRB-	punct	O
NFkappaB	NN	appos	B-protein
)	-RRB-	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
evaluated	VBN	ROOT	O
.	.	punct	O

GM	NNP	nsubj	O
decreased	VBD	ROOT	O
the	DT	det	O
TNFalpha	NN	compound	B-protein
production	NN	dobj	O
of	IN	case	O
LPS-stimulated	JJ	amod	O
monocytes	NNS	nmod	B-cell_type
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
mRNA	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
increased	VBD	conj	O
the	DT	det	O
IL-10	NN	compound	B-protein
production	NN	dobj	O
of	IN	case	O
LPS-stimulated	JJ	amod	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

GM	NNP	nsubj	O
also	RB	advmod	O
suppressed	VBD	ROOT	O
the	DT	det	O
NFkappaB	NN	compound	B-protein
activity	NN	dobj	O
of	IN	case	O
LPS-stimulated	JJ	amod	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

UTI	NNP	nsubj	O
decreased	VBD	ROOT	O
the	DT	det	O
TNFalpha	NN	compound	B-protein
production	NN	dobj	O
of	IN	case	O
LPS-stimulated	JJ	amod	O
monocytes	NNS	nmod	B-cell_type
,	,	punct	O
but	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
inhibit	VB	conj	O
the	DT	det	O
TNFalpha	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	dobj	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
GM	NNP	nmod	O
on	IN	case	O
the	DT	det	O
TNFalpha	NN	compound	B-protein
production	NN	nmod	O
of	IN	case	O
activated	VBN	amod	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
suppression	NN	nmod	O
of	IN	case	O
NFkappaB	NN	compound	B-protein
activation	NN	nmod	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
mechanism	NN	nsubj	O
of	IN	case	O
UTI	NN	nmod	O
inhibiting	VBG	acl	O
TNFalpha	NN	compound	B-protein
production	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
may	MD	aux	O
be	VB	cop	O
due	JJ	case	O
to	TO	mwe	O
the	DT	det	O
inhibition	NN	advcl	O
of	IN	case	O
either	CC	cc:preconj	O
the	DT	dep	O
translation	NN	nmod	O
or	CC	cc	O
secretion	NN	conj	O
of	IN	case	O
TNFalpha	NN	nmod	B-protein
.	.	punct	O

Homocysteine	NN	nsubj	O
stimulates	VBZ	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
monocyte	NN	compound	B-protein
chemoattractant	NN	compound	I-protein
protein-1	NN	nmod	I-protein
in	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
leading	VBG	acl	O
to	TO	case	O
enhanced	VBN	amod	O
monocyte	NN	compound	O
chemotaxis	NN	nmod	O
.	.	punct	O

Hyperhomocysteinemia	NNP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
as	IN	case	O
an	DT	det	O
independent	JJ	amod	O
risk	NN	compound	O
factor	NN	nmod	O
for	IN	case	O
atherosclerosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
infiltration	NN	nsubj	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
into	IN	case	O
the	DT	det	O
arterial	JJ	amod	O
wall	NN	nmod	O
is	VBZ	ROOT	O
one	CD	attr	O
of	IN	prep	O
the	DT	det	O
key	JJ	amod	O
events	NNS	pobj	O
during	IN	case	O
atherogenesis	NN	nmod	O
.	.	punct	O

Monocyte	NN	compound	B-protein
chemoattractant	NN	compound	I-protein
protein-1	NN	nsubj	I-protein
(	-LRB-	punct	O
MCP-1	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
chemokine	NN	ROOT	B-protein
that	WDT	nsubj	O
stimulates	VBZ	acl:relcl	O
the	DT	det	O
migration	NN	dobj	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
into	IN	case	O
the	DT	det	O
intima	NN	nmod	O
of	IN	case	O
the	DT	det	O
arterial	JJ	amod	O
wall	NN	nmod	O
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubj	O
by	IN	case	O
which	WDT	nmod	O
increased	VBN	acl:relcl	O
monocyte	NN	compound	O
infiltration	NN	dobj	O
occurs	VBZ	ROOT	O
in	IN	case	O
atherosclerotic	JJ	amod	O
lesions	NNS	nmod	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
hyperhomocysteinemia	NN	nmod	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
delineated	VBN	advcl	O
.	.	punct	O

The	DT	det	O
objective	NN	nsubj	O
of	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
homocysteine	NN	nmod	O
on	IN	case	O
MCP-1	NN	compound	B-protein
production	NN	nmod	O
in	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Cells	NNS	nsubjpass	O
were	VBD	auxpass	O
incubated	VBN	ROOT	O
with	IN	case	O
homocysteine	NN	nmod	O
.	.	punct	O

The	DT	det	O
secretion	NN	nsubjpass	O
of	IN	case	O
MCP-1	NN	compound	B-protein
protein	NN	nmod	I-protein
was	VBD	auxpass	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
(	-LRB-	punct	O
195	CD	nummod	O
%	NN	dep	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
the	DT	det	O
control	NN	nmod	O
)	-RRB-	punct	O
in	IN	case	O
cells	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
pathological	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
homocysteine	NN	nmod	O
.	.	punct	O

Such	JJ	amod	O
effect	NN	nsubjpass	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
an	DT	det	O
increased	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
MCP-1	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
(	-LRB-	punct	O
176	CD	nummod	O
%	NN	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
the	DT	det	O
control	NN	nmod	O
)	-RRB-	punct	O
in	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
which	WDT	nsubj	O
resulted	VBD	acl:relcl	O
in	IN	case	O
enhanced	VBN	amod	O
monocyte	NN	compound	O
chemotaxis	NN	nmod	O
.	.	punct	O

The	DT	det	O
p38	NN	compound	B-protein
MAP	NN	compound	I-protein
kinase	NN	nsubjpass	I-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
other	JJ	amod	O
members	NNS	conj	O
of	IN	case	O
the	DT	det	O
p38	NN	compound	O
MAP	NN	compound	O
kinase	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
including	VBG	case	O
MKK3	NN	nmod	B-protein
,	,	punct	O
MKK6	NN	conj	B-protein
,	,	punct	O
ATF-2	NN	conj	B-protein
and	CC	cc	O
Elk-1	NN	conj	B-protein
,	,	punct	O
were	VBD	auxpass	O
activated	VBN	ROOT	O
in	IN	case	O
homocysteine-treated	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Homocysteine-induced	JJ	amod	O
MCP-1	NN	compound	B-protein
expression	NN	nsubjpass	O
and	CC	cc	O
subsequent	JJ	amod	O
monocyte	NN	compound	O
chemotaxis	NN	conj	O
were	VBD	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
p38	NN	compound	B-protein
MAP	NN	compound	I-protein
kinase	NN	compound	I-protein
inhibitor	NN	nmod	O
(	-LRB-	punct	O
SB203580	NN	appos	O
)	-RRB-	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
p38	NN	compound	B-protein
MAP	NN	compound	I-protein
kinase	NN	compound	I-protein
pathway	NN	nsubjpass	O
might	MD	aux	O
be	VB	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
homocysteine-induced	JJ	amod	O
MCP-1	NN	compound	B-protein
expression	NN	nmod	O
in	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
staurosporine	NN	nsubj	O
,	,	punct	O
a	DT	det	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
inhibitor	NN	appos	O
,	,	punct	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
homocysteine-induced	JJ	amod	O
MCP-1	NN	compound	B-protein
expression	NN	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
homocysteine	NN	nsubj	O
stimulates	VBZ	ccomp	O
MCP-1	NN	compound	B-protein
expression	NN	dobj	O
in	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
leading	VBG	acl	O
to	TO	case	O
enhanced	VBN	amod	O
monocyte	NN	compound	O
chemotaxis	NN	nmod	O
.	.	punct	O

Inducible	JJ	amod	O
resistance	NN	ROOT	O
to	TO	case	O
Fas-mediated	JJ	amod	O
apoptosis	NN	nmod	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Apoptosis	NN	nsubjpass	O
produced	VBN	acl	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
through	IN	case	O
Fas	NN	compound	B-protein
(	-LRB-	punct	O
APO-1	NN	appos	B-protein
,	,	punct	O
CD95	NN	appos	B-protein
)	-RRB-	punct	O
triggering	NN	nmod	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
signals	NNS	nmod	O
derived	VBN	acl	O
from	IN	case	O
other	JJ	amod	O
surface	NN	compound	O
receptors	NNS	nmod	O
:	:	punct	O
CD40	NN	compound	O
engagement	NN	nsubj	O
produces	VBZ	parataxis	O
upregulation	NN	dobj	O
of	IN	case	O
Fas	NN	compound	B-protein
expression	NN	nmod	O
and	CC	cc	O
marked	JJ	amod	O
susceptibility	NN	conj	O
to	TO	case	O
Fas	NN	compound	B-protein
-induced	JJ	amod	O
cell	NN	compound	O
death	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
antigen	NN	compound	O
receptor	NN	compound	O
engagement	NN	dobj	O
,	,	punct	O
or	CC	cc	O
IL-4R	NN	compound	O
engagement	NN	conj	O
,	,	punct	O
inhibits	VBZ	conj	O
Fas	NN	compound	B-protein
killing	NN	dobj	O
and	CC	cc	O
in	IN	conj	O
so	RB	dep	O
doing	VBG	dep	O
induces	VBZ	conj	O
a	DT	det	O
state	NN	dobj	O
of	IN	case	O
Fas	NN	compound	B-protein
-resistance	NN	nmod	O
,	,	punct	O
even	RB	advmod	O
in	IN	case	O
otherwise	RB	advmod	O
sensitive	JJ	amod	O
,	,	punct	O
CD40	NN	nmod:npmod	B-protein
-stimulated	JJ	amod	O
targets	NNS	nmod	O
.	.	punct	O

Surface	NN	compound	B-protein
immunoglobulin	NN	nsubj	I-protein
and	CC	cc	O
IL-4R	NN	conj	B-protein
utilize	VBP	ROOT	O
at	IN	advmod	O
least	JJS	advmod	O
partially	RB	advmod	O
distinct	JJ	amod	O
pathways	NNS	dobj	O
to	TO	mark	O
produce	VB	acl	O
Fas	NN	compound	B-protein
-resistance	NN	dobj	O
that	WDT	nsubj	O
differentially	RB	advmod	O
depend	VBP	acl:relcl	O
on	IN	case	O
PKC	NN	nmod	B-protein
and	CC	cc	O
STAT6	NN	conj	B-protein
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
surface	NN	compound	O
immunoglobulin	NN	compound	O
signaling	NN	nsubj	O
for	IN	case	O
inducible	JJ	amod	O
Fas	NN	compound	B-protein
-resistance	NN	amod	O
bypasses	NNS	nmod	O
Btk	NN	dep	B-protein
,	,	punct	O
requires	VBZ	ROOT	O
NF-kappaB	NN	dobj	B-protein
,	,	punct	O
and	CC	cc	O
entails	VBZ	conj	O
new	JJ	amod	O
macromolecular	JJ	amod	O
synthesis	NN	dobj	O
.	.	punct	O

Terminal	JJ	amod	O
effectors	NNS	nsubj	O
of	IN	case	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
Fas	NN	compound	B-protein
-resistance	NN	nmod	O
include	VBP	ROOT	O
the	DT	det	O
known	JJ	amod	O
anti-apoptotic	JJ	amod	B-protein
gene	NN	compound	I-protein
products	NNS	dobj	I-protein
,	,	punct	O
Bcl-xL	NN	appos	B-protein
and	CC	cc	O
FLIP	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
a	DT	det	O
novel	JJ	amod	O
anti-apoptotic	JJ	amod	B-DNA
gene	NN	conj	I-DNA
that	WDT	nsubj	O
encodes	VBZ	acl:relcl	O
FAIM	NN	dobj	B-protein
(	-LRB-	punct	O
Fas	NN	compound	B-protein
Apoptosis	NN	compound	I-protein
Inhibitory	NNP	compound	I-protein
Molecule	NNP	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

faim	NN	nsubjpass	B-protein
was	VBD	auxpass	O
identified	VBN	ROOT	O
by	IN	case	O
differential	JJ	amod	O
display	NN	nmod	O
and	CC	cc	O
exists	VBZ	conj	O
in	IN	case	O
two	CD	nummod	O
alternatively	RB	advmod	O
spliced	VBN	amod	O
forms	NNS	nmod	O
;	:	punct	O
faim-S	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
broadly	RB	advmod	O
expressed	VBN	conj	O
,	,	punct	O
but	CC	cc	O
faim-L	JJ	amod	O
expression	NN	nsubj	O
is	VBZ	cop	O
tissue-specific	JJ	conj	O
.	.	punct	O

The	DT	det	O
FAIM	NN	compound	B-DNA
sequence	NN	nsubj	I-DNA
is	VBZ	auxpass	O
highly	RB	advmod	O
evolu-	JJ	amod	O
tionarily	RB	advmod	O
conserved	VBN	ROOT	O
,	,	punct	O
suggesting	VBG	advcl	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
this	DT	det	O
molecule	NN	nmod	O
throughout	IN	case	O
phylogeny	NN	nmod	O
.	.	punct	O

Inducible	JJ	amod	O
resistance	NN	nsubjpass	O
to	TO	case	O
Fas	NN	compound	B-protein
killing	NN	nmod	O
is	VBZ	auxpass	O
hypothesized	VBN	ROOT	O
to	TO	mark	O
protect	VB	xcomp	O
foreign	JJ	amod	O
antigen-specific	JJ	amod	O
B	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
during	IN	case	O
potentially	RB	advmod	O
hazardous	JJ	amod	O
interactions	NNS	nmod	O
with	IN	case	O
FasL-bearing	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
whereas	IN	dep	O
autoreactive	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
fail	VBP	parataxis	O
to	TO	mark	O
become	VB	xcomp	O
Fas	NN	nmod:npmod	B-protein
-resistant	JJ	xcomp	O
and	CC	cc	O
are	VBP	auxpass	O
deleted	VBN	conj	O
via	IN	case	O
Fas	NN	compound	B-protein
-dependent	JJ	amod	O
cytotoxicity	NN	nmod	O
.	.	punct	O

Inadvertent	NN	nsubj	O
or	CC	cc	O
aberrant	JJ	conj	O
acquisition	NN	conj	O
of	IN	case	O
Fas	NN	compound	B-protein
-resistance	NN	nmod	O
may	MD	aux	O
permit	VB	ROOT	O
autoreactive	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
to	TO	mark	O
escape	VB	xcomp	O
Fas	NN	compound	B-protein
deletion	NN	dobj	O
,	,	punct	O
and	CC	cc	O
malignant	JJ	amod	B-cell_type
lymphocytes	NNS	conj	I-cell_type
to	TO	mark	O
impede	VB	xcomp	O
anti-tumor	JJ	amod	O
immunity	NN	dobj	O
.	.	punct	O

Stromal	JJ	amod	B-protein
cell-derived	JJ	amod	I-protein
factor	NN	compound	I-protein
1	CD	nummod	I-protein
alpha	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
chemotaxis	NN	nsubjpass	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
nitric	JJ	amod	O
oxide	NN	compound	O
signaling	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O

Stromal	JJ	amod	B-protein
cell-derived	JJ	amod	I-protein
factor	NN	compound	I-protein
1	CD	nummod	I-protein
alpha	NN	nsubj	I-protein
(	-LRB-	punct	O
SDF1	NN	compound	B-protein
alpha	NN	appos	I-protein
)	-RRB-	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
cognate	JJ	amod	O
chemokine	NN	compound	B-protein
receptor	NN	compound	I-protein
CXCR4	NN	conj	I-protein
act	VBP	ROOT	O
as	IN	case	O
potent	JJ	amod	O
chemoattractants	NNS	nmod	O
and	CC	cc	O
regulate	VB	conj	O
trafficking	VBG	dobj	O
and	CC	cc	O
homing	NN	conj	O
of	IN	case	O
hematopoietic	JJ	amod	B-cell_type
progenitor	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
lymphocytes	NNS	conj	B-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nsubjpass	O
regulating	VBG	acl	O
SDF1	NN	nmod:npmod	B-protein
alpha	NN	nmod:npmod	I-protein
-driven	JJ	amod	O
cell	NN	compound	O
migration	NN	dobj	O
are	VBP	auxpass	O
not	RB	neg	O
well	RB	advmod	O
defined	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
explored	VBN	ROOT	O
the	DT	det	O
roles	NNS	dobj	O
of	IN	case	O
the	DT	det	O
second	JJ	amod	O
messenger	NN	compound	O
NO	NN	nmod	O
and	CC	cc	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	I-protein
B	NN	conj	I-protein
in	IN	case	O
SDF1	NN	compound	B-protein
alpha	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
migration	NN	nmod	O
.	.	punct	O

SDF1	NN	compound	B-protein
alpha	NN	compound	I-protein
treatment	NN	nsubj	O
of	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
increased	VBD	ROOT	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
NO	NN	compound	B-protein
synthase	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
catalyzes	VBZ	acl:relcl	O
the	DT	det	O
generation	NN	dobj	O
of	IN	case	O
NO	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
observed	VBD	ROOT	O
that	IN	mark	O
pretreatment	NN	nsubj	O
of	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
or	CC	cc	O
activated	VBN	amod	O
PBLs	NNS	conj	B-cell_type
with	IN	case	O
several	JJ	amod	O
NO	NN	compound	O
donors	NNS	nmod	O
significantly	RB	advmod	O
enhanced	VBD	ccomp	O
the	DT	det	O
SDF1	NN	nmod:npmod	B-protein
alpha	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
migration	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
various	JJ	amod	O
inhibitors	NNS	nsubj	O
of	IN	case	O
NO	NN	compound	B-protein
synthase	NN	nmod	I-protein
markedly	RB	advmod	O
abrogated	VBD	parataxis	O
the	DT	det	O
chemotactic	JJ	amod	O
response	NN	dobj	O
in	IN	case	O
a	DT	det	O
concentration-dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
that	IN	mark	O
inhibitors	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
linked	VBN	acl:relcl	O
to	TO	case	O
NO	NN	compound	O
signaling	NN	compound	O
pathways	NNS	nmod	O
,	,	punct	O
also	RB	advmod	O
significantly	RB	advmod	O
blocked	VBD	ccomp	O
the	DT	det	O
SDF1	NN	compound	B-protein
alpha	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
chemotactic	JJ	amod	O
response	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
these	DT	det	O
compounds	NNS	nsubj	O
did	VBD	aux	O
not	RB	neg	O
have	VB	ROOT	O
a	DT	det	O
significant	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
SDF1	NN	compound	B-protein
alpha	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
mitogen-activated	JJ	amod	O
protein	NN	compound	O
kinase	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
MAP/Erk	NN	compound	O
kinase	NN	compound	O
kinase	NN	compound	O
inhibitor	NN	compound	O
PD98059	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
abrogate	VB	ROOT	O
SDF1	NN	nmod:npmod	B-protein
alpha	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
chemotaxis	NN	dobj	O
.	.	punct	O

AKT	NNP	nsubjpass	B-protein
,	,	punct	O
which	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	acl:relcl	O
to	TO	mark	O
mediate	VB	xcomp	O
NO	NN	compound	O
production	NN	dobj	O
,	,	punct	O
was	VBD	auxpass	O
also	RB	advmod	O
phosphorylated	VBN	ROOT	O
upon	IN	case	O
SDF1	NN	compound	B-protein
alpha	NN	compound	I-protein
stimulation	NN	nmod	O
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
NO-related	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	nsubj	O
may	MD	aux	O
mediate	VB	ccomp	O
SDF1	NN	nmod:npmod	B-protein
alpha	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
chemotaxis	NN	dobj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
activation	NN	conj	O
.	.	punct	O

The	DT	det	O
lack	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	O
B	NN	compound	O
transactivation	NN	nmod	O
and	CC	cc	O
PKC	NN	compound	O
epsilon	NN	compound	O
expression	NN	conj	O
in	IN	case	O
CD4	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
CD8	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
thymocytes	NNS	nmod	I-cell_type
correlates	VBZ	ROOT	O
with	IN	case	O
negative	JJ	amod	O
selection	NN	nmod	O
.	.	punct	O

Deletion	NN	nsubj	O
of	IN	case	O
autoreactive	JJ	amod	B-cell_type
thymocytes	NNS	nmod	I-cell_type
at	IN	case	O
the	DT	det	O
DP	NN	compound	O
stage	NN	nmod	O
is	VBZ	cop	O
the	DT	det	O
basis	NN	ROOT	O
for	IN	case	O
tolerance	NN	nmod	O
to	TO	case	O
thymus-expressed	JJ	amod	B-protein
self	NN	compound	I-protein
antigens	NNS	nmod	I-protein
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
whether	IN	mark	O
distinct	JJ	amod	O
signalling	NN	amod	O
pathways	NNS	nsubjpass	O
are	VBP	auxpass	O
induced	VBN	ccomp	O
in	IN	case	O
DP	NN	compound	B-cell_type
thymocytes	NNS	nmod	I-cell_type
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
mature	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
upon	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
antigen	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
triple	JJ	amod	O
transgenic	JJ	amod	O
mice	NNS	dobj	O
expressing	VBG	acl	O
a	DT	det	O
TCR	NN	compound	B-DNA
transgene	NN	dobj	I-DNA
,	,	punct	O
dominant	JJ	amod	B-protein
negative	JJ	amod	I-protein
ras/Mek	JJ	compound	I-protein
proteins	NNS	conj	I-protein
and	CC	cc	O
a	DT	det	O
reporter	NN	compound	B-DNA
gene	NN	compound	I-DNA
construct	NN	conj	I-DNA
with	IN	case	O
AP-1	NN	nmod	B-DNA
or	CC	cc	I-DNA
NF-kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	conj	I-DNA
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
a	DT	det	O
complete	JJ	amod	O
lack	NN	dobj	O
of	IN	case	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
but	CC	cc	O
not	RB	cc	O
AP-1	NN	conj	B-protein
in	IN	case	O
DP	NN	compound	B-cell_type
thymocytes	NNS	nmod	I-cell_type
,	,	punct	O
whereas	IN	mark	O
both	DT	nsubj	O
were	VBD	cop	O
transcriptionally	RB	advmod	O
active	JJ	advcl	O
in	IN	case	O
mature	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
after	IN	case	O
antigenic	JJ	amod	O
stimulation	NN	nmod	O
.	.	punct	O

Lack	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
induction	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
increased	VBN	amod	O
death	NN	nmod	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
antigen	NN	nmod	B-protein
.	.	punct	O

AP-1	NN	compound	B-protein
induction	NN	nsubj	O
was	VBD	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
integrity	NN	nmod	O
of	IN	case	O
the	DT	det	O
ras/Mek	NN	compound	O
pathway	NN	nmod	O
indicating	VBG	xcomp	O
that	IN	mark	O
this	DT	det	O
pathway	NN	nsubjpass	O
was	VBD	auxpass	O
activated	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
DP	NN	compound	B-cell_type
thymocytes	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
a	DT	det	O
complete	JJ	amod	O
lack	NN	dobj	O
of	IN	case	O
constitutive	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
epsilon	NN	compound	B-protein
isoform	NN	nmod	I-protein
of	IN	case	I-protein
Protein	NN	compound	I-protein
Kinase	NN	compound	I-protein
C	NN	nmod	I-protein
(	-LRB-	punct	O
PKC	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
DP	NN	compound	B-cell_type
thymocytes	NNS	nmod	I-cell_type
,	,	punct	O
although	IN	mark	O
it	PRP	nsubj	O
was	VBD	cop	O
present	JJ	advcl	O
in	IN	case	O
mature	JJ	amod	B-cell_type
thymocytes	NNS	nmod	I-cell_type
and	CC	cc	O
peripheral	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Taken	VBN	ROOT	O
together	RB	advmod	O
the	DT	det	O
results	NNS	nsubj	O
suggest	VBP	parataxis	O
that	IN	mark	O
the	DT	det	O
lack	NN	nsubj	O
of	IN	case	O
PKC	NN	compound	B-protein
epsilon	NN	nmod	I-protein
in	IN	case	O
DP	NN	compound	B-cell_type
thymocytes	NNS	nmod	I-cell_type
could	MD	aux	O
lead	VB	ccomp	O
to	TO	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nmod	O
after	IN	case	O
antigenic	JJ	amod	O
stimulation	NN	nmod	O
contributing	VBG	acl	O
to	TO	case	O
negative	JJ	amod	O
selection	NN	nmod	O
.	.	punct	O

Cell	NNP	compound	O
Death	NNP	ROOT	O
and	CC	cc	O
Differentiation	NN	conj	O
(	-LRB-	punct	O
2000	CD	appos	O
)	-RRB-	punct	O
7	CD	nummod	O
,	,	punct	O
1253	CD	nummod	O
-	SYM	punct	O
1262	CD	appos	O
.	.	punct	O

CD2	NN	compound	O
stimulation	NN	nsubj	O
leads	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
delayed	VBN	amod	O
and	CC	cc	O
prolonged	JJ	conj	O
activation	NN	nmod	O
of	IN	case	O
STAT1	NN	nmod	B-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
not	RB	cc	O
NK	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nsubjpass	I-cell_type
can	MD	aux	O
be	VB	auxpass	O
activated	VBN	dep	O
by	IN	case	O
soluble	JJ	amod	O
factors	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
cytokines	NNS	nmod	B-protein
or	CC	cc	O
through	IN	case	O
direct	JJ	amod	O
cell-cell	JJ	amod	O
interactions	NNS	conj	O
.	.	punct	O

Although	IN	mark	O
cytokine	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
known	VBN	advcl	O
to	TO	case	O
signal	VB	nmod	O
through	IN	case	O
STAT	NN	compound	B-protein
family	NN	compound	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
,	,	punct	O
the	DT	det	O
mechanisms	NNS	nsubj	O
by	IN	case	O
which	WDT	nmod	O
other	JJ	amod	O
cell-surface	JJ	amod	B-protein
molecules	NNS	nsubj	I-protein
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
CD2	NN	nmod	B-protein
,	,	punct	O
transduce	VBP	acl:relcl	O
signals	NNS	dobj	O
is	VBZ	cop	O
unclear	JJ	ROOT	O
.	.	punct	O

The	DT	det	O
goal	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
stimulation	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
through	IN	case	O
CD2	NN	nmod	B-protein
recapitulates	VBZ	ccomp	O
aspects	NNS	dobj	O
of	IN	case	O
cytokine	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
T-cell	NN	compound	O
activation	NN	nmod	O
by	IN	case	O
use	NN	nmod	O
of	IN	case	O
STAT	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

MATERIALS	NNS	ROOT	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
T	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
treated	VBN	dep	O
with	IN	case	O
anti-CD2	JJ	amod	B-protein
antibodies	NNS	nmod	I-protein
or	CC	cc	O
cells	NNS	conj	O
bearing	VBG	acl	O
the	DT	det	O
natural	JJ	amod	O
CD2	NN	compound	B-protein
ligand	NN	compound	I-protein
CD58	NN	dobj	I-protein
,	,	punct	O
after	IN	case	O
which	WDT	nmod	O
signaling	NN	nsubjpass	O
through	IN	case	O
STAT	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
was	VBD	auxpass	O
assessed	VBN	advcl	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Stimulation	NN	nsubj	O
of	IN	case	O
CD2	NN	nmod	B-protein
on	IN	case	O
primary	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
leads	VBZ	dep	O
to	TO	case	O
the	DT	det	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
,	,	punct	O
nuclear	JJ	amod	O
translocation	NN	conj	O
,	,	punct	O
and	CC	cc	O
DNA	NN	compound	O
binding	NN	conj	O
of	IN	case	O
STAT1	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
to	TO	case	O
stimulation	NN	nmod	O
by	IN	case	O
cytokines	NNS	nmod	B-protein
,	,	punct	O
the	DT	det	O
activation	NN	nsubjpass	O
of	IN	case	O
STAT1	NN	nmod	B-protein
in	IN	case	O
response	NN	dep	O
to	TO	case	O
CD2	NN	compound	O
ligation	NN	nmod	O
is	VBZ	auxpass	O
delayed	VBN	ROOT	O
and	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
involve	VB	conj	O
Jak	NN	compound	B-protein
kinases	NNS	dobj	I-protein
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
while	IN	mark	O
STAT	NN	compound	O
phosphorylation	NN	nsubj	O
induced	VBN	acl	O
by	IN	case	O
cytokines	NNS	nmod	B-protein
is	VBZ	cop	O
generally	RB	advmod	O
transient	JJ	advcl	O
,	,	punct	O
STAT1	NN	compound	O
phosphorylation	NN	conj	O
following	VBG	case	O
CD2	NN	compound	O
stimulation	NN	nmod	O
persists	VBZ	ROOT	O
for	IN	prep	O
a	DT	det	O
period	NN	pobj	O
of	IN	prep	O
days	NNS	pobj	O
.	.	punct	O

Transcription	NN	nsubj	O
of	IN	case	O
key	JJ	amod	O
target	NN	compound	O
genes	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
IRF1	NN	nmod	B-DNA
and	CC	cc	O
c-fos	NN	conj	B-DNA
proceeds	VBZ	ROOT	O
with	IN	case	O
delayed	VBN	amod	O
kinetics	NNS	nmod	O
following	VBG	case	O
CD2	NN	compound	O
stimulation	NN	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
this	DT	det	O
unique	JJ	amod	O
pattern	NN	nsubj	O
of	IN	case	O
STAT	NN	compound	O
activation	NN	nmod	O
may	MD	aux	O
lead	VB	ccomp	O
to	TO	case	O
a	DT	det	O
distinct	JJ	amod	O
cellular	JJ	amod	O
response	NN	nmod	O
following	VBG	case	O
CD2	NN	compound	O
ligation	NN	nmod	O
.	.	punct	O

This	DT	det	O
pathway	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
restricted	JJ	xcomp	O
to	TO	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
as	IN	mark	O
stimulation	NN	nsubj	O
of	IN	case	O
CD2	NN	nmod	B-protein
on	IN	case	O
NK	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
does	VBZ	aux	O
not	RB	neg	O
lead	VB	advcl	O
to	TO	case	O
STAT1	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

CONCLUSION	NN	dep	O
:	:	punct	O
Stimulation	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
through	IN	case	O
cell-surface	JJ	amod	B-protein
molecules	NNS	nmod	I-protein
such	JJ	case	O
as	IN	mwe	O
CD2	NN	nmod	B-protein
involves	VBZ	ROOT	O
activation	NN	dobj	O
of	IN	case	O
STAT	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
,	,	punct	O
thus	RB	advmod	O
recapitulating	VBG	advcl	O
elements	NNS	dobj	O
of	IN	case	O
cytokine	NN	compound	O
signaling	NN	nmod	O
.	.	punct	O

NFATc1	NN	nsubj	B-protein
and	CC	cc	O
NFATc2	NN	conj	B-protein
together	RB	advmod	O
control	VBP	ROOT	O
both	CC	cc:preconj	O
T	NN	dobj	O
and	CC	cc	O
B	NN	conj	O
cell	NN	conj	O
activation	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

NFAT	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nsubj	I-protein
play	VBP	ROOT	O
critical	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
gene	NN	compound	O
transcription	NN	nmod	O
during	IN	case	O
immune	JJ	amod	O
responses	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
further	RBR	advmod	O
the	DT	det	O
two	CD	nummod	O
most	RBS	advmod	O
prominent	JJ	amod	O
NFAT	NN	compound	B-protein
family	NN	compound	I-protein
members	NNS	dobj	I-protein
,	,	punct	O
NFATc1	NN	appos	B-protein
and	CC	cc	O
NFATc2	NN	conj	B-protein
,	,	punct	O
we	PRP	nsubj	O
generated	VBD	ROOT	O
mice	NNS	dobj	O
bearing	VBG	acl	O
lymphoid	JJ	amod	O
systems	NNS	dobj	O
devoid	JJ	amod	O
of	IN	case	O
both	DT	nmod	O
.	.	punct	O

Doubly	RB	advmod	O
deficient	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
displayed	VBD	ROOT	O
cell	NN	compound	O
surface	NN	compound	O
markers	NNS	dobj	O
of	IN	case	O
activation	NN	nmod	O
yet	RB	advmod	O
were	VBD	cop	O
significantly	RB	advmod	O
deficient	JJ	conj	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
multiple	JJ	amod	O
effector	NN	compound	O
functions	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
Th	NN	compound	B-protein
cytokine	NN	compound	I-protein
production	NN	nmod	O
,	,	punct	O
surface	NN	compound	B-protein
effector	NN	compound	I-protein
molecule	NN	compound	I-protein
expression	NN	conj	O
,	,	punct	O
and	CC	cc	O
cytolytic	JJ	amod	O
activity	NN	conj	O
.	.	punct	O

Nevertheless	RB	advmod	O
,	,	punct	O
doubly	RB	advmod	B-cell_type
deficient	JJ	amod	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
hyperactivated	VBN	ROOT	O
,	,	punct	O
as	IN	mark	O
evidenced	VBN	advcl	O
by	IN	case	O
extremely	RB	advmod	O
elevated	JJ	amod	O
serum	NN	compound	O
IgG1	NN	nmod	B-protein
and	CC	cc	O
IgE	NN	conj	B-protein
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
plasma	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
expansion	NN	conj	O
and	CC	cc	O
infiltration	NN	conj	O
of	IN	case	O
end	NN	compound	O
organs	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
NFATc1	NN	nsubj	B-protein
and	CC	cc	O
NFATc2	NN	conj	B-protein
are	VBP	cop	O
dispensable	JJ	ROOT	O
for	IN	case	O
inflammatory	JJ	amod	O
reactivity	NN	nmod	O
but	CC	cc	O
are	VBP	auxpass	O
required	VBN	conj	O
for	IN	case	O
effector	NN	compound	O
differentiation	NN	nmod	O
,	,	punct	O
while	IN	mark	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
NFATs	NN	nsubj	B-protein
regulate	VBP	advcl	O
both	CC	cc:preconj	O
normal	JJ	amod	O
homeostasis	NN	dobj	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

Epstein-barr	JJ	amod	O
virus	NN	compound	O
immediate-early	JJ	amod	B-protein
protein	NN	compound	I-protein
BZLF1	NN	nsubj	I-protein
is	VBZ	auxpass	O
SUMO-1	NN	nmod:npmod	O
modified	VBN	ROOT	O
and	CC	cc	O
disrupts	VBZ	conj	O
promyelocytic	JJ	amod	O
leukemia	NN	compound	O
bodies	NNS	dobj	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
immediate-early	JJ	amod	B-protein
proteins	NNS	nsubjpass	I-protein
of	IN	case	O
both	DT	cc:preconj	O
herpes	NN	compound	O
simplex	NN	compound	O
virus	NN	nmod	O
(	-LRB-	punct	O
HSV	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
cytomegalovirus	NN	conj	O
(	-LRB-	punct	O
CMV	NN	appos	O
)	-RRB-	punct	O
are	VBP	auxpass	O
known	VBN	advcl	O
to	TO	mark	O
modify	VB	xcomp	O
promyelocytic	JJ	amod	O
leukemia	NN	compound	O
(	-LRB-	punct	O
PML	NN	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
ND10	NN	appos	O
)	-RRB-	punct	O
bodies	NNS	dobj	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
of	IN	case	O
the	DT	det	O
host	NN	compound	O
cell	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
has	VBZ	aux	O
been	VBN	cop	O
unclear	JJ	ROOT	O
whether	IN	mark	O
lytic	JJ	amod	O
infection	NN	nsubj	O
with	IN	case	O
gamma	NN	compound	O
herpesviruses	NNS	nmod	O
induces	VBZ	ccomp	O
a	DT	det	O
similar	JJ	amod	O
effect	NN	dobj	O
.	.	punct	O

The	DT	det	O
PML	NN	compound	B-protein
protein	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
interferon	NN	nmod	B-protein
,	,	punct	O
involved	VBN	xcomp	O
in	IN	case	O
major	JJ	amod	B-protein
histocompatibility	NN	compound	I-protein
complex	NN	compound	I-protein
class	NN	compound	I-protein
I	CD	nummod	I-protein
presentation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
necessary	JJ	conj	O
for	IN	case	O
certain	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
likely	JJ	ROOT	O
that	IN	mark	O
PML	NN	compound	O
bodies	NNS	compound	O
function	VBP	ccomp	O
in	IN	case	O
an	DT	det	O
antiviral	JJ	amod	O
capacity	NN	nmod	O
.	.	punct	O

SUMO-1	NN	compound	O
modification	NN	nsubjpass	O
of	IN	case	O
PML	NN	nmod	B-protein
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
required	VBN	xcomp	O
for	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
PML	NN	compound	O
bodies	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
whether	IN	mark	O
Epstein-Barr	JJ	amod	O
virus	NN	compound	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
lytic	JJ	amod	O
replication	NN	nsubj	O
interferes	VBZ	ccomp	O
with	IN	case	O
PML	NN	compound	O
bodies	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
expressed	VBD	ROOT	O
the	DT	det	O
EBV	NN	compound	B-DNA
immediate-early	JJ	amod	I-DNA
genes	NNS	dobj	I-DNA
BZLF1	NN	dep	B-DNA
(	-LRB-	punct	I-DNA
Z	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
and	CC	cc	O
BRLF1	NN	conj	B-DNA
(	-LRB-	punct	I-DNA
R	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
in	IN	case	O
EBV-positive	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
and	CC	cc	O
examined	VBN	conj	O
PML	NN	compound	B-protein
localization	NN	dobj	O
.	.	punct	O

Both	CC	cc:preconj	O
Z	NN	compound	O
and	CC	cc	O
R	NN	conj	O
expression	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
PML	NN	compound	B-protein
dispersion	NN	nmod	O
in	IN	case	O
EBV-positive	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Z	NN	nsubj	O
but	CC	cc	O
not	RB	cc	O
R	NN	compound	O
expression	NN	conj	O
is	VBZ	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
disrupt	VB	xcomp	O
PML	NN	compound	O
bodies	NNS	dobj	O
in	IN	case	O
EBV-negative	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
dispersion	NN	nsubj	O
of	IN	case	O
PML	NN	compound	O
bodies	NNS	nmod	O
by	IN	case	O
Z	NN	nmod	B-DNA
requires	VBZ	ccomp	O
a	DT	det	O
portion	NN	dobj	O
of	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	B-DNA
activation	NN	compound	I-DNA
domain	NN	nmod	I-DNA
of	IN	case	O
Z	NN	nmod	B-DNA
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
DNA-binding	JJ	amod	O
function	NN	conj	O
.	.	punct	O

As	IN	mark	O
was	VBD	auxpass	O
previously	RB	advmod	O
reported	VBN	advcl	O
for	IN	case	O
the	DT	det	O
HSV-1	NN	compound	B-protein
ICP0	NN	nmod	I-protein
and	CC	cc	I-protein
CMV	NN	compound	I-protein
IE1	NN	compound	I-protein
proteins	NNS	conj	I-protein
,	,	punct	O
Z	NN	nsubj	B-DNA
reduces	VBZ	ROOT	O
the	DT	det	O
amount	NN	dobj	O
of	IN	case	O
SUMO-1-modified	JJ	amod	B-protein
PML	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
found	VBD	ROOT	O
that	IN	mark	O
Z	NN	nsubjpass	B-DNA
itself	PRP	dep	O
is	VBZ	auxpass	O
SUMO-1	NN	nmod:npmod	O
modified	VBN	ccomp	O
(	-LRB-	punct	O
through	IN	case	O
amino	NN	compound	O
acid	NN	nmod	O
12	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
that	IN	mark	O
Z	NN	nsubj	B-DNA
competes	NNS	conj	O
with	IN	case	O
PML	NN	nmod	B-protein
for	IN	case	O
limiting	VBG	amod	O
amounts	NNS	nmod	O
of	IN	case	O
SUMO-1	NN	nmod	B-protein
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
disruption	NN	nsubj	O
of	IN	case	O
PML	NN	compound	O
bodies	NNS	nmod	O
is	VBZ	cop	O
important	JJ	ccomp	O
for	IN	case	O
efficient	JJ	amod	O
lytic	JJ	amod	O
replication	NN	nmod	O
of	IN	case	O
EBV	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
Z	NN	nsubj	B-DNA
may	MD	aux	O
potentially	RB	advmod	O
alter	VB	ROOT	O
the	DT	det	O
function	NN	dobj	O
of	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	O
proteins	NNS	nmod	O
by	IN	mark	O
inhibiting	VBG	advcl	O
SUMO-1	NN	compound	O
modification	NN	dobj	O

Suppression	NN	ROOT	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod	I-protein
and	CC	cc	O
stimulation	NN	conj	O
of	IN	case	O
inhibitor	NN	compound	B-protein
kappaB	NN	nmod	I-protein
by	IN	case	O
troglitazone	NN	nmod	O
:	:	punct	O
evidence	NN	dep	O
for	IN	case	O
an	DT	det	O
anti-inflammatory	JJ	amod	O
effect	NN	nmod	O
and	CC	cc	O
a	DT	det	O
potential	JJ	amod	O
antiatherosclerotic	JJ	amod	O
effect	NN	conj	O
in	IN	case	O
the	DT	det	O
obese	JJ	nmod	O
.	.	punct	O

To	TO	mark	O
elucidate	VB	advcl	O
whether	IN	mark	O
troglitazone	NN	nsubj	O
exerts	VBZ	ccomp	O
an	DT	det	O
antiinflammatory	JJ	amod	O
effect	NN	dobj	O
in	IN	case	O
humans	NNS	nmod	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
suppression	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappaB	NN	nmod	I-protein
(	-LRB-	punct	O
NFkappaB	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	I-cell_type
MNC	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
by	IN	case	O
this	DT	det	O
drug	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
measured	VBD	ROOT	O
intranuclear	JJ	amod	B-protein
NFkappaB	NN	dobj	I-protein
,	,	punct	O
total	JJ	amod	O
cellular	JJ	amod	B-protein
NFkappaB	NN	conj	I-protein
,	,	punct	O
inhibitor	NN	compound	B-protein
kappaB	NN	compound	I-protein
(	-LRB-	punct	I-protein
IkappaB	NN	compound	I-protein
)	-RRB-	punct	I-protein
alpha	NN	conj	I-protein
,	,	punct	O
reactive	JJ	amod	O
oxygen	NN	compound	O
species	NNS	compound	O
(	-LRB-	punct	O
ROS	NN	appos	O
)	-RRB-	punct	O
generation	NN	conj	O
,	,	punct	O
and	CC	cc	O
p47	NN	compound	B-protein
(	-LRB-	punct	I-protein
phox	NN	compound	I-protein
)	-RRB-	punct	I-protein
subunit	NN	conj	I-protein
(	-LRB-	punct	O
a	DT	det	O
key	JJ	amod	O
component	NN	amod	O
protein	NN	dep	O
of	IN	case	O
nicotinamide	NN	compound	B-protein
adenine	NN	nmod	I-protein
dinucleotide	NN	compound	I-protein
phosphate	NN	compound	I-protein
oxidase	NN	appos	I-protein
)	-RRB-	punct	O
in	IN	case	O
MNC	NN	nmod	B-cell_type
.	.	punct	O

Plasma	NN	compound	B-protein
tumor	NN	compound	I-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
TNF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-alpha	NN	nsubjpass	I-protein
,	,	punct	O
soluble	JJ	amod	B-protein
intercellular	JJ	amod	I-protein
adhesion	NN	compound	I-protein
molecule-1	NN	appos	I-protein
(	-LRB-	punct	O
sICAM-1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
monocyte	NN	compound	B-protein
chemoattractant	NN	compound	I-protein
protein-1	NN	conj	I-protein
(	-LRB-	punct	I-protein
MCP-1	NN	appos	I-protein
)	-RRB-	punct	I-protein
,	,	punct	O
plasminogen	NN	compound	B-protein
activator	NN	compound	I-protein
inhibitor	NN	compound	I-protein
type	NN	appos	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
PAI-1	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
C-reactive	JJ	amod	B-protein
protein	NN	appos	I-protein
(	-LRB-	punct	I-protein
CRP	NN	appos	I-protein
)	-RRB-	punct	I-protein
,	,	punct	O
and	CC	cc	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	appos	I-protein
)	-RRB-	punct	I-protein
-10	CD	nummod	I-protein
(	-LRB-	punct	O
antiinflammatory	JJ	amod	B-protein
cytokine	NN	appos	I-protein
)	-RRB-	punct	O
concentrations	NNS	conj	O
were	VBD	auxpass	O
also	RB	advmod	O
measured	VBN	ROOT	O
as	IN	case	O
mediators	NNS	nmod	O
of	IN	case	O
inflammatory	JJ	amod	O
activity	NN	nmod	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
regulated	VBN	acl:relcl	O
by	IN	case	O
the	DT	det	O
proinflammatory	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
NFkappaB	NN	nmod	I-protein
.	.	punct	O

Seven	CD	nummod	O
nondiabetic	JJ	amod	O
obese	JJ	amod	O
patients	NNS	nsubjpass	O
were	VBD	auxpass	O
given	VBN	ROOT	O
400	CD	compound	O
mg	NN	compound	O
troglitazone	NN	dobj	O
daily	RB	advmod	O
for	IN	case	O
4	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

Blood	NN	compound	O
samples	NNS	nsubjpass	O
were	VBD	auxpass	O
collected	VBN	ROOT	O
before	IN	prep	O
and	CC	cc	O
at	IN	conj	O
weekly	JJ	amod	O
intervals	NNS	pobj	O
thereafter	RB	advmod	O
.	.	punct	O

MNC	NN	nsubjpass	B-cell_type
were	VBD	auxpass	O
separated	VBN	ROOT	O
;	:	punct	O
and	CC	cc	O
the	DT	det	O
levels	NNS	nsubjpass	O
of	IN	case	O
intranuclear	JJ	amod	B-protein
NFkappaB	NN	nmod	I-protein
,	,	punct	O
total	JJ	amod	O
cellular	JJ	amod	B-protein
NFkappaB	NN	nsubjpass	I-protein
,	,	punct	O
IkappaBalpha	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
p47	NN	compound	B-protein
(	-LRB-	punct	I-protein
phox	NN	compound	I-protein
)	-RRB-	punct	I-protein
subunit	NN	conj	I-protein
and	CC	cc	O
ROS	NN	compound	O
generation	NN	conj	O
were	VBD	auxpass	O
determined	VBN	conj	O
.	.	punct	O

Plasma	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
measure	VB	xcomp	O
insulin	NN	compound	O
glucose	NN	dobj	O
,	,	punct	O
TNFalpha	NN	conj	B-protein
,	,	punct	O
sICAM	NN	conj	B-protein
,	,	punct	O
MCP-1	NN	conj	B-protein
,	,	punct	O
PAI-1	NN	conj	B-protein
,	,	punct	O
CRP	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-10	NN	conj	B-protein
.	.	punct	O

Plasma	NN	compound	O
insulin	NN	compound	O
concentrations	NNS	nsubj	O
fell	VBD	ROOT	O
significantly	RB	advmod	O
at	IN	case	O
week	NN	nmod	O
1	CD	nummod	O
,	,	punct	O
from	IN	case	O
31.2	CD	nummod	O
+/-	CC	cc	O
29.1	CD	conj	O
to	TO	case	O
14.2	CD	nmod	O
+/-	CC	cc	O
11.4	CD	conj	O
mU/L	NN	nmod	O
(	-LRB-	punct	O
P	NN	compound	O
<	-LRB-	dep	O
0.01	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
remained	VBD	conj	O
low	JJ	xcomp	O
throughout	IN	case	O
4	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

Plasma	NN	compound	O
glucose	NN	compound	O
concentrations	NNS	nsubj	O
did	VBD	aux	O
not	RB	neg	O
alter	VB	ROOT	O
significantly	RB	advmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
fall	NN	attr	O
in	IN	case	O
intranuclear	JJ	amod	B-protein
NFkappaB	NN	nmod	I-protein
,	,	punct	O
total	JJ	amod	O
cellular	JJ	amod	B-protein
NFkappaB	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
p47	NN	compound	B-protein
(	-LRB-	punct	I-protein
phox	NN	compound	I-protein
)	-RRB-	punct	I-protein
subunit	NN	conj	I-protein
,	,	punct	O
with	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
cellular	JJ	amod	O
IkappaBalpha	NN	nmod	B-protein
at	IN	case	O
week	NN	nmod	O
2	CD	nummod	O
,	,	punct	O
which	WDT	nsubj	O
persisted	VBD	relcl	O
until	IN	case	O
week	NN	nmod	O
4	CD	nummod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ccomp	O
a	DT	det	O
parallel	JJ	amod	O
fall	NN	attr	O
in	IN	case	O
ROS	NN	compound	O
generation	NN	nmod	O
by	IN	case	O
MNC	NN	nmod	B-cell_type
at	IN	case	O
week	NN	nmod	O
1	CD	nummod	O
;	:	punct	O
this	DT	nsubj	O
progressed	JJ	ROOT	O
and	CC	cc	O
persisted	VBD	conj	O
until	IN	case	O
week	NN	nmod	O
4	CD	nummod	O
(	-LRB-	punct	O
P	NN	compound	O
<	-LRB-	compound	O
0.001	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Plasma	NN	compound	O
TNF-alpha	NN	nsubj	B-protein
,	,	punct	O
sICAM-1	NN	conj	B-protein
,	,	punct	O
MCP-1	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
PAI-1	NN	compound	B-protein
concentrations	NNS	conj	O
fell	VBD	ROOT	O
significantly	RB	advmod	O
at	IN	case	O
week	NN	nmod	O
4	CD	nummod	O
.	.	punct	O

Plasma	NN	compound	O
IL-10	NN	compound	B-protein
concentration	NN	nsubj	O
increased	VBD	ROOT	O
significantly	RB	advmod	O
,	,	punct	O
whereas	IN	dep	O
plasma	NN	compound	B-protein
CRP	NN	compound	I-protein
concentrations	NNS	nsubj	O
decreased	VBD	parataxis	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
troglitazone	NN	nsubj	O
has	VBZ	ccomp	O
an	DT	det	O
antiinflammatory	JJ	amod	O
action	NN	dobj	O
that	WDT	nsubj	O
may	MD	aux	O
contribute	VB	acl:relcl	O
to	TO	case	O
its	PRP$	nmod:poss	O
putative	JJ	amod	O
antiatherosclerotic	JJ	amod	O
effects	NNS	nmod	O
.	.	punct	O

Tyrosine	NN	compound	O
phosphorylation-dependent	JJ	amod	O
activation	NN	ROOT	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

Requirement	NN	ROOT	O
for	IN	case	O
p56	NN	compound	B-protein
LCK	NN	nmod	I-protein
and	CC	cc	I-protein
ZAP-70	NN	compound	I-protein
protein	NN	compound	I-protein
tyrosine	NN	compound	I-protein
kinases	NNS	conj	I-protein
.	.	punct	O

Phosphorylation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
N-terminal	JJ	amod	B-protein
domain	NN	nmod	I-protein
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
inhibitory	JJ	amod	I-protein
subunits	NNS	nmod	I-protein
induces	VBZ	ROOT	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
.	.	punct	O

Although	IN	mark	O
serine	NN	compound	O
phosphorylation	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	advcl	O
to	TO	mark	O
induce	VB	xcomp	O
ubiquitination	NN	dobj	O
and	CC	cc	O
subsequent	JJ	amod	O
proteasome-mediated	JJ	amod	O
degradation	NN	conj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B-alpha	NN	nmod	I-protein
,	,	punct	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
about	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
that	WDT	nsubj	O
lead	VBP	acl:relcl	O
to	TO	case	O
release	NN	nmod	O
of	IN	case	O
active	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
as	IN	case	O
a	DT	det	O
consequence	NN	nmod	O
of	IN	case	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B-alpha	NN	intj	I-protein
[	-LRB-	punct	O
Imbert	NNP	compound	O
,	,	punct	O
V.	NNP	nmod	O
,	,	punct	O
Rupec	NNP	compound	O
,	,	punct	O
R.A.	NNP	conj	O
,	,	punct	O
Livolsi	NNP	compound	O
,	,	punct	O
A.	NN	conj	O
,	,	punct	O
Pahl	NNP	conj	O
,	,	punct	O
H.L.	NNP	conj	O
,	,	punct	O
Traenckner	NNP	compound	O
,	,	punct	O
B.M.	NNP	conj	O
,	,	punct	O
Mueller-Dieckmann	NNP	compound	O
,	,	punct	O
C.	NNP	conj	O
,	,	punct	O
Farahifar	NNP	advmod	O
,	,	punct	O
D.	NNP	conj	O
,	,	punct	O
Rossi	NNP	compound	O
,	,	punct	O
B.	NNP	conj	O
,	,	punct	O
Auberger	NNP	compound	O
,	,	punct	O
P.	NNP	conj	O
,	,	punct	O
Baeuerle	NNP	compound	O
,	,	punct	O
P.	NNP	conj	O
&	CC	cc	O
Peyron	NNP	conj	O
,	,	punct	O
J.F.	NNP	compound	O
(	-LRB-	punct	O
1996	CD	appos	O
)	-RRB-	punct	O
Cell	NNP	appos	O
86	CD	nummod	O
,	,	punct	O
787	CD	nummod	O
--	:	punct	O
798	CD	nummod	O
]	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
involvement	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
tyrosine	NN	compound	B-protein
kinases	NNS	nmod	I-protein
p56	NN	dep	B-protein
(	-LRB-	punct	I-protein
lck	NN	appos	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	O
ZAP-70	NN	conj	B-protein
in	IN	case	O
this	DT	det	O
reaction	NN	nmod	O
is	VBZ	auxpass	O
demonstrated	VBN	ROOT	O
here	RB	advmod	O
using	VBG	xcomp	O
specific	JJ	amod	O
pharmacological	JJ	amod	O
inhibitors	NNS	dobj	O
and	CC	cc	O
Jurkat	NN	compound	B-cell_line
mutants	NNS	conj	I-cell_line
unable	JJ	amod	O
to	TO	mark	O
express	VB	xcomp	O
these	DT	det	O
kinases	NNS	dobj	B-protein
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
inhibitors	NNS	nsubj	O
prevented	VBD	advcl	O
both	CC	cc:preconj	O
pervanadate-induced	JJ	amod	O
phosphorylation	NN	dobj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B-alpha	NN	nmod	I-protein
on	IN	case	O
Tyr42	NN	nmod	O
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
observed	VBD	ROOT	O
that	IN	mark	O
,	,	punct	O
in	IN	case	O
p56	NN	compound	B-cell_line
(	-LRB-	punct	I-cell_line
lck	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
-deficient	JJ	amod	I-cell_line
Jurkat	NN	compound	I-cell_line
mutants	NNS	nmod	I-cell_line
,	,	punct	O
NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
could	MD	aux	O
still	RB	advmod	O
associate	VB	ccomp	O
with	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B-alpha	NN	nmod	I-protein
despite	IN	case	O
phosphorylation	NN	nmod	O
on	IN	case	O
Tyr42	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
SH2	NN	compound	B-protein
domain	NN	nsubj	I-protein
of	IN	case	O
p56	NN	nmod	B-protein
(	-LRB-	punct	I-protein
lck	NN	appos	I-protein
)	-RRB-	punct	I-protein
appeared	VBD	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
required	VBN	xcomp	O
for	IN	case	O
pervanadate-induced	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
but	CC	cc	O
not	RB	neg	O
for	IN	case	O
Tyr42	NN	compound	O
phosphorylation	NN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
p56	NN	nsubj	B-protein
(	-LRB-	punct	I-protein
lck	NN	appos	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	O
ZAP-70	NN	conj	B-protein
are	VBP	cop	O
key	JJ	amod	O
components	NNS	ccomp	O
of	IN	case	O
the	DT	det	O
signaling	NN	compound	O
pathway	NN	nmod	O
that	WDT	nsubj	O
leads	VBZ	acl:relcl	O
to	TO	case	O
phosphotyrosine-dependent	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
confirm	VBP	conj	O
that	IN	mark	O
tyrosine	NN	compound	B-protein
kinases	NNS	nsubj	I-protein
must	MD	aux	O
control	VB	ccomp	O
at	IN	case	O
least	JJS	nmod:npmod	O
two	CD	nummod	O
different	JJ	amod	O
steps	NNS	dobj	O
to	TO	mark	O
induce	VB	acl	O
activation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
H	NN	compound	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
O	NN	nsubj	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
stimulates	VBZ	acl:relcl	O
p56	NN	dobj	B-protein
(	-LRB-	punct	I-protein
lck	NN	appos	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	O
ZAP-70	NN	conj	B-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
is	VBZ	cop	O
an	DT	det	O
activator	NN	ccomp	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
through	IN	case	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B-alpha	NN	nmod	I-protein
.	.	punct	O

Specific	JJ	amod	O
missense	NN	compound	O
mutations	NNS	nsubj	O
in	IN	case	O
NEMO	NN	nmod	B-DNA
result	VBP	ROOT	O
in	IN	case	O
hyper-IgM	JJ	amod	O
syndrome	NN	nmod	O
with	IN	case	O
hypohydrotic	JJ	amod	O
ectodermal	JJ	amod	O
dysplasia	NN	nmod	O
.	.	punct	O

The	DT	det	O
gene	NN	nsubjpass	O
that	WDT	nsubj	O
encodes	VBZ	acl:relcl	O
nuclear	JJ	amod	B-DNA
factor	NN	compound	I-DNA
kappaB	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
NF-kappaB	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
essential	JJ	amod	I-DNA
modulator	NN	dobj	I-DNA
(	-LRB-	punct	O
or	CC	cc	O
NEMO	NN	conj	B-DNA
,	,	punct	O
also	RB	advmod	O
known	VBN	acl	O
as	IN	case	O
IKKgamma	NN	nmod	B-DNA
)	-RRB-	punct	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappaB	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
describe	VBP	ROOT	O
mutations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
putative	JJ	amod	B-protein
zinc-finger	JJ	amod	I-protein
domain	NN	nmod	I-protein
of	IN	case	O
NEMO	NN	nmod	B-protein
that	WDT	nsubj	O
result	VBP	acl:relcl	O
in	IN	case	O
an	DT	det	O
X-linked	JJ	amod	O
primary	JJ	amod	O
immunodeficiency	NN	nmod	O
characterized	VBN	acl	O
by	IN	case	O
hyper-IgM	NN	amod	O
syndrome	NN	nmod	O
and	CC	cc	O
hypohydrotic	JJ	amod	O
ectodermal	JJ	amod	O
dysplasia	NN	conj	O
(	-LRB-	punct	O
XHM-ED	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
mutations	NNS	nsubj	O
prevent	VBP	ROOT	O
CD40	NN	compound	B-protein
ligand	NN	compound	I-protein
(	-LRB-	punct	O
CD40L	NN	compound	B-protein
)	-RRB-	punct	O
-mediated	JJ	amod	O
degradation	NN	dobj	O
of	IN	case	O
inhibitor	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
alpha	NN	nmod	I-protein
(	-LRB-	punct	O
IkappaB-alpha	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
account	VBP	conj	O
for	IN	case	O
the	DT	det	O
following	JJ	amod	O
observations	NNS	nmod	O
:	:	punct	O
B	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
from	IN	case	O
XHM-ED	NN	compound	O
patients	NNS	nmod	O
are	VBP	cop	O
unable	JJ	parataxis	O
to	TO	mark	O
undergo	VB	xcomp	O
immunoglobulin	NN	compound	O
class-switch	JJ	compound	O
recombination	NN	dobj	O
and	CC	cc	O
antigen-presenting	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
(	-LRB-	punct	O
APCs	NNS	appos	B-cell_type
)	-RRB-	punct	O
are	VBP	cop	O
unable	JJ	conj	O
to	TO	mark	O
synthesize	VB	xcomp	O
the	DT	det	O
NF-kappaB-regulated	JJ	amod	B-protein
cytokines	NNS	dobj	I-protein
interleukin	NN	dep	B-protein
12	CD	nummod	I-protein
(	-LRB-	punct	O
IL-12	NN	appos	B-protein
)	-RRB-	punct	O
or	CC	cc	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	conj	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
when	WRB	advmod	O
stimulated	VBN	advcl	O
with	IN	case	O
CD40L	NN	nmod	B-protein
.	.	punct	O

Nevertheless	RB	advmod	O
,	,	punct	O
innate	JJ	amod	O
immunity	NN	nsubjpass	O
is	VBZ	auxpass	O
preserved	VBN	ROOT	O
in	IN	case	O
XHM-ED	NN	compound	O
patients	NNS	nmod	O
because	IN	mark	O
APCs	NNS	nsubj	B-cell_type
retain	VBP	advcl	O
the	DT	det	O
capacity	NN	dobj	O
to	TO	mark	O
respond	VB	acl	O
to	TO	case	O
stimulation	NN	nmod	O
by	IN	case	O
lipopolysaccharide	NN	nmod	O
or	CC	cc	O
Staphylococcus	FW	conj	B-protein
aureus	FW	compound	I-protein
Cowan	NN	nmod:poss	I-protein
's	POS	case	I-protein
antigen	NN	dobj	I-protein
(	-LRB-	punct	O
SAC	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Overall	RB	advmod	O
,	,	punct	O
the	DT	det	O
phenotype	NN	nsubj	O
observed	VBN	acl	O
in	IN	case	O
XHM-ED	NN	compound	O
patients	NNS	nmod	O
shows	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
putative	JJ	amod	B-protein
zinc-finger	JJ	amod	I-protein
domain	NN	nsubj	I-protein
of	IN	case	O
NEMO	NN	nmod	B-protein
has	VBZ	ccomp	O
a	DT	det	O
regulatory	JJ	amod	O
function	NN	dobj	O
and	CC	cc	O
demonstrates	VBZ	conj	O
the	DT	det	O
definite	JJ	amod	O
requirement	NN	dobj	O
of	IN	case	O
CD40	NN	compound	B-protein
-mediated	JJ	amod	O
NF-kappaB	NN	compound	O
activation	NN	nmod	O
for	IN	case	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
immunoglobulin	NN	compound	O
class-switching	NN	nmod	O
.	.	punct	O

Granulocytic	JJ	amod	O
differentiation	NN	ROOT	O
of	IN	case	O
human	JJ	amod	B-cell_type
NB4	NN	compound	I-cell_type
promyelocytic	JJ	amod	I-cell_type
leukemia	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
induced	VBN	acl	O
by	IN	case	O
all-trans	JJ	amod	O
retinoic	JJ	amod	O
acid	NN	compound	O
metabolites	NNS	nmod	O
.	.	punct	O

The	DT	det	O
metabolism	NN	nsubjpass	O
of	IN	case	O
all-trans	JJ	amod	O
retinoic	JJ	amod	O
acid	NN	nmod	O
(	-LRB-	punct	O
ATRA	NN	appos	O
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
partly	RB	advmod	O
responsible	JJ	xcomp	O
for	IN	case	O
the	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
resistance	NN	nmod	O
to	TO	case	O
ATRA	NN	nmod	O
seen	VBN	acl	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
acute	JJ	amod	O
promyelocytic	JJ	amod	O
leukemia	NN	nmod	O
(	-LRB-	punct	O
APL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
ATRA	NN	compound	O
metabolism	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
in	IN	case	O
the	DT	det	O
growth	NN	compound	O
inhibition	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
cancer	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

The	DT	det	O
purpose	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
activity	NN	dobj	O
of	IN	case	O
the	DT	det	O
principal	JJ	amod	O
metabolites	NNS	nmod	O
of	IN	case	O
ATRA	NN	nmod	O
[	-LRB-	punct	O
4-hydroxy-retinoic	JJ	amod	O
acid	NN	dep	O
(	-LRB-	punct	O
4-OH-RA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
18-hydroxy-retinoic	JJ	amod	O
acid	NN	conj	O
(	-LRB-	punct	O
18-OH-RA	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
4-oxo-retinoic	JJ	amod	O
acid	NN	appos	O
(	-LRB-	punct	O
4-oxo-RA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
5	CD	conj	O
,	,	punct	O
6-epoxy-retinoic	JJ	amod	O
acid	NN	conj	O
(	-LRB-	punct	O
5	CD	nummod	O
,	,	punct	O
6-epoxy-RA	NN	appos	O
)	-RRB-	punct	O
]	-RRB-	punct	O
in	IN	case	O
NB4	NN	nmod	B-cell_line
,	,	punct	I-cell_line
a	DT	det	I-cell_line
human	JJ	amod	I-cell_line
promyelocytic	JJ	amod	I-cell_line
leukemia	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	appos	I-cell_line
that	WDT	nsubj	O
exhibits	VBZ	acl:relcl	O
the	DT	det	O
APL	NN	compound	O
diagnostic	JJ	amod	O
t	NN	compound	O
(	-LRB-	punct	O
15	CD	nummod	O
;	:	punct	O
17	CD	dep	O
)	-RRB-	punct	O
chromosomal	JJ	amod	O
translocation	NN	dobj	O
and	CC	cc	O
expresses	VBZ	conj	O
the	DT	det	O
PML-RAR	NN	compound	B-protein
alpha	NN	compound	I-protein
fusion	NN	compound	I-protein
protein	NN	dobj	I-protein
.	.	punct	O

We	PRP	nsubj	O
established	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
four	CD	nummod	O
ATRA	NN	compound	O
metabolites	NNS	nsubjpass	O
were	VBD	auxpass	O
indeed	RB	advmod	O
formed	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
NB4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

NB4	NN	compound	O
cell	NN	compound	O
growth	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
(	-LRB-	punct	O
69-78	CD	nummod	O
%	NN	dep	O
at	IN	case	O
120	CD	nummod	O
h	NN	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
cell	NN	compound	O
cycle	NN	compound	O
progression	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
G1	NN	compound	O
phase	NN	nmod	O
(	-LRB-	punct	O
82-85	CD	nummod	O
%	NN	dep	O
at	IN	case	O
120	CD	nummod	O
h	NN	nmod	O
)	-RRB-	punct	O
was	VBD	auxpass	O
blocked	VBN	conj	O
by	IN	case	O
ATRA	NN	nmod	O
and	CC	cc	O
all	DT	conj	O
of	IN	case	O
the	DT	det	O
metabolites	NNS	nmod	O
at	IN	case	O
1	CD	compound	O
microM	NN	amod	O
concentration	NN	nmod	O
.	.	punct	O

ATRA	NN	nsubj	O
and	CC	cc	O
its	PRP$	nmod:poss	O
metabolites	NNS	conj	O
could	MD	aux	O
induce	VB	ROOT	O
NB4	NN	compound	B-cell_line
cells	NNS	compound	I-cell_line
differentiation	NN	dobj	O
with	IN	case	O
similar	JJ	amod	O
activity	NN	nmod	O
,	,	punct	O
as	IN	mark	O
evaluated	VBN	advcl	O
by	IN	case	O
cell	NN	compound	O
morphology	NN	nmod	O
,	,	punct	O
by	IN	case	O
the	DT	det	O
nitroblue	JJ	amod	O
tetrazolium	NN	compound	O
reduction	NN	compound	O
test	NN	nmod	O
(	-LRB-	punct	O
82-88	CD	nummod	O
%	NN	dep	O
at	IN	case	O
120	CD	nummod	O
h	NN	nmod	O
)	-RRB-	punct	O
or	CC	cc	O
by	IN	case	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
the	DT	det	O
maturation	NN	compound	B-protein
specific	JJ	amod	I-protein
cell	NN	compound	I-protein
surface	NN	compound	I-protein
marker	NN	compound	I-protein
CD11c	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
nuclear	JJ	amod	O
body	NN	compound	O
reorganization	NN	nsubjpass	O
to	TO	case	O
macropunctated	VBN	amod	O
structures	NNS	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
degradation	NN	conj	O
of	IN	case	O
PML-RAR	NN	compound	B-protein
alpha	NN	nmod	I-protein
,	,	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
similar	JJ	xcomp	O
for	IN	case	O
ATRA	NN	nmod	O
and	CC	cc	O
all	DT	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
metabolites	NNS	nmod	O
.	.	punct	O

Comparison	NN	nsubj	O
of	IN	case	O
the	DT	det	O
relative	JJ	amod	O
potency	NN	nmod	O
of	IN	case	O
the	DT	det	O
retinoids	NNS	nmod	O
using	VBG	acl	O
the	DT	det	O
nitroblue	JJ	amod	O
tetrazolium	NN	compound	O
reduction	NN	compound	O
test	NN	dobj	O
showed	VBD	ROOT	O
effective	JJ	amod	O
concentrations	NNS	dobj	O
required	VBN	acl	O
to	TO	mark	O
differentiate	VB	xcomp	O
50	CD	nummod	O
%	NN	dobj	O
of	IN	case	O
cells	NNS	nmod	O
in	IN	case	O
72	CD	nummod	O
h	NN	nmod	O
as	IN	mark	O
follows	VBZ	advcl	O
:	:	punct	O
ATRA	NN	dep	O
,	,	punct	O
15.8	CD	nummod	O
+/-	CC	cc	O
1.7	CD	conj	O
nM	NN	appos	O
;	:	punct	O
4-oxo-RA	NN	dep	O
,	,	punct	O
38.3	CD	nummod	O
+/-	CC	cc	O
1.3	CD	conj	O
nM	NN	appos	O
;	:	punct	O
18-OH-RA	CD	dep	O
,	,	punct	O
55.5	CD	nummod	O
+/-	CC	cc	O
1.8	CD	conj	O
nM	NN	conj	O
;	:	punct	O
4-OH-RA	NN	conj	O
,	,	punct	O
79.8	CD	nummod	O
+/-	CC	cc	O
1.8	CD	conj	O
nM	NN	conj	O
;	:	punct	O
and	CC	cc	O
5	CD	nummod	O
,	,	punct	O
6-epoxy-RA	CD	conj	O
,	,	punct	O
99.5	CD	nummod	O
+/-	CC	cc	O
1.5	CD	conj	O
nM	NN	appos	O
.	.	punct	O

The	DT	det	O
ATRA	NN	compound	O
metabolites	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
exert	VB	xcomp	O
their	PRP$	nmod:poss	O
differentiation	NN	compound	O
effects	NNS	dobj	O
via	IN	case	O
the	DT	det	O
RAR	NN	compound	B-protein
alpha	NN	compound	I-protein
nuclear	JJ	amod	I-protein
receptors	NNS	nmod	I-protein
,	,	punct	O
because	IN	mark	O
the	DT	det	O
RAR	NN	nmod:npmod	O
alpha-specific	JJ	amod	O
antagonist	NN	compound	O
BMS614	NN	nsubj	O
blocked	VBD	advcl	O
metabolite-induced	JJ	amod	O
CD11c	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
NB4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
principal	JJ	amod	O
ATRA	NN	compound	O
Phase	NN	compound	O
1	CD	nummod	O
metabolites	NNS	nsubj	O
can	MD	aux	O
elicit	VB	ccomp	O
leukemia	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
growth	NN	compound	O
inhibition	NN	dobj	O
and	CC	cc	O
differentiation	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
through	IN	case	O
the	DT	det	O
RAR	NN	compound	O
alpha	NN	compound	O
signaling	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
and	CC	cc	O
they	PRP	nsubj	O
suggest	VBP	conj	O
that	IN	mark	O
these	DT	det	O
metabolites	NNS	nsubj	O
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
ATRA	NN	compound	O
antileukemic	JJ	amod	O
activity	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
oestrogen	NN	compound	B-protein
and	CC	cc	I-protein
progesterone	NN	conj	I-protein
receptors	NNS	nmod	I-protein
by	IN	case	O
mast	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
alone	RB	advmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
lymphocytes	NNS	conj	B-cell_type
,	,	punct	O
macrophages	NNS	conj	B-cell_type
or	CC	cc	O
other	JJ	amod	O
immune	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
in	IN	case	O
human	JJ	amod	O
upper	JJ	amod	O
airways	NNS	nmod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Nasal	JJ	amod	O
polyposis	NN	nsubj	O
often	RB	advmod	O
coexists	VBZ	dep	O
with	IN	case	O
asthma	NN	nmod	O
in	IN	case	O
airway	NN	compound	O
inflammatory	JJ	amod	O
conditions	NNS	nmod	O
characterised	VBN	acl	O
by	IN	case	O
the	DT	det	O
infiltration	NN	nmod	O
of	IN	case	O
a	DT	det	O
range	NN	nmod	O
of	IN	case	O
immune	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
potentially	RB	advmod	O
important	JJ	amod	O
role	NN	nsubjpass	O
for	IN	case	O
ovarian	JJ	amod	O
hormones	NNS	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
airway	NN	compound	O
inflammation	NN	nmod	O
but	CC	cc	O
the	DT	det	O
cellular	JJ	amod	O
target	NN	nsubjpass	O
for	IN	case	O
such	JJ	amod	O
action	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
known	VBN	conj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Expression	NN	nsubjpass	O
of	IN	case	O
oestrogen	NN	compound	B-protein
receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
ER	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
progesterone	NN	compound	B-protein
receptors	NNS	conj	I-protein
(	-LRB-	punct	O
PR	NN	appos	B-protein
)	-RRB-	punct	O
was	VBD	auxpass	O
examined	VBN	dep	O
using	VBG	xcomp	O
immunohistochemistry	NN	dobj	O
in	IN	case	O
formalin	NN	compound	O
fixed	JJ	amod	O
nasal	JJ	amod	O
polyp	NN	compound	O
tissues	NNS	nmod	O
from	IN	case	O
47	CD	nummod	O
subjects	NNS	nmod	O
.	.	punct	O

The	DT	det	O
cells	NNS	nsubjpass	O
positive	JJ	amod	O
for	IN	case	O
ER	NN	nmod	B-protein
or	CC	cc	O
PR	NN	conj	B-protein
were	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
spatial	JJ	amod	O
location	NN	nmod	O
,	,	punct	O
dual	JJ	amod	O
immunolabelling	NN	conj	O
,	,	punct	O
and	CC	cc	O
histochemical	JJ	amod	O
staining	NN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Consistent	JJ	appos	O
with	IN	case	O
the	DT	det	O
known	JJ	amod	O
features	NNS	nmod	O
of	IN	case	O
nasal	JJ	amod	O
polyps	NN	amod	O
,	,	punct	O
CD4+	JJ	conj	B-cell_type
(	-LRB-	punct	I-cell_type
T	NN	compound	I-cell_type
helper/inducer	NN	nmod	I-cell_type
)	-RRB-	punct	I-cell_type
,	,	punct	O
CD8+	JJ	conj	B-cell_type
(	-LRB-	punct	I-cell_type
cytotoxic/suppressor	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
,	,	punct	O
CD68+	JJ	dep	B-cell_type
(	-LRB-	punct	O
macrophages	NNS	appos	B-cell_type
)	-RRB-	punct	O
,	,	punct	O
mast	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
eosinophils	NNS	nsubjpass	B-cell_type
and	CC	cc	O
neutrophils	NNS	conj	B-cell_type
were	VBD	auxpass	O
all	DT	advmod	O
clearly	RB	advmod	O
detected	VBN	dep	O
by	IN	case	O
their	PRP$	nmod:poss	O
relevant	JJ	amod	O
monoclonal	JJ	amod	B-protein
antibodies	NNS	nmod	I-protein
or	CC	cc	O
appropriate	JJ	amod	O
histochemical	JJ	amod	O
staining	NN	conj	O
,	,	punct	O
but	CC	cc	O
only	RB	advmod	O
mast	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
tested	VBN	acl	O
positive	JJ	xcomp	O
for	IN	case	O
ER	NN	compound	B-protein
/PR	NNP	compound	O
labelling	VBG	xcomp	O
with	IN	case	O
their	PRP$	nmod:poss	O
polyclonal	JJ	amod	B-protein
and	CC	cc	I-protein
monoclonal	JJ	conj	I-protein
antibodies	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
frequencies	NNS	nsubj	O
for	IN	prep	O
expression	NN	pobj	O
were	VBD	cop	O
61.7	CD	nummod	O
%	NN	ROOT	O
for	IN	case	O
ER	NN	compound	B-cell_type
positive	JJ	nmod	I-cell_type
and	CC	cc	O
59.6	CD	nummod	O
%	NN	conj	O
for	IN	case	O
PR	NN	compound	B-cell_type
positive	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
ER	NN	nmod	B-protein
/	:	punct	O
PR	NN	nmod	B-protein
was	VBD	cop	O
independent	JJ	ROOT	O
of	IN	case	O
patient	NN	compound	O
sex	NN	nmod	O
and	CC	cc	O
age	NN	conj	O
but	CC	cc	O
was	VBD	auxpass	O
highly	RB	advmod	O
correlated	VBN	conj	O
with	IN	case	O
the	DT	det	O
numbers	NNS	nmod	O
of	IN	case	O
mast	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	dep	O
0.973	CD	dobj	O
,	,	punct	O
p	NN	dep	O
<	:	parataxis	O
0.001	CD	dep	O
for	IN	case	O
ER	NN	nmod	B-protein
;	:	punct	O
r	NN	nsubj	O
=	JJ	parataxis	O
0.955	CD	dobj	O
,	,	punct	O
p	NN	dep	O
<	:	dep	O
0.001	CD	dobj	O
for	IN	case	O
PR	NN	nmod	B-protein
)	-RRB-	punct	O
.	.	punct	O

Fewer	JJR	amod	O
than	IN	quantmod	O
5	CD	nummod	O
%	NN	nsubjpass	O
of	IN	case	O
mast	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
negative	JJ	xcomp	O
for	IN	case	O
ER	NN	compound	B-protein
/	:	punct	O
PR	NN	compound	B-protein
expression	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Mast	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
alone	RB	advmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
lymphocytes	NNS	conj	B-cell_type
,	,	punct	O
macrophages	NNS	conj	B-cell_type
,	,	punct	O
or	CC	cc	O
other	JJ	amod	O
immune	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
express	VBP	dep	O
ER	NN	compound	B-protein
/	:	punct	O
PR	NN	dobj	B-protein
in	IN	case	O
human	JJ	amod	O
upper	JJ	amod	O
airways	NNS	nmod	O
.	.	punct	O

Numerous	JJ	amod	O
ER/PR	NN	compound	B-cell_type
positive	JJ	amod	I-cell_type
mast	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
exist	VBP	ROOT	O
in	IN	case	O
nasal	JJ	amod	O
polyps	NN	nmod	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
this	DT	nsubj	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
major	JJ	amod	O
route	NN	ccomp	O
for	IN	case	O
the	DT	det	O
involvement	NN	nmod	O
of	IN	case	O
sex	NN	compound	O
hormones	NNS	nmod	O
in	IN	case	O
airway	NN	compound	O
inflammation	NN	nmod	O
when	WRB	advmod	O
exposed	VBN	advcl	O
to	TO	case	O
the	DT	det	O
higher	JJR	amod	O
and	CC	cc	O
varying	VBG	conj	O
concentration	NN	nmod	O
of	IN	case	O
oestrogen	NN	nmod	O
and	CC	cc	O
progesterone	NN	conj	O
characteristic	JJ	amod	O
of	IN	case	O
females	NNS	nmod	O
.	.	punct	O

NF	NN	compound	O
kappa	NN	compound	O
b	NN	compound	O
signaling	NN	ROOT	O
in	IN	case	O
posthypoxic	JJ	amod	B-cell_type
endothelial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
relevance	NN	dep	O
to	TO	case	O
E-selectin	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
neutrophil	NN	compound	O
adhesion	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
previous	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
implicated	VBN	ROOT	O
the	DT	det	O
nuclear	JJ	amod	O
transcription	NN	compound	O
factor	NN	compound	O
kappa	NN	compound	O
B	NN	dobj	O
(	-LRB-	punct	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
adhesion	NN	compound	B-protein
molecule	NN	compound	I-protein
expression	NN	nmod	O
in	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
exposed	VBN	acl	O
to	TO	case	O
anoxia-reoxygenation	NN	nmod	O
(	-LRB-	punct	O
A/R	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
a	DT	det	O
redox	NN	compound	O
imbalance	NN	conj	O
.	.	punct	O

The	DT	det	O
objectives	NNS	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
were	VBD	ROOT	O
(	-LRB-	punct	O
1	LS	attr	O
)	-RRB-	punct	O
to	TO	mark	O
define	VB	xcomp	O
the	DT	det	O
kinetics	NNS	dobj	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
activation	NN	nmod	O
by	IN	mark	O
examining	VBG	advcl	O
I	NN	compound	O
kappa	NN	compound	O
B	NN	compound	O
alpha	NN	compound	O
degradation	NN	dobj	O
and	CC	cc	O
the	DT	det	O
nuclear	JJ	amod	O
translocation	NN	conj	O
of	IN	case	O
p65	NN	nmod	B-protein
in	IN	case	O
response	NN	dep	O
to	TO	case	O
A/R	NN	nmod	O
or	CC	cc	O
redox	NN	compound	O
imbalance	NN	conj	O
(	-LRB-	punct	O
induced	VBN	dep	O
by	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
with	IN	case	O
diamide	NN	nmod	O
and	CC	cc	O
buthionine	NN	compound	O
sulfoximine	NN	conj	O
)	-RRB-	punct	O
and	CC	cc	O
(	-LRB-	punct	O
2	LS	conj	O
)	-RRB-	punct	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
the	DT	det	O
signal	NN	nsubj	O
for	IN	case	O
I	NN	compound	O
kappa	NN	compound	O
B	NN	compound	O
alpha	NN	compound	O
degradation	NN	nmod	O
,	,	punct	O
nuclear	JJ	amod	O
translocation	NN	nsubj	O
of	IN	case	O
p65	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
E-selectin	NN	compound	B-protein
-mediated	JJ	amod	O
neutrophil	NN	compound	O
adhesion	NN	conj	O
is	VBZ	cop	O
related	JJ	ccomp	O
to	TO	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
protein	NN	compound	B-protein
tyrosine	NN	compound	I-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
PTK	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
protein	NN	compound	B-protein
tyrosine	NN	compound	I-protein
phosphatase	NN	conj	I-protein
(	-LRB-	punct	O
PTPase	NN	appos	B-protein
)	-RRB-	punct	O
and/or	CC	cc	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	conj	I-protein
(	-LRB-	punct	O
PKC	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
A/R	NN	compound	O
and	CC	cc	O
redox	NN	conj	O
imbalance	NN	nsubj	O
led	VBD	ccomp	O
to	TO	case	O
I	NN	compound	O
kappa	NN	compound	O
B	NN	compound	O
alpha	NN	compound	O
degradation	NN	nmod	O
within	IN	case	O
30	CD	nummod	O
min	NN	nmod	O
and	CC	cc	O
the	DT	det	O
concomitant	JJ	amod	O
appearance	NN	conj	O
of	IN	case	O
p65	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
,	,	punct	O
consistent	JJ	xcomp	O
with	IN	case	O
rapid	JJ	amod	O
cytosolic	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
and	CC	cc	O
subsequent	JJ	amod	O
nuclear	JJ	amod	O
translocation	NN	conj	O
of	IN	case	O
the	DT	det	O
activated	VBN	amod	B-protein
p65	NN	compound	I-protein
subunit	NN	nmod	I-protein
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
PKC	NN	nmod	B-protein
blocked	VBD	ROOT	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	compound	I-protein
degradation	NN	dobj	O
and	CC	cc	O
p65	NN	compound	B-protein
translocation	NN	conj	O
in	IN	case	O
A/R-challenged	NN	amod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
redox-altered	JJ	conj	O
,	,	punct	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
both	CC	cc:preconj	O
A/R-	JJ	nsubjpass	O
and	CC	cc	O
redox-induced	JJ	amod	O
NF	NN	compound	O
kappa	NN	compound	O
B	NN	compound	O
activation	NN	conj	O
was	VBD	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
PTK	NN	nmod	B-protein
.	.	punct	O

Similarly	RB	advmod	O
,	,	punct	O
A/R-induced	JJ	amod	O
E-selectin	NN	compound	O
expression	NN	nsubjpass	O
and	CC	cc	O
neutrophil-endothelial	JJ	amod	O
cell	NN	compound	O
adhesion	NN	conj	O
were	VBD	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
PKC	NN	nmod	B-protein
or	CC	cc	O
PTK	NN	conj	B-protein
,	,	punct	O
while	IN	mark	O
only	RB	advmod	O
PTK	NN	nsubj	B-protein
inhibited	VBD	advcl	O
the	DT	det	O
redox-induced	JJ	amod	O
adhesion	NN	compound	O
response	NN	dobj	O
.	.	punct	O

Pretreatment	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	O
with	IN	case	O
N-acetyl	JJ	amod	O
cysteine	NN	nmod	O
effectively	RB	advmod	O
blocked	VBD	ROOT	O
A/R-	NN	dobj	O
or	CC	cc	O
redox-induced	JJ	amod	O
I	NN	compound	O
kappa	NN	compound	O
B	NN	compound	O
degradation	NN	conj	O
and	CC	cc	O
significantly	RB	advmod	O
attenuated	VBD	conj	O
the	DT	det	O
respective	JJ	amod	O
neutrophil	NN	compound	O
adhesion	NN	compound	O
responses	NNS	dobj	O
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
A/R-induced	JJ	amod	O
E-selectin	NN	compound	O
expression	NN	nsubjpass	O
and	CC	cc	O
neutrophil-endothelial	JJ	amod	O
cell	NN	compound	O
adhesion	NN	conj	O
are	VBP	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
both	CC	cc:preconj	O
PKC	NN	nmod	B-protein
and	CC	cc	O
PTK	NN	conj	B-protein
,	,	punct	O
which	WDT	nsubj	O
signal	VBP	acl:relcl	O
rapid	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
.	.	punct	O

This	DT	det	O
A/R-induced	JJ	amod	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
signaling	NN	compound	O
response	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
mediated	VBN	xcomp	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
by	IN	case	O
intracellular	JJ	amod	O
redox	NN	compound	O
imbalance	NN	nmod	O
.	.	punct	O

Copyright	NN	compound	O
2001	CD	nummod	O
S.	NNP	compound	O
Karger	NNP	compound	O
AG	NNP	ROOT	O
,	,	punct	O
Basel	NNP	appos	O

Induction	NN	ROOT	O
of	IN	case	O
apoptosis	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
by	IN	case	O
the	DT	det	O
herbicide	NN	compound	O
2	CD	nummod	O
,	,	punct	O
4-dichlorophenoxyacetic	JJ	amod	O
acid	NN	nmod	O
.	.	punct	O

Dimethylammonium	NN	compound	O
salt	NN	nsubj	O
of	IN	case	O
2	CD	nummod	O
,	,	punct	O
4-dichlorophenoxyacetic	JJ	amod	O
acid	NN	nmod	O
(	-LRB-	punct	O
DMA-2	NN	dep	O
,	,	punct	O
4-D	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
widely	RB	advmod	O
used	VBN	amod	O
herbicide	NN	ROOT	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
considered	VBN	acl:relcl	O
moderately	RB	advmod	O
toxic	JJ	oprd	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
DMA-2	NN	nsubj	O
,	,	punct	O
4-D	NN	conj	O
is	VBZ	cop	O
able	JJ	ccomp	O
to	TO	mark	O
cause	VB	xcomp	O
apoptosis	NN	dobj	O
in	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
of	IN	case	O
healthy	JJ	amod	O
individuals	NNS	nmod	O
and	CC	cc	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

Apoptosis	NN	nsubj	O
induced	VBN	acl	O
by	IN	case	O
DMA-2	NN	nmod	O
,	,	punct	O
4-D	NN	nsubj	O
was	VBD	cop	O
dose	NN	ROOT	O
and	CC	cc	O
time	NN	nmod:npmod	O
dependent	JJ	conj	O
,	,	punct	O
independent	JJ	conj	O
of	IN	case	O
Fas	NN	nmod	B-protein
,	,	punct	O
TNF	NN	compound	B-protein
receptor	NN	conj	I-protein
1	CD	nummod	I-protein
or	CC	cc	O
the	DT	det	O
aromatic	JJ	amod	B-protein
hydrocarbon	NN	compound	I-protein
receptor	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
involved	VBN	amod	O
disruption	NN	conj	O
of	IN	case	O
the	DT	det	O
mitochondrial	JJ	amod	O
transmembrane	JJ	compound	O
potential	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
caspase-9	NN	nmod	B-protein
.	.	punct	O

ZVAD-FMK	NN	nsubj	O
,	,	punct	O
a	DT	det	O
broad-spectrum	JJ	amod	O
inhibitor	NN	appos	O
of	IN	case	O
caspases	NNS	nmod	B-protein
,	,	punct	O
blocked	VBD	ROOT	O
DMA-2	NN	dobj	O
,	,	punct	O
4-D-induced	JJ	amod	O
apoptosis	NN	conj	O
completely	RB	advmod	O
.	.	punct	O

While	IN	mark	O
an	DT	det	O
inhibitor	NN	nsubj	O
of	IN	case	O
caspase-9	NN	nmod	B-protein
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
caspase-9	NN	compound	B-protein
and	CC	cc	O
caspase-3	NN	conj	O
inhibitors	NNS	conj	O
in	IN	case	O
combination	NN	nmod	O
,	,	punct	O
strongly	RB	advmod	O
blocked	VBD	advcl	O
DMA-2	NN	dobj	O
,	,	punct	O
4-D-induced	JJ	amod	O
apoptosis	NN	conj	O
,	,	punct	O
an	DT	det	O
inhibitor	NN	nsubj	O
of	IN	case	O
caspase-3	NN	nmod	B-protein
had	VBD	ROOT	O
a	DT	det	O
moderate	JJ	amod	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
.	.	punct	O

Unlike	IN	case	O
Fas	NN	compound	B-protein
-mediated	JJ	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
the	DT	det	O
initiator	NN	compound	B-protein
caspase	NN	nsubjpass	I-protein
,	,	punct	O
caspase-8	NN	appos	B-protein
,	,	punct	O
was	VBD	auxpass	O
not	RB	neg	O
involved	VBN	ROOT	O
in	IN	case	O
DMA-2	NN	nmod	O
,	,	punct	O
4-D-induced	JJ	amod	O
apoptosis	NN	appos	O
.	.	punct	O

Transfection	NN	nsubj	O
of	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
Bcl-2	NN	nmod	B-protein
prevented	VBD	ROOT	O
DMA-2	NN	dobj	O
,	,	punct	O
4-D-induced	JJ	amod	O
disruption	NN	appos	O
of	IN	case	O
the	DT	det	O
mitochondrial	JJ	amod	O
transmembrane	JJ	compound	O
potential	NN	nmod	O
and	CC	cc	O
led	VBD	conj	O
to	TO	case	O
a	DT	det	O
complete	JJ	amod	O
blockage	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
DMA-2	NN	nsubj	O
,	,	punct	O
4-D	NN	appos	O
kills	VBZ	ccomp	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	dobj	I-cell_type
by	IN	mark	O
initiating	VBG	advcl	O
apoptosis	NN	dobj	O
via	IN	case	O
a	DT	det	O
direct	JJ	amod	O
effect	NN	nmod	O
on	IN	case	O
mitochondria	NN	nmod	O
.	.	punct	O

The	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
caspases	NNS	nmod	B-protein
occurs	VBZ	ROOT	O
downstream	RB	advmod	O
of	IN	case	O
mitochondrial	JJ	amod	O
damage	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
dysfunction	NN	nsubj	O
of	IN	case	O
mitochondria	NN	nmod	O
appears	VBZ	conj	O
to	TO	mark	O
be	VB	cop	O
sufficient	JJ	xcomp	O
for	IN	mark	O
triggering	VBG	advcl	O
all	DT	det	O
downstream	JJ	amod	O
events	NNS	dobj	O
leading	VBG	acl	O
to	TO	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubjpass	O
of	IN	case	O
Th1	NN	compound	O
differentiation	NN	nmod	O
by	IN	case	O
IL-6	NN	nmod	B-protein
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
SOCS1	NN	nmod	B-protein
.	.	punct	O

Interleukin	NN	nsubj	B-protein
6	CD	nummod	I-protein
(	-LRB-	punct	O
IL-6	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
cytokine	NN	ROOT	B-protein
produced	VBN	acl	O
by	IN	case	O
immune	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
nonimmune	JJ	conj	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
exhibits	VBZ	conj	O
functional	JJ	amod	O
pleiotropy	NN	dobj	O
and	CC	cc	O
redundancy	NN	conj	O
.	.	punct	O

IL-6	NN	nsubj	B-protein
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
differentiation	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
describe	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
function	NN	dobj	O
of	IN	case	O
IL-6	NN	nmod	B-protein
:	:	punct	O
the	DT	det	O
negative	JJ	amod	O
regulation	NN	dobj	O
of	IN	case	O
CD4	NN	nmod	B-protein
+	CC	cc	O
Th1	NN	conj	O
cell	NN	compound	O
differentiation	NN	dep	O
.	.	punct	O

While	IN	mark	O
IL-6	NN	compound	B-protein
-directed	JJ	amod	O
CD4	NN	compound	B-protein
+	CC	cc	O
Th2	NN	conj	O
differentiation	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	advcl	O
by	IN	case	O
IL-4	NN	nmod	B-protein
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
Th1	NN	compound	O
differentiation	NN	nmod	O
by	IN	case	O
IL-6	NN	nmod	B-protein
is	VBZ	cop	O
independent	JJ	ROOT	O
of	IN	case	O
IL-4	NN	nmod	B-protein
.	.	punct	O

IL-6	NN	nsubj	B-protein
upregulates	VBZ	ROOT	O
suppressor	NN	dobj	B-protein
of	IN	case	I-protein
cytokine	NN	compound	I-protein
signaling	NN	compound	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
SOCS1	NN	appos	B-protein
)	-RRB-	punct	O
expression	NN	nmod	O
in	IN	case	O
activated	VBN	amod	B-cell_type
CD4+	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
thereby	RB	advmod	O
interfering	VBG	advcl	O
with	IN	case	O
signal	NN	compound	B-protein
transducer	NN	nmod	I-protein
and	CC	cc	I-protein
activator	NN	compound	I-protein
of	IN	case	I-protein
transcription	NN	compound	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
STAT1	NN	appos	B-protein
)	-RRB-	punct	O
phosphorylation	NN	conj	O
induced	VBN	acl	O
by	IN	case	O
interferon	NN	compound	B-protein
gamma	NN	nmod	I-protein
(	-LRB-	punct	O
IFNgamma	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
IFNgamma	NN	nmod:npmod	B-protein
receptor-mediated	JJ	amod	O
signals	NNS	nmod	O
by	IN	case	O
IL-6	NN	nmod	B-protein
prevents	VBZ	ROOT	O
autoregulation	NN	dobj	O
of	IN	case	O
IFNgamma	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
by	IN	case	O
IFNgamma	NN	nmod	B-protein
during	IN	case	O
CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
activation	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
preventing	VBG	advcl	O
Th1	NN	compound	O
differentiation	NN	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
IL-6	NN	nsubj	B-protein
promotes	VBZ	ROOT	O
CD4	NN	compound	B-protein
+	CC	cc	O
Th2	NN	conj	O
differentiation	NN	dobj	O
and	CC	cc	O
inhibits	VBZ	conj	O
Th1	NN	compound	O
differentiation	NN	dobj	O
by	IN	case	O
two	CD	nummod	O
independent	JJ	amod	O
molecular	JJ	amod	O
mechanisms	NNS	nmod	O
.	.	punct	O

Interaction	NN	nsubj	O
between	IN	case	O
CCAAT/enhancer	NN	compound	B-protein
binding	NN	compound	I-protein
protein	NN	nmod	I-protein
and	CC	cc	O
cyclic	JJ	amod	B-protein
AMP	NN	compound	I-protein
response	NN	compound	I-protein
element	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	conj	I-protein
1	CD	nummod	I-protein
regulates	VBZ	ROOT	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
transcription	NN	dobj	O
in	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
the	DT	det	O
monocyte/macrophage	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
.	.	punct	O

Recent	JJ	amod	O
observations	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
two	CD	nummod	O
CCAAT/enhancer	NN	compound	B-DNA
binding	NN	compound	I-DNA
protein	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
C/EBP	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
to	TO	mark	O
be	VB	cop	O
critically	RB	advmod	O
important	JJ	xcomp	O
for	IN	case	O
efficient	JJ	amod	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
replication	NN	nmod	O
within	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
the	DT	det	O
monocyte/macrophage	NN	compound	B-cell_type
lineage	NN	nmod	I-cell_type
,	,	punct	O
a	DT	det	O
cell	NN	compound	O
type	NN	appos	O
likely	RB	advmod	O
involved	VBN	acl	O
in	IN	case	O
transport	NN	nmod	O
of	IN	case	O
the	DT	det	O
virus	NN	nmod	O
to	TO	case	O
the	DT	det	O
brain	NN	nmod	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
sequence	NN	compound	O
variation	NN	nsubjpass	O
at	IN	case	O
C/EBP	NN	compound	B-DNA
site	NN	nmod	I-DNA
I	CD	nummod	I-DNA
,	,	punct	O
which	WDT	nsubj	O
lies	VBZ	acl:relcl	O
immediately	RB	advmod	O
upstream	JJ	advmod	O
of	IN	case	O
the	DT	det	O
distal	JJ	amod	B-DNA
nuclear	JJ	amod	I-DNA
factor	NN	compound	I-DNA
kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
site	NN	nmod	I-DNA
and	CC	cc	O
immediately	RB	advmod	O
downstream	RB	conj	O
of	IN	case	O
a	DT	det	O
binding	VBG	amod	O
site	NN	nmod	O
for	IN	mark	O
activating	VBG	advcl	B-protein
transcription	NN	compound	I-protein
factor	NN	dobj	I-protein
(	-LRB-	punct	O
ATF	NN	appos	B-protein
)	-RRB-	punct	O
/	:	punct	O
cyclic	JJ	amod	B-protein
AMP	NN	compound	I-protein
response	NN	compound	I-protein
element	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	conj	I-protein
(	-LRB-	punct	O
CREB	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
affect	VB	xcomp	O
HIV-1	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	compound	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
activity	NN	dobj	O
.	.	punct	O

Given	VBN	mark	O
that	IN	mark	O
C/EBP	NN	compound	B-protein
proteins	NNS	nsubjpass	I-protein
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	advcl	O
to	TO	mark	O
interact	VB	xcomp	O
with	IN	case	O
many	JJ	amod	O
other	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
including	VBG	case	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
ATF/CREB	NN	compound	B-protein
family	NN	nmod	I-protein
,	,	punct	O
we	PRP	nsubj	O
proceeded	VBD	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
an	DT	det	O
adjacent	JJ	amod	O
ATF/CREB	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	nsubj	I-DNA
could	MD	aux	O
affect	VB	ccomp	O
C/EBP	NN	compound	B-protein
protein	NN	dobj	I-protein
binding	VBG	acl	O
to	TO	case	O
C/EBP	NN	compound	B-DNA
site	NN	nmod	I-DNA
I	CD	nummod	I-DNA
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
analyses	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	dobj	O
selected	VBN	amod	O
ATF/CREB	NN	compound	B-DNA
site	NN	compound	I-DNA
variants	NNS	dep	I-DNA
assisted	VBN	acl	O
in	IN	case	O
the	DT	det	O
recruitment	NN	nmod	O
of	IN	case	O
C/EBP	NN	compound	B-protein
proteins	NNS	nmod	I-protein
to	TO	case	O
an	DT	det	O
adjacent	JJ	amod	O
,	,	punct	O
naturally	RB	advmod	O
occurring	VBG	dep	O
,	,	punct	O
low-affinity	JJ	amod	O
C/EBP	NN	compound	B-DNA
site	NN	nmod	I-DNA
.	.	punct	O

This	DT	det	O
biophysical	JJ	amod	O
interaction	NN	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
occur	VB	xcomp	O
via	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
two	CD	nummod	O
mechanisms	NNS	nmod	O
.	.	punct	O

First	RB	advmod	O
,	,	punct	O
low	JJ	amod	O
amounts	NNS	nsubj	O
of	IN	case	O
CREB-1	NN	nmod	B-protein
and	CC	cc	O
C/EBP	NN	conj	B-protein
appear	VBP	ROOT	O
to	TO	mark	O
heterodimerize	VB	xcomp	O
and	CC	cc	O
bind	VBP	conj	O
to	TO	case	O
a	DT	det	O
site	NN	nmod	O
consisting	VBG	acl	O
of	IN	case	O
a	DT	det	O
half	JJ	amod	O
site	NN	nmod	O
from	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
ATF/CREB	NN	compound	B-DNA
and	CC	cc	I-DNA
C/EBP	NN	conj	I-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
CREB-1	NN	compound	B-protein
homodimers	NNS	nsubj	I-protein
bind	VBP	ROOT	O
to	TO	case	O
the	DT	det	O
ATF/CREB	NN	compound	B-DNA
site	NN	nmod	I-DNA
and	CC	cc	O
recruit	VB	conj	O
C/EBP	NN	compound	B-protein
dimers	NNS	dobj	I-protein
to	TO	case	O
their	PRP$	nmod:poss	O
cognate	JJ	amod	O
weak	JJ	amod	B-DNA
binding	VBG	amod	I-DNA
sites	NNS	nmod	I-DNA
.	.	punct	O

This	DT	det	O
interaction	NN	nsubj	O
is	VBZ	cop	O
reciprocal	JJ	ROOT	O
,	,	punct	O
since	IN	mark	O
C/EBP	NN	compound	B-protein
dimer	NN	nsubj	I-protein
binding	VBG	acl	O
to	TO	case	O
a	DT	det	O
strong	JJ	amod	O
C/EBP	NN	compound	B-DNA
site	NN	nmod	I-DNA
leads	VBZ	advcl	O
to	TO	case	O
enhanced	VBN	amod	O
CREB-1	NN	compound	B-protein
recruitment	NN	nmod	O
to	TO	case	O
ATF/CREB	NN	compound	B-DNA
sites	NNS	nmod	I-DNA
that	WDT	nsubjpass	O
are	VBP	auxpass	O
weakly	RB	advmod	O
bound	VBN	acl:relcl	O
by	IN	case	O
CREB	NN	nmod	B-protein
.	.	punct	O

Sequence	NN	compound	O
variation	NN	nsubj	O
at	IN	case	O
both	CC	cc:preconj	O
C/EBP	NN	compound	B-DNA
and	CC	cc	I-DNA
ATF/CREB	NN	conj	I-DNA
sites	NNS	nmod	I-DNA
affects	VBZ	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
interactions	NNS	dobj	O
involved	VBN	acl	O
in	IN	mark	O
mediating	VBG	advcl	O
both	DT	dobj	O
of	IN	case	O
these	DT	det	O
mechanisms	NNS	nmod	O
.	.	punct	O

Most	RBS	advmod	O
importantly	RB	advmod	O
,	,	punct	O
sequence	NN	compound	O
variation	NN	nsubj	O
at	IN	case	O
the	DT	det	O
ATF/CREB	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	nmod	I-DNA
affected	VBD	ROOT	O
basal	JJ	amod	O
LTR	NN	compound	B-DNA
activity	NN	dobj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
LTR	NN	compound	B-DNA
function	NN	conj	O
following	VBG	case	O
interleukin-6	NN	compound	B-protein
stimulation	NN	nmod	O
,	,	punct	O
a	DT	det	O
treatment	NN	dobj	O
that	WDT	nsubj	O
leads	VBZ	acl:relcl	O
to	TO	mark	O
increases	NNS	nmod	O
in	IN	case	O
C/EBP	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
HIV-1	NN	compound	B-DNA
LTR	NN	compound	I-DNA
ATF/CREB	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	compound	I-DNA
sequence	NN	compound	O
variation	NN	nsubj	O
may	MD	aux	O
modulate	VB	ROOT	O
cellular	JJ	amod	O
signaling	NN	dobj	O
at	IN	case	O
the	DT	det	O
viral	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
through	IN	case	O
the	DT	det	O
C/EBP	NN	compound	O
pathway	NN	nmod	O

Selective	JJ	amod	O
inhibition	NN	ROOT	O
of	IN	case	O
interleukin-4	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
aspirin	NN	nmod	O
.	.	punct	O

Previous	JJ	amod	O
studies	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
aspirin	NN	nsubj	O
(	-LRB-	punct	O
acetylsalicylic	JJ	amod	O
acid	NN	dep	O
[	-LRB-	punct	O
ASA	NN	appos	O
]	-RRB-	punct	O
)	-RRB-	punct	O
can	MD	aux	O
have	VB	ccomp	O
profound	JJ	amod	O
immunomodulatory	JJ	amod	O
effects	NNS	dobj	O
by	IN	mark	O
regulating	VBG	advcl	O
cytokine	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
several	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
cells	NNS	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
first	JJ	ROOT	O
in	IN	case	O
which	WDT	nmod	O
concentrations	NNS	nsubjpass	O
of	IN	case	O
ASA	NN	nmod	O
in	IN	case	O
the	DT	det	O
therapeutic	JJ	amod	O
range	NN	nmod	O
were	VBD	auxpass	O
found	VBN	acl:relcl	O
to	TO	mark	O
significantly	RB	advmod	O
reduce	VB	xcomp	O
interleukin	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL	NN	compound	I-protein
)	-RRB-	punct	I-protein
-4	CD	nummod	I-protein
secretion	NN	dobj	O
and	CC	cc	O
RNA	NN	compound	O
expression	NN	conj	O
in	IN	case	O
freshly	RB	advmod	B-cell_type
isolated	VBN	amod	I-cell_type
and	CC	cc	I-cell_type
mitogen-primed	JJ	conj	I-cell_type
human	JJ	amod	I-cell_type
CD4+	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
ASA	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
IL-13	NN	dobj	B-protein
,	,	punct	O
interferon-gamma	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL-2	NN	compound	B-protein
expression	NN	conj	O
.	.	punct	O

ASA	NN	nsubj	O
inhibited	VBD	ROOT	O
IL-4	NN	dobj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
IL-2	NN	conj	B-protein
,	,	punct	O
promoter-driven	JJ	amod	O
chloramphenicol	NN	compound	O
acetyltransferase	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
transiently	RB	advmod	O
transfected	VBN	amod	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
structurally	RB	advmod	O
unrelated	JJ	amod	O
nonsteroidal	JJ	amod	O
anti-inflammatory	JJ	amod	O
drugs	NNS	nsubj	O
indomethacin	NN	dep	O
and	CC	cc	O
flurbiprofen	NN	conj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
cytokine	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
weak	JJ	amod	O
cyclo-oxygenase	JJ	compound	O
inhibitor	NN	compound	O
salicylic	JJ	amod	O
acid	NN	nsubj	O
was	VBD	cop	O
at	IN	advmod	O
least	JJS	mwe	O
as	RB	advmod	O
effective	JJ	parataxis	O
as	IN	case	O
ASA	NN	nmod	O
in	IN	mark	O
inhibiting	VBG	advcl	O
IL-4	NN	compound	B-protein
expression	NN	dobj	O
and	CC	cc	O
promoter	NN	compound	O
activity	NN	conj	O
.	.	punct	O

The	DT	det	O
inhibitory	JJ	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
ASA	NN	nmod	O
on	IN	case	O
IL-4	NN	compound	O
transcription	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
mediated	VBN	ROOT	O
by	IN	case	O
decreased	VBN	amod	O
nuclear	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
known	JJ	amod	O
salicylate	NN	compound	B-protein
target	NN	compound	I-protein
nuclear	JJ	amod	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-kappaB	NN	nmod	I-protein
and	CC	cc	O
was	VBD	auxpass	O
accompanied	VBN	conj	O
by	IN	case	O
reduced	VBN	amod	O
binding	NN	nmod	O
of	IN	case	O
an	DT	det	O
inducible	JJ	amod	O
factor	NN	nmod	O
to	TO	case	O
an	DT	det	O
IL-4	NN	compound	B-DNA
promoter	NN	compound	I-DNA
region	NN	nmod	I-DNA
upstream	JJ	amod	O
of	IN	advmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
overlapping	VBG	conj	O
,	,	punct	O
the	DT	dep	O
NF	NN	compound	B-DNA
of	IN	amod	I-DNA
activated	VBN	amod	I-DNA
T	NN	compound	I-DNA
cells-	NN	amod	I-DNA
and	CC	cc	I-DNA
NF-kappaB-binding	JJ	conj	I-DNA
P1	NN	compound	I-DNA
element	NN	nmod	I-DNA
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
concluded	VBN	ROOT	O
that	IN	mark	O
anti-inflammatory	JJ	amod	O
salicylates	NNS	nsubj	O
,	,	punct	O
by	IN	case	O
means	NNS	dep	O
of	IN	case	O
a	DT	det	O
previously	RB	advmod	O
unrecognized	JJ	amod	O
mechanism	NN	conj	O
of	IN	case	O
action	NN	nmod	O
,	,	punct	O
can	MD	aux	O
influence	VB	ccomp	O
the	DT	det	O
nature	NN	dobj	O
of	IN	case	O
adaptive	JJ	amod	O
immune	JJ	amod	O
responses	NNS	nmod	O
by	IN	mark	O
selectively	RB	advmod	O
inhibiting	VBG	advcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
IL-4	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
critical	JJ	amod	O
effector	NN	appos	O
of	IN	case	O
these	DT	det	O
responses	NNS	nmod	O
,	,	punct	O
in	IN	case	O
CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Molecular	JJ	amod	O
and	CC	cc	O
cellular	JJ	conj	O
mediators	NNS	ROOT	O
of	IN	case	O
interleukin-1	NN	compound	B-protein
-dependent	JJ	amod	O
acute	JJ	amod	O
inflammatory	JJ	amod	O
arthritis	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
examine	VB	dep	O
the	DT	det	O
molecular	JJ	amod	O
and	CC	cc	O
cellular	JJ	conj	O
mechanisms	NNS	dobj	O
in	IN	case	O
a	DT	det	O
model	NN	nmod	O
of	IN	case	O
acute	JJ	amod	O
inflammatory	JJ	amod	O
monarticular	JJ	amod	O
arthritis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
methylated	VBN	amod	B-protein
bovine	JJ	amod	I-protein
serum	NN	compound	I-protein
albumin	NN	nmod	I-protein
(	-LRB-	punct	O
mBSA	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
interleukin-1	NN	conj	B-protein
(	-LRB-	punct	O
IL-1	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Mice	NNS	nsubjpass	O
were	VBD	auxpass	O
injected	VBN	ROOT	O
intraarticularly	RB	advmod	O
with	IN	case	O
mBSA	NN	nmod	B-protein
on	IN	case	O
day	NN	nmod	O
0	CD	nummod	O
and	CC	cc	O
subcutaneously	RB	advmod	O
with	IN	case	O
recombinant	JJ	amod	B-protein
human	JJ	amod	I-protein
IL-1beta	NN	nmod	I-protein
on	IN	case	O
days	NNS	nmod	O
0-2	CD	nummod	O
.	.	punct	O

At	IN	prep	O
day	NN	pobj	O
7	CD	nummod	O
,	,	punct	O
knee	NN	compound	O
joints	NNS	nsubjpass	O
were	VBD	auxpass	O
removed	VBN	ROOT	O
and	CC	cc	O
assessed	VBN	conj	O
histologically	RB	advmod	O
.	.	punct	O

Flow	NN	compound	O
cytometry	NN	nsubjpass	O
and	CC	cc	O
RNase	NN	compound	O
protection	NN	conj	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
analyze	VB	xcomp	O
IL-1	NN	compound	B-protein
-dependent	JJ	amod	O
events	NNS	dobj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
C57BL/6	NN	compound	O
(	-LRB-	punct	O
B6	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
129/Sv	CD	conj	O
,	,	punct	O
and	CC	cc	O
(	-LRB-	punct	O
B6	NN	compound	O
x	CC	cc	O
129/	CD	conj	O
Sv	NN	conj	O
)	-RRB-	punct	O
F1	NN	compound	O
hybrid	NN	compound	O
mice	NNS	dep	O
,	,	punct	O
all	DT	det	O
H-2b	NN	compound	O
strains	NNS	nsubj	O
,	,	punct	O
were	VBD	cop	O
susceptible	JJ	appos	O
to	TO	case	O
mBSA	NN	nmod:npmod	B-protein
/IL-1-induced	JJ	nummod	O
arthritis	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
C3H/HeJ	NN	compound	O
(	-LRB-	punct	O
H-2k	NN	appos	O
)	-RRB-	punct	O
mice	NNS	nsubj	O
were	VBD	parataxis	O
not	RB	neg	O
.	.	punct	O

B6	NN	compound	O
mice	NNS	nsubj	O
lacking	VBG	acl	O
T	NN	compound	B-cell_type
and	CC	cc	I-cell_type
B	NN	conj	I-cell_type
cells	NNS	dobj	I-cell_type
(	-LRB-	punct	O
RAG1-/-	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
major	JJ	amod	B-protein
histocompatibility	NN	compound	I-protein
complex	NN	compound	I-protein
(	-LRB-	punct	I-protein
MHC	NN	compound	I-protein
)	-RRB-	punct	I-protein
class	NN	compound	I-protein
II	CD	nummod	I-protein
antigens	NNS	conj	I-protein
(	-LRB-	punct	O
MHCII-/-	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
B6	NN	compound	O
mice	NNS	conj	O
treated	VBN	acl	O
with	IN	case	O
a	DT	det	O
CD4+	JJ	amod	B-protein
T	NN	compound	I-protein
cell-depleting	JJ	amod	I-protein
monoclonal	JJ	amod	I-protein
antibody	NN	nmod	I-protein
,	,	punct	O
were	VBD	cop	O
resistant	JJ	ROOT	O
to	TO	case	O
disease	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
B	NN	compound	O
cell-deficient	JJ	amod	O
(	-LRB-	punct	O
muMT/	NN	compound	O
muMT	NN	dep	O
)	-RRB-	punct	O
mice	NNS	nsubj	O
developed	VBD	ROOT	O
arthritis	NN	dobj	O
at	IN	case	O
an	DT	det	O
incidence	NN	nmod	O
and	CC	cc	O
severity	NN	conj	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

RelB-deficient	JJ	amod	O
(	-LRB-	punct	O
RelB-/-	NN	appos	O
)	-RRB-	punct	O
bone	NN	compound	O
marrow	NN	compound	O
chimeric	JJ	amod	O
mice	NNS	nsubj	O
had	VBD	ROOT	O
arthritis	NN	dobj	O
that	WDT	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
reduced	VBN	acl:relcl	O
in	IN	case	O
incidence	NN	nmod	O
and	CC	cc	O
severity	NN	conj	O
.	.	punct	O

In	IN	case	O
B6	NN	compound	O
mice	NNS	nmod	O
,	,	punct	O
flow	NN	compound	O
cytometry	NN	nsubj	O
demonstrated	VBD	ROOT	O
an	DT	det	O
IL-1-dependent	JJ	amod	B-cell_type
leukocyte	NN	compound	I-cell_type
infiltration	NN	dobj	O
into	IN	case	O
the	DT	det	O
synovial	JJ	amod	O
compartment	NN	nmod	O
and	CC	cc	O
RNase	NN	compound	O
protection	NN	compound	O
assays	NNS	conj	O
revealed	VBD	conj	O
induction	NN	dobj	O
of	IN	case	O
messenger	NN	compound	B-RNA
RNA	NN	nmod	I-RNA
(	-LRB-	punct	O
mRNA	NN	appos	B-RNA
)	-RRB-	punct	O
for	IN	case	O
the	DT	det	O
chemokines	NNS	nmod	B-protein
monocyte	NN	compound	B-protein
chemoattractant	NN	compound	I-protein
protein	NN	dep	I-protein
1	CD	nummod	I-protein
,	,	punct	O
macrophage	NN	compound	B-protein
inhibitory	JJ	amod	I-protein
protein	NN	conj	I-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
MIP-2	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
RANTES	NN	conj	B-protein
,	,	punct	O
MIP-1alpha	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
MIP-1beta	NN	conj	B-protein
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Arthritis	NN	nsubj	O
induced	VBN	acl	O
by	IN	case	O
mBSA	NN	nmod	B-protein
/	:	punct	O
IL-1	NN	nsubj	B-protein
is	VBZ	cop	O
strain	NN	nmod:npmod	O
specific	JJ	amod	O
and	CC	cc	O
dependent	JJ	conj	O
on	IN	case	O
CD4+	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
at	IN	advmod	O
least	JJS	mwe	O
partially	RB	advmod	O
on	IN	case	O
RelB	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
on	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	conj	I-cell_type
or	CC	cc	O
antibody	NN	conj	B-protein
.	.	punct	O

IL-1	NN	nsubj	B-protein
contributes	VBZ	ROOT	O
to	TO	case	O
leukocyte	NN	compound	O
recruitment	NN	nmod	O
to	TO	case	O
the	DT	det	O
synovium	NN	nmod	O
and	CC	cc	O
directly	RB	advmod	O
induces	VBZ	conj	O
chemokine	NN	compound	O
mRNA	NN	compound	O
production	NN	dobj	O
by	IN	case	O
synovial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	det	O
model	NN	nsubj	O
of	IN	case	O
acute	JJ	amod	O
monarticular	JJ	amod	O
arthritis	NN	nmod	O
is	VBZ	cop	O
particularly	RB	advmod	O
suitable	JJ	ROOT	O
for	IN	case	O
further	JJ	amod	O
investigations	NNS	nmod	O
into	IN	case	O
cell-mediated	JJ	amod	O
immunity	NN	nmod	O
in	IN	case	O
arthritis	NN	nmod	O
and	CC	cc	O
the	DT	det	O
role	NN	conj	O
of	IN	case	O
IL-1	NN	nmod	B-protein
.	.	punct	O

Positive	JJ	amod	O
and	CC	cc	O
negative	JJ	conj	O
regulation	NN	ROOT	O
of	IN	case	O
granulopoiesis	NN	nmod	O
by	IN	case	O
endogenous	JJ	amod	B-protein
RARalpha	NN	nmod	I-protein
.	.	punct	O

Acute	JJ	amod	O
promyelocytic	JJ	amod	O
leukemia	NN	nsubjpass	O
(	-LRB-	punct	O
APL	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
always	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
chromosomal	JJ	amod	O
translocations	NNS	nmod	O
that	WDT	nsubj	O
disrupt	VBP	acl:relcl	O
the	DT	det	O
retinoic	JJ	amod	B-DNA
acid	NN	compound	I-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
RARalpha	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	dobj	I-DNA
.	.	punct	O

Whether	IN	mark	O
these	DT	det	O
translocations	NNS	nsubj	O
relate	VBP	advcl	O
to	TO	case	O
a	DT	det	O
role	NN	nmod	O
for	IN	case	O
endogenous	JJ	amod	B-protein
RARalpha	NN	nmod	I-protein
in	IN	case	O
normal	JJ	amod	O
granulopoiesis	NN	nmod	O
remains	VBZ	ROOT	O
uncertain	JJ	xcomp	O
because	IN	mark	O
most	JJS	amod	O
studies	NNS	nsubj	O
addressing	VBG	acl	O
this	DT	det	O
question	NN	dobj	O
have	VBP	aux	O
used	VBN	advcl	O
non-physiological	JJ	amod	O
overexpression	NN	compound	O
systems	NNS	dobj	O
.	.	punct	O

Granulocyte	NN	compound	O
differentiation	NN	nsubjpass	O
in	IN	case	O
cells	NNS	nmod	O
derived	VBN	acl	O
from	IN	case	O
RARalpha-deficient	JJ	amod	O
(	-LRB-	punct	O
RARalpha	NN	dep	O
(	-LRB-	punct	O
-/-	CD	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
mice	NNS	nmod	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
and	CC	cc	O
evaluated	VBN	conj	O
in	IN	case	O
the	DT	det	O
context	NN	nmod	O
of	IN	case	O
agonist-bound	JJ	amod	B-protein
and	CC	cc	I-protein
ligand-free	JJ	conj	I-protein
RARalpha	NN	nmod	I-protein
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
RARalpha	NN	nsubj	B-protein
is	VBZ	cop	O
dispensable	JJ	ccomp	O
for	IN	case	O
granulopoiesis	NN	nmod	O
,	,	punct	O
as	IN	mark	O
RARalpha	NN	compound	O
(	-LRB-	punct	O
-/-	JJ	appos	O
)	-RRB-	punct	O
mice	NNS	nsubj	O
have	VBP	advcl	O
a	DT	det	O
normal	JJ	amod	B-cell_type
granulocyte	NN	compound	I-cell_type
population	NN	dobj	I-cell_type
despite	IN	case	O
an	DT	det	O
impaired	JJ	amod	O
ability	NN	nmod	O
to	TO	mark	O
respond	VB	acl	O
to	TO	case	O
retinoids	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
although	IN	mark	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
absolutely	RB	advmod	O
required	VBN	advcl	O
,	,	punct	O
RARalpha	NN	nsubj	B-protein
can	MD	aux	O
bidirectionally	RB	advmod	O
modulate	VB	ROOT	O
granulopoiesis	NN	dobj	O
.	.	punct	O

RARalpha	NN	nsubj	B-protein
stimulates	VBZ	ROOT	O
differentiation	NN	dobj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
exogenous	JJ	amod	O
retinoic	JJ	amod	O
acid	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
endogenous	JJ	amod	O
retinoids	NNS	compound	O
control	VBP	compound	O
granulopoiesis	NN	nsubj	O
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
as	IN	case	O
either	CC	cc:preconj	O
vitamin	NN	nmod:npmod	O
A-deficient	JJ	amod	O
mice	NNS	nmod	O
or	CC	cc	O
animals	NNS	conj	O
treated	VBN	acl	O
with	IN	case	O
an	DT	det	O
RAR	NN	compound	O
antagonist	NN	nmod	O
accumulate	VBP	ROOT	O
more	RBR	advmod	O
immature	JJ	amod	B-cell_type
granulocytes	NNS	dobj	I-cell_type
in	IN	case	O
their	PRP$	nmod:poss	O
bone	NN	compound	O
marrow	NN	nmod	O
.	.	punct	O

Conversely	RB	advmod	O
,	,	punct	O
RARalpha	NN	nsubj	B-protein
acts	VBZ	ROOT	O
to	TO	mark	O
limit	VB	xcomp	O
differentiation	NN	dobj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
ligand	NN	nmod	B-protein
because	IN	mark	O
granulocyte	NN	compound	B-cell_type
precursors	NNS	nsubj	I-cell_type
from	IN	case	O
RARalpha	NN	compound	O
(	-LRB-	punct	O
-/-	JJ	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	O
differentiate	VBP	advcl	O
earlier	RBR	advmod	O
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
block	NN	nsubj	O
in	IN	case	O
granulopoiesis	NN	nmod	O
exerted	VBN	acl	O
by	IN	case	O
RARalpha	NN	compound	B-protein
fusion	NN	compound	B-protein
proteins	NNS	nmod	I-protein
expressed	VBN	acl	O
in	IN	case	O
APL	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
may	MD	aux	O
correspond	VB	ROOT	O
to	TO	case	O
an	DT	det	O
amplification	NN	nmod	O
of	IN	case	O
a	DT	det	O
normal	JJ	amod	O
function	NN	nmod	O
of	IN	case	O
unliganded	JJ	amod	B-protein
RARalpha	NN	nmod	I-protein
.	.	punct	O

Expression	NN	ROOT	O
and	CC	cc	O
function	NN	conj	O
of	IN	case	O
a	DT	det	O
stem	NN	compound	B-DNA
cell	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
for	IN	case	O
the	DT	det	O
murine	JJ	amod	B-DNA
CBFalpha2	NN	compound	I-DNA
gene	NN	nmod	I-DNA
:	:	punct	O
distinct	JJ	amod	O
roles	NNS	dep	O
and	CC	cc	O
regulation	NN	conj	O
in	IN	case	O
natural	JJ	amod	B-cell_type
killer	NN	nmod	I-cell_type
and	CC	cc	I-cell_type
T	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
development	NN	conj	O
.	.	punct	O

The	DT	det	O
Runt	NN	compound	B-protein
family	NN	compound	I-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
CBFalpha2	NN	nsubjpass	B-protein
(	-LRB-	punct	O
AML1	NN	dep	B-protein
,	,	punct	O
PEBP2alphaB	NN	conj	B-protein
,	,	punct	O
or	CC	cc	O
Runx1	NN	conj	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
by	IN	case	O
hematopoietic	JJ	amod	B-cell_type
stem	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
expressed	VBN	conj	O
at	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
T-lineage	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	compound	I-cell_type
CBFalpha2	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
usually	RB	advmod	O
transcribed	VBN	ROOT	O
from	IN	case	O
a	DT	det	O
different	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
(	-LRB-	punct	O
distal	JJ	amod	B-DNA
promoter	NN	appos	I-DNA
)	-RRB-	punct	O
than	IN	case	O
in	IN	case	O
myeloid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
proximal	JJ	amod	B-DNA
promoter	NN	appos	I-DNA
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
developmental	JJ	amod	O
and	CC	cc	O
functional	JJ	conj	O
significance	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
promoter	NN	compound	O
switch	NN	nmod	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
known	VBN	conj	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
coding	VBG	amod	B-DNA
and	CC	cc	I-DNA
noncoding	JJ	conj	I-DNA
sequences	NNS	nsubjpass	I-DNA
of	IN	case	O
the	DT	det	O
distal	JJ	amod	B-DNA
5	CD	nummod	I-DNA
'	''	punct	I-DNA
end	NN	nmod	I-DNA
are	VBP	auxpass	O
highly	RB	advmod	O
conserved	VBN	ccomp	O
between	IN	case	O
the	DT	det	O
human	JJ	nmod	B-DNA
and	CC	cc	I-DNA
the	DT	det	I-DNA
murine	JJ	amod	I-DNA
genes	NNS	conj	I-DNA
,	,	punct	O
and	CC	cc	O
the	DT	det	O
distal	JJ	amod	B-DNA
promoter	NN	nsubj	I-DNA
is	VBZ	cop	O
responsible	JJ	conj	O
for	IN	case	O
the	DT	det	O
overwhelming	JJ	amod	O
majority	NN	nmod	O
of	IN	case	O
CBFalpha2	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
murine	JJ	amod	O
hematopoietic	JJ	amod	B-cell_type
stem	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Distal	JJ	amod	O
promoter	NN	compound	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
maintained	VBN	ROOT	O
throughout	IN	case	O
T	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
and	CC	cc	O
at	IN	case	O
lower	JJR	amod	O
levels	NNS	conj	O
in	IN	case	O
B	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
,	,	punct	O
but	CC	cc	O
downregulated	VBD	conj	O
in	IN	case	O
natural	JJ	amod	O
killer	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
.	.	punct	O

The	DT	det	O
distal	JJ	amod	B-DNA
N-terminal	JJ	amod	I-DNA
isoform	NN	nsubj	I-DNA
binds	VBZ	ROOT	O
to	TO	case	O
functionally	RB	advmod	O
important	JJ	amod	O
regulatory	JJ	amod	B-DNA
sites	NNS	nmod	I-DNA
from	IN	case	O
known	JJ	amod	O
target	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
with	IN	case	O
two-	CD	nmod	O
to	TO	dep	O
threefold	RB	dep	O
higher	JJR	amod	O
affinity	NN	dep	O
than	IN	case	O
the	DT	det	O
proximal	JJ	amod	B-DNA
N-terminal	JJ	amod	I-DNA
isoform	NN	nmod	I-DNA
.	.	punct	O

Neither	DT	det	O
full-length	JJ	amod	B-DNA
isoform	NN	nsubj	I-DNA
alters	VBZ	ROOT	O
growth	NN	dobj	O
of	IN	case	O
a	DT	det	O
myeloid	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
under	IN	case	O
nondifferentiating	JJ	compound	O
conditions	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
proximal	JJ	amod	B-DNA
isoform	NN	nsubj	I-DNA
selectively	RB	advmod	O
delays	VBZ	conj	O
mitotic	JJ	amod	O
arrest	NN	dobj	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
line	NN	nmod	O
under	IN	case	O
differentiating	VBG	amod	O
conditions	NNS	nmod	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
the	DT	det	O
generation	NN	nmod	O
of	IN	case	O
greater	JJR	amod	O
numbers	NNS	nmod	O
of	IN	case	O
neutrophils	NNS	nmod	B-cell_type
.	.	punct	O

Constitutive	JJ	amod	O
PI3-K	NN	compound	O
activity	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
survival	NN	conj	O
,	,	punct	O
of	IN	case	O
Theileria	FW	compound	B-cell_type
parva-transformed	JJ	amod	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Theileria	NNP	nsubj	O
is	VBZ	ROOT	O
an	DT	det	O
intracellular	JJ	amod	O
parasite	NN	attr	O
that	WDT	nsubj	O
causes	VBZ	acl:relcl	O
lymphoproliferative	JJ	amod	O
disorders	NNS	dobj	O
in	IN	case	O
cattle	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
infection	NN	nsubj	O
of	IN	case	O
leucocytes	NNS	nmod	B-cell_type
induces	VBZ	conj	O
a	DT	det	O
transformed	VBN	amod	O
phenotype	NN	dobj	O
similar	JJ	amod	O
to	TO	case	O
tumour	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanisms	NNS	nsubjpass	O
by	IN	case	O
which	WDT	nmod	O
the	DT	det	O
parasite	NN	nsubj	O
induces	VBZ	acl:relcl	O
this	DT	det	O
phenotype	NN	dobj	O
are	VBP	auxpass	O
not	RB	neg	O
understood	VBN	conj	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
infected	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nsubj	I-cell_type
display	VBP	ccomp	O
constitutive	JJ	amod	O
phosphoinositide	NN	compound	O
3-kinase	NN	compound	O
(	-LRB-	punct	O
PI3-K	NN	appos	O
)	-RRB-	punct	O
activity	NN	dobj	O
,	,	punct	O
which	WDT	nsubj	O
appears	VBZ	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
necessary	JJ	xcomp	O
for	IN	case	O
proliferation	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
survival	NN	conj	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
one	CD	nummod	O
mechanism	NN	nsubj	O
by	IN	case	O
which	WDT	nmod	O
PI3-K	NN	nsubj	B-protein
mediates	VBZ	acl:relcl	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
infected	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
is	VBZ	cop	O
through	IN	case	O
the	DT	det	O
induction	NN	ccomp	O
of	IN	case	O
a	DT	det	O
granulocyte-monocyte	JJ	compound	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	O
GM-CSF	NN	compound	B-protein
)	-RRB-	punct	O
-dependent	JJ	amod	O
autocrine	JJ	compound	O
loop	NN	nmod	O
.	.	punct	O

PI3-K	NN	compound	B-protein
induction	NN	nsubj	O
of	IN	case	O
GM-CSF	NN	nmod	B-protein
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
at	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
level	NN	xcomp	O
and	CC	cc	O
,	,	punct	O
consistently	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	parataxis	O
that	IN	mark	O
PI3-K	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
also	RB	advmod	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
constitutive	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
AP-1	NN	nmod	B-protein
and	CC	cc	O
NF-kappaB	NN	conj	B-protein
,	,	punct	O
which	WDT	nsubj	O
characterizes	VBZ	acl:relcl	O
Theileria-infected	JJ	amod	O
leucocytes	NNS	dobj	B-cell_type
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
highlight	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
strategy	NN	dobj	O
exploited	VBN	acl	O
by	IN	case	O
the	DT	det	O
intracellular	JJ	amod	O
parasite	NN	nmod	O
Theileria	NNP	dep	O
to	TO	mark	O
induce	VB	xcomp	O
continued	VBN	amod	O
proliferation	NN	dobj	O
of	IN	case	O
its	PRP$	nmod:poss	O
host	NN	compound	B-cell_type
leucocyte	NN	nmod	I-cell_type
.	.	punct	O

Lymphokine	NN	compound	B-protein
dependence	NN	ROOT	O
of	IN	case	O
STAT3	NN	compound	O
activation	NN	nmod	O
produced	VBN	acl	O
by	IN	case	O
surface	NN	compound	O
immunoglobulin	NN	compound	O
cross-linking	NN	nmod	O
and	CC	cc	O
by	IN	case	O
phorbol	NN	compound	O
ester	NN	conj	O
plus	CC	cc	O
calcium	NN	compound	O
ionophore	NN	compound	O
treatment	NN	conj	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Stimulation	NN	nsubjpass	O
of	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
surface	NN	compound	B-protein
immunoglobulin	NN	compound	I-protein
(	-LRB-	punct	O
sIg	NN	appos	B-protein
)	-RRB-	punct	O
triggering	NN	nmod	O
,	,	punct	O
or	CC	cc	O
through	IN	case	O
the	DT	det	O
mitogenic	JJ	amod	O
combination	NN	conj	O
of	IN	case	O
phorbol	NN	compound	O
ester	NN	nmod	O
and	CC	cc	O
calcium	NN	compound	O
ionophore	NN	conj	O
,	,	punct	O
is	VBZ	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
STAT	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubjpass	O
responsible	JJ	amod	O
for	IN	case	O
the	DT	det	O
delayed	VBN	amod	O
nuclear	JJ	amod	O
accumulation	NN	nmod	O
of	IN	case	O
phosphorylated	VBN	amod	B-protein
STAT3	NN	nmod	I-protein
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
detail	NN	nmod	O
,	,	punct	O
focusing	VBG	advcl	O
on	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
B	NN	compound	B-protein
cell-derived	JJ	amod	I-protein
lymphokines	NNS	nmod	I-protein
.	.	punct	O

sIg	JJ	compound	B-protein
-induced	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
STAT3	NN	nmod	B-protein
was	VBD	auxpass	O
partially	RB	advmod	O
inhibited	VBN	ROOT	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
obtained	VBN	acl	O
from	IN	case	O
IL-6-	NN	amod	O
or	CC	cc	O
IL-10-deficient	JJ	conj	O
mice	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
was	VBD	auxpass	O
partially	RB	advmod	O
blocked	VBN	conj	O
by	IN	case	O
neutralizing	VBG	amod	B-protein
antibodies	NNS	nmod	I-protein
directed	VBN	acl	O
against	IN	case	O
either	DT	nmod	O
of	IN	case	O
these	DT	det	O
lymphokines	NNS	nmod	B-protein
.	.	punct	O

sIg	NN	compound	B-protein
-induced	JJ	amod	O
STAT3	NN	compound	O
activation	NN	nsubjpass	O
was	VBD	auxpass	O
completely	RB	advmod	O
inhibited	VBN	ROOT	O
by	IN	mark	O
combining	VBG	advcl	O
IL-6-	NN	amod	B-protein
and	CC	cc	I-protein
IL-10-specific	JJ	conj	I-protein
neutralizing	VBG	compound	I-protein
antibodies	NNS	dobj	I-protein
,	,	punct	O
or	CC	cc	O
by	IN	mark	O
adding	VBG	conj	O
individual	JJ	amod	O
neutralizing	VBG	amod	B-protein
antibodies	NNS	dobj	I-protein
to	TO	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
obtained	VBN	acl	O
from	IN	case	O
lymphokine-deficient	JJ	amod	O
animals	NNS	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
IL-10	NN	nsubj	B-protein
alone	RB	advmod	O
appeared	VBD	ROOT	O
to	TO	mark	O
account	VB	xcomp	O
for	IN	case	O
STAT3	NN	compound	O
activation	NN	nmod	O
resulting	VBG	acl	O
from	IN	case	O
B	NN	compound	O
cell	NN	compound	O
stimulation	NN	nmod	O
with	IN	case	O
phorbol	NN	compound	O
ester	NN	nmod	O
and	CC	cc	O
calcium	NN	compound	O
ionophore	NN	conj	O
.	.	punct	O

In	IN	prep	O
keeping	VBG	pcomp	O
with	IN	case	O
these	DT	det	O
results	NNS	nmod	O
,	,	punct	O
soluble	JJ	amod	O
IL-6	NN	nsubjpass	B-protein
and	CC	cc	O
IL-10	NN	conj	B-protein
were	VBD	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
supernatant	JJ	amod	O
fluid	NN	nmod	O
obtained	VBN	acl	O
from	IN	case	O
stimulated	VBN	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	det	O
work	NN	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
a	DT	det	O
lymphokine	NN	compound	O
pathway	NN	nsubj	O
is	VBZ	cop	O
responsible	JJ	ccomp	O
for	IN	case	O
STAT3	NN	compound	O
activation	NN	nmod	O
that	WDT	nsubj	O
occurs	VBZ	acl:relcl	O
late	RB	advmod	O
after	IN	case	O
B	NN	compound	O
cell	NN	compound	O
stimulation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
points	VBZ	conj	O
out	RP	dep	O
differences	NNS	dobj	O
in	IN	case	O
B	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
that	WDT	nsubj	O
result	VBP	acl:relcl	O
from	IN	case	O
stimulation	NN	nmod	O
through	IN	case	O
the	DT	det	O
antigen	NN	compound	B-protein
receptor	NN	nmod	I-protein
and	CC	cc	O
through	IN	case	O
pharmacological	JJ	amod	O
mimicry	NN	conj	O
of	IN	case	O
signaling	VBG	compound	B-protein
mediators	NNS	nmod	I-protein
.	.	punct	O

Transcription	NN	compound	B-protein
factor	NN	compound	I-protein
AP-4	NN	nsubj	I-protein
is	VBZ	cop	O
a	DT	det	O
ligand	NN	ROOT	B-protein
for	IN	case	O
immunoglobulin-kappa	NN	compound	B-DNA
promoter	NN	compound	I-DNA
E-box	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
.	.	punct	O

Immunoglobulin	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
Ig	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
-kappa	NN	compound	I-DNA
promoters	NNS	nsubj	I-DNA
from	IN	case	O
humans	NNS	nmod	O
and	CC	cc	O
mice	NNS	conj	O
share	VBP	ROOT	O
conserved	VBN	amod	B-DNA
sequences	NNS	dobj	I-DNA
.	.	punct	O

The	DT	det	O
octamer	NN	compound	B-DNA
element	NN	nsubj	I-DNA
is	VBZ	cop	O
common	JJ	ROOT	O
to	TO	case	O
all	DT	det	O
Ig	NN	compound	B-DNA
promoters	NNS	nmod	I-DNA
and	CC	cc	O
pivotal	JJ	conj	O
for	IN	case	O
their	PRP$	nmod:poss	O
function	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
other	JJ	amod	O
conserved	VBN	amod	B-DNA
sequence	NN	compound	I-DNA
motifs	NNS	nsubjpass	I-DNA
,	,	punct	O
that	WDT	nsubj	O
differ	VBP	acl:relcl	O
between	IN	case	O
Ig	NN	compound	B-DNA
variable	JJ	amod	I-DNA
gene	NN	compound	I-DNA
families	NNS	nmod	I-DNA
,	,	punct	O
are	VBP	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
normal	JJ	amod	O
promoter	NN	compound	O
function	NN	nmod	O
.	.	punct	O

These	DT	det	O
conserved	VBN	amod	O
motifs	NNS	nsubj	O
do	VBP	aux	O
not	RB	neg	O
stimulate	VB	ROOT	O
transcription	NN	dobj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
an	DT	det	O
octamer	NN	nmod	B-DNA
.	.	punct	O

One	CD	nummod	O
example	NN	nsubj	O
is	VBZ	ROOT	O
an	DT	det	O
E-box	NN	attr	B-DNA
of	IN	case	O
the	DT	det	O
E47/E12	NN	compound	B-DNA
type	NN	nmod	I-DNA
(	-LRB-	punct	I-DNA
5'-CAGCTG-3	NN	appos	I-DNA
'	''	punct	I-DNA
)	-RRB-	punct	I-DNA
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
found	VBN	acl:relcl	O
in	IN	case	O
all	DT	det	O
promoters	NNS	nmod	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
and	CC	cc	I-DNA
murine	JJ	conj	I-DNA
Ig-kappa	NN	compound	I-DNA
gene	NN	compound	I-DNA
subgroups/families	NNS	nmod	I-DNA
,	,	punct	O
with	IN	case	O
the	DT	det	O
exception	NN	advcl	O
of	IN	case	O
subgroups	NNS	nmod	O
II	CD	nummod	O
and	CC	cc	O
VI	NN	conj	O
and	CC	cc	O
their	PRP$	nmod:poss	O
related	JJ	amod	O
murine	JJ	amod	B-DNA
families	NNS	conj	I-DNA
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
ubiquitously	RB	advmod	O
expressed	VBN	amod	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
AP-4	NN	nsubj	I-protein
,	,	punct	O
and	CC	cc	O
not	RB	cc	O
E47	NN	conj	B-protein
,	,	punct	O
interacts	VBZ	ccomp	O
specifically	RB	advmod	O
with	IN	case	O
the	DT	det	O
kappa	NN	compound	B-DNA
promoter	NN	compound	I-DNA
E-boxes	NNS	nmod	I-DNA
when	WRB	advmod	O
tested	VBN	advcl	O
in	IN	case	O
electrophoretic	JJ	amod	O
mobility-shift	JJ	amod	O
assays	NNS	nmod	O
using	VBG	acl	O
nuclear	JJ	amod	O
extracts	NNS	dobj	O
derived	VBN	acl	O
from	IN	case	O
human	JJ	amod	B-cell_line
and	CC	cc	I-cell_line
murine	JJ	conj	I-cell_line
B-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
AP-4	NN	nsubj	B-protein
,	,	punct	O
unlike	IN	case	O
E47	NN	nmod	B-protein
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
act	VB	ROOT	O
as	IN	case	O
a	DT	det	O
transactivator	NN	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
in	IN	case	O
agreement	NN	acl:relcl	O
with	IN	case	O
previous	JJ	amod	O
studies	NNS	nmod	O
on	IN	case	O
intact	JJ	amod	O
kappa	NN	compound	B-DNA
promoters	NNS	nmod	I-DNA
,	,	punct	O
showing	VBG	xcomp	O
that	IN	mark	O
transcription	NN	nsubj	O
is	VBZ	cop	O
absent	JJ	ccomp	O
when	WRB	advmod	O
the	DT	det	O
octamer	NN	compound	B-DNA
element	NN	nsubjpass	I-DNA
has	VBZ	aux	O
been	VBN	auxpass	O
mutated	VBN	advcl	O
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
these	DT	det	O
data	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
conservation	NN	conj	O
of	IN	case	O
the	DT	det	O
5'-CAGCTG-3	NN	nmod:poss	B-DNA
'	POS	punct	I-DNA
motif	NN	nmod	I-DNA
among	IN	case	O
human	JJ	amod	B-DNA
and	CC	cc	I-DNA
murine	JJ	conj	I-DNA
kappa	NN	compound	I-DNA
promoters	NNS	nmod	I-DNA
,	,	punct	O
we	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
AP-4	NN	nsubj	B-protein
is	VBZ	cop	O
the	DT	det	O
major	JJ	amod	B-protein
ligand	NN	ccomp	I-protein
for	IN	case	O
Ig-kappa	NN	compound	B-DNA
promoter	NN	compound	I-DNA
E-boxes	NNS	nmod	I-DNA
.	.	punct	O

A	DT	det	O
16-mer	JJ	amod	O
peptide	NN	nsubj	O
(	-LRB-	punct	O
RQIKIWFQNRRMKWKK	NN	appos	O
)	-RRB-	punct	O
from	IN	case	O
antennapedia	NN	nmod	O
preferentially	RB	advmod	O
targets	VBZ	ROOT	O
the	DT	det	O
Class	NN	compound	O
I	CD	compound	O
pathway	NN	dobj	O
.	.	punct	O

Translocation	NN	nsubj	O
of	IN	case	O
antigenic	JJ	amod	O
peptides	NNS	nmod	O
into	IN	case	O
the	DT	det	O
cytosol	NN	nmod	O
of	IN	case	O
antigen	NN	compound	B-cell_type
presenting	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
facilitates	VBZ	ROOT	O
proteosomal	JJ	amod	O
processing	NN	dobj	O
and	CC	cc	O
loading	VBG	conj	O
into	IN	case	O
Class	NN	compound	B-protein
I	CD	nummod	I-protein
molecules	NNS	nmod	I-protein
for	IN	case	O
MHC	NN	compound	O
presentation	NN	nmod	O
on	IN	case	O
the	DT	det	O
cell	NN	compound	O
surface	NN	nmod	O
.	.	punct	O

The	DT	det	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
domain	NN	nsubjpass	I-protein
of	IN	case	O
the	DT	det	O
Drosophila	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
Antennapedia	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
60	CD	nummod	B-protein
amino	NN	compound	I-protein
acid	NN	compound	I-protein
protein	NN	appos	I-protein
,	,	punct	O
is	VBZ	auxpass	O
rapidly	RB	advmod	O
taken	VBN	ROOT	O
up	RP	advmod	O
by	IN	case	O
cells	NNS	nmod	O
and	CC	cc	O
has	VBZ	aux	O
been	VBN	auxpass	O
fused	VBN	conj	O
to	TO	case	O
selected	VBN	amod	O
antigens	NNS	nmod	B-protein
to	TO	mark	O
enhance	VB	xcomp	O
their	PRP$	nmod:poss	O
immunogenicity	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
16	CD	nummod	O
amino	NN	compound	O
acid	NN	compound	O
peptide	NN	nsubj	O
from	IN	case	O
antennapedia	NN	nmod	O
can	MD	aux	O
facilitate	VB	ccomp	O
the	DT	det	O
cytoplasmic	JJ	amod	O
uptake	NN	dobj	O
of	IN	case	O
CTL	NN	compound	O
epitope	NN	compound	O
9-mer	JJ	compound	O
peptides	NNS	nmod	O
.	.	punct	O

Synthetic	JJ	amod	O
peptides	NNS	nsubjpass	O
were	VBD	auxpass	O
made	VBN	ROOT	O
containing	VBG	xcomp	O
the	DT	det	O
16-mer	JJ	amod	O
antennapedia	NN	compound	O
peptide	NN	dobj	O
linked	VBN	acl	O
in	IN	case	O
tandem	JJ	nmod	O
to	TO	case	O
the	DT	det	O
ovalbumin	NN	compound	O
SIINFEKL	NN	compound	O
CTL	NN	compound	O
peptide	NN	dep	O
.	.	punct	O

The	DT	det	O
peptide	NN	compound	O
complex	NN	nsubjpass	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
rapidly	RB	advmod	O
internalise	VB	xcomp	O
into	IN	case	O
APCs	NNS	nmod	B-cell_type
by	IN	case	O
confocal	JJ	amod	O
microscopy	NN	nmod	O
.	.	punct	O

This	DT	det	O
peptide	NN	nsubj	O
induced	VBD	ROOT	O
CTL	NN	dobj	B-cell_type
in	IN	case	O
C57BL/6	NN	compound	O
mice	NNS	nmod	O
and	CC	cc	O
protected	VBD	conj	O
them	PRP	dobj	O
against	IN	case	O
growth	NN	nmod	O
of	IN	case	O
an	DT	det	O
ovalbumin	NN	nmod	B-cell_line
expressing	VBG	acl	I-cell_line
tumour	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	dobj	I-cell_line
(	-LRB-	punct	O
E.G7-OVA	NN	appos	B-cell_line
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
the	DT	det	O
hybrid	NN	compound	O
peptide	NN	nmod	O
to	TO	mark	O
be	VB	auxpass	O
processed	VBN	acl	O
and	CC	cc	O
presented	VBN	conj	O
by	IN	case	O
APCs	NNS	nmod	B-cell_type
was	VBD	cop	O
similar	JJ	ROOT	O
,	,	punct	O
whether	IN	mark	O
the	DT	det	O
SIINFEKL	NN	compound	O
sequence	NN	nsubjpass	O
was	VBD	auxpass	O
appended	VBN	advcl	O
at	IN	case	O
the	DT	det	O
C-terminus	NN	nmod	B-protein
or	CC	cc	O
N-terminus	NN	conj	B-protein
of	IN	case	O
the	DT	det	O
Antennapedia	NN	compound	O
peptide	NN	nmod	O
.	.	punct	O

The	DT	det	O
production	NN	nsubj	O
of	IN	case	O
synthetic	JJ	amod	O
peptides	NNS	nmod	O
containing	VBG	acl	O
other	JJ	amod	O
CTL	NN	compound	O
peptide	NN	compound	O
epitopes	NNS	dobj	O
may	MD	aux	O
be	VB	cop	O
useful	JJ	ROOT	O
for	IN	case	O
priming	VBG	amod	O
CTLs	NNS	nmod	B-cell_type
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O

Bone	NN	compound	B-cell_type
marrow	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
promote	VBP	ROOT	O
TH2	NN	compound	O
polarization	NN	dobj	O
and	CC	cc	O
inhibit	VBP	conj	O
virus-specific	JJ	amod	O
CTL	NN	compound	O
generation	NN	dobj	O
.	.	punct	O

This	DT	det	O
laboratory	NN	nsubj	O
recently	RB	advmod	O
reported	VBD	ROOT	O
that	IN	mark	O
human	JJ	amod	B-cell_type
bone	NN	compound	I-cell_type
marrow	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
(	-LRB-	punct	O
BMC	NN	appos	B-cell_type
)	-RRB-	punct	O
inhibit	VBP	ccomp	O
the	DT	det	O
generation	NN	dobj	O
of	IN	case	O
virus-specific	JJ	amod	B-cell_type
CTL	NN	nmod	I-cell_type
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O

The	DT	det	O
culture	NN	compound	O
supernatants	NNS	nsubj	O
contained	VBD	ROOT	O
increased	VBN	amod	O
levels	NNS	dobj	O
of	IN	case	O
prostaglandin	NN	compound	B-protein
E	NN	nmod	I-protein
(	-LRB-	punct	I-protein
2	CD	appos	I-protein
)	-RRB-	punct	I-protein
(	-LRB-	punct	I-protein
PGE	NN	appos	I-protein
(	-LRB-	punct	I-protein
2	CD	appos	I-protein
)	-RRB-	punct	I-protein
)	-RRB-	punct	I-protein
(	-LRB-	punct	O
shown	VBN	dep	O
to	TO	mark	O
favor	VB	xcomp	O
TH2	NN	compound	O
cell	NN	compound	O
development	NN	dobj	O
)	-RRB-	punct	O
and	CC	cc	O
also	RB	advmod	O
inhibited	VBD	conj	O
EBV-CTL	NN	compound	O
effector	NN	compound	O
cell	NN	compound	O
development	NN	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
obtained	VBD	ROOT	O
PBL	NN	dobj	B-cell_type
from	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	compound	O
(	-LRB-	punct	O
EBV	NN	appos	O
)	-RRB-	punct	O
IgG	NN	compound	B-protein
antibody	NN	compound	I-protein
positive	JJ	amod	O
kidney	NN	compound	O
transplant	JJ	amod	O
recipients	NNS	nmod	O
(	-LRB-	punct	O
R	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
living-related	JJ	amod	O
donors	NNS	conj	O
(	-LRB-	punct	O
LRD	NN	appos	O
)	-RRB-	punct	O
one	CD	nummod	O
year	NN	npadvmod	O
after	IN	case	O
renal	JJ	amod	O
transplantation	NN	pobj	O
.	.	punct	O

EBV-specific	JJ	amod	B-cell_type
CTL	NN	nsubjpass	I-cell_type
were	VBD	auxpass	O
then	RB	advmod	O
generated	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
by	IN	mark	O
stimulating	VBG	advcl	O
PBL	NN	dobj	B-cell_type
with	IN	case	O
autologous	JJ	amod	O
EBV-transformed	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
EBV-B	NN	appos	B-cell_type
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
or	CC	cc	O
absence	NN	conj	O
of	IN	case	O
autologous	JJ	amod	B-cell_type
BMC	NN	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
addition	NN	nsubj	O
of	IN	case	O
BMC	NN	nmod	B-cell_type
to	TO	case	O
the	DT	det	O
EBV-CTL	NN	compound	B-cell_type
generation	NN	compound	I-cell_type
cultures	NNS	nmod	I-cell_type
increased	VBD	ROOT	O
the	DT	det	O
intracellular	JJ	amod	O
expression	NN	dobj	O
in	IN	case	O
CD3+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
IL-4	NN	nmod	B-protein
,	,	punct	I-protein
-5	CD	conj	I-protein
,	,	punct	I-protein
-6	CD	conj	I-protein
,	,	punct	I-protein
-10	CD	conj	I-protein
,	,	punct	I-protein
and	CC	cc	I-protein
-13	CD	conj	I-protein
.	.	punct	O

These	DT	det	O
CD3+	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
also	RB	advmod	O
expressed	VBD	ROOT	O
increased	VBN	amod	O
levels	NNS	dobj	O
of	IN	case	O
the	DT	det	O
TH2	NN	compound	B-protein
associated	JJ	amod	I-protein
receptor	NN	compound	I-protein
CCR3	NN	nmod	I-protein
.	.	punct	O

Inhibition	NN	nsubjpass	O
was	VBD	auxpass	O
even	RB	advmod	O
observed	VBN	ROOT	O
by	IN	mark	O
preparing	VBG	advcl	O
EBV-CTL	NN	nsubj	B-cell_type
generating	NN	ccomp	I-cell_type
cultures	NNS	dobj	I-cell_type
in	IN	case	O
trans-wells	NNS	nmod	O
that	WDT	nsubj	O
separated	VBD	acl:relcl	O
the	DT	det	O
autologous	JJ	amod	B-cell_type
BMC	NN	dobj	I-cell_type
from	IN	case	O
the	DT	det	O
PBL	NN	nmod	B-cell_type
+	CC	cc	O
EBV-B	NN	conj	B-cell_type
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
then	RB	advmod	O
observed	VBN	ROOT	O
that	IN	mark	O
CD3+	JJ	amod	B-cell_type
cells	NNS	nsubjpass	I-cell_type
obtained	VBN	acl	O
after	IN	case	O
7	CD	nummod	O
days	NNS	nmod	O
of	IN	case	O
culture	NN	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
autologous	JJ	amod	B-cell_type
BMC	NN	nmod	I-cell_type
could	MD	aux	O
be	VB	auxpass	O
used	VBN	ccomp	O
as	IN	case	O
inhibitors	NNS	nmod	O
of	IN	case	O
EBV-CTL	NN	compound	O
generation	NN	nmod	O
.	.	punct	O

Protein	NN	compound	B-protein
Kinase	NN	compound	I-protein
A	NN	nsubjpass	I-protein
(	-LRB-	punct	O
PKA	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
cAMP	NN	compound	B-protein
kinase	NN	appos	I-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
upregulation	NN	nmod	O
of	IN	case	O
TH2	NN	compound	B-protein
cytokine	NN	compound	I-protein
activity	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
in	IN	case	O
EBV-CTL	NN	compound	B-cell_type
cultures	NNS	nmod	I-cell_type
by	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
BMC	NN	nmod	B-cell_type
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
IL-4-mediated	JJ	amod	O
signal	NN	compound	O
transduction	NN	nsubjpass	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
transcription	NN	compound	O
(	-LRB-	punct	O
STAT-6	NN	appos	B-protein
)	-RRB-	punct	O
phosphorylation	NN	nmod	O
was	VBD	auxpass	O
slightly	RB	advmod	O
increased	VBN	ROOT	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
BMC	NN	compound	B-cell_type
inhibition	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
soluble	JJ	amod	B-protein
factors	NNS	nmod	I-protein
(	-LRB-	punct	O
cytokines	NNS	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
that	IN	mark	O
cell-cell	JJ	amod	O
contact	NN	nsubjpass	O
in	IN	case	O
this	DT	det	O
autologous	JJ	amod	O
system	NN	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
required	VBN	conj	O
,	,	punct	O
so	IN	mark	O
that	IN	mark	O
BMC	NN	nsubj	B-cell_type
(	-LRB-	punct	O
at	IN	advmod	O
least	JJS	advmod	O
partially	RB	cc	O
,	,	punct	O
via	IN	case	O
cytokine	NN	compound	O
production	NN	appos	O
)	-RRB-	punct	O
promote	VBP	advcl	O
TH2	NN	compound	O
polarization	NN	dobj	O
in	IN	case	O
culture	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
TH2	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
induced	VBN	acl	O
by	IN	mark	O
culturing	VBG	nmod	O
with	IN	case	O
autologous	JJ	amod	B-cell_type
BMC	NN	nmod	I-cell_type
directly	RB	advmod	O
inhibit	VBP	ROOT	O
EBV-CTL	NN	compound	O
generation	NN	dobj	O
,	,	punct	O
and	CC	cc	O
TH2	NN	nmod:npmod	B-protein
associated	VBD	amod	O
PKA	NN	nsubjpass	B-protein
,	,	punct	O
CCR3	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
STAT-6	NN	compound	B-protein
phosphorylation	NN	conj	O
are	VBP	auxpass	O
enhanced	VBN	conj	O
by	IN	case	O
BMC	NN	nmod	B-cell_type
.	.	punct	O

Reduction	NN	ROOT	O
in	IN	case	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	nmod	I-protein
Pax-5a	NN	dep	B-protein
in	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
of	IN	case	O
aged	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

Aging	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
intrinsic	JJ	amod	O
changes	NNS	nmod	O
of	IN	case	O
the	DT	det	O
humoral	JJ	amod	O
immune	JJ	amod	O
response	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
lead	VB	acl:relcl	O
to	TO	case	O
an	DT	det	O
increased	VBN	amod	O
occurrence	NN	nmod	O
of	IN	case	O
autoimmune	JJ	amod	O
disorders	NNS	nmod	O
and	CC	cc	O
pathogenic	JJ	amod	O
susceptibility	NN	conj	O
.	.	punct	O

The	DT	det	O
transcription	NN	compound	B-protein
factor	NN	nsubj	I-protein
Pax-5	NN	dep	B-protein
is	VBZ	cop	O
a	DT	det	O
key	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
B	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
.	.	punct	O

Pax-5a/B	NN	compound	B-protein
cell-specific	JJ	amod	I-protein
activator	NN	compound	I-protein
protein	NN	nsubj	I-protein
and	CC	cc	O
an	DT	det	O
alternatively	RB	advmod	B-protein
spliced	VBN	amod	I-protein
isoform	NN	conj	I-protein
,	,	punct	I-protein
Pax-5d	NN	appos	I-protein
,	,	punct	O
may	MD	aux	O
have	VB	ROOT	O
opposing	VBG	amod	O
functions	NNS	dobj	O
in	IN	case	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
due	JJ	case	O
to	TO	case	O
the	DT	det	O
lack	NN	nmod	O
of	IN	case	O
a	DT	det	O
transactivation	NN	compound	B-protein
domain	NN	nmod	I-protein
in	IN	case	O
Pax-5d	NN	nmod	B-protein
.	.	punct	O

To	TO	mark	O
study	VB	advcl	O
B	NN	nmod:npmod	B-cell_type
cell	NN	nmod:npmod	I-cell_type
-specific	JJ	amod	O
changes	NNS	dobj	O
that	WDT	nsubj	O
occur	VBP	acl:relcl	O
during	IN	case	O
the	DT	det	O
aging	NN	compound	O
process	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
expression	NN	compound	O
patterns	NNS	dobj	O
of	IN	case	O
Pax-5a	NN	nmod	B-protein
and	CC	cc	I-protein
5d	NN	conj	I-protein
in	IN	case	O
mature	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
young	JJ	amod	O
and	CC	cc	O
aged	JJ	conj	O
mice	NNS	nmod	O
.	.	punct	O

RNase	NN	compound	O
protection	NN	compound	O
assays	NNS	nsubj	O
showed	VBD	ROOT	O
a	DT	det	O
similar	JJ	amod	O
transcriptional	JJ	amod	O
pattern	NN	dobj	O
for	IN	case	O
both	CC	det	O
age	NN	compound	O
groups	NNS	nmod	O
that	WDT	nsubj	O
indicates	VBZ	acl:relcl	O
that	IN	mark	O
aging	NN	nsubj	O
has	VBZ	ccomp	O
no	DT	neg	O
affect	NN	dobj	O
on	IN	case	O
transcription	NN	compound	O
initiation	NN	nmod	O
or	CC	cc	O
alternative	JJ	amod	O
splicing	NN	conj	O
for	IN	case	O
either	DT	det	O
isoform	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
reduction	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
Pax-5a	NN	nmod	B-protein
but	CC	cc	O
not	RB	cc	O
Pax-5d	JJ	compound	B-protein
protein	NN	conj	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
aged	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
while	IN	mark	O
Western	NN	compound	O
blot	NN	compound	O
analyses	NNS	nsubj	O
showed	VBD	advcl	O
that	IN	mark	O
similar	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
Pax-5a	NN	nmod	B-protein
and	CC	cc	I-protein
5d	NN	conj	I-protein
proteins	NNS	dep	O
were	VBD	cop	O
present	JJ	ccomp	O
in	IN	case	O
both	DT	det	O
age	NN	compound	O
groups	NNS	nmod	O
.	.	punct	O

The	DT	det	O
observed	VBN	amod	O
decrease	NN	nsubj	O
in	IN	case	O
Pax-5a	JJ	compound	B-protein
binding	NN	compound	O
activity	NN	nmod	O
correlated	VBD	ROOT	O
with	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
expression	NN	nmod	O
of	IN	case	O
two	CD	nummod	O
Pax-5	NN	compound	B-DNA
target	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
aged	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
Ig	NN	compound	B-protein
J	NN	compound	I-protein
chain	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
secreted	JJ	amod	O
form	NN	conj	O
of	IN	case	O
Ig	NN	compound	B-protein
mu	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
are	VBP	auxpass	O
both	DT	dep	O
known	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
suppressed	VBN	xcomp	O
by	IN	case	O
Pax-5a	NN	nmod	B-protein
in	IN	case	O
mature	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
were	VBD	auxpass	O
increased	VBN	conj	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
aged	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
studies	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
changes	NNS	nsubj	O
associated	VBN	acl	O
with	IN	case	O
the	DT	det	O
aging	VBG	compound	O
phenotype	NN	nmod	O
cause	VBP	ccomp	O
posttranslational	JJ	amod	O
modification	NN	compound	O
(	-LRB-	punct	O
s	NNS	dobj	O
)	-RRB-	punct	O
of	IN	case	O
Pax-5a	NN	nmod	B-protein
but	CC	cc	O
not	RB	cc	O
Pax-5d	JJ	conj	B-protein
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
lead	VB	acl:relcl	O
to	TO	case	O
an	DT	det	O
abnormal	JJ	amod	O
B	NN	compound	O
cell	NN	compound	O
phenotype	NN	nmod	O
in	IN	case	O
aged	JJ	amod	O
mice	NNS	nmod	O
,	,	punct	O
associated	VBN	acl	O
with	IN	case	O
elevated	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
J	NN	compound	B-protein
chain	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
secretion	NN	conj	O
of	IN	case	O
IgM	NN	nmod	B-protein

NF-kappa	NN	compound	B-protein
B/Rel	NN	compound	I-protein
participation	NN	ROOT	O
in	IN	case	O
the	DT	det	O
lymphokine-dependent	JJ	amod	O
proliferation	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Proliferative	JJ	amod	O
responses	NNS	nsubj	O
of	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
IL-2	NN	nmod	B-protein
and	CC	cc	O
IL-4	NN	conj	B-protein
depend	VBP	ROOT	O
on	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanism	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubjpass	O
)	-RRB-	punct	O
by	IN	case	O
which	WDT	nmod	O
activation	NN	nsubj	O
enhances	VBZ	acl:relcl	O
cellular	JJ	amod	O
competence	NN	dobj	O
to	TO	mark	O
respond	VB	xcomp	O
to	TO	case	O
cytokines	NNS	nmod	B-protein
is	VBZ	auxpass	O
not	RB	neg	O
fully	RB	advmod	O
understood	VBN	conj	O
.	.	punct	O

The	DT	det	O
NF-kappaB/Rel	NN	compound	B-protein
family	NN	nsubj	I-protein
represents	VBZ	ROOT	O
one	CD	nummod	O
signal	NN	compound	O
transduction	NN	compound	O
pathway	NN	dobj	O
induced	VBN	acl	O
during	IN	case	O
such	JJ	amod	O
activation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
that	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
through	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
an	DT	det	O
IkappaBalpha	NN	nmod	B-protein
(	-LRB-	punct	O
inhibitory	JJ	amod	B-protein
protein	NN	dep	I-protein
that	WDT	nsubj	O
dissociates	VBZ	nsubj	O
from	IN	case	O
NF-kappaB	NN	nmod	B-protein
)	-RRB-	punct	O
mutant	JJ	amod	O
refractory	JJ	acl:relcl	O
to	TO	case	O
signal-induced	JJ	amod	O
degradation	NN	nmod	O
(	-LRB-	punct	O
IkappaBalpha	NN	dep	B-protein
(	-LRB-	punct	I-protein
DeltaN	NN	appos	I-protein
)	-RRB-	punct	I-protein
)	-RRB-	punct	O
interfered	VBD	ccomp	O
with	IN	case	O
the	DT	det	O
acquisition	NN	nmod	O
of	IN	case	O
competence	NN	nmod	O
to	TO	mark	O
proliferate	VB	acl	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
IL-4	NN	nmod	B-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
IL-2	NN	conj	B-protein
.	.	punct	O

Thymocytes	NNS	nsubj	B-cell_type
and	CC	cc	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
from	IN	case	O
IkappaBalpha	NN	compound	B-protein
(	-LRB-	punct	I-protein
DeltaN	NN	compound	I-protein
)	-RRB-	punct	I-protein
transgenic	JJ	amod	O
mice	NNS	nmod	O
expressed	VBD	ROOT	O
normal	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
IL-2R	NN	compound	B-protein
subunits	NNS	nmod	I-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
transgenic	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
exhibited	VBD	ROOT	O
a	DT	det	O
dramatic	JJ	amod	O
defect	NN	dobj	O
in	IN	case	O
Stat5A	NN	compound	O
activation	NN	compound	O
treatment	NN	nmod	O
with	IN	case	O
IL-2	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
a	DT	det	O
similar	JJ	amod	O
defect	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	conj	O
for	IN	case	O
IL-4	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
Stat5	NN	nmod	B-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
T	NN	compound	B-cell_type
lymphoid	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
with	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
showed	VBD	ROOT	O
normal	JJ	amod	O
insulin	NN	compound	O
receptor	NN	compound	O
substrate-2	NN	compound	O
phosphorylation	NN	dobj	O
and	CC	cc	O
only	RB	advmod	O
a	DT	det	O
modest	JJ	amod	O
decrease	NN	conj	O
in	IN	case	O
Stat6	NN	compound	O
activation	NN	nmod	O
and	CC	cc	O
insulin	NN	compound	O
receptor	NN	compound	O
substrate-1	NN	compound	O
phosphorylation	NN	conj	O
after	IN	case	O
IL-4	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
NF-kappaB/Rel/IkappaBalpha	NN	compound	O
system	NN	nsubj	O
can	MD	aux	O
regulate	VB	ccomp	O
cytokine	NN	compound	B-protein
receptor	NN	compound	I-protein
capacitation	NN	dobj	O
through	IN	case	O
effects	NNS	nmod	O
on	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
downstream	JJ	amod	O
signaling	NN	nmod	O
by	IN	case	O
the	DT	det	O
Stat	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
family	NN	nmod	I-protein
.	.	punct	O

BMS-189453	JJ	nsubj	O
,	,	punct	O
a	DT	det	O
novel	JJ	amod	O
retinoid	NN	compound	O
receptor	NN	compound	O
antagonist	NN	appos	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
testicular	JJ	amod	O
toxin	NN	ROOT	O
.	.	punct	O

BMS-189453	JJ	nsubj	O
is	VBZ	ROOT	O
a	DT	det	O
synthetic	JJ	amod	O
retinoid	NN	attr	O
that	WDT	nsubj	O
acts	VBZ	relcl	O
as	IN	case	O
an	DT	det	O
antagonist	NN	nmod	O
at	IN	case	O
retinoic	JJ	amod	B-protein
acid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
alpha	NN	dep	I-protein
,	,	punct	I-protein
beta	NN	conj	I-protein
,	,	punct	I-protein
and	CC	cc	I-protein
gamma	NN	conj	I-protein
.	.	punct	O

In	IN	prep	O
Sprague	NNP	compound	O
Dawley	NNP	compound	O
rats	VBZ	pobj	O
at	IN	prep	O
daily	RB	amod	O
oral	JJ	amod	O
doses	NNS	pobj	O
of	IN	prep	O
15	CD	nummod	O
,	,	punct	O
60	CD	nummod	O
,	,	punct	O
or	CC	cc	O
240	CD	nummod	O
mg/kg	NN	pobj	O
for	IN	prep	O
1	CD	nummod	O
month	NN	pobj	O
,	,	punct	O
BMS-189453	JJ	nsubj	O
produced	VBN	ROOT	O
increases	NNS	dobj	O
in	IN	case	O
leukocyte	NN	compound	B-cell_type
counts	NNS	nmod	O
,	,	punct	O
alkaline	NN	compound	B-protein
phosphatase	NN	conj	I-protein
and	CC	cc	O
alanine	NN	compound	B-protein
aminotransferase	NN	compound	I-protein
levels	NNS	conj	O
,	,	punct	O
and	CC	cc	O
marked	JJ	amod	O
testicular	JJ	amod	O
degeneration	NN	conj	O
and	CC	cc	O
atrophy	NN	conj	O
at	IN	case	O
all	DT	det	O
doses	NNS	nmod	O
.	.	punct	O

Significant	JJ	amod	O
overt	JJ	nsubj	O
signs	NNS	nsubj	O
of	IN	prep	O
toxicity	NN	pobj	O
and	CC	cc	O
deaths	NNS	conj	O
occurred	VBD	ROOT	O
at	IN	case	O
240	CD	nummod	O
mg/kg	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
body-weight	JJ	nsubj	O
and	CC	cc	O
food-consumption	JJ	conj	O
decreases	NNS	dep	O
occurred	VBD	advcl	O
at	IN	case	O
60	CD	nummod	O
and	CC	cc	O
240	CD	conj	O
mg/kg	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
BMS-189453	NN	nsubjpass	O
was	VBD	auxpass	O
administered	VBN	advcl	O
to	TO	case	O
male	JJ	amod	O
rats	NNS	nmod	O
at	IN	case	O
daily	JJ	amod	O
doses	NNS	nmod	O
ranging	VBG	acl	O
from	IN	case	O
12.5	CD	compound	O
to	TO	dep	O
100	CD	nummod	O
mg/kg	NN	nmod	O
for	IN	case	O
1	CD	nummod	O
week	NN	nmod	O
,	,	punct	O
only	RB	advmod	O
minimal	JJ	amod	O
testicular	JJ	amod	O
changes	NNS	nsubj	O
occurred	VBD	ROOT	O
at	IN	case	O
all	DT	det	O
doses	NNS	nmod	O
,	,	punct	O
shortly	RB	advmod	O
after	IN	case	O
the	DT	det	O
dosing	NN	compound	O
period	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
after	IN	case	O
a	DT	det	O
1-month	JJ	amod	O
drug-free	JJ	amod	O
observation	NN	compound	O
period	NN	nmod	O
,	,	punct	O
marked	JJ	amod	O
testicular	JJ	amod	O
atrophy	NN	nsubj	O
was	VBD	cop	O
evident	JJ	ROOT	O
at	IN	case	O
all	DT	det	O
doses	NNS	nmod	O
.	.	punct	O

BMS-189453	NN	nsubjpass	O
was	VBD	auxpass	O
then	RB	advmod	O
administered	VBN	ROOT	O
at	IN	case	O
doses	NNS	nmod	O
of	IN	case	O
2	CD	nummod	O
,	,	punct	O
10	CD	nummod	O
,	,	punct	O
or	CC	cc	O
50	CD	conj	O
mg/kg	NN	nmod	O
to	TO	case	O
male	JJ	amod	O
rats	NNS	nmod	O
for	IN	case	O
1	CD	nmod	O
,	,	punct	O
3	CD	conj	O
,	,	punct	O
or	CC	cc	O
7	CD	nummod	O
consecutive	JJ	amod	O
days	NNS	conj	O
.	.	punct	O

Dose-	JJ	amod	O
and	CC	cc	O
duration-dependent	JJ	conj	O
testicular	JJ	amod	O
toxicity	NN	nsubj	O
that	WDT	nsubj	O
occurred	VBD	acl:relcl	O
after	IN	case	O
a	DT	det	O
1-month	JJ	amod	O
observation	NN	compound	O
period	NN	nmod	O
did	VBD	aux	O
not	RB	neg	O
recover	VB	ROOT	O
,	,	punct	O
and	CC	cc	O
,	,	punct	O
in	IN	prep	O
some	DT	det	O
cases	NNS	pobj	O
,	,	punct	O
was	VBD	conj	O
more	RBR	advmod	O
severe	JJ	acomp	O
4	CD	nummod	O
months	NNS	npadvmod	O
after	IN	prep	O
the	DT	det	O
last	JJ	amod	O
dose	NN	pobj	O
.	.	punct	O

In	IN	case	O
rabbits	NNS	nmod	O
administered	VBN	advcl	O
BMS-189453	JJ	dobj	O
at	IN	case	O
oral	JJ	amod	O
doses	NNS	nmod	O
of	IN	case	O
2	CD	nummod	O
,	,	punct	O
10	CD	nummod	O
,	,	punct	O
or	CC	cc	O
50	CD	nummod	O
mg/kg	NN	nmod	O
for	IN	case	O
1	CD	nummod	O
week	NN	nmod	O
,	,	punct	O
testicular	JJ	amod	O
degeneration	NN	nsubj	O
and	CC	cc	O
atrophy	NN	conj	O
were	VBD	cop	O
evident	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
high-dose	JJ	amod	O
group	NN	nmod	O
at	IN	case	O
1	CD	nummod	O
month	NN	nmod	O
following	VBG	case	O
treatment	NN	nmod	O
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
retinoid	NN	compound	O
antagonists	NNS	nsubj	O
can	MD	aux	O
selectively	RB	advmod	O
produce	VB	ccomp	O
progressive	JJ	amod	O
and	CC	cc	O
prolonged	JJ	conj	O
testicular	JJ	amod	O
toxicity	NN	dobj	O
after	IN	case	O
single	JJ	amod	O
or	CC	cc	O
repeated	VBN	conj	O
oral	JJ	amod	O
doses	NNS	nmod	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
otherwise	RB	advmod	O
well	RB	advmod	O
tolerated	VBN	acl:relcl	O
.	.	punct	O

Sequential	JJ	amod	O
involvement	NN	ROOT	O
of	IN	case	O
NFAT	NN	compound	B-protein
and	CC	cc	O
Egr	NN	conj	B-protein
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
in	IN	case	O
FasL	NN	compound	O
regulation	NN	nmod	O
.	.	punct	O

The	DT	det	O
critical	JJ	amod	O
function	NN	nsubjpass	O
of	IN	case	O
NFAT	NN	compound	B-protein
proteins	NNS	nmod	I-protein
in	IN	mark	O
maintaining	VBG	acl	O
lymphoid	JJ	amod	O
homeostasis	NN	dobj	O
was	VBD	auxpass	O
revealed	VBN	ROOT	O
in	IN	case	O
mice	NNS	nmod	O
lacking	VBG	acl	O
both	CC	cc:preconj	O
NFATp	NN	dobj	B-protein
and	CC	cc	O
NFAT4	NN	conj	B-protein
(	-LRB-	punct	O
DKO	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

DKO	NN	compound	O
mice	NNS	nsubj	O
exhibit	VBP	ROOT	O
increased	VBN	amod	O
lymphoproliferation	NN	dobj	O
,	,	punct	O
decreased	VBD	conj	O
activation-induced	JJ	amod	O
cell	NN	compound	O
death	NN	dobj	O
,	,	punct	O
and	CC	cc	O
impaired	JJ	amod	O
induction	NN	dobj	O
of	IN	case	O
FasL	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nsubj	I-protein
Egr2	NN	dep	B-protein
and	CC	cc	O
Egr3	NN	conj	B-protein
are	VBP	cop	O
potent	JJ	amod	O
activators	NNS	ROOT	O
of	IN	case	O
FasL	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
find	VBP	ROOT	O
that	IN	mark	O
Egr2	NN	nsubj	B-DNA
and	CC	cc	O
Egr3	NN	conj	B-DNA
are	VBP	cop	O
NFAT	NN	compound	B-DNA
target	NN	compound	I-DNA
genes	NNS	ccomp	I-DNA
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
FasL	NN	nmod	B-protein
occurs	VBZ	ROOT	O
via	IN	case	O
the	DT	det	O
NFAT	NN	compound	B-protein
-dependent	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
Egr3	NN	nmod	B-DNA
,	,	punct	O
as	IN	mark	O
demonstrated	VBN	advcl	O
by	IN	case	O
the	DT	det	O
ability	NN	nmod	O
of	IN	case	O
exogenously	RB	advmod	O
provided	VBN	amod	O
NFATp	NN	nmod	B-protein
to	TO	mark	O
restore	VB	acl	O
Egr	NN	compound	B-protein
-dependent	JJ	amod	O
FasL	NN	compound	O
promoter	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
DKO	NN	compound	B-cell_type
lymph	NN	compound	I-cell_type
node	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Further	RB	advmod	O
,	,	punct	O
Egr3	NN	compound	B-DNA
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
enriched	VBN	ROOT	O
in	IN	case	O
Th1	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
molecular	JJ	amod	O
basis	NN	dobj	O
for	IN	case	O
the	DT	det	O
known	JJ	amod	O
preferential	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
FasL	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
Th1	NN	compound	O
versus	CC	cc	O
Th2	NN	conj	O
subset	NN	nmod	O
.	.	punct	O

Mechanisms	NNS	ROOT	O
and	CC	cc	O
clinical	JJ	amod	O
relevance	NN	conj	O
of	IN	case	O
nongenomic	JJ	amod	O
glucocorticoid	NN	compound	O
actions	NNS	nmod	O
.	.	punct	O

Glucocorticoids	NNS	nsubj	O
have	VBP	ROOT	O
profound	JJ	amod	O
anti-inflammatory	JJ	amod	O
and	CC	cc	O
immunosuppressive	JJ	conj	O
actions	NNS	dobj	O
when	WRB	advmod	O
used	VBN	advcl	O
therapeutically	RB	advmod	O
.	.	punct	O

The	DT	det	O
therapeutic	JJ	amod	O
dose	NN	nsubj	O
is	VBZ	cop	O
quite	RB	advmod	O
variable	JJ	ROOT	O
and	CC	cc	O
depends	VBZ	conj	O
on	IN	case	O
the	DT	det	O
disease	NN	nmod	O
,	,	punct	O
but	CC	cc	O
ranges	NNS	conj	O
from	IN	case	O
very	RB	advmod	O
low	JJ	nmod	O
to	TO	case	O
extremely	RB	advmod	O
high	JJ	nmod	O
.	.	punct	O

The	DT	det	O
rationale	NN	nsubj	O
for	IN	prep	O
the	DT	det	O
use	NN	pobj	O
of	IN	case	O
various	JJ	amod	O
dosage	NN	compound	O
regimens	NNS	nmod	O
for	IN	case	O
specific	JJ	amod	O
clinical	JJ	amod	O
indications	NNS	nmod	O
is	VBZ	cop	O
the	DT	det	O
existence	NN	ROOT	O
of	IN	case	O
three	CD	nummod	O
distinct	JJ	amod	O
,	,	punct	O
therapeutically	RB	advmod	O
relevant	JJ	amod	O
effects	NNS	nmod	O
:	:	punct	O
genomic	JJ	dep	O
,	,	punct	O
specific	JJ	dep	O
nongenomic	JJ	dep	O
and	CC	cc	O
unspecific	JJ	conj	O
nongenomic	JJ	conj	O
.	.	punct	O

Genomic	JJ	amod	O
effects	NNS	nsubjpass	O
are	VBP	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
cytosolic	JJ	amod	B-protein
receptors	NNS	nmod	I-protein
that	WDT	nsubj	O
alter	VBP	acl:relcl	O
expression	NN	dobj	O
of	IN	case	O
specific	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O

Specific	JJ	amod	O
nongenomic	JJ	amod	O
effects	NNS	nsubj	O
occur	VBP	ROOT	O
within	IN	case	O
a	DT	det	O
few	JJ	amod	O
minutes	NNS	nmod	O
and	CC	cc	O
are	VBP	auxpass	O
mediated	VBN	conj	O
by	IN	case	O
steroid-selective	JJ	amod	B-protein
membrane	NN	compound	I-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Unspecific	JJ	amod	O
nongenomic	JJ	amod	O
effects	NNS	nsubj	O
occur	VBP	ROOT	O
within	IN	case	O
seconds	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
only	RB	advmod	O
at	IN	case	O
high	JJ	amod	O
glucocorticoid	NN	compound	O
dosages	NNS	conj	O
,	,	punct	O
and	CC	cc	O
seem	VBP	conj	O
to	TO	mark	O
result	VB	xcomp	O
from	IN	case	O
direct	JJ	amod	O
interactions	NNS	nmod	O
with	IN	case	O
biological	JJ	amod	O
membranes	NNS	nmod	O
.	.	punct	O

For	IN	case	O
unspecific	JJ	amod	O
nongenomic	JJ	amod	O
effects	NNS	nmod	O
,	,	punct	O
methylprednisolone	NN	nsubjpass	O
and	CC	cc	O
other	JJ	amod	O
glucocorticoids	NNS	conj	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
cation	NN	compound	O
cycling	NN	dobj	O
across	IN	case	O
the	DT	det	O
plasma	NN	compound	O
membrane	NN	nmod	O
,	,	punct	O
but	CC	cc	O
to	TO	mark	O
have	VB	conj	O
little	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
protein	NN	compound	O
synthesis	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
glucocorticoids	NNS	nsubj	O
could	MD	aux	O
diminish	VB	ROOT	O
or	CC	cc	O
prevent	VB	conj	O
the	DT	det	O
acute	JJ	amod	O
immune	JJ	amod	O
response	NN	dobj	O
by	IN	mark	O
interfering	VBG	advcl	O
with	IN	case	O
processes	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
rise	NN	nmod	O
in	IN	case	O
intracellular	JJ	amod	O
Ca2+	NN	compound	O
concentration	NN	nmod	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
proposed	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
additional	JJ	amod	O
therapeutic	JJ	amod	O
benefit	NN	nsubjpass	O
of	IN	case	O
higher	JJR	amod	O
doses	NNS	nmod	O
is	VBZ	auxpass	O
obtained	VBN	ccomp	O
via	IN	case	O
these	DT	det	O
nongenomic	JJ	amod	O
effects	NNS	nmod	O
.	.	punct	O

High	JJ	amod	O
glucose-induced	JJ	amod	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	compound	I-protein
(	-LRB-	punct	O
ICAM-1	NN	appos	B-protein
)	-RRB-	punct	O
expression	NN	nsubj	O
through	IN	case	O
an	DT	det	O
osmotic	JJ	amod	O
effect	NN	nmod	O
in	IN	case	O
rat	NN	compound	B-cell_type
mesangial	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	cop	O
PKC-NF-kappa	NN	nmod:npmod	O
B-dependent	JJ	ROOT	O
.	.	punct	O

AIMS/HYPOTHESIS	NN	ROOT	O
:	:	punct	O
Infiltration	NN	nsubj	O
of	IN	case	O
mononuclear	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
glomerular	JJ	amod	O
enlargement	NN	conj	O
accompanied	VBN	acl	O
by	IN	case	O
glomerular	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
proliferation	NN	nmod	O
are	VBP	cop	O
very	RB	advmod	O
early	JJ	amod	O
characteristics	NNS	appos	O
of	IN	case	O
the	DT	det	O
pathophysiology	NN	nmod	O
of	IN	case	O
diabetes	NNS	nmod	O
.	.	punct	O

To	TO	mark	O
clarify	VB	advcl	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
early	JJ	amod	O
diabetic	JJ	amod	O
nephropathy	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
measured	VBD	ROOT	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
-thymidine	NN	amod	O
incorporation	NN	dobj	O
and	CC	cc	O
cell	NN	compound	O
numbers	NNS	conj	O
to	TO	mark	O
show	VB	xcomp	O
the	DT	det	O
influence	NN	dobj	O
of	IN	case	O
a	DT	det	O
high	JJ	amod	O
ambient	NN	amod	O
glucose	NN	compound	O
concentration	NN	nmod	O
and	CC	cc	O
the	DT	det	O
osmotic	JJ	amod	O
effect	NN	conj	O
on	IN	case	O
rat	NN	compound	B-cell_type
mesangial	JJ	amod	I-cell_type
cell	NN	compound	I-cell_type
proliferation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
measured	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
high	JJ	amod	O
glucose	NN	nmod	O
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nmod	I-protein
and	CC	cc	O
vascular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	conj	I-protein
by	IN	case	O
flow	NN	compound	O
cytometry	NN	nmod	O
and	CC	cc	O
semiquantitative	JJ	amod	O
RT-PCR	NN	conj	O
in	IN	case	O
mesangial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
the	DT	det	O
adhesion	NN	conj	O
of	IN	case	O
leukocytes	NNS	nmod	B-cell_type
to	TO	case	O
mesangial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

METHODS/RESULTS	NN	ROOT	O
:	:	punct	O
Cells	NNS	nsubj	O
exposed	VBN	acl	O
to	TO	case	O
high	JJ	amod	O
D-glucose	NN	nmod	O
(	-LRB-	punct	O
30	CD	nummod	O
mmol/l	NN	appos	O
)	-RRB-	punct	O
caused	VBD	dep	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
-thymidine	NN	amod	O
incorporation	NN	nmod	O
and	CC	cc	O
cell	NN	compound	O
numbers	NNS	conj	O
at	IN	case	O
24	CD	nummod	O
and	CC	cc	O
48	CD	conj	O
h	NN	nmod	O
and	CC	cc	O
normalized	VBN	conj	O
at	IN	case	O
72	CD	nummod	O
h	NN	nmod	O
(	-LRB-	punct	O
p	NN	dep	O
<	CD	dep	O
0.05	CD	nummod	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
these	DT	det	O
changes	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
found	VBN	parataxis	O
in	IN	case	O
high	JJ	amod	O
mannitol	NN	nmod	O
(	-LRB-	punct	O
30	CD	nummod	O
mmol/l	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
IL-1	NN	compound	B-protein
beta	NN	conj	I-protein
,	,	punct	O
or	CC	cc	O
TNF	NN	nmod:npmod	B-protein
alpha	NN	nmod:npmod	I-protein
-stimulated	JJ	amod	O
mesangial	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Cells	NNS	nsubj	O
exposed	VBN	acl	O
to	TO	case	O
high-glucose	JJ	nmod	O
(	-LRB-	punct	O
15	CD	dep	O
,	,	punct	O
30	CD	conj	O
,	,	punct	O
or	CC	cc	O
60	CD	nummod	O
mmol/l	NN	conj	O
)	-RRB-	punct	O
or	CC	cc	O
osmotic	JJ	amod	O
agents	NNS	conj	O
(	-LRB-	punct	O
L-glucose	JJ	dep	O
,	,	punct	O
raffinose	NN	conj	O
and	CC	cc	O
mannitol	NN	conj	O
)	-RRB-	punct	O
showed	VBD	ROOT	O
that	IN	mark	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	compound	I-protein
expression	NN	nsubj	O
began	VBD	ccomp	O
to	TO	mark	O
increase	VB	xcomp	O
after	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
,	,	punct	O
reached	VBD	conj	O
its	PRP$	nmod:poss	O
maximum	NN	dobj	O
at	IN	case	O
24	CD	nummod	O
and	CC	cc	O
48	CD	conj	O
h	NN	nmod	O
and	CC	cc	O
gradually	RB	advmod	O
decreased	VBN	amod	O
afterwards	RB	conj	O
.	.	punct	O

The	DT	det	O
stimulatory	JJ	amod	O
effects	NNS	nsubjpass	O
of	IN	case	O
high	JJ	amod	O
glucose	NN	nmod	O
and	CC	cc	O
high	JJ	amod	O
mannitol	NN	conj	O
on	IN	case	O
mRNA	NN	compound	O
expression	NN	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
as	RB	advmod	O
early	RB	advmod	O
as	IN	case	O
6	CD	nummod	O
h	NN	nmod	O
and	CC	cc	O
reached	VBD	conj	O
its	PRP$	nmod:poss	O
maximum	NN	dobj	O
at	IN	case	O
12	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

Up-regulation	NN	nsubjpass	O
of	IN	case	O
ICAM-1	NN	compound	B-protein
protein	NN	nmod	O
and	CC	cc	O
mRNA	NN	conj	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
in	IN	case	O
IL-1-beta	NN	nmod	B-protein
and	CC	cc	O
TNF-alpha	NN	nmod:npmod	B-protein
-stimulated	JJ	amod	O
mesangial	JJ	amod	B-cell_type
cells	NNS	dep	I-cell_type
.	.	punct	O

Neither	CC	cc:preconj	O
vascular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	compound	I-protein
protein	NN	nsubjpass	O
nor	CC	cc	O
mRNA	NN	compound	O
expression	NN	conj	O
was	VBD	auxpass	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
affected	VBN	ROOT	O
by	IN	case	O
high	JJ	amod	O
glucose	NN	nmod	O
and	CC	cc	O
high	JJ	amod	O
mannitol	NN	conj	O
.	.	punct	O

Notably	RB	advmod	O
,	,	punct	O
the	DT	det	O
protein	NN	compound	O
kinase	NN	compound	O
C	NN	compound	O
inhibitors	NNS	nsubj	O
calphostin	NN	compound	O
C	NN	dep	O
and	CC	cc	O
staurosporine	NN	conj	O
reduced	VBD	ROOT	O
high	JJ	amod	O
glucose-	NN	dobj	O
or	CC	cc	O
high	JJ	amod	O
mannitol-induced	JJ	amod	O
intercellular	JJ	amod	B-RNA
adhesion	NN	compound	I-RNA
molecule-1	NN	compound	I-RNA
mRNA	NN	compound	O
expression	NN	dep	O
and	CC	cc	O
high	JJ	amod	O
glucose-induced	JJ	amod	O
proliferation	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
NF-kappa	NN	compound	O
B	NN	compound	O
inhibitor	NN	compound	O
N-tosyl-L-phenylalanine	NN	compound	O
chloromethyl	NN	compound	O
ketone	NN	nsubj	O
reduced	VBD	ROOT	O
high	JJ	amod	O
glucose-	NN	dobj	O
or	CC	cc	O
high	JJ	amod	O
mannitol-induced	JJ	amod	O
intercellular	JJ	amod	B-RNA
adhesion	NN	compound	I-RNA
molecule-1	NN	compound	I-RNA
mRNA	NN	compound	O
expression	NN	dep	O
and	CC	cc	O
high	JJ	amod	O
glucose-induced	JJ	amod	O
proliferation	NN	conj	O
.	.	punct	O

Results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
high	JJ	amod	O
glucose	NN	nsubj	O
(	-LRB-	punct	O
15	CD	dep	O
,	,	punct	O
30	CD	nummod	O
mmol/l	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
high	JJ	amod	O
concentrations	NNS	conj	O
of	IN	case	O
osmotic	JJ	amod	O
agents	NNS	nmod	O
remarkably	RB	advmod	O
increased	VBD	ccomp	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
adherent	JJ	amod	O
leukocytes	NNS	nmod	B-cell_type
to	TO	case	O
mesangial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
p	NN	dep	O
<	JJR	amod	O
0.01	CD	nummod	O
)	-RRB-	punct	O
compared	VBN	case	O
with	IN	case	O
control	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
5	CD	nummod	O
mmol/l	NN	nmod:npmod	O
D-glucose	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Functional	JJ	amod	O
blocking	NN	nsubj	O
of	IN	case	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nmod	I-protein
on	IN	case	O
mesangial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
rat	NN	compound	B-protein
intercellular	JJ	amod	I-protein
adhesion	NN	compound	I-protein
molecule-1	NN	compound	I-protein
monoclonal	JJ	amod	I-protein
antibody	NN	nmod	I-protein
,	,	punct	O
calphostin	NN	compound	O
C	NN	conj	O
,	,	punct	O
staurosporine	NN	conj	O
,	,	punct	O
or	CC	cc	O
N-tosyl-L-phenylalanine	NN	compound	O
chloromethyl	NN	compound	O
ketone	NN	conj	O
significantly	RB	advmod	O
inhibited	VBD	ROOT	O
high	JJ	amod	O
glucose-	NN	amod	O
or	CC	cc	O
high	JJ	amod	O
mannitol-induced	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
leukocyte	NN	compound	O
adhesion	NN	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	amod	O
<	ADD	dep	O
0.05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSION/INTERPRETATION	NN	dep	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
high	JJ	amod	O
glucose	NN	nsubj	O
can	MD	aux	O
upregulate	VB	ccomp	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	compound	I-protein
protein	NN	dobj	O
and	CC	cc	O
mRNA	NN	compound	O
expression	NN	conj	O
but	CC	cc	O
not	RB	cc	O
vascular	JJ	amod	O
adhesion	NN	compound	O
molecule-1	NN	compound	O
expression	NN	conj	O
in	IN	case	O
mesangial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
promote	VBP	conj	O
leukocyte	NN	compound	O
adhesion	NN	dobj	O
through	IN	case	O
up-regulation	NN	nmod	O
of	IN	case	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nmod	I-protein
through	IN	case	O
osmotic	JJ	amod	O
effect	NN	nmod	O
,	,	punct	O
possibly	RB	advmod	O
depending	VBG	advcl	O
on	IN	case	O
the	DT	det	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	compound	I-protein
(	-LRB-	punct	O
PKC	NN	compound	B-protein
-	HYPH	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
pathway	NN	nmod	O
.	.	punct	O

High	JJ	amod	O
glucose	NN	nsubj	O
itself	PRP	dep	O
can	MD	aux	O
also	RB	advmod	O
promote	VB	ROOT	O
mesangial	JJ	amod	O
cell	NN	compound	O
proliferation	NN	dobj	O
through	IN	case	O
the	DT	det	O
PKC-NF-kappa	NN	compound	O
B	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
hyperglycaemia	NN	nsubj	O
in	IN	case	O
itself	PRP	nmod	O
seems	VBZ	ccomp	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
factor	NN	xcomp	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
early	JJ	amod	O
diabetic	JJ	amod	O
nephropathy	NN	nmod	O
.	.	punct	O

Combined	JJ	amod	O
corticosteroid/	JJ	amod	O
granulocyte	NN	compound	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	O
G-CSF	NN	compound	B-protein
)	-RRB-	punct	O
therapy	NN	ROOT	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
severe	JJ	amod	O
congenital	JJ	amod	O
neutropenia	NN	nmod	O
unresponsive	JJ	amod	O
to	TO	case	O
G-CSF	NN	nmod	B-protein
:	:	punct	O
Activated	VBN	amod	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nsubj	I-protein
synergize	VBP	dep	O
with	IN	case	O
G-CSF	NN	compound	B-protein
signals	NNS	nmod	O
.	.	punct	O

More	JJR	amod	O
than	IN	quantmod	O
90	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
severe	JJ	amod	O
congenital	JJ	amod	O
neutropenia	NN	nmod	O
(	-LRB-	punct	O
SCN	NN	appos	O
)	-RRB-	punct	O
respond	VBP	ROOT	O
to	TO	case	O
granulocyte	NN	compound	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	O
G-CSF	NN	compound	B-protein
)	-RRB-	punct	O
therapy	NN	nmod	O
.	.	punct	O

The	DT	det	O
basis	NN	nsubj	O
for	IN	case	O
the	DT	det	O
refractory	JJ	amod	O
state	NN	nmod	O
in	IN	case	O
the	DT	det	O
remaining	VBG	amod	O
patients	NNS	nmod	O
is	VBZ	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

To	TO	aux	O
address	VB	advcl	O
this	DT	det	O
issue	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
a	DT	det	O
child	NN	dobj	O
with	IN	case	O
SCN	NN	nmod	O
who	WP	nsubj	O
was	VBD	cop	O
totally	RB	advmod	O
unresponsive	JJ	acl:relcl	O
to	TO	case	O
G-CSF	NN	nmod	B-protein
and	CC	cc	O
had	VBD	conj	O
a	DT	det	O
novel	JJ	amod	O
point	NN	compound	O
mutation	NN	dobj	O
in	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-protein
domain	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
G-CSF	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
GCSF-R	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Marrow	JJ	compound	O
stromal	JJ	amod	O
support	NN	nsubjpass	O
of	IN	case	O
granulopoiesis	NN	nmod	O
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
by	IN	mark	O
plating	VBG	advcl	O
CD34	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	dobj	I-cell_type
on	IN	case	O
preformed	JJ	amod	O
stromal	JJ	amod	O
layers	NNS	nmod	O
.	.	punct	O

Nonadherent	JJ	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
harvested	VBN	ROOT	O
and	CC	cc	O
assayed	VBN	conj	O
in	IN	case	O
clonogenic	JJ	amod	O
assays	NNS	nmod	O
for	IN	case	O
granulocytic	JJ	amod	O
colony	NN	compound	O
production	NN	nmod	O
.	.	punct	O

The	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
effect	NN	nsubjpass	O
of	IN	case	O
G-CSF	NN	nmod	B-protein
and	CC	cc	O
corticosteroids	NNS	conj	O
on	IN	case	O
granulopoiesis	NN	nmod	O
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
in	IN	case	O
clonogenic	JJ	amod	O
assays	NNS	nmod	O
of	IN	case	O
marrow	JJ	compound	B-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
by	IN	case	O
proliferation	NN	compound	O
studies	NNS	nmod	O
of	IN	case	O
the	DT	det	O
murine	JJ	amod	B-cell_line
myeloid	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	compound	I-cell_line
32D	NN	nmod	I-cell_line
expressing	VBG	acl	O
the	DT	det	O
patient	NN	nmod:poss	O
's	POS	case	O
mutated	VBN	amod	B-protein
G-CSFR	NN	dobj	I-protein
,	,	punct	O
and	CC	cc	O
by	IN	mark	O
measuring	VBG	conj	O
STAT5	NN	compound	O
activation	NN	dobj	O
in	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
from	IN	case	O
stimulated	VBN	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Patient	NNP	nmod:poss	O
's	POS	case	O
stroma	NN	nsubj	O
supported	JJ	ROOT	O
granulopoiesis	NN	dobj	O
derived	VBN	acl	O
from	IN	case	O
control	NN	compound	O
marrow	NN	compound	B-cell_type
CD34	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
a	DT	det	O
normal	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Normal	JJ	amod	O
stroma	NN	nsubj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
failed	VBD	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
granulopoiesis	NN	dobj	O
from	IN	case	O
patient	NN	nmod:poss	O
's	POS	case	O
CD34	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Clonogenic	JJ	amod	O
assays	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
patient	NN	nmod:poss	O
's	POS	case	O
marrow	NN	compound	B-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
incorporating	VBG	acl	O
either	CC	cc:preconj	O
G-CSF	NN	dobj	B-protein
or	CC	cc	O
hydrocortisone	NN	conj	O
produced	VBD	ROOT	O
little	JJ	amod	O
neutrophil	NN	compound	O
growth	NN	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
inclusion	NN	nsubj	O
of	IN	case	O
both	CC	cc:preconj	O
G-CSF	NN	nmod	B-protein
and	CC	cc	O
hydrocortisone	NN	conj	O
in	IN	case	O
the	DT	det	O
cytokine	NN	compound	B-protein
``	``	punct	I-protein
cocktail	NN	nmod	I-protein
''	''	punct	I-protein
markedly	RB	advmod	O
increased	VBD	ROOT	O
the	DT	det	O
neutrophil	NN	compound	O
numbers	NNS	dobj	O
.	.	punct	O

Proliferation	NN	nsubjpass	O
of	IN	case	O
32D	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
expressing	VBG	acl	O
the	DT	det	O
mutated	VBN	amod	B-protein
receptor	NN	compound	I-protein
and	CC	cc	O
STAT5	NN	conj	O
activation	NN	dobj	O
were	VBD	auxpass	O
improved	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
combination	NN	nmod	O
of	IN	case	O
G-CSF	NN	nmod	B-protein
and	CC	cc	O
dexamethasone	NN	conj	O
.	.	punct	O

When	WRB	advmod	O
small	JJ	amod	O
daily	JJ	amod	O
doses	NNS	nsubjpass	O
of	IN	case	O
oral	JJ	amod	O
prednisone	NN	nmod	O
were	VBD	auxpass	O
then	RB	advmod	O
administered	VBN	advcl	O
to	TO	case	O
the	DT	det	O
patient	NN	nmod	O
with	IN	case	O
conventional	JJ	amod	O
doses	NNS	nmod	O
of	IN	case	O
subcutaneous	JJ	amod	B-protein
G-CSF	NN	nmod	I-protein
,	,	punct	O
the	DT	det	O
patient	NN	nsubj	O
responded	VBD	ROOT	O
with	IN	case	O
increased	VBN	amod	O
neutrophil	NN	compound	O
numbers	NNS	nmod	O
and	CC	cc	O
with	IN	case	O
a	DT	det	O
complete	JJ	amod	O
reversal	NN	conj	O
of	IN	prep	O
the	DT	det	O
infectious	JJ	amod	O
problems	NNS	pobj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
provide	VBP	ROOT	O
insight	NN	dobj	O
into	IN	case	O
SCN	NN	nmod	O
unresponsive	JJ	amod	O
to	TO	case	O
standard	JJ	amod	O
G-CSF	NN	compound	B-protein
treatment	NN	nmod	O
and	CC	cc	O
to	TO	case	O
the	DT	det	O
potential	JJ	amod	O
corrective	JJ	amod	O
action	NN	conj	O
of	IN	case	O
combined	JJ	amod	O
treatment	NN	nmod	O
with	IN	case	O
G-CSF	NN	nmod	B-protein
and	CC	cc	O
corticosteroids	NNS	conj	O
through	IN	case	O
synergistic	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
STAT5	NN	nmod	B-protein
.	.	punct	O

Human	JJ	amod	B-cell_type
renal	JJ	amod	I-cell_type
mesangial	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
are	VBP	cop	O
a	DT	det	O
target	NN	ROOT	O
for	IN	case	O
the	DT	det	O
anti-inflammatory	JJ	amod	O
action	NN	nmod	O
of	IN	case	O
9-cis	JJ	amod	O
retinoic	JJ	amod	O
acid	NN	nmod	O
.	.	punct	O

Mesangial	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
play	VBP	ROOT	O
an	DT	det	O
active	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
inflammatory	JJ	amod	O
response	NN	nmod	O
to	TO	case	O
glomerular	JJ	amod	O
injury	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
studied	VBN	ROOT	O
in	IN	case	O
cultured	VBN	amod	B-cell_line
human	JJ	amod	I-cell_line
mesangial	JJ	amod	I-cell_line
cells	NNS	compound	I-cell_line
(	-LRB-	punct	O
CHMC	NN	appos	B-cell_line
)	-RRB-	punct	O
several	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
9-cis	JJ	amod	O
retinoic	JJ	amod	O
acid	NN	nmod	O
(	-LRB-	punct	O
9-cRA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
activator	NN	appos	O
of	IN	case	O
both	CC	cc:preconj	O
retinoic	JJ	amod	B-protein
acid	NN	compound	I-protein
receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
RARs	NNS	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
retinoid	NN	compound	B-protein
X	NN	compound	I-protein
receptors	NNS	conj	I-protein
(	-LRB-	punct	O
RXRs	NNS	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

9-cRA	NN	nsubj	O
inhibited	VBD	ROOT	O
foetal	JJ	amod	O
calf	NN	nmod:npmod	O
serum-induced	JJ	amod	O
CHMC	NN	compound	B-cell_line
proliferation	NN	dobj	O
.	.	punct	O

It	PRP	nsubj	O
also	RB	advmod	O
prevented	VBD	ROOT	O
CHMC	NN	compound	B-cell_line
death	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
the	DT	det	O
inflammatory	JJ	amod	O
mediator	NN	compound	O
H	NN	compound	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
O	NN	nmod	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
preventive	JJ	amod	O
effect	NN	nsubj	O
was	VBD	cop	O
not	RB	neg	O
due	JJ	case	O
to	TO	mwe	O
any	DT	det	O
increase	NN	ROOT	O
in	IN	case	O
H	NN	compound	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
O	NN	compound	O
(	-LRB-	punct	O
2	LS	appos	O
)	-RRB-	punct	O
catabolism	NN	nmod	O
and	CC	cc	O
it	PRP	nsubj	O
persisted	VBD	conj	O
even	RB	advmod	O
when	WRB	advmod	O
both	CC	cc:preconj	O
catalase	NN	nsubjpass	O
and	CC	cc	O
glutathione	NN	compound	O
synthesis	NN	conj	O
were	VBD	auxpass	O
inhibited	VBN	advcl	O
.	.	punct	O

Finally	RB	ROOT	O
,	,	punct	O
9-cRA	NN	nsubj	O
diminished	VBD	amod	O
monocyte	NN	compound	O
adhesion	NN	intj	O
to	TO	case	O
FCS-stimulated	JJ	amod	B-cell_line
CHMC	NN	nmod	I-cell_line
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
retinoid	NN	nsubj	O
also	RB	advmod	O
inhibited	VBD	ROOT	O
in	IN	case	O
FCS-stimulated	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
the	DT	det	O
protein	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
mesangial	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecules	NNS	nmod	I-protein
,	,	punct	O
fibronectin	NN	appos	B-protein
and	CC	cc	O
osteopontin	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
it	PRP	nsubj	O
did	VBD	aux	O
not	RB	neg	O
modify	VB	conj	O
the	DT	det	O
protein	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nmod	I-protein
and	CC	cc	O
vascular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	conj	I-protein
.	.	punct	O

All	DT	det	O
major	JJ	amod	O
RARs	NNS	nsubjpass	B-protein
and	CC	cc	I-protein
RXRs	NNS	compound	I-protein
isotypes	NNS	conj	I-protein
were	VBD	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
CHMC	NNP	nmod	B-cell_line
regardless	RB	advmod	O
of	IN	case	O
the	DT	det	O
presence	NN	nmod	O
or	CC	cc	O
absence	NN	conj	O
of	IN	case	O
9-cRA	NN	nmod	O
.	.	punct	O

Transcripts	NNS	nsubj	O
to	TO	case	O
RAR-alpha	NN	nmod	B-RNA
,	,	punct	O
RAR-beta	NN	conj	B-RNA
and	CC	cc	O
RXR-alpha	NN	conj	B-RNA
increased	VBD	ROOT	O
after	IN	case	O
incubation	NN	nmod	O
with	IN	case	O
9-cRA	NN	nmod	O
whereas	IN	mark	O
RXR-gamma	NN	nsubjpass	B-RNA
was	VBD	auxpass	O
inhibited	VBN	advcl	O
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
major	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
RARs	NNS	nmod	B-protein
and	CC	cc	O
RXRs	NNS	conj	B-protein
in	IN	case	O
9-cRA-anti-inflammatory	JJ	amod	O
effects	NNS	nmod	O
.	.	punct	O

9-cRA	NN	nsubj	O
was	VBD	cop	O
toxic	RB	ROOT	O
only	RB	advmod	O
at	IN	case	O
50	CD	nummod	O
microM	NN	nmod	O
(	-LRB-	punct	O
a	DT	det	O
concentration	NN	dep	O
50	CD	nummod	O
-	HYPH	punct	O
5000	CD	nummod	O
times	NNS	npadvmod	O
higher	JJR	amod	O
than	IN	mark	O
required	VBN	advcl	O
for	IN	case	O
the	DT	det	O
effects	NNS	nmod	O
above	IN	amod	O
)	-RRB-	punct	O
.	.	punct	O

Cell	NN	compound	O
death	NN	nsubj	O
occurred	VBD	ROOT	O
by	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
whose	WP$	nmod:poss	O
onset	NN	nsubjpass	O
was	VBD	auxpass	O
associated	VBN	parataxis	O
with	IN	case	O
a	DT	det	O
pronounced	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
catalase	NN	compound	O
activity	NN	nmod	O
and	CC	cc	O
reduced	VBD	amod	O
glutathione	NN	compound	O
content	NN	conj	O
,	,	punct	O
being	VBG	auxpass	O
more	RBR	advmod	O
effectively	RB	advmod	O
induced	VBN	advcl	O
by	IN	case	O
all-trans	JJ	amod	O
retinoic	JJ	amod	O
acid	NN	nmod	O
.	.	punct	O

Modulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
oxidant/antioxidant	JJ	amod	O
balance	NN	nmod	O
failed	VBD	ROOT	O
to	TO	mark	O
inhibit	VB	xcomp	O
apoptosis	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
mesangial	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
might	MD	aux	O
be	VB	cop	O
a	DT	det	O
target	NN	ccomp	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
inflammatory	JJ	amod	O
glomerulopathies	NNS	nmod	O
with	IN	case	O
9-cRA	NN	nmod	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
mammalian	JJ	amod	B-DNA
defensin	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Antimicrobial	JJ	amod	O
peptides	NNS	nsubj	O
are	VBP	cop	O
a	DT	det	O
prevalent	JJ	amod	O
mechanism	NN	ROOT	O
of	IN	case	O
host	NN	compound	O
defense	NN	nmod	O
found	VBN	acl	O
throughout	IN	case	O
nature	NN	nmod	O
.	.	punct	O

In	IN	case	O
mammals	NNS	nmod	O
,	,	punct	O
defensins	NNS	nsubj	B-protein
are	VBP	cop	O
among	IN	case	O
the	DT	det	O
most	RBS	amod	O
abundant	JJ	ROOT	O
of	IN	case	O
these	DT	det	O
broad-spectrum	NN	compound	O
antibiotics	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
are	VBP	auxpass	O
expressed	VBN	conj	O
in	IN	case	O
epithelial	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
hematopoietic	JJ	conj	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
defensin	NN	compound	O
peptides	NNS	nsubj	O
are	VBP	cop	O
especially	RB	advmod	O
abundant	JJ	ROOT	O
in	IN	case	O
neutrophils	NNS	nmod	B-cell_type
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
gene	NN	compound	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
limited	JJ	parataxis	O
to	TO	case	O
the	DT	det	O
promyelocyte	JJ	amod	O
stage	NN	nmod	O
.	.	punct	O

In	IN	case	O
epithelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
defensin	NN	compound	B-DNA
genes	NNS	nsubjpass	I-DNA
are	VBP	auxpass	O
found	VBN	ROOT	O
as	IN	mark	O
both	CC	cc:preconj	O
constitutively	RB	advmod	O
expressed	VBN	advcl	O
and	CC	cc	O
inducible	JJ	conj	O
.	.	punct	O

Induction	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
observed	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
by	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
bacterial	JJ	amod	O
lipopolysaccharide	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
inflammatory	JJ	amod	O
mediators	NNS	conj	O
.	.	punct	O

In	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
up-regulation	NN	nsubj	O
of	IN	case	O
several	JJ	amod	O
defensin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
occurs	VBZ	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
infectious	JJ	amod	O
and	CC	cc	O
inflammatory	JJ	conj	O
states	NNS	nmod	O
.	.	punct	O

Gene	NN	compound	O
regulation	NN	nsubj	O
occurs	VBZ	ROOT	O
via	IN	case	O
signal	NN	compound	O
transduction	NN	compound	O
pathways	NNS	nmod	O
common	JJ	amod	O
to	TO	case	O
other	JJ	amod	O
innate	JJ	amod	O
immune	JJ	amod	O
responses	NNS	nmod	O
,	,	punct	O
utilizing	VBG	xcomp	O
transcription	NN	compound	B-protein
factors	NNS	dobj	I-protein
such	JJ	case	O
as	IN	mwe	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-kappaB	NN	nmod	I-protein
and	CC	cc	O
NF	NN	compound	B-protein
interleukin-6	NN	conj	I-protein
.	.	punct	O

Together	RB	advmod	O
,	,	punct	O
the	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
broad-based	JJ	amod	O
innate	JJ	amod	O
host	NN	compound	O
defense	NN	dobj	O
whereby	WRB	advmod	O
potent	JJ	amod	O
antimicrobial	JJ	amod	O
peptides	NNS	nsubj	O
are	VBP	cop	O
present	JJ	acl:relcl	O
to	TO	mark	O
prevent	VB	xcomp	O
initial	JJ	amod	O
colonization	NN	dobj	O
by	IN	case	O
pathogenic	JJ	amod	O
microorganisms	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
recognition	NN	nsubj	O
of	IN	case	O
bacteria	NNS	nmod	O
coupled	VBN	acl	O
with	IN	case	O
a	DT	det	O
nascent	JJ	amod	O
inflammatory	JJ	amod	O
response	NN	nmod	O
can	MD	aux	O
bolster	VB	ROOT	O
this	DT	det	O
defense	NN	dobj	O
by	IN	case	O
a	DT	det	O
coordinated	VBN	amod	O
up-regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
peptides	NNS	nmod	O
.	.	punct	O

Multiple	JJ	amod	O
signals	NNS	ROOT	O
required	VBN	acl	O
for	IN	case	O
cyclic	JJ	amod	B-protein
AMP-responsive	JJ	amod	I-protein
element	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	compound	I-protein
(	-LRB-	punct	O
CREB	NN	compound	B-protein
)	-RRB-	punct	O
binding	NN	compound	O
protein	NN	compound	O
interaction	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
CD3/CD28	NN	compound	O
costimulation	NN	nmod	O
.	.	punct	O

The	DT	det	O
optimal	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
cAMP-responsive	JJ	amod	B-protein
element	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
CREB	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
similar	JJ	amod	O
to	TO	case	O
the	DT	det	O
full	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
requires	VBZ	ROOT	O
the	DT	det	O
stimulation	NN	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
CD3	NN	nmod	B-protein
and	CC	cc	O
CD28	NN	conj	B-protein
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
reporter	NN	compound	O
system	NN	dobj	O
to	TO	mark	O
detect	VB	advcl	O
interaction	NN	dobj	O
of	IN	case	O
CREB	NN	nmod	B-protein
and	CC	cc	O
CREB-binding	JJ	amod	B-protein
protein	NN	conj	I-protein
(	-LRB-	punct	O
CBP	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
CREB	NN	nsubj	B-protein
binds	VBZ	ccomp	O
to	TO	case	O
CBP	NN	nmod	B-protein
only	RB	advmod	O
by	IN	case	O
engagement	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
CD3	NN	nmod	B-protein
and	CC	cc	O
CD28	NN	conj	B-protein
.	.	punct	O

CD3/CD28	NN	compound	B-protein
-promoted	JJ	amod	O
CREB	NN	compound	B-protein
-	:	punct	O
CBP	NN	compound	B-protein
interaction	NN	nsubj	O
was	VBD	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
p38	NN	compound	B-protein
mitogen-activated	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
MAPK	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
calcium/calmodulin-dependent	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	I-protein
CaMK	NN	appos	I-protein
)	-RRB-	punct	I-protein
IV	CD	conj	I-protein
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
the	DT	det	O
previously	RB	advmod	O
identified	VBN	amod	O
extracellular	JJ	amod	O
signal-regulated	JJ	amod	O
kinase	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

Extracellular	JJ	amod	B-protein
signal-regulated	JJ	amod	I-protein
kinase	NN	nsubj	I-protein
,	,	punct	I-protein
CaMKIV	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
p38	NN	compound	B-protein
MAPK	NN	conj	I-protein
were	VBD	cop	O
also	RB	advmod	O
the	DT	det	O
kinases	NNS	ROOT	O
involved	VBN	acl	O
in	IN	case	O
CREB	NN	compound	B-protein
Ser	NN	compound	O
(	-LRB-	punct	O
133	CD	dep	O
)	-RRB-	punct	O
phosphorylation	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
CD3/CD28	NN	nmod	B-protein
.	.	punct	O

A	DT	det	O
reconstitution	NN	compound	O
experiment	NN	nsubj	O
illustrated	VBD	ROOT	O
that	IN	mark	O
optimum	JJ	compound	O
CREB	NN	compound	B-protein
-	:	punct	O
CBP	NN	compound	B-protein
interaction	NN	nsubjpass	O
and	CC	cc	O
CREB	NN	compound	B-protein
trans-activation	NN	conj	O
were	VBD	auxpass	O
attained	VBN	ccomp	O
when	WRB	advmod	O
these	DT	det	O
three	CD	nummod	O
kinase	NN	compound	O
pathways	NNS	nsubjpass	O
were	VBD	auxpass	O
simultaneously	RB	advmod	O
activated	VBN	advcl	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
coordinated	VBN	amod	O
activation	NN	nsubj	O
of	IN	case	O
different	JJ	amod	O
kinases	NNS	nmod	B-protein
leads	VBZ	ccomp	O
to	TO	case	O
full	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
CREB	NN	nmod	B-protein
.	.	punct	O

Notably	RB	advmod	O
,	,	punct	O
CD28	NN	compound	O
ligation	NN	nsubj	O
activated	VBD	ROOT	O
p38	NN	compound	B-protein
MAPK	NN	dobj	I-protein
and	CC	cc	O
CaMKIV	NNP	conj	B-protein
,	,	punct	O
the	DT	det	O
kinases	NNS	dobj	B-protein
stimulated	VBN	acl	O
by	IN	case	O
CD3	NN	compound	O
engagement	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
CD28	NN	nsubj	B-protein
acts	VBZ	ccomp	O
by	IN	mark	O
increasing	VBG	advcl	O
the	DT	det	O
activation	NN	compound	O
extent	NN	dobj	O
of	IN	case	O
p38	NN	compound	B-protein
MAPK	NN	nmod	I-protein
and	CC	cc	O
CaMKIV	NNP	conj	B-protein
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
model	NN	dobj	O
of	IN	case	O
a	DT	det	O
minimum	JJ	amod	O
activation	NN	nmod	O
threshold	NN	dep	O
for	IN	case	O
CREB	NN	compound	B-protein
-	HYPH	punct	O
CBP	NN	compound	B-protein
interaction	NN	nmod	O
that	WDT	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
reached	VBN	acl:relcl	O
only	RB	advmod	O
when	WRB	advmod	O
both	CC	cc:preconj	O
CD3	NN	nsubjpass	B-protein
and	CC	cc	O
CD28	NN	conj	B-protein
are	VBP	auxpass	O
stimulated	VBN	advcl	O
.	.	punct	O

The	DT	det	O
murine	JJ	amod	B-DNA
IL-2	NN	compound	I-DNA
promoter	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
distal	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
elements	NNS	dobj	I-DNA
responsive	JJ	amod	O
to	TO	case	O
the	DT	det	O
Ah	NN	compound	B-protein
receptor	NN	nmod	I-protein
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
evolutionarily	RB	advmod	O
conserved	VBN	amod	O
bHLH-PAS	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
family	NN	nmod	I-protein
.	.	punct	O

Signaling	VBG	nsubj	O
through	IN	case	O
the	DT	det	O
TCR	NN	nmod	B-protein
and	CC	cc	O
costimulatory	JJ	amod	O
signals	NNS	conj	O
primarily	RB	advmod	O
control	VBP	ROOT	O
transcription	NN	dobj	O
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
naive	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
minimal	JJ	amod	B-DNA
promoter	NN	nsubj	I-DNA
necessary	JJ	amod	O
for	IN	case	O
this	DT	det	O
expression	NN	nmod	O
lies	VBZ	ROOT	O
proximal	JJ	xcomp	O
,	,	punct	O
between	IN	case	O
-300	CD	nmod	O
and	CC	cc	O
the	DT	det	O
transcription	NN	compound	B-DNA
start	NN	compound	I-DNA
site	NN	conj	I-DNA
.	.	punct	O

We	PRP	nsubj	O
had	VBD	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
arylhydrocarbon	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
AHR	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
bHLH-PAS	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
,	,	punct	O
leads	VBZ	ccomp	O
to	TO	case	O
increased	VBN	amod	O
mRNA	NN	compound	O
expression	NN	nmod	O
of	IN	case	O
IL-2	NN	nmod	B-RNA
in	IN	case	O
murine	JJ	amod	B-cell_type
fetal	JJ	amod	I-cell_type
thymocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
AHR	NN	nsubj	B-protein
is	VBZ	cop	O
abundant	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
thymus	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
play	VB	conj	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
its	PRP$	poss	O
overactivation	NN	nsubj	O
by	IN	case	O
chemicals	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
dioxins	NNS	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
immunosuppression	NN	nmod	O
and	CC	cc	O
thymic	JJ	amod	O
involution	NN	conj	O
.	.	punct	O

Binding	VBG	amod	O
motifs	NNS	nsubjpass	O
for	IN	case	O
the	DT	det	O
liganded	JJ	amod	B-protein
AHR	NN	nmod	I-protein
can	MD	aux	O
be	VB	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
distal	JJ	amod	B-DNA
region	NN	nmod	I-DNA
-1300	CD	dep	I-DNA
to	TO	dep	I-DNA
-800	CD	nmod	I-DNA
of	IN	case	O
the	DT	det	O
mouse	NN	compound	B-DNA
IL-2	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
these	DT	det	O
DNA	NN	compound	B-DNA
motifs	NNS	nsubj	I-DNA
,	,	punct	O
the	DT	det	O
so-called	JJ	amod	O
dioxin	NN	compound	B-DNA
response	NN	compound	I-DNA
elements	NNS	appos	I-DNA
,	,	punct	O
after	IN	mark	O
binding	VBG	acl	O
to	TO	case	O
the	DT	det	O
liganded	JJ	amod	B-protein
AHR	NN	nmod	I-protein
are	VBP	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
transactivate	VB	xcomp	O
luciferase	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
a	DT	det	O
reporter	NN	compound	O
gene	NN	compound	O
system	NN	nmod	O
.	.	punct	O

The	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
can	MD	aux	O
be	VB	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
AHR	NN	nmod	B-protein
also	RB	advmod	O
in	IN	case	O
thymocytes	NNS	nmod	B-cell_type
in	FW	compound	O
vivo	FW	advmod	O
after	IN	case	O
injection	NN	nmod	O
of	IN	case	O
2	CD	nummod	O
,	,	punct	O
3	CD	conj	O
,	,	punct	O
7	CD	conj	O
,	,	punct	O
8-tetrachlorodibenzo-p-dioxin	NN	nmod	O
,	,	punct	O
a	DT	det	O
potent	JJ	amod	O
ligand	NN	appos	O
of	IN	case	O
the	DT	det	O
AHR	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
AHR	NN	nsubj	B-protein
mediates	VBZ	ROOT	O
the	DT	det	O
IL-2	NN	compound	O
induction	NN	dobj	O
as	IN	mark	O
shown	VBN	advcl	O
with	IN	case	O
AHR	NN	compound	B-protein
-deficient	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
spleen	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
in	FW	amod	O
vitro	FW	dep	O
costimulation	NN	nsubj	O
via	IN	case	O
the	DT	det	O
TCR	NN	nmod	B-protein
is	VBZ	cop	O
necessary	JJ	ROOT	O
for	IN	case	O
optimal	JJ	amod	O
IL-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
induction	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
region	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
novel	JJ	amod	O
distal	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
elements	NNS	dobj	I-DNA
that	WDT	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
addressed	VBN	acl:relcl	O
by	IN	case	O
the	DT	det	O
AHR	NN	nmod	B-protein
to	TO	mark	O
induce	VB	xcomp	O
IL-2	NN	dobj	B-DNA
and	CC	cc	O
can	MD	aux	O
cooperate	VB	conj	O
with	IN	case	O
the	DT	det	O
proximal	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA

Visualization	NN	ROOT	O
of	IN	case	O
Syk-antigen	NN	compound	B-protein
receptor	NN	compound	I-protein
interactions	NNS	nmod	O
using	VBG	acl	O
green	JJ	amod	B-protein
fluorescent	NN	amod	I-protein
protein	NN	dobj	I-protein
:	:	punct	O
differential	JJ	amod	O
roles	NNS	dep	O
for	IN	case	O
Syk	NN	nmod	B-protein
and	CC	cc	O
Lyn	NN	conj	B-protein
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
receptor	NN	nmod	O
capping	NN	dep	O
and	CC	cc	O
internalization	NN	conj	O
.	.	punct	O

The	DT	det	O
cross-linking	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
B	NN	compound	B-protein
cell	NN	compound	I-protein
Ag	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
BCR	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	auxpass	O
coupled	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
stimulation	NN	nmod	O
of	IN	case	O
multiple	JJ	amod	O
intracellular	JJ	amod	O
signal	NN	compound	O
transduction	NN	compound	O
cascades	NNS	nmod	O
via	IN	case	O
receptor-associated	JJ	amod	O
,	,	punct	O
protein	NN	dep	B-protein
tyrosine	NN	compound	I-protein
kinases	NNS	nmod	I-protein
of	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
Src	NN	nmod	B-protein
and	CC	cc	I-protein
Syk	NN	conj	I-protein
families	NNS	nmod	I-protein
.	.	punct	O

To	TO	mark	O
monitor	VB	advcl	O
changes	NNS	dobj	O
in	IN	case	O
the	DT	det	O
subcellular	JJ	amod	O
distribution	NN	nmod	O
of	IN	case	O
Syk	NN	nmod	B-protein
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
responding	VBG	acl	O
to	TO	case	O
BCR	NN	compound	B-protein
cross-linking	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
expressed	VBD	ROOT	O
in	IN	case	O
Syk	NN	compound	B-protein
-deficient	JJ	amod	O
DT40	NN	compound	B-cell_line
B	NN	compound	I-cell_line
cells	VBZ	nmod	I-cell_line
a	DT	det	O
fusion	NN	compound	B-protein
protein	NN	dobj	I-protein
consisting	VBG	acl	O
of	IN	case	O
Syk	NN	nmod	B-protein
coupled	VBN	acl	O
to	TO	case	O
green	JJ	amod	B-protein
fluorescent	NN	amod	I-protein
protein	NN	nmod	I-protein
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
with	IN	case	O
anti-IgM	JJ	amod	B-protein
Abs	NNS	nmod	I-protein
leads	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
recruitment	NN	nmod	O
of	IN	case	O
the	DT	det	O
kinase	NN	nmod	B-protein
from	IN	case	O
cytoplasmic	JJ	amod	O
and	CC	cc	O
nuclear	JJ	conj	O
compartments	NNS	nmod	O
to	TO	case	O
the	DT	det	O
site	NN	nmod	O
of	IN	case	O
the	DT	det	O
cross-linked	JJ	amod	B-protein
receptor	NN	nmod	I-protein
at	IN	case	O
the	DT	det	O
plasma	NN	compound	O
membrane	NN	nmod	O
.	.	punct	O

The	DT	det	O
Syk-receptor	NN	amod	B-protein
complexes	NNS	nsubj	I-protein
aggregate	VBP	ROOT	O
into	IN	case	O
membrane	NN	compound	O
patches	NNS	nmod	O
that	WDT	nsubj	O
redistribute	VBP	acl:relcl	O
to	TO	aux	O
form	VB	xcomp	O
a	DT	det	O
cap	NN	dobj	O
at	IN	case	O
one	CD	nummod	O
pole	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	nmod	O
.	.	punct	O

Syk	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
not	RB	neg	O
demonstrably	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
internalized	VBN	amod	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Catalytically	RB	advmod	O
active	JJ	amod	O
Syk	NN	nsubj	B-protein
promotes	NNS	ROOT	O
and	CC	cc	O
stabilizes	VBZ	conj	O
the	DT	det	O
formation	NN	dobj	O
of	IN	case	O
tightly	RB	advmod	B-protein
capped	VBN	amod	I-protein
BCR	NN	compound	I-protein
complexes	NNS	nmod	I-protein
at	IN	case	O
the	DT	det	O
plasma	NN	compound	O
membrane	NN	nmod	O
.	.	punct	O

Lyn	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
not	RB	neg	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
recruitment	NN	nmod	O
of	IN	case	O
Syk	NN	nmod	B-protein
to	TO	case	O
the	DT	det	O
cross-linked	JJ	amod	B-protein
receptor	NN	nmod	I-protein
,	,	punct	O
but	CC	cc	O
is	VBZ	auxpass	O
required	VBN	conj	O
for	IN	case	O
the	DT	det	O
internalization	NN	nmod	O
of	IN	case	O
the	DT	det	O
clustered	VBN	amod	O
BCR	NN	compound	B-protein
complexes	NNS	nmod	I-protein
.	.	punct	O

In	IN	case	O
the	DT	det	O
absence	NN	pobj	O
of	IN	case	O
Lyn	NN	compound	B-protein
,	,	punct	O
receptor-Syk	NN	amod	B-protein
complexes	NNS	nsubjpass	I-protein
at	IN	case	O
the	DT	det	O
plasma	NN	compound	O
membrane	NN	nmod	O
are	VBP	auxpass	O
long	RB	advmod	O
lived	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
receptor-mediated	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
NF-AT	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
is	VBZ	auxpass	O
enhanced	VBN	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
Lyn	NN	nsubj	B-protein
appears	VBZ	ROOT	O
to	TO	mark	O
function	VB	xcomp	O
to	TO	mark	O
negatively	RB	advmod	O
regulate	VB	xcomp	O
aspects	NNS	dobj	O
of	IN	case	O
BCR	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
signaling	NN	nmod	O
by	IN	mark	O
stimulating	VBG	advcl	O
receptor	NN	compound	O
internalization	NN	dobj	O
and	CC	cc	O
down-regulation	NN	conj	O
.	.	punct	O

Renal	JJ	amod	O
interstitial	JJ	amod	O
fibrosis	NN	nsubjpass	O
is	VBZ	auxpass	O
reduced	VBN	ROOT	O
in	IN	case	O
angiotensin	NN	compound	B-protein
II	CD	nummod	I-protein
type	NN	compound	I-protein
1a	NN	compound	I-protein
receptor	NN	compound	I-protein
-deficient	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

Unilateral	JJ	amod	O
ureteral	JJ	amod	O
obstruction	NN	nsubj	O
(	-LRB-	punct	O
UUO	NN	appos	O
)	-RRB-	punct	O
results	VBZ	ROOT	O
in	IN	case	O
tubulointerstitial	JJ	compound	O
fibrosis	NN	nmod	O
of	IN	case	O
the	DT	det	O
affected	VBN	amod	O
kidney	NN	nmod	O
by	IN	mark	O
stimulating	VBG	advcl	O
the	DT	det	O
renin-angiotensin	JJ	amod	O
system	NN	dobj	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
established	VBD	ROOT	O
a	DT	det	O
UUO	NN	compound	O
model	NN	dobj	O
in	IN	case	O
angiotensin	NN	compound	B-protein
type	NN	compound	I-protein
1a	NN	compound	I-protein
receptor	NN	dep	I-protein
(	-LRB-	punct	O
AT1a	NN	appos	B-protein
)	-RRB-	punct	O
deficient	JJ	intj	O
(	-LRB-	punct	O
mutant	JJ	amod	O
)	-RRB-	punct	O
mice	NNS	nmod	O
to	TO	mark	O
elucidate	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
angiotensin	NN	nmod	B-protein
II	CD	nummod	I-protein
through	IN	case	O
AT1a	NN	nmod	B-protein
on	IN	case	O
the	DT	det	O
fibrosis	NN	nmod	O
of	IN	case	O
the	DT	det	O
obstructed	JJ	amod	O
kidney	NN	nmod	O
(	-LRB-	punct	O
OBK	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
relative	JJ	amod	O
volume	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
tubulointerstitium	NN	nmod	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
an	DT	det	O
image	NN	amod	O
analyzer	NN	nmod	O
;	:	punct	O
deposition	NN	nsubjpass	O
of	IN	case	O
collagen	NN	compound	B-protein
types	NNS	nmod	I-protein
III	CD	dep	I-protein
and	CC	cc	I-protein
IV	CD	conj	I-protein
and	CC	cc	O
monocyte	NN	compound	B-cell_type
/	:	punct	O
macrophage	NN	conj	B-cell_type
infiltration	NN	nmod	O
were	VBD	auxpass	O
histologically	RB	advmod	O
examined	VBN	parataxis	O
using	VBG	xcomp	O
specific	JJ	amod	B-protein
antibodies	NNS	dobj	I-protein
.	.	punct	O

Also	RB	advmod	O
determined	VBN	ROOT	O
were	VBD	cop	O
the	DT	det	O
mRNA	NN	compound	O
levels	NNS	dobj	O
of	IN	case	O
transforming	VBG	amod	B-protein
growth	NN	compound	I-protein
factor-beta	NN	nmod	I-protein
by	IN	case	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor-kappaB	NN	compound	I-protein
activity	NN	nsubjpass	O
was	VBD	auxpass	O
assessed	VBN	ROOT	O
by	IN	case	O
gel	NN	compound	O
shift	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

UUO	NN	nsubj	O
in	IN	case	O
wild	JJ	amod	O
mice	NNS	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
marked	JJ	amod	O
expansion	NN	nmod	O
of	IN	case	O
relative	JJ	amod	O
volume	NN	nmod	O
of	IN	case	O
the	DT	det	O
tubulointerstitium	NN	nmod	O
,	,	punct	O
together	RB	advmod	O
with	IN	case	O
increased	VBN	amod	O
deposition	NN	nmod	O
of	IN	case	O
collagen	NN	compound	B-protein
types	NNS	nmod	I-protein
III	CD	dep	I-protein
and	CC	cc	I-protein
IV	CD	conj	I-protein
and	CC	cc	O
number	NN	conj	O
of	IN	case	O
infiltrated	VBN	amod	O
monocytes	NNS	nmod	B-cell_type
/	:	punct	O
macrophages	NNS	conj	B-cell_type
in	IN	case	O
the	DT	det	O
interstitium	NN	nmod	O
,	,	punct	O
relative	JJ	case	O
to	TO	case	O
sham-operated	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

In	IN	case	O
comparison	NN	nmod	O
,	,	punct	O
these	DT	det	O
changes	NNS	nsubj	O
were	VBD	cop	O
significantly	RB	advmod	O
lower	JJR	ROOT	O
in	IN	case	O
mutant	JJ	amod	O
mice	NNS	nmod	O
with	IN	case	O
UUO	NN	nmod	O
.	.	punct	O

The	DT	det	O
mRNA	NN	compound	O
level	NN	nsubj	O
of	IN	case	O
transforming	VBG	amod	B-protein
growth	NN	compound	I-protein
factor-beta	NN	nmod	I-protein
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
in	IN	case	O
the	DT	det	O
OBK	NN	nmod	O
of	IN	case	O
wild	JJ	amod	O
mice	NNS	nmod	O
with	IN	case	O
UUO	NN	nmod	O
compared	VBN	case	O
with	IN	case	O
sham-operated	JJ	amod	O
mice	NNS	advcl	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
increase	NN	nsubj	O
in	IN	case	O
mRNA	NN	compound	O
level	NN	nmod	O
in	IN	case	O
the	DT	det	O
OBK	NN	nmod	O
of	IN	case	O
mutant	JJ	amod	O
mice	NNS	nmod	O
was	VBD	cop	O
significantly	RB	advmod	O
less	JJR	ROOT	O
than	IN	case	O
in	IN	case	O
wild	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
UUO	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
activation	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod	I-protein
in	IN	case	O
wild	JJ	amod	O
mice	NNS	nmod	O
but	CC	cc	O
was	VBD	auxpass	O
inhibited	VBN	conj	O
in	IN	case	O
the	DT	det	O
OBK	NN	nmod	O
of	IN	case	O
mutant	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
provide	VBP	ROOT	O
direct	JJ	amod	O
evidence	NN	dobj	O
that	IN	mark	O
angiotensin	NN	nsubj	B-protein
II	CD	nummod	I-protein
acting	VBG	acl	O
via	IN	case	O
the	DT	det	O
AT1a	NN	nmod	B-protein
plays	VBZ	ccomp	O
a	DT	det	O
pivotal	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
tubulointerstitial	JJ	compound	O
fibrosis	NN	nmod	O
in	IN	case	O
UUO	NN	nmod	O
.	.	punct	O

HLA-DQ	NN	compound	B-protein
tetramers	NNS	nsubj	I-protein
identify	VBP	ROOT	O
epitope-specific	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
in	IN	case	O
peripheral	JJ	amod	O
blood	NN	nmod	O
of	IN	case	O
herpes	NN	compound	O
simplex	NN	compound	O
virus	NN	nmod:npmod	O
type	NN	nmod:npmod	O
2-infected	JJ	amod	O
individuals	NNS	nmod	O
:	:	punct	O
direct	JJ	amod	O
detection	NN	dep	O
of	IN	case	O
immunodominant	JJ	amod	B-cell_type
antigen-responsive	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Ag-specific	JJ	amod	B-cell_type
CD4+	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
are	VBP	cop	O
present	JJ	ROOT	O
in	IN	case	O
peripheral	JJ	amod	O
blood	NN	nmod	O
in	IN	case	O
low	JJ	amod	O
frequency	NN	nmod	O
,	,	punct	O
where	WRB	advmod	O
they	PRP	nsubj	O
undergo	VBP	acl:relcl	O
recruitment	NN	dobj	O
and	CC	cc	O
expansion	NN	conj	O
during	IN	case	O
immune	JJ	amod	O
responses	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	conj	O
of	IN	case	O
numerous	JJ	amod	O
autoimmune	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

MHC	NN	compound	B-protein
tetramers	NNS	nsubj	I-protein
,	,	punct	O
which	WDT	nsubj	O
constitute	VBP	relcl	O
a	DT	det	O
labeled	VBN	amod	B-protein
MHC-peptide	NN	compound	I-protein
ligand	NN	dobj	I-protein
suitable	JJ	amod	O
for	IN	mark	O
binding	VBG	nmod	O
to	TO	case	O
the	DT	det	O
Ag-specific	JJ	amod	B-protein
receptor	NN	nmod	I-protein
on	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
provide	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
approach	NN	dobj	O
for	IN	case	O
the	DT	dep	O
detection	NN	nmod	O
and	CC	cc	O
characterization	NN	conj	O
of	IN	case	O
such	JJ	amod	O
rare	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
utilized	VBD	ROOT	O
this	DT	det	O
technology	NN	dobj	O
to	TO	mark	O
identify	VB	xcomp	O
HLA	NN	compound	B-protein
DQ	NN	compound	I-protein
-restricted	JJ	amod	O
Ag-specific	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
in	IN	case	O
the	DT	det	O
peripheral	JJ	amod	O
blood	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
subjects	NNS	nmod	O
and	CC	cc	O
to	TO	mark	O
identify	VB	conj	O
immunodominant	JJ	amod	O
epitopes	NNS	dobj	O
associated	VBN	acl	O
with	IN	case	O
viral	JJ	amod	O
infection	NN	nmod	O
.	.	punct	O

Peptides	NNS	nsubjpass	O
representing	VBG	acl	O
potential	JJ	amod	O
epitope	NN	compound	B-protein
regions	NNS	dobj	I-protein
of	IN	case	O
the	DT	det	O
VP16	NN	compound	B-protein
protein	NN	nmod	I-protein
from	IN	case	O
HSV-2	NN	nmod	O
were	VBD	auxpass	O
loaded	VBN	ROOT	O
onto	IN	case	O
recombinant	JJ	amod	B-protein
DQ0602	NN	compound	I-protein
molecules	NNS	nmod	I-protein
to	TO	mark	O
generate	VB	xcomp	O
a	DT	det	O
panel	NN	dobj	O
of	IN	case	O
Ag-specific	JJ	amod	B-protein
DQ0602	NN	compound	I-protein
tetramers	NNS	nmod	I-protein
.	.	punct	O

VP16	NN	compound	B-protein
Ag	NN	compound	I-protein
-specific	JJ	amod	O
DQ-restricted	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
identified	VBN	ROOT	O
and	CC	cc	O
expanded	VBN	conj	O
from	IN	case	O
the	DT	det	O
peripheral	JJ	amod	O
blood	NN	nmod	O
of	IN	case	O
HSV-2-infected	JJ	amod	O
individuals	NNS	nmod	O
,	,	punct	O
representing	VBG	advcl	O
two	CD	nummod	O
predominant	JJ	amod	O
epitope	NN	compound	O
specificities	NNS	dobj	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
VP16	NN	compound	O
369-380	CD	nummod	O
peptide	NN	nsubj	O
has	VBZ	advcl	O
a	DT	det	O
lower	JJR	amod	O
binding	NN	compound	O
affinity	NN	dobj	O
for	IN	case	O
DQ0602	NN	compound	B-protein
molecules	NNS	nmod	I-protein
than	IN	case	O
the	DT	det	O
VP16	NN	compound	O
33-52	CD	nummod	O
peptide	NN	nmod	O
,	,	punct	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
that	WDT	nsubj	O
recognized	VBD	acl:relcl	O
the	DT	det	O
VP16	NN	compound	O
369-380	CD	nummod	O
peptide	NN	dobj	O
occurred	VBD	ROOT	O
at	IN	case	O
a	DT	det	O
much	RB	advmod	O
higher	JJR	amod	O
frequency	NN	nmod	O
than	IN	case	O
those	DT	nmod	O
that	WDT	nsubj	O
were	VBD	cop	O
specific	JJ	acl:relcl	O
for	IN	case	O
the	DT	det	O
VP16	NN	compound	O
33-52	CD	nummod	O
peptide	NN	nmod	O
.	.	punct	O

Down-regulation	NN	nsubj	O
of	IN	case	O
BOB.1/OBF.1	NN	nmod	B-protein
and	CC	cc	O
Oct2	NN	conj	B-protein
in	IN	case	O
classical	JJ	amod	O
Hodgkin	NN	compound	O
disease	NN	nmod	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
lymphocyte	NN	compound	O
predominant	JJ	amod	O
Hodgkin	NN	compound	O
disease	NN	conj	O
correlates	VBZ	ROOT	O
with	IN	case	O
immunoglobulin	NN	compound	O
transcription	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
to	TO	case	O
the	DT	det	O
tumor	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
L	NN	dep	B-cell_type
&	CC	cc	I-cell_type
H	NN	conj	I-cell_type
cells	NNS	dep	I-cell_type
)	-RRB-	punct	O
of	IN	case	O
lymphocyte	NN	compound	O
predominant	JJ	amod	O
Hodgkin	NN	compound	O
disease	NN	nmod	O
(	-LRB-	punct	O
LPHD	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
Hodgkin	NN	compound	B-cell_type
and	CC	cc	I-cell_type
Reed-Sternberg	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
HRS	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nsubj	I-cell_type
of	IN	case	O
classical	JJ	amod	O
Hodgkin	NN	compound	O
disease	NN	nmod	O
(	-LRB-	punct	O
cHD	NN	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
unable	JJ	ROOT	O
to	TO	mark	O
transcribe	VB	xcomp	O
immunoglobulin	NN	dobj	B-protein
,	,	punct	O
despite	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
rearranged	VBN	amod	B-DNA
immunoglobulin	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Although	IN	mark	O
initial	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
suggested	VBN	advcl	O
crippling	VBG	amod	O
immunoglobulin	NN	compound	O
gene	NN	compound	O
mutations	NNS	dobj	O
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
cause	NN	xcomp	O
of	IN	case	O
absent	JJ	amod	O
immunoglobulin	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
cHD	NN	nmod	O
,	,	punct	O
recent	JJ	amod	O
work	NN	nsubj	O
of	IN	case	O
our	PRP$	poss	O
group	NN	nmod	O
has	VBZ	aux	O
demonstrated	VBN	ROOT	O
an	DT	det	O
impaired	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
as	IN	case	O
a	DT	det	O
superior	JJ	amod	O
mechanism	NN	nmod	O
.	.	punct	O

As	IN	mark	O
immunoglobulin	NN	compound	O
transcription	NN	nsubjpass	O
is	VBZ	auxpass	O
mainly	RB	advmod	O
regulated	VBN	advcl	O
by	IN	case	O
the	DT	det	O
B-cell	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
Oct2	NN	dep	B-protein
and	CC	cc	O
BOB.1/OBF.1	NN	conj	B-protein
,	,	punct	O
we	PRP	nsubj	O
analyzed	VBD	ROOT	O
35	CD	nummod	O
cases	NNS	dobj	O
of	IN	case	O
LPHD	NN	nmod	O
,	,	punct	O
32	CD	nummod	O
cases	NNS	appos	O
of	IN	case	O
cHD	NN	nmod	O
,	,	punct	O
and	CC	cc	O
2	CD	nummod	O
Hodgkin	NN	compound	B-cell_line
disease	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
for	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
these	DT	det	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
and	CC	cc	O
also	RB	advmod	O
in	IN	case	O
parallel	NN	conj	O
for	IN	case	O
immunoglobulin	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
an	DT	det	O
absence	NN	dobj	O
of	IN	case	O
Oct2	NN	nmod	B-protein
and/or	CC	cc	O
BOB.1/OBF.1	NN	conj	B-protein
in	IN	case	O
cHD	NN	nmod	O
and	CC	cc	O
a	DT	det	O
striking	JJ	amod	O
overexpression	NN	conj	O
of	IN	case	O
Oct2	NN	nmod	B-protein
in	IN	case	O
LPHD	NN	nmod	O
.	.	punct	O

Immunoglobulin	NN	compound	O
expression	NN	nsubj	O
was	VBD	aux	O
lacking	VBG	ROOT	O
in	IN	case	O
cHD	NN	nmod	O
but	CC	cc	O
present	JJ	conj	O
in	IN	case	O
LPHD	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
reintroduction	NN	nsubj	O
of	IN	case	O
BOB.1/OBF.1	NN	nmod	B-protein
and	CC	cc	O
Oct2	NN	conj	B-protein
into	IN	case	O
cultured	VBN	amod	O
HRS	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
restored	VBD	ROOT	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
cotransduced	VBN	amod	O
immunoglobulin	NN	compound	B-DNA
promoter	NN	compound	I-DNA
constructs	NNS	nmod	I-DNA
.	.	punct	O

Our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
dismiss	VBP	ROOT	O
the	DT	det	O
concept	NN	dobj	O
that	IN	mark	O
the	DT	det	O
different	JJ	amod	O
immunoglobulin	NN	compound	O
expression	NN	nsubj	O
in	IN	case	O
cHD	NN	nmod	O
and	CC	cc	O
LPHD	NN	conj	O
is	VBZ	cop	O
due	JJ	ccomp	O
to	TO	mark	O
disrupting	VBG	xcomp	O
mutations	NNS	dobj	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
V	NN	compound	I-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
cHD	NN	nmod	O
but	CC	cc	O
is	VBZ	cop	O
most	RBS	advmod	O
likely	RB	conj	O
due	JJ	case	O
to	TO	mwe	O
a	DT	det	O
down-regulation	NN	nmod	O
of	IN	case	O
Oct2	NN	nmod	B-protein
and/or	CC	cc	O
BOB.1/OBF.1	NN	conj	B-protein
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
further	RB	advmod	O
revealed	VBD	ROOT	O
Oct2	NN	dobj	B-protein
as	IN	case	O
a	DT	det	O
new	JJ	amod	O
and	CC	cc	O
valuable	JJ	conj	O
marker	NN	nmod	O
for	IN	case	O
the	DT	det	O
identification	NN	nmod	O
of	IN	case	O
L	NN	compound	B-cell_type
&	CC	cc	I-cell_type
H	NN	conj	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
their	PRP$	nmod:poss	O
distinction	NN	conj	O
from	IN	case	O
HRS	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
impairment	NN	nsubj	O
of	IN	case	O
immunoglobulin	NN	compound	O
transcription	NN	nmod	O
with	IN	case	O
a	DT	det	O
down-regulated	JJ	amod	O
synthesis	NN	nmod	O
of	IN	case	O
Oct2	NN	nmod	B-protein
and	CC	cc	O
BOB.1/OBF.1	NN	conj	B-protein
is	VBZ	cop	O
the	DT	det	O
first	JJ	amod	O
established	JJ	amod	O
general	JJ	amod	O
recurrent	JJ	amod	O
defect	NN	ROOT	O
found	VBN	acl	O
in	IN	case	O
HRS	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Constitutive	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
is	VBZ	cop	O
a	DT	det	O
characteristic	JJ	amod	O
feature	NN	ROOT	O
of	IN	case	O
mycosis	JJ	compound	O
fungoides	NNS	nmod	O
:	:	punct	O
implications	NNS	dep	O
for	IN	case	O
apoptosis	NN	compound	O
resistance	NN	nmod	O
and	CC	cc	O
pathogenesis	NN	conj	O
.	.	punct	O

The	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
family	NN	nsubj	I-protein
of	IN	case	I-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
genes	NNS	nmod	O
expressed	VBN	acl	O
during	IN	case	O
inflammatory	JJ	amod	O
responses	NNS	nmod	O
,	,	punct	O
immunoglobulin	NN	compound	O
(	-LRB-	punct	O
Ig	NN	compound	O
)	-RRB-	punct	O
class	NN	compound	O
switching	NN	conj	O
,	,	punct	O
cellular	JJ	amod	O
differentiation	NN	conj	O
,	,	punct	O
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
members	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
family	NN	nmod	I-protein
,	,	punct	O
including	VBG	case	O
p65	NN	compound	B-protein
(	-LRB-	punct	I-protein
Rel	NN	compound	I-protein
A	NN	nmod	I-protein
)	-RRB-	punct	I-protein
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
in	IN	mark	O
promoting	VBG	advcl	O
survival	NN	dobj	O
of	IN	case	O
various	JJ	amod	O
hematopoeitic	JJ	amod	O
neoplasms	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
T	NN	compound	O
cell	NN	compound	O
malignancies	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
adult	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
leukemia-lymphoma	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
active	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	compound	I-protein
p65	NN	compound	I-protein
(	-LRB-	punct	I-protein
Rel	NN	compound	I-protein
A	NN	nmod	I-protein
)	-RRB-	punct	I-protein
in	IN	case	O
cases	NNS	nmod	O
of	IN	case	O
mycosis	NN	compound	O
fungoides	NNS	nmod	O
(	-LRB-	punct	O
MF	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
effect	NN	conj	O
of	IN	case	O
chemical	JJ	amod	O
inhibitors	NNS	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
on	IN	case	O
apoptosis	NN	nmod	O
in	IN	case	O
cutaneous	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lymphoma	NN	compound	I-cell_line
(	-LRB-	punct	I-cell_line
CTCL	NN	compound	I-cell_line
)	-RRB-	punct	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Paraffin-embedded	JJ	amod	O
tissues	NNS	nsubjpass	O
from	IN	case	O
23	CD	nummod	O
cutaneous	JJ	amod	O
lesions	NNS	nmod	O
and	CC	cc	O
a	DT	det	O
single	JJ	amod	O
lymph	NN	compound	O
node	NN	compound	O
biopsy	NN	conj	O
from	IN	case	O
patients	NNS	nmod	O
diagnosed	VBN	acl	O
with	IN	case	O
MF	NN	nmod	O
were	VBD	auxpass	O
evaluated	VBN	ROOT	O
for	IN	case	O
p65	NN	compound	O
(	-LRB-	punct	O
Rel	NN	compound	O
A	NN	appos	O
)	-RRB-	punct	O
expression	NN	nmod	O
by	IN	mark	O
using	VBG	advcl	O
a	DT	det	O
monoclonal	JJ	amod	B-protein
mouse	NN	compound	I-protein
antibody	NN	dobj	I-protein
that	WDT	nsubj	O
detects	VBZ	acl:relcl	O
the	DT	det	O
activated	VBN	amod	O
form	NN	dobj	O
of	IN	case	O
p65	NN	compound	B-protein
(	-LRB-	punct	I-protein
Rel	NN	compound	I-protein
A	NN	nmod	I-protein
)	-RRB-	punct	I-protein
.	.	punct	O

Apoptosis	NN	nsubjpass	O
after	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	O
B	NN	compound	O
inhibitors	NNS	nmod	O
gliotoxin	NN	dep	O
,	,	punct	O
MG132	NN	conj	O
,	,	punct	O
BAY	NN	conj	O
11-7082	CD	nummod	O
,	,	punct	O
and	CC	cc	O
BAY	NN	compound	O
11-7085	CD	conj	O
was	VBD	auxpass	O
quantitatively	RB	advmod	O
measured	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
CTCL	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
HuT-78	NN	dep	I-cell_line
and	CC	cc	I-cell_line
HH	NN	conj	I-cell_line
by	IN	case	O
propidium	NN	compound	O
iodide	NN	compound	O
(	-LRB-	punct	O
PI	NN	compound	O
)	-RRB-	punct	O
/cell	NN	compound	O
cycle	NN	compound	O
analysis	NN	nmod	O
for	IN	case	O
detection	NN	nmod	O
of	IN	case	O
a	DT	det	O
hypodiploid	NN	nmod	O
(	-LRB-	punct	O
sub-G	NN	dep	O
(	-LRB-	punct	O
0	CD	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
population	NN	dep	O
and	CC	cc	O
by	IN	case	O
determination	NN	conj	O
of	IN	case	O
increased	VBN	amod	O
Annexin	NN	compound	O
V/7-amino-actinomycin	NN	compound	O
D	NN	compound	O
(	-LRB-	punct	O
7-AAD	NN	appos	O
)	-RRB-	punct	O
expression	NN	nmod	O
.	.	punct	O

Nuclear	JJ	amod	O
extracts	NNS	nsubjpass	O
from	IN	case	O
CTCL	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
before	IN	nmod	O
and	CC	cc	O
after	IN	conj	O
chemical	JJ	amod	O
inhibition	NN	nmod	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
for	IN	case	O
NF-kappa	NN	compound	O
B	NN	compound	O
nuclear	JJ	amod	O
DNA-binding	JJ	amod	O
activity	NN	nmod	O
by	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	nmod	O
(	-LRB-	punct	O
EMSA	NN	appos	O
)	-RRB-	punct	O
with	IN	case	O
quantitative	JJ	amod	O
densitometry	NN	nmod	O
.	.	punct	O

Nuclear	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
p65	NN	compound	B-protein
(	-LRB-	punct	I-protein
Rel	NN	compound	I-protein
A	NN	nmod	I-protein
)	-RRB-	punct	I-protein
before	IN	nmod	O
and	CC	cc	O
after	IN	conj	O
treatment	NN	nmod	O
with	IN	case	O
the	DT	det	O
various	JJ	amod	O
inhibitory	JJ	amod	O
compounds	NNS	nmod	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
by	IN	case	O
immunofluorescence	NN	compound	O
staining	NN	nmod	O
in	IN	case	O
each	DT	det	O
CTCL	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

Neoplastic	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nsubj	I-cell_type
from	IN	case	O
22	CD	compound	O
of	IN	advmod	O
24	CD	nummod	O
cases	NNS	nmod	O
of	IN	case	O
MF	NN	nmod	O
showed	VBD	ROOT	O
strong	JJ	amod	O
nuclear	JJ	amod	O
and	CC	cc	O
cytoplasmic	JJ	conj	O
expression	NN	dobj	O
of	IN	case	O
active	JJ	amod	B-protein
p65	NN	compound	I-protein
(	-LRB-	punct	I-protein
Rel	NN	compound	I-protein
A	NN	nmod	I-protein
)	-RRB-	punct	I-protein
.	.	punct	O

Compared	VBN	case	O
with	IN	case	O
untreated	JJ	amod	O
control	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
a	DT	det	O
marked	JJ	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
decrease	NN	appos	O
in	IN	case	O
NF-kappa	NN	compound	O
B	NN	compound	O
DNA-binding	JJ	amod	O
activity	NN	nmod	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
marked	JJ	amod	O
decrease	NN	nsubjpass	O
in	IN	case	O
nuclear	JJ	amod	O
p65	NN	compound	O
(	-LRB-	punct	O
Rel	NN	compound	O
A	NN	appos	O
)	-RRB-	punct	O
expression	NN	nmod	O
were	VBD	auxpass	O
seen	VBN	ROOT	O
in	IN	case	O
cells	NNS	nmod	O
from	IN	case	O
both	CC	det	O
CTCL	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
after	IN	case	O
chemical	JJ	amod	O
NF-kappa	NN	compound	O
B	NN	compound	O
inhibition	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
active	JJ	amod	O
form	NN	nsubjpass	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
p65	NN	compound	I-protein
(	-LRB-	punct	I-protein
Rel	NN	compound	I-protein
A	NN	nmod	I-protein
)	-RRB-	punct	I-protein
is	VBZ	auxpass	O
commonly	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
neoplastic	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
MF	NN	nmod	O
.	.	punct	O

In	IN	case	O
CTCL	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
the	DT	det	O
significant	JJ	amod	O
decrease	NN	nsubj	O
in	IN	case	O
nuclear	JJ	amod	O
NF-kappa	NN	compound	O
B	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
the	DT	det	O
marked	JJ	amod	O
increase	NN	conj	O
in	IN	case	O
spontaneous	JJ	amod	O
apoptosis	NN	nmod	O
caused	VBN	acl	O
by	IN	case	O
chemical	JJ	amod	O
NF-kappa	NN	compound	O
B	NN	compound	O
inhibition	NN	nmod	O
suggest	VBP	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	O
cell	NN	compound	O
maintenance	NN	conj	O
of	IN	case	O
CTCLs	NN	nmod	O
.	.	punct	O

HUM	NNP	compound	O
PATHOL	NNP	ROOT	O
31	CD	nummod	O
:	:	punct	O
1482-1490	CD	nummod	O
.	.	punct	O

Human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
tax	NN	compound	B-protein
protein	NN	nsubj	I-protein
activates	VBZ	ROOT	O
transcription	NN	dobj	O
through	IN	case	O
AP-1	NN	compound	B-DNA
site	NN	nmod	I-DNA
by	IN	mark	O
inducing	VBG	advcl	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Human	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HTLV-1	NN	compound	O
)	-RRB-	punct	O
Tax	NN	compound	B-protein
protein	NN	nsubj	I-protein
induces	VBZ	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
various	JJ	amod	O
family	NN	compound	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
AP-1	NN	nmod	I-protein
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
c-Jun	NN	nmod	B-protein
,	,	punct	O
JunD	NN	conj	B-protein
,	,	punct	O
c-Fos	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
Fra-1	NN	conj	B-protein
,	,	punct	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
RNA	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
Tax	NN	nmod	B-protein
in	IN	case	O
transcription	NN	nmod	O
through	IN	case	O
AP-1-binding	JJ	amod	B-DNA
sites	NNS	nmod	I-DNA
(	-LRB-	punct	O
AP-1	NN	compound	B-DNA
site	NN	appos	I-DNA
)	-RRB-	punct	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Transient	JJ	amod	O
transfection	NN	compound	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
Tax	NN	nsubj	B-protein
activated	VBD	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
a	DT	det	O
luciferase	NN	compound	B-DNA
gene	NN	nmod	I-DNA
regulated	VBN	acl	O
by	IN	case	O
two	CD	nummod	O
copies	NNS	nmod	O
of	IN	case	O
an	DT	det	O
AP-1	NN	compound	B-DNA
site	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
T-cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

Tax	NN	nsubj	B-protein
activates	VBZ	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
viral	JJ	amod	B-DNA
and	CC	cc	I-DNA
cellular	JJ	conj	I-DNA
genes	NNS	nmod	I-DNA
through	IN	case	O
two	CD	nummod	O
different	JJ	amod	O
enhancers	NNS	nmod	O
:	:	punct	O
a	DT	det	O
cAMP-responsive	JJ	amod	B-DNA
(	-LRB-	punct	I-DNA
CRE	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
-like	JJ	amod	I-DNA
element	NN	dep	I-DNA
and	CC	cc	O
a	DT	det	O
kappaB	NN	compound	B-DNA
element	NN	conj	I-DNA
.	.	punct	O

Two	CD	nummod	O
Tax	NN	compound	B-protein
mutants	NNS	nsubj	I-protein
differentially	RB	advmod	O
activated	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
these	DT	det	O
two	CD	nummod	O
elements	NNS	nmod	O
.	.	punct	O

Tax703	NN	nsubj	B-protein
preferentially	RB	advmod	O
activated	VBD	ROOT	O
the	DT	det	O
kappaB	NN	compound	B-DNA
element	NN	dobj	I-DNA
but	CC	cc	O
not	RB	cc	O
the	DT	det	O
CRE-like	JJ	amod	O
one	CD	conj	O
,	,	punct	O
whereas	IN	mark	O
TaxM22	NN	nsubj	B-protein
showed	VBD	advcl	O
the	DT	det	O
reverse	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
Tax703	NN	nsubj	B-protein
and	CC	cc	O
Tax	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
TaxM22	NN	conj	B-protein
,	,	punct	O
converted	VBD	ROOT	O
cell	NN	compound	O
growth	NN	dobj	O
of	IN	case	O
a	DT	det	O
mouse	NN	compound	B-cell_line
T-cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
from	IN	mark	O
being	VBG	cop	O
interleukin	NN	compound	O
(	-LRB-	punct	O
IL	NN	nmod	O
)	-RRB-	punct	O
-2-dependent	JJ	nummod	O
to	TO	mark	O
being	VBG	advcl	O
IL-2-independent	JJ	acomp	O
.	.	punct	O

Unlike	IN	case	O
the	DT	det	O
wild-type	JJ	amod	B-protein
Tax	NN	nmod	I-protein
,	,	punct	O
Tax703	NN	conj	B-protein
and	CC	cc	O
TaxM22	NN	conj	B-protein
only	RB	advmod	O
weakly	RB	advmod	O
activated	VBD	ROOT	O
the	DT	det	O
AP-1	NN	compound	B-DNA
site	NN	dobj	I-DNA
in	IN	case	O
the	DT	det	O
T-cell	NN	compound	B-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
Tax	NN	nsubj	B-protein
seems	VBZ	ROOT	O
to	TO	mark	O
activate	VB	xcomp	O
the	DT	det	O
AP-1	NN	compound	B-DNA
site	NN	dobj	I-DNA
via	IN	case	O
mechanisms	NNS	nmod	O
distinct	JJ	amod	O
from	IN	case	O
those	DT	nmod	O
of	IN	case	O
kappaB	NN	nmod	B-DNA
or	CC	cc	I-DNA
CRE-like	JJ	conj	I-DNA
elements	NNS	dep	I-DNA
,	,	punct	O
and	CC	cc	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
AP-1	NN	compound	B-DNA
site	NN	nmod	I-DNA
is	VBZ	cop	O
dispensable	JJ	conj	O
for	IN	case	O
IL-2-independent	JJ	amod	O
growth	NN	nmod	O
of	IN	case	O
CTLL-2	NN	nmod	O
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
Tax	NN	nsubj	B-protein
induced	VBD	ccomp	O
strong	JJ	amod	O
binding	NN	compound	O
activity	NN	dobj	O
to	TO	case	O
an	DT	det	O
AP-1	NN	compound	B-DNA
site	NN	nmod	I-DNA
in	IN	case	O
CTLL-2	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
Tax703	NN	nsubj	B-protein
did	VBD	advcl	O
not	RB	neg	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
binding	NN	compound	O
activity	NN	nmod	O
to	TO	case	O
the	DT	det	O
AP-1	NN	compound	B-DNA
site	NN	nmod	I-DNA
is	VBZ	cop	O
essential	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
by	IN	case	O
Tax	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
binding	VBG	compound	B-protein
complex	NN	nsubj	I-protein
induced	VBN	acl	O
by	IN	case	O
Tax	NN	nmod	B-protein
in	IN	case	O
CTLL-2	NN	nmod	O
contained	VBD	ROOT	O
JunD	NN	dobj	B-protein
and	CC	cc	O
Fra-2	NN	conj	B-protein
.	.	punct	O

Other	JJ	amod	O
AP-1	NN	compound	B-protein
proteins	NNS	nsubj	I-protein
were	VBD	cop	O
undetectable	JJ	ROOT	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
transcription	NN	nmod	O
through	IN	case	O
the	DT	det	O
AP-1	NN	compound	B-DNA
site	NN	nmod	I-DNA
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
by	IN	case	O
JunD	NN	nmod	B-protein
and/or	CC	cc	O
Fra-2	NN	conj	B-protein
was	VBD	cop	O
weak	JJ	ROOT	O
.	.	punct	O

c-Jun	NN	nsubj	B-protein
,	,	punct	O
JunB	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
c-Fos	NN	compound	B-protein
activation	NN	conj	O
was	VBD	cop	O
greater	JJR	ROOT	O
,	,	punct	O
although	IN	mark	O
the	DT	det	O
level	NN	nsubj	O
was	VBD	cop	O
still	RB	advmod	O
less	JJR	advcl	O
than	IN	case	O
that	DT	nmod	O
with	IN	case	O
Tax	NN	nmod	B-protein
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
AP-1	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
by	IN	case	O
Tax	NN	nmod	B-protein
may	MD	aux	O
not	RB	neg	O
be	VB	cop	O
sufficient	JJ	ROOT	O
for	IN	case	O
a	DT	det	O
complete	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
AP-1	NN	compound	B-DNA
site	NN	nmod	I-DNA
by	IN	case	O
Tax	NN	nmod	B-protein
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
Tax	NN	nsubj	B-protein
activates	VBZ	ccomp	O
the	DT	det	O
transcription	NN	dobj	O
of	IN	case	O
cellular	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
with	IN	case	O
AP-1	NN	compound	B-DNA
sites	NNS	nmod	I-DNA
by	IN	mark	O
inducing	VBG	advcl	O
the	DT	det	O
DNA-binding	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
AP-1	NN	compound	B-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
a	DT	det	O
mechanism	NN	appos	O
distinct	JJ	amod	O
from	IN	case	O
those	DT	nmod	O
of	IN	case	O
CRE-like	JJ	nmod	B-DNA
and	CC	cc	I-DNA
kappaB	NN	conj	I-DNA
elements	NNS	dep	I-DNA
.	.	punct	O

Copyright	NN	dep	O
2001	CD	nummod	O
Academic	NNP	compound	O
Press	NNP	ROOT	O
.	.	punct	O

Strict	JJ	amod	O
control	NN	ROOT	O
of	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
replication	NN	nmod	O
by	IN	case	O
a	DT	det	O
genetic	JJ	amod	O
switch	NN	nmod	O
:	:	punct	O
Tet	NN	dep	O
for	IN	case	O
Tat	NN	nmod	O
.	.	punct	O

Live-attenuated	JJ	amod	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
variants	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
great	JJ	amod	O
promise	NN	dobj	O
as	IN	case	O
AIDS	NN	compound	O
vaccines	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
continued	VBD	amod	O
replication	NN	nsubj	O
can	MD	aux	O
lead	VB	conj	O
to	TO	case	O
the	DT	det	O
selection	NN	nmod	O
of	IN	case	O
faster-replicating	JJ	amod	O
variants	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
pathogenic	JJ	acl:relcl	O
.	.	punct	O

We	PRP	nsubj	O
therefore	RB	advmod	O
designed	VBD	ROOT	O
HIV-1	NN	compound	B-DNA
genomes	NNS	dobj	I-DNA
that	WDT	nsubj	O
replicate	VBP	acl:relcl	O
exclusively	RB	advmod	O
upon	IN	case	O
addition	NN	nmod	O
of	IN	case	O
the	DT	det	O
nontoxic	JJ	amod	O
effector	NN	compound	O
doxycycline	NN	nmod	O
(	-LRB-	punct	O
dox	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	nsubjpass	O
was	VBD	auxpass	O
achieved	VBN	ROOT	O
by	IN	case	O
replacement	NN	nmod	O
of	IN	case	O
the	DT	det	O
viral	JJ	amod	O
TAR-Tat	NN	compound	O
system	NN	nmod	O
for	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
by	IN	case	O
the	DT	det	O
Escherichia	FW	compound	O
coli-derived	JJ	amod	O
Tet	NN	compound	O
system	NN	nmod	O
for	IN	case	O
inducible	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

These	DT	det	O
designer	NN	compound	O
``	``	punct	O
HIV-rtTA	NN	amod	O
''	''	punct	O
viruses	NNS	nsubj	O
replicate	VBP	ROOT	O
in	IN	case	O
a	DT	det	O
strictly	RB	advmod	O
dox-dependent	JJ	amod	O
manner	NN	nmod	O
both	CC	cc:preconj	O
in	IN	case	O
a	DT	det	O
T-cell	NN	compound	B-cell_line
line	NN	nmod	I-cell_line
and	CC	cc	O
in	IN	case	O
primary	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
the	DT	det	O
rate	NN	nsubjpass	O
of	IN	case	O
replication	NN	nmod	O
can	MD	aux	O
be	VB	auxpass	O
fine-tuned	VBN	conj	O
by	IN	case	O
simple	JJ	amod	O
variation	NN	nmod	O
of	IN	case	O
the	DT	det	O
dox	NN	amod	O
concentration	NN	nmod	O
.	.	punct	O

These	DT	det	O
HIV-rtTA	NN	amod	O
viruses	NNS	nsubj	O
provide	VBP	ROOT	O
a	DT	det	O
tool	NN	dobj	O
to	TO	mark	O
perform	VB	acl	O
genetics	NNS	dobj	O
,	,	punct	O
e.g.	FW	dep	O
,	,	punct	O
selection	NN	dobj	O
and	CC	cc	O
optimization	NN	compound	O
experiments	NNS	conj	O
,	,	punct	O
with	IN	case	O
the	DT	det	O
E.	FW	compound	O
coli-derived	JJ	amod	O
Tet	NN	compound	O
reagents	NNS	nmod	O
in	IN	case	O
a	DT	det	O
eukaryotic	JJ	amod	O
background	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
such	JJ	amod	O
viruses	NNS	nsubj	O
may	MD	aux	O
represent	VB	ROOT	O
improved	JJ	amod	O
vaccine	NN	compound	O
candidates	NNS	dobj	O
because	IN	mark	O
their	PRP$	nmod:poss	O
replication	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
turned	VBN	advcl	O
on	RP	advmod	O
and	CC	cc	O
off	IN	conj	O
at	IN	prep	O
will	MD	pobj	O
.	.	punct	O

Synovial	JJ	amod	O
fluid	NN	nsubj	O
induced	VBD	ROOT	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	compound	I-protein
DNA	NN	compound	O
binding	NN	dobj	O
in	IN	case	O
a	DT	det	O
monocytic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
determine	VB	dep	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
synovial	JJ	amod	O
fluids	NNS	nmod	O
(	-LRB-	punct	O
SF	NN	appos	O
)	-RRB-	punct	O
on	IN	case	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod	I-protein
(	-LRB-	punct	O
NF-kappaB	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
Mono	NN	compound	B-cell_line
Mac	NN	compound	I-cell_line
6	CD	nummod	I-cell_line
monocytic/macrophage	NN	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
as	IN	case	O
a	DT	det	O
model	NN	nmod	O
for	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
between	IN	case	O
SF	NN	nmod	O
and	CC	cc	O
synovial	JJ	amod	B-cell_type
tissue	NN	compound	I-cell_type
macrophages	NNS	conj	I-cell_type
in	IN	case	O
arthritis	NN	nmod	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Mono	NN	compound	B-cell_line
Mac	NN	compound	I-cell_line
6	CD	nummod	I-cell_line
cells	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
incubated	VBN	ROOT	O
with	IN	case	O
SF	NN	nmod	O
from	IN	case	O
the	DT	det	O
knee	NN	compound	O
joints	NNS	nmod	O
of	IN	case	O
human	JJ	amod	O
subjects	NNS	nmod	O
with	IN	case	O
rheumatoid	JJ	amod	O
arthritis	NN	nmod	O
(	-LRB-	punct	O
RA	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
undifferentiated	JJ	amod	O
seronegative	JJ	amod	O
oligoarthritis	NN	conj	O
,	,	punct	O
and	CC	cc	O
osteoarthritis	NN	conj	O
(	-LRB-	punct	O
OA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Nuclear	JJ	amod	O
extracts	NNS	nsubjpass	O
prepared	VBN	acl	O
from	IN	case	O
the	DT	det	O
Mono	NN	compound	B-cell_line
Mac	NN	compound	I-cell_line
6	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
and	CC	cc	O
RA	NN	compound	O
synovial	JJ	amod	O
tissue	NN	conj	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
by	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
analysis	NN	nmod	O
(	-LRB-	punct	O
EMSA	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
NF-kappaB	NN	compound	B-protein
DNA	NN	compound	I-protein
binding	NN	compound	I-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Induction	NN	nsubjpass	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	nmod	O
by	IN	case	O
the	DT	det	O
p65	NN	compound	B-protein
(	-LRB-	punct	I-protein
RelA	NN	compound	I-protein
)	-RRB-	punct	I-protein
/p50	NN	compound	I-protein
heterodimer	NN	nmod	I-protein
was	VBD	auxpass	O
observed	VBN	dep	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
incubation	NN	nmod	O
of	IN	case	O
Mono	NN	compound	B-cell_line
Mac	NN	compound	I-cell_line
6	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
SF	NN	nmod	O
(	-LRB-	punct	O
20	CD	nummod	O
%	NN	dep	O
in	IN	case	O
culture	NN	compound	O
medium	NN	nmod	O
)	-RRB-	punct	O
from	IN	case	O
5	CD	compound	O
of	IN	advmod	O
8	CD	nummod	O
subjects	NNS	nmod	O
with	IN	case	O
RA	NN	nmod	O
,	,	punct	O
4	CD	conj	O
of	IN	case	O
5	CD	nmod	O
with	IN	case	O
OA	NN	nmod	O
,	,	punct	O
and	CC	cc	O
none	NN	conj	O
of	IN	case	O
3	CD	nmod	O
with	IN	case	O
undifferentiated	JJ	amod	O
seronegative	JJ	amod	O
oligoarthritis	NN	nmod	O
.	.	punct	O

Incubation	NN	nsubj	O
of	IN	case	O
SF	NN	nmod	O
with	IN	case	O
neutralizing	VBG	amod	B-protein
antibodies	NNS	nmod	I-protein
against	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	nmod	I-protein
(	-LRB-	punct	I-protein
TNF-alpha	NN	appos	I-protein
)	-RRB-	punct	I-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
antibodies	NNS	conj	B-protein
against	IN	case	O
interleukin	NN	nmod	B-protein
6	CD	nummod	I-protein
(	-LRB-	punct	I-protein
IL-6	NN	appos	I-protein
)	-RRB-	punct	I-protein
,	,	punct	O
significantly	RB	advmod	O
reduced	VBD	ROOT	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
p65/p50	JJ	compound	O
binding	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
SF	NN	nmod	O
from	IN	case	O
subjects	NNS	nmod	O
with	IN	case	O
RA	NN	nmod	O
and	CC	cc	O
OA	NN	conj	O
.	.	punct	O

Unexpectedly	RB	advmod	O
,	,	punct	O
a	DT	det	O
slowly	RB	advmod	O
migrating	VBG	amod	O
SF	NN	compound	O
inducible	JJ	amod	O
NF-kappaB	NN	compound	B-protein
-binding	JJ	amod	O
complex	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
EMSA	NN	nmod	O
of	IN	case	O
Mono	NN	compound	B-cell_line
Mac	NN	compound	I-cell_line
6	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
after	IN	case	O
incubation	NN	nmod	O
with	IN	case	O
SF	NN	nmod	O
from	IN	case	O
5	CD	compound	O
of	IN	advmod	O
8	CD	nummod	O
RA	NN	nmod	O
and	CC	cc	O
2	CD	compound	O
of	IN	advmod	O
5	CD	nummod	O
OA	NN	compound	O
subjects	NNS	conj	O
.	.	punct	O

The	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
complex	NN	nmod	O
by	IN	case	O
SF	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
affected	VBN	ROOT	O
by	IN	case	O
neutralization	NN	nmod	O
of	IN	case	O
TNF-alpha	NN	nmod	B-protein
or	CC	cc	O
IL-6	NN	conj	B-protein
in	IN	case	O
SF	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
complex	NN	nsubj	O
was	VBD	cop	O
not	RB	neg	O
inducible	JJ	conj	O
by	IN	case	O
TNF-alpha	NN	nmod	B-protein
,	,	punct	O
IL-1beta	NN	conj	O
,	,	punct	O
TNF-alpha	NN	conj	B-protein
/	:	punct	O
IL-1beta	NN	conj	B-protein
,	,	punct	O
IL-6	NN	conj	B-protein
,	,	punct	O
platelet	NN	compound	B-protein
derived	VBD	amod	I-protein
growth	NN	compound	I-protein
factor	NN	conj	I-protein
,	,	punct	O
lipopolysaccharide	NN	conj	O
,	,	punct	O
or	CC	cc	O
tetradecanoyl	NN	compound	O
phorbol	NN	compound	O
acetate	NN	conj	O
.	.	punct	O

The	DT	det	O
slowly	RB	advmod	O
migrating	VBG	amod	B-protein
complex	NN	nsubjpass	I-protein
could	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
supershifted	VBN	ROOT	O
with	IN	case	O
antibodies	NNS	nmod	B-protein
against	IN	case	O
NF-kappaB	NN	nmod	B-protein
,	,	punct	O
Jun	NN	conj	B-protein
,	,	punct	O
or	CC	cc	O
the	DT	det	O
transcriptional	JJ	amod	O
coactivators	NNS	compound	O
p300	NN	conj	B-protein
or	CC	cc	O
CBP	NN	conj	B-protein
.	.	punct	O

A	DT	det	O
NF-kappaB-binding	JJ	amod	B-protein
complex	NN	nsubjpass	I-protein
with	IN	case	O
similar	JJ	amod	O
slow	JJ	amod	O
mobility	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
prepared	VBN	acl	O
from	IN	case	O
fresh	JJ	amod	O
human	JJ	amod	O
RA	NN	compound	O
synovial	JJ	amod	O
tissue	NN	nmod	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Biological	JJ	amod	O
activity	NN	nsubj	O
of	IN	case	O
TNF-alpha	NN	nmod	B-protein
in	IN	case	O
SF	NN	nmod	O
from	IN	case	O
RA	NN	nmod	O
and	CC	cc	O
OA	NN	conj	O
subjects	NNS	dep	O
is	VBZ	cop	O
capable	JJ	appos	O
of	IN	mark	O
inducing	VBG	advcl	O
p65/p50	NN	compound	B-protein
NF-kappaB	NN	compound	I-protein
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
macrophages	NNS	nmod	B-cell_type
.	.	punct	O

A	DT	det	O
property	NN	nsubj	O
of	IN	case	O
SF	NN	nmod	O
that	WDT	nsubj	O
is	VBZ	cop	O
independent	JJ	acl:relcl	O
of	IN	case	O
TNF-alpha	NN	nmod	B-protein
and	CC	cc	O
other	JJ	amod	O
cytokines	NNS	conj	B-protein
is	VBZ	cop	O
responsible	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	O
slowly	RB	advmod	O
migrating	VBG	amod	O
NF-kappaB-binding	JJ	amod	B-protein
complex	NN	nmod	I-protein
.	.	punct	O

Soluble	JJ	amod	O
mediators	NNS	nsubj	O
in	IN	case	O
SF	NN	nmod	O
of	IN	case	O
subjects	NNS	nmod	O
with	IN	case	O
RA	NN	nmod	O
and	CC	cc	O
OA	NN	conj	O
can	MD	aux	O
therefore	RB	advmod	O
modulate	VB	ROOT	O
binding	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
to	TO	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
binding	NN	compound	I-protein
site	NN	nmod	I-protein
in	IN	case	O
macrophages	NNS	nmod	B-cell_type
and	CC	cc	O
may	MD	aux	O
play	VB	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
inflammatory	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
arthritis	NN	nmod	O
.	.	punct	O

Peroxisome	NN	compound	B-protein
proliferator	NN	compound	I-protein
activator	NN	compound	I-protein
receptor-gamma	NN	compound	I-protein
agonists	NNS	nsubj	O
and	CC	cc	O
15-deoxy-Delta	NN	conj	O
(	-LRB-	punct	O
12	CD	nummod	O
,	,	punct	O
14	CD	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
12	CD	nummod	O
,	,	punct	O
14	CD	dep	O
)	-RRB-	punct	O
-PGJ	NN	conj	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
induce	VBP	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
malignant	JJ	conj	O
B-lineage	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
research	NN	nsubj	O
described	VBN	acl	O
herein	RB	advmod	O
evaluates	VBZ	ROOT	O
the	DT	det	O
expression	NN	dobj	O
and	CC	cc	O
functional	JJ	amod	O
significance	NN	conj	O
of	IN	case	O
peroxisome	NN	compound	B-protein
proliferator	NN	compound	I-protein
activator	NN	compound	I-protein
receptor-gamma	NN	nmod	I-protein
(	-LRB-	punct	I-protein
PPAR-gamma	NN	appos	I-protein
)	-RRB-	punct	I-protein
on	IN	case	O
B-lineage	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Normal	JJ	amod	B-cell_type
mouse	NN	compound	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
and	CC	cc	O
a	DT	det	O
variety	NN	conj	O
of	IN	case	O
B	NN	compound	B-cell_type
lymphoma	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
reflective	JJ	amod	O
of	IN	case	O
stages	NNS	nmod	O
of	IN	case	O
B	NN	compound	O
cell	NN	compound	O
differentiation	NN	nmod	O
(	-LRB-	punct	O
e.g.	FW	dep	O
,	,	punct	O
70Z/3	NN	dep	O
,	,	punct	O
CH31	NN	conj	O
,	,	punct	O
WEHI-231	NN	conj	O
,	,	punct	O
CH12	NN	conj	O
,	,	punct	O
and	CC	cc	O
J558	NN	conj	O
)	-RRB-	punct	O
express	VBP	ROOT	O
PPAR-gamma	NN	compound	B-RNA
mRNA	NN	dobj	I-RNA
and	CC	cc	O
,	,	punct	O
by	IN	case	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
the	DT	det	O
67-kDa	JJ	amod	B-protein
PPAR-gamma	NN	compound	I-protein
protein	NN	appos	I-protein
.	.	punct	O

15-Deoxy-Delta	NN	nsubj	O
(	-LRB-	punct	O
12	CD	nummod	O
,	,	punct	O
14	CD	dep	O
)	-RRB-	punct	O
-PGJ	NN	conj	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
15d-PGJ	NN	appos	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
PPAR-gamma	NN	compound	O
agonist	NN	appos	O
,	,	punct	O
has	VBZ	ROOT	O
a	DT	det	O
dose-dependent	JJ	amod	O
antiproliferative	JJ	amod	O
and	CC	cc	O
cytotoxic	JJ	conj	O
effect	NN	dobj	O
on	IN	case	O
normal	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
malignant	JJ	conj	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
[	-LRB-	punct	O
(	-LRB-	punct	O
3	LS	nummod	O
)	-RRB-	punct	O
H	NN	intj	O
]	-RRB-	punct	O
thymidine	NN	nmod	O
and	CC	cc	O
3-	CD	conj	O
[	-LRB-	punct	O
4	CD	dep	O
,	,	punct	O
5-dimethylthiazol-2-yl	NN	conj	O
]	-RRB-	punct	O
-2	CD	dep	O
,	,	punct	O
5-diphenyltetrazolium	NN	compound	O
bromide	NN	compound	O
assays	NNS	dep	O
.	.	punct	O

Only	RB	advmod	O
PPAR-gamma	NN	compound	O
agonists	NNS	nsubj	O
(	-LRB-	punct	O
thiazolidinediones	NNS	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
not	RB	cc	O
PPAR-alpha	NN	compound	O
agonists	NNS	conj	O
,	,	punct	O
mimicked	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
15d-PGJ	NN	nmod	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
on	IN	case	O
B-lineage	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
mechanism	NN	nsubj	O
by	IN	case	O
which	WDT	nmod	O
15d-PGJ	NN	nsubj	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
negatively	RB	advmod	O
affects	VBZ	acl:relcl	O
B-lineage	JJ	amod	B-cell_type
cells	NNS	dobj	I-cell_type
involves	VBZ	ccomp	O
in	IN	case	O
part	NN	compound	O
PPAR-gamma	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubj	O
by	IN	case	O
which	WDT	nmod	O
PPAR-gamma	NN	compound	O
agonists	NNS	nsubj	O
induce	VBP	acl:relcl	O
cytotoxicity	NN	dobj	O
is	VBZ	cop	O
via	IN	case	O
apoptosis	NN	ROOT	O
,	,	punct	O
as	IN	mark	O
shown	VBN	advcl	O
by	IN	case	O
annexin	NN	compound	O
V	NN	compound	O
staining	NN	nmod	O
and	CC	cc	O
as	IN	mark	O
confirmed	VBN	conj	O
by	IN	case	O
DNA	NN	compound	O
fragmentation	NN	nmod	O
detected	VBN	acl	O
using	VBG	xcomp	O
the	DT	det	O
TUNEL	NN	compound	O
assay	NN	dobj	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
addition	NN	nsubj	O
of	IN	case	O
PGF	NN	nmod	O
(	-LRB-	punct	O
2alpha	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
known	VBN	acl:relcl	O
to	TO	mark	O
affect	VB	xcomp	O
lymphocytes	NNS	dobj	B-cell_type
,	,	punct	O
dramatically	RB	advmod	O
attenuated	VBD	ROOT	O
the	DT	det	O
deleterious	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
PPAR-gamma	NN	compound	O
agonists	NNS	nmod	O
on	IN	case	O
B	NN	compound	B-cell_type
lymphomas	NNS	nmod	I-cell_type
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
15d-PGJ	NN	nsubj	O
(	-LRB-	punct	O
2	CD	nummod	O
)	-RRB-	punct	O
induced	VBD	ROOT	O
a	DT	det	O
massive	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
nuclear	JJ	amod	O
mitogen-activated	JJ	amod	O
protein	NN	compound	O
kinase	NN	compound	O
activation	NN	nmod	O
,	,	punct	O
and	CC	cc	O
pretreatment	NN	nsubj	O
with	IN	case	O
PGF	NN	nmod	O
(	-LRB-	punct	O
2alpha	NN	appos	O
)	-RRB-	punct	O
blunted	VBD	conj	O
the	DT	det	O
mitogen-activated	JJ	amod	O
protein	NN	compound	O
kinase	NN	compound	O
activation	NN	dobj	O
.	.	punct	O

This	DT	nsubj	O
is	VBZ	cop	O
the	DT	det	O
first	JJ	amod	O
study	NN	ROOT	O
evaluating	VBG	acl	O
PPAR-gamma	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
its	PRP$	nmod:poss	O
significance	NN	conj	O
on	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

PPAR-gamma	NN	amod	O
agonists	NNS	nsubj	O
may	MD	aux	O
serve	VB	ROOT	O
as	IN	prep	O
a	DT	det	O
counterbalance	NN	pobj	O
to	IN	prep	O
the	DT	det	O
stimulating	JJ	amod	O
effects	NNS	pobj	O
of	IN	case	O
other	JJ	amod	O
PGs	NNS	nmod	O
,	,	punct	O
namely	RB	advmod	O
PGE	NN	appos	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
promotes	VBZ	acl:relcl	O
B	NN	compound	O
cell	NN	compound	O
differentiation	NN	dobj	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
the	DT	det	O
use	NN	nsubj	O
of	IN	case	O
PGs	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
15d-PGJ	NN	nmod	O
(	-LRB-	punct	O
2	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
synthetic	JJ	amod	O
PPAR-gamma	NN	compound	O
agonists	NNS	conj	O
to	TO	mark	O
induce	VB	acl	O
apoptosis	NN	dobj	O
in	IN	case	O
B-lineage	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
may	MD	aux	O
lead	VB	ROOT	O
to	TO	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
novel	JJ	amod	O
therapies	NNS	nmod	O
for	IN	case	O
fatal	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphomas	NNS	nmod	I-cell_type

Inhibition	NN	nsubj	O
of	IN	case	O
STAT3	NN	compound	O
signaling	NN	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
apoptosis	NN	nmod	O
of	IN	case	O
leukemic	JJ	amod	B-cell_type
large	JJ	amod	I-cell_type
granular	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
decreased	VBD	conj	O
Mcl-1	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

Large	JJ	amod	O
granular	JJ	amod	O
lymphocyte	NN	compound	O
(	-LRB-	punct	O
LGL	NN	compound	O
)	-RRB-	punct	O
leukemia	NN	nsubjpass	O
is	VBZ	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
expansion	NN	nmod	O
of	IN	case	O
antigen-activated	JJ	amod	B-cell_type
cytotoxic	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
are	VBP	cop	O
resistant	JJ	ROOT	O
to	TO	case	O
Fas-mediated	JJ	amod	O
apoptosis	NN	nmod	O
despite	IN	mark	O
expressing	VBG	advcl	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
Fas	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
leukemic	JJ	amod	B-cell_type
LGL	NN	nsubj	I-cell_type
from	IN	case	O
19	CD	nummod	O
patients	NNS	nmod	O
displayed	VBD	ccomp	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
activated	VBN	amod	B-protein
STAT3	NN	nmod	I-protein
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
leukemic	JJ	amod	B-cell_type
LGL	NN	nmod	I-cell_type
with	IN	case	O
the	DT	det	O
JAK-selective	JJ	amod	O
tyrosine	NN	compound	O
kinase	NN	compound	O
inhibitor	NN	compound	O
AG-490	NN	nmod	O
induced	VBD	ROOT	O
apoptosis	NN	dobj	O
with	IN	case	O
a	DT	det	O
corresponding	JJ	amod	O
decrease	NN	nmod	O
in	IN	case	O
STAT	NN	compound	B-protein
-DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
using	VBG	advcl	O
an	DT	det	O
antisense	JJ	amod	O
oligonucleotide	NN	compound	O
approach	NN	dobj	O
to	TO	mark	O
diminish	VB	acl	O
STAT3	NN	compound	O
expression	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
Fas	NN	compound	O
sensitivity	NN	nsubjpass	O
was	VBD	auxpass	O
restored	VBN	ccomp	O
in	IN	case	O
leukemic	JJ	amod	B-cell_type
LGL	NN	nmod	I-cell_type
.	.	punct	O

AG-490-induced	JJ	amod	O
apoptosis	NN	nsubj	O
in	IN	case	O
leukemic	JJ	amod	B-cell_type
LGL	NN	nmod	I-cell_type
was	VBD	cop	O
independent	JJ	ROOT	O
of	IN	case	O
Bcl-xL	NN	nmod	O
or	CC	cc	O
Bcl-2	NN	compound	O
expression	NN	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
Bcl-2-family	JJ	amod	B-protein
protein	NN	compound	I-protein
Mcl-1	NN	nsubjpass	I-protein
was	VBD	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ccomp	O
by	IN	case	O
AG-490	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

Activated	VBN	amod	B-protein
STAT3	NN	nsubjpass	I-protein
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
bind	VB	xcomp	O
an	DT	det	O
SIE-related	JJ	amod	B-DNA
element	NN	dobj	I-DNA
in	IN	case	O
the	DT	det	O
murine	JJ	amod	B-DNA
mcl-1	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
luciferase	NN	compound	O
reporter	NN	compound	O
assay	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
v-src	NN	compound	O
overexpression	NN	nsubj	O
in	IN	case	O
NIH3T3	NN	nmod	O
induced	VBD	ccomp	O
STAT3	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
from	IN	case	O
the	DT	det	O
mcl-1	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
and	CC	cc	O
increased	VBD	amod	O
endogenous	JJ	amod	O
Mcl-1	NN	compound	O
protein	NN	compound	O
levels	NNS	conj	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
STAT3	NN	compound	B-protein
activation	NN	nsubj	O
contributed	VBD	ccomp	O
to	TO	case	O
accumulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
leukemic	JJ	amod	B-cell_type
LGL	NN	compound	I-cell_type
clones	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
investigation	NN	nsubj	O
should	MD	aux	O
focus	VB	ccomp	O
on	IN	case	O
novel	JJ	amod	O
strategies	NNS	nmod	O
targeting	VBG	acl	O
STAT3	NN	dobj	B-protein
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
LGL	NN	compound	O
leukemia	NN	nmod	O
.	.	punct	O

Decreased	VBN	amod	O
immediate	JJ	amod	O
inflammatory	JJ	amod	B-DNA
gene	NN	compound	I-DNA
induction	NN	ROOT	O
in	IN	mark	O
activating	VBG	acl	B-protein
transcription	NN	compound	I-protein
factor-2	NN	compound	I-protein
mutant	JJ	amod	O
mice	NNS	dobj	O
.	.	punct	O

Transcription	NN	compound	B-protein
factor	NN	nsubjpass	I-protein
activating	VBG	acl	I-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
ATF	NN	dobj	I-protein
)	-RRB-	punct	I-protein
-2	CD	nummod	I-protein
is	VBZ	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
inflammatory	JJ	amod	O
signals	NNS	nmod	O
transduced	VBN	acl	O
by	IN	case	O
the	DT	dep	O
JNK	NN	nmod	O
and	CC	cc	O
p38	NN	compound	O
MAP	NN	compound	O
kinase	NN	compound	O
pathways	NNS	conj	O
.	.	punct	O

To	TO	mark	O
better	RBR	advmod	O
define	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
ATF-2	NN	nmod	B-protein
in	IN	case	O
inflammation	NN	nmod	O
,	,	punct	O
adult	JJ	amod	O
mice	NNS	nsubjpass	O
expressing	VBG	acl	O
small	JJ	amod	O
amounts	NNS	dobj	O
of	IN	case	O
a	DT	det	O
mutant	JJ	amod	B-protein
ATF-2	NN	compound	I-protein
protein	NN	nmod	I-protein
were	VBD	auxpass	O
challenged	VBN	ROOT	O
with	IN	case	O
lipopolysaccharide	NN	nmod	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
anti-CD3	JJ	amod	B-protein
antibody	NN	conj	I-protein
or	CC	cc	O
virus	NN	conj	O
.	.	punct	O

Within	IN	case	O
3	CD	nummod	O
h	NN	nmod	O
of	IN	case	O
challenge	NN	nmod	O
by	IN	case	O
LPS	NN	nmod	O
,	,	punct	O
ATF-2	NN	compound	O
mutant	JJ	amod	O
mice	NNS	nsubj	O
had	VBD	aux	O
decreased	VBN	ROOT	O
induction	NN	dobj	O
of	IN	case	O
the	DT	det	O
adhesion	NN	compound	B-protein
molecules	NNS	nmod	I-protein
E-selectin	NN	dep	B-protein
,	,	punct	O
P-selectin	NN	conj	B-protein
and	CC	cc	O
VCAM-1	NN	conj	B-protein
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
cytokines	NNS	conj	B-protein
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	dep	I-protein
,	,	punct	O
IL-1beta	NN	conj	B-protein
and	CC	cc	O
IL-6	NN	conj	B-protein
compared	VBN	case	O
with	IN	case	O
control	JJ	amod	O
mice	NNS	nmod	O
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
by	IN	case	O
anti-CD3	JJ	amod	B-protein
antibody	NN	nmod	I-protein
also	RB	advmod	O
showed	VBD	ROOT	O
less	JJR	amod	O
induction	NN	dobj	O
of	IN	case	O
IL-1	NN	nmod	B-protein
and	CC	cc	O
IL-6	NN	conj	B-protein
in	IN	case	O
ATF-2	NN	compound	O
mutant	JJ	amod	O
tissues	NNS	nmod	O
.	.	punct	O

ATF-2	NN	compound	B-cell_type
mutant	JJ	amod	I-cell_type
thymocytes	NNS	nsubj	I-cell_type
treated	VBN	acl	O
with	IN	case	O
anti-CD3	JJ	amod	B-protein
antibody	NN	nmod	I-protein
in	FW	compound	O
vitro	FW	advmod	O
demonstrated	VBN	ROOT	O
reduced	VBN	amod	O
induction	NN	dobj	O
of	IN	case	O
c-Jun	NN	nmod	B-protein
,	,	punct	O
JunB	NN	conj	B-protein
,	,	punct	O
JunD	NN	conj	B-protein
and	CC	cc	O
Fra-2	NN	conj	B-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
similar	JJ	advcl	O
to	IN	mark	O
what	WP	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	nmod	O
after	IN	case	O
p38	NN	compound	O
kinase	NN	compound	O
inhibition	NN	nmod	O
in	IN	case	O
normal	JJ	amod	O
mice	NNS	nmod	O
,	,	punct	O
relative	JJ	amod	O
ATF-2	NN	compound	O
deficiency	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
prevent	VB	ROOT	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
a	DT	det	O
mononuclear	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
infiltrate	NN	nmod	O
in	IN	case	O
the	DT	det	O
week	NN	nmod	O
following	VBG	case	O
an	DT	det	O
inflammatory	JJ	amod	O
stimulus	NN	nmod	O
.	.	punct	O

ATF-2	NN	compound	O
mutant	JJ	amod	O
mice	NNS	nsubj	O
proved	VBD	ROOT	O
more	RBR	advmod	O
susceptible	JJ	xcomp	O
to	TO	case	O
death	NN	nmod	O
than	IN	case	O
control	NN	amod	O
mice	NNS	nmod	O
from	IN	case	O
LPS	NN	nmod	O
plus	CC	cc	O
D-galactosamine	NN	conj	O
injection	NN	dep	O
or	CC	cc	O
Coxsackievirus	NN	compound	O
B3	NN	compound	O
infection	NN	nmod	O
and	CC	cc	O
had	VBD	conj	O
a	DT	det	O
higher	JJR	amod	O
incidence	NN	dobj	O
of	IN	case	O
mononuclear	JJ	amod	O
pulmonary	JJ	amod	O
infiltrates	NNS	nmod	O
after	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
Herpes	NN	compound	O
simplex	NN	compound	O
virus-1	NN	nmod	O
.	.	punct	O

ATF-2	NN	nsubj	B-protein
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
maximal	JJ	amod	O
immediate	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
adhesion	NN	compound	B-protein
molecules	NNS	nmod	I-protein
and	CC	cc	O
cytokine	NN	compound	B-DNA
genes	NNS	conj	I-DNA
,	,	punct	O
but	CC	cc	O
at	IN	case	O
later	JJR	amod	O
time	NN	compound	O
points	NNS	nsubj	O
may	MD	aux	O
even	RB	advmod	O
protect	VB	conj	O
against	IN	case	O
overactive	JJ	amod	O
immune	JJ	amod	O
responses	NNS	nmod	O
.	.	punct	O

LIGHT	NN	nsubj	B-protein
,	,	punct	O
a	DT	det	O
TNF-like	JJ	amod	B-protein
molecule	NN	appos	I-protein
,	,	punct	O
costimulates	VBZ	ROOT	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	dobj	O
and	CC	cc	O
is	VBZ	auxpass	O
required	VBN	conj	O
for	IN	case	O
dendritic	JJ	amod	B-cell_type
cell	NN	nmod:npmod	I-cell_type
-mediated	JJ	amod	O
allogeneic	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
response	NN	nmod	O
.	.	punct	O

LIGHT	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
recently	RB	advmod	O
identified	VBN	amod	O
member	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
TNF	NN	compound	B-protein
superfamily	NN	nmod	I-protein
and	CC	cc	O
its	PRP$	nmod:poss	O
receptors	NNS	conj	O
,	,	punct	O
herpesvirus	NN	compound	B-protein
entry	NN	compound	I-protein
mediator	NN	conj	I-protein
and	CC	cc	O
lymphotoxin	NN	compound	B-protein
beta	NN	compound	I-protein
receptor	NN	conj	I-protein
,	,	punct	O
are	VBP	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
stromal	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
LIGHT	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
selectively	RB	advmod	O
expressed	VBN	ccomp	O
on	IN	case	O
immature	JJ	amod	B-cell_type
dendritic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
DCs	NNS	appos	B-cell_type
)	-RRB-	punct	O
generated	VBN	acl	O
from	IN	case	O
human	JJ	amod	B-cell_type
PBMCs	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
LIGHT	NN	nsubj	B-protein
is	VBZ	cop	O
not	RB	neg	O
detectable	JJ	ROOT	O
in	IN	case	O
DCs	NNS	nmod	B-cell_type
either	CC	cc:preconj	O
freshly	RB	advmod	O
isolated	VBN	ccomp	O
from	IN	case	O
PBMCs	NNS	nmod	B-cell_type
or	CC	cc	O
rendered	VBN	conj	O
mature	JJ	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
by	IN	case	O
LPS	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

Blockade	NN	nsubj	O
of	IN	case	O
LIGHT	NN	nmod	B-protein
by	IN	case	O
its	PRP$	nmod:poss	O
soluble	JJ	amod	B-protein
receptors	NNS	nmod	I-protein
,	,	punct	O
lymphotoxin	NN	compound	B-protein
beta	NN	compound	I-protein
receptor-Ig	NN	conj	I-protein
or	CC	cc	O
HVEM-Ig	NN	conj	B-protein
,	,	punct	O
inhibits	VBZ	ROOT	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
DC	NN	compound	B-cell_type
-mediated	JJ	amod	O
primary	JJ	amod	O
allogeneic	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
response	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
engagement	NN	nsubj	O
of	IN	case	O
LIGHT	NN	nmod	B-protein
costimulates	VBZ	ROOT	O
human	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	dobj	O
,	,	punct	O
amplifies	VBZ	conj	O
the	DT	det	O
NF-kappaB	NN	compound	O
signaling	NN	compound	O
pathway	NN	dobj	O
,	,	punct	O
and	CC	cc	O
preferentially	RB	advmod	O
induces	VBZ	conj	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
IFN-gamma	NN	nmod	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
IL-4	NN	conj	B-protein
,	,	punct	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
an	DT	det	O
antigenic	JJ	amod	O
signal	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
LIGHT	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
costimulatory	JJ	amod	B-protein
molecule	NN	ccomp	I-protein
involved	VBN	acl	O
in	IN	case	O
DC	NN	nmod:npmod	B-cell_type
-mediated	JJ	amod	O
cellular	JJ	amod	O
immune	JJ	amod	O
responses	NNS	nmod	O
.	.	punct	O

Suppression	NN	ROOT	O
of	IN	case	O
HIV	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
replication	NN	nmod	O
by	IN	case	O
a	DT	det	O
dominant-negative	JJ	amod	B-protein
Ets-1	NN	compound	I-protein
mutant	NN	nmod	I-protein
.	.	punct	O

Activity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
distal	JJ	amod	B-DNA
region	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
contains	VBZ	acl:relcl	O
binding	VBG	amod	B-DNA
sites	NNS	dobj	I-DNA
for	IN	case	O
the	DT	dep	O
Ets-1	NN	nmod	B-protein
and	CC	cc	I-protein
USF-1	NN	conj	I-protein
proteins	NNS	dep	I-protein
,	,	punct	O
is	VBZ	cop	O
integral	JJ	ROOT	O
for	IN	case	O
HIV-1	NN	compound	O
replication	NN	nmod	O
.	.	punct	O

The	DT	det	O
Ets-1	NN	nsubj	B-protein
and	CC	cc	I-protein
USF-1	NN	conj	I-protein
proteins	NNS	dep	I-protein
play	VBP	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
LTR	NN	compound	I-DNA
distal	JJ	amod	I-DNA
enhancer	NN	compound	I-DNA
region	NN	nmod	I-DNA
,	,	punct	O
as	IN	mark	O
indicated	VBN	advcl	O
by	IN	case	O
the	DT	det	O
potent	JJ	amod	O
dominant	JJ	amod	O
negative	JJ	amod	O
effect	NN	nmod	O
of	IN	case	O
a	DT	det	O
mutant	JJ	amod	B-DNA
Ets-1	NN	nmod	I-DNA
lacking	VBG	acl	I-DNA
trans-activation	NN	compound	I-DNA
domains	NNS	dobj	I-DNA
on	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
LTR	NN	nmod	B-DNA
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
the	DT	det	O
biological	JJ	amod	O
relevance	NN	dobj	O
of	IN	case	O
the	DT	det	O
Ets-1	NN	nmod	B-protein
and	CC	cc	I-protein
USF-1	NN	conj	I-protein
proteins	NNS	dep	I-protein
in	IN	case	O
HIV-1	NN	compound	O
replication	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
dominant-negative	JJ	amod	O
mutant	NN	nmod	O
of	IN	case	O
Ets-1	NN	nmod	B-DNA
(	-LRB-	punct	O
dnEts-1	NN	appos	B-DNA
)	-RRB-	punct	O
on	IN	case	O
HIV-1	NN	compound	O
infection	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
dnEts	NN	nmod	B-DNA
markedly	RB	advmod	O
suppressed	VBD	ccomp	O
HIV-1	NN	compound	O
infection	NN	dobj	O
of	IN	case	O
a	DT	det	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

This	DT	det	O
finding	NN	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
formation	NN	nsubj	O
of	IN	case	O
a	DT	det	O
transcriptionaly	NN	amod	B-protein
active	JJ	amod	I-protein
USF-1/Ets-1	NN	compound	I-protein
complex	NN	nmod	I-protein
is	VBZ	cop	O
important	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
productive	JJ	amod	O
infection	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
by	IN	case	O
HIV-1	NN	nmod	O
,	,	punct	O
and	CC	cc	O
suggests	VBZ	conj	O
that	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
between	IN	case	O
USF-1	NN	nmod	B-protein
and	CC	cc	O
Ets-1	NN	conj	B-protein
with	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
may	MD	aux	O
provide	VB	ccomp	O
a	DT	det	O
new	JJ	amod	O
target	NN	dobj	O
for	IN	case	O
anti-HIV-1	JJ	amod	O
gene	NN	compound	O
therapy	NN	nmod	O
.	.	punct	O

Human	JJ	amod	B-cell_type
eosinophils	NNS	nsubj	I-cell_type
constitutively	RB	advmod	O
express	VBP	ROOT	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	dobj	I-protein
p	NN	dep	I-protein
and	CC	cc	I-protein
c	NN	conj	I-protein
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Eosinophils	NNS	nsubjpass	B-cell_type
are	VBP	auxpass	O
now	RB	advmod	O
known	VBN	dep	O
to	TO	mark	O
produce	VB	xcomp	O
a	DT	det	O
variety	NN	dobj	O
of	IN	case	O
proinflammatory	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
,	,	punct	O
although	IN	mark	O
the	DT	det	O
molecular	JJ	amod	O
factors	NNS	nsubjpass	O
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
their	PRP$	nmod:poss	O
production	NN	dobj	O
are	VBP	auxpass	O
poorly	RB	advmod	O
understood	VBN	advcl	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
almost	RB	advmod	O
all	DT	nmod	O
of	IN	case	O
the	DT	det	O
cytokines	NNS	nmod	B-protein
produced	VBN	acl	O
by	IN	case	O
eosinophils	NNS	nmod	B-cell_type
,	,	punct	O
including	VBG	case	O
the	DT	det	O
proallergic	JJ	amod	B-protein
cytokine	NN	compound	I-protein
IL-4	NN	nmod	I-protein
,	,	punct	O
is	VBZ	auxpass	O
now	RB	advmod	O
known	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
regulated	VBN	xcomp	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
transcription	NN	nmod	O
by	IN	case	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	compound	I-protein
(	-LRB-	punct	O
NFAT	NN	compound	B-protein
)	-RRB-	punct	O
family	NN	nmod	O
of	IN	case	O
transcription	NN	compound	O
factors	NNS	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
We	PRP	nsubj	O
sought	VBD	dep	O
to	TO	mark	O
characterize	VB	xcomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
different	JJ	amod	O
NFAT	NN	compound	B-protein
proteins	NNS	nmod	I-protein
in	IN	case	O
resting	VBG	amod	B-cell_type
and	CC	cc	I-cell_type
activated	VBN	conj	I-cell_type
eosinophils	NNS	nmod	I-cell_type
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Nuclear	JJ	amod	O
and	CC	cc	O
whole	JJ	conj	O
cell	NN	compound	O
extracts	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
from	IN	case	O
both	CC	cc:preconj	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
eosinophils	NNS	nmod	I-cell_type
and	CC	cc	O
those	DT	conj	O
obtained	VBN	acl	O
from	IN	case	O
bronchoalveolar	JJ	amod	O
lavage	NN	compound	O
fluid	NN	nmod	O
of	IN	case	O
asthmatic	JJ	amod	O
subjects	NNS	nmod	O
after	IN	case	O
endobronchial	JJ	amod	O
allergen	NN	compound	O
challenge	NN	nmod	O
.	.	punct	O

NFAT	NN	compound	B-protein
expression	NN	nsubjpass	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	mark	O
using	VBG	advcl	O
immunoprecipitation	NN	dobj	O
and	CC	cc	O
Western	NN	compound	O
blot	NN	compound	O
analysis	NN	conj	O
,	,	punct	O
DNA-binding	JJ	amod	O
assays	NNS	conj	O
,	,	punct	O
and	CC	cc	O
RT-PCR	NN	compound	O
analysis	NN	conj	O
of	IN	case	O
eosinophil	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Both	CC	cc:preconj	O
peripheral	JJ	amod	B-cell_type
blood	NN	nsubj	I-cell_type
and	CC	cc	I-cell_type
bronchoalveolar	JJ	amod	I-cell_type
lavage	NN	compound	I-cell_type
fluid	NN	compound	I-cell_type
eosinophils	NNS	conj	I-cell_type
expressed	VBD	dep	O
NFATp	NN	compound	B-protein
and	CC	cc	I-protein
NFATc	NN	conj	I-protein
protein	NN	dobj	I-protein
.	.	punct	O

Unlike	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
which	WDT	nsubj	O
express	VBP	acl:relcl	O
multiple	JJ	amod	O
NFATc	NN	compound	O
isoforms	NNS	dobj	O
,	,	punct	O
eosinophils	NNS	nsubj	B-cell_type
preferentially	RB	advmod	O
express	VBP	ROOT	O
the	DT	det	O
approximately	RB	advmod	O
85-kd	JJ	amod	O
isoform	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
eosinophils	NNS	nsubjpass	B-cell_type
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
constitutively	RB	advmod	O
express	VB	xcomp	O
NFATc	NN	compound	B-RNA
mRNA	NN	dobj	I-RNA
.	.	punct	O

A	DT	det	O
brief	JJ	amod	O
incubation	NN	nsubj	O
with	IN	case	O
the	DT	det	O
T	NN	compound	B-protein
(	-LRB-	punct	I-protein
H	NN	compound	I-protein
)	-RRB-	punct	I-protein
2	CD	nummod	I-protein
cytokines	NNS	nmod	I-protein
IL-4	NN	dep	B-protein
and	CC	cc	O
IL-5	NN	conj	B-protein
was	VBD	cop	O
sufficient	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
the	DT	det	O
nuclear	JJ	amod	O
translocation	NN	dobj	O
of	IN	case	O
NFATc	NN	nmod	B-protein
.	.	punct	O

Eosinophil	NN	compound	O
nuclear	JJ	amod	O
extracts	NNS	nsubj	O
contain	VBP	ROOT	O
multiple	JJ	amod	O
factors	NNS	dobj	O
that	WDT	nsubj	O
can	MD	aux	O
specifically	RB	advmod	O
recognize	VB	acl:relcl	O
the	DT	det	O
IL-4	NN	compound	B-DNA
promoter	NN	compound	I-DNA
P1	NN	compound	I-DNA
NFAT	NN	compound	I-DNA
site	NN	dobj	I-DNA
in	IN	case	O
DNA-binding	JJ	amod	O
assays	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
NFATp	NN	nmod	B-protein
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
NFATp	NN	nsubj	B-protein
and	CC	cc	O
NFATc	NN	conj	B-protein
can	MD	aux	O
regulate	VB	dep	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
and	CC	cc	O
other	JJ	amod	O
genes	NNS	conj	O
in	IN	case	O
eosinophils	NNS	nmod	B-cell_type
but	CC	cc	O
appear	VBP	conj	O
to	TO	mark	O
be	VB	auxpass	O
regulated	VBN	xcomp	O
by	IN	case	O
a	DT	det	O
novel	JJ	amod	O
signal	NN	compound	O
transduction	NN	compound	O
mechanism	NN	nmod	O
in	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

BLyS	NN	amod	B-protein
BINDS	NN	compound	O
TO	TO	compound	O
B	NN	compound	B-cell_type
CELLS	NN	ROOT	I-cell_type
WITH	IN	case	O
HIGH	NN	compound	O
AFFINITY	NN	dep	O
AND	CC	cc	O
INDUCES	VBZ	compound	O
ACTIVATION	NN	conj	O
OF	IN	case	O
THE	DT	compound	O
TRANSCRIPTION	NN	compound	B-protein
FACTORS	NN	compound	I-protein
NF-kappaB	NN	nmod	B-protein
AND	CC	cc	O
ELF-1	NN	conj	B-protein
.	.	punct	O

B	NN	compound	B-protein
lymphocyte	NN	compound	I-protein
stimulator	NN	nsubj	I-protein
(	-LRB-	punct	O
BLyS	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
member	NN	ROOT	O
of	IN	case	O
the	DT	det	O
TNF	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	I-protein
proteins	NNS	nmod	I-protein
expressed	VBN	acl	O
by	IN	case	O
myeloid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
as	IN	case	O
membrane-bound	JJ	amod	O
and	CC	cc	O
soluble	JJ	conj	O
forms	NNS	nmod	O
.	.	punct	O

BLyS	NN	nsubjpass	B-protein
was	VBD	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
act	VB	xcomp	O
specifically	RB	advmod	O
on	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
inducing	VBG	xcomp	O
proliferation	NN	dobj	O
and	CC	cc	O
immunoglobulin	NN	compound	O
production	NN	conj	O
both	CC	cc:preconj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
undertaken	VBN	ROOT	O
to	TO	mark	O
characterize	VB	xcomp	O
binding	NN	dobj	O
of	IN	case	O
radiolabeled	VBN	amod	B-protein
BLyS	NN	nmod	I-protein
to	TO	case	O
its	PRP$	nmod:poss	O
cognate	JJ	amod	B-protein
receptor	NN	nmod	I-protein
on	IN	case	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
examine	VB	conj	O
intracellular	JJ	amod	O
events	NNS	dobj	O
initiated	VBN	acl	O
by	IN	case	O
BLyS	NN	compound	B-protein
binding	NN	nmod	O
.	.	punct	O

Similar	JJ	advmod	O
to	TO	case	O
other	JJ	amod	O
TNF	NN	compound	B-protein
family	NN	compound	I-protein
members	NNS	nmod	I-protein
,	,	punct	O
BLyS	NN	nsubj	B-protein
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
solution	NN	nmod	O
as	IN	case	O
a	DT	det	O
homotrimer	NN	nmod	B-protein
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
gel	NN	compound	O
filtration	NN	compound	O
chromatography	NN	nmod	O
and	CC	cc	O
light	JJ	amod	O
scattering	NN	amod	O
analysis	NN	conj	O
.	.	punct	O

BLyS	NN	nsubj	B-protein
binding	VBG	acl	O
to	TO	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	cop	O
specific	JJ	ROOT	O
as	IN	case	O
other	JJ	amod	O
TNF	NN	compound	B-protein
family	NN	compound	I-protein
members	NNS	nmod	I-protein
tested	VBN	acl	O
did	VBD	aux	O
not	RB	neg	O
compete	VB	advcl	O
for	IN	case	O
(	-LRB-	punct	O
125	CD	dep	O
)	-RRB-	punct	O
I-	NN	compound	O
BLyS	NN	compound	B-protein
binding	NN	nmod	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
equilibrium	NN	compound	O
binding	NN	nmod	O
of	IN	case	O
(	-LRB-	punct	B-protein
125	CD	dep	I-protein
)	-RRB-	punct	I-protein
I-labeled	JJ	amod	I-protein
BLyS	NN	nmod	I-protein
to	TO	case	O
purified	VBN	amod	O
human	JJ	amod	B-cell_type
tonsillar	JJ	amod	I-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
demonstrated	VBD	ROOT	O
saturable	JJ	amod	O
binding	NN	dobj	O
.	.	punct	O

Scatchard	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
binding	VBG	compound	O
data	NNS	nmod	O
revealed	VBD	ROOT	O
a	DT	det	O
single	JJ	amod	O
class	NN	dobj	O
of	IN	case	O
high-affinity	JJ	amod	O
binding	NN	nmod	O
on	IN	case	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
approximately	RB	advmod	O
2600	CD	nummod	O
binding	VBG	amod	O
sites	NNS	nmod	O
per	IN	case	O
cell	NN	nmod	O
and	CC	cc	O
an	DT	det	O
apparent	JJ	amod	O
dissociation	NN	compound	O
constant	NN	conj	O
(	-LRB-	punct	O
K	NN	compound	O
(	-LRB-	punct	O
D	NN	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
of	IN	case	O
about	RB	advmod	O
0.1	CD	nummod	O
nM	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
BLyS	NN	nsubj	B-protein
binding	NN	acl	O
to	TO	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
results	VBZ	ccomp	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
and	CC	cc	O
the	DT	det	O
Ets	NN	compound	B-protein
family	NN	compound	I-protein
transcription	NN	compound	I-protein
factor	NN	conj	I-protein
,	,	punct	O
ELF-1	NN	appos	B-protein
,	,	punct	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
induction	NN	conj	O
of	IN	case	O
mRNA	NN	nmod	O
for	IN	case	O
Polo-like	JJ	amod	B-protein
kinase	NN	nmod	I-protein
(	-LRB-	punct	O
PLK	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Copyright	NN	dep	O
2001	CD	nummod	O
Academic	NNP	compound	O
Press	NNP	ROOT	O
.	.	punct	O

Design	NN	ROOT	O
and	CC	cc	O
use	NN	conj	O
of	IN	case	O
an	DT	det	O
inducibly	RB	advmod	O
activated	VBN	amod	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
Nef	NN	nmod	B-protein
to	TO	mark	O
study	VB	acl	O
immune	JJ	amod	O
modulation	NN	dobj	O
.	.	punct	O

The	DT	det	O
Nef	NN	compound	B-protein
protein	NN	nsubjpass	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
enhance	VB	xcomp	O
the	DT	det	O
infectivity	NN	dobj	O
of	IN	case	O
virus	NN	compound	O
particles	NNS	nmod	O
,	,	punct	O
downmodulate	JJ	amod	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
proteins	NNS	conj	I-protein
,	,	punct	O
and	CC	cc	O
associate	VBP	conj	O
with	IN	case	O
many	JJ	amod	O
intracellular	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
that	WDT	nsubjpass	O
are	VBP	auxpass	O
thought	VBN	acl:relcl	O
to	TO	mark	O
facilitate	VB	xcomp	O
HIV	NN	compound	O
infection	NN	dobj	O
.	.	punct	O

One	CD	nsubj	O
of	IN	prep	O
the	DT	det	O
challenges	NNS	pobj	O
in	IN	prep	O
defining	VBG	pcomp	O
the	DT	det	O
molecular	JJ	amod	O
events	NNS	dobj	O
regulated	VBN	acl	O
by	IN	case	O
Nef	NN	nmod	B-protein
has	VBZ	aux	O
been	VBN	aux	O
obtaining	VBG	ROOT	O
good	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
Nef	NN	compound	B-protein
protein	NN	nmod	I-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
attributed	VBN	ROOT	O
to	TO	case	O
effects	NNS	nmod	O
of	IN	case	O
Nef	NN	nmod	B-protein
on	IN	case	O
cell	NN	nmod	O
proliferation	NN	dep	O
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
designed	VBN	ROOT	O
a	DT	det	O
Nef	NN	compound	B-protein
protein	NN	dobj	I-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
readily	RB	advmod	O
expressed	VBN	acl:relcl	O
in	IN	case	O
T-cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
and	CC	cc	O
whose	WP$	nmod:poss	O
function	NN	nsubjpass	O
is	VBZ	auxpass	O
inducibly	RB	advmod	O
activated	VBN	conj	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
composed	VBN	ROOT	O
of	IN	case	O
a	DT	det	O
fusion	NN	nmod	O
between	IN	case	O
full-length	JJ	amod	B-protein
Nef	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
estrogen	NN	compound	B-protein
receptor	NN	compound	I-protein
hormone-binding	JJ	amod	I-protein
domain	NN	conj	I-protein
(	-LRB-	punct	O
Nef-ER	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
Nef-ER	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
kept	VBN	ROOT	O
in	IN	case	O
an	DT	det	O
inactive	JJ	amod	O
state	NN	nmod	O
due	JJ	case	O
to	TO	mwe	O
steric	JJ	amod	O
hindrance	NN	nmod	O
,	,	punct	O
and	CC	cc	O
addition	NN	conj	O
of	IN	case	O
the	DT	det	O
membrane-permeable	JJ	amod	O
drug	NN	nmod	O
4-hydroxytamoxifen	NN	dep	O
(	-LRB-	punct	O
4-HT	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
ER	NN	compound	B-protein
domain	NN	nmod	I-protein
,	,	punct	O
leads	VBZ	conj	O
to	TO	case	O
inducible	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
Nef-ER	NN	nmod	B-protein
within	IN	case	O
cells	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
Nef-ER	NN	nsubj	B-protein
inducibly	RB	advmod	O
associates	VBZ	ccomp	O
with	IN	case	O
the	DT	det	O
62-kDa	JJ	amod	B-protein
Ser/Thr	NN	compound	I-protein
kinase	NN	nmod	I-protein
and	CC	cc	O
is	VBZ	cop	O
localized	JJ	conj	O
to	TO	case	O
specific	JJ	amod	O
membrane	NN	compound	O
microdomains	NNS	nmod	O
(	-LRB-	punct	O
lipid	NN	compound	O
rafts	NNS	appos	O
)	-RRB-	punct	O
only	RB	advmod	O
after	IN	case	O
activation	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
this	DT	det	O
inducible	JJ	amod	O
Nef	NN	dobj	B-protein
,	,	punct	O
we	PRP	nsubj	O
also	RB	advmod	O
compared	VBD	ROOT	O
the	DT	det	O
specific	JJ	amod	O
requirements	NNS	dobj	O
for	IN	case	O
CD4	NN	compound	B-protein
and	CC	cc	O
HLA-A2	NN	conj	B-protein
downmodulation	NN	nmod	O
in	IN	case	O
a	DT	det	O
SupT1	NN	amod	B-cell_line
T-cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

Half-maximal	JJ	amod	O
downmodulation	NN	nsubj	O
of	IN	case	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
CD4	NN	nmod	I-protein
required	VBD	ROOT	O
very	RB	advmod	O
little	JJ	amod	O
active	JJ	amod	O
Nef-ER	NN	dobj	B-protein
and	CC	cc	O
occurred	VBD	conj	O
as	RB	advmod	O
early	RB	advmod	O
as	IN	case	O
4	CD	nummod	O
h	NN	nmod	O
after	IN	case	O
addition	NN	nmod	O
of	IN	case	O
4-HT	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
50	CD	compound	O
%	NN	amod	O
downmodulation	NN	nsubj	O
of	IN	case	O
HLA-A2	NN	nmod	B-protein
by	IN	case	O
Nef	NN	nmod	B-protein
required	VBD	ROOT	O
16	CD	compound	O
to	TO	dep	O
24	CD	nummod	O
h	NN	dobj	O
and	CC	cc	O
about	RB	case	O
50-	CD	conj	O
to	TO	case	O
100-fold-greater	JJ	compound	O
concentrations	NNS	nmod	O
of	IN	case	O
4-HT	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
HLA-A2	NN	compound	B-protein
downmodulation	NN	nsubj	O
may	MD	aux	O
require	VB	ccomp	O
certain	JJ	amod	O
threshold	NN	compound	O
levels	NNS	dobj	O
of	IN	case	O
active	JJ	amod	O
Nef	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
differential	JJ	amod	O
timing	NN	nsubj	O
of	IN	case	O
CD4	NN	nmod	B-protein
and	CC	cc	O
HLA-A2	NN	compound	B-protein
downmodulation	NN	conj	O
may	MD	aux	O
have	VB	ROOT	O
implications	NNS	dobj	O
for	IN	case	O
HIV	NN	compound	O
pathogenesis	NN	nmod	O
and	CC	cc	O
immune	JJ	amod	O
evasion	NN	conj	O
.	.	punct	O

Regulation	NN	ROOT	O
of	IN	case	O
chemokine	NN	compound	O
mRNA	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
a	DT	det	O
rat	NN	compound	O
model	NN	nmod	O
of	IN	case	O
vanadium-induced	JJ	amod	O
pulmonary	JJ	amod	O
inflammation	NN	nmod	O
.	.	punct	O

Environmental	JJ	amod	O
and	CC	cc	O
occupational	JJ	conj	O
exposure	NN	nsubj	O
to	TO	case	O
vanadium	NN	compound	O
dusts	NNS	nmod	O
results	VBZ	ROOT	O
in	IN	case	O
toxic	JJ	amod	O
effects	NNS	nmod	O
mainly	RB	advmod	O
confined	VBD	acl	O
to	TO	case	O
the	DT	det	O
respiratory	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
rat	NN	compound	O
model	NN	dobj	O
of	IN	case	O
acute	JJ	amod	O
lung	NN	compound	O
inflammation	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
intratracheal	JJ	amod	O
instillation	NN	nmod	O
of	IN	case	O
sodium	NN	compound	O
metavanadate	NN	nmod	O
(	-LRB-	punct	O
NaVO3	NN	appos	O
)	-RRB-	punct	O
at	IN	case	O
the	DT	det	O
dose	NN	nmod	O
of	IN	case	O
200	CD	nummod	O
microg	NN	compound	O
V/kg	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
relationship	NN	dobj	O
between	IN	case	O
the	DT	det	O
cytologic	JJ	amod	O
characterization	NN	nmod	O
of	IN	case	O
pulmonary	JJ	amod	O
inflammation	NN	nmod	O
and	CC	cc	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
chemokine	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

Significant	JJ	amod	O
polymorphonuclear	JJ	amod	B-cell_type
leukocyte	NN	compound	I-cell_type
(	-LRB-	punct	O
PMN	NN	appos	B-cell_type
)	-RRB-	punct	O
influx	NN	nsubjpass	O
(	-LRB-	punct	O
P	NN	compound	O
<	-LRB-	dep	O
0.01	CD	nummod	O
)	-RRB-	punct	O
into	IN	case	O
the	DT	det	O
lung	NN	nmod	O
was	VBD	auxpass	O
noted	VBN	ROOT	O
4	CD	nummod	O
h	NN	nmod	O
after	IN	case	O
NaVO3	NN	compound	O
instillation	NN	dep	O
,	,	punct	O
whereas	IN	dep	O
alveolar	JJ	amod	B-cell_type
macrophages	NNS	nsubj	I-cell_type
(	-LRB-	punct	O
AMs	NNS	appos	B-cell_type
)	-RRB-	punct	O
in	IN	case	O
bronchoalveolar	JJ	amod	B-cell_type
lavage	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
BAL	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
appeared	VBD	parataxis	O
to	TO	mark	O
decrease	VB	xcomp	O
significantly	RB	advmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
neither	CC	cc:preconj	O
PMNs	NNS	nsubj	B-cell_type
nor	CC	cc	O
AMs	NN	conj	B-cell_type
changed	VBD	ROOT	O
substantially	RB	advmod	O
1	CD	nummod	O
h	NN	dobj	O
after	IN	case	O
NaVO3	NN	compound	O
instillation	NN	nmod	O
.	.	punct	O

By	IN	case	O
Northern	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
macrophage	NN	compound	B-RNA
inflammatory	JJ	amod	I-RNA
protein	NN	compound	I-RNA
(	-LRB-	punct	I-RNA
MIP	NN	compound	I-RNA
)	-RRB-	punct	I-RNA
-2	CD	nummod	I-RNA
mRNA	NN	nsubj	I-RNA
in	IN	case	O
BAL	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
increased	VBD	ROOT	O
markedly	RB	advmod	O
1	CD	nummod	O
h	NN	dobj	O
after	IN	case	O
NaVO3	NN	compound	O
instillation	NN	nmod	O
and	CC	cc	O
reduced	VBD	conj	O
a	DT	det	O
little	JJ	amod	O
bit	NN	dobj	O
at	IN	case	O
4	CD	nummod	O
h	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
MIP-1alpha	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
in	IN	case	O
BAL	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	auxpass	O
expressed	VBN	parataxis	O
relatively	RB	advmod	O
high	JJ	amod	O
1	CD	nummod	O
h	NN	nmod	O
after	IN	case	O
NaVO3	NN	compound	O
instillation	NN	nmod	O
,	,	punct	O
although	IN	mark	O
a	DT	det	O
basal	JJ	amod	O
expression	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	advcl	O
in	IN	case	O
control	JJ	compound	O
group	NN	nmod	O
,	,	punct	O
and	CC	cc	O
returned	VBD	conj	O
rapidly	RB	advmod	O
nearly	RB	advmod	O
to	TO	mark	O
control	VB	xcomp	O
level	NN	dobj	O
at	IN	case	O
4	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

Since	IN	mark	O
MIP-2	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
PMN	NN	compound	B-cell_type
chemoattractant	NN	nsubjpass	O
and	CC	cc	O
MIP-1alpha	NN	conj	B-protein
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
macrophage/monocyte	NN	compound	O
chemoattractant	NN	conj	O
has	VBZ	aux	O
been	VBN	auxpass	O
well	RB	advmod	O
known	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
facts	NNS	ROOT	O
that	IN	mark	O
PMN	NN	compound	B-cell_type
influx	NN	nsubjpass	O
was	VBD	auxpass	O
preceded	VBN	ccomp	O
by	IN	case	O
increased	VBN	amod	O
MIP-2	NN	compound	O
mRNA	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
suggesting	VBG	acl	O
that	IN	mark	O
MIP-2	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
NaVO3-induced	JJ	amod	O
pulmonary	JJ	amod	O
inflammation	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
increased	VBN	amod	O
MIP-1alpha	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
expression	NN	nsubjpass	O
was	VBD	auxpass	O
followed	VBN	conj	O
by	IN	case	O
decreased	VBN	amod	O
AMs	NN	nmod	B-cell_type
in	IN	case	O
BAL	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
suggesting	VBG	xcomp	O
AMs	NNS	nsubjpass	B-cell_type
might	MD	aux	O
be	VB	auxpass	O
activated	VBN	ccomp	O
by	IN	case	O
MIP-1alpha	NN	nmod	B-protein
,	,	punct	O
adherent	JJ	conj	O
to	TO	case	O
the	DT	det	O
lining	JJ	amod	O
surface	NN	nmod	O
of	IN	case	O
the	DT	det	O
airways	NNS	nmod	O
and	CC	cc	O
then	RB	advmod	O
resistant	JJ	conj	O
to	TO	aux	O
be	VB	auxpass	O
washed	VBN	xcomp	O
out	RP	prt	O
.	.	punct	O

To	TO	mark	O
delineate	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
of	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
recently	RB	advmod	O
cloned	VBD	ROOT	O
the	DT	det	O
5'-flanking	JJ	amod	B-DNA
region	NN	dobj	I-DNA
of	IN	case	O
the	DT	det	O
MIP-2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
promotor	NN	compound	B-DNA
region	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
consensus	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
for	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
nuclear	JJ	amod	I-protein
factor	NN	compound	I-protein
kappaB	NN	nmod	I-protein
(	-LRB-	punct	O
NF-kappaB	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
activator	NN	compound	B-protein
protein-1	NN	conj	I-protein
(	-LRB-	punct	O
AP-1	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Using	VBG	advcl	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	dobj	O
,	,	punct	O
increased	VBN	amod	O
nuclear	JJ	amod	O
NF-kappaB	NN	dobj	B-protein
,	,	punct	O
not	RB	cc	O
AP-1	NN	conj	B-protein
,	,	punct	O
binding	NN	compound	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
1	CD	nummod	O
h	NN	dobj	O
after	IN	case	O
NaVO3	NN	compound	O
instillation	NN	dep	O
,	,	punct	O
which	WDT	nsubj	O
correlated	VBD	acl:relcl	O
with	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
MIP-2	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

p65	NN	nsubj	B-protein
(	-LRB-	punct	I-protein
Rel	NN	compound	I-protein
A	NN	appos	I-protein
)	-RRB-	punct	I-protein
and	CC	cc	O
p50	NN	compound	B-protein
protein	NN	conj	I-protein
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
in	IN	case	O
MIP-2	NN	compound	O
NF-kappaB	NN	compound	B-protein
binding	NN	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
studies	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
MIP-2	NN	nsubj	B-protein
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
mediator	NN	ccomp	O
of	IN	case	O
NaVO3-induced	JJ	amod	O
pulmonary	JJ	amod	O
inflammation	NN	nmod	O
in	IN	case	O
the	DT	det	O
rat	NN	compound	O
model	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
elevated	JJ	amod	O
MIP-2	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nsubjpass	O
are	VBP	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
increased	VBN	amod	O
NF-kappaB	NN	compound	B-protein
binding	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
BAL	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
suggesting	VBG	xcomp	O
possible	JJ	amod	O
MIP-2	NN	compound	B-protein
transcriptional	JJ	amod	O
regulation	NN	dobj	O
through	IN	case	O
NF-kappaB	NN	nmod	B-protein
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
signal	NN	compound	O
transduction	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
healthy	JJ	amod	B-cell_type
lymphomonocytes	NNS	nmod	I-cell_type
exposed	VBN	acl	O
to	TO	mark	O
bystander	VB	xcomp	O
HIV-1-infected	JJ	amod	B-cell_type
cells	NNS	dobj	I-cell_type
.	.	punct	O

Persistent	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
hallmarks	NNS	nmod	O
of	IN	case	O
HIV-1	NN	compound	O
infection	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
analysed	VBD	ROOT	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
factors	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
cytokine	NN	compound	O
signal	NN	compound	O
transduction	NN	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
STAT	NN	compound	B-protein
1	CD	nummod	I-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
IRF-1	NN	compound	B-RNA
mRNA	NN	conj	I-RNA
,	,	punct	O
in	IN	case	O
normal	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBMC	NNS	appos	B-cell_type
)	-RRB-	punct	O
exposed	VBN	acl	O
to	TO	case	O
HIV-infected	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
the	DT	det	O
induction	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
analyses	NNS	nsubj	O
and	CC	cc	O
reverse	JJ	amod	O
transcriptase-polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	compound	O
results	NNS	conj	O
indicate	VBP	ROOT	O
that	IN	mark	O
both	DT	det	O
cells	NNS	nsubj	O
infected	VBN	acl	O
with	IN	case	O
a	DT	det	O
X4	NN	compound	O
strain	NN	nmod	O
and	CC	cc	O
cells	NNS	conj	O
infected	VBN	acl	O
with	IN	case	O
a	DT	det	O
R5	NN	compound	O
strain	NN	nmod	O
are	VBP	cop	O
able	JJ	ccomp	O
to	TO	mark	O
increase	VB	xcomp	O
intracellular	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
STAT	NN	compound	B-protein
1alpha	NN	compound	I-protein
and	CC	cc	I-protein
beta	NN	conj	I-protein
proteins	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
IRF-1	NN	compound	B-RNA
mRNA	NN	conj	I-RNA
.	.	punct	O

This	DT	det	O
effect	NN	nsubjpass	O
was	VBD	auxpass	O
prevented	VBN	ROOT	O
by	IN	case	O
neutralizing	VBG	amod	O
antibodies	NNS	nmod	O
against	IN	case	O
interferon-alpha	NN	nmod	B-protein
(	-LRB-	punct	O
IFN-alpha	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

HIV-1-infected	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
dose-dependently	RB	advmod	O
induced	VBD	ROOT	O
apoptotic	JJ	amod	O
commitment	NN	dobj	O
in	IN	case	O
normal	JJ	amod	B-cell_type
PBMC	NN	nmod	I-cell_type
,	,	punct	O
as	IN	mark	O
revealed	VBN	advcl	O
by	IN	case	O
DNA	NN	compound	O
fragmentation	NN	compound	O
analysis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
this	DT	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
accompanied	VBN	conj	O
by	IN	case	O
an	DT	det	O
increase	NN	nmod	O
of	IN	case	O
caspase-3	NN	compound	O
activity	NN	nmod	O
,	,	punct	O
even	RB	advmod	O
if	IN	mark	O
a	DT	det	O
slight	JJ	amod	O
up-regulation	NN	nsubjpass	O
of	IN	case	O
IL-1beta-converting	JJ	amod	B-RNA
enzyme	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
was	VBD	auxpass	O
detected	VBN	advcl	O
.	.	punct	O

Apoptosis	NN	compound	O
induction	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
abrogated	VBN	ROOT	O
mainly	RB	advmod	O
by	IN	case	O
antibodies	NNS	nmod	B-protein
against	IN	case	O
tumour	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	nmod	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
,	,	punct	O
to	TO	case	O
a	DT	det	O
lesser	JJR	amod	O
extent	NN	nmod	O
,	,	punct	O
by	IN	case	O
antibodies	NNS	nmod	B-protein
against	IN	case	O
IFN-gamma	NN	nmod	B-protein
.	.	punct	O

All	PDT	det:predet	O
these	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
uninfected	JJ	amod	B-cell_type
PBMC	NN	nsubj	I-cell_type
can	MD	aux	O
undergo	VB	ccomp	O
activation	NN	dobj	O
of	IN	case	O
signal	NN	compound	O
transduction	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
after	IN	case	O
exposure	NN	nmod	O
to	TO	mark	O
bystander	VB	acl	O
HIV-infected	JJ	amod	B-cell_type
cells	NNS	dobj	I-cell_type
,	,	punct	O
subsequent	JJ	advcl	O
to	TO	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
such	JJ	case	O
as	IN	mwe	O
IFNs	NNS	nmod	B-protein
and	CC	cc	O
TNF-alpha	NN	conj	B-protein
.	.	punct	O

The	DT	det	O
physical	JJ	amod	O
association	NN	nsubj	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
theta	NN	nmod	I-protein
with	IN	case	O
a	DT	det	O
lipid	NN	nmod:npmod	O
raft-associated	JJ	amod	O
inhibitor	NN	nmod	O
of	IN	case	O
kappa	NN	compound	B-protein
B	NN	compound	I-protein
factor	NN	compound	I-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	I-protein
IKK	NN	compound	I-protein
)	-RRB-	punct	I-protein
complex	NN	nmod	I-protein
plays	VBZ	ROOT	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	O
B	NN	compound	O
cascade	NN	nmod	O
by	IN	case	O
TCR	NN	nmod	B-protein
and	CC	cc	O
CD28	NN	conj	B-protein
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
theta	NN	nmod	I-protein
(	-LRB-	punct	O
PKCtheta	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
NF-kappaB	NN	compound	B-protein
cascade	NN	nmod	O
in	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
CD4	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Among	IN	case	O
six	CD	nummod	O
or	CC	cc	O
so	RB	conj	O
PKC	NN	compound	B-protein
isoforms	NNS	nmod	I-protein
expressed	VBN	acl	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
only	RB	advmod	O
PKCtheta	NN	nsubj	B-protein
participates	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
assembly	NN	nmod	O
of	IN	case	O
the	DT	det	O
supramolecular	JJ	amod	O
activation	NN	compound	O
clusters	NNS	nmod	O
at	IN	case	O
the	DT	det	O
contact	NN	amod	O
site	NN	nmod	O
of	IN	case	O
the	DT	det	O
TCR	NN	nmod	B-protein
with	IN	case	O
Ag	NN	nmod	B-protein
.	.	punct	O

Signaling	NN	nsubjpass	O
via	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
TCR	NN	nmod	B-protein
and	CC	cc	O
CD28	NN	conj	B-protein
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
optimal	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
multisubunit	NN	amod	B-protein
IkappaB	NN	compound	I-protein
kinase	NN	compound	I-protein
(	-LRB-	punct	I-protein
IKK	NN	compound	I-protein
)	-RRB-	punct	I-protein
complex	NN	nmod	I-protein
in	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
;	:	punct	O
this	DT	det	O
activation	NN	nsubjpass	O
could	MD	aux	O
be	VB	auxpass	O
inhibited	VBN	parataxis	O
by	IN	case	O
a	DT	det	O
Ca	NN	compound	O
(	-LRB-	punct	O
2+	NN	dep	O
)	-RRB-	punct	O
-independent	JJ	amod	O
PKC	NN	compound	O
isoform	NN	compound	O
inhibitor	NN	nmod	O
,	,	punct	O
rottlerin	NN	appos	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
endogenous	JJ	amod	O
PKCtheta	NN	nsubj	B-protein
physically	RB	advmod	O
associates	VBZ	ROOT	O
with	IN	case	O
activated	VBN	amod	O
IKK	NN	compound	B-protein
complexes	NNS	nmod	I-protein
in	IN	case	O
CD3/CD28-costimulated	JJ	amod	B-cell_type
primary	JJ	amod	I-cell_type
CD4	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
same	JJ	amod	O
set	NN	nsubj	O
of	IN	case	O
stimuli	NNS	nmod	O
also	RB	advmod	O
induced	VBD	ROOT	O
relocation	NN	dobj	O
of	IN	case	O
endogenous	JJ	amod	O
PKCtheta	NN	nmod	B-protein
and	CC	cc	O
IKKs	NNS	conj	B-protein
to	TO	case	O
a	DT	det	O
GM1	NN	compound	O
ganglioside-enriched	JJ	amod	O
,	,	punct	O
detergent-insoluble	JJ	dep	O
membrane	NN	compound	O
compartment	NN	nmod	O
in	IN	case	O
primary	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

IKKs	NNS	nsubj	B-protein
recruited	VBN	acl	O
to	TO	case	O
these	DT	det	O
lipid	NN	compound	O
rafts	NNS	nmod	O
were	VBD	cop	O
capable	JJ	ROOT	O
of	IN	mark	O
phosphorylating	VBG	advcl	O
a	DT	det	O
recombinant	JJ	amod	O
IkappaBalpha	NN	compound	O
sustrate	NN	dobj	O
.	.	punct	O

Confocal	JJ	amod	O
microscopy	NN	nsubj	O
further	RB	advmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
exogenously	RB	advmod	O
expressed	VBN	amod	O
PKCtheta	NN	nsubj	B-protein
and	CC	cc	O
IKKss	NN	conj	B-protein
colocalize	VBP	ccomp	O
in	IN	case	O
the	DT	det	O
membrane	NN	nmod	O
of	IN	case	O
CD3/CD28-costimulated	JJ	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Constitutively	RB	advmod	O
active	JJ	ROOT	O
but	CC	cc	O
not	RB	cc	O
kinase-inactive	JJ	amod	B-protein
PKCtheta	NN	nsubj	I-protein
activated	VBD	conj	O
IKKbeta	NN	dobj	B-protein
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
dominant-active	JJ	amod	B-protein
PKCtheta	NN	nmod	I-protein
also	RB	advmod	O
had	VBD	ROOT	O
stimulatory	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
the	DT	det	O
CD28	NN	compound	B-DNA
response	NN	compound	I-DNA
element	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
PKCtheta	NN	nmod	B-protein
by	IN	case	O
the	DT	det	O
TCR	NN	nmod	B-protein
and	CC	cc	O
CD28	NN	conj	B-protein
plays	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
assembly	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
IKK	NN	compound	B-protein
complexes	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
T	NN	compound	O
cell	NN	compound	O
membrane	NN	nmod	O

T-cell	NN	nmod:npmod	B-cell_type
-mediated	JJ	amod	O
regulation	NN	ROOT	O
of	IN	case	O
osteoclastogenesis	NN	nmod	O
by	IN	mark	O
signalling	VBG	acl	O
cross-talk	NN	dobj	O
between	IN	case	O
RANKL	NN	nmod	B-protein
and	CC	cc	O
IFN-gamma	NN	conj	B-protein
.	.	punct	O

Bone	NN	compound	O
resorption	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
,	,	punct	O
where	WRB	advmod	O
T-cell	NN	compound	B-cell_type
expression	NN	nsubj	O
of	IN	case	O
RANKL	NN	nmod	B-protein
(	-LRB-	punct	O
receptor	NN	compound	B-protein
activator	NN	dep	I-protein
of	IN	case	I-protein
nuclear	JJ	amod	I-protein
factor	NN	compound	I-protein
(	-LRB-	punct	I-protein
NF	NN	compound	I-protein
)	-RRB-	punct	I-protein
-kappaB	NN	compound	I-protein
ligand	NN	nmod	I-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
tumour-necrosis	JJ	amod	B-protein
factor	NN	compound	I-protein
family	NN	nmod	I-protein
that	WDT	nsubj	O
is	VBZ	cop	O
essential	JJ	acl:relcl	O
for	IN	case	O
osteoclastogenesis	NN	nmod	O
,	,	punct	O
may	MD	aux	O
contribute	VB	acl:relcl	O
to	TO	case	O
pathological	JJ	amod	O
conditions	NNS	nmod	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
autoimmune	JJ	amod	O
arthritis	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
whether	IN	mark	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
maintain	VBP	advcl	O
bone	NN	compound	O
homeostasis	NN	dobj	O
by	IN	mark	O
counterbalancing	VBG	advcl	O
the	DT	det	O
action	NN	dobj	O
of	IN	case	O
RANKL	NN	nmod	B-protein
remains	VBZ	ROOT	O
unknown	JJ	xcomp	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
T-cell	NN	compound	B-cell_type
production	NN	nsubj	O
of	IN	case	O
interferon	NN	compound	B-protein
(	-LRB-	punct	I-protein
IFN	NN	compound	I-protein
)	-RRB-	punct	I-protein
-gamma	NN	nmod	I-protein
strongly	RB	advmod	O
suppresses	VBZ	ccomp	O
osteoclastogenesis	NN	dobj	O
by	IN	mark	O
interfering	VBG	advcl	O
with	IN	case	O
the	DT	det	O
RANKL	NN	nmod	B-protein
-RANK	JJ	dep	O
signalling	NN	amod	O
pathway	NN	dobj	O
.	.	punct	O

IFN-gamma	NN	nsubj	B-protein
induces	VBZ	ROOT	O
rapid	JJ	amod	O
degradation	NN	dobj	O
of	IN	case	O
the	DT	det	O
RANK	NN	compound	B-protein
adapter	NN	compound	I-protein
protein	NN	nmod	I-protein
,	,	punct	O
TRAF6	NN	appos	B-protein
(	-LRB-	punct	O
tumour	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
receptor-associated	JJ	amod	I-protein
factor	NN	appos	I-protein
6	CD	nummod	I-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
results	VBZ	acl:relcl	O
in	IN	case	O
strong	JJ	amod	O
inhibition	NN	nmod	O
of	IN	case	O
the	DT	det	O
RANKL	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappaB	NN	nmod	B-protein
and	CC	cc	O
JNK	NN	conj	B-protein
.	.	punct	O

This	DT	det	O
inhibition	NN	nsubjpass	O
of	IN	case	O
osteoclastogenesis	NN	nmod	O
is	VBZ	auxpass	O
rescued	VBN	ROOT	O
by	IN	mark	O
overexpressing	VBG	advcl	O
TRAF6	NN	dobj	B-protein
in	IN	case	O
precursor	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
which	WDT	nsubj	O
indicates	VBZ	acl:relcl	O
that	IN	mark	O
TRAF6	NN	nsubj	B-protein
is	VBZ	cop	O
the	DT	det	O
target	NN	ccomp	O
critical	JJ	amod	O
for	IN	case	O
the	DT	det	O
IFN-gamma	NN	compound	B-protein
action	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
the	DT	det	O
accelerated	VBN	amod	O
degradation	NN	nsubj	O
of	IN	case	O
TRAF6	NN	nmod	B-protein
requires	VBZ	ccomp	O
both	CC	cc:preconj	O
its	PRP$	nmod:poss	O
ubiquitination	NN	dobj	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
initiated	VBN	acl:relcl	O
by	IN	case	O
RANKL	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
IFN-gamma	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
activation	NN	conj	O
of	IN	case	O
the	DT	det	O
ubiquitin-proteasome	JJ	amod	O
system	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
there	EX	expl	O
is	VBZ	ccomp	O
cross-talk	NN	acomp	O
between	IN	case	O
the	DT	det	O
tumour	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	nmod	I-protein
and	CC	cc	O
IFN	NN	compound	B-protein
families	NNS	conj	I-protein
of	IN	case	O
cytokines	NNS	nmod	B-protein
,	,	punct	O
through	IN	case	O
which	WDT	nmod	O
IFN-gamma	NN	nsubj	B-protein
provides	VBZ	ccomp	O
a	DT	det	O
negative	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
T-cell	NN	compound	B-cell_type
activation	NN	nmod	O
and	CC	cc	O
bone	NN	compound	O
resorption	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
may	MD	aux	O
offer	VB	ROOT	O
a	DT	det	O
therapeutic	JJ	amod	O
approach	NN	dobj	O
to	TO	mark	O
treat	VB	acl	O
the	DT	det	O
inflammation-induced	JJ	amod	O
tissue	NN	compound	O
breakdown	NN	dobj	O
.	.	punct	O

Stromal-derived	JJ	amod	B-protein
factor	NN	nsubj	I-protein
1	CD	nummod	I-protein
and	CC	cc	O
thrombopoietin	NN	conj	B-protein
regulate	VBP	ROOT	O
distinct	JJ	amod	O
aspects	NNS	dobj	O
of	IN	case	O
human	JJ	amod	O
megakaryopoiesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
role	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
chemokine	NN	compound	B-protein
binding	NN	compound	O
stromal-derived	JJ	amod	B-protein
factor	NN	nmod	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
SDF-1	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	O
megakaryopoiesis	NN	nmod	O
at	IN	case	O
the	DT	dep	O
cellular	JJ	nmod	O
and	CC	cc	O
molecular	JJ	conj	O
levels	NNS	dep	O
and	CC	cc	O
its	PRP$	nmod:poss	O
comparison	NN	conj	O
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
thrombopoietin	NN	nmod	B-protein
(	-LRB-	punct	O
TPO	NN	appos	B-protein
)	-RRB-	punct	O
have	VBP	aux	O
not	RB	neg	O
been	VBN	auxpass	O
determined	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
that	IN	mark	O
SDF-1	NN	nsubj	B-protein
,	,	punct	O
unlike	IN	case	O
TPO	NN	nmod	B-protein
,	,	punct	O
does	VBZ	aux	O
not	RB	neg	O
stimulate	VB	ccomp	O
alpha	NN	compound	O
(	-LRB-	punct	O
IIb	NN	compound	O
)	-RRB-	punct	O
beta	NN	dobj	O
(	-LRB-	punct	O
3	CD	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
cell	NN	compound	O
proliferation	NN	dep	O
or	CC	cc	O
differentiation	NN	conj	O
or	CC	cc	O
have	VBP	conj	O
an	DT	det	O
antiapoptotic	JJ	amod	O
effect	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
does	VBZ	aux	O
induce	VB	ROOT	O
chemotaxis	NN	dobj	O
,	,	punct	O
trans-Matrigel	JJ	compound	O
migration	NN	conj	O
,	,	punct	O
and	CC	cc	O
secretion	NN	conj	O
of	IN	case	O
matrix	NN	compound	O
metalloproteinase	NN	nmod	B-protein
9	CD	nummod	I-protein
(	-LRB-	punct	O
MMP-9	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
vascular	JJ	amod	B-protein
endothelial	JJ	amod	I-protein
growth	NN	compound	I-protein
factor	NN	conj	I-protein
(	-LRB-	punct	O
VEGF	NN	appos	B-protein
)	-RRB-	punct	O
by	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
both	CC	cc:preconj	O
SDF-1	NN	nsubj	B-protein
and	CC	cc	O
TPO	NN	conj	B-protein
increase	VBP	conj	O
the	DT	det	O
adhesion	NN	dobj	O
of	IN	case	O
alpha	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
IIb	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
beta	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
3	CD	appos	I-cell_type
)	-RRB-	punct	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
fibrinogen	NN	nmod	B-protein
and	CC	cc	O
vitronectin	NN	conj	B-protein
.	.	punct	O

Investigating	VBG	csubj	O
the	DT	det	O
intracellular	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	dobj	O
induced	VBN	acl	O
by	IN	case	O
SDF-1	NN	nmod	B-protein
and	CC	cc	O
TPO	NN	conj	B-protein
revealed	VBD	ROOT	O
some	DT	det	O
overlapping	VBG	amod	O
patterns	NNS	dobj	O
of	IN	case	O
protein	NN	compound	O
phosphorylation/activation	NN	nmod	O
(	-LRB-	punct	O
mitogen-activated	JJ	amod	B-protein
protein	NN	compound	I-protein
kinase	NN	dep	I-protein
[	-LRB-	punct	I-protein
MAPK	NN	appos	I-protein
]	-RRB-	punct	I-protein
p42/44	RB	dep	I-protein
,	,	punct	O
MAPK	NN	compound	B-protein
p38	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
AKT	NN	compound	B-protein
[	-LRB-	punct	I-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
B	NN	conj	I-protein
]	-RRB-	punct	I-protein
)	-RRB-	punct	O
and	CC	cc	O
some	DT	conj	O
that	WDT	nsubj	O
were	VBD	cop	O
distinct	JJ	acl:relcl	O
for	IN	case	O
TPO	NN	nmod	B-protein
(	-LRB-	punct	O
eg	FW	dep	O
,	,	punct	O
JAK-STAT	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
for	IN	case	O
SDF-1	NN	conj	B-protein
(	-LRB-	punct	O
eg	FW	compound	O
,	,	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
found	VBN	ROOT	O
that	IN	mark	O
though	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
phosphatidyl-inositol	NN	compound	B-protein
3-kinase	NN	nmod	I-protein
(	-LRB-	punct	O
PI-3K	NN	appos	B-protein
)	-RRB-	punct	O
by	IN	case	O
LY294002	NN	nmod	O
in	IN	case	O
alpha	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
IIb	NN	compound	I-cell_type
)	-RRB-	punct	I-cell_type
beta	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
3	CD	appos	I-cell_type
)	-RRB-	punct	I-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nmod	I-cell_type
induced	VBD	advcl	O
apoptosis	NN	dobj	O
and	CC	cc	O
inhibited	VBD	conj	O
chemotaxis	NN	compound	O
adhesion	NN	dobj	O
and	CC	cc	O
the	DT	det	O
secretion	NN	conj	O
of	IN	case	O
MMP-9	NN	nmod	B-protein
and	CC	cc	O
VEGF	NN	conj	B-protein
,	,	punct	O
the	DT	det	O
inhibition	NN	nsubj	O
of	IN	case	O
MAPK	NN	compound	B-protein
p42/44	RB	nmod	I-protein
(	-LRB-	punct	O
by	IN	case	O
the	DT	det	O
MEK	NN	compound	O
inhibitor	NN	compound	O
U0126	NN	appos	O
)	-RRB-	punct	O
had	VBD	ccomp	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
survival	NN	nmod	O
,	,	punct	O
proliferation	NN	conj	O
,	,	punct	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

Hence	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
proliferative	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
TPO	NN	nmod	B-protein
is	VBZ	cop	O
more	RBR	advmod	O
related	JJ	ccomp	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
JAK-STAT	NN	compound	O
pathway	NN	nmod	O
(	-LRB-	punct	O
unique	JJ	dep	O
to	TO	case	O
TPO	NN	nmod	B-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
PI-3K-AKT	NN	compound	O
axis	NN	nsubjpass	O
is	VBZ	auxpass	O
differentially	RB	advmod	O
involved	VBN	conj	O
in	IN	case	O
TPO-	NN	amod	O
and	CC	cc	O
SDF-1-dependent	JJ	conj	O
signaling	NN	nmod	O
.	.	punct	O

Accordingly	RB	advmod	O
,	,	punct	O
PI-3K	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
involved	VBN	ROOT	O
in	IN	case	O
TPO	NN	nmod:npmod	B-protein
-mediated	JJ	amod	O
inhibition	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
TPO-	NN	amod	O
and	CC	cc	O
SDF-1-regulated	JJ	conj	O
adhesion	NN	conj	O
to	TO	case	O
fibrinogen	NN	nmod	B-protein
and	CC	cc	O
vitronectin	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
SDF-1	NN	compound	B-protein
-mediated	JJ	amod	O
migration	NN	conj	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
expands	VBZ	ROOT	O
the	DT	det	O
understanding	NN	dobj	O
of	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
SDF-1	NN	nmod	B-protein
and	CC	cc	O
TPO	NN	conj	B-protein
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	O
megakaryopoiesis	NN	nmod	O
and	CC	cc	O
indicates	VBZ	conj	O
the	DT	det	O
molecular	JJ	amod	O
basis	NN	dobj	O
of	IN	case	O
the	DT	det	O
observed	VBN	amod	O
differences	NNS	nmod	O
in	IN	case	O
cellular	JJ	amod	O
responses	NNS	nmod	O
.	.	punct	O

(	-LRB-	punct	O
Blood.	NNP	ROOT	O
2000	CD	nummod	O
;	:	punct	O
96	CD	dep	O
:	:	punct	O
4142-4151	CD	nummod	O
)	-RRB-	punct	O

Adhesion	NN	nsubj	O
of	IN	case	O
immature	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
mature	JJ	conj	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
induces	VBZ	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
thymic	JJ	amod	I-cell_type
epithelial	JJ	amod	I-cell_type
cells	NNS	compound	I-cell_type
(	-LRB-	punct	O
TEC	NNS	appos	B-cell_type
)	-RRB-	punct	O
activation	NN	nmod	O
of	IN	case	O
IL-6	NN	compound	B-protein
gene	NN	compound	I-protein
trascription	NN	compound	I-protein
factors	NNS	nmod	I-protein
(	-LRB-	punct	O
NF-kappaB	NN	dep	B-protein
and	CC	cc	O
NF-IL6	NN	conj	B-protein
)	-RRB-	punct	O
and	CC	cc	O
IL-6	NN	compound	O
gene	NN	compound	O
expression	NN	conj	O
:	:	punct	O
role	NN	dep	O
of	IN	case	O
alpha3beta1	NN	nmod	B-protein
and	CC	cc	I-protein
alpha6beta4	JJ	conj	I-protein
integrins	NNS	dep	I-protein
.	.	punct	O

T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
precursors	NNS	nsubj	I-cell_type
homed	VBN	ROOT	O
to	TO	case	O
thymus	NN	nmod	O
develop	VB	xcomp	O
in	IN	case	O
close	JJ	amod	O
contact	NN	nmod	O
with	IN	case	O
stromal	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Among	IN	case	O
them	PRP	nmod	O
,	,	punct	O
thymic	JJ	amod	B-cell_type
epithelial	JJ	amod	I-cell_type
cells	NNS	nsubjpass	I-cell_type
(	-LRB-	punct	O
TEC	NNS	appos	B-cell_type
)	-RRB-	punct	O
are	VBP	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
exert	VB	xcomp	O
dominant	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
their	PRP$	nmod:poss	O
survival	NN	nmod	O
and	CC	cc	O
functional	JJ	amod	O
shaping	NN	conj	O
.	.	punct	O

Key	JJ	amod	O
molecules	NNS	nsubj	O
mediating	VBG	acl	O
TEC	NNS	compound	B-cell_type
/	:	punct	O
thymocytes	NNS	compound	B-cell_type
interactions	NNS	dobj	O
include	VBP	ROOT	O
cytokines	NNS	dobj	B-protein
and	CC	cc	O
growth	NN	compound	B-protein
factors	NNS	conj	I-protein
secreted	VBN	acl	O
by	IN	case	O
the	DT	det	O
two	CD	nummod	O
cell	NN	compound	O
types	NNS	nmod	O
and	CC	cc	O
adhesion	NN	compound	B-protein
receptors	NNS	conj	I-protein
mediating	VBG	acl	O
cell	NN	compound	O
contact	NN	dobj	O
.	.	punct	O

Signaling	NN	compound	O
events	NNS	nsubjpass	O
triggered	VBN	acl	O
in	IN	case	O
thymocytes	NNS	nmod	B-cell_type
by	IN	case	O
adhesion	NN	nmod	O
to	TO	case	O
epithelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
have	VBP	aux	O
been	VBN	auxpass	O
extensively	RB	advmod	O
investigated	VBN	ROOT	O
,	,	punct	O
whereas	IN	dep	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	parataxis	O
on	IN	case	O
the	DT	det	O
opposite	JJ	amod	O
phenomenon	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
investigated	VBN	ROOT	O
this	DT	det	O
issue	NN	dobj	O
in	IN	case	O
a	DT	det	O
co-culture	JJ	amod	O
system	NN	nmod	O
composed	VBN	acl	O
of	IN	case	O
TEC	NN	compound	B-cell_type
cultures	NNS	nmod	I-cell_type
derived	VBN	acl	O
from	IN	case	O
human	JJ	amod	O
normal	JJ	amod	O
thymus	NN	nmod	O
and	CC	cc	O
heterologous	JJ	amod	B-cell_type
thymocytes	NNS	conj	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
thymocytes	NNS	nsubj	B-cell_type
adhere	RB	ccomp	O
to	TO	case	O
TEC	NN	nmod	B-cell_type
involving	VBG	acl	O
beta1	NN	compound	B-protein
and	CC	cc	I-protein
beta4	NN	conj	I-protein
integrins	NNS	dobj	I-protein
and	CC	cc	O
induce	VBP	conj	O
the	DT	det	O
clustering	NN	dobj	O
of	IN	case	O
alpha3beta1	NN	nmod	B-protein
and	CC	cc	I-protein
alpha6beta4	NN	conj	I-protein
heterodimers	NNS	dep	I-protein
at	IN	case	O
the	DT	det	O
TEC	NN	compound	O
surface	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	compound	O
thymocyte	NN	compound	O
adhesion	NN	nsubjpass	O
was	VBD	auxpass	O
followed	VBN	ROOT	O
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
and	CC	cc	O
NF-IL6	NN	conj	B-protein
gene	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
and	CC	cc	O
enhanced	VBD	amod	O
IL-6	NN	compound	O
production	NN	conj	O
.	.	punct	O

The	DT	det	O
two	CD	nummod	O
latter	JJ	amod	O
phenomena	NNS	nsubjpass	O
were	VBD	auxpass	O
reproduced	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
cross-linking	NN	nmod	O
of	IN	case	O
the	DT	det	O
alpha3	NN	nmod	B-protein
,	,	punct	O
alpha6	NN	conj	B-protein
,	,	punct	O
beta1	NN	conj	B-protein
and	CC	cc	I-protein
beta4	NN	conj	I-protein
integrins	NNS	dep	I-protein
,	,	punct	O
thus	RB	advmod	O
implying	VBG	xcomp	O
that	IN	mark	O
the	DT	dep	O
alpha3beta1	NN	nsubj	B-protein
and	CC	cc	I-protein
alpha6beta4	NN	conj	I-protein
heterodimers	NNS	dep	I-protein
can	MD	aux	O
signal	VB	ccomp	O
during	IN	case	O
thymocyte	NN	compound	O
adhesion	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
extended	VBN	ROOT	O
our	PRP$	poss	O
previous	JJ	amod	O
work	NN	dobj	O
investigating	VBG	acl	O
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
experimental	JJ	nmod	O
setting	VBG	acl	O
the	DT	det	O
inducing	NN	amod	O
activity	NN	dobj	O
of	IN	case	O
non	JJ	amod	O
stimulated	JJ	amod	O
or	CC	cc	O
activated	VBN	conj	O
policlonal	JJ	nmod	B-cell_type
or	CC	cc	I-cell_type
clonal	JJ	amod	I-cell_type
mature	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
as	IN	case	O
representative	NN	nmod	O
of	IN	case	O
the	DT	det	O
more	RBR	advmod	O
mature	JJ	amod	B-cell_type
thymocyte	NN	compound	I-cell_type
subset	NN	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
adhesion	NN	nsubj	O
of	IN	case	O
unstimulated	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cell	NN	nmod	I-cell_type
i	NN	nummod	O
)	-RRB-	punct	O
involved	VBD	ccomp	O
beta1	NN	dobj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
beta4	NN	compound	O
integrin	NN	conj	O
functions	NNS	dobj	O
at	IN	case	O
the	DT	det	O
surface	NN	nmod	O
ii	CD	advmod	O
)	-RRB-	punct	O
induced	VBD	ccomp	O
the	DT	det	O
clustering	NN	dobj	O
of	IN	case	O
alpha3beta1	NN	nmod	B-protein
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
alpha2beta1	NN	compound	B-protein
heterodimers	NNS	conj	I-protein
at	IN	case	O
the	DT	det	O
TEC	NN	compound	O
surface	NN	nmod	O
and	CC	cc	O
iii	LS	conj	O
)	-RRB-	punct	O
up-regulated	VBD	ccomp	O
the	DT	det	O
nuclear	JJ	amod	O
binding	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
NF-kappaB	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
IL-6	NN	compound	O
secretion	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
alpha3beta1	NN	nsubjpass	B-protein
and	CC	cc	I-protein
alpha6beta4	NN	conj	I-protein
heterodimers	NNS	conj	I-protein
are	VBP	auxpass	O
induced	VBN	ccomp	O
to	TO	case	O
cluster	VB	nmod	O
at	IN	case	O
the	DT	det	O
TEC	NN	compound	O
surface	NN	nmod	O
recognizing	VBG	acl	O
yet	RB	advmod	O
unknown	JJ	amod	O
cellular	JJ	amod	B-protein
ligands	NNS	dobj	I-protein
differentially	RB	advmod	O
expressed	VBN	acl	O
during	IN	case	O
T	NN	compound	O
cell	NN	compound	O
development	NN	nmod	O
.	.	punct	O

Identification	NN	ROOT	O
and	CC	cc	O
characterization	NN	conj	O
of	IN	case	O
SKAT-2	NN	nmod	B-DNA
,	,	punct	O
a	DT	det	O
novel	JJ	amod	O
Th2-specific	JJ	amod	B-DNA
zinc	NN	compound	I-DNA
finger	NN	compound	I-DNA
gene	NN	appos	I-DNA
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
novel	JJ	amod	O
Kruppel-type	JJ	compound	B-DNA
zinc	NN	compound	I-DNA
finger	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
ZF	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	dobj	I-DNA
,	,	punct	O
SKAT-2	NN	appos	B-DNA
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
selectively	RB	advmod	O
expressed	VBN	acl:relcl	O
by	IN	case	O
murine	JJ	amod	B-cell_type
Th2	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
protein	NN	nsubj	O
encoded	VBN	acl	O
by	IN	case	O
this	DT	det	O
gene	NN	nmod	O
has	VBZ	ROOT	O
14	CD	nummod	O
C2H2-type	NN	amod	O
ZF	NN	compound	O
tandemly	NN	dobj	O
arrayed	VBN	acl	O
at	IN	case	O
its	PRP$	nmod:poss	O
C	NN	compound	B-DNA
terminus	NN	nmod	I-DNA
and	CC	cc	O
N-terminal	JJ	amod	B-DNA
SCAN	NN	compound	B-DNA
box	NN	conj	I-DNA
and	CC	cc	O
KRAB	NN	compound	B-DNA
domains	NNS	conj	I-DNA
.	.	punct	O

SKAT-2	NN	nsubj	B-DNA
is	VBZ	cop	O
tissue	NN	ROOT	O
restricted	JJ	acl	O
in	IN	case	O
expression	NN	nmod	O
at	IN	case	O
the	DT	det	O
RNA	NN	compound	O
level	NN	nmod	O
,	,	punct	O
detectable	JJ	amod	O
only	RB	advmod	O
in	IN	case	O
brain	NN	nmod	O
and	CC	cc	O
at	IN	case	O
low	JJ	amod	O
levels	NNS	conj	O
in	IN	case	O
kidney	NN	nmod	O
and	CC	cc	O
spleen	NN	conj	O
and	CC	cc	O
few	JJ	amod	O
hematopoietic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

By	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nmod	O
,	,	punct	O
SKAT-2	NN	compound	B-DNA
expression	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
peak	VB	xcomp	O
in	IN	case	O
antigen-stimulated	JJ	amod	O
CD4	NN	nmod	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
after	IN	case	O
2-3	CD	nummod	O
days	NNS	nmod	O
of	IN	case	O
culture	NN	nmod	O
under	IN	case	O
Th2	NN	nmod	O
but	CC	cc	O
not	RB	cc	O
Th1	NN	compound	O
biasing	NN	compound	O
conditions	NNS	dep	O
.	.	punct	O

This	DT	det	O
pattern	NN	nsubj	O
of	IN	case	O
expression	NN	nmod	O
closely	RB	advmod	O
mirrored	VBD	ROOT	O
that	DT	dobj	O
of	IN	case	O
GATA-3	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
same	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

In	IN	case	O
transient	JJ	amod	O
transfection	NN	compound	O
experiments	NNS	nmod	O
in	IN	case	O
phorbol	NN	compound	O
12-myristate	NN	nmod:npmod	O
13-acetate/ionomycin-stimulated	JJ	amod	O
EL4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
SKAT-2	NN	nsubjpass	B-DNA
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
up-regulate	VB	xcomp	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
the	DT	det	O
IL-4	NN	nmod	B-DNA
but	CC	cc	I-DNA
not	RB	cc	I-DNA
the	DT	det	I-DNA
IL-5	NN	compound	I-DNA
promoter	NN	conj	I-DNA
,	,	punct	O
contrasting	VBG	advcl	O
with	IN	case	O
the	DT	det	O
ability	NN	nmod	O
of	IN	case	O
GATA-3	NN	nmod	B-protein
to	TO	mark	O
activate	VB	acl	O
both	DT	det	O
promoters	NNS	dobj	B-DNA
.	.	punct	O

This	DT	det	O
result	NN	nsubjpass	O
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
using	VBG	xcomp	O
clones	NNS	dobj	O
of	IN	case	O
EL4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
stably	RB	advmod	O
expressing	VBG	acl	O
an	DT	det	O
inducible	JJ	amod	O
form	NN	dobj	O
of	IN	case	O
SKAT-2	NN	nmod	B-DNA
,	,	punct	O
thus	RB	advmod	O
SKAT-2	NN	nsubj	B-DNA
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
Th2-specific	JJ	amod	B-DNA
gene	NN	advcl	I-DNA
that	WDT	nsubj	O
may	MD	aux	O
play	VB	acl:relcl	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
selective	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

hsp70	NN	compound	B-protein
interacting	VBG	compound	I-protein
protein	NN	compound	I-protein
Hip	NN	nsubj	I-protein
does	VBZ	aux	O
not	RB	neg	O
affect	VB	ROOT	O
glucocorticoid	NN	compound	B-protein
receptor	NN	dobj	I-protein
folding	VBG	acl	O
by	IN	case	O
the	DT	det	O
hsp90-based	JJ	amod	O
chaperone	NN	compound	O
machinery	NN	nmod	O
except	IN	mark	O
to	TO	mark	O
oppose	VB	advcl	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
BAG-1	NN	nmod	B-protein
.	.	punct	O

Reticulocyte	NN	compound	O
lysate	NN	nsubj	O
contains	VBZ	ROOT	O
a	DT	det	O
chaperone	NN	compound	O
system	NN	dobj	O
that	WDT	nsubj	O
assembles	VBZ	acl:relcl	O
glucocorticoid	NN	compound	B-protein
receptor	NN	dobj	I-protein
(	-LRB-	punct	I-protein
GR	NN	appos	I-protein
)	-RRB-	punct	I-protein
.hsp90	NN	punct	I-protein
heterocomplexes	NNS	ROOT	I-protein
.	.	punct	O

Using	VBG	advcl	O
purified	VBN	amod	B-protein
proteins	NNS	dobj	I-protein
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
prepared	VBN	ROOT	O
a	DT	det	O
five-protein	JJ	amod	O
heterocomplex	NN	compound	O
assembly	NN	compound	O
system	NN	dobj	O
consisting	VBG	acl	O
of	IN	case	O
two	CD	nummod	O
proteins	NNS	nmod	O
essential	JJ	amod	O
for	IN	case	O
heterocomplex	NN	compound	O
assembly-	JJ	compound	O
hsp90	NN	nmod	B-protein
and	CC	cc	O
hsp70	NN	conj	B-protein
-and	CD	conj	O
three	CD	nummod	O
proteins	NNS	dobj	O
that	WDT	nsubj	O
act	VBP	acl:relcl	O
as	IN	case	O
co-chaperones	NNS	nmod	O
to	TO	mark	O
enhance	VB	xcomp	O
assembly-	JJ	compound	O
Hop	NN	dobj	B-protein
,	,	punct	O
hsp40	NN	conj	B-protein
,	,	punct	O
p23	NN	compound	B-protein
[	-LRB-	punct	O
Morishima	NNP	compound	O
,	,	punct	O
Y.	NNP	conj	O
,	,	punct	O
Kanelakis	NNP	compound	O
,	,	punct	O
K.	NNP	appos	O
C.	NNP	conj	O
,	,	punct	O
Silverstein	NNP	compound	O
,	,	punct	O
A.	NNP	compound	O
M.	NNP	conj	O
,	,	punct	O
Dittmar	NNP	compound	O
,	,	punct	O
K.	NNP	compound	O
D.	NNP	conj	O
,	,	punct	O
Estrada	NNP	compound	O
,	,	punct	O
L.	NNP	conj	O
,	,	punct	O
and	CC	cc	O
Pratt	NNP	compound	O
,	,	punct	O
W.	NNP	compound	O
B.	NNP	conj	O
(	-LRB-	punct	O
2000	CD	nummod	O
)	-RRB-	punct	O
J.	NNP	compound	O
Biol.	NNP	compound	O
Chem.	NNP	appos	O
275	CD	nummod	O
,	,	punct	O
6894-6900	CD	nummod	O
]	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
hsp70	NN	compound	B-protein
co-chaperone	NN	compound	I-protein
Hip	NN	nsubjpass	I-protein
has	VBZ	aux	O
been	VBN	auxpass	O
recovered	VBN	ROOT	O
in	IN	case	O
receptor.hsp90	NN	compound	B-protein
heterocomplexes	NNS	nmod	I-protein
at	IN	case	O
an	DT	det	O
intermediate	JJ	amod	O
stage	NN	nmod	O
of	IN	case	O
assembly	NN	nmod	O
in	IN	case	O
reticulocyte	NN	compound	O
lysate	NN	nmod	O
,	,	punct	O
and	CC	cc	O
Hip	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
also	RB	advmod	O
thought	VBN	conj	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
intrinsic	JJ	amod	O
component	NN	xcomp	O
of	IN	case	O
the	DT	det	O
assembly	NN	compound	O
machinery	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
immunodepletion	NN	nsubj	O
of	IN	case	O
Hip	NN	nmod	B-protein
from	IN	case	O
reticulocyte	NN	compound	O
lysate	NN	nmod	O
or	CC	cc	O
addition	NN	conj	O
of	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
Hip	NN	nmod	B-protein
to	TO	case	O
the	DT	det	O
purified	VBN	amod	O
five-protein	JJ	amod	O
system	NN	nmod	O
does	VBZ	aux	O
not	RB	neg	O
affect	VB	ccomp	O
GR.hsp90	NN	compound	O
heterocomplex	NN	compound	O
assembly	NN	dobj	O
or	CC	cc	O
the	DT	det	O
activation	NN	conj	O
of	IN	case	O
steroid	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
that	WDT	nsubj	O
occurs	VBZ	acl:relcl	O
with	IN	case	O
assembly	NN	nmod	O
.	.	punct	O

Despite	IN	prep	O
the	DT	det	O
fact	NN	pobj	O
that	IN	mark	O
Hip	NN	nsubj	B-protein
does	VBZ	aux	O
not	RB	neg	O
affect	VB	acl	O
assembly	NN	dobj	O
,	,	punct	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
recovered	VBN	ROOT	O
in	IN	case	O
GR.hsp90	NN	compound	B-protein
heterocomplexes	NNS	nmod	I-protein
assembled	VBN	acl	O
by	IN	case	O
both	DT	det	O
systems	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
five-protein	JJ	amod	O
system	NN	nmod	O
,	,	punct	O
Hip	NN	nsubj	B-protein
prevents	VBZ	ROOT	O
inhibition	NN	dobj	O
of	IN	case	O
assembly	NN	nmod	O
by	IN	case	O
the	DT	det	O
hsp70	NN	compound	B-protein
co-chaperone	NN	compound	I-protein
BAG-1	NN	nmod	I-protein
,	,	punct	O
and	CC	cc	O
cotransfection	NN	nsubj	O
of	IN	case	O
Hip	NN	nmod	B-protein
with	IN	case	O
BAG-1	NN	nmod	B-protein
opposes	VBZ	conj	O
BAG-1	NN	compound	B-protein
reduction	NN	dobj	O
of	IN	case	O
steroid	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
in	IN	case	O
COS	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
Hip	NN	nsubj	B-protein
is	VBZ	cop	O
not	RB	neg	O
a	DT	det	O
component	NN	ccomp	O
of	IN	case	O
the	DT	det	O
assembly	NN	compound	O
machinery	NN	nmod	O
but	CC	cc	O
that	IN	mark	O
it	PRP	nsubj	O
could	MD	aux	O
play	VB	conj	O
a	DT	det	O
regulatory	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
opposition	NN	nmod	O
to	TO	case	O
BAG-1	NN	nmod	B-protein
.	.	punct	O

Cutting	JJ	amod	O
edge	NN	nsubj	O
:	:	punct	O
STAT6-deficient	JJ	amod	O
mice	NNS	nsubj	O
have	VBP	aux	O
enhanced	VBN	ROOT	O
tumor	NN	compound	O
immunity	NN	dobj	O
to	TO	case	O
primary	JJ	amod	O
and	CC	cc	O
metastatic	JJ	conj	O
mammary	JJ	amod	O
carcinoma	NN	nmod	O
.	.	punct	O

STAT4	NN	nsubj	B-protein
and	CC	cc	O
STAT6	NN	conj	B-protein
are	VBP	cop	O
essential	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
CD4	NN	nmod	O
(	-LRB-	punct	O
+	CC	dep	O
)	-RRB-	punct	O
Th1	NN	compound	O
and	CC	cc	O
Th2	NN	conj	O
development	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Tumor	NN	compound	O
immunologists	NNS	nsubj	O
have	VBP	aux	O
hypothesized	VBN	ROOT	O
that	IN	mark	O
Th1	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
are	VBP	cop	O
critical	JJ	ccomp	O
in	IN	case	O
tumor	NN	compound	O
immunity	NN	nmod	O
because	IN	mark	O
they	PRP	nsubj	O
facilitate	VBP	advcl	O
differentiation	NN	dobj	O
of	IN	case	O
CD8	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
potent	JJ	amod	O
anti-tumor	JJ	amod	B-cell_type
effectors	NNS	acl:relcl	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
STAT4	NN	dobj	O
(	-LRB-	punct	O
-/-	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
STAT6	NN	compound	O
(	-LRB-	punct	O
-/-	JJ	appos	O
)	-RRB-	punct	O
mice	NNS	conj	O
to	TO	mark	O
test	VB	xcomp	O
this	DT	det	O
hypothesis	NN	dobj	O
.	.	punct	O

BALB/c	NN	nsubjpass	O
and	CC	cc	O
knockout	JJ	conj	O
mice	NNS	dep	O
were	VBD	auxpass	O
challenged	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
mammary	JJ	amod	O
gland	NN	nmod	O
with	IN	case	O
the	DT	det	O
highly	RB	advmod	O
malignant	JJ	amod	O
and	CC	cc	O
spontaneously	RB	advmod	O
metastatic	JJ	conj	O
BALB/c-derived	JJ	compound	O
4T1	NN	compound	O
mammary	JJ	amod	O
carcinoma	NN	nmod	O
.	.	punct	O

Primary	JJ	amod	O
tumor	NN	compound	O
growth	NN	nsubjpass	O
and	CC	cc	O
metastatic	JJ	amod	O
disease	NN	conj	O
are	VBP	auxpass	O
reduced	VBN	ROOT	O
in	IN	case	O
STAT6	NN	compound	O
(	-LRB-	punct	O
-/-	JJ	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	O
relative	JJ	case	O
to	TO	case	O
BALB/c	NN	compound	O
and	CC	cc	O
STAT4	NN	conj	O
(	-LRB-	punct	O
-/-	JJ	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	O
.	.	punct	O

Ab	NN	compound	O
depletions	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
effect	NN	nsubjpass	O
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
by	IN	case	O
CD8	NN	nmod	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
immunized	VBD	amod	O
STAT6	NN	compound	O
(	-LRB-	punct	O
-/-	JJ	appos	O
)	-RRB-	punct	O
mice	NNS	nsubj	O
have	VBP	ccomp	O
higher	JJR	amod	O
levels	NNS	dobj	O
of	IN	case	O
4T1-specific	JJ	nummod	B-cell_type
CTL	NN	nmod	I-cell_type
than	IN	case	O
BALB/c	NN	compound	O
or	CC	cc	O
STAT4	NN	conj	O
(	-LRB-	punct	O
-/-	JJ	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	O
.	.	punct	O

Surprisingly	RB	advmod	O
,	,	punct	O
Th1	NN	compound	B-cell_type
or	CC	cc	I-cell_type
Th2	NN	conj	I-cell_type
cells	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
not	RB	neg	O
involved	VBN	ROOT	O
,	,	punct	O
because	IN	mark	O
CD4	NN	compound	O
depletion	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
diminish	VB	advcl	O
the	DT	det	O
anti-tumor	JJ	amod	O
effect	NN	dobj	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
deletion	NN	nsubj	O
of	IN	case	O
the	DT	det	O
STAT6	NN	compound	B-DNA
gene	NN	nmod	I-DNA
facilitates	VBZ	ROOT	O
development	NN	dobj	O
of	IN	case	O
potent	JJ	amod	O
anti-tumor	JJ	amod	O
immunity	NN	nmod	O
via	IN	case	O
a	DT	det	O
CD4	NN	compound	O
(	-LRB-	punct	O
+	CC	cc	O
)	-RRB-	punct	O
-independent	JJ	amod	O
pathway	NN	dobj	O
.	.	punct	O

Activation	NN	ROOT	O
of	IN	case	O
oncogenic	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
AP-1	NN	nmod	I-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
infected	VBN	acl	O
with	IN	case	O
human	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	nmod	O
1	CD	nummod	O
.	.	punct	O

Human	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HTLV-1	NN	compound	O
)	-RRB-	punct	O
Tax	NN	compound	B-protein
protein	NN	nsubj	I-protein
transforms	VBZ	ROOT	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	dobj	I-cell_type
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
showed	VBD	ROOT	O
that	IN	mark	O
Tax	NN	nsubj	B-protein
induces	VBZ	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
various	JJ	amod	O
family	NN	compound	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
AP-1	NN	nmod	I-protein
such	JJ	case	O
as	IN	mwe	O
c-Jun	NN	nmod	B-protein
,	,	punct	O
JunD	NN	conj	B-protein
,	,	punct	O
c-Fos	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
Fra-1	NN	conj	B-protein
at	IN	case	O
the	DT	det	O
mRNA	NN	compound	O
level	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
Tax	NN	nmod	B-protein
to	TO	mark	O
activate	VB	acl	O
transcription	NN	dobj	O
through	IN	case	O
the	DT	det	O
AP-1-binding	JJ	amod	B-DNA
site	NN	nmod	I-DNA
(	-LRB-	punct	O
AP-1	NN	compound	B-DNA
site	NN	appos	I-DNA
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
transient	JJ	amod	O
transfection	NN	compound	O
study	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
Tax	NN	nsubj	B-protein
can	MD	aux	O
activate	VB	ccomp	O
transcription	NN	dobj	O
through	IN	case	O
the	DT	det	O
AP-1-binding	JJ	amod	B-DNA
site	NN	nmod	I-DNA
in	IN	case	O
a	DT	det	O
human	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
whereas	IN	dep	O
any	DT	det	O
combination	NN	nsubj	O
of	IN	case	O
AP-1	NN	compound	B-protein
proteins	NNS	nmod	I-protein
did	VBD	parataxis	O
so	RB	advmod	O
much	RB	advmod	O
less	JJR	advmod	O
than	IN	case	O
Tax	NN	nmod	B-protein
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
AP-1	NN	compound	B-DNA
site	NN	nmod	I-DNA
by	IN	case	O
Tax	NN	nmod	B-protein
may	MD	aux	O
require	VB	ccomp	O
a	DT	det	O
mechanism	NN	dobj	O
other	JJ	amod	O
than	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
AP-1	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

Fresh	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
leukemia	NN	compound	I-cell_type
cells	NNS	nsubj	I-cell_type
of	IN	case	O
all	DT	advmod	O
surveyed	VBN	amod	O
ATL	NN	compound	O
patients	NNS	nmod	O
displayed	VBD	ROOT	O
constitutive	JJ	amod	O
AP-1	NN	compound	O
DNA-binding	JJ	amod	O
activity	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
no	DT	neg	O
normal	JJ	amod	O
individuals	NNS	nsubj	O
did	VBD	parataxis	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
HTLV-1	NN	compound	B-DNA
genes	NNS	nsubjpass	I-DNA
,	,	punct	O
including	VBG	case	O
tax	NN	nmod	B-DNA
,	,	punct	O
are	VBP	auxpass	O
not	RB	neg	O
significantly	RB	advmod	O
expressed	VBN	ROOT	O
in	IN	case	O
fresh	JJ	amod	O
leukemia	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
ATL	NN	compound	O
patients	NNS	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
present	JJ	amod	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
activation	NN	nsubj	O
of	IN	case	O
AP-1	NN	nmod	B-protein
occurs	VBZ	ccomp	O
through	IN	case	O
Tax-dependent	JJ	amod	O
and	CC	cc	O
-independent	JJ	conj	O
mechanisms	NNS	nmod	O
in	IN	case	O
HTLV-1-infected	JJ	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
play	VB	acl:relcl	O
some	DT	det	O
roles	NNS	dobj	O
in	IN	case	O
dysregulated	VBN	amod	O
phenotypes	NNS	nmod	O
of	IN	case	O
HTLV-1-infected	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

2	LS	nummod	O
,	,	punct	O
2	CD	dep	O
'	''	punct	O
,	,	punct	O
4	CD	conj	O
,	,	punct	O
6	CD	conj	O
,	,	punct	O
6'-pentachlorobiphenyl	NN	nsubj	O
induces	VBZ	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Polychlorinatedbiphenyls	NN	nsubj	O
(	-LRB-	punct	O
PCBs	NNS	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
a	DT	det	O
group	NN	nsubj	O
of	IN	case	O
persistent	JJ	amod	O
and	CC	cc	O
widely	RB	advmod	O
dispersed	JJ	conj	O
environmental	JJ	amod	O
pollutants	NNS	nmod	O
,	,	punct	O
some	DT	nsubj	O
of	IN	prep	O
which	WDT	pobj	O
may	MD	aux	O
be	VB	cop	O
immunotoxic	JJ	ROOT	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
PCBs	NNS	nmod	O
on	IN	case	O
immune	JJ	amod	O
system	NN	nmod	O
by	IN	mark	O
assessing	VBG	advcl	O
apoptotic	JJ	amod	O
cell	NN	compound	O
death	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_line
monocytic	JJ	amod	I-cell_line
U937	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Among	IN	case	O
the	DT	det	O
various	JJ	amod	O
congeners	NNS	pobj	O
tested	VBN	acl	O
,	,	punct	O
2	CD	pobj	O
,	,	punct	O
2	CD	conj	O
'	''	punct	O
,	,	punct	O
4	CD	conj	O
,	,	punct	O
6	CD	conj	O
,	,	punct	O
6'-pentachlorobiphenyl	NN	pobj	O
(	-LRB-	punct	O
PeCB	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
highly	RB	advmod	O
ortho-substituted	JJ	amod	O
congener	NN	ROOT	O
,	,	punct	O
specifically	RB	advmod	O
induced	VBD	amod	O
DNA	NN	compound	O
fragmentation	NN	appos	O
,	,	punct	O
a	DT	det	O
hallmark	NN	appos	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
other	JJ	amod	O
examined	VBN	amod	O
di-	JJ	nsubj	O
,	,	punct	O
tri-	NN	amod	O
,	,	punct	O
tetra-	NN	conj	O
,	,	punct	O
and	CC	cc	O
pentachlorobiphenyls	NN	nsubj	O
did	VBD	advcl	O
not	RB	neg	O
.	.	punct	O

To	TO	mark	O
further	RB	advmod	O
study	VB	advcl	O
the	DT	det	O
2	CD	nummod	O
,	,	punct	O
2	CD	dobj	O
'	''	punct	O
,	,	punct	O
4	CD	conj	O
,	,	punct	O
6	CD	conj	O
,	,	punct	O
6'-PeCB-induced	JJ	amod	O
cell	NN	compound	O
death	NN	conj	O
,	,	punct	O
various	JJ	amod	O
features	NNS	nsubjpass	O
of	IN	case	O
apoptosis	NN	nmod	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
.	.	punct	O

2	LS	nummod	O
,	,	punct	O
2	CD	dep	O
'	''	punct	O
,	,	punct	O
4	CD	conj	O
,	,	punct	O
6	CD	conj	O
,	,	punct	O
6'-PeCB	NNS	nsubj	O
caused	VBD	ROOT	O
a	DT	det	O
decrease	NN	dobj	O
in	IN	case	O
cell	NN	compound	O
viability	NN	nmod	O
and	CC	cc	O
induced	VBD	amod	O
cellular	JJ	amod	O
morphologic	JJ	amod	O
features	NNS	conj	O
characteristic	JJ	amod	O
of	IN	case	O
apoptosis	NN	nmod	O
such	JJ	case	O
as	IN	mwe	O
chromatin	NN	compound	O
aggregation	NN	nmod	O
and	CC	cc	O
apoptotic	JJ	amod	O
bodies	NNS	conj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
caspase-3	NN	nsubjpass	B-protein
,	,	punct	O
an	DT	det	O
executioner	NN	appos	O
of	IN	case	O
apoptosis	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
activated	VBN	ROOT	O
and	CC	cc	O
its	PRP$	nmod:poss	O
substrate	NN	conj	O
,	,	punct	O
poly	NN	amod	B-protein
(	-LRB-	punct	I-protein
ADP-ribose	NN	dep	I-protein
)	-RRB-	punct	I-protein
polymerase	NN	appos	I-protein
(	-LRB-	punct	O
PARP	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
cleaved	VBN	conj	O
during	IN	case	O
2	CD	nmod	O
,	,	punct	O
2	CD	conj	O
'	''	punct	O
,	,	punct	O
4	CD	conj	O
,	,	punct	O
6	CD	conj	O
,	,	punct	O
6'-PeCB-induced	JJ	dep	O
apoptosis	NN	dep	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
3	CD	nsubj	O
,	,	punct	O
3	CD	conj	O
'	''	punct	O
,	,	punct	O
4	CD	conj	O
,	,	punct	O
4	CD	conj	O
'	''	punct	O
,	,	punct	O
5-PeCB	NN	conj	O
,	,	punct	O
a	DT	det	O
congener	NN	appos	O
of	IN	case	O
coplanar	JJ	amod	O
structure	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
2	CD	conj	O
,	,	punct	O
3	CD	conj	O
,	,	punct	O
7	CD	conj	O
,	,	punct	O
8-TCDD	NN	conj	O
did	VBD	aux	O
not	RB	neg	O
induce	VB	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
these	DT	det	O
human	JJ	amod	B-cell_type
monocytic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
although	IN	mark	O
they	PRP	nsubj	O
potently	RB	advmod	O
induced	VBD	advcl	O
CYP	NN	compound	B-protein
1A1	NN	dobj	I-protein
in	IN	case	O
human	JJ	amod	B-cell_line
hepatoma	NN	compound	I-cell_line
Hep	NN	compound	I-cell_line
G2	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
the	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
2	CD	nsubj	O
,	,	punct	O
2	CD	conj	O
'	''	punct	O
,	,	punct	O
4	CD	conj	O
,	,	punct	O
6	CD	conj	O
,	,	punct	O
6'-PeCB	NN	conj	O
induces	VBZ	ccomp	O
apoptosis	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
through	IN	case	O
a	DT	det	O
mechanism	NN	nmod	O
that	WDT	nsubj	O
is	VBZ	cop	O
independent	JJ	acl:relcl	O
of	IN	case	O
the	DT	det	O
arylhydrocarbon	NN	compound	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

This	DT	nsubj	O
suggests	VBZ	ROOT	O
a	DT	det	O
possibly	RB	advmod	O
separate	JJ	amod	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
PCBs	NNS	nsubj	O
cause	VBP	acl:relcl	O
immunosuppression	NN	dobj	O
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
deregulated	VBN	amod	O
Raf	NN	compound	O
activation	NN	nmod	O
on	IN	case	O
integrin	NN	nmod	B-protein
,	,	punct	O
cytokine-receptor	JJ	compound	O
expression	NN	conj	O
and	CC	cc	O
the	DT	det	O
induction	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
in	IN	case	O
hematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
deregulated	VBN	amod	O
Raf	NN	compound	O
activation	NN	nmod	O
on	IN	case	O
the	DT	dep	O
growth	NN	nmod	O
and	CC	cc	O
differentiation	NN	conj	O
of	IN	case	O
hematopoietic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	auxpass	O
investigated	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
cytokine-dependent	JJ	amod	B-cell_line
murine	JJ	amod	I-cell_line
myeloid	JJ	amod	I-cell_line
FDC-P1	NN	nsubjpass	I-cell_line
and	CC	cc	O
human	JJ	amod	B-cell_line
erythroleukemic	JJ	amod	I-cell_line
TF-1	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
were	VBD	auxpass	O
transformed	VBN	ROOT	O
to	TO	mark	O
grow	VB	xcomp	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
deregulated	VBN	amod	O
Raf	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
exogenous	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
conditionally	RB	advmod	O
active	JJ	amod	O
Raf	NN	compound	B-protein
proteins	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
beta-estradiol	NN	nmod	O
as	IN	case	O
cDNAs	NNS	nmod	B-DNA
containing	VBG	acl	O
the	DT	det	O
Raf	NNP	compound	B-protein
catalytic	NN	dobj	I-protein
,	,	punct	O
but	CC	cc	O
lacking	VBG	conj	O
negative-regulatory	JJ	amod	B-protein
domains	NNS	dobj	I-protein
,	,	punct	O
were	VBD	auxpass	O
ligated	VBN	conj	O
to	TO	case	O
the	DT	det	O
hormone	NN	compound	B-protein
binding	NN	compound	I-protein
domain	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
estrogen	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
deltaRaf	NN	appos	B-protein
:	:	punct	I-protein
ER	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

Continuous	JJ	amod	O
deltaRaf	NN	compound	B-protein
expression	NN	nsubj	O
prevented	VBD	ROOT	O
apoptosis	NN	dobj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
exogenous	JJ	amod	B-protein
cytokines	NNS	nmod	I-protein
and	CC	cc	O
altered	VBD	conj	O
the	DT	det	O
morphology	NN	dobj	O
of	IN	case	O
the	DT	det	O
FD/deltaRaf	NNP	nmod	B-cell_type
:	:	punct	I-cell_type
ER	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
as	IN	mark	O
they	PRP	nsubj	O
grew	VBD	advcl	O
in	IN	case	O
large	JJ	amod	O
aggregated	JJ	amod	O
masses	NNS	nmod	O
(	-LRB-	punct	O
>	NN	amod	O
100	CD	nummod	O
cells	NNS	appos	O
)	-RRB-	punct	O
whereas	IN	mark	O
the	DT	det	O
parental	JJ	amod	B-cell_line
cytokine-dependent	JJ	amod	I-cell_line
FDC-P1	NN	compound	I-cell_line
cells	NNS	nsubj	I-cell_line
grew	VBD	advcl	O
in	IN	case	O
smaller	JJR	amod	O
grape-like	JJ	amod	O
clusters	NNS	nmod	O
(	-LRB-	punct	O
<	``	compound	O
10	CD	nummod	O
cells	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

FD/deltaRaf-1	JJ	ROOT	B-cell_line
:	:	punct	I-cell_line
ER	NN	compound	I-cell_line
cells	NNS	nsubj	I-cell_line
growing	VBG	acl	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
Raf	NN	compound	O
activation	NN	nmod	O
displayed	VBD	dep	O
decreased	VBN	amod	O
levels	NNS	dobj	O
of	IN	case	O
the	DT	det	O
Mac-2	NN	compound	B-protein
and	CC	cc	I-protein
Mac-3	NN	conj	I-protein
molecules	NNS	nmod	I-protein
on	IN	case	O
their	PRP$	nmod:poss	O
cell	NN	compound	B-cell_type
surface	NN	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
when	WRB	advmod	O
these	DT	det	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
cultured	VBN	advcl	O
in	IN	case	O
IL-3	NN	nmod	B-protein
,	,	punct	O
higher	JJR	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
these	DT	det	O
adhesion	NN	compound	B-protein
molecules	NNS	nmod	I-protein
were	VBD	auxpass	O
detected	VBN	ROOT	O
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
activated	VBN	amod	O
Raf	NN	compound	B-protein
oncoproteins	NNS	nmod	I-protein
also	RB	advmod	O
abrogated	VBD	ROOT	O
cytokine	NN	compound	O
dependency	NN	dobj	O
and	CC	cc	O
prevented	VBD	conj	O
apoptosis	NN	dobj	O
of	IN	case	O
TF-1	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
differentiation	NN	compound	O
status	NN	nsubj	O
of	IN	case	O
these	DT	det	O
Raf-responsive	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	cop	O
more	RBR	advmod	O
immature	JJ	ROOT	O
upon	IN	case	O
Raf	NN	compound	O
activation	NN	nmod	O
as	IN	case	O
culture	NN	nmod	O
with	IN	case	O
the	DT	det	O
differentiation-inducing	JJ	amod	O
agent	NN	nmod	O
phorbol	NN	compound	O
12	CD	nummod	O
myristate	NN	compound	O
13-acetate	NN	dep	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
beta-estradiol	NN	conj	O
resulted	VBD	advcl	O
in	IN	case	O
decreased	VBN	amod	O
levels	NNS	nmod	O
of	IN	case	O
the	DT	dep	O
CD11b	NN	nmod	B-protein
and	CC	cc	I-protein
CD18	NN	conj	I-protein
integrin	NN	compound	I-protein
molecules	NNS	dep	I-protein
on	IN	case	O
the	DT	det	O
cell	NN	compound	B-cell_type
surface	NN	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
when	WRB	advmod	O
the	DT	det	O
Raf-responsive	JJ	amod	B-cell_type
cells	NNS	nsubjpass	I-cell_type
were	VBD	auxpass	O
induced	VBN	ROOT	O
to	TO	mark	O
differentiate	VB	xcomp	O
with	IN	case	O
PMA	NN	nmod	O
and	CC	cc	O
GM-CSF	NN	conj	B-protein
,	,	punct	O
in	IN	case	O
the	DT	dep	O
absence	NN	dep	O
of	IN	case	O
deltaRaf	NN	nmod	B-protein
:	:	punct	I-protein
ER	NN	compound	I-protein
activation	NN	nsubjpass	O
,	,	punct	O
increased	VBN	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
the	DT	dep	O
CD11b	NN	nmod	B-protein
and	CC	cc	I-protein
CD18	NN	conj	I-protein
molecules	NNS	dep	I-protein
were	VBD	auxpass	O
detected	VBN	parataxis	O
.	.	punct	O

Retinoic	JJ	amod	O
acid	NN	nsubj	O
(	-LRB-	punct	O
RA	NN	appos	O
)	-RRB-	punct	O
inhibited	VBD	ROOT	O
3H-thymidine	JJ	amod	O
incorporation	NN	dobj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
GM-CSF	NN	nmod	B-protein
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
Raf	NN	compound	O
activation	NN	nsubj	O
counterbalanced	VBD	ROOT	O
the	DT	det	O
inhibition	NN	dobj	O
of	IN	case	O
DNA	NN	compound	O
synthesis	NN	nmod	O
caused	VBN	acl	O
by	IN	case	O
RA	NN	nmod	O
but	CC	cc	O
not	RB	cc	O
PMA	NN	conj	O
.	.	punct	O

Thus	RB	advmod	O
deregulated	VBN	amod	O
Raf	NN	compound	O
expression	NN	nsubj	O
can	MD	aux	O
alter	VB	ROOT	O
cytokine	NN	compound	O
dependency	NN	dobj	O
,	,	punct	O
integrin	NN	compound	O
expression	NN	conj	O
and	CC	cc	O
the	DT	det	O
stage	NN	conj	O
of	IN	case	O
differentiation	NN	nmod	O
.	.	punct	O

These	DT	det	O
Raf-responsive	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nsubj	I-cell_line
will	MD	aux	O
be	VB	cop	O
useful	JJ	ROOT	O
in	IN	mark	O
elucidating	VBG	advcl	O
the	DT	det	O
roles	NNS	dobj	O
of	IN	case	O
the	DT	det	O
MAP	NN	compound	O
kinase	NN	compound	O
cascade	NN	nmod	O
on	IN	case	O
hematopoietic	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
differentiation	NN	nmod	O
and	CC	cc	O
malignant	JJ	amod	O
transformation	NN	conj	O

Cyclic	JJ	amod	O
AMP	NN	nsubj	O
activates	VBZ	ROOT	O
p38	NN	compound	B-protein
mitogen-activated	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	dobj	I-protein
in	IN	case	O
Th2	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
:	:	punct	O
phosphorylation	NN	dep	O
of	IN	case	O
GATA-3	NN	nmod	B-protein
and	CC	cc	O
stimulation	NN	conj	O
of	IN	case	O
Th2	NN	compound	B-cell_type
cytokine	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

cAMP	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
second	JJ	dep	O
messenger	NN	ROOT	O
with	IN	case	O
immunomodulatory	JJ	amod	O
properties	NNS	nmod	O
.	.	punct	O

Elevation	NN	nsubj	O
of	IN	case	O
intracellular	JJ	amod	O
cAMP	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
induced	VBN	acl	O
by	IN	case	O
agents	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
IL-1alpha	NN	nmod	B-protein
or	CC	cc	O
PGs	NNS	conj	B-protein
,	,	punct	O
inhibits	VBZ	ROOT	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	dobj	O
.	.	punct	O

In	IN	case	O
effector	NN	compound	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
an	DT	det	O
increase	NN	nsubj	O
in	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
intracellular	JJ	amod	O
cAMP	NN	nmod	O
inhibits	VBZ	ROOT	O
cytokine	NN	compound	B-protein
production	NN	dobj	O
in	IN	case	O
Th1	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
stimulates	VBZ	conj	O
cytokine	NN	compound	B-protein
production	NN	dobj	O
in	IN	case	O
Th2	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
cAMP-induced	JJ	amod	O
effects	NNS	nsubj	O
in	IN	case	O
Th2	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
occur	VBP	ccomp	O
independently	RB	advmod	O
of	IN	case	O
the	DT	det	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
A	NN	compound	I-protein
pathway	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
the	DT	det	O
major	JJ	amod	O
mediator	NN	acl:relcl	O
of	IN	case	O
cAMP-induced	JJ	amod	O
signaling	NN	compound	O
events	NNS	nmod	O
in	IN	case	O
most	JJS	amod	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

Instead	RB	advmod	O
,	,	punct	O
cAMP	NN	nsubj	O
stimulates	VBZ	ROOT	O
activation	NN	dobj	O
of	IN	case	O
p38	NN	compound	B-protein
mitogen-activated	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
in	IN	case	O
Th2	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

This	DT	nsubj	O
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
Th2	NN	compound	B-cell_type
-selective	JJ	amod	O
event	NN	xcomp	O
because	IN	mark	O
cAMP	NN	nsubj	O
barely	RB	advmod	O
increased	VBD	advcl	O
p38	NN	compound	B-protein
phosphorylation	NN	dobj	O
in	IN	case	O
Th1	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
in	IN	case	O
Th2	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
cAMP	NN	nsubj	O
promotes	VBZ	ccomp	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
IL-5	NN	nmod	B-protein
and	CC	cc	O
IL-13	NN	conj	B-protein
,	,	punct	O
which	WDT	nsubj	O
play	VBP	acl:relcl	O
distinct	JJ	amod	O
but	CC	cc	O
critical	JJ	conj	O
roles	NNS	dobj	O
in	IN	case	O
asthma	NN	compound	O
pathogenesis	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
also	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
cAMP	NN	nsubj	O
causes	VBZ	ccomp	O
increased	VBN	amod	O
phosphorylation	NN	dobj	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
GATA-3	NN	nmod	I-protein
,	,	punct	O
which	WDT	dobj	O
we	PRP	nsubj	O
have	VBP	aux	O
shown	VBN	acl:relcl	O
is	VBZ	cop	O
a	DT	det	O
critical	JJ	amod	O
regulator	NN	ccomp	O
of	IN	case	O
Th2	NN	compound	B-cell_type
cytokine	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
,	,	punct	O
in	IN	case	O
turn	NN	nmod	O
,	,	punct	O
of	IN	case	O
airway	NN	compound	O
inflammation	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
Th2	NN	nmod:npmod	B-cell_type
-specific	JJ	amod	O
GATA-3	NN	compound	B-protein
expression	NN	nsubj	O
and	CC	cc	O
p38	NN	compound	B-protein
mitogen-activated	JJ	amod	I-protein
protein	NN	compound	I-protein
kinase	NN	compound	I-protein
activation	NN	conj	O
together	RB	advmod	O
provide	VBP	ROOT	O
a	DT	det	O
molecular	JJ	amod	O
basis	NN	dobj	O
for	IN	case	O
the	DT	det	O
differential	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
cAMP	NN	nmod	O
in	IN	case	O
the	DT	det	O
two	CD	nummod	O
T	NN	compound	B-cell_type
helper	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
subsets	NNS	nmod	I-cell_type
.	.	punct	O

Characterization	NN	ROOT	O
of	IN	case	O
IL-4	NN	compound	B-protein
and	CC	cc	O
IL-13	NN	conj	B-protein
signals	NNS	nmod	O
dependent	JJ	amod	O
on	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
IL-13	NN	compound	I-protein
receptor	NN	compound	I-protein
alpha	NN	compound	I-protein
chain	NN	nmod	I-protein
1	CD	nummod	I-protein
:	:	punct	O
redundancy	NN	dep	O
of	IN	case	O
requirement	NN	nmod	O
of	IN	case	O
tyrosine	NN	compound	O
residue	NN	nmod	O
for	IN	case	O
STAT3	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

IL-4	NN	nsubj	B-protein
and	CC	cc	O
IL-13	NN	conj	B-protein
are	VBP	cop	O
pleiotropic	JJ	amod	B-protein
cytokines	NNS	nsubj	I-protein
whose	WP$	nmod:poss	O
biological	JJ	amod	O
activities	NNS	nsubj	O
overlap	VBP	ROOT	O
with	IN	case	O
each	DT	det	O
other	JJ	nmod	O
.	.	punct	O

IL-13	NN	compound	B-protein
receptor	NN	compound	I-protein
alpha	NN	compound	I-protein
chain	NN	nsubj	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
IL-13R	NN	compound	B-protein
alpha	NN	appos	I-protein
1	CD	nummod	I-protein
)	-RRB-	punct	O
is	VBZ	cop	O
necessary	JJ	ROOT	O
for	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
IL-13	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
the	DT	det	O
heterodimer	NN	conj	O
composed	VBN	acl	O
of	IN	case	O
IL-13R	NN	compound	B-protein
alpha	NN	compound	I-protein
1	CD	nummod	I-protein
and	CC	cc	O
IL-4R	NN	compound	B-protein
alpha	NN	compound	I-protein
chain	NN	conj	I-protein
transduces	NNS	nmod	O
IL-13	NN	compound	B-protein
and	CC	cc	O
IL-4	NN	conj	B-protein
signals	NNS	dep	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
functional	JJ	amod	O
mapping	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
intracellular	JJ	amod	B-protein
domain	NN	nmod	I-protein
of	IN	case	O
IL-13R	NN	compound	B-protein
alpha	NN	nmod	I-protein
1	CD	nummod	I-protein
is	VBZ	auxpass	O
not	RB	neg	O
fully	RB	advmod	O
understood	VBN	parataxis	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
constructed	VBD	ROOT	O
wild	JJ	amod	O
and	CC	cc	O
mutated	VBN	conj	O
types	NNS	dobj	O
of	IN	case	O
human	JJ	amod	B-protein
IL-13R	NN	compound	I-protein
alpha	NN	nmod	I-protein
1	CD	nummod	I-protein
,	,	punct	O
and	CC	cc	O
analyzed	VBN	conj	O
IL-4	NN	compound	B-protein
and	CC	cc	O
IL-13	NN	conj	B-protein
signals	NNS	dobj	O
using	VBG	xcomp	O
an	DT	det	O
IL-13R	NN	compound	B-protein
alpha	NN	compound	I-protein
1	CD	nummod	I-protein
-transfected	JJ	amod	O
human	JJ	amod	B-cell_line
B	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	dobj	I-cell_line
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
IL-13R	NN	compound	B-protein
alpha	NN	nmod	I-protein
1	CD	nummod	I-protein
evoked	VBD	ROOT	O
STAT3	NN	compound	B-protein
activation	NN	dobj	O
by	IN	case	O
IL-4	NN	nmod	B-protein
and	CC	cc	O
IL-13	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
in	IN	case	O
stimulated	VBN	amod	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
,	,	punct	O
on	IN	case	O
which	WDT	nmod	O
IL-13R	NN	compound	B-protein
alpha	NN	nsubjpass	I-protein
1	CD	nummod	I-protein
was	VBD	auxpass	O
highly	RB	advmod	O
expressed	VBN	dep	O
,	,	punct	O
IL-4	NN	nsubj	B-protein
and	CC	cc	O
IL-13	NN	conj	B-protein
induced	VBD	conj	O
STAT3	NN	compound	B-protein
activation	NN	dobj	O
.	.	punct	O

Replacement	NN	nsubj	O
of	IN	case	O
the	DT	det	O
two	CD	nummod	O
tyrosine	NN	compound	O
residues	NNS	nmod	O
completely	RB	advmod	O
abolished	VBD	ROOT	O
STAT3	NN	compound	B-protein
activation	NN	dobj	O
,	,	punct	O
although	IN	mark	O
replacing	VBG	advcl	O
either	CC	cc:preconj	O
tyrosine	NN	compound	O
residue	NN	dobj	O
alone	RB	advmod	O
retained	VBD	advcl	O
it	PRP	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
Box1	NN	compound	B-protein
region	NN	nsubj	I-protein
and	CC	cc	O
the	DT	det	O
C-terminal	JJ	amod	B-protein
tail	NN	conj	I-protein
of	IN	case	O
IL-13R	NN	compound	B-protein
alpha	NN	nmod	I-protein
1	CD	nummod	I-protein
were	VBD	cop	O
critical	JJ	ccomp	O
for	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
Tyk2	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
Jak1	NN	nmod	B-protein
,	,	punct	O
Tyk2	NN	conj	B-protein
,	,	punct	O
the	DT	det	O
insulin	NN	compound	B-protein
receptor	NN	compound	I-protein
substrate-1	NN	appos	I-protein
and	CC	cc	O
STAT6	NN	conj	B-protein
respectively	RB	advmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
STAT3	NN	compound	B-protein
activation	NN	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
with	IN	case	O
IL-4	NN	compound	B-protein
and	CC	cc	O
IL-13	NN	conj	B-protein
signals	NNS	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
along	IN	case	O
with	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
STAT6	NN	nmod	B-protein
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
there	EX	expl	O
is	VBZ	conj	O
a	DT	det	O
unique	JJ	amod	O
sequence	NN	nsubj	O
in	IN	case	O
IL-13R	NN	compound	B-protein
alpha	NN	nmod	I-protein
1	CD	nummod	I-protein
to	TO	mark	O
activate	VB	acl	O
STAT3	NN	dobj	B-protein
.	.	punct	O

Functional	JJ	amod	O
uncoupling	NN	ROOT	O
of	IN	case	O
the	DT	det	O
Janus	NN	compound	O
kinase	NN	compound	O
3-Stat5	CD	amod	O
pathway	NN	nmod	O
in	IN	case	O
malignant	JJ	amod	O
growth	NN	nmod	O
of	IN	case	O
human	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1-transformed	JJ	amod	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Human	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
leukemia	NN	compound	O
virus	NN	compound	O
type	NN	nsubj	O
1	CD	nummod	O
(	-LRB-	punct	O
HTLV-1	NN	appos	O
)	-RRB-	punct	O
transforms	VBZ	ROOT	O
cytokine	NN	compound	B-protein
-dependent	JJ	amod	O
T	NN	compound	B-cell_type
lymphocytes	NNS	dobj	I-cell_type
and	CC	cc	O
causes	VBZ	conj	O
adult	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
leukemia	NN	dobj	O
.	.	punct	O

Janus	NN	compound	B-protein
tyrosine	NN	compound	I-protein
kinase	NN	nsubj	I-protein
(	-LRB-	punct	I-protein
Jak	NN	appos	I-protein
)	-RRB-	punct	I-protein
3	CD	nummod	I-protein
and	CC	cc	O
transcription	NN	compound	B-protein
factors	NNS	conj	I-protein
Stat5a	NN	dep	B-protein
and	CC	cc	O
Stat5b	NN	conj	B-protein
are	VBP	cop	O
essential	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
proliferation	NN	nmod	O
of	IN	case	O
normal	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
are	VBP	auxpass	O
constitutively	RB	advmod	O
hyperactivated	VBN	conj	O
in	IN	case	O
both	CC	cc:preconj	O
HTLV-1-transformed	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
and	CC	cc	O
lymphocytes	NNS	conj	B-cell_type
isolated	VBN	acl	O
from	IN	case	O
HTLV-1-infected	JJ	amod	O
patients	NNS	nmod	O
;	:	punct	O
therefore	RB	advmod	O
,	,	punct	O
a	DT	det	O
critical	JJ	amod	O
role	NN	nsubjpass	O
for	IN	case	O
the	DT	det	O
Jak3-Stat5	NN	compound	O
pathway	NN	nmod	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
this	DT	det	O
disease	NN	nmod	O
has	VBZ	aux	O
been	VBN	auxpass	O
postulated	VBN	parataxis	O
.	.	punct	O

We	PRP	nsubj	O
recently	RB	advmod	O
reported	VBD	ROOT	O
that	IN	mark	O
tyrphostin	NN	compound	O
AG-490	NN	nsubj	O
selectively	RB	advmod	O
blocked	VBD	ccomp	O
IL-2	NN	compound	O
activation	NN	dobj	O
of	IN	case	O
Jak3/Stat5	NN	nmod	B-protein
and	CC	cc	O
growth	NN	conj	O
of	IN	case	O
murine	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
disruption	NN	nsubj	O
of	IN	case	O
Jak3/Stat5a/b	JJ	compound	O
signaling	NN	nmod	O
with	IN	case	O
AG-490	NN	nmod	O
(	-LRB-	punct	O
50	CD	intj	O
&	CC	cc	O
mgr	NN	dep	O
;	:	punct	O
M	NN	appos	O
)	-RRB-	punct	O
blocked	VBD	ccomp	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
but	CC	cc	O
paradoxically	RB	advmod	O
failed	VBD	conj	O
to	TO	mark	O
inhibit	VB	xcomp	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
HTLV-1-transformed	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
HuT-102	NN	appos	B-cell_line
and	CC	cc	O
MT-2	NN	conj	B-cell_line
.	.	punct	O

Structural	JJ	amod	O
homologues	NNS	nsubj	O
of	IN	case	O
AG-490	NN	nmod	O
also	RB	advmod	O
inhibited	VBD	ROOT	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
HTLV-1-infected	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

Disruption	NN	nsubjpass	O
of	IN	case	O
constitutive	JJ	amod	O
Jak3/Stat5	NN	compound	O
activation	NN	nmod	O
by	IN	case	O
AG-490	NN	nmod	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
by	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
1	LS	nummod	O
)	-RRB-	punct	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
Jak3	NN	nmod	B-protein
,	,	punct	O
Stat5a	NN	compound	B-protein
(	-LRB-	punct	O
Tyr	NN	appos	O
(	-LRB-	punct	O
694	CD	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
Stat5b	NN	conj	B-protein
(	-LRB-	punct	O
Tyr	NN	appos	O
(	-LRB-	punct	O
699	CD	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
;	:	punct	O
2	LS	dep	O
)	-RRB-	punct	O
serine	NN	compound	O
phosphorylation	NN	conj	O
of	IN	case	O
Stat5a	NN	nmod	B-protein
(	-LRB-	punct	O
Ser	NN	appos	O
(	-LRB-	punct	O
726	CD	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
a	DT	det	O
novel	JJ	amod	O
phosphospecific	JJ	amod	B-protein
Ab	NNS	nmod	I-protein
;	:	punct	O
and	CC	cc	O
3	LS	nummod	O
)	-RRB-	punct	O
Stat5a/b	NN	dep	O
DNA	NN	compound	O
binding	NN	conj	O
to	TO	case	O
the	DT	det	O
Stat5-responsive	JJ	amod	B-DNA
beta-casein	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
AG-490	NN	nsubj	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
DNA	NN	compound	O
binding	NN	nmod	O
by	IN	case	O
p50/p65	NN	compound	B-protein
components	NNS	nmod	I-protein
of	IN	case	O
NF-kappaB	NN	nmod	B-protein
,	,	punct	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	appos	I-protein
activated	VBN	acl	O
by	IN	case	O
the	DT	det	O
HTLV-1-encoded	JJ	amod	B-protein
phosphoprotein	NN	nmod	I-protein
,	,	punct	I-protein
Tax	NN	appos	I-protein
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
Jak3-Stat5	NN	compound	O
pathway	NN	nsubj	O
in	IN	case	O
HTLV-1-transformed	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
has	VBZ	aux	O
become	VBN	cop	O
functionally	RB	advmod	O
redundant	JJ	ccomp	O
for	IN	case	O
proliferation	NN	nmod	O
.	.	punct	O

Reversal	NN	nsubjpass	O
of	IN	case	O
this	DT	det	O
functional	JJ	amod	O
uncoupling	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
required	VBN	ROOT	O
before	IN	case	O
Jak3/Stat5	NN	compound	O
inhibitors	NNS	nmod	O
will	MD	aux	O
be	VB	cop	O
useful	JJ	xcomp	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
this	DT	det	O
malignancy	NN	nmod	O
.	.	punct	O

The	DT	det	O
Epstein-Barr	JJ	amod	B-DNA
virus	NN	compound	I-DNA
promoter	NN	nsubjpass	I-DNA
initiating	VBG	acl	O
B-cell	NN	compound	O
transformation	NN	dobj	O
is	VBZ	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
RFX	NN	compound	B-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
the	DT	det	O
B-cell-specific	JJ	amod	B-protein
activator	NN	compound	I-protein
protein	NN	compound	I-protein
BSAP/Pax5	NN	conj	I-protein
.	.	punct	O

Epstein-Barr	JJ	amod	O
virus	NN	compound	O
(	-LRB-	punct	O
EBV	NN	compound	O
)	-RRB-	punct	O
-induced	JJ	amod	O
B-cell	NN	compound	B-cell_type
growth	NN	compound	O
transformation	NN	nsubj	O
,	,	punct	O
a	DT	det	O
central	JJ	amod	O
feature	NN	appos	O
of	IN	case	O
the	DT	det	O
virus	NN	nmod:poss	O
'	''	punct	O
strategy	NN	nmod	O
for	IN	mark	O
colonizing	VBG	acl	O
the	DT	det	O
human	JJ	amod	O
B-cell	NN	compound	O
system	NN	dobj	O
,	,	punct	O
requires	VBZ	ROOT	O
full	JJ	amod	O
virus	NN	compound	O
latent	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
is	VBZ	auxpass	O
initiated	VBN	conj	O
by	IN	case	O
transcription	NN	nmod	O
from	IN	case	O
the	DT	det	O
viral	JJ	amod	B-DNA
promoter	NN	compound	I-DNA
Wp	NN	nmod	I-DNA
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
EBV	NN	nsubj	O
accesses	VBZ	advcl	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	dobj	O
,	,	punct	O
this	DT	det	O
growth-transforming	JJ	amod	O
program	NN	nsubjpass	O
is	VBZ	auxpass	O
not	RB	neg	O
activated	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
work	NN	nsubj	O
focuses	VBZ	ROOT	O
on	IN	case	O
a	DT	det	O
region	NN	nmod	O
of	IN	case	O
Wp	NN	nmod	B-DNA
which	WDT	nsubj	O
in	IN	case	O
reporter	NN	compound	O
assays	NNS	nmod	O
confers	VBZ	acl:relcl	O
B-cell	NN	compound	B-cell_type
-specific	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

Bandshift	NN	compound	O
studies	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
this	DT	det	O
region	NN	nsubj	O
contains	VBZ	ccomp	O
three	CD	nummod	O
factor	NN	compound	O
binding	NN	compound	O
sites	NNS	dobj	O
,	,	punct	O
termed	VBN	acl	O
sites	NNS	xcomp	B-DNA
B	NN	dep	I-DNA
,	,	punct	I-DNA
C	NN	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
D	NN	conj	I-DNA
,	,	punct	O
in	IN	case	O
addition	NN	dep	O
to	TO	case	O
a	DT	det	O
previously	RB	advmod	O
characterized	VBN	amod	O
CREB	NN	compound	B-DNA
site	NN	nmod	I-DNA
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
site	NN	compound	B-DNA
C	NN	nsubj	I-DNA
binds	VBZ	ccomp	O
members	NNS	dobj	O
of	IN	case	O
the	DT	det	O
ubiquitously	RB	advmod	O
expressed	VBN	amod	O
RFX	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	I-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
notably	RB	advmod	O
RFX1	NN	nmod	B-protein
,	,	punct	O
RFX3	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
the	DT	det	O
associated	VBN	amod	O
factor	NN	compound	O
MIBP1	NN	conj	B-protein
,	,	punct	O
whereas	IN	dep	O
sites	NNS	nsubj	B-DNA
B	NN	dep	I-DNA
and	CC	cc	I-DNA
D	NN	conj	I-DNA
both	DT	dep	O
bind	VBP	parataxis	O
the	DT	det	O
B-cell-specific	JJ	amod	B-protein
activator	NN	compound	I-protein
protein	NN	compound	I-protein
BSAP/Pax5	NN	dobj	I-protein
.	.	punct	O

In	IN	case	O
reporter	NN	compound	O
assays	NNS	nmod	O
with	IN	case	O
mutant	JJ	amod	B-DNA
Wp	NN	compound	I-DNA
constructs	NNS	nmod	I-DNA
,	,	punct	O
the	DT	det	O
loss	NN	nsubj	O
of	IN	case	O
factor	NN	nmod	O
binding	VBG	acl	O
to	TO	case	O
any	DT	det	O
one	CD	nmod	O
of	IN	case	O
these	DT	det	O
sites	NNS	nmod	O
severely	RB	advmod	O
impaired	VBD	ROOT	O
promoter	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
while	IN	mark	O
the	DT	det	O
wild-type	JJ	amod	B-DNA
promoter	NN	nsubjpass	I-DNA
could	MD	aux	O
be	VB	auxpass	O
activated	VBN	advcl	O
in	IN	case	O
non-B	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
ectopic	JJ	amod	O
BSAP	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
Wp	NN	compound	B-DNA
regulation	NN	nsubj	O
by	IN	case	O
BSAP	NN	nmod	B-protein
helps	VBZ	ccomp	O
to	TO	mark	O
ensure	VB	xcomp	O
the	DT	det	O
B-cell	NN	compound	B-cell_type
specificity	NN	dobj	O
of	IN	case	O
EBV	NN	nmod:poss	O
's	POS	case	O
growth-transforming	JJ	amod	O
function	NN	nmod	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Lck	NN	compound	B-protein
tyrosine	NN	compound	I-protein
protein	NN	compound	I-protein
kinase	NN	nmod	I-protein
by	IN	case	O
the	DT	det	O
Herpesvirus	NN	compound	O
saimiri	NN	compound	O
tip	NN	compound	B-protein
protein	NN	nmod	I-protein
involves	VBZ	ROOT	O
two	CD	nummod	O
binding	VBG	compound	O
interactions	NNS	dobj	O
.	.	punct	O

The	DT	det	O
Tip	NN	compound	B-protein
protein	NN	nsubj	I-protein
of	IN	case	O
Herpesvirus	NN	compound	O
saimiri	NN	compound	O
strain	NN	compound	O
484C	NN	nmod	O
binds	VBZ	ROOT	O
to	TO	nmod	O
and	CC	cc	O
activates	VBZ	conj	O
the	DT	det	O
Lck	NN	compound	B-protein
tyrosine	NN	compound	I-protein
protein	NN	compound	I-protein
kinase	NN	dobj	I-protein
.	.	punct	O

Two	CD	nummod	O
sequences	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
Tip	NN	compound	B-protein
protein	NN	nmod	I-protein
were	VBD	auxpass	O
previously	RB	advmod	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
in	IN	case	O
binding	VBG	nmod	O
to	TO	case	O
Lck	NN	nmod	B-protein
.	.	punct	O

A	DT	det	O
proline-rich	JJ	amod	B-protein
region	NN	nsubj	I-protein
,	,	punct	O
residues	NNS	appos	O
132-141	CD	nummod	O
,	,	punct	O
binds	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
SH3	NN	compound	B-protein
domain	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
Lck	NN	compound	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
the	DT	det	O
other	JJ	amod	O
Lck-binding	JJ	amod	B-protein
domain	NN	nsubj	I-protein
,	,	punct	O
residues	NNS	appos	O
104-113	CD	nummod	O
,	,	punct	O
binds	VBZ	ccomp	O
to	TO	case	O
the	DT	det	O
carboxyl-terminal	JJ	amod	B-protein
half	NN	nmod	I-protein
of	IN	case	O
Lck	NN	nmod	B-protein
and	CC	cc	O
that	IN	mark	O
this	DT	det	O
binding	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
require	VB	conj	O
the	DT	det	O
Lck	NN	compound	B-protein
SH3	NN	compound	I-protein
domain	NN	dobj	I-protein
.	.	punct	O

Mutated	VBN	amod	O
Tip	NN	nsubj	B-protein
containing	VBG	acl	O
only	RB	advmod	O
one	CD	nummod	O
functional	JJ	amod	O
Lck-binding	JJ	amod	B-protein
domain	NN	dobj	I-protein
can	MD	aux	O
bind	VB	ROOT	O
stably	RB	advmod	O
to	TO	case	O
Lck	NN	nmod	B-protein
,	,	punct	O
although	IN	mark	O
not	RB	neg	O
as	RB	advmod	O
strongly	RB	advmod	O
as	IN	prep	O
wild-type	JJ	amod	B-protein
Tip	NN	pobj	I-protein
.	.	punct	O

Interaction	NN	nsubj	O
of	IN	case	O
Tip	NN	nmod	B-protein
with	IN	case	O
Lck	NN	nmod	B-protein
through	IN	case	O
either	CC	det	O
Lck-binding	JJ	amod	B-protein
domain	NN	nmod	I-protein
increases	VBZ	ROOT	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
Lck	NN	nmod	B-protein
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Simultaneous	JJ	amod	O
binding	NN	nsubjpass	O
of	IN	case	O
both	DT	det	O
domains	NNS	nmod	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
maximal	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
Lck	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
transient	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
Tip	NN	nmod	B-protein
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
stimulate	VB	xcomp	O
both	CC	cc:preconj	O
Stat3	NN	nmod:npmod	B-protein
-dependent	JJ	amod	O
and	CC	cc	O
NF-AT	NN	nmod:npmod	B-protein
-dependent	JJ	conj	O
transcription	NN	dobj	O
.	.	punct	O

Mutant	JJ	amod	O
forms	NNS	nsubj	O
of	IN	case	O
Tip	NN	nmod	B-protein
lacking	VBG	acl	O
one	CD	dobj	O
or	CC	cc	O
the	DT	det	O
other	JJ	conj	O
of	IN	case	O
the	DT	det	O
two	CD	nummod	O
Lck-binding	JJ	amod	B-protein
domains	NNS	nmod	I-protein
retained	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
to	TO	mark	O
stimulate	VB	acl	O
Stat3	NN	compound	B-protein
-dependent	JJ	amod	O
transcription	NN	dobj	O
.	.	punct	O

Tip	NN	nsubj	B-protein
lacking	VBG	acl	O
the	DT	det	O
proline-rich	JJ	amod	O
Lck-binding	JJ	amod	B-protein
domain	NN	dobj	I-protein
exhibited	VBD	ROOT	O
almost	RB	advmod	O
wild-type	JJ	amod	O
activity	NN	dobj	O
in	IN	case	O
this	DT	det	O
assay	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
ablation	NN	nsubj	O
of	IN	case	O
either	CC	det	O
Lck-binding	JJ	amod	B-protein
domain	NN	nmod	I-protein
abolished	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
Tip	NN	nmod	B-protein
to	TO	mark	O
stimulate	VB	acl	O
NF-AT	NN	compound	B-protein
-dependent	JJ	amod	O
transcription	NN	dobj	O
.	.	punct	O

Full	JJ	amod	O
biological	JJ	amod	O
activity	NN	nsubj	O
of	IN	case	O
Tip	NN	nmod	B-protein
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
appears	VBZ	ROOT	O
to	TO	mark	O
require	VB	xcomp	O
both	CC	det	O
Lck-binding	JJ	amod	B-protein
domains	NNS	dobj	I-protein
.	.	punct	O

Accumulation	NN	ROOT	O
of	IN	case	O
RXR	NN	compound	B-protein
alpha	NN	nmod	I-protein
during	IN	case	O
activation	NN	nmod	O
of	IN	case	O
cycling	VBG	amod	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
:	:	punct	O
modulation	NN	dep	O
of	IN	case	O
RXRE	NN	compound	O
transactivation	NN	compound	O
function	NN	nmod	O
by	IN	case	O
mitogen-activated	JJ	amod	O
protein	NN	compound	O
kinase	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
reported	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
activation	NN	nsubjpass	O
of	IN	case	O
resting	VBG	amod	O
human	JJ	amod	B-cell_type
immature	JJ	amod	I-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
PBT	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
the	DT	det	O
loss	NN	nmod	O
of	IN	case	O
retinoid	NN	compound	B-protein
X	NN	compound	I-protein
receptor	NN	compound	I-protein
alpha	NN	compound	I-protein
(	-LRB-	punct	O
RXRalpha	NN	appos	B-protein
)	-RRB-	punct	O
expression	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
,	,	punct	O
unlike	IN	case	O
resting	VBG	amod	O
cells	NNS	nmod	O
,	,	punct	O
activation	NN	nsubjpass	O
of	IN	case	O
cycling	VBG	amod	B-cell_type
human	JJ	amod	I-cell_type
mature	JJ	amod	I-cell_type
PBT	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
T	NN	compound	B-cell_line
lymphocyte	NN	compound	I-cell_line
leukemia	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
is	VBZ	auxpass	O
accompanied	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
accumulation	NN	nmod	O
of	IN	case	O
RXRalpha	NN	compound	B-protein
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
cyclosporin	NN	compound	O
A	NN	nsubj	O
further	RB	advmod	O
augmented	VBD	ROOT	O
RXRalpha	NN	compound	B-protein
expression	NN	dobj	O
,	,	punct	O
indicating	VBG	advcl	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
calcineurin	NN	compound	O
pathways	NNS	nmod	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
.	.	punct	O

9-cis	JJ	amod	O
retinoic	JJ	amod	O
acid	NN	nsubj	O
inhibited	VBD	ROOT	O
the	DT	det	O
accumulation	NN	dobj	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
retinoids	NNS	nsubj	O
can	MD	aux	O
regulate	VB	ccomp	O
the	DT	det	O
synthesis	NN	dobj	O
of	IN	case	O
their	PRP$	nmod:poss	O
own	JJ	amod	O
receptors	NNS	nmod	O
during	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Transfection	NN	compound	O
analysis	NN	nsubj	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
,	,	punct	O
using	VBG	acl	O
RXRE-dependent	JJ	amod	O
reporter	NN	compound	O
assays	NNS	dobj	O
,	,	punct	O
showed	VBD	ROOT	O
that	IN	mark	O
RXRalpha	NN	nsubj	B-protein
accumulated	VBD	acl	O
during	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
was	VBD	cop	O
transcriptionally	RB	advmod	O
inactive	JJ	ccomp	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
such	JJ	amod	O
inhibition	NN	nmod	O
,	,	punct	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
mitogen-activated	JJ	amod	O
protein	NN	compound	O
kinase	NN	compound	O
pathways	NNS	nmod	O
,	,	punct	O
c-Jun	NN	compound	B-protein
N-terminal	JJ	amod	I-protein
kinase	NN	appos	I-protein
(	-LRB-	punct	O
JNK	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
extracellular	JJ	amod	B-protein
signal-regulated	JJ	amod	I-protein
kinase	NN	conj	I-protein
(	-LRB-	punct	O
ERK	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
in	IN	mark	O
modulating	VBG	advcl	O
RXRE-dependent	JJ	amod	O
transcription	NN	dobj	O
,	,	punct	O
was	VBD	auxpass	O
explored	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
constitutively	RB	advmod	O
active	JJ	amod	O
MAP/ERK	NN	compound	B-protein
kinase	NN	compound	I-protein
kinase	NN	nmod	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
MEKK1	NN	appos	B-protein
)	-RRB-	punct	O
inhibited	VBD	ROOT	O
RXRE-dependent	JJ	amod	O
transcription	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
dominant	JJ	amod	B-protein
negative	JJ	amod	I-protein
MEKK1	NN	nsubj	I-protein
increased	VBD	parataxis	O
the	DT	det	O
transcription	NN	dobj	O
,	,	punct	O
indicating	VBG	advcl	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
JNK	NN	compound	B-protein
signaling	NN	compound	O
pathways	NNS	nmod	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
expression	NN	nsubj	O
of	IN	case	O
constitutively	RB	advmod	B-protein
active	JJ	amod	I-protein
MEK1	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
activates	VBZ	acl:relcl	O
ERK	NN	compound	B-protein
pathway	NN	dobj	O
,	,	punct	O
enhanced	VBD	ROOT	O
RXRE-dependent	JJ	amod	O
activation	NN	dobj	O
.	.	punct	O

When	WRB	advmod	O
both	DT	nsubjpass	O
were	VBD	auxpass	O
activated	VBN	advcl	O
simultaneously	RB	advmod	O
,	,	punct	O
JNK	NN	compound	B-protein
pathway	NN	nsubj	O
was	VBD	cop	O
dominant	JJ	ROOT	O
over	IN	case	O
ERK	NN	compound	B-protein
pathway	NN	nmod	O
and	CC	cc	O
resulted	VBD	conj	O
in	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
RXRE-mediated	JJ	amod	O
transcription	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
demonstrate	VBP	ROOT	O
a	DT	det	O
dual	JJ	amod	O
regulatory	JJ	amod	O
control	NN	dobj	O
of	IN	case	O
RXRalpha	NN	compound	B-protein
expression	NN	nmod	O
during	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
resting	VBG	amod	B-cell_type
and	CC	cc	I-cell_type
cycling	VBG	conj	I-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
indicate	VBP	conj	O
a	DT	det	O
dynamic	JJ	amod	O
balance	NN	dobj	O
between	IN	case	O
JNK	NN	nmod	O
and	CC	cc	O
ERK	NN	compound	O
pathways	NNS	conj	O
in	IN	mark	O
modulating	VBG	acl	O
RXRE-mediated	JJ	amod	O
transactivation	NN	dobj	O
.	.	punct	O

The	DT	det	O
proteasome	NN	nsubj	B-protein
regulates	VBZ	ROOT	O
receptor-mediated	JJ	amod	O
endocytosis	NN	dobj	O
of	IN	case	O
interleukin-2	NN	nmod	B-protein
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
increasingly	RB	advmod	O
implicated	VBN	ROOT	O
the	DT	det	O
proteasome	NN	dobj	B-protein
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-protein
surface	NN	compound	I-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
proteasome	NN	nmod	B-protein
for	IN	case	O
ligand-dependent	JJ	amod	O
endocytosis	NN	nmod	O
and	CC	cc	O
degradation	NN	conj	O
of	IN	case	O
the	DT	det	O
interleukin-2	NN	compound	B-protein
(	-LRB-	punct	I-protein
IL-2	NN	compound	I-protein
)	-RRB-	punct	I-protein
-interleukin-2	CD	compound	I-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	I-protein
IL-2R	NN	compound	I-protein
)	-RRB-	punct	I-protein
complex	NN	nmod	I-protein
.	.	punct	O

Proteasome	NN	compound	O
inhibitors	NNS	nsubj	O
impaired	JJ	ROOT	O
internalization	NN	dobj	O
of	IN	case	O
IL-2.IL-2R	NN	nmod	B-protein
and	CC	cc	O
prevented	VBD	conj	O
the	DT	det	O
lysosomal	JJ	amod	O
degradation	NN	dobj	O
of	IN	case	O
this	DT	det	O
cytokine	NN	nmod	B-protein
.	.	punct	O

Based	VBN	case	O
on	IN	case	O
time-course	JJ	amod	O
studies	NNS	nmod	O
,	,	punct	O
proteasome	NN	compound	B-protein
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
primarily	RB	advmod	O
required	VBN	ROOT	O
after	IN	case	O
initial	JJ	amod	O
endocytosis	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2.IL-2R	NNP	nmod	B-protein
.	.	punct	O

Proteasome	NN	compound	O
function	NN	nsubj	O
was	VBD	cop	O
also	RB	advmod	O
necessary	JJ	ROOT	O
for	IN	case	O
the	DT	det	O
lysosomal	JJ	amod	O
degradation	NN	nmod	O
of	IN	case	O
IL-2	NN	nmod	B-protein
internalized	VBN	acl	O
by	IN	case	O
IL-2R	NN	nmod	B-protein
that	WDT	nsubjpass	O
were	VBD	auxpass	O
comprised	VBN	acl:relcl	O
of	IN	case	O
cytoplasmic	JJ	amod	B-protein
tailless	JJ	compound	I-protein
beta-	NN	nmod	B-protein
or	CC	cc	I-protein
gamma	NN	conj	I-protein
c-subunits	NNS	dep	I-protein
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
the	DT	det	O
target	NN	compound	O
protein	NN	nsubj	O
for	IN	case	O
the	DT	det	O
proteasome	NN	nmod	B-protein
is	VBZ	cop	O
independent	JJ	ccomp	O
of	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
cytoplasmic	JJ	amod	B-protein
tail	NN	nmod	I-protein
of	IN	case	O
the	DT	det	O
IL-2R	NN	compound	B-protein
beta-	NN	nmod	B-protein
or	CC	cc	I-protein
gamma	NN	compound	I-protein
c-subunits	NNS	nmod	I-protein
and	CC	cc	O
their	PRP$	nmod:poss	O
associated	VBN	amod	O
signaling	NN	compound	O
components	NNS	conj	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
a	DT	det	O
functional	JJ	amod	O
proteasome	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
optimal	JJ	amod	O
endocytosis	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-2R/ligand	JJ	compound	B-protein
complex	NN	nmod	I-protein
and	CC	cc	O
is	VBZ	cop	O
essential	JJ	conj	O
for	IN	case	O
the	DT	det	O
subsequent	JJ	amod	O
lysosomal	JJ	amod	O
degradation	NN	nmod	O
of	IN	case	O
IL-2	NN	nmod	B-protein
,	,	punct	O
possibly	RB	advmod	O
by	IN	mark	O
regulating	VBG	advcl	O
trafficking	VBG	dobj	O
to	TO	prep	O
the	DT	det	O
lysosome	NN	pobj	O
.	.	punct	O

Functional	JJ	amod	O
characterization	NN	ROOT	O
of	IN	case	O
the	DT	det	O
two	CD	nummod	O
alternative	JJ	amod	O
promoters	NNS	nmod	O
of	IN	case	O
human	JJ	amod	B-DNA
p45	NN	compound	I-DNA
NF-E2	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-E2	NN	nsubjpass	I-protein
,	,	punct	O
a	DT	det	O
heterodimeric	JJ	amod	B-protein
protein	NN	compound	I-protein
complex	NN	appos	I-protein
composed	VBN	acl	O
of	IN	case	O
p45	NN	nmod	B-protein
and	CC	cc	O
small	JJ	amod	O
Maf	NN	compound	B-protein
family	NN	compound	I-protein
proteins	NNS	conj	I-protein
,	,	punct	O
is	VBZ	auxpass	O
considered	VBN	dep	O
crucial	JJ	xcomp	O
for	IN	case	O
the	DT	det	O
proper	JJ	amod	O
differentiation	NN	nmod	O
of	IN	case	O
erythrocytes	NNS	nmod	B-cell_type
and	CC	cc	O
megakaryocytes	NNS	conj	B-cell_type
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
the	DT	det	O
results	NNS	dobj	O
of	IN	case	O
studies	NNS	nmod	O
aimed	VBN	acl	O
at	IN	mark	O
understanding	VBG	advcl	O
the	DT	det	O
regulatory	JJ	amod	O
mechanisms	NNS	dobj	O
controlling	VBG	acl	O
p45	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
in	IN	case	O
erythroid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

MATERIALS	NNS	nsubj	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Human	JJ	amod	B-RNA
p45	NN	compound	I-RNA
mRNAs	NNS	nsubj	I-RNA
have	VBP	ROOT	O
two	CD	nummod	O
alternative	JJ	amod	O
isoforms	NNS	dobj	O
,	,	punct	O
aNF-E2	NN	appos	B-RNA
and	CC	cc	O
fNF-E2	NN	conj	B-RNA
,	,	punct	O
and	CC	cc	O
these	DT	det	O
isoforms	NNS	nsubjpass	O
are	VBP	auxpass	O
transcribed	VBN	conj	O
from	IN	case	O
the	DT	det	O
alternative	JJ	amod	B-DNA
promoters	NNS	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
lineage-specific	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
both	DT	det	O
isomers	NNS	nmod	O
in	IN	case	O
human	JJ	amod	O
erythroid	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
megakaryocytic	JJ	conj	I-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
reverse	JJ	amod	O
transcriptase	NN	compound	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
or	CC	cc	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	conj	O
.	.	punct	O

For	IN	case	O
functional	JJ	amod	O
characterization	NN	nmod	O
of	IN	case	O
both	DT	det	O
promoters	NNS	nmod	O
,	,	punct	O
plasmids	NNS	appos	O
in	IN	case	O
which	WDT	nmod	O
reporter	NN	compound	B-DNA
genes	NNS	nsubjpass	I-DNA
were	VBD	auxpass	O
placed	VBN	acl:relcl	O
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
a	DT	det	O
series	NN	nmod	O
of	IN	case	O
truncated	VBN	amod	O
or	CC	cc	O
mutated	VBN	conj	O
promoter	NN	compound	B-DNA
fragments	NNS	nmod	I-DNA
were	VBD	auxpass	O
transfected	VBN	ROOT	O
to	TO	case	O
human	JJ	amod	B-cell_line
hematopoietic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

RESULTS	NNS	nsubjpass	O
:	:	punct	O
When	WRB	advmod	O
CD34	NN	compound	B-cell_type
(	-LRB-	punct	I-cell_type
+	CC	cc	I-cell_type
)	-RRB-	punct	I-cell_type
cells	NNS	nsubjpass	I-cell_type
isolated	VBN	acl	O
from	IN	case	O
human	JJ	amod	O
cord	NN	compound	O
blood	NN	nmod	O
were	VBD	auxpass	O
induced	VBN	advcl	O
to	TO	case	O
unilineage	JJ	amod	O
erythroid	JJ	amod	O
or	CC	cc	O
megakaryocytic	JJ	conj	O
differentiation	NN	nmod	O
in	IN	case	O
liquid	JJ	amod	O
suspension	NN	compound	O
culture	NN	nmod	O
,	,	punct	O
both	DT	det	O
transcripts	NNS	nmod	O
,	,	punct	O
although	IN	mark	O
barely	RB	advmod	O
detected	VBN	advcl	O
at	IN	case	O
day	NN	nmod	O
0	CD	nummod	O
,	,	punct	O
were	VBD	auxpass	O
induced	VBN	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
erythroid	JJ	amod	O
and	CC	cc	O
megakaryocytic	JJ	conj	O
cultures	NNS	nmod	O
.	.	punct	O

fNF-E2	NN	amod	B-RNA
mRNA	NN	nsubjpass	I-RNA
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
more	RBR	advmod	O
abundant	JJ	xcomp	O
in	IN	case	O
erythroid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
than	IN	case	O
megakaryocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
at	IN	case	O
day	NN	nmod	O
7	CD	nummod	O
of	IN	case	O
culture	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
both	DT	det	O
isomers	NNS	nsubjpass	O
were	VBD	auxpass	O
expressed	VBN	advcl	O
in	IN	case	O
human	JJ	amod	B-cell_line
erythroid-megakaryocytic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
megakaryocytic	JJ	amod	O
maturation	NN	appos	O
with	IN	case	O
loss	NN	nmod	O
of	IN	case	O
erythroid	JJ	amod	O
phenotype	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	nmod	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
resulted	VBD	ROOT	O
in	IN	case	O
exclusive	JJ	amod	O
downregulation	NN	nmod	O
of	IN	case	O
fNF-E2	NN	nmod	B-RNA
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
fNF-E2	NN	compound	B-DNA
promoter	NN	nsubj	I-DNA
is	VBZ	cop	O
more	RBR	advmod	O
erythroid	JJ	amod	O
specific	JJ	ccomp	O
.	.	punct	O

Functional	JJ	amod	O
analysis	NN	nsubj	O
of	IN	case	O
fNF-E2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
promoter	NN	nsubj	O
is	VBZ	cop	O
active	JJ	ccomp	O
only	RB	advmod	O
in	IN	case	O
erythroid-megakaryocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
double	JJ	amod	B-DNA
GATA	NN	compound	I-DNA
sit	VBP	compound	I-DNA
e	NN	nsubj	O
in	IN	case	O
the	DT	det	O
proximal	JJ	amod	O
region	NN	nmod	O
is	VBZ	cop	O
necessary	JJ	conj	O
for	IN	case	O
its	PRP$	nmod:poss	O
efficient	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	dep	O
that	IN	mark	O
GATA	NN	compound	B-protein
proteins	NNS	nsubjpass	I-protein
,	,	punct	O
which	WDT	nsubj	O
govern	VBP	acl:relcl	O
the	DT	det	O
differentiation	NN	dobj	O
of	IN	case	O
erythroid	JJ	amod	B-cell_type
lineage	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
are	VBP	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
full	JJ	amod	O
promoter	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
p45	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Transcriptional	JJ	amod	O
activation	NN	ROOT	O
of	IN	case	O
heme	NN	compound	B-DNA
oxygenase-1	NN	nmod	I-DNA
and	CC	cc	O
its	PRP$	nmod:poss	O
functional	JJ	amod	O
significance	NN	conj	O
in	IN	case	O
acetaminophen-induced	JJ	amod	O
hepatitis	NN	nmod	O
and	CC	cc	O
hepatocellular	JJ	amod	O
injury	NN	conj	O
in	IN	case	O
the	DT	det	O
rat	NN	nmod	O
.	.	punct	O

BACKGROUND/AIM	NN	nsubj	O
:	:	punct	O
Glutathione	NN	compound	O
depletion	NN	nsubj	O
contributes	VBZ	ROOT	O
to	TO	mark	O
acetaminophen	NN	xcomp	O
hepatotoxicity	NN	dobj	O
and	CC	cc	O
is	VBZ	auxpass	O
known	VBN	conj	O
to	TO	mark	O
induce	VB	xcomp	O
the	DT	det	O
oxidative	JJ	amod	O
stress	NN	compound	O
reactant	JJ	amod	O
heme	NN	compound	B-protein
oxygenase-1	NN	dobj	I-protein
.	.	punct	O

The	DT	det	O
metabolites	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
heme	NN	compound	O
oxygenase	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
biliverdin	NN	appos	O
,	,	punct	O
carbon	NN	compound	O
monoxide	NN	conj	O
,	,	punct	O
and	CC	cc	O
iron	NN	conj	O
may	MD	aux	O
modulate	VB	ROOT	O
acetaminophen	NN	amod	O
toxicity	NN	dobj	O
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
assess	VB	xcomp	O
cell-type	JJ	amod	O
specific	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
heme	NN	compound	B-DNA
oxygenase-1	NN	nmod	I-DNA
and	CC	cc	O
its	PRP$	nmod:poss	O
impact	NN	conj	O
on	IN	case	O
liver	NN	compound	O
injury	NN	nmod	O
and	CC	cc	O
microcirculatory	JJ	amod	O
disturbances	NNS	conj	O
in	IN	case	O
a	DT	det	O
model	NN	nmod	O
of	IN	case	O
acetaminophen-induced	JJ	amod	O
hepatitis	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Gene	NN	compound	O
expression	NN	nsubjpass	O
of	IN	case	O
heme	NN	compound	B-DNA
oxygenase-1	NN	nmod	I-DNA
was	VBD	auxpass	O
studied	VBN	dep	O
by	IN	case	O
Northern-	NN	nmod	O
and	CC	cc	O
Western	NN	conj	O
analysis	NN	dep	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
immunohistochemistry	NN	conj	O
.	.	punct	O

The	DT	det	O
time	NN	compound	O
course	NN	nsubjpass	O
of	IN	prep	O
heme	NN	compound	B-protein
oxygenase-1	NN	pobj	I-protein
and	CC	cc	I-protein
-2	CD	conj	I-protein
,	,	punct	O
cytokine-induced	JJ	amod	B-protein
neutrophil	NN	compound	I-protein
chemoattractant-1	NN	conj	I-protein
,	,	punct	O
and	CC	cc	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nsubjpass	I-protein
was	VBD	auxpass	O
studied	VBN	ROOT	O
by	IN	case	O
Northern	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

DNA-binding	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod	I-protein
was	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

Sinusoidal	JJ	amod	O
perfusion	NN	nsubjpass	O
and	CC	cc	O
leukocyte-endothelial	JJ	amod	O
interactions	NNS	conj	O
were	VBD	auxpass	O
assessed	VBN	ROOT	O
by	IN	case	O
intravital	JJ	amod	O
microscopy	NN	nmod	O
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
Acetaminophen	NNP	advmod	O
caused	VBD	ROOT	O
a	DT	det	O
moderate	JJ	amod	O
sinusoidal	JJ	amod	O
perfusion	NN	compound	O
failure	NN	dobj	O
(	-LRB-	punct	O
-15	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
infiltration	NN	conj	O
of	IN	case	O
neutrophils	NNS	nmod	B-cell_type
along	IN	case	O
with	IN	case	O
activation	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	nmod	I-protein
and	CC	cc	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	conj	I-protein
and	CC	cc	O
cytokine-induced	JJ	amod	B-protein
neutrophil	NN	compound	I-protein
chemoattractant-1	NN	compound	I-protein
mRNAs	NNS	conj	O
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
heme	NN	compound	B-protein
oxygenase-1	NN	compound	I-protein
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
(	-LRB-	punct	O
approximately	RB	advmod	O
30-fold	JJ	appos	O
)	-RRB-	punct	O
in	IN	case	O
hepatocytes	NNS	nmod	B-cell_type
and	CC	cc	O
non-parenchymal	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
paralleled	VBD	ROOT	O
the	DT	det	O
inflammatory	JJ	amod	O
response	NN	dobj	O
.	.	punct	O

Blockade	NN	nsubj	O
of	IN	case	O
heme	NN	compound	O
oxygenase	NN	compound	O
activity	NN	nmod	O
with	IN	case	O
tin-protoporphyrin-IX	NN	compound	O
abrogated	VBD	amod	O
acetaminophen-induced	JJ	amod	O
hepatic	JJ	amod	B-cell_type
neutrophil	NN	compound	I-cell_type
accumulation	NN	nmod	O
and	CC	cc	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	compound	I-protein
activation	NN	conj	O
,	,	punct	O
but	CC	cc	O
failed	VBD	ROOT	O
to	TO	mark	O
affect	VB	xcomp	O
sinusoidal	JJ	amod	O
perfusion	NN	dobj	O
and	CC	cc	O
liver	NN	compound	O
injury	NN	conj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
inflammatory	JJ	amod	O
response	NN	nsubjpass	O
associated	VBN	acl	O
with	IN	case	O
acetaminophen	NN	compound	O
hepatotoxicity	NN	nmod	O
is	VBZ	auxpass	O
modulated	VBN	dep	O
by	IN	case	O
the	DT	det	O
parallel	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
heme	NN	compound	B-DNA
oxygenase-1	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
heme	NN	compound	B-DNA
oxygenase-1	NN	nsubj	I-DNA
has	VBZ	ROOT	O
no	DT	neg	O
permissive	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
sinusoidal	JJ	amod	O
perfusion	NN	nmod	O
and	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
affect	VB	conj	O
liver	NN	compound	O
injury	NN	dobj	O
in	IN	case	O
this	DT	det	O
model	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
argue	VBP	ROOT	O
against	IN	case	O
a	DT	det	O
central	JJ	amod	O
role	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappaB	NN	compound	I-protein
activation	NN	nmod	O
and	CC	cc	O
neutrophil	NN	compound	O
infiltration	NN	conj	O
as	IN	case	O
perpetuating	VBG	amod	O
factors	NNS	nmod	O
of	IN	case	O
liver	NN	compound	O
injury	NN	nmod	O
in	IN	case	O
acetaminophen	NN	compound	O
toxicity	NN	nmod	O
.	.	punct	O

Tumor	NN	nmod:npmod	B-protein
necrosis	NN	nmod:npmod	I-protein
factor-alpha	NN	nmod:npmod	I-protein
-induced	JJ	amod	O
proliferation	NN	nsubj	O
requires	VBZ	ROOT	O
synthesis	NN	dobj	O
of	IN	case	O
granulocyte-macrophage	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	nmod	I-protein
.	.	punct	O

OBJECTIVE	NN	nsubj	O
:	:	punct	O
Tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-	NN	compound	I-protein
alpha	NN	nsubj	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
induces	VBZ	ROOT	O
a	DT	det	O
variety	NN	dobj	O
of	IN	case	O
cellular	JJ	amod	O
responses	NNS	nmod	O
,	,	punct	O
some	DT	nsubj	O
of	IN	prep	O
them	PRP	pobj	O
being	VBG	cop	O
at	IN	advmod	O
least	JJS	advmod	O
seemingly	RB	advmod	O
contradictory	JJ	parataxis	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
set	VBD	ROOT	O
out	RP	prt	O
to	TO	aux	O
find	VB	xcomp	O
differences	NNS	dobj	O
in	IN	case	O
the	DT	det	O
modes	NNS	nmod	O
of	IN	case	O
proliferative	JJ	amod	O
and	CC	cc	O
apoptotic	JJ	conj	O
responses	NNS	nmod	O
to	TO	case	O
TNF-	NN	amod	B-protein
alpha	NN	nmod	I-protein
.	.	punct	O

MATERIALS	NNS	nsubj	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
We	PRP	nsubj	O
screened	VBD	ROOT	O
a	DT	det	O
panel	NN	dobj	O
of	IN	case	O
acute	JJ	amod	B-cell_line
myeloid	JJ	amod	I-cell_line
leukemia-derived	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
for	IN	case	O
TNF-	NN	amod	B-protein
alpha	NN	compound	I-protein
-responsiveness	NN	nmod	O
.	.	punct	O

In	IN	case	O
two	CD	nummod	O
lines	NNS	nmod	O
(	-LRB-	punct	O
OCI-AML-1	NN	dep	B-cell_line
,	,	punct	O
OCI-AML-11	NN	appos	B-cell_line
)	-RRB-	punct	O
,	,	punct	O
TNF-	NN	amod	B-protein
alpha	NN	nsubj	I-protein
acted	VBD	ROOT	O
as	IN	case	O
an	DT	det	O
apoptotic	JJ	amod	O
agent	NN	nmod	O
;	:	punct	O
in	IN	case	O
others	NNS	nmod	O
(	-LRB-	punct	O
HU-3	NN	dep	B-cell_line
,	,	punct	O
M-07e	NN	conj	B-cell_line
,	,	punct	O
TF-1	NN	appos	B-cell_line
)	-RRB-	punct	O
,	,	punct	O
it	PRP	nsubj	O
had	VBD	parataxis	O
the	DT	det	O
opposite	JJ	amod	O
effect	NN	dobj	O
,	,	punct	O
preventing	VBG	advcl	O
apoptosis	NN	dobj	O
and	CC	cc	O
inducing	VBG	conj	O
proliferation	NN	dobj	O
.	.	punct	O

Direct	JJ	amod	O
and	CC	cc	O
indirect	JJ	conj	O
signaling	NN	compound	O
mechanisms	NNS	nsubjpass	O
,	,	punct	O
including	VBG	case	O
NF-kappaB	NN	compound	B-protein
activation	NN	nmod	O
and	CC	cc	O
cytokine	NN	compound	O
synthesis	NN	conj	O
,	,	punct	O
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
All	DT	det	O
cell	NN	compound	O
lines	NNS	nsubj	O
tested	VBN	acl	O
expressed	VBD	dep	O
TNF-	NN	amod	B-protein
alpha	NN	compound	I-protein
receptors	NNS	dobj	I-protein
I	CD	dep	I-protein
and	CC	cc	I-protein
II	CD	conj	I-protein
and	CC	cc	O
responded	VBD	conj	O
to	TO	case	O
TNF-	NN	amod	B-protein
alpha	NN	nmod	I-protein
by	IN	case	O
upregulation	NN	nmod	O
of	IN	case	O
intercellular	JJ	amod	B-protein
adhesion	NN	compound	I-protein
molecule-1	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
contrast	NN	dep	O
to	TO	case	O
granulocyte-macrophage	JJ	amod	B-protein
colony-stimulating	JJ	amod	I-protein
factor	NN	nmod	I-protein
(	-LRB-	punct	O
GM-CSF	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
TNF-	NN	amod	B-protein
alpha	NN	nsubj	I-protein
did	VBD	aux	O
not	RB	neg	O
activate	VB	ROOT	O
the	DT	det	O
MAP	NN	compound	B-protein
kinase	NN	dobj	I-protein
and	CC	cc	O
p70S6	NN	compound	O
kinase	NN	compound	O
pathways	NNS	conj	O
.	.	punct	O

Nevertheless	RB	advmod	O
,	,	punct	O
inhibitors	NNS	nsubj	O
of	IN	case	O
these	DT	det	O
pathways	NNS	nmod	O
clearly	RB	advmod	O
reduced	VBD	ROOT	O
the	DT	det	O
TNF-alpha	NN	compound	B-protein
-induced	JJ	amod	O
cell	NN	compound	O
growth	NN	dobj	O
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
TNF-	NN	amod	B-cell_type
alpha-proliferative	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
produced	VBD	ccomp	O
a	DT	det	O
growth	NN	compound	O
factor	NN	dobj	O
that	WDT	nsubj	O
induced	VBD	acl:relcl	O
proliferation	NN	dobj	O
upon	IN	case	O
stimulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
above	JJ	amod	O
pathways	NNS	nmod	O
.	.	punct	O

Anti-GM-CSF	NN	compound	B-protein
antibodies	NNS	nsubj	I-protein
inhibited	VBD	ROOT	O
the	DT	det	O
TNF-alpha	NN	compound	B-protein
-induced	JJ	amod	O
growth	NN	dobj	O
,	,	punct	O
suggesting	VBG	advcl	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
an	DT	det	O
autocrine	JJ	amod	O
loop	NN	nmod	O
for	IN	case	O
cell	NN	compound	O
proliferation	NN	nmod	O
mediated	VBN	acl	O
by	IN	case	O
GM-CSF	NN	nmod	B-protein
.	.	punct	O

Supporting	VBG	ROOT	O
this	DT	det	O
notion	NN	dobj	O
,	,	punct	O
TNF-alpha	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
upregulation	NN	dobj	O
of	IN	case	O
GM-CSF	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nmod	O
and	CC	cc	O
protein	NN	compound	O
secretion	NN	conj	O
in	IN	case	O
the	DT	det	O
TNF-alpha	NN	compound	B-protein
-proliferative	JJ	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
the	DT	det	O
TNF-alpha-apoptotic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	conj	I-cell_line
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
These	DT	det	O
data	NNS	nsubj	O
identify	VBP	ROOT	O
GM-CSF	NN	compound	B-protein
synthesis	NN	dobj	O
as	IN	case	O
an	DT	det	O
early	JJ	amod	O
and	CC	cc	O
essential	JJ	conj	O
step	NN	nmod	O
in	IN	case	O
TNF-	NN	amod	O
alpha-induced	JJ	amod	O
proliferation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
for	IN	case	O
the	DT	det	O
first	JJ	amod	O
time	NN	nmod	O
that	IN	mark	O
TNF-alpha-treated	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nsubj	I-cell_line
producing	VBG	acl	O
no	DT	neg	O
or	CC	cc	O
only	RB	conj	O
minimal	JJ	amod	O
amounts	NNS	dobj	O
of	IN	case	O
GM-CSF	NN	nmod	B-protein
demonstrate	VBP	ccomp	O
an	DT	det	O
apoptotic	JJ	amod	O
phenotype	NN	dobj	O
,	,	punct	O
while	IN	mark	O
cell	NN	compound	O
lines	NNS	nsubj	O
with	IN	case	O
high	JJ	amod	O
GM-CSF	NN	compound	B-protein
expression	NN	compound	O
rates	NNS	nmod	O
can	MD	aux	O
escape	VB	advcl	O
from	IN	case	O
growth	NN	compound	O
arrest	NN	nmod	O
or	CC	cc	O
even	RB	advmod	O
apoptosis	NN	conj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
context	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
discuss	VBP	ROOT	O
arguments	NNS	dobj	O
pointing	VBG	acl	O
at	IN	case	O
NF-kappaB	NN	nmod	B-protein
as	IN	case	O
regulator	NN	nmod	O
of	IN	case	O
GM-CSF	NN	compound	B-protein
synthesis	NN	nmod	O
and	CC	cc	O
thus	RB	advmod	O
indirectly	RB	advmod	O
as	IN	case	O
regulator	NN	nmod	O
for	IN	case	O
the	DT	det	O
escape	NN	nmod	O
of	IN	case	O
TNF-alpha	NN	nmod:npmod	B-protein
-induced	JJ	amod	O
apoptosis	NN	nmod	O

Glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
content	NN	ROOT	O
of	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
:	:	punct	O
evidence	NN	dep	O
for	IN	case	O
heterogeneity	NN	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
measured	VBN	ROOT	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
that	WDT	nsubjpass	O
were	VBD	auxpass	O
isolated	VBN	acl:relcl	O
from	IN	case	O
peripheral	JJ	amod	O
blood	NN	nmod	O
by	IN	case	O
either	CC	cc:preconj	O
nylon	NN	compound	O
wool	NN	compound	O
filtration	NN	nmod	O
or	CC	cc	O
E-rosette	JJ	compound	O
sedimentation	NN	conj	O
.	.	punct	O

T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
isolated	VBN	acl	O
by	IN	case	O
nylon	NN	compound	O
wool	NN	compound	O
filtration	NN	nmod	O
specifically	RB	advmod	O
bind	VBP	ROOT	O
6.7	CD	nummod	O
+/-	CC	cc	O
0.2	CD	conj	O
fmol	NN	dobj	O
of	IN	case	O
dexamethasone	NN	nmod	O
per	IN	case	O
million	CD	nummod	O
cells	NNS	nmod	O
(	-LRB-	punct	O
equivalent	JJ	dep	O
to	TO	case	O
4000	CD	nummod	O
+/-	CC	cc	O
200	CD	conj	O
receptors	NNS	nmod	O
per	IN	case	O
cell	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
isolated	VBN	acl	O
by	IN	case	O
E-rosette	JJ	compound	O
sedimentation	NN	nmod	O
bind	VBP	parataxis	O
12.0	CD	nummod	O
+/-	CC	cc	O
0.7	CD	conj	O
fmol	NN	dobj	O
of	IN	case	O
dexamethasone	NN	nmod	O
per	IN	case	O
million	CD	nummod	O
cells	NNS	nmod	O
(	-LRB-	punct	O
equivalent	JJ	dep	O
to	TO	case	O
7200	CD	nummod	O
+/-	CC	cc	O
400	CD	conj	O
receptors	NNS	nmod	O
per	IN	case	O
cell	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
difference	NN	nsubj	O
in	IN	case	O
the	DT	det	O
amount	NN	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
bound	VBN	acl	O
by	IN	case	O
the	DT	det	O
two	CD	nummod	O
T	NN	compound	O
cell	NN	compound	O
preparations	NNS	nmod	O
was	VBD	cop	O
significant	JJ	ROOT	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	mwe	O
.001	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
was	VBD	cop	O
present	JJ	conj	O
immediately	RB	advmod	O
after	IN	case	O
cell	NN	compound	O
isolation	NN	nmod	O
.	.	punct	O

The	DT	det	O
binding	NN	compound	O
affinities	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
different	JJ	amod	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
preparations	NNS	nmod	I-cell_line
for	IN	case	O
dexamethasone	NN	nmod	O
were	VBD	cop	O
similar	JJ	ROOT	O
.	.	punct	O

T	NN	compound	O
cells	NNS	nsubj	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
isolated	VBN	acl:relcl	O
by	IN	case	O
a	DT	det	O
combination	NN	nmod	O
of	IN	case	O
nylon	NN	compound	O
wool	NN	compound	O
filtration	NN	nmod	O
followed	VBN	acl	O
by	IN	case	O
E-rosette	JJ	compound	O
sedimentation	NN	nmod	O
bind	VBP	ROOT	O
the	DT	det	O
same	JJ	amod	O
amount	NN	dobj	O
of	IN	case	O
dexamethasone	NN	nmod	O
as	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
isolated	VBN	acl	O
by	IN	case	O
nylon	NN	compound	O
wool	NN	compound	O
filtration	NN	nmod	O
alone	RB	advmod	O
.	.	punct	O

T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
isolated	VBN	acl	O
by	IN	case	O
a	DT	det	O
combination	NN	nmod	O
of	IN	case	O
E-rosette	JJ	compound	O
sedimentation	NN	nmod	O
following	VBG	case	O
by	IN	case	O
nylon	NN	compound	O
wool	NN	compound	O
filtration	NN	nmod	O
bind	VBP	ROOT	O
less	JJR	amod	O
dexamethasone	NN	dobj	O
than	IN	mark	O
do	VBP	advcl	O
T	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
isolated	VBN	acl	O
by	IN	case	O
E-rosette	JJ	compound	O
sedimentation	NN	nmod	O
alone	RB	advmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
T	NN	compound	B-cell_type
cells	NNS	nsubj	I-cell_type
are	VBP	cop	O
heterogeneous	JJ	ccomp	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
their	PRP$	nmod:poss	O
quantity	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Isolation	NN	ROOT	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
E-rosette	JJ	compound	O
sedimentation	NN	compound	O
enriches	NNS	nmod	O
for	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
that	WDT	nsubj	O
have	VBP	acl:relcl	O
a	DT	det	O
greater	JJR	amod	O
number	NN	dobj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
,	,	punct	O
and	CC	cc	O
isolation	NN	conj	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
nylon	NN	compound	O
wool	NN	compound	O
filtration	NN	compound	O
enriches	NNS	nmod	O
for	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
that	WDT	nsubj	O
have	VBP	acl:relcl	O
a	DT	det	O
lesser	JJR	amod	O
number	NN	dobj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
and	CC	cc	O
glucocorticoid	NN	compound	O
sensitivity	NN	conj	O
of	IN	case	O
human	JJ	amod	B-cell_type
leukemic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
established	VBN	ROOT	O
optimal	JJ	amod	O
conditions	NNS	dobj	O
for	IN	case	O
the	DT	det	O
measurement	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
human	JJ	amod	B-cell_type
white	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
using	VBG	acl	O
a	DT	det	O
whole-cell	JJ	amod	O
binding	NN	compound	O
assay	NN	dobj	O
with	IN	case	O
[	-LRB-	punct	O
3H	NN	nmod	O
]	-RRB-	punct	O
dexamethasone	NN	dep	O
as	IN	case	O
the	DT	det	O
ligand	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
subsequent	JJ	amod	O
determination	NN	conj	O
of	IN	case	O
the	DT	det	O
GR	NN	compound	B-protein
content	NN	nmod	O
in	IN	case	O
normal	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
in	IN	case	O
leukemic	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
various	JJ	amod	O
forms	NNS	nmod	O
of	IN	case	O
acute	JJ	amod	O
and	CC	cc	O
chronic	JJ	conj	O
leukemia	NN	nmod	O
.	.	punct	O

A	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
leukemia	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
in	IN	case	O
continuous	JJ	amod	O
culture	NN	nmod	O
were	VBD	auxpass	O
also	RB	advmod	O
subjected	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
GR	NN	compound	B-protein
assay	NN	nmod	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
results	NNS	nsubjpass	O
were	VBD	auxpass	O
correlated	VBN	conj	O
with	IN	case	O
the	DT	det	O
sensitivity	NN	nmod	O
of	IN	case	O
these	DT	det	O
cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
to	TO	case	O
glucocorticoid	NN	compound	O
steroids	NNS	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

The	DT	det	O
GR	NN	compound	B-protein
content	NN	ROOT	O
of	IN	case	O
normal	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
amounted	VBN	acl	O
to	IN	case	O
4	CD	nummod	O
,	,	punct	O
850	CD	conj	O
+/-	CC	cc	O
1	CD	conj	O
,	,	punct	O
340	CD	nummod	O
(	-LRB-	punct	O
mean	NN	compound	O
+/-	CC	cc	O
SD	NN	conj	O
)	-RRB-	punct	O
receptors/cell	NN	nmod	O
.	.	punct	O

The	DT	det	O
mean	NN	amod	O
equilibrium	NN	compound	O
dissociation	NN	compound	O
constant	NN	nsubj	O
(	-LRB-	punct	O
KD	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	intj	O
]	-RRB-	punct	O
dexamethasone	NN	nmod	O
with	IN	case	O
the	DT	det	O
GR	NN	nmod	B-protein
was	VBD	cop	O
1.2	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-8	CD	dep	O
)	-RRB-	punct	O
M	NN	ROOT	O
.	.	punct	O

Steroidal	JJ	amod	O
compounds	NNS	nsubj	O
with	IN	case	O
a	DT	det	O
known	JJ	amod	O
glucocorticoid	NN	compound	O
potency	NN	nmod	O
effectively	RB	advmod	O
competed	VBD	acl	O
for	IN	case	O
the	DT	det	O
binding	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
steroids	NNS	nsubj	O
devoid	JJ	amod	O
of	IN	case	O
glucocorticoid	NN	compound	O
activity	NN	nmod	O
(	-LRB-	punct	O
e.g.	FW	dep	O
estradiol-17	NN	compound	O
beta	NN	dep	O
and	CC	cc	O
testosterone	NN	conj	O
)	-RRB-	punct	O
were	VBD	cop	O
ineffective	JJ	ROOT	O
.	.	punct	O

The	DT	det	O
GR	NN	compound	B-protein
content	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
blast	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
obtained	VBN	acl	O
from	IN	case	O
eight	CD	nummod	O
patients	NNS	nmod	O
suffering	VBG	acl	O
from	IN	case	O
acute	JJ	amod	O
leukemia	NN	nmod	O
and	CC	cc	O
four	CD	nummod	O
patients	NNS	conj	O
with	IN	case	O
a	DT	det	O
blast	NN	compound	O
crisis	NN	nmod	O
of	IN	case	O
chronic	JJ	amod	O
myelocytic	JJ	amod	O
leukemia	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
highly	RB	advmod	O
variable	JJ	xcomp	O
(	-LRB-	punct	O
3	CD	dep	O
,	,	punct	O
230-29	NN	conj	O
,	,	punct	O
900	CD	nummod	O
receptors/cell	NNS	appos	O
)	-RRB-	punct	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
lymphocytes	NNS	nsubj	B-cell_type
of	IN	case	O
six	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
lymphatic	JJ	amod	O
leukemia	NN	nmod	O
contained	VBD	advcl	O
a	DT	det	O
rather	RB	advmod	O
stable	JJ	amod	O
GR	NN	compound	B-protein
content	NN	dobj	O
(	-LRB-	punct	O
2	CD	dep	O
,	,	punct	O
930-5	CD	conj	O
,	,	punct	O
120	CD	nummod	O
receptors/cell	NNS	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
was	VBD	cop	O
comparable	JJ	acl:relcl	O
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
normal	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

GR	NN	nsubjpass	B-protein
was	VBD	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
all	PDT	det:predet	O
the	DT	det	O
12	CD	nummod	O
malignant	JJ	amod	B-cell_line
continuous	JJ	amod	I-cell_line
white	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
studied	VBN	acl	O
.	.	punct	O

Large	JJ	amod	O
cells	NNS	nsubj	O
contained	VBD	ROOT	O
more	JJR	amod	O
GR	NN	dobj	B-protein
than	IN	case	O
the	DT	det	O
smaller	JJR	amod	O
ones	NNS	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
apparent	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
the	DT	det	O
GR	NN	compound	B-protein
concentration	NN	nmod	O
and	CC	cc	O
the	DT	det	O
sensitivity	NN	conj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
as	IN	mark	O
judged	VBN	advcl	O
by	IN	case	O
[	-LRB-	punct	O
3H	NN	compound	O
]	-RRB-	punct	O
thymidine	NN	compound	O
incorporation	NN	compound	O
studies	NNS	nmod	O
.	.	punct	O

Distribution	NN	nsubj	O
of	IN	case	O
the	DT	det	O
surface	NN	compound	O
markers	NNS	nmod	O
in	IN	case	O
the	DT	det	O
leukemic	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
did	VBD	aux	O
not	RB	neg	O
relate	VB	ROOT	O
to	TO	case	O
the	DT	det	O
GR	NN	compound	B-protein
concentration	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
GR	NN	nmod	B-protein
is	VBZ	cop	O
probably	RB	advmod	O
a	DT	det	O
universal	JJ	amod	O
feature	NN	ccomp	O
of	IN	case	O
the	DT	det	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
,	,	punct	O
from	IN	case	O
a	DT	det	O
clinical	JJ	amod	O
standpoint	NN	nmod	O
,	,	punct	O
probably	RB	advmod	O
does	VBZ	aux	O
not	RB	neg	O
alone	RB	advmod	O
imply	VB	ccomp	O
steroid	NN	compound	O
responsiveness	NN	dobj	O
.	.	punct	O

Evidence	NN	ROOT	O
for	IN	case	O
a	DT	det	O
steroid	NN	compound	B-protein
receptor	NN	nmod	I-protein
in	IN	case	O
rheumatoid	JJ	amod	B-cell_type
synovial	JJ	amod	I-cell_type
tissue	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

One	CD	nummod	O
mechanism	NN	nsubj	O
by	IN	case	O
which	WDT	nmod	O
glucocorticoids	NNS	nsubj	O
could	MD	aux	O
exert	VB	acl:relcl	O
their	PRP$	nmod:poss	O
anti-inflammatory	JJ	amod	O
action	NN	dobj	O
is	VBZ	cop	O
via	IN	case	O
rapidly	RB	advmod	O
saturable	JJ	dep	O
,	,	punct	O
stereo-specific	JJ	amod	B-protein
cytoplasmic	JJ	amod	I-protein
protein	NN	compound	I-protein
receptors	NNS	ROOT	I-protein
.	.	punct	O

This	DT	det	O
report	NN	nsubj	O
is	VBZ	ROOT	O
of	IN	prep	O
an	DT	det	O
investigation	NN	pobj	O
into	IN	case	O
such	PDT	det:predet	O
a	DT	det	O
possibility	NN	nmod	O
in	IN	case	O
synovial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Synovium	NN	nsubjpass	O
,	,	punct	O
obtained	VBN	acl	O
from	IN	case	O
knee	NN	compound	O
joints	NNS	nmod	O
of	IN	case	O
rheumatoid	JJ	amod	O
patients	NNS	nmod	O
undergoing	VBG	acl	O
surgery	NN	dobj	O
,	,	punct	O
was	VBD	auxpass	O
incubated	VBN	ROOT	O
with	IN	case	O
clostridiopeptidase	NN	compound	B-protein
A	NN	nmod	I-protein
and	CC	cc	O
trypsin-EDTA	NN	conj	B-protein
to	TO	mark	O
obtain	VB	xcomp	O
cell	NN	compound	O
suspensions	NNS	dobj	O
.	.	punct	O

These	DT	nsubjpass	O
,	,	punct	O
together	RB	advmod	O
with	IN	case	O
cells	NNS	nsubjpass	O
obtained	VBN	acl	O
from	IN	case	O
synovial	JJ	amod	O
fluid	NN	nmod	O
aspirated	VBN	acl	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
rheumatoid	JJ	amod	O
arthritis	NN	nmod	O
,	,	punct	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
by	IN	case	O
electron	NN	compound	O
microscopy	NN	nmod	O
.	.	punct	O

Duplicate	NN	compound	O
samples	NNS	nsubjpass	O
of	IN	case	O
these	DT	det	O
cell	NN	compound	O
suspensions	NNS	nmod	O
were	VBD	auxpass	O
incubated	VBN	ROOT	O
with	IN	case	O
increasing	VBG	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
H3Dexamethasone	NN	nmod	O
(	-LRB-	punct	O
1	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-10	CD	dep	O
)	-RRB-	punct	O
M-1	NN	dep	O
x	CC	cc	O
10	CD	nummod	O
(	-LRB-	punct	O
-9	CD	nummod	O
)	-RRB-	punct	O
M	NN	conj	O
)	-RRB-	punct	O
for	IN	case	O
30	CD	nummod	O
minutes	NNS	nmod	O
at	IN	case	O
37	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proportion	NN	nmod	O
of	IN	case	O
steroid	NN	nmod	O
bound	VBN	ROOT	O
to	TO	case	O
whole	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
showed	VBD	conj	O
evidence	NN	dobj	O
for	IN	case	O
specific	JJ	amod	O
,	,	punct	O
rapidly	RB	advmod	O
saturable	JJ	dep	O
,	,	punct	O
receptors	NNS	nmod	O
in	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
obtained	VBN	acl	O
from	IN	case	O
synovial	JJ	amod	O
tissue	NN	nmod	O
,	,	punct	O
but	CC	cc	O
this	DT	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
found	VBN	conj	O
in	IN	case	O
synovial	JJ	amod	B-cell_type
fluid	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Electron	NN	compound	O
micrographs	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	det	O
cells	NNS	ccomp	O
obtained	VBN	acl	O
from	IN	case	O
synovial	JJ	amod	O
tissue	NN	nmod	O
consisted	VBD	acl	O
of	IN	case	O
synovial	JJ	amod	B-cell_type
fibroblast	NN	nmod	I-cell_type
-	,	punct	O
and	CC	cc	O
macrophage-types	NNS	conj	B-cell_type
,	,	punct	O
lymphocytes	NNS	conj	B-cell_type
,	,	punct	O
monocytes	NNS	conj	B-cell_type
and	CC	cc	O
macrophages	NNS	conj	B-cell_type
.	.	punct	O

Polymorphonuclear	JJ	amod	B-cell_type
leucocytes	NNS	nsubj	I-cell_type
appeared	VBD	ROOT	O
to	TO	mark	O
be	VB	cop	O
absent	JJ	xcomp	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
synovial	JJ	amod	B-cell_type
fluid	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
type	NN	compound	I-cell_type
polymorphonuclear	JJ	amod	I-cell_type
leucocytes	NNS	nsubj	I-cell_type
were	VBD	cop	O
the	DT	det	O
predominant	JJ	amod	O
cell	NN	compound	O
type	NN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
concluded	VBD	ROOT	O
from	IN	prep	O
this	DT	pobj	O
,	,	punct	O
that	IN	mark	O
one	CD	nsubj	O
or	CC	cc	O
more	JJR	conj	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
present	JJ	amod	O
in	IN	case	O
synovial	JJ	amod	O
tissue	NN	nmod	O
contain	VBP	ccomp	O
a	DT	det	O
specific	JJ	amod	B-protein
steroid	NN	compound	I-protein
receptor	NN	dobj	I-protein
,	,	punct	O
but	CC	cc	O
that	IN	mark	O
this	DT	nsubj	O
is	VBZ	aux	O
lacking	VBG	conj	O
in	IN	case	O
synovial	JJ	amod	B-cell_type
fluid	NN	compound	I-cell_type
polymorphonuclear	JJ	amod	I-cell_type
leucocytes	NNS	nmod	I-cell_type
.	.	punct	O

Clinical	JJ	amod	O
implications	NNS	ROOT	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

Glucorticoid	JJ	compound	B-protein
receptors	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
various	JJ	amod	O
populations	NNS	nmod	O
of	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
leukemic	JJ	amod	B-cell_type
lymphoblasts	NNS	conj	I-cell_type
.	.	punct	O

Normal	JJ	amod	B-cell_type
lymphocytes	NNS	nsubj	I-cell_type
contain	VBP	ROOT	O
low	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
approximately	RB	advmod	O
2	CD	nummod	O
,	,	punct	O
500	CD	nummod	O
sites/cell	NNS	appos	O
)	-RRB-	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
identical	JJ	acl:relcl	O
in	IN	case	O
T-	NN	nmod	O
and	CC	cc	O
non-T-fractions	NNS	conj	O
.	.	punct	O

Phytohemagglutinin	NN	compound	B-protein
treatment	NN	nsubj	O
increases	VBZ	ROOT	O
levels	NNS	dobj	O
about	IN	advmod	O
3-fold	RB	nmod	O
.	.	punct	O

Leukemic	JJ	amod	B-cell_type
lymphoblasts	NNS	nsubj	I-cell_type
contain	VBP	ROOT	O
larger	JJR	amod	O
numbers	NNS	dobj	O
of	IN	case	O
receptor	NN	compound	O
sites	NNS	nmod	O
.	.	punct	O

Presence	NN	nsubjpass	O
of	IN	case	O
receptor	NN	nmod	O
is	VBZ	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
sensitivitiy	JJ	nmod	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
and	CC	cc	O
in	FW	amod	O
vivo	FW	dep	O
response	NN	conj	O
to	TO	case	O
therapy	NN	nmod	O
.	.	punct	O

Quantity	NN	nsubjpass	O
of	IN	case	O
receptor	NN	nmod	O
is	VBZ	auxpass	O
also	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
complete	JJ	amod	O
remission	NN	compound	O
duration	NN	nmod	O
independently	RB	advmod	O
of	IN	case	O
leukemic	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
type	NN	nmod	I-cell_type
(	-LRB-	punct	O
T	NN	dep	O
or	CC	cc	O
null	NN	conj	O
)	-RRB-	punct	O
,	,	punct	O
initial	JJ	amod	O
WBC	NN	conj	B-cell_type
,	,	punct	O
or	CC	cc	O
age	NN	conj	O
of	IN	case	O
patient	NN	nmod	O
.	.	punct	O

Quantitative	JJ	amod	O
determination	NN	nsubj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
levels	NNS	nmod	O
in	IN	case	O
acute	JJ	amod	O
lymphoblastic	JJ	amod	O
leukemia	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
of	IN	case	O
value	NN	ROOT	O
both	CC	cc:preconj	O
as	IN	case	O
an	DT	det	O
independent	JJ	amod	O
prognostic	JJ	amod	O
variable	NN	nmod	O
and	CC	cc	O
in	IN	mark	O
suggesting	VBG	advcl	O
which	WDT	mark	O
patients	NNS	nsubj	O
should	MD	aux	O
receive	VB	ccomp	O
glucocorticoid	NN	compound	O
therapy	NN	dobj	O
.	.	punct	O

Functional	JJ	amod	O
and	CC	cc	O
physical	JJ	conj	O
interaction	NN	ROOT	O
of	IN	case	O
protein-tyrosine	JJ	amod	B-protein
kinases	NNS	nmod	I-protein
Fyn	NN	dep	I-protein
and	CC	cc	I-protein
Csk	NN	conj	I-protein
in	IN	case	O
the	DT	det	O
T-cell	NN	compound	O
signaling	NN	compound	O
system	NN	nmod	O
.	.	punct	O

The	DT	det	O
Src-like	JJ	amod	B-protein
protein-tyrosine	NN	compound	I-protein
kinase	NN	compound	I-protein
Fyn	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
T-cell	NN	compound	B-protein
antigen	NN	compound	I-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Transient	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
actively	RB	advmod	O
mutated	VBN	amod	O
Fyn	NN	nmod	B-protein
,	,	punct	O
having	VBG	acl	O
Phe-528	NN	dobj	O
instead	RB	advmod	O
of	IN	case	O
Tyr-528	NN	nmod	O
or	CC	cc	O
Thr-338	NN	conj	O
instead	RB	advmod	O
of	IN	case	O
Ile-338	NN	nmod	O
,	,	punct	O
in	IN	case	O
Jurkat	NN	compound	B-cell_type
T-cells	NNS	nmod	I-cell_type
stimulated	VBD	ROOT	B-DNA
the	DT	det	I-DNA
serum	NN	compound	I-DNA
response	NN	compound	I-DNA
element	NN	dobj	I-DNA
(	-LRB-	punct	O
SRE	NN	appos	B-DNA
)	-RRB-	punct	O
,	,	punct	O
12-O-tetradecanoyl-phorbol-13-acetate	CD	nummod	B-DNA
response	NN	compound	I-DNA
element	NN	conj	I-DNA
,	,	punct	O
cyclic	JJ	amod	B-DNA
AMP	NN	compound	I-DNA
response	NN	compound	I-DNA
element	NN	conj	I-DNA
,	,	punct	O
and	CC	cc	O
c-fos	NN	compound	B-DNA
promoter	NN	conj	I-DNA
.	.	punct	O

The	DT	det	O
stimulation	NN	nsubj	O
of	IN	case	O
SRE	NN	nmod	B-DNA
was	VBD	cop	O
particularly	RB	advmod	O
prominent	JJ	ROOT	O
not	RB	neg	O
only	RB	cc:preconj	O
with	IN	case	O
active	JJ	amod	O
Fyn	NN	nmod	B-protein
but	CC	cc	O
also	RB	advmod	O
with	IN	case	O
normal	JJ	amod	B-protein
(	-LRB-	punct	I-protein
wild-type	JJ	amod	I-protein
)	-RRB-	punct	I-protein
Fyn	NN	conj	I-protein
.	.	punct	O

SRE	NN	nsubjpass	B-DNA
was	VBD	auxpass	O
also	RB	advmod	O
stimulated	VBN	ROOT	O
by	IN	case	O
both	CC	cc:preconj	O
normal	JJ	nmod	B-protein
and	CC	cc	I-protein
active	JJ	conj	I-protein
Lck	NN	dep	I-protein
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
normal	JJ	nsubj	B-protein
and	CC	cc	I-protein
active	JJ	conj	I-protein
Fyn	NN	dep	I-protein
stimulated	VBD	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
when	WRB	advmod	O
transfected	VBN	amod	O
cells	NNS	nsubjpass	O
were	VBD	auxpass	O
stimulated	VBN	advcl	O
by	IN	case	O
concanavalin	NN	compound	B-protein
A	NN	nmod	I-protein
plus	CC	cc	O
12-O-tetradecanoylphorbol-13-acetate	NN	conj	O
.	.	punct	O

Under	IN	prep	O
the	DT	det	O
same	JJ	amod	O
conditions	NNS	pobj	O
,	,	punct	O
Lck	NN	nsubj	B-protein
did	VBD	aux	O
not	RB	neg	O
stimulate	VB	ROOT	O
IL-2	NN	compound	B-DNA
promoter	NN	dobj	I-DNA
unless	IN	mark	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
activated	VBN	advcl	O
by	IN	case	O
mutation	NN	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
a	DT	det	O
mutant	JJ	amod	B-protein
Fyn	NN	nsubj	I-protein
,	,	punct	O
which	WDT	nsubj	O
has	VBZ	acl:relcl	O
deletions	NNS	dobj	O
within	IN	case	O
the	DT	det	O
SH2	NN	compound	B-protein
region	NN	nmod	I-protein
and	CC	cc	O
so	RB	advmod	O
is	VBZ	cop	O
able	JJ	conj	O
to	TO	mark	O
transform	VB	xcomp	O
chicken	NN	compound	B-cell_type
embryo	NN	compound	I-cell_type
fibroblasts	NNS	dobj	I-cell_type
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
stimulate	VB	ROOT	O
either	CC	cc:preconj	O
the	DT	det	O
c-fos	NN	compound	B-DNA
or	CC	cc	I-DNA
IL-2	NN	conj	I-DNA
promoter	NN	dobj	I-DNA
,	,	punct	O
suggesting	VBG	advcl	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
this	DT	det	O
region	NN	nmod	O
in	IN	case	O
T-cell	NN	compound	B-cell_type
signaling	NN	nmod	O
.	.	punct	O

Csk	NNP	ROOT	B-protein
,	,	punct	O
which	WDT	nsubj	O
phosphorylates	VBZ	acl:relcl	O
tyrosine	NN	compound	O
residues	NNS	dobj	O
in	IN	case	O
the	DT	det	O
negative	JJ	amod	O
regulatory	JJ	amod	O
sites	NNS	nmod	O
of	IN	case	O
Src	NN	compound	B-protein
family	NN	compound	I-protein
kinases	NNS	nmod	I-protein
,	,	punct	O
down-regulated	VBD	amod	O
Fyn-	JJ	amod	O
and	CC	cc	O
Lck-mediated	JJ	conj	O
stimulation	NN	conj	O
of	IN	case	O
the	DT	det	O
serum	NN	compound	B-DNA
response	NN	compound	I-DNA
element	NN	nmod	I-DNA
and	CC	cc	O
Fyn-mediated	JJ	amod	O
enhancement	NN	conj	O
of	IN	case	O
IL-2	NN	compound	B-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
Fyn	NN	nsubjpass	B-protein
and	CC	cc	O
Lck	NN	conj	B-protein
,	,	punct	O
whose	WP$	nmod:poss	O
activities	NNS	nsubjpass	O
are	VBP	auxpass	O
regulated	VBN	ccomp	O
by	IN	case	O
Csk	NNP	nmod	B-protein
,	,	punct	O
are	VBP	auxpass	O
involved	VBN	conj	O
in	IN	case	O
different	JJ	amod	O
phases	NNS	nmod	O
of	IN	case	O
T-cell	NN	compound	B-cell_type
activation	NN	nmod	O
.	.	punct	O

A	DT	det	O
novel	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
complex	NN	ROOT	I-protein
containing	VBG	acl	O
p65	NN	compound	B-protein
homodimers	NNS	dobj	I-protein
:	:	punct	O
implications	NNS	dep	O
for	IN	case	O
transcriptional	JJ	amod	O
control	NN	nmod	O
at	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
subunit	NN	compound	O
dimerization	NN	nmod	O
.	.	punct	O

The	DT	det	O
predominant	JJ	amod	O
inducible	JJ	amod	O
form	NN	nsubj	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
is	VBZ	cop	O
a	DT	det	O
heteromeric	JJ	amod	B-protein
complex	NN	ROOT	I-protein
containing	VBG	acl	O
two	CD	nummod	O
Rel-related	JJ	amod	B-protein
DNA-binding	JJ	amod	I-protein
subunits	NNS	dobj	I-protein
,	,	punct	O
termed	VBN	acl	B-protein
p65	NN	xcomp	I-protein
and	CC	cc	O
p50	NN	conj	B-protein
.	.	punct	O

Prior	JJ	amod	O
transfection	NN	compound	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
when	WRB	advmod	O
these	DT	det	O
p65	NN	compound	B-protein
and	CC	cc	I-protein
p50	NN	conj	I-protein
subunits	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
expressed	VBN	advcl	O
independently	RB	advmod	O
as	IN	case	O
stable	JJ	amod	B-protein
homodimers	NNS	nmod	I-protein
,	,	punct	O
p65	NN	nsubj	B-protein
stimulates	VBZ	ccomp	O
kappa	NN	nmod:npmod	O
B-directed	JJ	amod	O
transcription	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
p50	NN	nsubj	B-protein
functions	VBZ	advcl	O
as	IN	case	O
a	DT	det	O
kappa	NN	nmod:npmod	O
B-specific	JJ	amod	O
repressor	NN	nmod	O
.	.	punct	O

While	IN	mark	O
authentic	JJ	amod	O
p50	NN	compound	B-protein
homodimers	NNS	nsubjpass	I-protein
(	-LRB-	punct	O
previously	RB	advmod	O
termed	VBN	dep	O
KBF1	NN	xcomp	B-protein
)	-RRB-	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
detected	VBN	advcl	O
in	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
from	IN	case	O
nontransfected	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
experimental	JJ	amod	O
evidence	NN	nsubj	O
supporting	VBG	acl	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
p65	NN	compound	B-protein
homodimers	NNS	nmod	I-protein
in	FW	compound	O
vivo	FW	advmod	O
was	VBD	aux	O
lacking	VBG	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
provide	VBP	ROOT	O
direct	JJ	amod	O
biochemical	JJ	amod	O
evidence	NN	dobj	O
for	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
an	DT	det	O
endogenous	JJ	amod	O
pool	NN	nmod	O
of	IN	case	O
inducible	JJ	amod	O
p65	NN	compound	B-protein
homodimers	NNS	nmod	I-protein
in	IN	case	O
intact	JJ	amod	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

As	IN	case	O
with	IN	case	O
the	DT	det	O
prototypical	JJ	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
p50-p65	NN	compound	I-protein
heterodimer	NN	nmod	I-protein
,	,	punct	O
this	DT	det	O
novel	JJ	amod	O
p65	NN	compound	B-protein
homodimeric	JJ	amod	I-protein
form	NN	nsubjpass	I-protein
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
is	VBZ	auxpass	O
functionally	RB	advmod	O
sequestered	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
but	CC	cc	O
rapidly	RB	advmod	O
appears	VBZ	conj	O
in	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
compartment	NN	nmod	O
following	VBG	case	O
cellular	JJ	amod	O
stimulation	NN	nmod	O
.	.	punct	O

Site-directed	JJ	amod	O
mutagenesis	NN	compound	O
studies	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
homodimerization	NN	compound	O
function	NN	nsubj	O
of	IN	case	O
p65	NN	nmod	B-protein
is	VBZ	cop	O
dependent	JJ	ccomp	O
upon	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
cysteine	NN	nmod	O
216	CD	nummod	O
and	CC	cc	O
a	DT	det	O
conserved	VBN	amod	O
recognition	NN	compound	O
motif	NN	conj	O
for	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
A	NN	nmod	I-protein
(	-LRB-	punct	O
RRPS	NN	appos	B-protein
;	:	punct	O
amino	NN	compound	O
acids	NNS	conj	O
273	CD	nummod	O
to	TO	dep	O
276	CD	nummod	O
)	-RRB-	punct	O
,	,	punct	O
both	DT	nsubj	O
of	IN	case	O
which	WDT	nmod	O
reside	NN	advcl	O
within	IN	case	O
a	DT	det	O
91-amino-acid	JJ	amod	O
segment	NN	nmod	O
of	IN	case	O
the	DT	det	O
Rel	NN	compound	B-protein
homology	NN	compound	I-protein
domain	NN	nmod	I-protein
that	WDT	nsubj	O
mediates	VBZ	acl:relcl	O
self-association	NN	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
mutations	NNS	nsubj	O
at	IN	case	O
these	DT	det	O
two	CD	nummod	O
sites	NNS	nmod	O
do	VBP	aux	O
not	RB	neg	O
affect	VB	ROOT	O
heterodimerization	NN	dobj	O
of	IN	case	O
p65	NN	nmod	B-protein
with	IN	case	O
p50	NN	nmod	B-protein
or	CC	cc	O
its	PRP$	nmod:poss	O
functional	JJ	amod	O
interaction	NN	conj	O
with	IN	case	O
I	NN	compound	O
kappa	NN	compound	O
B	NN	compound	O
alpha	NN	nmod	O
.	.	punct	O

These	DT	det	O
later	JJ	amod	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
neither	CC	cc:preconj	O
homo-	JJ	amod	O
nor	CC	cc	O
heterodimer	NN	conj	O
formation	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
absolute	JJ	amod	O
prerequisite	NN	ccomp	O
for	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	compound	I-protein
recognition	NN	nmod	O
of	IN	case	O
p65	NN	nmod	B-protein
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
with	IN	case	O
prior	JJ	amod	O
in	FW	amod	O
vivo	FW	dep	O
transcription	NN	compound	O
studies	NNS	nmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
biological	JJ	amod	O
activities	NNS	nsubjpass	O
of	IN	case	O
p65	NN	compound	B-protein
and	CC	cc	I-protein
p50	NN	conj	I-protein
homodimers	NNS	nmod	I-protein
are	VBP	auxpass	O
independently	RB	advmod	O
regulated	VBN	ccomp	O
,	,	punct	O
thereby	RB	advmod	O
providing	VBG	advcl	O
an	DT	det	O
integrated	JJ	amod	O
and	CC	cc	O
flexible	JJ	conj	O
control	NN	dep	O
mechanism	NN	dobj	O
for	IN	case	O
the	DT	det	O
rapid	JJ	amod	O
activation	NN	nmod	O
and	CC	cc	O
repression	NN	conj	O
of	IN	case	O
NF-kappa	NN	nmod:npmod	B-protein
B	NN	nmod:npmod	I-protein
/	:	punct	O
Rel	NN	nmod:npmod	B-protein
-directed	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

Carrier	NN	compound	O
determination	NN	ROOT	O
for	IN	case	O
X-linked	JJ	amod	O
agammaglobulinemia	NN	nmod	O
using	VBG	acl	O
X	NN	compound	O
inactivation	NN	compound	O
analysis	NN	dobj	O
of	IN	case	O
purified	VBN	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
a	DT	det	O
relatively	RB	advmod	O
quick	JJ	amod	O
and	CC	cc	O
simple	JJ	conj	O
method	NN	nmod	O
for	IN	case	O
the	DT	det	O
assessment	NN	nmod	O
of	IN	case	O
X	NN	compound	O
inactivation	NN	compound	O
status	NN	nmod	O
for	IN	case	O
carrier	NN	compound	O
determination	NN	nmod	O
in	IN	case	O
families	NNS	nmod	O
affected	VBN	acl	O
by	IN	case	O
X-linked	JJ	amod	O
agammaglobulinemia	NN	nmod	O
(	-LRB-	punct	O
XLA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
method	NN	nsubj	O
utilises	VBZ	ROOT	O
an	DT	det	O
immunomagnetic	JJ	amod	O
separation	NN	compound	O
technique	NN	dobj	O
for	IN	case	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
purification	NN	nmod	O
and	CC	cc	O
a	DT	det	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	conj	O
(	-LRB-	punct	O
PCR	NN	appos	O
)	-RRB-	punct	O
based	JJ	amod	O
assay	NN	nmod	O
for	IN	case	O
the	DT	det	O
determination	NN	nmod	O
of	IN	case	O
methylation	NN	compound	O
status	NN	nmod	O
at	IN	case	O
the	DT	det	O
androgen	NN	compound	B-DNA
receptor	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
AR	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	compound	I-DNA
locus	NN	nmod	I-DNA
to	TO	mark	O
assess	VB	advcl	O
whether	IN	mark	O
X	NN	compound	O
inactivation	NN	nsubj	O
is	VBZ	cop	O
random	JJ	ccomp	O
or	CC	cc	O
non-random	JJ	conj	O
at	IN	case	O
this	DT	det	O
locus	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
the	DT	det	O
results	NNS	dobj	O
we	PRP	nsubj	O
have	VBP	aux	O
obtained	VBN	acl	O
using	VBG	xcomp	O
this	DT	det	O
assay	NN	dobj	O
to	TO	mark	O
investigate	VB	xcomp	O
females	NNS	dobj	O
known	VBN	acl	O
to	TO	mark	O
be	VB	cop	O
carriers	NNS	xcomp	O
of	IN	case	O
various	JJ	amod	O
X-linked	JJ	amod	O
immunodeficiency	NN	compound	O
disorders	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
four	CD	nummod	O
females	NNS	dobj	O
from	IN	case	O
different	JJ	amod	O
families	NNS	nmod	O
affected	VBN	acl	O
by	IN	case	O
XLA	NN	nmod	O
,	,	punct	O
two	CD	nsubj	O
of	IN	case	O
whom	WP	nmod	O
were	VBD	cop	O
of	IN	case	O
unknown	JJ	amod	O
carrier	NN	compound	O
status	NN	conj	O
,	,	punct	O
and	CC	cc	O
we	PRP	nsubj	O
discuss	VBP	conj	O
the	DT	det	O
results	NNS	dobj	O
obtained	VBN	acl	O
with	IN	case	O
this	DT	nmod	O
and	CC	cc	O
other	JJ	amod	O
X-inactivation	NN	compound	O
assays	NNS	conj	O
.	.	punct	O

A	DT	det	O
similar	JJ	amod	O
assay	NN	nsubjpass	O
has	VBZ	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
described	VBN	ROOT	O
by	IN	case	O
Allen	NNP	nmod	O
et	FW	dep	O
al.	FW	dep	O
(	-LRB-	punct	O
1992	CD	appos	O
)	-RRB-	punct	O
and	CC	cc	O
applied	VBN	conj	O
to	IN	case	O
members	NNS	nmod	O
of	IN	case	O
one	CD	nummod	O
family	NN	nmod	O
affected	VBN	acl	O
by	IN	case	O
XLA	NN	nmod	O
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
IL-4	NN	compound	B-protein
and	CC	cc	O
Fc	NN	compound	B-protein
gamma	NN	compound	I-protein
receptor	NN	conj	I-protein
II	CD	nummod	I-protein
engagement	NN	nmod	O
on	IN	case	O
Egr-1	NN	compound	B-protein
expression	NN	nmod	O
during	IN	case	O
stimulation	NN	nmod	O
of	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
by	IN	case	O
membrane	NN	compound	O
immunoglobulin	NN	compound	O
crosslinking	NN	nmod	O
.	.	punct	O

Egr-1	NN	nsubj	B-DNA
is	VBZ	cop	O
an	DT	det	O
immediate	JJ	amod	B-DNA
early	JJ	amod	I-DNA
gene	NN	ROOT	I-DNA
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
rapidly	RB	advmod	O
upregulated	VBN	acl:relcl	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
mitogenic	JJ	amod	O
signals	NNS	nmod	O
induced	VBN	acl	O
by	IN	case	O
antigen	NN	compound	O
receptor	NN	compound	O
crosslinking	VBG	nmod	O
on	IN	case	O
murine	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
levels	NNS	nsubjpass	O
of	IN	case	O
Egr-1	NN	compound	B-DNA
expression	NN	nmod	O
are	VBP	auxpass	O
closely	RB	advmod	O
correlated	VBN	ccomp	O
with	IN	case	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
proliferation	NN	nmod	O
in	IN	case	O
several	JJ	amod	O
models	NNS	nmod	O
of	IN	case	O
B	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
and	CC	cc	O
tolerance	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
compared	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
Egr-1	NN	nmod	B-DNA
during	IN	case	O
B	NN	compound	O
cell	NN	compound	O
stimulation	NN	nmod	O
with	IN	case	O
Fab'2	NN	nmod	B-protein
and	CC	cc	O
IgG	NN	compound	B-protein
anti-immunoglobulin	NN	conj	I-protein
(	-LRB-	punct	O
anti-Ig	JJ	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
since	IN	mark	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	advcl	O
that	IN	mark	O
Fab'2	NN	amod	B-protein
anti-Ig	NN	nsubj	I-protein
is	VBZ	cop	O
mitogenic	JJ	ccomp	O
while	IN	mark	O
IgG	NN	compound	B-protein
anti-Ig	NN	nsubj	I-protein
is	VBZ	cop	O
not	RB	neg	O
,	,	punct	O
owing	VBG	advcl	O
to	IN	case	O
a	DT	det	O
dominant	JJ	amod	O
inhibitory	JJ	amod	O
effect	NN	nmod	O
of	IN	mark	O
crosslinking	VBG	acl	O
the	DT	det	O
B	NN	compound	B-protein
cell	NN	compound	I-protein
Fc	NN	compound	I-protein
gamma	NN	compound	I-protein
RII	NN	dobj	I-protein
to	TO	case	O
membrane	NN	compound	B-protein
Ig	NN	nmod	I-protein
.	.	punct	O

While	IN	mark	O
mitogenic	JJ	amod	O
doses	NNS	nsubj	O
of	IN	case	O
Fab'2	NN	amod	B-protein
anti-Ig	NN	nmod	I-protein
induce	VBP	advcl	O
large	JJ	amod	O
and	CC	cc	O
rapid	JJ	conj	O
increases	NNS	dobj	O
in	IN	case	O
Egr-1	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
IgG	NN	compound	B-protein
anti-Ig	NN	nsubj	I-protein
results	VBZ	ROOT	O
in	IN	case	O
smaller	JJR	amod	O
increases	NNS	nmod	O
in	IN	case	O
Egr-1	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
,	,	punct	O
comparable	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
seen	VBN	acl	O
with	IN	case	O
submitogenic	JJ	amod	O
concentrations	NNS	nmod	O
of	IN	case	O
Fab'2	NN	amod	B-protein
anti-Ig	NN	nmod	I-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
correlation	NN	nsubj	O
between	IN	case	O
Egr-1	NN	compound	O
expression	NN	nmod	O
and	CC	cc	O
B	NN	compound	O
cell	NN	compound	O
proliferation	NN	conj	O
breaks	VBZ	ROOT	O
down	RP	prt	O
when	WRB	advmod	O
IL-4	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
added	VBN	advcl	O
as	IN	case	O
a	DT	det	O
co-mitogen	NN	nmod	O
to	TO	mark	O
induce	VB	acl	O
B	NN	compound	O
cell	NN	compound	O
proliferation	NN	dobj	O
with	IN	case	O
IgG	NN	compound	B-protein
anti-Ig	NN	nmod	I-protein
or	CC	cc	O
submitogenic	JJ	amod	O
concentrations	NNS	conj	O
of	IN	case	O
Fab'2	NN	amod	B-protein
anti-Ig	NN	nmod	I-protein
.	.	punct	O

No	DT	neg	O
corresponding	JJ	amod	O
increases	NNS	nsubjpass	O
in	IN	case	O
Egr-1	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nmod	O
are	VBP	auxpass	O
observed	VBN	ROOT	O
when	WRB	advmod	O
IL-4	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
added	VBN	advcl	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
IL-4	NN	nsubj	B-protein
overcomes	VBZ	ROOT	O
Fc	NN	nmod:npmod	O
receptor-mediated	JJ	amod	O
inhibition	NN	dobj	O
of	IN	case	O
B	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
proliferation	NN	nmod	O
without	IN	mark	O
affecting	VBG	advcl	O
inhibition	NN	dobj	O
of	IN	case	O
Egr-1	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
induction	NN	nmod	O
,	,	punct	O
as	IN	mark	O
demonstrated	VBN	advcl	O
earlier	RBR	advmod	O
for	IN	case	O
c-myc	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
this	DT	det	O
system	NN	nmod	O
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
a	DT	det	O
novel	JJ	amod	O
cyclosporin-sensitive	JJ	amod	B-DNA
element	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
tumor	NN	compound	I-DNA
necrosis	NN	compound	I-DNA
factor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	nsubjpass	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
cytokine	NN	appos	B-protein
with	IN	case	O
pleiotropic	JJ	amod	O
biological	JJ	amod	O
effects	NNS	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
produced	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
cell	NN	compound	O
types	NNS	nmod	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
induction	NN	nmod	O
by	IN	case	O
diverse	JJ	amod	O
stimuli	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
paper	NN	nmod	O
,	,	punct	O
TNF-alpha	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
is	VBZ	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
highly	RB	advmod	O
induced	VBN	xcomp	O
in	IN	case	O
a	DT	det	O
murine	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
clone	NN	nmod	I-cell_line
by	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
TCR	NN	compound	B-protein
)	-RRB-	punct	O
ligands	NNS	nmod	O
or	CC	cc	O
by	IN	case	O
calcium	NN	compound	O
ionophores	NNS	conj	O
alone	RB	advmod	O
.	.	punct	O

Induction	NN	nsubj	O
is	VBZ	cop	O
rapid	JJ	ROOT	O
,	,	punct	O
does	VBZ	aux	O
not	RB	neg	O
require	VB	conj	O
de	FW	amod	O
novo	FW	dep	O
protein	NN	compound	O
synthesis	NN	dobj	O
,	,	punct	O
and	CC	cc	O
is	VBZ	auxpass	O
completely	RB	advmod	O
blocked	VBN	conj	O
by	IN	case	O
the	DT	det	O
immunosuppressant	JJ	amod	O
cyclosporin	NN	compound	O
A	NN	nmod	O
(	-LRB-	punct	O
CsA	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
human	JJ	amod	B-DNA
TNF-alpha	NN	compound	I-DNA
promoter	NN	compound	I-DNA
element	NN	dobj	I-DNA
,	,	punct	O
kappa	NN	appos	B-DNA
3	CD	nummod	I-DNA
,	,	punct	O
which	WDT	nsubj	O
plays	VBZ	acl:relcl	O
a	DT	det	O
key	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
calcium-mediated	JJ	amod	O
inducibility	NN	nmod	O
and	CC	cc	O
CsA	NN	compound	O
sensitivity	NN	conj	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
.	.	punct	O

In	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
,	,	punct	O
an	DT	det	O
oligonucleotide	NN	nsubj	O
containing	VBG	acl	O
kappa	NN	dobj	B-DNA
3	CD	nummod	I-DNA
forms	VBZ	ROOT	O
two	CD	nummod	O
DNA	NN	compound	O
protein	NN	compound	O
complexes	NNS	dobj	O
with	IN	case	O
proteins	NNS	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
present	JJ	acl:relcl	O
in	IN	case	O
extracts	NNS	nmod	O
from	IN	case	O
unstimulated	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

These	DT	det	O
complexes	NNS	nsubj	O
appear	VBP	ROOT	O
in	IN	case	O
nuclear	JJ	amod	O
extracts	NNS	nmod	O
only	RB	advmod	O
after	IN	case	O
T	NN	compound	O
cell	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
the	DT	det	O
inducible	JJ	amod	O
nuclear	JJ	amod	B-protein
complexes	NNS	nmod	I-protein
is	VBZ	cop	O
rapid	JJ	ROOT	O
,	,	punct	O
independent	JJ	dep	O
of	IN	case	O
protein	NN	compound	O
synthesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
blocked	VBN	conj	O
by	IN	case	O
CsA	NN	nmod	O
,	,	punct	O
and	CC	cc	O
thus	RB	advmod	O
,	,	punct	O
exactly	RB	advmod	O
parallels	VBZ	dep	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
TNF-alpha	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
by	IN	case	O
TCR	NN	compound	O
ligands	NNS	nmod	O
or	CC	cc	O
by	IN	case	O
calcium	NN	compound	O
ionophore	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
studies	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
kappa	NN	compound	B-protein
3	CD	nummod	I-protein
binding	NN	compound	I-protein
factor	NN	nsubj	I-protein
resembles	VBZ	ccomp	O
the	DT	det	O
preexisting	VBG	amod	O
component	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
TNF-alpha	NN	compound	B-DNA
gene	NN	nsubj	I-DNA
is	VBZ	cop	O
an	DT	det	O
immediate	JJ	amod	O
early	JJ	amod	O
gene	NN	ROOT	O
in	IN	case	O
activated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
provides	VBZ	conj	O
a	DT	det	O
new	JJ	amod	O
model	NN	compound	O
system	NN	dobj	O
in	IN	case	O
which	WDT	nmod	O
to	TO	mark	O
study	VB	acl:relcl	O
CsA-sensitive	JJ	amod	B-DNA
gene	NN	compound	I-DNA
induction	NN	dobj	O
in	IN	case	O
activated	VBN	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Differences	NNS	ROOT	O
in	IN	case	O
expression	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
AP-1	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_line
promyelocytic	JJ	amod	I-cell_line
HL-60	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
during	IN	case	O
differentiation	NN	nmod	O
towards	IN	case	O
macrophages	NNS	nmod	B-cell_type
versus	CC	cc	O
granulocytes	NNS	conj	B-cell_type
.	.	punct	O

Commitment	NN	nsubjpass	O
of	IN	case	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
to	TO	case	O
macrophage	NN	nmod	O
or	CC	cc	O
granulocytic	JJ	conj	O
differentiation	NN	dep	O
was	VBD	auxpass	O
achieved	VBN	ROOT	O
by	IN	case	O
incubation	NN	nmod	O
with	IN	case	O
4	CD	nummod	O
beta-phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	nmod	O
(	-LRB-	punct	O
PMA	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
30-60	CD	nummod	O
min	NN	nmod	O
or	CC	cc	O
with	IN	case	O
dimethyl	JJ	amod	O
sulphoxide	NN	conj	O
(	-LRB-	punct	O
DMSO	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
respectively	RB	advmod	O
.	.	punct	O

The	DT	det	O
commitment	NN	compound	O
stage	NN	nsubjpass	O
towards	IN	case	O
PMA-induced	JJ	amod	O
macrophage	NN	compound	O
differentiation	NN	nmod	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
increases	NNS	nmod	O
in	IN	case	O
jun	NN	compound	O
B	NN	nmod	O
and	CC	cc	O
c-fos	NN	conj	O
mRNA	NN	compound	O
levels	NNS	dep	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
with	IN	case	O
an	DT	det	O
increase	NN	conj	O
in	IN	case	O
the	DT	det	O
binding	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
AP-1	NN	nmod	I-protein
.	.	punct	O

Nevertheless	RB	advmod	O
,	,	punct	O
gel	NN	compound	O
retardation	NN	compound	O
analysis	NN	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
AP-1	NN	compound	B-protein
activity	NN	nsubjpass	O
detected	VBN	acl	O
in	IN	case	O
untreated	JJ	amod	O
cells	NNS	nmod	O
was	VBD	auxpass	O
drastically	RB	advmod	O
reduced	VBN	ccomp	O
during	IN	case	O
the	DT	det	O
commitment	NN	amod	O
stage	NN	nmod	O
of	IN	case	O
DMSO-induced	JJ	amod	O
HL-60	NN	compound	O
differentiation	NN	nmod	O
towards	IN	case	O
granulocytes	NNS	nmod	B-cell_type
.	.	punct	O

When	WRB	advmod	O
HL-60	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
treated	VBN	advcl	O
with	IN	case	O
sodium	NN	compound	O
butyrate	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
induced	VBD	acl:relcl	O
monocytic	JJ	amod	O
differentiation	NN	dobj	O
,	,	punct	O
a	DT	det	O
remarkable	JJ	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
AP-1	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
1	CD	compound	O
alpha	NN	compound	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
,	,	punct	O
another	DT	det	O
monocytic	JJ	amod	O
differentiation	NN	compound	O
agent	NN	appos	O
,	,	punct	O
induced	VBD	ROOT	O
a	DT	det	O
weak	JJ	dobj	O
,	,	punct	O
but	CC	cc	O
appreciable	JJ	conj	O
,	,	punct	O
increase	NN	advcl	O
in	IN	case	O
AP-1	NN	compound	B-protein
activity	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
addition	NN	nsubj	O
of	IN	case	O
sodium	NN	compound	O
butyrate	NN	nmod	O
or	CC	cc	O
1	CD	compound	O
alpha	NN	compound	O
,	,	punct	O
25-dihydroxyvitamin	NN	appos	O
D3	NN	conj	O
to	TO	case	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
induced	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
c-fos	NN	nmod	B-DNA
,	,	punct	I-DNA
c-jun	NN	conj	I-DNA
,	,	punct	I-DNA
jun	NN	compound	I-DNA
B	NN	conj	I-DNA
and	CC	cc	I-DNA
jun	NN	compound	I-DNA
D	NN	conj	I-DNA
proto-oncogenes	NNS	dep	I-DNA
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
when	WRB	advmod	O
HL-60	NN	compound	B-cell_line
cells	NNS	nsubjpass	I-cell_line
were	VBD	auxpass	O
treated	VBN	advcl	O
with	IN	case	O
retinoic	JJ	amod	O
acid	NN	nmod	O
,	,	punct	O
a	DT	det	O
granulocytic	JJ	amod	O
differentiation	NN	compound	O
inducer	NN	appos	O
,	,	punct	O
no	DT	neg	O
enhanced	VBN	amod	O
AP-1	NN	compound	O
binding	NN	compound	O
activity	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
only	RB	advmod	O
a	DT	det	O
weak	JJ	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
jun	NN	compound	B-RNA
D	NN	compound	I-RNA
mRNA	NN	compound	I-RNA
level	NN	nmod	O
was	VBD	auxpass	O
detected	VBN	conj	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
formation	NN	nsubjpass	O
of	IN	case	O
AP-1	NN	nmod	B-protein
is	VBZ	auxpass	O
not	RB	neg	O
required	VBN	ccomp	O
for	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
HL-60	NN	compound	B-cell_line
differentiation	NN	nmod	O
towards	IN	case	O
granulocytes	NNS	nmod	B-cell_type
,	,	punct	O
whereas	IN	dep	O
induction	NN	nsubjpass	O
of	IN	case	O
monocytic	JJ	amod	O
differentiation	NN	nmod	O
is	VBZ	auxpass	O
correlated	VBN	parataxis	O
with	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
AP-1	NN	compound	B-protein
activity	NN	nmod	O
.	.	punct	O

The	DT	det	O
differential	JJ	amod	O
expression	NN	nsubj	O
of	IN	case	O
AP-1	NN	compound	B-protein
activity	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
critical	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
differentiation	NN	nmod	O
of	IN	case	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
towards	IN	case	O
monocytic	JJ	nmod	B-cell_type
or	CC	cc	I-cell_type
granulocytic	JJ	conj	I-cell_type
lineages	NNS	dep	I-cell_type

Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
and	CC	cc	O
sensitivity	NN	conj	O
in	IN	case	O
leukemias	NNS	nmod	O
.	.	punct	O

In	IN	case	O
an	DT	det	O
attempt	NN	nmod	O
to	TO	mark	O
investigate	VB	acl	O
the	DT	det	O
utility	NN	dobj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
determination	NN	nmod	O
to	TO	mark	O
predict	VB	advcl	O
clinical	JJ	amod	O
responsiveness	NN	dobj	O
in	IN	case	O
human	JJ	amod	O
leukemias	NNS	nmod	O
we	PRP	nsubj	O
have	VBP	aux	O
studied	VBN	ROOT	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	dobj	I-protein
in	IN	case	O
the	DT	det	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
from	IN	case	O
46	CD	nummod	O
patients	NNS	nmod	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
lymphocytes	NNS	conj	B-cell_type
from	IN	case	O
18	CD	nummod	O
normal	JJ	amod	O
donors	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
normal	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
there	EX	expl	O
were	VBD	ROOT	O
3	CD	nsubj	O
,	,	punct	O
875	CD	nummod	O
(	-LRB-	punct	O
Median	JJ	appos	O
)	-RRB-	punct	O
specific	JJ	amod	O
binding	VBG	amod	O
sites	NNS	nsubj	O
per	IN	case	O
cell	NN	nmod	O
.	.	punct	O

The	DT	det	O
blasts	NNS	nsubj	B-cell_type
from	IN	case	O
17	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
ANLL	NN	nmod	O
had	VBD	ROOT	O
on	IN	case	O
average	JJ	amod	O
higher	JJR	amod	O
levels	NNS	nmod	O
of	IN	case	O
binding	VBG	amod	B-protein
sites	NNS	nmod	I-protein
per	IN	case	O
cell	NN	nmod	O
(	-LRB-	punct	O
Median	NN	dep	O
=	JJ	amod	O
7	CD	dep	O
,	,	punct	O
250	CD	dep	O
,	,	punct	O
range	NN	dep	O
:	:	punct	O
0	CD	compound	O
to	TO	dep	O
15	CD	dep	O
,	,	punct	O
295	CD	dep	O
)	-RRB-	punct	O
than	IN	case	O
the	DT	det	O
other	JJ	amod	O
leukemias	NNS	nmod	O
.	.	punct	O

Of	IN	case	O
the	DT	det	O
15	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
CLL	NN	nmod	O
,	,	punct	O
six	CD	nsubj	O
had	VBD	aux	O
received	VBN	ROOT	O
glucocorticoid	NN	compound	O
treatment	NN	dobj	O
for	IN	case	O
3	CD	compound	O
to	TO	dep	O
5	CD	nummod	O
years	NNS	nmod	O
.	.	punct	O

Their	PRP$	nmod:poss	O
lymphocytes	NNS	nsubj	B-cell_type
had	VBD	ROOT	O
lower	JJR	amod	O
number	NN	dobj	O
of	IN	case	O
receptors	NNS	nmod	O
(	-LRB-	punct	O
Median	JJ	dep	O
=	JJ	amod	O
2	CD	dep	O
,	,	punct	O
000	CD	dep	O
)	-RRB-	punct	O
than	IN	case	O
the	DT	det	O
other	JJ	amod	O
cases	NNS	nmod	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
newly	RB	advmod	O
diagnosed	VBN	acl:relcl	O
(	-LRB-	punct	O
Median	JJ	amod	O
=	JJ	dep	O
4	CD	nummod	O
,	,	punct	O
500	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

Four	CD	nummod	O
patients	NNS	nsubj	O
had	VBD	ROOT	O
ALL/AUL	NN	dobj	O
,	,	punct	O
three	CD	nummod	O
patients	NNS	nsubj	O
had	VBD	conj	O
blast	NN	compound	O
crisis	NN	dobj	O
as	IN	case	O
terminal	JJ	amod	O
phase	NN	nmod	O
of	IN	case	O
CML	NN	nmod	O
,	,	punct	O
and	CC	cc	O
seven	CD	nsubj	O
had	VBD	conj	O
leukemic	JJ	amod	O
Non-Hodgkin	JJ	compound	O
lymphomas	NNS	dobj	O
(	-LRB-	punct	O
Median	NN	dep	O
=	JJ	dep	O
3	CD	dep	O
,	,	punct	O
500	CD	nummod	O
sites/cell	NNS	dep	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
24	CD	nummod	O
patients	NNS	nmod	O
we	PRP	nsubj	O
have	VBP	aux	O
also	RB	advmod	O
studied	VBN	ROOT	O
the	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
sensitivity	NN	dobj	O
of	IN	case	O
the	DT	det	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
to	TO	case	O
dexamethasone	NN	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
marked	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
levels	NNS	nmod	O
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
sensitivity	NN	conj	O
.	.	punct	O

An	DT	det	O
attempt	NN	nsubj	O
to	TO	mark	O
correlate	VB	acl	O
receptor	NN	compound	O
levels	NNS	dobj	O
with	IN	case	O
clinical	JJ	amod	O
responsiveness	NN	nmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
determination	NN	nsubj	O
might	MD	aux	O
be	VB	cop	O
of	IN	case	O
value	NN	ccomp	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
lymphoid	JJ	amod	O
malignancies	NNS	nmod	O
but	CC	cc	O
probably	RB	advmod	O
not	RB	neg	O
in	IN	case	O
patients	NNS	conj	O
with	IN	case	O
other	JJ	amod	O
leukemias	NNS	nmod	O
.	.	punct	O

'Activation-labile	IN	punct	B-protein
'	``	punct	I-protein
glucocorticoid-receptor	JJ	amod	I-protein
complexes	NNS	ROOT	I-protein
of	IN	case	O
a	DT	det	O
steroid-resistant	JJ	amod	O
variant	NN	nmod	O
of	IN	case	O
CEM-C7	NN	compound	B-cell_line
human	JJ	amod	I-cell_line
lymphoid	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

For	IN	case	O
cytoplasmic	JJ	amod	B-protein
glucocorticoid-receptor	JJ	compound	I-protein
complexes	NNS	nmod	I-protein
to	TO	mark	O
enter	VB	acl	O
and	CC	cc	O
accumulate	NN	conj	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
a	DT	det	O
temperature-dependent	JJ	amod	O
event	NN	dobj	O
,	,	punct	O
'activation	NN	nsubjpass	O
'	''	punct	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
.	.	punct	O

Activation	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
achieved	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
by	IN	case	O
increased	VBN	amod	O
ionic	JJ	amod	O
strength	NN	nmod	O
,	,	punct	O
dilution	NN	conj	O
or	CC	cc	O
gel	NN	compound	O
filtration	NN	conj	O
and	CC	cc	O
is	VBZ	auxpass	O
manifested	VBN	conj	O
by	IN	case	O
an	DT	det	O
increased	VBN	amod	O
affinity	NN	nmod	O
of	IN	case	O
steroid-receptor	JJ	amod	B-protein
complex	NN	nmod	I-protein
for	IN	case	O
DNA	NN	nmod	B-DNA
and	CC	cc	O
an	DT	det	O
altered	JJ	amod	O
elution	NN	compound	O
profile	NN	conj	O
from	IN	case	O
ion-exchange	JJ	amod	O
resins	NNS	nmod	O
.	.	punct	O

Munck	NNP	nsubj	O
and	CC	cc	O
Foley	NNP	conj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
activated	VBN	amod	B-protein
complexes	NNS	nsubj	I-protein
isolated	VBN	acl	O
from	IN	case	O
thymocytes	NNS	nmod	O
elute	VBP	ccomp	O
from	IN	case	O
DEAE-cellulose	JJ	nmod	O
in	IN	case	O
a	DT	det	O
manner	NN	nmod	O
identical	JJ	amod	O
to	TO	case	O
complexes	NNS	nmod	O
activated	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

We	PRP	nsubj	O
report	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
DEAE-cellulose	JJ	amod	O
chromatography	NN	nsubj	O
of	IN	case	O
steroid-receptor	JJ	amod	B-protein
complexes	NNS	nmod	I-protein
from	IN	case	O
CEM-C7	NN	nmod	B-cell_line
,	,	punct	O
a	DT	det	O
cloned	VBN	amod	B-cell_line
human	JJ	amod	I-cell_line
leukaemic	JJ	amod	I-cell_line
T-cell	NN	compound	I-cell_line
line	NN	appos	I-cell_line
sensitive	JJ	amod	O
to	TO	case	O
the	DT	det	O
cytolytic	JJ	amod	O
action	NN	nmod	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
steroid-resistant	JJ	amod	B-cell_line
subclone	NN	conj	I-cell_line
4R4	NN	dep	I-cell_line
demonstrated	VBD	ccomp	O
that	IN	mark	O
steroid	NN	compound	B-protein
receptors	NNS	nsubj	I-protein
of	IN	case	O
clone	NN	nmod	B-cell_line
4R4	NN	nummod	I-cell_line
can	MD	aux	O
not	RB	neg	O
form	VB	ccomp	O
stable	JJ	amod	O
activated	VBN	amod	O
complexes	NNS	dobj	O
.	.	punct	O

This	DT	nsubj	O
defines	VBZ	ROOT	O
a	DT	det	O
new	JJ	amod	O
defect	NN	dobj	O
in	IN	case	O
receptor	NN	compound	O
action	NN	nmod	O
,	,	punct	O
activation	NN	compound	O
lability	NN	conj	O
(	-LRB-	punct	O
r+act1	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
unlike	IN	case	O
either	CC	cc:preconj	O
the	DT	det	O
r-	NN	preconj	B-cell_line
,	,	punct	I-cell_line
r+nt-	NN	conj	I-cell_line
,	,	punct	I-cell_line
or	CC	cc	I-cell_line
r+nti	JJ	compound	I-cell_line
phenotypes	NNS	acl:relcl	I-cell_line
previously	RB	advmod	O
described	VBN	acl	O
for	IN	case	O
mouse	NN	compound	B-cell_line
lymphoid	JJ	amod	I-cell_line
variants	NNS	nmod	I-cell_line
.	.	punct	O

Granulocytes	NNS	ROOT	B-cell_type
in	IN	case	O
the	DT	det	O
endometrium	NN	nmod	O
of	IN	case	O
post-partum	JJ	amod	O
women	NNS	nmod	O
.	.	punct	O

Endometrial	JJ	amod	O
samples	NNS	nsubjpass	O
of	IN	case	O
women	NNS	nmod	O
at	IN	case	O
various	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
gonadal	NN	amod	O
activity	NN	nmod	O
after	IN	case	O
parturition	NN	nmod	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
presence	NN	nmod	O
and	CC	cc	O
numbers	NNS	conj	O
of	IN	case	O
endometrial	JJ	amod	B-cell_type
granulocytes	NNS	nmod	I-cell_type
.	.	punct	O

Although	IN	mark	O
samples	NNS	nsubj	O
at	IN	case	O
all	PDT	det:predet	O
the	DT	det	O
stages	NNS	nmod	O
contained	VBD	advcl	O
significant	JJ	amod	O
numbers	NNS	dobj	O
of	IN	case	O
the	DT	det	O
granulocytes	NNS	nmod	B-cell_type
(	-LRB-	punct	O
i.e.	FW	advmod	O
greater	JJR	advmod	O
than	IN	case	O
7/high-power	NN	amod	O
field	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
100	CD	nummod	O
%	NN	compound	O
values	NNS	nsubj	O
for	IN	case	O
late-proliferative	JJ	amod	O
and	CC	cc	O
adaptation	NN	conj	O
hyperplasia	NN	nmod	O
were	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
the	DT	det	O
values	NNS	nmod	O
for	IN	case	O
the	DT	det	O
resting	JJ	nmod	O
(	-LRB-	punct	O
81.8	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
early	JJ	amod	O
(	-LRB-	punct	O
82.4	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
and	CC	cc	O
mid-	NN	conj	O
(	-LRB-	punct	O
87.9	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
proliferative	JJ	conj	O
and	CC	cc	O
secretory	JJ	conj	O
(	-LRB-	punct	O
83.3	CD	nummod	O
%	NN	dep	O
)	-RRB-	punct	O
phases	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
this	DT	nsubj	O
correlates	VBZ	ccomp	O
with	IN	case	O
the	DT	det	O
suggestion	NN	nmod	O
that	IN	mark	O
the	DT	det	O
granulocytes	NNS	nsubj	B-cell_type
constitute	VBP	ccomp	O
a	DT	det	O
receptor	NN	compound	O
system	NN	dobj	O
for	IN	case	O
oestrogens	NNS	nmod	O
.	.	punct	O

Interaction	NN	ROOT	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
with	IN	case	O
macrophages	NNS	nmod	B-cell_type
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
and	CC	cc	O
macrophages	NNS	conj	B-cell_type
.	.	punct	O

Glucocorticoid	NN	compound	O
binding	NN	nsubjpass	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
in	IN	case	O
resident	JJ	amod	O
and	CC	cc	O
thioglycollate-elicited	JJ	conj	B-cell_type
mouse	NN	compound	I-cell_type
peritoneal	JJ	compound	I-cell_type
macrophages	NNS	nmod	I-cell_type
,	,	punct	O
rabbit	NN	compound	B-cell_type
alveolar	JJ	amod	I-cell_type
macrophages	NNS	conj	I-cell_type
,	,	punct	O
and	CC	cc	O
human	JJ	amod	B-cell_type
monocytes	NNS	conj	I-cell_type
.	.	punct	O

Two	CD	nummod	O
assays	NNS	nsubjpass	O
of	IN	case	O
binding	NN	nmod	O
were	VBD	auxpass	O
used	VBN	ROOT	O
--	:	punct	O
an	DT	det	O
assay	NN	dobj	O
with	IN	case	O
intact	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
suspension	NN	nmod	O
or	CC	cc	O
monolayers	NNS	conj	O
,	,	punct	O
and	CC	cc	O
an	DT	det	O
assay	NN	conj	O
of	IN	case	O
cytosol	NN	nmod	O
and	CC	cc	O
nuclear	JJ	amod	O
forms	NNS	conj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
mononuclear	JJ	amod	B-cell_type
phagocytes	NNS	nsubj	I-cell_type
contained	VBD	ROOT	O
approximately	RB	advmod	O
equal	JJ	advmod	O
to	IN	case	O
4	CD	nummod	O
--	:	punct	O
10	CD	nummod	O
X	NN	compound	O
10	CD	nummod	O
(	-LRB-	punct	O
3	LS	appos	O
)	-RRB-	punct	O
high	JJ	amod	B-protein
affinity	NN	compound	I-protein
receptor	NN	compound	I-protein
sites	NNS	nmod	I-protein
per	IN	case	O
cell	NN	nmod	O
,	,	punct	O
with	IN	case	O
dissociation	NN	compound	O
constants	NNS	nmod	O
of	IN	case	O
approximately	RB	advmod	O
equal	JJ	nmod	O
to	IN	case	O
2	CD	pobj	O
--	:	punct	O
8	CD	compound	O
nM	NN	dep	O
dexamethasone	NN	nmod	O
.	.	punct	O

The	DT	det	O
binding	NN	nsubj	O
to	TO	case	O
the	DT	det	O
saturable	JJ	amod	B-protein
sites	NNS	nmod	I-protein
was	VBD	cop	O
specific	JJ	ROOT	O
for	IN	case	O
steroids	NNS	nmod	O
with	IN	case	O
glucocorticoid	NN	nmod	O
or	CC	cc	O
antiglucocorticoid	JJ	conj	O
activity	NN	dep	O
.	.	punct	O

Cortisol	NN	nsubj	O
,	,	punct	O
corticosterone	NN	conj	O
,	,	punct	O
and	CC	cc	O
progesterone	NN	conj	O
competed	VBD	ROOT	O
with	IN	case	O
dexamethasone	NN	nmod	O
for	IN	case	O
binding	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
estradiol	NN	nsubj	O
,	,	punct	O
dihydrotestosterone	NN	conj	O
,	,	punct	O
and	CC	cc	O
11-epicortisol	NN	conj	O
competed	VBD	parataxis	O
very	RB	advmod	O
little	JJ	dobj	O
.	.	punct	O

Binding	NN	nsubjpass	O
of	IN	case	O
dexamethasone	NN	nmod	O
to	TO	case	O
cytosol	NN	nmod	O
and	CC	cc	O
nuclear	JJ	amod	O
forms	NNS	conj	O
of	IN	case	O
the	DT	det	O
receptor	NN	compound	B-protein
complex	NN	nmod	I-protein
and	CC	cc	O
temperature-sensitive	JJ	amod	O
translocation	NN	conj	O
of	IN	case	O
cytosol	NN	compound	O
forms	NNS	nmod	O
to	TO	case	O
nuclear	JJ	amod	O
forms	NNS	nmod	O
were	VBD	auxpass	O
shown	VBN	ROOT	O
.	.	punct	O

At	IN	case	O
37	CD	nummod	O
degrees	NNS	compound	O
C	VBP	nmod	O
the	DT	det	O
predominant	JJ	amod	O
form	NN	nsubj	O
of	IN	case	O
the	DT	det	O
hormone-receptor	NN	compound	B-protein
complex	NN	nmod	I-protein
was	VBD	cop	O
nuclear	JJ	ROOT	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
corticosteroids	NNS	nsubj	O
interact	VBP	ccomp	O
with	IN	case	O
macrophages	NNS	nmod	B-cell_type
at	IN	case	O
physiological	JJ	amod	O
concentrations	NNS	nmod	O
.	.	punct	O

Nitric	JJ	amod	O
oxide	NN	compound	O
signaling	NN	ROOT	O
:	:	punct	O
a	DT	det	O
possible	JJ	amod	O
role	NN	dep	O
for	IN	case	O
G	NN	compound	B-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
reported	VBN	ROOT	O
various	JJ	amod	O
inductive	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
nitric	JJ	amod	O
oxide	NN	nmod	O
on	IN	case	O
human	JJ	amod	B-cell_type
PBMC	NN	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
describe	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
and	CC	cc	O
potentially	RB	advmod	O
important	JJ	conj	O
mechanism	NN	dobj	O
of	IN	case	O
nitric	JJ	amod	O
oxide	NN	nmod:npmod	O
signaling-through	JJ	amod	O
direct	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
guanine	NN	compound	B-protein
nucleotide-binding	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
(	-LRB-	punct	O
G	NN	compound	B-protein
proteins	NNS	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
nitric	JJ	amod	O
oxide	NN	compound	O
treatment	NN	nsubj	O
of	IN	case	O
membranes	NNS	nmod	O
isolated	VBN	acl	O
from	IN	case	O
fresh	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
PBMC	NN	nmod	I-cell_type
enhances	VBZ	ccomp	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
these	DT	det	O
membranes	NNS	nmod	O
to	TO	mark	O
hydrolyze	VB	acl	O
[	-LRB-	punct	O
gamma-32P	NNP	dep	O
]	-RRB-	punct	O
GTP	NN	conj	O
and	CC	cc	O
bind	VBP	conj	O
[	-LRB-	punct	O
gamma-35S	NN	dep	O
]	-RRB-	punct	O
GTP	NNP	appos	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
treatment	NN	nsubj	O
of	IN	case	O
whole	JJ	amod	O
cells	NNS	nmod	O
with	IN	case	O
nitric	JJ	amod	O
oxide	NN	nmod	O
yielded	VBD	ROOT	O
membranes	NNS	dobj	O
with	IN	case	O
enhanced	VBN	amod	O
GTPase	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
GTPase	NN	compound	O
activity	NN	nsubjpass	O
of	IN	case	O
pure	JJ	nmod	O
,	,	punct	O
recombinant	JJ	amod	O
Gs	NN	compound	B-protein
alpha	NN	conj	I-protein
,	,	punct	O
Gi	NN	compound	B-protein
alpha	NN	conj	I-protein
1	CD	nummod	I-protein
,	,	punct	O
and	CC	cc	O
p21ras	NN	conj	B-protein
was	VBD	auxpass	O
greatly	RB	advmod	O
enhanced	VBN	ROOT	O
by	IN	case	O
nitric	JJ	amod	O
oxide	NN	nmod	O
.	.	punct	O

In	IN	case	O
support	NN	nmod	O
of	IN	case	O
the	DT	det	O
existence	NN	nmod	O
of	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
in	IN	case	O
whole	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
G	NN	compound	O
protein	NN	compound	O
inhibitor	NN	nsubj	O
,	,	punct	O
GDP-beta-S	NN	appos	O
,	,	punct	O
blocked	VBD	ccomp	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
translocation	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
nitric	JJ	amod	O
oxide	NN	nmod	O
or	CC	cc	O
LPS	NN	conj	O
in	IN	case	O
permeabilized	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
nitric	JJ	amod	O
oxide	NN	nsubj	O
greatly	RB	advmod	O
reduced	VBD	ROOT	O
the	DT	det	O
pertussis	NN	nmod:npmod	O
toxin-mediated	JJ	amod	O
ADP-ribosylation	NN	dobj	O
of	IN	case	O
45-	CD	nmod	B-protein
and	CC	cc	I-protein
41-kDa	JJ	conj	I-protein
proteins	NNS	dep	I-protein
in	IN	case	O
membranes	NNS	nmod	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

Because	IN	mark	O
G	NN	compound	B-protein
proteins	NNS	nsubj	I-protein
play	VBP	advcl	O
a	DT	det	O
central	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
many	JJ	amod	O
diverse	JJ	amod	O
signaling	NN	compound	O
systems	NNS	nmod	O
,	,	punct	O
activation	NN	nsubj	O
by	IN	case	O
an	DT	det	O
endogenous	JJ	amod	O
and	CC	cc	O
inducible	JJ	conj	O
oxidant	NN	nmod	O
may	MD	aux	O
represent	VB	ROOT	O
a	DT	det	O
novel	JJ	amod	O
signaling	NN	compound	O
pathway	NN	dobj	O
.	.	punct	O

The	DT	det	O
granulocyte-macrophage	JJ	amod	B-DNA
colony-stimulating	JJ	amod	I-DNA
factor	NN	compound	I-DNA
promoter	NN	compound	I-DNA
cis-acting	JJ	amod	I-DNA
element	NN	compound	I-DNA
CLE0	NN	nsubj	B-DNA
mediates	VBZ	ROOT	O
induction	NN	compound	O
signals	NNS	dobj	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
is	VBZ	auxpass	O
recognized	VBN	conj	O
by	IN	case	O
factors	NNS	nmod	O
related	JJ	amod	O
to	TO	case	O
AP1	NN	nmod	B-protein
and	CC	cc	O
NFAT	NN	conj	B-protein
.	.	punct	O

Expression	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
granulocyte-macrophage	JJ	amod	B-DNA
colony-stimulating	JJ	amod	I-DNA
factor	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
GM-CSF	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
T	NN	compound	O
cells	NNS	nmod	O
is	VBZ	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
combination	NN	nmod	O
of	IN	case	O
phorbol	NN	compound	O
ester	NN	nmod	O
(	-LRB-	punct	O
phorbol	NN	compound	O
myristate	NN	compound	O
acetate	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
calcium	NN	compound	O
ionophore	NN	conj	O
(	-LRB-	punct	O
A23187	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
mimic	VBP	acl:relcl	O
antigen	NN	compound	O
stimulation	NN	dobj	O
through	IN	case	O
the	DT	det	O
T-cell	NN	compound	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
a	DT	det	O
fragment	NN	nsubj	O
containing	VBG	acl	O
bp	NN	dobj	B-DNA
-95	CD	nummod	I-DNA
to	TO	dep	I-DNA
+27	CD	nummod	I-DNA
of	IN	case	O
the	DT	det	O
mouse	NN	compound	B-DNA
GM-CSF	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
can	MD	aux	O
confer	VB	ccomp	O
inducibility	NN	dobj	O
to	TO	case	O
reporter	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
Jurkat	NN	compound	I-cell_line
T-cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
use	VBP	ROOT	O
an	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
transcription	NN	compound	O
system	NN	dobj	O
to	TO	mark	O
demonstrate	VB	xcomp	O
that	IN	mark	O
a	DT	det	O
cis-acting	JJ	amod	B-DNA
element	NN	nsubj	I-DNA
(	-LRB-	punct	O
positions	NNS	appos	B-DNA
-54	CD	nummod	I-DNA
to	TO	dep	I-DNA
-40	CD	nummod	I-DNA
)	-RRB-	punct	O
,	,	punct	O
referred	VBN	acl	O
to	TO	nmod	O
as	IN	case	O
CLE0	NN	nmod	B-DNA
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
target	NN	ccomp	O
for	IN	case	O
the	DT	det	O
induction	NN	compound	O
signals	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
observed	VBD	ROOT	O
induction	NN	dobj	O
with	IN	case	O
templates	NNS	nmod	O
containing	VBG	acl	O
intact	JJ	amod	O
CLE0	NN	dobj	B-DNA
but	CC	cc	O
not	RB	neg	O
with	IN	case	O
templates	NNS	conj	O
with	IN	case	O
deleted	VBN	amod	B-DNA
or	CC	cc	I-DNA
mutated	VBN	conj	I-DNA
CLE0	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
observed	VBD	ROOT	O
that	IN	mark	O
two	CD	nummod	O
distinct	JJ	amod	O
signals	NNS	nsubjpass	O
were	VBD	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
the	DT	det	O
stimulation	NN	nmod	O
through	IN	case	O
CLE0	NN	nmod	B-DNA
,	,	punct	O
since	IN	mark	O
only	JJ	amod	O
extracts	NNS	nsubj	O
from	IN	case	O
cells	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
both	CC	cc:preconj	O
phorbol	NN	compound	O
myristate	NN	compound	O
acetate	NN	nmod	O
and	CC	cc	O
A23187	NN	conj	O
supported	VBD	advcl	O
optimal	JJ	amod	O
induction	NN	dobj	O
.	.	punct	O

Stimulation	NN	nsubjpass	O
probably	RB	advmod	O
was	VBD	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
CLE0-binding	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
because	IN	mark	O
depletion	NN	nsubj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
specifically	RB	advmod	O
reduced	VBD	advcl	O
GM-CSF	NN	compound	B-protein
transcription	NN	dobj	O
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
the	DT	det	O
binding	NN	amod	B-protein
factors	NNS	nmod	I-protein
possessed	VBD	ROOT	O
biochemical	JJ	amod	O
and	CC	cc	O
immunological	JJ	conj	O
features	NNS	dobj	O
identical	JJ	amod	O
to	TO	case	O
those	DT	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
AP1	NN	nmod	I-protein
.	.	punct	O

Another	DT	det	O
factor	NN	nsubj	O
resembled	VBD	ROOT	O
the	DT	det	O
T-cell-specific	JJ	amod	B-protein
factor	NN	compound	I-protein
NFAT	NN	dobj	I-protein
.	.	punct	O

The	DT	det	O
characteristics	NNS	nsubj	O
of	IN	case	O
these	DT	det	O
two	CD	nummod	O
factors	NNS	nmod	O
are	VBP	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
their	PRP$	nmod:poss	O
involvement	NN	nmod	O
in	IN	case	O
GM-CSF	NN	compound	O
induction	NN	nmod	O
.	.	punct	O

The	DT	det	O
presence	NN	nsubj	O
of	IN	case	O
CLE0-like	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
promoters	NNS	nmod	B-DNA
of	IN	case	O
interleukin-3	NN	nmod	B-DNA
(	-LRB-	punct	I-DNA
IL-3	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
,	,	punct	I-DNA
IL-4	NN	conj	I-DNA
,	,	punct	I-DNA
IL-5	NN	conj	I-DNA
,	,	punct	I-DNA
GM-CSF	NN	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
NFAT	NN	compound	I-DNA
sites	NNS	conj	I-DNA
in	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
factors	NNS	nsubj	O
we	PRP	nsubj	O
detected	VBD	acl:relcl	O
,	,	punct	O
or	CC	cc	O
related	JJ	amod	O
factors	NNS	conj	O
that	WDT	nsubj	O
recognize	VBP	acl:relcl	O
these	DT	det	O
sites	NNS	dobj	O
,	,	punct	O
may	MD	aux	O
account	VB	ccomp	O
for	IN	case	O
the	DT	det	O
coordinate	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
during	IN	case	O
T-cell	NN	compound	B-cell_type
activation	NN	nmod	O
.	.	punct	O

Identification	NN	ROOT	O
and	CC	cc	O
characterization	NN	conj	O
of	IN	case	O
an	DT	det	O
Alu-containing	JJ	amod	B-DNA
,	,	punct	I-DNA
T-cell-specific	JJ	dep	I-DNA
enhancer	NN	nmod	I-DNA
located	JJ	amod	O
in	IN	case	O
the	DT	det	O
last	JJ	amod	O
intron	NN	nmod	B-DNA
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
CD8	NN	compound	I-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
CD8	NN	compound	I-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
is	VBZ	aux	O
restricted	JJ	ROOT	O
to	TO	case	O
cells	NNS	nmod	O
of	IN	case	O
the	DT	det	O
lymphoid	JJ	amod	B-cell_type
lineage	NN	nmod	I-cell_type
and	CC	cc	O
developmentally	RB	advmod	O
regulated	VBN	conj	O
during	IN	case	O
thymopoiesis	NN	nmod	O
.	.	punct	O

As	IN	case	O
an	DT	det	O
initial	JJ	amod	O
step	NN	nmod	O
towards	IN	mark	O
understanding	VBG	acl	O
the	DT	det	O
molecular	JJ	amod	O
basis	NN	dobj	O
for	IN	case	O
tissue-specific	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
surveyed	VBD	ROOT	O
the	DT	det	O
surrounding	JJ	amod	O
chromatin	NN	compound	O
structure	NN	dobj	O
for	IN	case	O
potential	JJ	amod	O
cis-acting	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
regions	NNS	nmod	I-DNA
by	IN	case	O
DNase	NN	compound	B-protein
I	CD	nummod	I-protein
hypersensitivity	NN	compound	O
mapping	NN	nmod	O
and	CC	cc	O
found	VBD	conj	O
four	CD	nummod	O
hypersensitive	JJ	amod	O
sites	NNS	dobj	O
,	,	punct	O
three	CD	nsubj	O
of	IN	case	O
which	WDT	nmod	O
were	VBD	cop	O
T	NN	compound	O
cell	NN	nmod:npmod	O
restricted	JJ	parataxis	O
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
a	DT	det	O
reporter-based	JJ	amod	O
expression	NN	compound	O
approach	NN	dobj	O
,	,	punct	O
a	DT	det	O
T-cell-specific	JJ	amod	B-DNA
enhancer	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
identified	VBN	ROOT	O
by	IN	case	O
its	PRP$	nmod:poss	O
close	JJ	amod	O
association	NN	nmod	O
with	IN	case	O
a	DT	det	O
prominent	JJ	amod	O
T-cell-restricted	JJ	amod	B-DNA
hypersensitive	JJ	amod	I-DNA
sites	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
last	JJ	amod	O
intron	NN	nmod	O
of	IN	case	O
the	DT	det	O
CD8	NN	compound	B-DNA
alpha	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Deletion	NN	compound	O
studies	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
minimal	JJ	amod	O
enhancer	NN	nsubj	O
is	VBZ	cop	O
adjacent	JJ	ccomp	O
to	TO	case	O
a	DT	det	O
negative	JJ	amod	O
regulatory	JJ	amod	O
element	NN	nmod	O
.	.	punct	O

DNA	NN	compound	O
sequence	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
minimal	JJ	amod	B-DNA
enhancer	NN	nmod	I-DNA
revealed	VBD	ROOT	O
a	DT	det	O
striking	JJ	amod	O
cluster	NN	dobj	O
of	IN	case	O
consensus	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
for	IN	case	O
Ets-1	NN	nmod	B-protein
,	,	punct	I-protein
TCF-1	NN	conj	I-protein
,	,	punct	I-protein
CRE	NN	conj	I-protein
,	,	punct	I-protein
GATA-3	NN	conj	I-protein
,	,	punct	I-protein
LyF-1	NN	conj	I-protein
,	,	punct	I-protein
and	CC	cc	I-protein
bHLH	JJ	conj	I-protein
proteins	NNS	dep	I-protein
which	WDT	nsubjpass	O
were	VBD	auxpass	O
verified	VBN	acl:relcl	O
by	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
end	NN	nsubjpass	I-DNA
of	IN	case	O
the	DT	det	O
enhancer	NN	nmod	B-DNA
was	VBD	auxpass	O
composed	VBN	ROOT	O
of	IN	case	O
an	DT	det	O
Alu	NN	compound	O
repeat	NN	nmod	O
which	WDT	nsubj	O
contained	VBD	acl:relcl	O
the	DT	det	O
GATA-3	NN	compound	B-DNA
,	,	punct	I-DNA
bHLH	JJ	conj	I-DNA
,	,	punct	I-DNA
and	CC	cc	I-DNA
LyF-1	NN	conj	I-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
.	.	punct	O

Site-directed	JJ	amod	O
mutation	NN	nsubj	O
of	IN	case	O
the	DT	dep	O
Ets-1	NN	nmod	B-DNA
and	CC	cc	I-DNA
GATA-3	NN	conj	I-DNA
sites	NNS	dep	I-DNA
dramatically	RB	advmod	O
reduced	VBD	ROOT	O
enhancer	NN	compound	O
activity	NN	dobj	O
.	.	punct	O

The	DT	det	O
functional	JJ	amod	O
importance	NN	nsubj	O
of	IN	case	O
the	DT	det	O
other	JJ	amod	O
binding	VBG	amod	O
sites	NNS	nmod	O
only	RB	advmod	O
became	VBD	ROOT	O
apparent	JJ	acomp	O
when	WRB	advmod	O
combinations	NNS	nsubjpass	O
of	IN	case	O
mutations	NNS	nmod	O
were	VBD	auxpass	O
analyzed	VBN	advcl	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
human	JJ	amod	B-DNA
CD8	NN	compound	I-DNA
alpha	NN	compound	I-DNA
gene	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
regulated	VBN	ccomp	O
by	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
of	IN	case	O
multiple	JJ	amod	O
T-cell	NN	compound	B-protein
nuclear	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
with	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	O
enhancer	NN	nmod	O
located	JJ	amod	O
in	IN	case	O
the	DT	det	O
last	JJ	amod	O
intron	NN	nmod	B-DNA
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
.	.	punct	O

Comparison	NN	nsubj	O
of	IN	case	O
the	DT	det	O
CD8	NN	compound	B-DNA
alpha	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
with	IN	case	O
other	JJ	amod	O
recently	RB	advmod	O
identified	VBN	amod	O
T-cell-specific	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
elements	NNS	nmod	I-DNA
suggests	VBZ	ROOT	O
that	IN	mark	O
a	DT	det	O
common	JJ	amod	O
set	NN	nsubj	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
regulates	VBZ	ccomp	O
several	JJ	amod	O
T-cell	NN	compound	B-DNA
genes	NNS	dobj	I-DNA
.	.	punct	O

Molecular	JJ	amod	O
regulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
IL-3	NN	compound	I-DNA
gene	NN	nmod	I-DNA
:	:	punct	O
inducible	JJ	amod	O
T	NN	nmod:npmod	O
cell-restricted	JJ	amod	O
expression	NN	nsubj	O
requires	VBZ	ROOT	O
intact	JJ	amod	O
AP-1	NN	compound	B-DNA
and	CC	cc	I-DNA
Elf-1	NN	conj	I-DNA
nuclear	JJ	amod	I-DNA
protein	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
.	.	punct	O

Interleukin	NN	nsubj	B-protein
3	CD	nummod	I-protein
(	-LRB-	punct	O
IL-3	NN	appos	B-protein
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
hematopoietic	JJ	amod	B-protein
stem-cell	JJ	compound	I-protein
growth	NN	ROOT	I-protein
and	CC	cc	I-protein
differentiation	NN	compound	I-protein
factor	NN	conj	I-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
expressed	VBN	acl:relcl	O
solely	RB	advmod	O
in	IN	case	O
activated	VBN	amod	O
T	NN	compound	B-cell_type
and	CC	cc	I-cell_type
NK	NN	conj	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Studies	NNS	nsubj	O
to	TO	case	O
date	NN	nmod	O
have	VBP	aux	O
identified	VBN	ROOT	O
elements	NNS	dobj	O
5	CD	nummod	O
'	''	punct	O
to	TO	case	O
the	DT	det	O
IL-3	NN	compound	B-DNA
coding	NN	compound	I-DNA
sequences	NNS	nmod	I-DNA
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
its	PRP$	nmod:poss	O
transcription	NN	dobj	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
sequences	NNS	nsubj	O
that	WDT	nsubj	O
confer	VBP	acl:relcl	O
T	NN	nmod:npmod	O
cell-specific	JJ	amod	O
expression	NN	dobj	O
remain	VBP	conj	O
to	TO	mark	O
be	VB	auxpass	O
clearly	RB	advmod	O
defined	VBN	xcomp	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
now	RB	advmod	O
identified	VBN	ROOT	O
DNA	NN	compound	B-DNA
sequences	NNS	dobj	I-DNA
that	WDT	nsubjpass	O
are	VBP	auxpass	O
required	VBN	acl:relcl	O
for	IN	case	O
T	NN	nmod:npmod	O
cell-restricted	JJ	amod	O
IL-3	NN	compound	B-DNA
gene	NN	compound	I-DNA
transcription	NN	nmod	O
.	.	punct	O

A	DT	det	O
series	NN	nsubj	O
of	IN	case	O
transient	JJ	amod	O
transfections	NNS	nmod	O
performed	VBN	acl	O
with	IN	case	O
human	JJ	amod	B-DNA
IL-3-chloramphenicol	JJ	amod	I-DNA
acetyltransferase	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
CAT	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
reporter	NN	compound	I-DNA
plasmids	NNS	nmod	I-DNA
in	IN	case	O
T	NN	compound	B-cell_type
and	CC	cc	I-cell_type
non-T	JJ	conj	I-cell_type
cells	NNS	nmod	I-cell_type
revealed	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
plasmid	NN	nsubj	B-DNA
containing	VBG	acl	O
319	CD	nummod	O
bp	NN	dobj	O
of	IN	case	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
flanking	JJ	amod	I-DNA
sequences	NNS	nmod	I-DNA
was	VBD	cop	O
active	JJ	ccomp	O
exclusively	RB	advmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Deletion	NN	compound	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
specificity	NN	nsubjpass	O
was	VBD	auxpass	O
conferred	VBN	ccomp	O
by	IN	case	O
a	DT	det	O
49-bp	JJ	amod	B-DNA
fragment	NN	nmod	I-DNA
(	-LRB-	punct	O
bp	NN	appos	B-DNA
-319	CD	nummod	I-DNA
to	TO	dep	I-DNA
-270	CD	nummod	I-DNA
)	-RRB-	punct	O
that	WDT	nsubj	O
included	VBD	acl:relcl	O
a	DT	det	O
potential	JJ	amod	B-DNA
binding	VBG	compound	I-DNA
site	NN	dobj	I-DNA
for	IN	case	O
AP-1	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
6	CD	nummod	O
bp	NN	nmod:npmod	O
upstream	RB	advmod	O
of	IN	case	O
a	DT	det	O
binding	VBG	amod	B-DNA
site	NN	nmod	I-DNA
for	IN	case	I-DNA
Elf-1	NN	nmod	I-DNA
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
Ets	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

DNaseI	NN	compound	B-protein
footprint	NN	nsubj	O
and	CC	cc	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	compound	O
analyses	NNS	conj	O
performed	VBN	acl	O
with	IN	case	O
MLA-144	JJ	compound	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
nuclear	JJ	amod	O
extracts	NNS	nmod	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
this	DT	det	O
49-bp	JJ	amod	B-DNA
region	NN	nsubj	I-DNA
contains	VBZ	ccomp	O
a	DT	det	O
nuclear	JJ	amod	B-DNA
protein	NN	compound	I-DNA
binding	NN	compound	I-DNA
region	NN	dobj	I-DNA
that	WDT	nsubj	O
includes	VBZ	acl:relcl	O
consensus	NN	compound	B-DNA
AP-1	NN	dobj	I-DNA
and	CC	cc	I-DNA
Elf-1	NN	compound	I-DNA
binding	NN	compound	I-DNA
sites	NNS	conj	I-DNA
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
extracts	NNS	nsubj	O
prepared	VBN	acl	O
from	IN	case	O
purified	VBN	amod	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
contained	VBD	ROOT	O
proteins	NNS	dobj	O
that	WDT	nsubj	O
bound	VBD	acl:relcl	O
to	TO	case	O
synthetic	JJ	amod	O
oligonucleotides	NNS	nmod	O
corresponding	VBG	acl	O
to	TO	case	O
the	DT	det	O
AP-1	NN	compound	B-DNA
and	CC	cc	I-DNA
Elf-1	NN	conj	I-DNA
binding	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
.	.	punct	O

In	IN	case	O
vitro-transcribed	JJ	amod	O
and	CC	cc	O
-translated	JJ	conj	O
Elf-1	NN	compound	B-protein
protein	NN	nsubj	I-protein
bound	VBD	ROOT	O
specifically	RB	advmod	O
to	TO	case	O
the	DT	det	O
Elf-1	NN	compound	B-DNA
site	NN	nmod	I-DNA
,	,	punct	O
and	CC	cc	O
Elf-1	NN	compound	O
antisera	NNS	nsubj	O
competed	VBD	conj	O
and	CC	cc	O
super	JJ	amod	O
shifted	VBN	amod	O
nuclear	JJ	amod	O
protein	NN	compound	O
complexes	NNS	conj	O
present	JJ	amod	O
in	IN	case	O
MLA-144	JJ	compound	B-cell_line
nuclear	JJ	amod	O
extracts	NNS	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
addition	NN	nsubj	O
of	IN	case	O
anti-Jun	JJ	amod	O
family	NN	compound	O
antiserum	NN	nmod	O
in	IN	case	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	compound	O
reactions	NNS	nmod	O
completely	RB	advmod	O
blocked	VBD	ROOT	O
formation	NN	dobj	O
of	IN	case	O
the	DT	det	O
AP-1-related	JJ	amod	B-protein
complexes	NNS	nmod	I-protein
.	.	punct	O

Transient	JJ	amod	O
transfection	NN	compound	O
studies	NNS	nsubj	O
in	IN	case	O
MLA-144	JJ	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
revealed	VBD	ROOT	O
that	IN	mark	O
constructs	NNS	nsubj	O
containing	VBG	acl	O
mutations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
AP-1	NN	compound	B-DNA
site	NN	nmod	I-DNA
almost	RB	advmod	O
completely	RB	advmod	O
abolished	VBD	ccomp	O
CAT	NN	compound	O
activity	NN	dobj	O
while	IN	mark	O
mutation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
Elf-1	NN	compound	B-DNA
site	NN	nmod	I-DNA
or	CC	cc	O
the	DT	det	O
NF-IL-3	NN	compound	B-DNA
site	NN	conj	I-DNA
,	,	punct	O
a	DT	det	O
previously	RB	advmod	O
described	VBN	amod	O
nuclear	JJ	amod	B-DNA
protein	NN	compound	I-DNA
binding	NN	compound	I-DNA
site	NN	appos	I-DNA
(	-LRB-	punct	O
bp.	NNS	dep	B-DNA
-155	CD	compound	I-DNA
to	TO	dep	I-DNA
-148	CD	dep	I-DNA
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
IL-3	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
,	,	punct	O
reduced	VBD	advcl	O
CAT	NN	compound	O
activity	NN	dobj	O
to	TO	case	O
<	$	amod	O
25	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
the	DT	det	O
activity	NN	nmod	O
given	VBN	acl	O
by	IN	case	O
wild-type	JJ	amod	O
constructs	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
IL-3	NN	compound	I-DNA
gene	NN	nmod	I-DNA
requires	VBZ	ccomp	O
the	DT	det	O
AP-1	NN	compound	B-DNA
and	CC	cc	I-DNA
Elf-1	NN	conj	I-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
unlike	IN	case	O
other	JJ	amod	O
previously	RB	advmod	O
characterized	VBN	amod	O
cytokine	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
such	JJ	case	O
as	IN	mwe	O
IL-2	NN	nmod	B-protein
,	,	punct	O
the	DT	dep	O
AP-1	NN	compound	B-protein
and	CC	cc	I-protein
Elf-1	NN	conj	I-protein
factors	NNS	conj	I-protein
can	MD	aux	O
bind	VB	parataxis	O
independently	RB	advmod	O
in	IN	case	O
the	DT	det	O
IL-3	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
400	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

Combination	NN	compound	O
IL-2	NN	nsubj	B-protein
and	CC	cc	O
IL-4	NN	conj	B-protein
reduces	VBZ	ROOT	O
glucocorticoid	NN	compound	O
receptor-binding	JJ	amod	O
affinity	NN	dobj	O
and	CC	cc	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
response	NN	conj	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

The	DT	det	O
mechanisms	NNS	nsubjpass	O
contributing	VBG	acl	O
to	TO	case	O
persistent	JJ	amod	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	nmod	O
and	CC	cc	O
poor	JJ	amod	O
response	NN	conj	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
in	IN	case	O
chronic	JJ	amod	O
inflammatory	JJ	amod	O
illnesses	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
steroid	NN	compound	O
resistant	JJ	amod	O
(	-LRB-	punct	O
SR	JJ	dep	O
)	-RRB-	punct	O
asthma	NN	nmod	O
are	VBP	auxpass	O
poorly	RB	advmod	O
defined	VBN	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
certain	JJ	amod	O
cytokines	NNS	nsubj	O
,	,	punct	O
specifically	RB	advmod	O
IL-2	NN	appos	B-protein
and	CC	cc	O
IL-4	NN	conj	B-protein
,	,	punct	O
could	MD	aux	O
affect	VB	ccomp	O
T	NN	compound	O
cell	NN	compound	O
response	NN	dobj	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

A	DT	det	O
[	-LRB-	punct	O
3H	NN	appos	O
]	-RRB-	punct	O
dexamethasone	NN	compound	O
radioligand-binding	JJ	amod	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
measure	VB	xcomp	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
(	-LRB-	punct	O
GR	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
dissociation	NN	compound	O
constant	NN	conj	O
(	-LRB-	punct	O
Kd	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
PBMC	NN	nmod	B-cell_type
from	IN	case	O
normal	JJ	amod	O
donors	NNS	nmod	O
and	CC	cc	O
patients	NNS	conj	O
with	IN	case	O
SR	JJ	amod	O
asthma	NN	nmod	O
,	,	punct	O
cultured	VBN	advcl	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
and	CC	cc	O
presence	NN	conj	O
of	IN	case	O
these	DT	det	O
cytokines	NNS	nmod	B-protein
.	.	punct	O

PBMC	NNS	nsubj	O
from	IN	case	O
normal	JJ	amod	O
donors	NNS	nmod	O
incubated	VBN	acl	O
for	IN	case	O
48	CD	nummod	O
h	NN	nmod	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
combination	NN	nmod	O
IL-2	NN	dep	B-protein
+	CC	cc	O
IL-4	NN	conj	B-protein
had	VBD	ROOT	O
nuclear	JJ	amod	O
GR	NN	dobj	O
with	IN	case	O
significantly	RB	advmod	O
reduced	VBN	amod	O
binding	NN	compound	O
affinity	NN	nmod	O
(	-LRB-	punct	O
GR	NN	compound	O
Kd	NN	dep	O
=	JJ	amod	O
36.1	CD	nummod	O
+/-	CC	cc	O
1.63	CD	conj	O
nM	NN	dobj	O
,	,	punct	O
mean	NN	appos	O
+/-	CC	cc	O
SEM	NN	conj	O
;	:	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0.0001	CD	dobj	O
)	-RRB-	punct	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
PBMC	NN	nmod	B-cell_type
incubated	VBN	acl	O
with	IN	case	O
medium	NN	nmod	O
alone	RB	advmod	O
(	-LRB-	punct	O
GR	NN	compound	O
Kd	NN	nsubj	O
=	JJ	dep	O
6.74	CD	nummod	O
+/-	CC	cc	O
0.46	CD	conj	O
nM	NN	dobj	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
cytosolic	JJ	amod	O
GR	NN	compound	O
Kd	NN	nsubj	O
remained	VBD	ROOT	O
unchanged	JJ	xcomp	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
PBMC	NN	nsubjpass	B-cell_type
were	VBD	auxpass	O
incubated	VBN	advcl	O
with	IN	case	O
IL-2	NN	nmod	B-protein
alone	RB	advmod	O
or	CC	cc	O
IL-4	NN	conj	B-protein
alone	RB	advmod	O
,	,	punct	O
no	DT	neg	O
change	NN	nsubjpass	O
in	IN	case	O
GR-binding	JJ	amod	O
affinity	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
T	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
and	CC	cc	O
non-T	JJ	amod	B-cell_type
cells	NNS	conj	I-cell_type
were	VBD	auxpass	O
individually	RB	advmod	O
stimulated	VBN	advcl	O
with	IN	case	O
combination	NN	compound	O
IL-2	NN	nmod	O
+	CC	cc	O
IL-4	NN	conj	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
reduction	NN	nsubjpass	O
in	IN	case	O
GR-binding	JJ	amod	O
affinity	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
only	RB	advmod	O
in	IN	case	O
the	DT	det	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
population	NN	nmod	I-cell_type
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0.0001	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
IL-2	NN	compound	O
+	CC	cc	O
IL-4-induced	JJ	conj	O
alteration	NN	nsubjpass	O
in	IN	case	O
PBMC	NN	compound	O
GR	NN	compound	O
Kd	NN	nmod	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
GR	NN	compound	O
number	NN	nmod	O
(	-LRB-	punct	O
8348	CD	nummod	O
+/-	CC	cc	O
964	CD	conj	O
vs	CC	cc	O
1710	CD	conj	O
+/-	CC	cc	O
228	CD	conj	O
sites/cell	NNS	dep	O
;	:	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0.0003	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

More	RBR	advmod	O
importantly	RB	advmod	O
,	,	punct	O
the	DT	det	O
alteration	NN	nsubjpass	O
in	IN	case	O
PBMC	NN	compound	O
GR-binding	JJ	amod	O
affinity	NN	nmod	O
with	IN	case	O
IL-2	NN	nmod	B-protein
+	CC	cc	O
IL-4	NN	conj	B-protein
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
functional	JJ	amod	O
change	NN	nmod	O
in	IN	case	O
T	NN	compound	O
cell	NN	compound	O
response	NN	nmod	O
to	TO	case	O
methylprednisolone	JJ	compound	O
MPN	NN	nmod	O
,	,	punct	O
i.e.	FW	advmod	O
,	,	punct	O
a	DT	det	O
reduced	VBN	amod	O
inhibitory	JJ	amod	O
effect	NN	appos	O
of	IN	case	O
MPN	NN	nmod	O
on	IN	case	O
PMA/ionomycin-induced	JJ	amod	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
proliferation	NN	nmod	O
.	.	punct	O

These	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
IL-2	NN	nmod	B-protein
+	CC	cc	O
IL-4	NN	conj	B-protein
on	IN	case	O
PBMC	NN	compound	B-cell_type
GR	NN	compound	B-protein
affinity	NN	nmod	O
and	CC	cc	O
response	NN	conj	O
to	TO	case	O
MPN	NN	nmod	O
were	VBD	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
co-incubation	NN	nmod	O
with	IN	case	O
IFN-gamma	NN	nmod	B-protein
.	.	punct	O

Freshly	RB	advmod	O
isolated	VBN	amod	O
PBMC	NN	nsubj	B-cell_type
from	IN	case	O
four	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
SR	JJ	amod	O
asthma	NN	nmod	O
had	VBD	ROOT	O
a	DT	det	O
significantly	RB	advmod	O
reduced	VBN	amod	O
GR-binding	JJ	amod	O
affinity	NN	dobj	O
(	-LRB-	punct	O
Kd	NN	dep	O
=	JJ	amod	O
40.0	CD	nummod	O
+/-	CC	cc	O
2.68	CD	conj	O
nM	NN	dep	O
;	:	punct	O
p	NN	nsubj	O
=	JJ	dep	O
0.0001	CD	dobj	O
)	-RRB-	punct	O
when	WRB	advmod	O
compared	VBN	advcl	O
with	IN	case	O
seven	CD	nummod	O
normal	JJ	amod	O
subjects	NNS	nmod	O
(	-LRB-	punct	O
7.15	CD	nummod	O
+/-	CC	cc	O
0.41	CD	conj	O
nM	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
altered	JJ	amod	O
PBMC	NN	compound	O
GR	NN	compound	O
binding	NN	nsubj	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
SR	JJ	amod	O
asthma	NN	nmod	O
reversed	VBD	ROOT	O
to	TO	case	O
normal	JJ	nmod	O
when	WRB	advmod	O
incubated	VBN	advcl	O
with	IN	case	O
medium	NN	nmod	O
alone	RB	advmod	O
,	,	punct	O
but	CC	cc	O
was	VBD	auxpass	O
sustained	JJ	conj	O
with	IN	case	O
IL-2	NN	nmod	B-protein
+	CC	cc	O
IL-4	NN	conj	B-protein
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
with	IN	case	O
persistent	JJ	amod	O
inflammation	NN	compound	O
certain	JJ	amod	O
cytokines	NNS	nsubj	B-protein
may	MD	aux	O
contribute	VB	ccomp	O
to	TO	case	O
an	DT	det	O
impaired	JJ	amod	O
response	NN	nmod	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
IL-2	NN	nmod	B-protein
and	CC	cc	O
IL-4	NN	conj	B-protein
were	VBD	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
IFN-gamma	NN	nmod	B-protein
.	.	punct	O

Characterization	NN	ROOT	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
CD4	NN	compound	I-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
:	:	punct	O
transcription	NN	nsubj	O
from	IN	case	O
the	DT	det	O
CD4	NN	compound	B-DNA
gene	NN	compound	I-DNA
core	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
is	VBZ	cop	O
tissue-specific	JJ	dep	O
and	CC	cc	O
is	VBZ	auxpass	O
activated	VBN	conj	O
by	IN	case	O
Ets	NN	compound	B-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
5	CD	nummod	B-DNA
'	``	punct	I-DNA
transcription	NN	compound	I-DNA
control	NN	compound	I-DNA
sequences	NNS	dobj	I-DNA
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
CD4	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
located	VBD	ROOT	O
the	DT	det	O
transcription	NN	compound	B-DNA
initiation	NN	compound	I-DNA
site	NN	dobj	I-DNA
and	CC	cc	O
showed	VBD	conj	O
that	IN	mark	O
the	DT	det	O
CD4	NN	compound	B-DNA
core	NN	compound	I-DNA
promoter	NN	nsubj	I-DNA
(	-LRB-	punct	O
positions	NNS	dep	B-DNA
-40	CD	nummod	I-DNA
to	TO	case	I-DNA
+16	CD	nmod	I-DNA
)	-RRB-	punct	O
lacks	VBZ	ccomp	O
a	DT	det	O
classical	JJ	amod	O
``	``	punct	O
TATA	NN	dobj	O
''	''	punct	O
or	CC	cc	O
initiator	NN	compound	B-DNA
positioning	NN	compound	I-DNA
consensus	NN	compound	I-DNA
sequence	NN	conj	I-DNA
but	CC	cc	O
directs	VBZ	conj	O
precise	JJ	amod	O
and	CC	cc	O
efficient	JJ	conj	O
transcription	NN	dobj	O
when	WRB	advmod	O
coupled	VBN	advcl	O
to	TO	case	O
the	DT	det	O
ubiquitously	RB	advmod	O
active	JJ	amod	O
simian	JJ	amod	B-DNA
virus	NN	compound	I-DNA
40	CD	nummod	I-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
transcriptional	JJ	amod	O
activity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
CD4	NN	compound	B-DNA
gene	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
correlated	VBD	ROOT	O
with	IN	case	O
CD4	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
various	JJ	amod	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
the	DT	det	O
CD4	NN	compound	B-DNA
core	NN	compound	I-DNA
promoter	NN	nsubj	I-DNA
also	RB	advmod	O
displayed	VBD	ROOT	O
a	DT	det	O
tissue-specific	JJ	amod	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

Within	IN	case	O
this	DT	det	O
fragment	NN	nmod	O
,	,	punct	O
three	CD	nummod	O
nucleic	JJ	amod	O
acid	NN	compound	O
sequences	NNS	nsubjpass	O
are	VBP	auxpass	O
completely	RB	advmod	O
conserved	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
murine	JJ	amod	B-DNA
CD4	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
these	DT	det	O
sequences	NNS	nmod	O
contains	VBZ	ROOT	O
a	DT	det	O
perfect	JJ	amod	B-DNA
ETS	NN	compound	I-DNA
consensus	NN	compound	I-DNA
sequence	NN	dobj	I-DNA
.	.	punct	O

Another	DT	det	O
ETS	NN	compound	B-DNA
consensus	NN	compound	I-DNA
sequence	NN	nsubj	I-DNA
is	VBZ	cop	O
located	JJ	ROOT	O
1060	CD	nummod	O
nt	NN	nmod:npmod	O
upstream	RB	advmod	O
.	.	punct	O

Electrophoretic-mobility-shift	NN	compound	O
assays	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
core	NN	compound	O
promoter	NN	compound	O
ETS	NN	compound	O
motif	NN	nsubj	O
binds	VBZ	ccomp	O
an	DT	det	O
Ets-related	JJ	amod	B-protein
protein	NN	dobj	I-protein
specifically	RB	advmod	O
expressed	VBN	acl	O
at	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
in	IN	case	O
CD4+	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
in	IN	case	O
CD4-	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
overexpression	NN	nsubj	O
of	IN	case	O
Ets-1	NN	nmod	B-protein
or	CC	cc	O
Ets-2	NN	conj	B-protein
efficiently	RB	advmod	O
and	CC	cc	O
specifically	RB	advmod	O
activated	VBN	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
the	DT	det	O
CD4	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
and	CC	cc	O
core	NN	compound	B-DNA
promoter	NN	conj	I-DNA
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
Ets	NN	compound	B-protein
transcription	NN	compound	I-protein
factors	NNS	nsubj	I-protein
play	VBP	ccomp	O
a	DT	det	O
central	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
controlling	VBG	advcl	O
CD4	NN	compound	O
gene	NN	compound	O
expression	NN	dobj	O
,	,	punct	O
by	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
both	CC	cc:preconj	O
a	DT	det	O
classical	JJ	amod	B-DNA
remote	JJ	compound	I-DNA
site	NN	nmod	I-DNA
and	CC	cc	O
an	DT	det	O
unusual	JJ	amod	O
proximal	JJ	amod	B-DNA
activator	NN	compound	I-DNA
sequence	NN	conj	I-DNA

Glucocorticoid	NN	compound	O
receptor	NN	compound	O
activation	NN	ROOT	O
and	CC	cc	O
inactivation	NN	conj	O
in	IN	case	O
c	NN	compound	O
ultured	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

Although	IN	mark	O
glucocorticoids	NNS	nsubj	O
are	VBP	cop	O
not	RB	neg	O
cytolytic	JJ	advcl	O
for	IN	prep	O
and	CC	cc	O
do	VBP	aux	O
not	RB	neg	O
inhibit	VB	conj	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
the	DT	det	O
IM-9	NN	compound	B-cell_line
line	NN	nmod	I-cell_line
of	IN	case	O
cultured	VBN	amod	B-cell_line
human	JJ	amod	I-cell_line
lymphoblasts	NNS	nmod	I-cell_line
,	,	punct	O
these	DT	det	O
cells	NNS	nsubj	O
have	VBP	ROOT	O
a	DT	det	O
high	JJ	amod	O
steroid-binding	JJ	amod	O
capacity	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
IM-9	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
examine	VB	advcl	O
whether	IN	mark	O
unoccupied	JJ	amod	B-protein
glucocorticoid	NN	compound	I-protein
receptors	NNS	nsubjpass	I-protein
are	VBP	auxpass	O
inactivated	VBN	ccomp	O
and	CC	cc	O
activated	VBN	conj	O
in	IN	case	O
intact	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

when	WRB	advmod	O
IM-9	NN	compound	B-cell_type
cells	NNS	nsubjpass	I-cell_type
are	VBP	auxpass	O
incubated	VBN	ROOT	O
in	IN	case	O
glucose-free	JJ	amod	O
medium	NN	nmod	O
in	IN	case	O
a	DT	det	O
nitrogen	NN	compound	O
atmosphere	NN	nmod	O
,	,	punct	O
both	CC	cc:preconj	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
bind	VB	acl	O
triamcinolone	NN	compound	O
acetonide	NN	dobj	O
and	CC	cc	O
their	PRP$	nmod:poss	O
ATP	NN	compound	O
levels	NNS	nsubj	O
decline	VBP	conj	O
and	CC	cc	O
,	,	punct	O
when	WRB	advmod	O
glucose	NN	nsubjpass	O
and	CC	cc	O
oxygen	NN	conj	O
are	VBP	auxpass	O
reintroduced	VBN	advcl	O
,	,	punct	O
ATP	NN	compound	O
levels	NNS	nmod	O
and	CC	cc	O
receptor	NN	compound	O
activity	NN	compound	O
return	NN	conj	O
.	.	punct	O

The	DT	det	O
specific	JJ	amod	O
glucocorticoid-binding	JJ	amod	O
activity	NN	nsubjpass	O
of	IN	case	O
cytosol	NN	nmod	O
prepared	VBN	acl	O
from	IN	case	O
cells	NNS	nmod	O
exposed	VBN	acl	O
to	TO	case	O
various	JJ	amod	O
degrees	NNS	nmod	O
of	IN	case	O
energy	NN	compound	O
limitation	NN	nmod	O
is	VBZ	auxpass	O
directly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
ATP	NN	compound	O
content	NN	nmod	O
.	.	punct	O

Receptor	NN	compound	O
activation	NN	nsubj	O
in	IN	case	O
intact	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	cop	O
rapid	JJ	ROOT	O
and	CC	cc	O
independent	JJ	conj	O
of	IN	case	O
protein	NN	compound	O
synthesis	NN	nmod	O
.	.	punct	O

Cytosol	NN	nsubjpass	O
prepared	VBN	acl	O
from	IN	case	O
inactivated	VBN	amod	O
cells	NNS	nmod	O
can	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
addition	NN	nmod	O
of	IN	case	O
ATP	NN	nmod	O
.	.	punct	O

The	DT	det	O
inactivation	NN	nsubjpass	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
that	WDT	nsubj	O
occurs	VBZ	acl:relcl	O
when	WRB	advmod	O
cytosol	NN	nsubjpass	O
from	IN	case	O
normal	JJ	amod	O
IM-9	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
is	VBZ	auxpass	O
incubated	VBN	advcl	O
at	IN	case	O
25	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
is	VBZ	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
molybdate	NN	nmod	O
,	,	punct	O
vanadate	NN	conj	O
,	,	punct	O
fluoride	NN	conj	O
,	,	punct	O
ATP	NN	conj	O
,	,	punct	O
and	CC	cc	O
several	JJ	amod	O
other	JJ	amod	O
nucleotides	NNS	conj	O
.	.	punct	O

The	DT	det	O
experiments	NNS	nsubj	O
with	IN	case	O
intact	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
lymphoblasts	NNS	nmod	I-cell_type
suggest	VBP	ROOT	O
that	IN	mark	O
assays	NNS	nsubj	O
of	IN	case	O
specific	JJ	amod	O
glucocorticoid-binding	JJ	amod	O
capacity	NN	nmod	O
do	VBP	aux	O
not	RB	neg	O
necessarily	RB	advmod	O
reflect	VB	ccomp	O
the	DT	det	O
cellular	JJ	amod	O
content	NN	dobj	O
of	IN	case	O
receptor	NN	compound	B-protein
protein	NN	nmod	I-protein
.	.	punct	O

Glucocorticoids	NNS	ROOT	O
and	CC	cc	O
lymphocytes	NNS	conj	B-cell_type
.	.	punct	O

II	CD	ROOT	O
.	.	punct	O

Cell	NN	compound	O
cycle-dependent	JJ	amod	O
changes	NNS	ROOT	O
in	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
content	NN	nmod	O
.	.	punct	O

To	TO	mark	O
study	VB	advcl	O
variations	NNS	dobj	O
in	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
levels	NNS	nmod	O
during	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
separated	VBN	ROOT	O
mitogen-stimulated	JJ	amod	B-cell_line
human	JJ	amod	I-cell_line
peripheral	JJ	amod	I-cell_line
lymphocytes	NNS	dobj	I-cell_line
and	CC	cc	O
rat	NN	compound	B-cell_type
lymph	NN	compound	I-cell_type
node	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
by	IN	case	O
unit	NN	compound	O
gravity	NN	compound	O
sedimentation	NN	nmod	O
and	CC	cc	O
measured	VBD	conj	O
glucocorticoid	NN	compound	O
binding	NN	dobj	O
in	IN	case	O
the	DT	det	O
resultant	JJ	amod	O
fractions	NNS	nmod	O
.	.	punct	O

By	IN	case	O
morphologic	JJ	amod	O
criteria	NNS	nmod	O
and	CC	cc	O
thymidine	NN	compound	O
incorporation	NN	conj	O
,	,	punct	O
the	DT	det	O
fractions	NNS	nsubjpass	O
were	VBD	auxpass	O
separated	VBN	ROOT	O
into	IN	case	O
populations	NNS	nmod	O
of	IN	case	O
G0	NN	nmod	B-cell_type
and	CC	cc	I-cell_type
G1	NN	conj	I-cell_type
phase	NN	dep	I-cell_type
and	CC	cc	I-cell_type
S	NN	conj	I-cell_type
and	CC	cc	I-cell_type
post-S	NN	conj	I-cell_type
phase	NN	compound	I-cell_type
cells	NNS	dep	I-cell_type
.	.	punct	O

A	DT	det	O
2-	CD	compound	O
to	TO	dep	O
3-fold	JJ	nmod	O
increase	NN	nsubjpass	O
in	IN	case	O
glucocorticoid	NN	compound	O
receptor	NN	compound	O
sites	NNS	nmod	O
per	IN	case	O
cell	NN	nmod	O
,	,	punct	O
for	IN	case	O
cells	NNS	nmod	O
in	IN	case	O
the	DT	dep	O
S	NN	nmod	O
and	CC	cc	O
post-S	NN	conj	O
phase	NN	dep	O
over	IN	case	O
those	DT	nmod	O
in	IN	case	O
G0	NN	nmod	O
and	CC	cc	O
G1	NN	conj	O
,	,	punct	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
with	IN	case	O
both	CC	cc:preconj	O
nonstimulated	JJ	amod	B-cell_type
rat	NN	compound	I-cell_type
lymph	NN	compound	I-cell_type
node	NN	compound	I-cell_type
cell	NN	compound	I-cell_type
suspensions	NNS	nmod	I-cell_type
and	CC	cc	O
concanavalin	NN	compound	B-cell_line
A-stimulated	JJ	amod	I-cell_line
human	JJ	amod	I-cell_line
peripheral	JJ	amod	I-cell_line
lymphocytes	NNS	conj	I-cell_line
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
together	RB	advmod	O
with	IN	case	O
those	DT	nmod	O
from	IN	case	O
other	JJ	amod	O
studies	NNS	nmod	O
indicate	VBP	ROOT	O
that	IN	mark	O
formation	NN	nsubj	O
of	IN	case	O
new	JJ	amod	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
near	IN	case	O
the	DT	det	O
S	NN	compound	O
phase	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
general	JJ	amod	O
phenomenon	NN	ccomp	O
in	IN	case	O
proliferating	VBG	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
this	DT	det	O
increase	NN	nsubj	O
in	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
during	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
may	MD	aux	O
explain	VB	ccomp	O
the	DT	det	O
increase	NN	dobj	O
in	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
mitogen-stimulated	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
leukocyte	NN	compound	B-cell_type
migration	NN	compound	O
inhibition	NN	compound	O
response	NN	ROOT	O
to	TO	case	O
certain	JJ	amod	O
breast	NN	compound	B-protein
cancer-related	JJ	amod	I-protein
antigens	NNS	nmod	I-protein
(	-LRB-	punct	O
MCF-7	NN	dep	B-protein
and	CC	cc	O
MuMTV	NN	conj	B-protein
)	-RRB-	punct	O
:	:	punct	O
their	PRP$	nmod:poss	O
potential	NN	dep	O
as	IN	case	O
discriminants	NNS	nmod	O
.	.	punct	O

Certain	JJ	amod	O
oncogenic	JJ	amod	O
viruses	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	O
breast	NN	compound	O
cancer	NN	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
murine	JJ	amod	O
mammary	JJ	amod	O
tumor	NN	compound	O
virus	NN	nmod	O
(	-LRB-	punct	O
MuMTV	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
Mason-Pfizer	NNP	compound	O
monkey	NN	compound	O
virus	NN	conj	O
(	-LRB-	punct	O
MPMV	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
used	VBN	ROOT	O
the	DT	det	O
leukocyte	NN	compound	O
migration	NN	compound	O
inhibition	NN	compound	O
(	-LRB-	punct	O
LMI	NN	appos	O
)	-RRB-	punct	O
response	NN	dobj	O
to	TO	mark	O
assay	VB	acl	O
the	DT	det	O
response	NN	dobj	O
to	TO	case	O
several	JJ	amod	O
potential	JJ	amod	O
breast	NN	compound	O
cancer-related	JJ	amod	O
antigens	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
MuMTV	NN	nmod	B-protein
,	,	punct	O
MPMV	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
a	DT	det	O
breast	NN	compound	B-cell_line
cancer	NN	compound	I-cell_line
cultured	VBD	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	conj	I-cell_line
,	,	punct	O
MCF-7	NN	appos	B-cell_line
,	,	punct	O
in	IN	case	O
96	CD	nummod	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O
,	,	punct	O
in	IN	case	O
32	CD	nummod	O
women	NNS	nmod	O
with	IN	case	O
benign	JJ	amod	O
breast	NN	compound	O
disease	NN	nmod	O
,	,	punct	O
and	CC	cc	O
in	IN	case	O
67	CD	nummod	O
normal	JJ	amod	O
women	NNS	conj	O
.	.	punct	O

The	DT	det	O
lowest	JJS	amod	O
tenth	JJ	compound	O
percentile	NN	nsubjpass	O
of	IN	case	O
control	NN	compound	O
(	-LRB-	punct	O
LMI	NN	appos	O
)	-RRB-	punct	O
responses	NNS	nmod	O
was	VBD	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
the	DT	det	O
cutoff	NN	compound	O
point	NN	nmod	O
to	TO	mark	O
designate	VB	acl	O
responders	NNS	dobj	O
.	.	punct	O

Breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nsubj	O
showed	VBD	ROOT	O
significant	JJ	amod	O
responses	NNS	dobj	O
to	TO	case	O
MuMTV	NN	nmod	B-protein
(	-LRB-	punct	O
49	CD	nummod	O
%	NN	dep	O
and	CC	cc	O
to	TO	case	O
MCF-7	NN	conj	O
(	-LRB-	punct	O
50	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
to	TO	case	O
MPMV	NN	conj	B-protein
(	-LRB-	punct	O
29	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
a	DT	det	O
paired-antigen	NN	amod	O
study	NN	nmod	O
using	VBG	acl	O
MuMTV	NN	dobj	B-protein
and	CC	cc	O
MCF-7	NN	conj	B-protein
,	,	punct	O
75	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
the	DT	det	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O
responded	VBD	ROOT	O
,	,	punct	O
versus	CC	cc	O
18	CD	nummod	O
%	NN	conj	O
of	IN	case	O
the	DT	det	O
normal	JJ	amod	O
women	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.0050	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
potential	NN	nsubjpass	O
for	IN	case	O
this	DT	det	O
assay	NN	nmod	O
to	TO	mark	O
distinguish	VB	acl	O
``	``	punct	O
normal	JJ	dobj	O
''	''	punct	O
from	IN	case	O
``	``	punct	O
breast	NN	compound	O
cancer	NN	nmod	O
''	''	punct	O
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
using	VBG	xcomp	O
a	DT	det	O
migration	NN	compound	O
index	NN	dobj	O
derived	VBN	acl	O
from	IN	case	O
discriminant	JJ	amod	O
analysis	NN	nmod	O
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
the	DT	det	O
assay	NN	nmod	O
to	TO	mark	O
discriminate	VB	acl	O
``	``	punct	O
normal	JJ	dobj	O
''	''	punct	O
from	IN	case	O
``	``	punct	O
cancer	NN	nmod	O
''	''	punct	O
was	VBD	cop	O
significant	JJ	ROOT	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.001	CD	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
showed	VBD	conj	O
a	DT	det	O
sensitivity	NN	dobj	O
of	IN	case	O
detecting	VBG	amod	O
``	``	punct	O
cancer	NN	nmod	O
''	''	punct	O
of	IN	case	O
75	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

The	DT	det	O
overall	JJ	amod	O
responses	NNS	nsubjpass	O
to	TO	case	O
MuMTV	NN	nmod	B-protein
and	CC	cc	O
MCF-7	NN	conj	B-protein
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
with	IN	case	O
reference	NN	nmod	O
to	TO	case	O
certain	JJ	amod	O
prognostic	JJ	amod	O
factors	NNS	nmod	O
,	,	punct	O
but	CC	cc	O
showed	VBD	conj	O
no	DT	neg	O
relation	NN	dobj	O
to	TO	case	O
age	NN	nmod	O
,	,	punct	O
menstrual	JJ	amod	O
status	NN	conj	O
,	,	punct	O
estrogen	NN	compound	O
receptor	NN	compound	O
status	NN	conj	O
,	,	punct	O
or	CC	cc	O
stage	NN	conj	O
of	IN	case	O
disease	NN	nmod	O
.	.	punct	O

The	DT	det	O
above	JJ	amod	O
reactions	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
large	JJ	amod	O
proportion	NN	nsubj	O
of	IN	case	O
breast	NN	compound	O
cancer	NN	compound	O
patients	NNS	nmod	O
exhibit	VBP	ccomp	O
presensitization	NN	dobj	O
to	TO	case	O
antigenfs	NNS	nmod	O
found	VBN	acl	O
in	IN	case	O
MuMTV	NN	nmod	B-protein
and	CC	cc	O
MCF-7	NN	conj	B-protein
,	,	punct	O
which	WDT	nsubj	O
may	MD	aux	O
be	VB	cop	O
cross-reactive	JJ	acl:relcl	O
with	IN	case	O
antigens	NNS	nmod	O
in	IN	case	O
the	DT	det	O
primary	JJ	amod	O
cancer	NN	nmod	O
.	.	punct	O

These	DT	det	O
responses	NNS	nsubj	O
appear	VBP	ROOT	O
to	TO	mark	O
be	VB	cop	O
independent	JJ	xcomp	O
of	IN	case	O
major	JJ	amod	O
prognostic	JJ	amod	O
variables	NNS	nmod	O
.	.	punct	O

Further	JJ	amod	O
refinement	NN	nsubj	O
of	IN	case	O
this	DT	det	O
assay	NN	nmod	O
may	MD	aux	O
yield	VB	ROOT	O
one	CD	dobj	O
which	WDT	nsubj	O
is	VBZ	cop	O
more	RBR	advmod	O
highly	RB	advmod	O
discriminating	VBG	acl:relcl	O
for	IN	case	O
breast	NN	compound	O
cancer	NN	nmod	O
.	.	punct	O

Chronic	JJ	amod	O
lymphatic	JJ	amod	O
leukaemia	NN	ROOT	O
:	:	punct	O
cellular	JJ	amod	O
effects	NNS	dep	O
of	IN	case	O
glucocorticoids	NNS	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
levels	NNS	nsubjpass	O
and	CC	cc	O
steroid	NN	nmod:npmod	O
induced	JJ	amod	O
inhibition	NN	nsubjpass	O
of	IN	case	O
nucleic	JJ	amod	O
acid	NN	compound	O
precursors	NNS	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
from	IN	case	O
27	CD	nummod	O
patients	NNS	nmod	O
at	IN	case	O
different	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
chronic	JJ	amod	O
lymphatic	JJ	amod	O
leukaemia	NN	nmod	O
.	.	punct	O

No	DT	neg	O
correlation	NN	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
and	CC	cc	O
the	DT	det	O
stage	NN	conj	O
of	IN	case	O
the	DT	det	O
disease	NN	nmod	O
.	.	punct	O

On	IN	case	O
the	DT	det	O
other	JJ	amod	O
hand	NN	nmod	O
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
difference	NN	nsubjpass	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0.02	CD	nmod	O
)	-RRB-	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
stage	NN	compound	O
O	NN	nmod	O
and	CC	cc	O
stage	NN	conj	O
III/IV	JJ	amod	O
patients	NNS	dobj	O
,	,	punct	O
in	IN	case	O
terms	NNS	nmod	O
of	IN	case	O
the	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
effect	NN	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
on	IN	case	O
[	-LRB-	punct	O
3H	NN	dep	O
]	-RRB-	punct	O
uridine	JJ	compound	O
incorporation	NN	nmod	O
.	.	punct	O

Pyrrolidine	NN	compound	O
dithiocarbamate	NN	nsubj	O
inhibits	VBZ	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
mobilization	NN	dobj	O
and	CC	cc	O
TNF	NN	compound	O
production	NN	conj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
human	JJ	amod	B-DNA
TNF	NN	compound	I-DNA
promoter	NN	nsubj	I-DNA
contains	VBZ	ROOT	O
four	CD	nummod	O
potential	JJ	amod	O
nuclear	JJ	amod	B-DNA
factor-kappa	NN	compound	I-DNA
B	NN	dobj	I-DNA
(	-LRB-	punct	I-DNA
NF-kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
-binding	JJ	amod	I-DNA
sites	NNS	dep	I-DNA
,	,	punct	O
with	IN	case	O
the	DT	det	O
strongest	JJS	compound	O
binding	NN	nmod	O
seen	VBN	acl	O
for	IN	case	O
the	DT	det	O
-605	CD	nummod	O
motif	NN	nmod	O
.	.	punct	O

Nuclear	JJ	amod	O
extracts	NNS	nsubj	O
from	IN	case	O
unstimulated	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-cell_line
monocytic	JJ	amod	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
,	,	punct	O
Mono	NN	compound	B-cell_line
Mac	NN	appos	I-cell_line
6	CD	nummod	I-cell_line
,	,	punct	O
contain	VBP	ROOT	O
one	CD	nummod	O
specific	JJ	amod	B-protein
binding	NN	compound	I-protein
protein	NN	dobj	I-protein
(	-LRB-	punct	O
complex	NN	appos	B-protein
II	CD	nummod	I-protein
)	-RRB-	punct	O
,	,	punct	O
consistent	JJ	advcl	O
with	IN	case	O
a	DT	det	O
constitutive	JJ	amod	B-protein
p50	NN	compound	I-protein
homodimer	NN	nmod	I-protein
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
Mono	NN	compound	B-cell_line
Mac	NN	compound	I-cell_line
6	CD	nummod	I-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
LPS	NN	nmod	O
will	MD	aux	O
increase	VB	ROOT	O
complex	NN	dobj	B-protein
II	CD	nummod	I-protein
and	CC	cc	O
will	MD	aux	O
strongly	RB	advmod	O
induce	VB	conj	O
a	DT	det	O
second	JJ	amod	O
specific	JJ	amod	O
complex	NN	dobj	O
(	-LRB-	punct	O
complex	NN	appos	B-protein
I	NN	nummod	I-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
represents	VBZ	acl:relcl	O
the	DT	det	O
p50/65	JJ	compound	B-protein
heterodimer	NN	dobj	I-protein
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
Mono	NN	compound	B-cell_type
Mac	NN	compound	I-cell_type
6	CD	nummod	I-cell_type
cells	NNS	nmod	I-cell_type
with	IN	case	O
pyrrolidine-dithiocarbamate	JJ	nmod	O
(	-LRB-	punct	O
PDTC	NN	appos	O
)	-RRB-	punct	O
at	IN	case	O
300	CD	nummod	O
microM	NN	nmod	O
will	MD	aux	O
block	VB	ROOT	O
the	DT	det	O
LPS-induced	JJ	amod	B-protein
complex	NN	dobj	I-protein
I	PRP	dep	I-protein
almost	RB	advmod	O
completely	RB	advmod	O
and	CC	cc	O
will	MD	aux	O
reduce	VB	conj	O
complex	NN	dobj	B-protein
II	CD	nummod	I-protein
to	TO	prep	O
the	DT	det	O
constitutive	JJ	amod	O
level	NN	pobj	O
.	.	punct	O

Binding	NN	compound	O
activity	NN	nsubjpass	O
of	IN	case	O
other	JJ	amod	O
nuclear	JJ	amod	B-protein
factors	NNS	nmod	I-protein
that	WDT	nsubj	O
recognize	VBP	acl:relcl	O
the	DT	det	O
SP-1	NN	preconj	O
and	CC	cc	O
c/EBP	NN	amod	O
motifs	NNS	dobj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
TNF	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
is	VBZ	auxpass	O
not	RB	neg	O
affected	VBN	ROOT	O
by	IN	case	O
such	JJ	amod	O
treatment	NN	nmod	O
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
PDTC	NN	compound	O
treatment	NN	nsubj	O
will	MD	aux	O
strongly	RB	advmod	O
reduce	VB	ccomp	O
LPS-induced	JJ	amod	B-protein
TNF	NN	compound	I-protein
transcripts	NNS	dobj	I-protein
.	.	punct	O

Secreted	VBN	amod	O
TNF	NN	compound	B-protein
protein	NN	nsubjpass	I-protein
as	IN	mark	O
detected	VBN	acl	O
in	IN	case	O
the	DT	det	O
Wehi	NNP	compound	O
164S/ActD	NN	nummod	O
bioassay	NN	nmod	O
and	CC	cc	O
in	IN	case	O
a	DT	det	O
sandwich	JJ	amod	O
immunoassay	NN	conj	O
was	VBD	auxpass	O
similarly	RB	advmod	O
reduced	VBN	ROOT	O
by	IN	case	O
PDTC	NN	nmod	O
.	.	punct	O

Kinetic	JJ	amod	O
analyses	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
after	IN	case	O
LPS	NN	compound	O
stimulation	NN	nmod	O
,	,	punct	O
NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
will	MD	aux	O
peak	VB	ccomp	O
at	IN	case	O
1	CD	nummod	O
h	NN	nmod	O
,	,	punct	O
TNF	NN	compound	O
transcript	NN	compound	O
prevalence	NN	conj	O
at	IN	case	O
2	CD	nummod	O
h	NN	nmod	O
,	,	punct	O
and	CC	cc	O
TNF	NN	compound	B-protein
protein	NN	conj	I-protein
at	IN	case	O
4	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

PDTC	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
shift	VB	ROOT	O
this	DT	det	O
response	NN	dobj	O
to	TO	case	O
LPS	NN	nmod	O
to	TO	case	O
a	DT	det	O
later	JJ	amod	O
time	NN	nmod	O
,	,	punct	O
but	CC	cc	O
suppressed	VBD	conj	O
NF-kappa	NN	compound	O
B	NN	compound	O
mobilization	NN	dobj	O
,	,	punct	O
TNF	NN	compound	B-protein
transcripts	NNS	conj	I-protein
,	,	punct	O
and	CC	cc	O
TNF	NN	compound	B-protein
protein	NN	conj	I-protein
over	IN	case	O
the	DT	det	O
entire	JJ	amod	O
8-h	JJ	amod	O
observation	NN	compound	O
period	NN	nmod	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
freshly	RB	advmod	O
isolated	VBN	amod	O
,	,	punct	O
LPS-stimulated	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nmod	I-cell_type
showed	VBD	ROOT	O
a	DT	det	O
similar	JJ	amod	O
blockade	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
in	IN	case	O
these	DT	det	O
primary	JJ	amod	O
cells	NNS	nmod	O
,	,	punct	O
induction	NN	appos	O
of	IN	case	O
TNF	NN	compound	B-protein
transcripts	NNS	nmod	I-protein
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nmod	O
and	CC	cc	O
by	IN	case	O
quantitative	JJ	amod	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	conj	O
,	,	punct	O
was	VBD	auxpass	O
prevented	VBN	ROOT	O
by	IN	case	O
PDTC	NN	nmod	O
as	IN	mark	O
was	VBD	cop	O
TNF	NN	compound	B-protein
protein	NN	compound	I-protein
production	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
dithiocarbamates	NNS	nsubj	O
can	MD	aux	O
profoundly	RB	advmod	O
affect	VB	ccomp	O
cytokine	NN	compound	O
expression	NN	dobj	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
NF-kappa	NN	compound	B-protein
B	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
LPS-induced	JJ	amod	O
TNF	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

Comparing	VBG	amod	O
regions	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
Epstein-Barr	JJ	amod	B-protein
virus	NN	compound	I-protein
ZEBRA	NN	compound	I-protein
protein	NN	nmod	I-protein
which	WDT	nsubj	O
function	VBP	acl:relcl	O
as	IN	case	O
transcriptional	JJ	amod	B-DNA
activating	VBG	amod	I-DNA
sequences	NNS	nmod	I-DNA
in	IN	case	O
Saccharomyces	FW	compound	O
cerevisiae	FW	nmod	O
and	CC	cc	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

The	DT	det	O
ZEBRA	NN	compound	B-protein
protein	NN	nsubj	I-protein
activates	VBZ	ROOT	O
expression	NN	dobj	O
of	IN	case	O
Epstein-Barr	JJ	amod	O
virus	NN	compound	O
early-lytic-cycle	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
ZEBRA	NN	nsubj	B-protein
also	RB	advmod	O
behaves	VBZ	ccomp	O
as	IN	case	O
a	DT	det	O
sequence-specific	JJ	amod	B-protein
transcriptional	JJ	amod	I-protein
activator	NN	nmod	I-protein
in	IN	case	O
Saccharomyces	FW	compound	O
cerevisiae	FW	nmod	O
.	.	punct	O

Deletional	JJ	amod	O
mutagenesis	NN	nsubj	O
defined	VBD	ROOT	O
three	CD	nummod	O
regions	NNS	dobj	O
of	IN	case	O
ZEBRA	NN	nmod	B-protein
that	WDT	nsubj	O
participate	VBP	acl:relcl	O
in	IN	case	O
activation	NN	nmod	O
in	IN	case	O
S.	FW	compound	O
cerevisiae	FW	nmod	O
.	.	punct	O

These	DT	det	O
regions	NNS	nsubjpass	O
are	VBP	auxpass	O
designated	VBN	ROOT	O
YI	NN	xcomp	B-protein
(	-LRB-	punct	O
amino	NN	compound	B-protein
acids	NNS	appos	I-protein
[	-LRB-	punct	I-protein
aa	NNS	dep	I-protein
]	-RRB-	punct	I-protein
1	CD	compound	I-protein
to	TO	dep	I-protein
25	CD	dep	I-protein
)	-RRB-	punct	O
,	,	punct	O
YII	NN	appos	B-protein
(	-LRB-	punct	O
aa	NN	dep	B-protein
51	CD	nummod	I-protein
to	TO	dep	I-protein
102	CD	nummod	I-protein
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
YIII	NN	conj	B-protein
(	-LRB-	punct	O
aa	NN	dep	B-protein
228	CD	nummod	I-protein
to	TO	dep	I-protein
245	CD	nummod	I-protein
)	-RRB-	punct	O
.	.	punct	O

Two	CD	nsubj	O
of	IN	case	O
the	DT	det	O
three	CD	nummod	O
regions	NNS	nmod	O
of	IN	case	O
the	DT	det	O
native	JJ	amod	O
ZEBRA	NN	compound	B-protein
protein	NN	nmod	I-protein
act	VBP	ROOT	O
together	RB	advmod	O
to	TO	mark	O
mediate	VB	xcomp	O
activation	NN	dobj	O
when	WRB	advmod	O
assayed	VBN	advcl	O
on	IN	case	O
ZEBRA	NN	compound	B-protein
binding	NN	compound	I-protein
sites	NNS	nmod	I-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
when	WRB	advmod	O
fused	VBN	advcl	O
to	TO	case	O
the	DT	det	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
domain	NN	nmod	I-protein
of	IN	case	O
GAL	NN	nmod	B-protein
4	CD	nummod	O
and	CC	cc	O
assayed	VBN	conj	O
on	IN	case	O
GAL4	NN	compound	B-protein
binding	NN	compound	I-protein
sites	NNS	nmod	I-protein
,	,	punct	O
regions	NNS	nsubj	B-protein
YII	NN	dep	I-protein
and	CC	cc	I-protein
YIII	NN	conj	I-protein
were	VBD	cop	O
each	DT	det	O
sufficient	JJ	ROOT	O
to	TO	mark	O
confer	VB	xcomp	O
activation	NN	dobj	O
in	IN	case	O
S.	FW	compound	O
cerevisiae	FW	nmod	O
.	.	punct	O

Regions	NNS	nsubjpass	O
of	IN	case	O
ZEBRA	NN	nmod	B-protein
which	WDT	nsubj	O
affected	VBD	acl:relcl	O
activation	NN	dobj	O
in	IN	case	O
S.	FW	compound	O
cerevisiae	FW	nmod	O
were	VBD	auxpass	O
also	RB	advmod	O
required	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
amino-terminal	JJ	amod	B-protein
region	NN	nsubjpass	I-protein
of	IN	case	O
ZEBRA	NN	nmod	B-protein
(	-LRB-	punct	O
aa	NN	dep	B-protein
1	CD	nummod	I-protein
to	TO	dep	I-protein
98	CD	nummod	I-protein
)	-RRB-	punct	O
was	VBD	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
activation	NN	nmod	O
both	CC	cc:preconj	O
in	IN	case	O
S.	FW	compound	O
cerevisiae	FW	nmod	O
and	CC	cc	O
in	IN	case	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	conj	I-cell_type
;	:	punct	O
deletion	NN	nsubj	O
of	IN	case	O
the	DT	det	O
carboxy-terminal	JJ	amod	B-protein
18	CD	nummod	I-protein
aa	NNS	nmod	I-protein
also	RB	advmod	O
significantly	RB	advmod	O
reduced	VBD	parataxis	O
activation	NN	dobj	O
in	IN	case	O
both	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
the	DT	det	O
behavior	NN	nsubj	O
of	IN	case	O
ZEBRA	NN	nmod	B-protein
in	IN	case	O
human	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
S.	FW	compound	O
cerevisiae	FW	conj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
protein	NN	nsubj	O
contains	VBZ	ccomp	O
universal	JJ	amod	B-protein
activation	NN	compound	I-protein
motifs	NNS	dobj	I-protein
that	WDT	nsubj	O
interact	VBP	acl:relcl	O
with	IN	case	O
conserved	VBN	amod	O
components	NNS	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	O
machinery	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
certain	JJ	amod	O
deletion	NN	compound	B-protein
mutants	NNS	nsubj	I-protein
of	IN	case	O
ZEBRA	NN	nmod	B-protein
containing	VBG	acl	O
mutations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
N-terminal	JJ	amod	B-protein
region	NN	nmod	I-protein
exhibited	VBD	ROOT	O
discordant	JJ	amod	O
behaviors	NNS	dobj	O
in	IN	case	O
S.	FW	compound	O
cerevisiae	FW	nmod	O
and	CC	cc	O
in	IN	case	O
B	NN	compound	O
cells	NNS	conj	O
.	.	punct	O

For	IN	case	O
example	NN	nmod	O
,	,	punct	O
deletion	NN	nsubj	O
of	IN	case	O
ZEBRA	NN	compound	B-protein
aa	NN	nmod	I-protein
26	CD	compound	I-protein
to	TO	dep	I-protein
51	CD	nummod	I-protein
impaired	JJ	amod	O
activation	NN	nmod	O
to	TO	case	O
a	DT	det	O
great	JJ	amod	O
extent	NN	nmod	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
but	CC	cc	O
had	VBD	ROOT	O
little	JJ	amod	O
or	CC	cc	O
no	DT	conj	O
effect	NN	dobj	O
in	IN	case	O
S.	FW	compound	O
cerevisiae	FW	nmod	O
.	.	punct	O

The	DT	det	O
discordant	JJ	amod	O
mutants	NNS	nsubj	O
may	MD	aux	O
reflect	VB	ROOT	O
interactions	NNS	dobj	O
with	IN	case	O
a	DT	det	O
variable	JJ	amod	B-protein
domain	NN	nmod	I-protein
of	IN	case	O
a	DT	det	O
conserved	VBN	amod	O
component	NN	nmod	O
or	CC	cc	O
unique	JJ	amod	O
interactions	NNS	conj	O
with	IN	case	O
specialized	VBN	amod	O
components	NNS	nmod	O
of	IN	case	O
the	DT	det	O
basal	JJ	amod	O
transcription	NN	compound	O
apparatus	NN	nmod	O
in	IN	case	O
different	JJ	amod	O
cells	NNS	nmod	O
.	.	punct	O

Functional	JJ	amod	O
interaction	NN	ROOT	O
of	IN	case	O
the	DT	dep	O
v-Rel	NN	compound	B-protein
and	CC	cc	I-protein
c-Rel	NN	conj	I-protein
oncoproteins	NNS	nmod	I-protein
with	IN	case	O
the	DT	det	O
TATA-binding	JJ	amod	B-protein
protein	NN	nmod	I-protein
and	CC	cc	O
association	NN	conj	O
with	IN	case	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
IIB	NN	nmod	I-protein
.	.	punct	O

Rel	NN	compound	B-protein
family	NN	compound	I-protein
proteins	NNS	nsubj	I-protein
regulate	VBP	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
genes	NNS	nmod	O
linked	VBN	acl	O
to	TO	case	O
kappa	NN	compound	O
B-binding	JJ	amod	O
motifs	NNS	nmod	O
.	.	punct	O

Little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
of	IN	case	O
the	DT	det	O
mechanism	NN	nmod	O
by	IN	case	O
which	WDT	nmod	O
they	PRP	nsubj	O
enhance	VBP	acl:relcl	O
transcription	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
the	DT	dep	O
v-Rel	NN	compound	B-protein
and	CC	cc	I-protein
c-Rel	NN	conj	I-protein
oncoproteins	VBZ	nmod	I-protein
to	TO	mark	O
interact	VB	acl	O
with	IN	case	O
components	NNS	nmod	O
of	IN	case	O
the	DT	det	O
basal	JJ	amod	O
transcription	NN	compound	O
machinery	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
the	DT	det	O
acidic	JJ	amod	O
transcription	NN	compound	O
activation	NN	compound	O
domain	NN	nsubj	O
mapping	VBG	acl	O
to	TO	case	O
the	DT	det	O
unique	JJ	amod	O
C	NN	compound	B-protein
terminus	NN	nmod	I-protein
of	IN	case	O
chicken	NN	compound	B-protein
c-Rel	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
F9	NN	nmod:npmod	B-protein
cell-specific	JJ	amod	I-protein
activation	NN	compound	I-protein
region	NN	conj	I-protein
common	JJ	amod	O
to	TO	case	O
both	CC	cc:preconj	O
v-Rel	NN	nmod	B-protein
and	CC	cc	O
c-Rel	NN	conj	B-protein
interact	VBP	ccomp	O
with	IN	case	O
the	DT	det	O
TATA-binding	JJ	amod	B-protein
protein	NN	nmod	I-protein
(	-LRB-	punct	O
TBP	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
IIB	NN	conj	I-protein
(	-LRB-	punct	O
TFIIB	NN	appos	B-protein
)	-RRB-	punct	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
TPB	NN	compound	B-protein
interaction	NN	nsubj	O
with	IN	case	O
Rel	NN	compound	B-protein
activation	NN	compound	I-protein
regions	NNS	nmod	I-protein
leads	VBZ	ccomp	O
to	TO	case	O
synergistic	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
transcription	NN	nmod	O
of	IN	case	O
a	DT	det	O
kappa	NN	nmod:npmod	B-DNA
B-linked	JJ	amod	I-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

Combined	VBN	advmod	O
with	IN	case	O
the	DT	det	O
observation	NN	nmod	O
that	IN	mark	O
the	DT	det	O
mouse	NN	compound	B-protein
c-Rel	NN	nsubj	I-protein
and	CC	cc	I-protein
human	JJ	amod	I-protein
RelA	NN	compound	I-protein
proteins	NNS	conj	I-protein
also	RB	advmod	O
interact	VBP	ccomp	O
with	IN	case	O
TBP	NN	nmod	B-protein
and	CC	cc	O
TFIIB	NN	conj	B-protein
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
association	NN	nsubj	O
with	IN	case	O
basal	JJ	amod	B-protein
transcription	NN	compound	I-protein
factors	NNS	nmod	I-protein
is	VBZ	cop	O
important	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
activities	NNS	nmod	O
of	IN	case	O
Rel	NN	compound	B-protein
family	NN	compound	I-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

p21ras	NN	nsubj	B-protein
and	CC	cc	O
calcineurin	NN	conj	O
synergize	VBP	ROOT	O
to	TO	mark	O
regulate	VB	xcomp	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	O
activated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	dobj	I-cell_type
.	.	punct	O

In	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
triggering	NN	nsubj	O
of	IN	case	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
TCR	NN	appos	B-protein
)	-RRB-	punct	O
induces	VBZ	ROOT	O
several	JJ	amod	O
signaling	NN	compound	O
cascades	NNS	dobj	O
which	WDT	nsubj	O
ultimately	RB	advmod	O
synergize	VBP	acl:relcl	O
to	TO	mark	O
induce	VB	xcomp	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	O
activated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
NFAT	NN	appos	B-cell_line
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
complex	NN	appos	I-protein
critical	JJ	amod	O
to	TO	case	O
the	DT	dep	O
inducibility	NN	nmod	O
and	CC	cc	O
T	NN	compound	O
cell	NN	compound	O
specificity	NN	conj	O
of	IN	case	O
the	DT	det	O
T	NN	compound	B-protein
cell	NN	compound	I-protein
growth	NN	compound	I-protein
factor	NN	compound	I-protein
interleukin	NN	nmod	B-protein
2	CD	nummod	I-protein
.	.	punct	O

One	CD	nummod	O
immediate	JJ	amod	O
consequence	NN	nsubj	O
of	IN	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
via	IN	case	O
the	DT	det	O
TCR	NN	nmod	B-protein
is	VBZ	cop	O
an	DT	det	O
increase	NN	ROOT	O
in	IN	case	O
cytosolic	JJ	amod	O
calcium	NN	nmod	O
.	.	punct	O

Calcium	NN	compound	O
signals	NNS	nsubj	O
are	VBP	cop	O
important	JJ	ROOT	O
for	IN	case	O
NFAT	NN	compound	B-cell_line
induction	NN	nmod	O
,	,	punct	O
and	CC	cc	O
recent	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
identified	VBN	conj	O
calcineurin	NN	dobj	B-protein
,	,	punct	O
a	DT	det	O
calcium-calmodulin	JJ	amod	B-protein
dependent	JJ	amod	I-protein
serine-threonine	NN	compound	I-protein
phosphatase	NN	appos	I-protein
,	,	punct	O
as	IN	case	O
a	DT	det	O
prominent	JJ	amod	O
component	NN	nmod	O
of	IN	case	O
the	DT	det	O
calcium	NN	compound	O
signaling	NN	compound	O
pathway	NN	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
second	JJ	amod	O
important	JJ	amod	O
molecule	NN	nsubj	O
in	IN	case	O
TCR	NN	compound	O
signal	NN	compound	O
transduction	NN	nmod	O
is	VBZ	cop	O
the	DT	det	O
guanine	NN	compound	B-protein
nucleotide	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	ROOT	I-protein
,	,	punct	O
p21ras	NN	appos	B-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
coupled	VBN	acl:relcl	O
to	TO	case	O
the	DT	det	O
TCR	NN	nmod	B-protein
by	IN	case	O
a	DT	det	O
protein	NN	nmod:npmod	B-protein
tyrosine	NN	nmod:npmod	I-protein
kinase	NN	nmod:npmod	I-protein
dependent	JJ	amod	O
mechanism	NN	nmod	O
.	.	punct	O

The	DT	det	O
experiments	NNS	nsubj	O
presented	VBN	acl	O
here	RB	advmod	O
show	VBP	ROOT	O
that	IN	mark	O
expression	NN	nsubj	O
by	IN	case	O
transfection	NN	nmod	O
of	IN	case	O
mutationally	RB	advmod	O
activated	VBN	amod	O
calcineurin	NN	nmod	B-protein
or	CC	cc	O
activated	VBN	amod	O
p21ras	NN	conj	B-protein
alone	RB	advmod	O
is	VBZ	cop	O
insufficient	JJ	ccomp	O
for	IN	case	O
NFAT	NN	compound	B-cell_type
transactivation	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
coexpression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
activated	VBN	amod	O
calcineurin	NN	nmod	O
with	IN	case	O
activated	VBN	amod	O
p21ras	NN	nmod	O
could	MD	aux	O
mimic	VB	ROOT	O
TCR	NN	compound	O
signals	NNS	dobj	O
in	IN	case	O
NFAT	NN	compound	B-cell_type
induction	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
identify	VBP	ROOT	O
calcineurin	NN	dobj	B-protein
and	CC	cc	O
p21ras	NN	conj	B-protein
as	IN	case	O
cooperative	JJ	amod	O
partners	NNS	nmod	O
in	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
activation	NN	nmod	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
the	DT	det	O
chicken	NN	compound	B-protein
GATA	NN	compound	I-protein
factor	NN	compound	I-protein
family	NN	nmod	I-protein
during	IN	case	O
early	JJ	amod	O
erythroid	JJ	amod	O
development	NN	nmod	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

The	DT	det	O
DNA	NN	compound	O
motif	NN	nsubjpass	O
WGATAR	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
within	IN	case	O
transcriptional	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
domains	NNS	nmod	I-DNA
of	IN	case	O
globin	NN	nmod	B-DNA
and	CC	cc	O
other	JJ	amod	O
erythroid-specific	JJ	amod	B-DNA
genes	NNS	conj	I-DNA
and	CC	cc	O
the	DT	det	O
activator	NN	compound	B-protein
proteins	NNS	conj	I-protein
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
to	TO	case	O
this	DT	det	O
regulatory	JJ	amod	B-DNA
element	NN	nmod	I-DNA
,	,	punct	O
the	DT	det	O
GATA	NN	compound	B-protein
factors	NNS	appos	I-protein
,	,	punct	O
belong	VBP	advcl	O
to	TO	case	O
a	DT	det	O
multi-gene	JJ	amod	B-protein
family	NN	nmod	I-protein
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
expressed	VBN	acl:relcl	O
in	IN	case	O
chicken	NN	compound	B-cell_type
erythroid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
,	,	punct	O
as	IN	case	O
in	IN	case	O
chickens	NNS	nmod	O
,	,	punct	O
multiple	JJ	amod	O
members	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
GATA	NN	compound	B-protein
factor	NN	compound	I-protein
family	NN	nmod	I-protein
are	VBP	auxpass	O
expressed	VBN	ccomp	O
in	IN	case	O
human	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
murine	JJ	conj	I-cell_type
erythroid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

During	IN	case	O
the	DT	det	O
early	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
chicken	NN	compound	O
embryogenesis	NN	nmod	O
(	-LRB-	punct	O
well	RB	advmod	O
before	IN	case	O
blood	NN	compound	O
island	NN	compound	O
formation	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
each	DT	nsubjpass	O
of	IN	case	O
the	DT	det	O
GATA	NN	compound	B-protein
family	NN	compound	I-protein
members	NNS	nmod	I-protein
is	VBZ	auxpass	O
transcribed	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
unique	JJ	amod	O
temporal	JJ	amod	O
and	CC	cc	O
spatial	JJ	conj	O
pattern	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
primitive	JJ	amod	B-cell_type
erythroid	JJ	amod	I-cell_type
lineage	NN	nmod	I-cell_type
,	,	punct	O
transcription	NN	nsubj	O
of	IN	case	O
the	DT	det	O
embryonic	JJ	amod	B-DNA
epsilon-globin	NN	compound	I-DNA
gene	NN	nmod	I-DNA
parallels	VBZ	ROOT	O
GATA-1	NN	compound	O
expression	NN	dobj	O
while	IN	mark	O
the	DT	det	O
switch	NN	nsubjpass	O
to	TO	case	O
beta-globin	NN	compound	O
transcription	NN	nmod	O
in	IN	case	O
definitive	JJ	amod	B-cell_type
erythroid	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
is	VBZ	auxpass	O
directly	RB	advmod	O
preceded	VBN	advcl	O
by	IN	case	O
a	DT	det	O
pronounced	JJ	amod	O
increase	NN	nmod	O
in	IN	case	O
GATA-3	NN	compound	B-protein
accumulation	NN	nmod	O
.	.	punct	O

The	DT	det	O
timing	NN	nsubj	O
and	CC	cc	O
pattern	NN	conj	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
these	DT	det	O
different	JJ	amod	O
mRNAs	NNS	nmod	B-RNA
during	IN	case	O
avian	JJ	amod	O
erythroid	JJ	amod	O
development	NN	nmod	O
and	CC	cc	O
differentiation	NN	conj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
temporally	RB	advmod	O
regulated	VBN	amod	O
changes	NNS	nsubjpass	O
in	IN	case	O
GATA	NN	compound	B-protein
factor	NN	compound	I-protein
expression	NN	nmod	O
are	VBP	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
vertebrate	NN	amod	O
hematopoiesis	NN	nmod	O
.	.	punct	O

Molecular	JJ	amod	O
regulation	NN	ROOT	O
of	IN	case	O
human	JJ	amod	B-protein
interleukin	NN	nmod	I-protein
2	CD	nummod	I-protein
and	CC	cc	O
T-cell	NN	compound	B-cell_type
function	NN	conj	O
by	IN	case	O
interleukin	NN	nmod	B-protein
4	CD	nummod	I-protein
.	.	punct	O

Distinct	JJ	amod	O
functional	JJ	amod	O
T-cell	NN	compound	B-cell_type
subsets	NNS	nsubj	I-cell_type
,	,	punct	O
differing	VBG	acl	O
in	IN	case	O
the	DT	det	O
patterns	NNS	nmod	O
of	IN	case	O
lymphokines	NNS	nmod	B-protein
produced	VBN	acl	O
,	,	punct	O
regulate	VBP	ROOT	O
cell-mediated	JJ	amod	O
and	CC	cc	O
humoral	JJ	conj	O
immune	JJ	amod	O
responses	NNS	dobj	O
.	.	punct	O

The	DT	det	O
two	CD	nummod	O
major	JJ	amod	O
types	NNS	nsubj	O
and	CC	cc	O
their	PRP$	nmod:poss	O
principal	JJ	amod	O
products	NNS	conj	O
,	,	punct	O
interleukin	NN	appos	B-protein
4	CD	nummod	I-protein
and	CC	cc	O
interferon	NN	compound	B-protein
gamma	NN	conj	I-protein
(	-LRB-	punct	O
IL-4	NN	dep	B-protein
and	CC	cc	O
IFN-gamma	NN	conj	B-protein
)	-RRB-	punct	O
,	,	punct	O
are	VBP	cop	O
reciprocally	RB	advmod	O
negatively	RB	advmod	O
interactive	JJ	ROOT	O
.	.	punct	O

To	TO	mark	O
analyze	VB	advcl	O
the	DT	det	O
molecular	JJ	amod	O
mechanism	NN	dobj	O
of	IN	case	O
IL-4-mediated	JJ	amod	O
suppression	NN	nmod	O
of	IN	case	O
cell-mediated	JJ	amod	O
immunity	NN	nmod	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
its	PRP$	nmod:poss	O
effects	NNS	dobj	O
on	IN	case	O
expression	NN	nmod	O
of	IN	case	O
interleukin	NN	nmod	B-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
IFN-gamma	NN	conj	B-protein
.	.	punct	O

IL-4	NN	compound	B-protein
pretreatment	NN	nsubj	O
of	IN	case	O
Jurkat	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
prior	RB	case	O
to	TO	case	O
stimulation	NN	nmod	O
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL2	NN	compound	B-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

IL-4	NN	nsubj	B-protein
suppressed	VBD	ROOT	O
IL-2	NN	compound	O
and	CC	cc	O
IFN-gamma	NN	conj	O
mRNA	NN	compound	O
levels	NNS	dobj	O
in	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
addition	NN	nsubj	O
of	IN	case	O
anti-CD28	JJ	amod	B-protein
antibodies	NNS	nmod	I-protein
relieved	VBD	conj	O
this	DT	det	O
suppression	NN	dobj	O
.	.	punct	O

Using	VBG	advcl	O
enhancer-reporter	JJ	amod	B-DNA
constructs	NNS	dobj	I-DNA
,	,	punct	O
IL-4	NN	nsubj	B-protein
specifically	RB	advmod	O
down-regulated	VBD	ROOT	O
the	DT	det	O
NFIL-2B	NN	compound	B-DNA
element	NN	dobj	I-DNA
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	nsubj	O
using	VBG	acl	O
a	DT	det	O
DNA	NN	compound	O
oligomer	NN	dobj	O
containing	VBG	acl	O
the	DT	det	O
NFIL-2B	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	dobj	I-DNA
indicated	VBD	ROOT	O
that	IN	mark	O
IL-4	NN	nsubj	B-protein
inhibited	VBD	ccomp	O
the	DT	det	O
NFIL-2B	NN	compound	B-protein
complex	NN	dobj	I-protein
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
NFIL-2B	NN	compound	B-protein
DNA	NN	compound	I-protein
binding	NN	compound	I-protein
factor	NN	nsubj	I-protein
is	VBZ	cop	O
distinct	JJ	conj	O
from	IN	case	O
AP-	NN	nmod	B-protein
1	CD	nummod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
IL-4	NN	nsubj	B-protein
may	MD	aux	O
regulate	VB	ccomp	O
development	NN	dobj	O
and	CC	cc	O
function	NN	conj	O
of	IN	case	O
T-cell	NN	compound	B-cell_type
subsets	NNS	nmod	I-cell_type
involved	VBN	acl	O
in	IN	case	O
cell-mediated	JJ	amod	O
immunity	NN	nmod	O
in	IN	case	O
part	NN	nmod	O
by	IN	mark	O
inhibiting	VBG	advcl	B-protein
factors	NNS	dobj	I-protein
required	VBN	acl	O
for	IN	case	O
transcription	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL2	NN	compound	B-DNA
gene	NN	nmod	I-DNA

Immunochemical	JJ	amod	O
differences	NNS	ROOT	O
between	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
from	IN	case	O
corticoid-sensitive	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
-resistant	JJ	conj	I-cell_type
malignant	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
explored	VBN	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
of	IN	mark	O
using	VBG	acl	O
antibodies	NNS	dobj	B-protein
against	IN	case	O
purified	VBN	amod	O
rat	NN	compound	O
liver	NN	compound	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
to	TO	mark	O
study	VB	advcl	O
the	DT	det	O
immunochemical	JJ	amod	O
properties	NNS	dobj	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
from	IN	case	O
murine	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
human	JJ	conj	I-cell_type
malignant	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

For	IN	case	O
this	DT	det	O
purpose	NN	nmod	O
,	,	punct	O
purified	VBN	amod	B-protein
immune	JJ	amod	I-protein
immunoglobulin	NN	compound	I-protein
G	NN	nsubjpass	I-protein
was	VBD	auxpass	O
covalently	RB	advmod	O
linked	VBN	ROOT	O
to	IN	case	O
Sepharose	NN	compound	B-protein
CL-4B	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
then	RB	advmod	O
examined	VBD	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
the	DT	det	O
affinity	NN	compound	O
gel	NN	nmod	O
to	TO	mark	O
recognize	VB	acl	O
cytosolic	JJ	amod	B-protein
[	-LRB-	punct	I-protein
3H	NN	dep	I-protein
]	-RRB-	punct	I-protein
triamcinolone	NN	compound	I-protein
acetonide-receptor	NN	amod	I-protein
complexes	NNS	dobj	I-protein
from	IN	case	O
the	DT	det	O
corticoid-sensitive	JJ	amod	B-cell_line
(	-LRB-	punct	I-cell_line
CS	JJ	appos	I-cell_line
)	-RRB-	punct	I-cell_line
and	CC	cc	I-cell_line
-resistant	JJ	conj	I-cell_line
strains	NNS	nmod	I-cell_line
of	IN	case	I-cell_line
mouse	NN	compound	I-cell_line
lymphoma	NN	compound	I-cell_line
P1798	NN	nmod	I-cell_line
,	,	punct	O
from	IN	case	O
CS	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
of	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
chronic	JJ	amod	O
lymphatic	JJ	amod	O
leukemia	NN	nmod	O
,	,	punct	O
and	CC	cc	O
from	IN	case	O
a	DT	det	O
CS	JJ	amod	B-cell_line
clone	NN	conj	I-cell_line
of	IN	case	O
human	JJ	amod	B-cell_type
leukemic	JJ	amod	I-cell_type
lymphoblasts	NNS	nmod	I-cell_type
in	IN	case	O
tissue	NN	compound	O
culture	NN	nmod	O
(	-LRB-	punct	O
CH6	NN	appos	B-cell_line
)	-RRB-	punct	O
.	.	punct	O

Mouse	NN	compound	O
thymus	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
source	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	nmod	I-protein
from	IN	case	O
normal	JJ	amod	B-cell_type
CS	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Whereas	IN	mark	O
the	DT	det	O
immunoaffinity	NN	compound	O
column	NN	nsubj	O
retained	VBD	advcl	O
70	CD	quantmod	O
to	TO	dep	O
84	CD	nummod	O
%	NN	dobj	O
of	IN	case	O
the	DT	det	O
58-	CD	nmod	O
to	TO	dep	O
62-A	CD	dep	O
(	-LRB-	punct	O
Stokes	NN	compound	O
radius	NN	appos	O
)	-RRB-	punct	O
[	-LRB-	punct	B-protein
3H	NN	appos	I-protein
]	-RRB-	punct	I-protein
triamcinolone	NN	compound	I-protein
acetonide-receptor	NN	amod	I-protein
complexes	NNS	appos	I-protein
characteristic	JJ	amod	O
of	IN	case	O
the	DT	det	O
CS	JJ	compound	B-cell_line
mouse	NN	dep	I-cell_line
and	CC	cc	I-cell_line
human	JJ	amod	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
,	,	punct	O
it	PRP	nsubj	O
failed	VBD	ROOT	O
to	TO	mark	O
recognize	VB	xcomp	O
the	DT	det	O
27-	CD	compound	O
to	TO	dep	O
28-A	CD	compound	O
(	-LRB-	punct	O
Stokes	NN	compound	O
radius	NN	appos	O
)	-RRB-	punct	O
glucocorticoid	NN	compound	B-protein
receptor	NN	dobj	I-protein
present	JJ	amod	O
in	IN	case	O
corticoid-resistant	JJ	amod	O
mouse	NN	compound	B-cell_line
lymphoma	NN	compound	I-cell_line
P1798	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
under	IN	case	O
appropriate	JJ	amod	O
experimental	JJ	amod	O
conditions	NNS	nmod	O
,	,	punct	O
it	PRP	nsubj	O
was	VBD	cop	O
possible	JJ	ROOT	O
to	TO	mark	O
demonstrate	VB	xcomp	O
cross-reactivity	NN	dobj	O
between	IN	case	O
the	DT	det	O
antiserum	NN	nmod	O
against	IN	case	O
rat	NN	compound	B-protein
liver	NN	compound	I-protein
glucocorticoid	NN	compound	I-protein
receptor	NN	nmod	I-protein
and	CC	cc	O
the	DT	det	O
58-	CD	compound	O
to	TO	dep	O
62-A	CD	dep	O
(	-LRB-	punct	O
Stokes	NN	compound	O
radius	NN	appos	O
)	-RRB-	punct	O
glucocorticoid	NN	compound	B-protein
receptor	NN	conj	I-protein
from	IN	case	O
species	NNS	nmod	O
as	RB	advmod	O
diverse	JJ	advmod	O
as	IN	case	O
mouse	NN	nmod	O
and	CC	cc	O
humans	NNS	conj	O
.	.	punct	O

Heterogeneity	NN	ROOT	O
of	IN	case	O
the	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
responses	NNS	nmod	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
in	IN	case	O
acute	JJ	amod	O
leukemia	NN	nmod	O
.	.	punct	O

In	IN	case	O
leukocyte	NN	compound	B-cell_type
population	NN	nmod	I-cell_type
freshly	RB	advmod	O
isolated	VBN	acl	O
from	IN	case	O
the	DT	det	O
blood	NN	nmod	O
of	IN	case	O
26	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
acute	JJ	amod	O
leukemia	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
measured	VBN	ROOT	O
several	JJ	amod	O
parameters	NNS	dobj	O
including	VBG	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
,	,	punct	O
nucleoside	NN	compound	O
incorporation	NN	conj	O
,	,	punct	O
percentage	NN	appos	O
of	IN	case	O
cells	NNS	nmod	O
in	IN	case	O
S	NN	compound	O
phase	NN	nmod	O
,	,	punct	O
and	CC	cc	O
steroid-induced	JJ	amod	O
cell	NN	compound	O
lysis	NN	conj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
in	IN	case	O
some	DT	det	O
cases	NNS	nmod	O
,	,	punct	O
the	DT	det	O
short-term	JJ	amod	O
response	NN	nsubjpass	O
to	TO	case	O
steroid	NN	compound	O
therapy	NN	nmod	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
.	.	punct	O

Although	IN	mark	O
,	,	punct	O
in	IN	case	O
all	PDT	det:predet	O
the	DT	det	O
patients	NNS	nmod	O
studied	VBN	acl	O
,	,	punct	O
leukocytes	NNS	nsubjpass	B-cell_type
were	VBD	auxpass	O
found	VBN	advcl	O
to	TO	mark	O
contain	VB	xcomp	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	dobj	I-protein
,	,	punct	O
we	PRP	nsubj	O
failed	VBD	ROOT	O
to	TO	mark	O
demonstrate	VB	xcomp	O
any	DT	det	O
correlation	NN	dobj	O
between	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
binding	VBG	amod	O
sites	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
in	FW	compound	O
vitro	FW	advmod	O
or	CC	cc	O
in	FW	amod	O
vivo	FW	dep	O
response	NN	conj	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

This	DT	det	O
absence	NN	nsubj	O
of	IN	case	O
correlation	NN	nmod	O
could	MD	aux	O
be	VB	cop	O
in	IN	case	O
part	NN	ROOT	O
explained	VBN	acl	O
by	IN	case	O
the	DT	det	O
marked	JJ	amod	O
heterogeneity	NN	nmod	O
of	IN	case	O
the	DT	det	O
steroid	NN	compound	O
response	NN	nmod	O
demonstrated	VBN	acl	O
in	IN	case	O
leukocyte	NN	compound	O
subpopulations	NNS	nmod	O
.	.	punct	O

It	PRP	nsubj	O
appears	VBZ	ROOT	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
that	IN	mark	O
the	DT	det	O
degree	NN	nsubj	O
of	IN	case	O
steroid	NN	compound	O
action	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
extent	NN	conj	O
of	IN	case	O
spontaneous	JJ	amod	O
and	CC	cc	O
dexamethasone-induced	JJ	conj	O
cell	NN	compound	O
death	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
related	JJ	ccomp	O
to	TO	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	O
in	IN	case	O
the	DT	det	O
S	NN	compound	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	B-protein
receptors	NNS	ROOT	I-protein
in	IN	case	O
cytosol	NN	nmod	O
and	CC	cc	O
nuclear	JJ	amod	O
extract	NN	conj	O
of	IN	case	O
human	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
.	.	punct	O

Cortisol	NN	compound	O
binding	NN	nsubjpass	O
by	IN	case	O
cytosol	NN	nmod	O
and	CC	cc	O
0.4	CD	nummod	O
M	NN	conj	O
KCl	NN	compound	O
extract	NN	nmod	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	O
fraction	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
were	VBD	auxpass	O
studied	VBN	ROOT	O
by	IN	case	O
gel	NN	compound	O
chromatography	NN	nmod	O
and	CC	cc	O
ion	NN	compound	O
exchange	NN	compound	O
filtration	NN	conj	O
on	IN	case	O
DEAE	NN	compound	O
cellulose	NN	nmod	O
.	.	punct	O

The	DT	det	O
cytoplasmic	JJ	amod	B-protein
cortisol	NN	compound	I-protein
binding	NN	compound	I-protein
protein	NN	nsubj	I-protein
has	VBZ	ROOT	O
a	DT	det	O
molecular	JJ	amod	O
weight	NN	dobj	O
95	CD	nummod	O
000	CD	dep	O
and	CC	cc	O
the	DT	det	O
soluble	JJ	amod	B-protein
nuclear	JJ	amod	I-protein
binding	NN	compound	I-protein
protein	NN	conj	I-protein
50	CD	nummod	O
000	CD	nummod	O
.	.	punct	O

The	DT	det	O
absence	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
uptake	NN	nmod	O
of	IN	case	O
radioactive	JJ	amod	O
cortisol	NN	nmod	O
by	IN	case	O
isolated	VBN	amod	O
nuclei	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
apparent	JJ	amod	O
requirement	NN	conj	O
of	IN	case	O
the	DT	det	O
cytosol	NN	nmod	O
for	IN	case	O
glucocorticoid	NN	nmod:npmod	O
specific	JJ	amod	O
binding	NN	nmod	O
in	IN	case	O
nuclear	JJ	amod	O
receptor	NN	compound	O
sites	NNS	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
association	NN	compound	O
constant	NN	nsubj	O
characterising	VBG	acl	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
cortisol	NN	nmod	O
to	TO	case	O
cytosol	NN	nmod	O
was	VBD	cop	O
KA	NN	nsubj	O
=	JJ	ROOT	O
3.5	CD	dobj	O
.	.	punct	O
10	CD	nummod	O
(	-LRB-	punct	O
9	CD	dep	O
)	-RRB-	punct	O
l/mol	NN	ROOT	O
.	.	punct	O

Corticosteroid-induced	JJ	amod	O
lymphopenia	NN	ROOT	O
,	,	punct	O
immunosuppression	NN	conj	O
,	,	punct	O
and	CC	cc	O
body	NN	compound	O
defense	NN	conj	O
.	.	punct	O

The	DT	det	O
apparent	JJ	amod	O
paradox	NN	nsubjpass	O
of	IN	case	O
heightened	VBN	amod	O
adrenal	JJ	amod	O
corticosteroid	NN	compound	O
levels	NNS	nmod	O
associated	VBN	acl	O
with	IN	case	O
reduction	NN	nmod	O
in	IN	case	O
the	DT	det	O
competence	NN	nmod	O
of	IN	prep	O
the	DT	det	O
body	NN	poss	O
's	POS	case	O
defensive	JJ	amod	O
apparatus	NN	pobj	O
to	TO	aux	O
cope	VB	xcomp	O
with	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
new	JJ	amod	O
microbial	JJ	amod	B-protein
antigens	NNS	nmod	I-protein
is	VBZ	auxpass	O
considered	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
question	NN	nsubjpass	O
is	VBZ	auxpass	O
asked	VBN	ROOT	O
how	WRB	advmod	O
this	DT	det	O
lowered	JJ	amod	O
defensive	JJ	amod	O
capability	NN	nsubj	O
,	,	punct	O
which	WDT	nsubj	O
occurs	VBZ	acl:relcl	O
in	IN	case	O
the	DT	det	O
face	NN	nmod	O
of	IN	case	O
a	DT	det	O
threat	NN	nmod	O
to	TO	case	O
body	NN	compound	O
integrity	NN	nmod	O
,	,	punct	O
is	VBZ	cop	O
consistent	JJ	ccomp	O
with	IN	prep	O
Cannon	NNP	poss	O
's	POS	case	O
principals	NNS	pobj	O
of	IN	prep	O
the	DT	det	O
``	``	punct	O
wisdom	NN	pobj	O
of	IN	prep	O
the	DT	det	O
body.	NN	pobj	O
''	''	punct	O

The	DT	det	O
suggestion	NN	nsubjpass	O
is	VBZ	auxpass	O
offered	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
immunologic	JJ	amod	O
response	NN	nsubjpass	O
to	TO	case	O
self-antigens	NNS	nmod	B-protein
exposed	VBN	acl	O
by	IN	case	O
disease	NN	nmod	O
or	CC	cc	O
trauma	NN	conj	O
may	MD	aux	O
be	VB	auxpass	O
suppressed	VBN	ccomp	O
by	IN	case	O
corticosteroid	NN	nmod	O
to	TO	mark	O
offset	VB	xcomp	O
the	DT	det	O
likelihood	NN	dobj	O
of	IN	prep	O
autoimmune	JJ	amod	O
attack	NN	pobj	O
.	.	punct	O

Protein	NN	compound	B-protein
tyrosine	NN	compound	I-protein
kinase	NN	compound	I-protein
activation	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
lipopolysaccharide	NN	compound	O
induction	NN	nmod	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
in	IN	case	O
human	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
monocytes	NNS	nmod	I-cell_type
.	.	punct	O

Bacterial	JJ	amod	O
LPS	NN	nsubj	O
induce	VBP	ROOT	O
production	NN	dobj	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
such	JJ	case	O
as	IN	mwe	O
IL-1	NN	nmod	B-protein
,	,	punct	O
IL-6	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
TNF	NN	conj	B-protein
in	IN	case	O
mononuclear	JJ	amod	B-cell_type
phagocytes	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
this	DT	nsubj	O
represents	VBZ	conj	O
a	DT	det	O
central	JJ	amod	O
component	NN	dobj	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
septic	JJ	amod	O
shock	NN	compound	O
syndrome	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
mechanisms	NNS	nsubjpass	O
by	IN	case	O
which	WDT	nmod	O
LPS	NN	nsubj	O
activates	VBZ	acl:relcl	O
these	DT	det	O
cells	NNS	dobj	O
to	TO	mark	O
express	VB	xcomp	O
cytokines	NNS	nsubjpass	B-protein
are	VBP	auxpass	O
not	RB	neg	O
completely	RB	advmod	O
characterized	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
addressed	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
different	JJ	amod	O
protein	NN	compound	B-protein
kinases	NNS	nmod	I-protein
in	IN	case	O
the	DT	det	O
LPS	NN	compound	O
induction	NN	nmod	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
LPS	NN	nsubj	O
induced	VBD	ccomp	O
a	DT	det	O
12-	CD	compound	O
to	TO	dep	O
16-fold	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
IL-1	NN	compound	O
beta	NN	nmod	O
,	,	punct	O
IL-6	NN	conj	O
,	,	punct	O
and	CC	cc	O
TNF-alpha	NN	compound	O
mRNA	NN	compound	O
levels	NNS	conj	O
,	,	punct	O
and	CC	cc	O
this	DT	nsubj	O
was	VBD	cop	O
completely	RB	advmod	O
or	CC	advmod	O
more	JJR	amod	O
than	IN	quantmod	O
80	CD	nummod	O
%	NN	conj	O
blocked	VBN	acl	O
by	IN	case	O
the	DT	det	O
protein	NN	compound	O
tyrosine	NN	compound	O
kinase	NN	nmod:npmod	O
specific	JJ	amod	O
inhibitors	NNS	nmod	O
herbimycin	NN	compound	O
A	NN	dep	O
and	CC	cc	O
genistein	NN	conj	O
at	IN	case	O
the	DT	det	O
concentrations	NNS	nmod	O
of	IN	case	O
1.7	CD	nummod	O
and	CC	cc	O
37	CD	conj	O
microM	NN	nmod	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	compound	I-protein
inhibition	NN	nsubj	O
by	IN	case	O
staurosporine	NN	nmod	O
reduced	VBD	ROOT	O
LPS	NN	compound	O
induction	NN	dobj	O
of	IN	case	O
TNF-alpha	NN	nmod	B-protein
,	,	punct	O
whereas	IN	dep	O
it	PRP	nsubj	O
had	VBD	parataxis	O
no	DT	neg	O
effects	NNS	dobj	O
on	IN	case	O
IL-6	NN	nmod	B-protein
and	CC	cc	O
IL-1	NN	compound	O
beta	NN	conj	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
A	NN	nmod	I-protein
by	IN	case	O
H89	NN	nmod	O
reduced	VBD	ROOT	O
IL-6	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	dobj	O
but	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
detectably	RB	advmod	O
change	VB	conj	O
IL-1	NN	compound	O
beta	NN	dobj	O
or	CC	cc	O
TNF-alpha	NN	conj	O
mRNA	NN	compound	O
levels	NNS	dep	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
LPS	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
increase	VB	ROOT	O
leukemia	NN	compound	B-RNA
inhibitory	JJ	amod	I-RNA
factor	NN	compound	I-RNA
mRNA	NN	dobj	I-RNA
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
constitutively	RB	advmod	O
expressed	VBN	acl:relcl	O
and	CC	cc	O
not	RB	neg	O
significantly	RB	advmod	O
reduced	VBN	conj	O
by	IN	case	O
these	DT	det	O
inhibitors	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	case	O
cytokine	NN	compound	B-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nmod	O
,	,	punct	O
LPS-induced	JJ	amod	O
IL-6	NN	compound	O
protein	NN	compound	O
synthesis	NN	nsubjpass	O
and	CC	cc	O
IL-6	NN	compound	O
bioactivity	NN	conj	O
were	VBD	auxpass	O
also	RB	advmod	O
reduced	VBN	ROOT	O
to	TO	case	O
baseline	NN	compound	O
levels	NNS	nmod	O
by	IN	case	O
the	DT	det	O
PTK	NN	compound	O
inhibitors	NNS	nmod	O
herbimycin	NN	compound	O
A	NN	dep	O
and	CC	cc	O
genistein	NN	conj	O
.	.	punct	O

Both	DT	det	O
PTK	NN	compound	O
inhibitors	NNS	nsubj	O
also	RB	advmod	O
reduced	VBD	ROOT	O
the	DT	det	O
LPS	NN	compound	O
activation	NN	dobj	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
(	-LRB-	punct	O
NF-kappa	NN	compound	B-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
transcription	NN	compound	B-protein
factor	NN	acl:relcl	I-protein
involved	VBN	acl	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	B-RNA
genes	NNS	nmod	I-RNA
such	JJ	case	O
as	IN	mwe	O
IL-6	NN	nmod	B-DNA
and	CC	cc	O
TNF-alpha	NN	conj	B-DNA
.	.	punct	O

The	DT	det	O
activation	NN	nsubjpass	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
was	VBD	auxpass	O
also	RB	advmod	O
reduced	VBN	ROOT	O
by	IN	case	O
H89	NN	nmod	O
,	,	punct	O
whereas	IN	mark	O
staurosporine	NN	nsubj	O
had	VBD	advcl	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
this	DT	det	O
response	NN	nmod	O
.	.	punct	O

In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
these	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nsubj	I-protein
and	CC	cc	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
A	NN	conj	I-protein
appear	VBP	ccomp	O
to	TO	mark	O
have	VB	xcomp	O
selective	JJ	amod	O
effects	NNS	dobj	O
in	IN	case	O
the	DT	det	O
LPS	NN	compound	O
induction	NN	nmod	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
,	,	punct	O
whereas	IN	dep	O
PTK	NN	nsubjpass	B-protein
is	VBZ	auxpass	O
required	VBN	parataxis	O
for	IN	case	O
LPS	NN	compound	O
induction	NN	nmod	O
of	IN	case	O
a	DT	det	O
broad	JJ	amod	O
spectrum	NN	nmod	O
of	IN	case	O
cytokines	NNS	nmod	B-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	conj	O
in	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
control	NN	ROOT	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activation	NN	nmod	O
by	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
.	.	punct	O

The	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	B-protein
B	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
stored	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
in	IN	case	O
complexes	NNS	nmod	O
with	IN	case	O
the	DT	det	O
inhibitor	NN	compound	B-protein
protein	NN	compound	I-protein
I	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
that	IN	mark	O
dissociation	NN	nsubj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
from	IN	case	O
these	DT	det	O
complexes	NNS	nmod	O
results	VBZ	ccomp	O
in	IN	case	O
active	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
lipopolysaccharide	NN	nmod:npmod	O
(	-LRB-	punct	O
LPS	NN	nmod:npmod	O
)	-RRB-	punct	O
-induced	JJ	amod	O
activation	NN	nsubj	O
of	IN	case	O
B	NN	nmod	B-cell_type
or	CC	cc	I-cell_type
pre-B	JJ	conj	I-cell_type
cells	NNS	dep	I-cell_type
results	VBZ	ccomp	O
in	IN	case	O
loss	NN	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
from	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
complexes	NNS	nmod	I-protein
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Many	JJ	nsubj	O
liberated	VBN	amod	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
dimers	NNS	nsubj	I-protein
reached	VBD	ROOT	O
the	DT	det	O
nucleus	NN	dobj	O
,	,	punct	O
where	WRB	advmod	O
increased	VBN	acl:relcl	O
c-rel	NN	dobj	B-protein
,	,	punct	O
p65	NN	conj	O
and	CC	cc	O
p50	NN	conj	O
were	VBD	auxpass	O
detected	VBN	conj	O
by	IN	case	O
immunoblotting	NN	nmod	O
and	CC	cc	O
by	IN	case	O
DNA	NN	compound	O
binding	NN	compound	O
assays	NNS	conj	O
.	.	punct	O

Some	DT	det	O
liberated	JJ	amod	B-protein
dimers	NNS	nsubjpass	I-protein
were	VBD	auxpass	O
retained	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
through	IN	mark	O
binding	VBG	advcl	O
to	TO	case	O
newly	RB	advmod	O
synthesized	VBN	amod	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
,	,	punct	O
a	DT	det	O
finding	NN	appos	O
which	WDT	nsubj	O
strongly	RB	advmod	O
suggests	VBZ	acl:relcl	O
(	-LRB-	punct	O
i	LS	dep	O
)	-RRB-	punct	O
that	IN	mark	O
the	DT	det	O
LPS-induced	JJ	amod	O
signal	NN	nsubj	O
causes	VBZ	ccomp	O
dissociation	NN	dobj	O
of	IN	case	O
complexes	NNS	nmod	O
rather	RB	advmod	O
than	IN	mark	O
preventing	VBG	advcl	O
their	PRP$	nmod:poss	O
association	NN	dobj	O
and	CC	cc	O
(	-LRB-	punct	O
ii	LS	dep	O
)	-RRB-	punct	O
that	IN	mark	O
dissociation	NN	nsubj	O
results	VBZ	conj	O
from	IN	case	O
modification	NN	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
and	CC	cc	O
not	RB	neg	O
of	IN	case	O
c-rel	NN	conj	B-protein
or	CC	cc	O
p65	NN	conj	B-protein
.	.	punct	O

No	DT	neg	O
effect	NN	nsubjpass	O
of	IN	case	O
LPS	NN	compound	O
treatment	NN	nmod	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
on	IN	case	O
p105	NN	nmod	B-protein
or	CC	cc	O
p100	NN	conj	B-protein
,	,	punct	O
which	WDT	nsubj	O
also	RB	advmod	O
retain	VBP	acl:relcl	O
rel	NN	compound	B-protein
family	NN	compound	I-protein
members	NNS	dobj	I-protein
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	O
.	.	punct	O

Quite	RB	advmod	O
unexpectedly	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
also	RB	advmod	O
found	VBD	ROOT	O
that	IN	mark	O
in	IN	case	O
unstimulated	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
there	EX	expl	O
is	VBZ	ccomp	O
a	DT	det	O
constant	JJ	amod	O
ongoing	JJ	amod	O
process	NN	nsubj	O
of	IN	case	O
degradation	NN	nmod	O
and	CC	cc	O
replacement	NN	conj	O
of	IN	case	O
complexed	VBN	amod	B-protein
I	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
this	DT	det	O
turnover	NN	nsubj	O
results	VBZ	ccomp	O
in	IN	case	O
the	DT	det	O
low	JJ	amod	O
level	NN	nmod	O
of	IN	case	O
active	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
presumably	RB	advmod	O
necessary	JJ	amod	O
even	RB	advmod	O
in	IN	case	O
the	DT	det	O
unstimulated	JJ	amod	O
cell	NN	nmod	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
high	JJ	amod	O
rate	NN	nsubj	O
of	IN	case	O
synthesis	NN	nmod	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
provides	VBZ	conj	O
the	DT	det	O
ability	NN	dobj	O
to	TO	mark	O
turn	VB	acl	O
off	RP	case	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nmod	O
rapidly	RB	advmod	O
as	RB	advmod	O
soon	RB	advmod	O
as	IN	prep	O
the	DT	det	O
activating	VBG	amod	O
signal	NN	compound	O
ceases	NNS	pobj	O
.	.	punct	O

Identification	NN	ROOT	O
of	IN	case	O
a	DT	det	O
killer	NN	nmod:npmod	B-DNA
cell-specific	JJ	amod	I-DNA
regulatory	JJ	amod	I-DNA
element	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
mouse	NN	compound	B-DNA
perforin	NN	compound	I-DNA
gene	NN	nmod	I-DNA
:	:	punct	O
an	DT	det	O
Ets-binding	JJ	amod	O
site-homologous	JJ	amod	O
motif	NN	dep	O
that	WDT	nsubj	O
interacts	VBZ	acl:relcl	O
with	IN	case	O
Ets-related	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
gene	NN	nsubjpass	O
encoding	VBG	acl	O
the	DT	det	O
cytolytic	JJ	amod	B-protein
protein	NN	compound	I-protein
perforin	NN	dobj	B-protein
is	VBZ	auxpass	O
selectively	RB	advmod	O
expressed	VBN	ROOT	O
by	IN	case	O
activated	VBN	amod	B-cell_type
killer	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
the	DT	det	O
cell-type-specific	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
characterized	VBN	ROOT	O
the	DT	det	O
regulatory	JJ	amod	O
functions	NNS	dobj	O
and	CC	cc	O
the	DT	det	O
DNA-protein	JJ	amod	O
interactions	NNS	conj	O
of	IN	case	O
the	DT	det	O
5'-flanking	JJ	amod	B-DNA
region	NN	nmod	I-DNA
of	IN	case	O
the	DT	det	O
mouse	NN	compound	B-DNA
perforin	NN	compound	I-DNA
gene	NN	nmod	I-DNA
(	-LRB-	punct	O
Pfp	NN	appos	B-DNA
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
region	NN	nsubjpass	O
extending	VBG	acl	O
from	IN	case	O
residues	NNS	nmod	B-DNA
+62	CD	nummod	I-DNA
through	IN	case	I-DNA
-141	CD	nmod	I-DNA
,	,	punct	O
which	WDT	nsubj	O
possesses	VBZ	acl:relcl	O
the	DT	det	O
essential	JJ	amod	O
promoter	NN	compound	O
activity	NN	dobj	O
,	,	punct	O
and	CC	cc	O
regions	NNS	conj	O
further	RB	advmod	O
upstream	RB	amod	O
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
able	JJ	acl:relcl	O
to	TO	case	O
either	CC	cc:preconj	O
enhance	VB	nmod	O
or	CC	cc	O
suppress	VB	conj	O
gene	NN	compound	O
expression	NN	dobj	O
,	,	punct	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
region	NN	nsubjpass	O
between	IN	case	O
residues	NNS	nmod	B-DNA
-411	CD	dep	I-DNA
and	CC	cc	I-DNA
-566	CD	conj	I-DNA
was	VBD	auxpass	O
chosen	VBN	ROOT	O
for	IN	case	O
further	JJ	amod	O
characterization	NN	nmod	O
,	,	punct	O
since	IN	mark	O
it	PRP	nsubj	O
contains	VBZ	advcl	O
an	DT	det	O
enhancer-like	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
identified	VBN	ROOT	O
a	DT	det	O
32-mer	JJ	amod	O
sequence	NN	dobj	O
(	-LRB-	punct	O
residues	NNS	dep	B-DNA
-491	CD	nummod	I-DNA
to	TO	dep	I-DNA
-522	CD	dep	I-DNA
)	-RRB-	punct	O
which	WDT	nsubj	O
appeared	VBD	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
capable	JJ	xcomp	O
of	IN	mark	O
enhancing	VBG	advcl	O
gene	NN	compound	O
expression	NN	dobj	O
in	IN	case	O
a	DT	det	O
killer	NN	nmod:npmod	O
cell-specific	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Within	IN	case	O
this	DT	det	O
segment	NN	nmod	O
,	,	punct	O
a	DT	det	O
9-mer	JJ	amod	O
motif	NN	appos	O
(	-LRB-	punct	O
5'-ACAGGAAGT-3	NN	appos	O
'	''	punct	O
,	,	punct	O
residues	NNS	dep	B-DNA
-505	CD	compound	I-DNA
to	TO	dep	I-DNA
-497	CD	nummod	I-DNA
;	:	punct	O
designated	VBN	acl	O
NF-P	NN	compound	O
motif	NN	xcomp	O
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
highly	RB	advmod	O
homologous	JJ	acl:relcl	O
to	TO	case	O
the	DT	det	O
Ets	NN	compound	B-DNA
proto-oncoprotein-binding	JJ	amod	I-DNA
site	NN	nmod	I-DNA
,	,	punct	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
interact	VB	xcomp	O
with	IN	case	O
two	CD	nummod	O
proteins	NNS	nmod	O
,	,	punct	O
NF-P1	NN	appos	B-protein
and	CC	cc	O
NF-P2	NN	conj	B-protein
.	.	punct	O

NF-P2	NN	nsubj	B-protein
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
induced	VBN	xcomp	O
by	IN	case	O
reagents	NNS	nmod	O
known	VBN	acl	O
to	TO	mark	O
up-regulate	VB	xcomp	O
the	DT	det	O
perforin	NN	compound	O
message	NN	compound	O
level	NN	dobj	O
and	CC	cc	O
is	VBZ	cop	O
present	JJ	conj	O
exclusively	RB	advmod	O
in	IN	case	O
killer	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assay	NN	nsubj	O
and	CC	cc	O
UV	NN	compound	O
cross-linking	JJ	compound	O
experiments	NNS	conj	O
revealed	VBD	ROOT	O
that	IN	mark	O
NF-P1	NN	nsubj	B-protein
and	CC	cc	O
NF-P2	NN	conj	B-protein
may	MD	aux	O
possess	VB	ccomp	O
common	JJ	amod	O
DNA-binding	JJ	amod	B-protein
subunits	NNS	dobj	I-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
larger	JJR	amod	O
native	JJ	amod	O
molecular	JJ	amod	O
mass	NN	nsubj	O
of	IN	case	O
NF-P1	NN	nmod	B-protein
suggests	VBZ	ROOT	O
that	IN	mark	O
NF-P1	NN	nsubj	B-protein
contains	VBZ	ccomp	O
an	DT	det	O
additional	JJ	amod	O
non-DNA-binding	JJ	amod	B-protein
subunit	NN	compound	I-protein
(	-LRB-	punct	O
s	NNS	dobj	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
view	NN	nmod	O
of	IN	case	O
the	DT	det	O
homology	NN	nmod	O
between	IN	case	O
the	DT	det	O
NF-P	NN	compound	B-protein
motif	NN	nmod	I-protein
and	CC	cc	O
other	JJ	amod	O
Ets	NN	compound	B-protein
proto-oncoprotein-binding	JJ	amod	I-protein
sites	NNS	conj	I-protein
,	,	punct	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
postulated	VBN	ROOT	O
that	IN	mark	O
NF-P1	NN	nsubj	B-protein
and	CC	cc	O
NF-P2	NN	conj	B-protein
belong	VBP	ccomp	O
to	TO	case	O
the	DT	det	O
Ets	NN	compound	B-protein
protein	NN	compound	I-protein
family	NN	nmod	I-protein
.	.	punct	O

Results	NNS	nsubj	O
obtained	VBN	acl	O
from	IN	case	O
the	DT	det	O
binding	NN	compound	O
competition	NN	compound	O
assay	NN	nmod	O
,	,	punct	O
nevertheless	RB	advmod	O
,	,	punct	O
suggest	VBP	ROOT	O
that	IN	mark	O
NF-P1	NN	nsubj	B-protein
and	CC	cc	O
NF-P2	NN	conj	B-protein
are	VBP	cop	O
related	JJ	ccomp	O
to	TO	nmod	O
but	CC	cc	O
distinct	JJ	conj	O
from	IN	case	O
Ets	NN	compound	B-protein
proteins	NNS	nmod	I-protein
,	,	punct	O
e.g.	FW	advmod	O
,	,	punct	O
Ets-1	NN	conj	B-protein
,	,	punct	O
Ets-2	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
NF-AT/Elf-1	NN	conj	B-protein
,	,	punct	O
known	VBN	acl	O
to	TO	mark	O
be	VB	auxpass	O
expressed	VBN	xcomp	O
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
NF-kappa	NN	compound	B-DNA
B1	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
p50/p105	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
in	IN	case	O
activation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
T-lymphocytes	NNS	nmod	I-cell_type
via	IN	case	O
CD2	NN	compound	B-protein
and	CC	cc	I-protein
CD28	NN	conj	I-protein
adhesion	NN	compound	I-protein
molecules	NNS	nmod	I-protein
.	.	punct	O

Stimulation	NN	nsubj	O
of	IN	case	O
primary	JJ	amod	B-cell_type
human	JJ	amod	I-cell_type
T-lymphocytes	NNS	nmod	I-cell_type
via	IN	case	O
CD2	NN	compound	B-protein
and	CC	cc	I-protein
CD28	NN	conj	I-protein
adhesion	NN	compound	I-protein
molecules	NNS	nmod	I-protein
induces	VBZ	ROOT	O
a	DT	det	O
long-lasting	JJ	amod	O
proliferation	NN	dobj	O
(	-LRB-	punct	O
>	NN	dep	O
3	CD	nummod	O
weeks	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
potent	JJ	amod	O
activation	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
require	VB	ROOT	O
accessory	JJ	amod	O
cells	NNS	dobj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
monocytes	NNS	nmod	B-cell_type
,	,	punct	O
but	CC	cc	O
depends	VBZ	conj	O
on	IN	case	O
persistent	JJ	amod	O
interleukin	NN	compound	B-protein
2	CD	nummod	I-protein
(	-LRB-	punct	O
IL-2	NN	appos	B-protein
)	-RRB-	punct	O
secretion	NN	nmod	O
and	CC	cc	O
receptivity	NN	conj	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	acl:relcl	O
with	IN	case	O
high	JJ	amod	O
and	CC	cc	O
prolonged	JJ	conj	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
inducible	JJ	amod	O
CD25/IL-2	NN	compound	B-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
IL-2R	NN	compound	I-DNA
alpha	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
chain	NN	compound	I-DNA
gene	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
transcription	NN	compound	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	I-protein
B	NN	nsubj	I-protein
participates	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
both	CC	cc:preconj	O
IL-2	NN	compound	B-DNA
and	CC	cc	I-DNA
IL-2R	NN	compound	I-DNA
alpha	NN	conj	I-DNA
genes	NNS	nmod	I-DNA
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
multiple	JJ	amod	B-DNA
cellular	JJ	amod	I-DNA
genes	NNS	conj	I-DNA
involved	VBN	acl	O
in	IN	case	O
T-cell	NN	compound	O
proliferation	NN	nmod	O
.	.	punct	O

To	TO	mark	O
evaluate	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
T-lymphocytes	NNS	nmod	I-cell_type
,	,	punct	O
we	PRP	nsubj	O
previously	RB	advmod	O
analyzed	VBD	ROOT	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	nmod:npmod	B-protein
B-related	JJ	amod	I-protein
complexes	NNS	nmod	I-protein
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
CD2+CD28	NN	compound	O
costimulation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
demonstrated	VBD	ROOT	O
a	DT	det	O
long-term	JJ	amod	O
induction	NN	dobj	O
of	IN	case	O
p50/p65	NN	compound	B-protein
heterodimer	NN	nmod	I-protein
,	,	punct	O
a	DT	det	O
putative	JJ	amod	B-protein
p65/c-Rel	NN	compound	I-protein
heterodimer	NN	appos	I-protein
,	,	punct	O
and	CC	cc	O
a	DT	det	O
constitutive	JJ	amod	O
nuclear	JJ	amod	O
expression	NN	conj	O
of	IN	case	O
KBF1/p50	NN	compound	B-protein
homodimers	NNS	nmod	I-protein
.	.	punct	I-protein

As	IN	mark	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
p50	NN	nmod	B-protein
remains	VBZ	advcl	O
unclear	JJ	xcomp	O
,	,	punct	O
we	PRP	nsubj	O
focused	VBD	ROOT	O
our	PRP$	nmod:poss	O
present	JJ	amod	O
study	NN	dobj	O
on	IN	case	O
NF-kappa	NN	compound	B-protein
B1	NN	compound	I-protein
(	-LRB-	punct	O
p50/p105	NN	appos	B-protein
)	-RRB-	punct	O
gene	NN	compound	O
regulation	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	dobj	O
and	CC	cc	O
Western	NN	conj	O
and	CC	cc	O
Northern	NN	compound	O
blot	NN	compound	O
analyses	NNS	conj	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
NF-kappa	NN	compound	B-DNA
B1	NN	compound	I-DNA
gene	NN	compound	I-DNA
expression	NN	dobj	O
during	IN	case	O
T-cell	NN	compound	O
stimulation	NN	nmod	O
via	IN	case	O
CD2+CD28	NN	nmod	B-protein
.	.	punct	O

We	PRP	nsubj	O
observed	VBD	ROOT	O
a	DT	det	O
transient	JJ	amod	O
4-	CD	compound	O
to	TO	dep	O
5-fold	JJ	dep	O
increase	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	O
B1	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
at	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
levels	NNS	dep	O
,	,	punct	O
lasting	VBG	amod	O
for	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
24	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

p50	NN	compound	O
DNA-binding	JJ	amod	O
activity	NN	nsubj	O
apparently	RB	advmod	O
stays	VBZ	ROOT	O
highly	RB	advmod	O
controlled	VBN	xcomp	O
when	WRB	advmod	O
p105	NN	compound	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
enhanced	VBN	advcl	O
by	IN	case	O
a	DT	det	O
physiological	JJ	amod	O
stimulus	NN	nmod	O
of	IN	case	O
peripheral	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
T-cells	NNS	nmod	I-cell_type
.	.	punct	O

Partial	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
p50	NN	compound	O
and	CC	cc	O
p105	NN	conj	O
expression	NN	nmod	O
by	IN	case	O
NF-kappa	NN	compound	B-protein
B1	NN	compound	I-protein
antisense	JJ	amod	O
oligonucleotides	NNS	nmod	O
significantly	RB	advmod	O
reduced	VBD	ROOT	O
T-cell	NN	compound	O
proliferation	NN	dobj	O
and	CC	cc	O
CD25/IL-2R	NN	compound	B-protein
alpha	NN	compound	I-protein
cell	NN	compound	O
surface	NN	compound	O
expression	NN	conj	O
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
250	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

Vitamin	NN	compound	B-protein
D	NN	compound	I-protein
receptor	NN	compound	I-protein
quantitation	NN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
in	IN	case	O
health	NN	nmod	O
and	CC	cc	O
disease	NN	conj	O
.	.	punct	O

Vitamin	NN	compound	B-protein
D	NN	compound	I-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	O
VDR	NN	appos	O
)	-RRB-	punct	O
concentration	NN	nsubjpass	O
was	VBD	auxpass	O
quantitated	VBN	ROOT	O
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
(	-LRB-	punct	O
PBMC	NNS	appos	B-cell_type
)	-RRB-	punct	O
from	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
absorptive	JJ	amod	O
hypercalciuria	NN	nmod	O
(	-LRB-	punct	O
AH	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
patients	NNS	conj	O
with	IN	case	O
high	JJ	amod	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
due	JJ	case	O
to	TO	mwe	O
acquired	VBN	amod	O
or	CC	cc	O
transient	JJ	conj	O
disease	NN	compound	O
states	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
results	NNS	conj	O
compared	VBN	case	O
to	TO	case	O
those	DT	nmod	O
in	IN	case	O
normal	JJ	amod	O
subjects	NNS	nmod	O
.	.	punct	O

VDR	NN	compound	O
concentration	NN	nsubj	O
in	IN	case	O
resting	VBG	amod	B-cell_type
cells	NNS	nmod	I-cell_type
was	VBD	cop	O
not	RB	neg	O
different	JJ	ROOT	O
between	IN	case	O
the	DT	det	O
three	CD	nummod	O
groups	NNS	nmod	O
and	CC	cc	O
represented	VBD	conj	O
constitutive	JJ	amod	O
receptor	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
monocytes	NNS	nmod	B-cell_type
.	.	punct	O

Following	VBG	case	O
activation	NN	nmod	O
with	IN	case	O
phytohemagglutinin	NN	nmod	B-protein
,	,	punct	O
patients	NNS	nsubj	B-cell_type
with	IN	case	O
hypercalcitriolemia	NN	nmod	O
demonstrated	VBD	ROOT	O
significantly	RB	advmod	O
greater	JJR	amod	O
VDR	NN	compound	O
concentrations	NNS	dobj	O
.	.	punct	O

Patients	NNS	nsubj	O
with	IN	case	O
AH	NN	nmod	O
demonstrated	VBD	ROOT	O
a	DT	det	O
normal	JJ	amod	O
value	NN	dobj	O
for	IN	case	O
the	DT	det	O
group	NN	nmod	O
,	,	punct	O
but	CC	cc	O
6	CD	nummod	O
patients	NNS	nsubj	O
had	VBD	conj	O
significantly	RB	advmod	O
greater	JJR	amod	O
concentrations	NNS	dobj	O
of	IN	case	O
VDR	NN	nmod	B-protein
despite	IN	case	O
normal	JJ	amod	O
plasma	NN	compound	O
1	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
in	IN	case	O
four	CD	nmod	O
of	IN	case	O
the	DT	det	O
patients	NNS	nmod	O
.	.	punct	O

Proliferation	NN	nsubjpass	O
,	,	punct	O
as	IN	mark	O
assessed	VBN	advcl	O
from	IN	case	O
[	-LRB-	punct	O
3H	NN	intj	O
]	-RRB-	punct	O
thymidine	NN	compound	O
incorporation	NN	nmod	O
was	VBD	auxpass	O
inversely	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
serum	NN	nmod	O
1	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	conj	O
and	CC	cc	O
was	VBD	cop	O
significant	JJ	conj	O
(	-LRB-	punct	O
R	NN	nsubj	O
=	JJ	dep	O
-0.299	CD	dobj	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
0.048	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
the	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
PBMC	NN	nsubj	B-cell_type
provide	VBP	ccomp	O
a	DT	det	O
useful	JJ	amod	O
system	NN	dobj	O
for	IN	mark	O
studying	VBG	acl	O
VDR	NN	compound	B-protein
status	NN	dobj	O
in	IN	case	O
transient	JJ	amod	O
or	CC	cc	O
acquired	VBN	conj	O
states	NNS	nmod	O
of	IN	case	O
hypercalcitriolemia	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
studies	NNS	nsubj	O
in	IN	case	O
patients	NNS	nmod	O
with	IN	case	O
absorptive	JJ	amod	O
hypercalciuria	NN	nmod	O
disclosed	VBD	ROOT	O
it	PRP	dobj	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
heterogeneous	JJ	amod	O
disorder	NN	xcomp	O
,	,	punct	O
characterized	VBN	acl	O
by	IN	case	O
both	CC	cc:preconj	O
vitamin	NN	nmod:npmod	O
D-dependent	JJ	amod	O
and	CC	cc	O
D-independent	JJ	conj	O
forms	NNS	nmod	O
of	IN	case	O
receptor	NN	compound	O
up-regulation	NN	nmod	O
.	.	punct	O

Reactive	JJ	amod	O
oxygen	NN	compound	O
intermediates	NNS	nsubj	O
activate	VBP	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
in	IN	case	O
a	DT	det	O
tyrosine	NN	compound	O
kinase-dependent	JJ	amod	O
mechanism	NN	nmod	O
and	CC	cc	O
in	IN	case	O
combination	NN	conj	O
with	IN	case	O
vanadate	NN	nmod	O
activate	VBP	conj	O
the	DT	dep	O
p56lck	NN	dobj	B-protein
and	CC	cc	I-protein
p59fyn	NN	conj	I-protein
tyrosine	NN	compound	I-protein
kinases	NNS	dep	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
observed	VBN	ROOT	O
that	IN	mark	O
ionizing	VBG	amod	O
radiation	NN	nsubj	O
induces	VBZ	ccomp	O
tyrosine	NN	compound	O
phosphorylation	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
B-lymphocyte	NN	compound	I-cell_type
precursors	NNS	nmod	I-cell_type
by	IN	case	O
stimulation	NN	nmod	O
of	IN	case	O
unidentified	JJ	amod	O
tyrosine	NN	compound	B-protein
kinases	NNS	nmod	I-protein
and	CC	cc	O
this	DT	det	O
phosphorylation	NN	nsubjpass	O
is	VBZ	auxpass	O
substantially	RB	advmod	O
augmented	VBN	conj	O
by	IN	case	O
vanadate	NN	nmod	O
.	.	punct	O

Ionizing	VBG	amod	O
radiation	NN	nsubj	O
generates	VBZ	ROOT	O
reactive	JJ	amod	O
oxygen	NN	compound	O
intermediates	NNS	dobj	O
(	-LRB-	punct	O
ROI	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Because	IN	mark	O
H2O2	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
ROI	NN	compound	O
generator	NN	advcl	O
that	WDT	nsubj	O
readily	RB	advmod	O
crosses	VBZ	acl:relcl	O
the	DT	det	O
plasma	NN	compound	O
membrane	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
H2O2	NN	dobj	O
to	TO	mark	O
examine	VB	advcl	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
ROI	NN	nmod	O
on	IN	case	O
signal	NN	compound	O
transduction	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
the	DT	det	O
tyrosine	NN	compound	O
kinase	NN	compound	O
inhibitor	NN	compound	O
herbimycin	NN	compound	O
A	NN	nsubj	O
and	CC	cc	O
the	DT	det	O
free	JJ	amod	O
radical	NN	amod	O
scavenger	NN	compound	O
N-acetyl-cysteine	NN	conj	O
inhibit	VBP	ccomp	O
both	CC	cc:preconj	O
radiation-induced	JJ	amod	O
and	CC	cc	O
H2O2-induced	JJ	conj	O
activation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
activation	NN	nsubj	O
triggered	VBN	acl	O
by	IN	case	O
ROI	NN	nmod	O
is	VBZ	cop	O
dependent	JJ	ccomp	O
on	IN	case	O
tyrosine	NN	compound	O
kinase	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

H2O2	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
stimulate	VB	xcomp	O
Ins-1	NN	dobj	B-protein
,	,	punct	I-protein
4	CD	conj	I-protein
,	,	punct	I-protein
5-P3	NN	compound	I-protein
production	NN	conj	O
in	IN	case	O
a	DT	det	O
tyrosine	NN	compound	O
kinase-dependent	JJ	amod	O
manner	NN	nmod	O
and	CC	cc	O
to	TO	mark	O
induce	VB	conj	O
calcium	NN	compound	O
signals	NNS	dobj	O
that	WDT	nsubjpass	O
were	VBD	auxpass	O
greatly	RB	advmod	O
augmented	VBN	acl:relcl	O
by	IN	case	O
vanadate	NN	nmod	O
.	.	punct	O

The	DT	det	O
synergistic	JJ	amod	O
induction	NN	nsubj	O
of	IN	case	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
by	IN	case	O
H2O2	NN	nmod	O
plus	CC	cc	O
vanadate	NN	conj	O
included	VBD	ROOT	O
physiologically	RB	advmod	O
relevant	JJ	amod	O
proteins	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
PLC	NN	compound	B-protein
gamma	NN	nmod	I-protein
1	CD	nummod	I-protein
.	.	punct	O

Although	IN	mark	O
treatment	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	O
with	IN	case	O
H2O2	NN	nmod	O
alone	RB	advmod	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	advcl	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
src	NN	compound	B-protein
family	NN	compound	I-protein
kinases	NNS	nmod	I-protein
,	,	punct	O
treatment	NN	nsubj	O
with	IN	case	O
H2O2	NN	nmod	O
plus	CC	cc	O
vanadate	NN	conj	O
led	VBD	ROOT	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	dep	O
p56lck	NN	nmod	B-protein
and	CC	cc	I-protein
p59fyn	NN	conj	I-protein
tyrosine	NN	compound	I-protein
kinases	NNS	dep	I-protein
.	.	punct	O

The	DT	det	O
combined	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
phosphatases	NNS	nmod	B-protein
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
kinases	NNS	nmod	B-protein
provides	VBZ	ROOT	O
a	DT	det	O
potent	JJ	amod	O
mechanism	NN	dobj	O
for	IN	case	O
the	DT	det	O
synergistic	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
H2O2	NN	nmod	O
plus	CC	cc	O
vanadate	NN	conj	O
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
by	IN	case	O
ROI	NN	nmod	O
may	MD	aux	O
thus	RB	advmod	O
lead	VB	ROOT	O
to	TO	case	O
many	JJ	nmod	O
of	IN	case	O
the	DT	det	O
pleiotropic	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
ROI	NN	nmod	O
in	IN	case	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
including	VBG	case	O
downstream	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
PLC	NN	compound	B-protein
gamma	NN	nmod	I-protein
1	CD	nummod	I-protein
and	CC	cc	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein

Influence	NN	ROOT	O
of	IN	case	O
sex	NN	compound	B-protein
hormone	NN	compound	I-protein
binding	NN	compound	I-protein
globulin	NN	nmod	I-protein
and	CC	cc	O
serum	NN	compound	B-protein
albumin	NN	conj	I-protein
on	IN	case	O
the	DT	det	O
conversion	NN	nmod	O
of	IN	case	O
androstenedione	NN	nmod	O
to	TO	case	O
testosterone	NN	nmod	O
by	IN	case	O
human	JJ	amod	B-cell_type
erythrocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
influence	NN	nsubjpass	O
of	IN	case	O
human	JJ	amod	B-protein
serum	NN	compound	I-protein
albumin	NN	nmod	I-protein
and	CC	cc	O
sex	NN	compound	B-protein
hormone	NN	compound	I-protein
binding	NN	compound	I-protein
globulin	NN	conj	I-protein
(	-LRB-	punct	O
SHBG	NN	appos	B-protein
)	-RRB-	punct	O
on	IN	case	O
the	DT	det	O
enzymic	JJ	amod	O
conversion	NN	nmod	O
of	IN	case	O
androstenedione	NN	nmod	O
to	TO	case	O
testosterone	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-cell_type
erythrocytes	NNS	nmod	I-cell_type
was	VBD	auxpass	O
investigated	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Total	JJ	amod	O
plasma	NN	nsubj	O
and	CC	cc	O
albumin	NN	conj	B-protein
delayed	VBD	ROOT	O
the	DT	det	O
conversion	NN	compound	O
rate	NN	dobj	O
of	IN	case	O
androstenedione	NN	nmod	O
,	,	punct	O
while	IN	mark	O
SHBG	NN	nsubj	B-protein
increased	VBD	advcl	O
it	PRP	dobj	O
markedly	RB	advmod	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
SHBG	NN	nmod	B-protein
was	VBD	auxpass	O
largely	RB	advmod	O
abolished	VBN	ROOT	O
by	IN	mark	O
heating	VBG	advcl	O
to	TO	case	O
60	CD	nummod	O
degrees	NNS	compound	O
C	NN	nmod	O
for	IN	case	O
1	CD	nummod	O
h	NN	nmod	O
and	CC	cc	O
by	IN	mark	O
saturating	VBG	conj	O
its	PRP$	nmod:poss	O
binding	VBG	amod	O
sites	NNS	dobj	O
by	IN	case	O
DHT	NN	nmod	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
both	DT	det	O
proteins	NNS	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
related	JJ	xcomp	O
to	TO	case	O
their	PRP$	nmod:poss	O
concentration	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
appears	VBZ	ROOT	O
that	IN	mark	O
the	DT	det	O
binding	VBG	amod	O
sites	NNS	nsubj	O
of	IN	case	O
albumin	NN	nmod	B-protein
provide	VBP	ccomp	O
a	DT	det	O
mechanism	NN	dobj	O
for	IN	mark	O
retarding	VBG	acl	O
androstenedione	NN	compound	O
uptake	NN	dobj	O
by	IN	case	O
the	DT	det	O
erythrocytes	NNS	nmod	B-cell_type
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
high	JJ	amod	O
binding	NN	compound	O
affinity	NN	nsubj	O
of	IN	case	O
SHBG	NN	nmod	B-protein
for	IN	case	O
testosterone	NN	nmod	O
facilitates	VBZ	conj	O
the	DT	det	O
diffusion	NN	dobj	O
of	IN	case	O
this	DT	det	O
steroid	NN	nmod	O
out	IN	advmod	O
of	IN	case	O
the	DT	det	O
cell	NN	nmod	O
and	CC	cc	O
thus	RB	advmod	O
,	,	punct	O
displaces	VBZ	conj	O
the	DT	det	O
chemical	JJ	amod	O
equilibrium	NN	dobj	O
within	IN	case	O
the	DT	det	O
cell	NN	nmod	O
.	.	punct	O

Glucocorticoids	NNS	ROOT	O
and	CC	cc	O
lymphocytes	NNS	conj	B-cell_type
.	.	punct	O

I	PRP	ROOT	O
.	.	punct	O

Increased	VBN	amod	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
levels	NNS	ROOT	O
in	IN	case	O
antigen-stimulated	JJ	amod	B-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

Recently	RB	advmod	O
a	DT	det	O
2-	CD	compound	O
to	TO	dep	O
3-fold	JJ	amod	O
increase	NN	nsubjpass	O
in	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
has	VBZ	aux	O
been	VBN	auxpass	O
noted	VBN	ROOT	O
after	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
mitogen	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
extend	VBP	ROOT	O
these	DT	det	O
observations	NNS	dobj	O
to	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
immunization	NN	nmod	O
.	.	punct	O

After	IN	case	O
unilateral	JJ	amod	O
immunization	NN	nsubjpass	O
of	IN	case	O
adrenalectomized	JJ	amod	O
male	JJ	amod	O
rats	NNS	nmod	O
,	,	punct	O
a	DT	det	O
50	CD	nummod	O
%	NN	amod	O
increase	NN	appos	O
in	IN	case	O
glucocorticoid	NN	compound	O
receptor	NN	compound	O
sites	NNS	nmod	O
per	IN	case	O
cell	NN	nmod	O
,	,	punct	O
determined	VBN	acl	O
by	IN	case	O
binding	NN	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
cell	NN	compound	O
suspensions	NNS	nmod	O
of	IN	case	O
homolateral	JJ	amod	O
lymph	NN	compound	O
nodes	NNS	nmod	O
over	IN	case	O
those	DT	nmod	O
from	IN	case	O
the	DT	det	O
contralateral	JJ	amod	O
nonimmunized	JJ	amod	O
side	NN	nmod	O
of	IN	case	O
the	DT	det	O
same	JJ	amod	O
animal	NN	nmod	O
.	.	punct	O

The	DT	det	O
association	NN	compound	O
constant	NN	nsubj	O
for	IN	case	O
dexamethasone	NN	nmod	O
was	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
both	DT	det	O
groups	NNS	nmod	O
,	,	punct	O
as	IN	mark	O
was	VBD	cop	O
the	DT	det	O
stereospecificity	NN	advcl	O
for	IN	case	O
various	JJ	amod	O
steroids	NNS	nmod	O
,	,	punct	O
the	DT	det	O
time	NN	compound	O
course	NN	conj	O
of	IN	case	O
cytoplasmic	JJ	amod	O
and	CC	cc	O
nuclear	JJ	conj	O
association	NN	nmod	O
,	,	punct	O
and	CC	cc	O
cytoplasmic-to-nuclear	JJ	amod	O
translocation	NN	conj	O
.	.	punct	O

Despite	IN	case	O
a	DT	det	O
50	CD	compound	O
%	NN	amod	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	O
receptor	NN	compound	O
sites	NNS	nmod	O
per	IN	case	O
cell	NN	nmod	O
,	,	punct	O
the	DT	det	O
cells	NNS	nsubj	O
from	IN	case	O
the	DT	det	O
homolateral	JJ	amod	O
and	CC	cc	O
controlateral	JJ	conj	O
lymph	NN	compound	O
nodes	NNS	nmod	O
were	VBD	cop	O
equally	RB	advmod	O
sensitive	JJ	ROOT	O
to	TO	case	O
the	DT	det	O
inhibitory	JJ	amod	O
effects	NNS	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
measurements	NNS	nmod	O
of	IN	case	O
the	DT	det	O
incorporation	NN	nmod	O
of	IN	case	O
radiolabeled	VBN	amod	O
precursors	NNS	nmod	O
of	IN	case	O
protein	NN	nmod	O
,	,	punct	O
RNA	NN	conj	O
,	,	punct	O
and	CC	cc	O
DNA	NN	conj	O
,	,	punct	O
or	CC	cc	O
measurements	NNS	conj	O
of	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
cell	NN	compound	O
survival	NN	nmod	O
.	.	punct	O

Glucocorticoid	NN	compound	O
receptors	NNS	ROOT	O
and	CC	cc	O
actions	NNS	conj	O
in	IN	case	O
rat	NN	compound	B-cell_type
thymocytes	NNS	nmod	I-cell_type
and	CC	cc	O
immunologically	RB	advmod	O
stimulated	VBN	amod	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
lymphocytes	NNS	conj	I-cell_type
.	.	punct	O

After	IN	prep	O
reviewing	VBG	pcomp	O
briefly	NN	dobj	O
our	PRP$	poss	O
earlier	JJR	amod	O
studies	NNS	dobj	O
on	IN	case	O
glucocorticoid	NN	compound	O
receptors	NNS	nmod	O
and	CC	cc	O
mechanisms	NNS	conj	O
in	IN	case	O
thymus	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
outlined	VBN	ROOT	O
results	NNS	dobj	O
from	IN	prep	O
the	DT	det	O
following	VBG	amod	O
two	CD	nummod	O
areas	NNS	pobj	O
of	IN	prep	O
current	JJ	amod	O
interest	NN	pobj	O
in	IN	prep	O
our	PRP$	poss	O
laboratories	NNS	pobj	O
:	:	punct	O
the	DT	det	O
``	``	punct	O
life-cycle	JJ	dobj	O
''	''	punct	O
of	IN	case	O
glucocorticoid	NN	compound	O
receptors	NNS	nmod	O
and	CC	cc	O
complexes	NNS	conj	O
in	IN	case	O
thymus	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
the	DT	det	O
levels	NNS	conj	O
of	IN	case	O
glucocorticoid	NN	compound	O
receptors	NNS	nmod	O
and	CC	cc	O
sensitivity	NN	conj	O
in	IN	case	O
immunologically	RB	advmod	B-cell_type
stimulated	VBN	amod	I-cell_type
human	JJ	amod	I-cell_type
peripheral	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Several	JJ	nsubj	O
of	IN	prep	O
our	PRP$	poss	O
results	NNS	pobj	O
on	IN	prep	O
energetics	NNS	pobj	O
and	CC	cc	O
kinetics	NNS	conj	O
of	IN	case	O
hormone	NN	compound	O
binding	VBG	nmod	O
to	TO	case	O
glucocorticoid	NN	compound	B-protein
receptors	NNS	nmod	I-protein
in	IN	case	O
rat	NN	compound	B-cell_type
thymus	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
seem	VBP	ROOT	O
to	TO	mark	O
require	VB	xcomp	O
extension	NN	dobj	O
of	IN	case	O
the	DT	det	O
simplest	JJS	amod	O
model	NN	nmod	O
of	IN	case	O
hormone-receptor	NN	compound	O
transformations	NNS	nmod	O
in	IN	case	O
intact	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

ATP-depletion	JJ	compound	O
experiments	NNS	nsubj	O
suggest	VBP	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
a	DT	det	O
nonbinding	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
the	DT	det	O
receptor	NN	nmod	O
;	:	punct	O
``	``	punct	O
chase	NN	compound	O
''	''	punct	O
experiments	NNS	nsubj	O
suggest	VBP	parataxis	O
reaction	NN	dobj	O
of	IN	case	O
hormone	NN	nmod	O
directly	RB	advmod	O
with	IN	case	O
nuclear-bound	JJ	amod	O
receptor	NN	nmod	O
;	:	punct	O
experiments	NNS	nsubj	O
on	IN	case	O
depletion	NN	nmod	O
and	CC	cc	O
replenishment	NN	conj	O
of	IN	case	O
cytoplasmic	JJ	amod	B-protein
receptor	NN	nmod	I-protein
using	VBG	acl	O
cortisol	NN	dobj	O
and	CC	cc	O
dexamethasone	NN	conj	O
suggest	VBP	parataxis	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
two	CD	nummod	O
subpopulations	NNS	nmod	O
of	IN	case	O
nuclear-bound	JJ	amod	B-protein
hormone-receptor	NN	compound	I-protein
complex	NN	nmod	I-protein
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
mitogen	NN	nsubj	O
or	CC	cc	O
immunologic	JJ	amod	O
stimulation	NN	conj	O
of	IN	case	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	IN	case	O
culture	NN	nmod	O
leads	VBZ	ccomp	O
within	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
or	CC	cc	O
so	RB	advmod	O
to	TO	case	O
a	DT	det	O
striking	JJ	amod	O
increase	NN	conj	O
in	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
sites	NNS	nmod	O
per	IN	case	O
cell	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
believe	VBP	ROOT	O
this	DT	det	O
increase	NN	nsubj	O
may	MD	aux	O
be	VB	cop	O
due	JJ	case	O
to	TO	case	O
partial	JJ	amod	O
synchronization	NN	ccomp	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
population	NN	nmod	O
in	IN	case	O
a	DT	det	O
phase	NN	nmod	O
of	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
in	IN	case	O
which	WDT	nmod	O
receptor	NN	compound	O
content	NN	nsubj	O
is	VBZ	cop	O
high	JJ	acl:relcl	O
.	.	punct	O

Contrary	JJ	advmod	O
to	IN	prep	O
the	DT	det	O
widely	RB	advmod	O
held	VBN	amod	O
view	NN	pobj	O
that	IN	mark	O
mitogen-stimulated	JJ	amod	B-cell_type
cells	NNS	nsubj	I-cell_type
become	VBP	ccomp	O
insensitive	JJ	xcomp	O
to	TO	case	O
glucocorticoids	NNS	nmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
experiments	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
with	IN	case	O
respect	NN	nmod	O
to	TO	case	O
inhibition	NN	nmod	O
of	IN	case	O
thymidine	NN	nmod	O
and	CC	cc	O
uridine	NN	conj	O
incorporation	NN	dep	O
and	CC	cc	O
glucose	NN	compound	O
uptake	NN	conj	O
,	,	punct	O
the	DT	det	O
cells	NNS	nsubj	O
are	VBP	cop	O
highly	RB	advmod	O
sensitive	JJ	ccomp	O
to	TO	case	O
dexamethasone	NN	nmod	O
at	IN	case	O
24	CD	nummod	O
,	,	punct	O
48	CD	conj	O
,	,	punct	O
and	CC	cc	O
72	CD	conj	O
h	NN	nmod	O
after	IN	case	O
stimulation	NN	nmod	O
with	IN	case	O
concanavalin	NN	compound	B-protein
A	NN	nmod	I-protein
.	.	punct	O

Nuclear	JJ	amod	O
glucocorticoid	NN	compound	O
binding	NN	ROOT	O
in	IN	case	O
chronic	JJ	amod	B-cell_type
lymphatic	JJ	amod	I-cell_type
leukemia	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

A	DT	det	O
reliable	JJ	amod	O
procedure	NN	nsubjpass	O
is	VBZ	auxpass	O
described	VBN	ROOT	O
for	IN	mark	O
isolating	VBG	advcl	O
3H-triamcinolone	NN	compound	B-protein
acetonide	NN	compound	I-protein
(	-LRB-	punct	I-protein
3H-TA	NN	nummod	I-protein
)	-RRB-	punct	I-protein
receptor	NN	compound	I-protein
complexes	NNS	dobj	I-protein
from	IN	case	O
purified	VBN	amod	O
chronic	JJ	amod	O
lymphatic	JJ	amod	B-cell_type
leukemia	NN	compound	I-cell_type
(	-LRB-	punct	I-cell_type
CLL	NN	appos	I-cell_type
)	-RRB-	punct	I-cell_type
lymphocyte	NN	compound	I-cell_type
nuclei	NNS	nmod	O
,	,	punct	O
based	VBN	case	O
on	IN	case	O
the	DT	det	O
use	NN	nmod	O
of	IN	case	O
carbobenzoxy-L-phenylalanine	NN	nmod	O
(	-LRB-	punct	O
CBZ-L-phe	NN	appos	O
)	-RRB-	punct	O
to	TO	mark	O
prevent	VB	acl	O
breakdown	NN	dobj	O
of	IN	case	O
hormone-receptor	NN	compound	B-protein
complexes	NNS	nmod	I-protein
during	IN	case	O
extraction	NN	nmod	O
of	IN	case	O
nuclei	NNS	nmod	O
with	IN	case	O
0.6M	CD	nummod	O
KCl	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
this	DT	det	O
method	NN	dobj	O
,	,	punct	O
specific	JJ	amod	O
nuclear	JJ	amod	O
glucocorticoid	NN	compound	O
binding	NN	nsubjpass	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
in	IN	case	O
14/14	CD	nummod	O
patients	NNS	nmod	O
with	IN	case	O
untreated	JJ	amod	O
CLL	NN	nmod	O
.	.	punct	O

No	DT	neg	O
correlation	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
levels	NNS	nmod	O
of	IN	case	O
nuclear-associated	JJ	amod	O
3H-TA	NN	intj	O
and	CC	cc	O
peripheral	JJ	conj	O
white	JJ	amod	O
blood	NN	compound	O
cell	NN	compound	O
count	NN	nmod	O
or	CC	cc	O
rosetting	VBG	amod	O
ability	NN	conj	O
of	IN	case	O
circulating	VBG	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Multiple	JJ	amod	O
closely-linked	JJ	amod	O
NFAT/octamer	NN	nsubj	B-DNA
and	CC	cc	O
HMG	NN	compound	B-DNA
I	NN	nummod	I-DNA
(	-LRB-	punct	I-DNA
Y	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
binding	NN	compound	I-DNA
sites	NNS	conj	I-DNA
are	VBP	cop	O
part	NN	ROOT	O
of	IN	case	O
the	DT	det	O
interleukin-4	NN	compound	O
promoter	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
here	RB	advmod	O
that	IN	mark	O
the	DT	det	O
immediate	JJ	amod	B-DNA
upstream	JJ	amod	I-DNA
region	NN	nsubj	I-DNA
(	-LRB-	punct	O
from	IN	case	O
position	NN	dep	O
-12	CD	nummod	O
to	TO	dep	O
-270	CD	nummod	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
murine	JJ	amod	B-DNA
interleukin	NN	compound	I-DNA
4	CD	nummod	I-DNA
(	-LRB-	punct	I-DNA
Il-4	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
harbors	VBZ	ccomp	O
a	DT	det	O
strong	JJ	amod	O
cell-type	NN	amod	O
specific	JJ	amod	O
transcriptional	JJ	amod	B-DNA
enhancer	NN	dobj	I-DNA
.	.	punct	O

In	IN	case	O
T	NN	compound	B-cell_type
lymphoma	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
the	DT	det	O
activity	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
Il-4	NN	compound	B-DNA
promoter/enhancer	NN	nmod	I-DNA
is	VBZ	auxpass	O
stimulated	VBN	ROOT	O
by	IN	case	O
phorbol	NN	compound	O
esters	NNS	nmod	O
,	,	punct	O
Ca++	NN	amod	O
ionophores	NNS	conj	O
and	CC	cc	O
agonists	NNS	conj	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
A	NN	nmod	I-protein
and	CC	cc	O
inhibited	VBN	conj	O
by	IN	case	O
low	JJ	amod	O
doses	NNS	nmod	O
of	IN	case	O
the	DT	det	O
immunosuppressant	JJ	amod	O
cyclosporin	NN	compound	O
A	NN	nmod	O
.	.	punct	O

The	DT	det	O
Il-4	NN	compound	B-DNA
promoter/enhancer	NN	nsubj	I-DNA
is	VBZ	cop	O
transcriptionally	RB	advmod	O
inactive	JJ	ROOT	O
in	IN	case	O
B	NN	compound	B-cell_type
lymphoma	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
HeLa	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

DNase	NN	compound	O
I	CD	nummod	O
footprint	NN	compound	O
protection	NN	compound	O
experiments	NNS	nsubj	O
revealed	VBD	ROOT	O
six	CD	nummod	O
sites	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
Il-4	NN	compound	B-DNA
promoter/enhancer	NN	nmod	I-DNA
to	TO	mark	O
be	VB	auxpass	O
bound	VBN	ccomp	O
by	IN	case	O
nuclear	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
from	IN	case	O
lymphoid	JJ	nmod	B-cell_type
and	CC	cc	I-cell_type
myeloid	JJ	conj	I-cell_type
cells	NNS	dep	I-cell_type
.	.	punct	O

Among	IN	prep	O
them	PRP	pobj	O
are	VBP	ROOT	O
four	CD	nummod	O
purine	NN	compound	O
boxes	NNS	attr	O
which	WDT	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
described	VBN	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
important	JJ	amod	O
sequence	NN	compound	O
motifs	NNS	xcomp	O
of	IN	case	O
the	DT	det	O
Il-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

They	PRP	nsubj	O
contain	VBP	ROOT	O
the	DT	det	O
motif	NN	compound	O
GGAAA	NN	dobj	O
and	CC	cc	O
are	VBP	auxpass	O
recognized	VBN	conj	O
by	IN	case	O
the	DT	dep	O
inducible	JJ	nmod	B-protein
and	CC	cc	I-protein
cyclosporin	NN	nmod:npmod	I-protein
A-sensitive	JJ	conj	I-protein
transcription	NN	compound	I-protein
factor	NN	dep	I-protein
NFAT-1	NN	dep	I-protein
.	.	punct	O

Three	CD	nsubjpass	O
of	IN	case	O
the	DT	det	O
Il-4	NN	compound	B-DNA
NFAT-1	NN	compound	I-DNA
sites	NNS	nmod	I-DNA
are	VBP	auxpass	O
closely	RB	advmod	O
linked	VBN	ROOT	O
to	TO	case	O
weak	JJ	amod	O
binding	VBG	amod	O
sites	NNS	nmod	O
of	IN	case	O
Octamer	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Several	JJ	amod	O
purine	NN	compound	O
boxes	NNS	nsubjpass	O
and	CC	cc	O
an	DT	det	O
AT-rich	JJ	amod	B-DNA
protein-binding	JJ	amod	I-DNA
site	NN	conj	I-DNA
of	IN	case	O
the	DT	det	O
Il-4	NN	compound	O
promoter	NN	nmod	O
are	VBP	auxpass	O
also	RB	advmod	O
recognized	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
high	JJ	amod	B-protein
mobility	NN	compound	I-protein
group	NN	compound	I-protein
protein	NN	nmod	I-protein
HMG	NN	dep	B-protein
I	NN	nummod	I-protein
(	-LRB-	punct	I-protein
Y	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

Whereas	IN	mark	O
the	DT	det	O
binding	NN	nsubj	O
of	IN	case	O
NFAT-1	NN	compound	B-protein
and	CC	cc	O
Octamer	NN	conj	B-protein
factors	NNS	nmod	I-protein
enhance	VBP	advcl	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
the	DT	det	O
Il-4	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
,	,	punct	O
the	DT	det	O
binding	NN	nsubj	O
of	IN	case	O
HMG	NN	nmod	O
I	CD	nummod	O
(	-LRB-	punct	O
Y	NN	appos	O
)	-RRB-	punct	O
suppresses	VBZ	ROOT	O
its	PRP$	nmod:poss	O
activity	NN	dobj	O
and	CC	cc	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
appears	VBZ	parataxis	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
in	IN	case	O
the	DT	det	O
suppression	NN	nmod	O
of	IN	case	O
Il-4	NN	compound	B-protein
transcription	NN	nmod	O
in	IN	case	O
resting	VBG	amod	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

Reversibility	NN	ROOT	O
of	IN	case	O
the	DT	det	O
differentiated	VBN	amod	O
state	NN	nmod	O
in	IN	case	O
somatic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
de	FW	amod	O
novo	FW	dep	O
gene	NN	compound	O
activation	NN	nmod	O
in	IN	case	O
multinucleated	JJ	amod	B-cell_type
heterokaryons	NNS	nmod	I-cell_type
has	VBZ	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
differentiated	VBN	amod	O
state	NN	nsubj	O
,	,	punct	O
although	IN	mark	O
stable	JJ	advcl	O
,	,	punct	O
is	VBZ	cop	O
not	RB	neg	O
irreversible	JJ	ccomp	O
,	,	punct	O
and	CC	cc	O
can	MD	aux	O
be	VB	auxpass	O
reprogrammed	VBN	conj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
appropriate	JJ	amod	O
combinations	NNS	nmod	O
of	IN	case	O
trans-acting	JJ	amod	B-protein
regulatory	JJ	amod	I-protein
molecules	NNS	nmod	I-protein
.	.	punct	O

These	DT	det	O
properties	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
exploited	VBN	ROOT	O
to	TO	prep	O
design	VB	amod	O
strategies	NNS	pobj	O
for	IN	mark	O
identifying	VBG	advcl	O
novel	JJ	amod	O
regulators	NNS	dobj	O
of	IN	case	O
cellular	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

Phosphatidylcholine	NN	compound	O
hydrolysis	NN	nsubj	O
activates	VBZ	ROOT	O
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
and	CC	cc	O
increases	VBZ	conj	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
replication	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_type
monocytes	NNS	nmod	I-cell_type
and	CC	cc	O
T	NN	compound	B-cell_type
lymphocytes	NNS	conj	I-cell_type
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
tested	VBN	ROOT	O
whether	IN	mark	O
breakdown	NN	nsubj	O
of	IN	case	O
phosphatidylcholine	NN	nmod	O
(	-LRB-	punct	O
PC	NN	appos	O
)	-RRB-	punct	O
initiated	VBN	acl	O
by	IN	case	O
exogenous	JJ	amod	O
addition	NN	nmod	O
of	IN	case	O
a	DT	det	O
PC-specific	JJ	amod	B-protein
phospholipase	NN	compound	I-protein
C	NN	nmod	I-protein
(	-LRB-	punct	O
PC-PLC	NN	appos	B-protein
)	-RRB-	punct	O
from	IN	case	O
Bacillus	FW	compound	O
cereus	NN	nmod	O
or	CC	cc	O
by	IN	case	O
endogenous	JJ	amod	O
overexpression	NN	conj	O
of	IN	case	O
PC-PLC	NN	nmod	B-protein
induces	VBZ	ccomp	O
functional	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
and	CC	cc	O
increases	VBZ	conj	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
HIV	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
enhancer	NN	compound	I-DNA
activity	NN	dobj	O
.	.	punct	O

PC-PLC-activated	JJ	amod	O
hydrolysis	NN	nsubjpass	O
of	IN	case	O
PC	NN	nmod	O
was	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
bona	FW	compound	O
fide	FW	compound	O
p50/p65	NN	compound	B-protein
NF-kappa	NN	compound	I-protein
B	NN	compound	I-protein
binding	NN	compound	O
activity	NN	dobj	O
in	IN	case	O
three	CD	nummod	O
different	JJ	amod	O
cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
of	IN	case	O
human	JJ	amod	O
or	CC	cc	O
murine	JJ	conj	O
origin	NN	nmod	O
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
changes	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
turnover	NN	nmod	O
of	IN	case	O
other	JJ	amod	O
cellular	JJ	amod	O
phospholipids	NNS	nmod	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
PC-PLC-treated	JJ	amod	B-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
by	IN	case	O
PC-PLC	NN	nmod	B-protein
did	VBD	aux	O
not	RB	neg	O
depend	VB	ROOT	O
on	IN	case	O
de	FW	amod	O
novo	FW	dep	O
synthesis	NN	nmod	O
of	IN	case	O
proteins	NNS	nmod	O
or	CC	cc	O
autocrine	JJ	amod	O
secretion	NN	conj	O
of	IN	case	O
either	CC	cc:preconj	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	nmod	I-protein
or	CC	cc	O
interleukin	NN	conj	B-protein
1	CD	nummod	I-protein
.	.	punct	O

In	IN	case	O
human	JJ	amod	B-cell_line
monocytic	JJ	amod	I-cell_line
and	CC	cc	I-cell_line
lymphoblastoid	JJ	conj	I-cell_line
T-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
,	,	punct	O
induction	NN	nsubj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
by	IN	case	O
PC-PLC	NN	nmod	B-protein
resulted	VBD	ROOT	O
in	IN	case	O
clear	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
luciferase	NN	compound	B-protein
expression	NN	compound	O
vectors	NNS	nmod	O
placed	VBN	acl	O
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
synthetic	JJ	amod	B-DNA
kappa	NN	compound	I-DNA
B	NN	compound	I-DNA
enhancers	NNS	nmod	I-DNA
or	CC	cc	O
wild	JJ	amod	O
type	NN	conj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
kappa	NN	compound	O
B-mutated	JJ	conj	O
,	,	punct	O
HIV	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	compound	I-DNA
constructs	NNS	conj	I-DNA
.	.	punct	O

HIV	NN	compound	O
replication	NN	nsubjpass	O
was	VBD	auxpass	O
increased	VBN	ROOT	O
by	IN	case	O
PC-PLC	NN	nmod	B-protein
in	IN	case	O
chronically	RB	advmod	O
infected	JJ	amod	O
monocytes	NNS	nmod	B-cell_type
and	CC	cc	O
T	NN	compound	O
lymphocytes	NNS	conj	B-cell_type
.	.	punct	O

NF-kappa	NN	compound	O
B	NN	compound	O
activation	NN	nsubj	O
promoted	VBN	acl	O
by	IN	case	O
addition	NN	nmod	O
of	IN	case	O
exogenous	JJ	amod	B-protein
PC-PLC	NN	nmod	I-protein
correlated	VBD	ROOT	O
with	IN	case	O
an	DT	det	O
intense	JJ	amod	O
production	NN	nmod	O
of	IN	case	O
diacylglycerol	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
addition	NN	nsubj	O
of	IN	case	O
a	DT	det	O
phosphatidylinositol-specific	JJ	amod	B-protein
PLC	NN	nmod	I-protein
from	IN	case	O
B.cereus	NN	nmod	O
also	RB	advmod	O
induced	VBD	ROOT	O
diacylglycerol	NN	dobj	O
but	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
activate	VB	conj	O
kappa	NN	nmod:npmod	B-protein
B	NN	nmod:npmod	I-protein
enhancer-directed	JJ	amod	I-protein
vectors	NNS	dobj	I-protein
.	.	punct	O

PC-PLC-induced	JJ	amod	O
NF-kappa	NN	compound	O
B	NN	compound	O
activation	NN	nsubjpass	O
could	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
specific	JJ	amod	O
inhibitor	NN	nmod	O
of	IN	case	O
phorbol	NN	compound	B-protein
ester-inducible	JJ	amod	I-protein
protein	NN	compound	I-protein
kinases	NNS	compound	I-protein
C	NN	nmod	I-protein
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
cellular	JJ	amod	O
transduction	NN	compound	O
pathway	NN	nsubj	O
,	,	punct	O
dependent	JJ	amod	O
on	IN	case	O
specific	JJ	amod	O
PC	NN	compound	O
breakdown	NN	nmod	O
,	,	punct	O
is	VBZ	cop	O
functional	JJ	ccomp	O
in	IN	case	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
and	CC	cc	O
monocytes	NNS	conj	B-cell_type
and	CC	cc	O
may	MD	aux	O
be	VB	auxpass	O
used	VBN	conj	O
by	IN	case	O
various	JJ	amod	O
transmembrane	NN	compound	O
receptors	NNS	nmod	O
to	TO	mark	O
activate	VB	xcomp	O
HIV	NN	compound	O
transcription	NN	dobj	O
through	IN	case	O
NF-kappa	NN	nmod:npmod	O
B-dependent	JJ	amod	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
HIV	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

Novel	JJ	amod	O
mechanism	NN	ROOT	O
for	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
by	IN	case	O
glucocorticoids	NNS	nmod	O
.	.	punct	O

Glucocorticoids	NNS	nsubj	O
inhibit	VBP	ROOT	O
signal	NN	compound	O
transduction	NN	dobj	O
through	IN	case	O
IL-2	NN	compound	B-protein
receptor	NN	nmod	I-protein
.	.	punct	O

Interaction	NN	nsubj	O
of	IN	case	O
IL-2	NN	nmod	B-protein
with	IN	case	O
its	PRP$	nmod:poss	O
high	JJ	amod	B-protein
affinity	NN	compound	I-protein
membrane	NN	compound	I-protein
receptor	NN	compound	I-protein
complex	NN	nmod	I-protein
(	-LRB-	punct	O
IL-2R	NN	appos	B-protein
)	-RRB-	punct	O
present	JJ	amod	O
on	IN	case	O
activated	VBN	amod	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
induces	VBZ	ROOT	O
cell	NN	compound	O
proliferation	NN	dobj	O
and	CC	cc	O
mediates	VBZ	conj	O
effector	NN	compound	O
functions	NNS	dobj	O
.	.	punct	O

Glucocorticoids	NNS	nsubj	O
inhibit	VBP	ROOT	O
IL-2	NN	compound	B-protein
production	NN	dobj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
TCR-mediated	JJ	amod	O
signal	NN	compound	O
transduction	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
asked	VBD	ROOT	O
whether	IN	mark	O
they	PRP	nsubj	O
also	RB	advmod	O
inhibit	VBP	ccomp	O
the	DT	det	O
action	NN	dobj	O
of	IN	case	O
IL-2	NN	nmod	B-protein
by	IN	mark	O
inhibiting	VBG	advcl	O
signal	NN	compound	O
transduction	NN	dobj	O
through	IN	case	O
IL-2R	NN	nmod	B-protein
.	.	punct	O

Human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nsubjpass	I-cell_type
,	,	punct	O
stimulated	VBN	acl	O
with	IN	case	O
PMA	NN	nmod	O
for	IN	case	O
48	CD	nummod	O
h	NN	nmod	O
(	-LRB-	punct	O
PMA	NN	compound	B-cell_line
blasts	NNS	appos	I-cell_line
)	-RRB-	punct	O
,	,	punct	O
were	VBD	auxpass	O
incubated	VBN	ROOT	O
with	IN	case	O
IL-2	NN	nmod	B-protein
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
incremental	JJ	amod	O
dosages	NNS	nmod	O
of	IN	case	O
dexamethasone	NN	nmod	O
(	-LRB-	punct	O
Dex	NN	dep	O
;	:	punct	O
10	CD	nummod	O
(	-LRB-	punct	O
-5	CD	dep	O
)	-RRB-	punct	O
-10	CD	nummod	O
(	-LRB-	punct	O
-9	CD	nummod	O
)	-RRB-	punct	O
M	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Dex	NN	nsubj	O
inhibited	VBD	ROOT	O
the	DT	det	O
IL-2-dependent	JJ	amod	O
proliferation	NN	dobj	O
of	IN	case	O
PMA	NN	compound	B-cell_line
blasts	NNS	nmod	I-cell_line
in	IN	case	O
a	DT	det	O
dose-dependent	JJ	amod	O
fashion	NN	nmod	O
(	-LRB-	punct	O
IC50	NN	dep	O
,	,	punct	O
5	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
-8	CD	dep	O
)	-RRB-	punct	O
M	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Cell	NN	compound	O
surface	NN	compound	O
expression	NN	nsubjpass	O
of	IN	case	O
IL-2R	NN	compound	B-protein
alpha-	NN	nmod	I-protein
and	CC	cc	I-protein
beta-chains	VBZ	conj	I-protein
as	IN	mark	O
determined	VBN	dep	O
by	IN	case	O
immunofluorescence	NN	compound	O
analysis	NN	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
affected	VBN	ROOT	O
by	IN	case	O
Dex	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
Scatchard	NN	compound	O
plot	NN	compound	O
analysis	NN	nsubj	O
of	IN	case	O
125I-labeled	JJ	amod	B-protein
IL-2	NN	nmod	I-protein
showed	VBD	ROOT	O
that	IN	mark	O
Dex	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ccomp	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
IL-2	NN	nmod	B-protein
,	,	punct	O
thus	RB	advmod	O
suggesting	VBG	advcl	O
that	IN	mark	O
inhibition	NN	nsubj	O
is	VBZ	cop	O
due	JJ	ccomp	O
to	TO	case	O
a	DT	det	O
postreceptor	NN	compound	O
effect	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubjpass	O
of	IN	case	O
T	NN	compound	O
cell	NN	compound	O
proliferation	NN	nmod	O
by	IN	case	O
Dex	NN	nmod	O
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
decreased	VBN	amod	O
IL-2-dependent	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
intracellular	JJ	amod	B-protein
proteins	NNS	nmod	I-protein
and	CC	cc	O
decreased	VBD	conj	O
phosphorylation	NN	dobj	O
of	IN	case	O
the	DT	det	O
retinoblastoma	NN	compound	B-protein
gene	NN	compound	I-protein
product	NN	compound	I-protein
Rb	NN	nmod	I-protein
,	,	punct	O
a	DT	det	O
protein	NN	appos	O
essential	JJ	amod	O
for	IN	mark	O
controlling	VBG	advcl	O
the	DT	det	O
progression	NN	dobj	O
of	IN	case	O
cells	NNS	nmod	O
through	IN	case	O
the	DT	det	O
cell	NN	compound	O
cycle	NN	nmod	O
.	.	punct	O

IL-2-dependent	JJ	amod	O
IL-2R	NN	compound	O
alpha	NN	compound	O
expression	NN	nsubjpass	O
in	IN	case	O
PMA	NN	compound	B-cell_line
blasts	NNS	nmod	I-cell_line
and	CC	cc	O
NF-kB	NN	compound	B-protein
induction	NN	conj	O
in	IN	case	O
resting	VBG	amod	B-cell_type
human	JJ	amod	I-cell_type
T	NN	compound	I-cell_type
cells	NNS	nmod	I-cell_type
were	VBD	auxpass	O
also	RB	advmod	O
inhibited	VBN	ROOT	O
by	IN	case	O
Dex	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
glucocorticoids	NNS	nsubj	O
inhibit	VBP	ccomp	O
preactivated	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	dobj	I-cell_line
by	IN	case	O
down-regulating	JJ	amod	O
signal	NN	compound	O
transduction	NN	nmod	O
through	IN	case	O
IL-2R	NN	nmod	B-protein
.	.	punct	O

Chronic	JJ	amod	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
infection	NN	nsubj	O
stimulates	VBZ	ROOT	O
distinct	JJ	amod	O
NF-kappa	NN	compound	O
B/rel	NN	compound	O
DNA	NN	compound	O
binding	NN	compound	O
activities	NNS	dobj	O
in	IN	case	O
myelomonoblastic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
relationship	NN	nsubjpass	O
between	IN	case	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	compound	O
type	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
HIV-1	NN	appos	O
)	-RRB-	punct	O
infection	NN	nmod	O
and	CC	cc	O
the	DT	det	O
induction	NN	conj	O
of	IN	case	O
NF-kappa	NN	compound	O
B	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
myeloid	JJ	amod	B-cell_line
cell	NN	compound	I-cell_line
model	NN	nmod	I-cell_line
of	IN	case	O
HIV-1	NN	compound	O
infection	NN	nmod	O
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
PLB-985	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

Chronic	JJ	amod	O
infection	NN	nsubj	O
of	IN	case	O
PLB-985	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
led	VBD	ROOT	O
to	TO	case	O
increased	VBN	amod	O
monocyte-specific	JJ	amod	O
surface	NN	compound	O
marker	NN	compound	O
expression	NN	nmod	O
,	,	punct	O
increased	VBD	amod	O
c-fms	NN	compound	O
gene	NN	compound	O
transcription	NN	conj	O
,	,	punct	O
and	CC	cc	O
morphological	JJ	amod	O
alterations	NNS	conj	O
consistent	JJ	amod	O
with	IN	case	O
differentiation	NN	nmod	O
along	IN	case	O
the	DT	det	O
monocytic	JJ	amod	O
pathway	NN	nmod	O
.	.	punct	O

PLB-IIIB	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
displayed	VBD	ROOT	O
a	DT	det	O
constitutive	JJ	amod	O
NF-kappa	NN	nmod:npmod	O
B-like	JJ	amod	O
binding	NN	compound	O
activity	NN	dobj	O
that	WDT	nsubj	O
was	VBD	cop	O
distinct	JJ	acl:relcl	O
from	IN	case	O
that	DT	nmod	O
induced	VBN	acl	O
by	IN	case	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor	NN	compound	I-protein
alpha	NN	nmod	I-protein
or	CC	cc	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	compound	O
treatment	NN	conj	O
of	IN	case	O
the	DT	det	O
parental	JJ	amod	B-cell_line
PLB-985	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

This	DT	det	O
unique	JJ	amod	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nsubj	O
consisted	VBD	ROOT	O
of	IN	case	O
proteins	NNS	nmod	O
of	IN	case	O
70	CD	nummod	B-protein
,	,	punct	I-protein
90	CD	nummod	I-protein
,	,	punct	I-protein
and	CC	cc	I-protein
100	CD	nummod	I-protein
kDa	NN	nmod	I-protein
with	IN	case	O
a	DT	det	O
high	JJ	amod	O
degree	NN	nmod	O
of	IN	case	O
binding	NN	compound	O
specificity	NN	nmod	O
for	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
site	NN	nmod	I-protein
within	IN	case	O
the	DT	det	O
PRDII	NN	compound	B-protein
domain	NN	nmod	I-protein
of	IN	case	O
beta	NN	compound	B-protein
interferon	NN	nmod	I-protein
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
characterize	VBP	ROOT	O
the	DT	det	O
nature	NN	dobj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
and	CC	cc	O
demonstrate	VBP	conj	O
that	IN	mark	O
binding	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
is	VBZ	auxpass	O
also	RB	advmod	O
induced	VBN	ccomp	O
following	VBG	case	O
Sendai	NN	compound	O
paramyxovirus	NN	compound	O
infection	NN	nmod	O
.	.	punct	O

The	DT	det	O
70-kDa	JJ	amod	B-protein
protein	NN	nsubj	I-protein
corresponds	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
RelA	NN	compound	I-protein
(	-LRB-	punct	I-protein
p65	NN	compound	I-protein
)	-RRB-	punct	I-protein
subunit	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	acl:relcl	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
an	DT	det	O
acute	JJ	amod	O
paramyxovirus	NN	compound	O
infection	NN	nmod	O
or	CC	cc	O
a	DT	det	O
chronic	JJ	amod	O
HIV-1	NN	compound	O
infection	NN	conj	O
.	.	punct	O

Virus	NN	compound	O
infection	NN	nsubj	O
does	VBZ	aux	O
not	RB	neg	O
appear	VB	ROOT	O
to	TO	mark	O
alter	VB	xcomp	O
the	DT	det	O
amount	NN	dobj	O
of	IN	case	O
RelA	NN	nmod	B-protein
(	-LRB-	punct	O
p65	NN	appos	B-protein
)	-RRB-	punct	O
or	CC	cc	O
NFKB1	NN	conj	B-protein
(	-LRB-	punct	O
p50	NN	appos	B-protein
)	-RRB-	punct	O
but	CC	cc	O
rather	RB	advmod	O
affects	VBZ	conj	O
the	DT	det	O
capacity	NN	dobj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
to	TO	case	O
sequester	VB	compound	O
RelA	NN	nmod	B-protein
(	-LRB-	punct	I-protein
p65	NN	appos	I-protein
)	-RRB-	punct	I-protein
,	,	punct	O
therefore	RB	advmod	O
leading	VBG	advcl	O
to	TO	case	O
constitutive	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
RelA	NN	compound	O
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nmod	O
and	CC	cc	O
to	TO	case	O
increased	VBN	amod	O
levels	NNS	conj	O
of	IN	case	O
NF-kappa	NN	nmod:npmod	O
B-dependent	JJ	amod	O
gene	NN	compound	O
activity	NN	nmod	O
.	.	punct	O

The	DT	det	O
virally	RB	advmod	O
induced	VBN	amod	O
90-	CD	compound	B-protein
to	TO	dep	I-protein
100-kDa	JJ	amod	I-protein
proteins	NNS	nsubj	I-protein
have	VBP	ROOT	O
a	DT	det	O
distinct	JJ	amod	O
binding	NN	compound	O
specificity	NN	dobj	O
for	IN	case	O
the	DT	det	O
PRDII	NN	compound	B-DNA
domain	NN	nmod	I-DNA
and	CC	cc	O
an	DT	det	O
AT-rich	JJ	amod	B-DNA
sequence	NN	conj	I-DNA
but	CC	cc	O
do	VBP	aux	O
not	RB	neg	O
cross-react	VB	conj	O
with	IN	case	O
NF-kappa	NN	nmod:npmod	O
B	NN	nmod:npmod	O
subunit-specific	JJ	amod	O
antisera	NNS	nmod	O
directed	VBN	acl	O
against	IN	case	O
NFKB1	NN	nmod	B-protein
(	-LRB-	punct	O
p105	NN	dep	B-protein
or	CC	cc	O
p50	NN	conj	B-protein
)	-RRB-	punct	O
,	,	punct	O
NFKB2	NN	conj	B-protein
(	-LRB-	punct	O
p100	NN	dep	B-protein
or	CC	cc	O
p52	NN	conj	B-protein
)	-RRB-	punct	O
,	,	punct	O
RelA	NN	appos	B-protein
(	-LRB-	punct	O
p65	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
or	CC	cc	O
c-rel	NN	conj	B-protein
.	.	punct	O

DNA	NN	compound	O
binding	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
90-	CD	compound	B-protein
to	TO	dep	I-protein
100-kDa	JJ	amod	I-protein
proteins	NNS	nmod	I-protein
was	VBD	auxpass	O
not	RB	neg	O
inhibited	VBN	ROOT	O
by	IN	case	O
recombinant	JJ	amod	B-protein
I	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha/MAD-3	NN	nmod	I-protein
and	CC	cc	O
was	VBD	cop	O
resistant	JJ	conj	O
to	TO	case	O
tryptic	JJ	amod	O
digestion	NN	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
these	DT	det	O
proteins	NNS	nsubj	O
may	MD	aux	O
not	RB	neg	O
be	VB	cop	O
NF-kappa	NN	compound	B-protein
B	NN	nmod:npmod	I-protein
related	JJ	ccomp	I-protein
.	.	punct	O

Transient	JJ	amod	O
cotransfection	NN	compound	O
experiments	NNS	nsubj	O
demonstrated	VBD	ROOT	O
that	IN	mark	O
RelA	NN	compound	O
and	CC	cc	O
NFKB1	NN	conj	O
expression	NN	nsubj	O
maximally	RB	advmod	O
stimulated	VBD	ccomp	O
HIV-1	NN	compound	B-DNA
LTR-	NN	amod	I-DNA
and	CC	cc	I-DNA
NF-kappa	NN	nmod:npmod	I-DNA
B-dependent	JJ	conj	I-DNA
reporter	NN	compound	I-DNA
genes	NNS	dobj	I-DNA
;	:	punct	O
differences	NNS	nsubjpass	O
in	IN	case	O
NF-kappa	NN	compound	O
B-like	JJ	amod	O
binding	NN	compound	O
activity	NN	nmod	O
were	VBD	auxpass	O
also	RB	advmod	O
reflected	VBN	parataxis	O
in	IN	case	O
higher	JJR	amod	O
constitutive	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
NF-kappa	NN	nmod:npmod	O
B-regulated	JJ	amod	O
gene	NN	compound	O
expression	NN	nmod	O
in	IN	case	O
HIV-1-infected	JJ	amod	B-cell_line
myeloid	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

Presence	NN	ROOT	O
of	IN	case	O
estrogen-binding	JJ	amod	O
sites	NNS	nmod	O
on	IN	case	O
macrophage-like	JJ	amod	B-cell_type
synoviocytes	NNS	nmod	I-cell_type
and	CC	cc	O
CD8+	JJ	conj	B-cell_line
,	,	punct	I-cell_line
CD29+	JJ	conj	I-cell_line
,	,	punct	I-cell_line
CD45RO+	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
lymphocytes	NNS	conj	I-cell_line
in	IN	case	O
normal	JJ	amod	O
and	CC	cc	O
rheumatoid	JJ	conj	O
synovium	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
.	.	punct	O

To	TO	mark	O
study	VB	ROOT	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
estrogen-binding	JJ	amod	O
sites	NNS	nmod	O
(	-LRB-	punct	O
EBS	NNS	appos	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
synovial	JJ	amod	O
tissues	NNS	nmod	O
of	IN	case	O
male	JJ	amod	O
and	CC	cc	O
female	JJ	conj	O
patients	NNS	nmod	O
with	IN	case	O
rheumatoid	JJ	amod	O
arthritis	NN	nmod	O
(	-LRB-	punct	O
RA	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
in	IN	case	O
age-	NN	amod	O
and	CC	cc	O
sex-matched	JJ	conj	O
healthy	JJ	amod	O
controls	NNS	conj	O
.	.	punct	O

METHODS	NNS	ROOT	O
.	.	punct	O

Both	CC	cc:preconj	O
type	NN	compound	O
1	CD	nummod	O
(	-LRB-	punct	O
high	JJ	amod	O
affinity	NN	dep	O
,	,	punct	O
low	JJ	amod	O
binding	NN	compound	O
capacity	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
type	NN	conj	O
2	CD	nummod	O
(	-LRB-	punct	O
reduced	VBN	amod	O
affinity	NN	dep	O
,	,	punct	O
higher	JJR	amod	O
binding	NN	compound	O
capacity	NN	appos	O
)	-RRB-	punct	O
EBS	NNS	nsubjpass	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
soluble	JJ	amod	O
and	CC	cc	O
nuclear	JJ	conj	O
fractions	NNS	nmod	O
of	IN	case	O
homogenized	VBN	amod	O
synovial	JJ	amod	O
tissue	NN	compound	O
samples	NNS	nmod	O
by	IN	case	O
a	DT	det	O
dextran-coated	JJ	amod	O
charcoal	NN	compound	O
method	NN	nmod	O
.	.	punct	O

To	TO	mark	O
determine	VB	ROOT	O
what	WP	mark	O
type	NN	nsubj	O
of	IN	case	O
synovial	JJ	amod	B-cell_type
cell	NN	nmod	I-cell_type
was	VBD	cop	O
positive	JJ	ccomp	O
for	IN	case	O
EBS	NN	nmod	O
,	,	punct	O
cryosections	NNS	nsubjpass	O
of	IN	case	O
synovial	JJ	amod	O
tissues	NNS	nmod	O
were	VBD	auxpass	O
immunostained	VBN	parataxis	O
with	IN	case	O
a	DT	det	O
specific	JJ	amod	O
monoclonal	JJ	amod	B-protein
anti-estrogen	NN	compound	I-protein
receptor	NN	compound	I-protein
antibody	NN	nmod	I-protein
(	-LRB-	punct	O
anti-ER	JJ	amod	B-protein
MAb	NN	appos	I-protein
)	-RRB-	punct	O
using	VBG	acl	O
both	CC	cc:preconj	O
immunofluorescence	NN	dobj	O
and	CC	cc	O
immunoperoxidase	NN	conj	O
techniques	NNS	dep	O
.	.	punct	O

Double	JJ	amod	O
immunostaining	NN	nsubjpass	O
with	IN	case	O
the	DT	det	O
anti-ER	JJ	amod	B-protein
MAb	NN	nmod	I-protein
and	CC	cc	O
with	IN	case	O
specific	JJ	amod	B-protein
MAb	NN	conj	I-protein
to	TO	mark	O
detect	VB	acl	O
different	JJ	amod	O
macrophage	NN	compound	B-protein
antigens	NNS	dobj	I-protein
(	-LRB-	punct	O
Ber-MAC3	NN	dep	B-protein
,	,	punct	O
MAC387	NN	conj	B-protein
,	,	punct	O
CD68	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
CD8+	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
subsets	NNS	conj	I-cell_line
(	-LRB-	punct	O
CD29+	JJ	dep	B-cell_line
,	,	punct	O
CD45RO+	JJ	conj	B-cell_line
and	CC	cc	O
CD29-	NN	conj	B-cell_line
,	,	punct	O
CD45RO-	NN	appos	B-cell_line
)	-RRB-	punct	O
was	VBD	auxpass	O
performed	VBN	ROOT	O
.	.	punct	O

RESULTS	NNS	ROOT	O
.	.	punct	O

Higher	JJR	amod	O
affinity	NN	compound	O
EBS	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
mostly	RB	advmod	O
in	IN	case	O
nuclear	JJ	amod	O
cell	NN	compound	O
fractions	NNS	nmod	O
of	IN	case	O
either	CC	cc:preconj	O
RA	NN	nmod	O
or	CC	cc	O
control	JJ	amod	O
synovial	JJ	amod	O
tissues	NNS	conj	O
(	-LRB-	punct	O
28	CD	dep	O
of	IN	case	O
the	DT	det	O
33	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

These	DT	det	O
EBS	NNS	nsubj	O
were	VBD	cop	O
present	JJ	ROOT	O
to	TO	case	O
a	DT	det	O
lesser	JJR	amod	O
extent	NN	nmod	O
in	IN	case	O
soluble	JJ	amod	O
cell	NN	compound	O
fractions	NNS	nmod	O
(	-LRB-	punct	O
11	CD	dep	O
of	IN	case	O
the	DT	det	O
33	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Immunostaining	NN	nsubj	O
showed	VBD	ROOT	O
the	DT	det	O
estrogen	NN	compound	B-cell_type
receptor-positive	JJ	amod	I-cell_type
cells	NNS	dobj	I-cell_type
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
macrophage-like	JJ	amod	B-cell_type
synoviocytes	NNS	xcomp	I-cell_type
and	CC	cc	O
the	DT	det	O
CD8+	JJ	conj	B-cell_line
,	,	punct	O
CD29+	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	conj	I-cell_line
both	CC	cc:preconj	O
in	IN	case	O
RA	NN	nmod	O
and	CC	cc	O
in	IN	case	O
control	JJ	amod	O
synovial	JJ	amod	O
tissues	NNS	conj	O
.	.	punct	O

Higher	JJR	amod	O
nuclear	JJ	amod	O
content	NN	nsubj	O
of	IN	case	O
EBS	NN	nmod	O
was	VBD	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
more	RBR	advmod	O
intense	JJ	amod	O
nuclear	JJ	amod	O
staining	NN	nmod	O
of	IN	case	O
synoviocytes	NNS	nmod	B-cell_type
and	CC	cc	O
T	NN	compound	B-cell_type
cells	NNS	conj	I-cell_type
.	.	punct	O

CONCLUSION	NN	ROOT	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
conceivable	JJ	ROOT	O
that	IN	mark	O
the	DT	det	O
immunomodulatory	JJ	amod	O
activity	NN	nsubjpass	O
exerted	VBN	acl	O
by	IN	case	O
estrogens	NNS	nmod	O
is	VBZ	auxpass	O
at	IN	advmod	O
least	JJS	mwe	O
partly	RB	advmod	O
mediated	VBN	ccomp	O
through	IN	case	O
their	PRP$	nmod:poss	O
interaction	NN	nmod	O
with	IN	case	O
EBS	NN	nmod	O
that	WDT	nsubj	O
are	VBP	cop	O
present	JJ	acl:relcl	O
on	IN	case	O
macrophage-like	JJ	amod	B-cell_type
synoviocytes	NNS	nmod	I-cell_type
,	,	punct	O
functioning	VBG	advcl	O
as	IN	case	O
antigen-processing	JJ	amod	B-cell_type
and	CC	cc	I-cell_type
antigen-presenting	JJ	conj	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
on	IN	case	O
antigen-experienced	JJ	amod	B-cell_line
(	-LRB-	punct	I-cell_line
memory	NN	dep	I-cell_line
)	-RRB-	punct	I-cell_line
CD8+	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
lymphocytes	NNS	conj	I-cell_line
(	-LRB-	punct	O
CD29+	JJ	dep	B-cell_line
,	,	punct	O
CD45RO+	JJ	dep	B-cell_line

